text,label
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.743;	OD280: 0.932;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 65;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"patient: 227;	current medication: Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD;	birth date: 4/17/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/90;	diagnosis date: 1/1/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/72;	smoking amount: 5-14;	other illnesses: Prostate cancer 1985, Previous DVT's on warfarin;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed",pert
Male Sprague-Dawley (Crl:CD(SD)IGS Br;	Age: between 5 and 6 weeks old,pert
"seminoma specimen, pT1, patient age: 40y; W00 047",pert
Bone marrow-derived macrophages from mice deficient in signaling adaptor molecule MyD88,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50).,pert
"2102Ep cells SOX2 siRNA, biological replicate 1",pert
1705-383_24hr,pert
healthy CD4 T cells 9,ctrl
"Polyamide 1 treated LNCaP cells not stimulated with DHT, biological replicate 1",ctrl
Lacrimal Gland,pert
E81-/-SRFVP16-2,pert
Control_AF_4,ctrl
phenotype: alcoholic;	gender: male;	case_id: 256;	age: 37;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 17;	brain ph at time of freezing: 6.33;	labeling_batch: 2,pert
Bone-Marrow_MGUS_G1702,pert
A2CKO1,pert
"fibroblast, control subject NM5 rep 1",ctrl
tissue: Biceps muscle;	patient: C.b.5;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Shn2_Mutant_1,pert
A2CKO2,pert
"fibroblast, control subject NM10 rep 2",ctrl
"fibroblast, MFS subject FB969 rep 5",pert
liver_Wt_female_35wk_rep1,ctrl
"normal skeletal muscle, biological rep5",ctrl
E14 molar DMSO 1,ctrl
4 h,pert
Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
Wild type saline rep2,ctrl
Zfx-flox TC1 ESC;	Cultured in 15% KO + LIF without feeders,ctrl
EGF 12h replicate 1,pert
A375 cells 24h Vemurafenib rep1,pert
normal 1112,ctrl
LOX1 Untreated 2hr 282295553,pert
duration of untreated disease in month:8.5;	age at onset:4.5,pert
01-0044A_Day1_3,pert
Sample 1 Posterior  -/-,pert
control participant P327,ctrl
"human failing LV myocardium, Ischemic47",pert
gonadal WAT of five Fsp27 knockout mice,pert
Dilated cardiomyopathy_G54,pert
"brain, hippocampus: Ctr-24h-P15-II_e1_le1",ctrl
Patient: A;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
gender: F;	age at blood draw: 55;	tissue: whole blood,pert
"205, MUSCLE, Before",ctrl
Large cell carcinoma 015,pert
"affected status (disease state): control;	gender: male;	age-at-examination: 69;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever smoker, ever drinker",ctrl
BMM_BalbC_time0h,ctrl
KU_01T,pert
Kidney_Aqp11+/+_P7_4-2,ctrl
shRNA2-4-noDox-rep1,pert
"fibroblast, control subject NF6 rep 4",ctrl
age: 6 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),ctrl
Gallbladder- leptin treated,ctrl
cDNA ak 04,pert
lymphoma_5783_ADR,pert
med2d_1,pert
human preadipocytes+oligo1_day6_rep2,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 3,pert
retina_DBA_543L_8mo_rep1,pert
chip number: 12;	transfection plate: 3B;	target gene: YY1;	kd level: 0.66;	rin: 9.6;	transfection date: 2012-03-26,pert
NOMO-1 acute myeloid leukemia cells,pert
T146 U133p2,pert
"Ishikawa cell line, BPA, 10nM, 8hr",pert
PKBa-/- MEF time 2 replicate 1,pert
"Hippocampus, soman, 72h",pert
cell type: Peripheral blood leukocytes;	strain: DBA/2,ctrl
Normal mucosa 20,ctrl
"Acute Myeloid Leukemia, sample 62",pert
"Frontal Cerebrocortex, permethrin (10mg/kg), 6 hours",pert
striatum SNCA knockout 6 month replicate 3,ctrl
IM46_control,ctrl
D_Ctrl_1,ctrl
mef2a_2,pert
"Sodium arsenite added to food: None; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: 100 ppb, 5wk",pert
HeLa SCY1-like 1 knock down 1,pert
14-week-old WT liver_464WT,ctrl
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 5",pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 23.9589,ctrl
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep3,pert
umbilical cord_bpd: 5B,pert
Individual_4368_PP_sample,pert
NPC18,pert
"C57BL/10 TA, replicate 1",ctrl
Tendon_lesional_rep12,pert
Run1.a10a.000608jd.2.SkMNor924.CEL-IS stimulate,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 26;	gender: male,ctrl
A375P cells expressing PGC1a shRNA 66,pert
"Wild type used for MAT1A 8 month, replicate 4",ctrl
"Gender: female, Age: 37 years, Tissue: normal vulva,",ctrl
suppressed induction of AICD,ctrl
MO32_12,ctrl
RNA from whole tissue section of case 662 labeled with Cy5,pert
"Autoimmune pancreatic islets before cyclophosphamide treatment, rep 4",ctrl
Pool 3 Acute stage,ctrl
HF0670_U133P2,pert
LT 434 +/T after nicotine-induced seizures,pert
DMN-NF1Hippo20d-1bAv2-s2,pert
BS2011051057,pert
Human.AZ.CTRL.ECRB,ctrl
293TsiLL-1,pert
"Brain tissue from Fisher 344 male rat, Animal #265, 20mg/kg D-Serine",pert
P2C Progranulin-hippocampus,pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with lupus arthritis",pert
age: 54;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
chip number: 11;	transfection plate: 4;	target gene: IRF7;	kd level: 0.7;	rin: 9.4;	transfection date: 2011-10-17,pert
"ID: MLL_00266;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"amnion mesenchymal cells, 1h interleukin-1-beta, biological rep3",pert
"Patient  J, lesion, 12 week",pert
disease state: healthy control;	tissue: epidermis;	age: 46;	gender: female;	treatment: untreated;	time: control,ctrl
A2780-(2),ctrl
"cochlea at P7, wt, biological rep 3",ctrl
Ad infected murine liver-MO30k-(667)-6 hpi,pert
"breast tumor epithelium,19",pert
cell line: rtTA-Dmrt5;	differentiation: 7 days;	treatment: +Dox,pert
Normal Cervix N10,ctrl
cell type: B-cell;	cell line: Pfeiffer DLBCL,ctrl
microdissected breast cancer cells from case 651,pert
ve_M63B,pert
Wild type_liver _1,ctrl
V5-P385,pert
age: 12 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
reduction mammoplasty patient 309,ctrl
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,pert
Liver GPR120KO ND #718,pert
Normal-N_LJ_6,ctrl
"ShamC-21, biological rep 3",ctrl
Sle1a R4,pert
control-noDox-rep2,ctrl
Cell culture. A549 treated by MK886 1,pert
chip number: 22;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.63;	rin: 9.4;	transfection date: 2012-03-26,pert
JIA PBMC Pre treatment A235_L112,ctrl
Gender:F;	Age:47;	Tissue: Mucosa,pert
wild-type control 3,ctrl
3275-1 E2F WT,pert
HP-22,pert
SZ7,pert
Patient 4 a,pert
colon_adenoma_995,pert
"control, subject 8",ctrl
V5-P481,pert
blood_day0_patient1,pert
PCOS Endometrium Mesenchymal Cell_120.PC11++,pert
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",pert
"Uninfected treated with 1,25D, replicate 1",pert
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 4h",ctrl
"Pool of two samples (n=2);;	cells: CD3+ T cells, bone marrow;;	healthy volunteers; gender: one male, one female; age: 58 and 42 years old",ctrl
3880-2 E2F WT,ctrl
RORasg/sg WAT_HFD_rep5,pert
shNANOG_2,pert
HF0471_U133P2,pert
cell type: Primary hepatocytes;	donor: 1;	agent: control;	time: 6h;	gender: Male;	age: 63 years old,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N3, M0, G4",pert
BCell_lymphoma_marginal_sample3,pert
KM-final,pert
Mouse soleus,ctrl
PBMC from T cell LGL leukemia patient #123 (TLGL123),pert
Gene expression profiles of Lkb1 KO #7 HSCs,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 207;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
16C-ER-D,ctrl
S4C Sporadic-hippocampus,ctrl
CA2 NoCre Sox17E,ctrl
Bladder cancer cells,ctrl
PBMC_S6,pert
U937_luc_Replicate3,ctrl
"gender: Male;	age: 63;	post-mortem delay: 30h;	ph: 6.5;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"121, MUSCLE, Before",ctrl
tisue: cleared mammary fat pad;	genotype: Rarb -/-;	age: four weeks,pert
MacularDegen-injured-1cAv2-s2,pert
GIST882 Cell line,ctrl
COV434 Control [RR1016],ctrl
IDTC 2,pert
"CRT knockout mouse embryonic stem cell, biological rep5",pert
"LCL GM19238, Kd E2F6, 72hrs",pert
"tissue: kidney;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: control 72 hr",ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 67",pert
"fibroblast, MFS subject FB1234 rep 3",pert
"Autoimmune pancreatic islets before cyclophosphamide treatment, rep3",ctrl
Normoxic Adeno treated Control N1,ctrl
MCL_IGHV_MUT (02_201),pert
C4med,ctrl
Untreated Melan-Ink4a #2,ctrl
"heart, 30 months of age, resveratrol diet",pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID205,pert
Dysf +/+ QF control mouse muscle,ctrl
fresh tissue: splenocytes;	strain: DBA/2,ctrl
CuFi cell line treated at DMNQ biological rep2,pert
V5-P131,pert
MPM tumor specimen 42,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 2,pert
ancestral background: European-American (EA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD20-APC;	cell type: CD20 positive B cells,ctrl
"Control 2, biological rep2",ctrl
RV83.10_CHF_day10_Slide60,pert
A2CNT1,ctrl
"Muscle from WT, biological rep4",ctrl
IMR-32_pCMV-DPP3_48hr_rep 2,pert
"TCF-1 KO CD8 memory T cells, biological rep1",pert
Cervical cancer_CaCx54,pert
Monocyte human familial combined hyperlipidemia after treatment with atorvastatin (ATV) sample,pert
lymphocytes_HD_F_56y,pert
"GI_canc, Col1",pert
C2C12 MYOTUBES,ctrl
Parkinson's disease sample x176,pert
Ishikawa_LowDose_BPA_48h_rep4,pert
KN-sham-5 month-R1,pert
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 2, clone 1",pert
"Creatine-treated, biological rep3",pert
"Amniocytes, trisomy 21, 1573",pert
T117,pert
2d-sham-72,ctrl
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 3,ctrl
whole tissue section from case 633,pert
S6,pert
1124-02-A,pert
Mus musculus brain hemisphere,ctrl
disease: psoriasis;	skin: lesional,pert
INSENS 1 4hr,pert
Neurons overexpressing GFP,ctrl
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: Gadd45a-/-;	cell type: mouse embryonic fibroblasts (MEF cells),pert
"human failing LV myocardium, Idiopathic48",pert
Mock-treated MDA-MB-231,ctrl
9: NORMAL #00-0504,ctrl
cell type: monocyte;	disease state: control participant,ctrl
"siSCR ES, biological rep1",ctrl
CBA1,ctrl
shSOX2_1,pert
patient: 41027;	sample: tumor,pert
"ARD842, CAIS, F, GOF, 6 x 100nM DHT, 14d",pert
a_NY7,pert
"EGFP KD, replicate B",ctrl
"Wild type used for GNMT 3 month, replicate 1",ctrl
Moderate rep4 (retina),pert
WT_TER119-_rep3,ctrl
"Right brain hemisphere ,C57BL male mouse,Clozapine treated,Orally,4 weeks",pert
Ishikawa_VeryLowDose_BPA_8h_rep4,pert
Cal27_PBS1,ctrl
Untreated Control 12weeks AffyGC RMA rep3,ctrl
HepG2 cells control 2h,ctrl
subject: 40;	disease: CP;	muscle: ST;	gender: M;	age: 10.1;	gmfcs: 2;	popliteal angle: 120,pert
"granulocyte, patient. Mtx rep7",pert
Y HID_B039,ctrl
JIA PBMC Pre treatment A235_L016,ctrl
RNA from whole tissue section of case 687 labeled with Cy5,ctrl
"SWR/J CHR, Rep2",pert
HLA risk: Low;	Height: 134.6 cm;	Weight: 30.6 kg;	BMI: 16.7;	Age: 9.27 years;	Gender: Male;	Race: White;	Glucose: 245 mg/dl;	HbA1c: 7.5%,pert
chip number: 23;	transfection plate: 6;	target gene: RAD21;	kd level: 0.87;	rin: 9.6;	transfection date: 2012-03-26,pert
PHM-DM-2aUA-s2,pert
N30068,ctrl
Patient: L;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: M;	age: 65,pert
"Wild-type retina, biological rep1",ctrl
THRB 15b mutant + T3 replicate 2,pert
tissue: liver;	genotype: ClpP KO;	genetic background: C57BL/6,pert
control AU1327303,ctrl
"wt total RNA LSK, rep 3",ctrl
monolayer chondrocytes from OA donor 2,pert
"AD_TC, biological rep6",pert
"Gift Prof Dr Olivier De Wever, Ghent University Hospital, Ghent, Belgium)",pert
Laser Capture Microdissected Serous Ovarian Cancer Epithelia,pert
patient: 51091;	sample: normal,ctrl
mouse jejunum_hnf1alphamutant_rep2,pert
12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24727,pert
"Cervical cancer cell line, C4-I",pert
treatment: before Rituximab (control),ctrl
"KSR1 Alone, Replicate 2",ctrl
"HME-CC, 12h, sham B",ctrl
Bronchial Epithelial Cells MMA biological 1774K,pert
WT_MEF_un.1,ctrl
Bronchial Epithelial Cells SA biological 1623P,pert
CT-receptor-KO osteoclasts untreated 2,ctrl
pediatric AML GP7,pert
MDS patient 78,pert
NZM15_media_control_30hrs_rep1,ctrl
"cell type: Primary chondrocytes;	genotype: Wt;	antibody: Ago2 antibody;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant;	antibody manufacturer: Wako biochemicals;	antibody catalog #: 292-67301;	antibody lot #: PEK486",ctrl
DOV13+(3),pert
KO-control-3,pert
cell line: OVCAR-10;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
strain/background: mix of 129Sv and C57BL/6;	genotype: conditional keratinocyte-specific ADAM17 knockout;	tissue: back skin;	age: 10 days,pert
PancreaticSample53-Tumor,pert
HEK293 transiently pIRES2-EGFP-transfected 2,ctrl
Muscle-5 month-Myc heterozygous-technical replicate 2,pert
sample: #21;	subject: PD case #5;	brain: T-72;	age: 81;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
treatment: DMSO;	time: Day10;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
Uninjured Control - Epicenter Rep3,ctrl
S-IIP(UIP)2_Cy3,pert
PancreaticSample31-Tumor,pert
KU_23T,pert
V5-P408,ctrl
Pax3 WT E14.5 palatal shelves 2,ctrl
individual: patient2;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
BTBR+tf/J Vehicle liver sample batch 2,ctrl
"Frontal Cerebrocortex, deltamethrin (0.3 mg/kg), 6 hours",pert
"Crohn 03, CD03",pert
male;	CABG patient atrial tissue;	baseline before CABG surgery,ctrl
wildtype HUES6 2,ctrl
HC-WT-23A,ctrl
136A,ctrl
race: hispanic;	age (years): 47;	stage: IB;	grade: 1;	histology: endometrioid,pert
Mixed_E18.5_Whole_Kidney,pert
erStress_twins_AA_1743twin2_DMSO_4h,ctrl
Substantia nigra,ctrl
WT-smoke-high-5 month+1d-R2,ctrl
pMX-Oct4 vitamin C Oct4Vc+_1,pert
tissue: skin;	individual: Patient P10;	condition: ANL;	eczema severity: SCORAD: 0,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep8,pert
"GNMT knockout at 8 month age, biological replicate 3",pert
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: P,pert
Breast cancer,pert
PCOS Endometrium Mesenchymal Cell_106.PC07++,pert
3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24714,ctrl
"Embryonic cerebral cortex, Trnp1 knockdown, biological replicate 1",pert
Squamous cell lung cancer patient 31,pert
cerebellum_WT_0d_rep2,ctrl
"treatment with MeOPP, replicate 3",pert
cell line: prostate cancer cell line PC-3;	telomere status: Long;	exogenous htert: present,pert
"RNF40 siRNA - Undifferentiated, rep1",pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 6.2;	colon weight (mg): 177;	colon ratio (mg/mm): 2.855;	myeloperoxidase activity (u/mg): 0.217;	tissue: colon;	treatment: 5% DSS,pert
Psoriatic arthritis PsA 9,pert
healthy myeloid cells 4,ctrl
background strain: mixed (C57BL6/6J and 129);	genotype: Dmrt1 flox/flox with no Cre;	gender: male;	tissue: testis;	age: postnatal day 28 (P28),ctrl
SOCS3 Cre plus B,pert
Kidney_saline ip_mouse #062,ctrl
WT striatum Veh,ctrl
"Cultured ovarian cancer cell line OVCA433, Cisplatin treated",pert
Cultured TM cells-A,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12. Sample C,pert
Cultured HTM cells-C,ctrl
"Cell type: neuronal, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-13;	Primary Site:Floor of Mouth;	Age:54;	Sex:M;	TNM:;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
"NB4 cell line, wild-type, ATRA, 48hr",pert
NSC12,pert
Sox3 null Sample 2,pert
BAL_43_A0B0,ctrl
Untreated Control 4weeks AffyGC RMA rep3,ctrl
Subject 1 / lung subsegment instillated by LPS,pert
R1/E ESC,pert
TAC 6,pert
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: HIGH;	genome/variation: no mutation detected,ctrl
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P11;	clone: C18,pert
ak 03,pert
"Patient 17, Macroscopically intact tissue",ctrl
Sex: male;	Age at operation: 37 years;	Site: thigh;	Size in cm: 7x14x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: yes,pert
Normal Sample 2,ctrl
A431 PR 2,pert
"healthy breast 4, biological rep. 4",ctrl
HDAC2 KO mice colon rep 1,pert
"mouse aorta cross strain comparison, C3H_T24_NC_01",ctrl
THP1-shGSK3B-Construct1-rep2,pert
"Peripheral blood, normal control [N53]",ctrl
BAL_37_A1B1,pert
Leukemic mice 2 months after ENU treatment,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 3,pert
Temporal cortex of non-AD brain,ctrl
6h kin- Cel.07,pert
"10mg/kg/day PFOA, Rep 1, Block 2, liver (high dose)",pert
H17_S_B2,pert
MSE_N_617,ctrl
WT(Rnh1+/+) -3,ctrl
Ago2-IP RNA Mir140 KO-2,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 5. Replicate A,ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 56;	baseline tumor size (cm): 8x7;	patient id (to identify the 2 chips from the same patient): 16281659,ctrl
male_alcoholic_212,pert
061HZ: normal control,ctrl
"schizophrenia, BA46-100",pert
MiaPaCa2 rep-3,ctrl
rd1_P4_rep4,pert
KM_015T,pert
"ID:12-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
801B.INV,pert
gender: male;	batch: 1;	age (years): 46;	patient id: Control_4;	fev1 (% predicted): 92;	fvc (% predicted): 105;	medication: None;	cell type: CD4+ T-cells,ctrl
Gender:female,ctrl
10 days TAC-4,pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 0,ctrl
IRS-1 KO (jos0649),pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 28.105;	Ratio: 2.13,ctrl
"vector d0, rep 1",ctrl
A673_CloneAsp14_Dox_72h_1,pert
Sprague-Dawley Rat retina (male); 4h post injury,pert
CLS14_T5_PP_day7_059,pert
PsOEt-20-Week 2,pert
"Patient 112, 12 month of REBIF",pert
Moderate rep9 (OHN),pert
n8t30m,pert
age: 21 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),ctrl
Liver CTR replicate 1,ctrl
V5-P379,ctrl
MCF-10A shCHK2-2 replicate 1 [set 5],pert
wild-type control 2,ctrl
cerebellum wild type 6 month replicate 3,ctrl
N30617,ctrl
CDK9 Knock Down3,pert
"59B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
colon_IL10mouse_6weeks_rep1,pert
cell type: T cell;	disease state: homozygote FH,pert
HCT116 STAG2 knockout clone 7 (STAG2 deficient),pert
F-IIP(UIP)7_Cy3,pert
CD8 T cells isolated from spleen,ctrl
Control (C268),ctrl
TGFBeta Transcriptome Profiling {rpt},pert
female;	29 yr old;	Black,ctrl
12485 UC Inflamed ascending colon,pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",pert
ET 4,pert
Muscle PCOS control 13,ctrl
"brain, Entorhinal Cortex: 96-31 tangle_e1_le1",pert
"NPCxhIPSC CON, replicate 5",ctrl
PCOS Endometrium Stromal Cell_104.PC07-+,pert
KO mouse 1_heart_basal,pert
Gastrocnemius muscle mRNA from old (24 month old) wild-type mice,ctrl
F9 TSA sample #2,pert
strain: 129SV;	gender: female;	age: 6 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 48 hours;	agent: air;	exposure dose: 0 ppm O3",ctrl
"brain, cochlea: [2] Sample #2_le1",pert
GLY replicate 3,pert
hsa-mir-30a/30d inhibitor_24-5,pert
C_Ctrl_2,ctrl
PBS Treated Cells 2,ctrl
Ifng-/- biological rep 3,pert
cell line: TYK-nu;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
11406 Normal Uninflamed sigmoid colon,ctrl
duration of untreated disease in month:7.7;	age at onset:1.6,pert
SK-MEL-2 melanoma cells,ctrl
"prostate cancer cell line, CBFbeta knockdown",pert
cell type: Immortalized AR positive myofibroblast,pert
"alveolar macrophages, smoker 063",pert
"WT heart, CRE, biological rep1",ctrl
HCC_20N,ctrl
NALT_infected_24h_90-226att_rep3,pert
AtT20 cells overexpressing NSBP1WT protein rep3,pert
PML Knockout Mice fed Low Fat Diet 1,pert
sparse HUVECs stimulated with Angiopoietin for 1 hour,pert
3D-cultured chondrocytes from OA donor 2,pert
CON30,ctrl
human preadipocytes+oligo2_day6_rep2,pert
mammary gland,pert
PGA-MAH-C3H_OVA24h-2aA-s2,pert
H4-II-E-C3_low_rep3,pert
TMRI AO 24hr,ctrl
Estrogen treated ipsilateral to stroke E6IC-1a,pert
HUVEC_TSA_rep3,pert
cell line: HTB-58;	gender: male;	age: 65 years;	race: Caucasian;	disease: squamous cell carcinoma of the lung;	sirna: control,ctrl
LUC KD #1,ctrl
strain: C57BL/6;	genotype/variation: IkkβF/F,ctrl
"Global gene expression of NASH patients, P37",pert
MA_309,pert
No or early 1 rep10 (retina),pert
Normal Biological Replicate 6,ctrl
"HSCs from female mice treated with E2, replicate 2",pert
n9t24h,pert
"Patient  D, lesion, 2 week",pert
"Male F344 rats, sacrificed at the age 18 weeks",pert
Sh2b3 wild type NOTCH1 induced tumors,ctrl
"Control maternal diet, Cited2 -/-",pert
strain: C57BL/6J;	genotype: Homozygous dumbo;	developmental stage: P15,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 63 dpi,ctrl
gender: Male;	tissue: liver;	genotype: Wild Type;	treatment: DMSO 3-day;	genetic background: C57BL/6,ctrl
"Pancreas from adult Rkip-1 KO mice, biological replicate 1",pert
Animal 8,pert
HEK 293,ctrl
TAMs sorted from vehicle control tumors,ctrl
MDA-MB-231 - MTDH-WT-KD-2,pert
A549 AZA 1 uM (3213),pert
strain: Sprague-Dawley;	gender: Female;	tissue: ovary;	developmental stage: day P4 cultured for 2 more days,pert
PsOEt-16-Week 1,pert
"DBA/2J CHR, Rep2",pert
39A;pretreatment;female;breast tumor; responder,ctrl
Mouse cardiac left ventricle,ctrl
tissue: retina;	disease state: Control,ctrl
NPC1,pert
PGA-RMM-5h-1aA-s2,pert
"MLD, biallelic AML MLL_00268",pert
H1299 RBP2 KD1_rep 1,pert
4T1.2 base vector expressing cell,ctrl
"fibroblast, control subject NF4 rep 1",ctrl
PC-3_basalhTERT_ShortTelomeres_mockcre_2,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 145min;	race: White;	sex: Female,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: F;	age: 45,ctrl
"3T3-L1 siControl 48h, biological rep 1",pert
Skin_Control E16.5_rep2,ctrl
OE control 19A n,ctrl
T40975,pert
V5-P208,pert
RV63.01_CONTROL_day19_Slide33,ctrl
normal esophageal epithelium (N1),ctrl
"Crohn's Disease subject (56 year old caucasian female, SAK_1315817415)",pert
K562 AMN107 sample 4,pert
genotype/variation: wild type;	tissue: Brain Tissues,ctrl
Expression data from BAT of the KRAP deficient mice (KO2),pert
CD71+ bone marrow cells from Ifng-/- mouse 3,pert
ColonProx_022XAC3F_070.txt,ctrl
"Atm-/- 120 min post IR, B",ctrl
LZ10,ctrl
Aldosterone-producing adenoma (APA7),pert
Wistar rat liver tissue following animal exposure to orotic acid for 1 day,pert
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
"Biceps, control, cohort 18, subject 18U",ctrl
"seminoma specimen, pT3, patient age: 49y",pert
695-EV_16hr,ctrl
"C57Bl/6, CD-1",pert
"brain, hippocampus: KA-24h-P15-III_e1_le1",pert
Individual_5324_NN_sample,ctrl
Kidney_colistin_5,pert
brain_DLPFC_bipolar C_mr423,pert
P58 Non failing heart biopsy,ctrl
Lung; wild type; spontaneous breathing,ctrl
"Control, biological replicate 3",ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 38 yr;	population: white,pert
"Deltoid, FSHD, cohort 22, subject 22A",pert
HeLa cells;	(cervical cancer cells),pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 32;	maternal age: 35,ctrl
mutant_POST_PDE_060,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 6 months,ctrl
Patient identifyier: R;	Sex: male;	Age of patient: 56 years;	Duration of psoriasis: 16 years;	Body surface area: 30 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"Ott1 knock out, biological rep 2",pert
genotype/variation: Gb5-deficient;	tissue: Brain Tissues,pert
OCT4 shRNA_2 Days knockdown_rep3,pert
Adrenocortical adenoma with wild-type CTNNB1-4,ctrl
ID: MLL_00112;	cell type: PBMC;	disease state: control,ctrl
Diseased individual (ulcerative colitis) of twinpair #4,pert
MO32_10,pert
"control, subject 1",ctrl
Lung-normal-rep2,ctrl
SA_51,pert
"Control, biological rep 1",ctrl
treatment: vehicle;	genotype: wild type;	treatement time: 4 hours,ctrl
wild type parietal cell replicate 3,ctrl
"Ovol1 KO, biological rep2 (with calcium)",pert
FR-control-2,ctrl
MCF-10A shCHK1-3 replicate 3 [set 5],pert
cerebrum_PS-/-_ 0d_rep1,pert
explanted heart tissue at time of cardiac transplantation,pert
colon_CRC_1494,pert
"pt. HCL A treated with Vemurafenib 1000 nM for 72h, replicate1",pert
At Risk: -;	Age: 11;	Sex: F,pert
"Liver from MON exposed rats, biological rep 1",pert
quiescent p27WT MEFs 3,ctrl
Muscle PCOS after pioglitazone 272,pert
ndf + progerin,pert
RNA-DHL4-R406-6H-2,pert
control-4,ctrl
control-control rep 2,ctrl
Jak2VF vehicle (7991003040_B),pert
"brain, brainstem: CB3_e1_le1",ctrl
SCC25_rep1,ctrl
Disease_status: Healthy control;	Age (years): 41;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.0;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
disease: type 1 diabetes;	gender: female;	cell type: endothelial progenitor cell,ctrl
chip number: 23;	transfection plate: 5;	target gene: TAF1;	kd level: 0.65;	rin: 9.3;	transfection date: 2011-10-17,pert
51m1,ctrl
WILDTYPE cerebellum at new born,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 0,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 1,ctrl
ndf + preLA + ZMPSTE24,pert
"Patient 28, Macroscopically intact tissue",ctrl
"AD_FC, biological rep3",pert
Snell 6 month Dwarf Liver 89dw,pert
parental HeLa cells rep 1,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 32;	Usage number: 1;	Exposures: 4,pert
LIVER_diclofenac_repl5,pert
microdissected breast cancer cells from case 1405,ctrl
"Empty vector, biological rep2",ctrl
"BOEC, not_at_risk 1",pert
WT-control-2 (DFW),ctrl
"HEK293E cells, TDP-43 siRNA, replicate 4",pert
KO-Nrf2-Female-1,pert
Strain: FVB;	Genotype: MMTV-iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: not treated (0 hour),ctrl
"Vldlr knockout saline, biological rep4",pert
PGA-RMM-72h-3aA-s2,pert
"WT liver, biological rep1",ctrl
tumor cell line HepG2 with knockdown of HIF-1α rep1,pert
"cerebellum,12weeks,KO",pert
"E2F-1, #1 repeat",pert
"Normal skin from Tie2_control mouse, biological replicate 3",ctrl
Atxn1L HSC 1,pert
Human Chronic HIV Sample C102-CD4+ T cells,pert
wt-Gfp E16 replicate 4,ctrl
S/LV5,pert
SKBR3_1uM_Lapatinib_2,pert
DU145/NC siRNA #1,ctrl
gender: Female;	age: 78;	post-mortem delay: 8h;	ph: 6.7,ctrl
Saline treated mouse gallbladder 4,pert
subject id: 34;	infection: DENV;	status: DHF;	tissue: whole blood,pert
BALB/c d3 (187msn),pert
Liver antiangiogenic-treatment rep3,pert
erStress_twins_AA_1725twin2_500nM_thapsigargin_4h,pert
tissue: skin;	individual: Patient P1;	condition: AL;	eczema severity: SCORAD: 36,pert
Calu3-Parental_3,ctrl
16A;pretreatment;female;breast tumor,ctrl
pMX-Oct4 and pMX-jhdm1b(jmjc) no vitamin C O+JMJCVc-_2,ctrl
Myh11-CreERT2.Tgfbr2f/f Control 3,ctrl
cumulus_PCOS_Obese_rep3,pert
GM19238_Kd_IRF5_3_rep,pert
c 4-3,pert
"25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 18Q x50_16 months_replicate 2,pert
"S1P2-KO-hippocampus, biological rep9 (female)",pert
K_LS_Time0,ctrl
liver_STZ 0.1% quercetin diet_rep2,pert
cerebellum_PSNA_ 0d_rep1,pert
"Mouse bone marrow-derived mast cells treated with IL3, rep 5",ctrl
GV oocyte_Ring1 mut_rep2,pert
age_years: 43;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
cell line: HL60;	disease state: promyelocytic leukemia,pert
"Acute Myeloid Leukemia, sample 44",pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit and Sca1 (LSK) positive expressing bone marrow progenitors",ctrl
Peripheral blood mononuclear cells;	TTF=110min;	Race=White;	Sex=Male,pert
Strain: 129Sv (wildtype);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,ctrl
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 1",pert
nasopharynx,ctrl
Gender: male;	Source tissue: foreskin,ctrl
tissue: Peripheral blood;	disease status: patient with recurrent events,pert
"array 30, xenograft, DBP 500 mg/kg/d",pert
umbilical cord_nobpd: 9B,ctrl
5198 Normal Uninflamed sigmoid colon,ctrl
"Patient P, lesional skin",pert
CXCL4_B,pert
genotype: Villin-Claudin-2 transgenic (Cl-2TG);	cell type: colon epithelial cells;	gender: male;	treatment: water,pert
whole tissue section from case 772,pert
Murine Hippocampus,pert
Tendon_lesional_rep17,pert
Moderate rep10 (OHN),pert
EA_Case13_CD4,pert
RV64.02_CONTROL_day25,ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 50;	donor: 24;	disease state: Non-lesional,ctrl
"SBC-5 cells, siEGR4 (target), 72 hr after siRNA, duplicate sample 2",pert
1209-03-A,pert
chip number: 19;	transfection plate: 4;	target gene: IRF3;	kd level: 0.9;	rin: 9.2;	transfection date: 2011-10-17,pert
liver_Pink1 knockout_24 weeks_replicate_2,pert
Patient identifyier: N;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 20 years;	Body surface area: 25 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"genotype/variation: Brg1_cKO1;	strain: mixed background (Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.);	age: P1",pert
LCH7ani,pert
"Aorta, saline 14d, #5",ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: PKCZ -/-;	age: 32 weeks,pert
Evi1-1,pert
cell line: KARPAS-231;	cell type: diffuse large B-cell lymphoma (DLBCL) cells;	treatment: LITAF-specific siRNA,pert
colonic_mucosa_inflamation_93,pert
Control liver sample 1,ctrl
Calf muscle complex,ctrl
control AU081206,ctrl
HepG2,ctrl
expression array - AO3,pert
BRCA1 KD #2,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 52;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Bronchial Epithelial Cells MMA biological 1142Z,pert
RV82.03_CONTROL_day10_Slide54,ctrl
NoKD_SerumStarved->1hrEGF_rep1,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-6,pert
Uninvolved lung tissue sample from lung cancer patient,ctrl
no_22,ctrl
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
cell line: LICR HN1;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
LOX1 Untreated 6hr 282295653,pert
"jejunum, GATA4 mutant, 1",pert
cell line: LICR HN1;	treatment: PBS,ctrl
KM_049T,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 1 - Technical Replicate 2,pert
LICR_HN1_PBS3,ctrl
DBA d18 (123msn),pert
CD34+ cells without fenretinide treatment from CML35,pert
CAR.KO_phenobarbitol_rep1,pert
"E2-treated cells (3hr), biological rep_3",pert
e_B13,pert
F_Kin_2,pert
Individual_3777_PP_sample,pert
Liver wildtype HFD,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 32.96164,ctrl
7A;pretreatment;female;breast tumor; responder,ctrl
cell type: embryonic stem cells [E14];	transfected with: siRNA targeting the pCIP proteins,pert
C007_Control_M_54,ctrl
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 1957998117;	hybridization batch: I,pert
Ngn3 EB10 OFF replicate 2,pert
Patient no. 5: treated,pert
reduction mammoplasty patient 310,ctrl
EPLM,ctrl
A549 siRNA FAM60A CNTRL 3,ctrl
OVCA433-(1),ctrl
Liver_KnockOut_4,pert
PCOS Endometrium Endothelial Cell_107.PC07+-,pert
EA_Control3_CD8,ctrl
IFNb-treated MEF 2,pert
PsOEt-15-Week 1,pert
HSC-Evi1-KO-1,pert
Rybp#15 (OHT+)_12d_rep1,pert
TG mouse_left ventricle_tamoxifen treated_1,pert
HTH83 SCR 3,ctrl
SeroTest-2,pert
Mouse_Retina_P7_Rs1h_KO 1,pert
H5 HA 2h 1,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): EtOH vehicle,pert
04SAGEA,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 29;	maternal age: 33,pert
01MHB,pert
m1-WT6,ctrl
ERRa KO biological replicate 2,pert
Control 25 appendix,ctrl
"Patient CV, stable renal transplant recipients, male, 58 years old, T1 (3 months after the switching of the therapy)",pert
n8t7d,pert
patient: 12;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
T8E-LU,pert
ATP-treated AML blasts,pert
"Ulcerative Colitis (41 year old caucasian female, SAK_1318969188)",pert
PancreaticSample15-Normal,ctrl
RV16;	Age = 18;	Sex = F,pert
"DHL6, R406, 24h",pert
A_LS_Wk4,pert
"testis wt, 17dpp, Rep4",ctrl
colonic_mucosa_non_inflamed_758,pert
KN-smoke-med-5 month+13d-R4,pert
wildtype 1,ctrl
4 hour tunicamycin CHOP-/- C,pert
"Control, replicate 1",ctrl
PCOS Endometrium Stromal Cell_101.PC01-+,pert
disease state: control;	patient: 32,ctrl
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: control,ctrl
PBMCs enriched for CD8+ cells from normal control subject C,ctrl
64A;pretreatment;female;breast tumor,ctrl
rat distal colon,pert
U937_ROS_curcumin_18h_rep2,pert
IEC_GF-HDAC3FF -3,ctrl
MyD88_LPS_M2-0,ctrl
PBMC from T cell LGL leukemia patient #124 (TLGL124),pert
age: 65;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
HA99-96A,pert
AZ-521_doxycycline_18h_rep2,pert
Primary chondrocytes;Mir140 KO; total RNA,pert
disease state: Healthy;	cell type: CD4+T;	twin: T,ctrl
WT-smoke-med-5 month-R1,ctrl
"Embryonic stem cells, Vitamin C treated",pert
"jejunum, control, 3",ctrl
strain: C57BL/6;	genotype: wildtype;	age: 0 days;	tissue: muscle;	muscle type: Quadriceps,ctrl
Uninduced control 01-14-03_Lee_U133A_Tet,ctrl
Leg 23 Day control rep 3,ctrl
LOX1 Untreated 24hr 282295893,pert
Peripheral blood mononuclear cells (PBMC)-Patient GM T1,pert
"Wild type mouse aorta with placebo, biological rep2",ctrl
FMR1_3,pert
"DMSO-treated, sham UV exposed",pert
LOX1_Untreated_2hr,pert
"Age: 46;	Sex: M;	Ancestry: European;	Smoking status: smoker, 21 pack-years",pert
A549 vehicle control (3206),ctrl
jzo009-rp1-v5-u74av2-met,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: White;	sex: Female,pert
"HEK293E cells, scrambled siRNA, replicate 1",ctrl
220D1,pert
"3 uM EPZ004777 treated, DAY 6, biological rep.1, MOLM-13 cells",pert
age: 47;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
c57BL/6JTCE liver sample batch 6,pert
"Global gene expression of NASH patients, P41",pert
Day: 18; Drug: Heroin; Phase: Withdrawal; Replicate: 2,pert
Septic shock;	gender: Male;	Non survivor;	organism: Neisseria,pert
NTG mouse_tamoxifen2,ctrl
"Tip60 KD, replicate A",pert
P74 dilated cardiomyopathy heart biopsy,pert
PTEN_mutant_2_intestinal_polyp_30days,pert
KO618,pert
EB_6_5d_297_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
HUVEC exposure 1 ug/ml colchicine 12hr_2,pert
HF0488_U133P2,pert
MDS14,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.14;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"Control Day 3, biological rep2",ctrl
"Ishikawa cell line, BPA, 10nM, 48hr",pert
BAT_WT_3,ctrl
Individual_5256_NN_sample,ctrl
"C8161, 48h treatment with 5 AzadC",pert
"Untreated ES cells, Rep 1",ctrl
lesion_preUV_patient5,pert
CAR.AH_corn oil_rep1,pert
GM19238_Kd_TCF12_3,pert
adrenal gland,ctrl
WT Liver - Pooled -Cy5,pert
"Normal Skin, Normal-12",ctrl
E2F3 Heterozygous,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: rosiglitazone at 1uM,ctrl
striatum_Pink1 knockout_12 weeks_replicate 1,pert
HeLa_TP082505-26_HG-U133A_2_IMFGN0023,ctrl
PlagL2KO2,pert
SiTIF- rep2,pert
primary normal lung tissue 1473,ctrl
"control, BA46-71",ctrl
BCell_activated_sample2,ctrl
"Cultured ovarian cancer cell line OV90, Cisplatin treated",pert
Control with WY14643 replicate 1,pert
quadriceps_muscle_Akt1+/-_female_8wk_rep1,pert
siERK2E24h_2662,pert
Braak α-synuclein stage 1-2 BR12_3SN,pert
BE-rep1,pert
"Normal subject (47 year old caucasian female, SAK_1289471570)",ctrl
Colo-205 cell line,ctrl
cardiac syngraft,ctrl
ovaries dissected from 0-day old Sprague-Dawley rats and cleaned of ovarian bursa.,pert
colon_normal_1024,ctrl
healthy control H27,ctrl
"117, ADIPOOSE TISSUE, Before",ctrl
"brain, adrenal medulla: Sample#B2 (Ctrl Pt2)_e1_le1",ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: DMSO for 48h,ctrl
PGA-lv_4h_509,ctrl
disease state: healthy control;	tissue: epidermis;	age: 73;	gender: female;	treatment: untreated;	time: control,ctrl
"Control shRNA, rep1",ctrl
strain: C57/BL6;	genotype/variation: NEMO knockout (NemoΔhepa);	gender: male;	age: 8-9 weeks;	tissue: liver,pert
Time of Surgery:Pre;,pert
brain wild type replicate2,ctrl
Adult 7d SNI; Biological replicate 2,pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB without doxycycline,ctrl
tissue: Temporal cortex;	age: 82;	Sex: M,ctrl
"Control at ZT6, retina",ctrl
Nuclear RNA_WT_rep2,ctrl
B_cell_pool_melanoma_M09+M10,pert
BTBR+tf/JTCE liver sample batch 6,pert
WT 2 1509,ctrl
"Lesional skin from K5-Tie2 mouse, biological replicate 2",pert
"brain, hippocampus: C6-II_e1_le1",ctrl
"SLE patient, 1023V1",pert
Bone-Marrow_SMM_S1420,pert
Patient 2 c,pert
AO 48hr,ctrl
"Patient E, uninvolved skin",ctrl
Mouse heart at 6-weeks old,ctrl
"WKY adrenals, replicate 3",ctrl
Diabetes 1b,pert
"brain, hippocampus: LH5_e1_le1",pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: mir126 overexpression,ctrl
KU_08T,pert
PDAC_T_105,pert
Tendon;ECRB_Non-lesional,ctrl
"Wild type,pancreas",ctrl
brain_OFC_bipolar B_mr212,pert
PGA-RMM-8h-3aA-s2,pert
Control_2h_rep2,ctrl
chip number: 11;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.6;	transfection date: 2012-03-26,pert
Control for EGF 4h replicate 2,ctrl
"D425-shOTX2_1, t=24",pert
treatment: 0.1 μM CDKI-73 for 4h;	cell type: CLL B-cells,pert
EpiAdip GPR120KO ND,pert
patient: 19;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 8 weeks;	Tissue: whole brain,pert
Gastrin Knockout parietal cell replicate 2,pert
cell line: Hep G2;	genotype: wild-type THRB and;	treatment: with vehicle for 6h,ctrl
RNA from whole tissue section of case 633 labeled with Cy5,pert
"Pool of four samples (n=4);;	gender: three female/one male;;	age: 19/57/40/70 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA)",pert
SALINE 24 HOURS,ctrl
microdissected breast cancer cells from case 297,ctrl
sample =XCGD5 treatment=Control time=180 (min),pert
"Strain: B6CF1 x C57BL/6, Tissue: Bone marrow, Age: 7 weeks",ctrl
01L4P: normal control,ctrl
EB_6_24h_292_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"Healthy control, biological rep1",ctrl
IRF4_2,pert
COV434,pert
"C3_transgenic but unaltered, lung tissue",pert
"Tg brain, biological rep4",pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 53;	age-at-onset: 45;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
"schizophrenia, BA46-9",pert
umbilical cord_nobpd: 4A,ctrl
Laser Capture Microdissection (LCM) to isolate tissue sections of the hippocampus area of wild type mice brains,ctrl
age: 63;	gender: male,pert
biopsy specimen,pert
Hippocampus 1987 15 month Old,pert
TTP_WT_0ActD_BioRep4,ctrl
PBMC from Rhesus Macaque,ctrl
scc_14,pert
homozygous_TGFb_24hr_1,pert
GM19238_Kd_E2F6_2,pert
Brain hemisphere,ctrl
Gender: Female;	AJCC Stage: I;	Pathological T: 1;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
"control mice, whole uterine tissues, replicate 1",ctrl
non-malignant FTEb_patient 7,ctrl
"brain, hippocampus: PH7_e1_le1",pert
"Ovol2 KO, biological rep2",pert
01UMX_PolyRF-,pert
Atm+/+ untreated A,pert
"twin pair: #8;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
r3,pert
WT - Cre Treated - 2 hrs - repeat 1 - Cy5 - mAdbID:62602,ctrl
amygdala long access to cocaine replicate 3,pert
"non-AD_TC, biological rep10",ctrl
ab040 N,ctrl
antimicroRNA-140_rep3,pert
"Uninvolved Skin, NS-6",pert
ic22 -- APF on membrane A,ctrl
day 3 5-FU HSC 2,pert
30B,pert
THRB wt + vehicle replicate 1,ctrl
DU145 + Medi5117,pert
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 26;	gender: male,pert
Mouse E10.5 urogenital epithelium +/+ #1,ctrl
colon_Runx1-KO_Cy3_15447,pert
Prostate cancer cell line,ctrl
Liver-5 month-Myc heterozygous-technical replicate 3,pert
WHOLE BRAIN,pert
"EtOH treated, Vehicle",ctrl
S019_Scz_M_79,pert
"frontal cortex, healthy control",ctrl
treatment: naïve;	transgenic variant: AChE-S;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,pert
40A,pert
temporal lobe,ctrl
HCC002N,ctrl
3T3 Vector Control A-928605 2,pert
Oct4GipES_Luc_esiRNA_72h_rep3,ctrl
wild type oocyte,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 50 yr;	population: white;	dsm-iv: 295.3;	age of onset: 31 yr,pert
cell line: A2780;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
Cervical Cancer C540,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 18;	dfs-event: 1;	distant metastasis: 1",pert
microdissected breast cancer cells from case 1045,ctrl
HCC1954 Cell Control 3,ctrl
siHic5_2_4h_2,pert
Sarc_1,pert
chip number: 11;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
BE-rep2,pert
01UN7_Oligo,pert
humanMBC_FOXP1 overexpression_1,pert
"Whole blood - Autism no regression, Female",pert
"SKO-transduced MEFs, Vc treated, lysed on D4",pert
tissue: Frontal cortex;	age: 83;	Sex: M,pert
"Empty vector, plastic plate, rep3",ctrl
cerebellum wild type 21 month replicate 2,ctrl
5IDC_tumor ductal,pert
MacularDegen-injured-5bAv2-s2,pert
cerebellum_wild type_12 weeks_replicate 1,ctrl
race: caucasian;	age (years): 55;	stage: IB;	grade: 2;	histology: endometrioid,pert
"Polyamide 1 treated LNCaP cells not stimulated with DHT, biological replicate 3",ctrl
liver_WT,ctrl
"46, XY",ctrl
agent: EFNA4-Fc conjugate;	time: 48h,pert
"liver, genetic control, Nrf1(dN/+)",ctrl
HL60_shSYK_2_Replicate2,pert
"liver, LDLr-KO",ctrl
11_2_MOE_430A_HO,pert
"PBMC, healthy control, biological rep10",ctrl
KO9-3,pert
14m8,ctrl
CON-2-PLASTIC,pert
HES2_Mir122Mut_rep3,ctrl
cell line: HCT116 Human colon cancer;	shRNA expressing: NFX1-91,pert
MF-21,pert
Subject #8001-2d Postinfection,pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 31;	maternal age: n/a,ctrl
brain_OFC_bipolar B_mr351,pert
"brain, Entorhinal Cortex: 99-33 normal_e1_le1",ctrl
Primary neonatal keratinocytes,ctrl
WT_ANT_PDE_2-wt,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 46;	sex: M,ctrl
Bl6_Mock_3,ctrl
3 h-apra-10 nM,pert
EB_6_6h_284_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
H09_S_B1,ctrl
quadriceps_muscle_Wt_female_35wk_rep2,ctrl
CD4_T_cell_pool_healthy_H01+H02,ctrl
"Mammary gland, IGF1R-overexpressed, biological rep2",pert
oocyte_Brwd1_mutant_rep2,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 6 hr,pert
"MCF7/BUS cells, human breast adenocarcinoma cell line, estrogen receptor-positive",ctrl
obtained from RIKEN CELL BANK,ctrl
TAp63 alpha 24h without induction s1,ctrl
thyroid_normal_2,ctrl
"Total RNA, WT LSK",ctrl
Mutc-Met_2,pert
Plate vs. Nail:  1 Week Sham,ctrl
"Crohn 01, CD01",pert
Parkinson's disease sample x189,pert
"depression, BA10-39",pert
Oral Squamous cell Epithelium Tissue,pert
GM19238_Kd_RAD21_3,pert
Mouse_WT_colon_DSS_rep2,ctrl
"Atm-/- untreated, B",pert
"Patient  I, lesion, time: 0",ctrl
MDS8,pert
BxPC3_JMJD3KD_rep3,pert
Insm1 control #7_pituitary gland,ctrl
Normal mucosa 5,ctrl
GM19238_Kd_EP300_3,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 206,ctrl
HCC012N,ctrl
Saline T00278946,ctrl
1-WT,ctrl
E14 - WTMixA 2,ctrl
"48 hour-treated TG2 knockout NB4, biological rep2",pert
"WT, biological rep2",ctrl
IPMA 3,pert
"129P3/J CHR, Rep3",pert
ILD Study Number 1164,pert
H157 siCTL1,ctrl
CON-3-PLASTIC,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 2,pert
17L,pert
"Ishikawa cell line, BPA, 1uM, 24hr",pert
MH1C1_low_rep2,pert
HCC001T,pert
PancreaticSample14-Tumor,pert
WT_04,ctrl
patient: 30057;	sample: tumor,pert
Caco2-siRNA-control2-rep1,ctrl
"DMD skeletal muscle, biological rep10",pert
Mist1KO saline rep2,ctrl
Cav1KO 1761,pert
"BA OBCs, post doxycyclin withdrawal, rep4",pert
4121-1 E2F1 Null,pert
"Crohn's Disease subject (34 year old caucasian female, SAK_1275478033)",pert
01N4P,pert
A HID U_B049,pert
Mutated-ERα-positive breast cancer 42,pert
human esophageal squamous cell carcinoma cell line_KYSE70,pert
status: Control;	gender: Female;	age: 51;	tissue: Blood,ctrl
Waldenström’s macroglobulinemia (WM-PC 32833),pert
@52055800697862121408403718160406,pert
strain: mixed C57BL6;	genotype/variation: TSC1flox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
HEK293_pLKO_R2,ctrl
Diagnosis: AML M1;	Age: 64y ;	Gender: Male;	Blast %: 93;	Source: PB;	Cyto: t(2;12)del16;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
female,ctrl
"breast tumor epithelium,13",pert
Ischemic cardiomyopathy_G5,pert
NSC18,pert
baseline control 02,ctrl
WT BM LT-HSC,ctrl
Retina no or early glaucoma,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
Patient 3 b,pert
untreated_24hr_rep3,ctrl
WT Hippocampus - 3,ctrl
0164-01-c,ctrl
patient id: T163;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
cell line: HTB-58;	gender: male;	age: 65 years;	race: Caucasian;	disease: squamous cell carcinoma of the lung;	sirna: anti-Evi1,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_10 months_replicate 3,pert
Eed KO J1 ESCs on day 0,pert
"Tumor sample from patient with p53 mutant, replicate 2",pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 3 - Technical Replicate 1,pert
HP-12C,pert
Day: 18; Drug: Heroin; Phase: Withdrawal; Replicate: 1,pert
"Crohn's Disease subject (49 year old caucasian female, SAK_1304617942)",pert
DBTRG 10 uM Y15 rep1,pert
Nerve_Control_Vehicle_705,ctrl
"control_B3, empty vector",ctrl
Human skeletal muscle,pert
FoxO deficient LSK,pert
8-Mut_1,pert
Liver sample of WT mouse 1,ctrl
"MCF-10A cells, overexpression ΔNp63α",pert
expression array - O4,pert
FW_6a_BV7625,pert
RNA from HCC_22T,pert
si Control and vehicle replicate 3,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 50.98904,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous saline challenge""",ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 2 month;	treatment: fresh air, treatment over 2 month, 4x1h exposure per day",ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: Intermediate-CORT (ADX),pert
Individual_3992_PP_sample,pert
Run1.a10a.000609jd.2.SkMNor914.CEL-IS stimulate,pert
Md02h034,pert
STAT1-deficient naïve T cells stimulated for 3 hours with medium alone 2,pert
phenotype: alcoholic;	gender: female;	case_id: 285;	age: 67;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 68;	brain ph at time of freezing: 6.3;	labeling_batch: 2,pert
cell line: H1299;	agent: azacitidine;	dose: 1 uM,pert
"GSL30, PR04M005v0",pert
Fibroblasts_DBApatient_1,pert
C1_transgenic but unaltered,pert
NL A,ctrl
cell type: monocyte;	disease state: heterozygote FH,pert
"human failing LV myocardium, Ischemic38",pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID77,ctrl
V5-P037,pert
Wildtype 1,ctrl
Substantia nigra PD rep3,pert
age: 46;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Osteoblasts_Lrp5_Control_Day7_rep2,ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-14;	Primary Site:Floor of mouth;	Age:60;	Sex:F;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis",ctrl
"WT, biological rep3",ctrl
"BA OBCs, post doxycyclin withdrawal, rep1",pert
strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 8 months;	tissue: liver;	disease status: non-alcoholic steatohepatitis,pert
MDS patient 21,pert
Kidney_colistin_1,pert
"Normal T-cells, CD3+, donor 6",ctrl
"Patient 31, Atheroma plaque",pert
"suprarenal aorta, control, saline treated 7d",ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA2+dox,pert
sample =Healthy1 treatment=Control time=180 (min),ctrl
liver_male wt_rep2,ctrl
cell line: MLL-AF9 AML cell line 10977 (Zfx wt);	treatment protocol: vehicle;	genotype/variation: wt,ctrl
Subject #8018-Preinfection,pert
normal with no hydrocortisone treatment-1,ctrl
mortality: alive;	ethnicity: Hispanic;	gender: M;	age (yrs): 26;	tissue: Normal_Kidney_Biopsy,ctrl
KO_lung_PBS_control,pert
tissue: prefrontal cortex from adult APLP2 knock-out mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
genotype/variation: wt;	age: P8;	tissue: Whole eye,ctrl
Synovial fluid macrophages,pert
18h fasted hearts,pert
PND28 Rat Testis_Rat230-2_3hr MEHP_Animal#51_04005,pert
SKBR3-R_1uM_Lapatinib_2,pert
tissue: lung;	genotype: knock out,pert
"Patient  F, lesion, time: 0",ctrl
"Cnr1-/-/Cnr2-/- female number 1, untreated control ear (#7_Ko-C-4)",pert
MCF-10A_shCHK2-1,pert
MDS6,pert
"tissue: bone marrow;	disease status: B-precursor acute lymphoblastic leukemia, Non-Down syndrome",ctrl
siNS_0h_2,ctrl
MPM tumor 23,pert
Wild-type mice rep2,ctrl
E11_WT2,ctrl
01N3X_ERA,pert
"seminoma specimen, pT3, patient age: 49y; W01 134",pert
ILD Study Number 93,pert
A375 melanoma cells treated with vehicle (0.1% DMSO),ctrl
"5-FU-primed bone marrow mononuclear cells, control transduction",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp1,pert
3 PC3 2hr,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 13,pert
c-Kit + MA9 AML Zfx wt,pert
Cyclophosphamide-treated spleen 1 day - Biological Replicate 3 - Technical Replicate 2,pert
wild-type MEF 1,ctrl
"vector d10, rep 3",ctrl
ve_2m57,pert
Chondrogenic progenitor cells from OA female 3,pert
5091212024_E,ctrl
tissue: Pancreas;	strain: C57BL/6;	genotype: wildtype;	age: 8 weeks,ctrl
"KM-H2 Non-silencing, technical rep2",ctrl
HP-3,pert
cell line: U937;	shRNA construct: GSK3B Construct 1,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with acetaminophen (APAP)_17,pert
H157 siDJ-1 #2,pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu1,pert
EB_15_6_338_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
Cmah KO_lung_3,pert
Epididymal adipose WT ND #690,ctrl
"normal nasopharyngeal tissue, specimen N8",ctrl
race: caucasian;	age (years): 64;	stage: IA;	grade: 2;	histology: endometrioid,pert
Sex: male;	Age at operation: 60 years;	Site: thigh;	Size in cm: 7.5x6x5.5;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-3,pert
GEIM110-U133A-Norm,ctrl
"Lymphoblastoid cell lines derived from family 1757, member 1",pert
"experiment IV, hTERT transduced, replicate 1",pert
gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.1,pert
condition: Psoriasis;	patient: 287;	tissue: LS skin biopsy;	kit: Ovation,pert
E14 - nudelcko/ko 3,pert
"Ott1 knock out, biological rep 1",pert
"brain, lateral and medial ganglionic eminences: Arx+/Y #3_le1",ctrl
LNCaP/MYB siRNA #3,pert
GM19238_Kd_E2F1_3,pert
K562_ICL670_50uM_dup1,pert
"Crohn's Disease subject (56 year old caucasian male, SAK_1260008280)",pert
HPB-ALL NBD 1,pert
Hematopoietic Stem Cells,pert
HNF6_1+,pert
"SLE patient, 1024V2",pert
scpk/ikLL/57,ctrl
normal B cell 3,ctrl
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P8;	clone: 0,ctrl
quiescent p27WT MEFs 2,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 52 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 0,ctrl
thyroid_normal_6,ctrl
Normal testis 9014,ctrl
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
IM28_control,ctrl
CD19_selected_B-cells_before_R_rep6,ctrl
01UP0_PolyRF-,pert
"Wild type fetal liver 3, embryo at 12.5 days of development",ctrl
KO - 3 mo - repeat 2 - Cy5 - mAdbID:74595,pert
"EAE, placebo-treated #10",pert
Raji_mi-Ctrl_4,ctrl
Individual_3586_PN_sample,pert
Mening UNSTIM WB SW 24b,ctrl
SON siRNA rep2,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 27;	sex: F,ctrl
MSC_VUB03_DM1_1,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_4_17_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
HNF1b_2b+,pert
GEIM45-U133A-Norm,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 37;	gender: male;	tumor grade: AII,pert
"MCF7, biological rep1",ctrl
First shYY2,pert
Keratinocytes treated with EFNA4 for 4h,pert
patient: 32054;	disease state: LGSC;	component: Borderline,ctrl
HMEC X BC16 : 0095-5k,pert
wild type rep-2,ctrl
HD11,pert
lesion_postUV_patient7,pert
Day: 12; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 1,pert
"Epidydimal white adipose tissue from ASC-/- after 16 weeks of high fat diet feeding, replicate 1",pert
"coronary smooth muscle cells (hcaSMC), treated with nebivolol for 72 hours",pert
NINDS-RHS-Ctr_72h-2aUA-s2,ctrl
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
0118-01-C,ctrl
MGHU3 Cells_Control siRNA_Biological Replicate 1,ctrl
"15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Liver from Nrf2 wt mice, biological replicate 3",pert
short term cultures of epidermal keratinocytes,ctrl
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID352,ctrl
EE_IA_2_cauc_lcm,pert
clone type: AtT20 clone types infected with empty vector rep1,ctrl
SKNSH eGFP2,ctrl
Differentiation of hES cells line VUB01 towards MPC-like cells;	Mesenchymal stem cells phenotype,ctrl
"brain, cochlea: [8] Sample #8_le1",pert
treatment group: untreated in parallel to cadmium treated cells;	cell line: TK6 cells,ctrl
genotype: Nf1Prx1;	tissue: triceps muscle;	age: 3 months,pert
B7hi mTEC B6/129 wt1,ctrl
C57BL/6 heart left ventrical (LAD ligation 30 day),pert
01LNJ_CTRL,ctrl
H1299 AZA 3 uM (3233),pert
HW_436,pert
Colon,ctrl
12461 Normal Inflamed sigmoid colon,ctrl
MacularDegen-healthy-8cAv2-s2,ctrl
Cervical cancer_56-04T,pert
mRNA from Gastric tissue,pert
human_hepatocyte_vehicle_donorA_24hr_prep2,ctrl
race: caucasian;	age (years): 49;	stage: IA;	grade: 1;	histology: endometrioid,pert
"12-week-old 12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump",pert
tissue: white blood cells;	age: 13.33;	Sex: male,pert
treatment: BirA control;	cell line: J1 ES cells,ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4437,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 0,ctrl
db/db mice,pert
GFP-transfected JoMa1,ctrl
cell line: SUP-B15;	tissue: Human B cell precursor leukemia,ctrl
"fibroblast, control subject NF9 rep 2",ctrl
"114, ADIPOOSE TISSUE, Before",ctrl
"Crohn 10, CD10",pert
3T3-L1 Day 0 (passage 21) 48h after siLSD1 transfection,pert
"Resveratrol treatment exp 3T3-L1 cells, T1",pert
3T3 cells,pert
gallbladder saline treated,ctrl
Tgfbr2 fl/fl Control Posterior Palate 2,ctrl
sex: Male;	family: 4;	age: 16;	disease status: Control;	tissue: Muscle: Biceps,ctrl
TTP_WT_60ActD_BioRep4,pert
WTT 161 bleomycin treated,ctrl
"wild-type P9 hair follicle, biological rep1",ctrl
Bone marrow,ctrl
cell line: SLM2;	mutation: WT;	treatment: Treated with Sorafenib,pert
"Alk2 cKO mice, whole uterine tissues, replicate 2",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.04;	OD280: 0.53;	Ratio: 1.97;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 286;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Individual_4999_NN_sample,ctrl
B/OVX/no inj/0h/UTX 129/SvImJ WT,ctrl
Placenta_nl3,ctrl
RNA from HCC_27T,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID297,pert
"Liver from control exposed rats, biological rep 2",ctrl
purified Gfp+ photoreceptor cells,pert
tissue: hepatocellular carcinoma tumor;	treatment: vehicle;	strain: Wistar,ctrl
Insm1 control #10,ctrl
sex: Male;	Age: 50 months;	additional patient information found in Series supplementary file,ctrl
atopic eczema P7,pert
AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 2,pert
"Lymphoblastoid cell lines derived from family 1725, member 1",pert
12477 UC Inflamed ascending colon,pert
treatment: DMSO;	time: Day3;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
"12 weeks old normal mice, cerebellum",ctrl
human skeletal muscle,pert
Gata1KO25+#2,pert
Anterior tibialis,ctrl
E_LS_Wk4,pert
MDS patient 144,pert
Normal breast stroma,ctrl
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
Control male 5,ctrl
M325 C,ctrl
WFS1 WT USHT_03_335_wt,ctrl
Parkinson's disease sample x024,pert
"Mouse liver, wild type, healthy, 3 months",ctrl
primary normal lung tissue 1103,ctrl
01N43_ERA,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 209,pert
"Monuron-treated NRK-52E cells at 24h, biological rep 2",pert
CD8+_Tcells_healthy_donor_8,ctrl
EVI_GFP negative Lin- cells replicate 2,ctrl
adenocarcinoma (ADC6),pert
"A673 treated with Puromycin for 3 days with concentration of 0.09 uM (EC50), biological rep1",pert
patient E1542,pert
Txnip deficient tumor 22 months sample 3,pert
MCF-10A shATR-4 replicate 3 [set 5],pert
F_LS_Time0,ctrl
"Kdm2b KD E14, rep2",pert
"schizophrenia, BA10-6(2)",pert
Evi1-2,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 2,pert
abl cells depleted of EZH2 under hormone depleted conditions,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 19 yr;	population: white;	dsm-iv: 296.73;	age of onset: 17 yr,ctrl
liver_Wt_female_8wk_rep3,ctrl
WT #142,ctrl
B6_Male_CF_rep2,pert
Control 13,ctrl
PBMCs_Control_20 [IS],ctrl
tissue type: Primary lung tumor;	histology: LA,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: test compound CP-529414 (CETP+ /BP+ THQ+);	dose: 100 nM;	time: 3 hr,pert
ASO T00278948,pert
C2E-LU,ctrl
OE control 3,ctrl
"mouse aorta cross strain comparison, C3H_T04_NC_02",ctrl
Untreated Control 12weeks AffyGC RMA rep8,ctrl
memory P14 T cells #1,ctrl
CD47 null lung Endothelial cells,pert
microdissected breast cancer cells from case 1279,ctrl
"Control Day 0, biological rep1",ctrl
Lung myd88 mock repA,pert
Strain:C57BL/6;	Gender:male;	Age:8 weeks,pert
MCE301 cells treated with SB for 12 h-2,pert
MCL_IGHV_MUT (R1591),pert
strain: C57Bl/6;	genotype: Myc(F/F);CreER;	cell type: CD8+ T cells,pert
major non-tumor3,ctrl
microdissected breast cancer cells from case 25,pert
"RPMI8226_shLuc, replicate1",ctrl
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_3,pert
PE_D_651,pert
RAW_1.4mM_HOCl_#3,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with vehicle for 6h,ctrl
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 1",pert
Sample ID: TP27;	Twin Pair ID: CCN5.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 34;	Current Age (2007): 37;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: WT,pert
treatment: Non-specific shRNA (shNS);	cell line: MDA-MB-231,ctrl
Huh7 cells_Mock Infected 18 hours_ rep1,ctrl
healthy control C8,ctrl
Untreated Control 12weeks AffyGC RMA rep4,ctrl
RNAi -Transgenic replicate 6,pert
3IDC_normal_ductal,ctrl
RNA from microdissected breast cancer cells from case 518 labeled with Cy5,ctrl
01UP9_ERA,pert
CLL19-CD8,pert
Murine osteoclasts,pert
"CD14+ at baseline, biological replicate 2",ctrl
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep2,ctrl
wild type parietal cell replicate 1,ctrl
jzo032-rp1-v5_u74av2-met,pert
"48 hour-treated TG2 knockout NB4, biological rep1",pert
B7m3,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous endotoxin challenge""",pert
"213, ADIPOOSE TISSUE, Before",ctrl
Neocortex_Eomes_KO.8,pert
MCL_IGHV_UNMUT (R1394),ctrl
HOX424 Control Day14,ctrl
JIA PBMC Post treatment A235_L221(2),pert
tissue: brain;	genotype: mutant Ndel ko/+;	age: E14,pert
olfactory epithelium,pert
57SageA,pert
cell line: MLL-AF9 AML cell line 10986 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
Disease_status: Bipolar disorder;	Age (years): 64;	Gender: Male;	Age of onset (years): 19;	Duration of illness (years): 45;	Brain pH: 6.10;	Post mortem interval (hours): 16;	Side of brain: Right;	Fluphenazine mg. Equivalents: 130000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Peripheral blood mononuclear cells;	TTF=137min;	Race=White;	Sex=Male,pert
ILD Study Number S033,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 2x1h exposure per day",pert
A HID B_B082,pert
"mouse liver sample, WT strain, biological replicate 1",ctrl
"NCI-H1650, Untreated",ctrl
F6.04,pert
Cdx2 overexpression,ctrl
tissue: white blood cells;	age: 13.75;	Sex: male,pert
strain: C57/Bl6;	genotype: Akt1¬-/-;	gender: PND70 female,pert
gastric biopsies,ctrl
"human failing LV myocardium, Idiopathic14",pert
amygdala long access to cocaine replicate 4,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
tissue: testis;	genotype: repro9/repro9;	age: 17dpp,pert
HMEC X BC790,pert
whole tissue section from case 289,pert
A39 WT3	F7/3	A39	wild type	Mouse	4 months	Cerebellum	Male,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous endotoxin challenge""",pert
Myd88 KO control tissue  5,pert
uterus_P4_WT_4hrs_rep1,ctrl
01LMY_Oligo,pert
"WildType mice with water, replicate 1",ctrl
Colon_Wild Type+Quercetin_1,pert
P7A Progranulin-frontal,pert
"Cultured ovarian cancer cell line OVCAR-10, untreated",ctrl
IDCM6,pert
FMR1_1,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 40, stage IA, HPV 45",pert
TMRI AO 48hr,ctrl
"Patient M030-230, MSI colorectal tumor",pert
prefrontal cortex (BA46);	schizophrenia,pert
"24hr Hic5 siRNA, 16hr 10nM DHT treatment replicate 3",pert
PsOEt-22-LS,ctrl
Glucosamine Transcriptome Profiling {rpt},pert
PBMC;	Age: day 14,pert
10 week control spinal cord rep 1,ctrl
Rat Dorsal Root Ganglia,pert
individual: patient13;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with vehicle for 6h,pert
H1299 vehicle control (3224),ctrl
subject: 21U;	cohort: 21;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 63kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
CGR8 embryonic stem cells,ctrl
A2058 Ctrl siRNA,ctrl
tMLL01,ctrl
quadriceps_muscle_Wt_female_8wk_rep1,ctrl
mouse embryonic stem (ES) cells,pert
unstimulated confluent HUVECs,ctrl
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
WT-MAC-UV-1,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 1,pert
ubb_d28_ko_1,pert
Control with WY14643 replicate 4,pert
Sample ID: TP18;	Twin Pair ID: CCN2.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 27;	Current Age (2007): 30;	Sex: MALE;	Medication at blood sampling : None,ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 3,pert
E2-GemKD,pert
SK-BR-3 breast cancer cells stably transfected with empty vector,ctrl
visceral_fat_Akt1+/-_female_8wk_rep3,pert
Panc0403 rep-1,pert
"seminoma specimen, pT2, patient age: 30y",pert
HL-60 cells treated for 24h with 100 µM curcumin,pert
Patient liver biopsy,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 2,pert
"siPRMT8 neuron, biological rep2",pert
MOLM-13 cells,pert
siSPDEF_4,pert
"fibroblast, MFS subject FB1286 rep 2",pert
25SAGEA2,pert
female_alcoholic_443,pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T2, N1, M0, G4",pert
BALB/cByJ Vehicle liver sample batch 5,ctrl
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 1",pert
A39 WT7	F2/14	A39	wild type	Mouse	10 months	Cerebellum	Male,ctrl
HeLa cells transiently transfected with a control siRNA,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated, biological rep2",ctrl
Gastric_cancer_patient_5_dye_swap,ctrl
Postnatal 3 weeks control heart biological rep3,ctrl
"genetic background: B6;	genotype/variation: Gata1 knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
aneurysmal tissue: sample #2,pert
"DMSO-treated, 24h after UV, Replicate A",ctrl
Ada3FL/FL MEFs_Cre adenovirus,pert
"Donor 3, Ebola infected 1hr",pert
Tsc1-deficient CD8 naïve cells,pert
Endometrium from tibolone-treated postmenopausal woman,pert
3881-1 E2F WT,pert
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 24;	maternal age: 24,ctrl
gender: male;	disease state: healthy,pert
"Patient 7, lesion tissue",pert
inguinal fat,pert
ccRCC tumor of patient T183,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): EtOH vehicle,ctrl
PND28 Rat Testis_Rat230-2_6hr MEHP_Animal#32_04005,pert
L428-PAX5+M_rep1,ctrl
hNHEPS_control_0 h_rep4,ctrl
PC-3 cell  pre mir-221,pert
cell line: HCT116;	shRNA: non-target;	treatment: untreated,ctrl
cerebellum wild type 6 month replicate 3,pert
BT474_DMSO_24-3,ctrl
m1-carcinoma4,pert
"101, MUSCLE, Before",ctrl
iFGFR1 mammary gland NT,ctrl
MDS15,pert
"Wild type used for GNMT 3 month, replicate 2",ctrl
K562 cells CREB Knock-out replicate 5,pert
"PBMC, healthy control, biological rep1",ctrl
MKK7D control female replicate 10 late timepoint,pert
age: 12 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
PGA-lv_1h_511,ctrl
WT STR PDE10i 13,pert
Dexamethasone 3,pert
disease state: Control;	gender: Male,ctrl
"Peripheral blood, patient with recurrent events [N28]",pert
cell line: SF539;	transfection: Scramble siRNA,ctrl
A61 NES 142Q TG3	F6/23	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep2",ctrl
breast cancer patient 318,pert
pD  is a clonal control (puromycin resitant) stably-expressing stem cell line,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
pSUPER-scramble replicate 3,ctrl
strain: C57BL6,ctrl
LICR_HN1_PBS2,ctrl
CD4+_Tcells_severe_asthmatic_8,pert
MPM tumor 18,pert
FK3,ctrl
c_NY104,ctrl
Liver-5 month-wild type-technical replicate 3,ctrl
Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours,ctrl
"Normal subject (51 year old caucasian female, SAK_1290253859)",ctrl
473MM,pert
IMR-32_pCMV-DPP3_48hr,pert
whole blood_102321,pert
HT144 melanoma cell line,ctrl
tissue: skin;	individual: Patient P10;	condition: AL;	eczema severity: SCORAD: 37,pert
patient: 51176;	sample: tumor,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 50,pert
T146,pert
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID355,ctrl
mouse jejunum_hnf1alphacontrol_rep1,ctrl
Control mice,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 21;	gender: male,ctrl
no_17,ctrl
erStress_twins_AA_1733twin1_500nM_thapsigargin_4h,pert
126KD 18A n,pert
DRG_Capsaicin_10microM_Rep3,pert
"TH cells from LC, wild type control, biological replicate 3",ctrl
dex24hr_2,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: PTEN mutant = Mx1-Cre positive: PTENfx/fx. Sex: Female. Age: Eight and a half weeks (at tissue isolation). Tissue: Intestinal polyp from small intestine (jejunum/ileum region).",pert
strain: C57BL/6J;	genotype/variation: WT;	gender: Male;	age: embryonic day 15;	tissue: frontal cortex,ctrl
"control, BA46-15",ctrl
GFP4_1578J,ctrl
"array 21, xenograft, 0.3% Tween-20 vehicle",pert
S5-040803-SA,pert
SHP-/-_rep1,pert
HL60-shControl-rep3,ctrl
695_383_0hr_repeat,ctrl
control sample 1,ctrl
"Acute Myeloid Leukemia, sample 33",ctrl
shGFP-rep-1,ctrl
C2C12 myotubes 1uM H2O2 rep 4,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 8 hr AP20187,pert
Tendon;EDC_Non-lesional,ctrl
Mammary Gland_Cav-3KO_rep1,pert
"alveolar macrophages, non-smoker 021",ctrl
ND_1,ctrl
prostate normal 5,ctrl
CD19_selected_B-cells_after_R_rep5,pert
Phytohemagglutinin-activated PBMCs from normal control subject J (JAcPBMC),ctrl
CEPI_IIb_413,pert
strain: C57BL/6;	tissue: small intestine;	genotype: cftr-tm1Unc (cftr null);	treatment: none,ctrl
construct: Luciferase Control shRNA;	cell type: Primary human erythroid progenitor cells,ctrl
"RES-enriched Grape extract group, 6 months, patient number 62",pert
background strain: CD1;	age: p23;	tissue: pancreas;	genotype/variation: Sox9-EGFP;	facs: GFP-,ctrl
HD5,pert
race: caucasian;	age (years): 57;	stage: IB;	grade: 1;	histology: endometrioid,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 55, stage IIIB, HPV 16",pert
cerebellum_PS-/-_ 20d_rep1,pert
"AD_FC, biological rep2",pert
Squamous cell carcinoma 030,pert
Ischemic cardiomyopathy_G19,pert
N1+2,ctrl
Liver Experiment 2,pert
gastrocnemius-30 months of age-control diet-biological replicate3,ctrl
wild-type+PQ rep_3 (PQWT3),ctrl
"WT mouse heart at 6-weeks old, biological rep2",ctrl
Neocortex_Eomes_KO.4,pert
3274-2 E2F WT,ctrl
MDS patient 93,pert
H1 Ctrl 2h 1,ctrl
"Cadmium 1.2 µM, biological rep3",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: healthy control,ctrl
Liver_Control _Rep1,ctrl
sample description: pool of total RNA from 10 human cell lines,ctrl
murine Pten null prostate,pert
C_AN12240_T,ctrl
Bone-Marrow_SMM_S1331,pert
"Patient 3, lesion tissue",pert
Chronic active plaque 1 (CAP1),pert
MEKi 16h biological replicate 1,pert
liver cells from wildtype 8wk male mouse 8 challenged with acetaminophen (APAP)_14,pert
Superior Frontal Gyrus_5y_normal,ctrl
"fibroblast, MFS subject FB890 rep 2",pert
"30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
WT_PLACEBO_48hours_2,ctrl
EOM 112 Day Control rep 2,ctrl
D_LS_Time0,ctrl
Skeletal muscle tibialis anterior (TA) from mdx line,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,pert
"117, MUSCLE, Before",ctrl
H295R_Group_A_Dose_NA_TIMEPT1_001,ctrl
tMLL07,ctrl
"RES-enriched Grape extract group, 12 months, patient number 41",pert
BJ-iPSC_2,ctrl
strain: FVB/N;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Fibroblasts;	genotype: PtenloxP/loxP,ctrl
Lamp3 KD 3d 1,pert
Wt1-null MEFs-4,pert
homozygot FH P269 (human CD3 positive T cells),pert
ANL Chip#27,pert
"3T3-L1 siControl 48h, biological rep 1",ctrl
9SC- nbc,pert
Run3.aUa.010110d.SkMDbt1138D.CEL-DB basal,ctrl
SW480 Snail (1),pert
Nonlesional Epithelium Nonatopic Control rep2b,ctrl
WT4-iPS 3,ctrl
Female - caucasian - N-04-M,pert
A431 WT 1,ctrl
patient: 16;	disease state: hypertension;	tissue: Atheroma plaque,pert
cumulus_PCOS_Obese_rep2,pert
platelet_sickle_8,pert
bulk normal breast or normal bresat organoid,ctrl
Age (mean +- SE),pert
liver wild type replicate2,pert
ref,pert
P70 Non failing heart biopsy,ctrl
Head RNA of littermate wild@E13.5 No.4,ctrl
resected liver tumor,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
normal plasma cells (NPC 547),ctrl
strain: CD1;	tissue type: back skin,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A09",pert
"HMEC-TR, SiRNA anti-TIF1γ",pert
siControl repeat,ctrl
CA2 Cre Sox17E,pert
RE550_KPL4_un1,ctrl
Patient: A;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"C3H/HeJBir-Il10tm1Cgn, sample 2",pert
"gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Unpooled PBS-treated 4 hr spinal cord cultures,pert
"A549, +TNFα, control siRNA, rep3",ctrl
chip number: 23;	transfection plate: 4;	target gene: IRF7;	kd level: 0.76;	rin: 9.3;	transfection date: 2011-10-17,pert
liver_NEMO_KO_replicate3,pert
M12 - non-infected MBT/Pas fibroblasts,ctrl
"ALL_DS, K18 011409",pert
N3_Cy3,ctrl
Peripheral Blood Mononuclear Cells;	Unknown Age and Gender,ctrl
NPC_SA01_1,ctrl
Turner_AF_1,pert
M7KOepi_infect_0h_rep1,pert
CD34+ cells from the patient (CML32),ctrl
HeyA8-(2)b,ctrl
Individual_3690_PN_sample,pert
DNMT1-3,pert
Septic shock;	gender: Female;	Survivor;	organism: None,pert
Fetal heart control 6,ctrl
Cancer 13,pert
OSE4 shARID1A at 72h,pert
MCF-10A shControl replicate 2 [set 5],ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_4;	fev1 (% predicted): 65;	fvc (% predicted): 81;	medication: Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn;	cell type: CD8+ T-cells",pert
MRF conditional knockout cultured oligodendrocytes,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 74;	Sex: male;	region: LC;	age: 39;	genotype: Y/Mecp2-;TH/-,pert
Group5: 6 days differentiated Flk1+ Tal-1-/- ES cells,pert
"patient: 106;	current medication: None;	birth date: 5/29/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: Abdominal pain, upper GI symptoms.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
GFP_Untreated_24hr,ctrl
HD 3,ctrl
Squamous cell carcinoma 020,pert
hippocampus,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 3x1h exposure per day",pert
T-REx293-NPAP1-uninduced-1,ctrl
11_0020C_Day1_29,ctrl
chip number: 11;	transfection plate: 6;	target gene: JUND;	kd level: 0.77;	rin: 9.1;	transfection date: 2012-03-26,pert
01L4N: normal control,ctrl
"Normal subject (52 year old caucasian female, SAK_1290097388)",ctrl
4-Vinylcyclohexene Diepoxide (50uM) rep 1,pert
"seminoma specimen, pT2, patient age: 31y; W03 033",pert
tissue: Temporal cortex;	age: 88;	Sex: F,pert
DMSO Treated Control 4,ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 86;	Usage number: 4;	Exposures: 3,pert
Pediatric_GBM_6,pert
NL C,ctrl
Mut+/+ rep3,ctrl
Individual_5935_NN_sample,ctrl
sample =XCGD2 treatment=Stimulated time=180 (min),pert
A673 cell line that has been treated with Puromycin for 5 days with concentration of 0.09 uM (EC50).,pert
WT-sham-5 month-R3,ctrl
Kin- S49 Cells 6h cAMP treatment,pert
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate2,ctrl
kidney tissues from lean rats on diet with rosiglitazone,pert
c 4-2,pert
HRas-v12 transgenic female replicate 2 late timepoint,pert
Epidermal keratinocytes treated with EphB2 for 4h,pert
E12.5 Lim1 mutant embryo renal vesicles isolated by laser capture microdissection,pert
Individual_5257_NN_sample,ctrl
PBMC from T cell LGL leukemia patient #117 (TLGL117),pert
NE,ctrl
LNCaP + vehicle rep 2,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 4,pert
1195-03-A,pert
Human Uninfected Sample N141-CD8+ T cells,ctrl
SZ11,pert
4mo tg1,pert
"Lymphoblastoid cell lines derived from family 1757, member 1",ctrl
Strain: (129S4/SvJae) (PPARalpha knockout);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,pert
Skin_SKO_Rep3,pert
KU_34N,ctrl
Individual_4163_PN_sample,pert
Insig1 flox/flox /Insig2 -/- InsigKO_C1,ctrl
MDS43,pert
Tumor,ctrl
Run2.aUa.001206d.SkMInS1090D.CEL-IS basal,ctrl
Control spleen - Biological Replicate 2 - Technical Replicate 2,ctrl
H4-II-E-C3_untreated_rep4,ctrl
b143,ctrl
"experiment 2, ethanol-treated 3",pert
lesion_postUV_patient6,pert
Wild type unstimulated 2,ctrl
S8A Sporadic-frontal,ctrl
miR122-WT-125,ctrl
Tgfbr2 Wildtype Mouse Model MEPM 4,ctrl
APOE_KO_DM_9W_2,ctrl
"Wildtype, biological rep3",ctrl
Wt Mouse_cerebellum_Old_saline treatment_Replicate-1,ctrl
"IL22KO4_ileum, 5 days post-infection with T. gondii",pert
Individual_4505_PN_sample,pert
HepG2 cell line from ATCC at 8th generation after 30 minutes of PCB77 treatment.,pert
tissue: testis;	gestational age: 16 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
Ramos pRTS-CA-IKK2 F+,pert
fat_Wt_8wk_rep2,ctrl
N8_Cy3,ctrl
untreated_6hr_rep2,ctrl
U-87MG-V22 set 5,ctrl
I_LS_Wk1,pert
HCC_15T,pert
"PCOS, biological rep 7",pert
"granulocyte, healthy control, biological rep8",ctrl
"n24, surgically resected from patient of gastric cancer.",ctrl
S3-040330-SA,pert
con-13_B,ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 4",ctrl
Muscle PCOS pioglitazone 101,ctrl
Elf4 KO1 activated CD8 T cells,pert
heart female pbs 10 dpi rep2,ctrl
prostate_Klf5 ko_rep4,pert
RE550_H1650_4-Medi5117,pert
Nerve_Diabetic_Vehicle_708,pert
SLE myeloid cells 3,pert
genotype/variation: C57BL/KLS-leprdb/leprdb (db/db),ctrl
cell line: DAOY M2.1;	cell type: medulloblastoma;	genetic modification: siRNA scrambled,ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Palate 5,ctrl
KU_42T,pert
AR-CO-24-2-549,pert
Lung dnCREB-PBS replicate 3,pert
Rybp#10 (OHT-)_4d_rep2,ctrl
T51722,pert
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: normal condition (Naïve);	treated with: 0.8 uM INCB18424 for 4 hrs;	sample type: acute,pert
kidney,pert
Bone Marrow Mononuclear Cells;	27y Male,ctrl
RA_x,pert
Human monocyte-derived macrophages,ctrl
Liver_WT_Rep4,ctrl
con-13_C,ctrl
RI34,pert
whole heart,ctrl
LJMJDW3,pert
"brain, cerebellum, Purkinje cells, wild type",ctrl
48 hrs TAC-4,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 8h,ctrl
whole lung,ctrl
BALB_Male_Control_rep1,ctrl
Patient: D;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
34_C57_WT,ctrl
cell type: Primary hepatocytes;	strain: BalbC;	agent: Wy14643;	time: 6h;	gender: Male;	age: 6 months,pert
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 5",pert
MacularDegen-healthy-8dAv2-s2,ctrl
Dental pulp cells idipopathic autistic patient triplicate 3,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.06301,pert
5L,pert
H_Kin_2,pert
"siSCR ES, biological rep3",ctrl
48 hrs sham-3,ctrl
PBMCs_Control_14 [IS],ctrl
RNA from whole tissue section of case 1260 labeled with Cy5,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 122;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
KU_12N,ctrl
"breast tumor epithelium,38",pert
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate1,ctrl
"24hr Hic-5 siRNA, 16hr vehicle treatment replicate 3",pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: B;	experimental sample name: PC12-R,pert
CD-58-Aff,pert
231_GATA3_rep2,pert
tissue: Aorta;	genotype/variation: SRF-flex2neo -SM22CreERT2ki/+;	genotype/variation: smooth muscle specific SRF knockout;	age: 4 month-old,pert
FW_3a_BV8771,pert
cell line: non-clonal BMSC cultures,ctrl
sXBP3_1578S,pert
"Typically Developing Control, Gracilis, Patient Replicate 8",ctrl
RatLung_H24h_1,pert
WT Liver - Pooled -Cy3,ctrl
wt_rep2,ctrl
MacularDegen-injured-7aAv2-s2,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: untreated; biological replicate: 1,ctrl
EB_0_19d_73_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
"control, BA46-86",ctrl
"Gracilis Mucle, Cerebral Palsy",pert
"Patient S120, MSI colorectal tumor",pert
tissue: Spleen;	genotype: TRAF3flox/flox (littermate control),ctrl
heart-ko-2,pert
"EBF1 d4, rep 1",pert
Bone-Marrow_MM_M797,pert
H4-II-E-C3_low_rep1,pert
"Peripheral blood mononuclear cells, RF- polyarthritis",pert
3638-lcm,pert
"control, BA10-21",ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case1,pert
"Sh2b3 KO, biological rep2",pert
"Keratinocytes untreated control, 1h",ctrl
01MCY_Systemic,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 21;	gender: m;	treatment: -,ctrl
4 hour tunicamycin wild type A,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with MEK inhibitor for 16h,pert
"ADIPOSE TISSUE, PLC, Before",ctrl
T51628,pert
siEGFP (72 hr) _2,ctrl
"patient 011b, cancer, homogenized",pert
MPM tumor 8,pert
3551-1 E2F WT,pert
"control for Abca1 +/- ES, RNA 80",ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 32;	maternal age: 29,pert
CH2111,pert
40 year old male,ctrl
5253 UC Uninflamed sigmoid colon,pert
"Control, Liver, 14M",ctrl
Mouse old brain C30-Br-5,ctrl
ILD Study Number S034,ctrl
NCI-H716_Control.2,ctrl
cell line: HUES6;	treatment: control,ctrl
b9.2,pert
tissue type: normal thyroid;	matched/unmatched: matched to T16,ctrl
T56 U133p2,pert
"Control Day 5, biological rep3",ctrl
Pancreatic Sample 36-Tumor,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 43;	gender: male;	tumor grade: AIII,pert
BSKO 1,pert
"gender: Female;	age: 88;	post-mortem delay: 7h;	ph: 5.7;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
gender: female;	age (years): 45;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
No_abuse_1,ctrl
Wild type_heart_2,ctrl
Genotype: p38alpha wt;	Age: E13.5,ctrl
disease state: paediatric glioblastoma;	age: 2;	gender: F;	h3.3_status: wt,ctrl
C57 48 air 1,ctrl
P76 dilated cardiomyopathy heart biopsy,pert
P78 dilated cardiomyopathy heart biopsy,pert
age: 61;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"villin-creERT2:beta-catenin-/lox, induced by tamoxifen for 2days",pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 0, Units of Harvest Time Point: hr",pert
HLA risk: Low;	Height: 178 cm;	Weight: 81.7 kg;	BMI: 25.6;	Age: 32.78 years;	Gender: Male;	Race: White;	Glucose: 114 mg/dl;	HbA1c: NA,ctrl
agent: EphB2-Fc conjugate;	time: 24h,pert
"human failing LV myocardium, Ischemic48",pert
s5t1c,ctrl
Control spleen - Biological Replicate 2 - Technical Replicate 1,ctrl
infection status: mock-transduced control;	cell type: human ccRCC cell line,ctrl
Ishikawa_HighDose_BPA_48h_rep3,pert
"Atm-/- untreated, C",pert
Carbo Day14 (301L),pert
"twin pair: #9;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"Mutant in the absence of tetracycline, rep1",pert
Braak α-synuclein 3-4 BR34_3SN,pert
Wildtype_TAC_Rep3,pert
1a_b,pert
"affected status (disease state): control;	gender: male;	age-at-examination: 66;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",ctrl
MDS patient 39,pert
Day: 15; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 3,pert
wild-type littermate of B6.BKS Ighmbp2nmd-2J mice;	6 weeks of age;	male,ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.59;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
Sample Group: HD patient; Gender: male; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/45,pert
ATM_siRNA_0b,pert
"Patient 65N, normal colonic mucosa",ctrl
"Cervical cancer cell line, SW756",pert
con-9_A,ctrl
8DKD_SerumStarved->1hrEGF_rep2,pert
healthy control C10,ctrl
Preglaucoma control rep9 (OHN),ctrl
"Rat pups treated with acrylamide, spinal cord",pert
model: model: Fischer  344;	gender: Male;	age: 21 to 22 months old,pert
"NC1, biological replicate 3",ctrl
CD3+ cells,pert
"brain, hippocampus: KA-6h-P15-I_e1_le1",pert
Donor6_6h_Wy,pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with seronegative arthritis",ctrl
Mening SWB WB NP 6a,pert
H1299 SC_rep 2,ctrl
PZA treated-63d-2,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P60,pert
KU_43N,ctrl
BP23,pert
28n,ctrl
hippocampi pool from 3 SLA rats,pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P4,pert
"Control #8, Untreated",ctrl
Hippocampus_Soman_3h_rep6,pert
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: wild type;	cell type: mouse embryonic fibroblasts (MEF cells),ctrl
"PCB77 treated HepG2 cells at T0, biological replicate 2",ctrl
muscle_Wt_8wk_rep1,ctrl
Vit-WT,ctrl
FTO1_C1_48h,pert
mouse: 3;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
LacZ control_0b,ctrl
cell line: HT1080;	clone: 21;	genotype: Knockout,pert
tissue: testis;	gestational age: 16 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: corn oil vehicle,pert
19GOBMUC2H,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 2,pert
cell line: MOLM-14;	replicate: Replicate2;	treatment: shSYK_1,pert
"ASC, non-obese individual (ASCn)",ctrl
"skeletal muscle, long duration",pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: F;	experimental sample name: PC14-R,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID76,ctrl
HeLa cell line treated with esiRNA,pert
MDS patient 1,pert
PTC histology,pert
tissue: Embryonic lung E18.5;	genotype: C57BL/6 Hmga2 KO;	age: Embryonic Day 18.5,pert
24h PTD-DRBD GAPDH siRNA (SAMPLE 10),pert
"1mg/kg/day PFOA, Rep 2, Block 3, lung (low dose)",pert
"Spleen, CD4+CD25hi Tregs, Gata1 knockout",pert
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug TAK1 siRNA;	treated with: 100nM PD173074 for 48 hrs,pert
sample type: Primary culture of type II cells collected from SPC WT lung (adult);	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C WT;	genetic background: 129S6/SvEvTac,ctrl
HLA risk: High;	Height: 170 cm;	Weight: 59 kg;	BMI: 20.4;	Age: 40.56 years;	Gender: Female;	Race: White;	Glucose: 74 mg/dl;	HbA1c: NA,ctrl
ILD Study Number 1243,pert
06R028 RA,pert
strain: backcrossed 3-5 generations on C57BL/6 from FVB;	rna: TRAP;	driver: S100a10;	line: ES691/p11 KO;	tissue: cortex;	treatment: fluoxetine,pert
age: 52;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
APOE_KO_RAGE_KO_NODM_9W_13,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: Treg;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
Kidney_Aqp11+/+_P7_4-1,ctrl
Pt24_Pre,ctrl
Human mammary epithelial MCF10A cells,pert
CONTROL;	Age = 18;	Sex = F,ctrl
Brain of WT mice,ctrl
NSCL/P sample 5,pert
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting KDM3A,pert
"Mepenzolate treatment, 7 hours (replication 1)",pert
tissue: skeletal muscle;	disease status: healthy control,ctrl
CC1 21d replicate 3,pert
"E2A CLP LY6D-, biological rep4",pert
"psoriatic epidermis, phototherapy, 1 month",pert
Duoden22VAFBA_066.txt,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#111,pert
Cardiac Muscle_mdx_rep3,ctrl
409MM,pert
MDA-MB231 PIAS1 shRNA cells,ctrl
110A,ctrl
4-HPR_LIVER_3,pert
Rat fatty liver18,pert
"BMMC, WT, activated",ctrl
cell line: Abelson B cell line,pert
NPC_VUB03_DM1_3,pert
4T1.2 IRF7 expressing cell,pert
strain: FVB/N;	tissue: forebrain,pert
Cerebellum_nontransgenic control X50_16 months_replicate 2,ctrl
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep2",pert
Squamous cell lung cancer X42sqm,pert
uterus_veh_PRKO_4hrs_rep2,pert
control virus-infected replicate 1 (monocytes),ctrl
tissue: Temporal cortex;	age: 83;	Sex: M,pert
olfactory bulb,pert
EA_Case4_CD4,pert
MLL_00128,pert
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
treatment: STI (Imatinib);	cell line: K562,pert
tissue: Temporal cortex;	age: 77;	Sex: M,ctrl
H69_TGX221_5,pert
HF0332_U133P2,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 1;	choa: 379;	fata: ;	eea: 1510;	wtkg: 63.2;	perfat: 25.7;	lbm: 41.6;	fat_mass: 1624.24,ctrl
Wistar-derived-Liverpool John Moores University rats,ctrl
"human failing LV myocardium, Idiopathic72",pert
1833 cells,ctrl
"WT brain, biological rep4",ctrl
"Spi-21, biological rep 4",pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 0,pert
EA_Case21_CD8,pert
"Male, 49 years old, HIV infection of ~3 months",pert
CTL2 E2 72hr,pert
CD46+/STAT1-KO hippo - Untreated-E,pert
cell line HCT-116,ctrl
"cells treated with Scrambled siRNA, biological replicate 3",ctrl
Human Chronic HIV Sample C102-CD8+ T cells,pert
"cells treated with Vamp7 siRNA, biological replicate 2",pert
"TMD_GL, T2",pert
Control right atria,ctrl
"human failing LV myocardium, Ischemic44",pert
quiescent p27KO MEFs 3,pert
mES cells rep3,ctrl
Bronchial Epithelial Cells SA biological 2030T,pert
Ctrl siRNA 3d 2,ctrl
IMR-32_pCMV_48hr,ctrl
control participant P350,ctrl
LT 344 +/T untreated,pert
cell type: Primary hepatocytes;	strain: DBA;	agent: Wy14643;	time: 6h;	gender: Female;	age: 3 months,pert
"Mouse LV, WT 2",ctrl
S10A Sporadic-frontal,ctrl
P4_TR_2,pert
Mouse Soleus 4 weeks post birth,ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever drinker,ctrl
whole blood_101726,ctrl
"3mg/kg/day PFOA, Rep 4, Block 4, liver (low dose)",pert
Pcgf6_2_shRNA1-dox,ctrl
RORasg/sg liver_HFD_rep1,pert
PKBa-/- MEF time 0 replicate 3,pert
14-week-old WT liver_613WT,ctrl
HIF-1-/- S. aureus 5,pert
HeLa_TP082505-25_HG-U133A_2_IMFGN0023,ctrl
jejunum_control_3,ctrl
Age: 40;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Unknown,ctrl
"human failing LV myocardium, Idiopathic58",pert
C2C12 myotubes 1ulMH202 rep 1,pert
Gastrocnemius muscle mRNA from young (10 week old) wild-type mice,ctrl
"Scarmbled control knockdown, replicate 1",pert
"brain, wild type",pert
tissue type: Normal lung;	histology: Normal lung,ctrl
Bone-Marrow_MGUS_G403,pert
XBP1s B cells 1,pert
monocytes,pert
"LCL GM19238, Kd ESRRA, 72hrs",pert
siSPDEF_1,pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 24;	maternal age: n/a,ctrl
H03_P_B1,ctrl
1085PBMC,ctrl
"C57BL/6 female 3 weeks, 125",pert
B7hi mTEC B6/129 wt3,ctrl
siGFP-transfected sample 1,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 40.06301,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1mi;	er: 1;	pgr: 1;	dfs-month: 35;	dfs-event: 1;	distant metastasis: 0",pert
pool of thyroids from 6 months old wild type mice,ctrl
Chondrogenic progenitor cells from OA male 2,pert
9-cis-retinoic-acid_LIVER_4,pert
gender: male;	individual: patient 5;	treatment: control,ctrl
Cpr-lox_pool 1,ctrl
MDS patient 171,pert
"breast tumor epithelium,2",pert
S6A Sporadic-frontal,ctrl
BL Day 2 siSC transfected biological rep2,ctrl
age: 6 month postnatal;	tissue: striatum;	genotype: SNCA knockout,pert
amygdala no access to cocaine replicate 3,ctrl
MCF-7cells treated with 500 nM 4-hydroxytamoxifen and scrambled siRNA,pert
Normal Cervix N17,ctrl
siRNA-140_rep3,pert
BM_preTherapy_IIa,pert
A549 cell siRNA against STAT3,pert
negatively selected CD4+ splenocytes from an individual mouse treated with cecal ligation and puncture,pert
"KSR1 Alone, Replicate 1",ctrl
LY2 SRC1-siRNA untreated rep4,pert
MCL_IGHV_MUT (R1626),pert
Mammary gland R1 16 hr rep1,pert
Metastatic prostate cancer tissue pool WX2,pert
"Control siRNA - 2 days adipocyte differentiation, rep2",ctrl
cell line: MCF-7;	agent: control,ctrl
Mouse embryonic fibroblasts,pert
3979-1 E2F1 Null,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_1mM_HG-U133A_2_YCHSUP501,pert
"CA2, parental control SOX17 HESC- clone2",ctrl
B2KO; No Treatment #7,pert
"Peripheral blood was obtained by venipuncture from healthy adult volunteers. Blood samples from umbilical cords of the placentas of healthy, full-term infants after scheduled caesarean section or vaginal delivery were obtained by puncture of the cord immediately after delivery",pert
A_AN12457_T,pert
GM19238_Kd_STAT6_1,pert
pcdh12-deficient mice rep5,pert
2008 cells_rep2,ctrl
cell line: MDA-231;	transfection: pCMV-TARBP2,pert
"YPFH cells from M1, Mecp2 null, biological replicate 1",pert
IDTC 1,pert
SZ22,pert
pancreas,ctrl
TMRI AO 2hr,ctrl
tissue: blood;	control: 5;	gender: male;	age: 41,ctrl
39A;pretreatment;female;breast tumor,ctrl
cell type: fibroblast;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: P9;	clone: 0,ctrl
"Brain tissue from Fisher 344 male rat, Animal #243, control (0mg/kg) D-Serine",ctrl
Caries 2,pert
cell: MCF-7;	treatment: control siRNA and vehicle (control),ctrl
"CD8 DC Xbp1 KO (DC conditional KO), biological replicate 2",pert
age: 45;	gender: male;	ejection fraction: 34;	left ventricular end diastolic diameter: 62;	inflammation/PVB19: positive,pert
from Lim1 mutant mice E 12.5 renal vesicle,pert
WT - Cre Untreated - 0 hrs - repeat 1 - Cy5 - mAdbID:61713,ctrl
HepG2_5-aza_rep4,pert
sigmoid colon biopsy,ctrl
pool of thyroids from 2 months old RET-PTC transgenic mice,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: Trim28CKO,pert
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks;	Tissue: thymus,pert
"212, MUSCLE, Before",ctrl
lesional skin bioposy obtained from patient after 14 days of treatment,pert
Itk knockout unstimulated 2,pert
SENS 3 4hr,pert
A_AN06420_F,pert
mouse,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).,ctrl
age	24;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	5.2;	hemoglobin (g/dl)	12.5;	platelet count (/nl)	235,ctrl
DIA-n10; normal diaphragm 10 month,ctrl
U2OS_control_shRNA_pLenti_3_2007,ctrl
Cerebellum_nontransgenic control S25_3 months_replicate 2,ctrl
"Donor 2, mock infected 6hr",ctrl
BP patient 101_biological replicate 2,pert
"LCL GM19238, Kd NS, 72hrs",ctrl
"brain, frontal cortex: Sample53_e1_le1",pert
"Vldlr knockout saline, biological rep1",pert
KO - knock-out Untreated - 0 hrs - repeat 2 - Cy3 - mAdbID:61727,pert
LacZ control_4c,ctrl
Substantia nigra PD rep11,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.5;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 62;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
"MelJuSo, no treatment",ctrl
FW_4a_BV4281,pert
Hippocampus_Rasgrf1KO_rep2,pert
Bone Marrow Mononuclear Cells;	Unknown Age;	Unknown Gender,ctrl
Caco-2 Control siRNA 2,ctrl
"H1 hESCs, OE-NANOG",pert
chip number: 12;	transfection plate: 3A;	target gene: NS;	kd level: NA;	rin: 9.5;	transfection date: 2012-03-26,ctrl
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Klf9WT_jejunum_PND30_5,ctrl
umbilical cord_bpd: 3B,pert
"septic CD4+ splenocytes at 6h, biological replicate 1",pert
12h_RA2,pert
GM19238_Kd_ZBTB38_3,pert
A VIS _B033,pert
individual: patient17;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
KU_32T,pert
"Mouse, ATF6aKO, colon, DSS, rep2",pert
2.5-4.5 month old ovarioectomized female mouse,ctrl
S7,pert
mouse cerebellum at P30 wild type 1,ctrl
01LKT_CTRL,ctrl
Psoriatic arthritis PsA 6,pert
"C57BL/6J female number 2, 2 months old, whole ear tissue, untreated control ear",ctrl
Shn2_mutant,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp2,pert
patient: 51294;	sample: tumor,pert
normal B lymphocytes (NBL 002),ctrl
NCCIT siTET3 rep2,pert
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
"lung homogenates, WT, PBS control",ctrl
"P207 HCT-116, DNMT1 knockout, U0126-treated",pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: Wt;	tissue: Skeletal muscle (quadriceps),ctrl
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: PBS;	tissue: liver,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 24;	maternal age: n/a,ctrl
"TH cells from LC, Mecp2 null, biological replicate 2",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 1,pert
CML Patient 2 7 days therapy,pert
"Strain: Wild-type Polg+/+;	Gender: male;	Age: 9 months old;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 92;	Usage number: 4;	Exposures: 3,pert
"SUDHL-1, control repl 2",ctrl
Freshly dissected rat spinal cord,ctrl
PS-/- cerebellum at 20 days,pert
tissue: liver;	treatment: CCl4 and erlotinib 2mg;	strain: A/J,pert
SW480 Vector (2),ctrl
"Rescue pancreas, biological rep2",pert
Primary neonatal keratinocytes_ACTL6a_i_rep2,pert
R7_Pseudomonas_wildtype_422,ctrl
"Liposarcoma culture from tumor 387, untreated",ctrl
Cancer 10,pert
A535 Sham 1 day,ctrl
SLE6-TC,pert
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 24h",pert
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P30 postnatal stage,pert
heart control 3,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 37.89315,pert
Run5.aUa.010110d.SkMDbt1154D.CEL-DB basal,ctrl
SV129_6h_Wy,pert
Individual_4952_NN_sample,ctrl
"CL1-0, biological rep1",ctrl
"Patient F, lesional skin",pert
HT29 sensitive cells replicate 1,ctrl
P14 - WTMixA 3,ctrl
cell type: tumor-derived cell line;	ikk2 status: WT,ctrl
hair bulbs only from 9-day-old mice,ctrl
"Gender: Female, Age: 35, BMI: 22, Tissue: luteinized cumulus cells",pert
"nasopharyngeal carcinoma, specimen T21",pert
triplicate 2 of S. aureus infected HepG2 nt cells,ctrl
HCC_7N,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 65 years,pert
isoflurane 01,pert
cDNA ak 09+15,pert
V5-P490,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339046,ctrl
Lung-sarcoidosis-rep1,pert
IFNb treated,pert
Pt24_Post,pert
liver cells from wildtype 8wk male mouse 8 challenged with vehicle (saline)_10,ctrl
KO 569 R2,pert
hypothalamus,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_1mM_HG-U133A_2_YCHSUP501,pert
No_drug_#4865,ctrl
b156,ctrl
"E17.5 preB cells, Smchd1 wildtype",ctrl
genotype/variation: control;	strain: mlc1f-Cre/ Rpt3-floxed;	gender: female;	age: 6weeks;	tissue: tibialis anterior,ctrl
"Normal, biological rep 1",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.79726,pert
9837_CNTL,ctrl
Gender: male;	Age: 80;	Source: left arm,pert
cell line: Mkn28;	cell type: human gastric tubular adenocarcinoma;	tissue origin: stomach (70 year-old female),ctrl
ICM pool 1 (n=2),pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: pre-UV,pert
wt_rep3,ctrl
MDS19,pert
Muscle_Rpt3 null_1,pert
coronary smooth muscle cells control replicate 1,ctrl
3125-lcm,pert
KJD_rep2,ctrl
disease state: endometrioma;	patient: M2,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50).,pert
MDA-MB-231-pcDNA6 cell culture 1,pert
Muscle-AMPKgamma3-ko-4,pert
Patient no. 3: treated,pert
cell type: Embryonic stem cells;	genotype: wild type;	culture condition: ESC media,ctrl
CON - R19,ctrl
VillinCreERT2-_Rep4,ctrl
tri_CH1_hypoxia,pert
LCL Unaffected MZ twin pair 3 (CCN3.1)(TP23),ctrl
Knockout liver DEN-injected 12weeks repl3,pert
PTC BRAF mut 9,pert
"lymphoblastoid cell line from F16.01, one out of seven of insensitive group, 50*10e6 cells",pert
"208, ADIPOOSE TISSUE, After",pert
E14wt-SRFdM-VP16-1,ctrl
mdx5cv gastroc sample 1,pert
63A;pretreatment;female;breast tumor,ctrl
primary normal lung tissue 2266,ctrl
db/db 13-4,ctrl
PU.1 KD HSC 3,pert
Negative Control 1,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 7,pert
F-IIP(UIP)10_Cy3,pert
Liver_control mouse,ctrl
WT_rep_2,ctrl
231/NS (nonsilence)_3,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK2-1,pert
DBA/2JTCE_5 liver sample batch 5,pert
tissue: white blood cells;	age: 15.72;	Sex: male,pert
PGA-MAH-AJ_OVA24h-2aA-s2,pert
HCT 116 control rep3,ctrl
Biceps_Control_8,ctrl
tissue: resected liver tumor;	genotype: minor [rs8099917 TG/GG],pert
Liver Rosi3,pert
Gene expression profiling of normal cortex of patient 1393,ctrl
microdissected breast cancer cells from case 829,ctrl
CD19_selected_B-cells_before_R_rep4,ctrl
Human monocyte-derived macrophages,pert
sciatic nerve of P4 Pmp22 knockout mice,pert
Notch2 f/f C57Bl/6,ctrl
"Acute Myeloid Leukemia, sample 41",pert
CH1803,pert
patient1,pert
"Total RNA, Tet2 KO GMP",pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 2 days osteoblast differentiation,ctrl
Carbo Day4 (413L),pert
Control pool 2 (n=5),ctrl
Kidney_400 mg/kg VCM ip_mouse #106,pert
06_PAH,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 98min;	race: White;	sex: Male,ctrl
"hESC derived-NSCs passage 14, 24h",ctrl
c57BL/6JTCE liver sample batch 4,pert
2 with Cy5,pert
Injured 3 day Rat Retina 3,pert
HMEC_TNF-stimulated experiment 1,pert
"SPC-c-raf transgenic mice, 14 month old, male, tumor",pert
CLL 361-01 Control,ctrl
Bronchial Epithelial Cells MMA biological 1397G,pert
subject id: 55;	infection: DENV;	status: DF;	tissue: whole blood,pert
U-87MG,pert
tissue: sciatic nerve;	age: 2 months;	genotype: Bl6 wild type,ctrl
treatment: siYAP RNA #1 transfected;	cell type: Primary cell line,pert
skin.KO.replicate5,pert
Carboplatin 36 hours set 2,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 4,pert
Human prolactinoma 87,pert
age: 60;	gender: male;	ejection fraction: 34;	left ventricular end diastolic diameter: 76;	inflammation/PVB19: positive,pert
Healthy Pulp 2,ctrl
Sample Group: HD patient; Gender: female; Age: 36; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/51,pert
RWPE1 cells treated for 48 hours with vehicle (0.1% ethanol),ctrl
"DBA/2J Chronic morphine treated, biological replicate 3",pert
MCF7 cell line_resveratrol_250mM_biological replicate 1,pert
"normal skeletal muscle, biological rep6",ctrl
No_abuse_8,ctrl
sample: #8;	subject: Control case #3;	brain: T-638;	age: 78;	sex: Male;	region: Inferior olivary nucleus,ctrl
2022T,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 33 yr;	population: white,ctrl
HP-23c,ctrl
Thyroid_papillary carcinoma 26,pert
treatment: control;	cell line: NTERA2/D1,ctrl
"51B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
midbrain_wild type_6 weeks_replicate 2,ctrl
diet_mammary_2,ctrl
Rat fatty liver3,pert
S6C Sporadic-hippocampus,ctrl
FVB_MMTV_Wnt1_2495_1L_Rosen,ctrl
Wild type MEFs from 13.5 day embryos,pert
Primary human erythroid progenitor cells expressing HDAC2 B10 shRNA,pert
Postnatal 12 weeks mutant heart biological rep2,pert
MPM tumor 42,pert
cell line: KYSE140;	cell type: squamous cell carcinoma,pert
T51176,pert
J_LS_Wk1,pert
Gene expression profiles of Lkb1 KO #5 HSCs,pert
"expression at 4hr, bio rep2",pert
cell type: Primary hepatocytes;	donor: 2;	agent: Wy14643;	time: 6h;	gender: Male;	age: 44 years old,pert
uterus_veh_PRKO_40hrs_rep2,pert
"Neuroretina 8-week lean non-diabetic, Biological replica_2",ctrl
neocortex-30 months of age-control diet-biological replicate3,ctrl
Cochleae from a9 null mice at P13,pert
cell line: Mc3T3-E1;	cell type: osteoblastic cells,ctrl
SCC10,pert
lymphocytes_ctl_F_68y,ctrl
T1_HypM,pert
chip number: 13;	transfection plate: 5;	target gene: STAT2;	kd level: 0.78;	rin: 8.9;	transfection date: 2011-10-17,pert
E2 48hr,pert
N10B Normal-cerebellum,ctrl
lesion_midUV_patient3,pert
CD34+ cells with fenretinide treatment from CML35,pert
"Cultured ovarian cancer cell line OVCAR-10, Cisplatin treated",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 86min;	race: White;	sex: Female,pert
PancreaticSample4-Normal,ctrl
"fibroblast, control subject NM9 rep 1",ctrl
CD34+/CD38-,ctrl
28A,pert
WT_lung_bleomycin,ctrl
Untreated Control 12weeks AffyGC RMA rep5,ctrl
cadmium_08hr_rep2,pert
BALB/cByJ Vehicle liver sample batch 3,ctrl
MDS patient 133,pert
U-87 cells transfected with sh-control RNA and treated with DMSO for 16 hours,ctrl
untreated_24hr_rep1,ctrl
genotype/variation: Vax2-/-;	age: E12.5;	tissue: whole eye,pert
"Acute Myeloid Leukemia, sample 70",ctrl
astrocytes from second trimester human fetal brains,pert
"HEK293E cells, scrambled siRNA, replicate 2",ctrl
Satb1-/- clone 2-1,pert
V5-P176,pert
b86+,pert
sample =XCGD3 treatment=Control time=90 (min),pert
HA98-146B,pert
V5-P144,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep4",pert
LT340 wild-type untreated,ctrl
EP49_adipose_control,ctrl
Z5_Cont_TA,pert
HCC PBMC Sample 8,pert
Tendon_non-lesional_rep4,ctrl
wild type MEF time 6 replicate 1,ctrl
Ischemic cardiomyopathy_G1,pert
18 olanzapine,pert
human_hepatocyte_400uM_Trovafloxacin_donorB_24hr_prep1,pert
P7C Progranulin-hippocampus,pert
Syracuse High Avoidance (SHA) learning rats 3,ctrl
Basal IFE epidermal stem cells from KO mice 3,pert
Endothelial cells 3,ctrl
Subject #8034-Preinfection,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 1,ctrl
"Lesion Skin, LS-28",pert
Healthy chondrocytes 1,ctrl
MDS patient 18,pert
"seminoma specimen, pT1, patient age: 36y",pert
B6_Male_Control_rep3,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,pert
Postnatal 12 weeks control heart biological rep1,ctrl
"expression at 4hr, bio rep3",pert
CD34+ hemopoietic progenitors purified from bone marrow of healthy controls,ctrl
age: 56;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
11397 Normal Uninflamed descending colon,ctrl
"hMSC-Tert, RNF40 siRNA, 2 days osteoblast differentiation",pert
Sample Group: control; Gender: male; Age: 60; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Injured 4h Rat Retina,pert
Cell line MDA-MB-231_c-myc KD_expt2,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 29;	maternal age: 27,ctrl
"AALE-Vector uninfected, biological rep3",ctrl
"brain, brainstem: PB5_e1_le1",pert
Sarcoma cell line Null for Dicer,pert
major non-tumor8,ctrl
tissue: brain;	genotype: WT;	genetic background: C57BL/6,ctrl
DMN-NF1Hippo28d-1aAv2-s2,pert
Surgical Sham Control Tail Skin 3,ctrl
P16_WT_pancreas_rep1,ctrl
Muscle-AMPKgamma3-wt-10,ctrl
striatum wild type 6 month replicate 1,ctrl
TAp63 alpha 24h without induction s2,ctrl
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/85;	differentiation status: undifferentiated;	cell line: Q91,pert
CTIP 20 #2,pert
J_LS_Time0,ctrl
Pooled normal myocardium sold commercially (N),ctrl
"schizophrenia, BA46-87",pert
sirna: NR2F2 knockdown;	cell line: ES2;	cell type: Ovarian cancer cell line,pert
Series 3; old; 3 days after fracture,pert
Kidney_200 mg/kg VCM ip_mouse #089,pert
RNA pool from untreated LCLs generated from unaffected controls,ctrl
"S1P2-KO-hippocampus, biological rep6 (female)",pert
"Ishikawa cell line, control, 8hr",ctrl
"brain, hippocampus: KA-24h-P15-II_e1_le1",pert
bone marrow-derived macrophages,ctrl
strain: C57BL6J;	genotype: H3f3b -/-;	age: E12.5;	tissue: 1 of 2 mouse testes,pert
"Control #3, Untreated",ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep2,pert
APOE_KO_RAGE_KO_NODM_9W_14,pert
"normal nasopharyngeal tissue, specimen N9",ctrl
Human Acute HIV Sample A189-CD8+ T cells,pert
HeyA8-(2),ctrl
NB60 U133p2,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.515;	OD280: 0.791;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 232;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Full-thickness epidermis,pert
"Immortalized MEFs WC, empty retroviral vector infected, rep2",ctrl
48A;pretreatment;female;breast tumor,ctrl
strain: CD-1;	tissue: lung;	age: 20 week;	genotype: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-alpha promoter,pert
HeLa Cells,pert
Control (C272),ctrl
postnatal 12 weeks control heart,ctrl
"C57BL/6J Acute morphine treated, biological replicate 1",pert
Pre-Frontal contex of naïve AChE-R mice,pert
"Normal cervix epithelium, Age 64",ctrl
9-cis-retinoic-acid_Lung_4,pert
siIPMK no DNA Damage experiment 2,pert
genotype/variation: WT;	strain: C57BL6/N,ctrl
Ischemic cardiomyopathy_G60,pert
S46 WT2	F5/8	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
cell type: peripheral blood mononuclear cell (PBMC);	disease status: pancreatic cancer,pert
CD34+ cells isolated from the bone marrow of an MDs patient,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14454;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
race: caucasian;	age (years): 75-80;	stage: n/a;	grade: n/a;	histology: weakly proliferative w/cystic changes,ctrl
6 with Cy5,pert
Notch3 knockout cerebral microvascular fragments,pert
"RPMI8226_shKLF2#1, replicate2",pert
"Liver, Nrf2 deficient",pert
C598,pert
A_AN12457_F,pert
Embryonic fibroblast isolated from mouse,ctrl
UnInfected-1,ctrl
PsOEt-17-Week 2,pert
Subject 6 / lung subsegment instillated by LPS,pert
WT CD80lo mTEC sample1,ctrl
"Spi-21, biological rep 3",pert
coronary smooth muscle cells nebivolol replicate 1,pert
"brain, cochlea: [5] SAmple #5_le1",pert
agent: ConA;	time point: 1 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Monocyte control rep 3,ctrl
"MLD, biallelic AML MLL_00261",pert
NB58 U133p2,ctrl
TB 6,pert
"dy/dy dystrophic diaphragm 3, 8 week",pert
Spleen and lymph nodes,pert
Mouse: strain C57,ctrl
db/db 14-4,ctrl
56 Day MOuse extraocular muscle,ctrl
MCF-7cells treated with vehicle and scrambled siRNA,ctrl
28m1,ctrl
HCC_33N,ctrl
Normal cortex of patient 26,ctrl
HeLa,ctrl
gene-targeted derived R1 cell line,pert
"metastasis: none;	Stage: 3c;	tissue: cancer, homogenized",pert
HUVEC/NmenMC58_pilD_6h_rep1_1103,pert
MSC_VUB01_1,ctrl
strain/background: mixed B6/129/FVB;	genotype: MMTV-Cre;Runx1+/+;R26Y;	gender: female;	developmental stage: adult virgin;	cell type: mammary gland luminal epithelial cells,ctrl
D with Cy5,ctrl
"treatment: diclofenac;	batch: 4;	donor: 30;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
Mouse old brain w/ a-tocopherol aT-Br-5,pert
0151-01-C,ctrl
Leg 56 Day control rep 3,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.946;	OD280: 0.992;	Ratio: 1.92;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 129;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
jzo021-rp1-v5-u74av2-met,ctrl
sample B 18.5 homo,pert
strain background: C57BL/6;	genotype/variation: Runx1-knockout mice (Runx1floxed/floxedMxCre+/-);	tissue: bone marrow;	cell type: sorted c-Kit+/Sca-1+/Lin-/IL7Ra- (KSL) cells;	experimental procedure: 3 months after poly IC treatment,pert
06SAGEA2,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 2,pert
Wild-type CS_12_29_2_WT_2,ctrl
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #2.,pert
MDS patient 7,pert
"Patient 19, Atheroma plaque",pert
PLT-n7; normal plantaris 7 month,ctrl
"MCF-10A cells, overexpression vector control, biological rep2",ctrl
MCI-010,ctrl
Liver_nash_no.3,ctrl
"Amoxicillin treated Distal, Small Intestine 1 17 days old",pert
U-87MG-V22 set 4,ctrl
MPM tumor 39,pert
"Adult mouse, C57black background, left ventricle of heart",ctrl
thyroid_normal_1,ctrl
"Trained diabetic mice, time point 3 week",pert
clear cell sarcomas of the kidney and Wilms tumors,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.59178,pert
strain background: CD1;	genotype/variation: Raldh2 null mutant; Raldh2 -/-;	tissue: embryonic brain;	tissue region: posterior;	developmental stage: 4 somite stage,pert
myoblasts transduced with lentivirus carrying DUX4-fl,pert
ARPE-19,pert
23d wt11,ctrl
Normal_MS 36C7,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated",pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 2,ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 21;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
sample =Healthy3 treatment=Control time=90 (min),ctrl
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
CRG,pert
Nrl-ko-Gfp P6 replicate 3,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 3,pert
RAW LPS 2,pert
siRNA Stau1 Duplicate 2,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 4",ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 219,pert
BCells_WildType_day2_REP1,ctrl
rtTA-Dmrt5_d9_+Dox_rep_2,pert
disease state: healthy control;	tissue: epidermis;	age: 40;	gender: male;	treatment: untreated;	time: control,ctrl
"IN1472 siPD treated, Biological replicate2",pert
genotype: wild type;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: LPS;	tissue: liver,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID290,pert
Pt32_Post,pert
"control, BA46-33",ctrl
PsOEt-11-Week 2,pert
tissue: white blood cells;	age: 18.57;	Sex: female,pert
"MaF pre-iPSC9P2, Vc+, D5",pert
"Transgenic, snap frozen, diaphragm muscle, 7month age animal",pert
Mnk_3142-T-B,ctrl
"A549, +TNFα, Claudin 1 siRNA, rep3",pert
"male;	CABG patient, atrial tissue;	baseline before CABG surgery",ctrl
"Pten null, biological rep3",pert
Sample 4 Posterior  +/+,ctrl
chip number: 23;	transfection plate: 4;	target gene: RDBP;	kd level: 0.79;	rin: 9.5;	transfection date: 2011-10-17,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.77534,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 33 yr;	population: white;	dsm-iv: 296.53;	age of onset: 15 yr,pert
Subject 10_t=30days_placebo,ctrl
healthy control H12,ctrl
Seguin_IDR_BrownNorway_Liver_treated8,pert
shRNA4-1-noDox-rep2,ctrl
SCC-2_siScramble_rep.1,ctrl
Muscle KO Adult 0713,pert
MCF-10A_shATM-1,pert
CD-76-un,pert
P7 Patient None,pert
patient: 40836;	sample: normal,ctrl
SCC9,pert
C2C12 myotubes 10uM H2O2 rep 2,pert
KO fed  regular chow,pert
Normal cortex of patient T127,ctrl
disease group: normal;	cell type: chondrocytes;	cell culture: monolayer,ctrl
NonIR-KO_Rep1,pert
Patient no. 19: control,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.279;	Ratio: 2.12,pert
Cdh1_cKO_1,pert
"schizophrenia, BA46-78",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 62.05479,pert
Muscle KO Adult 01271,pert
HLA risk: High;	Height: 145.1 cm;	Weight: 32.1 kg;	BMI: 15.2;	Age: 10.16 years;	Gender: Female;	Race: White;	Glucose: 188 mg/dl;	HbA1c: 6.1%,pert
"control, BA46-60",ctrl
MO32_9,pert
microdissected epithelial cells from normal main pancreatic duct 4,ctrl
"Fibroblasts, baseline, time 0, patient 1, rep 1",ctrl
remitted schizophrenia patient  S02,pert
XBP1s Tumor 4,pert
uterine normal myometrium,ctrl
"Hereditary gingival fibromatosis (HGF) is a benign disorder manifested by a slowly progressive enlargement of the oral gingival tissues, which results in the teeth being partially or totally engulfed by keratinized gingiva.Affected gingiva tissues were removed from HGF volunteers during surgical procedure.",pert
clear cell sarcomas of the kidney and Wilms tumors,ctrl
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 40;	maternal age: 39,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 5,pert
Bronchial Epithelial Cells control biological 1619Y,ctrl
"Patient 9, Atheroma plaque",pert
"Wild type GM-BMMs, biological rep3",ctrl
Ficoll/PBMC,ctrl
"Cultured ovarian cancer cell line OVCAR-8, untreated",ctrl
gender: Female;	age: 67;	post-mortem delay: 6h;	ph: 6.7,ctrl
"ID: MLL_00230;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"WT mouse skin treated once with TPA and collected 24 hr later, replicate 2",ctrl
S5A Sporadic-frontal,ctrl
heart knock out replicate1,ctrl
disease state: healthy control;	cell type: Peripheral blood mononuclear cells,ctrl
"Kidney from control rats, biological rep 3",ctrl
"mouse aorta cross strain comparison, C3H_T40_HF_02",pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 147;	time: 0;	batch: 4,ctrl
Healthy donor_biological replicate3,ctrl
pediatric AML S19,pert
"RWPE1 cells treated for 6 hours with 100 nM 1,25(OH)2D",pert
neocortex-30 months of age-control diet-biological replicate4,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 1,ctrl
"Peripheral blood, normal control [N71]",ctrl
CTRL_esiGFP_rep2,ctrl
J1_plus LIF_rep2,ctrl
cell line: MCF7;	condition: siRNA Med12 + Estrogen,pert
Normal bladder 9-99,ctrl
liver wild type replicate1,ctrl
"Wild-type-hippocampus, biological rep7 (female)",ctrl
GSK3B shRNA replicate 1,pert
"Control, high-fat diet, rep1",ctrl
thyroid_normal_7,ctrl
Dilated cardiomyopathy_G24,pert
"Exp A, Animal #255, 200mg/kg D-Serine",pert
"Peripheral blood, normal control [N70]",ctrl
CHB PBMC_sample 6,pert
1212-6heart_Control,ctrl
Patient no. 10: treated,pert
C_AN01410_F,ctrl
CDF1-c (196msn),ctrl
"Control, biological rep11",ctrl
heart_QH2_6M_rep1,pert
"brain, cerebellum: RNA#10S_le1",ctrl
"brain, Entorhinal Cortex",pert
"SFM control cells (24hr), biological rep3",ctrl
Normal PBMC Sample 10,ctrl
SLE4,pert
E10.5 Vax2-/- 2,pert
RNA pool from MPH-treated LCLs generated from unaffected controls,pert
histology: chronic plaque;	disease state: multiple sclerosis after inflammation has subsided-late stage;	tissue: multiple sclerosis brain lesion,pert
MCF7 cells treated with 2uM Sangivamycin for 24 hours Array 1,pert
"human failing LV myocardium, Idiopathic81",pert
genotype/variation: PtenL/L (isogenic wildtype);	cell type: embryonic fibroblasts;	time: control;	genetic background: C57BL\6,ctrl
"WT mouse skin treated once with TPA and collected 24 hr later, replicate 3",ctrl
wild type MEF time 0 replicate 4,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 25;	maternal age: 27,ctrl
"breast, post AF treatment (H16_1717)",pert
multiple sclerosis_5,pert
Old Control;	female,ctrl
VillinCreERT2+_Brg1fl/fl_Rep1,pert
"mouse, liver (CCl4), treated with erlotinib 5mg (week 18)",pert
liver 1.0% quercetin diet rep2,pert
lesion_postUV_patient1,pert
"liver, STZ-treated mice",pert
392MM,pert
T183 U133p2,pert
EA_Case6_CD20,pert
3DKD_SerumStarved_rep2,pert
"Total RNA, WT CMP",ctrl
Squamous cell carcinoma 014,pert
gender: Female;	age: 82;	post-mortem delay: 8.5h;	ph: 5.9,pert
Subject #8038-Preinfection,pert
"0mg/kg/day PFOA, Rep 3, Block 2 lung (low dose)",ctrl
Control (shControl-2),ctrl
Muscle KO Aged 1215,pert
Cochlea_WT_9mo_1,ctrl
"MCF-7 cells-40mM g-T3, biological rep 4",pert
"fibroblast, control subject NF8 rep 2",ctrl
BP patient 60_biological replicate 2,pert
strain background: mixed (SV 129/C57BL/6);	genotype/variation: wild type (Rnh1 +/+);	age: embryonic day E9.5;	tissue: yolk sac,ctrl
V5-P285,pert
"DCIS 3, biological rep. 3",pert
Insm1 control #5,ctrl
Celecoxib_#4861,pert
Healthy control c7,ctrl
RL_siRNA_LIF1h_rep3,pert
rectal suction specimens,ctrl
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14502;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"D425-control, t=24",ctrl
"Normal Skin, Normal-14",ctrl
"Pool of four samples (n=4);;	gender: three female/one male;;	age: 19/57/40/70 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA)",pert
NK_cell_pool_healthy_H07+H08,ctrl
C57_LF_2,ctrl
subject: 1;	disease: TD;	muscle: ST;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
N28,ctrl
"mouse liver sample, KO strain, biological replicate 2",pert
Subject #8011-2d Postinfection,ctrl
G_LS_Wk4,pert
Control bone marrow - Biological Replicate 2 - Technical Replicate 1,ctrl
tissue: lung adenocarcinoma;	cell line: A549;	transfection: pcDNA-NME2-MYC,pert
Vit A deficient 2b,pert
MDS7,pert
retina_DBA_544R_8mo_rep2,pert
abl control at VEH rep 0,ctrl
subject id: 32;	infection: DENV;	status: DHF;	tissue: whole blood,pert
FACS-purified B cells_wildtype_non-infected_rep1,ctrl
wild-type male mice non-treated,pert
ET 6,pert
"15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
jejunum_control_2,ctrl
Hippocampus 1978 15 month Old,pert
ESO1644_muscle_mutation,pert
"Testes, 20 hours after cadmium treatment, biological rep 2",pert
gender: female;	batch: 1;	age (years): 26;	patient id: Control_3;	fev1 (% predicted): 105;	fvc (% predicted): 115;	medication: None;	cell type: CD4+ T-cells,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 38;	maternal age: 37,pert
Control A549 cell Replicate1,ctrl
brain_DLPFC_bipolar C_mr407,ctrl
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T1N0,pert
"CL1-0 mock control, biological rep3",ctrl
"Peripheral blood, patient without recurrent events [N40]",pert
Expression data from BAT of the KRAP deficient mice (KO1),pert
WFS1 KO USHT_13_312_ko,pert
WT_uninf_2,ctrl
"skin fibroblasts, passage #4",pert
CHB PBMC_sample 12,pert
129/BSw wt2 heart,ctrl
GFP 0hr 282295413,ctrl
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 12h,pert
GM19238_Kd_PAX5_2,pert
cerebellum_21 month,pert
HepG2 cell line from ATCC at 8th generation.,pert
Silberg3 ( S2) 120902BE,pert
GM19238_Kd_PAX5_1,pert
"Acute Myeloid Leukemia, sample 49",pert
Polyamide1_1,ctrl
"12-week-old 12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",pert
"Control siRNA - 2 days osteoblast differentiation, rep1",ctrl
tissue: white blood cells;	age: 11;	Sex: male,ctrl
"Endometrium, postmenopausal, control, 38",ctrl
Liver sample from Alcoholic hepatitis group (CA20),pert
Treated with 5% mannitol for 4 hrs -- replicate #1,ctrl
"Patient 3, Macroscopically intact tissue",ctrl
FR-si221-2,pert
27 weeks female,ctrl
01N70_CTRL,ctrl
PsOEt-23-Week 12,pert
THP1-shControl-rep2,ctrl
subject: 15V;	cohort: 15;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 107kb;	age (y): 60;	Sex: F;	batch: Batch_5,ctrl
50A;pretreatment;female;breast tumor; responder,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: untreated; biological replicate: 3,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID301,pert
"mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 61;	ld: HCV;	creatnine: 1.7;	mdrd: 47;	gfr: UN;	protein: 3;	hematuria: 1;	c3: 1;	c4: 1;	rf: 1420;	hcv: POS;	htn: 0;	dm: NEG;	hba1c: 5.7;	meld: 14;	ana: POS;	gp: Mild mesangial immune complex glomerulonephritis, Severe tubular atrophy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 2;	if (interstital fibrosis): 2;	as (arteiosclerosis): 0;	igg: 1;	iga: 0;	igm: 1;	c: 1;	empe: 1;	bmwid: 0;	bmd: 0;	edd: 1;	no of glomeruli: 9;	glomerulosclerosis: 0.11;	intact t: 0.3;	arteries: intimal duplication;	if: IGM+IGG+C3+C1Q++mesangial;	mesangium ig: MGC;	tissue: Kidney_Biopsy_Liver_disease",pert
RV16;	Age = 22;	Sex = M,pert
WT-smoke-low-5 month+1d-R4,ctrl
jzo012-rp1-v5-u74av2-met,pert
subject id: c5;	infection: control;	status: control;	tissue: whole blood,ctrl
Mnk_3137-T-7,pert
male,pert
PGC-1alpha -/- differentiated brown fat cells (rep2),pert
MGHU3 Cells_Control siRNA_Biological Replicate 3,ctrl
S009_Scz_M_87,pert
WAT from wild-type control fed high fat diet Replicate 2,ctrl
Nonlesional Epithelium Atopic Dermatitis rep5,pert
Retina no glaucoma,ctrl
Ileum_Wild Type+Quercetin_3,pert
sex: Female;	family: 2;	age: 38;	disease status: Control;	tissue: Muscle: Deltoid,ctrl
"Lymphoblastoid cell lines derived from family 1736, member 1",pert
Patient: L;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
4033-1 E2F WT,pert
human preadipocytes+oligo2_day0_rep2,pert
remitted schizophrenia patient  S01,pert
Human melanoma cell lines,ctrl
age: 7dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
15C-M4-D,ctrl
BP1,pert
HCC PBMC_sample 5,pert
human breast cancer cell line,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep3",pert
strain: C57BL/6;	cell type: bone marrow-derived mast cells;	treatment: interleukin 3 and stem cell factor,pert
SW1736_t0h_rep1,ctrl
SRF silenced R1881 rep 2,pert
PTC BRAF wt 6,pert
healthy CD4 T cells 3,ctrl
PancreaticSample27-Tumor,pert
AT2_control_rep1,ctrl
HEK293 transiently pIRES2-EGFP-transfected 1,ctrl
CD25+Xbp1KO#2,pert
strain/background: C57BL/6N;	genotype: wild-type;	tissue: liver,ctrl
Endometrial stromal cell - Jag1 retrovirus infected 3,pert
DES D2,pert
patient17,pert
SeV 3483,pert
KN-sham-5 month+1d-R2,pert
GM19238_Kd_IRF8_1,pert
Brain CD8 T cells that are IL-10+ rep2,ctrl
MB231 con-SCM,ctrl
C015_Control_M_91,ctrl
cell type: Embrionic stem cell line;	genotype: wild-type,ctrl
Human Neural Stem Cell Line F3 Wild Type,ctrl
430MM,ctrl
NORMAL LIVER TISSUE,pert
"fibroblast, control subject NF5 rep 1",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 31;	gender: male,pert
chip number: 21;	transfection plate: 6;	target gene: JUND;	kd level: 0.79;	rin: 9.3;	transfection date: 2012-03-26,pert
brain_DLPFC_bipolar C_mr407,pert
mouse liver C1,pert
"fibroblast, MFS subject FB783 rep 2",pert
Benign prostate tissue N2,ctrl
No or early 2 rep7 (retina),pert
Tk6 treated with arsenic rep1,pert
T21_1,pert
Carboplatin;	Carboplatin 30 hours set 2,pert
"Keratinocytes untreated control, 4h",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.4;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Control spleen - Biological Replicate 1 - Technical Replicate 1,ctrl
25 uM chlorpyrifos batch 2,pert
BxPC3-WT rep 5,ctrl
224 Day 1 siMut10 transfected biological rep2,pert
15KD_SerumStarved_rep1,pert
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-3,pert
microdissected breast cancer cells from case 374,pert
tissue type: brown adipose;	gender: male;	genotype/variation: ob/ob;	harvest time: 4 day post injection;	age: 3 months,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-3,pert
"Mouse Sciatic Nerve, Diabetic Vehicle",ctrl
Run7.aUa.001206d.SkMInS1075D.CEL-IS stimulate,pert
P1 eyeball,pert
Parental JoMa1,ctrl
"Patient H-c615T, MSI colorectal tumor",pert
whole tissue section from case 317,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus monosomy7/del7q plus trisomy8 plus other,pert
Endothelial cells 2,ctrl
Sample 14 Kidney Hyp Mouse - Low Phosphate Diet,pert
MF-11,ctrl
Pfeiffer NTshRNA 1,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.5;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
tissue: Temporal cortex;	age: 80;	Sex: F,ctrl
T4F-LU,pert
mouse liver,pert
Sex: male;	Age at operation: 60 years;	Site: thigh;	Size in cm: 7.5x6x5.5;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
gender: Female;	age: 88;	post-mortem delay: 5h;	ph: 6.8,ctrl
"fibroblast, control subject NF11 rep 1",ctrl
Tak1_2,pert
"1833 control, biological replicate 3",ctrl
Glioblastoma_11,pert
tissue: skin;	individual: Patient P2;	condition: AL;	eczema severity: SCORAD: 28,pert
c_NY103,ctrl
puroD replicate 1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 9;	paternal age: 33;	maternal age: 29,pert
Cell line,pert
LIVER_CONTROL_repl2,ctrl
cerebellum_wild type_18 month_replicate 2,ctrl
2 PC3 0hr,ctrl
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
"206, ADIPOOSE TISSUE, Before",ctrl
F9 embryonal Carcinoma cells,pert
SA_61,pert
Lung Cancer,pert
"human failing LV myocardium, Ischemic85",pert
cell line: FOXO null,pert
BP patient 98_biological replicate 1,pert
"BOEC, normal 14",ctrl
Aquaporin-11+/+_mouse P7 kidney #4-2,ctrl
untreated Rb-/- MEFs-1,pert
Tmod3 KO-3,pert
Control Male SM22-rtTA only Lung,ctrl
age: 18 month postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
patient: 231;	current medication: prednisolone 40mg heparin clarithromycin;	birth date: 10/29/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/00;	diagnosis date: 11/19/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/28/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
SLE CD19 B cells 3,pert
"Atria, Mutant, biological replicate 3",pert
V5-P170,pert
anti-FGFR1,pert
WT - Cre Untreated - 0 hrs - repeat 2 - Cy3 - mAdbID:61716,ctrl
potilas_DC_C,pert
KO_d00_e0,pert
"Uninvolved Skin, NS-7",pert
MPM tumor specimen 3,pert
JJ1717_muscle_mutation,pert
cell line: BL2;	transfection: scrb siRNA;	batch: 2,ctrl
"Acute Myeloid Leukemia, sample 38",ctrl
"control, BA46-80",ctrl
PBS Treated Cells 1,ctrl
midbrain_Pink1 knockout_6 weeks_replicate 3,pert
WAT from Ahnak knockout fed regular chow diet Replicate 1,pert
muscle_Akt1+/-_35wk_rep2,pert
8DKD,ctrl
H_Kin_3,pert
"ID:c 4-2, Genotype=(C57BL/6J), Treatment= none",pert
C5-7,pert
cell line: DBTRG;	treatment: untreated;	cell type: glioblastoma cancer cell line,ctrl
202/0,ctrl
CML-BM 2,pert
microdissected breast cancer cells from case 260,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID156,pert
pediatric AML S05,pert
Kidney_saline ip_mouse #061,ctrl
RNA from microdissected breast cancer cells from case 772 labeled with Cy5,pert
RNA-DHL4-R406-48H-3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: post-UV,pert
Dominant negative cJun  VZ16,pert
db/db 16 wk 2,pert
WT-Nrf2-Female-2,ctrl
PGA-RMM-2h-1aA-s2b,pert
Muscle Pio1,pert
"patient 045b, cancer, homogenized",pert
KO - knock-out Treated - 2 hrs - repeat 3 - Cy5 - mAdbID:51302,pert
normal adjacent esophageal tissue from patient E1589,ctrl
"WT brain, biological rep5",ctrl
XBP1s B cells 2,pert
Strain:  C57BL/6,pert
KU_29N,ctrl
CKO Wild Type V2,ctrl
MyD88_PIC_C-0,ctrl
kidney biopsy from patient after Tumor Nephrectomy,ctrl
"Lesion Skin, LS-1",pert
anti-FGFR1_rep1,pert
Strain C57BL/6;	Tissue: Backskin;	Age: e18,pert
"breast tumor epithelium,22",pert
28 Day Mouse Diaphragm muscle,ctrl
Carbo Day7 (417R),pert
myocardium sold commercially,ctrl
wt-Gfp P6 replicate 2,ctrl
cell line: SKMEL28;	time point: 6h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 6 h,pert
"Lesion Skin, LS-13",pert
"control, BA46-29",ctrl
TL3 cell lines,pert
Control biological rep1,ctrl
NPC Brain 84d Mouse1,pert
"Wild-type HFD 8 weeks, biological rep4",ctrl
BIO586220,ctrl
MCF10A-Myc-rep2,pert
442MM,pert
lymphocytes_HD_M_51y,pert
Normal_003,ctrl
THRB 15b mutant + vehicle replicate 1,pert
"Cell line:  Fibroblast TTP WT cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",pert
REH E/R positive leukemia cell line,ctrl
"Diclofenac treated THP-1 cells, biological replicate 2",pert
Nontransgenic littermate mouse;	Strain: C57 BL/6;	Gender: male;	Age: ~30wk;	Tissue: heart LV;	Treatment: tamoxifen,ctrl
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 2",ctrl
Disease_status: Bipolar disorder;	Age (years): 33;	Gender: Female;	Age of onset (years): 15;	Duration of illness (years): 18;	Brain pH: 6.51;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Normal-BM 1,ctrl
lesion_postUV_patient10,pert
Diaphragm 112 Day control rep 2,ctrl
"normal nasopharyngeal tissue, specimen N1",ctrl
Mtb infected-63d-1,pert
266D1,pert
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 7",ctrl
"WT+Empty, biological rep1",ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks,ctrl
A HID B_B013,pert
Diagnosis: AML M5;	Age: 60y ;	Gender: Male;	Blast %: 71;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
OVCAR-10+(2),pert
HCC_35N,ctrl
HN_109,ctrl
ADHD_untreat,ctrl
"AD_FC, biological rep9",pert
sample: #23;	subject: PD case #6;	brain: T-227;	age: 76;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
3976-1 E2F1 Null,ctrl
CML cell line: KU-812,pert
"Mouse Embryonice Stem Cells, pCIP siRNA 1, Rep1",pert
SNRK_1,pert
HeLa cells transfected with siSp1 rep 1,pert
MSC_VUB01_2,ctrl
strain: C57/Bl6;	age: 4 month;	gender: n/a;	weight: 25-30g;	tissue: whole trachea,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
age: 12 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
sample =XCGD4 treatment=Control time=0 (min),pert
0922-01-A,pert
"CD14+ monocytes, by positive selection",ctrl
mixed background e18.5 male cardiac ventricle,ctrl
"Uninfected treated with 1,25D, replicate 3",pert
C026_Control_M_58,ctrl
23 Day Mouse leg muscle,ctrl
IFN_Gamma_6hr_rep3,pert
Concordant for Epilepsy twin pair 4 (Affected patient of MZ twin pair CCE4),pert
Mouse WT mandibular molar [ABH_13A],ctrl
"Epithelial prostate primary cells from fresh explant from normal tissue, obtained from a cystoprostatectomy of a patient with a bladder carcinoma with no lesions in the prostate",ctrl
FBooth-CON-4Av2-s2,ctrl
Benign Prostate tissue N1,ctrl
PsOEt-23-LS,ctrl
cell line: U937;	shRNA construct: GSK3A Construct 6,pert
Patient: F;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
POAG-TM-B,pert
"Wild-type-hippocampus, biological rep6 (female)",ctrl
Bone-Marrow_NPC_N1645,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Post mortem interval (hours): 22;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
cell culture,pert
"t15, surgically resected from patient of gastric cancer.",pert
pediatric AML GP3,pert
N2A cells_Pou3f3 knockdown construct,pert
age: 34;	sex: F;	disease status: control subject;	Filter number: 88;	Usage number: 5;	Exposures: 3,ctrl
N2_Cy3,ctrl
H4-II-E-C3_low_rep4,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 309;	age-at-biopsy-years: 49,ctrl
"brain, adrenal medulla: Sample#A1(Exp pt 1)_e1_le1",pert
S25 NLS 142Q TG2	F4/26	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
Patient 4,ctrl
GM19238_Kd_SREBF2_1,pert
Emd KO male 2,pert
1000uM H2O2 rep 2,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 36;	maternal age: 30,pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor Low CD34 positive expressing bone marrow progenitors CMP",ctrl
strain: C57BL/6J;	cell type: LSK cells;	genotype/variation: Nfix depleted,pert
HCC_23T,pert
human_LIMA_artery_patient5_paclitaxel-eluting_stent,pert
A4_tumor,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
"fibroblast, control subject NF10 rep 1",ctrl
RatLung_H6h_3,pert
Bronchial Epithelial Cells SA biological 2016Z,pert
GM19238_Kd_E2F1_1,pert
"twin pair: #10;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
siRNA Smc3 [M2],pert
0810A-01_clone 2-2,pert
THRA 6a mutant + vehicle replicate 1,pert
VGLL4 HUES6 2,pert
coc-42,pert
HCC006T,pert
Cal27_CETU3,pert
06R025 RA,pert
MDS patient 150,pert
"Acute Myeloid Leukemia, sample 29",pert
SALL4 shRNA biological rep2,pert
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shControl.2,ctrl
Bone-Marrow_SMM_S1221,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 3,pert
NOMO-1 cells infected with scrambled shRNA control,ctrl
strain:C57BL/6; VillinCRE-HNF4loxp; female; tissue colon; mutant,pert
V5-P278,pert
"344SQ with PIK3CA shRNA, replicate 3",pert
6A,pert
lesional skin bioposy obtained from patient at baseline,ctrl
cell line: Hep G2;	genotype: wild-type THRB and;	treatment: with 100 nM T3 for 6h,pert
CAR.AH_TCPOBOP_rep2,pert
"BioBreeding  DRlyp/lyp rat, day 65, mast cells derived from pancreatic lymph node",pert
"urogenital ridge epithelium, E10.5, +/+",ctrl
GM19238_Kd_NR3C1_1,pert
tissue: Temporal cortex;	age: 55;	Sex: M,ctrl
Mening UNSTIM WB NP 3a,ctrl
microdissected epithelial cells from invasive cancer originating in IPMN 1,pert
Strain: C57BL/6J;	Gender: Male;	Age: 2-3 months;	Tissue: heart,ctrl
0790-01-A,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 33;	maternal age: 38,pert
26GOBMUC2H,ctrl
Human skeletal muscle biopsy sample;	Patient #50 with NORM,ctrl
Bronchial Epithelial Cells SA biological 1918I,pert
M249_R4_B_PLX,pert
Gastric tissue normal region,ctrl
T4.02,pert
"Gata4-KO heart, CRE, biological rep1",pert
RKO_liver_fasted_refed_3hr_rep4,pert
MB231 con-DMEM,ctrl
tissue source: patients with a mutation (Arg1174Gln) in the tyrosine kinase domain of the insulin receptor gene (INSR);	tissue: Vastus lateralis muscle;	tissue state: basal state,pert
H4-II-E-C3_untreated_rep2,ctrl
siERK2Veh24h_3495,pert
"HA-Fbxl10 cell, Replicate 1",pert
KO - 5 mo - repeat 2 - Cy3 - mAdbID:74110,pert
BTBR+tf/J Vehicle liver sample batch 1,ctrl
siNS_4h_1,ctrl
"Fibroblasts from UIP histology lung tissue, IPF-21",pert
control to Sample 7,ctrl
"Control, biological rep9",ctrl
Post Transduction:24 hr; treatment:WT;,ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 0 hrs,ctrl
diagnosis: healthy;	tissue: blood,ctrl
chronic lymphocytic leukemia (CLL 68148),pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 44 yr;	population: white;	dsm-iv: 296.53;	age of onset: 33 yr,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 7",ctrl
PGA-MAA-ctr-1cAv2-s2,ctrl
mESC_undifferentiated_wild type_rep3,ctrl
8 week old H3ff3b WT,ctrl
Brain from 40 days Npc1+/- mouse1,ctrl
44m3,ctrl
skeletal muscle myoblast_KO_day3,pert
BL Day 2 siMut10 transfected biological rep4,pert
patient: 40726;	sample: tumor,pert
"liver, ATP7B KO mouse, sample KO904",pert
Time 240 mins rep 2,pert
age: 12 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
control participant P311,ctrl
"mouse embryonic fibroblasts derived from FHL2-/- mice, FHL2mutJ",pert
"human failing LV myocardium, Ischemic108",pert
type 2 diabetes subject 04,pert
knockout rep-2,pert
sXBP4_1578T,pert
24h_RA1,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp2,pert
"non-AD_HI, biological rep9",ctrl
"Mouse Embryonice Stem Cells, pCIP siRNA 2, Rep2",pert
"Aorta, saline 14d, #3",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
n6t30m,pert
DLBCL_empty vector overexpression,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (9)",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: 128;	fata: 117;	eea: 1790;	wtkg: 78.3;	perfat: 20;	lbm: 60.4;	fat_mass: 1566,ctrl
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
"TH cells from LC, Mecp2 null, biological replicate 3",pert
01LQD_CTRL,ctrl
224 Day 1 siMut10 transfected biological rep3,pert
"adult mouse jejunum, hnf1alpha mutant",pert
tissue: Brain;	genotype: Npc1+/-;	age: 37 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
T51572,pert
MEF Wild Type 2-rep3,ctrl
P16_exPKO_pancreas_rep1,pert
0974-01-C,ctrl
"GFP Alone, Replicate 1",pert
"DMSO Control after 8hr, replicate 1",ctrl
adenocarcinoma (ADC5),pert
"wild type, control, biological rep2",ctrl
NB42,ctrl
normal B lymphocytes (NBL 001),ctrl
uninvolved skin from cases,pert
Neocortex_Eomes_KO.1,pert
PFR3_replicate_4,ctrl
striatum wild type 21 month replicate 1,ctrl
"KO liver, biological rep2",pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 66;	donor: 31;	disease state: Non-lesional,ctrl
LNCaP/MYB siRNA #1,pert
PBMCs enriched for CD8+ cells from normal control subject K (KCD8),ctrl
tissue: cerebellum;	strain: tia1 knock out;	age: 3 months;	genetic background: C57Bl/6,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 6",ctrl
LSK control 1,ctrl
Nr1_pre221,pert
control_00hr_rep2,ctrl
14 Day Mouse extraocular muscle,pert
KO_24A_4,pert
Bronchial Epithelial Cells MMA biological 1943H,pert
condition: control;	tissue: decidous teeth dental pulp;	gender: male,ctrl
WT-ac-1,ctrl
RPMI8226_shLuc,ctrl
SA_62,pert
Genotype: HtrA2 knockout,pert
treatment: no DOX,pert
IL8.1,pert
tissue: liver;	treatment: CCl4 and erlotinib 5 mg;	strain: A/J,pert
"5mg/kg/day PFOA, Rep 1, Block 5, lung (high dose)",pert
MCF-10A shCHK2-1 replicate 1 [set 5],pert
"N-58, NORM, M, GSF, 1 x 1000nM DHT, 24h",ctrl
11-0054A_Day1_32,pert
Contralateral 3,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.3;	age of onset: 9 yr,pert
"Biceps, control, cohort 15, subject 15V",ctrl
Trastuzumab treated after 4 days (T3_1),pert
C1_2,ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P7,ctrl
EB_6_8d_301_HCHO_Nasal_Rat230_2_CIIT05024,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 18",pert
tissue: left lung;	genotype: Wild Type;	age: 8-week-old,ctrl
Untreated after 4 days (C2_1),ctrl
normal muscle replicate 1,ctrl
NK_cell_pool_healthy_H05+H06,ctrl
4031-1 E2F3 Heterozygous,pert
"AD_FC, biological rep6",pert
HEL_JAK2 knockdown (Jak2-10 shRNA)_2,pert
cell line: A549;	cell type: adenocarcinomic human alveolar basal epithelial cells,ctrl
WT STR Veh 4,ctrl
"fatty (fa/fa), liver, Troglitazone",pert
treatment: control scrambled siRNA;	cell line: H441,pert
Age: 61;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
C33KD2_with doxycycline_1,pert
hepatocytes,pert
siIPMK no DNA Damage experiment 3,pert
"Lymphoblastoid cell lines derived from family 1725, member 2",pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 48 hours,pert
RIP-Aire transgenic,pert
braf status: not determined;	tissue: normal thyroid tissue,ctrl
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 72 hours;	agent: ozone;	exposure dose: 0.3 ppm O3;	test article cas no: 10028-15-6",ctrl
individual: patient7;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"Patient 26, Macroscopically intact tissue",ctrl
Jurkat-KD3,pert
"strain background: mixed 129S6/SvEvTac, C57BL/6J, Balb/c;	genotype/variation: WildType;	age: 3-4 months;	gender: Male;	tissue: whole lung tissue",ctrl
Akt1 double transgenic mice on a high fat diet (DH 3),pert
Cont subject 07,ctrl
Advanced IPF_explant_upper lobe_rep158,pert
"Mdr2-KO homozygous mouse, 12 month old mouse 1",pert
Monocyte ATV rep 1,pert
"mutant mouse embryonic fibroblast, biological rep 1",pert
"cultured PBMC, treated with Bt5",pert
Individual_5147_NN_sample,ctrl
treatment group: cadmium chloride 0.1 uM;	cell line: TK6 cells,pert
patient: CEM11;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Genotype: C57Bl/6 mice;	Age: 8-12 weeks old,pert
"human failing LV myocardium, Ischemic12",pert
cell line: MCF7-ADR;	treatment: Multi-step doxorubicin-selected subline,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection;	vector: pLKO.1;	activation: none,ctrl
astrocytes from second trimester human fetal brains,ctrl
5410-lcm,pert
SENS 5 0hr,ctrl
Mening UNSTIM WB NP 0a,ctrl
Human prostate cancer primary culture C25dx,pert
Donor2_6h_DMSO,ctrl
"fetal testis sample 23, 20 weeks gestation",pert
Dengue Fever Patient 44,pert
Paraquat wild-type,ctrl
Gata3_A3,ctrl
platelet_Ctrl_4,ctrl
V5-P163,pert
Cardian muscle Trained diabetic 5 week DT5,pert
"Kinin B1 receptor knockout, biological rep3",pert
Bcl6 KO 2 sample A,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous endotoxin challenge""",pert
Raji cells transfected with control mimic at 24 hours,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 209,ctrl
Blood_Control 1,ctrl
H1299 DAC 1 uM (3238),pert
in vitro differentiated DCs,pert
47SAGEA,pert
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep5",pert
Liver_Control _Rep3,ctrl
Luciferase control 2,ctrl
"EAE, 1,25(OH)2D3-treated #7",pert
WM1205 cell line,ctrl
"Rat Schwannoma cell line that express genes associated with glial characteristics including Sox10, p75, GFAP, and S100.  For additional information please see: Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I.;	(2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 69:497–.508.",ctrl
AA_128,pert
tissue: Frontal cortex;	age: 101;	Sex: F,pert
strain: F1 (C57BL6 X 129/SvEv);	genotype: AGTR1A-KO mice;	tissue: kidney;	gender: male;	treatment: NS diet,pert
EA_Case8_CD4,pert
Gfp+ photoreceptor cells,pert
Disease_status: Bipolar disorder;	Age (years): 37;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 23;	Brain pH: 6.5;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: 1200;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: Yes;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 4;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6,pert
TP06-998,ctrl
RT4D6_wild type Sox10 siRNA_rep1,pert
PsOEt-21-Week 12,pert
47B,pert
Individual_5331_PP_sample,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_1_36_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
AtT20 cells infected with empty vector rep2,ctrl
normal B lymphocytes (NBL 006),ctrl
"Crohn's Disease subject (20 year old black male, SAK_1259851809)",pert
Fetal heart 6 ug/kg TCDD rep4,pert
Control male 6,ctrl
human epithelial colorectal adenocarcinoma cells (Caco-2),pert
gender: male;	age (years): 58;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: No treatment,ctrl
mutant_crypt_day2_sample1,pert
fibroblast_5azacontrol_rep3,ctrl
MDS patient 107,pert
"human failing LV myocardium, Idiopathic37",pert
whole blood_100315,pert
LNCaP/NC siRNA,ctrl
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: Untreated,ctrl
RBP2-/- MEF,pert
C_AN12240_C,ctrl
"Uninfected treated with 1,25D, replicate 2",pert
SIRT4 WT liver_7244,ctrl
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119+;	genotype/variation: wildtype,ctrl
"siPRMT8 neuron, biological rep1",pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: Trim28CKO,pert
Control (C50),ctrl
SENS 7 0hr,ctrl
"PC from MM patient,isolated using CD38-APC.",pert
chip number: 13;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.61;	rin: 9.6;	transfection date: 2012-03-26,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 6,pert
M304 SKM-KO,ctrl
Colon_Wild Type_2,ctrl
schizophrenia,pert
ko 13.5d replicate 3,pert
RV82.01_CONTROL_day10,ctrl
Strain: C57BL/6;	Age: 4 months;	Tissue: retina,ctrl
Transgenic nr 657,pert
Tgfbr2 fl/fl Control Posterior Palate 1,ctrl
T2-FP_spleen_KO_rep3,pert
"Prdm14(+/+): 2i, rep2",ctrl
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate2,ctrl
gender: female;	age (years): 55;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
cell line: JURL-MK1;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
Embryonal carcinoma 1017,pert
CUTLL1 MigR1 GSIwash2h,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 6;	gender: male,pert
"Whole blood - mental retardation or developmental delay, Male",pert
C_AN03217_F,ctrl
"Ulcerative Colitis (47 year old caucasian male, SAK_1286408661)",pert
TET-on Human lung carcinoma H1299,pert
Intestine_KO_biological rep4,pert
"CD3+ T cells, bone marrow, SAA patients post therapy / in hematological remission",pert
skeletal muscle Crhr2+/+ replicate1,ctrl
"Acute Myeloid Leukemia, sample 18",pert
MCF10A-HER2-FKBP-HA cells,pert
M539_KO,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S25_3 months_replicate 3,pert
MDS patient 73,pert
Sample 8,ctrl
sample =XCGD4 treatment=Control time=180 (min),pert
human skeletal muscle from insulin sensitive individuals before insulin therapy,ctrl
FACS-purified B cells_129SV/EV_non-infected_rep4,ctrl
ko 13.5d replicate 8,pert
"PMA treated, doxycycline treated; biological replicate 1",pert
Proliferative Stage Endometrial Biopsy,ctrl
HGPS Fibroblast replicate 1,pert
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 546,ctrl
age: 62;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Trim28CKO unstimulated CD4 positve T cell rep1,pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with rheumatoid arthritis",ctrl
Huh7 cells_Mock Infected 12 hours_ rep3,ctrl
"testis, wild type",pert
Liver_KnockOut_1,pert
colon_IBD_1368,pert
Sorted Zfx wt myeloid progenitors overexpressing only GFP selectable marker,ctrl
Sample from retroviral MSCV-GFP control infected cyclin D1 knockout 3T3 cells (line 12).,pert
lung from control mouse,ctrl
BALB-RAG_PBS Replicate 1,pert
AEP-final,pert
"brain, frontal cortex: Sample56_e1_le1",pert
"Gender: Female, Age: 25, BMI: 31, Tissue: luteinized cumulus cells",pert
sex: Male;	Age: 7 months;	additional patient information found in Series supplementary file,pert
SynovCTRL_0227ACID_150.txt,ctrl
CLL 377-01 LMP-420,pert
11430 UC Inflamed sigmoid colon,pert
monocytes_T14_rep2,pert
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: wild type,pert
"Ifitm1-deficient lung tissue, biological replicate 4",pert
Liver sample of WT mouse 2,ctrl
gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.3,pert
Control subject 102_biological replicate 1,ctrl
Biceps_Pompe_7,pert
CF (D508) subject12,pert
MCF7_Doxorubicin_Array_1,pert
Psoriasis-Patient-A,pert
tissue: white blood cells;	age: 16.57;	Sex: female,pert
OTT1 knockout mouse;	sacrificed at gestational age,pert
Animal 7,pert
healthy CD4 T cells 4,ctrl
UV-SeV 3659,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 73 years,pert
SLE myeloid cells 9,pert
"patient 006b, cancer, homogenized",pert
"RWPE-PCAT1 cMyc siRNA #4, replicate 1",pert
3DKD_SerumStarved->1hrEGF_rep4,pert
cell type: ESC;	genotype/variation: control,ctrl
BCell_lymphoma_aggressive_sample3,pert
"Control, replicate 3",ctrl
"INS-1 cell line, clone #1-1.16",ctrl
"BMMCs from NTAL WT, pLKO.1 infected, nonactivated, biological rep2",ctrl
CD8_T_cell_pool_melanoma_M01+M02,pert
gender: Male;	strain: C57BL/10ScNJ;	genotype: TLR4-/-;	tissue: Kidney;	surgery: Sham;	reperfusion time: 4hr,pert
wt_P8_rep4,ctrl
RNA from whole tissue section of case 648 labeled with Cy5,ctrl
"MCF7 cells, non specific control",ctrl
47SAGEA2,pert
C1 Control None,ctrl
"KM-H2 Non-silencing, technical rep1",ctrl
SZ28,pert
F_LS_Wk12,pert
"Endometrium, postmenopausal, estradiol, 13",pert
"alveolar macrophages, smoker 025",pert
cardiac allograft,ctrl
heart of mouse subjected 1 week to chronic intermittent hypoxia (1A),pert
BP11,pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep1",pert
Control9,ctrl
3895-2 E2F1 Null,pert
"brain, hippocampus: KA-72h-P15-III_e1_le1",pert
WT White adipose tissue (WAT)_HFD_rep4,ctrl
Setdb1 2lox/1lox/Cre minus tamoxifen 1,ctrl
HNF4 Null_278,pert
cell line: HL-60;	shRNA construct: GSK3B Construct 2,pert
Brain from Meg3 knock-out E18.5 mouse embryo,pert
"Liver from Nrf2 wt mice, biological replicate 1",ctrl
BAT_WT_2,ctrl
Normal tail skin from control mouse,ctrl
patient: 51091;	sample: tumor,pert
"Mouse bone marrow-derived mast cells treated with IL3, rep 2",ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
age: 50;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 35 yr;	population: white,ctrl
control-2,pert
ACI DES-treated replicate 3,pert
"MCF-10A cells, overexpression TAp63γ",pert
EP71_adipose_control,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#113,pert
Adipose-24 month-wild type-technical replicate 2,ctrl
"Control 05, NC05",ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siSox2,pert
Mnk_3226-T-7,pert
Sirt1 siRNA KD1 2,pert
HCC_34N,ctrl
gender: Male;	age: 61;	post-mortem delay: 16.5h;	ph: 6.2,ctrl
Blood_Control 6,ctrl
218/0,pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 82;	Usage number: 4;	Exposures: 3,pert
2a_b,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days",ctrl
hES_SA01_3,ctrl
"DMSO Control after 24hr, replicate 2",ctrl
CF control DMW CHN313,ctrl
"human failing LV myocardium, Ischemic37",pert
BMM_C3H/HeJ_time0h,ctrl
BP patient 75_biological replicate 1,pert
Patient no. 15: treated,pert
ApoD KO rep_2 (CKO2),pert
CXCR4 knockout 4,pert
SHEP-SF neuroblastoma,ctrl
"airway epithelium, smal airways, obtained by bronchoscopy and brushing",ctrl
Head RNA of littermate wild@E13.5 No.3,ctrl
Soleus muscle,ctrl
genotype: Kdm2b knockdown;	strain: inbred 129;	cell line: E14;	cell type: embryonbic stem cells,pert
"Control cells, rep1",ctrl
DS1-iPS 6,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 206,ctrl
chip number: 21;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.51;	rin: 9;	transfection date: 2011-10-17,pert
GNMT-KO mouse hepatocytes (sample 3),pert
subject id: 35;	infection: DENV;	status: DF;	tissue: whole blood,pert
SKNSH MECP2_e1 2,pert
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 1;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
MDA-MB-231 cells_siRhoGDIbeta transfected_3 days post-tranfection,pert
3T3F442A-shGFP-rep1,ctrl
Bl6_Mock_2,ctrl
gender: Male;	age: 25;	post-mortem delay: 12h;	ph: 6.6,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET1 transcript,pert
patient: 270;	current medication: Becotide inhaler;	birth date: 4/30/52;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/99;	diagnosis date: 8/24/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/24/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 8/24/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: NEW;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Asthma;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"Acute Myeloid Leukemia, sample 59",pert
age: 49;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
PGA_MI_nilv_1h_394,pert
"nasopharyngeal carcinoma, specimen T11",pert
cell line: IGROV-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
WT_P60,ctrl
lymphoma_7890_nt,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID133,pert
"3T3-L1 siLSD1 48h, biological rep 2",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 3x1h exposure per day",pert
Mtb infected-42d-4,pert
control appendix,ctrl
231/ARF-4,pert
"amnion mesenchymal cells, no treatment, biological rep2",ctrl
diagnosis: NSIP;	fvc-group: FVC3;	tissue: lung,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 2,pert
FBooth-MDX-4Av2-s2,pert
cell line: HEK293 cells;	transgene: NPAP1/C15orf2;	treatment: induced,pert
T1C-LU,pert
strain: 129/Sv;	group: control;	genotype (hdh cag repeat length): 7/7;	differentiation status: undifferentiated,ctrl
"Cultured ovarian cancer cell line OVCA429, untreated",ctrl
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: resistant,ctrl
Patient 11,ctrl
U87 untreated rep1,ctrl
gender: Male;	tissue: Tendon;Subscapularis;	age: 44;	donor: 33;	disease state: Non-lesional,ctrl
siEGFP (72 hr) _1,ctrl
mdx gastroc sample 2,pert
"Deltoid, control, cohort 09, subject 09U",ctrl
microdissected breast cancer cells from case 763,ctrl
patient: 22;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
PGA-MAH-C3H_PBS24h-5aA-s2,ctrl
Healthy CD4+T cells 1-TP,ctrl
Wildtype liver DEN-injected 12weeks repl1,ctrl
BP26,pert
Brain from 54 days Npc1+/- mouse1,ctrl
"wildtype liver, biological rep 2",ctrl
EA_Case1_CD4,pert
ALS gray matter 7 Sporadic,pert
Infergen_6hr,pert
MA_16,pert
phenotype: control;	gender: female;	case_id: 477;	age: 52;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 11;	brain ph at time of freezing: 6.21;	labeling_batch: 1,ctrl
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 200 mg/kg,pert
"primary cortical neurons, FMR1 shRNA",pert
HUVEC/NmenMC58_WT_6h_rep1_1102,pert
VMM-MUT_MyoD24h-3MP-s2,pert
"Gastrocnemius, WT, 2 months old",ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 1 - Technical Replicate 1,pert
WT J1 ESCs on day 0,ctrl
brain_OFC_control C_mr381,ctrl
"brain, cerebellum: KCx12w#2_e1_le1",pert
normal thyroid,ctrl
Normal PBMC Sample 1,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: PTD-DRBD-mediated siRNA delivery;	time: 24hr,pert
Mouse testis,ctrl
wildtype MEFs without cisplatin treatment,ctrl
Ishikawa_Control_48h_rep3,ctrl
"SWR/J SAL, Rep1",ctrl
CD4IncTp1-2,pert
OVCA433+(2),pert
"A2 corrected_C2_transgenic but unaltered, lung tissue",pert
FBooth-CON-1Av2-s2,ctrl
"brain, cochlea: [10] Sample #10_le1",ctrl
Normal cervix epithelium_03-3505,ctrl
"human failing LV myocardium, Idiopathic77",pert
Wild type 3,ctrl
14: FCHL patient #99-0712,pert
H1P_4,ctrl
gender: female;	batch: 2;	age (years): 44;	patient id: Non_severe_2;	fev1 (% predicted): 87;	fvc (% predicted): 92;	medication: flixotide;	cell type: CD8+ T-cells,pert
WildType_3,ctrl
7 Ko,pert
pt. HCL F treated with Vemurafenib 1000 nM for 72h,pert
"E2-treated cells (24hr), biological rep_1",pert
s2t1c,ctrl
normal liver tissue,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: untreated; biological replicate: 2,ctrl
"Hippocampus, soman, 6h",pert
lesional skin bioposy obtained from patient after 1 day of treatment,pert
Day 14 (T3+4),pert
"cells treated with Vamp7 siRNA, biological replicate 3",pert
Wild type IFN-gamma 4 h,ctrl
Fog2flox/delta; alpha MHC Cre biological replicate 3,pert
tissue: white blood cells;	age: 15.23;	Sex: male,pert
CA1 Cre Sox7I,pert
1011-03-A-b,pert
"Normal skin from lmq_control mouse, biological replicate 2",ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 24 hrs AP20187,pert
cell line: OVCA433;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
WT4 SPLEEN,ctrl
tissue: neocortex;	developmental stage: E14.5;	genotype: Eomes KO;	genetic background: C57BL\6,pert
Liver_Female_WT_rep1,ctrl
control peptide-treated HPB-ALL 100mM 16h,ctrl
Wild type 1,ctrl
"wild-type DP cells, biological rep 1",ctrl
T2D-LU,pert
KGN,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: E;	experimental sample name: PC7-R,ctrl
28GOBMUC2A,pert
5223 UC Inflamed sigmoid colon,pert
CD11b+Gr1- cell sample_5 (derived from wild type mouse),ctrl
EB_0_24h_54_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
"Patient I-u58T, MSI colorectal tumor",pert
healthy control H07,ctrl
strain: BALB/cByJ;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: non-infected,ctrl
"SWR/J ACU, Rep2",pert
Nonirradiated-ATM-WT Replicative1,ctrl
sample 1:;	age: 45;	gender: female;	sample 2;	age: 81;	gender: female,pert
scram_lo_1,ctrl
"A673 treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50), biological rep2",pert
WT Tibialis Anterior at 4 weeks biological rep2,ctrl
"Control, standard diet, rep3",ctrl
MS25_4A_LV_220307,ctrl
GM19238_Kd_E2F6_1,pert
cadmium_08hr_rep1,pert
62 y/o male,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.767;	OD280: 1.439;	Ratio: 1.87;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 133;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Livers of TAK1 ko mice  sacrificed at 4 weeks,pert
"24hr non-specific siRNA, 16hr vehicle treatment replicate 3",ctrl
WT White adipose tissue (WAT)_HFD_rep2,ctrl
CHF - LV09,pert
TARBP2 over-expression (pCMV-TARBP2-2)_MDA-231,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr.;	Mouse supplier: Charles River.  Cultures were completed in Frank Beiers laborartory by Veronica Ulici and Claudine James",ctrl
Irradiated-ATM-KO Replicative1,pert
rat liver,ctrl
Donor6_6h_DMSO,ctrl
ILD Study Number 1236,pert
mock-4,ctrl
"DMD skeletal muscle, biological rep11",pert
A SIT_B035,pert
"Whole embryo, E9.5",pert
R4_saline_wildtype_422,ctrl
ubb_d7_wt_2,ctrl
"female,21,Caucasian",ctrl
Panc0504 cell line,pert
10 week mutant spinal cord rep 2,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14476;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
MDS patient 95,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 14 months,ctrl
Normal heart_G67,ctrl
Tendon_lesional_rep13,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Supraoptic nucleus,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP/HDC-KO;	age: 7 months;	tissue: colon tumor;	cell type: CD11b+Gr-1+ myeloid cells in the tumor stroma,pert
Snell 22 month Dwarf Liver 3dw,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: DMSO for 48h,ctrl
"spleen marginal zone B in WT, biological rep1",ctrl
colon_adenoma_1748,pert
pre-iPSC- siRNA to luciferase- biological replicate3,ctrl
"age at diagnosis: 35;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 5;	dfs-event: 1;	distant metastasis: 1",pert
major non-tumor4,ctrl
"Hematopoietic stem and progenitor cells (LineageLow, Sca1+, Kit+; LSK)",pert
Native wt biological replicate 3,ctrl
"Cell type: endothelial, age:55, gender:male, diagnostic group: control, PMI:31h",ctrl
"Affymetrix chip HG-U133A, siLuc 3",ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shScr,ctrl
"Strain: Wild-type, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Left",ctrl
Human Acute HIV Sample A064-CD8+ T cells,pert
"ADAM17 cKO skin, rep1",pert
"non-AD_TC, biological rep15",ctrl
Gene expression profiling of normal cortex of patient 26,ctrl
tissue: skin;	individual: Patient N-8;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
"brain, hippocampus: C1-I_e1_le1",ctrl
60 day LAD ligated heart from C57BL/6 strain,pert
"Strain: C57BL/6, Tissue: Airway Epithlium, Culture: Organotypic Air Liquid Interface",pert
No_drug_#4862,ctrl
"fetal testis sample 17/18, 22 weeks gestation",pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 48h,pert
LPS-PVH_1,pert
Rybp#10 (OHT-)_4d,ctrl
S25 NLS 142Q TG1	F4/23	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
heart of 2 week control male mouse,ctrl
agent: Nickel 40 µM,pert
"PBMC, healthy control, biological rep15",ctrl
AKT_PLACEBO_12hours_3,pert
coc-38_C,pert
liver 0.1% quercetin diet rep4,pert
Eed KO E14 ESCs on day 0 #2,pert
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 1 - Technical Replicate 1,pert
HA01-57A,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Female,pert
MDA-MB-231 breast cancer cells,pert
colon_adenoma_983,pert
"Female Nrf2 wild-type mice, liver sample",ctrl
"human embryonic stem (hES) cells line SA01, biological replicate  3",ctrl
Ovalbumin-induced inflammation 24 hourS,pert
"0mg/kg/day PFOA, Rep 1, Block 5 liver (low dose)",ctrl
DC3 RSG,pert
Human Acute HIV Sample A189-CD4+ T cells,pert
"MLD, biallelic AML MLL_00235",pert
WFS1 WT USHT_14_317_ko,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 29;	maternal age: 32,pert
Muscle Experiment 2,pert
PE_N_562,ctrl
si FoxA1 and vehicle replicate 1,pert
E2A-deficient double positive cells sorted from thymus of 8 week old mouse,pert
Human Neural Stem cell line with Nurr1 overexpression,pert
cell type: sorted LSK cells;	strain: C57BL/6;	genotype/variation: SRF KO,pert
Ramos pRTS-GFP C+,ctrl
6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24719,ctrl
homozygot FH P269,pert
U937_ROS_curcumin_4h_rep2,pert
Soleus muscles from male wildtype C57BL/6,ctrl
aggressive E-mu-BRD2 mediated lymphoma,pert
PCOS Endometrium Endothelial Cell_140.UC271+-,pert
T7F-LU,pert
control rep 4,ctrl
patient: 40899;	sample: tumor,pert
KO LSK,pert
66 year old male,pert
MEF E2F4 KO 1-rep2,pert
HepG2_As rep1,pert
Donor3_6h_Wy,pert
"LY2 cell line, SRC-1 scrambled untreated, biological rep2",ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 202,ctrl
Postmenopausal female. Tibolone treated. Patient 16.,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep8,pert
"control, BA46-49",ctrl
S-IIP(UIP)3_Cy3,pert
disease state: Control;	tissue: peripheral blood,ctrl
breast epithelium adjacent to tumor,pert
Ad infected murine liver-MO30k-(666)-6 hpi,pert
NLGN1_1,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.02;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 31;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
scram_lo_3,ctrl
"vector d0, rep 4",ctrl
"medulloblastoma, M2, scrambled",ctrl
Mist1KO saline rep3,pert
"Wild type GM-BMMs, biological rep2",ctrl
Nrl-ko-Gfp E16 replicate 2,pert
HEK293 cell line #5 with induced HNF1beta mutant A263insGG,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: trisomy8,pert
"CTR-B (CTR-2, biological replicate 2)",ctrl
Control (C80),ctrl
IFN/Vit-KO,pert
Muscle JDM (YJD-JDM-19UA-s2),pert
Common Reference 2 round amplification 2 ug,ctrl
MPM tumor specimen 27,pert
S3C Sporadic-hippocampus,ctrl
24h Lipofection GAPDH siRNA (SAMPLE 11),pert
Mouse female ES cells PGK12.1 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-4 in PGK12.1.,ctrl
OA 3,pert
"Diclofenac treated HL-60 cells, biological replicate 2",pert
IDCM2,pert
1 PC3 0hra,ctrl
Zfx fl MA9 cells + Vehicle [10950],ctrl
"brain, frontal cortex: Sample43_e1_le1",pert
Pancreatic Sample 22-Tumor,pert
EA_Case3_CD8,pert
"TH cells from LC, Mecp2 null, young time point, biological replicate 3",pert
01LNY_PolyRF+,pert
KO - knock-out Untreated - 0 hrs - repeat 3 - Cy5 - mAdbID:51300,pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14501;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Ileum",pert
WT kidneys,ctrl
Patient: D;	Time: 0;	Group: responder;	Condition: lesional,ctrl
control10,ctrl
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep5,pert
Control day 05 sample 2,ctrl
Oral Squamous Cell Epithelium Tissue,pert
DBA d3 (184msn),pert
CAB10_T5_PP_day7_035,pert
PTEN-111 (-/-),pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 61;	donor: 16;	disease state: Non-lesional,ctrl
Tissue: Lung,ctrl
"Lymphoblastoid cell lines derived from family 1712, member 2",pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 8 hours,pert
Colon_Wild Type_3,ctrl
Muscle-AMPKgamma3-wt-6,ctrl
HSC-3_vector_48hr culture_rep1,ctrl
Psoriasis-8 baseline,pert
"Control, biological rep12",ctrl
GM19238_Kd_E2F1_2,pert
Interleukin_6_3,pert
Wild Type 8,ctrl
age_years: 34;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
LNCaP + vehicle rep2,ctrl
KO PBS2,pert
microdissected epithelial cells from IPMC 3,pert
MCE301 cells treated with SB for 6 h-2,pert
HC CJ 2 water,ctrl
jzo013-rp1-v5-u74av2-met,ctrl
"10mg/kg/day PFOA, Rep 3, Block 3, lung (high dose)",pert
non-transgenic spleen B cells_20 weeks,ctrl
reduction mammoplasty patient 357,ctrl
"nasopharyngeal carcinoma, specimen T10",pert
sex: Male;	Age: 15 months;	additional patient information found in Series supplementary file,pert
Muscle WT Aged 0121,ctrl
Rat left ventricle,ctrl
siRNA-96_rep2,ctrl
MPA-treatment for 48hrs,pert
hippocampus: Sample #6_e1_le1,ctrl
strain: C57BL/6J;	cell type: bone marrow derived macrophage,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_Con_HG-U133A_2_YCHSUP501,ctrl
HeLa_TP082505_23_HG-U133A_2_IMFGN0023,ctrl
Large cell carcinoma 013,pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: control,ctrl
DRG_Capsaicin_10microM_Rep2,pert
Healthy CD4+T cells 11-RP,ctrl
Muscle JDM (YJD-JDM-30UA-s2),pert
ab171 IM,pert
01LLB_CTRL,ctrl
ILD Study Number S020,ctrl
Septic shock;	gender: Female;	Non survivor;	organism: Strep pneumo,pert
Targretin_LIVER_2,pert
A HID I_B056,pert
Postmenopausal female. Tibolone treated. Patient 30.,pert
Silberg2 (S2) 021101NE,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 3;	gender: male,ctrl
Differentiation of hES cells line VUB03_DM1 towards MPC-like cells;	Mesenchymal stem cells phenotype,pert
Cervical Cancer C494,pert
Tendon_non-lesional_rep8,ctrl
MCL_IGHV_UNMUT (R1680),ctrl
quiescent ulcerative colitis_UCN3,ctrl
Insm1 mutant #1_pituitary gland,pert
KO Tibialis Anterior at 4 weeks biological rep1,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 2,pert
Fibroid_2525A,pert
Pfeiffer NTshRNA,ctrl
"E18.5 ERRg +/- heart, biological rep 2",pert
whole tissue section from case 1037,ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 72 hr,ctrl
2B1_Dlx5_replicate1,pert
2B1 Otic vesicle cell line over-expressing GFP only,ctrl
"Biceps, FSHD, cohort 18, subject 18A",pert
patient id: T79;	tissue: Normal cortex;	gender: Male;	age: 59;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
HEL_Control shRNA (GFP)_2,ctrl
PND28 Rat Testis_Rat230-2_6hr MEHP_Animal#31_04005,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 318;	age-at-biopsy-years: 38,pert
colon_C57 mouse_12weeks_rep2,ctrl
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S25_3 months_replicate 2,pert
baseline control 08,ctrl
Fetal lung CD-1 background,pert
"Patient H-c340T, MSI colorectal tumor",pert
801B.LMP,ctrl
Huh7 cells_JFH-1 Infected 6 hours_ rep3,pert
MDA_PR_Paclitaxel_1,pert
fat_Akt1+/-_8wk_rep1,pert
Pancreatic Sample 35-Tumor,pert
"Crohn's Disease subject (38 year old caucasian male, SAK_1316800947)",pert
autism with FMR1-FM AU066703,pert
coronary smooth muscle cells nebivolol replicate 3,pert
RatLung_Con_3,ctrl
"4302_CD133-, laminin treated",pert
Patient identifyier: E;	Sex: male;	Age of patient: 51 years;	Duration of psoriasis: 24 years;	Body surface area: 8 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
"Normal Skin, Normal-18",ctrl
mouse cerebellum at P30 knockout 1,ctrl
Msgn1_48hMinDox-biological rep2,ctrl
MOLF/EiJTCE liver sample batch 2,pert
"C3H/HeJBir, sample 2",ctrl
PCOS Endometrium Epithelial Cell_138.UC271 EpCAM,pert
Tendon_lesional_rep4,pert
MDA-MB-231 control clone #4,ctrl
Liver Rosi1,pert
"p38alpha wild type fetal liver E13.5, biological rep3",ctrl
obtained from RIKEN CELL BANK,pert
race: caucasian;	age (years): 60;	stage: IB;	grade: 3;	histology: endometrioid,pert
N5A Normal-frontal,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,ctrl
MDA-MB231 control shRNA cells,ctrl
"YAP-overexpressing cells, biological rep2",pert
sample =Healthy4 treatment=Control time=360 (min),ctrl
Primary hepatocytes isolated from Donor 2 treated with DMSO for 24h,ctrl
"Bmi1 shRNA, biological rep1",pert
"WKY adrenals, replicate 1",ctrl
age: 12 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
"48 hour-treated TG2 knockout NB4, biological rep3",pert
P138,ctrl
"CD8 DC wild type, biological replicate 2",ctrl
HNF4 Control_1192,ctrl
INCB18424 Acute 2,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: rosiglitazone at 1uM,pert
muscle_Akt1+/-_35wk_rep1,pert
Ishikawa_VeryLowDose_BPA_48h_rep2,pert
"HA-Fbxl10 cell, Replicate 2",pert
Fetal heart TCDD 3 ug/kg TCDD rep1,pert
"Grape extract group, 6 months, patient number 32",ctrl
SKBR3-R_0.1uM_Lapatinib_1,pert
PML Knockout Mice fed Low Fat Diet 3,pert
RNA from microdissected breast cancer cells from case 25 labeled with Cy5,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-5;	Primary Site:Tongue;	Age:64;	Sex:M;	TNM:T1N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
Disease_status: Bipolar disorder;	Age (years): 49;	Gender: Female;	Age of onset (years): 20;	Duration of illness (years): 29;	Brain pH: 6.39;	Post mortem interval (hours): 38;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Tgfbr2 Wildtype Mouse Model MEPM 1,ctrl
ic11 -- cell line 2 treated with APF#2,ctrl
ID4+/+TCL1-tg spleen CD19+ B cells collected from 3 mice 3,ctrl
"seminoma specimen, pT1, patient age: 29y; W03 022",pert
N51292,ctrl
AA_71,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.98904,ctrl
Glioblastoma_1,pert
V5-P288,pert
Squamous cell carcinoma 009,pert
MDA-MB-231-ZNF217 cell culture 2,ctrl
ES cells,ctrl
Run1.a10a.000608jd.2.SkMNor923.CEL-IS basal,ctrl
HepG2_control_rep1,ctrl
1082PBMC,ctrl
AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 1,pert
Diagnosis: Secondary AML;	Age: 36y ;	Gender: Female;	Blast %: 67;	Source: BM;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
Male 8weekBL6 shamrep2,ctrl
Testis CREMKO 0h batch 4 [TeKOh00.29],pert
treatment: Sirt1 Overexpression;	cell line: Caco-2,pert
Dominant negative cJun  VZ19,pert
"LNCaP cells, treated with EtOH, biological rep 3",ctrl
DC3 AM,pert
"PCB153 treated HepG2 cells at T0, biological replicate 1",ctrl
Brain (Inferior Olivary Nucleus)_control subject_#2,ctrl
age: 6 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
IRAK2 KO_macrophages_0h,pert
N8,ctrl
tissue type: adjacent non-tumorous liver,ctrl
H22 Ctrl 24h 2,ctrl
striatum_ctip2_KO_1,pert
A39 WT6	F2/11	A39	wild type	Mouse	10 months	Cerebellum	Male,ctrl
PGK12.1_control RNAi-2,ctrl
"patient 15, arm treated with pimecrolimus",pert
5204 Normal Uninflamed sigmoid colon,ctrl
"Liver from Nrf2 wt mice, biological replicate 1",pert
strain background: mixed (SV 129/C57BL/6);	genotype/variation: Rnh1 Knock out (Rnh1-/-);	age: embryonic day E9.5;	tissue: yolk sac,pert
"Gender: Female, Age: 27, BMI: 19, Tissue: luteinized cumulus cells",pert
Control (pCMV-GFP-1)_MDA-231,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 8 hours,ctrl
SK-MEL-2 cells,ctrl
Gene expression data spleen marginal zone B in IRF8 conditional KO,pert
"WT HSC, biological rep3",ctrl
"amniocytes, euploid, 1569",ctrl
"SRF silenced, treated with EtOH, biological rep 2",ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 1 day;	treatment: 2R4F whole mainstream smoke 125 µg/ml, treatment over 1 day, 3x1h exposure per day",ctrl
15DKD_SerumStarved->3hrEGF_rep1,pert
s6,ctrl
"FACS-sorted cones, P40 C-DGCR8 KO mice",pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
X_p4_rep4,pert
HEK293_HNF1b_#2_induced,pert
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shSOX11.3,pert
race: african american;	age (years): 91;	stage: IB;	grade: 3;	histology: papillary serous,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
Age: 57;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: Yes,pert
monocytes_Q10H2_1,pert
strain: C57BL/6;	genotype/variation: Fcg-chain KO;	cell type: Peritoneal MF,pert
Soleus muscle,pert
C_AN00544_T,ctrl
0h Kin Cel.44,pert
CD positive WT T cell unstimulated rep4,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#100,pert
"Uninfected TG at 5 d.p.i., rep3",pert
Kidney_400 mg/kg VCM iv_mouse #047,pert
"HL-60 + 10 nM TCDD, biological replicate 1",pert
EA_Case12_CD4,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID321,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 6 weeks;	Treatment: untreated,ctrl
Diagnosis: AML M5;	Age: 58y ;	Gender: Male;	Blast %: 75;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
Control d 10 (5),ctrl
E18.5 Embryonic Liver,ctrl
P4_PMP22KO_1,pert
105A,ctrl
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep1,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 54, stage IIIB, HPV 16",pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 48 hours after nickel exposure",pert
"iPSC derived from CCALD patient fibroblast CCALD2, biological rep5",pert
8 wk old male mdx5cv diaphragm,pert
Human Chronic HIV Sample C080-CD4+ T cells,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 52 years,ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
WT V6.5 ESCs on day 3 #2,ctrl
Ileum_Wild Type_1,ctrl
Human hepatoma cell line (HepG2),ctrl
SZ23,pert
03_PAH,pert
4472-1 E2F3 Heterozygous,pert
NPC_p5ko_rep3,pert
gender: male;	tissue: heart;	tissue: Transmural sample taken from near the apex of the left ventricle,ctrl
human CF cell lines airway,ctrl
RA2,ctrl
"Muscle from WT, biological rep2",ctrl
"MCF-7 human cell line, siLRH-1_#3",pert
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep4,pert
BP9,pert
"Subject 13, Family 5, Affected",pert
primary normal lung tissue 1319,ctrl
E2C,ctrl
Aged 9,pert
subject: 2830 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
Waldenström’s macroglobulinemia (WM-PC 31489),pert
"Infected with H37Rv, replicate 2",ctrl
strain: FVB;	genotype: E2F3 heterozygous;	tissue: mammary gland tumor,pert
"human peripheral blood derived monocytes, 2 hour LPS stimulation, biological rep3",pert
negative control inhibitor (NTC1)_24-12,ctrl
"control_B1, empty vector",ctrl
RNA from microdissected breast cancer cells from case 849 labeled with Cy5,pert
Embryonic age 14.5 wild-type rep1 (PKD1_58),ctrl
KO 0h TPA rep2,pert
Female - caucasian - E-06-G,pert
Healthy donor_biological replicate2,ctrl
HF0329_U133P2,pert
NPC3,pert
AAA neck (Sample 7),pert
Pt23_Post,pert
221/0,pert
"HME-CC, 12h, 0.2uM DOX",pert
EA_Case2_CD8,pert
mES cells TR71 KD rep1,pert
18SAGEA,pert
Healthy untreated rats 2,ctrl
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-2,pert
inflammatory cardiomyopathy,pert
"ID:11-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Cell type: neuronal, age:44, gender:female, diagnostic group: schizophrenia, PMI:26h",pert
Moderate rep1 (OHN),pert
KU_38T,pert
"Ada3FL/FL MEF, Cre, biological replicate 2",pert
"Untreated LNCaP cells not stimulated with DHT, biological replicate 2",ctrl
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/22,pert
Control spleen - Biological Replicate 1 - Technical Replicate 2,ctrl
"BL6/C57 mouse heart, control, rep3",ctrl
treatment: baseline;	gender: M;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
PS_IA_3_cauc_lcm,pert
tDEA006.CEL,pert
"uninfected primary RPE, biological replicate 2",ctrl
HUVEC/NmenMC58_WT_4h_rep1_1102,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
cell line: TOV112D;	cell type: epithelial ovarian cancer cell;	treatment: NSC319726 (1 µM) for 24 hrs,pert
mdx5cv quadriceps sample 1,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4;	flt3 status: WT,ctrl
CD11b+Gr-1+ myeloid cells sorted from the colon tumors of HDC-EGFP transgenic mice induced with AOM/DSS,ctrl
HepG2_control rep2,ctrl
hESC H1 wt rep2 (H1B),ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 105;	medication: Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd;	cell type: CD4+ T-cells",pert
whole skin,ctrl
control;	control,ctrl
NPC 5-8F cells with NESG1-negative expression,ctrl
"Wild type, biological rep3",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: monosomy7/del(7q),pert
Fibroblasts_HealthyControl_6,ctrl
Bladder urothelium,pert
abl control at VEH rep 2,ctrl
BALB/c_PBS Replicate 1,ctrl
Liver_POR-null_1,ctrl
gender: male;	individual: patient 1;	treatment: control,ctrl
SARS patient blood sample,pert
Liver sample from Control group (N17),ctrl
lateral hypothalamus long access to cocaine replicate 4,pert
TYK-nu+(1),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 132min;	race: White;	sex: Female,pert
patient: 51721;	sample: normal,ctrl
cell line: A549;	agent: DMSO;	dose: control,ctrl
IRAK4-KD_BoneMarrowMacrophages_unstimulated_4hours_rep2,pert
"Control Proximal, Small Intestine 3 17 days old",ctrl
Muscle-AMPKgamma3-wt-9,ctrl
"human failing LV myocardium, Ischemic89",pert
human normal pituitary,ctrl
AL Chip#30,pert
MDA_PR_4,ctrl
Wildtype_Sham_Rep2,ctrl
strain: C57BL/6;	tissue: colon;	genotype: PPAR g fl/fl; Lysozyme M cre-;	phenotype: wild-type;	treatment: dextran sodium sulfate (DSS),ctrl
microdissected breast cancer cells from case 638,ctrl
Liver Control 2,ctrl
"vestibualr organ at P15 of Igf1 +/+, biological rep 2",ctrl
Supraoptic nucleus_control,ctrl
ONH preglaucoma,ctrl
V5-P222,pert
A2AR_WT_saline_24h_rep1,ctrl
"mouse strain: C57B/SV129;	genotype: Nrf2 ko;	tissue: mouse liver, 10 weeks",ctrl
4h 4OHT-treated-sample1,pert
RNA from whole tissue section of case 1370 labeled with Cy5,ctrl
"Patient 4, 3 month of BETAFERON",pert
Series 3; adult; no fracture control,ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 wild type mouse, Harlan Teklad TD03045 diet, liver",ctrl
cell line: MCF7;	condition: siRNA Smc3 + Estrogen,pert
gender: Female;	tissue: Tendon;Biceps;	age: 65;	donor: 21;	disease state: Non-lesional,ctrl
Calu-3 human lung epithelial cells,ctrl
"jejunum, GATA4 mutant, 3",pert
"tissue: whole lung;	strain: SPC(+)Cre(-), Dox E6.5-12.5, PN15;	genotype/variation: Foxa2-/-",pert
male_alcoholic_322,pert
ctrl.2,ctrl
carcinoma,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 7,ctrl
WT_embryonic brain_rostral,ctrl
No or early 2 rep2 (OHN),pert
Tumor_18w_erlotinib2_DEN_127,pert
"human failing LV myocardium, Idiopathic4",pert
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 72;	tissue: Blood,pert
age: 49;	sex: M;	disease status: Marfan subject;	Filter number: 95;	Usage number: 5;	Exposures: 3,pert
rd1_P8_rep4,pert
Testicular seminoma 0737,pert
EB_0_6_355_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
428A.LMP,ctrl
IP RNA_KO_rep1,pert
Reh_shCBFA2T3_2,pert
CT-receptor-KO osteoclasts untreated 2,pert
Cbfb-deficient Treg_rep1,pert
cell type: leukemic spleen cells;	genotype: CBFb-SMMHC chimera,ctrl
amygdala,ctrl
Human prostate cancer primary culture C19sx,pert
age_years: 55;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
control siRNA rep2,pert
RNA from microdissected breast cancer cells from case 420 labeled with Cy5,pert
duration of untreated disease in month:3.2;	age at onset:8.4,pert
TN 4,ctrl
cell line: HT1080;	clone: 2;	genotype: Wild type,ctrl
Bone-Marrow_MM_M1148,pert
Hes6_Castrated OWJ42,pert
MLL_PTD08,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.15616,pert
Pancreatic Sample 28-Tumor,pert
EB_0_6_354_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
RNA-DHL4-DMSO-1,ctrl
cerebrum_WT_0d_rep1,ctrl
WI-38 cells exposed to DMSO vehicle control for 24 h,ctrl
Targretin_Lung_3,pert
Hippocampus,ctrl
V5-P091,pert
"D425-shOTX2_3, t=0",pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MEF2A shRNA,pert
liver_Wt_female_35wk_rep2,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day1,ctrl
Control  VZ14,ctrl
Muscle control 3,ctrl
Hippocampus_Soman_96h_rep2,pert
Lung Epithelial Cell Line,pert
"ALL_NDS, K49 011509",ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 5,pert
PGA-MAA-ctr-1bAv2-s2,ctrl
"Female (age range 33-49), skin biopsy from upper nates taken 48 hours after nickel exposure",ctrl
Strain: C57BL/6;	Gender: male;	Age: 9 - 12 weeks;	Tissue: liver;	Treatment: 50 mg/kg of phenobarbital,pert
Untreated wild type B,ctrl
CF (D508) subject15,pert
MDS BM CD34 CELLS,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 71 years,pert
control AU1215303,ctrl
"SUDHL-1, Treated by ALK inhibitor repl 1",pert
A549 siRNA FAM60A 1,pert
"Healthy volunteer, Control_11820",ctrl
"IN1760 siPD treated, Biological replicate2",pert
"breast tumor epithelium,43",pert
TG KLS 2,pert
Donor6_24h_Wy,pert
SKMEL28_t0h_rep1,ctrl
strain: C57/BL6;129Ola mixed;	genotype/variation: Insm1 -/-;	developmental stage: embryo;	age: E17.5;	tissue: pituitary gland,pert
autism with FMR1-FM AU046707,pert
Retina of 4 month old C57BL/6 mouse,ctrl
HSF1-/- T cells activated at 37oC,pert
"NRK-52E cells (DeLarco and Todaro, 1978) (ATCC, CRL-1571)",pert
CLL3-CD4,pert
patient id: 260;	tissue: Normal cortex;	gender: Female;	age: n/a;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
treatment: treated with R1881 and control shRNA;	cell line: LNCaP,ctrl
Myd88 KO control tissue  1,pert
"WT heart, CRE, biological rep2",ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,pert
pt. HCL D treated with DMSO for 48h,ctrl
"Whole ovary from 8 Month Old FORKO mice_03, biological rep3",pert
BAL_29_A1B0,ctrl
cell line: bj-ipsc_2: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below,ctrl
cell type: CFBE41o-  ∆F508-CFTR,pert
Aquaporin-11-/-_mouse P7 kidney #2-4,pert
"nasopharyngeal carcinoma, specimen T28",pert
OVCA429-(2),ctrl
"H295R adrenocortical carcinoma cells, control",ctrl
ShKdm2b replicate 4,pert
Metastatic prostate cancer W2,pert
08_C57_KO,pert
WKY-vehicle pool sample2,ctrl
Subject #8011-8hr Postinfection,ctrl
3068-scrape,pert
control AU1157302,ctrl
"Crohn's Disease subject (58 year old caucasian female, SAK_1275433327)",pert
40B,pert
"HCT116 cells, XIAP shRNA, late passage",pert
Neuroblastoma cell line,pert
Run1.a10a.000609jd.2.SkMNor913.CEL-IS basal,ctrl
"cultured human airway smooth muscle, 4 hour dex treatment, replicate 3",pert
HCC_17N,ctrl
"liver, wt mouse, sample WT4",ctrl
No_abuse_2,ctrl
WT1 CD11b,ctrl
"Cultured ovarian cancer cell line OVCA429, Cisplatin treated",pert
04_PAH,pert
7L,pert
WT-sham-5 month+1d-R3,ctrl
"Lesion Skin, LS-15",pert
LOX1 Untreated 6hr 282295663,pert
"Lesion Skin, LS-10",pert
"PPARg d10, rep 2",pert
Bronchial Epithelial Cells MMA biological 1752A,pert
Sample from retroviral MSCV-D1a infected cyclin D1 knockout 3T3 cells (line 7).,ctrl
Esophagus cell line OE33 Control,ctrl
Haloperidol treated 12weeks AffyGC RMA rep9,pert
umbilical cord tissue; high gestational age,pert
liver_Wt_female_8wk_rep2,ctrl
C_AN14757_C,ctrl
BCell_resting_sample2,pert
01N46_PolyRF-,pert
Peripheral Blood Mononuclear Cells;	unknown age and gender,ctrl
Healthy-6 baseline,ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 69;	Usage number: 1;	Exposures: 4,pert
thyroid_tumor_6,pert
MacularDegen-injured-10aAv2-s2,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID52,ctrl
AO 72hr,ctrl
"Control, rep 2",ctrl
F191G B,ctrl
Normal-1 - mAdbID:91503,ctrl
"Normal Skin, Normal-9",ctrl
N/LV2,ctrl
RO37,ctrl
"fibroblast, MFS subject FB890 rep 1",pert
patient id: T158;	tissue: Normal cortex;	gender: Female;	age: 82;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"RNA from Cell line SLM2, mutant status WT, condition Control",ctrl
"Zen-Bio, Inc. (Research Triangle Park, NC) - SL0044",pert
"spc-c-raf transgenic mice, age: 7 month old, Gender: male, Tissue: unaltered",pert
U138MG shVEGFR-2 2,pert
293T cells stably transfected with 2 shRNA constructs (si1340/si1428) against LEDGF transcript (PSIP1 gene).,pert
6_b,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 1,pert
DU145/MYB siRNA #2,pert
STING tumor DNA,pert
"brain, Entorhinal Cortex",ctrl
Interleukin_6_1,pert
GM19238_Kd_YY1_3,pert
Gastrocnemius Muscle_WT_rep1,ctrl
pediatric AML S03,pert
Healthy control 16,ctrl
DN2 replicate 1,ctrl
whole blood_100247,pert
"MaF pre-iPSC9P2, Vc untreated, lysed on D3",ctrl
cell line: U373;	cell type: glioma;	vector: EGFP,ctrl
secondary glioblastoma_2,pert
mammary stoma-4w-KO-rep3,pert
Lung of hemorrhaged animal 48h,pert
"Total RNA, Tet2 KO LSK 5th plating",pert
"vehicle treatment, 72 hour time point, biological replicate 1",ctrl
WT-4,ctrl
"C2C12 Myotubes treated with BSA, rep1",ctrl
Astrocytoma_6,pert
striatum_Pink1 knockout_12 weeks_replicate 3,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: untreated,pert
gender: female;	age (years): 40;	evolution time (years): 13;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
heterozygot FH P387neu,pert
CD3+ cells,ctrl
con_B131,ctrl
PBMC from Rhesus Macaques,pert
embryonic fibroblasts from male IRAK4 kinase dead Balb/c mice,pert
Bone-Marrow_MGUS_G683,pert
"NPCxhIPSC SCZP, replicate 2",pert
gastrocnemius-30 months of age-resveratrol diet-biological replicate1,pert
HNF4 CONTROL_191,ctrl
"Wild-type-hippocampus, biological rep5 (male)",ctrl
"Control 1, 4hrs",ctrl
Muscle PCOS control 7,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Endothelial Cell,ctrl
Kidney_Aqp11-/-_P7_3-2,pert
Pool 2 Convalescent stage,pert
"100-200 motor neurons, sacral spinal cord, 60 days post sham opration",ctrl
FVB_MMTV_Wnt1_iFGFR2_3855_3R_ROSEN,pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 52;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
umbilical cord_nobpd: 4B,ctrl
Subject 5 / lung subsegment instillated by Saline,ctrl
MCL_IGHV_MUT (R1938),pert
U937_naive_curcumin_4h_rep2,pert
"Patient 22, Atheroma plaque",pert
control shRNA replicate 1,ctrl
CD11b+Gr1+ cell sample_3 (derived from IL17RC Kock out mouse),pert
Basal IFE epidermal stem cells from WT mice 2,ctrl
U2OS_PRC_shRNA1_pLenti_3_2007,pert
subject: 03U;	cohort: 3;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >40kb;	age (y): 42;	Sex: F;	batch: Batch_1,ctrl
Allo-14-4,pert
JIA PBMC Post treatment A235_L017(2),pert
tissue source: matched healthy control;	tissue: Vastus lateralis muscle;	tissue state: basal state,ctrl
"Normal tail skin from control mouse, biological replicate 3",ctrl
Bone-Marrow_MM_M1054,pert
genotype/variation: wildtype ThPOK (control),ctrl
Muscle WT Aged 0123,ctrl
Saline_2,ctrl
"MCF-10A cells, shRNA vector control, biological rep2",ctrl
Native wt biological replicate 1,ctrl
WT Tibialis Anterior at 4 weeks biological rep1,ctrl
Colon_POR-null+quercetin_2,pert
CT-receptor-KO osteoclasts untreated 1,ctrl
CLL 145-04 LMP-420,pert
gender: F;	age at blood draw: 41;	tissue: whole blood,ctrl
"Acute Myeloid Leukemia, sample 55",pert
"ID:c 4-1, Genotype=(C57BL/6J), Treatment= none",pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID61,ctrl
colonic_mucosa_inflamation_76,pert
Hippocampus Fluoxetine group 2,pert
SCD1 -/- liver rep2,pert
chip number: 19;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.4;	transfection date: 2011-10-17,ctrl
MGHU3 Cells_Control siRNA + PD173074,pert
patient: 243;	current medication: Atenolol Pravastatin Asprin Adalat BFZ Balsalizide;	birth date: 2/17/25;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/04;	diagnosis date: 3/29/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Deaf;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"prdm-control, biological rep1",ctrl
Sample Group: control; Gender: male; Age: 42; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
ubb_d28_wt_2,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 84 days;	subject: Mouse1;	genetic background: BALB/c,pert
SKI-DLCL cells_untreated_24h_2rpt,ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 31;	maternal age: 34,pert
wildtype 7,ctrl
"Wild-type iPSCs, NAS2",ctrl
normal control 4,ctrl
CLL 361-01 LMP-420,pert
IRS-4 KO (jos0700),pert
experiment II untransduced replicate 1,ctrl
"D425-shOTX2_2, t=24",pert
U2OS shControl replicate 2 [set 4],ctrl
0301-01-A,pert
Control liver_4 pm_rep3,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue 1,pert
cell line: PC-3;	treatment: gefitinib;	treatment duration: 24h,pert
18L,pert
"Primary aortic endothelial cells, Non_transgenic_control_3",ctrl
E_Ctrl_1,ctrl
siNonTarget replicate2,ctrl
Teratoma 0696,pert
"48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"Cell type: neuronal, age:42, gender:male, diagnostic group: bipolar disorder, PMI:32h",pert
tissue: skin;	individual: Patient P14;	condition: ANL;	eczema severity: SCORAD: 0,pert
tissue: brain;	strain: C57/BL6 Vert-X;	genotype: IL-10eGFP;	age: 6-8 weeks;	cell type: CD8 T cells that are IL-10-,pert
cell line: DOV13;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Mouse whole brain,pert
Ishikawa_LowDose_BPA_48h_rep3,pert
"Peripheral blood, patient without recurrent events [N51]",pert
colon_C57 mouse_12weeks_rep6,ctrl
37_C57_WT,ctrl
age: 24 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
treatment: Cyclin D1 siRNA Vehicle;	cell line: MCF7,pert
KO_PMΦ_rep2,pert
MDS patient 105,pert
"MS patient 11, technical replicate 2",pert
3415-scrape,pert
phenotype: control;	gender: male;	case_id: 335;	age: 44;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 50;	brain ph at time of freezing: 6.6;	labeling_batch: 2,ctrl
Heart left ventricle WT-PBS replicate 1,ctrl
Control  VZ11,ctrl
DIA-t10-2; transgenic diaphragm 10 month,pert
"siYAP RNA #2 transfected, biological rep 2",pert
RNA from HCC_38N,ctrl
bone-marrow mesenchymal stromal cells extracted from healthy donor,ctrl
Day: 6; Drug: Saline; Phase: Drug treatment; Replicate: 1,ctrl
"Pancreatic islets, control, 01",ctrl
VGLL4 HUES6 4,pert
HOX424 Carbo Day4,pert
"Epididymal fat, control",ctrl
"Cultured HepG2 cells,  ATCC# HB-8065",ctrl
E14 - nudelcko/ko 1,pert
mixed reference (MR = CRG + FR),pert
Bl6 - Control - rep2,ctrl
U-87MG-V22 set 3,ctrl
GM8839,pert
treatment: DMSO;	time: Day1;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
Insig1 ∆/∆ /Insig2 -/- InsigKO_E2,pert
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; 1h EGF,pert
gender: male;	strain: BL6/C57;	genotype/variation: wildtype;	age: 12 weeks,ctrl
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 55;	gender: m;	treatment: -,ctrl
2h 4OHT-treated-sample2,pert
"nasopharyngeal carcinoma, specimen T3",pert
disease state: control;	patient: 24,ctrl
"Wild Type, biological rep3",ctrl
Luciferase-rep3,ctrl
Biceps_Pompe_8,pert
Embryonal carcinoma 1740,pert
PGA-RMM-30h-1aA-s2,pert
"Lesion Skin, LS-23",pert
PBMC from T cell Large granular lymphocyte leukemia patient#130,pert
VMH of WT-3 mice,ctrl
M548_WT,ctrl
"Embryoid bodies, 48h,Min Dox",ctrl
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 49days;	genotype/variation: NSun2 KO,pert
GIST_KIT_4,pert
Vehicle 24 hours_2,ctrl
1005-01-A,pert
ctrl_516,ctrl
Mutant biological rep1,pert
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: lung",pert
Ileum epithelials cells,pert
Anti-scramble replicate 2,ctrl
"medulloblastoma, M2_cMYC_silenced, rep3",pert
"Distal and Proximal Large Intestine, 8week old mouse",ctrl
MCF7 cells from controls,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: P1,pert
human_hepatocyte_400uM_clinafloxacin_donorA_24hr_prep2,pert
cell line: MCF-7;	sirna knockdown: siControl,ctrl
tissue: glioblastoma xenografts,pert
GNMT-WT mouse hepatocytes (sample 2),ctrl
HF1613_U133P2,pert
Normal esophageal epithelium (N3),ctrl
ctrl- rep1,ctrl
Tendon_non-lesional_rep17,ctrl
Strain: (129S1/SvImJ) (wildtype);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,ctrl
"wdNHBE with KY/136 at 36hpi, biological rep3",pert
EB_0_19d_76_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
GFP Untreated 24hr 282295853,ctrl
TP06-708,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_4_37_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
male;	41 yr old;	White,ctrl
"MCF-10A cells, shRNA vector control, biological rep1",ctrl
strain: C57BL/6;	genotype/variation: Foxo1KO;	cell type: Regulatory T cells,pert
Mouse RSK2 mutant mandibular molar [ABH_15A],pert
Mouse lungs-uninfected,ctrl
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 3,pert
WT_PLACEBO_12hours_3,ctrl
Wistar rat liver tissue (control),ctrl
WT-GFP-lamin A Induction: day 5 Replicate B (2b_WT_5d_B),ctrl
TL3 LAMC2 KO 1,pert
CTRL_1_HSC,ctrl
"Whole ovary from 8 Month Old Wild Type mice_01, biological rep1",ctrl
Male 8week BL6 CBDLrep1,pert
N with Cy5,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 5 days osteoblast differentiation,pert
WT - Cre Treated - 2 hrs - repeat 3 - Cy3 - mAdbID:62607,ctrl
HF1156_U133P2,pert
hESC H1 B2M KO c2,pert
Cbx2_KO_XX_2,pert
sepsis patient #2,ctrl
Individual_4079_PN_sample,pert
"Ad(moi10)-infected, TOT-treated for 24hr",pert
Control_AF_5,ctrl
agent: control (untreated);	time: 1h,ctrl
A HID I_B052,pert
Individual_4177_PN_sample,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-4,pert
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate1,ctrl
Healthy10-CD8,ctrl
The placenta (E 10.5) of a congenic adra2B+/+ mouse embryo (maternal genotype Adra2b+/-) was rapidly dissected and flash frozen.,ctrl
B-CLL PB P249,pert
Run3.aUa.010110d.SkMDbt1140D.CEL-DB basal,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T142,pert
"Ulcerative Colitis (73 year old caucasian male, SAK_1285313364)",pert
293T cells with LEDGF transcript knockdown (PSIP1 gene).,pert
3T3-L1 Day 0 (passage 19) 24h after siLSD1 transfection,ctrl
A375 cells 24h Vemurafenib rep3,pert
Hippocampus_Rasgrf1KO_rep3,pert
"JurkatNegative (Mock stim)  0 hours, #1",ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep4",ctrl
"Cultured ovarian cancer cell line PA-1, untreated",ctrl
"liver, fed control AIN93G diet for 14 days",ctrl
RA_B,pert
genotype/variation: Zfx fl/y CreER;	treatment: infected with control retrovirus with GFP selectable marker,pert
"brain, Entorhinal Cortex: 99-21 tangle_e1_le1",pert
PBMCs_Control_9 [IS],ctrl
ACC Xenograft X5,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 357;	age-at-biopsy-years: 49,ctrl
"heart of mouse, 2 week control (2B)",ctrl
"E12.5 Ret-deficient embryonic kidney, biological rep1",pert
7A;pretreatment;female;breast tumor,ctrl
"MCF-7 cells, siCtrl treatment 60h, 0.1%EtOH for 4h",ctrl
A SIT_B100,pert
V5-P257,pert
T115,pert
Mammary gland R1 16 hr rep4,pert
FVB; No Treatment #1,ctrl
MCF7 cells treated with 2uM ARC,pert
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 45y/female/caucasian. Cause of death: multi-system organ failure,ctrl
patient: 51722;	sample: normal,ctrl
RKO_HSF1siRNA_6hDMSO_REP1,pert
K562 STI sample 6,pert
"patient 041b, normal, homogenized",ctrl
DIA-n10-2; normal diaphragm 10 month,ctrl
MCI-014,ctrl
bone marrow cells,pert
Weight:High;	CFstatus:control;	Sex:Female,ctrl
BL2,ctrl
"Patient 113, 24 month of REBIF",pert
Day: 18; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 2,pert
IOSE80pc Cells,pert
spleen,pert
"human failing LV myocardium, Idiopathic33",pert
2h WT Cel.02,ctrl
Mouse lungs infected with Mtb for 42 days,ctrl
WT - Cre Treated - 12 hrs - repeat 3 - Cy3 - mAdbID:61758,ctrl
HCC non-tumor,ctrl
Biceps_Pompe_9,pert
Bach2 KO - Thymus - biological repeat 1,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID132,pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep5,pert
"human failing LV myocardium, Idiopathic62",pert
Mouse fetal liver_E14.5_KO_rep5,pert
lymphocytes_ctl_F_30y,ctrl
NMRI_6h_DMSO,ctrl
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 5,ctrl
CD-59-un,pert
Basal IFE epidermal stem cells from KO mice 2,pert
Control siRNA 2,ctrl
strain/background: C57BL/6;	genotype/variation: non-transgenic;	tissue: brain (right cerebral hemisphere);	age: 7 days;	treatment: PBS control;	time post-infection: 5,ctrl
Squamous cell lung cancer X35sqm,pert
SP-C-rtTA/(tetO)7CMV-Cre double transgenic mice,ctrl
pcdh12-deficient mice rep2,pert
"mouse embryonic fibroblasts derived from WT mice, F",ctrl
liver_wild type_6 weeks_replicate_1,ctrl
ESC_Zfx-flox_Replicate1,ctrl
ES cells_OE_rep1,pert
DCIS,pert
24h_c1,ctrl
normal 2841,ctrl
Huh7 cells_JFH-1 Infected 12 hours_ rep1,pert
patient E1546,pert
6P-M4-ND,pert
healthy CD19 B cells 7,ctrl
GM19238_Kd_USF1_1,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 11;	tissue: GIST Tumor,ctrl
Halothane 10 exposures-2,pert
SLE CD19 B cells 9,pert
12h Control (SAMPLE 2),ctrl
"brain, hippocampus: KA-72h-P15-II_e1_le1",pert
At Risk: +;	Age: 13;	Sex: M,pert
Prostate Cancer_MS 36C1,pert
strain: C57BL/6;	genotype: wildtype;	tissue: liver;	age: 12 weeks,ctrl
Jurkat T-cells transfected with siRNA for GAPDH,ctrl
EA_Case16_CD8,pert
treatment: treated with vehicle and control shRNA;	cell line: LNCaP,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T3N2,pert
D3 patient,pert
M249_A_DMSO,ctrl
Wild Type Skeletal Muscle Sample (forelimb),ctrl
"brain, control (water-treated), P70 male",ctrl
p300_Regulatory T-cells CD4+CD25+,pert
strain: CD-1;	genotype/variation: Pkd1null/null mutant;	developmental stage: embryo;	age: E17.5;	tissue: kidney,pert
"220, MUSCLE, Before",ctrl
Control subject 40_biological replicate 2,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: no,ctrl
PC3 cells Untreated,ctrl
gender: Males;	strain: C57/B6;	age: 3 months old;	tissue: Brain,ctrl
9-cis-retinoic-acid_LIVER_1,pert
CHF - R09,pert
"NPCxhIPSC CON, replicate 4",ctrl
mouse cerebellum at P7 knockout 1,pert
"age at diagnosis: 66;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 30;	dfs-event: 0;	distant metastasis: 0",pert
"human failing LV myocardium, Idiopathic70",pert
NORMAL #99-0693,ctrl
cell line: Mkn28;	cell type: human gastric tubular adenocarcinoma;	tissue origin: stomach (70 year-old female),pert
"129P3/J Chronic morphine treated, biological replicate 3",pert
cell type: embryonic fibroblasts (MEFs);	genotype: VHL null,pert
"Strain: C57BL/6, Gender: female, Age: 6-10 weeks;	Tissue: nasal-associated lymphoid tissue (NALT)",ctrl
"DMSO-treated, Sham UV, Replicate C",ctrl
FHCRCAML1818,pert
shNANOG_1,pert
"HEK001, siLuciferase",ctrl
"Grape extract group, 12 months, patient number 15",ctrl
vulva biopsy of vulvar intraepithelial neoplasia (VIN),pert
"Untreated Testes, biological rep 1",ctrl
24C-ER,ctrl
Endometrium-Normal 7,ctrl
Bone-Marrow_MM_M801,pert
"Dermatomyositis, biological rep2",pert
Tendon_non-lesional_rep7,ctrl
Pt25_Pre,ctrl
5273 UC Inflamed sigmoid colon,pert
S4_sham_overexpressor_12,pert
Biceps_Pompe_4,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 60;	sex: M,ctrl
GM19238_Kd_NFE2L1_3,pert
K14deltaNB-cateninER  Time 7 replicate 1,pert
"gender: Female;	age: 67;	post-mortem delay: 6h;	ph: 6.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
RNA from HCC_35T,pert
age: 12 wk;	tissue: whole heart;	genotype: MCKcre Pitx2 Flox/Flox,pert
"Normal subject (60 year old caucasian male, SAK_1287302781)",ctrl
4_c,ctrl
Pancreatic Sample 53-Normal,ctrl
GM19238_Kd_IRF9_3,pert
Patient: C;	Time: 0;	Group: responder;	Condition: lesional,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 31;	age of psoriasis onset: 25,pert
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-C104A/C131A;	overexpression induced with doxycline: Yes,pert
Extract:LOX-1:113103;	Extract Description:GFP_0hr:113103;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.49;	Quality: Absent (%):58.03;	Quality: Absent (%) Dev.:0.17;	Quality: Scaling Factor:0.63;	Quality: Scaling Factor Dev.:0.13;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113103;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295433,ctrl
Pfeiffer BCL6siRNA 3,pert
Haloperidol treated 12weeks AffyGC RMA rep6,pert
Sex: male;	Age at operation: 74 years;	Site: thigh;	Size in cm: 16.5x9x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
EP1_adipose_pcos_rep1,pert
human_hepatocyte_400uM_Trovafloxacin_donorA_24hr_prep2,pert
patient: 15;	disease state: hypertension;	tissue: Atheroma plaque,pert
DMSO2_24H,ctrl
"wdNHBE with KY/136 at 36hpi, biological rep2",pert
"chimeric kidneys from mouse E15.5 embryos derived from blastocysts that were injected with GFP-positive, transferrin receptor (Tfrc)-deleted embryonic stem cells",pert
Muscle WT Adult 07272,ctrl
Mammary gland R1 16 hr rep3,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 38;	Usage number: 4;	Exposures: 2,pert
KO-992,pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p28;	strain: E14,ctrl
tissue: blood;	patient: 2;	gender: male;	age: 38,pert
EDL-t10; transgenic extensor digitorum longus 10 month,pert
liver western diet rep5,ctrl
"27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
NSC_FOXO_WT-1,ctrl
Normal Gingiva replicate1,ctrl
"ID:12-2 Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Patient 4, 12 month of BETAFERON",pert
"HCT116 shCDK19, low glucose",pert
"Ishikawa cell line, BPA, 1pM, 8hr",pert
Ezh2-Vec1,ctrl
"Please refer to Lilly et al., Am J Respir Crit Care Med. 2005 Mar 15;171(6):579-86",pert
"Wild type mouse aorta with placebo, biological rep5",ctrl
Mening UNSTIM WB SW 3b,ctrl
EB_0_6h_53_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
Untreated Control 12weeks AffyGC RMA rep7,ctrl
"disease group: Atopic Dermatitis;	Sex: f;	age: 20s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 15.2;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 290;	ige (kiu/l): normal (0-48.5 kIU/L): 2578;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
cell line: U937;	shRNA construct: Scrambled Control,ctrl
wt_off_rep1,ctrl
Human Uninfected Sample N141-CD4+ T cells,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous saline challenge""",ctrl
COP DES-treated replicate 4,pert
Heart sample from 8-week-old Ppif-/- mice,pert
Ischemic cardiomyopathy_G33,pert
normal main pancreatic duct 1,ctrl
PlagL2KO3,pert
patient id: 1393;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 83;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 1;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
tissue: retina;	age: postnatal day 4;	genotype: rd1,pert
"DMSO-treated, Sham UV, Replicate D",ctrl
Mc3T3 control_ 5day_rep1,ctrl
"Control, biological replicate 2",ctrl
patient: 31;	disease state: hypertension;	tissue: Atheroma plaque,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 48 hours,pert
subject: 18U;	cohort: 18;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 37;	Sex: M;	batch: Batch_4,ctrl
Panc-1 TGFβ Treated 2 48 hr,pert
Stable lentiviral shRNA;	,pert
"KO VSV infected, biological replicate 2",pert
BT474_Lap_24-2,pert
shCypB2,pert
RNA from microdissected breast cancer cells from case 856 labeled with Cy5,ctrl
"Heart, MAT1 CKO, 2 wk, sample 4",pert
PC-3_basalhTERT_ShortTelomeres_mock_2,ctrl
disease state: endometrioma;	patient: 7,pert
CHF - R15,pert
Trizol extracted total RNA from myometrium tissue (HLRCC).,ctrl
tissue: muscle;	genotype: ClpP KO;	genetic background: C57BL/6,pert
Vit A sufficient 2b,ctrl
Sample ID: TP39;	Twin Pair ID: CCE4.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-11.5;	Age at interview & blood sampling: 31;	Current Age (2007): 34;	Sex: MALE;	Medication at blood sampling : Epilim & Lamictal,pert
Wildtype liver DEN-injected 12weeks repl2,ctrl
untreated Rb-/- MEFs-2,pert
HN_127,ctrl
strain: FVB/N;	genotype/variation: Bmpr2-R899X mutation;	cell type: pulmonary vascular microendothelial cells (PMVEC),pert
Normal cervix epithelium_03-4508,ctrl
strain: C57BL/6J;	genotype: Tmod3+/+;	phenotype: normal,ctrl
Scd1-/- on chow diet replicate 1,ctrl
Strain: B6129;	Gender: male;	Age: 12 weeks;	Tissue: liver;	Developmental stage: adult,ctrl
V5-P549,pert
lesion_preUV_patient2,pert
WT-3,ctrl
"heterozygous, control, biological rep3",pert
"C2C12 Myotubes treated with BSA, rep2",ctrl
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant3],pert
0810A-01_clone 3-2,pert
cell line: sh2608 T47D;	sherbb3: +,pert
disease: cardiopathy;	gender: male;	age: 30 days;	tissue: thymus,ctrl
strain background: Mixed;	genotype/variation: VMH-specific FoxO1 Knockout;	tissue: ventromedial hypothalamus (VMH),pert
LDLR_HF_3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 87min;	race: White;	sex: Male,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-sp2,ctrl
K562_ICL670_50uM_dup2,pert
12L,pert
Patient: J;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
HTB58_controlsiRNA_1,ctrl
Pool 5 Acute stage,ctrl
WT - Cre Treated - 12 hrs - repeat 2 - Cy3 - mAdbID:61757,ctrl
cell type: R1/E ESC;	RNAi: Luciferase,ctrl
SKBR3-R_Control_2,ctrl
LOX1 Untreated 2hr 282295533,pert
PTEN25+_rep3,pert
cerebellum SNCA knockout 21 month replicate 2,ctrl
"fibroblast, MFS subject FB890 rep 4",pert
No or early 2 rep1 (retina),pert
Squamous cell lung cancer X36sqm,pert
SCC25+doxorubicin_rep2,pert
P0 - nudel129s6 2,pert
"genetic background: Cebpa-Cre;R26-LSL-Eyfp;Dicer1wt/fl/Dicer1fl/fl (donror), C57BL/6 (recipient);	genotype: Dicer heterozygous deletion;	cell type: YFP-positive  granulocyte-macrophage progenitor",pert
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: n/a;	maternal age: n/a,ctrl
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 686,ctrl
"WT cells, replicate 2",ctrl
age in weeks: 8-10wk;	gender: Male;	strain: C57BL/6,ctrl
OSCE-14N,ctrl
liver-AHRKO-cornoil-rep1,pert
normal 1361,ctrl
20SAGEA,pert
GM19238_Kd_NS_P2_23,ctrl
"Amniocytes, euploid, 1559",ctrl
"p53-, rep3",pert
Colo 668 SCLC cell line,pert
PMBCs,ctrl
Trib1 #2 KO macrophages were treated with LPS,pert
"SIN3A siRNA, biological replicate 1",pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; 1h EGF,pert
Control_Castrated OWJ75,ctrl
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",ctrl
Kidney_400 mg/kg VCM iv_mouse #045,pert
"control, BA10-53",ctrl
1295-1C,ctrl
mdx Biological Replicate 1,ctrl
HCT116 human colon cancer cells with PTEn -/-,pert
"Ulcerative Colitis (59 year old caucasian female, SAK_1286565132)",pert
siEGR4 (72 hr) _1,pert
"pancreas, control diet, replicate 1",ctrl
4N,ctrl
"GM8839, affected sister",pert
SF539 PARK2 siRNA#2 replicate 2,pert
CN3,ctrl
"wild type CTL, biological replicate 3",ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 105;	Usage number: 4;	Exposures: 2,pert
"Trained diabetic mice, time point 1 week",pert
A/JTCE liver sample batch 4,pert
healthy CD4 T cells 2,ctrl
01LPG_Systemic,pert
prostate tumor 2,pert
"Wild type mouse aorta with placebo, biological rep1",ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 63;	tissue: Blood,pert
"xenograft: Panc-1 human pancreatic carcinoma cell line, grown in mice;	treatment: GSK3B shRNA",pert
KU_36N,ctrl
normal;	Adjacent pair of T20,ctrl
WT-MAC-UV-2,ctrl
RNA from microdissected breast cancer cells from case 59 labeled with Cy5,pert
14-week-old Trim24-/- liver_466M,pert
"Untreated wild-type NB4, biological rep2",ctrl
DRG_DMSO_0.1%_Rep3,ctrl
"fibroblast, control subject NF12 rep 2",ctrl
NCI-H716,pert
breast tumor 5,pert
subject: 20U;	cohort: 20;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 39kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
1 Wild-type control macrophage,ctrl
endometrioma,pert
F6.01,pert
Bone-Marrow_MGUS_G727,pert
INF-157,pert
Ischemic cardiomyopathy_G15,pert
"Crohn's Disease subject (22 year old black female, SAK_1259740044)",pert
treatment: Control siRNA Estradiol;	cell line: MCF7,ctrl
Untreated wild type A,ctrl
WT - Thymus - biological repeat 3,ctrl
SimvaVeh1,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day14,pert
hBSMC_vitamin D_rep2,pert
26 mt E11.5 heart,pert
whole tissue section from case 1370,ctrl
"VPA 2, 16hrs",pert
Mus musculus brain hemisphere,pert
Z138-shSOX11,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 40;	gender: male;	tumor grade: AII,pert
strain: C57BL/6;	genotype/variation: RORasg/sg;	gender: male;	age: 5 Month old;	tissue: White adipose tissue (WAT);	diet: 35% Fat Diet (High Fat Diet; HFD),pert
"Luc control esiRNA, biological rep3",ctrl
"brain, hippocampus: Ctr-240h-P15-I_e1_le1",ctrl
"Lesional skin biopsy from psoriasis patient, Week1_etanercept",pert
MNR 1-2 WT 3,ctrl
"normal skeletal muscle, biological rep4",ctrl
49A;pretreatment;female;breast tumor,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.853;	OD280: 0.955;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 290;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"eye, retina: Diabetes 2_le1",pert
Ishikawa_LowDose_BPA_48h_rep2,pert
Quercetin day 10 sample 1,pert
GIST_KIT_11,pert
human_hepatocyte_grepafloxacin_24hr,pert
Primary hepatocytes isolated from DBA mouse strain treated with DMSO for 6h,ctrl
"Liposarcoma culture from tumor 314, doxorubicin treated",pert
cell line expressing inducible wt-GFP-lamin A. Induction: Day 0. Replicate A,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl; Wnt1-Cre;	tissue: Primary palate mesenchyme;	age: E13.5  + P2,pert
"DSS colon tissue, biological rep2",pert
"RNF40 siRNA - 5 days osteoblast differentiation, rep3",pert
"Crohn's Disease subject (58 year old caucasian female, SAK_1316890359)",pert
E18.5_Control_Kidney_array1,ctrl
b45+,pert
condition: Discoid Lupus;	patient: L2;	tissue: LS skin biopsy;	kit: Ovation,pert
Patient: B;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
tissue: testis;	gender: male;	age: 2-3 months;	genotype: Ing2 KO,pert
diabetic muscle replicate 1,pert
pcDNA3(CT1),ctrl
Genotype: Homo sapiens,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 77;	time: 0;	batch: 2,pert
Plate vs. Nail:  4 Week Sham,ctrl
"Donor 2, Ebola infected 1hr",pert
Ishikawa_VeryHighDose_BPA_24h_rep4,pert
Run4.aUa.010110d.SkMDbt1145D.CEL-DB stimulate,pert
human embryonic stem cells cultured with mouse embryonic fibroblasts,pert
Postmenopausal female. Untreated control. nr 2.,ctrl
sepsis patient #20,ctrl
SARRC-2089-02-A,pert
Tretinoin1,pert
ILD Study Number S001,ctrl
healthy control sample x198,ctrl
db/db mice,ctrl
B6.BKS Ighmbp2nmd-2J mouse;	6 weeks of age;	male,pert
Genotype: E2F4 Null,pert
HB1.F3,ctrl
"seminoma specimen, pT3, patient age: 48y",pert
"Lymphoblastoid cell lines derived from family 1720, member 2",ctrl
braak stage: CTRL;	rin: 70;	tissue: substantia nigra;	disease state: control,ctrl
Treg cells from WT mouse,ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 14.5, Tissue: Palatal Shelves",ctrl
chip number: 19;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.84;	rin: 9.4;	transfection date: 2012-03-26,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 1393,ctrl
N27,ctrl
"N-BMSCs, biological rep3",ctrl
DNGM-2,pert
"Patient 5, Macroscopically intact tissue",ctrl
TIG3  diploid lung embryonic fibroblasts,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 130min;	race: White;	sex: Male,ctrl
Huntington's disease,pert
"Pineal gland from NeuroD1 cKO mouse at ZT20, biological rep 2",pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 28;	age of psoriasis onset: 16,pert
SBVGA3 1,ctrl
"3T3-L1 siLSD1 48h, biological rep 3",ctrl
transfected with control siRNA_5,ctrl
Aquaporin-11-/-_mouse P7 kidney #4-4,pert
human head and neck normal mucosa,ctrl
treatment: treated with vehicle and ELK1-shRNA;	cell line: LNCaP,pert
pancreatic cancer cell line FA6 transiently transfected with non-targeting siRNA,ctrl
tissue type: Bone Marrow;	cell type: Multiple Myeloma (MM) plasma cells,pert
Sex: female;	Age at operation: 70 years;	Site: upper arm;	Size in cm: 3x5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
PIK3CA.DMSO.2,pert
LNT-6,pert
Gastrocnemius Muscle WT rep2,ctrl
H03_P_B2,pert
Subject 4 / lung subsegment instillated by Saline,ctrl
11_0013C_Day1_25,ctrl
T5D-LU,pert
Gene expression profiling of normal cortex of patient T142,ctrl
Cardian muscle Trained 1 week T1,ctrl
EB_6_6h_286_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
"eye, retina: Myoc 1_e1_le1",pert
Allogen,ctrl
con-15_A,ctrl
PGA-MAH-C3H_PBS24h-2aA-s2,ctrl
"non-AD_HI, biological rep2",ctrl
Fetal heart control 4,ctrl
SBVGA3 2,ctrl
KO_MEF_un.2,pert
Cell line MDA-MB-231_c-myc KD_expt1,pert
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep3",ctrl
tissue: brain;	genotype: mutant Lis1 ko/+;	age: P0,pert
"depression, BA10-33",pert
Injured 1 day Rat Retina 3,pert
"brain, frontal cortex",pert
patient: 30308;	sample: normal,ctrl
Plate vs. Nail:  2 Week Sham,ctrl
Prmt6 overexpressed embryonic stem cells,pert
Hep G2 treated with Bis [(+)-tartrato] diantimonate (III) dipotassium trihydrate,pert
tissue: Liver;	strain: C57BL/6;	genotype/variation: PXR-/-;	treatment group: vehicle 0 mg/kg,pert
Sex: female;	Age: 15;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
L428-PAX5+M_rep2,ctrl
Shn2_Wildtype_3,ctrl
patient: 27;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
U2OS_siNS_24h,ctrl
Txnip deficient normal 24 months sample 1,ctrl
V5-P427,pert
basolateral amygdala,ctrl
G4D_Sham_Rep2,pert
"Neurons overexpressing Hes1 and GFP, biological rep1",pert
tissue: Primary human lung fibroblasts;	treatment: None;	patient: 2;	time: Baseline,ctrl
Sedentary-17,ctrl
B6.IL10 24 air 1,pert
BMMs_untreated control_db,pert
P328L329_del5a-,ctrl
PBMCs_Control_1 [IS],ctrl
Squamous cell lung cancer X33sqm,pert
IRS-3 KO (jos0953),pert
"C57BL/6J Saline treated, biological replicate 2",ctrl
MCF-7,ctrl
blood_day0_patient5,pert
ko 13.5d replicate 13,pert
Subject #8032-Preinfection,pert
O_LS_Wk2,pert
1205-01-A,pert
39GOBMUC2A,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 35;	Usage number: 4;	Exposures: 2,pert
normal adjacent esophageal tissue from patient E1521,ctrl
Pax_S3,pert
WT-SB replicate 2,ctrl
H_LS_Wk2,pert
brain_control_sampleid_mr284,ctrl
Muscle control 15,ctrl
KM_051T,pert
heterozygot FH P387 (human CD3 positive T cells),pert
"SWR/J CHR, Rep1",pert
striatum SNCA knockout 6 month replicate 1,ctrl
"109, MUSCLE, Before",ctrl
Treg Trim28 conditional KO rep3,pert
"Patient I-c532T, MSI colorectal tumor",pert
gender: Male;	tissue: Tendon;EDC;	age: 48;	donor: 9;	disease state: Non-lesional,ctrl
Mammary gland R1 24 hr rep1,pert
HD10,pert
3D cultured chondrocytes from OA donor 3,pert
siHic5_2_0h_4,pert
tissue: Mouse heart;	genotype: wild type;	strain: C57BL/6,ctrl
FR-control-1,ctrl
Strain: mixed;	Tissue: liver;	Age: 28 days,pert
Rb heterozygous 129sv matings,pert
H with Cy5,ctrl
"10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Jurkat 4,pert
uterus - Early secretory endometrium from normal patient,ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: retina;	time: ZT6,pert
Background: mixed genetic backgroud of C57Bl/6 and 129/SvJ;	Genotype: IRF6 null;	Age: Embryonic day 17.5,pert
Insm1 control #3,ctrl
180D3,pert
I_LS_Wk12,pert
SW1736_t6h_rep2,pert
"human failing LV myocardium, Idiopathic31",pert
Negative Control 2,ctrl
human_LIMA_artery_patient5_control,ctrl
sampleID: SAM630146;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
PGA-MAH-AJ_OVA24h-4aA-s2,pert
cell type: AML blasts;	fab classification: M2,pert
HeLa control knock down 2,ctrl
strain: C57BL/6J;	genotype/variation: Transgenic;	gender: Male;	age: embryonic day 15;	tissue: frontal cortex,pert
microdissected breast cancer cells from case 1206,pert
"Global gene expression of NASH patients, P64",pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: tamoxifen for 120 min,ctrl
colon_IBD_1017,pert
EOM 112 Day Control rep 3,ctrl
"mouse aorta cross strain comparison, C3H_T24_HF_02",pert
Fertility Status: Fertile,ctrl
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
KN-smoke-med-5 month+1d-R1,pert
F_Ctrl_1,ctrl
"scr-control, biological rep2",ctrl
Kidney from mice treated with 7 daily ip injections of vancomycin at 200 mg/kg,pert
"Ifitm1-deficient lung tissue, biological replicate 1",pert
"47, XX, +21",pert
Braf 1,pert
chip number: 12;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.86;	rin: 9.5;	transfection date: 2012-03-26,pert
"IRAK4 kinase dead mouse bone marrow macrophages, unstimulated, 4 hours",pert
Human hepatocellular carcinoma cell line,ctrl
1212-4heart_Control,ctrl
Wild Type 11,ctrl
Day: 1; Drug: Heroin; Phase: Drug treatment; Replicate: 2,pert
DBA/2J hippocampus-Fluoxetine,pert
3526-lcm,pert
age: 38;	sex: F;	disease status: control subject;	Filter number: 105;	Usage number: 5;	Exposures: 3,ctrl
448MM,pert
Tg34,pert
Muscle KO Aged 1027,pert
A VIS _B096,pert
Gata3 overexpression in Cdx2 null cells,pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.254;	OD280: 0.641;	Ratio: 1.98;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 296;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
OE-OCT4_1,pert
ES2 NT-5 25nM,ctrl
day 10 5-FU HSC 2,pert
ApoD transgenic mouse rep_1 (CTG1),pert
wtPrE serumfree 1,ctrl
CTRL_3_HSC,ctrl
Ecad_Con_3,ctrl
266C1,ctrl
"Trained mice, time point 3 week",ctrl
"wild type saline, biological rep1",ctrl
HNF4a2_2-,ctrl
heterozygot FH P273 (human CD3 positive T cells),pert
siDdb1 replicate1,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50), biological rep1",pert
remitted schizophrenia patient  S10,pert
ILD_21,pert
agent: Nickel 400 µM,pert
"breast tumor epithelium,51",pert
CD8+_Tcells_non_severe_asthmatic_1,pert
source tissue: lymphoid;	cell type: Splenic CD11b+Gr-1 cells;	disease state: no tumor;	genotype: wild type;	genetic background: H-2b,ctrl
tissue: brain;	genotype: mutant Lis1 ko/+;	age: E14,pert
optic nerve head astrocyte,pert
Cochlea_WT_9mo_3,ctrl
OVCA420+(3),pert
brain_DLPFC_bipolar C_mr701,ctrl
Wildtype liver_saline-injected 12weeks repl1,ctrl
FO_spleen_wt_rep1,ctrl
Control replicate 2,ctrl
U937-shGSK3B-Construct1-rep1,pert
con_B135,ctrl
MCF-7 +scrambled siRNA + vehicle rep2 (MD32),ctrl
56 Day Mouse Diaphragm muscle,ctrl
53SageA2,pert
Control Day7 (316L),ctrl
ATP-treated AML 6B blasts,pert
BCells_Transgenic_day2_REP3,pert
"iPSC derived from healthy control fibroblast WT1, biological rep3",ctrl
5922012047_E,ctrl
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 25;	maternal age: 27,ctrl
Etoh 5,ctrl
Pancreatic Sample 33-Normal,ctrl
"Patient H-c614T-W, MSI colorectal tumor",pert
tissue: white blood cells;	age: 8.31;	Sex: male,pert
Cell line expressing inducible GFP-progerin. Induction: day 0. Replicate A,pert
condition: Normal;	patient: N_LJ_8;	tissue: Normal skin biopsy;	kit: Affy,ctrl
murine lungs,pert
HMEC control,ctrl
RUES2_shRNA control,ctrl
"Normal cervix, Age 50",ctrl
HCC827 PR 1,pert
BCell_lymphoma_aggressive_sample6,pert
"This allele contains a deletion of the second coding exon of Gata4, including the start codon and the Nterminal 46% of the coding region. The mice used in this study were all male and on a uniform F1 genetic background resulting from the cross of Gata4WT/Δex2 (abbreviated;	G4D) mice, backcrossed for greater than 8 generations into C57BL6/J, to wild-type FVB/N mice. G4D progeny from this cross were present at weaning at the expected Mendelian ratio (104/218, 48%), survived normally to 18 months of age, and had no evidence of structural heart disease (0 out of 15 embryos examined histologically at E15.5-E18.5). Gata4WT/WT littermates (WT) from these crosses were used as controls.",pert
strain: FVB/N;	genotype/variation: Wild-type;	cell type: pulmonary vascular microendothelial cells (PMVEC),ctrl
HeLa cells with the decreased expression of Sp1,pert
gender: male;	age: adult;	tissue: liver;	genotype: wild type;	treatment: fasted 16hr then given ad libitum access to food for 3 hr,ctrl
MCF-10A shATM-3 replicate 1 [set 5],pert
Gender:F;	Age:48;	Tissue: Mucosa,pert
"BMMCs from NTAL KO, noninfected, 2 h activated, biological rep1",pert
Sample Group: HD patient; Gender: female; Age: 44; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/48,pert
"patient 027b, cancer, homogenized",pert
"Patient 999, 24 month of BETAFERON",pert
umbilical cord_nobpd: 5I,ctrl
0184-01-1,ctrl
"vector d4, rep 4",ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 4",ctrl
cell line: HSC-3;	cell type: human tongue squamous cell carcinoma;	genotype/variation: control vector (no trypsin-2 expression),ctrl
Patient: J;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
36A;pretreatment;female;breast tumor,ctrl
HF1345_U133P2,pert
GM19238_Kd_CREBBP_3,pert
NOD non-transgenic islet rep3,ctrl
P60 wt2,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: SHANK3 shRNA,pert
WT.DMSO_2,ctrl
3765-1 E2F1 Null,pert
3T3 cells from cyclin D1KO mice infected with MSCV-D1a.,ctrl
cell line: U937;	shRNA construct: GSK3A Construct 5,pert
muscle WT 3 control,ctrl
MEFs-1,ctrl
Bach2 KO - Thymus - biological repeat 3,pert
Gene expression profiling of normal cortex of patient 14,ctrl
siNonTarget,ctrl
tissue: hepatocellular carcinoma tumor;	treatment: erlotinib 2mg;	strain: Wistar,pert
Untreated Myd88 knockout - repeat 2 - mAdbID:102772,pert
b45-,pert
X_p4_rep2,pert
"Normal testis, adjacent to germ cell tumor",ctrl
tissue: Barrett's,pert
HC-KO-21A,pert
Eed KO J1 ESCs on day 0 #1,pert
MDA-MB-231 RRP1B over-expressing clone #5,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
"E18.5 ERRg +/- heart, biological rep 1",pert
transgene: FTO;	treatment: 24h after induced espression of integrated copy of the FTO gene,pert
strain background: C57BL/6;	genotype/variation: Parp-2-/-;	cell type: sorted Ter119+CD71+ bone marrow cells,pert
Sample 17 Kidney Hyp Mouse - Control Diet,pert
01LM4_PolyRF-,pert
MDS patient 92,pert
Liver_POR-null_3,pert
HSC-3_TAT-2_48hr culture_ rep1,pert
Individual_4616_PP_sample,pert
Healthy Donors 2,ctrl
strain: Gata4tm1.1Sad/J;	infection: Nuclear β-galactosidase;	culture: Differentiation medium for 3 days,ctrl
cell line: SKM-1,pert
480MM,pert
miR122-KO-318-T,pert
mdx Biological Replicate 4,pert
H1299 DAC 0.3 uM (3236),pert
Control 2 c,ctrl
COV434 Wildtype [RR1022],pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 73;	age-at-onset: 70;	geographical origin: Vila-Real,pert
LKR13_Control-4,ctrl
HET Brain 55d Mouse1,ctrl
umbilical cord_nobpd: 5F,ctrl
normal,ctrl
untreated or induced,ctrl
CME-Emerin0d-2MA-S2,pert
B cells - IFNAR1-/-mice - influenza-infected,pert
MacularDegen-injured-14aAv2-s2,pert
Quercetin day 10 sample 2,pert
genotype: STAT1-KO;	time (h): 0;	cell type: primary hippocampal neuron;	treatment: untreated;	genetic background: C57BL/6,pert
HT29 PLX Day1 rep1,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 1,pert
2062T,pert
cell line: mNB-A1;	strain/background: mixed C57BL/6 x 129X1/SvJ;	cell type: MYCN-driven neuroblastoma;	treatment: DMSO,ctrl
genotype/variation: bitransgenic Pdx1-cre/Kras*A;	cell type: pancreatic tumor,pert
human fibroblasts overexpressing prelamin A and ZMPSTE24,pert
Pool Eu_P15_hyb1,ctrl
CLL2-CD8,pert
"liver, phenobarbital treated",pert
BL Day 2 siSC transfected biological rep1,ctrl
"Foxd3 conditional knockout cells treated with DMSO, biological rep1",ctrl
T183,pert
liver 0.1% quercetin diet rep6,pert
subjectid: 5278;	imatinib: IM;	lbh589: NoLBH,pert
CML-BM 5,pert
U2OS_siHic5_2_24h,pert
Primary hepatocytes isolated from SV129 mouse strain treated with DMSO for 6h,ctrl
ILD Study Number 1281,pert
V5-P588,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 8.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 40;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
"Retina, 30 days old wildtype mice",ctrl
reduction mammoplasty patient 352,ctrl
"array 25, unimplanted",ctrl
BAT_WT_5,ctrl
"Gender: female, Age: 33 years, Tissue: VIN 3",pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 24 hr,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post LPS 0.33mg/kg BW ip.,pert
K562_NoTreatmentControl_24hrs_rep3,ctrl
FVB_MMTV_Wnt1_3718.3R_Rosen,ctrl
MRF CKO Oligodendrocyte Replicate 1,pert
GAS-n7-2; normal gastrocnemus 7 month,ctrl
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 5",pert
Five-week-old C3H/HeN female mice liver,pert
disease state: Diamond-Blackfan anaemia;	gender: Female,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 1,pert
sampleID: SAM630139;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 159,pert
hur status: KO;	rna subtype: nuclear RNA after HnRNPA1 Immunoprecipitation,pert
"brain, cerebellum: RNA#5S_le1",pert
56 Day Mouse extraocular muscle,ctrl
strain: Sprague-Dawley;	tissue: spinal cord (ipsilateral dorsal horn);	developmental stage: Adult (8-12wks);	treatment group: 7 day post sciatic nerve SNI injury,pert
01LNX_Oligo,pert
EBS,pert
hESC H1 B2M KO c1,pert
Subtype: RAEB2;	Karyotype: normal,pert
agent: pristane;	time: 3 days;	strain: DBA;	tissue: mesentery,pert
gender: male;	dietary group: grape extract (B);	time point: 12 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),ctrl
Hippocampus 1985 15 month Old,pert
"TLR4 null sham kidney, biological rep3",pert
strain: C57BL/6;	genotype: Captain Morgan (DOCK8 deficient animal strain),pert
Young 2,ctrl
SLE myeloid cells 11,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 200min;	race: White;	sex: Female,pert
n4t7d,pert
Dexamethasone 1,pert
Wild-type mice without treatment,ctrl
Calu3-GemR_Veh_2,pert
S-IIP(NSIP)1_Cy3,pert
strain: FVB/NCrIBR;	tissue type: tail skin,pert
cell line: BV-173;	tissue: Human B cell precursor leukemia,pert
ARF1 siRNA knockdown MDA-MB-231 sample 9,pert
siSPDEF_6,pert
duration of untreated disease in month:2.1;	age at onset:8.3,pert
stomach_0h_rep1,ctrl
Run4.aUa.010110d.SkMDbt1143D.CEL-DB stimulate,pert
"Patient G, lesional skin",pert
P14 - WTMixB 2,ctrl
MLL_PTD09,pert
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject C,ctrl
4031-2 E2F3 Heterozygous,pert
TFEB_Overexpression(S1),pert
"Global gene expression of NASH patients, P66",pert
siLRH-1_#3_rep_4,pert
cerebellum_Pink1 knockout_6 weeks_replicate 3,pert
ACC 3 cell line Sox4-RNAi replicate 3,pert
Gastric biopsies,pert
blood_day0_patient3,pert
age: 18 month postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
WildType_2,ctrl
P4_Ovary_NT3_biological rep1,pert
PTC BRAF mut 10,pert
Strain: C57BL/6J;	Gender: male;	Age: 6 weeks;	Tissue: whole brain,ctrl
482 cells Sox2shRNA-rep1,pert
U937-shGSK3B-Construct2-rep1,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: cisplatin;	timepoint: 2 hours,pert
E14.5_Mutant_Kidney_array2,pert
No_drug_#4881,ctrl
human fibroblasts,ctrl
"MOLT4 cell line, treated with GSI",pert
"Normal T-cells, CD3+, donor 4",ctrl
CD11b+Gr1- cell sample_4 (derived from IL17RC Knock out mouse),pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr.;	Timed-pregnant CD1 mice were purchased from Charles River Laboratories at embryonic day E15.5 mice (E15.5). Dexamethasone was obtained from Calbiochem and reconstituted in Dimethyl sulfoxide (DMSO, vehicle).",pert
HT29 methotrexate-sensitive cells,pert
colon_normal_1357,ctrl
siCITED1#3 replicate4,pert
"eye, retina: Diabetic 1_le1",pert
MCF7 cells treated with 2uM Doxorubicin,pert
KSR1-null MEFs with GFP,pert
Run7.aUa.001206d.SkMInS1073D.CEL-IS stimulate,pert
WT 2 mon replicate 1,ctrl
EB_07_6h_130_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
MIY_day_5-5,ctrl
Hippocampus_Soman_3h_rep4,pert
human_hepatocyte_400uM_levofloxacin_donorA_24hr_prep2,pert
"brain, cochlea: [17] Sample #17_le1",ctrl
RNA-DHL4-DMSO-2,ctrl
cell line: H1299;	agent: DMSO;	dose: control,ctrl
Human Non-progressor HIV Sample L134-CD8+ T cells,pert
"bcatGOF  mouse kidney E12.5, biological rep 1",pert
Patient 5 skin treated,pert
MDS patient 58,pert
Retina wildtype 42 days 4,ctrl
EmptyVector 3,ctrl
GM19238_Kd_NS1_21A,ctrl
Strain: Long-Evans;	Gender: Male;	Age: Adult (PND62-PND64);	Tissue:  Cerebrocortex,pert
SZ14,pert
S013_Scz_F_65,pert
T30308,pert
RNA from microdissected breast cancer cells from case 1370 labeled with Cy5,ctrl
non-infected BALB/cByJ fibroblasts,ctrl
Gastrin Knockout fundus,pert
CON-2-COLLAGEN,ctrl
IL8.2,pert
Strain:B6.V-Lepob;	gender: female;	age: 12 weeks;	tissue: gallbladder,ctrl
bone marrow macrophages from 1 female and 1 male IRAK4 kinase dead Balb/c mouse,pert
MCF10A_Vehicle_rep3,ctrl
cell type: PBMC;	group: Healthy control;	patient treatment: not applicable,ctrl
Ishikawa_Control_24h_rep3,ctrl
patient: 51308;	sample: tumor,pert
5_DMSO-5,ctrl
"Control, biological rep6",ctrl
"seminoma specimen, pT2, patient age: 34y; W03 013",pert
"A673 treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50), biological rep1",pert
HCC_40N,ctrl
chip number: 14;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.64;	rin: 9.5;	transfection date: 2012-03-26,pert
RV63.01_CONTROL_day19,ctrl
180C0,ctrl
Kyoto rat liver tissue following animal exposure to orotic acid for 3 days,ctrl
cell line: BxPC3;	genotype: CTNNB1 KO;	beta-catenin gene (ctnnb1): gene disrupted,pert
Control Braak α- synuclein Stage 0 C5SN,ctrl
A7_C7_nasal_stem_cell_rep1,pert
SV589 3 Day KD Serum Starved-> 1hr EGF,pert
5922012008_C,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#1,pert
A11_C11_nasal_stem_cell_rep1,pert
Clozapine treated 12weeks AffyGC RMA rep10,pert
WILDTYPE cerebellum at 12 weeks,ctrl
"BMMC, NTAL KO, activated",pert
"twin pair: #8;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
male_control_277,ctrl
H4-II-E-C3 cells,ctrl
"Gata6-KO heart, CRE, biological rep2",pert
"Lymphoblastoid cell lines derived from family 1724, member 2",ctrl
GATA6 KO lung E18.5 mouse,pert
STV_H,pert
E1 clone infected with Deaf-1-expressing retrovirus.,pert
Patient: C;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"affected sister,",pert
WT_d00_e0,ctrl
3274-2 E2F WT,pert
FmrKO4_blood,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,pert
age_years: 60;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
hOB1705_shRB1383_24hr_IR,pert
"non-AD_FC, biological rep5",ctrl
Kidney_Biopsy_Liver_Disease_3,pert
Bronchial Epithelial Cells SA biological 1929N,pert
RV63.03_CONTROL_day19,ctrl
siRNA-1-PLASTIC,ctrl
Primary combined SCLC-AD 4544,pert
"shControl cells, rep1",ctrl
NSCLC adenocarcinoma cell line,pert
NORMAL MAMMARY GLAND,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 40;	sex: F,ctrl
12469 UC Inflamed ascending colon,pert
Nonspecific siRNA3,ctrl
prostate normal 1,ctrl
Postnatal 12 weeks control heart biological rep2,ctrl
Control Colon 3 21 days old,ctrl
"genotype/variation: ApoE-/- RAGE-/-;	strain: C57BL/6;	mouse provider: Ann Marie Schmidt laboratory, Columbia University;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: non-diabetic",pert
HeLa cells nucleofacted with CABIN1 siRNA,pert
pt. HCL D treated with Vemurafenib 1000 nM for 72h,pert
"mouse aorta cross strain comparison, C3H_T40_NC_03",ctrl
Strain: C57BL/6;	Genotype: AMPK gamma3 mutant (R225Q) transgenic;	Generation: F5;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 28.88767,pert
X78-,pert
Normal Unoperated,ctrl
VMM-WT_MyoD24h-3MP-s2,ctrl
"CBP, p300, CH1, TAZ1, hypoxia, MEF",pert
tissue: Temporal cortex;	age: 84;	Sex: M,pert
"SFM control cells (24hr), biological rep_3",ctrl
Control Day1 (392L),ctrl
Mouse heart,ctrl
adrenal gland,pert
aa_NY39,pert
"SBC-5 cells, siEGR4 (target), 48 hr after siRNA, duplicate sample 1",pert
WT MEF CT30-1,ctrl
05SAGEA2,pert
cell line: COV434;	transfection: pFOXL2wt,pert
"Deltoid, control, cohort 12, subject 12V",ctrl
hNHEPS_control_0 h_rep3,ctrl
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 24hr,ctrl
2103-03-A,pert
Normal-BM 6,ctrl
CAST/EiJTCE liver sample batch 3,pert
liver_Akt1+/-_female_35wk_rep2,pert
RV63.12_CHF_day19_Slide43,pert
BH4,ctrl
strain: ICR;	cell type: bronchoalveolar stem cells (BASC);	genotype/variation: control,ctrl
"kn muscle 2, biological rep 2",pert
01N28_Oligo,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: normal,pert
PGA-FVB_3m_2f-m5,ctrl
Saline T00278944,ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 3",ctrl
GIST882 DMSO Rep2,ctrl
4_Hr_No_MGd_2,ctrl
Primary hepatocytes isolated from BalbC mouse strain treated with Wy14643 for 24h,pert
cerebrum_WT_20d_rep2,ctrl
cell type: Primary hepatocytes;	strain: DBA;	agent: Wy14643;	time: 24h;	gender: Female;	age: 3 months,pert
"hippocampus, MSM",pert
subject id: 40;	infection: DENV;	status: DHF;	tissue: whole blood,pert
DDR-1-KO mouse (KO_Tal5),pert
"Mdr2-KO homozygous mouse, 3 month old mouse 1",pert
siNS_2h_1,ctrl
Injured 4h Rat Retina 2,pert
HP-8,ctrl
"paraventricular nucleus of the hypothalamus, LPS, 10 micrograms, 3 hours",pert
Control knock out ESCs,ctrl
"heart, knock out",ctrl
Liver_KnockOut_3,pert
gender: Male;	tissue: liver;	genotype: FGF21-/-;	treatment: DMSO 3-day;	genetic background: C57BL/6,pert
sample =Healthy3 treatment=Control time=180 (min),ctrl
tissue type: Lesional skin;	time: Week1_etanercept,pert
Patient 5,pert
SARRC-0994-01-C,ctrl
Ngn3 EB10 OFF replicate 1,pert
Bone-Marrow_NPC_N1351,ctrl
XDP caudate nucleus,pert
treatment: Cyclin D1 siRNA Estradiol;	cell line: MCF7,pert
VCaP/NC siRNA #1,ctrl
"RWPE1 cells, vehicle, 48h, biological rep4",ctrl
H1299 RBP2 KD2_rep 1,pert
MDA_PR_3,ctrl
"Data 2, Vbeta5",pert
ILD_12,pert
A549 siRNA FAM60A 2,pert
pLenti transduced cell lines overexpressing CDH1a,pert
ID: MLL_00116;	cell type: PBMC;	disease state: control,ctrl
Individual_4641_NN_sample,ctrl
OV90+(3),pert
LRRK2 mutant knockin H9 hESC derived NSC 3,pert
"Control ES cells 96hr, replicate 1",ctrl
08SE1183,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: 56;	fata: 125;	eea: 1860;	wtkg: 74;	perfat: 26;	lbm: 52;	fat_mass: 1924,ctrl
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 8.5 weeks-old,pert
RV82.09_CHF_day10,pert
tissue: Temporal cortex;	age: 74;	Sex: M,ctrl
hES_VUB03_DM1_3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
genotype: EFLmDREAM;	stimulation: non stimulated;	cell type: B cells,pert
PMBCs,pert
CLL6-CD4,pert
A2CKO3,pert
"patient 031b, normal, homogenized",ctrl
"Aorta, saline 14d, #6",ctrl
M238_R1_B_DMSO,ctrl
0148-01-C,ctrl
"Endometrium, postmenopausal, tibolone, 32",pert
C57Bl/6 peritonial macrophages,ctrl
Lung Tissue of Non-Transgenic Female Mice,ctrl
sample =Healthy4 treatment=Control time=90 (min),ctrl
patient12,pert
subject id: 7;	infection: DENV;	status: DF;	tissue: whole blood,pert
NCCIT-SNF5oe-rep1,pert
CEM-C1 T-ALL cell line treated with DMSO,ctrl
cell type: B-cell;	cell line: OCI-Ly7 DLBCL,ctrl
BALB_Male_CF_rep3,pert
GEIM186-U133A-Norm,ctrl
"alveolar macrophages, smoker 023",pert
cell type: Mouse embryonic fibroblasts;	genotype: MLL1 KO;	time: CT18,pert
Mnk_3133-S-7,pert
"spinal cord, ventral spinal cord",ctrl
5216 UC Inflamed descending colon,pert
cell line: OVCA429;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
"Patient 22, Macroscopically intact tissue",ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 32;	maternal age: 29,ctrl
"siPRMT1 ES, biological rep1",pert
"MLD, biallelic AML MLL_00255",pert
cell line: Lung Epithelial Cell Line MLE15;	genotype/variation: control,ctrl
Retina ko/wt rep2,pert
nt S. aureus 12,ctrl
Mouse_ATF6aKO_colon_UT_rep2,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.86;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
cell type: Neuronal Stem Cells;	developmental stage: E14.5;	strain: CD-1 albino,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 48h,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 4",ctrl
untreated WT MEFs-2,ctrl
MF-33,pert
peripheral blood,pert
Bicalutamide_3,pert
E14 - Lis1ko/+ 1,pert
Ulk1/2-/- + IFNβ 3,pert
TRPM2-AS siRNA rep3,pert
"PC from healthy donors, isolated using CD38-APC.",ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 154;	fata: 54;	eea: 1420;	wtkg: 81.5;	perfat: 41.9;	lbm: 44.1;	fat_mass: 3414.85,ctrl
Epidermal keratinocytes treated with EFNA4 for 1h,pert
EP69_adipose_control,ctrl
age: 38;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Knee articular cartilage, 4 weeks following sham surgery",ctrl
prostate normal 3,ctrl
"FA6 transiently transfected with AGR2 siRNA, transfection B",pert
MH1C1_low_rep1,pert
Liver_hyperglycima_no.2,pert
brain_QH2_6M_rep3,pert
A HID U_B020,pert
human CD14 positive monopcytes,pert
Patient 13 appendix,pert
3587-1 E2F1 Null,pert
Individual_3591_PN_sample,pert
Psoriasis-Patient-E,pert
bleomycin injected mouse lung,pert
Y VIS _B028,ctrl
"control for Abca1 +/- ES, RNA 77",ctrl
SOCS3 Cre plus C,pert
"PBMC, patient. Mtx rep10",pert
age_years: 37;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
skin.wt.replicate28,ctrl
F3-NGN1-1st,pert
01LPG: new onset sJIA,pert
WT biological rep 1,ctrl
"Empty vector, biological rep1",ctrl
RNA prepared from fibroblast cell lines treated with 10% serum for 90 min,ctrl
02_NML,ctrl
"C57BL/6J, 4 week old, sample 2",ctrl
mdx5cv gastroc sample 2,pert
DMN-NF1Hippo18d-1bAv2-s2,pert
primary normal lung tissue 1345,ctrl
CD8_Tcells_healthy_donor,ctrl
PGA-MAH-AJ_PBS6h-5aA-s2,ctrl
A549 cells,pert
esiOgt_rep2,pert
Mouse lung wild type,ctrl
female_alcoholic_402,pert
"Creatine-treated, biological rep4",pert
"Cells transfected with sirtuin 6, biological rep3",pert
EGF12h replicate 3,pert
cell type: NPC 5-8F cells;	genotype/variation: control,ctrl
Subtype: RAEB2;	Karyotype: del(5q),pert
cell line: HL-60;	replicate: Replicate1;	treatment: shSYK_2,pert
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; 3h EGF,pert
sampleID: SAM630133;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
HaCaT_Control_ biological rep2,pert
control_16hr_rep2,ctrl
MOLM-14 cell line infected with GSK3B Construct 1 shRNA,pert
MSE_D_516,pert
Tissue: whole retina,pert
CD4IncTp1-6,pert
CD4DecTp2-4,pert
"MCF-7 cells-control, biological rep 2",ctrl
Spleen,ctrl
intestine_wildtype_24hfasted_rep2,ctrl
clone 48 replicate 1,pert
brain_DLPFC_bipolar B_mr697,pert
untreated WT MEFs-3,ctrl
patient: 240;	current medication: Asacol 800mg BD;	birth date: 1/10/59;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 8/2/04;	diagnosis date: 12/14/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Gene expression profiles of Lkb1 WT #5 HSCs,ctrl
brownfat_KO4_day3,pert
SLE CD4 T cells 6,pert
01-0036A_Day1_1,pert
Mutated-ERα-positive breast cancer 69,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,pert
Subject #8038-2d Postinfection,pert
HRas-v12 transgenic female replicate 3 late timepoint,pert
RNA mix 2 of nomarl lungs,ctrl
coronary smooth muscle cells nebivolol replicate 2,pert
GNMT-WT mouse hepatocytes (sample 1),ctrl
"DBA/2J Chronic morphine treated, biological replicate 1",pert
"Patient  E, lesion, 12 week",pert
tissue: Frontal cortex;	age: 105;	Sex: F,pert
Diaphragm 23 Day mdx rep 3,pert
wt_P4_rep4,ctrl
C5 Control None,ctrl
Calu3-Parental_2,ctrl
"IN1760 siNT treated, Biological replicate1",ctrl
cell type: HeLa;	genotype/variation: Transfected with G392E Neuroserpin,pert
STV_F,pert
206/4,ctrl
Bone-Marrow_MGUS_G779,pert
harmane 1uM batch 1,pert
01UNM_PolyRF+,pert
"TH cells from LC, wild type control, biological replicate 2",ctrl
DOV13+(2),pert
C18-1,pert
"gender: Female;	age: 89;	post-mortem delay: 8h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"MEKi 4 days, biological rep4",pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu3,pert
"201, ADIPOOSE TISSUE, Before",ctrl
HMEC X HMEC -EGF for 2days,ctrl
"peripheral blood leukocytes, Cyclophosphamide-treated 1 day",pert
V5-P600,pert
MDS patient 12,pert
Patient: K;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
colon_epithelium_IL10mouse_12weeks_rep6,pert
Hippocampus_Soman_3h_rep5,pert
cell line: HeyC2;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
wild-type #3,ctrl
E12 wt.1,ctrl
CML_2_CMP,pert
subcuteneous fat,ctrl
esophageal squamous cell carcinoma from patient E1521,pert
TOV112D COUP-TFII-1,pert
EE_IC_1_cauc_lcm,pert
iA50clone6-,pert
Phan_011_KO.bleomycin rep2,pert
"control pancreas, biological rep2",ctrl
cerebellum SNCA knockout 6 month replicate 2,ctrl
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 8",ctrl
CON29,ctrl
N13B Normal-cerebellum,ctrl
testis knock out replicate2,ctrl
Panc-1 Pancreatic Cancer Cells,pert
Extract:LOX-1:213202;	Extract Description:LOX1_Untreated_2hr:213202;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.8;	Quality: Background Mean Dev.:0.27;	Quality: Absent (%):57.58;	Quality: Absent (%) Dev.:0.52;	Quality: Scaling Factor:0.62;	Quality: Scaling Factor Dev.:0.05;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213202;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295543,pert
Disease_status: Healthy control;	Age (years): 31;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.13;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
strain: C57BL6 mixed FVB;	genotype/variation: cMetflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: BaCl2 muscle injury;	tissue: hindlimb muscle contralateral to BaCl2 muscle injury;	cell type: CSC;	time: 2.5 days post injury,pert
WT CFTR unexposed replicate 4,ctrl
patient code: 123;	gender: Male;	age: 74;	tumor grade: 3;	t-stage: 1;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
Bone-Marrow_MGUS_G626,pert
Haloperidol treated 12weeks AffyGC RMA rep5,pert
G4D_Sham_Rep5,pert
"Sham NALT (PBS), biological replicate 1",ctrl
siERK1Veh4h_2658,ctrl
HeLa cells treated with luciferase siRNA,ctrl
5243 UC Inflamed sigmoid colon,pert
Aorta from ApoE-/- mouse without diabetes sacrificed at 9 weeks.,ctrl
"SKO-transduced MEFs, Vc untreated, lysed on D4",ctrl
Mtb infected mouse lungs treated with PZA-63 days post infection,pert
"Uninvolved Skin, NS-12",pert
Time:4 day; condition:Emerin ko;,pert
bone-marrow mesenchymal stromal cells extracted from myeloma patient,pert
cell line: M12;	treatment: EGR3 knockdown,pert
Trip12 mut/mut mouse embryonic stem cell,pert
WT V6.5 ESCs on day 3 #1,ctrl
"brain, Entorhinal Cortex: 98-18 normal_e1_le1",ctrl
PancreaticSample1-Tumor,pert
KO-Nrf2-Male-1,pert
Brain BA22 post-mortem schizophrenic,pert
24h_c3,ctrl
Human medulloblastoma DAOY cell line,pert
HT29 methotrexate-resistant cells,ctrl
cDNA ak 03,pert
gastrocnemus muscle,pert
BCR-ABL1-control rep 4,pert
"liver RNA, WT  mouse",ctrl
"129P3/J Acute morphine treated, biological replicate 3",pert
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
F6.01,ctrl
tissue: adipose tissue;	sample group: resveratrol;	treatment: after;	gender: Female,pert
"TNFa-OMe-P siRNA-C, replicate 5",pert
HL-60 cell line infected with scrambled control shRNA,ctrl
"hMSC-Tert, control siRNA, 2 days adipocyte differentiation",ctrl
KU_35N,ctrl
Dicer WT CD4 T cells 3,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q,pert
M327 SKM-KO,ctrl
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 29;	maternal age: 26,pert
WT-1 (EPLM),ctrl
Cutaneous psoriasis without arthritis PsC 20,pert
Muscle_Rpt3 null_2,pert
DMSO Treated Control 3,ctrl
pooled skins,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 160min;	race: White;	sex: Female,pert
"p53-null NSC, vector",ctrl
ICM pool 3 (n=4),pert
sirna: Syk siRNA knockdown;	plate: plastic;	cell line: MCF10A,ctrl
11400 Normal Uninflamed sigmoid colon,ctrl
"Lymphoblastoid cell lines derived from family 1757, member 2",ctrl
Wildtype 2 (jos0927),ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 6 hours",pert
Bone-Marrow_SMM_S1496,pert
"DSS + L-Arg colon tissue, biological rep2",pert
JIA PBMC Pre treatment A235_L017,ctrl
MCAD + LPS 5,pert
CH2123,ctrl
"Prkaca+/- caudal vertebral bone, rep2",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q plus other,pert
Normal-ERα-positive breast cancer 30,ctrl
"DHL6, R406, 6h",pert
"Rat_Tracheal_Control_2hr, rep2",ctrl
01LKV: normal control,ctrl
5062-scrape,pert
Liver_D3T _Rep4,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,pert
sex: Male;	Age: 5 months;	additional patient information found in Series supplementary file,pert
CRC_nodrug_F4863,ctrl
"A549, -TNFα, control siRNA, rep2",ctrl
scan batch: Batch 2;	group: autism;	subject age: 9;	paternal age: 37;	maternal age: 30,pert
"Fmr1 wildtype mouse, cerebellum",ctrl
Haloperidol treated 12weeks AffyGC RMA rep8,pert
K562_NoTreatmentControl_24hrs_rep1,ctrl
PancreaticSample28-Tumor,pert
01LQE_CTRL,ctrl
NPC8,pert
"AD_HI, biological rep1",pert
tissue: Hodgkin lymphoma;	cell line: KM-H2,ctrl
A519 MI 7 day,pert
3IDC_tumor ductal,pert
Liver_nash_no.2,ctrl
strain: 129SvEv;	developmental stage: E11.5;	tissue: ventricle,pert
Trained 5 weeks T5,ctrl
01LNK: normal control,ctrl
RNA from whole tissue section of case 1389 labeled with Cy5,ctrl
m1-WT4,ctrl
brain_OFC_bipolar B_mr94,pert
"RES-enriched Grape extract group, 6 months, patient number 28",pert
liver_Akt1+/-_35wk_rep2,pert
"Ishikawa cell line, control, 48hr",ctrl
heart of male mouse subjected 4 week to chronic constant hypoxia.,pert
Peripheral blood mononuclear cells;	TTF=75min;	Race=White;	Sex=Male,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 36;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Psoriasis-7 baseline,pert
"fibroblast, control subject NM5 rep 2",ctrl
Small intestine,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 195min;	race: White;	sex: Female,pert
Ero1-C104A/C131A non-induced biological repB,ctrl
"Exp A, Animal #259, 50mg/kg D-Serine",pert
"Embryoid bodies, 48h,Plus Dox",pert
Barrett's esophagus (B5),pert
Placenta_PE(EO)2,pert
Bone marrow-derived macrophages from mice deficient in signaling adaptor molecule MyD88,ctrl
"WT, PR02M005v0",ctrl
"Healthy volunteer, Control_11815",ctrl
sample 1;	age: 68;	gender: male;	sample 2;	age: 77;	gender: female;	sample 3;	age: 72;	gender: male;	sample 4;	age: unknown;	gender: unknown,ctrl
"human failing LV myocardium, Ischemic101",pert
WT - Cre Treated - 2 hrs - repeat 1 - Cy3 - mAdbID:62605,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Mirandela;	lifestyle characteristics: ever drinker,ctrl
Whole adrenal RNA from Crem-/- mouse #1 at 0h,pert
Karyotype: inv(14)(q11q32);	Age: 54 years;	Gender: female,pert
Aorta mutant,pert
cell type: fibroblast;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P8;	clone: 0,pert
embryonic stem cells,pert
"Epidermal keratinocytes untreated control, 4h",ctrl
Mtb infected-63d-1,ctrl
28 Day Mouse leg muscle,ctrl
126OE 16A,pert
Day: 12; Drug: Saline; Phase: Drug treatment; Replicate: 3,ctrl
PGA-MAH-AJ_OVA24h-5aA-s2,pert
H2009_shGFP,ctrl
liver_Akt1+/-_35wk_rep4,pert
Cardiac biventricle of vehicle injected PGC-1a-/-bf/f/MerCre mouse (control),ctrl
BALB/c BMDM naive,ctrl
Patient: O;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
"DMD skeletal muscle, biological rep12",pert
G93A-SOD1 mouse spinal cord 110 day,pert
Normal HEK293 cell,ctrl
Series 3; young; 4 weeks after fracture,pert
siTNIK+7hr Wnt (Experiment 1),pert
untreated Murine 3T3-L1 cells,ctrl
tissue: minor salivary gland;	disease status: non-SS control,ctrl
"GM8922A, affected sister",pert
sex: Male;	family: 2;	age: 30;	disease status: Affected;	tissue: Muscle: Deltoid,pert
M229_A_DMSO,ctrl
n3_lo_4,pert
tissue: Frontal cortex;	age: 95;	Sex: F,pert
"U87MG - CASP2siRNA, biological rep1",pert
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus_WT-POU_80",pert
Uninjured Control - Epicenter Rep2,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2. Sample B,pert
03_NML,ctrl
control MLL_00116,ctrl
"wt total RNA LSK, rep 4",ctrl
n10t6h,pert
disease state: healthy control;	tissue: epidermis;	age: 43;	gender: male;	treatment: untreated;	time: control,ctrl
BP14,pert
12: FCHL patient #99-1191,pert
VMM-MUT_MyoD12h-1MP-s2,pert
"BPH adrenals, replicate 3",pert
"HEK293E cells, TDP-43 siRNA, replicate 2",pert
"Ulcerative Colitis (53 year old caucasian male, SAK_1285246305)",pert
"C57BL/10 control TA, replicate 2",ctrl
ALI patient #13,pert
Control subject 32_biological replicate 1,ctrl
813.3PBMC,ctrl
strain: Swiss Webster;	treatment: Saline;	tissue: substantia nigra,ctrl
Individual_649_PP_sample,pert
normal bone marrow NBM3,ctrl
triplicate 3 of uninfected HepG2 HIF-1-/-  cells,pert
10 week control OMN rep 1,ctrl
"nasopharyngeal carcinoma, specimen T6",pert
MH1C1_low_rep3,pert
gender: male;	individual: patient 1;	treatment: paclitaxel-eluting stent,pert
"Healthy control, biological rep3",ctrl
"Control, biological rep13",ctrl
"brain, hippocampus: Ctr-24h-P15-I_e1_le1",ctrl
13a_c,ctrl
H1993 BRMS1 KD_2,pert
sample =Healthy1 treatment=Stimulated time=360 (min),ctrl
"Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h",pert
cell line: SW1736;	time point: 0h;	mutation: BRAFV600E;	treatment: untreated,ctrl
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-4,pert
cell type: MEF derived stable cell line;	genotype/variation: Tet-off HA-Fbxl10,pert
genotype/variation: wt;	age: E10.5;	tissue: whole eye,ctrl
8 hour tunicamycin CHOP-/- D,pert
Mouse female ES cells PGK12.1 after double RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-1 in PGK12.1.,pert
brain wild type replicate1,pert
sex: Male;	Age: 1.5 months;	additional patient information found in Series supplementary file,pert
"Control cells unstimulated, biological rep3",ctrl
"breast tumor epithelium,52",pert
A549 AZA 0.3uM (3210),pert
N10,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 1 hour",ctrl
"non-SS control gland, patient 16, batch 2",ctrl
BC5 TC,ctrl
MPM tumor specimen 8,pert
12462 Normal Uninflamed sigmoid colon,ctrl
HT-KO-21A,pert
XBP1s Tumor 6,pert
"Placebo treated, HIV-1 positive male, day 14 (5)",ctrl
H11 HA 6h 1,pert
SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1),ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.172;	OD280: 1.137;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 214;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
treatment: DMSO;	time: Day1;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
20GOBMUC2H,ctrl
WT J1 ESCs on day 7,ctrl
umbilical cord_nobpd: 2E,ctrl
Patient 5 skin baseline,ctrl
Control_2months_retina9,ctrl
Cell line,ctrl
"Control Day 5, biological rep1",ctrl
"BOEC, not_at_risk 2",pert
Pooled carious pulpal tissue,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep1",pert
H1299,pert
mdx Biological Replicate 3,ctrl
Cre_day_3-4,pert
"cardiac muscle, left ventricle",pert
N51681,ctrl
Control 3 b,ctrl
15d Dicer cKO_Pool 10,pert
sidroshaC-transfected sample,pert
ALS gray matter 5 Sporadic,pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/+; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 14.5; Tissue: whole kidneys from 23 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Mist1KO caerulein rep3,pert
Braak α-synuclein stage 1-2 BR12_5SN,pert
"CFU-PreB colonies Wildtype littermate, biological replicate 5",ctrl
reduction mammoplasty patient 314,ctrl
4112-2 E2F WT,pert
CCI 14d replicate 2,pert
disease affected colon of an adult with ulcerative colitis (UC).,pert
cell line: ONS76;	cell type: medulloblastoma;	treatment: KDM5A siRNA;	transfectant: ONS76_si_KDM5A,pert
strain: C57BL6/J;	genotype/variation: wild type;	gender: male;	age: 12 weeks;	diet: 8 wks of high-fat diet;	tissue: gonadal white adipose tissue (WAT),ctrl
"new born normal mice, cerebrum",ctrl
CONTROL;	Age = 22;	Sex = F,ctrl
PancreaticSample19-Tumor,pert
A SIT_B036,pert
"brain, hippocampus: Aldh5a1-/- #3389 Cereb_e1_le1",pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 37;	maternal age: 35,ctrl
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50), biological rep1",pert
sample =Healthy2 treatment=Control time=90 (min),ctrl
NOMO-1 control 1,ctrl
PTC BRAF mut 2,pert
"Pancreatic tumor cells, replicate 1",pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: control, shRNAmir #9;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",ctrl
Control_2_intestine_30days,ctrl
"famale Sprague-Dawley rat, 4-hydroxyphenylretinamide, 782 mg/kg diet for seven days, tissue: liver",pert
WT rep3,ctrl
122B,ctrl
Rybp#10 (OHT+)_4d_rep1,pert
Breast_cancer_cell_line,ctrl
liver tissue from 21 days old mice,pert
MSE_D_97A,pert
Scd1+/+ on chow diet replicate 4,ctrl
lesion_midUV_patient11,pert
INSENS 2 4hr,pert
intestine_PPARa_kockout_24hfasted_rep2,pert
7 Day Mouse leg muscle,ctrl
siAgo1 repeat,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 95min;	race: UK;	sex: Male,ctrl
Human prostate cancer primary culture C39dx,pert
amygdala long access to cocaine replicate 1,pert
Capan2 cells transduced with control lentivirus,ctrl
B_cell_pool_melanoma_M11+M12,pert
"normal nasopharyngeal tissue, specimen N2",ctrl
"Untreated, biological rep7",ctrl
Placental tissue from late onset Preeclampsia,pert
strain background: C57BL/6N;	genotype/variation: Stat1 KO (ko);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
age: 5;	sex: F;	disease status: control subject;	Filter number: 80;	Usage number: 1;	Exposures: 2,ctrl
MDA-MB-231_TR30003: transfected with a vector containing a non-effective shRNA cassette against GFP,ctrl
C_AN13295_C,ctrl
Donor2_24h_DMSO,ctrl
wild type MEF time 24 replicate 1,ctrl
tMLL04,ctrl
"E18.5 brain, wild-type, rep 6",ctrl
LNCaP-LM xenograft control,ctrl
B_cell_pool_healthy_H03+H04,ctrl
"WT mouse heart at 6-weeks old, biological rep4",ctrl
Individual_953_PP_sample,pert
Strain: DBA/2J Sex: Male Age: 8-10 weeks Treatment: Control,ctrl
Txnip deficient tumor 27 months sample 2,pert
Patient 6 appendix,pert
cell type: Immortalized human neural stem cell;	cell line: HB-1;	treatment: control,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (2)",pert
"Frontal Cerebrocortex, deltamethrin (1 mg/kg), 6 hours",pert
rd1_P8_rep1,pert
"brain, cerebellum: KCb4w#2_e1_le1",pert
B4 367 wild-type untreated,ctrl
"TIG3 diploid lung embryonic fibroblasts, background.",ctrl
"Exp A, Animal #247, 500mg/kg D-Serine",pert
s4t3c,ctrl
MDA-MB-231-ZNF217 cell culture 2,pert
ES cells,pert
disease state: homozygous Nxnl1 null;	strain: BALB/c AJ,pert
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep3",pert
subject id: 36;	infection: DENV;	status: DF;	tissue: whole blood,pert
Peripheral blood mononuclear cells;	TTF=119min;	Race=White;	Sex=Male,pert
Subject #8008-8hr Postinfection,ctrl
depression,pert
"Immortalized MEFs WB, empty retroviral vector infected, rep2",ctrl
treatment: 1 ug/ml doxycyline;	time: 96 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
N3,ctrl
Pertuzumab treated after 4 days (P2_2),pert
gentrap derived AB2.2 ES cell,pert
Wild-type rep3,ctrl
Insm1 control #9_pituitary gland,ctrl
M11 - non-infected MBT/Pas fibroblasts,ctrl
SIRT4 KO liver_7581-2,pert
CTRL_esiGFP_rep1,ctrl
"peripheral ganglion, unknown: nicotine 24 hr_3",pert
Allo-25-5,pert
"Sh2b3 WT, biological rep1",ctrl
WT Non stim 1,ctrl
Mannitol_3,ctrl
H3bt5,pert
FoxO deficient LSK (4),pert
"Wild Type, biological rep1",ctrl
Squamous cell carcinoma 004,pert
Human.AN.CP.FCU,pert
Liver WT3,ctrl
ST045849 12 hours_1,pert
"Spi-21, biological rep 5",pert
Control day 05 sample 1,ctrl
"female,20,Caucasian",pert
Aged 10,pert
E18.5_Mutant_Kidney_array2,pert
Liver TG replicate 2,pert
HCC827 PR 2,pert
Gastrocnemius muscle mRNA from young (10 week old) knock-out mice,pert
MCF-10A shATR-3 replicate 1 [set 5],pert
"H1 hESCs, OE-OCT4",pert
MCF7_CHX_EtOH_24h_rep4,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 6 months,ctrl
BL136,ctrl
"embryonic stem cells, KD replicate A",ctrl
Control subject 87_biological replicate 1,ctrl
K562 cells control replicate 5,ctrl
Mouse striatum,ctrl
Liver of pup from control group rep3,ctrl
cell type: Human melanoma cell line;	cell line: M249_R4;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
liver sample group: : Alcoholic hepatitis,pert
PGA-MAH-AJ_OVA24h-3aA-s2,pert
brain_DLPFC_bipolar B_mr553,pert
DMSO3,ctrl
0-day rat ovary cultured 2 days,ctrl
"human failing LV myocardium, Ischemic95",pert
NOD_T2,pert
E14 cells_control RNAi-rep2,ctrl
miR122-KO-T,pert
"WT in the presence of tetracycline, rep1",ctrl
"Granulosa Cell, 44-46hr PMSG",ctrl
Dot1l -/- day 3 after transduction with cre,pert
Angiopoietin-1(confluent)-2,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-1,pert
S6B Sporadic-cerebellum,ctrl
"Human male subjects with familial combined hyperlipidemia  after treatment with atorvastatin (ATV), peripheral blood monocytes",pert
Frontal_Cerebrocortex_Vehicle_6hr_rep9,ctrl
Wild-type rep2,ctrl
129_Sv_1_WT_d6_4302,ctrl
Nrl ko 2 mon replicate 3,pert
B-CLL PB P271,pert
M833 / Reference_13425520,pert
LSK cells from wild type mouse rep2,ctrl
NSC15,pert
CF (D508) subject14,pert
"strain background: C57BL/6J;	genotype/variation: IRF4 +/-;	tissue: spleen;	cell type: Naïve CD4+, CD62L hi, CD25 - T cells;	differentiation condition: Th17;	timepoint: 42 hrs",ctrl
"Epidermal keratinocytes untreated control, 1h",ctrl
MDS patient 28,pert
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Aurka;	condition: +Dox,pert
11396 Normal Uninflamed ascending colon,ctrl
Undifferentiated Dicer -/- (27H) ES cell line replicate_3,pert
RE550_H1650_6-Medi5117,pert
Strain: C57BL/6J;	Gender: male	;	Age: day3;	Genotype: WT;	Tissue: brown fat ,ctrl
MDS patient 135,pert
CON - R21,ctrl
tissue: white blood cells;	age: 13;	Sex: male,ctrl
patient: 228;	current medication: None;	birth date: 11/22/48;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/80;	diagnosis date: 1/1/82;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Migraines;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"colonic tissue from macrophage-specific PPARgamma-deficient mouse, biological rep2",pert
gender: male;	strain: C57BL/6J;	genotype/variation: Scd1flox/flox (Lox) control;	tissue: Dorsal skin;	age: 8-9 wks old,ctrl
Healthy control c5,ctrl
TOV112D cells_treated with NSC319726,pert
Heart_caAkt_03,pert
Control Treg_rep1,ctrl
"miR-148b-A (miR-148b-1, biological replicate 1)",pert
HNF6_2-,ctrl
"Undifferentiated Dicer +/- ES cell line, passage 20",ctrl
GM19238_Kd_PAX5_3,pert
Experimental 1,pert
Cal27_PBS3,ctrl
"Sv129/C57B6 intercrossed hybrid line, 12 week old male",ctrl
01LLX: normal control,ctrl
"Normal cervix, commercial_Ambion",ctrl
S005_Scz_M_82,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
7d-IR-48,pert
GIST882 DMSO Rep1,ctrl
Md02h031,ctrl
malignant tissue_TMPRSS2:ERG fusion negative,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: retina;	time: ZT20,ctrl
A549 stretch 4hr Jan 31 2003,pert
R26Pax3/Pax3 E14.5 palatal shelves 4,pert
Msgn1_12hMinDox-biological rep3,ctrl
tissue: liver;	gender: male;	disease status: normal glucose tolerance,ctrl
WT-PB_rep-2,ctrl
age_years: 47;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
C26_skeletal 3,pert
MS patient 3,pert
CRC_celecoxib_F4873,pert
Sample ID: TP17;	Twin Pair ID: CCN2.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 27;	Current Age (2007): 30;	Sex: MALE;	Medication at blood sampling : None,ctrl
"4 weeks normal mice, cerebrum",ctrl
PTC BRAF mut 1,pert
SKMEL28_t6h_rep1,pert
human_hepatocyte_400uM_Ciprofloxacin_donorA_24hr_prep1,pert
MPM tumor 19,pert
Wildtype mice,ctrl
Thymus,pert
V5-P330,ctrl
"vector d2, rep 1",ctrl
cMyb virus-infected replicate 2	(monocytes),pert
Individual_3983_PP_sample,pert
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 2,ctrl
INHA3,pert
"sh3293 (to target ERBB3) T47D cell line, replicate 2",pert
"imr-32,cdk4 siRNA,t=48, 2",pert
2 hr vehicle repl 2,ctrl
tissue: blood;	control: 4;	gender: male;	age: 26,ctrl
Pooled normal myocardium sold commercially,ctrl
siERK5Veh 2,pert
t06,pert
PGC-1a-/- rep3,ctrl
PTEN+/- ep_C,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: DMSO for 48h,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated, biological rep3",ctrl
"Heart, MAT1 CKO, 2 wk, sample 1",pert
HUVEC control,ctrl
6 h-apra-10 nM,pert
Bone-Marrow_MM_M1017,pert
Extract:LOX-1:213401;	Extract Description:LOX1_Untreated_12hr:213401;	Quality: Classification:Medium;	Quality: Gradient Severity:0.12;	Quality: Distortion Severity:0.05;	Quality: Defective Area (%):0.27;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.51;	Quality: Background Mean Dev.:0.52;	Quality: Absent (%):56.98;	Quality: Absent (%) Dev.:0.98;	Quality: Scaling Factor:0.6;	Quality: Scaling Factor Dev.:0.12;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213401;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295773,pert
iTreg,pert
"Autoimmune pancreatic islets before cyclophosphamide treatment, rep 2",ctrl
strain: Myd88 KO;	gender: N/A;	age: 4 month;	weight: 25-30g;	tissue: whole trachea,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 215,pert
"cochlea at P60, wt, biological rep 1",ctrl
Huh7 cells_JFH-1 Infected 48 hours_ rep3,pert
KO - knock-out Treated - 2 hrs - repeat 2 - Cy3 - mAdbID:62611,pert
patient: 51721;	sample: tumor,pert
"ID: MLL_00252;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; 1h EGF,pert
striatum_wild type_6 weeks_replicate 1,ctrl
MZ1774 YAPshRNA rep 2,pert
MCF-7_DMSO,ctrl
chip number: 9;	transfection plate: 1;	target gene: E2F1;	kd level: 0.78;	rin: 9.9;	transfection date: 2011-03-29,pert
Tmod3 WT-2,ctrl
WFS1 WT USHT_05_318_ko,ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 4 - Technical Replicate 1,pert
Seguin_IDR_BrownNorway_Liver_treated5,pert
"Mouse Embryonice Stem Cells, pCIP siRNA 1, Rep2",pert
Bone-Marrow_SMM_S1395,pert
Mouse No Cldn16 B9 442,ctrl
Day6 Estrogen treatment replicate 1,pert
4 hr unpooled 2 vs PBS 4hrpooled,pert
Sprague-Dawley Rat (male),ctrl
"SBC-5 cells, siEGFP (control), 24 hr after siRNA, duplicate sample 2",ctrl
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
erStress_twins_AA_1736twin2_500nM_thapsigargin_4h,pert
treatment: TRAF6 knockdown,pert
RNA from microdissected breast cancer cells from case 829 labeled with Cy5,ctrl
PlagL2WT3,ctrl
NZW/LacJTCE liver sample batch 2,pert
DNMT1-2,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 6s,pert
"Mouse heart, control, replicate 4",ctrl
status: Rapid;	age: 66;	gender: male;	tissue: cultured human fibroblasts,pert
umbilical cord_nobpd: 8D,ctrl
NSC16,pert
cell line: U937;	replicate: Replicate2;	treatment: shSYK_1,pert
disease state: normal;	age: 20 weeks;	tissue: ventral prostate;	strain: FVB,ctrl
H15_S_B2,pert
GM19238_Kd_RXRA_1,pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of saline for one week,ctrl
10 days sham-4,ctrl
whole tissue section from case 280,pert
RPMI8226_shKLF2A#2,pert
agent: 0.03% ethanol (control);	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,ctrl
"brain, brainstem: CB2_e1_le1",ctrl
female heart 10 days post pbs injection,ctrl
CCC103B,ctrl
cell line: HSC-3;	cell type: human tongue squamous cell carcinoma;	genotype/variation: overexpressing trypin-2,pert
Hunk WT rep3,ctrl
Series 3; adult; 2 weeks after fracture,pert
"age at diagnosis: 40;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 47;	dfs-event: 0;	distant metastasis: 0",pert
pediatric AML S13,pert
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 2;	age: Post natal day 3-11,pert
MCF-10A_shATR-3,pert
WT-PBS_rep-2,ctrl
KRAS expression uninfected,pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"spleen follicular B in WT, biological rep3",ctrl
control shRNA replicate 3,ctrl
Control_Castrated OWJ2,ctrl
"age at diagnosis: 62;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 37;	dfs-event: 0;	distant metastasis: 0",pert
2102Ep cells transfected with Ambion Silencer Select Negative Control #1,ctrl
cell line: D3;	treatment: scrambled,ctrl
"Luc control esiRNA, biological rep4",ctrl
"brain, hippocampus: CH1_e1_le1",ctrl
10EXPLANTH,ctrl
"Mouse liver, GNMT knockout, hepatocellular carcinoma, 8 months",pert
subject: 18;	disease: TD;	muscle: GR;	gender: F;	age: 17.4;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cell type: late passage (LP50) LNCaP,pert
"Pancreatic islets, VhlhKO, 02",pert
Animal 10,ctrl
"Pancreatic islets, VhlhKO, 01",pert
age: 63;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 3,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 60 yr;	population: white,ctrl
shRNA4-1-noDox-rep2,pert
Normal cervix_05-1308,ctrl
Patient identifyier: B;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 15 years;	Body surface area: 6 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
wt 13.5d replicate 6,ctrl
"Mutator, biological rep3",pert
"FACS-sorted cones, P50 wild type mice",ctrl
Bronchial Epithelial Cells MMA biological 1908F,pert
PBMC from T cell Large granular lymphocyte leukemia patient#122,pert
47A;pretreatment;female;breast tumor,ctrl
"breast tumor epithelium,29",pert
Control 874E,ctrl
A3_C3_nasal_stem_cell_rep1,pert
U937_naive_curcumin_18h_rep1,pert
Human Acute HIV Sample A144-CD4+ T cells,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 64;	gender: female;	tumor grade: IV,pert
Control (C62),ctrl
EGFR+EGF_2,pert
GNMT-KO mouse hepatocytes,pert
WT V6.5 ESCs on day 7 #2,ctrl
"Whole embryo, E9.5",ctrl
mouse_islets_ctrl_03,ctrl
wild type mouse retina at age postnatal day 8,ctrl
Diabetic F344 RAT penis,pert
CONTROL 4,ctrl
Bmi1 embryoid body sample_1 (Bmi1_EB_1),pert
"Neural precursor cells derived from hES cells line VUB01, biological replicate  2",ctrl
"NF-YC KD ES cells 96hr, replicate 2",pert
"CD11b DC wild type, biological replicate 3",ctrl
background strain: C57Bl/6;	genotype/variation: Notch1 knockout,pert
MDA-MB-231-pcDNA6 cell culture 1,ctrl
strain: C57Bl/6;	genotype/variation: : control ROSA(N1IC) mice (NICD wild-type),ctrl
"Patient P, uninvolved skin",ctrl
sex: Male;	family: 5;	age: 39;	disease status: Control;	tissue: Muscle: Biceps,ctrl
Squamous cell lung cancer patient 35,ctrl
microdissected breast cancer cells from case 687,ctrl
Tet2 KO CMP rep2,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).,pert
"p38alpha wild type fetal liver E15.5, biological rep3",ctrl
m1-WT1,ctrl
Whole testis RNA from WT mouse #80 at 0h,ctrl
E14 - WTMixB 1,ctrl
"Patient  I, lesion, 4 week",pert
Gastrocnemius muscle for transgenic mouse overexpressing PPARalpha in a skeletal muscle-specific manner,pert
Array Type: HG-U133A_2;	Ratio: 1.98;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
"E18.5 brain, Meg3 knock-out, rep 2",pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: E18.5;	genotype: Igf1 -/-,pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 knock-out;	age: 30 days;	tissue: retina,pert
"Hematopoietic stem and progenitor cells (LineageLow, Sca1+, Kit+; LSK)",ctrl
"Liver from MON exposed rats, biological rep 2",pert
MPM tumor specimen 12,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 1,ctrl
"Acute Myeloid Leukemia, sample 6",pert
Brain from 62 days Npc1+/- mouse1,ctrl
MV 4,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: High fat diet,ctrl
Run7.aUa.001206d.SkMInS1081D.CEL-IS stimulate,pert
shRNA4-1-plusDox-rep3,pert
PKBa-/- MEF time 24 replicate 4,pert
Series 1; adult; 3 days,pert
TG mouse lung,pert
"Liposarcoma culture from tumor 399, doxorubicin treated",pert
strain: Sprague-Dawley;	cell type: aortic valve interstitial cells,ctrl
Squamous cell carcinoma 031,pert
INS-1 cell line (FLP-In T-REx clone #5-3.19),ctrl
healthy control H06,ctrl
MCF-7 breast cancer cells,ctrl
EVI_GFP negative Lin- cells replicate 3,ctrl
RV64.04_CONTROL_day25,ctrl
Individual_5331_PN_sample,pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 1",pert
"Overexpress TFPIalpha, biological rep. 3",pert
strain: 129SV;	gender: female;	age: 10 months;	tissue: right ventricle;	genotype: wt,ctrl
THRA 6a mutant + vehicle replicate 2,ctrl
"liver, fed Western diet for 20 weeks",ctrl
MHC-I-positive microdissected myofibers,pert
Wild type embryo yolk sac,ctrl
HMEC X HMEC+Interferon alpha 24hrs,ctrl
5193 Normal Uninflamed sigmoid colon,ctrl
"breast tumor epithelium,50",pert
"TNFa-OMe-P siRNA-C, replicate 6",pert
tissue: lung;	lung source: routine lung volume reduction;	phenotype: healthy;	gender: unknown;	age: unknown,ctrl
Control 12,ctrl
"patient 031b, cancer, homogenized",pert
T8A-LU,pert
"Healthy volunteer, Control_11697",ctrl
heart from non-transgenic mice,ctrl
Ribavirin Treated Cells 3,pert
Parkinson's disease sample x098,pert
Cyclophosphamide-treated spleen 1 day - Biological Replicate 4 - Technical Replicate 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.236;	OD280: 1.154;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 374;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Liver WT HFD #560,ctrl
061K0: normal control,ctrl
pediatric AML S15,pert
Patient 19,pert
patient id: 1524;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 70;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
"Autoimmune pancreatic islets, day 2 cyclophosphamide treatment, rep 3",pert
cell type: Primary hepatocytes;	donor: 3;	agent: control;	time: 6h;	gender: Female;	age: 70 years old,ctrl
"Right brain hemisphere ,C57BL male mouse,Clozapine treated,Orally,12 weeks",pert
"treatment: diclofenac;	batch: 3;	donor: 29;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
"Donor 3, mock infected 6hr",ctrl
Normal-N_LJ_7,ctrl
wild type MEF time 24 replicate 3,ctrl
spleens from mice on C57/Bl6 x 129 Sv background,pert
individual: Control9;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
EA_Case6_CD4,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 3 - Technical Replicate 2,pert
R6_Pseudomonas_wildtype_422,ctrl
MCSF_B,ctrl
"Fibroblasts, formoterol, time 3h, patient 2, rep 1",pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 40,pert
PancreaticSample35-Normal,ctrl
Celecoxib_#4874,pert
tissue: Hippocampus;	age: 88;	Sex: F,pert
"maternal exposure to dioxin, pitM",pert
Embryonic fibroblast isolated from mouse,pert
MDS patient 142,pert
Individual_4697_PN_sample,pert
age: 14;	sex: M;	disease status: control subject;	Filter number: 97;	Usage number: 1;	Exposures: 3,ctrl
male JAK2 KO liver sample 122,pert
JIA PBMC Post treatment A235_L112(2),pert
Liver FC1,ctrl
PKBa-/- MEF time 48 replicate 4,pert
Wild Type Skeletal Muscle Sample (Hind limb 2),ctrl
Female - caucasian - E-04-M,pert
Wildtype 3 (jos1525),ctrl
colon_CRC_1316,pert
HA01-149B,pert
WT2 activated CD8 T cells,ctrl
NPCs derived from patient with schizophrenia,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.708;	OD280: 0.905;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 53;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
siRNA-3-PLASTIC,ctrl
8DKD_rep3,ctrl
Subject #8013-2d Postinfection,ctrl
3 Wild-type control macrophage,ctrl
MNR 2-2 WT 4,ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 1,ctrl
"Mkl2-/-, sample 3",pert
injury stage: Sham 60 days;	gender: male;	strain: Wistar,ctrl
cell line: OSE4;	knockdown: ARID1A;	cell type: ovarian surface epithelial cells,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Good-responder).,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-5,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 16 hrs,ctrl
"Healthy volunteer, Control_11818",ctrl
3DKD_SerumStarved->3hrEGF_rep2,pert
ubb_d14_wt_2,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: DMSO for 72h,ctrl
B_cell_pool_healthy_H05+H06,ctrl
transduced NIH-3T3 cellline,pert
"experiment I, passage 13, replicate 1",ctrl
"IL22KO2_ileum, 5 days post-infection with T. gondii",pert
ILD Study Number S017,ctrl
mouse colon_hnf4mutant_rep3,pert
B10.H2g7_T2,ctrl
A_AN08792_F,pert
HeLa cells with depleted BRCA1,pert
chip number: 11;	transfection plate: 4;	target gene: RDBP;	kd level: 0.78;	rin: 8.9;	transfection date: 2011-10-17,pert
LSK control 2,ctrl
Oct4 KD replicate 2,pert
"hMSC-Tert, control siRNA, 2 days osteoblast differentiation",ctrl
control participant P330,ctrl
"testis, knock out",ctrl
"epidermoid carcinoma, cell line",pert
phenotype: severe glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
"Wt Gata4, Wt Gata6, heart, CRE transgenic, biological rep2",ctrl
WT CD80hi mTEC sample2,ctrl
KO9-2,pert
strain/background: C57/B6x129 mixed background;	genotype/variation: control;	age: 12.5 dpc;	cell type: mouse embryonic fibroblasts,ctrl
Brg1 mutant 2 cell embryo rep1,pert
sip53mut.exp2,pert
cell type: Primary neonatal keratinocytes,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.007;	OD280: 0.497;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 67;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Aorta, saline 7d, #1",ctrl
JURL-MK1 Imatinib-treated,pert
nucleus accumbens long access to cocaine replicate 4,pert
MDA_PR_1,ctrl
liver_male ko_rep3,pert
2N,ctrl
Human colon biopsies from non-inflammatory control,ctrl
08SAGEA,pert
cell line: HCC1954 cells;	subtype: HER2 Positive;	treatment type: Vehicle Only;	treatment time: 3 Days,ctrl
F_Ctrl_2,ctrl
01LZD_Oligo,pert
Benign prostate tissue N3,ctrl
Brain (Inferior Olivary Nucleus)_control subject_#1,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.72329,pert
THRA wt + vehicle replicate 3,ctrl
KM_025T,pert
"kn muscle 3, biological rep 3",pert
"seminoma specimen, pT1, pN1, patient age: 42y; W95 194",pert
female;	33 yr old;	White,pert
Dysf -/- TA mouse muscle,pert
MPM tumor specimen 14,pert
"Patient  C, lesion, 2 week",pert
Huh7 cells_JFH-1 Infected 6 hours_ rep2,pert
CD4DecTp1-6,pert
3080-lcm,pert
Individual_4503_PN_sample,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (2),pert
"Control shRNA, rep3",ctrl
27 weeks female,pert
patient E1566,ctrl
"normal breast epithelium,4",ctrl
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 5 months;	genotype: Wild type,ctrl
CD4+CD8+ double positive (DP) thymocytes 3h Dexamethasone(DEX) (final concentration 1E-07 M) treated,pert
BCell_lymphoma_transitional_sample3,pert
patient: 801B;	disease state: LGSC;	component: Borderline,ctrl
Patient 1 b,pert
patient: 249;	current medication: Azathioprine 150mg Salazopyrine;	birth date: 1/12/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/90;	diagnosis date: 3/24/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/8/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 4/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"Cadmium 1.2 µM, biological rep4",pert
RE550_DU145_9-Medi5117,pert
"14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"Wt, biological rep1",ctrl
L-540_CTRL_24hrs_1B,ctrl
PGA_MI_nilv_1w_663,pert
hepatocytes,ctrl
Rat fatty liver16,ctrl
"Hdh knock-in embryonic stem cells, Q20 line, biological replicate 3",pert
mdx Biological Replicate 2,pert
MEF.WT.I,ctrl
"Human cutaneous T cell lymphoma HuT-102 cells, vector control",ctrl
HMEC_50,ctrl
33_C57_WT,ctrl
SHR12-2,pert
2117-01-A,pert
transduced NIH-3T3 cellline,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 48h",pert
GFP C,ctrl
"bipolar disorder, BA10-11",pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 4,pert
day 10 5-FU HSC 1,pert
"Control, replicate 8",ctrl
1% dmso batch 1,ctrl
"Subject 8, Family 3, Asymptomatic",pert
Diaphragm 7 day mdx rep 1,pert
Liver FC3,ctrl
tissue: Liver;	genotype/variation: Hmgn1+/+;	treatment: injection of 10 µg/g body weight of saline,ctrl
Liver KO6,pert
Substantia nigra PD rep13,pert
"111, MUSCLE, Before",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, mock",ctrl
Metastatic prostate cancer W4,pert
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 1",pert
H32 HA 12h 4,pert
8h 4OHT-treated-sample3,pert
"Diagnosis:AML M2;	Age: 66y ;	Gender: Male;	Blast %: 87;	Source: PB;	Cyto: INV9, INV14;	FLT3 ITD: No Data;	FLT3 TKD: No Data",pert
CUTLL1 MigR1 GSI-rep1,ctrl
"DMSO treated HL60 cells, biological replicate 1",ctrl
MDS patient 182,pert
tissue: brain;	genotype: mutant Ndel ko/cko;	age: P14,pert
WT-Fibr2 2,ctrl
Aurka_R_+Dox_rep3,pert
C26_heart 2,pert
"liver, PPAR KO_ctr_118",pert
cell line: neuro 2A (N2A);	cell type: neuroblastoma cell line;	genotype/variation: transiently transfected with Pou3f3 knockdown construct,pert
Infergen_6hr_rep3,pert
"Sh2b3 WT, biological rep3",ctrl
WildType B cells Spleen 1,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#108,pert
strain: C57BL6/J;	genotype/variation: wildtype;	age: 8wks;	developmental stage: adult;	gender: male;	agent: acetaminophen (APAP);	tissue: liver,pert
MDA_PR_1,pert
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: wild type,ctrl
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 68",pert
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-1,pert
LY2 SRC1-siRNA untreated rep1,pert
Individual_5575_NN_sample,ctrl
Normal cortex of patient 14,ctrl
LCL Concordant for Epilepsy twin pair 4 (CCE4.2)(TP40),pert
Plate vs. Nail:  6 Week Sham,ctrl
"Mouse liver, MAT1A knockout, steatosis, 3 months",pert
RNA from HCC_28N,ctrl
Genotype: NHE3-/-;	Age: 6-8 weeks,pert
genetic background: C57BL/6;	tissue: liver;	genotype: wt;	gender: female;	age: 3 mo,ctrl
"human failing LV myocardium, Ischemic68",pert
Strain: C57BL/6; Tissue: liver,ctrl
01N71_CTRL,ctrl
White adipose tissue in wild-type mice (rep1),ctrl
Brain from 84 days Npc1-/- mouse1,pert
01LQH_CTRL,ctrl
gender: male;	age (years): 34;	evolution time (years): 7;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
tMLL05,ctrl
"patient 7, arm treated with pimecrolimus",pert
Dissociated dorsal root ganglia treated for 30 min with DMSO,ctrl
patient id: T127;	tissue: Normal cortex;	gender: Male;	age: 35;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Normal heart_G75,ctrl
0 h (2) (Control sample),ctrl
FU-OV-1+(3),pert
cumulus_PCOS_Lean_rep3,pert
HepG2_control rep3,ctrl
WT - Cre Control - 3 mo - repeat 2 - Cy5 - mAdbID:74588,ctrl
BRCA1_1,pert
3883-1 E2F WT,ctrl
CD4IncTp2-5,pert
FCHL patient #98-1056,pert
FVB_MMTV_Wnt1_2494.2L_Rosen,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: PGC1a shRNA 66,pert
Cpr-low_pool 2,pert
Scd1+/+ on chow diet replicate 3,ctrl
RNA from HCC_35N,ctrl
"mouse skin, Tcfap2 mutant",pert
GIST Pre Treatment Biopsy 09,ctrl
THRB bN mutant + vehicle replicate 3,pert
gender: male;	age: 6 months old;	genotype: Pdx1flox/flox;VilCre (KO);	litter: brother of the same litter,pert
"BPL adrenals, replicate 2",ctrl
"Biceps, FSHD, cohort 21, subject 21B",pert
Colon_POR-null_3,ctrl
H11_SS10_01Nov07,pert
GIST882 Imatinib Rep3,pert
V5-P299,pert
pLenti transduced cell lines Mock (empty vector),ctrl
cell line: AGS;	tissue origin: stomach;	cell type: human gastric carcinoma cells;	treated with: none (control),ctrl
27SMOKEH,ctrl
WT - Cre Treated - 0.5 hrs - repeat 2 - Cy5 - mAdbID:62545,ctrl
ILD Study Number 890,pert
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-1,pert
Liver_POR-null_1,pert
Liver_Nrf1 CKO_rep3.,pert
brain_DLPFC_bipolar C_mr700,ctrl
HF0899_U133P2,pert
cell line: HEK293 human embryonic kidney cell line;	protocol: control (untreated),ctrl
cell line: IEC-6;	tissue: colon epithelium,ctrl
Cochlea_D257A_9mo_5,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Jejunum",pert
male_control_329,ctrl
"brain, lateral and medial ganglionic eminences",ctrl
"Spi-60, biological rep 5",pert
"Patient 3, control tissue",ctrl
"DOCK8 knockout, thymic, NK1.1+ NKT cells replicate3",pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b retrovirus,pert
HCC008N,ctrl
E2-uninduced (no Dox) control,ctrl
Squamous cell carcinoma 008,pert
Individual_4368_PN_sample,pert
41wk FVB(97%)/CF-1 (3%) mammary gland,ctrl
139B,ctrl
Day: 24; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 1,pert
tissue: Temporal cortex;	age: 91;	Sex: F,pert
mixed reference (CRG+ FR),pert
wt PBS3,ctrl
WT MEF CT18-2,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: B;	experimental sample name: PC8-R,pert
lateral hypothalamus,pert
"125, ADIPOOSE TISSUE, Before",ctrl
ccRCC tumor of patient 209,pert
Run1.a10a.000607jd.2.SkMNor921.CEL-IS basal,ctrl
Testis_KO_rep3,pert
56 Day Mouse leg muscle,ctrl
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage_3",pert
MCF7/c p.1,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 10",pert
TMRI E2 1hr,pert
"Male, 32 years old, HIV infection of >2 years",pert
SLE10-TC,pert
Untreated after 4 days (C1_1),ctrl
15KD_SerumStarved->1hrEGF_rep3,pert
"biopsies from healthy individuals undergoing colonoscopic examination, snap-frozen immediately, stored at -80ºC",ctrl
"Aorta, saline 7d, #5",ctrl
EA_Case20_CD4,pert
Fibroblasts_HealthyControl_5,ctrl
"peripheral ganglion, unknown: control 24 hr",ctrl
"lymphoblastoid cell line from T3.02, one out of seven of insensitive group, 50*10e6 cells",pert
HMEC_TNF-stimulated experiment 3,pert
"breast tumor epithelium,30",pert
50uM_Zn_3,pert
MDA-MB-231 cells siLuc (ctrl) transfected rep2 HG-U133A,ctrl
minor HCC6,pert
"alveolar macrophages, smoker 001",pert
mixed reference,ctrl
"hMSC-Tert, RNF40 siRNA, 2 days adipocyte differentiation",pert
445MM,pert
Pediatric_GBM_30,ctrl
aa.1,pert
"Liver from Nrf2 k.o. mice, biological replicate 1",pert
sample C 18.5 homo,pert
remitted schizophrenia patient  S06,pert
Control_Castrated OWJ5,ctrl
Squamous cell carcinoma 017,pert
MCF7,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: Wt;	tissue: Skeletal muscle (quadriceps),pert
APBMNC.LPS+.3,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 40;	gender: female;	tumor grade: IV,pert
HWS18,pert
cell line: JoMa1;	cell type: neural crest precursor cells;	transfectant: GFP control,ctrl
sepsis patient #12,ctrl
Prostate Cancer_NUGEN TEST07,pert
Normal-N_LJ_9,ctrl
"schizophrenia, BA46-68",pert
46A,pert
"schizophrenia, BA46-73",pert
MCAD 2,pert
Msgn1_12hPlusDox-biological rep3,pert
tumor cell line HepG2 rep1,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T26,pert
PTEN 121 (-/-),ctrl
heart knock out replicate2,ctrl
Sle1a R3,pert
"ALL_NDS, K55 012109",ctrl
C2C12 MYOTUBES STARVED 4 DAYS,pert
2 hr EE repl 2,pert
cell line: SA-01;	treatment: with X5050 (100 µM final),pert
Wild Type Time 7 replicate 1,ctrl
Patient 2 skin treated,pert
A61 NES 142Q TG1	F6/13	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#2,ctrl
strain: C57BL/6J;	tissue: E13.5 embryonic fibroblasts;	genotype/variation: Tfam+/-,pert
"human nonfailing LV myocardium, NonFailing14",ctrl
06R030 RA,pert
Squamous cell lung cancer patient 42,ctrl
heart wild type replicate1,pert
disease state: Healthy Control;	gender: Female,ctrl
MDS54,pert
"siTERC-BMSCs, biological rep2",pert
"Vehicle treated, no doxycycline; biological replicate 2",ctrl
NK_cell_pool_melanoma_M01+M02,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep8,pert
4A;pretreatment;female;breast tumor,ctrl
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Group B Strep,pert
FCHL patient #99-0308,pert
B7m1,pert
Endometrium-Normal 1,ctrl
treatment: siRNA LMG4,pert
kidney_co_6M_rep1,ctrl
cell type: E9.0 embryonic cardiac progenitors,pert
C13+(1),pert
Normal Cervix N9,ctrl
"17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
IPMC 1,pert
MLL2 siRNA biological rep 1,pert
"Patient S-337-N, normal colonic mucosa",ctrl
Carbo Day4 (413R),pert
3T3-L1 20uM troglitazone,pert
11390 Normal Uninflamed terminal ileum,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EED. Sample B,pert
Dgcr8 KO replicate 2,pert
"Sample Type: human cellular RNA, Cell Line: primary airway epithelial cells, Cell Type: tracheobronchial",pert
6169 Wild Type Mouse White Adipose Tissue,ctrl
TREx_Flp_Scrambled_siRNA_1,ctrl
cell line: OVCAR-8;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
White matter from age-matched healthy controls,ctrl
MCE301 cells treated with SB for 0 h-2,ctrl
"LY2 cell line, SRC-1 scrambled treated 120min,  biological rep3",ctrl
rd1_P2_rep4,pert
T30162,pert
cell type: Human melanoma cell line;	cell line: M249;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
uterus_veh_WT_4hrs_rep2,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep2",pert
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate C,pert
colon_CRC_1883,pert
scpk/WT/83,ctrl
"age at diagnosis: 56;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0;	er: 0;	pgr: NA;	dfs-month: 18;	dfs-event: 0;	distant metastasis: 0",pert
"222, ADIPOOSE TISSUE, Before",ctrl
"NPTX1 shRNA Day 3, biological rep2",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 204,ctrl
"CA1, SOX7 expressing HESC - clone1",pert
"DMSO Control after 1hr, replicate 1",ctrl
B3_saline_overexpressor_422,pert
RV63.09_CHF_day19,pert
Cell line MCF-7_control_expt3,ctrl
genotype/variation: Vax2-/-;	age: E16.5;	tissue: Whole eye,pert
"Tibialis Anterior Muscle, Wildtype, Adult",ctrl
cortex_WT_rep1,ctrl
BN control replicate 2,ctrl
CD19_selected_B-cells_after_R_rep1,pert
BC8 TC,ctrl
"Deltoid, control, cohort 13, subject 13U",ctrl
Whole testis from Ing2 -/- littermate,pert
BxPC3_Ctrl_rep1,ctrl
XBP1s Tumor 1,pert
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: E14,pert
"Wild-type-neocortex, biological rep4 (male)",ctrl
colon_epithelium_IL10mouse_6weeks_rep3,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 4h,pert
Patient: H;	Time: 0;	Group: responder;	Condition: lesional,ctrl
"nTreg Foxo1 WT, rep2",ctrl
cell line: BL2;	transfection: LEF siRNA;	batch: 1,pert
E14.5 Tgfbr2 Wildtype Mouse Model Tongue 3,ctrl
WT Non stim 2,ctrl
s3t0c,ctrl
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14532;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
0 hr KLF4 Time Course,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 14 months,pert
"Exp A, Animal #244, control (0mg/kg) D-Serine",ctrl
wild type CBA (sample1),ctrl
age_years: 55;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
P14 - WTMixB 3,ctrl
RE550_H1650_un3,ctrl
HepG2_Cr rep3,pert
09_PAH,pert
"HEK293 stably EWS-FLI1-transfected, BULK",pert
antimicroRNA-140_rep1,pert
ATL-1 - mAdbID:91501,pert
"gene expression of CTCF-depleted oocyte, replicate 1",pert
Bl6_WAP_2,pert
mdx TA sample 1,pert
Commercial RNA from normal cervix,ctrl
S002_Scz_M_82,pert
SHANK3_2,pert
Heart of 10 weeks old mice,pert
DMN-NF1Hippo28d-1bAv2-s2,pert
"Pten F341V epithelials cells, biological rep2",pert
KM_057N,ctrl
MDA-MB-231-pcDNA6 cell culture 2,ctrl
age: 24 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
WT - Cre Control - 5 mo - repeat 2 - Cy5 - mAdbID:74099,ctrl
"RISC-free control transfected, biological rep 3",ctrl
S-IIP(NSIP)10_Cy3,pert
LNCaP.GFP.3,ctrl
MGP1,pert
"normal breast epithelium,1",ctrl
genotype: wildtype;	diet: high fat;	muscle hypertrophy: none;	sex: male;	tissue: liver;	treatment: doxycycline 3wks,ctrl
Yy1_siRNA,pert
KO Ang4,ctrl
Sample 09 Kidney Hyp Mouse - Control Diet,pert
"human failing LV myocardium, Idiopathic63",pert
"human nonfailing LV myocardium, NonFailing1",ctrl
hepatocytes treated with 625 μM BZP,pert
Myoblast-GATA4-OE-day3-3,pert
Trim33-KD-SB-1,pert
affection: ADHD;	treatment: untreated;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 7 ADHD patients,ctrl
db/m 5-3,ctrl
siERK2Veh4h_2650,pert
male_alcoholic_326,pert
patient: 51628;	sample: tumor,pert
chip number: 21;	transfection plate: 3B;	target gene: EP300;	kd level: 0.73;	rin: 9.1;	transfection date: 2012-03-26,pert
Control Braak α- synuclein Stage 0 C7SN,ctrl
Rsk2-KO Hippocampus - 2,pert
Endometrium-Normal 4,ctrl
Braak α-synuclein stages 5-6  BR56_7SN,pert
15-0011A_Day1_38,pert
B6.IL10 72 O3 1,pert
cDNA no 22,ctrl
SW480_ezrin RNAi_rep2,pert
P4,pert
WT tumor DNA III,ctrl
ShKdm2b replicate 1,pert
MDS patient 137,pert
"AG825-treated, 6h after UV, Replicate D",pert
"Wild type used for MAT1A 15 month, replicate 3",ctrl
INS-1 cell line #1a with non-induced HNF1b,ctrl
PGA-MAH-C3H_OVA6h-2aA-s2,pert
Tendon_non-lesional_rep21,ctrl
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 31;	maternal age: 29,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 67y",ctrl
1025-04-A,pert
MCF7 silenced Estrogen receptor alpha (PII),pert
"shBAP1 #1 cells, rep3",pert
HMEC X LN5,pert
OSCE-17T,pert
"A673 treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50), biological rep3",pert
tissue: Melanoma Lymph node Metastasis;	cell line: WM164;	treatment: DMSO,ctrl
NINDS-RHS-Ctr_72h-1aUA-s2,ctrl
G93A non transgenic littermate 803,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M2;	flt3 status: WT,ctrl
P14 - WTMixB 1,ctrl
C2 corrected_A2_tumor,pert
Parkinson's disease sample x036,pert
strain: C57BL/6J;	genotype: Homozygous Wild-type;	developmental stage: P15,ctrl
strain: C57BL/6 * 129;	age: 3 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
tissue: Frontal cortex;	age: 84;	Sex: F,ctrl
C032_Control_M_76,ctrl
ILD_9,pert
RI36,pert
"mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 60;	ld: HCV;	creatnine: 1.3;	mdrd: 57;	gfr: 50;	protein: 0;	hematuria: 1;	c3: 1;	c4: 1;	rf: neg;	hcv: POS;	htn: 0;	dm: NEG;	hba1c: 5.1;	meld: 11;	ana: UN;	gp: ATN, mild IFTA, moderate arterisclerosis;	mm (mesangial matrix expansion): 0;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 1;	igm: 0;	c: 0;	empe: 3;	bmwid: 0;	bmd: 0;	edd: 0;	no of glomeruli: 12;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: moderate intimal fibrois;	if: IGG+IGA+;	mesangium ig: A;	tissue: Kidney_Biopsy_Liver_disease",pert
BTBR_Liver_rep1,pert
N30162,ctrl
A3,pert
pediatric AML PP4,pert
C2C12 myotubes 0uM H202 rep1,ctrl
"Crohn's Disease subject (34 year old caucasian female, SAK_1288107729)",pert
01N0Y_Systemic,pert
Snell 22 month Dwarf Liver 8dw,pert
"liver, ATP7B KO mouse, sample KO903",pert
cerebellum_wild type_18 month_replicate 1,ctrl
pre-iPSC- siRNA to Cbx3- biological replicate3,pert
Vector expression/control suppression,ctrl
Tet1 KD mouse ES cells,pert
MCF7 fulvestrant-resistant cell line transfected by antisense hsa-miR-222,pert
colon_CRC_1708,pert
Mouse E10.5 urogenital epithelium -/- #3,pert
Tissue: normal thyroid; Gender:female; Age:65,ctrl
30 with Cy5,pert
KM_057T,pert
patient: 14;	disease state: hypertension;	tissue: Atheroma plaque,pert
HepG2_HIF-1α knockdown,pert
"D3_non-transgenic mice, lung tissue",ctrl
Atxn1L HSC 2,pert
"A673 treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50), biological rep2",pert
Pancreatic Sample 32-Tumor,pert
Control6,ctrl
"CBFb-SMMHC animal 2, replicate 1",ctrl
"Cell type: endothelial, age:19, gender:male, diagnostic group: schizophrenia, PMI:28h",pert
"344SQ with PIK3CA shRNA, replicate 1",pert
NuLi cell line treated at DMNQ biological rep1,pert
male_control_339,ctrl
MA_19,pert
12h PTD-DRBD GAPDH siRNA (SAMPLE 3),pert
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep4,pert
LT 410 +/T after nicotine-induced seizures,pert
MacularDegen-healthy-9aAv2-s2,ctrl
siHic5_2_0h_3,pert
Control 9,ctrl
"liver, control, 14 months",ctrl
AVC_mutant_rep2,pert
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: 0.8 uM INCB18424 for 4 wks (Persistent);	treated with: 0.8 uM INCB18424 for 4 hrs;	sample type: persistent,pert
"HepG2 cells at T18 Control, biological replicate 3",ctrl
Mouse C2C12 Myotubes treated with Palmitate for 16 hours,pert
Myd88 KO control tissue  2,pert
agent: ConA;	time point: 6 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Total RNA from bone marrow derived macrophage from C3H/ARC mice after 10ug/ml LPS (S. minnesota) stimulation for 21 hours,pert
Human.AT.CP.FCU,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 36;	Usage number: 4;	Exposures: 3,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 31;	maternal age: 29,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 168;	colon ratio (mg/mm): 2.82;	myeloperoxidase activity (u/mg): 1.157;	tissue: colon;	treatment: 5% DSS,pert
"Heart, MAT1 control, 2 wk, sample 2",ctrl
colon_Runx1-WT_Cy3_15550,ctrl
Patient no. 17: treated,pert
T12,pert
Wild Type Control Set A,ctrl
V5-P401,pert
whole tissue section from case 374,pert
Jurkat cells with LEDGF transcript knockdown (PSIP1 gene),pert
CME-LaminA4d-2MA-S2,pert
Gfi1b overexpressed,pert
"Crohn's Disease subject (33 year old caucasian male, SAK_1260857762)",pert
"Mkl2-/-, sample 2",pert
Cell culture of Melanoma Cell Line - A375,pert
KO_24A_1c,pert
Endometrium/Ovary-Disease 5,pert
"normal skeletal muscle, biological rep13",ctrl
MO_CTC_SON_NCBI,ctrl
ccRCC tumor of patient T79,pert
"Exp A, Animal #254, 200mg/kg D-Serine",pert
"Placebo treated, HIV-1 positive male, day 14 (2)",ctrl
Advanced IPF_explant_upper lobe_rep152,pert
A549 DAC 0.3 uM (3218),pert
A_AN09730_F,pert
TTF=156min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
gender: female;	age (years): 50;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
11098 UC Uninflamed descending colon,pert
TTP_KO_60ActD_BioRep5,pert
Total RNA from bone marrow derived macrophage from C3H/HeJ mice after 10ug/ml LPS (S. minnesota) stimulation for 21 hours,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.265;	OD280: 1.203;	Ratio: 1.85;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 144;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
E14 cells_Zfp322a RNAi-rep2,pert
Brain area 8/9 from two 8 year-old girls suffering from Rett Syndrome.,pert
Donor4_24h_DMSO,ctrl
L428+M_rep1,ctrl
"Exp A, Animal #253, 200mg/kg D-Serine",pert
Unaffected MZ twin pair 4 (Unaffected patient of MZ twin pair CCN4),ctrl
gender: male;	individual: patient 2;	treatment: control,ctrl
colon from macrophage-specific PPARg-deficient mouse,pert
"brain, hippocampus: PH1_e1_le1",pert
RV63.03_CONTROL_day19_Slide34,ctrl
"Jurkat cells stably transfected with shRNA constructs (si1340) against LEDGF transcript (PSIP1 gene), derived from Jurkat si1340JK Cl-2 which was established and described in LLano et al. (2004). J. Virol. 78 (17):9524-9537.",pert
X_p8_rep2,pert
"WM1205, 48h treatment with 5 AzadC",pert
Murine skeletal muscle (gas),ctrl
"breast tumor epithelium,31",pert
tissue: retina;	age: postnatal day 8;	genotype: wild type,ctrl
BIO586218,ctrl
DMSO Control 1,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L003,ctrl
multiple myeloma (MM 501),pert
CD4+_Tcells_healthy_donor_6,ctrl
primary normal lung tissue 3370,ctrl
10 days sham-3,ctrl
HOX424 Control Day0,ctrl
connective tissue,ctrl
human fibroblasts overexpressing prelamin A,pert
strain: C57 BL6NCr;	tissue: Distal colon,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 2x1h exposure per day",ctrl
brain_DLPFC_bipolar C_mr546,pert
ASC_lean_biological rep1,ctrl
"Wild-type HFD 8 weeks, biological rep7",ctrl
sample =XCGD5 treatment=Control time=0 (min),pert
KU_21T,pert
CD8_Tcells_non_severe_asthma,pert
disease state: healthy;	group: baseline,ctrl
Age: 36;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
SIRT4 KO liver_7236-2,pert
Wtc-Met_1,ctrl
brain_OFC_bipolar B_mr221,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep6,pert
SKBR3_Control_3,ctrl
WT8,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #1.,pert
race: caucasian;	age (years): 85;	stage: IB;	grade: 3;	histology: endometrioid,pert
CLL 141-08 LMP-420,pert
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 44;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
Pediatric_GBM_46,ctrl
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 7,ctrl
PS-/- cerebrum at 10 days,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: B;	transfectant type: stably transfected with RNAi against DJ-1,pert
"RES-enriched Grape extract group, 6 months, patient number 51",pert
BL Day 2 siMut12 transfected biological rep2,pert
"MaF pre-iPSC9P2, Vc untreated, lysed on D5",ctrl
WT S49 Cells 6h treatment with cAMP,ctrl
genetic modification:;	tissue: breast adenocarcinoma,ctrl
HepG2_Vehicle_24hr,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep7",pert
Strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E16.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
Subject #8046-Preinfection,ctrl
11398 Normal Uninflamed sigmoid colon,ctrl
"human embryonic stem (hES) cells line VUB03_DM1, biological replicate  1",pert
OSCE-11T,pert
human normal breast tissue RNA,ctrl
"Deltoid, control, cohort 21, subject 21U",ctrl
Megacaryocyte-Erythrocyte Progenitors,pert
KO - knock-out Treated - 0.5 hrs - repeat 1 - Cy3 - mAdbID:62496,pert
chip number: 19;	transfection plate: 3A;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2012-03-26,ctrl
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
"Control 04, NC04",ctrl
WT-PBS_rep-3,ctrl
cell line: HEK293;	sirna: hCdc73;	condition: confluent cell density,pert
ND_4,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 15,ctrl
CON27,ctrl
cerebellum_wildtype_1,ctrl
MCF7_EtOH_24h_rep2,ctrl
"wild type, prenatal stress, biological rep1",pert
batch: B;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,ctrl
Liver sample from Alcoholic hepatitis group (CA22),pert
"male, healthy, no medicamentation",ctrl
"Crohn's Disease subject (52 year old caucasian male, SAK_1280775705)",pert
Fourth day of N2B27 differentiation,ctrl
8 week old wild type mice spleen,ctrl
WT_d00_eX,ctrl
01UPE_Systemic,pert
Tobacco_abuse_4,pert
Healthy control 13,ctrl
"SKO-transduced MEFs, Vc untreated, lysed on D10",ctrl
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 72 hrs;	Drug: No Rosiglitazone present,pert
"N-56, NORM, M, GSF, 1 x 100nM DHT, 24h",ctrl
platelet_sickle_4,pert
"wildtype (GFP-negative) kidney cells, biological rep2",ctrl
01N3H_ERA,pert
A HID U_B084,pert
Non-transgenic mouse rep 1,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle/giant cell;	matched/unmatched: unmatched,pert
MCF-10A sh53BP1-2 replicate 2 [set 5],pert
n3_hi_12,pert
left hippocampus,ctrl
ESE_D_27A,pert
"BMDM, Tpl2 WT, unstimulated, biological replicate 2",ctrl
Flexor carpi ulnaris from cerebral palsy patient,ctrl
Adrenal CREMKO 0h batch 2 [AdKOh00.16],pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: n/a;	maternal age: n/a,ctrl
"8 wk old BALB/c (or BALB-RAG) mice were sensitized to ovalbumin (or PBS)]on days 1 and 7, and challenged with aerosolized ovalbumin (or PBS) on days 15-21, and samples harvested on day 22",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.123;	Ratio: 2.13,pert
adipocytes expressing spliced XBP1,pert
HF1227_U133P2,pert
Wild type caerulein rep3,pert
"Patient W, lesional skin",pert
patient11,pert
P14 - Lis1ko/+ 1,pert
Cancer 22,pert
genetic background: C57BL/6;	gender: male;	cell type: primary murine fibroblast-like synoviocytes (FLS);	genotype: human TNF transgenic and knockout in Rsk2 gene (Rsk2-/y FLS);	flow cytometric cell sorting: CD90.2pos/VCAM1pos/CD11bneg,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: High fat diet,pert
Heart ventricle,ctrl
"C57BL/6J ACU, Rep1",pert
MiaPaCa2 pCEP4 clone 5,ctrl
liver_STZ treated diabetic_rep3,pert
"MCF-7 transfected with pcDNA3.2-BP1, rep.1",pert
pSuper vector control 2,ctrl
V5-P598,pert
SV589_8DayKD_SerumStarved->1hr EGF,pert
age: 21 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,ctrl
SM12,ctrl
"BMMs, untreated control, da, Replicate 2",pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 14 months,ctrl
"Transgenic, snap frozen, extensor digitorum longus muscle, 10 month age animal",pert
mouse intestine pLagl2 wild type 3,ctrl
AGS cells - Celecoxib treated biological rep 1,pert
NORMAL #99-0834,ctrl
A SIT_B099,pert
GM19238_Kd_POU2F1_1,pert
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"Male, 36 years old, HIV infection of >1 year",pert
"NCI-H69 xenografts, PDT treated and control untreated",ctrl
SUBSTANCE P 4 HOURS,pert
"IKK2 -/- cell line, biological replicate 1",pert
homozygous_TGFb_4hr_2,pert
SON siRNA rep1,ctrl
cont_OO12,ctrl
MB231 PIAS1 shRNA-DMEM,ctrl
Biceps_Pompe_3,pert
"Adherent lung cancer cell line, control siRNA",ctrl
Liver_Female_CF_rep3,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): R1881,ctrl
VEC C,ctrl
ubb_d28_ko_2,pert
MF-31,pert
GFP Replicate A,ctrl
whole tissue section from case 1205,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
C57BL/6J-ob/ob;	Liver ;	Age: 14 weeks;	Gender: Male,ctrl
OA3,ctrl
Disease_status: Down syndrome;	Age (years): 52;	Gender: Male;	Post mortem interval (hours): 24;	Braak stage: VI;	Cause of death: Bronchopnuemonia,pert
"Mouse wt heart ventricular tissue at E17.5, pool of 3",pert
"Ulcerative Colitis (57 year old caucasian male, SAK_1285291011)",pert
asthma_saline_3,ctrl
Colo-205 PLX Day 10,pert
con-52_C,ctrl
O_LS_Wk4,pert
Liver vehicle rep1,ctrl
ES cell RNA,ctrl
SNB19 GBM cell line,pert
"human failing LV myocardium, Ischemic63",pert
Kin- S49 Cells 24h cAMP treatment,pert
liver_Akt1+/-_8wk_rep1,pert
age: 50;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"control, BA10-4(2)",ctrl
KCL-22 non-treated,ctrl
ns DHT 1,ctrl
"primary cortical neurons, NLGN3 shRNA",pert
retina_DBA_1024L_3mo_rep1,ctrl
siRNA-2-COLLAGEN,pert
AZ-521_uninduced_12h_rep2,ctrl
"Pancreas from adult Rkip-1 KO mice, biological replicate 2",pert
180D6,pert
GEIM133-U133A-Norm,ctrl
A549 cultured cell,pert
"liver, ATP7B KO mouse, sample KO905",pert
E16.5 wt2,ctrl
Control subject 33_biological replicate 1,ctrl
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 3",pert
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: control hairpins targeting GFP,ctrl
4121-1 E2F1 Null,ctrl
"Nickel 40 µM, biological rep4",pert
tissue biopsy of non-lesional skin from CIU patient,ctrl
"SIRT3KO, high-fat diet, rep3",pert
"110, ADIPOOSE TISSUE, After",pert
brain_DLPFC_bipolar B_mr953,pert
Bone-Marrow_SMM_S1530,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1tetO-Nanog/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: esophagus,pert
Ppif-/- heart 1,pert
protocol: control,ctrl
strain: C57BL/6;	tissue: cerebral cortex;	age: E14;	gender: not determined;	genotype: Trnp1 knockdown,pert
"testis with regular spermatogenesis with status after vasectomy, patient age: 34y; W03 020",ctrl
Nrl-ko-Gfp 4 weeks replicate 4,pert
PGA-RMM-12h-2aA-s2,pert
WT biological replicate 2,ctrl
subject: 31;	disease: TD;	muscle: GR;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
HF1551_U133P2,pert
THRB bN mutant + vehicle replicate 2,pert
Liver_Wild Type+Quercetin_2,pert
CLS14_T4_PP_day3_058,pert
pool of thyroids from 6 months old RET-PTC transgenic mice,pert
liver_male wt_rep1,ctrl
DBA_6h_Wy,pert
PsOEt-14-Week 2,pert
Cont subject 02,ctrl
BCR/FGFR1 biological replicate 1,pert
U-87MG-V8 set 2,ctrl
"ALL_NDS, K34 011409",ctrl
KO_IL-6_100_rep2,pert
N4,ctrl
CD4DecTp2-10,pert
MA_237,pert
Trained diabetic 1 week DT1,pert
TA-n10; normal tibialis anterior 10 month,ctrl
cell line: U-87MG;	treatment: parkin,pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 2 days adipocyte differentiation,ctrl
Hereditary gingival fibromatosis(HGF) patient Gingiva replicate2,pert
"vector d4, rep 7",ctrl
DS1-iPS 4,pert
TLW18_T3_PP_day1_015,pert
24h_c4,ctrl
VMM-WT_MyoD24h-2MP-s2,ctrl
"Crohn's Disease subject (51 year old caucasian female, SAK_1287951234)",pert
23 weeks female,pert
Disease_status: Bipolar disorder;	Age (years): 31;	Gender: Male;	Age of onset (years): 21;	Duration of illness (years): 10;	Brain pH: 6.3;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 41, stage IIIB, HPV 16",pert
Mouse Spleen CD8 T cells,ctrl
surgical specimen,ctrl
"Crohn 07, CD07",pert
P328L329_del6a-,ctrl
"Entire small intestine, wild type, control",ctrl
"MTDH control, biological replicate 3",ctrl
genotype/variation: control,ctrl
umbilical cord_nobpd: 2G,ctrl
Oga_KO_MEF_E7_rep2,pert
Squamous cell carcinoma 025,pert
"S1P2-KO-hippocampus, biological rep3 (male)",pert
"DMSO-treated NRK-52E cells at 24h, biological rep 1",ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,pert
Hippocampus_Soman_24h_rep2,pert
quadriceps_muscle_Akt1+/-_female_35wk_rep4,pert
PFC FVB/N control 2,ctrl
Tolerizing allografts 70 days No.1,ctrl
Liver Control 1,ctrl
"Neuroretina 8-week diabetic, Biological replica_4",pert
MEFs-4,ctrl
age: 55;	gender: female;	ejection fraction: 31;	left ventricular end diastolic diameter: 61;	inflammation/PVB19: positive,pert
GBM_differentiation_4 days_2,pert
5A;pretreatment;female;breast tumor; responder,ctrl
Psoriasis-Patient-L,pert
Infergen_24hr_rep2,pert
age_years: 54;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
MOLM14_luc_Replicate2,ctrl
genotype: Male;	age: 15 years adolescent male,ctrl
HDAC2 WT E17.5 Ventricle 1A,ctrl
cell type: lymphoblastic leukemia;	gc resistant: TRUE;	treatment: GC,pert
Pediatric_GBM_22,ctrl
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_2,pert
S3_sham_overexpressor_12,pert
MLL_00117,ctrl
U2OS shCHK1-3 replicate 1 [set 4],pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 7.0;	age of psoriasis onset: 41,pert
patient: 2;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
U2OS_PRC_shRNA4_pLenti_2,pert
Aged 4,pert
Liver GPR120KO ND #720,pert
"NPCxhIPSC CON, replicate 3",ctrl
Cultured human trabecular meshwork cells,ctrl
WT 4,ctrl
C2C12 myotubes 0uM H2O2 rep4,ctrl
SW1736_t1h_rep2,pert
H69_Ctr_5,ctrl
"Wild type epithelials cells, biological rep1",ctrl
[Aiolos]-1,pert
Normal Adrenal Gland (AN11),ctrl
"19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Cutaneous psoriasis without arthritis PsC 14,pert
XBP1s_Tumor,pert
Brwd1 mutant_GV-stage_oocytes,pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 3,ctrl
con_B004,ctrl
"ERRa ko baseline heart, sample 2",ctrl
KO - knock-out Untreated - 0 hrs - repeat 3 - Cy3 - mAdbID:51962,pert
"liver, STZ-treated fed AIN93G diet for 14 days",ctrl
T-REx293-NPAP1-uninduced-3,ctrl
age_years: 66;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
IFN-WT,ctrl
"Lymphoblastoid cell lines derived from family 1733, member 2",pert
siLRH-1_#2_rep_3,pert
Brg1 mutant 2 cell embryo rep4,pert
Primary hepatocytes isolated from Donor 4 treated with Wy14643 for 24h,pert
Chondrogenic progenitor cells from OA male 3,pert
Bronchial Epithelial Cells SA biological 1628Z,pert
WT - Cre Treated - 24 hrs - repeat 3 - Cy3 - mAdbID:54725,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.25205,pert
shCDK8_Time_30_2,pert
Time:4 day; condition:ctr;,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.74521,pert
human head and neck cancer,pert
695_383_2hr_repeat,pert
treatment: atRA + cycloheximide;	genotype: WT;	cell line: F9,pert
TG MEP 2,pert
M229_B_DMSO,ctrl
strain: C57BL/6;	treatment: Cebpa knockdown;	cell type: lineage-negative marrow progenitors,pert
strain: MBT/Pas;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: infected,pert
V5-P535,ctrl
siLRH-1_#2_rep_1,pert
Huntington's disease 820E,pert
MDA-MB-231,pert
background mouse strain: C57BL/6;	source: white adipose tissue;	genotype: Rap1 knockout,pert
Ishikawa_VeryLowDose_BPA_8h_rep1,pert
"BMDM, Tpl2 WT, unstimulated, biological replicate 1",ctrl
"age: Embryonic day 14.5;	genotype: wild type (WT);	tissue type: fetal liver;	strain: b6, 129 mixed background strain",ctrl
jejunum_control_1,ctrl
liver western diet 0.05% quercetin rep4,pert
CUTLL1 DNMAML1 GSI,ctrl
Prostate-specific Pten deletion anterior prostate tumor 3,pert
cell line: BL2;	transfection: LEF siRNA;	batch: 3,pert
Gene expression profiling of Phgdh knockout embryo KO1,pert
Hippocampus 2004 2 month Old,ctrl
AF cell free mRNA from 2nd trimester euploid fetus,ctrl
"HSCs from female mice treated with E2, replicate 3",pert
tissue: whole blood;	disease state: global developmental delay and autistic features,pert
PsOEt-21-LS,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 24 hours,pert
ESE_N_664,ctrl
cell lines HUVEC (human umbilical vein EC),pert
cell line: H1299 lung cancer cell line;	genotype/variation: RBP2 depletion;	shRNA: RBP2 KD2,pert
Braak α-synuclein 3-4 BR34_4SN,pert
PS-NA cerebellum at 4 weeks,pert
Mut+/+ rep2,ctrl
"Control, biological rep. 1",ctrl
pRb+/+.1,ctrl
pre-iPSC- siRNA to Cbx3- biological replicate1,pert
cDeaf,pert
LUC 20 KD #2,ctrl
Liver from C57BL/6NTac mouse,pert
"patient 033b, cancer, homogenized",pert
"fibroblast, MFS subject FB1211 rep 1",pert
primary dermal fibroblasts treated,pert
brain_OFC_control C_mr202,ctrl
monolayer chondrocytes from normal donor 3,ctrl
sample =Healthy2 treatment=Control time=180 (min),ctrl
"Wild-type-hippocampus, biological rep10 (female)",ctrl
GM19238_Kd_IRF7_3,pert
"Patient  L, lesion, 2 week",pert
"cerebellum, wild type, 3 month",ctrl
Individual_4908_NN_sample,ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 2,ctrl
"siPRMT1 neuron, biological rep1",pert
H06_S_B1,ctrl
01LLA_PolyRF+,pert
KN-smoke-med-5 month+1d-R3,pert
"A2BAR -/- mouse heart, control, rep2",pert
Run7.aUa.010110d.SkMDbt1132D.CEL-DB basal,ctrl
Day: 24; Drug: Saline; Phase: Withdrawal; Replicate: 2,ctrl
Scd1-/- on chow diet replicate 3,pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 101;	Usage number: 5;	Exposures: 3,pert
Nrl ko P2 replicate 4,pert
mouselung_wt_control_rep03,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 36.89315,pert
cell line: MDA-MB-231 1833;	cell type: breast cancer cells;	genotype/variation: expressing induced Tet1,pert
WT_rep_1,ctrl
HT-WT-9A,ctrl
01_0052A_Day1_14,pert
ILD Study Number 917,pert
r24,pert
"lymphoblastoid cell line from T6.01, one out of seven of insensitive group, 50*10e6 cells",pert
CD4+ cells IL1RN wild type 1 month rep1,ctrl
Control Day1 (380R),ctrl
scrambled control-1,ctrl
"Mouse liver, MAT1A knockout, non-alcoholic steatohepatitis, 8 months",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 21.45479,pert
56_129_KO,pert
Glioblastoma_8,pert
melanoma cell line,ctrl
Low weight gainer KOZAK2_ABI_HYP_L4,ctrl
FBooth-MDX-1Av2-s2,pert
H3f3b KO 3973,pert
wild type MEF time 48 replicate 4,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 150min;	race: Caucasian/White;	sex: Female;	group: Con;	prototype: N,pert
11413 UC Uninflamed ascending colon,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 17;	maternal age: n/a,ctrl
Jejunum_Wild Type+Quercetin_3,pert
sample type: Negative control;	cell line: H1;	cell type: embryonic stem cell;	protocol: control;	time: 2 Days,ctrl
"wild type Treg, replicate 1",ctrl
Human Uninfected Sample N050-CD4+ T cells,ctrl
diabetic muscle replicate 4,pert
A3243G-MELAS subject 1,pert
HF0163_U133P2,ctrl
"pancreas, control diet, sham injected",ctrl
Ovarian cancer cell line,ctrl
patient: 205;	current medication: Pentaza 3g/d;	birth date: 6/8/79;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/03;	diagnosis date: 8/30/04;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 15;	crp: 19;	hb: 110;	wcc: 5;	neutrophils: 3;	albumin: 43;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: NEW;	smoking status: ex;	smoking start date: 1/1/85;	smoking stop date: 3/1/03;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
3D-cultured chondrocytes from normal donor 2,ctrl
Ainv15 EB3 replicate 2,ctrl
strain: C57/BL6;	genotype/variation: wild type;	gender: male;	age: 8-9 weeks;	tissue: liver,ctrl
"imr-32,gfp siRNA,t=48,3",ctrl
ex vivo cultivated melanocytes,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 72;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
Female - caucasian - N-03-G,pert
WT-smoke-high-5 month+1d-R4,ctrl
V5-P569,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 110min;	race: Black/African American;	sex: Male,pert
Skin_ K5IKKb_1,pert
E12.5 heart_wildtype_sample a,ctrl
"GV oocyte, Rnf2 mutant",pert
Heart sample3,ctrl
06R004 Control,ctrl
Moderate rep8 (retina),pert
Saline treated mouse gallbladder 2,pert
"ALL_NDS, K58 011509",ctrl
134A,ctrl
10609 Normal Uninflamed terminal ileum,ctrl
laminin alpha 2 chain deficient mouse,pert
wt-Gfp P2 replicate 4,ctrl
CF (D508) subject13,pert
peripheral blood CD8 T cells,ctrl
FCHL patient #98-1174,pert
"brain, hippocampus: Ctr-1h-P15-III_e1_le1",ctrl
BAL_15b_A0B0,ctrl
"Cnr1-/-/Cnr2-/- female number 3, 2 months old, whole ear tissue, untreated control ear",pert
Bach2 KO Thymus,pert
15SAGEA2,pert
C57BL/6J_Muscle_rep2,ctrl
PPAR WT_ctr_52,ctrl
GM19238_Kd_IRF8_3,pert
liver_STZ treated diabetic_rep5,ctrl
Cnah KO_heart_3,pert
"Sh2b3 KO, biological rep3",pert
colonic_mucosa_non_inflamed_95,pert
"whole-blood leukocytes, etanercept, 4hr",pert
"Dermatomyositis, biological rep5",pert
NIL,pert
gender: female;	genotype: Wild type for TWIST2;	ethnicity: Puerto Rican,ctrl
treatment: si221;	cell line: MCF7-FR,pert
Prostate-specific Pten deletion anterior prostate tumor 2,pert
EB_2_8d_222_HCHO_Nasal_Rat230_2_CIIT05024,pert
male;	38 yr old;	White,pert
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 2",ctrl
Myoblast-GATA4-Wt-day0-3,ctrl
"150 pos, CD 48 neg, Lin neg Sca and c-kit pos BM cells",pert
PTEN 121 (-/-),pert
coc-38_B,pert
heart knock out replicate2,pert
WT_TER119+_rep1,ctrl
treatment: siYAP RNA #2 transfected;	cell type: Primary cell line,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 10,pert
umbilical cord_nobpd: 2A,ctrl
thyroid_normal_5,ctrl
"Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:30h",pert
Age: 47;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
EB_400_6_372_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
"ME180 cells, 10μM ATRA, 1 hour",pert
miR122-KO-266-T,pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; no EGF,pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. ;	PMID: 12888219 [PubMed - indexed for MEDLINE] ",pert
MOLM14-shGSK3B-Construct1-rep1,pert
E14.5 top2b-/- brain,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection - NTAL knock down;	vector: pLKO.1/TRCN0000127243;	activation: 2 h 100 ng/ml TNP-BSA,pert
"Quercetin, sample 2",pert
s3t1c,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 48h,pert
CD4IncTp1-5,pert
"D3T treated rat liver, snap frozen",pert
"NTera-2 cells negative control, biological replicate 3",ctrl
DEX treated rep 3,pert
normal B cell 4,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 12 hour",ctrl
chip number: 6;	transfection plate: 1;	target gene: E2F1;	kd level: 0.8;	rin: 9.6;	transfection date: 2011-03-29,pert
Lung-sarcoidosis-rep6,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep10,ctrl
"human failing LV myocardium, Idiopathic21",pert
"C2C12 Myotubes treated with Palmitate, rep1",pert
HW_437,ctrl
"Hdh knock-out embryonic stem cells, biological replicate 5",pert
BP patient 52_biological replicate 1,pert
BP12,pert
MSE_N_M158,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 9",pert
4-HPR_mammary_4,pert
C2C12 myotubes 10uM H2O2 rep 4,pert
Celecoxib_#4873,pert
DMN-NF1Hippo10d-2aAv2-s2,pert
SCC4,pert
28 Day Mouse extraocular muscle,ctrl
GM19238_Kd_NFKB2_3,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous neoplasm (IPMN),pert
Cardiac Muscle_WT_rep2,ctrl
"Normal testis, donor with no known history of cancer",ctrl
chondrocyte_5azatreated_rep3,pert
RNA-DHL6-R406-6H-3,pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
Liver sample from Control group (N54),ctrl
AA_Case14_CD8,pert
FHCRCAML1038,pert
Muscle-AMPKgamma3-ko-3,pert
Control Female FVB/N,ctrl
human_LIMA_artery_patient1_control,ctrl
BRCA1-KD-1 (total RNA),pert
"lung adenocarcinoma, cell line",ctrl
diseased cells unstimulated,ctrl
Exercised-9,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	treatment: Pyrazinamide;	time: 42 dpi,pert
Normal Chip#7,ctrl
"Cell type: endothelial, age:44, gender:female, diagnostic group: control, PMI:10h",ctrl
"Cell type: neuronal, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h",pert
CAB10_T4_PP_day3_034,pert
BAL_33_A0B1,ctrl
imr-32,pert
Strain: C57BL/6J;	Gender: M;	Age: 9 weeks;	Treatment: untreated,ctrl
Pooled total RNAs from lymphoblastoid cells of 14 individuals,ctrl
"lymphoblastoid cell line from F23.05, one out of seven of insensitive group, 50*10e6 cells",pert
Wt1-null MEFs-3,pert
Manca 4,pert
U2-OS-ERa vehicle control 2,ctrl
G_Kin_3,pert
Tendon;Biceps_Non-lesional,ctrl
strain: C57BL/6;	tissue: liver;	genotype/variation: Nrg4 knockout;	diet: high-fat diet fed starting at 3 months of age for eight weeks.,pert
n10t0h,pert
genotype: Villin-Cre + / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 101,pert
"5mg/kg/day PFOA, Rep 3, Block 2, lung (high dose)",pert
Mus musculus liver - wildtype,ctrl
SKMEL28_t0h_rep3,ctrl
chip number: 19;	transfection plate: 4;	target gene: RDBP;	kd level: 0.73;	rin: 9.1;	transfection date: 2011-10-17,pert
Primary brain tumor tissue,ctrl
H1299 DAC 3 uM (3241),pert
pancreatic beta-cells,pert
TF1_antiEvi1siRNA_2,pert
WT3 CD11b,ctrl
VMH of WT-1 mice,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 4;	psoriasis duration: 44.2600958247776;	age of psoriasis onset: 8,pert
Individual_4160_PP_sample,pert
"Patient  C, lesion, 4 week",pert
Individual_5942_NN_sample,ctrl
2d-sham-74,ctrl
"HSCs from female mice treated with oil, replicate 2",ctrl
Muscle-AMPKgamma3-wt-8,ctrl
Caco2-siRNA-control1-rep1,ctrl
FHCRCAML2557,pert
sample 1:;	age: 46;	gender: male;	sample 2;	age: unknown;	gender: unknown,ctrl
27SAGEA,pert
"wt, no doxycycline",ctrl
Cardian muscle Diabetic 3 week D3,pert
Panc0403 rep-3,pert
Adipose tissue from male Casp1-/- animal (C57/Bl6 background),pert
Diaphragm 23 Day control rep 2,ctrl
Silberg3 ( S5) 191102-1BE,pert
t03,pert
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic.",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 49.07945,pert
01LMJ_Systemic,pert
Total RNA from Ph+ ALL (C57Bl6 and Bach2 -/- background),pert
WT6,pert
Tissue: lung;;	Genetics: Familial IIP;;	Histology: Nonspecific Interstitial Pneumonia,pert
normal skin from controls,ctrl
ILD Study Number 1237,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 6x5;	patient id (to identify the 2 chips from the same patient): 16821717,pert
"WT BM LT-HSC, biological rep1",ctrl
LCL Concordant for Epilepsy twin pair 1 (CCE1.1)(TP21),pert
Subject 4_t=30days_resveratrol,pert
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: lung",pert
"pancreas, control diet, male Wistar rat",ctrl
lumbar spinal cord,ctrl
"Male, Wistar, 6hrs/day access to cocaine, amygdala",pert
8 weeks cardiac muscle,ctrl
03SAGEA2,pert
WT #177,ctrl
ASO T00278950,pert
pool,pert
Wild Type Skeletal Muscle Sample (Hind limb),ctrl
blood_day0_patient6,pert
batch: B;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,pert
3-WT,ctrl
lesion_midUV_patient10,pert
Src-overexpression - replicate 2,pert
Whole body,ctrl
"lymphoblastoid cell line from R, one out of seven of sensitive group, 50*10e6 cells",pert
"fatty (fa/fa), adipose tissue (epididymal), Troglitazone",pert
Human Non-progressor HIV Sample L128-CD4+ T cells,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 13 days;	treatment: fresh air, treatment over 5 month + 15 days recovery, 4x1h exposure per day",pert
12h_c3,ctrl
"p63shRNA_B3, p63-depleted",pert
nfia E18KO2,pert
normal adjacent esophageal tissue from patient E2644,ctrl
Metastatic prostate cancer W1,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep6,pert
Bronchial Epithelial Cells SA biological 1998G,pert
"Fmr1 knockout mouse, cerebellum",pert
Homogenized lung tissue,ctrl
genetic background: CD1;	genotype: WT;	Sex: male;	age: 14 weeks;	tissue: ventricular myocardium;	treatment: saline,ctrl
cell line: MCF-7;	cell type: Breast Cancer Cells,ctrl
platelet_sickle_9,pert
"Acute Myeloid Leukemia, sample 57",pert
INSENS 6 0hr,ctrl
A506 MI 1 day,pert
T11,pert
T7A-LU,pert
CD8+_Tcells_non_severe_asthmatic_2,pert
"202, MUSCLE, After",pert
No_drug_#4860,ctrl
Huh7 cells_JFH-1 Infected 12 hours_ rep3,pert
C57_HF_2,ctrl
erStress_twins_AA_1724twin2_500nM_thapsigargin_4h,pert
"0mg/kg/day PFOA, Rep 4, Block 4, liver (low dose)",ctrl
"age at diagnosis: 67;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1bi;	er: 1;	pgr: 1;	dfs-month: 29;	dfs-event: 1;	distant metastasis: 1",pert
01LQJ: normal control,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 24 months;	genotype: Wild type,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-jhdm1b retrovirus,ctrl
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-4,ctrl
WT-SB-1,ctrl
whole tissue section from case 651,pert
22GOBMUC2H,ctrl
"Control animal, biological repeat 1",ctrl
"brain, brainstem: CB4_e1_le1",ctrl
MH1C1_untreated_rep4,ctrl
Striatum of 8-10 week old SWR/J mice,pert
Human hepatocellular carcinoma cell line,pert
Patient 8 after folic acid,pert
"MCF7 silenced Estrogen receptor, biological rep3",pert
ICR MEF infected  with pMX-jhdm1b retrovirus,ctrl
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).,pert
MC3T3 cell line,ctrl
RKO_NEGsiRNA_6hDMSO_REP3,ctrl
"liver_ABCA1-TG, biological replicate 4",pert
Kyoto Rat liver tissue following animal exposure to orotic acid for 14 days,pert
alveolar epithelial cells exposed to cyclic stretch 20% elongation,pert
Healthy5-CD4,ctrl
OE33 Control rep2,ctrl
"YWHAZ overexpressed CL1-0, biological rep2",pert
"LCL GM19238, Kd IRF5, 72hrs",pert
Control Colon 2 21 days old,ctrl
pediatric AML GP4,pert
Run7.aUa.001206d.SkMInS1083D.CEL-IS stimulate,pert
Affected,pert
transgene strong 1,ctrl
No or early 2 rep8 (OHN),pert
MCI-005,ctrl
FC 01,ctrl
Pancreatic Sample 38-Normal,ctrl
EB_07_8d_144_HCHO_Nasal_Rat230_2_CIIT05024,pert
"brain, lateral and medial ganglionic eminences: Arx-/Y #4_le1",pert
cell type: MCF-7;	sirna: SPDEF,pert
Differentiation of hES cells line VUB01 towards neural rosettes;	Neural precursor phenotype,ctrl
25 weeks female,pert
"Control shRNA cells passage 7, rep 2",ctrl
T7E-LU,pert
"Human lung adenocarcinoma A549 cells treated without TNFα, in presence of Claudin 1 siRNA",pert
14A;pretreatment;female;breast tumor; responder,ctrl
Wild Type Time 1 replicate 2,ctrl
"PIO, subject 12",pert
C3 patient,ctrl
genotype: WT;	tissue: brown adipose;	genetic background: 129,ctrl
genotype/variation: Fbn1 wild-type;	tgfbr2 status: conditional disruption of Tgfbr2;	tissue: ascending aorta;	age: 6 weeks,pert
PKBa-/- MEF time 48 replicate 3,pert
siNS_0h_1,ctrl
Neurointermediate lobe _3d dehydration,pert
Obese Control-3,ctrl
oocyte_Brwd1_mutant_rep1,pert
mouse liver A1,pert
"uninfected primary RPE, biological replicate 3",ctrl
T21.01,pert
"NALT infected with 90-226att, 24h, biological rep2",pert
"129 Wildtype mice, pineal glands taken at postnatal day zero",ctrl
Trasnsformed Lymphocytes Bipolar Disorder Affected Twin Pair 1 (DCBD1.1)(TP5),pert
Cpr-lox_pool 3,ctrl
Wild type saline rep1,ctrl
"HCT116 cells with empty vector, technical replicate 2",ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M0;	flt3 status: WT,pert
Isoflurane 10 exposures-3,pert
"WT Heart with no treatment, biological rep1",ctrl
Sample 08 Kidney Hyp Mouse - Low Phosphate Diet,pert
HepG2_vehicle_24hr,ctrl
"MCF10A cells, HER2 over-expression",pert
MH1C1_high_rep1,pert
Clinically localized primary prostate cancer P2,pert
gender: male;	dietary group: grape extract (B);	time point: 6 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),ctrl
Sex: male;	Age at operation: 76 years;	Site: thigh;	Size in cm: 3.5x3x3;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
"hMSC-Tert, control siRNA, 5 days osteoblast differentiation",ctrl
"18 weeks old normal mice, cerebellum",ctrl
WT-control-2,ctrl
"Affymetrix chip HG-U133A, siLuc 2",ctrl
Human medulloblastoma DAOY cell line,ctrl
WT - Cre Treated - 0.5 hrs - repeat 3 - Cy3 - mAdbID:62543,ctrl
"Empty vector control, 2 hrs, No Rosiglitazone (NONE_2_1)",ctrl
"Neural precursor cells derived from hES cells line VUB03_DM1, biological replicate  3",pert
Cadmium_00hr_rep1,pert
6 h-control (EtOH),ctrl
"testis, Repro9 mutant, 17dpp, Rep3",pert
LT 341 +/T untreated,ctrl
tissue: Temporal cortex;	age: 54;	Sex: F,ctrl
CD4DecTp1-10,pert
EA_Case7_CD20,pert
V5-P563,ctrl
Strain: RPE65-/-;	Age: 4 months;	Tissue: retina,pert
"33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
liver_Wt_35wk_rep4,ctrl
"fibroblast, MFS subject FB1627 rep 2",pert
erStress_twins_AA_1757twin2_500nM_thapsigargin_4h,pert
"disease state: Nasopharyngeal carcinoma;	stage: III, T3, N2, M0, G4",pert
Human normal prostate primary culture C16sx,ctrl
microdissected epithelial cells from IPMC 5,pert
SW1736_t0h_rep2,ctrl
"SWR/J Chronic morphine treated, biological replicate 2",pert
clone type: AtT20 clone types overexpressing NSBP1SE protein rep2,pert
C002_Control_F_87,ctrl
"Amoxicillin treated Distal, Small Intestine 2 21 days old",pert
"Age: 59;	Sex: M;	Ancestry: European;	Smoking status: smoker, 60 pack-years",pert
control MLL_00117,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.631;	OD280: 0.833;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 146;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: embryonic stem cell;	genetic background: C57BL/6;	genotype: Prdm14 knockout,pert
Patient 6 skin baseline,ctrl
0810-01-A,pert
MDS patient 98,pert
APBMNC.LPS+.1,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 2,pert
H06_S_B2,pert
"Rad21 esiRNA, biological rep2",pert
tetO-Satb2 #1,ctrl
disease: Down syndrome;	gender: female;	age: 6 months;	tissue: thymus,pert
ab177 IM,pert
"Liposarcoma culture from tumor 393, untreated",ctrl
knockdown Tcof1 [C],pert
cell type: Embryonic Stem Cell;	genotype: wild type;	strain: C57BL/6,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 43 yr;	population: white;	dsm-iv: 296.64;	age of onset: 25 yr,pert
e_NY2,pert
481MM,pert
Peripheral blood mononuclear cells (PBMC)-Patient CCa T0,ctrl
38m5,ctrl
"fibroblast, control subject NF7 rep 1",ctrl
"mental retardation or developmental delay, Female",pert
A673_CloneAsp14_Dox_36h_1,pert
9-cis-retinoic-acid_Lung_1,pert
Human heart,ctrl
HCC_19T,pert
01_0051A_Day1_13,pert
Sample ID: TP40;	Twin Pair ID: CCE4.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-10.5;	Age at interview & blood sampling: 31;	Current Age (2007): 34;	Sex: MALE;	Medication at blood sampling : Epilim,pert
Cisplatin-treated wildtype MEFs-c,pert
"Control siRNA - 2 days osteoblast differentiation, rep2",ctrl
C57BL/6J_Liver_rep1,ctrl
U2OS shCHK1-3 replicate 2 [set 4],pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 24;	maternal age: 25,ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
siHic5_2_2h_2,pert
tumor cell line HepG2 with knockdown of HIF-2α rep3,pert
RPE30,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep1,pert
1200-03-A,pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; 3h EGF,pert
tissue: Whole pancreas;	genotype: WT;	background: C57BL/6;	age: 8 weeks,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 719,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty,pert
FmrWT4_blood,ctrl
Patient identifyier: Z;	Sex: female;	Age of patient: 42 years;	Duration of psoriasis: 36 years;	Body surface area: 5 percent;	Overall erythema: mild;	Induration: minimal (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Gender: Female;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: well;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
Saline_1,ctrl
CP Pool,ctrl
Normal Cervix N6,ctrl
"new born PS-NA mice, cerebrum",pert
7P-ER-ND,pert
"BA OBCs, post doxycyclin withdrawal, rep5",pert
"Crohn's Disease subject (49 year old caucasian female, SAK_1313179761)",pert
BAL_17_A0B0,ctrl
MDS28,pert
SALINE 1 HOUR,ctrl
NSCL/P sample 6,pert
"EBF1 d4, rep 5",pert
retina at age PN40,pert
Colon 17 days old,ctrl
"MCF-7 cells-control, biological rep 4",ctrl
"dy/dy mouse, 8 week",pert
CON11,ctrl
CXCR4 knockout 8,pert
male_alcoholic_330,pert
Leg 7 Day Control rep 3,ctrl
Mouse No Cldn16 B9 450,ctrl
liver_STZ treated diabetic_rep6,pert
liver_STZ 0.5% quercetin diet_rep6,pert
Cisplatin-treated wildtype MEFs-a,pert
PBMC from T cell Large granular lymphocyte leukemia patient#129,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_16,pert
mouse fetal liver at E14.5,ctrl
"D1_non-transgenic mice, lung tissue",ctrl
Mouse brown preadipocyte cell line,ctrl
Wild type_VMH,ctrl
V5-P226,pert
Strain: C57BL/6J;	Gender: Male;	Age: 16 weeks;	Tissue: testis,ctrl
"Wild-type, biological rep1",ctrl
"YPFH cells from M1, Mecp2 null, biological replicate 2",pert
NPC Brain 55d Mouse1,pert
C57BL10 quadriceps sample 1,ctrl
8 Weeks Heart MDX rep 3,pert
Granulocyte-Macrophage Progenitors,pert
Tissue:tumor; Gender:female; Age:65  Tumor stage:T2NxMx,pert
"Tsc2 +/- mouse, cerebellum",pert
"Untreated, biological rep2",ctrl
Kidney from mice treated with 7 daily ip injections of vancomycin at 50 mg/kg,pert
age: 14;	sex: M;	disease status: control subject;	Filter number: 86;	Usage number: 1;	Exposures: 3,ctrl
"fibroblast, MFS subject GDO21 rep 3",pert
19: NORMAL #99-0834,ctrl
Ad infected murine liver-MO30k-(469)-6 hpi,pert
KU_13N,ctrl
pancreatic cancer cell line FA6 transiently transfected with AGR2 siRNA,pert
shGFP-rep-2,ctrl
"Liver, Intermittent Hypoxia 4",pert
PGA-MAH-AJ_OVA6h-5bA-s2,pert
Papilloma_tumour_epithelial_cells_CTRL_rep1,ctrl
mouse cerebellum at P7 knockout 3,pert
BAL_25_A0B0,ctrl
cell line: HeyA8;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 3",pert
BALB_Male_Control_rep2,ctrl
cell line: prostate cancer cell line PC-3M;	genotype/variation: negative control siRNA,ctrl
P0 Quadriceps Klhl40 WT 3,ctrl
"gene expression of CTCF-depleted oocyte, replicate 3",pert
OSE_567,ctrl
"Peripheral blood, patient with recurrent events [N31]",pert
heart_co_6M_rep2,ctrl
"spleen follicular B in WT, biological rep5",ctrl
ILD_11,pert
GM19238_Kd_ZBTB38_1,pert
strain: C57BL/6J;	genotype: wild type;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,ctrl
MLL_PTD14,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: D;	experimental sample name: PC13-R,pert
Spleen_uninfected_control_rep2,ctrl
con-7_A,ctrl
"Crohn's Disease subject (43 year old caucasian male, SAK_1315906827)",pert
S-IIP(UIP)5_Cy3,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 2,pert
Skinbiopsy_48hoursnickel_controlsubject_k3,ctrl
"Grape extract group, 12 months, patient number 14",ctrl
12486 UC Inflamed descending colon,pert
cell type: Endothelial cells;	strain: C57Bl/6;	genotype/variation: wild type,ctrl
"18 weeks old PS-NA mice, cerebellum",pert
23d tg5,pert
chip number: 21;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.75;	rin: 9.5;	transfection date: 2012-03-26,pert
Bone-Marrow_MM_M880,pert
Nrl ko P2 replicate 2,pert
GIST_KIT_12,pert
136B,ctrl
A549 AZA 0.3uM (3211),pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID54,ctrl
"shBAP1 #1 cells, rep2",pert
ACC Xenograft MAD04-385,pert
Mesenchymal derived mouse cell line,ctrl
"spinal cord, ventral spinal cord: EP 151/L - SDneg e14",ctrl
THRA wt + vehicle replicate 2,ctrl
Argyrin A treated 24h,pert
NSC1,pert
"Patient  D, lesion, time: 0",ctrl
"129P3/J CHR, Rep1",pert
Rybp#15 (OHT-)_12d,ctrl
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: Dicer1 conditional knockout, Atoh1-Cre;Dicer1(flox/flox);	tissue: organ of Corti from cochlea, basal half;	age: postnatal day 16",pert
Tissue: normal thyroid; Gender:male; Age:36,ctrl
Dengue Hemorrhagic Fever Patient 32,pert
12480 UC Inflamed descending colon,pert
0998-01-C,ctrl
FHCRCAML482,pert
Human prolactinoma 273,pert
"Normal Skin, Normal-15",ctrl
"HUVEC, untreated",ctrl
MDS patient 70,pert
"RNF40 siRNA - 2 days osteoblast differentiation, rep1",pert
Gene expression profiling of normal cortex of patient 233,ctrl
"treatment: control;	batch: 2;	donor: 28;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
Setdb1 2lox/1lox/Cre minus tamoxifen 2,ctrl
patient: 2;	disease state: hypertension;	tissue: Atheroma plaque,pert
NTG mouse_tamoxifen3,ctrl
BL Day 1 siSC transfected biological rep1,ctrl
CD4DecTp2-1,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.3;	colon weight (mg): 195;	colon ratio (mg/mm): 3.1;	myeloperoxidase activity (u/mg): 0.703;	tissue: colon;	treatment: 5% DSS,pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 retrovirus,pert
"Crohn's Disease subject (47 year old caucasian female, SAK_1315705650)",pert
S3B Sporadic-cerebellum,ctrl
Vehicle-Control 30 hours set 1,ctrl
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 68",pert
Strain: Fischer 344;	Gender: Male;	Age: 6;	Tissue: Liver of vehicle treated rat,ctrl
Injured 4h Rat Retina 3,pert
siControl_6,ctrl
r8,pert
Tk6 treated with cadmium rep1,pert
Embryonic age 17.5 mutant rep4 (PKD1_42),pert
colon_IL10mouse_12weeks_rep6,pert
"age at diagnosis: 42;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 26;	dfs-event: 1;	distant metastasis: 0",pert
diabetic muscle replicate 5,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
"MCF7/BUS cells, human breast adenocarcinoma cell line, estrogen receptor-positive",pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
P104,ctrl
RNA from whole tissue section of case 68 labeled with Cy5,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_6;	fev1 (% predicted): 55;	fvc (% predicted): 69;	medication: Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd;	cell type: CD4+ T-cells",pert
Muscle 50 eccentric contractions 12 hours WT Adult 07273,ctrl
"Patient  I, lesion, 1 week",pert
Heart,pert
V5-P158,pert
"ADIPOSE TISSUE, CR, Before",ctrl
HES2_Mir122WT_rep1,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,pert
WT1,ctrl
pMX-Oct4 no vitamin C Oct4Vc-_2,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 3x1h exposure per day",ctrl
Kyoto rat liver tissue following animal exposure to orotic acid for 1 day,pert
"Resveratrol treatment exp 3T3-L1 cells, T3",pert
Subject #8001-Preinfection,pert
BP patient 54_biological replicate 1,pert
"Patient 998, baseline",ctrl
"Vehicle treatment, 7 hours (replication 2)",ctrl
"brain, hippocampus: KA-1h-P15-III_e1_le1",pert
Normal Cervix N5,ctrl
Replicate 2 - Vehicle,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shGFP,pert
E14 - 14-3-3Epsilon 2,pert
"Normal Skin, Normal-2",ctrl
3348-scrape,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 3,ctrl
Cervical cancer_CC205,pert
age: 29;	sex: F;	disease status: Marfan subject;	Filter number: 90;	Usage number: 5;	Exposures: 3,pert
"AD_HI, biological rep5",pert
C57_HF_1,ctrl
"hMSC-Tert, RNF40 siRNA, 5 days adipocyte differentiation",pert
11_0014C_Day1_26,ctrl
cell type: Primary hepatocytes;	strain: BalbC;	agent: control;	time: 24h;	gender: Male;	age: 6 months,ctrl
"glioma cell line U373, MAML1-dn expressing",pert
CD positive WT T cell TCR-stimulated rep4,ctrl
Flp-InTMT-RExTM-293 (Invitrogen) cell line derived from the human embryonic kidney cell line HEK293 carrying tetracycline inducible transgene,ctrl
healthy control sample x004,ctrl
"ALL_DS, K2 011609",pert
BP patient 51_biological replicate 1,pert
Control_pancreas_3,ctrl
MDS patient 145,pert
V5-P085,pert
T51084,pert
Muscle-5 month-Myc heterozygous-technical replicate 1,pert
gender: female;	age (years): 34;	evolution time (years): 13;	disease extension: Pancolitis;	treatment: 5-ASA,pert
RNA from HCC_29N,ctrl
Gastrocnemius Muscle Galgt2 Transgenic rep2,pert
MDS53,pert
age: 6 month postnatal;	tissue: striatum;	genotype: SNCA knockout,ctrl
breast normal 1,ctrl
NOD Aire WT MEC rep1,ctrl
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p30;	strain: E14,ctrl
Karyotype: inv(14)(q11q32);	Age: 90 years;	Gender: female,pert
genotype: wild type;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: vehicle;	tissue: liver,ctrl
Mus musculus embryonic stem cells derived from wild type embryos,ctrl
Sprague-Dawley rat diaphyseal femoral callus,ctrl
liver knock out replicate2,pert
P5,pert
MCF-7-Pit-1 rep 1,pert
"WT, rep1",ctrl
disease state: control;	patient: 1,ctrl
E8C,ctrl
NINDS-RHS-Ctr_240h-2aUA-s2,ctrl
5222 UC Inflamed sigmoid colon,pert
Liver WT ND #690,ctrl
PBMC from T cell LGL leukemia patient #129 (TLGL129),pert
pediatric AML S02,pert
Sample ID: TP31;	Twin Pair ID: CCE2.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-4.5;	Age at interview & blood sampling: 34;	Current Age (2007): 36;	Sex: FEMALE;	Medication at blood sampling : None,pert
Scrambled 24 hours_3,ctrl
CD8-IGF1R 3T3 Vehicle 3,ctrl
P5C Progranulin-hippocampus,pert
"PPARg d10, rep 1",pert
Ex1_cells_rep2,pert
cell line: MCF7;	condition: siRNA Med12,pert
"transfection: pRTS-CA-IKK2;	cell type: human Burkitt lymphoma;	dsmz no.: ACC 603;	origin: established from the ascitic fluid of a 3-year-old boy with American-type Burkitt lymphoma in 1972; cells were described to be EBV-negative but EBV infectible, to carry the (8;14) translocation and p53 mutations",pert
PC3 Wee1 Rep3,pert
V5-P541,pert
"E18.5 brain, wild-type, rep 5",ctrl
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: SD supplemented with 100 mg/kgchow resveratrol ad libitum,pert
Embryonic lung at E18.5 days from an Hmga2 KO mice,pert
H8 HA 2h 4,pert
P 25 Control,ctrl
Genetic background: C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow; Non-fasted; Genetic modification: None (Scd1 +/+; wide type control).,ctrl
CUTLL1 GSI-rep1,ctrl
"E18.5 ERRg +/+ heart, biological rep 1",ctrl
50uM_Zn_1,pert
C021_Control_M_25,ctrl
Bone-Marrow_SMM_S1258,pert
MDA-MB-231ER+ Breast Cancer Cells,pert
0711-04-A,pert
Spleen_infected_7weeks_rep1,pert
"E12.5 Ret-deficient embryonic kidney, biological rep2",pert
"Mutant in the absence of tetracycline, rep2",pert
129S1/SvImJ Vehicle liver sample batch 4,ctrl
Setleis Syndrome patient 4,pert
B4 398 b4-/- untreated,ctrl
colon_adenoma_1154,pert
HF0291_U133P2,pert
LNCaP.GFP.2,ctrl
Concordant for Epilepsy twin pair 3 (Affected patient of MZ twin pair CCE3),pert
individual: patient4;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"human failing LV myocardium, Idiopathic71",pert
anti-FGFR1_rep5,pert
"Patient Z, lesional skin",pert
Parkinson's disease sample x023,pert
U-87MG-V8 set 3,ctrl
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 72 hr,pert
brain_OFC_bipolar B_mr91,pert
"AD_FC, biological rep15",pert
BM_02879,ctrl
"granulocyte, healthy control, biological rep10",ctrl
knockout mouse kidney - 1,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 5. Replicate B,ctrl
(ca)erbB-2_1,pert
NINDS-RHS-Kainate_24h-1aUA-s2,pert
Subject 5 / lung subsegment instillated by LPS,pert
con-11,ctrl
"MCF-10A cells, overexpression vector control, biological rep1",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.79452,pert
HDAC2 siRNA_3_Huh7 [HDAC2 siRNA subset],pert
"BOEC, normal 11",ctrl
"D425-shOTX2_1, t=16",pert
multiple sclerosis_6,pert
IM63_case,pert
Strain: C57BL/6J;	Gender: Male;	age: 3days;	genotype:KO;	tissue: brown fat,pert
"MCF-7 cells, siERK2 treatment 60h, 10 nM E2 for 24h",pert
tetO-Satb1 #2,ctrl
tissue: muscle;	sample group: resveratrol;	treatment: before;	gender: Female,ctrl
"202, MUSCLE, Before",ctrl
homozygous_TGFb_24hr_2,pert
BMMs_untreated control_ko,pert
Jurkat-J3,ctrl
tissue: white blood cells;	age: 16.53;	Sex: female,pert
patient: 222;	current medication: Prednisolone 20mg Balsalazide;	birth date: 4/13/52;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 9/1/85;	diagnosis date: 6/20/86;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 9;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Insm1 mutant #4_pituitary gland,pert
EB_0_6_356_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
No or early 2 rep4 (OHN),pert
GIST Pre Treatment Biopsy 02,ctrl
"MCF-10A cells, overexpression TAp63γ, biological rep3",pert
Replicate 3 - Vehicle,ctrl
Syracuse Low Avoidance (SLA) learning rats 3,pert
"vestibualr organ at P15 of Igf1 +/+, biological rep 3",ctrl
cerebellum_PSNA_ 18w_rep1,pert
Liver_POR-null_2,ctrl
SKI-DLCL cells_AraC 20nM_24h_rpt1,pert
M229_A_PLX,pert
CML_7_HSC,pert
SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1),pert
A HID I_B051,pert
"strain:BALB/c WT, gender:male, age:8wks, tissue: whole lung, condition: uninfected control",ctrl
"ID:11-2, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
Donor4_6h_DMSO,ctrl
control to Sample 17,ctrl
Array Type: HG-U133A_2;	Ratio: 1.97;	RNA Integrity Number: 9.9;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Mening UNSTIM WB SW 6b,ctrl
Menadione (5uM) rep 3,pert
Mus Musculus Kidney,pert
"K562, 250nM1R-Chl, 24hrs, rep3",pert
strain: C57BL/6;	tissue: cerebral cortex;	age: E14;	gender: not determined;	genotype: WT,ctrl
"Femal C57BL/6, ovariectomized",pert
2h Kin Cel.06,pert
D2-Gpnmb+ control rep5 (retina),ctrl
optineurin expression-b01,ctrl
FVB_MMTV_Wnt1_iFGFR2_3861_3L_ROSEN,pert
FHCRCAML7216,pert
"SiRNA-scrambled, replicate 4",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q,pert
"human failing LV myocardium, Ischemic21",pert
56 year old female,ctrl
race: caucasian;	age (years): 88;	stage: IC;	grade: 3;	histology: endometrioid,pert
strain: C57Bl/6;	genotype: wt;	treatment: Freshly isolated cells,ctrl
genotype/variation: wildtype;	strain: C57/Bl6;	age: newborn 0-6 h;	tissue: Lung,ctrl
WT Liver - Pooled -Cy5,ctrl
25_C57_WT,ctrl
H1993 shRNA Control _2,ctrl
cell line: H1299 lung cancer cell line;	genotype/variation: control;	shRNA: scramble,ctrl
FSH-NHM-3UA-s2,ctrl
gender: Male;	age: 75;	post-mortem delay: 9h;	ph: 6.3,pert
Pancreatic islets,pert
Y YOKE_B059,ctrl
Age: 47;	Cycle: Follicular;	BRCA1/2 mutation: BRCA2 6174delT;	Family History: Yes,ctrl
KN-sham-1 day-R4,pert
Tumor from MYF-5 CRE/SSM2 mouse SSM4,pert
Normospermic individual: Sample N2,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous endotoxin challenge""",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 53 yr;	population: white;	dsm-iv: 295.9;	age of onset: 23 yr,pert
Tissue: brain (frontal cortex);	Disease state: HIVE-control,ctrl
"LCL GM19238, Kd RAD21, 72hrs",pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: Calcitonin,pert
Mic34_muscle_control,ctrl
"Foxd3 conditional knockout cells treated with DMSO, biological rep2",ctrl
"strain: Swiss;	tissue: adult mouse intestine, kidney, and liver plus fetus tissue",pert
ZF6B7,ctrl
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep1",ctrl
"Sciatic nerve, acrylamide treated, biological rep1",pert
CD11b+Gr1- cell sample_1 (derived from wild type mouse),ctrl
Wild-type ESCs Rep3,ctrl
"DBA/2J Acute morphine treated, biological replicate 1",pert
wild-type,ctrl
PPARg WT macrophages rep 1,ctrl
ab072 IM,pert
Pooled_1,pert
Acute samples,ctrl
S/SM2,pert
FO_spleen_wt_rep3,ctrl
wt 13.5d replicate 7,ctrl
01UNJ_Oligo,pert
"WT BMMC, uninfected",ctrl
"BMDM, LPS 5hr",ctrl
BMMs_untreated control_da,pert
normal adjacent esophageal tissue from patient E1603,ctrl
Plate vs. Nail:  6 Week Nail,pert
tissue: brain,ctrl
platelet_Ctrl_9,ctrl
14A;pretreatment;female;breast tumor,ctrl
"LCL GM19238, Kd ZHX2, 72hrs",pert
colon_CRC_1479,pert
TA-t10-2; transgenic tibialis anterior 10 month,pert
Sample 06 Kidney Normal Mouse - Low Phosphate Diet,ctrl
12h Lipofection GAPDH siRNA (SAMPLE 5),pert
"wild type ES cells, biological replicate 3",ctrl
Disease_status: Down syndrome;	Age (years): 63;	Gender: Male;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
OCI-Ly7_FOXP1 overexpression,pert
"Control #2, Untreated",ctrl
MCL_IGHV_MUT (269-01-5TR),pert
"cell type: Normal human diploid WI-38 lung fibroblasts, CCL-75(TM), passage 7-12.",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.908;	OD280: 1.959;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 356;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
cell: Cultured oligodendrocytes;	genotype: Myelin-gene Regulatory Factor conditional knockout,pert
A2AR_KO_saline_24h_rep2,pert
N_LS_Wk4,pert
Cervical Cancer C290,pert
liver tissue from 21 days old mice,ctrl
"patient: 108;	current medication: Asacol 400mg BD;	birth date: 8/30/33;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: Altered bowel habbit, ? UC 1974, never on Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
A HID I_B050,pert
3702-2 E2F3 Heterozygous,pert
GM8921A,ctrl
"Vehicle, biological rep1",ctrl
Sprague-Dawley diaphyseal femur,ctrl
"Patient  B, lesion, 4 week",pert
HCT 116 cells transfected with siChe-1,pert
T6,pert
"Normal subject (47 year old caucasian male, SAK_1279993350)",ctrl
strain background: CD1;	genotype/variation: wild type; Raldh2 +/+;	tissue: embryonic brain;	tissue region: Rostral/Anterior;	developmental stage: 14 somite stage,ctrl
56 Day Mouse leg muscle,pert
reduction mammoplasty patient 340,ctrl
B7hi mTEC B6/129 aire-/- 3,pert
siPin1.exp3,pert
WT-4 (Large PreB),ctrl
lateral hypothalamus no access to cocaine replicate 1,ctrl
"A673 treated with Puromycin for 3 days with concentration of 0.09 uM (EC50), biological rep2",pert
siCtrlVeh4h_2649,ctrl
WT.DMSO.1,ctrl
"seminoma specimen, pT1, patient age: 25y",pert
treatment protocol: GSK-3 inhibitor (SB216763) treated for 20 hours,pert
liver_Akt1+/-_35wk_rep1,pert
RNA from HCC_16T,pert
"Pancreas from adult WT mice, biological replicate 1",pert
C013_Control_M_61,ctrl
"U373-DTX1-myc, rep 2",pert
WT LSK rep1,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.48;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
mouse ventral prostate,ctrl
AAA neck (Sample 6),pert
Control_3,ctrl
HL60_luc_Replicate2,ctrl
wt_2,ctrl
Liver_SRC-2 Knockout_Rep1,pert
MSC_SA01_3,ctrl
Pediatric_GBM_11,pert
Patient 6,pert
mammary stoma-4w-KO-rep2,pert
cerebellum_wild type_24 weeks_replicate 1,ctrl
"imr-32, cdk4 siRNA, t=48, 4",pert
NFIa E18KO2,pert
Muscle Control 1,ctrl
muscle,pert
Normal-N_AJ2,ctrl
"granulocyte, patient. Mtx rep2",pert
HL60-shControl-rep3,pert
695_383_0hr_repeat,pert
T134,pert
age_years: 60;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
Total RNA from Monkey PBMC labeled with cyanine-5 (red),pert
"Cultured HepG2 cells,  ATCC# HB-8065",pert
CF (D508) subject10,pert
Pancreas,ctrl
phenotype: control;	gender: male;	case_id: 190;	age: 68;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 16.75;	brain ph at time of freezing: 6.59;	labeling_batch: 1,ctrl
Adipose Tissue,ctrl
"human failing LV myocardium, Ischemic32",pert
WT hippocampus PDE10i,pert
brain knock out replicate1,pert
"Control 08, NC08",ctrl
pediatric AML S17,pert
K14deltaNB-cateninER  Time 7 replicate 2,pert
MDS patient 104,pert
Superior Frontal Gyrus from 2 and 4 year-old girls suffering from Rett Syndrome.,pert
BALB/c control (200msn),ctrl
Placenta_PE(LO)2,pert
rheumatoid arthritis 2-21,pert
6h_RA1,pert
Cardiomyocyte control 2,ctrl
heart MHC-Plin5 1,pert
Substantia nigra normal rep8,ctrl
Lung; nmMLCK-/-; VILI,pert
SARRC-1100-03-Aq,pert
"DMSO-treated, Sham UV, Replicate A",ctrl
WT-smoke-low-5 month+1d-R1,ctrl
"N-56, NORM, M, GSF, 6 x 100nM DHT, 14d",ctrl
brain_control_sampleid_mr283,ctrl
"TNFa siRNA-A, replicate 4",pert
MDS patient 117,pert
ctrl_514,ctrl
NPC13,pert
"Other: Equal quantities of total RNA from each cell line (brain, breast, B-lymphocyte, cervix, liver, liposarcoma, macrophages, skin, testis, Y-lymphocyte) were pooled together.",pert
"fibroblast, control subject NM8 rep 2",ctrl
"BOEC, normal 22",ctrl
chip number: 7;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2011-03-29,ctrl
Patient no. 13: treated,pert
Csbm/m Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-1,pert
MDS patient 138,pert
"RES-enriched Grape extract group, 12 months, patient number 51",pert
"Wildtype, thymic, NK1.1+ NKT cells replicate3",ctrl
Day3 Genistein treatment replicate 2,pert
T3D-LU,pert
"bipolar disorder, BA10-8(2)",pert
transfected with FoxP1 siRNA_1,pert
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep4",ctrl
Trim33-KD-ac-1,pert
PBMC from T cell Large granular lymphocyte leukemia patient#1352,pert
scpk/ikLLtumor/146,pert
NINDS-RHS-Ctr_72h-3aUA-s2,ctrl
Normal_MS 36D2,ctrl
"D425-shOTX2_2, t=0",pert
con_B148,ctrl
Saline T00278943,ctrl
SKMEL28_t0h_rep2,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID323,ctrl
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/8,pert
CD-76-Aff1,pert
Subject 5_t=30days_placebo,ctrl
Disease_status: Healthy control;	Age (years): 39;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.46;	Post mortem interval (hours): 58;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,ctrl
strain:C57BL/6; VillinCRE-HNF4loxp; female; tissue colon; control,ctrl
P72 dilated cardiomyopathy heart biopsy,pert
cMyb virus-infected replicate 1 (MCF7),pert
Brain_nAChRbeta4SubunitDeficent_MiceNob4365,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 35;	Usage number: 1;	Exposures: 4,pert
WT-GFP-lamin A Induction: day 10 Replicate B (3b_WT_10d_B),ctrl
RNA from microdissected breast cancer cells from case 289 labeled with Cy5,pert
HNF4 Null_1191,pert
"Immortalized MEFs WA, v-src expression retroviral vector infected, rep2",pert
"U-87 glioma cell line with shp105, biological rep2",pert
age: 3 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
"A pool of RNA from lung from three female mice, raised at Denver altitude (nearly normoxic), with SM22-rtTA x tetO7-BMPR2delx4+ transgene activated for 8 weeks",pert
"genetic control Alb-Cre:Keap1(flox/+), gender- male, age- 9 weeks, n = 1, # of tissue = 1 tissue: Liver",ctrl
"Peripheral blood, patient without recurrent events [N48]",pert
immortalized cells derived from brown fat tissue of mouse of mixed background.;	passage number: 4,ctrl
ubb_d14_wt_1,ctrl
KO - knock-out Treated - 12 hrs - repeat 2 - Cy3 - mAdbID:61763,pert
Sham-operated,ctrl
"Mdr2-KO homozygous mouse, 3 month old mouse 3",pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 0.5, Units of Harvest Time Point: hr",pert
CF knockout HFCF CHN308,pert
hTNFtg FLS,ctrl
tissue: whole blood;	disease state: healthy,ctrl
tissue: resected liver tumor;	genotype: major [rs8099917 TT],ctrl
source: JAX stock # 005823;	strain: B6.129P2-Lrp5tm1Dgen/J;	tissue: retina;	age: P8;	genotype: Lrp5 KO,pert
MEF_WT_rep2,ctrl
M327 SKM-KO,pert
KO.ES. rep2,pert
colonoscopic biopsy from adult with affected colon from adult with UC,pert
heart left ventricle,ctrl
kidney_Q10_14M_rep1,pert
Dilated cardiomyopathy_G59,pert
colon_CRC_1158,pert
CH2113,pert
individual: Control4;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"human failing LV myocardium, Idiopathic46",pert
shOCT4_4,pert
Sample M559,ctrl
HeLa cells treated with RENT1 siRNA,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379045;	hybridization batch: IV,ctrl
RE550_H1650_Un1_REHYB,ctrl
MCF7_Doxorubicin_Array_2,pert
Human melanoma cell lines,pert
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 84;	Usage number: 4;	Exposures: 3,pert
HCC PBMC_sample 10,pert
E2 2hr,pert
Globin_C4,ctrl
CD-76-Aff2,pert
KU_25T,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 6x5;	patient id (to identify the 2 chips from the same patient): 16821717,ctrl
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2-/-;	agent: IFNβ,pert
whole tissue section from case 319,pert
BALB_Male_Control_rep3,ctrl
brain_DLPFC_bipolar C_mr945,ctrl
BL Day 1 siSC transfected biological rep3,ctrl
157B,ctrl
GFP-KD-3 (mRNA),ctrl
cell type: PGC;	genotype/variation: control,ctrl
"wildype 129 mice, pineal glands disected at postnatal day zero.",ctrl
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep3",pert
Cell line BT-474_c-myc KD_expt2,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 3,pert
A HID U_B004,pert
Mutant_liver_5,pert
erStress_twins_AA_1727twin2_DMSO_4h,ctrl
Mouse_Retina_P7_Control 1,ctrl
"WT, PE treated whole heart, individual 4",ctrl
KM_079T,pert
"BMMs, untreated control, db, Replicate 1",pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 48;	gender: male,pert
"Knee articular cartilage, 4 weeks following OA surgery",pert
Bone-Marrow_SMM_S1433,pert
lucif_4,ctrl
A375 control-4,ctrl
Clozapine treated 12weeks AffyGC RMA rep7,pert
"NPTX1 shRNA Day 5, biological rep2",pert
Tumor_Pdk1 knock out,pert
race: african american;	age (years): unknown;	stage: IA;	grade: 3;	histology: papillary serous,pert
cell line: MDA-LM2-shTARBP2;	transfection: shControl,ctrl
wt-Gfp P2 replicate 2,ctrl
E9_Embryo_Wild Type_1,ctrl
NSC6,pert
patient: 9;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Rybp#10 (OHT-)_12d_rep1,ctrl
"Wild type fibroblasts, biological rep4",ctrl
anti-FGFR1_rep6,pert
Concordant for Epilepsy twin pair 1 (Affected patient of MZ twin pair CCE1),pert
SKI-DLCL cells,pert
PKCZ -/- male mice non-treated,ctrl
Disease_status: Bipolar disorder;	Age (years): 56;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 42;	Brain pH: 6.58;	Post mortem interval (hours): 26;	Side of brain: Left;	Fluphenazine mg. Equivalents: 25000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Patient no. 6: treated,pert
New El-Ashry 012.CEL,pert
OSE4 shGFP Ctr at 72h,ctrl
cell line: MCF7;	condition: siRNA Smc3,pert
"Liver, fasted, phenobarbital",ctrl
Treg cells Ptenfl/flFoxp3-Cre replicate 3,pert
Frontal cortex of AD brain,pert
12468 UC Inflamed sigmoid colon,pert
THRA wt + vehicle replicate 1,ctrl
"Cell type: neuronal, age:39, gender:female, diagnostic group: control, PMI:58h",ctrl
3406-lcm,pert
"WT LSC, biological rep2",ctrl
Brain tissue from epilepsy patient,ctrl
"Liposarcoma culture from tumor 377, untreated",ctrl
#1_Wt-C-3,ctrl
WT #2,ctrl
cerebellum_WT_10d_rep1,ctrl
Shn2_Mutant_4,pert
Normal_Kidney_Biopsy_9,ctrl
U138MG shcontrol 3,ctrl
endothelial_rep7,pert
KO PBS4,pert
CRC_nodrug_M4876,ctrl
tissue: skin;	individual: Patient N-1;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
SLE1,pert
48h_RA2,pert
HT29 siRNAc.G,pert
placebo treated ipsilateral to stroke replicate,ctrl
"HSCs from male mice treated with E2, replicate 2",pert
sex: Male;	Age: 108 months;	additional patient information found in Series supplementary file,ctrl
c 2-3,pert
B5_pseudomonas_overexpressor_422,pert
"strain: Swiss;	tissue: adult mouse intestine, kidney, and liver plus fetus tissue",ctrl
sal-PVH3_2,ctrl
"ID:13-2, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
umbilical cord_bpd: 6F,pert
Bmpr1a-/- N2B27 sample 1,pert
Wild type IFN-beta 4 h,ctrl
Normal-N_AJ3,ctrl
cell line: ACC525 [DND41];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
YFP+Foxp3delta r2,pert
SZ26,pert
"Crohn's Disease subject (47 year old caucasian female, SAK_1280820411)",pert
"BOEC, at_risk 8",pert
K562_1R-Chl_24hrs_rep3,pert
testis knock out replicate1,ctrl
"Patient H-s115T, MSI colorectal tumor",pert
Mouse WT memory CD8 T cells,ctrl
cell type: placental trophoblast;	developmental stage: E12.5;	genotype/variation: wild type,ctrl
E1-uninduced (no Dox) control,ctrl
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P2,pert
Luciferase shRNA_2 Days knockdown_rep3,ctrl
Expression data from liver of the KRAP deficient mice (WT3),ctrl
"experiment II, hTERT, replicate 2",pert
s4t4c,ctrl
MPM tumor specimen 17,pert
KO_48A_2c,pert
ID: MLL_00118;	cell type: PBMC;	disease state: control,ctrl
"alveolar macrophages, smoker 044",pert
Genotype: wild type;	Strain: C57BL/6J;	Age: 8-weeks,ctrl
EA_Control4_CD8,ctrl
WT_cells_rep3,pert
Tendon;Subscapularis_Non-lesional,ctrl
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 65;	gender: f;	treatment: NSAIDs,ctrl
"imr-32,gfp siRNA,T=48,2",ctrl
CD4+ T cells derived by negative selection from leukopheresed blood sample,pert
A2AR_KO_saline_24h_rep3,pert
"WI-38 cells, at 24 h after exposure to 0.1 uM BPDE, biological rep3",pert
wild type control tissue  4,ctrl
231/NS (nonsilence),ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
MDA_PR_4,pert
Day: 15; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 2,pert
"Hippocampus, soman, 1h",pert
3509-scrape,pert
11085 Normal Uninflamed descending colon,ctrl
subject: 22A;	cohort: 22;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 27kb;	age (y): 71;	Sex: F;	batch: Batch_5,pert
DRG_Capsaicin_10microM_Rep4,pert
SCD1 +/+ liver rep5,ctrl
Human lung adenocarcinoma cells_Non targeting (NS) siRNA transfected,ctrl
"SKO-transduced MEFs, Vc treated, lysed on D5",pert
subject: 2;	disease: TD;	muscle: ST;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
subject: 5;	disease: TD;	muscle: ST;	gender: F;	age: 12.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G52,ctrl
12488 UC Inflamed sigmoid colon,pert
"Wild type used for MAT1A 8 month, replicate 2",ctrl
Uninfected control_0c,ctrl
"Kidney, wild type mice, control",ctrl
ccRCC tumor of patient 1393,ctrl
Brain_Wild-type_MiceNoB4395,ctrl
Diabetic Male Wistar rat  after 28 days of diabetes induced with streptozotocin,pert
Third shYY1,pert
LECs from control rats 2,ctrl
BASC-Myc-depletion-2 [mRNA],pert
Cochleae from a9 null mice at P3,pert
cell type: HUVEC;	treatment: empty lentiviral vector pLVX-IRES-puro,pert
WT V6.5 ESCs on day 7,ctrl
treatment: progesterone;	genotype: progesterone receptor knockout;	treatement time: 40 hours,pert
Rat fatty liver14,pert
LRRK2 mutant knockin H9 hESC derived NSC 2,pert
Liver-24 month-wild type-technical replicate 1,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 3 - Technical Replicate 2,pert
Wild type (untreated) 5241,ctrl
Pediatric_GBM_41,ctrl
"PMA treated, doxycycline treated; biological replicate 3",pert
Ls174T-pTER-β-catenin dox3,pert
cerebrum_WT_12w_rep1,ctrl
N-BMSCs were transfected with siTERC-RNA (siTERC) construct,pert
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"SKO-transduced MEFs, Vc untreated, lysed on D6",ctrl
patient: 40728;	sample: tumor,pert
Sex: male;	Age at operation: 38 years;	Site: knee;	Size in cm: 8.3x4x7;	Histological Subtype: myxoid liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
Wild-type control 2,ctrl
T37 U133p2,pert
"cerebellum,24weeks,WT",ctrl
gender: female;	cell type: peritoneal macrophages;	strain: C57Bl/6,ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: mutant channel;	agent: tetracycline,ctrl
"IKK2 -/- tumor, biological replicate 2",pert
T161,pert
Subject 7 / lung subsegment instillated by LPS,pert
2_b,pert
phenotype: control;	gender: female;	case_id: 393;	age: 71;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 16;	brain ph at time of freezing: 6.2;	labeling_batch: 2,ctrl
181C3,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 63,pert
"Normal cervix, commercial_BioChain",ctrl
cell line: bj-fib_2: BJ (CRL-2522) fibroblasts were purchased from ATCC.,ctrl
Parkinson's disease sample x017a,pert
gender: male;	age: 7.5 mo +/-2.5 weeks;	genotype/variation: PPAR WT;	treatment: control,ctrl
siNS_4h_3,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 1",pert
Liver of pup from control group rep1,ctrl
fat_Akt1+/-_8wk_rep3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 144;	time: 0;	batch: 1,pert
H07_S_B2,pert
MDS patient 165,pert
Tobacco_abuse_3,pert
braak stage: CTRL;	rin: 60;	tissue: substantia nigra;	disease state: control,ctrl
MOLM14-shGSK3A-Construct5-rep2,pert
GNMT-WT mouse hepatocytes (sample 3),ctrl
A673_CloneAsp14_Dox_53h_2,pert
Patient: G;	Time: 1 week;	Group: responder;	Condition: lesional,pert
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
chip number: 12;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.81;	rin: 9.2;	transfection date: 2011-10-17,pert
Aldosterone-producing adenoma (APA12),pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Knock-out postnatal day 10 rep 3,pert
"MGSKO, PR02M008v0",pert
"brain, cochlea: [15] Sample #15_le1",ctrl
con-52_A,ctrl
M24met_Wnt1_4,pert
Genotype: Mdr2-KO heterozygous mouse;	Age: 12 month,ctrl
genotype/variation: Control (wild-type);	tissue: liver;	gender: male;	strain: mixed C57BL6 and 129SV,ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 33;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
"WT brain, biological rep3",ctrl
Silberg2 (9) 021301NE,ctrl
C57BL/6 female control,ctrl
"Uninvolved Skin, NS-11",pert
Aged 5,pert
Pancreatic Sample 11-Tumor,pert
healthy myeloid cells 11,ctrl
PBMC sample from gastric cancer patient,pert
"peripheral ganglion, unknown: control 1 hr_2",ctrl
miR122-WT-27,ctrl
Gata1WT25+#1,ctrl
Lung wt mock repA,ctrl
Healthy 5 weeks C5,ctrl
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 81;	Usage number: 5;	Exposures: 3,pert
"3mg/kg/day PFOA, Rep 5, Block 2, liver (low dose)",pert
WT GMP rep1,ctrl
24h WT Cel.19,ctrl
"Control shRNA cells passage 11, rep 1",ctrl
"spinal cord, ventral spinal cord",pert
Parkinson's disease sample x200,pert
LOX1_Untreated_12hr,pert
Unaffected MZ twin pair 1 (Unaffected patient of MZ twin pair CCN1),ctrl
A_AN01570_T,pert
cell line: Panc1;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
11440 UC Uninflamed sigmoid colon,pert
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50), biological rep3",pert
Gallbladder-leptin treated,pert
nmMLCK-/- -VILI replicate 1,pert
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: TFPI beta,pert
"non-AD_TC, biological rep17",ctrl
BL Day 0 Untransfected biological rep1,ctrl
Subject #8027-2d Postinfection,ctrl
con_B124,ctrl
HMEC_50 vs ZR_75_1,pert
Gnmt_KO_2,pert
non-CF subject 31,ctrl
ATF2 KO-3,pert
Cutaneous psoriasis without arthritis PsC 9,pert
"schizophrenia, BA46-11",pert
TRO-4--71602,pert
sepsis patient #18,ctrl
"human failing LV myocardium, Ischemic72",pert
MCF-7 cells treated with vehicle for 3h.,ctrl
PBMC from T cell LGL leukemia patient #122 (TLGL122),pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 49.34795,ctrl
"Lesion Skin, LS-17",pert
MGP melanoma,pert
"Alk shRNA, biological rep1",pert
01L4J: normal control,ctrl
Clint-Cont-1-011411,ctrl
Setdb1 2lox/1lox/Cre plus tamoxifen 3,pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),pert
HUVEC exposure 1 ug/ml colchicine 12 hr_1,pert
cell line: LICR HN2;	treatment: PBS,ctrl
HCC_31N,ctrl
cell line: NALM1;	tissue: Human B cell precursor leukemia,pert
V5-P561,pert
Against CDK19-1 rep2,pert
"wt total RNA LSK, rep 6",ctrl
"E18.5 ERRg -/- heart, biological rep 2",pert
braf status: BRAFmutant;	tissue: PTC with a BRAF mutation,pert
"Gata4-KO heart, CRE, biological rep2",pert
SHR16-1,pert
DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma) Replicate 1,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T3N2,pert
CML_5_HSC,pert
56A;pretreatment;female;breast tumor; not assessable,ctrl
HCT116 with Bgal knockdown,ctrl
Leg 56 Day mdx rep 2,pert
"ID:c 2-2, Genotype=(C57BL/6J), Treatment= none",pert
"ID:8-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
HA96-112B,pert
CEPI_IV_489,pert
wild-type_phenobarbitol_rep2,ctrl
cell line: SKBR3 resistant;	treatment: basal conditions,ctrl
Human normal pituitary -N4,ctrl
EB_2_6h_205_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
SCLC cell line SBC-5,pert
brain_DLPFC_bipolar C_mr444,ctrl
"non-AD_FC, biological rep4",ctrl
full differentiated 3T3F422A adipocyte,ctrl
transfected with control siRNA_6,ctrl
695_383_24hr_repeat,pert
"Wt, biological rep3",ctrl
RO37,pert
MS25_3B_MEK5_220307,pert
uterus - Proliferative endometrium from normal patient,ctrl
parental Ainv15 undifferentiated ESC,ctrl
hepatocellular carcinoma cell line,pert
Intestine_KO_biological rep2,pert
sex: Female;	family: 1;	age: 69;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
1056-05-A,pert
"non-SS control gland, patient 19, batch 2",ctrl
"Vehicle treated, DAY 6, biological rep.3, MOLM-13 cells",ctrl
12P-M4,pert
tissue: white blood cells;	age: 14.94;	Sex: male,pert
braak stage: BR12;	rin: 58;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
B4 395 wild-type untreated,ctrl
Old neocortex,ctrl
UnInfected-2,ctrl
PGA-HMO-NonObese-5aUA-s2,ctrl
mouse cerebellar granule cells wild type 5,ctrl
tissue: leukemia;	genotype: Sh2b3 wild type ΔE-NOTCH1;	strain: C57BL6,ctrl
"TH cells from LC, wild type control, young time point, biological replicate 1",ctrl
patient: 257;	current medication: 6MP 50mg;	birth date: 5/16/64;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 2/1/05;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Syracuse Low Avoidance (SLA) learning rats 2,pert
3 ERRg WT E18.5 male cadiac ventricles,ctrl
Wild type naïve T cells stimulated for 3 hours with medium alone 2,ctrl
treatment: AMN107 (Nilotinib);	cell line: K562,pert
01LN1_PolyRF-,pert
"Patient R, uninvolved skin",ctrl
Normal-ERα-positive breast cancer 12,ctrl
BP patient 50_biological replicate 1,pert
Macro-dissected renal epithelial tissue from wild-type littermate controls,ctrl
"AML blasts from bone marrow (at diagnosis), mutated NPM",pert
Mouse No Cldn16 B9 443,pert
Extract:LOX-1:113501;	Extract Description:GFP_Untreated_24hr:113501;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.38;	Quality: Absent (%):56.87;	Quality: Absent (%) Dev.:1.07;	Quality: Scaling Factor:0.52;	Quality: Scaling Factor Dev.:0.75;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113501;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295833,ctrl
Primary hepatocytes isolated from FVB mouse strain treated with Wy14643 for 6h,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 50.28767,pert
Normal-ERα-positive breast cancer 4,ctrl
ePuro,ctrl
"NF-YA KD ES cells 96hr, replicate 2",pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 59;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 16101647,ctrl
G93A 120 days sample 2,pert
Run8.aUa.010615d.SkMInS1080D.CEL-IS basal,ctrl
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: exogenous SNF5 overexpression,pert
Dengue Hemorrhagic Fever Patient 38,pert
Thyroid_ unaffected_paired with PTC26T,ctrl
KU_14T,pert
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 2",pert
Mouse lungs infected with Mtb for 63days,ctrl
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): ex-iTreg,pert
c_B51,ctrl
Knockout liver_saline-injected 12weeks repl2,pert
"NTera-2 cells SOX2 siRNA, biological replicate 1",pert
Tendon_lesional_rep6,pert
"Liver from control mice, biological replicate 7",ctrl
Mut+/+ rep1,ctrl
"SBC-5 cells, siEGR4 (target), 72 hr after siRNA, duplicate sample 1",pert
3978-1 E2F1 Null,ctrl
Cultured cell line,pert
"non-AD_FC, biological rep2",ctrl
Pten cKO rep1,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_16,ctrl
"cerebellum, knock out, 3 month",pert
mouse fetal liver at E14.5,pert
tissue: lesional skin;	urticaria status: affected;	patient: 1,pert
E10_otic_vesicle_mut_replicate2,pert
"ID:10-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
phenotype: alcoholic;	gender: male;	case_id: 252;	age: 59;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.57;	labeling_batch: 1,pert
Bone-Marrow_MM_M956,pert
Floxed_Mstn_3,pert
2065N,ctrl
PBMCs_Control_13 [IS],ctrl
D_LS_Wk12,pert
"Vehicle treated, no doxycycline; biological replicate 3",pert
"CRT knockout mouse embryonic stem cell, biological rep1",pert
"211, ADIPOOSE TISSUE, Before",ctrl
F9 WT treated 8hr with EtOH,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 41 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
H31 Ctrl 12h 1,ctrl
mutant_ANT_PDE_10-1,pert
condition: Discoid Lupus;	patient: L1;	tissue: LS skin biopsy;	kit: Ovation,pert
Mouse hypothalamus,pert
patient id: T142;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Carbo Day4 (379R),pert
KO (Rnh1-/-) -3,pert
"Brain tissue from Fisher 344 male rat, Animal #262, 20mg/kg D-Serine",pert
"Heart, wild type2",ctrl
mouse embryonic fibroblasts,ctrl
Patient skin sample-Acne Lesion,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
"DBA/2J ACU, Rep1",pert
ID4+/+TCL1-tg spleen CD19+ B cells collected from 3 mice 1,ctrl
Blood,pert
control AU1165305,ctrl
T57 Non failing heart biopsy,ctrl
strain: C57BL/6;	tissue: heart;	genotype/variation: KO;	age: 6-weeks old,pert
sciatic nerve of P60 wild type mice,ctrl
siCtrlE24h_2655,pert
IFN_Gamma_24hr_rep3,pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: SNF5 shRNA infenction,pert
Patient 1 a,pert
NM4 healthy control,ctrl
"Liver from STZ-treated mice, biological replicate 1",pert
"Acute Myeloid Leukemia, sample 56",pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shLuciferase,ctrl
female_control_460,ctrl
Bronchial Epithelial Cells MMA biological 2079X,pert
Wild type CD4+ CD3-stimulated 2,ctrl
Mouse Liver,ctrl
"miR-148b-D (miR-148b-3, biological replicate 4)",pert
N/A,pert
GM19238_Kd_NS3_21A,ctrl
MBD1 WT #3,ctrl
Primary MEF from 13.5 dpc E2F4 null mouse,pert
Control spleen - Biological Replicate 3 - Technical Replicate 2,ctrl
SGK1-IL23 rep2,pert
06R049 RA,pert
Teratoma,pert
PKBa-/- MEF time 24 replicate 2,pert
MMA mutant,pert
wildtype HUES6 1,ctrl
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14439;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
embryonic stage: E14;	cell type: embryonic stem cells;	genotype/variation: Trip12 mut/mut,pert
cDNA scc 11,pert
Adam10 wildtype mouse,ctrl
Calu3-GemR_Veh_1,pert
RNA-DHL6-R406-48H-2,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: NLGN1 shRNA,pert
gender: Female;	age: 75;	post-mortem delay: 3h;	ph: 6,pert
Control LM2 Cell on HMVEC-L Replicate 3,ctrl
Control male 2,ctrl
mutant Dcx ko/Y,pert
Pias1 null IFN-gamma 2 h,pert
"strain: C57BL/6;	tissue: heart, left ventricle;	gender: male;	genotype/variation: Hsp22 KO;	stress: control",pert
15_0005C_Day1_43,ctrl
RNA from NCCIT human cells depleted of TET1 by siRNA,pert
RNA from microdissected breast cancer cells from case 1037 labeled with Cy5,ctrl
patient: 18;	disease state: hypertension;	tissue: Atheroma plaque,pert
"Subject 6, Family 2, Control",ctrl
HL60-shGSK3B-Construct2-rep1,pert
"Mutant in the presence of tetracycline, rep1",ctrl
"Cultured ovarian cancer cell line IGROV-1, Cisplatin treated",pert
Normal-ERα-positive breast cancer 27,ctrl
TMRI E2 48hr,pert
chip number: 14;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.51;	rin: 9.2;	transfection date: 2011-10-17,pert
control siRNA rep1,ctrl
MLL_00129,pert
Run8.aUa.010615d.SkMInS1074D.CEL-IS basal,ctrl
cell line: PC3;	treatment: none,ctrl
Gastric Cancer PBMC Sample 1,pert
"A673 treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50), biological rep1",pert
"Mesodermal Precursor Cells derived from hES cells line SA01, biological replicate 3",ctrl
patient: 238;	current medication: Enalapril Zantac;	birth date: 9/27/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 9/25/03;	diagnosis date: 1/14/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: NEW;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: Hypertension Diverticular disease;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
HF0120_U133P2,ctrl
IkkβΔ_replicate1,pert
coc-57_A,pert
PsOEt-12-Week 2,pert
PND28 Rat Testis_Rat230-2_12hr Corn Oil_Animal#60_04005,ctrl
HCC_31T,pert
Cancer 1,pert
2944-lcm,pert
47A,pert
cerebellum_wild type_6 weeks_replicate 1,ctrl
"vestibualr organ at E18.5 of Igf1 -/-, biological rep 3",pert
"paraventricular nucleus of the hypothalamus, saline, 1 hour",ctrl
BP3,pert
cMetKO CSC Technical Rep.2,pert
"cochlea at P7, ko, biological rep 2",pert
autism with dup(15q) 01-19,pert
Jejunum_POR-null_3,pert
Frontal_cerebrocortex_Deltamethrin_3mg/kg_6hr_rep6,pert
Patient: B;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
healthy chondrocytes,ctrl
"Healthy volunteer, Control_11819",ctrl
Healthy control c4,ctrl
HeLa_TP082505-28_HG-U133A_2_IMFGN0023,ctrl
intestinal crypt cells isolated by laser capture microdissection,ctrl
2830 WT,ctrl
Discoid Lupus-L1,pert
MDA-MB-231+ERalpha-WT,ctrl
Arid3a KD replicate 1,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr.",ctrl
T8F-LU,pert
Aged 2,pert
heart left ventricle,pert
Day: 15; Drug: Heroin; Phase: Withdrawal; Replicate: 3,pert
cerebellum_Pink1 knockout_18 month_replicate 2,pert
Peripheral blood mononuclear cells;	ttf: 120min;	race: White;	sex: Male,pert
HUVEC_control experiment 3,ctrl
"Cell culture. A549 treated by MK886, control 2",ctrl
Lung Adenocarcinomas of c-Myc-Transgenic Female Mice,pert
sirna: control;	plate: collagen coated;	cell line: MCF10A,pert
KU_07T,pert
Sham 9,ctrl
"RISC-free control transfected, biological rep 4",ctrl
Bone-Marrow_SMM_S1360,pert
wild type control tissue  1,ctrl
Pancreatic Sample 1-Tumor,pert
tissue: Frontal cortex;	age: 84;	Sex: M,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Hypoxia;	Tobacco Use: No,ctrl
E9_Embryo_Heterozygous_3,pert
Mouse WT mandibular molar [ABH_11A],ctrl
T cells,ctrl
control IgG_rep5,ctrl
Yolk sac tumor 2110,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous endotoxin challenge""",pert
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 30;	maternal age: 29,ctrl
Brain from wild-type E18.5 mouse embryo,ctrl
Adipose from a 5 month old Myc heterozygous mouse,pert
PGA-MPF-C57-saline-24h-2bAv2-s1,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): EtOH vehicle,ctrl
wild-type mouse kidney - 1,ctrl
"control, subject 2",ctrl
ID4+/-TCL1-tg spleen CD19+ B cells collected from 3 mice 1,pert
"HL-60 cell line, transduced with a control luciferase and selected with  1 µg/ml puromycin 48 hours post-infection",ctrl
Csbm/m Mouse_cerebellum_Old_saline treatment_Replicate-1,ctrl
pSUPER-scramble replicate 2,ctrl
RKO colon cancer cells,ctrl
F-IIP(NSIP)3_Cy3,pert
"DMD skeletal muscle, technical rep1",pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 5;	gender: male,pert
PGK12.1_Kdm6a RNAi-2,pert
CD4IncTp1-4,pert
shCON3,ctrl
UTX knockout (KO) cell line 1,pert
colon cancer cells,pert
Genotype: FGF23 TG on C57Bl strain;	Age: 8 weeks,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: sh53BP1-1,pert
human peripheral blood mononuclear cells (healthy subject),pert
EP66_adipose_pcos,pert
estrogen treated ipsilateral to stroke,pert
Grid2 deleted mouse 3,pert
age: 14dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
7dpp wild type testis,ctrl
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 7.8;	colon weight (mg): 172;	colon ratio (mg/mm): 2.21;	myeloperoxidase activity (u/mg): 0.076;	tissue: colon;	treatment: 5% DSS,ctrl
MCF10A cells,ctrl
"Testes, 20 hours after cadmium treatment, biological rep 1",pert
Control  VZ12,ctrl
Moderate rep7 (OHN),pert
"PBMC, healthy control, biological rep13",ctrl
6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24721,pert
"Acute Myeloid Leukemia, sample 14",pert
Normal skin from Stat3c_control mouse,ctrl
Control Replicate 1,ctrl
12h PTD-DRBD GAPDH siRNA (SAMPLE 4),pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 4,ctrl
miR122-WT,ctrl
Expression data from liver of the KRAP deficient mice (KO2),pert
"seminoma specimen, pT2, pN2, pM1, patient age: 37y",pert
E2F WT,ctrl
tissue: rectal mucosal epithelia;	genotype: non-CF,ctrl
B-CLL PB P254,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),pert
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50), biological rep2",pert
"PBMC, patient. Mtx rep2",pert
SA_257,pert
WT_cerebellum at P30,pert
WildType_1,ctrl
"A673 treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50), biological rep1",pert
MGd_3,pert
"non-AD_FC, biological rep18",ctrl
FMR1_2,pert
whole blood_101094,pert
Mening UNSTIM WB SW 3a,ctrl
37A;pretreatment;female;breast tumor,ctrl
control participant P338,ctrl
MOLM14-shGSK3A-Construct6-rep1,pert
Posterior_wild type,ctrl
HeLa cells transduced shYY1 control lentivirus.,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: control (none);	timepoint: 2 hours,ctrl
WT CFTR unexposed replicate 1,ctrl
e_2m51,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Reh_shCBFA2T3_1,pert
RV64.11_CHF_day25,pert
"Control, biological rep1 (E17.5)",ctrl
LPS 3hr 2,pert
"P210 HCT-116, DNMT3B knockout, U0126-treated",pert
RV16;	Age = 20;	Sex = M,pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC;	Vehicle Treated 0.1N KOH (equivalent volume to treated) in cell culture media,ctrl
"seminoma specimen, pT2, patient age: 34y; W03 037",pert
"wild type Treg, replicate 2",ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 44;	sex: M,ctrl
Subject #8009-8hr Postinfection,ctrl
TAp63 alpha Q540L 24h without induction s1,pert
Erythroblast_SOD2+/+_repWT29,ctrl
01LN4_Oligo,pert
cell line: U373;	cell type: glioma;	vector: MAML1 dominant-negative,pert
"Normal subject (45 year old caucasian male, SAK_1290589154)",ctrl
"Rb null fetal liver 1, embryo at 12.5 days of development",pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/8,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 12h",pert
"Patient 26, Atheroma plaque",pert
WFS1 KO USHT_18_330_wt,pert
42A,pert
N29,ctrl
"HeLa cells, 72 hs after transfection",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-tu2,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 43, stage IIB, HPV 16",pert
H16_P_B2,pert
MCF-10A shATM-1 replicate 3 [set 5],pert
"Liposarcoma culture from tumor 385, untreated",ctrl
Treg cells WT replicate 3,ctrl
"fibroblast, MFS subject GDO21 rep 2",pert
MDA-MB-231_siZMPSTE24_rep.2,pert
tissue: Biceps muscle;	patient: C.b.1;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 1y 2m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
HIF-1-/- control 2,pert
"heart, QH2, 6 months",pert
"age at diagnosis: 75;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 28;	dfs-event: 1;	distant metastasis: 1",pert
TA-n7-2; normal tibialis anterior 7 month,ctrl
C15-7,pert
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 3",pert
chondrocyte_5azatreated_rep2,pert
TF1_controlsiRNA_3,ctrl
KO_MEF_un.1,pert
"Dumbo retina, biological rep2",pert
MS patient 10,pert
MCF7/c p.2,ctrl
sorted CML CD34+CD38- cells cultured without exposure to drugs (controls),ctrl
RNA from microdissected breast cancer cells from case 633 labeled with Cy5,pert
wild-type replicate 2,ctrl
06R033 Control,ctrl
"expression at 0hr, bio rep3",ctrl
"HCT116 shControl, low glucose",ctrl
"strain background: C57BL/6;	genotype/variation: wild type; Cdh1+, P53+;	age: 2 months;	gender: female;	tissue: uterus",ctrl
NTG replicate 2,ctrl
Cnah KO_heart_2,pert
"fibroblast, MFS subject GDO21 rep 4",pert
Patient: C;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Native-0-4,ctrl
genotype: PIK3CA.H1047R;	agent: DMSO,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 8",ctrl
HC-WT-20A,ctrl
HCC014T,pert
human preadipocytes+oligo1_day0_rep2,pert
PE_D_587,pert
"Empty vector, plastic plate, rep2",ctrl
patient E1635,ctrl
LT 341 +/T untreated,pert
abl cells transfected with control siRNA under hormone depleted conditions,ctrl
Control MEF 3,ctrl
brain_DLPFC_bipolar B_mr446,pert
sample type: Primary culture of type II cells collected from SPC KO lung adult;	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C KO;	genetic background: 129S6/SvEvTac,pert
"breast, post AF treatment (H8_1389)",pert
LKO_102412,pert
ILD Study Number S014,ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: heart;	age: 12 weeks,ctrl
FHCRCAML7209,pert
30A;pretreatment;female;breast tumor; nonresponder,ctrl
"Hdh knock-in embryonic stem cells, Q91 line, biological replicate 2",pert
Bronchial Epithelial Cells MMA biological 0154V,pert
OCUBM,pert
Rat fatty liver19,ctrl
Mouse embryo fibroblast,ctrl
High weight gainer Kozak1_ABI_ING_H2,pert
Mening UNSTIM WB NP 3b,ctrl
"brain, cerebellum: RNA#3S_le1",pert
PBMCs from normal control subject K (KPBMC),ctrl
placenta (E 10.5),pert
Retina of 6 month old RPE65 -/- mouse,pert
"38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.242;	OD280: 1.132;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 50;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Individual_5414_PP_sample,pert
pMX-jhdm1b vitamin C Jhdm1BVc+_1,pert
"strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 15 months;	tissue: liver, peritumoral tissue;	disease status: hepatocellular carcinoma",pert
KU_15N,ctrl
patient: 10;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible",pert
"Spinal cord, acrylamide treated, biological rep1",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 1,pert
treatment: progesterone;	genotype: progesterone receptor knockout;	treatement time: 4 hours,pert
Cancer 18,pert
tissue: Pancreas;	strain: C57BL/6;	genotype: Mist1Cre-ER/Cre-ER;	age: 8 weeks,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case2,ctrl
Wildtype 3 (jos0951),ctrl
2 hr vehicle repl 1,ctrl
"Nrl-ko, purified Gfp+ photoreceptor cell",pert
"HSCs from female mice treated with oil, replicate 1",ctrl
Eed KO J1 ESCs on day 7 #1,pert
Female - caucasian - N-03-G,ctrl
agent: untreated;	time point: 0 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
"Acute Myeloid Leukemia, sample 19",pert
Normal-ERα-positive breast cancer 41,ctrl
"Heart, wild type3",ctrl
Testis_WT_rep2,ctrl
PBMC_C5,ctrl
Cardian muscle Trained diabetic 1 week DT1,pert
Gastric_cancer_patient_9_dye_swap,ctrl
Donor6_24h_DMSO,ctrl
16SAGEA,pert
wild type MEF time 6 replicate 3,ctrl
Cerebellum_nontransgenic control A39_4 months_replicate 4,ctrl
"Patient 6, control tissue",ctrl
HCV_Control_3,ctrl
Sample 5,pert
BRCA1_2,pert
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 3",pert
FmrWT5_brain,ctrl
Hippocampus_Soman_72h_rep1,pert
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 2,pert
subject: 2826 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
Mouse old brain w/ a-tocopherol aT-Br-2,pert
Raji_mi-Ctrl_2,ctrl
G93A mouse 1261,pert
KO_TER119+_rep1,pert
Colonic mucosal endoscopic pinch biopsy,ctrl
RWPE-PCAT1 cells transfected with cMyc siRNA #4,pert
colonoscopic biopsy from normal adult,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 33;	maternal age: 32,pert
"brain, brainstem: CB6_e1_le1",ctrl
liver wild type replicate2,ctrl
"Male, Wistar, 6hrs/day access to cocaine, nucleus accumbens",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M2;	flt3 status: WT,ctrl
AFFS084-4-291004,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 14,ctrl
healthy CD4 T cells 1,ctrl
age: 31;	gender: female;	ejection fraction: 56;	left ventricular end diastolic diameter: 71;	inflammation/PVB19: positive,pert
Chondrogenic progenitor cells from OA male 1,pert
HLA risk: High;	Height: 171.8 cm;	Weight: 82.4 kg;	BMI: 28;	Age: 57.67 years;	Gender: Female;	Race: White;	Glucose: 78 mg/dl;	HbA1c: NA,ctrl
disease state: sarcoidosis;	biopsy type: transbronchial;	tissue: lung,pert
Healthy control 8,ctrl
New 3 hr 1,pert
"Rat_Tracheal_Control_2hr, rep6",ctrl
A61 WT3	F24/2	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
"Wild type used for MAT1A 15 month, replicate 2",ctrl
21day 4OHT-treated-sample3,pert
"E-FABP knockout GM-BMMs, biological rep1",pert
colonic_mucosa_non_inflamed_94,pert
RAW_0.7mM_HOCl#3,pert
heart of male mouse subjected 4 week to chronic intermittent hypoxia.,pert
"24hr non-specific siRNA, 16hr 10nM DHT treatment replicate 2",ctrl
"Aorta, Ang II 7d, #4",pert
Mening SWB WB SW 6a,pert
MKK7D control female replicate 2 early timepoint,pert
mESCs_Tip60KD_rep3,pert
KD control replicate 2,ctrl
P1 mouse eyeball extracted total RNA_wt3_GSM618317,ctrl
"Patient 32, Atheroma plaque",pert
G_LS_Wk2,pert
White portion of the gastrocnemius muscle,pert
AA_Control1_CD8,ctrl
Wild-type rep1,ctrl
"D425-shOTX2_3, t=48",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day0,ctrl
gender: male;	age: 2-3 months;	tissue: kidney;	genotype: ERRa KO,pert
"BMDC, wt",ctrl
"patient 10, right arm treated with pimecrolimus until day 22",pert
B6_Male_Control_rep1,ctrl
Epidermal keratinocytes treated with EphB2 for 48h,pert
RNA-DHL6-DMSO-1,ctrl
Eed KO E14 ESCs on day 7,pert
astrocyte,ctrl
cell type: Dorsal skin Basal IFE epidermal stem cells;	genotype: wild type,ctrl
Run4.aUa.010110d.SkMDbt1150D.CEL-DB basal,ctrl
b78+,pert
LSK cells from wild type mouse rep3,ctrl
RT4D6_wild type Sox10 siRNA_rep2,pert
HL60-shGSK3A-Construct6-rep2,pert
Heart dissected from wildtype E12.5 fetus.,ctrl
race: caucasian;	age (years): 66;	stage: IB;	grade: 1;	histology: endometrioid,pert
"array 27, xenograft, DBP 500 mg/kg/d",pert
"CFU-PreB colonies Hspa9+/-, biological replicate 4",pert
major HCC6,ctrl
mouse cerebellum at P30 wild type 2,pert
tissue: muscle;	genotype: WT;	genetic background: C57BL/6,ctrl
"Patient I-1031-N, normal colonic mucosa",ctrl
GM19238_Kd_NS4_22,ctrl
"human failing LV myocardium, Ischemic3",pert
mouse model: 3xTG-AD;	gender: female;	age: 14 months old,pert
10A,pert
subject id: 38;	infection: DENV;	status: DHF;	tissue: whole blood,pert
WT - Cre Control - 5 mo - repeat 4 - Cy5 - mAdbID:74103,ctrl
Muscle PCOS after pioglitazone 122,pert
race: african american;	age (years): 73;	stage: IB;	grade: 3;	histology: papillary serous,pert
"testis, Repro9 mutant, 17dpp, Rep2",pert
S3star_Sham_wildtype_8,ctrl
Flp-In™ T-REx™ 293,ctrl
THP-1 cell line infected with GSK3B Construct 2 shRNA,pert
KO-Nrf2-Male-2,pert
PTC BRAF wt 11,pert
HDAC2 siRNA_4_Huh7 [HDAC2 siRNA subset],pert
SCC-40_siScramble_rep.2,ctrl
placenta,ctrl
OCI-Ly10_ctrloverexpression,ctrl
"TCF-1 KO CD8 memory T cells, biological rep2",pert
"SKI-DLCL cells, not treated and cultured for 24h. Total RNA was isolated using RNeasy kit",ctrl
Muscle-AMPKgamma3-wt-2,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 67y; W03 002",ctrl
cell line: MDA-MB231;	treatment: G9a knockdown;	cell type: less metastatic breast cancer cells,pert
Dicer WT CD4 T cells 2,ctrl
Donor3_24h_Wy,pert
"Liposarcoma culture from tumor 389, doxorubicin treated",pert
AVIC sample#3 treated with DAPT,pert
mouse E12.5 embryonic kidney isolated from wild-type pregnant female,ctrl
"midbrain,18month,KO",pert
11404 Normal Uninflamed ascending colon,ctrl
"genotype: Ring1B mutant generated by gene targeting (Leeb et al., 2007);	cell line: ES",pert
CD71+ bone marrow cells from CD70TG (clone F13) mouse 1,pert
SLE CD19 B cells 7,pert
Parkinson's disease sample x178,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 64, stage IIB, HPV 18",pert
M24met_control_2,ctrl
s3t3c,ctrl
Normal mucosa 22,ctrl
ctrl_MPH,pert
disease state: healthy control;	tissue: epidermis;	age: 74;	gender: female;	treatment: untreated;	time: control,ctrl
V5-P061,pert
MCF10A_SFN_rep3,pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 59;	donor: 17;	disease state: Non-lesional,ctrl
"Ada3FL/FL MEF, control, biological replicate 1",ctrl
"Peripheral blood, normal control [N65]",ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 45;	age-at-onset: n/a;	geographical origin: Mirandela,ctrl
control participant P336,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.549;	OD280: 0.803;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 63;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"sebocytes cultured from M, 55, normal preauricular sebaceous glands and SV-40 immortalized",pert
Cell line: NALM1,ctrl
Adipose from a 24 month old Myc heterozygous mouse,pert
Control 1 a,ctrl
MCF-7 +scrambled siRNA + vehicle rep2 (MD40),ctrl
"liver,fasted,refed, 3hr",pert
Brain area 8/9 from 6 year-old RTT girl,pert
cell line: TOV112D;	cell type: epithelial ovarian cancer cell;	treatment: Untreated,ctrl
control to Sample 21,ctrl
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: resistant,pert
Control Colon 1 17 days old,ctrl
Extract:LOX-1:113202;	Extract Description:GFP_Untreated_2hr:113202;	Quality: Classification:Medium;	Quality: Gradient Severity:0.06;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.75;	Quality: Background Mean Dev.:2.27;	Quality: Absent (%):59.11;	Quality: Absent (%) Dev.:0.67;	Quality: Scaling Factor:0.55;	Quality: Scaling Factor Dev.:0.5;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113202;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295483,ctrl
53_129_KO,pert
Liver-5 month-Myc heterozygous-technical replicate 1,pert
Extract:LOX-1:113503;	Extract Description:GFP_Untreated_24hr:113503;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.04;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.36;	Quality: Absent (%):58.28;	Quality: Absent (%) Dev.:0.02;	Quality: Scaling Factor:0.65;	Quality: Scaling Factor Dev.:0.34;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113503;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295853,ctrl
Dengue Hemorrhagic Fever Patient 39,pert
Run4.aUa.010110d.SkMDbt1149D.CEL-DB stimulate,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-3,ctrl
WT littermate1,ctrl
Normal myocardium sold commercially (F),ctrl
S5_S5010928,pert
Whole adrenal RNA from WT mouse #146 at 0h,ctrl
"seminoma specimen, pT1, patient age: 55y",pert
"SHR adrenals, replicate 1",pert
Wild-type Rep2,ctrl
strain: mixed 129/Ola-C57BL/6 background;	genotype/variation: Jun delta mu,pert
EB_07_19d_156_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
tissue: T cells;	genotype: CTLA-4 KO 5C.C7;	background mouse strain: B10.A,pert
LT-HSC Zbtb7a F/F Mx1-Cre+ #1,pert
APLP2_R1,pert
TET-on Human lung carcinoma H1299,ctrl
PC-3 cell  control mir,ctrl
RNA from microdissected breast cancer cells from case 260 labeled with Cy5,pert
CLL1-CD8,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 50;	donor: 27;	disease state: Lesional,pert
Phan_012_KO.bleomycin rep3,pert
HUVEC infected by retroviral vectors bearing a control scramble sequence,ctrl
RNA from microdissected breast cancer cells from case 1304 labeled with Cy5,pert
gender: Male;	age: 60;	post-mortem delay: 16h;	ph: 6.9,ctrl
tissue: Breast adenocarcinoma,ctrl
Fat FC3,ctrl
"cells treated with Scrambled siRNA, biological replicate 2",ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID60,ctrl
chip number: 20;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.65;	rin: 9.5;	transfection date: 2012-03-26,pert
Hec50co human endometrial cancer cells with MTDH knocked down using ShRNA,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: control;	time: 6h;	gender: Male;	age: 6 months,ctrl
fibroblast_Slow_D69_Media_7,pert
COV434 Mutant [RR1019],pert
lung_control_1,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 4",pert
colon_C57mouse_6weeks_rep6,ctrl
129_Sv_3_WT_d6_4302,ctrl
PsOEt-24-Week 1,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 6",pert
"C57BL/6N, adult, female",ctrl
"PDK1 null CTL, biological replicate 3",pert
Day: 6; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 1,pert
HepG2_100uM_Trovafloxacin_24hr_prep1,pert
BV2_Curcumin_rep3,pert
humanMBC_FOXP1 overexpression_2,pert
FBooth-CON-2Av2-s2,ctrl
ApoD KO rep_1 (CKO1),pert
HUVEC_TSA_rep1,pert
No or early 1 rep3 (retina),pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.898;	OD280: 0.49;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 7.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 209;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Whole adrenal RNA from Crem-/- mouse #144 at 0h,pert
Large PreB,ctrl
NHEK_MLL2 siRNA_1.8mM Ca_48hr,pert
Wild type fully-grown GV oocyte from transgenic mice,ctrl
RNA from whole tissue section of case 420 labeled with Cy5,pert
Sle1a R2,pert
Severe rep5 (OHN),pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep1,pert
Tissue:tumor; Gender:male; Age:36; Tumor stage:T4aN1aM1,pert
RatLung_H24h_2,pert
JoMa1_3,ctrl
X_p8_rep4,pert
HMEC X Senescent HMEC-2,ctrl
48 hrs TAC-5,pert
mutant testis at 14dpp,pert
"KSR1 Alone, Replicate 3",ctrl
liver_Akt1+/-_35wk_rep3,pert
con-11_A,ctrl
"HUVEC treated with Non-sense SiRNA , biological rep1",pert
Muscle-AMPKgamma3-wt-7,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 4,pert
"endometrial stromal cell - Jag1 retrovirus infected3, 3 days post infection",pert
A39 NES 142Q TG6	F1/4	A39	NES Htt exon 1 142Q	Mouse	10.5 months	Cerebellum	Female,pert
"ID:c 4-5, Genotype=(C57BL/6J), Treatment= none",pert
cell line: HCT 116;	treatment: control,ctrl
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14504;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
51104.INV,pert
age: 20;	sex: M;	disease status: Marfan subject;	Filter number: 89;	Usage number: 4;	Exposures: 3,pert
Subject #8009-2d Postinfection,ctrl
ko 13.5d replicate 4,pert
Gnmt_KO_1,pert
"iPSC derived from healthy control fibroblast WT1, biological rep2",ctrl
"Wild-type-neocortex, biological rep6 (female)",ctrl
"BMMs, untreated control, db, Replicate 2",pert
8 week old leg MDX rep 3,pert
tetO-Satb2 #1 +DOX,pert
"Heart, MAT1 CKO, 4 wk, sample 3",pert
AEP-first,ctrl
F-IIP(UIP)6_Cy3,pert
"Control siRNA - 5 days adipocyte differentiation, rep1",ctrl
mdx diaphragm sample 1,pert
RNA from NCCIT human cells depleted of TET3 by siRNA,pert
cell line: mda-mb-231;	transfectant: siRNA for LacZ,ctrl
ColonTum_022HAFC9_cta.txt,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Post mortem interval (hours): 29;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
skin.KO.replicate26,pert
129/BSw het1 heart,pert
"Strain: Polg+/+ mice;	Gender: male;	Age: 9 month-old ;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
2_WT_1,ctrl
Embryonal carcinoma,pert
RNA from 3 MCF7 cell culture plates treated with 250 mM of resveratrol (SIGMA St. Louis MO),pert
"89 y/o female. 46,XX",pert
01LQK: normal control,ctrl
HNF4 Control_1193,ctrl
CUTLL1 MigR1 GSI-rep2,ctrl
control participant P329,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 6.6;	colon weight (mg): 160;	colon ratio (mg/mm): 2.42;	myeloperoxidase activity (u/mg): 0.423;	tissue: colon;	treatment: 5% DSS,pert
Gene expression of murine fibroblast-like synoviocytes Grp2_C57BL6_3_FLS_TNFtg,ctrl
A4_C4_nasal_stem_cell_rep1,ctrl
ko 13.5d replicate 12,pert
cell type: primary human monocyte-derived macrophages;	differentiation factor: MCSF,ctrl
gender: Female;	age: 65;	post-mortem delay: 3h;	ph: 6.1,pert
cell type: embryonic stem cells;	genetic modification: WT,ctrl
"T-cell prolymphocytic leukemia, no inv(14)(q11q32), case 8",pert
"A549, +TNFα, control siRNA, rep2",ctrl
YFP+Foxp3delta r1,pert
RV83.09_CHF_day10_Slide76,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep2",ctrl
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 90,pert
"Spi-60, biological rep 8",pert
"K562, NoTreatmentControl, 24hrs, rep3",ctrl
DN4 cells sorted from mouse n°129 (Cre+),pert
Ishikawa_VeryLowDose_BPA_8h_rep3,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: male;	age: 5 Month old;	tissue: Liver;	diet: 35% Fat Diet (High Fat Diet; HFD),ctrl
Normal Pleura 2,ctrl
Breast Cancer Cell Line,ctrl
PancreaticSample6-Tumor,pert
PancreaticSample37-Tumor,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, mock (24h post-infection)",ctrl
EGFR+EGF_1,pert
Severe rep8 (OHN),pert
EA_Control5_CD8,ctrl
"AALE-KRAS uninfected, biological rep1",pert
fibroblast cultured from normal esophageal tissue_HEF_2111,ctrl
No or early 1 rep7 (OHN),pert
MCAD + LPS 1,pert
"KARPAS-231, non-targeting siRNA, REP1",ctrl
3458-scrape,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
SLE CD19 B cells 6,pert
21day 4OHT-treated-sample1,pert
host strain: nude mice;	injected with: iNRAS-475 mouse melanoma cells;	tissue: Melanoma allograft;	treated with: AZD6244 MEK inhibitor 100mg/kg for 4 days,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 50;	sex: F,ctrl
R7E 8,pert
RNA from HCC_14T,pert
Fourth day of N2B27 differentiation,pert
BP19,pert
Ebola-infected macrophages harvested at 1h post-treatment from donor 3,pert
db/m 8wk 1,ctrl
wt_rep1,ctrl
"breast tumor epithelium,45",pert
MLL_00255,pert
Pooled PBMC sample enriched for CD8+ cells from normal control subjects (140CD8),ctrl
LY2 SRC1-siRNA untreated rep2,pert
Klf9KO_jejunum_PND30_2,pert
"P16 mutant OC base, biological rep 2",pert
01N6Z_CTRL,ctrl
jzo023-rp1-v5-u74av2-met,ctrl
"age at diagnosis: 38;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 60;	dfs-event: 0;	distant metastasis: 0",pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID325,ctrl
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
aorta of Tgfbr2 knockout mice,pert
IRAK2 KO_macrophages_2h,pert
5796 KSR2-/- Mouse White Adipose Tissue,pert
"wt total RNA LSK, rep 2",ctrl
Healthy control_sample11,ctrl
WT HPC Veh 5,ctrl
E2 4hr,pert
ak_09+15,pert
"SIRT3KO, standard diet, rep3",pert
F16.01,ctrl
231-Empty_rep3,ctrl
Cell line: BV-173,pert
"vestibualr organ at P90 of Igf1 +/+, biological rep 3",ctrl
11399 Normal Uninflamed terminal ileum,ctrl
3D-cultured chondrocytes from OA donor 1,pert
RNA from HCC_17N,ctrl
"Male, Wistar, 0 access to cocaine, lateral hypothalamus",ctrl
Total RNA from LM2 cells labeled with Cyanine-5 (red).,ctrl
cell type: HeLa cells,pert
V5-P127,ctrl
"breast tumor epithelium,14",pert
"healthy control fibroblast, biological rep5",ctrl
HepG2 cells,ctrl
"RWPE-PCAT1 cMyc siRNA #4, replicate 2",pert
CD8_T_cell_pool_healthy_H07+H08,ctrl
"mouse aorta cross strain comparison, C3H_T40_NC_02",ctrl
tissue: Adrenocortical adenoma;	tumor secretion profile: Aldosterone;	genotype: CTNNB1 mutation (T41A),pert
HT29 derived clone with vector expressing GFP directed shRNA,ctrl
gender: male;	strain: CBA/C57BL/6;	genotype/variation: IL8 transgenic;	tissue: colon cancer tumor,pert
Ctrl siRNA 4d 2,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 5 months;	genotype: Myc heterozygous,pert
"A549 human adenocarcinoma cell line, control",ctrl
APPsa_R6,pert
"siThoc5-1, biological rep1",pert
"HEK293 cell, siRNA-mediated MIF knockdown",pert
tissue: liver;	genotype: WT;	genetic background: C57BL/6,pert
"Lens epithelium, SPARC KO, #1R",pert
healthy CD19 B cells 5,ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, 1.25uM sapphyrin PCI-2050 (1.25uM final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
brain_DLPFC_bipolar C_mr423,ctrl
heart female CVD3 10 dpi rep1,pert
MIY_day_5-4,ctrl
tissue: Cop1-null embryos,pert
"MGSKO, PR02M006v0",pert
ATCC CRL-2868,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: Caucasian/White;	sex: Female;	group: A;	prototype: Y,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	1st technical replicate,pert
01_C57_KO,pert
human_hepatocyte_vehicle_donorB_24hr_prep2,ctrl
IRAK4-KD-MEFs_unstimulated_4hours_rep2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 54.90137,pert
human epithelial colorectal adenocarcinoma cells (Caco-2),ctrl
5IDC_normal_ductal,ctrl
strain: FVB/N;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Fibroblasts;	genotype: Fsp-cre; PtenloxP/loxP,pert
NuLi cell line treated at DMNQ biological rep3,pert
1_CD34+_12h_TCDD-,ctrl
brain_DLPFC_bipolar C_mr539,pert
GSK3B shRNA replicate 2,pert
S46 WT7	F5/55	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
"striatum,24weeks,WT",ctrl
"AALE-Vector + shTBK1, biological rep1",pert
Mut+/+ rep4,ctrl
Liver_normal_no.3,ctrl
"Right brain hemisphere ,C57BL male mouse,Un-treated Control,4 weeks",ctrl
"brain, cochlea: [3] Sample #3_le1",pert
ubb_d21_wt_1,ctrl
GhrhKO_006,pert
S46 NLS 142Q TG7	F4/3	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
MSE_N_626,ctrl
Bone Marrow Mononuclear Cells;	26y Female,ctrl
Trib1 #1 Wild-type macrophage LPS,ctrl
subjectid: 5269;	imatinib: IM;	lbh589: NoLBH,pert
LNCaP prostate cancer epithelial cell line,pert
Nonspecific siRNA2,ctrl
Cardiac Muscle_WT_rep1,ctrl
olfactory epithelium,ctrl
race: caucasian;	age (years): 85-90;	stage: n/a;	grade: n/a;	histology: cystic atrophy with sessile polyp,ctrl
H9_d15_hepatic differentiated_3,ctrl
EA_Case4_CD8,pert
E_Kin_3,pert
4033-1 E2F WT,ctrl
hNHEPS human hepatocytes not exposed to VX at the beginning of experiment,ctrl
Strain: NMRI mouse;	Age: 14 day embryo;	Tissue: molar tooth germ,pert
"Cerebral Palsy, Gracilis, Patient Replicate 3",pert
Individual_4208_PN_sample,pert
small_intestine_complete_24h_fasted,pert
Regulatory T-cells CD4+CD25+ from HDAC6 knock out mice,pert
lean control-2,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: fresh air, treatment over 5 month + 1 day recovery, 4x1h exposure per day",pert
"human failing LV myocardium, Ischemic1",pert
Mouse spleen at 1 month,ctrl
484MM,pert
"24hr Hic5 siRNA, 16hr 10nM DHT treatment replicate 2",pert
453MM,pert
M229_R5_B_DMSO,ctrl
V5-P582,pert
Alb73 mutant mouse,pert
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Control;	condition: -Dox,ctrl
Biceps_Pompe_1,pert
MDS patient 143,pert
whole tissue section from case 1389,ctrl
Cell line expressing inducible wt-GFP-lamin A. Induction: day 0. Replicate B,ctrl
NTB_heart 1,ctrl
baseline control 04,ctrl
01MJ9_Oligo,pert
"C57BL/10-SJL.Dysf TA, replicate 1",pert
U937-shControl-rep1,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 65;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
neocortex-30 months of age-resveratrol diet-biological replicate4,pert
CD11b+Gr1- cell sample_5 (derived from IL17RC Knock out mouse),pert
"Grape extract group, 12 months, patient number 32",ctrl
"fibroblast, control subject NF5 rep 2",ctrl
uterus_veh_PRKO_4hrs_rep1,pert
"Patient  M, lesion, time: 0",ctrl
Hippocampus_Soman_168h_rep1,pert
WT-smoke-low-5 month+1d-R2,ctrl
29_C57_WT,ctrl
RAW CstF-64 3,pert
MA_301,pert
"Peripheral blood, patient without recurrent events [N39]",pert
"4105_CD133+, laminin treated",pert
GIST Pre Treatment Biopsy 12,ctrl
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 3,pert
RORasg/sg liver_HFD_rep3,pert
treatment: Mepenzolate;	time: 7,pert
Pfeiffer NTshRNA 2,ctrl
liver wild type replicate3,ctrl
"2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
GATA3KO_3,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 27.56164,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 102;	Usage number: 4;	Exposures: 3,pert
Female - caucasian - E-05-G,pert
Cochlea_D257A_9mo_2,pert
P5 Patient None,pert
sMPNST_shBrd4.552_3day_rep3,pert
patient: TLW18;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Lung; nmMLCK-/-; spontaneous breathing,pert
EUR12_T6_PP_day14_048,pert
CPU R control 1,pert
3896-1 E2F1 Null,ctrl
"Wild-type Liver, replicate1",ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep4,pert
Run4.aUa.010110d.SkMDbt1147D.CEL-DB stimulate,pert
NET1 knockdown AGS cells,ctrl
RNA from microdissected breast cancer cells from case 1507 labeled with Cy5,ctrl
Pediatric_GBM_45,ctrl
Strain: 129Sv/C57BL/6,ctrl
PGA-HMO-NonObese-3aUA-s2,ctrl
"FOXP3, WT, REP4, 0h",ctrl
"wdNHBE with KY/180 at 36hpi, biological rep2",pert
Run7.aUa.001206d.SkMInS1079D.CEL-IS stimulate,pert
"DSS + L-Arg colon tissue, biological rep1",pert
Cochleae from a9 null mice at P7,pert
FVB_8W_3_3,ctrl
mouse: 4;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
Evi1-3,pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep1",pert
695-383_24hr,pert
Mus musculus embryo E8.5 wild-type,ctrl
liver_Pink1 knockout_24 weeks_replicate_3,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 43;	gender: female;	tumor grade: IV,pert
PBMC from T cell Large granular lymphocyte leukemia patient#114,pert
A549 cells Stretch 1hr Oct 20 2002,pert
coc-53_A,pert
strain: C57BL/6;	tissue: small intestine;	genotype: cftr-tm1Unc (cftr null);	treatment: lubiprostone,pert
major HCC3,ctrl
SEB-1 vehicle control biological replicate 2,ctrl
Young 6,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID300,pert
"human failing LV myocardium, Idiopathic6",pert
WTT 161 bleomycin treated,pert
disease state: wild type;	strain: BALB/c AJ,ctrl
Individual_4981_NN_sample,ctrl
HSF1+/+ T cells at 37oC replicate #1,ctrl
MLL_00230,pert
"Patient 7, Macroscopically intact tissue",ctrl
control AU0943303,ctrl
wildtype strong 3,pert
AVIC sample#1 treated with DMSO,ctrl
BACH2-/- ALL (Sample1),pert
strain: C57BL/6J;	genotype: HDC-EGFP/HDC-KO;	age: 3-4 months;	tissue: bone marrow;	cell type: bone marrow CD11b+Gr-1+ myeloid cells,pert
CD8 KLF13 WT 2,ctrl
RelA_siRNA_0c,pert
Prdm14(-/-) ESC-like cells,pert
CON13,ctrl
"Control shRNA cells passage 7, rep 3",ctrl
12465 UC Inflamed ascending colon,pert
"AD_TC, biological rep7",pert
rd1_P2_rep2,pert
8 wk old male mdx5cv EDL,pert
"Lesional skin from K5-Stat3c mouse, biological replicate 2",pert
LJMJDW14,pert
0-day rat ovary cultured 2 days,pert
E14 cells in ESC media,ctrl
061HZ_CTRL,ctrl
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: PTEN mutant = Mx1-Cre positive: PTENfx/fx. Sex: Male. Age: Eight and a half weeks (at tissue isolation). Tissue: Intestinal Polyp (from jejunun/ileum).",pert
"human failing LV myocardium, Ischemic35",pert
MDS32,pert
01N3M: new onset sJIA,pert
T9.01,pert
G93A non transgenic littermate 1263,ctrl
biopsy specimen,ctrl
RV16;	Age = 22;	Sex = F,pert
Lung-normal-rep5,ctrl
HeLa cells infected with shLSD2 retrovirus,ctrl
benign tissue,ctrl
"Wild type mouse embryonic stem cell, biological rep1",ctrl
Dicer KO replicate 1,pert
SR-A mutant olfactory epithlium 0 h replicate3,pert
ATF6-MER TG mouse_tamoxifen1,pert
"Acute Myeloid Leukemia, sample 1",pert
Adipose-24 month-wild type-technical replicate 1,ctrl
treatment: DMSO;	time: Day8;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
KrasG12D PDEC,ctrl
WT-Fibr1 9,ctrl
Corl51 SCLC cell line,pert
"vastus lateralis biopsy, 76 year-old healthy trained male (#71)",pert
Control bone marrow - Biological Replicate 3 - Technical Replicate 1,ctrl
11409 UC Inflamed ascending colon,pert
Liver sample from Alcoholic hepatitis group (CA28),pert
MDS patient 118,pert
"skeletal muscle, short duration",pert
S011_Scz_M_82,pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 8 hour",ctrl
"mortality: alive;	ethnicity: Hispanic;	gender: M;	age (yrs): 48;	ld: ETOH;	creatnine: 1.9;	mdrd: 38;	gfr: 63;	protein: 1.2;	hematuria: 1;	c3: 1;	c4: 1;	rf: 52;	hcv: NEG;	htn: 0;	dm: NEG;	hba1c: 5.1;	meld: 19;	ana: POS;	gp: Mesangial Immune complex deposit, lupus class II;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 0;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 2;	igm: 1;	c: 2;	empe: NA;	bmwid: NA;	bmd: NA;	edd: P;	no of glomeruli: 7;	glomerulosclerosis: 0;	intact t: 0.95;	arteries: intimal fibrosis, thickening;	if: IGM+IGG+IGA++C3++C1Q+mesangial;	mesangium ig: ACMG;	tissue: Kidney_Biopsy_Liver_disease",pert
WT_P14_Naive_rep1,ctrl
gender: female;	age (years): 62;	evolution time (years): 4;	disease extension: Pancolitis;	treatment: Azathioprine,pert
"striatum,6weeks,KO",pert
"mortality: alive;	ethnicity: Hispanic;	gender: F;	age (yrs): 52;	ld: HCV;	creatnine: 1.5;	mdrd: 39;	gfr: UN;	protein: 0;	hematuria: 0;	c3: 0;	c4: 0;	rf: neg;	hcv: NEG;	htn: 0;	dm: POS;	hba1c: 7;	meld: 23;	ana: NEG;	gp: arterisclerosis, mild mesangial expansion;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 0;	igg: NA;	iga: NA;	igm: NA;	c: NA;	empe: NA;	bmwid: NA;	bmd: P;	edd: P;	no of glomeruli: 1;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: intimal duplication/fibrosis;	if: not submitted;	tissue: Kidney_Biopsy_Liver_disease",pert
Huntington's disease 820F,pert
gender: female;	batch: 1;	age (years): 31;	patient id: Control_7;	fev1 (% predicted): 85;	fvc (% predicted): 96;	medication: None;	cell type: CD8+ T-cells,ctrl
strain: C57BL6;	genotype: WT;	tissue: hippocampus;	treatment: PDE10i,pert
Dilated cardiomyopathy_G8,pert
AQA C,pert
Healthy individual of twinpair #1,ctrl
15A;pretreatment;female;breast tumor; responder,ctrl
"Control small intestine 1, polyI:C, 30 days",ctrl
disease: Down syndrome;	gender: male;	age: 1 year and 2 months;	tissue: thymus,pert
Substantia nigra normal rep3,ctrl
Lesional skin from K5-Tgfbeta mouse,pert
"hepatic gene expression at ""1 hr"", rep1",pert
ESC Cultured in 15% KO + LIF without feeders,ctrl
patient: 24;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Vector control 3,ctrl
NPC5,pert
Aquaporin-11+/+_mouse P7 kidney #5-1,ctrl
"breast adenocarcinoma, cell line",ctrl
Liver_WildType_2,ctrl
CEPI_Ic_317,pert
"Mesodermal Precursor Cells derived from hES cells line VUB01, biological replicate 3",ctrl
32GOBMUC2H,ctrl
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 24 hours",pert
Caudate-Putamen of naive AChE-R mice,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 64 years,ctrl
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/45;	differentiation status: undifferentiated;	cell line: Q50,pert
"Liposarcoma culture from tumor 401, untreated",ctrl
40SAGEA,pert
phenotype: control;	gender: male;	case_id: 329;	age: 48;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.73;	labeling_batch: 1,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:64;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
2059N,ctrl
"MGSKO, PR01M006v0",pert
Brain_Adult_Salineip_4hr_mouse2 (YP2_#59),ctrl
Heart sample4,pert
Nerve_Control_Vehicle_704,pert
strain: C57B6;	genotype: Tgfbr2fl/fl;	tissue: Secondary palate;	age: E14.5;	gender: Not determined,ctrl
TAp63 alpha Q540L 24h without induction s2,pert
"brain, cerebellum: RNA#4*_le1",ctrl
brown adipose tissue,ctrl
Normal cortex of patient T158,ctrl
"Patient 25, Macroscopically intact tissue",ctrl
WT vehicle (7991003040_A),ctrl
tissue: blood;	control: 3;	gender: female;	age: 38,ctrl
Cutaneous psoriasis without arthritis PsC 16,pert
"breast, post AFI treatment (H5_1332)",pert
Cavin-1/PTRF KO #238,pert
P4B Progranulin-cerebellum,pert
"47, XY, +21",pert
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
"patient: 106;	current medication: None;	birth date: 5/29/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: Abdominal pain, upper GI symptoms.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
cell line: SV589;	knockdown (days): 0;	treatment: no treatment,ctrl
"Wild type fetal liver 2, embryo at 12.5 days of development",ctrl
HVS-CD4-control_unstim_rep3,ctrl
laser-captured pancreatic islets,ctrl
Pancreatic Sample 15-Normal,ctrl
Control (C56),ctrl
4_Hr_+MGd_1,pert
OVCAR3_rep2/CD157_DS,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 1",pert
"villin-creERT2:beta-catenin+/lox, induced by tamoxifen for 2days",ctrl
age: 68;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
WT1(-KTS) expression induced for 8 hrs 01-14-03_Lee_U133A_8_2,pert
Pancreatic Sample 35-Normal,ctrl
cell type: MCF-7;	sirna: control non-targeting pool,ctrl
"A673 treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50), biological rep3",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 74,ctrl
gender: Female;	age: 28;	post-mortem delay: 11h;	ph: 6.3,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 180;	colon ratio (mg/mm): 2.95;	myeloperoxidase activity (u/mg): 0.27;	tissue: colon;	treatment: 5% DSS,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 2",ctrl
"Mouse liver, wild type, healthy, 8 months",ctrl
"72 hour-treated wild-type NB4, biological rep3",ctrl
"129 Mouse P0 Pineal Tissue, Sample 3, 05-31-06",ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),pert
Expression data from liver of the KRAP deficient mice (WT2),ctrl
mdx Biological Replicate 3,pert
"Pten null epithelials cells, biological rep2",pert
NS4-040331-SA,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-KO;	tissue: Skeletal muscle (quadriceps),ctrl
"213, MUSCLE, After",pert
Gata3_H4,ctrl
"Placebo treated, HIV-1 positive male, day 14 (1)",ctrl
FmrKO1_brain,pert
"Cerebral Palsy, Gracilis, Patient Replicate 5",pert
Colon_POR-null_2,ctrl
Cerebellum_nontransgenic control A39_4 months_replicate 3,ctrl
Control spleen - Biological Replicate 5 - Technical Replicate 2,ctrl
24h WT Cel.39,ctrl
T2-FP_spleen_wt_rep3,ctrl
"5mg/kg/day PFOA, Rep 5, Block 4, lung (high dose)",pert
AAA neck (Sample 5),pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
Disease_status: Healthy control;	Age (years): 58;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.0;	Post mortem interval (hours): 27;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
Liver_PXR KO_Vehicle_Rep3,pert
Type II cells from Nrf2+/+ mouse.,ctrl
"Neuroblastoma SH-SY5Y cells, transfected with scramble control",ctrl
male_control_257,ctrl
Mus Musculus Kidney,ctrl
NTB_skeletal 2,ctrl
microdissected breast cancer cells from case 295,pert
3 wks sham-4,ctrl
H_LS_Wk12,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: LPA,pert
"HEK293T human embryonic kidney cells, CM, si-control",ctrl
pancreatic islets,pert
Individual_4136_PN_sample,pert
EA_Case9_CD20,pert
Intracranial arterial aneurysm (unruptured),pert
"seminoma specimen, pT1, patient age: 39y; W02 102",pert
pt. HCL F treated with DMSO for 72h,ctrl
status: Control;	gender: Male;	age: 66;	tissue: Blood,ctrl
PGA-MLS-Dil-1bAv2-s1,ctrl
SC-RbKO 3,pert
Subject 6_t=30days_resveratrol,pert
PGA_MI_nilv_24h_362,pert
HF0151_U133P2,ctrl
"Wild-type-hippocampus, biological rep1 (male)",ctrl
"Wild type fibroblasts, biological rep2",ctrl
"hMSC-Tert, RNF40 siRNA, 5 days osteoblast differentiation",pert
RNA A549 cells Static Control 4hr Replicate 1,ctrl
53A;pretreatment;female;breast tumor,ctrl
Endometrium/Ovary-Disease 1,pert
020109-4,pert
TOtal RNA,ctrl
WT_72_O3_2,ctrl
0810A-01_clone 2-1,pert
CHB PBMC_sample 5,pert
shNANOG_6,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 73,ctrl
chip number: 20;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
01J46: new onset sJIA,pert
subject id: c9;	infection: control;	status: control;	tissue: whole blood,ctrl
microdissected breast cancer cells from case 1218,pert
04_NOR,ctrl
CH 4,ctrl
liver_STZ treated diabetic_rep1,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: normal,pert
agent: ConA;	time point: 6 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 0,pert
Bronchial Epithelial Cells MMA biological 2143G,pert
ethanol_ethanol_31,ctrl
ESE_D_599,pert
15KD_SerumStarved->1hrEGF_rep2,pert
untreated WT MEFs-1,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): R1881,pert
brain_control_sampleid_mr951,ctrl
HeLa-LAMP3siRNA-3d,pert
Parkinson's disease sample x012,pert
KN-smoke-high-5 month-R3,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 68;	gender: male;	tumor grade: IV,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case4,pert
Jejunum_POR-null+quercetin_1,pert
tissue: Frontal cortex;	age: 89;	Sex: M,ctrl
HMEC X Confluent HMEC,ctrl
neuron_rep7,pert
SCC1,pert
"human failing LV myocardium, Idiopathic66",pert
mES cells TR71 KD rep2,pert
e_M45B,pert
"GNMT knockout at 3 month age, biological replicate 1",pert
EOM 28 Day Control rep 2,ctrl
healthy control sample x121,ctrl
cell: MCF-7;	treatment: FoxA1 siRNA and vehicle (control),pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: No;	1st technical replicate,pert
"control, BA46-30",ctrl
male JAK2 KO liver sample 207,pert
H4_SS11_01Nov07,pert
129S1/SvImJ Vehicle liver sample batch 5,ctrl
"U373-MAML1-dn, rep 2",pert
MCL_IGHV_UNMUT (R1762),ctrl
Pax3 WT E14.5 palatal shelves 8,ctrl
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep3,pert
wildtype_normoxia,ctrl
Bronchial Epithelial Cells SA biological 2184U,pert
EA_Case19_CD4,pert
MEF_TFAMhet_rep2,pert
Mouse Liver,pert
Wild-type anterior prostate 1,ctrl
"Gata4-KO heart, CRE, biological rep3",pert
FACS-purified B cells_129SV/EV_non-infected_rep3,ctrl
control replicate 2,ctrl
C33KD2_without doxycycline_2,ctrl
subject: 13B;	cohort: 13;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 16kb;	age (y): 42;	Sex: F;	batch: Batch_3,pert
RPE65_KO_4months_retina33,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.753;	Ratio: 2.10,pert
Transfected MCF-7 cell line (control non-targeting pool),ctrl
Carbo Day1 (332L),pert
strain: FVB;	genotype: wild-type;	tissue: mammary gland tumor,ctrl
batch: A;	knock-in: VEC;	cell line: MycCap prostate cancer cells,pert
C57BL/6 BMDM infected with WA(pYV),pert
s8,ctrl
Individual_5919_NN_sample,ctrl
HeyC2+(1),pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14503;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Psoriatic arthritis PsA 15,pert
cell line: CL1-0;	gender: male,ctrl
1087CTRPBMC,ctrl
01UN9_ERA,pert
F9 TSA sample #1,pert
EA_Case15_CD4,pert
Bronchial Epithelial Cells MMA biological 0828C,pert
"Patient I-840-N, normal colonic mucosa",ctrl
Diaphragm 7 Day control  rep 2,ctrl
Normal ear skin from control mouse,ctrl
WT LSK rep2,ctrl
TscHet3_brain,pert
genotype/variation: Vax2-/-;	age: E10.5;	tissue: whole eye,pert
tetO-Satb2 #2,ctrl
Mouse old brain w/ a-tocopherol aT-Br-4,pert
H1bt5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.811;	OD280: 0.9;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 372;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
GM8830,pert
liver_STZ 0.5% quercetin diet_rep2,pert
06R052 Control,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 27;	sex: F,ctrl
B137+,pert
"LNCaP cells, treated with EtOH, biological rep 2",ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 41;	maternal age: 32,pert
Setleis Syndrome patient 2,pert
Brain from 55 days Npc1-/- mouse1,pert
striatum_wild type_24 weeks_replicate 1,ctrl
fluorescent activated cell sorter (FACS)-selected cells,ctrl
WT S49 T-lymphoma cells,ctrl
H441 lung cancer cells,pert
tissue: skin;	individual: Patient P2;	condition: ANL;	eczema severity: SCORAD: 0,pert
"BCL-3 vector, biological rep2",pert
C3_transgenic but unaltered,pert
LNCaP + vehicle rep1,ctrl
GM19238_Kd_KLF13_1,pert
Dilated cardiomyopathy_G28,pert
WT MEFs at passage 3_biological replicate 3,ctrl
Brain from 82 days Npc1+/- mouse1,ctrl
midbrain_Pink1 knockout_18 month_replicate 2,pert
mouse strain: C57BL/6J;	genotype/variation: normal control,ctrl
cell line: MH1C1,pert
HepG2-control-2,ctrl
Regulatory T-cells CD4+CD25+ from wild type mice,ctrl
U2OS shControl replicate 1 [set 4],ctrl
H01_S_B2,pert
"Amoxicillin treated Proximal, Small Intestine 3 17 days old",pert
"CBFb-SMMHCd179-221 animal 2, replicate 3",pert
iPSC derived from CCALD patient dermal fibroblast,pert
HeLa cells were transfected with siRNA specific for optineurin mRNA,ctrl
THP1-shGSK3B-Construct2-rep2,pert
"brain, hippocampus: CH2_e1_le1",ctrl
Kidney_400 mg/kg VCM iv_mouse #046,pert
treatment: control;	time: 0 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,ctrl
Diaphragm 14 Day control rep 1,ctrl
"Liposarcoma culture from tumor 340, doxorubicin treated",pert
"vector d4, rep 5",ctrl
Adrenal WT 0h batch 3 [AdWTh00.23],ctrl
WildType_4,ctrl
A_AN01570_F,pert
RNA from whole tissue section of case 180 labeled with Cy5,ctrl
gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6,pert
tissue: Temporal cortex;	age: 83;	Sex: M,ctrl
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: Regular chow diet,ctrl
clone type: AtT20 clone types treated with control siRNA rep 3,ctrl
RPMI8226_shKDM3A#2,pert
Normal-N_LJ_1,ctrl
"ALL_NDS, K38 011409",ctrl
IRF4-mut_Th17_cells_42hr_rep2,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: post-UV,pert
"Rb KO, biological rep2",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 1,ctrl
microdissected epithelial cells from normal main pancreatic duct 7,ctrl
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/22,ctrl
"ERaKO mouse aorta with placebo, biological rep2",pert
"Cultured ovarian cancer cell line A2008, untreated",ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, actinomycin D (5 ug/mL final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
"Heart, MAT1 control, 2 wk, sample 1",ctrl
"human failing LV myocardium, Idiopathic86",pert
B3_saline_overexpressor_48,pert
colon_Runx1-WT_Cy3_15479,ctrl
SUDHL-1 cell line teated by ALK inhibitor,pert
tissue: Brain;	genotype: Npc1-/-;	age: 82 days;	subject: Mouse1;	genetic background: BALB/c,pert
V5-P104,pert
mouse hippocampus,ctrl
"genotype: wild-type;	strain: C57BL/6;	gender: male;	age: 8 weeks, 3 days;	tissue: colon",ctrl
KU_15T,pert
"ALL_DS, K1 011409",pert
batch: A;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,ctrl
T144 U133p2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 105min;	race: White;	sex: Female,ctrl
ic20 -- APF on membrane B,ctrl
MDA-MB-231-pcDNA6 cell culture 2,pert
"CCM3 shRNA cells, passage 7",pert
wt_TGFb_24hr_1,ctrl
E2f8 KO Mouse spleen Ter19+CD71high sorted cells,pert
cerebellum_WT_4w_rep1,ctrl
DC-5LA,pert
con-7,ctrl
"Acute Myeloid Leukemia, sample 37",ctrl
BALB/c d3 (190msn),pert
skeletal muscle myoblast_WT_day3,ctrl
Hippocampus 1989 15 month Old,pert
"U-87 glioma cell line with shcontrol, biological rep3",ctrl
Insig1 ∆/∆ /Insig2 -/- InsigKO_E3,pert
"BMMCs from NTAL WT, pLKO.1 infected, 2 h activated, biological rep2",ctrl
Bronchial Epithelial Cells MMA biological 2073L,pert
CD4_T_cell_pool_melanoma_M01+M02,pert
Trabecular meshwork tissue from POAG donor A. 59y/male/caucasian. Cause of death: Renal failure. Othe ocular diseases: cataracts. IOP: 17-28. Drug therapy: Xalatan,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep4,pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 7.5;	colon weight (mg): 166;	colon ratio (mg/mm): 2.21;	myeloperoxidase activity (u/mg): 0.009;	tissue: colon;	treatment: 5% DSS,ctrl
"Strain: C57BL/6; PGC1beta mutant mopuse, Tissue: quadriceps muscle",pert
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
DS-Fibr 2,pert
A/J Vehicle liver sample batch 2,ctrl
non-malignant FTEn_patient 7,ctrl
P14 - nudelkoMix/+ 1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.606;	OD280: 0.744;	Ratio: 2.12;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 145;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CONTROL;	Age = 19;	Sex = M,ctrl
266C6,ctrl
34208.LMP,ctrl
Pooled normal myocardium sold commercially (B),ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep1",pert
"human failing LV myocardium, Ischemic51",pert
"Lens epithelium, SPARC KO, #4L",pert
TL3 LAMC2 KO 3,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 68;	baseline tumor size (cm): 8x8;	patient id (to identify the 2 chips from the same patient): 12781328,pert
Ad infected murine liver-MO30k-(230)-6hpi,ctrl
Tet1-kd_ES_rep1,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 3,ctrl
01LKY_PolyRF-,pert
wt-Gfp P10 replicate 1,ctrl
"breast tumor epithelium,36",pert
Subject #8009-Preinfection,ctrl
"3mg/kg/day PFOA, Rep 1, Block 3, liver (low dose)",pert
sample =Healthy4 treatment=Control time=180 (min),ctrl
Cardiacmyocyte,ctrl
GEIM164-PM,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: LPA,pert
IP RNA_KO_rep2,pert
B_LS_Wk4,pert
miR122-KO,pert
HEK293 F18_doxycycline untreated,pert
affected brother,pert
C1_CLP_wildtype_8,ctrl
subject: 22A;	cohort: 22;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 27kb;	age (y): 71;	Sex: F;	batch: Batch_5,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 30;	maternal age: 28,ctrl
Strain: C57BL/6; Tissue: quadriceps muscle,ctrl
I_LS_Time0,ctrl
Diagnosis: AML M5;	Age: 68y ;	Gender: Male;	Blast %: 69;	Source: BM;	Cyto: tris8;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
34 with Cy5,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 6h",pert
mouse cerebellum at P30 knockout 2,pert
"HA-Fbxl10 cell, Replicate 3",pert
Trim28CKO unstimulated CD4 positve T cell rep3,pert
HeLa cells treated with Cas-II-gly,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: marginal;	Ig clonality: oligoclonal,pert
2008-Ets1 stable inducible (tetracycline) ovarian cancer cells,pert
Du145-PCAT1 cells transfected with cMyc siRNA #3,pert
"Vehicle treated, no doxycycline; biological replicate 2",pert
HNF4a2_1+,pert
Bmpr1a-/- N2B27 sample 3,pert
genotype: Villin-Cre - / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 88,ctrl
knockdown Tcof1 [A],pert
231_GATA3_rep3,pert
"4105_CD133-, untreated",ctrl
CD46+ hippo - Untreated-C,ctrl
OSCE-5T,pert
"non-AD_FC, biological rep10",ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 8",ctrl
"20 days old normal mice, cerebellum",ctrl
C57BL10 quadriceps sample 2,ctrl
OSCE-18N,ctrl
P0 Whole Brain,ctrl
LNCaP.FoxA1.6,pert
Liver_nash_no.1,ctrl
RA patient,pert
"Vehicle treated, no doxycycline; biological replicate 3",ctrl
"S1P2-KO-neocortex, biological rep6 (female)",pert
"control triceps, biological rep1",ctrl
J1 mouse embryonic stem cell,ctrl
"Normal subject (47 year old caucasian male, SAK_1274874502)",ctrl
"midbrain,6weeks,WT",ctrl
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic.",ctrl
Globin_S6,pert
MO32_15,pert
WT HPC PDE10i 15,pert
C4bt5,pert
CD3-purified cells from T-PLL peripheral blood sample. >95% purity,pert
"Ishikawa cell line, BPA, 100pM, 8hr",pert
human skeletal muscle from diabetic individuals before insulin therapy,ctrl
age: 44;	gender: female,pert
Bone marrow derive macrophage,ctrl
H25 HA 24h 1,pert
umbilical cord_nobpd: 3C,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 24 hours,pert
Saline treated mouse gallbladder 1,ctrl
Tendon_lesional_rep18,pert
"10mg/kg/day PFOA, Rep 3, Block 3, liver (high dose)",pert
LT 339 +/T untreated,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp3,pert
coMCF-7_3,ctrl
NM Spinal cord 75 day,ctrl
NE-rep5,ctrl
Subject #8040-8hr Postinfection,pert
L428+MAT_rep3,pert
"human nonfailing LV myocardium, NonFailing11",ctrl
patient: CLS14;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
HCC PBMC Sample 3,pert
"Patient 4, Macroscopically intact tissue",ctrl
brain_DLPFC_bipolar C_mr801,pert
"Bone Marrow sorted Zfx-flox HSC (Lin-, Sca1+, c-Kit+)",ctrl
"SiRNA-scrambled, replicate 5",ctrl
"Acute Myeloid Leukemia, sample 50",pert
subject: 21B;	cohort: 21;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 59;	Sex: F;	batch: Batch_5,pert
2002T,pert
strain: FVB/N;	genotype/variation: wildtype;	age: embryonic day 9.5;	cell type: erythroid cells,ctrl
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: FIZZ2 knockout,ctrl
OVCAR-8+(3),pert
JIA PBMC Pre treatment A235_L010,ctrl
age_years: 45;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
"fibroblast, MFS subject FB1234 rep 2",pert
Psoriatic arthritis PsA 10,pert
"Exp A, Animal #270, 5mg/kg D-Serine",pert
tissue: blood;	patient: 6;	gender: male;	age: 46,pert
Human skeletal muscle biopsy sample;	Patient #17 with PM,pert
Control siRNA 1,ctrl
"t22, surgically resected from patient of gastric cancer.",pert
"WI-38 cells, at 24 h after exposure to 0.5 uM BPDE, biological rep3",pert
Cisplatin_2h_rep2,pert
8 week old EOM MDX rep 1,pert
non-malignant FTEn_patient 10,ctrl
PND28 Rat Testis_Rat230-2_1hr MEHP_Animal#39_04005,pert
4m3,pert
0972-01-C,ctrl
SKM WT1,ctrl
s5t4c,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.48;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Tissue: striatum;	Age: 6 months;	Gender: F,pert
"Patient #1, Untreated",pert
SKBR3_1uM_Lapatinib_1,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-sp2,pert
unstimulated sparse HUVECs,ctrl
mammary stoma-4w-KO-rep1,pert
jzo015-rp1-v5-u74av2-met,ctrl
Peripheral blood mononuclear cells;	TTF=65min;	Race=White;	Sex=Female,pert
"Testes, 8 hours after cadmium treatment, biological rep 1",pert
pediatric AML PP5,pert
liver,ctrl
"WI-38 cells, at 24 h after exposure to 0.5 uM BPDE, biological rep1",pert
Disease_status: Healthy control;	Age (years): 51;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
quiescent ulcerative colitis_UCN4,ctrl
HEK293 cells siRNA BAHD1 biological rep3,pert
GEIM63-NORM,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day14,ctrl
"HERVH shRNA, rep3",pert
Control Treg,pert
Control_4,ctrl
"Mouse, ATF6aKO, colon, DSS, rep1",pert
brain_OFC_control C_mr350,ctrl
4015-1 E2F2 Null,pert
"ALL_DS, K28 011409",pert
5192 Normal Uninflamed sigmoid colon,ctrl
MCF10A-Vector-rep3,ctrl
Diagnosis: MDS/AML;	Age: 76y ;	Gender: Female;	Blast %: 96;	Source: PB;	Cyto: No Data;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
whole blood_101794,ctrl
Fetal heart 3 ug/kg TCDD rep2,pert
human preadipocytes+oligo1_day6_rep1,pert
colonic_mucosa_non_inflamed_123,pert
Scrambled 12 hours_2,ctrl
6171 Wild Type Mouse White Adipose Tissue,ctrl
Large cell neuroendocrine carcinoma 001,pert
CF (D508) subject1,pert
"schizophrenia, BA46-97",pert
Pax_S4,pert
strain background: F2 of C57BL/6J and DBA;	gender: female;	genotype/variation: wild type;	age: 3 months;	tissue: hippocampus,ctrl
FR-si222-3,pert
patient: 30364;	sample: tumor,pert
nebivolol treated muscle cells,pert
RKO_liver_fasted_refed_3hr_rep3,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.03;	RNA Integrity Number: 8.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Strain: Fischer 344;	Gender: Male ;	Age: 6 ;	Tissue: Liver of D3T treated rat,pert
"Lesion Skin, LS-16",pert
cell line: HEK293 cells WTX inducible clone F18;	agent: doxycycline,ctrl
CuFi cell line treated at DMNQ biological rep1,pert
NINDS-RHS-Ctr_240h-3aUA-s2,ctrl
scrambled siRNA biological rep 2,ctrl
ASC_lean_biological rep2,ctrl
"normal breast epithelium,2",ctrl
"gender: Female;	age: 90;	post-mortem delay: 12.5h;	ph: 5.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Patient 3 a,pert
KO - 3 mo - repeat 4 - Cy3 - mAdbID:74675,pert
5238 UC Uninflamed sigmoid colon,pert
Against CDK8-2 rep2,pert
C10-4,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 2, Units of Harvest Time Point: hr",ctrl
Cdh1_cKO_3,pert
CAB10_T3_PP_day1_033,pert
EB_2_6h_206_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
"healthy breast 2, biological rep. 2",ctrl
COP control replicate 1,ctrl
NFIA P16KO2,pert
"acutely admitted, severely psychotic schizophrenia patient  A25",pert
ILD Study Number 1107,pert
Tet1-kd_ES_rep2,pert
"Alk shRNA, biological rep3",pert
AA_Case18_CD8,pert
"midbrain,24weeks,WT",ctrl
whole tissue section from case 607,ctrl
"brain, cerebellum: RNA#42a_le1",pert
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
5241 UC Uninflamed sigmoid colon,pert
Individual_4618_NN_sample,ctrl
"gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
MLL_00123,pert
"DBA/2J SAL, Rep2",ctrl
3x Ez f/wt,ctrl
I_LS_Wk4,pert
293T cells with scramble shRNA (control cell line).,ctrl
MO32_17,ctrl
"SRF silenced, treated with EtOH, biological rep 1",ctrl
P60 wt1,ctrl
cell line: Panc0504;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 3;	psoriasis duration: 16.9158110882957;	age of psoriasis onset: 18,pert
HCT116-Neo124 PTEN +/+,ctrl
race: caucasian;	age (years): 58;	stage: IB;	grade: 1;	histology: endometrioid,pert
"shCDK8, normal growth, replicate 2",pert
RKO colon cancer cells,pert
HCC1954 Cell Treated 1,pert
patient: CEM11;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
T30617,pert
CH1+(1),pert
b38+,pert
MA_67,pert
"DMSO-treated NRK-52E cells at 6h, biological rep 1",ctrl
Wild-type standard cage Rep1,ctrl
3880-1 E2F WT,ctrl
brain_DLPFC_bipolar C_mr677,pert
KN-sham-5 month+13d-R3,pert
MIC3,ctrl
"Femal C57BL/6, ovariectomized",ctrl
Disease_status: Bipolar disorder;	Age (years): 44;	Gender: Female;	Age of onset (years): 26;	Duration of illness (years): 18;	Brain pH: 6.37;	Post mortem interval (hours): 37;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
4041-1 E2F3 Heterozygous,pert
PBMC from T cell Large granular lymphocyte leukemia patient#123,pert
GB 9 65A NO LPA,ctrl
"MCF-7 cells-40mM g-T3, biological rep 3",pert
PTEN+/- ep_A,ctrl
"Control Day 5, biological rep2",ctrl
fibroblast_Normal_D207_Media_6,ctrl
Wild type IFN-gamma 2 h,ctrl
T56,pert
HUVEC_control experiment 4,ctrl
P0 - WTMixA 2,ctrl
db/db 14-1,ctrl
RL_siRNA_LIF1h_rep2,pert
colonic_mucosa_inflamation_119,pert
U937-shControl-rep3,ctrl
"nasopharyngeal carcinoma, specimen T5",pert
"Liver from STZ-treated mice, biological replicate 6",pert
Seltzer 21d replicate 2,pert
n16,ctrl
WT 1 cerebellum 3 month,ctrl
D2-Gpnmb+ control rep1 (retina),ctrl
Sample 4,pert
"breast tumor epithelium,33",pert
Capan2 cells transduced with lentivirus carrying shRNAs targeting LLGL1 transcript,pert
Muscle PCOS control 8,ctrl
Liver_Control _Rep4,ctrl
MS patient 1,pert
STV_E,pert
"ARD291, CAIS, F, GOF, 6 x 100nM DHT, 14d",pert
DC-7LA,pert
Healthy3-CD8,ctrl
Muscle-AMPKgamma3-wt-1,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 4,pert
RNA from HCC_13T,pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 687,ctrl
kontrolli_DC_D,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with a 1st generation (E1-E3-CMVLacZ) vector.,pert
siRNA-1-PLASTIC,pert
Postnatal 12 weeks control heart biological rep3,ctrl
Human wildtype fibroblast,ctrl
1067-03-A,pert
01MLB: new onset sJIA,pert
in situ 2,pert
511MM,pert
BAT_KO_4,pert
NOMO-1 control 2,ctrl
db/m 5-4,pert
B6-rep1,ctrl
sample type: ove26 mice;	strain: fvb(cg)-tg(ins2-calm1)26ove tg(cryaa-tag)1ove/pnej;	gender: Male;	age: 8 weeks;	tissue: glomerulus;	disease state: Diabetic,pert
Wild-type standard cage Rep3,ctrl
MDS patient 96,pert
13: NORMAL #99-0583,ctrl
H1299_shGFP,ctrl
high grade serous carcinoma_patient 7,pert
9m5,ctrl
BL Day 2 siSC transfected biological rep4,ctrl
Psoriatic arthritis PsA 20,pert
MDS26,pert
PGA-HMO-MObese-6aUA-s2,pert
59A;pretreatment;female;breast tumor; nonresponder,ctrl
sample =XCGD5 treatment=Control time=90 (min),pert
cell line: A549;	agent: decitabine;	dose: 0.3 uM,pert
AZ-521_doxycycline_18h_rep1,pert
SCHT control 2,ctrl
"Endometrium, postmenopausal, control, 2",ctrl
"shEGFP T47D cell line, replicate 1",ctrl
sample =XCGD3 treatment=Stimulated time=90 (min),pert
CUTLL1 MigR1 GSI,ctrl
L_LS_Time0,ctrl
cerebellum_WT_18w_rep1,ctrl
Satb1-/- clone 1-2,pert
GLIP2,pert
Actinomycin D treated A549 human lung cancer cell cultures replicate A,pert
10 week mutant OMN rep 1,pert
Control subject 106_biological replicate 1,ctrl
MeCP2_1,pert
Pool Eu_P0_hyb1,ctrl
Wild type_kidney_3,ctrl
multiple myeloma (MM 158),pert
Y SIT_B070,ctrl
"205, ADIPOOSE TISSUE, After",pert
Insm1 mutant #3,pert
CLL14-CD4,pert
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 15 months;	tissue: liver;	disease status: healthy,ctrl
p53_siRNA_0a,pert
B10.H2g7 Idd3_S1,ctrl
Liver Tro3,pert
Skinbiopsy_0h_controlsubject_k4,ctrl
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"69B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Global gene expression of NASH patient, P59",pert
HepG2_Ni rep3,pert
2h WT Cel.37,ctrl
"brain, hippocampus: KA24-II_e1_le1",pert
B cells - wildtype mice - not infected,ctrl
PGA-RMM-18h-3aA-s2b,pert
RNA-DHL4-R406-48H-2,pert
SPC WT lung (adult),ctrl
5922012008_D,pert
Jurkat T-cells non-transfected,ctrl
"4B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
PPARg KO macrophages rep 2,pert
cell line: A549;	agent: azacitidine;	dose: 3 uM,pert
ILD Study Number 558,pert
individual: patient11;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"2102Ep cells SOX2 siRNA, biological replicate 2",pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.76164,ctrl
"H1299 treated with PTD-DRBD GAPDH siRNA, 12hr",pert
"human failing LV myocardium, Ischemic4",pert
73 year old male,pert
"CL1-0 mock control, biological rep1",ctrl
heart_Q10_6M_rep2,pert
V5-P276,pert
duration of untreated disease in month: 63.5;	age at onset: 5.1,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
HCC PBMC Sample 2,pert
KO STR Veh 26,pert
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: wildtype,ctrl
LY2 SRC1-siRNA untreated rep3,pert
cKO 24h V1::3,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 8",ctrl
NICM pool 3 (n=4),pert
4-HPR_LUNG_4,pert
Control subject 40_biological replicate 1,ctrl
human liver; early HCC,pert
strain: C57BL/6J;	tissue: WAT;	genotype/variation: wild-type;	gender: male;	age: 3 month,ctrl
Sox2-ShRNA-1,pert
mortality: alive;	ethnicity: Asian;	gender: M;	age (yrs): 33;	tissue: Normal_Kidney_Biopsy,ctrl
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 3",pert
16: NORMAL #99-1053,ctrl
"ERbKO mouse aorta with placebo, biological rep2",pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient B;	treatment: Vemurafenib 1000 nM for 48h,pert
"Gata6-KO heart, CRE, biological rep3",pert
BP27,pert
"Endometrium, postmenopausal, control, 37",ctrl
"E18.5 brain, Meg3 knock-out, rep 5",pert
"Lung tissue of Nrf2 knock-out mouse, smoke treated",pert
"The Identification of gene expression changes in human embryonic fibroblast cells, background. Sample B",ctrl
Sex: female;	Age at operation: 57 years;	Site: thorax;	Size in cm: 4.9x4x3;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,pert
heart female pbs 10 dpi rep1,ctrl
remitted schizophrenia patient  S08,pert
Testis WT 0h batch 4 [TeWTh00.25],ctrl
11439 UC Uninflamed descending colon,pert
"age at diagnosis: 60;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3a;	er: 0;	pgr: 0;	dfs-month: 19;	dfs-event: 1;	distant metastasis: 1",pert
"normal skeletal muscle, biological rep7",ctrl
Nerve_Diabetic_Rosi_720,pert
1P-M4-ND,pert
Subject 6 / lung subsegment instillated by Saline,ctrl
TAC 4,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 18.378;	Ratio: 2.09,ctrl
PND28 Rat Testis_Rat230-2_6hr MEHP_Animal#33_04005,pert
Zucker rats,pert
"Normal skin from Tgfbeta_control mouse, biological replicate 3",ctrl
genetic background: hybrid C57BL/6J and 129S5/SvEvBrd;	genotype: Alk2 cKO,pert
CH2128,ctrl
Retina wildtype 30 days 1,ctrl
MDS patient 173,pert
"Uninvolved Skin, NS-2",pert
Brg1 deficient,pert
IMR90 cells stably expressing H-RasV12 treated with Metformin,pert
age_years: 62;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
batch: A;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,pert
db/db 11-4,pert
Mock,ctrl
NSC_FOXO_WT-3,ctrl
Normal mucosa 1,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 6;	gender: male,ctrl
tissue: primary brain tumor;	cell type: oligodendrioglioma;	age: 45;	gender: male;	tumor grade: OGIII,pert
"liver_LDLr-KO, biological replicate 3",ctrl
RNA from HCC_2N,ctrl
"Normal subject (40 year old caucasian male, SAK_1265998952)",ctrl
"Mouse embryonic fibroblasts, control",ctrl
MCL_IGHV_MUT (R1333),pert
"schizophrenia, BA10-29",pert
11420 UC Uninflamed ascending colon,pert
"breast tumor epithelium,25",pert
No or early 1 rep8 (OHN),pert
"A673 treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50), biological rep3",pert
Dysf +/+ TA control mouse muscle,ctrl
Subject #8017-Preinfection,ctrl
Tendon_non-lesional_rep11,ctrl
Patient 9 after folic acid,pert
LNT-1,ctrl
"AALE-Vector uninfected, biological rep2",ctrl
ATP-treated AML 13 blasts,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 220,pert
GM19238_Kd_CLOCK_3,pert
215/0,pert
ko 13.5d replicate 9,pert
"Control, sample 1",ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 90;	Usage number: 1;	Exposures: 2,ctrl
"wild-type P9 hair follicle, biological rep2",ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 6",pert
Peripheral blood mononuclear cells;	TTF=125min;	Race=White;	Sex=Male,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-sp2,pert
cell line: HEK001,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: G;	transfectant type: stably transfected with RNAi against DJ-1,ctrl
"Uninfected TG at 5 d.p.i., rep2",pert
Muscle PCOS pioglitazone 161,ctrl
wild-type prostate epithelial cell line,ctrl
sciatic nerve of PMP22 knockout mice at P4,pert
age: 49;	sex: M;	disease status: control subject;	Filter number: 84;	Usage number: 5;	Exposures: 3,ctrl
age: 36;	sex: M;	disease status: control subject;	Filter number: 98;	Usage number: 5;	Exposures: 3,ctrl
3_3_MOE_430A_WT,ctrl
SKM KO7,pert
BE-rep7,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.57808,pert
KU_03N,ctrl
Substantia nigra normal rep9,ctrl
"pancreas, ethanol diet, male Wistar rat",pert
U2OS osteosarcoma cell line transfected with an shControl construct,ctrl
erlot2_CT41,pert
Mening UNSTIM WB SW 0b,ctrl
"LCL GM19238, Kd TCF12, 72hrs",pert
CH2119,pert
"MaF pre-iPSC9P2, Vc treated, lysed on D6",pert
Low pH stimulated SKGT4 cells,pert
Run4.aUa.010110d.SkMDbt1146D.CEL-DB basal,ctrl
"Ls174T, β-catenin siRNA, induced",pert
liver_Wt_female_35wk_rep4,ctrl
cDNA no 18,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 6,ctrl
"fatty (fa/fa), liver, Pioglitazone",pert
Brain area 8/9_8yp_RTT,pert
cell line: PC-3;	transfection: control miR,ctrl
cell line: PA-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Bone-Marrow_SMM_S1216,pert
"wild type saline, biological rep2",ctrl
WTGFP QSC Biological Rep.2 Technical Rep.2,ctrl
Fetal heart 3.0 ug/kg TCDD rep4,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shControl,ctrl
T14,pert
colonic_mucosa_non_inflamed_743,ctrl
"Liver from MON exposed rats, biological rep 4",pert
heart of male mouse subjected 2 week to chronic constant hypoxia,pert
BACH2-/- ALL (Sample2),pert
"testis, Repro9 mutant, 14dpp, Rep1",pert
33 with Cy5,pert
V5-P107,pert
DC2,ctrl
"anN1 P9 hair follicle, biological rep1",pert
Liver,pert
Nasal Epithelium,ctrl
"gender: female;	batch: 1;	age (years): 45;	patient id: Severe_7;	fev1 (% predicted): 71;	fvc (% predicted): 105;	medication: Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline;	cell type: CD8+ T-cells",pert
"patient 8, left arm treated with pimecrolimus until day 22",pert
Gastrocnemius Muscle WT rep1,ctrl
B4 436 b4-/- after nicotine-induced seizures,pert
b2.2,pert
"age at diagnosis: 46;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): TX;	n (lymph node metastasis): N2;	er: 1;	pgr: 1;	dfs-month: 60;	dfs-event: 0;	distant metastasis: 0",pert
Leg 112 Day mdx rep 1,pert
SeroTest-7,pert
"male sprague-dawley rat, 21 days olanzapine",pert
SNB19 PARK2 siRNA#1 replicate 2,pert
695-383_16hr,pert
antimicroRNA-449_rep1,ctrl
"Ulcerative Colitis (25 year old caucasian female, SAK_1286453367)",pert
Human colon cancer cell line Caco-2,pert
NFIA P16WT2,ctrl
"brain, cerebellum: RNA#17_le1",ctrl
Cutaneous psoriasis without arthritis PsC 3,pert
pediatric AML S20,pert
Quercetin day 05 sample 1,pert
Mock infected macrophages harvested at 1h post-treatment from donor 3,ctrl
Mouse old heart C30-Ht-5,ctrl
4 hour tunicamycin CHOP-/- A,pert
Wild Type 650,ctrl
Psoriatic arthritis PsA 11,pert
age: 62;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Female - caucasian - E-06-M,pert
3461,pert
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Control_AF_2,ctrl
Cmah KO_kidney_1,pert
"BMDM, LPS 1hr",pert
Eed KO E14 ESCs on day 3 #2,pert
M24met_control_4,ctrl
FmrKO5_brain,pert
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 719,pert
Bronchial Epithelial Cells MMA biological 2134F,pert
"schizophrenia, BA46-37",pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 4 hour",pert
"immortalized cells derived from brown fat tissue of PGC-1alpha KO mouse (mixed background), expressing a siRNA specific for PGC-1beta knockdown.",pert
U2-OS-ERa,pert
cell line: MLL-AF9 AML cell line 10949 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
tissue: white blood cells;	age: 5;	Sex: male,ctrl
PBMCs_IS_17 [IS],pert
"Patient I-c396T, MSI colorectal tumor",pert
Tendon_non-lesional_rep9,ctrl
Parkinson's disease sample x102,pert
"wild-type Nrf2 mice, liver sample",ctrl
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC,pert
strain background: 129/B6 hybrid;	cell type: embryonic stem cells;	genotype/variation: Rybp-KO,pert
control4,ctrl
EB_2_5d_218_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
EA_Case12_CD8,pert
Control d10 (4),ctrl
WT-SB-2,ctrl
Mnk_3176-R-7,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 4,ctrl
MNR 5-2 KO 2,pert
Cancer 12,pert
CD11b+Gr1+ cell sample_4 (derived from IL17RC Knock out mouse),pert
"ESCs overexpressed Foxd3, biological rep1",pert
"DMD skeletal muscle, biological rep15",pert
156B,ctrl
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: corn oil vehicle,pert
Liver_untreated_wild type_rep3,ctrl
pt. HCL A treated with DMSO for 48h,ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siUbr5,pert
"prdm-Rosi, biological rep2",pert
Patient: L;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID284,pert
15d control_Pool 11,ctrl
original diagnosis: Psoriatic;	cell type: Peripheral blood mononuclear cells,pert
T137 U133p2,pert
01 Con,ctrl
Insm1 mutant #6_pituitary gland,pert
aa.4,pert
Snell 6 month Wild Type Liver 86c,ctrl
ab144 IM,pert
HDAC6_1,pert
Control_Castrated OWJ59,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Female,ctrl
ILD Study Number S027,ctrl
"129 Mouse P0 Pineal Tissue, Sample 2, 05-23-06",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 50.55616,pert
GSK-3 inhibitor effect on MLL leukemia cells - 3,pert
NPC_VUB01_2,ctrl
"Untreated ES cells, Rep 3",ctrl
"Carcinoma in situ_2 (CIS, double transgene)",pert
"breast, pre AF treatment (H1_1278)",ctrl
"brain, hippocampus: Ctr-240h-P15-II_e1_le1",ctrl
e_M43B,pert
age: 62;	gender: male;	ejection fraction: 51;	left ventricular end diastolic diameter: 73;	inflammation/PVB19: positive,pert
3 day LAD ligated heart from MRL/MpJ strain,pert
"Mouse organ of Corti from cochlea, basal half, Dicer1 conditional knockout",pert
Control with WY14643 replicate 6,pert
"Distal, Small Intestine 21 days old",ctrl
Lmna H222P heterozygous male 4,pert
Skin_ K5IKKb_2,pert
con-56_B,ctrl
181D6,pert
Wtc-Met_2,ctrl
mESCs_Tip60KD_rep4,pert
EB_6_6h_287_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
"Age: 44;	Sex: M;	Ancestry: European;	Smoking status: smoker, 45 pack-years",pert
Wild Type 10,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep5",ctrl
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 400 mg/kg,pert
"Wild-type-neocortex, biological rep8 (female)",ctrl
"Retina from control mouse at ZT6, biological rep 1",ctrl
"acutely admitted, severely psychotic schizophrenia patient  A08",pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P60,ctrl
siHic5 VC 1,pert
Retina,ctrl
age: 91;	post-mortem delay: 4.5h;	ph: 6.3,ctrl
sex: Male;	Age: 6 months;	additional patient information found in Series supplementary file,pert
IOSE80pc shARID1A at 72h,pert
Blood_Control 5,ctrl
Second shYY1,pert
"Normal 12, control tissue",ctrl
E12.5 wt1,ctrl
"NB4 cell line, TG2 knockout, untreated",ctrl
brain_DLPFC_bipolar C_mr283,ctrl
Gender: Female;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: poor;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
"shBAP1 #1 cells, rep1",pert
Retina homozygous KO 30 days 4,pert
quadriceps_muscle_Wt_female_35wk_rep3,ctrl
strain: FVB;	genotype: E2F2 null;	tissue: mammary gland tumor,pert
Tk6 untreated controls for arsenic exposure rep2,ctrl
"24hr Hic-5 siRNA, 16hr vehicle treatment replicate 2",pert
Knock-out postnatal day 10,pert
cell line: SKBR3 resistant;	treatment: 1uM Lapatinib,pert
strain: C57BL6/J;	genotype/variation: Sfrp5 KO (Q27Stop);	gender: male;	age: 12 weeks;	diet: 8 wks of high-fat diet;	tissue: gonadal white adipose tissue (WAT),pert
"Pou4f1-/- cells, transduced with control virus_KO_MSCV_84",pert
"Patient C-c215T, MSI colorectal tumor",pert
Insig1 flox/flox /Insig2 -/- InsigKO_C3,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 24;	tissue: Normal_Kidney_Biopsy,ctrl
sepsis patient #9,ctrl
Rybp#15 (OHT+)_4d_rep2,pert
control siRNA (siCon) tranfected into C2C12 myoblasts rep2,ctrl
normal 1037,ctrl
FVB_MMTV_Wnt1_2543-4L_Rosen,ctrl
A549 DAC 3 uM (3223),pert
quiescent p27KO MEFs 1,pert
patient liver biopsy,pert
126OE 20A n,pert
minor HCC1,pert
tissue: breast;	normal/tumor: tumor,pert
human subcultured chondrocytes (passage 2) from OA donors maintained for 14 days in scaffold culture,pert
tissue: Hodgkin lymphoma;	cell line: KM-H2,pert
"Mel18 shRNA, biological rep2",pert
E9C,ctrl
CLDN18_KnockOut_1,pert
RAW Untreated 3,ctrl
Ebs at Day2.5 were treated with Activin for 2 h,pert
"Control siRNA - Undifferentiated, rep2",ctrl
tissue: Frontal cortex;	age: 80;	Sex: M,ctrl
age: 48;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"G42 cells from M1, wild type control, biological replicate 3",ctrl
cerebellum wild type 21 month replicate 1,ctrl
blank_7,ctrl
ARF1 siRNA knockdown MDA-MB-231 sample 1,pert
Healthy-10 baseline,ctrl
DUSP1+/+ control replicate 3,ctrl
wild type MEF time 0 replicate 3,ctrl
NT2,pert
MOLT4_ctrl_B,ctrl
unused donor heart with normal LV function,ctrl
"brain, Entorhinal Cortex: 01-22 tangle_e1_le1",pert
"129P3/J Saline treated, biological replicate 3",ctrl
Scrambled 12 hours_3,ctrl
brain_DLPFC_bipolar C_mr521,pert
Liver KO5,pert
E14.5 Tgfbr2 Wildtype Mouse Model Tongue 1,ctrl
CKO Wild Type V1,ctrl
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: STAG2 knockout clone 21 (STAG2 deficient),pert
"RNA from 3 MCF7 cell culture plates treated with vehicle (ethanol 0,3%).",ctrl
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
CME-Emerin4d-2MA-S2,pert
PGA-lv_1h_514,ctrl
GIST_WT_2,ctrl
cell type: peripheral blood mononuclear cells;	disease state: healthy control,ctrl
siRNA COP1 scanned on 07/21/10,pert
Grhl2 downregulation in MLE 15 cells 3,pert
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 2 days osteoblast differentiation,pert
alveolar macrophages from bronchoalveolar lavage,ctrl
"Deltoid, FSHD, cohort 19, subject 19A",pert
A_AN08873_F,pert
GM19238_Kd_RAD21_1,pert
HF0383_U133P2,ctrl
PBMCs from CIS patient after IFNb-1a in-vivo treatment,pert
Strain: C57BL/6J;	Gender: female;	Age: 7 weeks;	Tissue: whole brain,ctrl
patient: 25;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
NCCIT siTET2 rep2,pert
patient: 30277;	sample: tumor,pert
HCC PBMC_sample 1,pert
whole tissue section from case 180,ctrl
KO - 5 mo - repeat 4 - Cy3 - mAdbID:74139,pert
control IgG_rep3,ctrl
HMEC X BC2-2,pert
Flp-InTMT-RExTM-293 (Invitrogen) cell line derived from the human embryonic kidney cell line HEK293 carrying tetracycline inducible transgene,pert
Pt_3 Acne Lesion,pert
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
Kidney_400 mg/kg VCM ip_mouse #107,pert
BALB-RAG_PBS Replicate 2,pert
5922012047_B,ctrl
"NTera-2 cells SOX2 siRNA, biological replicate 2",pert
"Liver, untreated, rep3",ctrl
Patient no. 11: treated,pert
7113.3PBMC,ctrl
sample 1;	age: 58;	gender: male;	sample 2;	age: 58;	gender: male,ctrl
SK-MEL-2 melanoma cell line,pert
T-ALL Cell line,ctrl
cell type: E14 murine embryonic stem cells;	genotype: Zfp322a Knock-down cells,pert
Control peripheral blood leukocytes - Biological Replicate 2 - Technical Replicate 1,ctrl
BS2011051061,ctrl
Endometrium-Normal 10,ctrl
"P116 ZAP70 negative  0 hours, #2",pert
NESG1-overexpressed 2F4-5-8F NPC cells rep1,pert
"control, rep1",ctrl
"PBMC, patient. Mtx rep12",pert
"disease group: Nonatopic Control;	Sex: f;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 50;	ige (kiu/l): normal (0-48.5 kIU/L): 2.5;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
"TF-1 cells, pLKO, d2.5",ctrl
HEK293_pLKO_R1,ctrl
CD4+_Tcells_severe_asthmatic_1,pert
Kidney_400 mg/kg VCM ip_mouse #108,pert
cerebellum_6 month,pert
"Index, patient1",pert
tissue: Frontal cortex;	age: 100;	Sex: F,pert
CA2 Cre Sox17D,pert
ARF1 siRNA knockdown MDA-MB-231 sample 2,pert
"DMSO Control after 4hr, replicate 3",ctrl
shRNA control R11 T5,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: DMSO for 48h,ctrl
PC3 Control Rep1,ctrl
gender: male;	strain: BL6/C57;	genotype/variation: A2BAR-/-;	age: 12 weeks,pert
"DMD skeletal muscle, biological rep21",pert
WT J1 ESCs on day 0 #2,ctrl
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Bach2 knockout,pert
11084 Normal Uninflamed descending colon,ctrl
"mouse aorta cross strain comparison, times 0, 4, 10, 24, 40 weeks",ctrl
human skeletal muscle from diabetic individuals after insulin therapy,pert
"Control, biological rep2 (E17.5)",ctrl
"A673 treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50), biological rep3",pert
8DKD_SerumStarved_rep1,pert
transgenic (LH-overexpressing) mammary gland,pert
HLA risk: High;	Height: 147 cm;	Weight: 58.9 kg;	BMI: 27.3;	Age: 9.9 years;	Gender: Male;	Race: White;	Glucose: 94 mg/dl;	HbA1c: NA,ctrl
RV63.10_CHF_day19_Slide44,pert
tissue: white blood cells;	age: 10.58;	Sex: female,pert
Mouse Spleen CD8 T cells,pert
"brain, frontal cortex: Sample48_e1_le1",pert
S028_Scz_F_28,pert
brain_Q10_14M_rep3,pert
Normal Biological Replicate 1,ctrl
NEO-1_HG-U133 Plus 2_Rep,ctrl
"CA1, SOX7 expressing HESC - clone2",pert
"CCM3 shRNA cells, passage 11",pert
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case3,ctrl
colon_IL10mouse_6weeks_rep2,pert
"RET-PTC, 6 months",pert
Hippocampus_WildType_rep1,ctrl
pooled reference mRNA from 4 harvests of ME16C cells,pert
batch: B;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,ctrl
Ainv15 ES0 replicate 2,ctrl
n12,ctrl
CD11b+Gr1- cell sample_2 (derived from wild type mouse),ctrl
35A;pretreatment;female;breast tumor,ctrl
con-52_B,ctrl
Hodgkin lymphoma cell line KM-H2,ctrl
HCC012T,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 43;	maternal age: 36,pert
amygdala long access to cocaine replicate 2,pert
CLL 11-18 LMP-420,pert
Strain: J1 Cell type: mouse embryonis stem cell,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 143;	time: 0;	batch: 2,pert
Normal PBMC Sample 7,ctrl
KOPT-K control 1,ctrl
B10.H2g7_T1,ctrl
n7t6h,pert
"MelJuSo, 48h treatment with 5 AzadC",pert
"Gender: female, Age: 16 years, Tissue: normal vulva,",ctrl
"AD_FC, biological rep10",pert
tissue: inner ear;	genotype/variation: Wild-type;	age: E10.5,ctrl
Normal bladder 277-99,ctrl
Patient: N;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Strain: D3, mouse embryonic stem cell",pert
AGS cells - Celecoxib treated biological rep 3,pert
PBMC;	Age: day 3,pert
GEIM57-U133A-Norm,ctrl
Rosi-treated diabetic-3,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 77;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
Epithelials cells isolated from mouse mammary glands with Wild-type Pten expression,ctrl
Normal_Kidney_Biopsy_2,ctrl
"36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
PS-first,ctrl
RPMI8226_shKDM3A#1,pert
NPC Brain 82d Mouse1,pert
"DBA/2J Saline treated, biological replicate 3",ctrl
11378 Normal Uninflamed ascending colon,ctrl
CD8+CD28low regulatory T cells,pert
T5_pitM,pert
"patient: 213;	current medication: PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI;	birth date: 11/1/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/82;	diagnosis date: 2/2/83;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/12/04;	followup rectum: COLONOSCOPIC;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/74;	smoking amount: unknown;	other illnesses: ISCHEAMIC HEART DISEASE;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
"HIV-1 positive male, 18-60 years old, weight loss of 5-15% in preceding 6 months, stable anti-retroviral therapy. CD4+ T-cells >50/ml, HIV copies =< 10,000/ml, free testosterone <50pg/ml.",ctrl
patient: 25;	disease state: hypertension;	tissue: Atheroma plaque,pert
lucif_1,ctrl
32m4,ctrl
age	34;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.3;	hemoglobin (g/dl)	14.5;	platelet count (/nl)	293,ctrl
N51308,ctrl
PND28 Rat Testis_Rat230-2_1hr Corn Oil_Animal#42_04005,ctrl
Errb mutant mouse stria vascularis,pert
8- to 10-week-old male balb/c mice. tissue: whole liver,ctrl
PC-3_basalhTERT_ShortTelomeres_mockcre_3,ctrl
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1b;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 52;	dfs-event: 0;	distant metastasis: 0",pert
Kidney_50 mg/kg VCM ip_mouse #072,pert
healthy control C4,ctrl
HNF1b_1a-,ctrl
SV589_3Day KD_Serum Starved,pert
ATP-treated AML 8 blasts,pert
patient: 40892;	sample: tumor,pert
No_abuse_7,ctrl
Age: 36;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
Wildtype_Sham_Rep3,ctrl
Disease_status: Healthy control;	Age (years): 39;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.46;	Post mortem interval (hours): 58;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Patient 1 after folic acid,pert
#1,ctrl
cell line: RWPE-1-PCAT-1 (CRL-11609);	age: < 20 cell passages from derivation,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 119;	genotype/variation: WT;	age: 8 weeks,ctrl
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: shKDM4C construct 2,pert
OV1002 Carbo Day2,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 32; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.,pert
WT / Reference_13425675,ctrl
age: 24 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep4,pert
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate C,pert
K562 cell line,ctrl
KO-control-4,pert
S-IIP(UIP)13_Cy3,pert
LCL Unaffected MZ twin pair 5 (CCN5.1)(TP27),ctrl
RNA mix 1 of nomarl lungs,ctrl
hNHEPS_0.1 μM_6 h_rep1,pert
219/4,pert
MKK3bE transgenic female replicate 2 early timepoint,pert
HL-60 cell line infected with GSK3A Construct 6 shRNA,ctrl
U2OS_shCHK1-4,pert
WSD-final,pert
Cy3: Human Common Reference,pert
CME-Ctr_LaminA0d-2MA-S2,ctrl
Transgenic ATF6-MER mouse;	Strain: C57 BL/6;	Gender: male;	Age: ~30wk;	Tissue: heart LV;	treatment: tamoxifen,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 2,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
RAW_0.7mM_HOCl_#2,pert
"Female (age range 33-49), skin biopsy from upper nates taken 7 hours after nickel exposure",ctrl
T47D breast cancer cells,ctrl
SiTIF- rep1,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
"cochlea at P13, ko, biological rep 3",pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p29;	strain: E14,ctrl
Muscle 50 eccentric contractions 12 hours WT Aged 0106,ctrl
resected non-tumor liver tissue,ctrl
LNCaP + AR-shRNA rep1,pert
UV-SeV 3663,ctrl
No or early 1 rep2 (retina),pert
Human CD34+ cord blood cells expressing BCR/FGFR1,pert
Female - caucasian - N-06-M,ctrl
Kidney from mice treated with 7 daily iv injections of saline,ctrl
HF0434_U133P2,pert
Wildtype_XX_1,ctrl
NOD/LtJTCE liver sample batch 2,pert
24h Kin- Cel.43,pert
V5-P501,pert
KO_0525-3,pert
ZMYM2/FGFR1 biological replicate 3,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant],pert
HET Brain 40d Mouse1,ctrl
Adrenocortical adenoma with CTNNB1 mutation_(S37C),pert
cell line: A549;	agent: azacitidine;	dose: 1 uM,pert
Bmi1 embryonic stem cells sample_2 (Bmi1_ESC_2),pert
"DMD skeletal muscle, biological rep5",pert
CN1,ctrl
"WT, PR01M002v0",ctrl
patient: 41027;	sample: normal,ctrl
treatment: DMSO;	time: Day3;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
"C57BL/6, CD-1",ctrl
strain background: 129/SvEv;	genotype/variation: wild type;	cell type: bone marrow derived dendritic cells (BMDCs);	stimulated with: purified tumor-cell derived DNA,ctrl
"shEGFP T47D cell line, replicate 2",ctrl
8- to 10-week-old male balb/c mice. tissue: whole liver,pert
7 Day Mouse Diaphragm muscle,pert
BTBR+tf/JTCE liver sample batch 5,pert
homozygot FH P261,pert
agent: pristane;	time: 18 days;	strain: BALB/c;	tissue: mesentery,pert
Ileum_POR-null_1,ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 4",pert
Bmpr2-Delx4 2,pert
"Patient J, uninvolved skin",ctrl
sample =XCGD5 treatment=Control time=360 (min),pert
BTBR+tf/JTCE liver sample batch 4,pert
cell line: WM-266;	pir knock-down: yes,pert
R3_saline_wildtype_48,ctrl
MOLF/EiJ Vehicle liver sample batch 5,ctrl
CUTLL1 MigR1 GSIwash4h-rep1,pert
NOD Aire KO MEC rep3,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 5",pert
Control bone marrow - Biological Replicate 4 - Technical Replicate 1,ctrl
"MCF-7 cells, siGL3 treatment 72h, 10 nM E2 for 24h",pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep2",pert
wt LSK,ctrl
dorsal skin from GR+/+ E18.5 embryo,ctrl
Panc1005 rep-2,pert
5255 UC Uninflamed terminal ileum,pert
GIST_KIT_2,pert
LNCaP R1881 rep 1,ctrl
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ WT ES cells,ctrl
"125, ADIPOOSE TISSUE, After",pert
"ERaKO mouse aorta with placebo, biological rep1",pert
Individual_5063_NN_sample,ctrl
H28 HA 24h 4,pert
CD47 null Endothelial cells 2,pert
"RT4D6 Schwannoma cells, treated with wild type siRNA for Sox 10, 48 hours",pert
E18.5_Control_Kidney_array2,ctrl
normal adjacent esophageal tissue from patient E1546,ctrl
"Strain: SPARC-null, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Left",pert
Unaffected MZ twin pair 1 Repeat (Unaffected patient of MZ twin pair CCN1),ctrl
24h_c2,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_Con_HG-U133A_2_YCHSUP501,ctrl
MRL/MpJ heart left ventrical (LAD ligation 30 day),pert
MCF7_CHX_EtOH_24h_rep2,pert
infection status: stably expressing shRNA directed against YAP;	cell type: human ccRCC cell line,pert
SKNSH MECP2_e1 3,pert
NOD2wt_0h_MDP_biological replicate 2,ctrl
"105, MUSCLE, After",pert
Patient no. 18: treated,pert
MLL1-KO MEF CT30-1,pert
Disease_status: Healthy control;	Age (years): 37;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"T47D, sh2608",pert
liver 1.0% quercetin diet rep3,pert
PGA-MAH-OuJAir-1bAv2-s1,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_1_1_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
postmortem brain tissue,pert
Liver of pup from control group rep5,ctrl
subject: 09U;	cohort: 9;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 47kb;	age (y): 57;	Sex: F;	batch: Batch_2,ctrl
01MHW_Oligo,pert
DMSO treated MC3T3 mice,ctrl
NTG mouse heart left ventricle,ctrl
A549 DAC 3 uM (3222),pert
Run5.aUa.010110d.SkmDbt1960D.CEL-DB stimulate,pert
disease state: healthy control;	tissue: epidermis;	age: 26;	gender: male;	treatment: untreated;	time: control,ctrl
"control endometrium, patient 1",ctrl
"Healthy volunteer, Control_11696",ctrl
"human failing LV myocardium, Idiopathic73",pert
"Rat pups treated with acrylamide, sciatic nerve",pert
Male 8week AJ sham rep1,ctrl
Diaphragm 112 Day control rep 1,ctrl
Carotid atheroma plaque obtained from endarterectomy,pert
overexpressed Tcof1 [C],pert
HDAC2_B10-rep3,pert
"patient 045b, normal, homogenized",ctrl
lung_E18_sftpc-nmyc_rep2,pert
3894M patient’s mucosa,pert
gender: Male;	age: 54;	post-mortem delay: 12h;	ph: 6.6,ctrl
cell line: T47D;	sherbb3: -;	sample type: control,ctrl
strain: ICR;	agent: saline/distilled water;	time point (week end): 2;	disease state: normal,ctrl
MGHU3 Cells_TAK1 siRNA,pert
wild-type rep_3 (CWT3),ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep3",pert
phenotype: control;	gender: male;	case_id: 277;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 19;	brain ph at time of freezing: 6.26;	labeling_batch: 2,ctrl
duration of untreated disease in month:2.6;	age at onset:8.8,pert
74_129_WT,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 13 days;	treatment: fresh air, treatment over 5 month + 15 days recovery, 4x1h exposure per day",ctrl
type_of_rx: AF;	pre_or_post_treatment: post;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 76;	baseline tumor size (cm): 7x8;	patient id (to identify the 2 chips from the same patient): 13491389,pert
gastric biopsies,pert
Halothane 10 exposure-1,pert
PancreaticSample25-Normal,ctrl
non-malignant FTEb_patient 1,ctrl
Klf9WT_jejunum_PND30_3,ctrl
Normal Cervix N14,ctrl
Healthy8-CD8,ctrl
ab047 IM,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M2;	flt3 status: WT,pert
@52055800697862121408403718160344,ctrl
HEK293 F5_doxycycline untreated,pert
"Normal subject (42 year old caucasian male, SAK_1274829796)",ctrl
Skin biopsy from upper nates taken 7 hours after exposure to 5% nickel sulfate,ctrl
"genotype/variation: wildtype;	strain: mixed background (Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.);	age: P1",ctrl
"whole right lung, when moribund after a bleomycin dose of 125mg/kg, given by osmotic minipump.",pert
"Patient S242, MSI colorectal tumor",pert
Patient identifyier: G;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 19 years;	Body surface area: 12 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
K562 cells CREB Knock-out replicate 9,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 3",ctrl
01LPP_PolyRF-,pert
DDR-1-KO mouse (KO_Tal2),pert
"Normal cervix, age 27 years, micordissected squamous epitheilium",ctrl
batch: B;	knock-in: VEC;	cell line: MycCap prostate cancer cells,ctrl
"WT VSV infected, biological replicate 3",ctrl
Wildtype white adipose tissue,ctrl
"MLD, biallelic AML MLL_00252",pert
HSC cells from MSI2-inducible mouse rep1,pert
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
splenocytes,pert
Human myeloid leukemia cell line,ctrl
ILD Study Number 897,pert
WT.DMSO_4,ctrl
"H1 hESCs, OE-SOX2",pert
IPMA 4,pert
Huh7_TGFbeta_plus_1,ctrl
0671-01-C,ctrl
SR-A mutant olfactory epithlium 0 h replicate2,pert
"jejunum, control, 2",ctrl
Septic shock;	gender: Female;	Survivor;	organism: None;	update,pert
disease: Down syndrome;	gender: female;	age: 1 year and 2 months;	tissue: thymus,pert
"ALL_NDS, K60 011409",ctrl
MDS patient 108,pert
"Global gene expression of NASH patients, normal control A107",ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: phenobarbitol,ctrl
5194 Normal Uninflamed sigmoid colon,ctrl
KU_05N,ctrl
V5-P480,pert
individual: Control2;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
LKR13_Wt1 sh-1,pert
KM-first,ctrl
Sox9egfp_p23-1,pert
"PBMC, healthy control, biological rep9",ctrl
MKK3bE transgenic female replicate 2 late timepoint,pert
0159-01-C,ctrl
Treatment 3,pert
Liver WT HFD #547,ctrl
05_NML,ctrl
Gene expression profiling of normal cortex of patient 83,ctrl
erStress_twins_AA_1736twin1_500nM_thapsigargin_4h,pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: Lipofection-mediated siRNA delivery;	time: 12hr,pert
Sex: female;	Age at operation: 78 years;	Site: thigh;	Size in cm: 13x10x6;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: high;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
Control subject 116_biological replicate 2,ctrl
"1mg/kg/day PFOA, Rep 1, Block 5, liver (low dose)",pert
sex: Male;	Age: 28 months;	additional patient information found in Series supplementary file,pert
sex: Female;	family: 5;	age: 57;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
Mannitol control treated A549 human lung cancer cell cultures replicate C,ctrl
"205, MUSCLE, After",pert
mouse jejunum_hnf1alphamutant_rep1,pert
"sirna: siRNA1 (Ambion);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",pert
"CD14+ after 2 wk quercetin supplementation, biological replicate 3",pert
"SIN3A siRNA, biological replicate 3",pert
"Granulosa Cell, 44-46hr PMSG",pert
WT 570 R2,ctrl
"genotype Cldn16 +/+, renal tissue",ctrl
"201, MUSCLE, Before",ctrl
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 3,ctrl
umbilical cord_nobpd: 3F,ctrl
colon_IBD_1156,pert
"Cultured ovarian cancer cell line HeyA8, untreated",ctrl
chip number: 17;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.74;	rin: 9.2;	transfection date: 2012-03-26,pert
Bl6_p60_2,pert
Individual_4609_PN_sample,pert
"Inclusion body myositis, biological rep1",pert
Huh7 cells_Mock Infected 12 hours_ rep2,ctrl
SKI-DLCL cells were treated with Aplidin at concentration 3nM for 24h. Total RNA was extracted.,pert
gender: Males;	strain: C57/B6;	age: 3 months old;	tissue: Brain,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 3",pert
male;	42 yr old;	Black,pert
E12.5 Lim1 mutant renal vesicles isolated by laser capture microdissection.,pert
patient10,pert
CHF - R14,pert
HepG2_5-aza_rep3,pert
Y YOKE_B024,ctrl
"Line A39 transgenic cerebellum, mouse, male, 10 months",pert
RNA from HCC_25T,pert
"DSS + L-Arg colon tissue, biological rep3",pert
RNA from microdissected breast cancer cells from case 868 labeled with Cy5,ctrl
"Female (age range 33-49), skin biopsy taken from upper nates 7 hours after nickel exposure",ctrl
MEF E2F4 KO 2-rep2,pert
Slow progressing fibrosis,pert
Diseased individual (ulcerative colitis) of twinpair #12,pert
"ZR-75-1, 12h, 0.4uM DOX B",pert
cell line: Y79;	passage: 29;	cell type: Retinoblastoma,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age: 12 weeks;	Tissue:  Gallbladder,pert
"83 y/o male 46,XY",pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
disease state: paediatric glioblastoma;	age: 8;	gender: F;	h3.3_status: K27M,pert
"Patient  G, lesion, 2 week",pert
scan batch: Batch 2;	group: autism;	subject age: n/a;	paternal age: 36;	maternal age: 38,pert
PBMC_S3,pert
AA_Case11_CD8,pert
GIST Tumor,ctrl
strain: C57BL/6;	genotype: Cmah knockout;	tissue: heart;	age: 12 weeks,pert
Cav1 knockout,pert
Muscle from a 5 month old wild type mouse,ctrl
Normal cervix_05-1352,ctrl
shGFP-rep-1,pert
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-3,pert
chip number: 16;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.66;	rin: 9.5;	transfection date: 2012-03-26,pert
MH1C1 cells untreated,ctrl
Insm1 control #4,ctrl
Teratozoospermic individual: Sample T2,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,ctrl
C1 clone infected with Deaf-1-expressing retrovirus.,pert
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 2;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
Normal cervix epithelium_CaCx4,ctrl
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Female;	Age of onset (years): 18;	Duration of illness (years): 11;	Brain pH: 6.74;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
HEK293_A263insGG_#6_uninduced,ctrl
Wild_Type Circadian_Time_02,ctrl
Mouse No Cldn16 B9 441,pert
Individual_5258_PN_sample,pert
Sprague-Dawley rat diaphyseal femoral fracture callus,pert
CTRL_4_GMP,ctrl
Skeletal muscle,pert
3 wks TAC-5,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: scrambled;	transfection time: 24h,pert
Sample Group: control; Gender: female; Age: 39; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Hippocampus_Soman_1h_rep3,pert
MEF_WT_rep1,ctrl
Plate vs. Nail:  3 Day Sham,ctrl
tissue: resected non-tumor liver tissue;	genotype: major [rs8099917 TT],pert
Patient no. 13: control,ctrl
NuLi cell line biological rep1,ctrl
Liver_Female_CF_rep4,pert
Patient 7 appendix,pert
"EtOH, RARaKO, set 2",ctrl
Moderate rep10 (retina),pert
day 30 5-FU HSC 2,pert
"GV oocyte, control",ctrl
peripheral blood from E12.5 Cbfb-/-  embryos,pert
patient: 223;	current medication: Prednisolone 20mg Asacol 2.4g;	birth date: 1/18/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/04;	diagnosis date: 3/15/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
CH2120,ctrl
"AALE-Vector + shGFP, biological rep3",ctrl
CON2,ctrl
E8.5 wt.1,ctrl
"brain, cerebellum: RNA#2_le1",pert
healthy control C6,ctrl
wt 13.5d replicate 8,ctrl
cell line: H1299;	agent: azacitidine;	dose: 0.3 uM,pert
Cont subject 09,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),pert
KM_015N,ctrl
"Vehicle treated, DAY 6, biological rep.1, MV4-11 cells",ctrl
Plate vs. Nail:  4 Week Plate,pert
"brain, cerebellum: WCx12w#1_e1_le1",ctrl
Leptin treated mouse gallbladder 5,pert
sex: Female;	family: 3;	age: 35;	disease status: Control;	tissue: Muscle: Deltoid,ctrl
CON18,ctrl
Liver_Nrf2 Control_rep2.,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.708;	OD280: 0.892;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 298;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
HEK293_A08_R2,pert
Control siRNA transfected HeLa S3 cell,ctrl
RTX8 T12,pert
EB_07_24h_132_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
whole blood_100603,pert
tissue: temporal lobe;	strain: C57;	genotype: WFS1 KO,pert
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Stromal Cell,ctrl
age: 18 month postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp1,pert
Cardian muscle Trained diabetic 3 week DT3,pert
"hepatic gene expression at ""0 hr"", rep1",ctrl
"human failing LV myocardium, Ischemic105",pert
MCF10A-HER2(+) 1.5days,pert
Primary human erythroid progenitor cells expressing HDAC1 A3 shRNA,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),pert
"PCB77 treated HepG2 cells at T6, biological replicate 2",pert
WT HPC PDE10i 14,pert
Human Chronic HIV Sample C062-CD8+ T cells,pert
hepatocytes treated with 0.1% DMSO,ctrl
V5-P124,pert
NCCIT-Mock-rep2,ctrl
CD19_selected_B-cells_before_R_rep5,ctrl
Parent 2,ctrl
E14wt-vector-1,ctrl
"Liposarcoma culture from tumor 392, untreated",ctrl
"mouse embryonic fibroblasts derived from WT mice, I",ctrl
An XDP Filipino (aged 52 yr),pert
colon_IBD_1606,pert
OCUBM,ctrl
CF (D508) subject8,pert
strain: C57Bl/6;	genotype/variation: Notch2 KO;	cell type: cDC;	cell type subset: CD11b+,pert
"Healthy volunteer, Control_11692",ctrl
HeLa cell,pert
E12 distal retina progenitors_control_rep 3,ctrl
Abca1 +/- mouse liver,pert
"twin pair: #4;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
SW480 Vector (1),ctrl
Cerebellum_nontransgenic control S46_10 months_replicate 3,ctrl
race: caucasian;	age (years): 53;	stage: IC;	grade: 3;	histology: endometrioid,pert
Low Glucose Transcriptome Profiling {rpt},ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 30;	maternal age: 29,ctrl
OVSAYO ovarian cancer cell line,pert
"PBMC, healthy control, biological rep11",ctrl
"ERRa ko ventricle, baseline",ctrl
"human failing LV myocardium, Idiopathic68",pert
"E2-treated cells (24hr), biological rep_3",pert
"Control shRNA, rep2",ctrl
Brain_Adult_LPSip_4hr_mouse2 (YL2_#65),pert
C_AN07176_T,ctrl
race: caucasian;	age (years): 57;	stage: IC;	grade: 2;	histology: endometrioid,pert
MDS patient 100,pert
Hippocampus_Soman_48h_rep2,pert
12458 Normal Uninflamed ascending colon,ctrl
"41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
OBF-1 overexpression BCS-1 (Large PreB),pert
Adrenal CREMKO 0h batch 1 [AdKOh00.8],pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 4,pert
r04,pert
Bone-Marrow_MM_M786,pert
"Normal Skin, Normal-1",ctrl
Strain: 129Sv (PPARalpha knockout);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,pert
"Human hepatoma cell line (HepG2), grown for 6 or 12 hours, and then total RNA harvested with Trizol and Qiagen Rneasy kit.",pert
dental pulp cell from control 5,ctrl
CO_3,ctrl
MLL_00268,pert
"normal skeletal muscle, biological rep12",ctrl
U-87MG,ctrl
WT_03,ctrl
"MCF-7 cells-40mM g-T3, biological rep 2",pert
PBMCs_Control_15 [IS],ctrl
9m3,ctrl
MCL_IGHV_MUT (R1339),pert
Postmenopausal female. Untreated control. nr 12.,ctrl
lesional skin bioposy obtained from patient after 3 days of treatment,pert
liver 1.0% quercetin diet rep6,pert
EB_6_8d_298_HCHO_Nasal_Rat230_2_CIIT05024,pert
"CBP, p300, CH1, TAZ1, hypoxia, MEF",ctrl
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection - NTAL knock down;	vector: pLKO.1/TRCN0000127243;	activation: none,pert
wildtype 6,ctrl
treatment: control,ctrl
fibroblast_Rapid_D26_Media_15,pert
batch: B;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,pert
cell line: HT1080;	clone: 8;	genotype: Knockout,pert
BACH2+/+ ALL (Sample2),ctrl
"p63shRNA_B2, p63-depleted",pert
Md02h029,ctrl
RBP2-/- MEF(2),pert
BP20,pert
HMEC_control experiment 2,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: saline;	dose: 0 mg/kg,ctrl
CD-58-un,pert
heterozygot FH P273,pert
"EBF1 d4, rep 2",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 220,pert
embryonic stem cells,ctrl
12h control (2);HT-29;colon:carcinoma;NONE;42995,ctrl
0h Kin Cel.14,pert
hOB695_shRB1383_24hr_IR,pert
Endometrium-Normal 5,ctrl
"P116 ZAP70 negative  0 hours, #1",pert
Stratagene Human Universal Reference Pool,pert
KN-sham-5 month+13d-R1,pert
myoblast_untreated_rep1,ctrl
No or early 2 rep6 (OHN),pert
Neocortex_Eomes_WT.5,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous saline challenge""",ctrl
CTRL_siRNA_rep1,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 427,pert
cell line: MOLM-14;	shRNA construct: GSK3B Construct 2,pert
Snell 22 month Wild Type Liver 24c,ctrl
mutant mouse embryonic kidney day 12.5,pert
TAC 2,pert
Muscle PCOS after pioglitazone 42,pert
"mortality: alive;	ethnicity: Hispanic;	gender: F;	age (yrs): 58;	ld: HCV;	creatnine: 1.4;	mdrd: 41;	gfr: 39;	protein: 0;	hematuria: 0;	c3: 1;	c4: 1;	rf: 102;	hcv: POS;	htn: 1;	dm: POS;	hba1c: 7;	meld: 15;	ana: NEG;	gp: MESANGAIL PROLIFEATION,Ig A nephropathy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 0;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 2;	if (interstital fibrosis): 2;	as (arteiosclerosis): 2;	igg: 1;	iga: 3;	igm: 2;	c: 0;	empe: 2;	bmwid: 1;	bmd: 0;	edd: 0;	no of glomeruli: 31;	glomerulosclerosis: 0.13;	intact t: 0.5;	arteries: intimal fibrosis,duplication n widening;	if: IGG+IGM+IGA+++C1Q+ mesangial only IgG and focal capillary walls;	mesangium ig: A;	tissue: Kidney_Biopsy_Liver_disease",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 124;	Sex: male;	region: LC;	age: 39;	genotype: Y/Mecp2-;TH/-,pert
"non-transgenic mice, 7 month old, male",ctrl
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 3",pert
patient: 259;	current medication: pentaza 2g D;	birth date: 9/20/78;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/03;	diagnosis date: 1/13/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
KU_34T,pert
patient E1709,pert
"GSL30, PR04M007v0",pert
Gene expression of murine fibroblast-like synoviocytes Grp1_C57BL6_2_FLS_TNFtg_plus_RSK2-KO,pert
SV589_8Day KD_Serum Starved -> 3hr EGF,pert
Untreated CLL2,ctrl
atopic eczema P6,pert
ApoD transgenic mouse+PQ rep_1 (PQTG1),pert
58A;pretreatment;female;breast tumor,ctrl
"human failing LV myocardium, Ischemic34",pert
S46 NLS 142Q TG4	F5/12	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
lineage: colorectal;	cell line: SW480;	treatment: none,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 51 yr;	population: white;	dsm-iv: 296.44;	age of onset: 23 yr,pert
C_AN07176_F,ctrl
"UM-UC-3 bladder cancer cells, stably transfected with GFP-tagged RhoGDI2, biological replicate B",pert
"alveolar macrophages, non-smoker 008",ctrl
"Sv129/C57B6 hybrid strain, 12 week old male",ctrl
whole blood_100309,pert
Epidermal keratinocytes treated with EphB2 for 24h,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep2,ctrl
MSC_VUB03_DM1_2,pert
MOLM14-shControl-rep3,ctrl
Gastrocnemius muscle PPARalpha overexpressing transgenic mouse,pert
Strain: C57BL/6J;	Gender: male;	Age: 9 weeks;	Tissue: whole brain,ctrl
coronary smooth muscle cells metoprolol replicate 2,pert
"HepG2 cells at T18 Control, biological replicate 1",ctrl
wild-type 3,ctrl
siGL3E2 1,pert
Normal,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 13 days;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 15 days recovery, 3x1h exposure per day",pert
42_C57_WT,ctrl
"Lymphoblastoid cell lines derived from family 1733, member 1",pert
Pt_4 Acne Lesion,pert
Notch2 f/f CD11c-cre C57Bl/6,pert
Whole brain,ctrl
A_AN17254_F,pert
myoblast_treated_rep1,pert
Lung Normal,ctrl
PB_postTherapy_IIb,pert
female_control_270,ctrl
Kidney_50 mg/kg VCM iv_mouse #009,pert
Jejunum,pert
Primary chondrocytes; Wt; total RNA,ctrl
"C57BL/6N, adult, male",ctrl
cell line: Reh;	transfection: CBFA2T3 shRNA;	malignancy: non-Hodgkin lymphoma,pert
hNHEPS_control_0 h_rep1,ctrl
"nTreg Foxo1 KO, rep2",pert
"YPFH cells from M1, wild type control, biological replicate 1",ctrl
"peripheral ganglion, unknown: control 24 hr_2",ctrl
K562 AMN107 sample 1,pert
whole blood_101584,pert
58A;pretreatment;female;breast tumor; responder,ctrl
Estrogen [H1],ctrl
Control 2 at age 35-day,ctrl
first-episode BP patient 120_biological replicate 2,pert
SUP-B15 non-treated,ctrl
"ZR-75-1, 12h, sham",ctrl
genotype: wildtype;	strain: C57Bl/6;	cell type: HSC,ctrl
23 Day Mouse Diaphragm muscle,pert
SC-RbKO 2,pert
206_DMSO,ctrl
01SAGEA,pert
No_drug_#4882,ctrl
MPM tumor 6,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
treatment: Untreated,ctrl
Bone marrow from naive C57BL/6 mice,pert
PBMC GM T0,ctrl
Ad infected murine liver-MO30k-(231)-6hpi,pert
wild type stria vascularis replicate 2,ctrl
control_00hr,ctrl
HCT116 human colon cancer cells with intact PTEN,pert
"n09, surgically resected from patient of gastric cancer.",ctrl
Adolescent mouse tumor sample,pert
"whole right lung, when moribund after a bleomycin dose of 100mg/kg, given by osmotic minipump.",pert
striatum SNCA knockout 21 month replicate 3,pert
subject: 18A;	cohort: 18;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 21kb;	age (y): 36;	Sex: F;	batch: Batch_4,pert
MPM tumor 1,pert
"Primary, localized, prostate cancer",pert
Haloperidol treated 4weeks AffyGC RMA rep2,pert
tissue: Biceps muscle;	patient: C.b.10.MELAS;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2y 9m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
SCC12,pert
WT-MAC-SEV-2,pert
sirna: Syk siRNA knockdown;	plate: plastic;	cell line: MCF10A,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: Vemurafenib 1000 nM for 48h,pert
BAL_40_A0B0,ctrl
IKK2 -/- cell line,pert
hTERT-immortalized human skin fibroblasts,pert
DMSO1_24H,ctrl
>95% CD3+ T cells negatively isolated with Dynal kit,pert
Control biological rep4,ctrl
"Wild type used for GNMT 3 month, replicate 3",ctrl
H69_Ctr_1,ctrl
"Uninvolved Skin, NS-26",pert
human_hepatocyte_400uM_grepafloxacin_donorA_24hr_prep1,pert
Cell line: TOM-1,pert
"Acute Myeloid Leukemia, sample 23",pert
OSCE-16T,pert
Subject #8010-8hr Postinfection,ctrl
ctrl_519,ctrl
T5+6,pert
"array type: Affymetrix Mouse 430_2,;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7",ctrl
"ALL_NDS, K63 011409",ctrl
"WT, PR03M005v0",ctrl
Liver control pool1 Affy,ctrl
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID372,pert
"KO VSV infected, biological replicate 1",pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: PDK1 null,pert
A673 cell line that has been treated with Puromycin for 3 days with concentration of 0.09 uM (EC50).,pert
Male BALB/c deficient in Il1rn,pert
1a_c,ctrl
U2-OS-ERb E2 4 hours 2,pert
Mouse Tibialis Anterior 4 weeks post birth,ctrl
GFP_Untreated_2hr,ctrl
uterus_veh_WT_4hrs_rep1,ctrl
"MCF7 cells stably transfected with pCDNA3.1, passage 2",ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 wild type mouse, chow diet, liver",ctrl
Tslc1 +/+ mice_rep2,ctrl
"Patient  N, lesion, 2 week",pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:60;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 47 yr;	population: white,ctrl
strain: 129/Sv,ctrl
gastrocnemius-30 months of age-resveratrol diet-biological replicate2,pert
"infected primary RPE, biological replicate 1",pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 6",ctrl
Rybp#15 (OHT-)_12d_rep1,ctrl
strain: C57BL/6;	genotype: WT;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,ctrl
strain: C57BL/6;	cell type: MEFs;	genotype/variation: wild type,ctrl
MCF-7 cells,ctrl
YFP-pos GMPs,ctrl
WFS1 WT USHT_20_331_wt,ctrl
Lung wt mock repC,ctrl
PTEN deletion Replicate1,pert
MDA-231 cells,pert
Cell line expressing inducible GFP-progerin. Induction: day 10. Replicate A,pert
LRRK2 (G2019S) heterozygous iPSC sample 2,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Cmah KO_liver _3,pert
disease state: Normal,ctrl
"SIN3A siRNA, biological replicate 2",pert
"mouse aorta cross strain comparison, C3H_T40_NC_01",ctrl
age: 72;	sex: M;	disease status: control subject;	Filter number: 103;	Usage number: 4;	Exposures: 3,ctrl
CON12,ctrl
pMX-Oct4 vitamin C Oct4Vc+_2,pert
dex4hr_2,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
SKM-1 control 2,ctrl
potilas_DC_A,pert
WFS1 WT USHT_19_320_ko,ctrl
Head RNA of Phgdh Knockout@E13.5 No.3,pert
"Patient L, lesional skin",pert
+7hr Wnt (dye swap),ctrl
GFP-kd_ES_rep3,ctrl
DNGM-12,pert
mortality: alive;	ethnicity: Asian;	gender: F;	age (yrs): 26;	tissue: Normal_Kidney_Biopsy,ctrl
"human failing LV myocardium, Idiopathic1",pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep7,pert
"RNA was prepared from papilomas of 2-3 mice (2 for WT and 3 for Knockout) and this was pooled to perform the array. Each pooled sample was run in triplicates.   The mice were treated once with DMBA, followed by TPA application for 30 wks.",pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: control;	time: 24hr,ctrl
"Cadmium 0.55 µM, biological rep4",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 75 years,pert
"DCIS 4, biological rep. 4",pert
ab035 IM,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle/squamoid cell;	matched/unmatched: unmatched,pert
White portion of the gastrocnemius muscle,ctrl
"control endometrium, patient 18",ctrl
"fibroblast, control subject NF9 rep 1",ctrl
"PMA treated, doxycycline treated; biological replicate 1",ctrl
AO C2,ctrl
"Peripheral blood, patient with recurrent events [N21]",pert
tissue: liver tissue;	disease state: hepatocellular carcinoma tumor,pert
"NASP Overexpression, sample #3",pert
mouse full-thickness skin,ctrl
Tissue: lung,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 720,pert
Strain: C57BL/6; Tissue: liver;,ctrl
SW480 cells,pert
FVB; No Treatment #10,ctrl
WT_uninf_1,ctrl
day 3 5-FU HSC 1,pert
Bone Marrow,pert
iA50clone9-,pert
"5mg/kg/day PFOA, Rep 4, Block 3, lung (high dose)",pert
MLL_PTD05,pert
"K562, NoTreatmentControl, 24hrs, rep2",ctrl
CA1 Cre Sox7H,pert
Subject #8007-2d Postinfection,pert
NB64,ctrl
"human failing LV myocardium, Ischemic99",pert
brain_DLPFC_bipolar B_mr777,pert
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 1.5,pert
"4 weeks old PS-NA mice, cerebellum",pert
Wild type Mice-M23,ctrl
Tendon_lesional_rep22,pert
"brain, hippocampus: LH7_e1_le1",pert
5244 UC Uninflamed sigmoid colon,pert
cell type: myoblast;	transduction: lentiDUX4short,pert
"Primary aortic endothelial cells, transgenic_PPARG_V290M_1",pert
sex: Male;	Age: 7 months;	additional patient information found in Series supplementary file,ctrl
Cardiac Muscle_mdx_rep3,pert
"WT brain, biological rep1",ctrl
OV1002 Carbo Day7,pert
PGA-RMM-45m-2aA-s2,pert
siRNA Stau1 Duplicate 1,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
SV589_3DKD,ctrl
WT Uterus_saline_24h_rep3,ctrl
Run1.a10a.000608jd.2.SkMNor925.CEL-IS basal,ctrl
MCF7 cells treated with 2uM Sangivamycin for 24 hours Array 2,pert
07R054 RA,pert
"Control 2 small intestine, 30 days",ctrl
ctrl_502,ctrl
"C57BL/6J ACU, Rep3",pert
Individual_5883_NN_sample,ctrl
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50), biological rep1",pert
Myh11-CreERT2.Tgfbr2f/f Knockout 1,pert
db/m 1-1,pert
Empty vector CCE embryonic stem cells (CCE_ESC_Vector),ctrl
"infected primary RPE, biological replicate 2",pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 80;	Usage number: 5;	Exposures: 3,pert
2000N_2,ctrl
GM19238_Kd_EP300_1,pert
Day: 6; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 3,pert
CF (D508) subject3,pert
RNA from HCC_31N,ctrl
SW1736_t6h_rep3,pert
"peripheral blood leukocytes, untreated",ctrl
protocol: AP-2 gamma targetting siRNA 2;	cell line: MCF7,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 3,ctrl
wt_TGFb_4hr_1,ctrl
Donor5_24h_DMSO,ctrl
sciatic nerve of Pmp22 knockout mice,pert
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: none;	disease: atherosclerosis;	age: 32-34 weeks,pert
CML_5_MEP,pert
"Whole ovary from 8 Month Old Wild Type mice_03, biological rep3",ctrl
"Wt mouse, cerebellum, young, nicotinamide riboside treatment",pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: CTNNB1 mutation (S37C),pert
"adenocarcinoma at 20wk, biological rep 2",pert
sex: Female;	family: 3;	age: 14;	disease status: Affected;	tissue: Muscle: Deltoid,pert
"fibroblast, control subject NM6 rep 2",ctrl
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
PKBa-/- MEF time 6 replicate 1,pert
"human failing LV myocardium, Ischemic33",pert
"reference, mock treated sample",pert
MZ1774 mock rep 1,ctrl
PGA-MAH-C3H_PBS24h-1aA-s2,ctrl
"Colitis 02, UC02",pert
Supraoptic nucleus_3d Dehydration,pert
Leg 112 day mdx rep 3,pert
MPZ-Tfam Knockout - rep2,pert
4 Ctrl 4,ctrl
WT mix background A,ctrl
BS2011051063,pert
Diseased individual (ulcerative colitis) of twinpair #8,pert
"107, MUSCLE, Before",ctrl
WT-VILI replicate 2,ctrl
"brain, Entorhinal Cortex: 96-18 tangle_e1_le1",pert
H295R_Group_C_Dose_100_TIMEPT1_032,pert
Bronchoalveolar lavage cells,ctrl
Whole testis RNA from WT mouse #78 at 0h,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
HeLa cells control,ctrl
N51091,ctrl
ONH no or early glaucoma,pert
3883-2 E2F WT,ctrl
Array Type: HG-U133A_2;	Ratio: 2.01;	RNA Integrity Number: 9.4;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
race: caucasian;	age (years): 47;	stage: IC;	grade: 2;	histology: endometrioid,pert
"Endometrium, postmenopausal, control, 17",ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep2,ctrl
WAT from Ahnak knockout fed regular chow diet Replicate 3,pert
HaCaT_ZNF750i_ biological rep1,pert
CH1-(2),ctrl
brain_DLPFC_bipolar C_mr869,pert
"Patient 112, 24 month of REBIF",pert
SNB19 PARK2 siRNA#2 replicate 1,pert
CEM NBD 1,pert
Monocyte FCH rep 3,pert
HSC,pert
"4105_CD133+, untreated",ctrl
Buffy Coat blood of healthy donors,pert
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: control siRNA,ctrl
"Control, replicate 2",ctrl
E9.5 FVB/N erythroid cells-10,ctrl
BCell_lymphoma_aggressive_sample7,pert
tissue: Brain;	genotype: Npc1+/-;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
MCF7 expressing Estrogen receptor alpha,ctrl
Patient: N;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
"ID:5-4, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
WT striatum PDE10i,pert
sampleID: SAM630132;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
NSC miR-Control 1,ctrl
siERK1E24h_2664,pert
11_0011C_Day1_23,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L009,pert
WT_R6_rep1,ctrl
"Exp A, Animal #258, 50mg/kg D-Serine",pert
05 MINUS OHT 3,ctrl
disease state: allergic asthmatic;	cell type: Keratinocytes;	tissue origin: skin biopsies with no stimulation,pert
H16 Ctrl 12h 2,ctrl
Prostate Cancer_NUGEN TEST05,pert
"Brain tissue from Fisher 344 male rat, Animal #257, 50mg/kg D-Serine",pert
3416M patient's mucosa,pert
"LCL GM19238, Kd E2F1, 72hrs",pert
Mock-treated SCC-40,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 26;	gender: male;	years of disease: 1 y;	treatment: phototherapy;	time: pre-UV,pert
age: 66;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
neuron_rep15,ctrl
PTEN_mutant_3_intestinal_polyp_30_days,pert
Targretin_LIVER_3,pert
"expression at 0hr, bio rep1",ctrl
genotype/variation: wt;	age: E16.5;	tissue: Whole eye,ctrl
Genotype: non-transgenic;	In the non-transgenic control animals no abnormalities in lung tissue was detected with the exception of a single animal which showed a slight focal interstitial mononuclear cell infiltration.,ctrl
CTL2 E2 1hr,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: scrambled;	transfection time: 24h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.245;	OD280: 1.679;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 321;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
PGA-HMO-Obese-4bUA-s2,pert
Elf4 KO2 activated CD8 T cells,pert
Lean Rosiglitazone 1,pert
"ARD842, CAIS, F, GOF, 6 x ETOH, 14d",pert
hippocampus: Sample #5_e1_le1,ctrl
Subject #8042-Preinfection,ctrl
Control (C85),ctrl
colon_IBD_1533,pert
H4-II-E-C3 cells exposed to 62 µM CoCl2 for 24 h,pert
Cervical cancer_CC163,pert
whole skin,pert
"DMSO-treated NRK-52E cells at 72h, biological rep 2",ctrl
"Monuron-treated NRK-52E cells at 72h, biological rep 2",pert
Placenta_PE(LO)5 with Cy5,pert
OVE26_8W_3_6,pert
ND_6,ctrl
ANL Chip#23,pert
"Monuron-treated NRK-52E cells at 6h, biological rep 3",pert
"heart, subendocardial left ventricle",pert
hippocampal CA1 tissue,pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: standard AIN-93G diet (SD; carbohydrate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum for 8 months,ctrl
"WT, PR04M004v0",ctrl
cell line: HM1 embryonic stem cell line;	genotype/variation: Prmt6 overexpression,pert
X66-,pert
"Fibroblasts, formoterol, time 6h, patient 1, rep 1",pert
"SIRT7 Knockout Liver, replicate1",pert
DMN-CtrHippo15d-2dAv2-s2,ctrl
"Patient 14, Atheroma plaque",pert
sMPNST_shCONTROL_3day_rep3,ctrl
"DMSO-treated, 24h after UV, Replicate E",ctrl
heart of male mouse subjected 1 week to chronic intermittent hypoxia.,pert
Double_positive_thymocytes_Dexamethasone (1E-07 M) _3h_rep1,pert
"Vldlr knockout saline, biological rep3",pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 3,ctrl
proband-MS,pert
Severe rep10 (OHN),pert
sex: Male;	Age: 20 months;	additional patient information found in Series supplementary file,pert
jzo028-rp1-v5-u74av2-met,pert
B6-WT2 melanocytes,ctrl
Floxed_Mstn_1,pert
"AALE-KRAS uninfected, biological rep3",pert
c_B53,ctrl
HaCaT_ZNF750i_ biological rep1,ctrl
Human prostate cancer cell line,ctrl
db/db 10-5,pert
"strain:BALB/c SCID, gender:male, age:8wks, tissue: whole lung, condition: uninfected control",pert
10.5 Months Heart MDX rep 3,pert
IkkβΔ_replicate2,pert
Cardian muscle Healthy 1 week C1,ctrl
shNANOG_3,pert
5206 Normal Uninflamed sigmoid colon,ctrl
Trained diabetic 3 weeks DT3,pert
homozygot FH P254 (human CD3 positive T cells),pert
tissue: Gastrocnemius muscle;	genotype: WT;	age: OLD,ctrl
strain background: CD1;	genotype/variation: wild type; Raldh2 +/+;	tissue: embryonic brain;	tissue region: posterior;	developmental stage: 4 somite stage,ctrl
Individual_4505_PP_sample,pert
RPE65_KO_2months_retina3,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 8",pert
BP patient 110_biological replicate 1,pert
cerebrum_PSNA_ 12w_rep1,pert
"Keratinocytes untreated control, 48h",ctrl
NZM15 metastatic melanoma cells media-only control,ctrl
KU_49T,pert
Ero1-C104A/C131A non-induced biological repC,ctrl
LECs from cirrhotic rats 1,pert
Normal lung,ctrl
Telencephalon cKO 1,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 96 hours after nickel exposure",pert
01LSC_Oligo,pert
Intestine_KO_biological rep3,pert
0193-01-C,ctrl
genetic background: C57Bl/6;	genotype: wildtype;	cell type: Osteoclasts;	treatment: Calcitonin,pert
Labeled microRNA,pert
Early IPF_surgical biopsy_upper lobe_rep144,pert
"hepatic gene expression at ""3 hr"" (rep3)",pert
Human lung adenocarcinoma cell line,pert
T41,pert
status: Control;	gender: Female;	age: 54;	tissue: Blood,ctrl
db/db 7-5,ctrl
CUTLL1 wash4h-CHX,pert
braak stage: BR56;	rin: 78;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"Liposarcoma culture from tumor 377, doxorubicin treated",pert
WT Liver - Pooled -Cy3,pert
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-GFP retrovirus,ctrl
BAL_4_A0B0,ctrl
11_0019C_Day1_28,ctrl
Postnatal 3 weeks control heart biological rep1,ctrl
P1 mouse eyeball extracted total RNA_wildtype3,ctrl
"human failing LV myocardium, Idiopathic39",pert
GIST Pre Treatment Biopsy 32,ctrl
C2C12 myotubes 100uM H2O2 rep 1,pert
Gastrocnemius and Soleus muscles,ctrl
Genotype: Mdr2-KO heterozygous mouse;	Age: 3 month,ctrl
age: 71;	sex: M;	disease status: control subject;	Filter number: 87;	Usage number: 1;	Exposures: 3,ctrl
12h_c1,ctrl
ME180 DMSO rep 1,ctrl
5207 Normal Uninflamed sigmoid colon,ctrl
01UN4_PolyRF-,pert
"Male Nrf2 wild-type mice, liver sample",ctrl
Diaphragm 28 Day mdx rep 2,pert
Allo-4-5,pert
parental Ainv15 ESC differentiated as EB for 3 days,ctrl
"Normal 13, control tissue",ctrl
non-CF subject 40,ctrl
Individual_4079_PP_sample,pert
HCC004T,pert
WT / Reference_13425478,ctrl
atopic eczema P5,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5;	flt3 status: internal tandem duplication (ITD),pert
"Deltoid, FSHD, cohort 03, subject 03A",pert
37A;pretreatment;female;breast tumor; not assessable,ctrl
Primary chondroyctes; Mir140 KO; Ago2-IP,pert
"SPC-c-raf transgenic mice, 5 month old, female, unaltered",pert
Lung Epithelial Cell Line,ctrl
Patient: L;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Normal control 3,ctrl
LNCaP.GFP.6,ctrl
02SAGEA,pert
FoxO3 null mutant,pert
C4_pitM,ctrl
Postmenopausal female. Tibolone treated. Patient 1.,pert
t21,pert
01_0049A_Day1_12,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 72 hrs;	Drug: No Rosiglitazone present,ctrl
"Lesion Skin, LS-14",pert
Native-0-3,ctrl
H3f3b WT 3974,ctrl
WT STR PDE10i 11,pert
E9.5 FVB/N erythroid cells-12,ctrl
Superior Frontal Gyrus from two 8 year-old RTT girls,pert
age: 56;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 24hr.",ctrl
tissue: T cells;	genotype: wild type 5C.C7;	background mouse strain: B10.A,ctrl
GM19238_Kd_CLOCK_2,pert
HF0975_U133P2,pert
Healthy2-CD8,ctrl
CD4IncDec-test-1,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
WT.DMSO.2,ctrl
"Control, untreated",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 07/15/05;	# cells: 38;	Sex: male;	region: M1;	age: 45;	genotype: Y/X;G42/-,ctrl
Control PB C105,ctrl
LOX1 Untreated 24hr 282295913,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
IDTC 3,pert
Isolated PBMCs from diabetic male patient_RES-enriched Grape extract_6 months,pert
Globin_S3,pert
"wild type, sample 2",ctrl
Advanced IPF_explant_lower lobe_rep157,pert
ATM_siRNA_4b,pert
VGP2,pert
"depression, BA10-38",pert
WT J1 ESCs on day 3 #2,ctrl
autism with dup(15q) 03-43,pert
CD positive WT T cell TCR-stimulated rep2,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L009,ctrl
"Wildtype luminal mammary epithelial cells, MD892",ctrl
"Wildtype, biological rep2",ctrl
day 6 5-FU HSC 1,pert
01LNS_PolyRF-,pert
Non-transgenic mouse rep 2,ctrl
SHR12-3,pert
"IκBα-deficient animal, biological repeat 1",pert
mouse PPTA knockout lung 8 h after cecal ligation and puncture surgery,pert
race: caucasian;	age (years): 60;	stage: IB;	grade: 2;	histology: endometrioid,pert
Csbm/m Mouse_cerebellum_Young_saline treatment_Replicate-3,ctrl
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep1",ctrl
E14 - nudelko/+ 2,pert
FVB_8W_1_1,ctrl
A/OVX/P4/6h/UTX 129/SvImJ WT,pert
"Series 3, young, no fracture",ctrl
"cell line: 1104, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
NONE_24,ctrl
patient id: 131;	tissue: Normal cortex;	gender: Male;	age: 51;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
strain: C57BL/6;	treatment: control;	cell type: lineage-negative marrow progenitors,ctrl
Normal mucosa 12,ctrl
cell line: TYK-nu;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
IOSE80pc shGFP Ctr at 72h,ctrl
tissue: skeletal muscle;	strain: mixed background (C57Bl/6 and 129);	genotype: Yin Yang 1 (YY1) knockout;	age: 6 months,pert
Muscle-5 month-wild type-technical replicate 1,ctrl
Leg 112 Day control rep 2,ctrl
asthma_OVA24h_2,pert
Subject 7_t=30days_resveratrol,pert
minor HCC7,pert
C6 Control None,ctrl
"seminoma specimen, pT1, patient age: 38y; W99 063",pert
colon_IL10mouse_12weeks_rep3,pert
cerebrum_WT_4w_rep1,ctrl
patient: 229;	current medication: Naproxen;	birth date: 11/27/61;	gender: unknown;	ethnicity: CAUCASIAN;	symptoms onset date: 1/14/05;	diagnosis date: 1/18/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/26/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: NEW;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, U0126-treated",ctrl
chip number: 15;	transfection plate: 5;	target gene: RXRA;	kd level: 0.78;	rin: 9.6;	transfection date: 2011-10-17,pert
WT MEF CT18-3,ctrl
Patient identifyier: F;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 28 years;	Body surface area: 15 percent;	Overall erythema: moderate;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
gender: female;	strain: C3H/HeN;	genotype/variation: WT;	tissue: liver;	age: Five-weeks-old;	agent: EtOH,pert
Carboplatin 24 hours set 1,pert
Muscle-24 month-Myc heterozygous-technical replicate 3,pert
NOD/LtJTCE liver sample batch 6,pert
Diaphragm 56 Day mdx rep 3,pert
3_CD34+_12h_TCDD+,pert
Ileum_Wild Type_3,ctrl
Psoriasis-Patient-D,pert
HSF1-/- T cells at 37oC replicate #2,pert
OBF-1 overexpression BCS-2 (EPLM),pert
microdissected breast cancer cells from case 180,ctrl
Normal mucosa 17,ctrl
strain: 116;	Disorder: normal scar;	Condition: +hydrocortisone,pert
MacularDegen-injured-15aAv2-s2,pert
Young 3,ctrl
64SmokeH,ctrl
Whole liver,ctrl
01ML9_PolyRF-,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_4 months_replicate 3,pert
Donor1_24h_DMSO,ctrl
cDNA scc 01,pert
control MLL_00107,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 43 yr;	population: white;	dsm-iv: 295.9;	age of onset: 25 yr,pert
V5-P260,pert
6h_c1,ctrl
MEKi 16h biological replicate 2,pert
HCC_37N,ctrl
Liver from a 5 month old Myc heterozygous mouse,pert
Control subject 39_biological replicate 2,ctrl
"ARD842, CAIS, F, GOF, 1 x 1000nM DHT, 24h",pert
"WT2_ileum, 5 days post-infection with T. gondii",ctrl
Peripheral blood mononuclear cells (PBMC)-Patient SE T0,ctrl
wild-type naïve CD4 T cells KAI270,ctrl
U937-derived cell line harboring TRIPZ-shRNAmir TetOn cassette (clone ID: V3THS-381738),pert
MDS patient 84,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.572;	OD280: 1.326;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 369;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"RNA from RAW 264.7 CellsArray Type; Affymetrix Mouse 430_2,",pert
RNA from MLL1-KO MEF (30h after serum shock),pert
Rat heart,pert
C6_CLP_wildtype_12,ctrl
Human.AQ.CP.ECRB,pert
Tetracycline-inducible glioma cells no dox 3,ctrl
baseline control 09,ctrl
Rb-/-PrE serum 1,pert
Msgn1_12hMinDox-biological rep2,ctrl
mdx5cv diaphragm sample 2,pert
27A;pretreatment;female;breast tumor,ctrl
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: acetaminophen (APAP);	tissue: liver,pert
WT_ANT_PDE_B2,ctrl
Muscle Control 2,ctrl
visceral_fat_Wt_female_8wk_rep1,ctrl
Kidney_200 mg/kg VCM ip_mouse #087,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 133min;	race: White;	sex: Male,pert
treatment: vehicle;	genotype: progesterone receptor knockout;	treatement time: 40 hours,pert
4_Hr_+MGd_3,pert
healthy control_1,ctrl
PND28 Rat Testis_Rat230-2_2hr MEHP_Animal#44_04005,pert
"brain, hippocampus: KA240-II_e1_le1",pert
Alveolar epithelial Cell Line A549,ctrl
CyP 3hr 2,pert
gender: male;	batch: 1;	age (years): 33;	patient id: Control_5;	fev1 (% predicted): 78;	fvc (% predicted): 77;	medication: None;	cell type: CD4+ T-cells,ctrl
5195 Normal Uninflamed sigmoid colon,ctrl
Carbo Day1 (73R),pert
4321-1 E2F2 Null,pert
healthy myeloid cells 5,ctrl
V5-P025,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep6",ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 2.8104038329911;	age of psoriasis onset: 26,pert
"Male, 34 years old",ctrl
3446M patient’s mucosa,pert
multiple sclerosis_4,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_4,ctrl
Fetal heart 1.5 ug/kg TCDD rep4,pert
EUR12_T2_PP_day0_044,ctrl
chip number: 8;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.8;	transfection date: 2011-03-29,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: mild;	Ig clonality: oligoclonal,pert
6h_RA3,pert
EOM 112 Day mdx rep 2,pert
TK6 cells,pert
TG KLS 1,pert
PBMCs enriched for CD8+ cells from normal control subject K,ctrl
brain_DLPFC_bipolar C_mr404,pert
RAW_0.14mM_HOCl_#1,pert
"KO total RNA LSK, rep 1",pert
MDS patient 34,pert
"Patient L, uninvolved skin",ctrl
"twin pair: #7;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
tumor tissue from mastectomy specimen from postmenopausal patient with invasive ductal carcinoma (IDC),pert
"wt muscle 3, biological rep 3",ctrl
tissue: temporal lobe;	strain: C57;	genotype: WT,ctrl
cell line: L8057;	cell type: megakaryocytic cells;	genotype/variation: shRNA-mediated Ring1b knockdown,pert
Control subject 45_biological replicate 1,ctrl
"brain, frontal cortex: Sample47_e1_le1",pert
siControl_rep_3,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 2,ctrl
condition: Psoriasis;	patient: PS-D;	tissue: LS skin biopsy;	kit: Affy,pert
tissue: skin;	individual: Patient P7;	condition: AL;	eczema severity: SCORAD: 56,pert
Cervical cancer_841T,pert
ILD Study Number 1115,pert
H441 transfected with ETS2-specific siRNA 1,pert
Normal Gingiva replicate2,ctrl
Subject 3_t=30days_resveratrol,pert
461MM,pert
scc_01,pert
MCF10A-HER2(+) 9days,pert
SU8686 cell line,ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 0.5, Units of Harvest Time Point: hr",ctrl
"Normal cervical epithelium, microdissected, Age 30",ctrl
P2,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 29;	maternal age: 27,pert
subject: 07U;	cohort: 7;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 34kb;	age (y): 49;	Sex: F;	batch: Batch_2,ctrl
"A673 treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50), biological rep1",pert
patient: 136;	current medication: metranidazole 400mg TDS Prednisolone;	birth date: 5/21/51;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/20/05;	indictation for procedure: Diarrhoea PR bleeding;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
MH1C1_untreated_rep1,ctrl
14.5_WT_522B,ctrl
WT littermate2,ctrl
Huh-7/Fluc rep2,ctrl
multiple sclerosis_2,pert
siCITED1#1 replicate2,pert
"Patient B, lesional skin",pert
E9.5 FVB/N erythroid cells-11,ctrl
91 year old male,pert
WT CMP rep2,ctrl
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate1,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus other,pert
Strain: C57BL/6J;	Gender: M;	Age: 6 weeks;	Treatment: untreated,ctrl
GIST Pre Treatment Biopsy 08,ctrl
129_Sv_3_Tal1_Ko_d6_4302,pert
"Vehicle treated, DAY 6, biological rep.3, MV4-11 cells",ctrl
sex: female;	tissue: liver,ctrl
E12.5 Whisker pad Trps1 mutant,pert
"ALL_DS, K25 011509",pert
HCT116-Neo124 human colon cancer cells with intact PTEN,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-tu3,ctrl
EVI_GFP positive Lin- cells replicate 2,pert
Braak α-synuclein stages 5-6  BR56_4SN,pert
strain: C57Bl6;	gender: female;	age: 6 months;	tissue: white adipose tissue;	genotype: WT,ctrl
healthy control H20,ctrl
Tendon_non-lesional_rep14,ctrl
Heregulin 979-CLA-36,pert
"PCB153 treated HepG2 cells at T6, biological replicate 1",pert
"mouse aorta cross strain comparison, times 0, 4, 10, 24, 40 weeks",pert
RNA from HCC_9N,ctrl
cell line: MLL-AF9 AML cell line 10949 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
cell line: ACC483 [HPB-ALL];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
"Typically Developing Control, Gracilis, Patient Replicate 7",ctrl
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 2 hrs;	Drug: Rosiglitazone present,pert
Kidney_400 mg/kg VCM iv_mouse #043,pert
B6_Female_Control_rep3,ctrl
Cell line HeLa_control_expt1,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 1;	time: 0;	batch: 1,pert
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed,ctrl
0950-01-A,pert
siERK2Veh24h_3500,pert
TTP_WT_60ActD_BioRep5,pert
chip number: 20;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.59;	rin: 9.8;	transfection date: 2012-03-26,pert
CD8+_Tcells_severe_asthmatic_5,pert
WT_IL-6_400_rep3,ctrl
lesion_preUV_patient11,pert
Human synovial biopsies from the knee of a patient with severe rheumatoid arthritis,ctrl
CEPI_III_183,pert
CPU S control 1,pert
Patient: E;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
976PBMC,pert
b6.2,pert
subject: 03A;	cohort: 3;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 40;	Sex: F;	batch: Batch_1,pert
"PBMC, healthy control, biological rep4",ctrl
cultured skin fibroblasts from Marfan subjects,pert
"PTEN mutant 1 intestinal polyp, 30 days post polyI:C",pert
WT3 SPLEEN,ctrl
cerebellum_Pink1 knockout_12 weeks_replicate 2,pert
NPC17,pert
diet_mammary_3,ctrl
PLT-t7; transgenic plantaris 7 month,pert
FR-si221-1,pert
Mut_M_2,pert
Day: 15; Drug: Saline; Phase: Withdrawal; Replicate: 1,ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: untreated,ctrl
cell type: hRPE;	disease state: uninfected;	gender: male,ctrl
cell line: THP-1;	shRNA construct: Scrambled Control,ctrl
MDS44,pert
treatment: baseline;	gender: M;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
B_lymphoma_3,pert
human_hepatocyte_clinafloxacin_24hr,pert
Weight:High;	CFstatus:control;	Sex:Male,ctrl
Human Uninfected Sample N050-CD8+ T cells,ctrl
Ulk1/2-/- (untreated) 2,pert
"Gastrocnemius, Cmah KO, mdx, 2 months old",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 79 years,pert
5091212024_D,pert
control participant P306wdh (human CD3 positive T cells),ctrl
Huh-7/Fluc rep1,ctrl
"Mouse heart, IDH2 R140Q mutant, replicate 3",pert
"BPL adrenals, replicate 1",ctrl
SLE CD19 B cells 14,pert
SZ24,pert
Human prostate cancer primary culture C39sx,pert
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P55;	clone: C18,pert
"Hdh knock-in embryonic stem cells, Q91 line, biological replicate 1",pert
C5med,ctrl
EA_Control1_CD20,ctrl
TNKSi 4h biological replicate 1,pert
CTL2 AO 4hr,ctrl
"brain, hippocampus: C24-II_e1_le1",ctrl
Bone-Marrow_SMM_S1377,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse 3",ctrl
"endometrioma, patient 2",pert
"human failing LV myocardium, Idiopathic50",pert
FmrWT5_blood,ctrl
T133 U133p2,pert
48 hrs TAC-1,pert
SZ20,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 2;	gender: male,pert
"AALE-Vector + shTBK1, biological rep2",pert
"RPMI8226_shKLF2#2, replicate2",pert
MLL_00109,ctrl
NPC_SA01_2,ctrl
jzo016-rp1-v5-u74av2-met,pert
P0 - WT129s6 2,ctrl
CLL15-CD4,pert
"Lesion Skin, LS-20",pert
BALB_Female_Control_rep2,ctrl
HC-WT-15B,ctrl
Day: 15; Drug: Saline; Phase: Withdrawal; Replicate: 3,ctrl
RNA from HCC_9T,pert
Wt_ liver_fasted_refed_3hr_ rep1,ctrl
"BMMs, untreated control, db, Replicate 3",pert
"SLE patient, 1001V1",pert
control participant P312,ctrl
GB 10 65B NO LPA,ctrl
KU_39T,pert
"Control siRNA - Undifferentiated, rep1",ctrl
"Biceps muscle, Pompe patient",pert
F/F.ES. rep1,ctrl
05_C57_KO,pert
patient E1589,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with a 1st generation (E1-E3-CMVLacZ) vector.,pert
Brain from 20 days Npc1-/- mouse1,pert
Cre_day_7-2,pert
RatLung_H24h_3,pert
strain: C57BL/6;	genotype/variation: KLF5 WT;	cell type: LSK BM cells,ctrl
genotype: wild-type;	cell type: naive CD8 T cells;	genetic background: C57BL\6,ctrl
PBMC from T cell LGL leukemia patient #132 (TLGL132),pert
SALL4 shRNA biological rep1,pert
"Uninvolved Skin, NS-16",pert
Moderate rep3 (retina),pert
Z6_TA,ctrl
K562 cells control replicate 4,ctrl
"NTERA2/D1 cells, control siRNA",ctrl
WT-sham-2 month-R1,ctrl
Bl6_WAP_3,pert
embryons of mice at 14.5 days.,pert
CME-LaminA3d-1MA-S2,pert
Gender: male;	Age: 31;	Ethnicity: White,ctrl
"INS-1 cell line, clone #1-1.2",ctrl
subject id: 3;	infection: DENV;	status: DF;	tissue: whole blood,pert
"46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
ccRCC tumor of patient T163,pert
Backskin_Get1_e18_KO3,pert
3030,pert
siNS_4h_4,ctrl
Pertuzumab treated after 4 days (P1_2),pert
tissue: minor salivary gland;	disease status: early SS,pert
"E17.5 preB cells, Smchd1 null",pert
Human skeletal muscle biopsy sample;	Patient #128 with NORM,ctrl
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 114;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
human liver; very advanced HCC,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 258;	age-at-biopsy-years: 65,pert
CD4IncTp2-2,pert
WT1 activated CD8 T cells,ctrl
ESE_D_517,pert
knockout mouse kidney - 2,pert
E9.5 FVB/N erythroid cells-9,ctrl
EP34_adipose_pcos,pert
tissue: testis;	genotype: WT;	genetic background: C57BL/6,ctrl
NALT_infected_24h_90-226_rep3,pert
MCF10A-Myc-rep1,pert
"IRF6 knockout, biological rep3",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 53 yr;	population: white,ctrl
No or early 1 rep4 (retina),pert
10_b,pert
AMWT_Ker42,ctrl
CD8+ cells isolated from spleen,ctrl
Replicate 1 - Vehicle,ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Cell line expressing inducible GFP-progerin. Induction: day 0. Replicate B,pert
Caudate-Putamen of naive AChE-S mice,pert
"Uninfected, replicate 2",ctrl
scan batch: Batch 1;	group: control;	subject age: 5;	paternal age: 32;	maternal age: n/a,ctrl
"human nonfailing LV myocardium, NonFailing16",ctrl
Akt1-deficient 2,pert
Ovarian Surface Epithelia,ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,pert
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: FIZZ2 knockout,pert
MCF-10A shCHK1-4 replicate 3 [set 5],pert
NSC_ DMSO_24h_biological rep2,ctrl
ccRCC tumor of patient T26,pert
"Peripheral blood, patient without recurrent events",pert
subject id: c7;	infection: control;	status: control;	tissue: whole blood,ctrl
"Normal cervix epithelium, Age 41",ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype squamoid/giant cell;	matched/unmatched: unmatched,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 29;	sex: F,ctrl
NSCLC cell line H157. Transfected with Oligofectamine (Invitrogen) without RNA,ctrl
"human failing LV myocardium, Ischemic46",pert
"RES-enriched Grape extract group, 12 months, patient number 13",pert
T1008ni,pert
BN DES-treated replicate 2,pert
HEK293 transiently EWS-FLI1-transfected 2,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse 1",ctrl
"SLE patient, 1004V1",pert
HT144 melanoma cell line,pert
RKO_HSF1siRNA_6hDMSO_REP2,pert
KL2_muscle_control,ctrl
Muscle Control 3,ctrl
"Lesional tail skin from K14-Areg mouse, biological replicate 3",pert
B cell lymphocytes from MCL patient,pert
GATA3KO_2,pert
A_AN11989_C,pert
"PCB77 treated HepG2 cells at T0.5, biological replicate 3",pert
P0 - lis1cko/ko Mix 3,pert
RNA from 3 MCF7 cell culture plates treated with 150 mM of resveratrol (SIGMA St. Louis MO),pert
vastus lateralis biopsy,ctrl
0967-01-C,ctrl
"bipolar disorder, BA10-18",pert
"p38alpha knock out fetal liver E13.5, biological rep1",pert
liver western diet 0.05% quercetin rep1,pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 40;	Usage number: 4;	Exposures: 2,pert
immortalized mouse brown preadipocyte,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#132,pert
"MCF10A cells, vector control",ctrl
erStress_twins_AA_1717twin1_500nM_thapsigargin_4h,pert
Wild type MEFs from 13.5 day embryos,ctrl
PC-3M/MYB siRNA #3,pert
NE-rep6,ctrl
RPE65_KO_6months_retina4,pert
Targretin_Lung_1,pert
umbilical cord_nobpd: 9D,ctrl
(ca)MEK_2,pert
T123,pert
chip number: 18;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.55;	rin: 9.3;	transfection date: 2011-10-17,pert
"gender: Male;	age: 72;	post-mortem delay: 12h;	ph: 6.8;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
1705-EV_24hr,pert
Ishikawa_VeryHighDose_BPA_24h_rep3,pert
cell line: OV90;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
db/db 11-3,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#6,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: PDGFRA mutation detected,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ,ctrl
Kidney_saline iv_mouse #001,ctrl
Colon_Wild Type+Quercetin_3,pert
Cervical Cancer C405,pert
liver-AHRKO-cornoil-rep3,pert
Subject #8042-2d Postinfection,ctrl
"Peripheral blood, patient without recurrent events [N41]",pert
Nrl ko P10 replicate 1,pert
RNA from WT MEF (30h after serum shock),ctrl
Shn2_Wildtype_2,ctrl
strain background: C57Bl/6;	genotype/variation: BATF-/- P14 TCR transgenic C57Bl/6;	cell state: Day 0 Naïve CD8+ T cells,pert
MCI-017,pert
Bl6_WAP_1,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3WT;	age: 12 weeks;	nutrient state: 24h fasted;	diet: Standard diet,ctrl
Individual_4503_PP_sample,pert
"Patient 7, Atheroma plaque",pert
NCCIT siTET3 rep1,pert
cell line: HEK293T;	transfection: si-control;	induction agent: CM;	induction time: 4 hours,ctrl
Tgfbr2 Wildtype Mouse Model MEPM 3,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#124,pert
"Pten null fibroblasts, biological rep3",pert
Seltzer 21d replicate 3,pert
"patient 036b, cancer, homogenized",pert
"treatment: control;	batch: 5;	donor: 5;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
3wks sham-1,ctrl
untreated AML 7C blasts,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 7;	gender: male,ctrl
"210, MUSCLE, After",pert
human pancreatic cancer cell line BxPC3 transfected with vector expressing shJMJD3,pert
"genetic background: B6;	genotype/variation: Xbp1 knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
AA_Control_CD8,ctrl
Ribavirin Treated Cells 2,pert
HEK293_ControlsiRNAConfluent_rep1,ctrl
E2 8hr,pert
"heart of mouse, 1 week control (1A)",ctrl
intestine_PPARa_kockout_24hfasted_rep3,pert
Human fibroblast,pert
Cultured hESC H1 B2M KO,pert
TYK-nu+(2),pert
AVIC sample#1 treated with DAPT,pert
F4,ctrl
"Lung, Sporadic Idiopathic Interstitial Pneumonia (S-IIP), Nonspecific Interstitial Pneumonia (NSIP)",pert
"SWR/J Saline treated, biological replicate 2",ctrl
LNCaP.GFP.5,ctrl
"knockout liver, biological rep 3",pert
Aquaporin-11+/+_mouse P7 kidney #4-1,ctrl
"brain, brainstem",ctrl
Primary hepatocytes isolated from FVB mouse strain treated with DMSO for 6h,ctrl
Infergen_24hr,pert
"human peripheral blood derived monocytes, 2 hour LPS stimulation, biological rep2",pert
A_AN19511_T,pert
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep3",pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
DMSO2,ctrl
"Peripheral blood, patient without recurrent events [N27]",pert
C13-(1),ctrl
SKNSH MECP2_e1 1,pert
"non-AD_HI, biological rep7",ctrl
cell line: HCT116;	shRNA: CDK19;	treatment: untreated,pert
disease state: healthy control;	tissue: epidermis;	age: 59;	gender: male;	treatment: untreated;	time: control,ctrl
K562 cells control replicate 7,ctrl
"Lesion Skin, LS-12",pert
ApoD KO rep_3 (CKO3),pert
liver-AHRKO-cornoil,pert
MIY_day_3-4,ctrl
PND28 Rat Testis_Rat230-2_2hr MEHP_Animal#43_04005,pert
20A;pretreatment;female;breast tumor,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 13.0;	age of psoriasis onset: 30,pert
Patient: D;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
DBA/2J hippocampus-Control,ctrl
"Ulcerative Colitis (45 year old caucasian male, SAK_1286475720)",pert
hdh genotype: Q111/Q111;	tissue: cerebellum;	age: 3~10 weeks,pert
New El-Ashry 001.CEL,ctrl
11_1_MOE_430A_WT,ctrl
MOLM14_shSYK_1_Replicate1,pert
LCL Unaffected MZ twin pair 5 (CCN5.2)(TP28),ctrl
High weight gainer KOZAK2_ABI_HYP_H1,pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with microcrystalline arthritis",ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 3,ctrl
Glomeruli from nondiabetic male FVB mouse sacrificed at 8 weeks,ctrl
quadriceps_muscle_Wt_female_35wk_rep4,ctrl
"120, ADIPOOSE TISSUE, After",pert
"Epithelial prostate primary cells from fresh explant of controlateral normal tissue characterized by the presence of few areas of ""PIN"" (Prostatic In Situ Neoplasia)",ctrl
esophageal squamous cell carcinoma from patient E2644,pert
HF0966_U133P2,pert
ANL Chip#31,pert
PGA_MI_nilv_8w_311,pert
Lmna H222P homozygous male 6,pert
"Global gene expression of NASH patients, normal control A99",ctrl
whole tissue section from case 1125,ctrl
"Gata4_S105Amut, untreated whole heart",pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep3",pert
"age at diagnosis: 69;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2a;	er: 1;	pgr: 0;	dfs-month: 31;	dfs-event: 1;	distant metastasis: 1",pert
"HL-60 + 100 µM curcumin, biological replicate 2",pert
cumulus_PCOS_Lean_rep4,pert
P 27 Control,ctrl
WM-266 cells transfected with CONTROL siRNA - Replica 2,ctrl
tissue: white blood cells;	age: 16.61;	Sex: female,pert
"Gender: female;	Age: 51;	Source: skin, neck",pert
HeLa Cells,ctrl
Lymphedema Tail Skin 1,pert
Sex: female;	Age at operation: 67 years;	Site: thigh;	Size in cm: 35x15x12;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
Dengue Fever Patient 37,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: female;	sample type: control,ctrl
whole blood_100961,pert
Allo-25-2,pert
thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age and pooled before synthesis of cDNA,pert
MV 3,pert
ND_5,ctrl
GM19238_Kd_ESRRA_2,pert
Gene expression of murine fibroblast-like synoviocytes Grp2_C57BL6_2_FLS_TNFtg,ctrl
V5-P077,pert
Mouse RSK2 mutant mandibular molar [ABH_16A],pert
"Gender: Female, Age: 33, BMI: 33, Tissue: luteinized cumulus cells",ctrl
"Wild type used for GNMT 3 month, replicate 4",ctrl
"Myd88 null C57BL/6 mice, liver, 10-12 weeks old, sacrificed 2 hours after 85% liver resection",pert
Psoriatic arthritis PsA 2,pert
"NB4 cell line, wild-type, untreated",ctrl
Dengue Fever Patient 80,pert
"SBC-5 cells, siEGFP (control), 24 hr after siRNA, duplicate sample 1",ctrl
"A673 cell line, a human EWS/FLI translocated Ewing sarcoma cell line.",pert
"DMSO-treated NRK-52E cells at 24h, biological rep 3",ctrl
Y HID_B002,ctrl
3 wks sham-3,ctrl
cell line: MCF-7;	expression: Control,ctrl
control participant P332wh,ctrl
Seltzer 50d replicate 1,pert
"Index, patient2",pert
wild-type mouse kidney - 2,ctrl
sample =XCGD4 treatment=Stimulated time=180 (min),pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 274;	age-at-biopsy-years: 49,pert
Mening SWB WB NP 12b,pert
HepG2 cells quercetin 24h,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
Total Prefrontal cortex RNA,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 33, stage IIB, HPV 16",pert
cell line: FU-OV-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
N/LV4,ctrl
Control 26,ctrl
CLL19-CD4,pert
cell line: SNB19;	transfection: Scramble siRNA,ctrl
"NALT infected with 90-226 deltaM, 24h, biological rep4",pert
3T3-L1 Day 0 (passage 19) 24h after siControl transfection,pert
GATA-1deltaN mutant E12.5 fetal liver derived megakaryocyte progenitors,pert
WT 541 L5,ctrl
C_AN04479_F,ctrl
"Global gene expression of NASH patients, P55",pert
"PMA treated, doxycycline treated; biological replicate 3",ctrl
"DMD skeletal muscle, biological rep20",pert
06R041 RA,pert
PGA-lv_1w_672,ctrl
"affected status (disease state): control;	gender: female;	age-at-examination: 73;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia",ctrl
"Huh7 cells, Mock Infected, 18 hours",ctrl
lung_silica_1,pert
Muscle from a 24 month old wild type mouse,ctrl
Saline treated mouse gallbladder 3,pert
control cerebral microvascular fragments,ctrl
cerebrum_WT_10d_rep1,ctrl
B4 392 b4-/- after nicotine-induced seizures,pert
"Mouse Sciatic Nerve, Non-diabetic Vehicle",pert
MGd_1,pert
H13 HA 6h 3,pert
"colon from floxed mouse, wild-type phenotype",ctrl
Thioglycollate-elicited PPARg KO macrophages,pert
"Lymphoblastoid cell lines derived from family 1720, member 1",pert
CD43+/41+/235+ progenitors generated from Trisomy 21 iPSCs,pert
Oct4GipES_Luc_esiRNA_72h_rep2,ctrl
Nrl ko 2 mon replicate 2,pert
Normal_MS 36A5,ctrl
N2A cells_non-targeting vector,ctrl
medial gastrocnemius,pert
Control (C60),ctrl
brain_DLPFC_bipolar B_mr409,pert
T-REx293-NPAP1-induced-3,pert
"WT cells, replicate 4",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: LPA,pert
IkL/L thymocytes,ctrl
ic9 -- Cell line 2 treated with APF#1,ctrl
WT1 PBS,ctrl
patient id: T144;	tissue: Normal cortex;	gender: Male;	age: 74;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
sample type: Negative control;	cell line: H1;	cell type: embryonic stem cell;	protocol: control;	time: 3 Days,ctrl
RORasg/sg WAT_HFD_rep2,pert
cerebellum_wild type_12 weeks_replicate 3,ctrl
PsOEt-15-LS,ctrl
SRF Wt. IgM+IgD+ (GBF0551),ctrl
APP_R6_rep2,pert
cell type: embryonic fibroblasts (MEFs);	genotype: FIH null,pert
murine medullary thymic epithelial cells,pert
strain: C57B6;	genotype: Tgfbr2fl/fl;Wnt1-Cre;	tissue: Secondary palate;	age: E14.5;	gender: Not determined,pert
PWD/PhJTCE liver sample batch 1,pert
"MCF-10A cells, overexpression TAp63γ, biological rep2",pert
GM19238_Kd_POU2F1_3,pert
siTNIK+4hr Wnt,pert
KGN Knockdown [RR1008],pert
No or early 1 rep5 (OHN),pert
Patient: I;	Time: 0;	Group: responder;	Condition: lesional,ctrl
"ALL_DS, K24 011609",pert
cKO_P69,pert
WT_P14_Naive,ctrl
4_day_old_Prnp_knockout_mouse_rep2,pert
"SS gland, early, patient 5, batch 1",pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 3,pert
tissue: skin;	individual: Patient P14;	condition: AL;	eczema severity: SCORAD: 33,pert
Control Day14 (329L),ctrl
NPC_wt_rep1,ctrl
F191G C,pert
130A,ctrl
4040-1 E2F3 Heterozygous,pert
Pfeiffer BCL6siRNA,pert
umbilical cord_nobpd: 1A,ctrl
V5-P482,pert
"control, BA46-19",ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 232;	age-at-biopsy-years: 59,pert
"brain, cochlea: [1] Sample #1_le1",pert
"11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Normal-ERα-positive breast cancer 2,ctrl
PGA-RMM-7h-3aA-s2,pert
diseased_media,ctrl
age_years: 37;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"Strain: C57BL/10J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle Treated with AAV carrying Galgt2, Deficient in Dystrophin",pert
T64 dilated cardiomyopathy heart biopsy,pert
chip number: 14;	transfection plate: 4;	target gene: IRF8;	kd level: 0.66;	rin: 9.3;	transfection date: 2011-10-17,pert
Cisplatin_24h_rep3,pert
sciatic nerve of P60 Pmp22 transgenic mice,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep2",ctrl
BAL_42_A0B0,ctrl
"46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
Sorted Zfx ko myeloid progenitors overexpressing only GFP selectable marker,pert
NSC4,pert
"Tet1 KD, rep3",pert
tissue: lesional skin;	urticaria status: affected;	patient: 2,pert
"scr-Rosi, biological rep1",pert
microdissected epithelial cells from normal main pancreatic duct 6,ctrl
"C2C12 myoblasts, untreated, replicate 3",ctrl
P0 - lis1cko/ko Mix 2,pert
SALL4 shRNA biological rep3,pert
wild-type 1,ctrl
"ERRA KO ventricle, baseline",ctrl
normal brain tissue,ctrl
"Ifitm1-deficient lung tissue, biological replicate 3",pert
Patient no. 1: control,ctrl
s4t0c,ctrl
WT_P14_D3_Effector_rep1,ctrl
HCC PBMC Sample 4,pert
LM2 cells,ctrl
DW298_Tg_M,pert
MCI-004,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID138,pert
M479 Wt,pert
erStress_twins_AA_1727twin1_500nM_thapsigargin_4h,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: matched to N14,pert
WFS1 WT USHT_07_314_ko,ctrl
"HepG2 cells, control, rep1",ctrl
HCC PBMC Sample 1,pert
Posterior_Shh mutant,pert
sMPNST_shCONTROL_3day_rep2,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (3)",pert
C3H10T1/2 cell line,ctrl
"Gender: Female, Age: 35, BMI: 27, Tissue: luteinized cumulus cells",ctrl
Control peripheral blood leukocytes - Biological Replicate 4 - Technical Replicate 2,ctrl
"Biceps, FSHD, cohort 09, subject 09A",pert
newborn (P0) Krt1+/+ skin_replicate 3,ctrl
"34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 31;	maternal age: 30,ctrl
midbrain_Pink1 knockout_12 weeks_replicate 2,pert
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle",ctrl
cell line: BV2;	treatment: untreated,ctrl
Tia-1 122972 cerebellum 3 month,pert
"WT, rep2",ctrl
chip number: 14;	transfection plate: 6;	target gene: JUND;	kd level: 0.71;	rin: 9.6;	transfection date: 2012-03-26,pert
atopic eczema P3,pert
Dilated cardiomyopathy_G68,pert
ME180 3 hours rep 1,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-sp2,pert
human_LIMA_artery_patient4_control,ctrl
cell line: JoMa1;	cell type: neural crest precursor cells,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 11.938;	Ratio: 2.09,ctrl
Pt23_Pre,ctrl
siHic5 DHT 2,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6;	colon weight (mg): 172;	colon ratio (mg/mm): 2.87;	myeloperoxidase activity (u/mg): 0.384;	tissue: colon;	treatment: 5% DSS,pert
Fog2flox/delta; alpha MHC Cre biological replicate 1,pert
ATCC CRL-2868,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.8;	colon weight (mg): 150;	colon ratio (mg/mm): 2.76;	myeloperoxidase activity (u/mg): 0.393;	tissue: colon;	treatment: 5% DSS,ctrl
female JAK2 WT liver sample 132,ctrl
BL2,pert
GEIM218-NORM,ctrl
control12,ctrl
DEX4_6H,pert
siCtrl.exp2,ctrl
Insm1 mutant #5,pert
F3-NGN1-2nd,pert
siHic5 DHT 3,pert
HeLa_06_21_04 TP-1,pert
CCRPKO-PB_rep-2,pert
midbrain_Pink1 knockout_24 weeks_replicate 3,pert
Individual_582_PN_sample,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 2,ctrl
DW83_WT_M,ctrl
Control subject 42_biological replicate 2,ctrl
Replicate 2 - R5020,pert
subcutaneous fat,pert
"Patient  B, lesion, 2 week",pert
control 2,ctrl
"seminoma specimen, pT1, patient age: 33y",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_8_18_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
01LRF_ERA,pert
GNMT-WT mouse hepatocytes,ctrl
Infergen_6hr_rep2,pert
microdissected breast cancer cells from case 317,pert
Nonirradiated-ATM-WT Replicative3,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 304B;	age-at-biopsy-years: 49,pert
WT CFTR unexposed,ctrl
cell line: HepG2;	genotype/variation: HNF4a knockdown,pert
"Biological Material: Cell line, grown invitro; Tissue derivation: Adenoid cystic carinoma of the parotid gland",ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID213,pert
Heart_caAkt_02,pert
Bone-Marrow_MGUS_G721,pert
normal main pancreatic duct 3,ctrl
HUVEC/NmenMC58_WT_4h_rep2_1108,pert
murine ES cells overexpressing Satb2,pert
Exercised-4,pert
"CD1, E15 pregant mouse",ctrl
Sample Group: HD patient; Gender: male; Age: 62; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/47,pert
Liver WT ND #687,ctrl
Sex: male;	genotype: sst +/+;	tissue: liver;	genetic background: C57BL/6,ctrl
"Wild type used for MAT1A 15 month, replicate 4",ctrl
Normal esophageal epithelium (N7),ctrl
NFIA E18WT2,ctrl
Kyoto Rat liver tissue (control),ctrl
Ischemic cardiomyopathy_G30,pert
shRNA6-16-noDox-rep1,pert
FoxO deficient LSK (6),pert
PDAC_T_117,pert
"cell type: myeloid monocytic cells;	protocol: 24h Q10H2 preincubation, 4h LPS stimulation",pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,pert
F with Cy5,ctrl
"control, BA10-30",ctrl
MEF E2F4 KO 5-rep1,pert
B_cell_pool_melanoma_M01+M02,pert
Individual_5839_NN_sample,ctrl
A39 NES 142Q TG3	F7/4	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Male,pert
CD8+_Tcells_healthy_donor_7,ctrl
Explanted neonatal cardiomyocyte,ctrl
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 24h,pert
control to Sample 13,ctrl
LY2 control-siRNA untreated rep4,ctrl
PGA-RMM-7h-1aA-s2,pert
abl siEZH2 at VEH rep 0,pert
Liver_POR-null+quercetin_1,pert
strain background: C57BL/6;	gender: female;	genotype/variation: MMA heterozygote;	tissue: kidney;	diet: high protein diet for 2 months,pert
No or early 2 rep5 (retina),pert
A6_LEF1,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 251;	age-at-biopsy-years: 45,pert
IFN_Gamma_24hr,pert
fat_Wt_8wk_rep3,ctrl
Skin biopsy from upper nates taken 7 hours after exposure to 5% nickel sulfate,pert
Tendon;Biceps_Lesional,pert
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: wild type;	treatment: stimulated for 3 hours with medium alone,ctrl
Skinbiopsy_7hoursnickel_controlsubject_k5,ctrl
Spleen,pert
untreated_24hr_rep2,ctrl
"human failing LV myocardium, Idiopathic19",pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 3,ctrl
cerebellum_Pink1 knockout_6 weeks_replicate 1,pert
IRS-4 KO (jos1529),pert
CKO V5,pert
14 Day Mouse leg muscle,ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: Cas,pert
P14 - WTMixA 2,ctrl
"fibroblast, wild-type, untreated, biological replicate 5",ctrl
M464 Wt,ctrl
Rb-/-PrE serumfree 1,pert
"brain, hippocampus: C240-I_e1_le1",ctrl
Phan_006_WT.bleomycin rep3,pert
Mouse colonic epithelial cell line MCE301,ctrl
Nrl-ko-Gfp 4 weeks retina replicate 1,pert
Jurkat T-cells 48 hour transfection,ctrl
"MCF10A cells, Myc over-expression",pert
Superior Frontal Gyrus_2-4y_RTT,pert
Huh-7/IRF1 rep3,pert
retina,pert
Control PB C103,ctrl
CML Patient 6 before therapy,ctrl
WT #182,ctrl
112 Day Mouse Diaphragm muscle,pert
A_AN01570_C,pert
SKM-Tg,ctrl
type 2 diabetes subject 03,pert
minor non-tumor3,pert
cell line: MCF7 breast cancer;	treatment: SIN3A silenced and LIF-stimulated,pert
GAS-t10-2; transgenic gastrocnemus 10 month,pert
Endometrium-Normal 9,ctrl
Sample Group: HD patient; Gender: male; Age: 55; Tissue: lymphocytes (blood); IT15 CAG repeats: 25/43,pert
striatum_wild type_12 weeks_replicate 1,ctrl
SW1736_t48h_rep2,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 1,pert
K562 cells control replicate 6,ctrl
"MCF7 cells, SIN3A silenced, NS",pert
siHic5_2_24h_1,pert
Ishikawa_VeryHighDose_BPA_8h_rep2,pert
SRF silenced EtOH rep 3,pert
Control Endometrium Mesenchymal Cell_031.UC208++,ctrl
2_CD34+_12h_TCDD+,pert
Bronchial Epithelial Cells control biological 2129M,ctrl
Insig1 flox/flox /Insig2 -/-,ctrl
affection: ADHD;	treatment: MPH;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 7 ADHD patients,pert
AZ-521_uninduced_18h_rep3,ctrl
"age: 8 month;	strain: FVB/N;	genotype: H-ras+/-, p53-/-;	tissue: carcinoma in situ",pert
tissue: normal esopahgus,ctrl
"AZ521 dnSox2 cells, induced, 18h",pert
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50), biological rep1",pert
WT_cerebellar granule cells at P5+2 DIV,ctrl
alveolar epithelial cells exposed to cyclic stretch 20% elongation for 1 hr,pert
BAT_WT_1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 59,pert
Wildtype_Sham_Rep4,ctrl
Saline treated mouse gallbladder 2,ctrl
cell line: HCT116;	cell type: colon cancer;	sirna: control,ctrl
Bronchial Epithelial Cells MMA biological 2122Y,pert
condition: Normal;	patient: N_LJ_3;	tissue: Normal skin biopsy;	kit: Affy,ctrl
"BMMC, WT pLKO.1, activated",ctrl
Epithelials cells isolated from mouse mammary glands with mono-allelic Pten expression,pert
MPM tumor specimen 32,pert
BALB_Female_CF_rep2,pert
CD34+ cells without fenretinide treatment from CML34,pert
"strain: FVB/C57B6 mixed backgroud;	cell type: primary KrasG12D Pten L/+ pancreatic ductal epithelial cells, P4;	genotype/variation: Pdx1-Cre;LSL-KrasG12D L/+;Pten L/+",pert
8DKD_SerumStarved->1hrEGF_rep1,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G48,pert
control participant P300 (human CD3 positive T cells),ctrl
TA-n10-2; normal tibialis anterior 10 month,ctrl
fibroblast cultured from normal esophageal tissue,ctrl
liver_STZ treated diabetic_rep5,pert
Cardiac Muscle_Cmah KO_mdx_rep3,pert
patient: 32023;	disease state: LGSC;	component: Invasive,pert
strain background: C57BL/6N;	genotype/variation: Stat1 delta beta (db);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
ALS gray matter 2 Familial,pert
KM_032N,ctrl
EE_IA_3_cauc_lcm,pert
strain: BALB/c;	gender: female;	type: Wild-type;	treatment: none,ctrl
"seminoma specimen, pT1, patient age: 33y; W03 015",pert
Wild type naïve T cells stimulated for 3 hours with medium alone 1,ctrl
heart-30 months of age-control diet-biological replicate3,ctrl
02-0002A_Day1_16,pert
siCtrlE24h_2661,pert
"Patient I-c451T, MSI colorectal tumor",pert
"vertebral bone, Prkaca+/-",pert
Healthy7-CD8,ctrl
MPM tumor specimen 34,pert
thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age; RNA was pooled before synthesis of cDNA,pert
WT Tibialis Anterior at 4 weeks biological rep3,ctrl
umbilical cord_nobpd: 1E,ctrl
S-IIP(UIP)14_Cy3,pert
mammary stoma-4w-wt-rep2,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.139;	OD280: 0.58;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 154;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"whole right lung, 6 weeks after a bleomycin dose of 125mg/kg, given by osmotic minipump.",pert
ubb_d14_ko_1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 6,pert
Caco2-siRNA1-rep1,pert
"KM-H2 cells, Non-silencing control, replicate 2",ctrl
"soleus muscle, young female pathogen-free Wistar rats",pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 52;	tissue: Blood,pert
"Strain: Bl6, Tissue: Bone marrow, Age: 7 weeks",ctrl
Healthy control 1,ctrl
Patient 3 c,pert
Liver,ctrl
RAW_3.5mM_HOCl_#1,pert
Obese Control-1,ctrl
"Patient  L, lesion, time: 0",ctrl
KO_TER119+_rep2,pert
THP-1 cell line infected with GSK3A Construct 5 shRNA,pert
Human muscle (vastus laterlis),pert
Splenic T1 cells,ctrl
Gender:F;	Age:45;	Tissue: Mucosa,ctrl
ATF2 KO-2,pert
"ID:10-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
F_LS_Wk4,pert
brain_control_sampleid_mr275,ctrl
10 mg/kg MPH tr1003,pert
WT A,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
GBM_stem_4 days_2,ctrl
liver_Akt1+/-_female_35wk_rep1,pert
optineurin expression-b02,ctrl
PKCZ -/- male mice angiotensin II treated,pert
MCL_IGHV_UNMUT (043-01-4TR),ctrl
Sample 1 Posterior  +/+,ctrl
control3,ctrl
Cervical cancer_20-04T,pert
patient: 24;	disease state: hypertension;	tissue: Atheroma plaque,pert
Melanoma allograft_vehicle-treated,ctrl
gender: Male;	tissue: Tendon;Subscapularis;	age: 50;	donor: 27;	disease state: Non-lesional,ctrl
"Patient GM, stable renal transplant recipients, female, 53 years old, T1 (3 months after the switching of the therapy)",pert
Normal-ERα-positive breast cancer 68,ctrl
HOX424 Carbo Day14,pert
BTBR_Islet_rep1,pert
"genotype: Gata6-KO;	cell: Peritoneal resident (CD11b-high, MHCII-low/negative) macrophages",pert
heart_WT_rep3,ctrl
control shRNA replicate 4,ctrl
tissue: skin;	individual: Patient P9;	condition: AL;	eczema severity: SCORAD: 55,pert
3880-3 E2F WT,ctrl
Healthy4-CD4,ctrl
siRNA-96_rep1,ctrl
prostate from PB-NICD model,pert
"7B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
KU_10T,pert
gender: Male;	tissue: Tendon;ECRB;	age: 55;	donor: 26;	disease state: Non-lesional,ctrl
"non-AD_TC, biological rep3",ctrl
KU_18T,pert
R1_control,ctrl
MDS patient 63,pert
Control (C267),ctrl
RNA-DHL6-R406-2H-2,pert
Sham 8,ctrl
X6752318096 E MYC positive#3394,pert
Pertuzumab treated after 4 days (P3_2),pert
sample M 18.5 wt,ctrl
strain background: C57Bl/6;	genotype/variation: BATF-/- P14 TCR transgenic C57Bl/6;	cell state: Day 3 in vitro effector CD8+ T cells,pert
chip number: 21;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.8;	rin: 9.7;	transfection date: 2012-03-26,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 218,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,ctrl
myoblasts-expt1_untransduced-rep1,ctrl
HOX424 Control Day1,ctrl
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 4",ctrl
"whole-blood leukocytes, etanercept, 0hr",pert
Cerebellum_nontransgenic control A39_8 months_replicate 2,ctrl
LY2 control-siRNA untreated rep3,ctrl
E9.0 ko.1,pert
gender: female;	age (years): 36;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: No treatment,pert
s5t0c,ctrl
astrocytes normoxia batch 3,ctrl
Spleen_wt_1m_rep2,ctrl
"HME-CC, 12h, sham",ctrl
"Immortalized MEFs WC, v-src expression retroviral vector infected, rep1",pert
sepsis patient #11,ctrl
PancreaticSample30-Normal,ctrl
breast tumor 1,pert
"Mice_c-myc trans, biological rep4",pert
C57BL/6J Mouse Male Kidney,ctrl
Macro-dissected renal cystic epithelial tissue from Fh1 knockout mouse,pert
IDCM1,pert
"Peripheral blood, patient without recurrent events [N35]",pert
4_day_old_Prnp_knockout_mouse_rep3,pert
"Lymphoblastoid cell lines derived from family 1743, member 2",pert
BM single-cell suspensions from bone fragments and aspirates were used to establish non-clonal BMSC cultures from normal donors (N-BMSCs),ctrl
"PDAC, sample 3",pert
Human hepatocellular carcinoma cell line infected with MIR517A and GFP protein 2,pert
IRS-3 KO (jos0699),pert
Control peripheral blood leukocytes - Biological Replicate 3 - Technical Replicate 1,ctrl
REH_shG1_rep2,pert
Cervical cancer_1434T,pert
strain: C57BL6/J;	age: 12 weeks;	gender: female,ctrl
WT13,pert
VEC B,ctrl
S25 NLS 142Q TG3	F4/34	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
patient: 51292;	sample: tumor,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T165,pert
"PC-3 cells, 60μM gefitinib (Gef), 24h",pert
status: Slow;	age: 54;	gender: female;	tissue: cultured human fibroblasts,pert
Leg 14 Day mdx rep 1,pert
GFP Replicate B,ctrl
12_2 cells with Tetracycline-repressible WT1(-KTS) expression,pert
female JAK2 KO liver sample 141,pert
Cervical cancer tissue,pert
healthy control H03,ctrl
THRA 6a mutant + T3 replicate 2,pert
PB_DON097,ctrl
AL Chip#43,pert
Kidney,ctrl
Waldenström’s macroglobulinemia (WM-BL 31098),pert
patient: 133;	current medication: Omeprazole 20mg;	birth date: 4/23/65;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/13/05;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Ing1 knockout embryo MEF cells,pert
strain: C57Bl/6;	genotype/variation: : ARR2PB-Cre;ROSA(N1IC) model (a.k.a. PB-NICD) that expresses the Notch1 intracellular domain (NICD or N1IC) in the prostate and develops prostatic intraepithelial neoplasia (PIN lesions).,pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp2,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 4,pert
A375P cells expressing PGC1a shRNA 65,pert
liver_Wt_35wk_rep3,ctrl
T63 dilated cardiomyopathy heart biopsy,pert
WT-Fibr1 3,ctrl
"Brain tissue from Fisher 344 male rat, Animal #253, 200mg/kg D-Serine",pert
knockdown: shControl;	cell line: MDA-MB-231,ctrl
CXCR4 knockout 7,pert
"LacZ, #2 repeat",ctrl
CD8+ T cells derived by negative selection from leukopheresed blood sample,ctrl
SW1736_t6h_rep1,pert
"CD11b DC Xbp1 KO (DC conditional KO), biological replicate 3",pert
NB60,ctrl
DK-final,pert
WT78,ctrl
PWD/PhJ Vehicle liver sample batch 3,ctrl
78_129_WT,ctrl
"Control, rep 3",ctrl
"Strain: MRL/MpJ;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Male,ctrl
strain: Balb/C;	Sex: female;	tissue: pancreas;	age: 30 days old;	maternal diet: Control diet;	treatment: streptozotocin,pert
hESC H1 wt rep1 (H1A),ctrl
"PBMC, patient. Mtx rep1",pert
WT-2 (Large PreB),ctrl
"Testosterone treated, HIV-1 positive male, day 14 (6)",pert
cell type: brown preadipocyte;	genotype: Ezh2 -/-,pert
WT-VILI replicate 3,ctrl
female JAK2 WT liver sample 119,ctrl
HepG2_5-aza_rep1,pert
WT25+_rep1,ctrl
NTG 3,ctrl
FRD440 1,pert
cell type: Neuronal Stem Cells;	developmental stage: E14.5;	strain: CD-1 albino,ctrl
Cbfb-deficient Treg_rep1,ctrl
"Male, 59 years old, HIV infection of 15 years",pert
Human Uninfected Sample N071-CD8+ T cells,ctrl
tissue: brain;	genotype: mutant Dcx ko/Y;	age: P0,pert
uterus_P4_WT_4hrs_rep3,ctrl
SEB-1 vehicle control biological replicate 1,ctrl
patient id: 324;	tissue: Normal cortex;	gender: Male;	age: 60;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Kidney from mice treated with 7 daily iv injections of vancomycin at 400 mg/kg,pert
WT2-iPS 1,ctrl
MMA wild type,ctrl
CLL 145-04 Control,ctrl
High weight gainer KOZAK2_ABI_HYP_H3,pert
FoxO1 KO_VMH,pert
A_AN16641_F,pert
"63B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
tissue type: Bone Marrow;	cell type: Normal Plama Cells (NPC),ctrl
Control 11 appendix,ctrl
chip number: 18;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.82;	rin: 9;	transfection date: 2011-10-17,pert
Eed KO J1 ESCs on day 3 #1,pert
01UP3_Oligo,pert
Subject 7 / lung subsegment instillated by Saline,ctrl
"Control KD, rep3",ctrl
0h WT Sample 01,ctrl
cont_OO11,ctrl
PC-3M/MYB siRNA #2,pert
"shKDM4C 1, clone 2, rep 2",pert
G93A 120 days sample 3,pert
knockout mouse kidney - 3,pert
background strain: C57Bl6;	genotype: Rsk2 knockout,pert
cerebellum SNCA knockout 21 month replicate 2,pert
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 2,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 3,pert
24: NORMAL #99-0739,ctrl
"SPC-c-raf transgenic mice, 5 month old, male, unaltered",pert
020112-6,pert
renal_vesicle_Lim1_mutant_1,pert
MPM tumor 36,pert
"Subject 7, Family 3, Affected",pert
strain: Wistar;	agent (mother exposed to): TCDD;	gender (pup): male;	age (pup): PND70;	tissue (pup): pituitary,pert
tumor cell line HepG2 rep2,ctrl
L-540_CTRL_24hrs_1C,ctrl
+4hr Wnt,ctrl
MGd_2,pert
Healthy donor_biological replicate4,ctrl
Liver phenobarbital pool3 Affy,pert
"Mouse, ATF6bKO, colon, UT, rep1",pert
Primary hepatocytes isolated from Donor 5 treated with Wy14643 for 6h,pert
"2 months, sham group, biological replicate 3",ctrl
heart_co_6M_rep1,ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA;	treated with: 100nM PD173074 for 48 hrs,pert
Control ESC media sample 1,ctrl
"EBF1 d10, rep 1",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu2,pert
strain/background: C57/B6x129 mixed background;	genotype/variation: Bptf KO;	age: 12.5 dpc;	cell type: mouse embryonic fibroblasts,pert
BAL_26_A2B0,pert
Lamp3 KD 3d 2,pert
colon_IL10mouse_6weeks_rep3,pert
59_129_KO,pert
Cutaneous psoriasis without arthritis PsC 4,pert
MDS patient 31,pert
MKO_rep_1,pert
"gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
ab045 N,ctrl
Day 3 (T21),pert
Patient no. 9: control,ctrl
cell line: WM-266;	pir knock-down: no,ctrl
genotype: ß-catenin gain-of-function mutant (ß-catGOF-UB);	tissue: kidney (uteric bud);	developmental stage: embryo;	age: 12.5 days,pert
high grade serous carcinoma_patient 9,pert
HF1381_U133P2,pert
cell line: PA-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
"C57BL/6, Male, Contol",ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).,ctrl
healthy CD19 B cells 3,ctrl
EPLM,pert
Huh7,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 28.0;	age of psoriasis onset: 13,pert
"brain, motor cortex, layer 5 thick tufted pyramidal neurons, Mecp2 null",pert
3386-scrape,pert
E14.5 Tgfbr2fl/fl Wildtype Mouse Model Palate,ctrl
Igf1 +/+ mouse vestibular organs at embrionic stage E18.5,ctrl
untreated or induced,pert
"sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta, aneurysm;	agent: Ang II;	time: 14d",pert
disease state: healthy donor;	tissue: PBMC,ctrl
"BMMs, untreated control, da, Replicate 3",pert
Cervical cancer_CC222,pert
Carbo Day4 (358L),pert
erythroblast transduced with empty vector,ctrl
"NB4 cell line, TG2 knockout, ATRA, 48hr",pert
Telencephalon WT 2,ctrl
Normal bladder 18-99,ctrl
11405 Normal Uninflamed descending colon,ctrl
Insm1 control #8_pituitary gland,ctrl
IR-KO_Rep2,pert
A2 corrected_C2_transgenic but unaltered,pert
Total RNA from WT ESCs,ctrl
genetic modification: no modification;	tissue:  spleen: FACS sorted IgM+IgD+ cells,ctrl
diet_LIVER_3,ctrl
Control #3,ctrl
C7bt5,pert
MDS patient 154,pert
"schizophrenia, BA10-7(2)",pert
"Prospectively purified bone marrow hematopoietic stem cells (LSK, defined as Lineage- Sca-1+ c-Kit+) and myeloid progenitors (defined as Lineage- Sca-1- c-Kit+) from Mx-Cre-; FoxO1/O3/O4LoxP/LoxP and Mx-Cre+; FoxO1/O3/O4LoxP/LoxP mice 4 weeks after induction of excision with polyinosine-polycyticylic acid (pIpC, 300ug)",pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 72hr,ctrl
"brain, forebrain: WCx4w#2_e1_le1",ctrl
"Patient  N, lesion, 4 week",pert
"human failing LV myocardium, Idiopathic67",pert
Carbo Day14 (351L),pert
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-18;	Primary Site:Floor of Mouth;	Age:52;	Sex:M;	TNM:T4N2M0;	;	Abbreviation:TNM,Tumor-node-metastasis",ctrl
GM19238_Kd_NS3_23,ctrl
microdissected breast cancer cells from case 648,ctrl
siERK2Veh4h_2660,ctrl
T1alpha (-/-) lung at birth (term),pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/8,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, non-treated",pert
PBMC from T cell LGL leukemia patient #1352 (TLGL1352),pert
T74 U133p2,pert
"experiment I, hTERT, replicate 1",pert
cell line: MLL-AF9 AML cell line 10977 (Zfx wt);	treatment protocol: +OHT;	genotype/variation: wt,pert
"FACS-sorted cones, P60 C-DGCR8 KO mice",pert
C_LS_Wk4,pert
"wt-Gfp, Gfp+ photoreceptor cells",ctrl
patient id: 1393;	tissue: Normal cortex;	gender: Male;	age: 83;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_Con_HG-U133A_2_YCHSUP501,ctrl
cell line: SKBR3 parental;	treatment: 1uM Lapatinib,ctrl
T105,pert
Basal IFE epidermal stem cells from WT mice 1,ctrl
Kidney tissue from obese rats on diet with rosiglitazone,pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Treg cell,ctrl
H16_P_B1,ctrl
human skin biopsy,pert
umbilical cord_nobpd: 4C,ctrl
Murine Lung,pert
duration of untreated disease in month:4.9;	age at onset:8.3,pert
LNCaP.GFP.4,ctrl
PND28 Rat Testis_Rat230-2_12hr MEHP_Animal#58_04005,pert
SV589_3DayKD_SerumStarved->1hr EGF,pert
Nerve_Control_Rosi_715,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 58,pert
Disease_status: Bipolar disorder;	Age (years): 59;	Gender: Male;	Age of onset (years): 25;	Duration of illness (years): 34;	Brain pH: 6.65;	Post mortem interval (hours): 84;	Side of brain: Right;	Fluphenazine mg. Equivalents: 500;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: Yes;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
atopic eczema P10,pert
Tissue: brain (frontal cortex);	Disease State: HIVE-control,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 3,pert
RORasg/sg liver_HFD_rep5,pert
Squamous cell carcinoma 016,pert
"cerebellum,6weeks,KO",pert
Cells: HCT116 colon cancer cell line,ctrl
20: FCHL patient #99-1225,pert
HCT116-Neo124 human colon cancer cells with intact PTEN,pert
RatLung_H6h_5,pert
"RNF40 siRNA - 5 days adipocyte differentiation, rep3",pert
Raji_mi-142-3p_4,pert
"MCF7 cells stably transfected with XBP1, passage 3",pert
DBA_24h_Wy,pert
cell line: SKBR3 parental;	treatment: 0.1uM Lapatinib,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 14.5x7.5x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"Normal Skin, Normal-5",ctrl
"HepG2 cells, HNF4a RNAi treated,  rep1",pert
P 29 Control,ctrl
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 21;	maternal age: 21,pert
"schizophrenia, BA10-46",pert
LSK cell from Gfi1 knockout mice,pert
Mouse otic vesicle at E10.5 mut,pert
Hes6_Castrated OWJ64,pert
FmrKO2_blood,pert
TNKSi 16h biological replicate 2,pert
HCC_27T,pert
Tslc1-/- mice_rep1,pert
NOD Aire KO MEC rep2,pert
P8 Patient None,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 5,ctrl
siUbr5 replicate1,pert
CUTLL1 DNMAML1 GSI-rep3,ctrl
EA_Case7_CD8,pert
patient id: T127;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 35;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
"Whole blood - General population, Male",ctrl
DNGL-4,pert
BALB/c control (bmsnmix8),ctrl
RNA pool from untreated LCLs generated from ADHD patients,ctrl
BASC-Control-2 [mRNA],ctrl
MLL_00266,pert
P910,pert
PBMC GM T1,pert
H295R_Group_B_Dose_100_TIMEPT1_007,pert
0562-01-A,pert
Aquaporin-11+/+_mouse P7 kidney #1-1,ctrl
HCC017N,ctrl
S031_Scz_M_79,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.674;	OD280: 0.969;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 293;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
WT-control-4 (DFW),ctrl
"Prospectively purified bone marrow hematopoietic stem cells (LSK, defined as Lineage- Sca-1+ c-Kit+) and myeloid progenitors (defined as Lineage- Sca-1- c-Kit+) from Mx-Cre-; FoxO1/O3/O4LoxP/LoxP and Mx-Cre+; FoxO1/O3/O4LoxP/LoxP mice 4 weeks after induction of excision with polyinosine-polycyticylic acid (pIpC, 300ug)",ctrl
"brain, cerebellum: WCb12w#2_e1_le1",ctrl
MCF-7 cell line treated with FoxA1 siRNA and vehicle (control),pert
"0mg/kg/day PFOA, Rep 5, Block 3, liver (low dose)",ctrl
"Crohn's Disease subject (39 year old caucasian male, SAK_1275567445)",pert
MIY_day_7-3,ctrl
Placenta Adra2bKO 3,pert
fatty (fa/fa) adipose tissue (epididymal),ctrl
STHdhQ7/Q7-B,ctrl
"C57BL/6, Male, CF",pert
Human_macrophages_hypoxia_repB,pert
Grid2 deleted mouse 1,pert
E14 cells_Zfp322a RNAi,pert
Mnk_3220-S-7,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Female;	Age of onset (years): 16;	Duration of illness (years): 32;	Brain pH: 5.8;	Post mortem interval (hours): 22;	Side of brain: Left;	Fluphenazine mg. Equivalents: 32000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
normal tissue from mastectomy specimen from postmenopausal patient with invasive ductal carcinoma (IDC),ctrl
gender: male;	age (years): 50;	evolution time (years): 6;	disease extension: Pancolitis;	treatment: Azathioprine,pert
T152 U133p2,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_10 months_replicate 2,pert
MacularDegen-healthy-12aAv2-s2,ctrl
sex: Male;	Age: 61 months;	additional patient information found in Series supplementary file,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	treatment: Pyrazinamide;	time: 63 dpi,pert
PancreaticSample15-Tumor,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 8 hours,pert
cell line: TOM-1;	tissue: Human B cell precursor leukemia,pert
24 weeks female,pert
MCF-10A sh53BP1-2 replicate 3 [set 5],pert
C_AN10833_F,ctrl
"214, MUSCLE, Before",ctrl
"Cultured ovarian cancer cell line HeyC2, untreated",ctrl
478MM,pert
IRAK4-KD-MEFs_unstimulated_4hours_rep1,pert
"Colitis 05, UC05",pert
age: 40;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Expression data from BAT of the KRAP deficient mice (KO3),pert
Muscle_control,ctrl
"wdNHBE with KY/180 at 36hpi, biological rep3",pert
Moderate rep5 (OHN),pert
MacularDegen-healthy-6bAv2-s2,ctrl
strain: mixed background;	age: 4 months;	genotype: hnf1alpha KO;	tissue: jejunum;	sample type: mutant,pert
EA_Case11_CD8,pert
Rb F19/F19;	age: newborn;	strain: FVB;	tissue: skin,ctrl
normal embryonic day 18 lungs,ctrl
sample =Healthy4 treatment=Stimulated time=90 (min),ctrl
WT_48A_2,ctrl
568.B6,ctrl
06R022 RA,pert
M833 / Reference_13431199,pert
BALB/c control (bmsnmix6),ctrl
7 Day Mouse Leg muscle,ctrl
"brain, cerebellum: RNA#8S_le1",ctrl
Bronchial Epithelial Cells MMA biological 2163M,pert
P52 Non failing heart biopsy,ctrl
APBMNC.LPS-.1,ctrl
Moderate rep9 (retina),pert
"Control Proximal, Small Intestine 2 17 days old",ctrl
A_AN00493_F,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 27.651;	Ratio: 2.11,ctrl
Huh7 cells_Mock Infected 48 hours_ rep2,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 4 hours,ctrl
"SW480, stable line of treatment of ezrin RNAi. Incubate in L15 medium, 37.0°C, air 100%",pert
Injured 1 day Rat Retina 1,pert
SENS 4 4hr,pert
"rat, hepatocellular carcinoma (DEN 50mg), treated with erlotinib 2mg (week 18)",pert
HeLa cells transiently transfected with SON siRNA,pert
type 2 diabetes subject 07,pert
cell line: SCC-2;	cell line origin: Oral cancer;	genotype/variation: control,ctrl
470MM,pert
uterus_veh_WT_40hrs_rep3,ctrl
Ifng-/- biological rep 2,pert
1044-03-A,pert
liver-AHRWT-cornoil-rep3,ctrl
Clozapine treated 4weeks AffyGC RMA rep2,pert
race: caucasian;	age (years): 49;	stage: IC;	grade: 3;	histology: endometrioid,pert
cell type: Endothelial cell;	agent: estradiol;	dose: 1 nM;	time: 24 h,pert
"primary mucosal tissue,  colon",pert
156A,ctrl
"BOEC, normal 10",ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical carcinoma, Separation Type: trypsin, Harvest Time Point: 4, Units of Harvest Time Point: hr",ctrl
Fibroblasts_HealthyControl_4,ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA,ctrl
Aldosterone-producing adenoma (APA6),pert
left hippocampus of prenatal stressed mice,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-WT cells, expression induced with doxycycline for 24 h",pert
"SLE patient, 1014V1",pert
NS3_NS010823,ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 11;	tissue: GIST Tumor,pert
Control Day1 (394L),ctrl
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: n/a;	maternal age: n/a,pert
H157 siCTL2,ctrl
"WT1_ileum, 5 days post-infection with T. gondii",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.57534,pert
TP02-402,ctrl
"Normal diaphragm 4, 8 week",ctrl
Control (C64),ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID296,pert
AMWT_Ker41,ctrl
"GM8923, proband-MS",pert
"seminoma specimen, pT3, pN1, pM1, patient age: 23y; W00 011",pert
race: caucasian;	age (years): 49;	stage: IA;	grade: 2;	histology: endometrioid,pert
LC1024ni,pert
"Control skin, rep2",ctrl
Replication 1 control,ctrl
INSENS 4 4hr,pert
CD8+_Tcells_healthy_donor_3,ctrl
"Wild type, pancreas",pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 50,pert
AKR/JTCE liver sample batch 2,pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P30 postnatal stage,ctrl
"non-AD_TC, biological rep2",ctrl
ANL Chip#29,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
chip number: 20;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.74;	rin: 9.6;	transfection date: 2012-03-26,pert
FmrWT2_blood,ctrl
"imr-32,gfp siRNA, t=48, 4",ctrl
Healthy5-CD8,ctrl
8DKD_SerumStarved->1hrEGF_rep4,pert
breast cancer patient 304B,pert
"BOEC, at_risk 5",pert
breast cancer patient 351,pert
"ALL_NDS, K37 011609",ctrl
HC CM 2 alcohol,pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P6,pert
A501 Sham 7 day,ctrl
sex: Male;	Age: 6 months;	additional patient information found in Series supplementary file,ctrl
B_lymphoma_2,pert
GB 7 63A NO LPA,pert
Substantia nigra PD rep8,pert
"embryonic stem cells, KD replicate B",pert
age: 46;	gender: female;	ejection fraction: 61;	left ventricular end diastolic diameter: 49;	inflammation/PVB19: negative,ctrl
WT_PLACEBO_12hours_1,ctrl
M7KOepi_infect_0h_rep2,pert
GFP_2,ctrl
SLE CD19 B cells 10,pert
Extensor carpi radialis brevis muscle from cerebral palsy patient,ctrl
A549 NSCLC cell line,pert
EA_Case13_CD20,pert
normal mammary gland,ctrl
7 Etoh 3,pert
L_LS_Wk1,pert
WT fundus,ctrl
A YOKE_B062,pert
DS2-iPS 4,pert
B_Kin_1,pert
breast normal 4,ctrl
C3_HypM,ctrl
MPM tumor 17,pert
"BMMCs from NTAL WT, NTAL shRNA infected, nonactivated, biological rep1",pert
e_B7,pert
Hippocampus 1992 15 month Old,pert
"Empty vector, plastic plate, rep1",pert
endothelial_rep9,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: internal tandem duplication (ITD),pert
Disease_status: Bipolar disorder;	Age (years): 42;	Gender: Female;	Age of onset (years): 20;	Duration of illness (years): 22;	Brain pH: 6.65;	Post mortem interval (hours): 49;	Side of brain: Left;	Fluphenazine mg. Equivalents: 15000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
A514 Sham 7 day,ctrl
3024-lcm,pert
"WT, PR04M003v0",ctrl
sMPNST_JQ1_2day_rep1,pert
Msgn1_24hPlusDox-biological rep2,pert
mouse E12.5 embryonic kidney isolated from Ret-knockout pregnant female,pert
"0mg/kg/day PFOA, Rep 2, Block 1 lung (low dose)",ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: WT,ctrl
healthy control H30,ctrl
ApoD KO+PQ rep_1 (PQKO1),pert
"H1 hESCs, OCT4 shRNA",pert
"Gata4_S105Amut, PE treated whole heart, individual 8",pert
Mouse C57/bl6,pert
"Strain: C57BL/6, NOD-SCID;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal);	C57BL/6, NOD-SCID Eeyore T2996C",pert
BV2_rep1,ctrl
coc-12_A,pert
WT mouse skin treated once with acetone and collected 24 hr later,pert
db/m 16 wk 3,ctrl
PS-NA cerebellum at 12 weeks,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 32;	maternal age: 33,pert
cell type: LSK;	tissue: hematopoietic stem cell enriched fraction from bone marrow,ctrl
12481 UC Uninflamed sigmoid colon,pert
WT Primary Hepatocytes - Pooled -Cy5,pert
"SWR/J Acute morphine treated, biological replicate 1",pert
ic5 -- cell line 1 treated with APF#1,ctrl
Clock_mutant Circadian_Time_14,pert
At Risk: -;	Age: 15;	Sex: M,pert
Subject #8031-2d Postinfection,ctrl
Mtb infected-42d-2,pert
FO_spleen_KO_rep2,pert
MF-46,pert
Sca+ SP (side population) bone marrow cells,ctrl
Retina ko/ko rep1,pert
Testis_WT_rep3,ctrl
Keratinocytes treated with EFNA4 for 1h,pert
brain_DLPFC_bipolar C_mr275,ctrl
coc-14_A,pert
Quercetin day 05 sample 2,pert
Nerve_Control_Rosi_712,ctrl
BACH2+/+ ALL + Imatinib (Sample3),pert
Gene expression profiling of Phgdh knockout embryo wild2,ctrl
KO_72_O3_1,pert
Subject #8045-2d Postinfection,ctrl
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: F,pert
Celecoxib_#4866,pert
tissue: dental pulp cells;	genotype: control;	passages: 5,ctrl
"septic CD4+ splenocytes at 6h, biological replicate 4",pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep8,pert
disease state: normal;	specimen: Ovarian Surface Epithelia,ctrl
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: untreated;	treatment time: 4 hours,ctrl
O_LS_Time0,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: maxilla;	donor sex: female,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr",ctrl
liver_co_6M_rep2,ctrl
"Human healthy male subjects, peripheral blood monocytes",ctrl
"gender: Male;	age: 76;	post-mortem delay: 6h;	ph: 6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
OVCA429+(3),pert
treatment: empty vector;	cell line: HaCaT;	tissue: Immortalized keratinocytes;	cell type: Immortalized cell line,ctrl
Array Type: HG-U133A_2;	RNA Integrity Number: 9.6;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Native ko biological replicate 1,pert
male_alcoholic_256,pert
Mouse No Cldn16 B9 449,pert
Hunk Knock-Out rep 4,pert
HEK293_MIF siRNA 1#_24h_Illumina,pert
strain: c57/bl6;	age: 4 month;	gender: n/a;	weight: 25-30g;	tissue: whole trachea,ctrl
AA_Case3_CD8,pert
coc-53,pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 31;	maternal age: 26,pert
Tendon_non-lesional_rep12,ctrl
GEIM128-NORM,ctrl
Human Uninfected Sample N110-CD4+ T cells,ctrl
colon_IL10mouse_6weeks_rep6,pert
Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier,ctrl
UC Inflamed sigmoid colon,pert
CD4_T_cell_pool_melanoma_M09+M10,pert
"Control shRNA cells passage 11, rep 2",ctrl
"Liposarcoma culture from tumor 389, untreated",ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Epithelial Cell,pert
male;	34 yr old;	Black,ctrl
"Heart, KO1",pert
PGA-RMM-5h-3aA-s2,pert
Heart left ventricle dnCREB-PBS replicate 2,pert
"Dermatomyositis, biological rep1",pert
E10C,ctrl
treated MCF-7 cells,pert
14-week-old Trim24-/- liver_648M,pert
Healthy control 4,ctrl
PGA-HMO-Obese-5aUA-s2,pert
"Atm+/+ 30 min post IR, A",pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 1",ctrl
"Tumor sample from patient with p53 wild type, replicate 1",ctrl
tissue: white blood cells;	age: 15.6;	Sex: male,pert
AIRE ko CD80hi mTEC sample2,pert
"C57BL/6J-Il10tm1Cgn, sample 2",pert
wt-Gfp P10 replicate 3,ctrl
cell line: REH E/R positive leukemia;	treatment: treated with non targeting lacZ shRNA,ctrl
n6t6h,pert
genotype: ILKR211A Tg;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,pert
24A,pert
"gender: Female;	age: 68;	post-mortem delay: 6h;	ph: 6.4;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Normal-3 - mAdbID:91658,ctrl
"Deltoid, FSHD, cohort 12, subject 12A",pert
NT3,pert
"BMDC, wt, replicate 3",ctrl
"HeJ, air, biological rep 2",pert
Control Endometrium Epithelial Cell_034.UC209_EpCAM,ctrl
WT-smoke-high-5 month-R2,ctrl
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3KO;	age: 12 weeks;	nutrient state: 24h fasted;	diet: High-fat diet,pert
"iPSC derived from healthy control fibroblast WT2, biological rep6",ctrl
KN-smoke-high-5 month-R2,pert
Bronchial Epithelial Cells MMA biological 1958U,pert
"liver, PPAR WT_ctr_53",ctrl
"DSS colon tissue, biological rep1",pert
RV16;	Age = 19;	Sex = M,pert
Jurkat-KD2,pert
Allo-14-5,pert
"treatment with BZP, replicate 3",pert
mT4,pert
NM Spinal cord 110 day,ctrl
"Vehicle, biological rep3",ctrl
gender: male;	age: 8 weeks;	strain: Sprague Dawley rats;	tissue: lumbar dorsal root ganglia,ctrl
tissue: breast;	normal/tumor: normal,ctrl
Ls174T-pTER-β-catenin con3,pert
Tumor-WT-rep3,ctrl
Pancreatic Sample 53-Tumor,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 50;	baseline tumor size (cm): missing;	patient id (to identify the 2 chips from the same patient): 22332259,pert
"AZ521 dnSox2 cells, uninduced, 18h",ctrl
"Wild type epithelials cells, biological rep3",ctrl
PND28 Rat Testis_Rat230-2_6hr Corn Oil_Animal#35_04005,ctrl
skin squamous cell carcinoma,pert
age: 49;	sex: M;	disease status: control subject;	Filter number: 100;	Usage number: 5;	Exposures: 3,ctrl
gender: male;	individual: patient 4;	treatment: paclitaxel-eluting stent,pert
C028_Control_F_54,ctrl
"human failing LV myocardium, Idiopathic49",pert
"Immortalized MEFs WB, empty retroviral vector infected, rep3",ctrl
0536-01-C,ctrl
MDS18,pert
Pre-Frontal contex of naïve FVB/N mice,ctrl
"heart, beta1-Gly389 transgenic mice at 90 days of age",pert
293TsiLL-3,pert
pediatric AML GP6,pert
14L,pert
L425-PAX5+MAT_rep3,pert
MDS patient 109,pert
chip number: 21;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.62;	rin: 9.2;	transfection date: 2012-03-26,pert
protocol: NGN1 overexpression;	cells: Neural Neural Stem Cell Line F3,pert
hippocampal tissue from heterozygous p300 mice,pert
Muscle-AMPKgamma3-wt-5,ctrl
T178 U133p2,pert
pediatric AML PP6,pert
gender: Male;	cell type: hESC H1 cells;	genotype/variation: wt,ctrl
Bl6_p60_3,pert
HB1.F5,ctrl
MDS patient 4,pert
"Ring1B deficient ES cells, biological replicate 2",pert
age	55;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	25.8;	leukocyte count (/nl)	206;	hemoglobin (g/dl)	10.1;	platelet count (/nl)	331,pert
Male 8week AJ CBDLrep2,pert
Healthy donor_biological replicate1,ctrl
8 wk old male C57BL10 TA,ctrl
T1,pert
PB_DON046,ctrl
"human failing LV myocardium, Ischemic75",pert
13_PAH,pert
genotype/variation: Cbx2_KO_XX;	tissue: gonads;	age: E11.5,pert
con-9,ctrl
TN4b-control,ctrl
"CA2, SOX17 expressing HESC - clone1",pert
condition: Non-syndromic cleft lip/palate (NSCL/P);	tissue: decidous teeth dental pulp;	gender: male,pert
1 h (2),pert
BxPC3-KO111 rep 2,pert
TTP_KO_0ActD_BioRep2,ctrl
"knockout mouse embryonic fibroblast, biological rep 3",pert
EE_IC_2_amind_lcm,pert
WT P2 replicate 1,ctrl
Control10,ctrl
tissue: Biceps muscle;	patient: C.b.6;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep1,pert
K562 DMSO sample 10,ctrl
25uM_Zn_1,pert
KM_075N,ctrl
cell line: RT112;	transduced: EGFP shRNA;	doxycycline treatment: yes,ctrl
normal with no hydrocortisone treatment-2,ctrl
"Retina from control mouse at ZT20, biological rep 1",ctrl
OVCA429+(1),pert
SKBR3_Control_2,ctrl
"human failing LV myocardium, Idiopathic56",pert
"new born PS-NA mice, cerebellum",pert
Ovarian Cancer xenograft,pert
MLL_00122,pert
NOD RIP-Aire27 islet rep1,pert
IFN_Gamma_6hr_rep1,pert
Mouse_ESC_Pcl2_mismatch_control_sample 2,ctrl
braak stage: BR12;	rin: 71;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
"nasopharyngeal carcinoma, specimen T9",pert
CEM-C1 cells treated with 10 nM rapmycin for 3 hours,pert
"Patient  O, lesion, 4 week",pert
"Lesion Skin, LS-11",pert
T-ALL cell line,ctrl
ic patient 1,pert
LCL Concordant for Epilepsy twin pair 1 (CCE1.2)(TP22),pert
"fibroblast, control subject NF3 rep 2",ctrl
"genotype/variation: Pten-null (Ptenloxp/loxp), with doxycycline-inducible PTEN transgene;	cell type: embryonic fibroblasts;	transgene: tet-inducible Pten transgene;	time: 0 h;	genetic background: C57BL\6",pert
NB64 U133p2,ctrl
microdissected breast cancer cells from case 1260,ctrl
Substantia nigra PD rep5,pert
MEF_TFAMhet_rep1,pert
Liver_D3T _Rep2,pert
BM_01000,ctrl
Nod2-/- 1,pert
Gene expression profiling of Phgdh knockout embryo KO4,pert
LCL Unaffected MZ twin pair 3 (CCN3.2)(TP24),ctrl
"C57BL/6 male sick, 100",pert
U937-shGSK3B-Construct1-rep2,pert
A375 cells 24h Control rep3,ctrl
GFP-KD-1 (total RNA),ctrl
WFS1 WT USHT_17_315_ko,ctrl
CUTLL1 DNMAML1 GSI-rep1,ctrl
"Wild type used for GNMT 8 month, replicate 3",ctrl
S1A Sporadic-frontal,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: sh53BP1-2,pert
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 3,pert
Array Type: HG-U133A_2;	Ratio: 1.99;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Mouse liver (8 weeks),pert
striatum SNCA knockout 6 month replicate 2,ctrl
"Brain tissue from Fisher 344 male rat, Animal #248, 500mg/kg D-Serine",pert
CML Patient 2 before therapy,ctrl
pMX-GFP vitamin C GFPVc+_1,pert
"seminoma specimen, pT2, pN1, patient age: 43y; W00 120",pert
"Fibroblasts from normal histology lung tissue, NL-7",ctrl
"HSCs from female mice treated with E2, replicate 1",pert
neocortex-30 months of age-control diet-biological replicate5,ctrl
SBVGA1 2,pert
aortic biopsy,ctrl
Mouse female ES cells PGK12.1 after double RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-2 in PGK12.1.,ctrl
Patient 7 skin baseline,ctrl
"EtOH, RARaKO, set 3",pert
18B,pert
3883-1 E2F WT,pert
Whole testis RNA from WT mouse #145 at 0h,ctrl
Osteoblasts_Lrp5_Knockout_Day7_rep1,pert
No or early 1 rep8 (retina),pert
coc-10_A,pert
multiple myeloma (MM 409),pert
COP DES-treated replicate 3,pert
U2OS control shRNA_pLenti,ctrl
siHic5 DHT 1,pert
age: 14dpp;	genotype/variation: wild type;	tissue: testis,ctrl
5203 Normal Uninflamed sigmoid colon,ctrl
lymphocytes_HD_F_43y_1,pert
cell type: IMR90 (Normal human diploid lung fibroblast);	gender: Female;	overexpression: H-RasV12;	treatment: Vehicle,ctrl
ILD_23,pert
THP1-shControl-rep1,ctrl
"129P3/J ACU, Rep3",pert
tissue: lesional skin;	urticaria status: affected;	patient: 3,pert
Squamous cell carcinoma 029,pert
GEIM50-NORM,ctrl
Wt,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 4",pert
Diabetic Rat Retinal Müller Cells (technical replicate 2),pert
mutant 14-3-3 ko/ko inbred,pert
agent: EFNA4-Fc conjugate;	time: 24h,pert
V5-P577,pert
gender: Female;	tissue: Tendon;Teres minor;	age: 46;	donor: 32;	disease state: Non-lesional,ctrl
SKBR3 WT 2,ctrl
cumulus_PCOS_Lean_rep2,pert
Mouse embryonic stem cell line E14,pert
Gender: Male;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Rectosigmoid;	Drug Treatment: NO,ctrl
ET 1,pert
35A,pert
C1D-LU,ctrl
"Uninvolved Skin, NS-22",pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: tamoxifen for 120 mins,pert
background strain: Derived from blastcysts from a 129 female crossed to a (129 X PGK)F1 male.;	cell line: PGK12.1;	cell type: ES cell;	passage: 14-18,ctrl
MDA-MB-231 cells transfected with SDC1-siRNA,pert
tissue: skin;	individual: Patient P5;	condition: AL;	eczema severity: SCORAD: 57,pert
E14 molar TCDD 1,pert
m1-carcinoma1,pert
3885-1 E2F WT,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 6",pert
"BMDM, not treated, KO Vdr -/-",pert
Anti-scramble replicate 1,ctrl
hRPE cells 24h post-infection with WNV,pert
cell line: HEK293 cells WTX inducible clone F5;	agent: control,pert
"patient 13, arm treated with pimecrolimus",pert
"HMEC-TR, SiRNA scramble",ctrl
GIST882 Imatinib Rep2,pert
THRB bN mutant + T3 replicate 3,pert
MDA-MB-231-ZNF217 cell culture 1,pert
"A pool of RNA from lung from three male mice, raised at Denver altitude (nearly normoxic), with SM22-rtTA x tetO7-BMPR2delx4+ transgene activated for 8 weeks; mice are 12 weeks old when sac'd.",pert
PBMC from T cell Large granular lymphocyte leukemia patient#116,pert
con-9_B,ctrl
baseline control 01,ctrl
"wild type, sample 1",ctrl
"ONS76, mock control",ctrl
S4_S010926,pert
colon_normal_1440,ctrl
Healthy11-CD4,ctrl
"Sciatic nerve, saline control, biological rep2",ctrl
brain wild type replicate3,pert
12470 UC Inflamed descending colon,pert
HEK293 cell line #1 with uninduced HNF1beta,ctrl
ZNF395 knock-down (shZNF395-4),pert
cultured human melanoma cancer cell BL,ctrl
Gastrocnemius muscle from PPARalpha overexpressing mouse,pert
Healthy control_sample6,ctrl
Ad infected murine liver-MO30k-(340)-6 hpi,pert
Cisplatin_24h_rep2,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 59;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
"human failing LV myocardium, Idiopathic61",pert
"fetal sex: female;	karyotype: 45,X",pert
wild-type naïve CD8 T cells,ctrl
breast cancer patient 248,pert
Affymetrix chip HG-U133A,ctrl
control AU016804,ctrl
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: Rap1 I312R mutant,pert
"Crohn's Disease subject (33 year old caucasian female, SAK_1316622123)",pert
LIVER_diclofenac_repl2,pert
Liver KO7,pert
gender: Female;	age: 67;	post-mortem delay: 3.5h;	ph: 6.1,pert
Whole adrenal RNA from WT mouse #147 at 0h,ctrl
695-383_4hr,pert
siCtrlVeh24h rep1,ctrl
jzo018-rp1-v5-u74av2-met,pert
6h WT Cel.18,ctrl
"prdm-control, biological rep2",pert
cell line: HL-60;	replicate: Replicate2;	treatment: shSYK_2,pert
Wild type Retina Rep3,ctrl
Age: 38;	Sex: M;	Ancestry: Hispanic;	Smoking status: non-smoker,ctrl
OSE_434,ctrl
No or early 1 rep6 (retina),pert
"seminoma specimen, pT1, patient age: 38y; W97 082",pert
Strain: CBA,ctrl
MKO_rep_4,pert
"P202 HCT-116, DNMT wildtype, U0126-treated",ctrl
race: caucasian;	age (years): 59;	stage: IB;	grade: 2;	histology: endometrioid,pert
E18.5 Top2b+/+ brain,ctrl
KM_012N,ctrl
S2A Sporadic-frontal,ctrl
EGF 4h replicate 3,pert
si FoxA1 and vehicle replicate 2,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P5,ctrl
SARRC-0146-01-C,ctrl
PGA_Ras_1-m5,pert
"lymphoblastoid cell line from T21.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
Run5.aUa.010110d.SkmDbt1962D.CEL-DB stimulate,pert
bone-marrow-derived macrophages,pert
Sample M535,ctrl
strain background: C57BL/6;	gender: female;	genotype/variation: Mut -/- ;TgINS-Alb-Mut (MMA mutant);	tissue: kidney;	diet: high protein diet for 2 months,pert
strain: C57BL/6J;	genotype: wild type;	gender: male;	age: 2 months;	tissue: cardiac muscle,ctrl
T54 Non failing heart biopsy,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 5 days adipocyte differentiation,pert
LJMJDW4,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
T30068,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.04;	OD280: 1.071;	Ratio: 1.88;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 131;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Control_EHL, C2",ctrl
Argyrin A treated 12h_2,pert
cortex_HtrA2_KO_rep1,pert
Gastric Cancer PBMC Sample 3,pert
Tumor_Ker22,pert
HCC tumor,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: phenobarbitol,pert
HCT116_shN91_rep1,pert
cell line: SK-N-SH;	lentivirus isoform: e1;	lentivirus: WT,pert
"Transgenic mice with water, replicate 2",pert
"knockout white adipose tissue, biological rep 3",pert
Healthy-1 baseline,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp3,pert
Turner_AF_3,pert
KOPT-K NBD 2,pert
Emd KO male 4,pert
"seminoma specimen, pT1, patient age: 38y",pert
Gene expression profiles of Lkb1 WT #7 HSCs,ctrl
P0 - WTMixA 3,ctrl
Early IPF_surgical biopsy_lower lobe_rep159,pert
RatLung_H72h_3,pert
cell line: Mc3T3-E1;	cell type: osteoblastic cells;	treated with: 50µg of Ascorbic Acid (AA) for 5 days,pert
"E18.5 ERRg +/- heart, biological rep 3",pert
Human prostate cancer primary culture C13dx,pert
Pax_C4,ctrl
"RNF40 siRNA - 2 days osteoblast differentiation, rep3",pert
01UNK_PolyRF-,pert
"Reh, transient expression of IKKb(EE)",pert
Control Day1 (393L),ctrl
strain: 2nd Gen. FVB/N from 129Sv/Ev and Black Swiss mix;	age: 13.5 days;	tissue: whole body;	cell type: Fibroblasts;	genotype: Ptenloxp/loxp,pert
HCC008T,pert
"WT, PR02M004v0",ctrl
"non-AD_HI, biological rep5",ctrl
Kidney_Aqp11+/+_P7_1-1,ctrl
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
G206-lcm,pert
Control_4months_retina14,ctrl
"EAE, 1,25(OH)2D2 treated #6",pert
OCI-Ly7 BCL6siRNA 1,pert
ctrl_511,ctrl
"Wild-type-neocortex, biological rep2 (male)",ctrl
Age: 46;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"Lymphoblastoid cell lines derived from family 1712, member 1",ctrl
HGPS-iPSC_2,pert
Individual_4778_NN_sample,ctrl
HeLa_01-04-05 TP2_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
WT Soleus at 4 weeks biological rep3,ctrl
"Gift Prof Dr Sandra Nuyts (University Hospital Leuven, Leuven, Belgium)",pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 38;	gender: f;	treatment: -,pert
"Notch3 knockout mouse cerebral microvascular fragments, biological rep2",pert
Disease_status: Bipolar disorder;	Age (years): 30;	Gender: Male;	Age of onset (years): 7;	Duration of illness (years): 23;	Brain pH: 5.8;	Post mortem interval (hours): 56;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
H27 HA 24h 3,pert
Cbx2_KO_XX gonads at E11.5,ctrl
WT3R1,pert
Vit A deficient 1b,pert
"IRF6 knockout, biological rep2",pert
TB 7,pert
Tendon_lesional_rep16,pert
HL-60 cells treated for 24h with 10 nM TCDD,pert
Lacrimal Gland,ctrl
"Subject 1, Family 1, Affected",pert
PBMC from T cell LGL leukemia patient #107 (TLGL107),pert
high grade serous carcinoma_patient 2_sample 2,pert
strain: C57BL/6;	genotype/variation: Zmpste24-/-;	cell type: mouse embryonic fibroblasts,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.999;	Ratio: 2.12,pert
181D3,pert
cell line: A2008;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
Subconfluent RBP2-/- primary mouse embryonic fibroblasts at passage 3.,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
Ishikawa_HighDose_BPA_48h_rep1,pert
8 week old leg control rep 1,ctrl
"Wild-type-neocortex, biological rep1 (male)",ctrl
RNA from whole tissue section of case 518 labeled with Cy5,ctrl
liver_NEMO_KO_replicate2,pert
TOV112D cells_treated with NSC319726_biological rep1,pert
"BA OBCs, post doxycyclin withdrawal, rep3",pert
jejunum_0h_rep1,ctrl
H1299,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_4_32_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
SCC13,pert
cerebrum_PSNA_ 12w_rep2,pert
LY2 control-siRNA tamoxifen treated rep1,ctrl
Treg WT rep4,ctrl
"Diabetic mice, time point 3 week",pert
"Healthy volunteer, Control_11691",ctrl
con-15_C,ctrl
uterus_P4_PRKO_4hrs_rep1,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 59 yr;	population: white;	dsm-iv: 296.53;	age of onset: 25 yr,pert
No or early 1 rep2 (OHN),pert
ILD Study Number 1196,pert
Striatum of 8-10 week old SWR/J mice,ctrl
Post Transduction:24 hr; treatment:Mut;,pert
Bronchial Epithelial Cells SA biological 1986Z,pert
OV90-(3),ctrl
KO PGC rep2,pert
Tet1 shRNA-transfected ES cells in ES cell culture,pert
BC1 TC_NOC,pert
race: african american;	age (years): 72;	stage: IC;	grade: 2;	histology: endometrioid,pert
Retina RNA,pert
Human skeletal muscle biopsy sample;	Patient #176 with NORM,ctrl
PGA-RMM-48h-3aA-s2,pert
"GTF2iTrap line, biological rep 1",pert
m1-WT2,ctrl
112 Day Mouse Diaphragm muscle,ctrl
Nrl-ko-Gfp P10 replicate 4,pert
"iPSC derived from healthy control fibroblast WT1, biological rep1",ctrl
CML_5_GMP,pert
Cell line HeLa_c-myc KD_expt3,pert
"normal skeletal muscle, biological rep8",ctrl
Diaphragm 28 Day control rep 1,ctrl
H17_S_B1,ctrl
MDA-MB-231 - Control-1,ctrl
siGL3E2 1,ctrl
MDS12,pert
Pool Eu_P30_hyb1,ctrl
AA_88,pert
Kidney_saline ip_mouse #063,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case4,pert
"Du145-PCAT1 cMyc siRNA #4, replicate 1",pert
Liver_Nrf1 CKO_rep1.,pert
aa_NY74,pert
"Lymphoblastoid cell lines derived from family 1736, member 2",pert
"fibroblast, control subject NM10 rep 1",ctrl
Gadd45a knockout embryo MEF cells,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
Donor1_24h_Wy,pert
4-Vinylcyclohexene Diepoxide (50uM) rep 3,pert
PBMC CCo T1,pert
db/db 12-1,pert
"SWR/J Chronic morphine treated, biological replicate 3",pert
LKR13_Kras sh-1,pert
"experiment XI, hTERT",pert
9_5_MOE_430A_HO,pert
C_AN19442_F,ctrl
Muscle PCOS case 101,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 78;	time: 0;	batch: 1,ctrl
total RNA,ctrl
condition: Psoriasis;	patient: PS-I;	tissue: LS skin biopsy;	kit: Affy,pert
wt-Gfp P2 replicate 3,ctrl
Cont G3,ctrl
Control;	Survivor;	gender: Female,ctrl
"Global gene expression of NASH patients, normal control A154",ctrl
fasted liver standard chow diet 1,ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 7",ctrl
NOD/LtJ Vehicle liver sample batch 3,ctrl
male JAK2 WT liver sample 116,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_8_8_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
02_ADL,pert
normal main pancreatic duct 2,ctrl
"metastasis: none;	Stage: 2b;	tissue: normal, homogenized",ctrl
CD4IncTp1-3,pert
14.5_KO_615B,pert
N40656,ctrl
wild type MEF time 48 replicate 3,ctrl
CD34+ cells with fenretinide treatment from CML34,pert
"vector d4, rep 2",ctrl
Series 2; young; no fracture,ctrl
HCC_22T,pert
P32_exPKO_pancreas,pert
"A673 treated with DMSO vehicle control for 3 days, biological rep5",ctrl
RV16;	Age = 21;	Sex = M,pert
1193-03-A-b,pert
"Immortalized MEFs WA, empty retroviral vector infected, rep1",ctrl
"breast tumor epithelium,7",pert
G with Cy5,ctrl
Mouse Megakaryocytes,ctrl
51A;pretreatment;female;breast tumor; responder,ctrl
cell line: Calu-3;	cell type: airway epithelia cells,ctrl
patient: 26;	disease state: hypertension;	tissue: Atheroma plaque,pert
newborn (P0) Krt1-/- skin_replicate 3,pert
tissue: cardiac biventricle;	genotype/variation: PGC-1a KO (PGC-1b expression is unaffected),ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Untreated-Control, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",ctrl
MDA-MB-231_TR30003,ctrl
wild type 2 cell embryo rep1,ctrl
tissue: Peripheral blood;	disease status: normal control,ctrl
Control_9,ctrl
T130,pert
genotype/variation: WT;	cell type: pancreatic cells,ctrl
"MCF7 cells, SIN3A silenced, LIF 1h",pert
"MCF-10A cells, overexpression ΔNp63α, biological rep1",pert
db/db 11-5,pert
11418 UC Uninflamed ascending colon,pert
Liver_hyperglycima_no.6,pert
CEM Control 2,ctrl
Bronchial Epithelial Cells MMA biological 2048M,pert
Backskin_Get1_e18_WT3,ctrl
Md02h023,ctrl
"NPTX1 shRNA Day 3, biological rep3",pert
Control 120 days sample 1,ctrl
Patient identifyier: D;	Sex: male;	Age of patient: 61 years;	Duration of psoriasis: 21 years;	Body surface area: 12 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
liver control diet rep3,ctrl
18A;pretreatment;female;breast tumor,ctrl
Gender:M;	Age:22;	Tissue: Mucosa,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 35week,ctrl
brain_DLPFC_bipolar B_mr425,pert
A VIS _B067,pert
0537-01-C,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 50;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: HIF-2α knockdown;	cell subtype: 10 days old tumor spheroids,pert
181D1,pert
non-malignant FTEb_patient 4,ctrl
disease state: control;	patient: 25,ctrl
"Trim28 conditional KO mice Treg cell, replicate 4",pert
Normal Chip#8,ctrl
CONTROL;	Age = 21;	Sex = M,ctrl
strain background: C57Bl/6;	genotype/variation: P14 TCR transgenic C57Bl/6;	cell state: Day 3 in vitro effector CD8+ T cells,ctrl
IM24_control,ctrl
PBMCs_IS_9 [IS],pert
E14Tg2a ES Cells,ctrl
Peripheral blood mononuclear cells;	TTF=90min;	Race=White;	Sex=Male,pert
siControl_2,ctrl
tissue: Temporal cortex;	age: 77;	Sex: F,ctrl
MF-16,ctrl
01L4M_CTRL,ctrl
patient: 6;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
WT - Cre Treated - 0.5 hrs - repeat 3 - Cy5 - mAdbID:62546,ctrl
C with Cy5,ctrl
RNA from HCC_13N,ctrl
"KO total RNA LSK, rep 5",pert
NS1-030915-SA,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-tu1,pert
jzo019-rp1-v5-u74av2-met.TXT,ctrl
Amniocytes_trisomy 21_1573,pert
Fiona Biological Replicate 5,pert
LT346 wilt-type untreated,ctrl
482 cells scrambledshRNA rep3,ctrl
WD44_control RNAi-2,ctrl
Control 2_Huh7 [HDAC2 siRNA subset],ctrl
sex: Female;	family: 1;	age: 41;	disease status: Control;	tissue: Muscle: Biceps,ctrl
Tet1-kd_ES_rep3,pert
"t04, surgically resected from patient of gastric cancer.",pert
a_NY70,pert
CML_6_HSC,pert
"septic CD4+ splenocytes at 6h, biological replicate 5",pert
MOLT4_GSI_B,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 4",ctrl
cRNA;	postnatal day 16;	WT,ctrl
short-hairpin rna: shControl;	cell line: HCT116,ctrl
lung,ctrl
SHR-vehicle pool sample3,pert
Whole testis RNA from Crem-/- mouse #77 at 0h,pert
"human whole blood, PAXgene",pert
strain: Myd88 KO;	age: 4 month;	gender: N/A;	weight: 25-30g;	tissue: whole trachea,pert
db/db 14-3,ctrl
mouse: 1;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
CCl4_CT19,ctrl
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 2;	time: 3h,pert
heart,pert
RL_siRNA_NS_rep1,ctrl
HDAC6_2,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-4,pert
cell line: HT29RC PLX4720 resistant cell line;	cell type: colon cancer,pert
shScr replicate 1,ctrl
PancreaticSample30-Tumor,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.15;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Strain: a mixed C57BL6/129 genetic background,pert
11a_c,ctrl
TOV112D cells_treated with NSC319726_biological rep2,pert
"Wild-type myeloid-derived suppressor cell from bone marrow, rep1",ctrl
MKK3bE transgenic female replicate 1 early timepoint,pert
"Distal and Proximal Large Intestine, 8week old Wild-type mouse 3",ctrl
WT Brain 25d Mouse1,ctrl
HLA risk: Low;	Height: 147.2 cm;	Weight: 35.2 kg;	BMI: 16.2;	Age: 11.45 years;	Gender: Female;	Race: White;	Glucose: 247 mg/dl;	HbA1c: 6.7%,pert
race: caucasian;	age (years): 45;	stage: IA;	grade: 1;	histology: endometrioid,pert
Series 2; adult; 3 days,pert
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle, Galgt2 Transgenic",pert
liver-AHRWT-cornoil,ctrl
KU_19T,pert
esr1 genotype: WT;	agent: saline control;	time point: 24h;	strain: C57bl6/Jx129;	age: adult (10+ weeks);	gender: ovariectomized female;	tissue: uterus,ctrl
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB with doxycycline for 3 days,pert
patient id: 209;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 63;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
695_EV_0hr,ctrl
cell line: MDA-LM2-shTARBP2;	transfection: shZNF395,pert
WT - Cre Treated - 0.5 hrs - repeat 1 - Cy5 - mAdbID:62544,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_4_7_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
"fetal testis sample 21, 16 weeks gestation",pert
nucleus accumbens ctrl replicate 4,ctrl
OBF-1 overexpression BCS-4 (Large PreB),pert
KU_28N,ctrl
Sham 3,ctrl
"RPMI8226_shLuc2, replicate1",ctrl
control peptide-treated CEM 100mM 16h,ctrl
"siYAP RNA #1 transfected, biological rep 2",pert
FcgKO Non stim 2,pert
Tendon_lesional_rep5,pert
Tumor-KO-rep1,pert
3451-1 E2F WT,pert
Individual_4356_PN_sample,pert
Insm1 control #9,ctrl
chip number: 20;	transfection plate: 4;	target gene: IRF3;	kd level: 0.91;	rin: 9.1;	transfection date: 2011-10-17,pert
01MKV: new onset sJIA,pert
"Patient  O, lesion, time: 0",ctrl
"breast tumor epithelium,53",pert
"siRNA, plastic plate, rep2",ctrl
hBSMC_vitamin D_rep3,pert
left lung lobe,ctrl
"fibroblast, control subject NM3 rep 2",ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Liver phenobarbital pool1 Affy,pert
healthy CD4 T cells 8,ctrl
Individual_5844_NN_sample,ctrl
retina_DBA_1025L_3mo_rep2,ctrl
"WT, PE treated whole heart",ctrl
siERK2Veh4h_2654,pert
Knockdown Cell on HMVEC-L Replicate 2,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).;	,ctrl
mouse adipose tissue,pert
siOGT 24 hours_2,pert
Age: 45;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
Normal Pleura 1,ctrl
Prostate Cancer_MS 36D6,pert
ALI patient #10,pert
visceral_fat_Akt1+/-_female_8wk_rep1,pert
TRAF3 deleted,pert
Wild type pancreas,ctrl
6 hr KLF4 Time Course Control,ctrl
E2A-deficient DN2 replicate 2,pert
"Embryonic cerebral cortex, control, biological replicate 2",ctrl
"liver, Nrf2 knockout, Nrf2(-/-)",pert
A513 Sham 7 day,ctrl
"RNA from HnRNP A1 IPs, HuR WT MEFs",ctrl
KU_11N,ctrl
disease state: Diamond-Blackfan anaemia;	gender: Male,pert
AVC_control_rep2,ctrl
U937_ROS_curcumin_4h_rep1,pert
rectal suction specimens,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-WT cells, expression not induced",ctrl
healthy control C9,ctrl
patient: 21;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
HL60_luc_Replicate3,ctrl
"brain, hippocampus: KA1-I_e1_le1",pert
PBMC SE T1,pert
Strain: B6SJL-G93A-SOD1;	Age: 75 day,pert
HRas-v12 transgenic male replicate 3 early timepoint,pert
Control Braak α- synuclein Stage 0 C1SN,ctrl
"human failing LV myocardium, Ischemic11",pert
cadmium_32hr_rep2,pert
U2OS_PRC_shRNA4_pLenti_1,pert
Kidney_saline ip_mouse #065,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 11,pert
cell line: E14;	treatment: Usp22 depletion,pert
Nerve_Control_Rosi_712,pert
clone 3-2,pert
0180-01-C,ctrl
striatum wild type 21 month replicate 3,ctrl
40SAGEA2,pert
Against CDK8-2 rep3,pert
"Liver from Nrf2 k.o. mice, biological replicate 2",pert
3 ERRg HET E18.5 male cadiac ventricles,pert
Muscle_control_1,ctrl
2x' Ez f/wt,ctrl
mES cells rep1,ctrl
cell line: IOSE80pc;	knockdown: control;	cell type: ovarian surface epithelial cells,ctrl
GM19238_Kd_NS1_11,ctrl
coc-10_B,pert
Wild-type Type II 1_8_9_04,ctrl
"human failing LV myocardium, Ischemic17",pert
rtTA-Dmrt5_d7_+Dox_rep_2,pert
"Crohn's Disease subject (28 year old caucasian female, SAK_1316711535)",pert
Velcade I1,pert
SCARKO d10 (2),pert
CML_7_MEP,pert
P117,ctrl
Parkinson's disease sample x205,pert
tissue: dental pulp cells;	genotype: control;	passages: 6,ctrl
airway epithelial brushing,pert
Time 0 mins rep 2,ctrl
E with Cy5,ctrl
F9 RA sample #1,pert
"brain, lateral and medial ganglionic eminences: Arx-/Y #3_le1",pert
MCL_IGHV_UNMUT (268-01-5TR),ctrl
CBMNC.LPS+.1,pert
GM19238_Kd_SP3_2,pert
3216M patient's mucosa,pert
"MaF pre-iPSC9P2, Vc untreated, lysed on D6",ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: DMSO for 72h,ctrl
"BA OBCs, post doxycyclin withdrawal, rep2",pert
Cochleae from wild type mice at P7,ctrl
"IDC 2, biological rep. 2",pert
gender: male;	age (years): 53;	evolution time (years): 8;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
PGA-MAH-C3H_OVA6h-5aA-s2,pert
oocyte_wildtype_rep2,ctrl
Mouse lungs infected with Mtb for 63 days,pert
T143,pert
AIRE ko CD80lo mTEC sample2,pert
"Wild type, biological rep 2",ctrl
Strain: Inbred C57BL/6J;;	 Gender: male;;	 Age: day of life 3;;	 Tissue: liver,pert
cell line: KYSE30;	cell type: squamous cell carcinoma,pert
cell line: KYSE50;	cell type: squamous cell carcinoma,pert
siCITED1#1 replicate4,pert
UM30_Wt_rep3,ctrl
p300_3,pert
6h Kin- Cel.42,pert
3987-1 E2F1 Null,ctrl
lymphoma_1032_ADR,pert
Surgical sample,pert
Hdh knock-in mice striatal cells,pert
"skeletal muscle, normal control",ctrl
RAW_1.4mM_HOCl_#2,pert
IM69_control,ctrl
440MM,pert
brain_DLPFC_bipolar B_mr950,pert
"heart, Q10, 14 months",pert
brain_DLPFC_bipolar C_mr540,ctrl
OVCAR-10-(2),ctrl
wild-type mES,ctrl
"Uninfected NT at 5 d.p.i., rep3",ctrl
"foxp3 expression: YES;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 wild type;	gender: female;	treatment: anti-CD3, anti-CD28 for 72 h",ctrl
ROSI-4--71602,pert
"E14 embryonic stem cells, VPA",pert
Skin_SKO_Rep1,pert
"Lung, Normal Tissue",ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 42 dpi,ctrl
DES D3,pert
NCI-H716_Control.1,ctrl
striatum_21 month,pert
Tfam+/- MEF,pert
"Liver from Nrf2 wt mice, biological replicate 2",ctrl
"Knockout Heart with no treatment, biological rep3",pert
U937 cell line infected with GSK3A Construct 6 shRNA,pert
rd1_P2_rep1,pert
CF_control,ctrl
XBP1s_B_cells_spleen_20weeks,pert
tissue: muscle;	sample group: placebo;	treatment: before;	gender: Female,ctrl
condition: Discoid Lupus;	patient: L3;	tissue: LS skin biopsy;	kit: Ovation,pert
GM19238_Kd_JUND_3,pert
lymphocytes_ctl_F_60y,ctrl
brownfat_KO1_day3,pert
batch: A;	knock-in: Twist-DQD;	cell line: MycCap prostate cancer cells,pert
"HeLa, epithelial cells, adenocarcinoma (CCL-2; American Tissue Culture Collection ATCC, Manassas, VA, USA)",pert
SV589_NoKD_SerumStarved->1hr EGF,pert
AKR/JTCE liver sample batch 1,pert
lung_wt_mock_repC,ctrl
Cancer 7,pert
CD4IncTp1-1,pert
cell type: HeLa;	genotype/variation: nucleofacted with HIRA siRNA,pert
SKBR3_Control_1,ctrl
Tsc1-deficient CD8 naïve cells KAI286,pert
Psoriasis-Patient-O,pert
31A;pretreatment;female;breast tumor; responder,ctrl
WT P2 replicate 2,ctrl
P3B Progranulin-cerebellum,pert
"Aorta, saline 14d, #2",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 48h",pert
"VPA 2, 4hrs",pert
CD4+ CD25hi Foxp3+ T cells,pert
DBA mouse untreated control,ctrl
"MIST1-null pancreas, biological rep4",pert
tissue: bone marrow;	genotype: HEB-KO;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),pert
"twin pair: #6;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
scpk/WT/17,ctrl
"Trip12 mut/mut, biological rep3",pert
"Wild type used for MAT1A 3 month, replicate 4",ctrl
CD4+ T cells from B6.Sle1a.1 mice,pert
"patient: 203;	current medication: Asacol 800mg BD, Simvastatin;	birth date: 1/10/35;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/92;	diagnosis date: 3/23/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/1/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 14;	crp: 0;	hb: 147;	wcc: 6;	neutrophils: 4;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: HISTOLOGICAL;	diagnosis recto sigmoid: HISTOLOGICAL;	diagnosis splen flex: HISTOLOGICAL;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/57;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
"A673 treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50), biological rep1",pert
MiaPaCa2 pCEP4 clone 1,ctrl
Jejunum_POR-null_2,pert
Sedentary-24,ctrl
"DHL6, R406, 2h",pert
"metastasis: metastatic recurrence;	Stage: 2b;	tissue: normal, homogenized",ctrl
"N-BMSCs, biological rep1",ctrl
MDS patient 26,pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: hepatocellular carcinoma (HCC),pert
human thyroid,pert
FACS-purified B cells_wildtype_influenza-infected_rep1,ctrl
muscle_Wt_35wk_rep3,ctrl
status: Control;	gender: Female;	age: 49;	tissue: Blood,ctrl
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: LSD1;	transfection time: 24h,ctrl
"Kinin B1 receptor knockout, biological rep4",pert
Control  VZ13,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 2 - Technical Replicate 1,pert
28 Day Mouse leg muscle,pert
liver western diet rep4,ctrl
HD9,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 7,ctrl
FC 03,ctrl
XBP1s Tumor 3,pert
ADHC4,pert
"Histopathological diagnostic: oligodendroglioma, grade 2",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 5,ctrl
"Control, biological rep10",ctrl
"strain background: C57BL/6;	genotype/variation: Cdh1 knock-out; Cdh1-, P53+;	age: 2 months;	gender: female;	tissue: uterus",pert
"CRT knockout mouse embryonic stem cell, biological rep4",pert
"Infected with H37Rv and treated with 1,25D, replicate 2",pert
8 wk old male mdx5cv gastroc,pert
"12 weeks old PS-NA mice, cerebrum",pert
Bone-Marrow_MGUS_G1694,pert
ILD_3,pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 wildtype;	age: 42 days;	tissue: retina,ctrl
"210, ADIPOOSE TISSUE, Before",ctrl
ab060 IM,pert
P7B Progranulin-cerebellum,pert
Aquaporin-11-/-_mouse P7 kidney #3-4,pert
pediatric AML S08,pert
Patient: N;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
age: 65;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
P0 - nudelko/+ 2,pert
ILKS343D3,pert
Breast Cancer Cell Line,pert
strain: FVB;	transduction: none;	tissue: Primary prostate epithelial cell culture,ctrl
erStress_twins_AA_1743twin1_500nM_thapsigargin_4h,pert
CD4+_Tcells_healthy_donor_7,ctrl
"Gender: Female, Age: 31, BMI: 37, Tissue: luteinized cumulus cells",pert
"human failing LV myocardium, Idiopathic18",pert
Proximal hindlimb bud tissue (~500um from base of limb bud) pooled from 3 embryos (6 limbs total).,pert
con-56_A,ctrl
"Cultured ovarian cancer cell line A2780, Cisplatin treated",pert
Nanog overexpressing liver,pert
cell line: MCF-7;	agent: gamma tocotrienol,pert
10.5 Months Heart MDX rep 1,pert
26 year old male,ctrl
AVC_mutant_rep3,pert
Mutated-ERα-positive breast cancer 11,pert
Sex: male;	Age at operation: 37 years;	Site: thigh;	Size in cm: 7x14x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: yes,ctrl
Ishikawa_Control_48h_rep1,ctrl
cell line: KOPT-K;	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
nt S. aureus 10,ctrl
Het-pDC2,pert
Bronchial epithelium,ctrl
negatively selected CD4+ splenocytes from an individual mouse treated with sham laparotomy,ctrl
HepG2_Ni rep2,pert
T2-FP_spleen_KO_rep2,pert
Bone-Marrow_SMM_S1398,pert
MS patient 2,pert
HCC SNU-398_control,ctrl
genotype: SRC-2 null;	tissue: Liver;	genetic background: C57;	Sex: Female,pert
WT-IL23 rep2,ctrl
Jurkat 1,pert
Nrf2 KO rep1,pert
Adrenal CREMKO 0h batch 2 [AdKOh00.15],pert
"LIGHT Tg, HFD 2wks",pert
"empty vector, biological rep3",ctrl
"uninfected primary RPE, biological replicate 1",ctrl
WT31,ctrl
"GV oocyte, Ring1 mutant",pert
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 73;	Usage number: 1;	Exposures: 4,pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 10 μM;	agent: VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothiolate),pert
El-Ashry 004.CEL,pert
"vector d4, rep 1",ctrl
strain: 129/Sv;	group: knock-out;	genotype (hdh cag repeat length): null;	differentiation status: undifferentiated,pert
patient: TLW18;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
3T3 Vector Control Vehicle 1,ctrl
Liver_hyperglycima_no.10,pert
EA_Case1_CD20,pert
Lung dnCREB-PBS replicate 1,pert
colon_adenoma_1187,pert
XX3_Paf,ctrl
Treg Trim28 conditional KO rep1,pert
Series 2; young; 3 day,pert
Murine skeletal muscle,ctrl
wild type E12.5 fetal liver derived megakaryocyte progenitors,ctrl
DH 2,pert
FmrWT3_blood,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 58y; W03 003",ctrl
TFEB_Overexpression(S3),pert
subject id: 44;	infection: DENV;	status: DF;	tissue: whole blood,pert
Treated with 50uM Zinc for 4 hrs -- replicate #2,pert
CLL 149-05 Control,ctrl
Large cell carcinoma 012,pert
P1 mouse eyeball extracted total RNA_Snf2h_cKO4,pert
"gastrocnemius, 30 months of age, resveratrol diet",pert
Cancer 16,pert
P0 Quadriceps Klhl40 KO 2,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 3,pert
Nerve_Control_Vehicle_702,ctrl
"Patient 4, lesion tissue",pert
"non-AD_FC, biological rep16",ctrl
3871-1 E2F WT,pert
cell type: Primary hepatocytes;	donor: 6;	agent: Wy14643;	time: 6h;	gender: Male;	age: 73 years old,pert
"MaF pre-iPSC9P2, Vc-, D6",ctrl
BxPC3-KO4 rep 6,pert
Igf1 +/+ mouse vestibular organs 15day old (P15),ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: metastasis to lung;	organ site at which tumor arose: parotid salivary gland;	donor sex: male,pert
P0 Whole Brain,pert
HP-13,ctrl
GM9016,pert
strain: Gata4tm1.1Sad/J;	infection: Mouse GATA4;	culture: Differentiation medium for 3 days,pert
coc-53_B,pert
"genetic modification: cells stably expressing the oncogenes c-myc and Ha-ras under the control of the Tet-off regulatable promoter, konstitutive expression of the estradiol activatabel IRF-1hER fusion protein;	tissue: fibroblast",ctrl
RV63.10_CHF_day19,pert
ACC 3 cell line Sox4-RNAi replicate 2,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.69;	Ratio: 2.13,pert
Liver Experiment 1,pert
cell line: U2OS;	treatment: shBAP1 #1,pert
"shCDK8, normal growth, replicate 3",pert
day 2 5-FU HSC 1,pert
rd1 mouse retina at age postnatal day 2,pert
"age at diagnosis: 67;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i+);	er: 1;	pgr: 1;	dfs-month: 17;	dfs-event: 0;	distant metastasis: 0",pert
PBMC from T cell LGL leukemia patient #1233 (TLGL1233),pert
Endometrium/Ovary-Disease 10,pert
Extensor carpi radialis brevis muscle from cerebral palsy patient,pert
A549 NSCLC cell line,ctrl
SKM KO5,pert
gender: male;	strain: C57/BL6;	tissue: heart;	genotype/variation: wild type,ctrl
126OE 24A n,pert
KO hippocampus Veh,pert
Cutaneous psoriasis without arthritis PsC 17,pert
CH2112,pert
cell line: LKR13,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-17;	Primary Site:Tongue;	Age:47;	Sex:M;	TNM:T4N3M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
Strain: C57BL/6J;	Gender: female;	Age: 7 weeks;	Tissue: whole brain,pert
"Acute Myeloid Leukemia, sample 5",pert
SA_271,pert
Day: 1; Drug: Saline; Phase: Drug treatment; Replicate: 1,ctrl
strain: C57/Bl6;	genotype/variation: wild-type;	gender: male;	tissue: epididymal white adipose tissue,ctrl
brain_DLPFC_bipolar B_mr430,pert
GIST 1,pert
healthy CD4 T cells 5,ctrl
Nr3_ctrl,ctrl
MA_15,pert
genotype: Male;	age: 15 years adolescent male,pert
D2_non-transgenic,ctrl
"patient: 102;	current medication: Movicol 1 sachet daily;	birth date: 9/5/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: RIF pain, persistent anaemia.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"lymphoblastoid cell line from T9.01, one out of seven of insensitive group, 50*10e6 cells",pert
Dominant negative cJun  VZ17,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 248;	age-at-biopsy-years: 49,pert
TscHet2_brain,pert
Mening UNSTIM WB SW 12a,ctrl
WT.DMSO_1,ctrl
"E18.5 brain, wild-type, rep 4",ctrl
INS-1 cell line #1a with induced HNF1b,pert
SLE CD4 T cells 9,pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",ctrl
"PBMC, healthy control, biological rep3",ctrl
LY2 SRC1-siRNA untreated rep4,ctrl
B6_Female_CF_rep2,pert
HaCaT cells at day 12 of in-vitro calcium induced differentiation,ctrl
"Empty vector control, 2 hrs, Rosiglitazone (ROS_2_1)",pert
"reference, C2siRNA treated sample",ctrl
TARBP2 over-expression (pCMV-TARBP2-1)_MDA-231,pert
"sodium arsenite added to food: 10 ppb, 5wk;	diet: LRD-5001",pert
treatment: transfected with Ambion Silencer Select SOX2 siRNA;	cell type: embryonal carcinoma;	cell line: 2102Ep;	passage: 35-50,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 1",ctrl
"PPARg d2, rep 4",pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep2,pert
"FACS purified YFP+ muscle stem cells, harvest immediately after isolation",ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID146,pert
shSOX2_5,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-5,ctrl
gender: Male;	age (y): 39;	tissue: prolactinoma,pert
A/OVX/no inj/0h/UTX 129/SvImJ WT,ctrl
MIG control biological replicate 1,ctrl
"Wild-type MEFs, biological rep1",ctrl
Healthy control_sample5,ctrl
Tk6 untreated controls for arsenic exposure rep1,ctrl
nodex_2,ctrl
Dental pulp cells control sample triplicate 3,ctrl
Liver sample from Alcoholic hepatitis group (CA80),pert
microdissected breast cancer cells from case 1085,pert
Liver WT1,ctrl
P14 - WTMixA 1,ctrl
"cultured human airway smooth muscle, 24 hour dex treatment, replicate 2",pert
PGA-lv_24h_510,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.675;	OD280: 0.838;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 234;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"WT, PR01M004v0",ctrl
RNA from microdissected breast cancer cells from case 356 labeled with Cy5,pert
Mouse hypothalamus,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 2,pert
3094-lcm,pert
"Lymphoblastoid cell lines derived from family 1744, member 1",pert
Normospermic individual: Sample N3,ctrl
Ebs at Day2.5 were treated with SB431542 for 2 h,ctrl
"PCOS, biological rep 2",pert
A375 melanoma cell-line,ctrl
cell culture: grade VI GBM short term cultures,pert
P14 - nudelkoMix/+ 3,pert
UM23_Wt_rep2,ctrl
dex4hr_4,pert
"SKO-transduced MEFs, Vc+, D3",pert
surgically resected material,ctrl
Leg 112 Day control rep 3,ctrl
SeroTest-5,pert
chip number: 19;	transfection plate: 3B;	target gene: YY1;	kd level: 0.63;	rin: 9.3;	transfection date: 2012-03-26,pert
BalbC_24h_Wy,pert
"E14 molar teeth, DMSO control",ctrl
background strain: C57Bl/6;	developmental stage: E11.5;	tissue: fore-limb;	genotype/variation: Sost-/-; Sostdc1-/-,pert
DS-Fibr 3,pert
Tip60 KD mouse embryonic stem cells,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 13;	gender: male;	tumor grade: IV,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 83,pert
siRNA-2-COLLAGEN,ctrl
diabetic muscle replicate 3,pert
"ALL_DS, K3 012109",pert
"Crohn's Disease subject (46 year old black female, SAK_1259829456)",pert
imanitib5,pert
"Entire small intestine, CF, lubiprostone treated",pert
70_129_WT,ctrl
TLW18_T4_PP_day3_016,pert
FoxO3null_2_1,pert
"Exp A, Animal #271, 5mg/kg D-Serine",pert
Hippocampus 1988 15 month Old,pert
Zfx-null TC1 ESC;	Cultured in 15% KO + LIF without feeders,pert
"NASP Overexpression, sample #1",pert
11L,pert
ESE_D_496,pert
LIN-CB,pert
Knockout cre_ppar_beta_floxed_rep1,pert
tissue: brain;	genotype: WT mix background B;	age: E14,ctrl
PlagL2WT4,ctrl
"Placebo treated, HIV-1 positive male, day 14 (6)",ctrl
Control 120 days sample 3,ctrl
01MJU_PolyRF-,pert
umbilical cord_nobpd: 6E/2F,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 2h,pert
214/0,pert
brain_Q10_14M_rep1,pert
RNA from whole tissue section of case 878 labeled with Cy5,ctrl
Spleen_wt_4m_rep2,ctrl
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: DMSO,ctrl
agent: Cadmium 1.2 µM,pert
multiple myeloma (MM 410),pert
Huh7 cells_Mock Infected 48 hours_ rep1,ctrl
OV1002 Carbo Day4,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 3,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 78;	time: 0;	batch: 3,ctrl
PTEN_4,pert
"vestibualr organ at P90 of Igf1 +/+, biological rep 2",ctrl
4T1.2-IRF7-2,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep5",pert
E17.5 preB cells_Smchd1 null_Rep 2,pert
WT V6.5 ESCs on day 0 #2,ctrl
B4 528 b4-/- after nicotine-induced seizures,pert
MDS patient 8,pert
siRNA-3-COLLAGEN,pert
126KD 22A n,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: mid-UV,pert
cell line: Panc-1;	transfected with: pCIG (empty vector),ctrl
Tg35,pert
whole blood_100676,pert
siCONTROL + MMC experiment 2,ctrl
KU_27N,ctrl
cell type: breast cancer cells;	agent: 200 uM Lacciac Acid A,pert
HeTH-4 +DOX rep-1,pert
DR AA4+ replicate 1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.229;	OD280: 1.143;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 297;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CD8_T_cell_pool_melanoma_M05+M06,pert
"GM8921A, unaffected brother",ctrl
cell type: F442A cultured adipocyte;	cell line: 3T3L1;	back ground strain: Swiss,pert
"Strain:Wistar, Gender: male, Tissue: cirrhotic liver, Induction of cirrhosis: CCl4",ctrl
Ishikawa_Control_48h_rep4,ctrl
"Normal, biological rep 3",ctrl
treatment: STAT3 siRNA;	cell line: Esophagus cell line OE33;	array id: 5617835005,pert
EB_0_24h_58_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
Pediatric_GBM_39,ctrl
patient: 263;	current medication: Azathioprine 75mg Fosomax 70mg;	birth date: 11/9/58;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/00;	diagnosis date: 6/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 7/8/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Gata3_Cdx2_null_9,pert
mouse jejunum_hnf1alphamutant_rep3,pert
V5-P154,pert
H295R adrenocortical carcinoma cell line,pert
CH1801,pert
PBMCs_Control_18 [IS],ctrl
Wildtype_TAC_Rep6,pert
breast normal 3,ctrl
Bronchial Epithelial Cells SA biological 2136J,pert
WT Brain 20d Mouse1,ctrl
cell type: preadipocytes;	tissue: white adipose tissue,ctrl
MCL_IGHV_UNMUT (R1587),ctrl
Bronchial Epithelial Cells control biological 1701J,ctrl
M24met_Wnt1_3,pert
race: caucasian;	age (years): 56;	stage: IA;	grade: 2;	histology: endometrioid,pert
cell line: THP-1;	shRNA construct: GSK3B Construct 1,pert
r22,pert
"Grape extract group, 6 months, patient number 15",ctrl
Liver_Nrf2 Control_rep3.,ctrl
brain_DLPFC_bipolar C_mr523,pert
"t17, surgically resected from patient of gastric cancer.",pert
"AZ521 dnSox2 cells, induced, 12h",pert
Control_6months_retina3,ctrl
pt. HCL C treated with DMSO for 48h,ctrl
0165-01-C,ctrl
"Mdr2-KO homozygous mouse, 3 month old mouse 2",pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 58.44932,ctrl
"male, healthy, no medicamentation",pert
MV 2,pert
Celecoxib_#4875,pert
"129 Mouse P0 Pineal Tissue, Sample 1, 05-16-06",ctrl
18C-ER,ctrl
Scd1+/+ on chow diet replicate 1,ctrl
Trizol extracted total RNA from myometrium tissue. Trizol extracted total RNA from myometrium tissue (HLRCC).,ctrl
gender: mixed;	genotype: Homozygous for the Q119X mutation in the TWIST2 gene;	ethnicity: Puerto Rican,pert
Sex: male;	Age: 14;	SL: 3.57;	House: 0;	Severity: SS;	Ashworth: 3;	Zancolli: 3;	PEFF: 45;	PESF: 40;	AEFF:,pert
genotype: Sox3 positive;	cell line: R1;	cell type: Embryonic stem cells differentiated into neural progenitor cells,ctrl
"normal colorectal mucosa, biological rep 3",ctrl
"Hippocampus, soman, 48h",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 2,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.1;	colon weight (mg): 170;	colon ratio (mg/mm): 2.62;	myeloperoxidase activity (u/mg): 0.463;	tissue: colon;	treatment: 5% DSS,pert
Control_24h_rep1,ctrl
BL Day 1 siMut12 transfected biological rep4,pert
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: undifferentiated,pert
baseline control 03,ctrl
Phytohemagglutinin-activated PBMCs from normal control subject C (CAcPBMC),ctrl
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 41;	donor: 28;	disease state: Lesional,pert
"control, rep3",ctrl
tissue: Temporal cortex;	age: 65;	Sex: F,ctrl
"gender: female;	batch: 1;	age (years): 21;	patient id: Severe_2;	fev1 (% predicted): 105;	fvc (% predicted): 101;	medication: Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn;	cell type: CD4+ T-cells",pert
Seltzer 50d replicate 2,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-tu2,ctrl
"TGCT cell line 2102Ep/clone 2A6, treated 7 days with retinoic acid",pert
RKO_liver_fasted_refed_3hr_rep1,pert
TB 5,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L015,ctrl
sample D 18.5 homo,pert
"brain, hippocampus: LH4_e1_le1",pert
"human failing LV myocardium, Ischemic97",pert
HeLa_01-04-05 TP9_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
KSR1-null MEFs with KSR1,ctrl
agent: pristane;	time: 18 days;	strain: DBA;	tissue: mesentery,pert
strain: C57BL/6J;	genotype: K14-Cre;Tgfbr2 fl/fl;	tissue: Posterior Palate;	age: E15.5;	gender: Not determined,pert
T-ALL1 Control 1,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 4 hour",ctrl
CLL 119-09 LMP-420,pert
HepG2_Ni rep1,pert
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with 100 nM T3 for 6h,pert
H295R_Group_B_Dose_100_TIMEPT1_009,pert
strain: CD-1;	genotype/variation: wild-type;	developmental stage: embryo;	age: E14.5;	tissue: kidney,ctrl
Recent-onset T1D_sample1,pert
V5-P426,pert
erStress_twins_AA_1724twin1_DMSO_4h,ctrl
strain: FVB;	genotype: E2F1 null;	tissue: mammary gland tumor,pert
adult peripheral blood mononuclear cells without LPS-treatment,ctrl
tissue: brain;	genotype: WT mix background A;	age: P0,ctrl
Dengue Fever Patient 43,pert
"IN1760 siNT treated, Biological replicate2",ctrl
Heart sample1,ctrl
HeLa_01-04-05 TP8_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
control participant P319,ctrl
GM19238_Kd_NR3C1_2,pert
wt PBS5,pert
SK-BR-3 breast cancer cells stably overexpressing TFPIalpha,pert
Double_positive_thymocytes_medium _3h_rep2,ctrl
Aorta_APOE-deficient with atherosclerosis_2,pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: C;	tissue: Skeletal muscle (quadriceps),pert
Patient: H;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
N1,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 3,pert
lateral hypothalamus long access to cocaine replicate 1,pert
Teratozoospermic individual: Sample T1,pert
Untreated diabetic-5,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: FRAG.cRNA-4A,pert
"Patient H-615-N, normal colonic mucosa",ctrl
Active ITP chip B,pert
5922012047_A,pert
Rb-/-PrE serum 2,pert
RptorKO CSC Technical Rep.1,pert
Postmenopausal female. Untreated control. nr 33.,ctrl
strain: C57BL/6;	tissue: small intestine;	genotype: wild type;	treatment: none,ctrl
cell line: BL2;	transfection: scrb siRNA;	batch: 1,ctrl
Knockout 2,pert
"Oct4-Gip ES cells, Luc RNAi, 72h post transfection",ctrl
Igf1 -/- mouse vestibular organs 90 days old (P90),pert
COP control replicate 3,ctrl
D3_non-transgenic,ctrl
10 week mutant OMN rep 2,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu1,pert
5278-lcm,pert
MCF-7 control rep 1,ctrl
C_AN10028_T,ctrl
WT liver_HFD_rep5,ctrl
Mock infected murine liver-MO30k-(C)-6 hpi,ctrl
KM-H2 non-silencing,ctrl
BP patient 96_biological replicate 1,pert
Empty vector transduced CCE embryonic stem cells (empty vector CCE ES cells),ctrl
HCC001N,ctrl
"cell type: Primary chondrocytes;	genotype: Wt;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant",ctrl
patient E1521,ctrl
MCK-PPARa rep 1,pert
C011_Control_F_89,ctrl
normal brain_1,ctrl
Control 7,ctrl
Monocyte human control sample,ctrl
"liver, wt mouse, sample WT5",ctrl
"human failing LV myocardium, Idiopathic24",pert
HUVEC_TNF-stimulated experiment 2,pert
"PBMC, patient. Mtx rep14",pert
"EBF1 d4, rep 6",pert
RNA from whole tissue section of case 856 labeled with Cy5,ctrl
"Control, biological rep7",ctrl
liver cells from wildtype 8wk male mouse 8 challenged with vehicle (saline)_9,ctrl
PTEN-22 (-/-),ctrl
"Mdr2-KO homozygous mouse, 12 month old mouse 2",pert
patient E1532,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 45 yr;	population: white,ctrl
Cbx2_KO_XY gonads at E11.5,pert
Moderate rep1 (retina),pert
ethnicity: Hispanic;	Gender: Male;	Age: 31;	Tissue: primary human bronchial smooth muscle cells,ctrl
Mammary gland R1 NT rep4,ctrl
08SE1179,ctrl
MDA_Parental_2,ctrl
Sex: female;	Age at operation: 70 years;	Site: thorax;	Size in cm: 1.9x1.3x1;	Histological Subtype: pleomorphic liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: residual tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genotype: HDAC6 knock out,pert
tissue: inner ear;	genotype/variation: Dlx5-null;	age: E10.5,pert
lymphocytes_HD_M_59y,pert
fibroblast_5azacontrol_rep2,ctrl
"H1299 treated with Lipofection GAPDH siRNA, 12hr",pert
age_years: 62;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: female;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,ctrl
pediatric AML S32,pert
NCCIT siNTC rep1,ctrl
HMEC X BC4 : 0088-5k,pert
V5-P175,pert
umbilical cord tissue; high gestational age,ctrl
BCR-ABL1-control rep 1,pert
siNS_24h_4,ctrl
"spleen marginal zone B in WT, biological rep4",ctrl
Ulk1/2-/- + IFNβ 1,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 47;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
MPM tumor specimen 6,pert
WT CD80lo mTEC sample2,ctrl
MKK3bE transgenic male replicate 4 late timepoint,pert
"Mouse Sciatic Nerve, Diabetic Rosi",pert
Control AGS cells (transduced with non targetting shRNA) treated with 10 microM LPA for 4 hr,pert
Diagnosis: AML M1;	Age: 68y;	Gender: Female;	Blast %: 81;	Source: BM;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_4mM_HG-U133A_2_YCHSUP501,pert
"Normal Skin, Normal-21",ctrl
FBooth-MDX-2Av2-s2,pert
expression array - BRAIN 1,ctrl
P8 Vax2-/- 2,pert
left hippocampus of 5HTT +/- control mice,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 77min;	race: White;	sex: Female,ctrl
5-KO_RD3a,pert
HMEC_TNF-stimulated experiment 2,pert
V5-P474,pert
KO SPC Type II 2_8_9_04,pert
Liver sample from Control group (C12),ctrl
TOM-1 Imatinib-treated,pert
treatment: no DOX,ctrl
B cell lymphocytes from MCL patient,ctrl
thyroid_tumor_4,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 69;	gender: male;	tumor grade: IV,pert
umbilical cord_nobpd: 4F,ctrl
Age: 45;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
THRA 6a mutant + T3 replicate 3,pert
MDA cells resistant to paclitaxel,pert
Strain: J1 Cell type: mouse embryonic stem cell,ctrl
APPsa_R6_rep1,pert
Tendon;ECRB_Lesional,pert
wild type MEF time 6 replicate 4,ctrl
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with vehicle for 6h,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure",pert
Mock infected murine liver-MO30k-(788)-6 hpi,ctrl
Universal Human Reference RNA,ctrl
hNHEPS_10 μM_6 h_rep1,pert
age	28;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	11.2;	leukocyte count (/nl)	164;	hemoglobin (g/dl)	9.5;	platelet count (/nl)	842,pert
G_Kin_2,pert
"eye, cornea: TRizol Extraction_le1 3",pert
"spinal cord, ventral spinal cord: EP133/L - hSOD1(Chan)/e14-wildtype hSOD1_le2",ctrl
Nerve_Control_Vehicle_703,pert
"Retina, 42 days old homozygous Egr-1 knock-out mice",pert
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14480;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
TscHet1_brain,pert
"Patient 14, Macroscopically intact tissue",ctrl
FU-OV-1-(1),ctrl
tissue: large intestine;	genotype: HDAC3ΔIEC;	strain: C57BL/6,pert
WT leukemia stem cell,ctrl
BALB_Female_CF_rep1,pert
tissue: Hippocampus;	age: 83;	Sex: M,pert
5252 UC Inflamed sigmoid colon,pert
01UN8_Oligo,pert
Sex: male;	Age at operation: 53 years;	Site: thigh;	Size in cm: 10x3x5;	Histological Subtype: atypical liposarcoma;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
446MM,pert
S012_Scz_M_63,pert
Cardiac muscle,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 41;	gender: male,pert
Strain: C57BL/6;	Age: 2 months;	Tissue: retina,ctrl
3217-lcm,pert
Human skeletal muscle biopsy sample;	Patient #63 with NORM,ctrl
HUVEC/NmenMC58_frpC/frpA_4h_rep3_1117,pert
Liver sample from Alcoholic hepatitis group (CA62),pert
NTera-2 cells transfected with Ambion Silencer Select Negative Control #1,ctrl
Ad+TOT replicate3,pert
HCC_41N,ctrl
brain_OFC_bipolar B_mr421,pert
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
Genotype: B6.Pdss2loxP/loxP;	Age: 140-day-old male;	40 mg liver used for RNA extraction,ctrl
"Liver, LmnaG609G/G609G",pert
Tissue: Primary Human Hepatocyte;	Gender: female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,pert
"Patient 999, 3 month of BETAFERON",pert
"non-AD_FC, biological rep3",ctrl
jejunum_GATA4mutant_3,pert
TOV112D NT-4,ctrl
Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 3,ctrl
PGA-RMM-6h-3aA-s2,pert
C57 72 ozone 2,ctrl
"Wild type, pancreas",ctrl
STING tumor DNA III,pert
Placenta_PE(LO)5,pert
WT_2,ctrl
ic patient 4,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 1,pert
P0 - DCXko/Y 1,pert
GC resistant clone C7H2-R19F2 treated for 6 hours with EtOH,ctrl
"Patient M030-827N, normal colonic mucosa",ctrl
Control3,ctrl
WAT from wild-type control fed regular chow diet Replicate 1,ctrl
mononuclear cells isolated from peripheral blood or bone marrow,pert
control_32hr_rep1,ctrl
Control (0.1% DMSO) rep 3,ctrl
Muscle PCOS pioglitazone 41,ctrl
DW292_Tg_M,pert
"age at diagnosis: 80;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T3;	n (lymph node metastasis): NX;	er: 1;	pgr: 1;	dfs-month: 45;	dfs-event: 0;	distant metastasis: 0",pert
V5-P254,pert
MLL_PTD15,pert
11100 UC Uninflamed descending colon,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
HF0593_U133P2,ctrl
"Biceps, control, cohort 13, subject 13U",ctrl
"Control 1, biological rep1",ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (16),pert
Peripheral blood from individuals with systemic lupus erythematosus,pert
PC-3M/MYB siRNA #1,pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle,pert
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 3",pert
"Normal skin from Stat3c_control mouse, biological replicate 1",ctrl
pSUPER-mir-210 replicate 2,pert
"Soleus muscle, basal state, WT",ctrl
Subject 3 Pre allergen challenge,ctrl
siERK1E24h_2651,pert
Muscle 50 eccentric contractions 12 hours KO Adult 01271,pert
control MLL_00109,ctrl
"adult female mouse colon, wildtype",ctrl
lox95 control mouse,ctrl
"NeuroD1 cKO at ZT6, pineal gland",pert
genotype: E-mu-BRD2;	cell-type: lymphoma_aggressive;	splenomegaly: severe;	Ig clonality: monoclonal,pert
Subject #8019-Preinfection,pert
Patient: J;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 84,ctrl
m1-adenoma1,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: pineal gland;	time: ZT6,pert
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 48h,ctrl
Spleen_ko_4m_rep1,pert
01L4G: normal control,ctrl
MCF-10A_sh53BP1-2,pert
new onset sJIA,pert
colon_epithelium_IL10mouse_6weeks_rep1,pert
Tk6 treated with arsenic rep2,pert
Septic shock;	gender: Female;	Survivor;	organism: Group A Strep,pert
siRNA Smc3 + Estrogen [N1],pert
Patient: L;	Time: 0;	Group: responder;	Condition: lesional,ctrl
miR122-WT-258,ctrl
"17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
unstimulated CD4+ T-cells from Wt C57BL/6 mice,ctrl
LOX1_0hr,pert
wt-Gfp P10 replicate 2,ctrl
11092 Normal Uninflamed descending colon,ctrl
01 MINUS OHT 1A,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2. Sample C,pert
Cebpg-/- MEFs at passage 3_biological replicate 1,pert
50SageA2,pert
disease state: paediatric glioblastoma;	age: 7.3;	gender: M;	h3.3_status: wt,ctrl
"RNF40 siRNA - Undifferentiated, rep2",pert
"Patient 15, Atheroma plaque",pert
Gender: Male; Tissue: Prostate.,pert
colon_IL10mouse_6weeks_rep4,pert
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 74,pert
minor HCC10,pert
Leg 14 Day Control rep 3,ctrl
Nrl-ko-Gfp 4 weeks replicate 3,ctrl
16 with Cy5,pert
"n04, surgically resected from patient of gastric cancer.",ctrl
"patient 12, arm treated with pimecrolimus",pert
transfection: control siRNA (siCon);	cell: C2C12,ctrl
Fibroid_2540A,pert
APPsa_R6_rep2,pert
SUM149_siControl_rep2,ctrl
pt. HCL B treated with Vemurafenib 1000 nM for 48h,pert
GEIM186-NORM,ctrl
U2OS_siNS_2h,ctrl
"PPARg2 expression construct, 24 hrs, No Rosiglitazone (PPAR_24_2)",pert
Age: 58;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
mouse cerebellum at P30 knockout 1,pert
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep1,ctrl
H4-II-E-C3 cells untreated,ctrl
2_c,ctrl
hTERT-immortalized human skin fibroblasts,ctrl
33A;pretreatment;female;breast tumor,ctrl
HCC_14N,ctrl
E35,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 9.9;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Subject #8046-8hr Postinfection,ctrl
"TNFa siRNA-A, replicate 1",pert
treatment: TRPM2-AS siRNA;	cell line: PC3,pert
cell type: mouse embryonic fibroblasts (MEF);	phase: cycling,ctrl
"Patient H-c870T, MSI colorectal tumor",pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 19",pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: Wild type,ctrl
"patient 8, arm treated with pimecrolimus",pert
"MIST1-null pancreas, biological rep2",pert
Allo-25-4,pert
pool,ctrl
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep4",ctrl
liver 0.1% quercetin diet rep5,pert
siCITED1#3 replicate3,pert
cell line: BV2;	treatment: Curcimun,pert
mouse embryo forelimbs,pert
Vit A sufficient 4a,ctrl
diabetic muscle replicate 2,pert
"NeuroD1 knockout mouse, P0 Pineal Tissue, Sample 1, 05-16-06",pert
V5-P066,pert
"E12.5 wild-type embryonic kidney, biological rep1",ctrl
"Spinal cord, acrylamide treated, biological rep2",pert
"Control, biological rep8",ctrl
cell line: MLL-AF9 AML cell line 10986 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
"Healthy volunteer, Control_11699",ctrl
GM19238_Kd_NS_P3_11,ctrl
Strain:  C57BL/6,ctrl
36A;pretreatment;female;breast tumor; nonresponder,ctrl
whole blood_101291,pert
Liver_TAK1KO_Rep2,pert
tissue: testis;	genotype: repro9/repro9;	age: 14dpp,pert
H1P_3,ctrl
gender: male;	dietary group: resveratrol-enriched grape extract (C);	time point: 12 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),pert
"Patient 998, 24 month of BETAFERON",pert
Phan_007_KO.saline rep1,pert
H2009_shPTK7-2,pert
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14440;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Deltoid, FSHD, cohort 07, subject 07A",pert
HRas-v12 transgenic male replicate 4 late timepoint,pert
55A;pretreatment;female;breast tumor,ctrl
E10.5_otic_vesicle_wt_replicate1,ctrl
Patient identifyier: L;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 22 years;	Body surface area: 10 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Ad+veh replicate1 b,ctrl
NSCLC cell line H157. Transfected with scrambeled control non-targetting oligomer siRNA - #2,ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 6",ctrl
tissue: Whole pancreas;	genotype: WT;	background: C57BL/6;	age: 8 weeks,pert
sex: Female;	Age: 8 months;	additional patient information found in Series supplementary file,ctrl
Control Endometrium Mesenchymal Cell_035.UC209++),ctrl
1 PC3 0hr,ctrl
muscle,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 2,pert
Gender: Male;	Age: 57;	Ethnicity: White,ctrl
THRB 15b mutant + vehicle replicate 1,ctrl
"Cell line:  Fibroblast TTP WT cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",ctrl
KM_103N,ctrl
TTE3 cells treated with BPA for 6 h-2,pert
medial gastrocnemius,ctrl
"age at diagnosis: 54;	diagnosis: Adenocarcinoma of breast, ductal, recurrent;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
expression array - BRAIN 4,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#121,pert
hepatocytes treated with 522 μM MeOPP,pert
Gender:F;	Age:48;	Tissue: Mucosa,ctrl
AA_Case19_CD8,pert
Ischemia-reperfusion #1,pert
ST045849 12 hours_2,pert
gender: Female;	age: 81;	post-mortem delay: 22h,pert
"HL-60 + 0.5 % DMSO, biological replicate 1",ctrl
11408 UC Inflamed sigmoid colon,pert
RAW_1.4mM_HOCl_#1,pert
IRAK2 KO macrophages stimulated with MALP-2 for 8 h,pert
MPM tumor 14,pert
EB_0_8d_68_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
"Myeloid cell line, control siRNA",ctrl
HeLa_TP082505-19_HG-U133A_2_IMFGN0023,ctrl
100uM H2O2 rep 3,pert
Parkinson's disease sample x149,pert
Testis_KO_rep4,pert
tissue: Hippocampus;	age: 78;	Sex: F,ctrl
lateral hypothalamus,ctrl
patient: 40730;	sample: normal,ctrl
PGA-RMM-45m-3aA-s2,pert
KO9-1,pert
H441 transfected with scrambled siRNA 3,pert
Colon_POR-null_1,pert
Liver WT HFD #546,ctrl
"PPARg d2, rep 3",pert
esophageal squamous cell carcinoma from patient E1520,pert
Adrenocortical adenoma with CTNNB1 mutation (T41A),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 112min;	race: White;	sex: Male,pert
CCI 14d replicate 3,pert
"WT liver, biological rep2",ctrl
brain_QH2_6M_rep2,pert
"human failing LV myocardium, Ischemic36",pert
U2-OS-ERb,ctrl
K562 cells CREB Knock-out replicate 10,pert
Sex: male;	Age at operation: 70 years;	Site: thigh;	Size in cm: 9x3x6;	Histological Subtype: atypical lipoma;	Responder type: medium;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
"endometrioma, patient M4",pert
Diaphragm 14 Day mdx rep 2,pert
Donor (Sample 21),ctrl
siCABIN1 2,pert
"male;	CABG patient, atrial tissue;	sevoflurane anesthesia, after CABG surgery",pert
129_Sv_1_Tal1_Ko_d6_4302,pert
cell line: KYSE150;	cell type: squamous cell carcinoma,pert
HeLa_01-04-05 TP5_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
"EAE, placebo treated #5",pert
CLL12-CD8,pert
mouse embryonic stem cells,pert
TTF=122min;	Race=Black or African American;	Sex=Female;	Group=A;	Prototype_N,pert
"Overexpress TFPIalpha, biological rep. 1",pert
N1A Normal-frontal,ctrl
tissue: Lung Epithelium,ctrl
Control ppar_beta_floxed_rep3,ctrl
Gene expression profiling of normal cortex of patient T144,ctrl
"B cells, wild type, stimulated",ctrl
U2OS PRC shRNA1_pLenti_2007,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: del5q,pert
agent: EphB2-Fc conjugate;	time: 48h,pert
Human colon cancer cell line Caco-2,ctrl
phenotype: alcoholic;	gender: female;	case_id: 337;	age: 62;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 22;	brain ph at time of freezing: 6.74;	labeling_batch: 1,pert
overexpressed Tcof1 [B],pert
56SageA2,pert
B2KO; No Treatment #9,pert
"CD3+ T cells, bone marrow derived, healthy volunteers",ctrl
"Typically Developing Control, Gracilis, Patient Replicate 3",ctrl
Wild-type Type II 9_27_04,ctrl
M7KOepi_infect_0h_rep3,pert
"control endometrium, patient 25",ctrl
"lymphoblastoid cell line from F23.05, one out of seven of insensitive group, 50*10e6 cells",ctrl
expression array - AO1,pert
age_years: 42;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
RKO human colorectal carcinoma cells,ctrl
Subject 1 / lung subsegment instillated by Saline,ctrl
"knockout mouse embryonic fibroblast, biological rep 1",pert
db/db 16 wk 3,pert
DMN-NF1Hippo18d-1aAv2-s2,pert
RI39,pert
U-87MG-V17 set 2,ctrl
siNS_24h_1,ctrl
(ca)Raf_2,pert
Normal-BM 5,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 6 months,pert
WT STR Veh 2,ctrl
P14 - nudelko/+ 3,pert
CA2,pert
FRD1 2,pert
cell line: U937;	shRNA construct: GSK3B Construct 2,pert
G609-lcm,pert
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-2,pert
Skin biopsy from upper nates no nickel exposure,pert
FBooth-MDX-3Av2-s2,pert
61 year old female,pert
MLL_00113,ctrl
WILDTYPE cerebellum at 4 weeks,ctrl
38SAGEA,pert
Calu3-Parental_4,ctrl
WT_POST_PDE_042,ctrl
C57BL10 EDL sample 1,ctrl
MPM tumor 7,pert
"Patient 7, control tissue",ctrl
race: caucasian;	age (years): unknown;	stage: IC;	grade: 1;	histology: endometrioid,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 67;	baseline tumor size (cm): 9x7;	patient id (to identify the 2 chips from the same patient): 12791332,ctrl
Healthy-8 baseline,ctrl
cell type: DN4,pert
"granulocyte, healthy control, biological rep13",ctrl
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
gender: male;	age: 2-3 months;	tissue: kidney;	genotype: WT,ctrl
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
"BMMs, untreated control, da, Replicate 1",pert
c_M101,ctrl
Bulun 1-3h-,ctrl
MCI-015,pert
T84,pert
11A,pert
"Acute Myeloid Leukemia, sample 35",ctrl
Wild type  lung at birth (term),ctrl
V5-P492-2,pert
Tendon;Patellar_Non-lesional,ctrl
DMN-CtrHippo10d-2aAv2-s2,ctrl
(ca)erbB-2_2,pert
patient id: 233;	tissue: Normal cortex;	gender: Female;	age: 79;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"liver_ABCA1-TG, biological replicate 1",pert
"treatment with TFMPP, replicate 2",pert
"HepG2 cells, HNF4a RNAi treated, rep2",pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to 30 min intravenous saline challenge""",ctrl
"P30_wt cones, replicate 1 [array]",ctrl
heterozygot FH P265 (human CD3 positive T cells),pert
NTac_liver_vehicle 0 mg/kg_96 hr_5,pert
genotype: Wild type,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep3,pert
KU_19N,ctrl
human peripheral blood derived monocytes,ctrl
SFM,ctrl
Cdx2 null ES cells expressing human Gata3 T2ER fusion,pert
liver wild type replicate3,pert
Diabetic 3 weeks D3,pert
"brain, hippocampus: KA6-III_e1_le1",pert
Mus musculus liver - txnrd1 null,ctrl
"H295R adrenocortical carcinoma cells, 2-OH-BDE85-treated",pert
"Hdh knock-in embryonic stem cells, Q50 line, biological replicate 1",pert
FHCRCAML169018,pert
cumulus_nonPCOS_Lean_rep2,ctrl
MCF-10A_shCHK1-3,pert
OCI-Ly7_FOXP1 overexpression,ctrl
Amoxicillin treated Colon 3 21 days old,pert
Trizol extracted total RNA from myometrium tissue. Trizol extracted total RNA from myometrium tissue.,ctrl
erStress_twins_AA_1717twin2_DMSO_4h,ctrl
146_SIO,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (30),pert
0238-01-A,pert
E9.0 ko.2,pert
microdissected breast cancer cells from case 871,pert
"experiment VIII, hTERT",pert
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T3;	n (lymph node metastasis): N0;	er: 0;	pgr: NA;	dfs-month: 21;	dfs-event: 1;	distant metastasis: 1",pert
MDS patient 149,pert
HCT116 cells,pert
Individual_4089_PP_sample,pert
Whole testis RNA from WT mouse #146 at 0h,ctrl
HVS-CD4-ITK-R335W_unstim_rep1,pert
cell type: Bladder cancer;	treatment: mock,ctrl
Keratinocytes treated with EphB2 for 1h,pert
MPM tumor specimen 28,pert
Postmenopausal female. Untreated control. nr 21.,ctrl
"KO mouse heart at 6-weeks old, biological rep4",pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 36;	maternal age: n/a,ctrl
mock-1,ctrl
lung_wt_mock_repA,ctrl
"Empty vector, plastic plate, rep3",pert
Melanoma,pert
Normal cortex of patient 209,ctrl
MCF7 cells treated with 2uM ARC for 24 hours Array 2,pert
Muscle PCOS 5,pert
"Chromium 1 µM, biological rep2",pert
"3T3-L1 siLSD1 48h, biological rep 1",ctrl
17GOBMUC2H,ctrl
"ID: MLL_00268;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"PC from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE,CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
LDLR_HF_2,pert
"wildtype mouse embryonic fibroblast, biological rep 2",ctrl
Lung,pert
tissue: heart;	gender: male;	genotype: WT;	age: 3 months;	strain: C57BL/6,ctrl
BIO586221,ctrl
NPC10,pert
ex vivo cultivated melanocytes,pert
"Liver from control mice, biological replicate 2",ctrl
GM19238_Kd_TAF1_2,pert
CLL 38-11 Control,ctrl
"breast tumor epithelium,20",pert
Morbidly obese control subject,ctrl
A YOKE_B025,pert
BJ-fib_2,ctrl
"126 (221), ADIPOOSE TISSUE, After",pert
"Liposarcoma culture from tumor 394, doxorubicin treated",pert
Mut-/- rep3,pert
"strain background: C57BL/6;	genotype/variation: P53 knock-out; Cdh1+, P53-;	age: 2 months;	gender: female;	tissue: uterus",pert
B6_Male_Control_rep2,ctrl
MLL_00126,pert
bone marrow-derived macropahges,pert
cell line: KOPT-K;	cell type: human T-ALL cell line;	agent: control,ctrl
GLY replicate 4,pert
1006-03-A,pert
WT MEP 1,ctrl
mouse bladder,ctrl
PGA-lv_1w_651,ctrl
L_LS_Wk12,pert
SeV 3479,pert
Nrl ko P10 replicate 2,pert
cell line: Y79;	passage: 29;	cell type: Retinoblastoma,ctrl
IRF4-control_Th17_cells_42hr_rep2,ctrl
Strain:B6.V-Lepob;	gender: female;	age: 12 weeks;	tissue: gallbladder,pert
U87 untreated rep2,ctrl
PGA_MI_nilv_1h_395,pert
"WT uterus, saline control",ctrl
"ALL_DS, K4 011509",pert
duration of untreated disease in month: 20.6;	age at onset: 6.0,pert
RI57,pert
ANL Chip#38,pert
"Pten null fibroblasts, biological rep2",pert
Mouse male kidney C57BL/6J,ctrl
ovaries dissected from 0-day old Sprague-Dawley rats and cleaned of ovarian bursa.,ctrl
colon_adenoma_1419,pert
LICR_HN2_CETU1,pert
1212-2heart_OTT1KO,pert
"Lesional skin biopsy from psoriasis patient, Week2_etanercept",pert
HNF4 Control_8,ctrl
brain_co_14M_rep2,ctrl
TTF=90min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
14.5_KO_615A,pert
V5-P565,pert
Vector expression/TBK1 suppression,pert
platelet_sickle_5,pert
Atopic eczema,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 69;	age-at-onset: 65;	geographical origin: Mirandela;	clinical characteristics: Hypertension, diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"Patient 13, Atheroma plaque",pert
"Rb null fetal liver 3, embryo at 12.5 days of development",pert
"Vehicle treated, DAY 6, biological rep.2, MV4-11 cells",ctrl
MCF10A_Empty vector_1,ctrl
"3T3-L1 siLSD1 24h, biological rep 2",pert
Individual_4935_NN_sample,ctrl
cerebellum_Pink1 knockout_24 weeks_replicate 1,pert
age_years: 56;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
IRF4_4,pert
Osteoblasts_Lrp5_Knockout_Day7_rep2,pert
RNA from HCC_21N,ctrl
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14536;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
KU_33T,pert
T81 U133p2,pert
"shKDM4C 2, clone 2, rep 2",pert
CTRL_2_HSC,ctrl
RNA from HCC_38T,pert
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-C104A/C131A;	overexpression induced with doxycline: No,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: wild type;	cell type: B-lymphoid,ctrl
Resting CD4 T cells,ctrl
"Foxd3 conditional knockout cells treated with Tamoxifen, biological rep3",pert
cell line: MOLM-14;	shRNA construct: Scrambled Control,ctrl
"A673 treated with DMSO vehicle control for 24 hours, biological rep3",ctrl
CML_1_HSC,pert
Run3.aUa.010110d.SkMDbt1134D.CEL-DB basal,ctrl
strain/background: A/J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: cholestatic intestinal injury,pert
"breast, pre AFI treatment (H17_1910)",ctrl
T41027,pert
GFPRhoGDI2 Replicate A,pert
"T47D, WT",ctrl
cerebellum SNCA knockout 6 month replicate 1,ctrl
Striatum of 6-10 week old C57BL/6J mice,ctrl
"Quercetin, sample 4",pert
gender: female;	age (years): 36;	evolution time (years): 3;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
"DP thymocytes, dicer KO",pert
3T3 Vector Control Vehicle 2,ctrl
wild-type macrophages unstimulated,ctrl
scan batch: Batch 1;	group: autism;	subject age: 2;	paternal age: n/a;	maternal age: n/a,pert
Cell line BT-474_control_expt2,ctrl
brain_OFC_control C_mr169,ctrl
Amniocytes_trisomy 21_1549,pert
"Patient CCa, stable renal transplant recipients, female, 70 years old, T0 (time of enrollment)",ctrl
"D425-shOTX2_2, t=16",pert
464MM,pert
MV 1,pert
"tissue: heart;	strain: mixed background of C57BL/6, 129/sv, and Balb/c",ctrl
437MM,ctrl
Muscle PCOS case 201,pert
db/db 9-1,pert
"217, MUSCLE, Before",ctrl
Run5.aUa.010110d.SkMDbt1151D.CEL-DB stimulate,pert
>95% CD3+ T cells negatively isolated with Dynal kit from SLE patient,pert
"AG825-treated, Sham UV, Replicate D",pert
COV434 Mutant [RR1024],pert
Liver_KnockOut_2,pert
"MCF-10A cells, overexpression vector control, biological rep3",ctrl
Colon 21 days old,pert
siWTAP 2,pert
11415 UC Uninflamed ascending colon,pert
Series 1; young; 3 days,pert
344SQ with control shRNA,ctrl
"coronary smooth muscle cells (hcaSMC), treated with control medium for 72 hours",ctrl
Sample: alpha-TM180;	Replicate: 4;	Pool: P,pert
lateral hypothalamus no access to cocaine replicate 3,ctrl
cell type: Human melanoma cell line;	cell line: M249_R4;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
whole blood_101467,ctrl
IRF4-control_Th17_cells_42hr_rep1,ctrl
genotype: WT;	gender: Female;	cell type: MEF,ctrl
tissue: Frontal cortex;	age: 88;	Sex: M,pert
siRNA-140_rep1,pert
asthma_OVA24h_1,pert
15d control_Pool 7,ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 3,pert
siControl_rep_1,ctrl
Adrenal WT 0h batch 3 [AdWTh00.19],ctrl
HUVEC/NmenMC58_pilD_4h_rep3_1114,pert
MCF7 cell line_resveratrol_150mM_biological replicate 1,pert
Regulatory T-cells CD4+CD25+,ctrl
WT - Cre Control - 5 mo - repeat 3 - Cy3 - mAdbID:74102,ctrl
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate2,pert
RNA from whole tissue section of case 1405 labeled with Cy5,ctrl
"TNFa siRNA-A, replicate 6",pert
"whole ear tissue, untreated control ear",ctrl
"Endothelial control cells, passage 11",ctrl
11426 UC Uninflamed ascending colon,pert
Bone marrow from naive C57BL/6 mice,ctrl
ILD Study Number 942,pert
age: 53;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
2824 TG,pert
NoKD,ctrl
"Cadmium 0.2 µM, biological rep2",pert
HSC_Zfx-flox_Replicate2,ctrl
Pancreatic Sample 34-Tumor,pert
WT - Cre Treated - 24 hrs - repeat 2 - Cy3 - mAdbID:54726,ctrl
cells: CD8+ cells;	tissue: spleen;	strain: Elf4-/- KO,pert
"WT mouse skin treated once with acetone and collected 24 hr later, replicate 3",pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 5",ctrl
remitted schizophrenia patient  S13,pert
age: 61;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
tissue: brain;	genotype: mutant Ndel ko/+ mix background;	age: P14,pert
Bone-Marrow_MM_M1041,pert
MPM tumor specimen 26,pert
HepG2_As rep3,pert
ic 19 -- with mock APF,ctrl
HUVEC transfected with a scramble-LNA,ctrl
Bone Marrow Mononuclear Cells;	44y Female,ctrl
MPM tumor 4,pert
eNOS Knockout Mice-M4,pert
Alb69 mutant mouse,pert
strain: C57BL/6J;	cell type: MEP;	genotype/varation: ∆Hmga2,pert
tissue: Whole pancreas;	genotype: Rkip-1 KO;	background: C57BL/6;	age: 8 weeks,ctrl
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 5,pert
"Patient S-414-N, normal colonic mucosa",ctrl
Bone-Marrow_MM_M813,pert
"breast, post AFI treatment (H20_1950)",pert
Rex KO_plus LIF_rep4r,pert
primary CD4+ T cells from spleen and lymph nodes,ctrl
MCF-10A sh53BP1-1 replicate 1 [set 5],pert
4IDC_normal_ductal,ctrl
Ovarian cancer cell line,pert
prefrontal cortex (BA10);	schizophrenia,pert
WT_cells_rep1,pert
uterus_veh_WT_4hrs_rep3,ctrl
Bronchial Epithelial Cells MMA biological 2128K,pert
age	64;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	7.1;	leukocyte count (/nl)	38.3;	hemoglobin (g/dl)	14.1;	platelet count (/nl)	212,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 24h,ctrl
C2_2,ctrl
01LMN_Systemic,pert
CLL22-CD4,pert
"brain, cerebellum: RNA #5_le1",pert
"Liver, fasted, PBS",pert
CLDN18_KnockOut_2,pert
"control embryonic stem cells, biological replicate 1",ctrl
"Female (age range 33-49), skin biopsy upper nates. No nickel exposure",ctrl
gender: female;	batch: 1;	age (years): 25;	patient id: Control_2;	fev1 (% predicted): 103;	fvc (% predicted): 107;	medication: None;	cell type: CD4+ T-cells,ctrl
INSENS 4 0hr,ctrl
Normal subject 3,ctrl
cerebellum_WT_20d_rep1,ctrl
Wild-type ESCs Rep1,ctrl
SLE myeloid cells 10,pert
Clint-Dhh-2-011411,pert
resected non-tumor liver tissue,pert
High weight gainer KOZAK2_ABI_HYP_H2,pert
skin_tissue,pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 52;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Muscle 50 eccentric contractions 12 hours KO Aged 1027,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 0,pert
Recent-onset T1D_sample5,pert
control sample 2,ctrl
"Neurons overexpressing GFP, biological rep2",ctrl
patient E1709,ctrl
DS2-iPS 6,pert
DBA control (122msn),ctrl
skeletal muscle myoblast_OE_day3,pert
"RWPE1 cells, vehicle, 48h, biological rep3",ctrl
GC resistant clone C7H2-R9C10 treated for 6 hours with EtOH,ctrl
Silberg2 (S3) 23100BE,pert
BL305,pert
"IN1472 siNT treated, Biological replicate3",ctrl
"Metformin, biological rep3",pert
Liver_Wildtype_Rep3,ctrl
E14 - nudelcko/ko 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.542;	OD280: 0.787;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 62;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Karyotype: inv(14)(q11q32);	Age: 74 years;	Gender: female,pert
DN2 replicate 2,ctrl
"Normal subject (27 year old caucasian female, SAK_1276081571)",ctrl
"Normal subject (31 year old indian male, SAK_1274852149)",ctrl
44SMOKEH,ctrl
ccRCC tumor of patient T142,pert
Colon_POR-null+quercetin_1,pert
age: 49;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
H1_SS12_01Nov07,ctrl
A673_CloneAsp14_Dox_36h_3,pert
"Global gene expression of NASH patients, P62",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.793;	OD280: 0.877;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 143;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: littermate control, Atoh1-Cre;Dicer1(flox/wt);	tissue: organ of Corti from cochlea, basal half;	age: postnatal day 16",ctrl
KO624,pert
"RNA from HnRNP A1 IPs, HuR KO MEFs",pert
Proliferative Phase Endometriosis,pert
H720 MK886 1 micromole 24h serum free Sample 3,pert
Human Fresh Bronchial Epithelial cells,ctrl
Control 1 b,ctrl
ACC Xenograft X5M1,pert
13 with Cy5,pert
Pancreatic Sample 23-Tumor,pert
Bronchial Epithelial Cells control biological 1656E,ctrl
CML-BM 1,pert
Skin_Tcfap2c Mutant E16.5_rep3,pert
R6/1 22 week wildtype_OAD3,ctrl
GM8922A,pert
F1 ES Cells,ctrl
"MCF-7, 12h, sham",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.167;	OD280: 1.069;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 134;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"control mouse cerebral microvascular fragments, biological rep1",ctrl
Rybp#15 (OHT+)_4d_rep1,pert
Tobacco_abuse_6,pert
wt_P8_rep2,ctrl
"cell type: MYC positive B-cell;	transgene: MycEGFP (a Myc reporter allele, in which a MYC-EGFP fusion protein (MYCEGFP) is expressed from the endogenous Myc locus);	genetic background: C57/Bl6",pert
"Genotype: c-Myc transgenic;	c-Myc transgenic female mice displayed morphological alterations with varying degree of nuclear atypia, such as bronchiolo-adenomas and bronchiolo-adenocarcinomas. Thus, different stages of malignant transformation of alveolar epithelium were observed.",pert
harmane 1uM batch 3,pert
"Liver from MON exposed rats, biological rep 3",pert
Tendon;Brachialis_Non-lesional,ctrl
MPM tumor 20,pert
"Strain: C57BL/6, Gender: female, Age: 6-10 weeks;	Tissue: nasal-associated lymphoid tissue (NALT)",pert
Hippocampus from mouse,ctrl
RV83.02_CONTROL_day10,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: pre-UV,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVA, T4, N2, M0, G4",pert
Striatum of 8-10 week old C57BL/6J mice,pert
strain: C57BL/6J;	genotype: Cmah KO;	gender: male;	age: 2 months;	tissue: cardiac muscle,pert
prostate normal 2,ctrl
"mouse aorta cross strain comparison, C3H_T24_NC_03",ctrl
NB4 INFECTED 1,pert
SC263_CETU1,pert
"Lymphoblastoid cell lines derived from family 1734, member 2",ctrl
Methoxychlor (50uM) rep 2,pert
ILD Study Number S019,ctrl
Neuroblastoma cell line,ctrl
36SAGEA,pert
mouse B6xCF-1  Non-transgenic (control-2),ctrl
"Peripheral blood, normal control [N56]",ctrl
WT replicate 2,ctrl
wild type MEF time 2 replicate 1,ctrl
CD71+ bone marrow cells from Ifng-/- mouse 2,pert
genetic background: 129SV;	genotype: WFS1 WT;	tissue: hypothalamus,ctrl
db/db 13-2,ctrl
tissue type: Lesional skin;	time: Week2_etanercept,pert
CD8 KLF13 KO,pert
WFS1 WT USHT_07_314_ko,pert
"HepG2 cells, control, rep1",pert
U937_shSYK_1_Replicate2,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-2,pert
"Control Distal, Small Intestine 1 21 days old",ctrl
"Normal subject (51 year old caucasian female, SAK_1276014509)",ctrl
Time 180 mins rep 2,pert
CD4DecTp1-5,pert
Donor5_6h_DMSO,ctrl
ERα-positive breast tumors with PIK3CA mutation,pert
Individual_4356_PP_sample,pert
"AG825-treated, Sham UV, Replicate C",pert
SCD1 -/- liver rep3,pert
Sarcoma cell line heterozygous for Dicer,ctrl
CD8+_Tcells_severe_asthmatic_4,pert
human liver; advanced HCC,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 4;	gender: male,ctrl
HUH-YAP-#2,pert
CD34+ cells from the patient (CML35),pert
KU_20T,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep3,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 20;	age of psoriasis onset: 33,pert
29A;pretreatment;female;breast tumor; responder,ctrl
C_Kin_3,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID129,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 6 months,pert
colonic_mucosa_non_inflamed_721,ctrl
"SRF silenced, treated with R1881, biological rep 3",pert
db/db 9-2,pert
TRPM2-AS siRNA rep2,pert
FmrKO2_brain,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-tu1,pert
"PCB153 treated HepG2 cells at T0.5, biological replicate 2",pert
"fetal testis sample 21, 16 weeks gestation",ctrl
sex: Male;	Age: 47 months;	additional patient information found in Series supplementary file,pert
F348_WBS,pert
FU-OV-1+(1),pert
"genotype Cldn16 -/-, renal tissue",pert
Hippocampus_WildType_rep3,ctrl
control mice colon rep 2,ctrl
homozygous_2,pert
lung_CLP_wildtype_rep3,ctrl
RNA from HCC_31T,pert
cell type: endometrial stromal cells;	growth phase: early passage,ctrl
7 Day Mouse Leg muscle,pert
Primary neonatal keratinocytes_control_rep2,ctrl
Sham 21 replicate 1,ctrl
cerebrum_WT_4w_rep2,ctrl
disease group: osteoarthritis;	cell type: chondrocytes;	cell culture: 3-D,pert
MEF,ctrl
cerebellum_21 month,ctrl
Syracuse High Avoidance (SHA) learning rats 1,ctrl
A_Ctrl_3,ctrl
G4D_Sham_Rep4,pert
02_PAH,pert
BaF3 cell line transduced MPLW515L3 mutant grown in 0.8 uM INCB18424 for 4 wks,pert
PBMCs enriched for CD8+ cells from normal control subject C (CCD8),ctrl
subject: 32;	disease: CP;	muscle: ST;	gender: F;	age: 7.9;	gmfcs: 2;	popliteal angle: 95,pert
NTac_liver_vehicle 0 mg/kg_96 hr_3,pert
"C57BL/6 female, fasted 18h (overnight), age 4-5 months",ctrl
"tissue: liver;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: monuron 72 hr",pert
EosWTCD25+#1,ctrl
Heart dissected from E12.5 fetus with a null mutation for the Sp3 transcription factor.,pert
WT-smoke-med-5 month+13d-R2,ctrl
V5-P270,ctrl
"wdNHBE uninfected at 36hpi, biological rep2",ctrl
clone 3-1,pert
"whole brain, nicotinic acetylcholine receptor subunit mutant mice and littermate controls",pert
146_DMSO,ctrl
P14 - Lis1cko/ko 1,pert
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate1,pert
"3T3-L1 siLSD1 24h, biological rep 1",ctrl
WT liver_HFD_rep4,ctrl
8 hour tunicamycin wild type D,ctrl
A_AN16641_T,pert
sampleID: SAM630143;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"Male, 32 years old",ctrl
U133A_G3,ctrl
S4_Sham_wildtype_8,ctrl
SK-MEL-2 Melanoma cell line,ctrl
CML Patient 6 7 days therapy,pert
"Embryoid bodies, 12h,Min Dox",ctrl
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 4",pert
Human.AI.CP.ECRB,pert
293T cells stably transfected with 1 scramble shRNA construct. Control cell line for 293TsiLL cell line (LEDGF transcript knockdown - PSIP1 gene).;	,ctrl
OE Sirt1 1,pert
siUbr5 replicate2,pert
brain_OFC_control C_mr170,ctrl
siCONTROL no DNA Damage experiment 3,ctrl
G668-lcm,pert
NOD2wt_0h_MDP_biological replicate 1,ctrl
01UP6_PolyRF-,pert
"Male, 32 years old, HIV infection of ~4 months",pert
"control, BA46-84",ctrl
M833 / Reference_13425521,pert
"Female Nrf2 Knock-out mice, liver sample",pert
RORasg/sg WAT_HFD_rep4,pert
KO MEF 3,pert
WT10,pert
"Csbm/m mouse, cerebellum, standard diet ad lib",ctrl
KN-sham-2 month-R4,pert
siLMO3_oligo1_0_rep1,pert
"Wild-type HFD 8 weeks, biological rep2",ctrl
"Wild type, 6 weeks old",ctrl
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P6,ctrl
"age at diagnosis: 34;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 61;	dfs-event: 1;	distant metastasis: 0",pert
strain background: C57BL/6;	genotype/variation: IL-22-/-;	infected with: ME49 strain of T. gondii;	time point: at day 5 post-infection;	tissue: ileum,pert
HF0726_U133P2,pert
HCC1954 Cell Treated 3,pert
Stratagene reference,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50), biological rep3",pert
"Control, biological rep2 (with calcium)",ctrl
cultured human melanoma cancer cell 224,ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 24,pert
Control 1_Huh7 [HDAC2 siRNA subset],ctrl
"ID:11-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Patient M030-827T, MSI colorectal tumor",pert
primary cell culture,ctrl
Untreated diabetic-1,ctrl
Individual_5243_NN_sample,ctrl
"Rb KO, biological rep1",pert
ID: MLL_00114;	cell type: PBMC;	disease state: control,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 2",ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case3,pert
"Frontal cerebrocortex, Permethrin (1 mg/kg), 6 hours",pert
"PCOS, biological rep 5",pert
"Empty vector control, 2 hrs, No Rosiglitazone (NONE_2_2)",ctrl
adenocarcinoma (ADC3),pert
ST045849 24 hours_1,pert
HCC_6T,pert
cell type: Immortalized AR positive myofibroblast,ctrl
P19_exPKO_pancreas,pert
Wild type Retina Rep1,ctrl
"brain, hippocampus: CH5_e1_le1",ctrl
ILD_18,pert
sex: Female;	family: 3;	age: 32;	disease status: Asymptomatic;	tissue: Muscle: Deltoid,pert
"heart, atrial tissue, after CABG surgery",pert
bladder epithelial cells,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.33973,ctrl
Postmenopausal female. Untreated control. nr 17.,ctrl
Human prostate cancer primary culture C35sx,pert
normal 3208,ctrl
heart-ko-1,pert
strain: C57BL/6;	diet: MCD + HF diet mixed with 0.1% metformin (nash metformin);	tissue: liver,pert
mouse strain: C57BL/6J;	genotype/variation: AhR null,pert
CML Patient 5 7 days therapy,pert
SNB19 PARK2 siRNA#2 replicate 2,pert
brain_OFC_bipolar B_mr89,pert
01N3C: new onset sJIA,pert
18h fasted hearts,ctrl
CLL8-CD4,pert
HEK293 F5_doxycycline treated,pert
RV64.03_CONTROL_day25,ctrl
"C57BL6J-backcrossed, male",pert
normal 1050,ctrl
WA09 human embryonic stem cells,ctrl
Gender:F;	Age:45;	Tissue:Mucosa,pert
U937-shGSK3A-Construct5-rep1,pert
Ex1_cells_rep1,ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
M10KOepi_infect_0h_rep1,pert
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of saline for one week,ctrl
"GI, P.Col",ctrl
Cre_day_3-2,pert
Time:3 day; condition:ctr;,ctrl
Mouse liver (8 weeks),ctrl
SUM149_siControl_rep1,ctrl
iPSC idiopathic autistic patient triplicate 2,pert
Bronchial Epithelial Cells MMA biological 2065M,pert
PGA-RMM-8h-2aA-s2,pert
"mutant mouse embryonic fibroblast, biological rep 3",pert
Human.BP.CTRL.ECRB,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: parotid salivary gland;	donor sex: male,pert
Patient no. 16: control,ctrl
EA_Case5_CD8,pert
9A;pretreatment;female;breast tumor; responder,ctrl
OBF-1 overexpression BCS-2 (Large PreB),pert
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate2,pert
"KO total RNA LSK, rep 3",pert
Mouse spleen at 4 month,ctrl
"Normal cervix, microdissected, Age 42",ctrl
5A,pert
siNS_2h_3,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 70min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 176,pert
"Patient 13, Macroscopically intact tissue",ctrl
FVB_skin_5dpn_3,ctrl
Phan_002_WT.saline rep2,ctrl
"12 weeks normal mice, cerebrum",ctrl
"brain, cochlea: [7] Sample #7_le1",pert
MLL1-KO MEF CT30-3,pert
colonic_mucosa_non_inflamed_741,ctrl
A YOKE_B095,pert
Liver sample from Alcoholic hepatitis group (CA39),pert
N_LS_Wk12,pert
"SFM control cells (3hr), biological rep1",ctrl
"pancreas, control diet, replicate 2",ctrl
[OBF-1]-1,pert
umbilical cord_bpd: 7H,pert
NOMO-1 STK33-2077,pert
HepG2_100uM_Trovafloxacin_24hr_prep3,pert
miR122-KO-265-T,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 42 yr;	population: white;	dsm-iv: 296.64;	age of onset: 20 yr,pert
PBMC from T cell Large granular lymphocyte leukemia patient#128,pert
"cell line: HeTH-4;	genotype/variation: control;	comments: HeLa cell line with inducible THOC1-depletion, non induced",ctrl
patient: 40645;	sample: normal,ctrl
"Deltoid, FSHD, cohort 09, subject 09A",pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: Treg;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
PC3 Control Rep3,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day7,ctrl
whole tissue section from case 518,ctrl
cell type: brown preadipocyte;	genotype: Ezh2 +/+,ctrl
13SC-nbc,pert
Liver_normoglycima_no.1,ctrl
Ngn3 EB3 OFF replicate 2,ctrl
Liver_Female_CF_rep2,pert
MDS patient 119,pert
"soleus muscle, young female pathogen-free Wistar rats",ctrl
"G42 cells from Cerebellum, wild type control, biological replicate 2",ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 retrovirus,ctrl
MCF7 - Control,ctrl
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: mammary gland",pert
normal;	Adjacent pair of T18,ctrl
ApoE-/- mouse infected wtih a control adenovirus expressing GFP,ctrl
Mannitol control treated A549 human lung cancer cell cultures replicate A,ctrl
Cre_day_3-5,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
JIA PBMC Post treatment A235_L027(2),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Female,pert
age: 54;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
3514-lcm,pert
tissue: colon biopsie,ctrl
RNA from HCC_41T,pert
heart/muscle-specific MnSOD-deficient mouse (d/d),pert
Day 3 (T12),pert
"testis, Repro9 mutant, 17dpp, Rep4",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.814;	OD280: 0.932;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 137;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
lymphocytes_HD_F_50y,pert
HT29 cell line,pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB with doxycycline,pert
"granulocyte, healthy control, biological rep12",ctrl
202/4,ctrl
Dengue Fever Patient 7,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 50;	gender: male,pert
siHic5_2_4h_4,pert
strain: GNMT KO;	developmental stage: Post natal day 90,ctrl
38m1,ctrl
strain: Ola129;	cell type: Embryonic Stem Cells;	genotype/variation: Ogt silencing,pert
ESE_N_629,ctrl
21day 4OHT-treated-sample2,pert
Modified MCF10A Cells,ctrl
CD3-stimulated CD4+ T-cells from Itk knockout C57BL/6 mice,pert
MCF7 - MTDH_WT_KD_3,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 146;	time: 0;	batch: 2,ctrl
subject: 12U;	cohort: 12;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 24;	Sex: F;	batch: Batch_3,ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 1,ctrl
WT-sham-1 day-R4,ctrl
"S1P2-KO-neocortex, biological rep4 (male)",pert
"experiment I, passage 9, replicate 2",ctrl
rtTA-Dmrt5_d9_+Dox_rep_1,pert
CLL 38-11 LMP-420,pert
MEF Wild Type 3-rep3,ctrl
GIST Pre Treatment Biopsy 30,ctrl
F6.04,ctrl
"brain, frontal cortex: Sample57_e1_le1",ctrl
"age at diagnosis: 70;	diagnosis: Adenocarcinoma of breast, ductal, mucinous;	tumor grade: G1;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 1;	pgr: 1;	dfs-month: 37;	dfs-event: 0;	distant metastasis: 0",pert
"Spinal cord, saline control, biological rep1",ctrl
Postmenopausal female. Estradiol treated. Patient 36.,pert
Control peripheral blood leukocytes - Biological Replicate 1 - Technical Replicate 1,ctrl
hnf4KD_H9_d20_hepatic differentiated_1,pert
WT S49 2 h cAMP treatment,ctrl
"CD11b DC wild type, biological replicate 1",ctrl
Subject 2_t=30days_resveratrol,pert
0702-01-C-b,ctrl
P82 dilated cardiomyopathy heart biopsy,pert
OE33 Control rep1,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day4,pert
HL60-shControl-rep1,pert
disease state: healthy control;	tissue: epidermis;	age: 17;	gender: male;	treatment: untreated;	time: control,ctrl
2825 WT,ctrl
HeLa_01-04-05 TP11_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
Testis_wild type_rep1,ctrl
DP (CD4+/8+) cells from Normal Thymus Replicate 1,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T2, N3, M0, G4",pert
condition: Non-syndromic cleft lip/palate (NSCL/P);	tissue: decidous teeth dental pulp;	gender: female,pert
"control triceps, biological rep3",ctrl
CT2 vs PBS 4 hr pooled,ctrl
BV2_Curcumin_rep1,pert
3550-1 E2F WT,pert
PGA-RMM-48h-1aA-s2,pert
whole blood_100416,pert
Telencephalon WT 3,ctrl
kidney_co_6M_rep2,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: LOW;	genome/variation: PDGFRA mutation detected,pert
subject id: 80;	infection: DENV;	status: DF;	tissue: whole blood,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep1",ctrl
TB 9,pert
strain: Gata4tm1.1Sad/J;	infection: Mouse GATA4;	culture: Growth medium,pert
siERK2E224h_3493,pert
"shControl clone 1, rep2",ctrl
fibroblast cultured from normal esophageal tissue_HEF_1173,ctrl
chip number: 13;	transfection plate: 4;	target gene: IRF5;	kd level: 0.79;	rin: 9.3;	transfection date: 2011-10-17,pert
"Patient  H, lesion, time: 0",ctrl
MDS patient 148,pert
lesion_postUV_patient4,pert
chip number: 22;	transfection plate: 4;	target gene: IRF5;	kd level: 0.65;	rin: 9.1;	transfection date: 2011-10-17,pert
"NF-YC KD ES cells 96hr, replicate 3",pert
Treatment 6,pert
brain_DLPFC_bipolar C_mr540,pert
Carrier-inj_C57_rep2,ctrl
quadriceps femoris,pert
fibroblast_Rapid_D200_Media_14,pert
"cell line: MCF7;	disease state: Breast adenocarcinoma, estrogen receptor-positive;	genotype/variation: Control",ctrl
Phan_001_WT.saline rep1,ctrl
12457 Normal Inflamed sigmoid colon,ctrl
158A,ctrl
Waldenström’s macroglobulinemia (WM-PC 33325),pert
disease unaffected colon of a adult with Crohn's disease (CD),pert
Individual_5008_NN_sample,ctrl
WT S49  2h cAMP treatment,ctrl
"tissue: neurectoderm derived from embryonic stem cells;	treatment: Geminin knockdown, shRNAmir #11;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",pert
oocyte_wildtype_rep1,ctrl
HNF4loxp/-villin cre,pert
Animal 5,pert
cell type: neuron progenitor cells (NPC);	disease group: schizophrenia,pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P3,pert
AZ-521_uninduced_8h_rep2,ctrl
lucif_2,ctrl
"Wild Type, 2",ctrl
"P60_wt cones, replicate 2 [array]",ctrl
unstimulated(confluent)-2,ctrl
"Patient 113, 3 month of REBIF",pert
"vestibualr organ at P15 of Igf1 -/-, biological rep 2",pert
microdissected epithelial cells from IPMA 4,pert
"LckCre Dicer lox/lox KO, biological rep2",pert
cell type: iPSC;	genotype: healthy control,ctrl
strain: GNMT WT;	developmental stage: Post natal day 90,pert
"MEFs carrying a tet-inducible Pten transgene, 24 hrs after inducing PTEN",pert
WT HPC Veh 4,ctrl
"31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
PWD/PhJTCE liver sample batch 5,pert
Wild Type Mice fed Low fat diet 2,ctrl
"Neurons overexpressing GFP, biological rep1",ctrl
3976-3 E2F1 Null,pert
biopsy of normal esophagus from the same patient as a matched Barrett's esophagus biposy,ctrl
Carbo Day1 (370L),pert
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting KLF2,pert
Normal cortex of patient T144,ctrl
"Mmp7-/- epithelium, uninfected, 0h",pert
01J46_Systemic,pert
"human failing LV myocardium, Ischemic2",pert
01LN8_Systemic,pert
2d-sham-71,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: extensor digitorum longus;	age at biopsy: 65;	Sex: male,pert
cell type: Human melanoma cell line;	cell line: M229_R5;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
tissue: resected non-tumor liver tissue;	genotype: minor [rs8099917 TG/GG],pert
CML_3_GMP,pert
01N1R,pert
"PPARg d4, rep 5",pert
CON6,ctrl
UnInfected-3,ctrl
Hippocampus 1995 15 month Old,pert
Gene expression profiling of normal cortex of patient T79,ctrl
MS patient 7,pert
T-ALL1 NBD 2,pert
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 58",pert
"Exp A, Animal #267, 5mg/kg D-Serine",pert
ID: MLL_00111;	cell type: PBMC;	disease state: control,ctrl
HCT116 PTEN +/+,pert
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 12/1/03,pert
patient: 40656;	sample: normal,ctrl
Scd1-/- on chow diet replicate 3,ctrl
HCC013T,pert
No or early 2 rep9 (retina),pert
nucleus accumbens long access to cocaine replicate 3,pert
genotype/variation: ApoE-/-;	strain: C57BL/6;	mouse provider: Jackson labs (backcrossed >10 generations against C57BL/6 background).;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: non-diabetic,ctrl
"Muscle from WT, biological rep1",ctrl
"SUDHL-1, control repl 3",ctrl
KO - knock-out Treated - 0.5 hrs - repeat 2 - Cy3 - mAdbID:62530,pert
major non-tumor7,pert
disease state: skin squamous cell carcinoma,pert
hdh genotype: Q7/Q7;	tissue: cerebellum;	age: 3~10 weeks,ctrl
HN_119,ctrl
Spleen_ko_1m_rep3,pert
genotype/variation: Cavin-1 deficiency;	age: newborn 0-6 h;	tissue: Lung,pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 31;	maternal age: 31,pert
"treatment with BZP, replicate 2",pert
NZM12 metastatic melanoma cells treated with PAX3 siRNA,pert
liver_STZ treated diabetic_rep2,pert
4145M patient’s mucosa,pert
cell line: L8057;	cell type: megakaryocytic cells;	genotype/variation: empty vector control,ctrl
"brain, hippocampus: C72-I_e1_le1",ctrl
"Tibialis posterior, healthy control",ctrl
healthy control C1,ctrl
A375P cells expressing Control shGFP,pert
10.5 months cardiac muscle,pert
C57BL10 TA sample 1,ctrl
HCC_26T,pert
AAA neck (Sample 9),pert
CD19_selected_B-cells_after_R_rep10,pert
01UND_PolyRF+,pert
Carbo Day4 (66L),pert
MS25_3A_LV_220307,ctrl
TL3 SCR 2,ctrl
T74,pert
Time 240 mins rep 1,pert
EGF 4h replicate 2,pert
PS-NA cerebrum at new born,pert
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 49days;	genotype/variation: WT,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 38;	Sex: male;	region: M1;	age: 38;	genotype: Y/Mecp2-;YFPH/-,pert
lesion_postUV_patient12,pert
A673_CloneAsp14_Dox_53h_1,pert
EA_Case14_CD8,pert
"cells treated with Vamp7 siRNA, biological replicate 1",pert
"Age: 48;	Sex: M;	Ancestry: European;	Smoking status: smoker, 20 pack-years",pert
Whole blood,ctrl
colonic_mucosa_non_inflamed_728,ctrl
cell line: Panc-1;	transfected with: pCIG-Gli3T (expressing Gli3T),pert
Patient: O;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
cell line: Normal bone cell line 695;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),pert
MDS patient 178,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 5,pert
"SWR/J ACU, Rep1",pert
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),ctrl
01MKV_Systemic,pert
11102 UC Uninflamed descending colon,pert
erStress_twins_AA_1712twin2_DMSO_4h,ctrl
01LKT: normal control,ctrl
CD71+ bone marrow cells from WT mouse 2,ctrl
Sample 12 Kidney Normal Mouse - Low Phosphate Diet,ctrl
WFS1 WT USHT_09_332_wt,ctrl
"paraventricular nucleus of the hypothalamus, LPS, 1 hour",pert
9 olanzapine,pert
0156-01-C,ctrl
G501,pert
"SKO-transduced MEFs, Vc-, D8",ctrl
Normal-2 - mAdbID:91659,ctrl
"non-AD_TC, biological rep7",ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 26 weeks;	genotype/variation: VhlhKO",pert
GFP-kd_ES_rep1,ctrl
"breast tumor epithelium,56",pert
BALB/cByJ Vehicle liver sample batch 4,ctrl
DMN-NF1Hippo10d-2bAv2-s2,pert
"Control, biological rep. 3",ctrl
human_hepatocyte_400uM_Ciprofloxacin_donorA_24hr_prep2,pert
Pool Ts1Cje_P30_hyb2,pert
GM19238_Kd_JUND_1,pert
ethnicity: Hispanic;	Gender: Male;	Age: 31;	Tissue: primary human bronchial smooth muscle cells,pert
"Inclusion body myositis, biological rep4",pert
HMEC X BC24,pert
"Lesion Skin, LS-32",pert
H01_S_B1,ctrl
01UMW_ERA,pert
HCC_35T,pert
"Control 02, NC02",ctrl
Head RNA of littermate wild@E13.5 No.2,ctrl
transfection: scrambled transfected,ctrl
Cal51 cells,pert
RNA-DHL4-R406-24H-2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.509;	OD280: 0.793;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 58;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Gastrin Knockout parietal cell replicate 1,pert
R6/2 (untreated) 5197,pert
age: 21dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
PGA-RMM-330m-2aA-s2,pert
"SIRT7 Knockout Liver, replicate2",pert
"Control group, replicate 2 [GY_Con2]",ctrl
Liver endothelial cells,pert
Normal PBMC_sample 5,ctrl
Murine cell culture,pert
ctrl_503,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
FVB_MMTV_Wnt1_iFGFR2_3068_2L_ROSEN,pert
Kidney_Aqp11-/-_P7_5-2,pert
"TNFa-OMe siRNA-B, replicate 6",pert
remitted schizophrenia patient  S07,pert
0993-01-C,ctrl
CHB PBMC_sample 3,pert
White adipose tissue in Fsp27 knockout mice (rep1),pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.539;	OD280: 1.303;	Ratio: 1.91;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 221;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"PTEN inducible MEFs at T1 = 24hr, biological rep2",pert
SBVGA1,pert
Embryonic day 14.5 and 16.5 pancreas,ctrl
HDAC2 siRNA_2_Huh7 [HDAC2 siRNA subset],pert
Human hepatocellular carcinoma cell line infected with MIR517A and GFP protein 3,pert
lesion_preUV_patient7,pert
Strain: C57BL/6J;	Gender: male;	Age: 9 weeks;	Tissue: whole brain,pert
KOC 67 PBS treated,pert
"126 (221), MUSCLE, After",pert
4_day_old_Prnp_knockout_mouse_rep1,pert
non-targeting siRNA treated for 10 days,ctrl
HGPS-iPSC_1,pert
Gender:M;	Age:27;	Tissue: Mucosa,ctrl
Liver of pup from control group rep4,ctrl
"WI-38 cells, at 24 h after exposure to 0.5 uM BPDE, biological rep2",pert
cell line: ONS76;	cell type: medulloblastoma;	treatment: mock control;	transfectant: ONS76_si_mock,ctrl
4 STAT6KO control macrophage,pert
age in weeks: 8-10wk;	gender: Male;	strain: C57BL/6,pert
5278 UC Inflamed descending colon,pert
Bicalutamide_2,pert
LOX1 Untreated 12hr 282295783,pert
cell line: OVCA420;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
Sprague-Dawley Rat retina (male); 1d post injury,pert
"breast tumor epithelium,46",pert
2000N_1,ctrl
"216, ADIPOOSE TISSUE, Before",ctrl
"brain, frontal cortex: Sample55_e1_le1",pert
"129P3/J Saline treated, biological replicate 1",ctrl
strain: C57BL/6;	Sex: Female;	age: 3-weeks old;	genotype: WT,ctrl
murine ES cells,ctrl
Subject #8032-8hr Postinfection,pert
"GATA6 knockout, biological rep 2",pert
HMEC-I control,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case2,pert
disease state: endometrioma;	patient: M3,pert
5021-lcm,pert
Pancreatic Sample 30-Tumor,pert
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1+/+Rnf2F/FZp3-cre (Rnf2 mutant),pert
JGB-Post-1UP_Run2-S2,ctrl
01-0061A_Day1_7,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: lung;	age: 12 weeks,pert
Array Type: HG-U133A_2;	Ratio: 2.02;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
control participant P310,ctrl
"Spleen, CD4+CD25hi Tregs, Eos (Ikzf4) knockout",pert
"control, BA46-96",ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 48.72877,ctrl
BTBR_Muscle_rep2,pert
PBMCs_IS_6 [IS],pert
"Control KD, rep4",ctrl
muscle Smad4KO 1 control,pert
INS-1 cell line #1 with non-induced HNF6,ctrl
L428+M_rep3,ctrl
10N,ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 67",pert
Primary hepatocytes isolated from Donor 4 treated with Wy14643 for 6h,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 6,ctrl
"Normal Skin, Normal-6",ctrl
Panc1 rep-1,ctrl
NoKD_SerumStarved->1hrEGF_rep3,pert
Mouse Reference,ctrl
"Mouse ex-iTreg cells, replicate pool 2",pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 28;	maternal age: 28,pert
MDS patient 158,pert
"GI, D.Col",ctrl
Hippocampus_Rasgrf1KO_rep1,pert
Mock-treated SCC-2,ctrl
patient id: T84;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T4N1M1;	Stage: IV;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
D_LS_Wk2,pert
"T47D, shEGFP",ctrl
triplicate 3 of S. aureus infected HepG2 HIF-1-/- cells,pert
Normal mucosa 4,ctrl
"Mouse brain, Adult, 4hr post LPS ip injection",pert
Bone-Marrow_MGUS_G1386,pert
IFN_Gamma_6hr_rep4,pert
TA-t7; transgenic tibialis anterior 7 month,pert
individual: Control5;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"Ulcerative Colitis (30 year old black female, SAK_1286498073)",pert
J1 ES Cells,ctrl
B4 363 b4-/- untreated,pert
mouse_islets_VhlhKO_02,pert
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
high grade serous carcinoma_patient 4,pert
Strain: C57BL/6J;	Gender: Male;	Tissue: primary culture tracheal epithelial cells,ctrl
Diabetic untreated rats 3,pert
MLL_PTD04,pert
T21,pert
Bronchial Epithelial Cells MMA biological 1784N,pert
Normal cervix epithelium_03-5419,ctrl
murine ES cells overexpressing Satb1,pert
sepsis patient #19,ctrl
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G with 0.1% quercetin diet for 14 days,pert
Hunk Knock-Out rep 3,pert
tissue: white blood cells;	age: 12.35;	Sex: female,pert
Extract:LOX-1:113203;	Extract Description:GFP_Untreated_2hr:113203;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:2.09;	Quality: Background Mean Dev.:0.23;	Quality: Absent (%):59.1;	Quality: Absent (%) Dev.:0.66;	Quality: Scaling Factor:0.68;	Quality: Scaling Factor Dev.:0.6;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113203;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295493,ctrl
"MOLM-14 cell line, transduced with shSYK_2 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
kidney_QH2_14M_rep1,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 74,ctrl
Macrophages derived from pheripheral blood,ctrl
"MGSKO, PR02M007v0",pert
optineurin expression-a03,pert
INS-1 cell line (FLP-In T-REx clone #1-1.2),ctrl
mouse liver D3,pert
"cultured human airway smooth muscle, no treatment, replicate 1",ctrl
cell line: MCF10A;	transduction: Empty vector,ctrl
Pancreatic Sample 17-Tumor,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: untreated,pert
MOLM14_shSYK_1_Replicate2,pert
48h_RA3,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6.4;	colon weight (mg): 162;	colon ratio (mg/mm): 2.53;	myeloperoxidase activity (u/mg): 0.815;	tissue: colon;	treatment: 5% DSS,pert
none provided,ctrl
tissue: retina;	age: postnatal day 4;	genotype: wild type,ctrl
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
17beta estradiol: 0 pM,ctrl
human endothelial cells isolated from postmortem dorsolateral prefrontal cortex,ctrl
Extract:LOX-1:113301;	Extract Description:GFP_Untreated_6hr:113301;	Quality: Classification:Medium;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.52;	Quality: Background Mean Dev.:1.13;	Quality: Absent (%):61.55;	Quality: Absent (%) Dev.:2.56;	Quality: Scaling Factor:0.77;	Quality: Scaling Factor Dev.:1.36;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113301;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295593,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 0,pert
PC-3 cells,pert
N26,ctrl
KN-smoke-med-1 day-R1,pert
adjacent non-tumorous liver,ctrl
cell line: DBTRG;	treatment: 10 uM Y15;	cell type: glioblastoma cancer cell line,pert
"heterozygous, control, biological rep1",pert
Invasive cancer originating in IPMN 1,pert
hippocampal tissue from cbp+/- mice (standard cage),pert
strain: C57BL/6;	tissue: heart;	genotype/variation: WT;	age: 6-weeks old,ctrl
TIG3 diploid lung embryonic fibroblasts,pert
condition: Normal;	patient: N_LJ_10;	tissue: Normal skin biopsy;	kit: Affy,ctrl
SLE myeloid cells 8,pert
23d tg6,pert
HUVEC/NmenMC58_WT_1h_rep1_1102,pert
"control, BA10-59",ctrl
"48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
liver control mouse,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 6 weeks;	Treatment: untreated,pert
MLL_PTD02,pert
duration of untreated disease in month:0.6;	age at onset:5.5,pert
Six week old male C57BL/6 mouse.,ctrl
mouse cerebellum at P30 knockout 2,ctrl
Gender:F;	Age:44;	Tissue: Mucosa,ctrl
HMEC X Hs578t,pert
WT STR PDE10i 10,pert
iFGFR1 mammary gland not treated,ctrl
Cell culture. A549 treated by MK886 2,pert
non-CF subject 36,ctrl
Calu-3_Scr_control,ctrl
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep4",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 8 hrs AP20187,pert
mouse embryonic stem (ES) cells,ctrl
S9C Sporadic-hippocampus,ctrl
strain background: (BALB/c x C57BL/6J) F1 obtained by breeding heterozygote mice(+/-) with a C57BL/6J and BALB/cA background;	genotype/variation: wild type;	age: adult;	gender: male;	tissue: hippocampus,ctrl
Normal mucosa 2,ctrl
Intima media,ctrl
HCT116 non-recombinant clone 24 (STAG2 wild-type),ctrl
CD4DecTp2-2,pert
BP patient 81_biological replicate 1,pert
renal_vesicle_Lim1_mutant_2,pert
"pancreas, control diet, STZ injected",pert
T40728,pert
"human failing LV myocardium, Idiopathic23",pert
initial tumor increase/(-)decrease: n/a;	kit mutation: unknown;	tissue: GIST Tumor,ctrl
WT White adipose tissue (WAT)_HFD_rep3,ctrl
"BOEC, normal 12",ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 7,ctrl
gender: male;	strain: C57/BL6;	tissue: heart;	genotype/variation: KLF15-null,pert
sample: #18;	subject: PD case #3;	brain: T-3321;	age: 77;	sex: Female;	region: Inferior olivary nucleus,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: none,ctrl
Strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue:  gallbladder,pert
blood_day6_patient7,pert
WT_cells_rep3,ctrl
Liver WT ND #686,ctrl
PGA_MI_nilv_8w_332,pert
MB231 con-SCM,pert
Cervical cancer_1907T,pert
"gender: Female;	age: 97;	post-mortem delay: 3.5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 6",ctrl
Genotype: Taf7l knockout;	Strain: C57BL/6J;	Age: 8-weeks,pert
"treatment with MDBP, replicate 2",pert
gender: male;	strain: CBA/C57BL/6;	genotype/variation: wild type;	tissue: colon cancer tumor,ctrl
V5-P584,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 2,ctrl
Ishikawa_Control_8h_rep4,ctrl
Rosi-treated diabetic-5,pert
8 wk old male C57BL10 gastroc,ctrl
"gender: Male;	age: 71;	post-mortem delay: 6.5h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"human failing LV myocardium, Ischemic74",pert
Healthy control 3,ctrl
Raji_mi-Ctrl_1,ctrl
tissue: temporal lobe;	strain: 129SV;	genotype: WT,ctrl
Individual_4257_PN_sample,pert
Naive (control) #2,ctrl
A1_C1_nasal_stem_cell_rep1,pert
"G42 cells from Cerebellum, Mecp2 null, biological replicate 1",pert
Kidney_50 mg/kg VCM iv_mouse #010,pert
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
20A;pretreatment;female;breast tumor; responder,ctrl
NK_cell_pool_melanoma_M03+M04,pert
GIST_PDGFRA_10,pert
RV16;	Age = 21;	Sex = F,pert
BP16,pert
disease state: paediatric glioblastoma;	age: 7;	gender: M;	h3.3_status: wt,ctrl
Primary hepatocytes isolated from NMRI mouse strain treated with DMSO for 24h,ctrl
WT-Fibr2 3,ctrl
WT2 naive CD8 T cells,ctrl
Un-stimulated CD4+CD25+high regulatory T cells from PBMCs,pert
Mnk_3137-T-B,ctrl
"HEK293T human embryonic kidney cells, Wnt3A, si-control",pert
4h 4OHT-treated-sample3,pert
Liver sample from Alcoholic hepatitis group (CA77),pert
non-malignant FTEb_patient 5,ctrl
background strain: B6/129;	genotype/variation: mir-122 knockout;	age: 11 Month;	tissue type: Tumor,pert
Adult 7d SNI; Biological replicate 1,pert
MDS patient 74,pert
RNAi -Transgenic replicate 13,pert
cell line: CL-0;	transfection: YWHAZ vector,pert
Germinal center B-cells,pert
cell line: BT474;	cell type: breast cancer;	lapatinib sensitivity: lapatinib-sensitive;	her2 status: HER2-positive;	treatment: DMSO,ctrl
Patient 3 after folic acid,pert
Tendon_non-lesional_rep19,ctrl
CA97-14A,ctrl
Individual_511_PP_sample,pert
"schizophrenia, BA46-7",pert
Genotype: Rb null MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,pert
A549 cells EGF stimulated,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T1, N0, M0, G4",pert
"control, BA46-105",ctrl
Gene expression profiling of Phgdh knockout embryo wild4,ctrl
"fibroblast, wild-type, untreated, biological replicate 3",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 9.883;	Ratio: 2.1,pert
Diagnosis: AML M4;	Age: 53y ;	Gender: Male;	Blast %: 65;	Source: BM;	Cyto: No Data;	FLT3 ITD: No Data;	FLT3 TKD: No Data,pert
subject: 35;	disease: CP;	muscle: ST;	gender: M;	age: 5.9;	gmfcs: 5;	popliteal angle: 130,pert
WT 0h TPA rep2,ctrl
Parkinson's disease sample x118,pert
"Tumor sample from patient with p53 mutant, replicate 3",pert
SA_291,pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 100;	Usage number: 4;	Exposures: 3,pert
human bronchial smooth muscle cell_VitD_100nM_24h,pert
HepG2-control-3,ctrl
uterus - Mid secretory endometrium from patient with  endometriosis,pert
Sex: female;	Age: 14;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
3 Ctrl 3,ctrl
array 3 plus E,ctrl
MCF10A 7days,ctrl
"kidney, QH2, 6 months",pert
HCC_5T,pert
AhR-KO1 melanocytes,pert
"Gender: Female, Age: 28, BMI: 30, Tissue: luteinized cumulus cells",ctrl
brain_healthy_control_sampleid_jg1745,ctrl
MDA-MB-231-ZNF217 cell culture 1,ctrl
"0mg/kg/day PFOA, Rep 2, Block 1 liver (high dose)",ctrl
age: 40;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
non-CF subject 35,ctrl
A673_CloneAsp14_Dox_96h_1,pert
genotype/variation: Cyp27b1 flox/flox;Cre+;	tissue: breast tumor;	genetic background: FVB,pert
Individual_3140_PN_sample,pert
cell line: prostate cancer cell line LNCaP;	genotype/variation: MYB siRNA,pert
"Healthy control, biological rep4",ctrl
H20_S_B2,pert
Prostate Cancer_MS 36D8,pert
INSENS 6 4hr,pert
"human failing LV myocardium, Ischemic84",pert
MCL_IGHV_MUT (R1629),pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 62;	gender: male,ctrl
"patient 14, baseline",ctrl
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 2,pert
IkkβF/F_replicate2,ctrl
murine total uterus,ctrl
Retina homozygous KO 42 days 3,pert
8 Week Heart Control rep 1,ctrl
HCC_14T,pert
NOMO-1_ZFX-SH3,pert
PND28 Rat Testis_Rat230-2_3hr MEHP_Animal#49_04005,pert
MDS patient 16,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep5",ctrl
"Peripheral blood, patient without recurrent events [N30]",pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 26;	gender: male;	years of disease: 1 y;	treatment: phototherapy;	time: mid-UV,pert
LIVER_CONTROL_repl5,ctrl
"wild-type DP cells, biological rep 2",ctrl
SENS 7 4hr,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 71;	age-at-onset: 65;	geographical origin: Porto,pert
Cdx2_E1,ctrl
APOE_KO_RAGE_KO_DM_9W_10,pert
Normal cortex of patient 233,ctrl
cell type: Human melanoma cell line;	cell line: M229_R5;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
patient: 51084;	sample: normal,ctrl
"Cadmium 0.2 µM, biological rep4",pert
"UACC903, 48h treatment with 5 AzadC",pert
NOMO-1 STK33-2081,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 3,pert
"Primary aortic endothelial cells, Non_transgenic_control_2",ctrl
siERK2E24h_2652,pert
MDS22,pert
Panc0504 rep-1,pert
MLL_00127,pert
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 1,pert
Preglaucoma control rep10 (OHN),ctrl
"Gender: female, Age: 39 years, Tissue: VIN 3",pert
Healthy-3 baseline,ctrl
Lung from SM22-dnBMPR2 inducible transgenic females activated 8 weeks,pert
"129P3/J Saline treated, biological replicate 2",ctrl
M238_A_PLX,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.93;	choa: 184;	fata: 14;	eea: 1070;	wtkg: 62.6;	perfat: 33.6;	lbm: 38.9;	fat_mass: 2103.36,ctrl
Postmenopausal female. Tibolone treated. Patient 32.,pert
cell type: CD4+CD25+;	strain: C57BL6;	genotype/variation: fl-DNMT1/Foxp3cre,pert
colon_adenoma_1115,pert
"Lesional ear skin from K14-Areg mouse, biological replicate 3",pert
"Liver from control mice, biological replicate 3",ctrl
patient: 428;	disease state: LGSC;	component: Invasive,pert
Wild-type ESCs Rep2,ctrl
Aorta-APOE-deficient and vitamin E treatment-rep1,pert
WT2-iPS 3,ctrl
mouse cerebellar granule cells knockout 3,pert
"patient 11, arm treated with pimecrolimus",pert
strain: SW129/C57BL/6J  cells;	genotype/variation: c-jun knock out;	cell type: B-lymphoid,ctrl
Patient: K;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Wild-type HFD 8 weeks, biological rep6",ctrl
H441 transfected with scrambled siRNA 2,ctrl
Cont subject 10,ctrl
57A;pretreatment;female;breast tumor; responder,ctrl
11103 UC Uninflamed descending colon,pert
wild type MEF time 48 replicate 1,ctrl
cumulus_PCOS_Obese_rep7,pert
"BL from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
tissue: arterial;	status: unruptured aneurysm,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-sp3,pert
PBMC_C2,ctrl
b76,ctrl
"S1P3-KO-neocortex, biological rep3 (female)",pert
Hippocampus 1986 15 month Old,pert
"p38alpha knock out fetal liver E15.5, biological rep3",pert
WT #179,ctrl
Liver sample from Alcoholic hepatitis group (CA45),pert
CON20,ctrl
"liver, ctrl mice",ctrl
Bone marrow CD34+ cells,pert
cell line: HEK293T;	transfection: si-TNIK;	induction agent: Wnt3A;	induction time: 4 hours,pert
cell line: MLL-AF9 AML cell line 10980 (Zfx wt);	treatment protocol: +OHT;	genotype/variation: wt,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.701;	OD280: 1.82;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 354;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 49;	maternal age: 36,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: Vemurafenib 1000 nM for 72h,pert
chip number: 18;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.83;	rin: 9.3;	transfection date: 2012-03-26,pert
WT White adipose tissue (WAT)_HFD_rep1,ctrl
Sex: female;	Age at operation: 85 years;	Site: lower arm;	Size in cm: 11x8x4;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
patient: 51677;	sample: tumor,pert
liver_Akt1+/-_female_35wk_rep4,pert
H_Ctrl_3,ctrl
WT_MEF_rep2,ctrl
G_Ctrl_2,ctrl
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 18.2, Strain:DBA/2J",ctrl
mouse B6xCF-1  RNAi transgenic,ctrl
Bone-Marrow_MM_M1111,pert
3381-scrape,pert
cell type: embryonic stem cells;	genotype/variation: control,ctrl
Squamous cell carcinoma 007,pert
E12 ko.2,pert
microdissected breast cancer cells from case 1368,ctrl
Placenta_PE(EO)4,pert
PKBa-/- MEF time 6 replicate 2,pert
"Rad21 esiRNA, biological rep1",pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L027,ctrl
Run1.a10a.000607jd.2.SkMNor918.CEL-IS stimulate,pert
nmMLCK-/- -SB replicate 3,pert
OCI-Ly1_sictrl,ctrl
rat heart,pert
umbilical cord_nobpd: 7D,ctrl
Normal-N_LJ_5,ctrl
Muscle Tro3,pert
"Scd1 knock out mouse, Harlan Teklad TD03045 diet, liver",pert
HC-WT-23B,ctrl
8 week old H3f3b WT,ctrl
HGPS-fib_2,pert
tissue: white blood cells;	age: 11.58;	Sex: female,pert
WT B,ctrl
"schizophrenia, BA46-44",pert
WT mice fed with a HFD for 6 weeks,ctrl
"20 days old prosaposin knockout mice, cerebrum",pert
"Deltoid, control, cohort 20, subject 20U",ctrl
Papilloma_tumour_epithelial_cells_Sox2cKO_rep2,pert
RNA from microdissected breast cancer cells from case 295 labeled with Cy5,pert
liver_co_14M_rep1,ctrl
Untreated Jurkat cells (replicate 3),ctrl
NL E,ctrl
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50), biological rep3",pert
MDS patient 91,pert
strain: MBT/Pas;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: non-infected,ctrl
JGB-Pre-1UP_Run2-S2,pert
MCF10A_HER2_1,pert
BE-rep10,pert
kidney tissues from lean rats on control diet,ctrl
Control_Time_0_1,ctrl
Frontal cortex brain tissue from HIVE patient,pert
"testis wt, 14dpp, Rep2",ctrl
GV oocyte_Rnf2 mut_rep1,pert
brain_DLPFC_bipolar C_mr418,ctrl
"Human lung carcinoma H1299 cells (p53 null, no p63 expression) Tet-on",pert
HUVEC_1h_rep2_1107,ctrl
"CD4+ splenocytes at 6h, biological replicate 1 sham-5",ctrl
"siTERC-BMSCs, biological rep3",pert
DC2 AM,pert
S259A-2,pert
"Age: 45;	Sex: M;	Ancestry: African;	Smoking status: smoker, 24 pack-years",pert
"MCF-7 cells, siCtrl treatment 60h, 10 nM E2 for 4h",pert
lesion_midUV_patient8,pert
KM_009N,ctrl
"MGSKO, PR03M007v0",pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: none,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case4,ctrl
"seminoma specimen, pT2, patient age: 45y",pert
24h PTD-DRBD GAPDH siRNA (SAMPLE 9),pert
siSPDEF_3,pert
"Cell type: neuronal, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h",pert
gender: Male;	age: 72;	post-mortem delay: 12h;	ph: 6.8,ctrl
P1 mouse eyeball extracted total RNA_wt2_GSM618316,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.70685,pert
microdissected breast cancer cells from case 1419,ctrl
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: shKDM4C construct 1,pert
23: FCHL patient #99-0562,pert
monocytes_Q10H2_3,pert
Bronchoalveolar lavage cells,pert
"Cultured ovarian cancer cell line DOV13, untreated",ctrl
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep3,pert
strain: 129SV;	gender: male;	genotype/variation: SIRT4 KO;	tissue: liver,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 72 hours;	agent: ozone;	exposure dose: 0.3 ppm O3;	test article cas no: 10028-15-6",pert
Individual_3937_PN_sample,pert
Liver from a 24 month old Myc heterozygous mouse,pert
db/m 8wk 3,ctrl
neuron_rep16,ctrl
"shKDM4C 2, clone 2, rep 1",pert
"age at diagnosis: 39;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 0;	pgr: 0;	dfs-month: 15;	dfs-event: 1;	distant metastasis: 0",pert
OV1002 Control Day0,ctrl
CD-45-un2,pert
C7 Control None,ctrl
patient: 40977;	sample: normal,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 21.8274,pert
V5-P391,pert
STAT3-deficient naïve T cells stimulated for 3 hours with medium alone 1,pert
phenotype: alcoholic;	gender: female;	case_id: 327;	age: 59;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 19.5;	brain ph at time of freezing: 6.63;	labeling_batch: 1,pert
INSENS 1 0hr,ctrl
HUVEC cell culture,pert
PPC1_CBFbeta shRNA replicate 2,pert
Control Day14 (457L),ctrl
Cadherin-11 siRNA (RNAi 4A)_1of2,pert
HCC_9T,pert
WT mouse liver after 16 hrs fast,ctrl
cell type: Primary hepatocytes;	strain: SV129;	agent: Wy14643;	time: 24h;	gender: Male;	age: 4 months,pert
EB_2_24h_212_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
pooled 4 -1.0 square centimeter rat skin excisions,ctrl
Cutaneous psoriasis without arthritis PsC 15,pert
Individual_4288_NN_sample,ctrl
mouse intestine pLagl2 knockout 3,pert
condition: Psoriasis;	patient: PS-E;	tissue: LS skin biopsy;	kit: Affy,pert
"patient: 209;	current medication: AZA 150mg/d, Mesalazine 800mg TDS;	birth date: 3/27/80;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 10/15/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/15/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
control retinal progenitors,ctrl
"A673 treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50), biological rep3",pert
TF_1_shTRAF6_d2.5_rep2,pert
AVC_control_rep4,ctrl
pt. HCL F treated with Vemurafenib 1000 nM for 48h,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: A,ctrl
brain_DLPFC_bipolar B_mr943,pert
race: caucasian;	age (years): 75;	stage: IB;	grade: 2;	histology: endometrioid,pert
25 weeks male,pert
HA01-57B,pert
parental Ainv15 ESC differentiated as EB for 10 days,ctrl
N40728_rep,ctrl
V5-P296,pert
ns DHT 2,ctrl
BC-036,pert
AL Chip#47,pert
IM CD34+ Pool I,pert
WTGFP QSC Biological Rep.3 Technical Rep.1,ctrl
"Patient H-c661T, MSI colorectal tumor",pert
Neurons overexpressing Hes1 and GFP,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_10 months_replicate 1,pert
Bronchial Epithelial Cells MMA biological 0667E,pert
sample: #10;	subject: Control case #4;	brain: T-779;	age: 76;	sex: Female;	region: Inferior Olivary Nucleus,ctrl
Clinically localized primary prostate cancer P1,pert
Gene expression profiling of normal cortex of patient 324,ctrl
Mid Secretory Phase Normal,ctrl
Rejecting allografts 7 days No.1,pert
PTEN25+_rep1,pert
"seminoma specimen, pT1, pN1, patient age: 42y",pert
FVB_6h_Wy,pert
Human Acute HIV Sample A064-CD4+ T cells,pert
TTP_KO_0ActD_BioRep3,pert
patient: 23;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
wtPrE serum 3,ctrl
"E18.5 brain, wild-type, rep 1",ctrl
LCL Concordant for Epilepsy twin pair 3 (CCE3.1)(TP35),pert
CD3-stimulated CD8+ T-cells from Wt C57BL/6 mice,ctrl
"Hdh knock-in embryonic stem cells, Q50 line, biological replicate 2",pert
2IDC_normal_ductal,ctrl
EBS_4,pert
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 1;	age: Post natal day 3-4,ctrl
tissue: Biceps muscle;	patient: P.b.2;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
Liver_Control _Rep2,ctrl
HW_453,ctrl
wild-type E18.5 mouse,ctrl
Mammary Gland,pert
Human prostate cancer primary culture C45,pert
MDS patient 46,pert
NonIR-KO_Rep3,pert
Control subject 102_biological replicate 2,ctrl
WKY20-3,ctrl
Mouse RSK2 mutant mandibular molar [ABH_26A],pert
Nod2-/- 3,pert
Diseased individual (ulcerative colitis) of twinpair #6,pert
"Amniocytes, euploid, 1561",ctrl
Hippocampus_Soman_3h_rep2,pert
MDS patient 153,pert
RPE65_KO_2months_retina1,pert
"liver, SCD-/-",pert
"Wild type, 2 month old male mice parietal cell",ctrl
Muscle PCOS control 3,ctrl
T21_2,pert
"breast, post AF treatment (H24_2259)",pert
shRNA4-1-noDox-rep1,pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 5 months;	genotype: Myc heterozygous,pert
Bronchial Epithelial Cells MMA biological 1765J,pert
"0mg/kg/day PFOA, Rep 1, Block 5 lung (low dose)",ctrl
E12.5 heart_Sp3 knockout_sample b,pert
"Control cells, rep2",ctrl
"CA1, parental control SOX7 HESC- clone1",ctrl
KU_38N,ctrl
G93A mouse 1266,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: female;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 201,ctrl
day: d00;	strain: C57BL/6;	genotype: KO;	experimental run: e0,pert
LSK cells from heterozygous JAK2V617F mouse rep2,pert
BM_postTherapy_IIb,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 18 weeks;	genotype/variation: control",ctrl
RatLung_H3h_3,pert
"AZ521 dnSox2 cells, induced, 8h",pert
"12 weeks old PS-NA mice, cerebellum",pert
Normal_MS 36D5,ctrl
NoKD_rep2,ctrl
transfected with YAP-specific siRNA,pert
"Normal Skin, Normal-19",ctrl
mouse liver,ctrl
H441 lung cancer cells,ctrl
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 8 months;	tissue: liver;	disease status: healthy,ctrl
LY2 SRC1-siRNA tamoxifen treated rep1,pert
"ARD531, CAIS, F, GOF, 6 x 100nM DHT, 14d",pert
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: TGF-alpha,pert
"Mouse stable invitro iTreg cells, replicate pool 1",pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 46;	gender: male;	tumor grade: IV,pert
OSCE-8T,pert
8 wk old male mdx diaphragm,pert
Peripheral Blood,ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 7,pert
CRC_nodrug_M4870,ctrl
53 year old male,ctrl
"breast tumor epithelium,1",pert
MPA 5,pert
CON 2,ctrl
Subject #8042-8hr Postinfection,ctrl
"nTreg Foxo1 KO, rep1",pert
"cochlea at P60, ko, biological rep 3",pert
"heart of mouse, 4 week control (4B)",ctrl
sample F term homo,pert
patient id: 265;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 43;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
FHCRCAML2852,pert
Dermal fibroblasts from DBA patient,pert
1705-383_16hr,pert
genotype: wild type;	cell type: FoxP3+ Treg,ctrl
Tissue: HepG2 Cells;	Gender: male;	Source: ATCC,ctrl
Lrp5 Retina Rep1,pert
disease state: healthy control;	tissue: epidermis;	age: 67;	gender: male;	treatment: untreated;	time: control,ctrl
"Wild Type, 3",ctrl
LT-HSCs of LRF knockout mouse,pert
Tendon_lesional_rep23,pert
"human failing LV myocardium, Idiopathic8",pert
gender: female;	age (years): 43;	evolution time (years): 7;	disease extension: Pancolitis;	treatment: Azathioprine,pert
CCRPKO-PB_rep-3,pert
cell line: MCF7 breast cancer;	treatment: RL silenced,ctrl
V5-P592,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5b;	flt3 status: WT,pert
CD8_T_cell_pool_healthy_H09+H10,ctrl
"brain, hippocampus: KA-72h-P15-I_e1_le1",pert
PGA-MPF-C57-bleo-24h-2aAv2-s2,pert
sample A 18.5 homo,pert
"Acute Myeloid Leukemia, sample 42",pert
diagnosis: systemic lupus erythematosus (SLE);	tissue: blood,pert
"GNMT knockout at 3 month age, biological replicate 5",pert
Substantia nigra PD rep9,pert
strain/background: C57BL/6;	genotype: Pb-Cre4;PtenLoxP/LoxP;	tissue: anterior prostate;	age: 12 weeks,pert
SLE1-TC,pert
07R065 RA,pert
miR122-KO-90,pert
E10.5 wt.1,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID66,ctrl
"Control Day 3, biological rep3",ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation. At the end of the treatment, drug level in the plasma was assessed by Tandem mass Spectrometry LC- MS/MS.",pert
"gender: Male;	age: 41;	post-mortem delay: 8h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
CLL cells,ctrl
Normal-ERα-positive breast cancer 64,ctrl
695-EV_4hr,ctrl
PEC control - replicate 2,ctrl
SLE3-TC,pert
NOD2-L1007fsinsC_0h_MDP_biological replicate 2,pert
RI45,pert
"P116 ZAP70 negative  0 hours, #3",pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep4,pert
shNANOG_8,pert
"Atria, Mutant, biological replicate 1",pert
patient id: 42;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 45;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0M0;	Stage: II;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
ALI patient #3,pert
Healthy CD4+T cells 5-PS,ctrl
whole blood_100476,pert
Normospermic individual: Sample N11,ctrl
HMEC X HB2 (0164),pert
"Ulcerative Colitis (27 year old caucasian female, SAK_1286587485)",pert
myoblast_treated_rep3,pert
C5_pitM,ctrl
heart female CVD3 10 dpi rep3,pert
Nonspecific siRNA,ctrl
affected status (disease state): IS patient;	gender: male;	age-at-examination: 46;	age-at-onset: 45;	geographical origin: Mirandela;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
"Patient 30, Atheroma plaque",pert
patient id: 26;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 77;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
MCF-7_parental_cell_rep_2,ctrl
THP1-shGSK3A-Construct6-rep2,pert
Disease_status: Healthy control;	Age (years): 68;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.3;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
3416-lcm,pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
liver_QH2_14M_rep2,pert
HCC016N,ctrl
2965M patient's mucosa,pert
Myeloid cells pooled from 2-3 7 week old wild type mice,ctrl
Patient: O;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
cell line: SC263;	treatment: PBS,ctrl
sirna: NT control;	cell line: TOV112D;	cell type: Ovarian cancer cell line,ctrl
F9 con sample #2,ctrl
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
"Sample Type: tissue, Tissue: testis",ctrl
U-87MG-PK7 set 1,pert
4 hr KLF4 Time Course Control,ctrl
48h_c3,ctrl
Muscle PCOS 25,pert
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep1",pert
"KO total RNA LSK, rep 2",pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 75;	Usage number: 1;	Exposures: 4,pert
"Heart, KO2",pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 2",pert
BALB/c_PBS Replicate 3,ctrl
S-IIP(UIP)9_Cy3,pert
WT_4,ctrl
Patient: I;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Splenic CD11b+Gr-1 high cell populations,ctrl
Hematopoietic Stem Cells,ctrl
Braf 3,pert
Control Endometrium Endothelial Cell_036.UC209+-,ctrl
KU_03T,pert
MDS patient 44,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.89;	choa: 197;	fata: 43;	eea: 1380;	wtkg: 61.8;	perfat: 26.9;	lbm: 43;	fat_mass: 1662.42,ctrl
CML_7_GMP,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant4],pert
patient code: 91;	gender: Female;	age: 51;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,pert
PsOEt-16-Week 12,pert
tissue: minor salivary gland;	disease status: moderate SS,pert
"human failing LV myocardium, Ischemic79",pert
NB4 INFECTED 3,pert
Mouse_Retina_P7_Control 2,ctrl
MCF-7 +scrambled siRNA + vehicle rep1 (MD31),ctrl
Primary hepatocytes isolated from Donor 1 treated with Wy14643 for 6h,pert
Calu-3 human lung epithelial cells,pert
SKI-DLCL cells_AraC 20nM_24h_rpt3,pert
"Cell culture. A549 treated by MK886, control 1",ctrl
cell line: HCT116;	shRNA: CDK19;	treatment: low glucose,pert
"Cerebral Palsy, Gracilis, Patient Replicate 10",pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, mock (24h post-infection)",ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 2,ctrl
MCAD + LPS 3,pert
Liver_WT_Vehicle_Rep2,ctrl
NIXKO6 SPLEEN,pert
Gnmt_WT_1,ctrl
wt_P8_rep3,ctrl
Knockdown Cell Replicate 1,pert
SUM149 cells transfected with siGENOME Non-Targeting siRNA Pool (control siRNA),ctrl
E12.5 Vax2-/- 1,pert
17: NORMAL #99-0160,ctrl
1065-03-C,ctrl
817PBMC,pert
PS_IB_3_asian_lcm,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.15;	OD280: 0.539;	Ratio: 2.03;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 217;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"LCL GM19238, Kd NFE2L1, 72hrs",pert
"NeuroD1 cKO at ZT6, retina",pert
gonadal WAT of five wild-type mice,ctrl
Basal IFE epidermal stem cells from WT mice 3,ctrl
"0mg/kg/day PFOA, Rep 4, Block 4, liver (high dose)",ctrl
Ishikawa_Control_24h_rep4,ctrl
COP DES-treated replicate 2,pert
"strain background: mixed C57BL/6, FVB, 129 background;	genotype/variation: BrafV600E::Pten-/-::Pdk1-/-, Pdk1 knock out;	tissue: tumor",pert
LT 342 +/T untreated,pert
WI-38 cells exposed to 0.1 uM BPDE for 24 h,pert
Colo-205 cell line,pert
BALB/DBA F1 mouse untreated control,ctrl
SKM-Tg,pert
db/m 1-2,pert
"Transgenic, snap frozen, tibialis anterior muscle, 7month age animal",pert
KM_025N,ctrl
"vestibualr organ at P90 of Igf1 -/-, biological rep 3",pert
Normal PBMC Sample 2,ctrl
"brain, hippocampus: C240-II_e1_le1",ctrl
Alveolar type 2 cells_control,ctrl
"brain, hippocampus: KA-240h-P15-II_e1_le1",pert
V5-P092,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Good-responder).,ctrl
control replicate 1,ctrl
Mannitol_2,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 8",pert
sex: Male;	family: 5;	age: 38;	disease status: Affected;	tissue: Muscle: Biceps,pert
Injured 30 day Rat Retina 1,pert
Sprague-Dawley Rat retina (male); 30d post injury,pert
211/0,ctrl
"twin pair: #1;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
cell line: KYSE180;	cell type: squamous cell carcinoma,pert
MSE_N_M153,ctrl
02 PLUS OHT 1,pert
"ES cell control, RNA 298",ctrl
Series 3; old; no fracture,ctrl
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 25+29=54;	Sex: male;	region: M1;	age: 38,41;	genotype: Y/X;G42/-",ctrl
"Primary aortic endothelial cells, transgenic_PPARG_V290M_3",pert
09SAGEA,pert
MDS patient 83,pert
"U373-DTX1-myc, rep 1",pert
WT_M_2,ctrl
C57/BL,ctrl
A549 AZA 1 uM (3212),pert
Normal mucosa 13,ctrl
"Brain tissue from Fisher 344 male rat, Animal #255, 200mg/kg D-Serine",pert
age_years: 73;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
C57Bl6N Mouse;	gd17.5 fetal heart,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 8",pert
BT-20 cells,ctrl
genotype: C57BL/6;	gender: male;	age: 10 weeks;	tissue: Liver;	diet: chow diet,pert
BL Day 1 siSC transfected biological rep2,ctrl
siCITED1#3 replicate2,pert
SF539 PARK2 siRNA#2 replicate 1,pert
mRNA from A549 Static Control 1hr Jan 31 2003,ctrl
MEF.FHL2mutH,pert
NLGN1_4,pert
RA5,ctrl
"human failing LV myocardium, Idiopathic38",pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 2;	age: Post natal day 3-8,pert
siCtrl_FM_rep1,ctrl
469MM,pert
112 Day Mouse extraocular muscle,ctrl
Cavin-1/PTRF KO #235,pert
129 mouse pineal gland tissues taken at postnatal day zero.,ctrl
GB 3 65A +LPA,pert
non-malignant FTEn_patient 5,ctrl
PGA-HMO-NonObese-7aUA-s2,ctrl
CD19_selected_B-cells_before_R_rep1,ctrl
"Uninvolved Skin, NS-20",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day7,ctrl
"LCL GM19238, Kd CLOCK, 72hrs",pert
monocytes_T0_rep2,ctrl
AKT_PLACEBO_12hours_5,pert
2-WT_RD1b,ctrl
Trib1 #2 Wild-type macrophages were treated with LPS,ctrl
patient: 40977;	sample: tumor,pert
4-ONS76 Mock_a,ctrl
Wild type fetal lung dpc 18.5,ctrl
11392 Normal Uninflamed descending colon,ctrl
"NALT infected with 90-226att, 24h, biological rep3",pert
"IKK2 -/- cell line, biological replicate 2",pert
disease state: tibial muscular dystrophy (TMD);	tissue: soleus;	age at biopsy: 52;	Sex: male,pert
11093 Normal Uninflamed descending colon,ctrl
8 Month FORKO Ovary_01,pert
strain: C57BL/6;	tissue type: back skin,pert
V5-P392,pert
sample =XCGD5 treatment=Stimulated time=90 (min),pert
Itk knockout CD8+ unstimulated 1,pert
Severe rep7 (retina),pert
first-episode BP patient 120_biological replicate 1,pert
"hepatic gene expression at ""6 hr"" (rep2)",pert
ic patient3,pert
genotype: Emu-myc;Suv39h1-/-;	transduction: Bcl2;	cell type: primary lymphoma cells from lymph nodes;	treatment: none,ctrl
Cell culture of Melanoma Cell Line - A375,ctrl
sample =Healthy2 treatment=Stimulated time=180 (min),ctrl
"S1P2-KO-neocortex, biological rep2 (male)",pert
Peripheral blood mononuclear cells;	TTF=101min;	Race=White;	Sex=Male,pert
No_drug_#4864,ctrl
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: mild stress + morphine,pert
con-7_C,ctrl
5240 UC Inflamed sigmoid colon,pert
"Male, 29 years old, HIV infection of 3.5 years",pert
Oct4GipES_Panct1_esiRNA_72h_rep3,pert
control-noDox-rep1,ctrl
CD8+CD28low regulatory T cells,ctrl
OVSAYO ovarian cancer cell line,ctrl
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
A VIS _B032,pert
"Wild type, biological rep 1",ctrl
E9_Embryo_Heterozygous_2,pert
Sample ID: TP22;	Twin Pair ID: CCE1.2;	Clinical Status:  Childhood Absence Epilepsy + Febrile Seizures;	Age of Onset:-5;	Age at interview & blood sampling: 22;	Current Age (2007):25;	Sex: FEMALE;	Medication at blood sampling : None,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_4mM_HG-U133A_2_YCHSUP501,pert
SALINE 4 HOURS,ctrl
HepG2 cell line from ATCC at 8th generation before PCB77 treatment.,ctrl
"MOLT4 cell line, untreated",ctrl
colon_C57mouse_6weeks_rep5,ctrl
"BOEC, at_risk 6",pert
Dilated cardiomyopathy_G62,pert
HLA risk: Medium;	Height: 151.2 cm;	Weight: 42.9 kg;	BMI: 18.4;	Age: 11.22 years;	Gender: Female;	Race: White;	Glucose: 230 mg/dl;	HbA1c: 6.8%,pert
MDS patient 147,pert
SV589 8 Day KD Serum Starved-> 1hr EGF,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 150min;	race: White;	sex: Female,pert
KM_069T,pert
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Patient 7 after folic acid,pert
cell line: HUVEC,ctrl
01LLR: normal control,ctrl
F6.06,ctrl
N-BMSCs were transfected with negative control (siNC) construct,ctrl
GEIM16-PM,pert
Bone marrow HSC,pert
normal gingiva tissue from volunteers,ctrl
Embryonic day 14.5 and 16.5 pancreas,pert
lateral hypothalamus no access to cocaine replicate 2,ctrl
3285-lcm,pert
WT biological rep 3,ctrl
cell line: KYSE170;	cell type: squamous cell carcinoma,pert
ventral prostate,ctrl
CD8+_Tcells_healthy_donor_5,ctrl
"EBF1 d0, rep 1",pert
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
Array Type: HG-U133A_2;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Wildtype H9 hESC derived NSC 3,ctrl
Experimental 4,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 132min;	race: White;	sex: Female,pert
"Wild type sham, biological rep1",ctrl
1023-01-A-b,pert
PB_preTherapy_I,pert
control siRNA,ctrl
patient: 32023;	disease state: LGSC;	component: Borderline,ctrl
gallbladder -saline treated,pert
cell type: CD47 null Endothelial cells;	strain: C57Bl/6;	genotype/variation: CD47 null,pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.80;	Post mortem interval (hours): 47;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.4;	colon weight (mg): 180;	colon ratio (mg/mm): 2.81;	myeloperoxidase activity (u/mg): 0.031;	tissue: colon;	treatment: 5% DSS,pert
plasma;	patient with sepsis only,ctrl
Mid Secretory Phase Endometriosis,pert
Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 15/50,pert
SZ2,pert
BAT_KO_3,pert
"46, XX",ctrl
"seminoma specimen, pT2, patient age: 46y; W03 017",pert
Substantia nigra normal rep7,ctrl
tissue: skin;	individual: Patient P11;	condition: AL;	eczema severity: SCORAD: 64,pert
Percutaneous biopsies of vastus lateralis,ctrl
ctrl_517,ctrl
P57 Non failing heart biopsy,ctrl
cell type: Oct4-Gip ES;	RNAi: Luciferase;	treatment time: 72h,ctrl
gender: male;	genotype: TAK1 flox;	strain: C57BL/6;	tissue: liver;	age: 4 wk,ctrl
MOLM14-shGSK3A-Construct5-rep1,pert
siERK1Veh4h_2653,ctrl
WD44_Kdm6a RNAi-1,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.20;	Post mortem interval (hours): 10;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Ulcerative Colitis (42 year old caucasian male, SAK_1285268658)",pert
strain: C57BL/6;	genotype: PTEN+/- IKK2ca/ca (epithelium);	age: 12 months;	tissue: lateral prostate,pert
PBMCs from normal control subject K,ctrl
Individual_4334_PN_sample,pert
ILD Study Number S024,ctrl
H04_P_B1,ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: H;	transfectant type: stably transfected with scramble control,ctrl
Strain: FVB/N;	Genotype: mCftr+|+,ctrl
cell type: Primary hepatocytes;	donor: 3;	agent: control;	time: 24h;	gender: Female;	age: 70 years old,ctrl
patient: 259;	current medication: pentaza 2g D;	birth date: 9/20/78;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/03;	diagnosis date: 1/13/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
CAR.KO_TCPOBOP_rep1,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep4",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 82min;	race: White;	sex: Male,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep7",pert
"Metformin, biological rep1",pert
E12.5 Whisker pad wild-type,ctrl
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
wild type parietal cell replicate 2,ctrl
WT_POST_PDE_050,ctrl
"VHL null MEFs, biological rep2",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 100min;	race: Black/African American;	sex: Male,pert
subject: 20A;	cohort: 20;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 28;	Sex: M;	batch: Batch_5,pert
sex: Male;	Age: 11 months;	additional patient information found in Series supplementary file,ctrl
normal rat testis,ctrl
Jurkat 2,pert
HW_447,pert
n7t24h,pert
HPRT KO ES cells,pert
Tissue: endothelial cells,ctrl
Total RNA Wildtype-1,ctrl
Exercised-8,pert
Asthmatic after Placebo,pert
"triceps, mutant mouse",pert
"Patient  D, lesion, 4 week",pert
tissue: white blood cells;	age: 11.16;	Sex: female,pert
Control bone marrow - Biological Replicate 1 - Technical Replicate 1,ctrl
Stroma associated to breast invasive tumor,pert
TN2,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 44 yr;	population: white,ctrl
CD-33-Aff,pert
"Control Proximal, Small Intestine 1 17 days old",ctrl
MDS patient 114,pert
Kidney_Aqp11-/-_P7_3-4,pert
Subject 3 Post allergen challenge,pert
Human Non-progressor HIV Sample L115-CD4+ T cells,pert
"PCB153 treated HepG2 cells at T0.5, biological replicate 1",pert
KN-sham-1 day-R2,pert
Empty control #2,ctrl
Heart tissues,ctrl
C_AN10028_F,ctrl
Mc3T3 AA_ 5day_rep2,pert
striatum_Pink1 knockout_24 weeks_replicate 2,pert
cardiomyocyte SRF-null 1,pert
Strain: C57BL/6J;	Gender: male;	Age: 7 days;	Tissue: kidney,ctrl
"5mg/kg/day PFOA, Rep 3, Block 2, liver (high dose)",pert
"100-200 motor neurons, sacral spinal cord, 21days post sham opration",ctrl
PTC BRAF wt 8,pert
Uninfected TG mouse brain at 5 d.p.i.,pert
quadriceps muscle tissue of presymptomatic DMD children,pert
PFR3_replicate_2,ctrl
"septic CD4+ splenocytes at 6h, biological replicate 3",pert
shRNA6-16-noDox-rep2,pert
Muscle PCOS 22,pert
strain: mixed background of 129/SV and C57BL/6;	cell type: macrophage;	genotype/variation: PPARg WT,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 0h,ctrl
Nerve_Diabetic_Vehicle_710,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
WT - Cre Treated - 2 hrs - repeat 3 - Cy5 - mAdbID:62604,ctrl
BAL_39_A0B1,ctrl
DW307_WT_M,ctrl
29SAGEA2,pert
Donor5_24h_Wy,pert
Healthy untreated rats 3,ctrl
Rat liver,ctrl
Time 180 mins rep 1,pert
PEC control - replicate 3,ctrl
age: 45;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"DMSO-treated NRK-52E cells at 72h, biological rep 3",ctrl
"cell line: SW480-Vector, vector control treated stable line",ctrl
heart tissue from WT mouse,ctrl
3 ERRg KO E18.5 male cadiac ventricles,pert
agent: control;	strain: BALB/c;	tissue: mesentery,ctrl
"seminoma specimen, pT2, patient age: 46y",pert
agent: EFNA4-Fc conjugate;	time: 4h,pert
THP1-shGSK3A-Construct5-rep1,pert
AL Chip#32,pert
"heart, wild type",pert
tissue: blood;	patient: 1;	gender: male;	age: 54,pert
tissue: Hippocampus;	age: 83;	Sex: M,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue,pert
Actinomycin D treated A549 human lung cancer cell cultures replicate B,pert
control IgG_rep1,ctrl
AA_126,pert
whole tissue section from case 68,pert
"Tet1 KD, rep4",pert
genotype/variation: Tpl2 wild type;	treatment: unstimulated,ctrl
IDCM3,pert
brain_Down_syndrome_sampleid_jg1738,pert
Individual_4284_PN_sample,pert
CML-BM 4,pert
HSC-3_TAT-2_48hr culture_ rep3,pert
"SW480, stable line of treatment of luciferase RNAi. Incubate in L15 medium, 37.0°C, air 100%",ctrl
"General population, Female",ctrl
"Female (age range 33-49), skin biopsy taken from upper nates 48 hours after nickel exposure",ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 5",pert
female;	37 yr old;	Black,pert
Human Non-progressor HIV Sample L115-CD8+ T cells,pert
38m4,ctrl
Cell line: TOM-1,ctrl
tissue: skin;	individual: Patient N-7;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID223,pert
coc-38_A,pert
IRF4-mut_Th17_cells_42hr_rep1,pert
"fibroblast, control subject NM8 rep 1",ctrl
healthy control H10,ctrl
Ex1_cells_rep2,ctrl
untreated control,ctrl
"DMSO-treated, 6h after UV, Replicate F",ctrl
brain_DLPFC_bipolar B_mr676,pert
Hypothalamus,pert
LNCaP-abl_siControl_2,ctrl
colon_epithelium_IL10mouse_12weeks_rep4,pert
Asthmatic at baseline,pert
Gene expression profiling of Phgdh knockout embryo KO3,pert
"Pten WT/null epithelials cells, biological rep3",pert
MKK7D control female replicate 8 late timepoint,pert
PancreaticSample9-Tumor,pert
TG MEP 1,pert
MCF7_siRNA_GCMedControl_24h_AM0004_14.1,ctrl
carcinoma,ctrl
"BALB/c, Female, CF",pert
Patient identifyier: W;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 27 years;	Body surface area: 6 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
non-malignant FTEn_patient 3,ctrl
HIF-1-/- S. aureus 4,pert
Cell line: MDA-MB-231,ctrl
"twin pair: #7;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
subject: 22U;	cohort: 22;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 60kb;	age (y): 43;	Sex: F;	batch: Batch_5,ctrl
"Control shRNA cells passage 7, rep 4",ctrl
metoprolol treated muscle cells,pert
WT-smoke-med-1 day-R2,ctrl
MS patient 4,pert
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: mammary gland",pert
neuron_rep5,pert
BP8,pert
Cervical cancer_CC218,pert
"Peripheral blood, patient with recurrent events",pert
T41 U133p2,pert
"Peripheral blood, patient without recurrent events [N24]",pert
Mouse WT mandibular molar [AZN_MolairesWT3],ctrl
H15 Ctrl 12h 1,ctrl
cell type: Embrionic stem cell line;	genotype: HPRT -/-,pert
cell line: U20S;	tissue type: osteosarcoma,ctrl
tMLL08,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: control;	time: 6h;	gender: Male;	age: 44 years old,ctrl
DMSO treated CEM-C1 cells_1,ctrl
"mouse, liver (CCl4), treated with erlotinib 2mg (week 18)",pert
"Pancreas from adult WT mice, biological replicate 3",ctrl
CBMNC.LPS-.2,ctrl
tissue: skeletal muscle;	strain: mixed background (C57Bl/6 and 129);	genotype: wild type;	age: 6 months,ctrl
S1_sham_overexpressor_12,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: untreated,ctrl
"Wild-type myeloid-derived suppressor cell from bone marrow, rep2",ctrl
Liver_WT_Rep3,ctrl
5279 UC Inflamed ascending colon,pert
"MGSKO, PR01M007v0",pert
B7m5,pert
cell type: Primary hepatocytes;	donor: 5;	agent: Wy14643;	time: 24h;	gender: Male;	age: 73 years old,pert
CLP2,pert
CD19_selected_B-cells_before_R_rep3,ctrl
P79 dilated cardiomyopathy heart biopsy,pert
NeuoD1 transgenic animals die very shortly after birth.,pert
wild-type_TCPOBOP_rep1,ctrl
MCF10A_SFN_rep4,pert
Telencephalon WT 1,ctrl
mutant_ANT_PDE_21,pert
RL_siRNA_LIF1h_rep2,ctrl
Kidney_200 mg/kg VCM iv_mouse #029,pert
cell type: pre-iPSCs;	sirna mediated knockdown: control,ctrl
Disease_status: Bipolar disorder;	Age (years): 56;	Gender: Male;	Age of onset (years): 28;	Duration of illness (years): 28;	Brain pH: 6.07;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: Unknown;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: Yes (60 treatments);	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
"fibroblast, control subject NF6 rep 3",ctrl
Skin from Irf6 null,pert
RNA from HCC_24T,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 75,ctrl
OVE26_8W_1_4,pert
77 year old male,pert
Lin- Rosa26rtTA cells untransduced,ctrl
U87 20 uM Temozolomide rep2,pert
EB_0_19d_77_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
transfection: H19 siRNA (simH19);	cell: C2C12,pert
CRC_celecoxib_M4875,pert
"Cadmium 0.55 µM, biological rep2, repeated microarray",pert
"HEB CLP LY6D-, biological rep2",pert
AZ-521_uninduced_24h_rep2,ctrl
"experiment I, passage 9, replicate 1",ctrl
MCF10A-Her2Myc-rep2,pert
Healthy donors,ctrl
clone type: AtT20 clone types treated with NSBP1 siRNA rep 2,pert
MCF7 DMSO+E2,pert
KU_35T,pert
Dengue Hemorrhagic Fever Patient 81,pert
pediatric AML S22,pert
V5-P250,pert
T137,pert
"pancreas, ethanol diet, replicate 2",pert
MCF7 cell line_resveratrol_250mM_biological replicate 3,pert
Kidney_200 mg/kg VCM ip_mouse #086,pert
"Rb KO, biological rep3",pert
"Gastrocnemius-soleus muscles, basal status, integrin alpha7 transgenic  mouse",pert
Myd88 KO control tissue  3,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T1N1,pert
EE_IC_2_aa_lcm,pert
Bone marrow HSC,ctrl
strain: 170;	Disorder: normal scar;	Condition: +hydrocortisone,pert
"spleen marginal zone B in WT, biological rep5",ctrl
tissue: Temporal cortex;	age: 78;	Sex: F,ctrl
KO STR Veh 30,pert
7 Day Mouse leg muscle,pert
Waldenström’s macroglobulinemia (WM-BL 30866),pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 173;	Sex: male;	region: LC;	age: 38;	genotype: Y/X;TH/-,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-3,pert
SOCS3 Cre minus A,ctrl
MacularDegen-injured-9aAv2-s2,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 65;	age-at-onset: 65;	geographical origin: Vila-Real;	clinical characteristics: Hypertension,pert
Control ESC media sample 3,ctrl
Gene expression data spleen marginal zone B in WT,ctrl
strain: C57Bl/6;	cell type: Regulatory T-cells CD4+CD25+;	genotype/variation: fl-p300/Foxp3cre,pert
genotype/variation: wt;	age: P60;	tissue: Whole eye,ctrl
tissue type: Benign prostate tissue,ctrl
sepsis patient #6,ctrl
ab104 IM,pert
BN DES-treated replicate 4,pert
"104, ADIPOOSE TISSUE, Before",ctrl
WT-smoke-med-5 month-R4,ctrl
Wild type mice on a high fat diet (CH 1),ctrl
"A pool of two pure subsets of peripheral blood CD56dim natural killer cells (CD19- CD3- CD56dim Cd16+), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
Treg cells Ptenfl/flFoxp3-Cre replicate 2,pert
tetO-Satb1 #2 +DOX,pert
genetic background: C57BL/6-129Sv hybrid background;	genotype: Setdb1 2lox/1lox/Cre;	cell type: embryonic stem cell,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu1,pert
"Crohn's Disease subject (31 year old caucasian male, SAK_1315951533)",pert
whole blood_101621,pert
hippocampal tissue from wild-type mice,ctrl
FACS sorted IgM+IgD+ cells,ctrl
"human embryonic stem (hES) cells line SA01, biological replicate  1",ctrl
01MJ2_ERA,pert
ILD_4,pert
4124-1 E2F2 Null,pert
Kidney tissue from obese rats on control diet,ctrl
Wild type saline replicate3,ctrl
T3.02,ctrl
"C1_transgenic but unaltered, lung tissue",pert
MCF7 cells treated with 2uM Doxorubicin for 24 hours Array 1,pert
S008_Scz_F_81,pert
"atRA RARaKO, set 2",pert
C_AN14757_T,ctrl
Control mouse embryonic stem cells,ctrl
Control mouse 3,ctrl
cell line: AST18;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: SNCA triplication,pert
RNAi -Transgenic replicate 4,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 94;	Usage number: 5;	Exposures: 3,pert
AAA neck (Sample 13),pert
EB_07_24h_136_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
GM9018,ctrl
MacularDegen-healthy-13aAv2-s2,ctrl
genotype: WT;	time (h): 0;	cell type: primary hippocampal neuron;	treatment: untreated;	genetic background: C57BL/6,ctrl
WT MEP 2,ctrl
BRCA1_3,pert
2A;pretreatment;female;breast tumor,ctrl
Map3k7 (TAK1) knockout replicate 1,pert
HUVEC exposure no colchicine 12 hr_2,ctrl
HEK293 F18 WTX inducible,pert
Substantia nigra PD rep15,pert
Heregulin 979-CLA-34,pert
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate2,ctrl
WT - Cre Control - 5 mo - repeat 1 - Cy3 - mAdbID:74098,ctrl
"Patient 1, lesion tissue",pert
ALI patient #8,pert
Primary CLL cells (untreated),ctrl
CLL17-CD8,pert
"Spinal Cord, Epicenter (~T8)",ctrl
male_control_510,ctrl
CLL 378-01 Control,ctrl
striatum_wildtype_2,ctrl
erStress_twins_AA_1736twin1_DMSO_4h,ctrl
Lmna H222P heterozygous male 5,pert
"Colitis 04, UC04",pert
"genotype/variation: Pten-null (Ptenloxp/loxp), with doxycycline-inducible PTEN transgene;	cell type: embryonic fibroblasts;	transgene: tet-inducible Pten transgene;	time: 24 h;	genetic background: C57BL\6",pert
H6PDH knockout,pert
Sirt1 siRNA control 1,ctrl
cell line: MCF-7;	sirna knockdown: siLRH-1_#2,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 2,pert
HP-50,ctrl
cell line,ctrl
Control Treg_rep3,ctrl
THP-1 AML cells,pert
Empty vector replicate 2,ctrl
SimvaVeh2,pert
"shControl, normal growth, replicate 1",ctrl
"human failing LV myocardium, Ischemic56",pert
"Mouse LV, akt2-/- 2",pert
cell line: SNB19;	transfection: PARK2 siRNA#1,pert
CAR.AH_phenobarbitol_rep1,pert
157_DMSO,ctrl
cell line: HEK293 human embryonic kidney cell line;	protocol: control (control RNA),ctrl
"A549, -TNFα, Claudin 1 siRNA, rep2",pert
LT-HSC Zbtb7a F/+ Mx1-Cre+ #2,ctrl
"WT5_ileum, 5 days post-infection with T. gondii",ctrl
IPMC 4,pert
"16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
EA_Control5_CD20,ctrl
Tumor-WT-rep1,ctrl
Healthy CD4+T cells 13-UD,ctrl
"Quadriceps muscle, PGC1beta mutant mouse",pert
Colo205RC PLX4720 resistant cell line,pert
midbrain_Pink1 knockout_6 weeks_replicate 2,pert
miR122-KO-157-T,pert
73_129_WT,ctrl
STAT3-deficient naïve T cells stimulated for 3 hours with medium alone 3,pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; 3h EGF,pert
C1_CLP_overexpressor_12,pert
chip number: 18;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.67;	rin: 9.5;	transfection date: 2012-03-26,pert
"cochlea at P3, ko, biological rep 3",pert
strain: Wistar;	agent (mother exposed to): vehicle;	gender (pup): male;	age (pup): PND70;	tissue (pup): pituitary,ctrl
Patient: B;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: untreated,pert
AA_Case12_CD8,pert
Muscle Pio3,pert
HD 1,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 4,ctrl
Control_liver_3,ctrl
pediatric AML S10,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 6 hr,ctrl
gender: male;	strain: BALB/c;	tissue: liver,ctrl
Postmenopausal female. Tibolone treated. Patient 6.,pert
MA_306,pert
WT_Mstn_2,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 237;	age-at-biopsy-years: 55,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep5,pert
"brain, cerebellum: KCb4w#1_e1_le1",pert
cell line: 344SQ lung cancer cell line;	genotype.variation: control,ctrl
NHE3+/+ replicate 2,ctrl
"ID:7-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
3497-3 E2F2 Null,pert
HDAC2 KO mice colon rep 2,pert
Day 14 (T1+2),pert
Normal Chip#2,ctrl
SZ3,pert
monocyte derived DCs,ctrl
"ID:c 4-4, Genotype=(C57BL/6J), Treatment= none",pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 5.5;	colon weight (mg): 164;	colon ratio (mg/mm): 2.982;	myeloperoxidase activity (u/mg): 0.301;	tissue: colon;	treatment: 5% DSS,pert
HTB58_antiEvi1siRNA_3,pert
Mononcyte-healthy-untreated-3,ctrl
GFP_3,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.894;	OD280: 0.979;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 61;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
healthy control sample x062,ctrl
Rat fatty liver10,pert
V5-P324,pert
HCC_9N,ctrl
Jak2VF vehicle (7991003028_F),pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 2",pert
"human failing LV myocardium, Idiopathic65",pert
Individual_953_PN_sample,pert
LCL Concordant for Epilepsy twin pair 2 (CCE2.1)(TP31),pert
Mixed_E14.5_Whole_Kidney,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:56;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
Trasnsformed Lymphocytes Unaffected (Unaffected pateint of MZ twin pair 1),ctrl
LY2 control-siRNA untreated rep2,ctrl
TTP_WT_0ActD_BioRep2,ctrl
Eed KO J1 ESCs on day 7,pert
cerebellar total RNA,ctrl
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 86;	Usage number: 5;	Exposures: 3,pert
Mtb infected-42d-5,ctrl
PsOEt-10-Week 2,pert
36B,pert
age: 54;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor High CD34 positive expressing bone marrow progenitors GMP",pert
fasted liver lard diet 1,pert
215/4,pert
BTBR-ob/ob;	Pancreatic islets;	Age: 14 weeks;	Gender: Male,pert
E9.5 embryo_wild-type_rep1,ctrl
Trib1 #2 KO macrophage LPS,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 27;	maternal age: 39,pert
microdissected breast cancer cells from case 772,pert
GM19238_Kd_BCL3_1,pert
"WT-UN2,experimental replicate 2",ctrl
"Patient 20, Atheroma plaque",pert
tissue: Lung;	strain: Lewis;	treatment: control,ctrl
"patient: 227;	current medication: Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD;	birth date: 4/17/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/90;	diagnosis date: 1/1/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/72;	smoking amount: 5-14;	other illnesses: Prostate cancer 1985, Previous DVT's on warfarin;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
brain_DLPFC_bipolar C_mr546,ctrl
Psoriatic arthritis PsA 1,pert
BRCA1-KD-2 (total RNA),pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: mid-UV,pert
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-6,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 1,pert
SKI-DLCL cells were treated with AraC alone at concentration 20nM for 24h. Total RNA was isolated.,pert
A375 melanoma cell-line,pert
HepG2_Vehicle_24hr_prep3,ctrl
HPB-ALL Control 2,ctrl
Bronchial Epithelial Cells SA biological 1870G,pert
DBA/2J Vehicle liver sample batch 1,ctrl
clone type: AtT20 clone types treated with NSBP1 siRNA rep 3,pert
"216, MUSCLE, Before",ctrl
BM_02496,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: untreated,pert
colon_normal_1122,ctrl
P1 eyeball,ctrl
"maternal exposure to vehicle, HypM",ctrl
KOT 72 bleomycin treated,pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing progerin treated with FTI;	cell line: GM00038,pert
strain: C57BL/6;	genotype: Wild Type;	replicate: 1,ctrl
race: african american;	age (years): 69;	stage: IB;	grade: 2;	histology: endometrioid,pert
Normospermic individual: Sample N10,ctrl
TscWT1_brain,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 49;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
"Control 01, NC01",ctrl
Human Uninfected Sample N001-CD4+ T cells,ctrl
Mouse lungs infected with Mtb for 63 days,ctrl
MDS patient 134,pert
"control, BA46-70",ctrl
WT-ac-2,ctrl
A673 cell line that has been treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50).,pert
Control bone marrow - Biological Replicate 3 - Technical Replicate 2,ctrl
"HUVEC treated with ERG SiRNA , biological rep1",ctrl
mouse cerebellum at P7 wild type 2,ctrl
human umbilical vein endothelial cells,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: LPA,pert
Kidney_400 mg/kg VCM iv_mouse #044,pert
GIST Tumor,pert
OSE_452,ctrl
E14.5 cKO 3,pert
Individual_5292_NN_sample,ctrl
NSC_ X5050_24h_biological rep3,pert
M17 - infected MBT/Pas fibroblasts (9 h post inf),pert
HCC PBMC_sample 8,pert
R26Pax3/Pax3 E14.5 palatal shelves 3,pert
sex: male;	tissue: liver,pert
N7A Normal-frontal,ctrl
4_2,ctrl
V5-P371,ctrl
01UNN,pert
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_4;	fev1 (% predicted): 65;	fvc (% predicted): 81;	medication: Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn;	cell type: CD4+ T-cells",pert
HCC_24T,pert
"Female Nrf2 Wild-type mice, spleen sample",ctrl
EOM 56 Day mdx rep 1,pert
construct: HDAC2 B10 shRNA;	cell type: Primary human erythroid progenitor cells,pert
E14 cells_control RNAi-rep1,ctrl
MCF7 - MTDH_WT_KD_2,pert
DEX1_24H,pert
PyV-mT St6gal1-/- tumor,pert
Donor1_6h_Wy,pert
braf status: BRAF wild type;	tissue: PTC without a BRAF mutation,pert
status: Control;	gender: Female;	age: 61;	tissue: Blood,ctrl
A673_CloneAsp14_Dox_36h_2,pert
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 7x6x4;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genetic background: 129SV;	genotype: WFS1 KO;	tissue: hypothalamus,pert
DC-8LA,pert
ARF1 siRNA knockdown MDA-MB-231 sample 6,pert
MO32_8,pert
"fibroblast, MFS subject FB881 rep 4",pert
Heart sample 11,ctrl
H9_d15_hepatic differentiated_1,ctrl
MDS25,pert
F9 RARaKO treated 8hr with EtOH,ctrl
NE-rep3,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 69 years,ctrl
subject id: 66;	infection: DENV;	status: DF;	tissue: whole blood,pert
92.1 - control #1 - replicate3,ctrl
Strain: B6SJL-G93A-SOD1H;	Age: 110 days,pert
GFAP-negative lamina cribrosa cells,pert
"hESC derived-NSCs passage 14, 24h",pert
KO fed  High Fat Diet,pert
erStress_twins_AA_1720twin1_500nM_thapsigargin_4h,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,pert
TP07-152,ctrl
remitted schizophrenia patient  S03,pert
Oga_KO_MEF_E7_rep3,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.04;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 36;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
LCH4ani,pert
"47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
mT3,pert
ID: MLL_00106;	cell type: PBMC;	disease state: control,ctrl
female_alcoholic_327,pert
"-Rosi, +PPAR, 72hrs",pert
Sample ID:TP10;	Twin Pair ID:DCBD3.2 ;	Clinical Status:Control;	Age of Onset:-;	Age at interview & blood sampling:35 ;	Current Age (2007):38 ;	Sex: Female ;	Medication at interview (duration) :None,ctrl
control MLL_00112,ctrl
"patient: 207;	current medication: Asacol 800mg BD, Colifoam Enemas Daily;	birth date: 4/29/47;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/88;	diagnosis date: 8/18/88;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/14/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 10/14/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/10/62;	smoking stop date: 3/15/75;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
HepG2_control_rep4,ctrl
Myeloid cells pooled from 2-3 7 week old knockout mice,pert
wild type 2 cell embryo rep2,ctrl
Panc-1 Untreated Control 1,ctrl
EA_Case6_CD8,pert
T2A-LU,pert
HT1080,pert
Mus musculus tissue,pert
cell line: OSE4;	knockdown: control;	cell type: ovarian surface epithelial cells,ctrl
Wt_cycling_rep3,ctrl
Leg 14 Day Control rep 2,ctrl
Day3 Estrogen treatment replicate 2,pert
FmrWT1_blood,ctrl
"CCALD patient fibroblast, biological rep2",pert
"treatment with MeOPP, replicate 1",pert
wild type 2 cell embryo rep3,ctrl
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep7,pert
Brain_Aged_Salineip_4hr_mouse2 (OP2_#62),ctrl
K562 cells control replicate 8,ctrl
GIST_PDGFRA_9,pert
5205 Normal Uninflamed sigmoid colon,ctrl
hepatocytes treated with 35 μM TFMPP,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Mbd3,pert
EA_Control3_CD20,ctrl
MF_43,pert
HCC_1T,pert
"ID:11-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
L-540_Perifosine 10µM_24hrs_2A,pert
FACS sorted IgM+IgD+ cells,pert
LT-HSC Zbtb7a F/F Mx1-Cre+ #3,pert
Kidney_saline_4,ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep2",pert
PTC BRAF mut 3,pert
SOCS3 Cre minus B,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 137min;	race: White;	sex: Female,pert
B9_102412,ctrl
158B,ctrl
"WT, PR03M001v0",ctrl
FHCRCAML4500,pert
Muscle PCOS 12,pert
subject: 21B;	cohort: 21;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 59;	Sex: F;	batch: Batch_5,pert
dermal fibroblast from CCALD patient,pert
CSTB KO_cerebellum at P7,pert
HMEC control X HMEC+Interferon gamma 24hrs,ctrl
Normal mucosa 3,ctrl
Halothane 5 exposures-3,pert
Colo-205 DMSO Day 3,ctrl
wildtype Tcof1 [C],ctrl
"GM9017, unaffectd brother",ctrl
cell line: MDA-MB-231;	cell type: Breast cancer cells;	group: SDC1-silenced group,pert
Control male 7,ctrl
pediatric AML S36,pert
MEF E2F4 KO 2-rep1,pert
V5-P564,pert
Squamous cell lung cancer patient 33,ctrl
11401 Normal Uninflamed ascending colon,ctrl
sampleID: SAM630136;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
HES2_Mir122Mut_rep1,ctrl
"gender: Male;	age: 91;	post-mortem delay: 13h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
8 week old EOM MDX rep 5,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 28;	maternal age: 28,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 97min;	race: White;	sex: Female,ctrl
"differentiated U937 cells, ROS exposed, 1uM curcumin treated, 4h",pert
N4_Cy5,ctrl
cell: ES cells;	genotype/variation: UTX knockout,pert
status: Rapid;	age: 49;	gender: male;	tissue: cultured human fibroblasts,pert
TTF=180min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
H11_S_B1,ctrl
V5-P301,ctrl
Aged 3,pert
At Risk: -;	Age: 14;	Sex: F,pert
patient code: 104;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 1;	ajcc classif. (2002): 2b,pert
"t14, surgically resected from patient of gastric cancer.",pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-GFP retrovirus,pert
status: Slow;	age: 71;	gender: male;	tissue: cultured human fibroblasts,pert
"human failing LV myocardium, Ischemic57",pert
genotype: Wild Type;	treatment: Low fat diet;	gender: male;	tissue: liver,ctrl
breast tumor,pert
"CCM3 shRNA cells passage 7, rep 4",pert
"kidney, QH2, 14 months",pert
"murine kidney, wild-type littermate controls",ctrl
genotype/variation: Cyp27b1 flox/flox;Cre-;	tissue: breast tumor;	genetic background: FVB,ctrl
CLL20-CD4,pert
Run8.aUa.010615d.SkMInS1078D.CEL-IS basal,ctrl
age_years: 39;	sex: F;	ethnicity: Latino;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
genotype/variation: Gfi1b KO,pert
ancestral background: African-American (AA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,pert
"PCB77 treated HepG2 cells at T0, biological replicate 3",ctrl
"IκBα-deficient animal, biological repeat 2",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 16.0;	age of psoriasis onset: 25,pert
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 1,pert
Reh_IKK_1,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: C;	experimental sample name: PC2-R,ctrl
"SKO-transduced MEFs, Vc+, D10",pert
WT - Cre Control - 3 mo - repeat 4 - Cy5 - mAdbID:74667,ctrl
"brain, hippocampus: LH6_e1_le1",pert
male_control_225,ctrl
Pool stratagene human,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: RNAi-6A,pert
12475 UC Inflamed descending colon,pert
dental pulp stem cells extracted from deciduos tooth,pert
Donor (Sample 17),ctrl
PBMCs_IS_2 [IS],pert
developmental stage: E14.5;	genotype: Prmt5F/F;	genetic background: mixed C57BL/6 X 129S1/SvlmJ;	cell type: NPC;	treatment: control,ctrl
Pediatric_GBM_8,pert
Carbo Day1 (75L),pert
"granulocyte, healthy control, biological rep5",ctrl
"PCB153 treated HepG2 cells at T0.5, biological replicate 3",pert
P4_TR_3,pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P15 postnatal stage,ctrl
Cadmium_00hr_rep2,pert
control2,ctrl
SKBR3-R_Control_1,ctrl
117B,ctrl
CLL,pert
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: U,pert
Liver-24 month-wild type-technical replicate 3,ctrl
MCL_IGHV_MUT (R1628),pert
colon_IL10mouse_12weeks_rep5,pert
LICR_HN2_PBS1,ctrl
"EtOH, RARaKO, set 2",pert
"RWPE1 cells, vehicle, 6h, biological rep3",ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 40s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 140;	ige (kiu/l): normal (0-48.5 kIU/L): 2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
A6_C6_nasal_stem_cell_rep1,ctrl
"Tet1 KD, rep2",pert
cell type: Primary hepatocytes;	strain: SV129;	agent: Wy14643;	time: 6h;	gender: Male;	age: 4 months,pert
MDA_PR_2,pert
RKO cells transfected with NEG Stealth siRNA treated 6 h with vehicle DMSO 0.5%,ctrl
"Patient 90N, normal colonic mucosa",ctrl
NME2 induced A549 cell Replicate1,pert
Wild-type_macrophages_2h,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 14 months,pert
BALB-RAG_PBS Replicate 4,pert
"brain, cochlea: [14] Sample #14_le1",ctrl
"222, MUSCLE, Before",ctrl
Caudate-Putamen of naive FVB/N mice,ctrl
brain_DLPFC_bipolar B_mr427,pert
Ebola-infected macrophages harvested at 6h post-treatment from donor 1,pert
age: 38;	sex: F;	disease status: control subject;	Filter number: 85;	Usage number: 5;	Exposures: 3,ctrl
"brain, brainstem: PB7_e1_le1",pert
cell line: MDA-MB-231,pert
Fetal heart 6 ug/kg TCDD rep2,pert
OV1002 Carbo Day14,pert
36SAGEA2,pert
"Mice_c-myc trans, biological rep3",pert
Substantia nigra normal rep5,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-sp1,pert
Placenta_PE(EO)5,pert
liver control diet rep6,ctrl
OBF-1 overexpression BCS-3 (Large PreB),pert
Control_4months_retina24,ctrl
"Grape extract group, 12 months, patient number 56",ctrl
"Control Day 3, biological rep1",ctrl
race: caucasian;	age (years): 67;	stage: IB;	grade: 1;	histology: endometrioid,pert
"HeLa control, biological rep1",ctrl
E14 cell cultured 3 days in N2B27,ctrl
hOB695_shEV_24hr_IR,ctrl
"Control lung tissue, biological replicate 5",ctrl
KU_46N,ctrl
Epithelial prostate primary cells from fresh tumor explant,pert
"Normal Skin, Normal-11",ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: WT channel;	agent: untreated,pert
Caco2-siRNA-control1-rep2,ctrl
"Ring1B deficient ES cells, biological replicate 3",pert
"114, MUSCLE, Before",ctrl
status: Slow;	age: 72;	gender: female;	tissue: cultured human fibroblasts,pert
Cont subject 04,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 37;	gender: male,ctrl
Placenta_PE(EO)3,pert
"brain, cerebellum: RNA#11S_le1",pert
SCLC cell line DMS53,pert
stomach_0h_rep2,ctrl
WT MEF CT30-2,ctrl
Healthy control_sample2,ctrl
CEM-C1 cells treated with rapamycin for 3 hours,pert
MDS patient 136,pert
01MLR_PolyRF+,pert
33/OVX/oil/6h/UTX 129 Hoxa-10+/+,ctrl
8P-ER-ND,pert
Low weight gainer Kozak1_ABI_ING_L3,ctrl
RNA from microdissected breast cancer cells from case 662 labeled with Cy5,pert
condition: Psoriasis;	patient: PS-F;	tissue: LS skin biopsy;	kit: Affy,pert
"Wild type used for GNMT 8 month, replicate 4",ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep6,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 57;	sex: F,ctrl
chip number: 22;	transfection plate: 3B;	target gene: YY1;	kd level: 0.65;	rin: 9.5;	transfection date: 2012-03-26,pert
tissue: Brain;	genotype: Npc1+/-;	age: 54 days;	subject: Mouse3;	genetic background: BALB/c,ctrl
MCF7 - Control_2,ctrl
ILD Study Number 901,pert
RNA from microdissected breast cancer cells from case 1047 labeled with Cy5,ctrl
"Otx2 deficient mouse strain (Puelles et al., 2003, Nature Neuroscience Vol 6(5))",pert
RNA from microdissected breast cancer cells from case 469 labeled with Cy5,ctrl
GM19238_Kd_NFYC_3,pert
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 2;	age: Post natal day 3-14,pert
age: 31;	sex: F;	disease status: Marfan subject;	Filter number: 38;	Usage number: 1;	Exposures: 4,pert
G4D_Sham_Rep3,pert
"5850, control, skin fibroblasts",ctrl
HVS-CD4-ITK-R335W_unstim_rep3,pert
CFU-PreB colonies Wildtype littermate,ctrl
Bronchial Epithelial Cells control biological 1878H,ctrl
"4 weeks old normal mice, cerebellum",ctrl
control_08hr,ctrl
DA rat jejunum control,ctrl
Gastric Cancer PBMC Sample 2,pert
tissue: Embryonic lung E18.5;	genotype: C57BL/6 WT;	age: Embryonic Day 18.5,ctrl
"Diclofenac treated HL-60 cells, biological replicate 1",pert
BL005,ctrl
mouse bone marrow-derived mast cells treated with IL3+SCF,pert
diagnosis: Normal;	fvc-group: Normal;	tissue: lung,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 8 hrs AP20187,pert
granulocyte RNA from patient achieved remission on MTX,pert
"S1P2-KO-neocortex, biological rep9 (female)",pert
"spleen follicular B in IRF8 conditional KO, biological rep2",pert
"human failing LV myocardium, Ischemic26",pert
Skin from Irf6 wt,ctrl
26 weeks male,pert
U2OS_PRC_shRNA4_pLenti_3,pert
RNA from whole tissue section of case 1279 labeled with Cy5,ctrl
"37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
cerebrum_WT_12w_rep2,ctrl
A508 Sham 1 day,ctrl
Skinbiopsy_96hoursnickel_controlsubject_k3,ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Tongue 2,ctrl
whole blood_100760,pert
TA-n7; normal tibialis anterior 7 month,ctrl
s4t1c,ctrl
"eye, retina: Control 2_le1",ctrl
BAL_21_A0B0,ctrl
Low weight gainer KOZAK2_ABI_HYP_L1,ctrl
dorsal mouse skin,ctrl
rat heart,ctrl
sample type: HeLa-Ctrl-siRNA-4d;	cell line: HeLa;	knockdown: Ctrl-siRNA;	time: 4d interferon alpha;	treatment: interferon alpha,ctrl
age: 12 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
DR AA4+ replicate 2,ctrl
"brain, QH2, 6 months",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day14,pert
duration of untreated disease in month:16.1;	age at onset:3.9,pert
"Gtf2i Mutant line, biological rep 1",pert
"disease group: Atopic Dermatitis;	Sex: m;	age: 20s;	race: Native American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 11.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 990;	ige (kiu/l): normal (0-48.5 kIU/L): 4136;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: pos",pert
4-HPR_mammary_2,pert
MDS patient 103,pert
KU_50T,pert
tissue: adipose tissue (epididymal);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
UC-32-Aff,pert
umbilical cord_bpd: 8I,pert
RatLung_H3h_2,pert
MV4-11 cells,pert
LICR_HN1_PBS1,ctrl
WT mouse (WT_Tal6),ctrl
Diseased individual (ulcerative colitis) of twinpair #7,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,ctrl
B6_Female_CF_rep1,pert
FVB; No Treatment #5,ctrl
GM19238_Kd_RDBP_1,pert
"WT, untreated whole heart, individual 1",ctrl
SHEP-SF neuroblastom,pert
wild type Jurkat cells,ctrl
NPC_VUB03_DM1_2,pert
OA1,ctrl
Barrett's esophagus (B3),pert
"E18.5 brain, Meg3 knock-out, rep 7",pert
BMMs_untreated control_wt,ctrl
MIG control biological replicate 2,ctrl
"Trabecular meshwork tissue from POAG donor B. 77y/female/africanamerican. Cause of death: renal failure. Other ocular diseases: cataracts. IOP: 15-25. Drug therapy: Xalatan, cosopt.",pert
Skinbiopsy_48hoursnickel_controlsubject_k4,ctrl
"brain, hippocampus: Wt #3406 Cereb_e1_le1",ctrl
"WT in the absence of tetracycline, rep3",pert
Disease_status: Bipolar disorder;	Age (years): 43;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 18;	Brain pH: 6.74;	Post mortem interval (hours): 39;	Side of brain: Left;	Fluphenazine mg. Equivalents: 4500;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
SimvaVeh3,pert
pMX-Oct4 no vitamin C Oct4Vc-_1,ctrl
SLE2-TC,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 71,pert
Strain: CBA/N (mutation R28C),pert
FBooth-MDX-5Av2-s2,pert
HCC006N,ctrl
Parkinson's disease sample x174,pert
MEFs-5,ctrl
G039-lcm,pert
small intestine,ctrl
"Embryonic cerebral cortex, control, biological replicate 1",ctrl
CD8_T_cell_pool_healthy_H05+H06,ctrl
Preglaucoma control rep4 (OHN),ctrl
C2C12 MYTOUBES,ctrl
Frontal cortex of non-AD brain,ctrl
"47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
brain_DLPFC_bipolar C_mr700,pert
Muscle KO Adult 01032,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep4,pert
PDAC_P_104,ctrl
"12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
RelA_siRNA_0b,pert
C016_Control_M_60,ctrl
control-3,ctrl
No_drug_#4872,ctrl
MCF-7 cells from ATCC,ctrl
Donor5_6h_Wy,pert
F191G A,ctrl
microdissected epithelial cells from IPMA 1,pert
HCC1954 Cell Treated 2,pert
Caco-2 Control siRNA 1,ctrl
cKO_P68,pert
HeyC2+(3),pert
breast normal 5,ctrl
INSENS 7 0hr,ctrl
MPM tumor specimen 40,pert
PGC-1a KO 3,pert
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
KO 541 L2,pert
HepG2 cells control 24h,ctrl
ctrl_505,ctrl
"age at diagnosis: 68;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: NA;	dfs-month: 9;	dfs-event: 0;	distant metastasis: 0",pert
Superior Frontal Gyrus from a 2 and 4 year-old RTT girl,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_4_22_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Human CD34+ cord blood cells expressing BCR/ABL1,pert
C3_CLP_wildtype_8,ctrl
Liver antiangiogenic-treatment rep1,pert
normal mammary gland,pert
"schizophrenia, BA10-56",pert
"650nM MLN4924 after 4hr, replicate 1",pert
Gender: Female;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 0;	Pathological M: 1;	Grade: well;	Tumor Site: Hepatic Flexure;	Drug Treatment: YES,pert
whole splenic B-cells from adult Btk KO mice,pert
GB 10 65B NO LPA,pert
Nrl-ko-Gfp P2 replicate 3,pert
KU_47N,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 320;	age-at-biopsy-years: 34,pert
cell line: NOMO-1,ctrl
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 1,pert
RNA-DHL6-R406-48H-1,pert
sample =XCGD2 treatment=Control time=180 (min),pert
KO3,pert
4117-1 E2F1 Null,ctrl
GB 11 NTA NO LPA,ctrl
Pancreatic Sample 38-Tumor,pert
TN2b-control,ctrl
TOV112D COUP-TFII-4,pert
Male 8weekBL6 shamrep1,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 29,ctrl
Phan_005_WT.bleomycin rep2,pert
strain: C57BL/6;	genotype: WT;	gender: Male;	age: 9 weeks;	tissue: kidney;	treatment: intraperitoneally injected with a single dose of vehicle (saline),ctrl
braak stage: BR12;	rin: 72;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
Sendai virus infected mouse tracheal epithelial cells.,pert
Argyrin A treated 12h_1,pert
Heart left ventricle WT-PBS replicate 3,ctrl
genotype/variation: Fmr1 knockout;	tissue: blood;	gender: Female,pert
01B Con,ctrl
PsOEt-24-Week 2,pert
E14 - nudelko/+ 3,pert
CML-BM 8,pert
Md02h025,pert
Diaphragm 56 Day control rep 1,ctrl
OSE_470,ctrl
WT_02,ctrl
"brain, hippocampus",ctrl
"Acute Myeloid Leukemia, sample 54",pert
day 1 5-FU HSC 2,pert
LJMJDW12,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID309,pert
siERK5E2 2,pert
IFN_Gamma_6hr_rep2,pert
BJ fibroblasts,ctrl
Spleen_ko_1m_rep2,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 24.116;	Ratio: 2.13,pert
01LNL: normal control,ctrl
whole tissue section from case 1085,pert
SF539 scramble siRNA replicate 2,ctrl
HUVEC/NmenMC58_WT_1h_rep2_1108,pert
PGC-1a KO mouse striatum,pert
WT C,ctrl
WM164 Melanoma cell Line,pert
Postmenopausal female. Estradiol treated. Patient 24.,pert
5091212024_F,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T2N1,pert
SKBR3_0.1uM_Lapatinib_3,ctrl
Cell line HeLa_c-myc KD_expt2,pert
HET Brain 59d Mouse1,ctrl
Multiple Myeloma Patient 3,pert
"LckCre Dicer lox/lox KO, biological rep1",pert
cell line: TOM-1;	tissue: Human B cell precursor leukemia,ctrl
"seminoma specimen, pT2, patient age: 40y; W03 025",pert
Mammary gland R1 24 hr rep4,pert
GM19238_Kd_BATF_3,pert
AZ-521_uninduced_24h_rep1,ctrl
"breast, post AFI treatment (H6_1346)",pert
D final PC3 AA 2hr,pert
WFS1 WT USHT_14_317_ko,ctrl
695-EV_24hr,ctrl
Normal Puerto Rican control 1,ctrl
"schizophrenia, BA46-81",pert
Lmx1b -/- E11.5 proximal hindlimb pool 1,pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: gastric cancer,pert
11086 Normal Uninflamed descending colon,ctrl
"Setd2 wild type mESCs, biological rep2",ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4424,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q,pert
Carrier-inj_C57_rep1,ctrl
SP-KO-Nrf2-Female-1,pert
Leg 28 Day control rep 1,ctrl
ku86(wt)_Terc(wt)_2,ctrl
"Amniocytes, euploid, 1567",ctrl
"39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
N40975,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: oral cavity;	donor sex: female,pert
shCON1,ctrl
coc-16,pert
C57Bl6N Mouse;	gd17.5 fetal heart,ctrl
control peptide-treated DND41 100mM 16h,ctrl
6P-ER-ND,pert
"Control, sample 2",ctrl
CA3,pert
"Patient H-c1095T, MSI colorectal tumor",pert
kidney biopsy from patient after Tumor Nephrectomy,pert
Patient: H;	Time: 1 week;	Group: responder;	Condition: lesional,pert
del337TR replicate 5,pert
striatum_ctip2_KO_2,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50).,pert
isolated keratinocytes from mouse skin,pert
Gene expression profiling of normal cortex of patient 42,ctrl
sample: #22;	subject: PD case #5;	brain: T-72;	age: 81;	sex: Male;	region: Inferior olivary nucleus,pert
tissue: Hippocampus;	age: 74;	Sex: M,ctrl
HP-45c,ctrl
06R044 Control,ctrl
"brain, cerebellum: RNA#41_le1",pert
Day: 12; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 2,pert
Cre_day_5-3,pert
lymphoma_1032_nt,ctrl
"Patient  K, lesion, time: 0",ctrl
condition: Normal;	patient: N_LJ_5;	tissue: Normal skin biopsy;	kit: Affy,ctrl
subjectid: 5269;	imatinib: NoIM;	lbh589: NoLBH,ctrl
healthy myeloid cells 8,ctrl
"Patient 116, baseline",ctrl
"Brg1 KD, replicate A",pert
"Wistar Han;	Crl:Wi(Han), Male, tissue: Heart",ctrl
14dpp wild type testis,ctrl
tissue: tumor;	disease state: IDC,pert
Cell line BT-474_control_expt1,ctrl
Sample M537,pert
HPB-ALL NBD 2,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 1",pert
MO_DH3c_SON_NCBI,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 368;	age-at-biopsy-years: 49,ctrl
human pancreatic cancer cell line BxPC3 transfected with control vector,ctrl
ERRa KO biological replicate 3,pert
U-87 cells transfected with sh-p105 RNA and treated with DMSO for 16 hours,pert
"brain, cochlea: [9] Sample #9_le1",pert
"CD3+ T cells, peripheral blood, SAA patients post therapy / in hematological remission",pert
2946-scrape,pert
3_month_old_Prnp_knockout_mouse_rep1,pert
erStress_twins_AA_1712twin2_500nM_thapsigargin_4h,pert
Undifferentiated Dicer +/- (D4) ES cell line replicate_1,ctrl
Individual_3983_PN_sample,pert
020109-3,ctrl
AIRE ko CD80lo mTEC sample1,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.41918,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.2;	colon weight (mg): 156;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.057;	tissue: colon;	treatment: 5% DSS,pert
healthy myeloid cells 6,ctrl
"3mg/kg/day PFOA, Rep 5, Block 2, lung (low dose)",pert
RAW_0mM_HOCl_#4,ctrl
HepG2_Phenol rep3,pert
tissue: peripheral blood;	subject: Control;	rna prep: PBMC;	molecule: RNA extracted from PBMC,ctrl
SLE myeloid cells 12,pert
Gastrocnemius muscle mRNA from old (24 month old) knock-out mice,pert
WT thymocyte,ctrl
cell line: SKBR3 parental;	treatment: 1uM Lapatinib,pert
17beta estradiol: 10 pM,pert
fibroblast-derived iPSC,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 90;	Usage number: 4;	Exposures: 3,pert
695_EV_2hr_repeat,ctrl
n23,ctrl
RNA from microdissected breast cancer cells from case 374 labeled with Cy5,pert
Psoriatic arthritis PsA 18,pert
"TNFa-OMe-P siRNA-C, replicate 2",pert
KN-sham-2 month-R2,pert
microdissected breast cancer cells from case 856,ctrl
HCT116_shN91_rep3,pert
mutant_ANT_PDE_A6,pert
fibroblast,ctrl
HeLa cells control 3 (Luciferase siRNA transfection),ctrl
umbilical cord_bpd: 2B,pert
ic23 -- mock APF on membrane B,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.920;	Ratio: 2.12,pert
Cell line HeLa_c-myc KD_expt1,pert
mutant Ndel ko/+ inbred,pert
rat hippocampus (CA1 region)_sham,ctrl
PBMC_S1,pert
disease state: paediatric glioblastoma;	age: 6;	gender: F;	h3.3_status: K27M,pert
Tumor_setB_Ker81,pert
SA3,ctrl
"Lymphoblastoid cell lines derived from family 1712, member 1",pert
ILD_16,pert
Non-Transgenic replicate 2,ctrl
normal bone marrow NBM2,ctrl
3527-lcm,pert
HEK293_Normal_24h_Illumina,ctrl
Heregulin 979-CLA-35,pert
2079N,ctrl
Mouse old heart C30-Ht-1,ctrl
L1 062502 Tro2,pert
"alveolar macrophages, non-smoker 014",ctrl
E9.0 embryo yolk sacs,pert
KO_lung_bleomycin,pert
MDA-MB-231 cells_siLuc transfected_3 days post-tranfection,ctrl
Cmah KO_liver _1,pert
s5t3c,ctrl
Control_24h_rep3,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#136,pert
"ALL_DS, K6 011509",pert
UM17_Mtu_rep3,pert
Panc0504 rep-2,pert
"P40_wt cones, replicate 1 [array]",ctrl
HepG2_Cr rep1,pert
esophageal squamous cell carcinoma from patient E1566,pert
K_LS_Wk12,pert
"DHL4, R406, 6h",pert
Carboplatin;	Carboplatin 36 hours set 1,pert
MBD1 KO #2,pert
lung_E18_wildtype_rep2,ctrl
5267 UC Inflamed sigmoid colon,pert
RNA from HCC_7T,pert
Fourth shYY2,pert
"wildtype mouse embryonic fibroblast, biological rep 3",ctrl
Carbo Day2 (409L),pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep1",pert
PFC S control 1,pert
non-treated CCRPKO_rep-2,pert
tissue: full-thickness skin;	age: newborn (P0);	genotype/variation: Krt1-/-;	strain: C57BL/6,pert
whole tissue section from case 1343,pert
cell type: primary mouse microglia;	genotype: TLR4 knockout,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 42,pert
"3T3-L1 siControl 24h, biological rep 2",pert
race: caucasian;	age (years): 58;	stage: IA;	grade: 1;	histology: endometrioid,pert
Waldenström’s macroglobulinemia (WM-BL 31489),pert
"WildType mice with water, replicate 2",ctrl
"RORalpha1delDE, 2",pert
lucif_3,ctrl
"Human cutaneous T cell lymphoma HuT-102 cells, shRNA-TAK1",pert
KU_16T,pert
CH2118,pert
RNA-DHL6-R406-6H-1,pert
sMPNST_shCONTROL_3day_rep1,ctrl
Rybp#10 (OHT+)_12d_rep2,pert
ILKR211A2,pert
Individual_4362_PN_sample,pert
9-cis-retinoic-acid_Lung_2,pert
hepatocytes treated with 467 μM MDBP,pert
CLL20-CD8,pert
MRF control Oligodendrocyte Replicate 2,ctrl
Fetal heart control 8,ctrl
Bronchial Epithelial Cells SA biological 1661X,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 30.2026009582478;	age of psoriasis onset: 30,pert
"Peripheral blood, patient without recurrent events [N42]",pert
A2008+(2),pert
No_DHT_control_2,ctrl
Control for EGF 12h replicate 1,ctrl
Ls174T-pTER-β-catenin con1,ctrl
Total RNA Wildtype-2,ctrl
KO - 3 mo - repeat 5 - Cy3 - mAdbID:74676,pert
major non-tumor6,ctrl
NS2_NS010119,ctrl
male_alcoholic_466,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: moderately severe;	Ig clonality: oligoclonal,pert
control mouse WT7,ctrl
background mouse strain: C57BL/6;	source: liver;	genotype: Rap1 knockout,pert
WT STR PDE10i 14,pert
SV589_NoKD_Serum Starved -> 3hr EGF,pert
IRF4-control_Th17_cells_42hr,ctrl
Gene expression profiling of normal cortex of patient 325,ctrl
25 uM cyfluthrin batch 3,pert
HUVEC/NmenMC58_frpC/frpA_4h_rep2_1112,pert
N22,ctrl
Fetal heart control 2,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 1,ctrl
HUVEC treated with Non-sense SiRNA  biological rep2,pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC;	2nd technical replicate,pert
Bone-Marrow_MM_M942,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L015,pert
Heart_WT_3,ctrl
"Knockout sham, biological rep2",pert
"liver, PPAR WT_ctr_52",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Male,pert
treatment: naïve;	transgenic variant: AChE-R;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,pert
A2CNT3,ctrl
"non-AD_TC, biological rep6",ctrl
histology: control;	disease state: healthy control;	tissue: brain white matter,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#1233,pert
gender: Male;	age: 91;	post-mortem delay: 13h;	ph: 6.3,ctrl
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 40;	gender: f;	treatment: NSAIDs,pert
batch: A;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,ctrl
n09,ctrl
colon_C57mouse_6weeks_rep2,ctrl
EB_6_5d_294_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-6;	Primary Site:Vestibule;	Age:72;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
Sprague-Dawley rat diaphyseal femur,ctrl
Lmna H222P homozygous male 3,pert
Aorta_APOE-deficient with atherosclerosis_1,pert
Sox3 null Sample 4,pert
Primary hepatocytes isolated from Donor 4 treated with DMSO for 24h,ctrl
"knockout liver, biological rep 2",pert
liver-AHRWT-cornoil-rep5,ctrl
Bone-Marrow_SMM_S1403,pert
"nasopharyngeal carcinoma, specimen T19",pert
"Cell line SLM2, mutant status WT, condition Treated with Sorafenib 2",pert
cell line: Normal bone cell line 695;	phenotype: Parental;	cell type: human osteoblast (hOB),ctrl
Subject #8019-2d Postinfection,pert
individual: Control6;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"mutant triceps, biological rep2",pert
db/m 3-3,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous endotoxin challenge""",pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 34;	Usage number: 1;	Exposures: 4,pert
WT / Reference_13425560,ctrl
PPC1_non-target shRNA_replicate 1,ctrl
"20 days old prosaposin knockout mice, cerebellum",pert
brain_healthy_control_sampleid_jg1744,ctrl
patient E1584,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: monosomy7/del(7q),pert
Frontal_Cerebrocortex_Vehicle_6hr_rep3,ctrl
Aorta_APOE-deficient and captopril treated_1,pert
No or early 2 rep8 (retina),pert
Lung-sarcoidosis-rep2,pert
Brain_Adult_Salineip_4hr_mouse1 (YP1_#58),ctrl
ILD_20,pert
RNA from whole tissue section of case 605 labeled with Cy5,ctrl
PGA-RMM-15m-1aA-s2,pert
heart MHC-Plin5 4,pert
braak stage: BR34;	rin: 63;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 5,pert
Pax_S1,pert
RNA from microdissected breast cancer cells from case 1205 labeled with Cy5,ctrl
"lymphoblastoid cell line from F6.01, one out of seven of sensitive group, 50*10e6 cells",ctrl
ab010 IM,pert
nTreg cells WT,ctrl
"brain, adrenal medulla: Sample#A4 (Exp pt 4)_e1_le1",pert
2907-lcm,pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
age_years: 66;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
1218-6C,ctrl
"Placebo treated, HIV-1 positive male, day 14 (4)",ctrl
NORMAL #00-0074,ctrl
gender: female;	age (years): 47;	evolution time (years): 1;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
Ad infected murine liver-MO30k-(665)-6 hpi,pert
L428+MAT_rep2,pert
"male,15,Caucasian",pert
umbilical cord_nobpd: 7I,ctrl
EF1a-control_2,ctrl
"Well-differentiated human lung epithelial cells, infected with KY/136 (pdmH1N1) for 36h",pert
OVCAR-10-(3),ctrl
striatum_wild type_18 month_replicate 3,ctrl
wild type BxPC3 cells,ctrl
first-episode BP patient 77_biological replicate 2,pert
LT 407 +/T after nicotine-induced seizures,pert
cell type: primary mouse microglia;	genotype: wild-type,ctrl
Capan2_NC-2 biological rep2,ctrl
status: Slow;	age: 73;	gender: male;	tissue: cultured human fibroblasts,pert
siLMO3_oligo1_0_rep2,pert
"Trip12 mut/mut, biological rep2",pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/lacZ; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 18.5; Tissue: whole kidneys from 9 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 16 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
BM_02417,ctrl
"fibroblast, control subject NM4 rep 1",ctrl
"S1P3-KO-hippocampus, biological rep5 (female)",pert
major non-tumor8,pert
tissue: brain;	genotype: WT;	genetic background: C57BL/6,pert
"Total RNA, Tet2 KO LSK",pert
ErbB2 1,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MEF2D shRNA,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 8h,pert
colon_epithelium_IL10mouse_12weeks_rep5,pert
sepsis patient #3,ctrl
YFP+Foxp3+ r1,ctrl
A375 control-3,ctrl
OCI-Ly7 NTsiRNA 2,ctrl
HepG2 cell line from ATCC at 8th generation after 6 hours of PCB77 treatment.,pert
3 h-apra-2 nM,pert
CLL 149-05 LMP-420,pert
KU_37T,pert
"COP strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
Pancreatic Sample 20-Tumor,pert
AtT20 cells treated with control siRNA rep 2,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 31.41096,ctrl
Healthy control c3,ctrl
Regulatory T-cells CD4+CD25+ from wild type mice,pert
"Mel18 shRNA, biological rep1",pert
lesion_preUV_patient1,pert
ab149 N,ctrl
Neuroretina 8-week old db/+ mouse: BKS.Cg- (lean)/OlaHsd,ctrl
"WT caudal vertebral bone, rep4",ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 99;	Usage number: 1;	Exposures: 2,ctrl
GFP- cells from Sox9-EGFP Mus Musculus pancreas at p23,ctrl
"Patient  A, lesion, 4 week",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.9;	age of onset: 16 yr,pert
"U-87 glioma cell line with shp105, biological rep1",pert
tissue: Lung;	strain: B6D2F1;	infection: uninfected;	time: control,ctrl
U-87MG-PK19 set 3,pert
EDL-t7; transgenic extensor digitorum longus 7 month,pert
MDA cells resistant to paclitaxel,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 6,pert
CH2127,ctrl
STHdhQ111/Q111-C,pert
clone 2-1,pert
"Overexpress TFPIbeta, biological rep. 1",pert
E16.5 Top2b+/+ brain,ctrl
Muscle PCOS after pioglitazone 202,pert
Nonlesional Epithelium Psoriasis rep4,pert
Saline T00278942,ctrl
platelet_sickle_17,pert
Muscle JDM (YJD-JDM-10UA-S2),pert
tumor cell line HepG2 with knockdown of HIF-2α rep1,pert
Kidney_Biopsy_Liver_Disease_7,pert
Muscle JDM (YJD-JDM-12UA-s2),pert
EB_0_6h_49_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
VGLL4 HUES6 1,pert
MacularDegen-injured-4cAv2-s2,pert
WT_P14_D3_Effector_rep3,ctrl
Sle1a R1,pert
"33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
EA_Case5_CD4,pert
EB_0_24h_57_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
"Huh7 cells, JFH-1 Infected, 12 hours",pert
tissue: Hippocampus;	age: 90;	Sex: M,pert
"MCF7 cells, RL silenced, LIF 1h",pert
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 24 hours,ctrl
"MCF7 cells stably transfected with pCDNA3.1, passage 6",ctrl
Brg1 mutant 2 cell embryo rep2,pert
EP47_adipose_pcos,pert
CME-Emerin3d-2MA-S2,pert
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID365,pert
colon_IL10mouse_12weeks_rep1,pert
KU_32N,ctrl
Cisplatin-treated Rb-/- MEFs-a,pert
FVB_6h_DMSO,ctrl
"siDsRed-2, biological rep2",ctrl
neuron_rep8,ctrl
TRPM2-AS siRNA rep1,pert
ID: MLL_00109;	cell type: PBMC;	disease state: control,ctrl
"P16 control OC base, biological rep 1",ctrl
MF-35,pert
Muscle control (YJD-JDM-54UA-s2),ctrl
Testis CREMKO 0h batch 4 [TeKOh00.28],pert
Tolerizing allografts 70 days No.2,ctrl
A2008+(1),pert
Human wildtype induced pluripotent stem cells,ctrl
tissue: peripheral blood from 8-10 E12.5 embryos;	genotype: Cbfb-/-;	progeny from cross: Cbfb+/- x Cbfb+/-,pert
"Hdh knock-in embryonic stem cells, Q111 line, biological replicate 1",pert
cell type: Human melanoma cell line;	cell line: M238;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
220D0,pert
liver from Cmah KO mouse,pert
VPA Treated Rep 4,pert
SLE CD19 B cells 1,pert
pediatric AML S30,pert
developmental stage: E14.5;	genotype: PtenloxP/+ and PtenloxP/loxP,ctrl
NPC Brain 37d Mouse1,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-18;	Primary Site:Floor of Mouth;	Age:52;	Sex:M;	TNM:T4N2M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	;	",pert
HeyA8-(1),ctrl
Seguin_IDR_BrownNorway_Liver_control1,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 27.08767,pert
agent: control;	strain: DBA;	tissue: mesentery,ctrl
05_PAH,pert
BL6_6h_Wy,pert
mef2a_1,pert
NBD inhibitory peptide-treated HPB-ALL 100mM 16h,pert
09SAGEA2,pert
chip number: 1;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.8;	transfection date: 2011-03-29,ctrl
Cervical Cancer C437,pert
SF539 PARK2 siRNA#1 replicate 1,pert
platelet_Ctrl_11,ctrl
Scrapings of the distal colon mucosa,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: non-treated;	tissue: liver,ctrl
mouse cerebellum at P30 knockout 3,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 82, HPV 16",pert
whole tissue section from case 1437,ctrl
DN4 cells sorted from mouse n°135 (Cre+),pert
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep3,pert
MPA 1,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: NLGN3 shRNA,pert
skin.wt.replicate6,ctrl
5922012047_D,ctrl
MRF control Oligodendrocyte Replicate 4,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 316;	age-at-biopsy-years: 39,pert
S4,pert
"Acute Myeloid Leukemia, sample 51",pert
COLO829_shSCR_DMSO_A,ctrl
strain: FVB;	developmental stage: newborn (4-day-old);	tissue: hippocampus;	genotype/variation: Prnp+/+,ctrl
"depression, BA10-35",pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID137,pert
Ischemic cardiomyopathy_G53,pert
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 6 hours",pert
healthy control sample x005,ctrl
"MLD, biallelic AML MLL_00259",pert
"Neuroblastoma SH-SY5Y cells, transfected with scramble control",pert
Hunk WT rep6,ctrl
WT12,pert
6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24723,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M0;	flt3 status: WT,ctrl
"Mice_non trans, biological rep1",ctrl
BP patient 91_biological replicate 1,pert
"Nickel 140 µM, biological rep4, repeated microarray",pert
IFNb-treated MEF 3,pert
Caco2-siRNA2-rep1,pert
HEK293 cell line #1 with uninduced HNF1alpha,ctrl
H18 HA 12h 1,pert
SV589_8DKD,ctrl
Seguin_IDR_BrownNorway_Liver_control3,ctrl
Thyroid_papillary carcinoma 67,pert
"CD14+ at baseline, biological replicate 3",ctrl
Ls174T-L8 dox3,pert
MDS patient 88,pert
Dgcr8 KO replicate 3,pert
G93A non transgenic littermate 805,ctrl
Huh7 cells_JFH-1 Infected 18 hours_ rep1,pert
Wild type caerulein rep1,pert
4_b,pert
"Ctrl OBCs, post doxycyclin withdrawal, rep4",ctrl
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; no EGF,pert
COLO829_shSCR_DMSO_B,ctrl
MCF7_E2_24h_rep1,pert
ILKR211A1,pert
bronchoalveolar stem cells,pert
Tissue: tumor; Gender:male; Age:33  Tumor stage:T1N0MX,pert
CME-Emerin3d-3MA-S2,pert
"wt, 2 ug/ml doxycycline",ctrl
JIA PBMC Pre treatment A235_L015,ctrl
"Empty vector, collagen plate, rep1",ctrl
patient: 4;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Gender:F;	Age:49;	Tissue:Mucosa,pert
S49 Murine T-Lymphoma Cells,ctrl
Ing1-/-_MEF_rep1,pert
8 hour tunicamycin CHOP-/- C,pert
PGA-RMM-330m-1aA-s2,pert
"Ulcerative Colitis (27 year old caucasian female, SAK_1286520426)",pert
C_AN14757_F,ctrl
"PPARg d2, rep 1",pert
GM19238_Kd_STAT6_3,pert
siHIRA 1,pert
OSCE-18T,pert
H4-II-E-C3_high_rep1,pert
Muscle-AMPKgamma3-ko-5,pert
KM_056T,pert
"brain, hippocampus: PH4_e1_le1",pert
"wild type ES cells, biological replicate 1",ctrl
"fibroblast, control subject NF12 rep 1",ctrl
"Control Proximal, Small Intestine 2 21 days old",ctrl
Parkinson's disease sample x204,pert
V5-P597,pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep4",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 2x1h exposure per day",pert
"Patient 2, Atheroma plaque",pert
A375 cells 24h Control rep1,ctrl
5271 UC Inflamed sigmoid colon,pert
CD4IncTp2-4,pert
Ulk1/2-/- + IFNβ 2,pert
subject: 19U;	cohort: 19;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 79kb;	age (y): 41;	Sex: F;	batch: Batch_4,ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.60;	Post mortem interval (hours): 11;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Peripheral blood mononuclear cells;	TTF=70min;	Race=White;	Sex=Female,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.413;	OD280: 1.719;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 323;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Msgn1_48hMinDox-biological rep3,ctrl
"A673 treated with DMSO vehicle control for 3 days, biological rep1",ctrl
ILD Study Number 1074,pert
Neonatal mouse ovaries cultured in Menadione (5uM),pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 62;	gender: m;	treatment: NSAIDs,ctrl
clone type: AtT20 clone types infected with empty vector rep2,ctrl
BL Day 1 siMut10 transfected biological rep3,pert
WT vehicle (7991003040_E),ctrl
46A;pretreatment;female;breast tumor; not assessable,ctrl
"RES-enriched Grape extract group, 6 months, patient number 22",pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 8.1;	colon weight (mg): 200;	colon ratio (mg/mm): 2.47;	myeloperoxidase activity (u/mg): 0.016;	tissue: colon;	treatment: 5% DSS,ctrl
brain_DLPFC_bipolar B_mr613,pert
CML_3_HSC,pert
Heart RNA,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 40, stage IIIB, HPV 16",pert
H1299_shPTK7,pert
MCI-020,ctrl
"non-AD_TC, biological rep16",ctrl
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 1,pert
microdissected epithelial cells from normal main pancreatic duct 5,ctrl
H2med,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 73,pert
Gender:M;	Age:36;	Tissue: Mucosa,pert
genotype/variation: ApoE-/-;	strain: C57BL/6;	mouse provider: Jackson labs (backcrossed >10 generations against C57BL/6 background).;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: diabetic,ctrl
"Retina from control mouse at ZT20, biological rep 3",ctrl
"129P3/J ACU, Rep1",pert
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P1,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,ctrl
Cerebellum_nontransgenic control X50_16 months_replicate 3,ctrl
"patient 15, right arm treated with pimecrolimus until day 22",pert
"Normal subject (42 year old caucasian male, SAK_1782808510)",ctrl
"Cultured ovarian cancer cell line HeyC2, Cisplatin treated",pert
"LCL GM19238, Kd RDBP, 72hrs",pert
"Brg1 KD, replicate B",pert
siRNA Med12 [K3],pert
liver western diet rep2,ctrl
phenotype: alcoholic;	gender: female;	case_id: 402;	age: 75;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 9;	brain ph at time of freezing: 6;	labeling_batch: 1,pert
CD19_selected_B-cells_before_R_rep2,ctrl
RNA from HCC_6T,pert
"Normal cervix epithelium, Age 49",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 75 years,ctrl
LIN-CB,ctrl
Total RNA from Ph+ ALL (C57Bl6),pert
TB 2,pert
N10A Normal-frontal,ctrl
"heart, non-transgenic mice at 90 days of age",ctrl
"fibroblast, control subject NF4 rep 2",ctrl
"NPTX1 shRNA Day 2, biological rep3",pert
tissue: left lung;	genotype: Gata5 KO;	age: 8-week-old,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: Wy14643;	time: 6h;	gender: Male;	age: 2 months,pert
E14 - 14-3-3Epsilon 1,pert
TN 1,ctrl
Nonlesional Epithelium Nonatopic Control rep4a,ctrl
45A;pretreatment;female;breast tumor; responder,ctrl
"BL6/C57 mouse heart, control, rep1",ctrl
"pancreas, ethanol diet, replicate 1",pert
"PC-3 Gefitinib, biological rep1 [mRNA]",pert
Tsc1-deficient CD4 naïve cells KAI279,pert
A263insGG_mut4a-,ctrl
061J0: normal control,ctrl
Substantia nigra normal rep6,ctrl
Morbidly obese PCOS patient,pert
HP-23,ctrl
Ctr MCF10A.B2 2,ctrl
"Brain tissue from Fisher 344 male rat, Animal #266, 20mg/kg D-Serine",pert
WT inbred background,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: pre-UV,pert
Gene expression data spleen follicular B in IRF8 conditional KO,pert
gender: male;	dietary group: resveratrol-enriched grape extract (C);	time point: 6 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),pert
phenotype: alcoholic;	gender: male;	case_id: 326;	age: 61;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 21;	brain ph at time of freezing: 6.93;	labeling_batch: 2,pert
"Neo6, no treatment",ctrl
human esophageal squamous cell carcinoma cell line_KYSE50,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA) post therapy / in hematological remission",pert
A_Kin_3,pert
SRF silenced EtOH rep 2,ctrl
WT HPC PDE10i 10,pert
WT5 SPLEEN,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 46 yr;	population: white,ctrl
"brain, cerebellum",ctrl
control MLL_00110,ctrl
Tissue: HepG2 cells;	Gender: Male;	Source: ATCC;	1st technical replicate,pert
UTX knockout (KO) cell line 2,pert
cells: spleen marginal zone B cells;	genotype: WT;	genetic background: C57BL/6J,ctrl
C2C12 myotubes 10uM H2O2,pert
cDNA ak 12,pert
strain: 129;	cell type: EBs;	genotype/variation: Trim33-KD,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_4mM_HG-U133A_2_YCHSUP501,pert
phenotype: control;	gender: male;	case_id: 367;	age: 57;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 18;	brain ph at time of freezing: 6.6;	labeling_batch: 1,ctrl
10_C57_KO,pert
+4hr Wnt (dye swap),ctrl
CD-48-un,pert
9-cis-retinoic-acid_mammary_3,pert
Epidermal keratinocytes treated with EFNA4 for 24h,pert
TF1_controlsiRNA_1,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 18 weeks;	genotype/variation: VhlhKO",pert
"vastus lateralis biopsy, 56 year-old healthy sedentary male (#3)",ctrl
liver_wild type_12 weeks_replicate_1,ctrl
Adult 7d SNI; Biological replicate 4,pert
tissue: lung;	genotype/variation: Tmem1002loxP/2loxP;ROSA26+/CreER,pert
117A,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 24h,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: A;	experimental sample name: PC4-R,ctrl
KU_06T,pert
Liver-24 month-wild type-technical replicate 2,ctrl
Thyroid_ unaffected_paired with PTC77T,ctrl
E12 embryo proper,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.692;	OD280: 1.387;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 49;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
gender: Female;	age: 88;	post-mortem delay: 7h;	ph: 5.7,pert
cerebellum_Pink1 knockout_18 month_replicate 3,pert
HL60-shGSK3A-Construct6-rep1,ctrl
DMN-CtrHippo10d-2bAv2-s2,ctrl
"Control pancreas, sample 2",ctrl
Control (C277),ctrl
t01,pert
Patient 4 b,pert
Wild Type Time 1 replicate 1,ctrl
Untreated WT - repeat 4 - mAdbID:102768,ctrl
BS2011051053,ctrl
Hippocampus of 2 months old Rsk2-KO males,pert
cell line: HL-60;	replicate: Replicate1;	treatment: shLuciferase,ctrl
Mc3T3 AA_ 5day_rep3,pert
R6/2 (untreated) 5213,pert
85 year old male,pert
BAT_KO_5,pert
KN-sham-5 month+13d-R4,pert
age: 58;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
GV oocyte_Rnf2 mut_rep2,pert
LY2 control-siRNA tamoxifen treated rep1,pert
"NASP siRNA treatment, sample #4",ctrl
MIY_day_7-1,ctrl
"whole-blood leukocytes, placebo, 0hr",ctrl
"208, MUSCLE, After",pert
RO38,pert
THRA wt + T3 replicate 3,pert
"C57BL/6J ACU, Rep2",pert
"Cell culture. A549 treated by MK886, control 4",ctrl
CON_C,ctrl
Male 8week AJ CBDLrep1,pert
"LCL GM19238, Kd SP3, 72hrs",pert
"Grape extract group, 6 months, patient number 56",ctrl
CML_3_MEP,pert
WT1R1,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 41;	gender: male;	tumor grade: AII,pert
483MM,pert
Normal-ERα-positive breast cancer 49,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: EtOH;	time: 4h,ctrl
"LCL GM19238, Kd PAX5, 72hrs",pert
[OBF-1]-2,pert
chip number: 15;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.74;	rin: 9.5;	transfection date: 2012-03-26,pert
"NALT infected with 90-226 deltaM, 24h, biological rep3",pert
MDS patient 163,pert
cell type: Primary hepatocytes;	donor: 1;	agent: Wy14643;	time: 24h;	gender: Male;	age: 63 years old,pert
adipocytes expressing GFP,ctrl
WM-266 cells transfected with CONTROL siRNA - Replica 1,ctrl
A549 AZA 3 uM (3214),pert
kidney from Cmah KO mouse,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 69;	tissue: Blood,pert
genotype/variation: MBD1 WT;	tissue type: thymus;	cell type: medullary thymic epithelial cell (mTECs),ctrl
12459 Normal Uninflamed descending colon,ctrl
Cell line: SUP-B15,ctrl
CD8+_Tcells_non_severe_asthmatic_4,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 347;	age-at-biopsy-years: 43,ctrl
A673 cell line that has been treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50).,pert
Embryonic Stem Cells,ctrl
02-P CF,pert
WT 3 1782,ctrl
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 5,pert
PTC BRAF mut 13,pert
1099-03-A,pert
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 1",pert
C2C12 myotubes 0uM H2O2 rep 3,ctrl
U937_naive_untreated_4h_rep2,ctrl
Muscle PCOS case 231,pert
A549 DAC 1 uM (3220),pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 4",pert
MO_DH1c_SON_NCBI,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 87;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
Glioma cells expressing Cyr61,pert
"Deltoid, control, cohort 07, subject 07U",ctrl
PBMC_C4,ctrl
"fibroblast, MFS subject GDO1051 rep 4",pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 2",pert
"MCF7 cells, RL silenced, NS",ctrl
HCC_11N,ctrl
Txnip deficient tumor 24 months sample 1,pert
Muscle PCOS control 15,ctrl
con-9_C,ctrl
Series 3; young; 6 weeks after fracture,pert
"lung, chronically exposed to silica",pert
8x  Ez f/fMef2c-cre,pert
HPB-ALL Control 1,ctrl
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed ,pert
HEK293_MIF siRNA 2#_24h_Illumina,pert
Strain: C57BL/6J;	Gender: male;	Age: 8 weeks;	Tissue: whole brain,ctrl
"4B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
lymphocytes_HD_F_43y_2,pert
Clozapine treated 12weeks AffyGC RMA rep1,pert
siCABIN1 3,pert
cell type: dental pulp cells,pert
Male mice from mdx (C57BL/10ScSn-Dmdmdx/J) line were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,ctrl
CD34-005,ctrl
Individual_5325_PP_sample,pert
"Ishikawa cell line, BPA, 100pM, 24hr",pert
Dysf -/- QF muscle,pert
human esophageal squamous cell carcinoma cell line_KYSE180,pert
BCell_lymphoma_transitional_sample2,pert
brain knock out replicate2,pert
genotype/variation: c-Myb sufficient;	age: 4-5weeks,ctrl
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
6h_RA2,pert
Lung Tissue,ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 24 hrs,ctrl
Total RNA,ctrl
EA_Control2_CD20,ctrl
Pax3 WT E14.5 palatal shelves 11,ctrl
MDA-MB-231_siZMPSTE24_rep.1,pert
5260 UC Uninflamed descending colon,pert
0152-01-C,ctrl
cell line: Y79;	passage: 25;	cell type: Retinoblastoma,ctrl
TOV112D cells_treated with NSC319726_biological rep3,pert
"Transgenic, snap frozen, gastrocnemus muscle, 7month age animal",pert
Empty vector replicate 1,ctrl
monocytes_T14_rep3,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.621;	OD280: 0.822;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 130;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Human lung adenocarcinoma cells_Nrf2 siRNA transfected,pert
Sex: female;	Age at operation: 70 years;	Site: upper arm;	Size in cm: 3x5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Wild type_kidney_1,ctrl
Lmx1b -/- E11.5 proximal hindlimb pool 2,pert
genotype: Wild Type;	stimulation: non stimulated;	cell type: B cells,ctrl
Mening UNSTIM WB SW 1b,ctrl
T2-FP_spleen_wt_rep2,ctrl
cell line: Du145-PCAT1 (HTB-81);	age: < 20 cell passages from derivation,ctrl
"E2A CLP LY6D-, biological rep2",pert
heart from Cmah KO mouse,pert
A515 MI 7 day,pert
"MLD, biallelic AML MLL_00266",pert
agent: LMP-420;	selection protocol: negatively selected cells,pert
"Cervical cancer cell line, HT-3",pert
RAW_0.35mM_HOCl_#3,pert
Ebola-infected macrophages harvested at 6h post-treatment from donor 2,pert
T2C-LU,pert
H4-II-E-C3_untreated_rep3,ctrl
E14.5 fetal liver TER119- wildtype,ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 24 hr,pert
BCells_WildType_day2_REP3,ctrl
Liver sample from Control group (N53),ctrl
"IN1472 siPD treated, Biological replicate1",pert
"24hr non-specific siRNA, 16hr vehicle treatment replicate 1",ctrl
RNA from HCC_16N,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2. Sample A,pert
"Crohn's Disease subject (46 year old black female, SAK_1307657998)",pert
RNA from microdissected breast cancer cells from case 1279 labeled with Cy5,ctrl
ET 5,pert
microdissected breast cancer cells from case 662,pert
"adenocarcinoma at 20wk, biological rep 1",pert
"Biceps, FSHD, cohort 19, subject 19A",pert
chip number: 14;	transfection plate: 5;	target gene: RXRA;	kd level: 0.88;	rin: 8.9;	transfection date: 2011-10-17,pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 85;	Usage number: 1;	Exposures: 3,ctrl
age: 35;	sex: F;	disease status: control subject;	Filter number: 87;	Usage number: 4;	Exposures: 3,ctrl
KN-smoke-med-5 month-R1,pert
female_control,ctrl
"C57BL/6 female sick, 125",pert
PU.1 KD HSC 2,pert
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 1",ctrl
LY2 control-siRNA tamoxifen treated rep3,pert
HRas-v12 transgenic female replicate 4 late timepoint,pert
P81 dilated cardiomyopathy heart biopsy,pert
patient id: 14;	tissue: Normal cortex;	gender: Female;	age: 64;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep5",pert
"LCL GM19238, Kd IRF7, 72hrs",pert
Dengue Hemorrhagic Fever Patient 60,pert
ILD Study Number 1039,pert
"10mg/kg/day PFOA, Rep 1, Block 2, lung (high dose)",pert
cerebrum_PSNA_ 4w_rep2,pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: WT;	age: 3-month,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 80;	Sex: male;	region: LC (locus coeruleus);	age: P24;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
"CD11b, KO",pert
N5+6,ctrl
DMN-CtrHippo18d-1cAv2-s2,ctrl
"Bone marrow-derived macrophages, MyD88 -/-, unstimulated, 0 minutes",ctrl
"0mg/kg/day PFOA, Rep 1, Block 2 liver (high dose)",ctrl
"ES cell control, RNA 297",ctrl
whole tissue section from case 59,pert
Parkinson's disease sample x109,pert
Tsc1-deficient CD8 naïve cells KAI288,pert
"Patient  E, lesion, 1 week",pert
cell type: PGC;	genotype/variation: Tcfap2c KO,pert
control mice colon rep 1,ctrl
Spleen_ko_4m_rep2,pert
"vestibualr organ at P90 of Igf1 +/+, biological rep 1",ctrl
"Histidine decarboxylase null myeloid-derived suppressor cell from colon tumor, rep1",pert
Control  VZ15,ctrl
scrambled biological rep3,ctrl
PBMC from T cell LGL leukemia patient #114 (TLGL114),pert
Whole testis from Ing2 WT littermate,ctrl
"E18.5 brain, Meg3 knock-out, rep 1",pert
"Untreated Testes, biological rep 3",ctrl
Hunk WT rep1,ctrl
KO-control-2,pert
negative control inhibitor (NTC1)_24-9,ctrl
Day: 15; Drug: Heroin; Phase: Withdrawal; Replicate: 2,pert
Disease_status: Healthy control;	Age (years): 61;	Gender: Female;	Post mortem interval (hours): 30;	Braak stage: 0;	Cause of death: Lung cancer,ctrl
FVB; No Treatment #9,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD20-APC;	cell type: CD20 positive B cells,pert
triplicate 3 of uninfected HepG2 nt cells,ctrl
KO_IL-6_400_rep3,pert
imr-32,ctrl
APOE_KO_NODM_9W_7,ctrl
"B cells, transgenic, unstimulated",pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID139,pert
Tendon_non-lesional_rep22,ctrl
HF1493_U133P2,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: severe stress + morphine,pert
colon_adenoma_980,pert
tissue: skin;	individual: Patient P4;	condition: AL;	eczema severity: SCORAD: 97.5,pert
WT-sham-1 day-R1,ctrl
"patient: 204;	current medication: AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin;	birth date: 8/15/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 7/1/02;	diagnosis date: 8/1/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/1/04;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 0;	nod 702: 0;	nod 908: 0;	dlg5 133a: 0;	nod 1007 fs: 0;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/58;	smoking stop date: 1/1/01;	smoking amount: 25+;	other illnesses: Type 2 DM 02/2004.-Gout.;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
"WT, LPS 1hr",pert
PGA-lv_1h_512,ctrl
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ shNotch3;	treatment: Ca 0.6mM, 72 h",pert
Wildtype 2,ctrl
Donor (Sample 16),ctrl
AKT_PLACEBO_12hours_2,pert
BAL_47b_A0B1,ctrl
chip number: 15;	transfection plate: 6;	target gene: NS;	kd level: NA;	rin: 9.6;	transfection date: 2012-03-26,ctrl
chip number: 13;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.62;	rin: 9.7;	transfection date: 2012-03-26,pert
C_AN04479_T,ctrl
CH1-(1),ctrl
atopic eczema P8,pert
"TNFa-OMe-P siRNA-C, replicate 8",pert
condition: Normal;	patient: N_LJ_1;	tissue: Normal skin biopsy;	kit: Affy,ctrl
tissue: liver;	treatment: vehicle;	strain: A/J,ctrl
Huh7 cells_JFH-1 Infected 18 hours_ rep3,pert
Liver_Nrf2 Control_rep1.,ctrl
Rat fatty liver15,ctrl
Bronchial Epithelial Cells MMA biological 2130X,pert
PE_D_647,pert
HeLa cell,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 4x1h exposure per day",pert
Recent-onset T1D_sample4,pert
cell type: Primary hepatocytes;	donor: 4;	agent: Wy14643;	time: 24h;	gender: Female;	age: 54 years old,pert
treatment: Arid3a overexpression high;	cell line: J1 ES cells;	sample type: single colony,pert
HeLa_01-04-05 TP3_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M1;	flt3 status: WT,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 13 days;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 15 days recovery, 3x1h exposure per day",ctrl
genetic background: C57BL/6;	tissue: liver;	genotype: LmnaG609G/G609G knock-in;	gender: female;	age: 3 mo,pert
Glioblastoma_3,pert
At Risk: +;	Age: 12;	Sex: M,pert
CD4DecTp2-12,pert
mES cells rep2,ctrl
Adult Sham; Biological replicate 6,ctrl
sample: #4;	subject: Control case #2;	brain: T-346;	age: 84;	sex: Male;	region: Inferior olivary nucleus,ctrl
Undifferentiated mouse embryonic stem cells,pert
RNA from microdissected breast cancer cells from case 1389 labeled with Cy5,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A and ZMPSTE24;	cell line: GM00038,pert
control participant P351,ctrl
sample =Healthy2 treatment=Control time=360 (min),ctrl
blank_5,ctrl
PGA-HMO-Obese-2aUA-s2,pert
"EBF1 d4, rep 3",pert
MCF10A-Her2-rep2,pert
Healthy controls; individual=CJ; time=2; beverage=water,ctrl
"TAMs sorted from vehicle control tumors, biological replicate#2",ctrl
cell line: U251;	transduction: stably expressing non-target control shRNA,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 102;	Usage number: 5;	Exposures: 3,ctrl
"Liver, wild-type",ctrl
Astrocytoma_3,pert
"Acute Myeloid Leukemia, sample 71",ctrl
strain: 129/Ola;	cell type: embryonic stem cells,ctrl
RNA from HCC_10N,ctrl
Ero1-WT induced biological repA,pert
GSK-3 inhibitor effect on MLL leukemia cells - 1,pert
BSKO 2,pert
tissue: retina;	age: postnatal day 2;	genotype: rd1,pert
2112-01-A,pert
Control spleen - Biological Replicate 4 - Technical Replicate 1,ctrl
A39 NES 142Q TG2	F5/52	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Female,pert
Y SIT_B076,ctrl
"A673 treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50), biological rep1",pert
Menadione (5uM) rep 2,pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 36;	maternal age: 34,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 42 yr;	population: white,ctrl
Cebpg-/- MEFs at passage 3_biological replicate 3,pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14532;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
ES cells_control_rep1,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 8 hours,pert
H1P_7,ctrl
Tissue: normal thyroid; Gender:male; Age:33,ctrl
Diagnosis: MDS/AML;	Age: 51y;	Gender: Female;	Blast %: 71;	Source: PB;	Cyto: t(15:17);	FLT3 ITD: 1;	FLT3 TKD: No Data,pert
2P-M4,pert
jos1987,ctrl
PGA-HMO-NonObese-2aUA-s2,ctrl
Brain BA22 post-mortem control,ctrl
genetic background: c57/bl;	gender: male;	tissue: heart;	genotype: MHC-Plin5,pert
220D3,pert
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P0 postnatal stage,pert
genotype/variation: Rpt3 null;	strain: mlc1f-Cre/ Rpt3-floxed;	gender: female;	age: 6weeks;	tissue: tibialis anterior,pert
tissue: xenograft tumor,pert
B_cell_pool_healthy_H07+H08,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 58;	tissue: Blood,pert
HT29 resistant cells replicate 2,pert
BALB_Female_CF_rep3,pert
11385 Normal Uninflamed ascending colon,ctrl
10_PAH,pert
GAS-t7-2; transgenic gastrocnemus 7 month,pert
EVI_GFP positive Lin- cells replicate 3,pert
patient: 230;	current medication: Asacol 1.6g/ day;	birth date: 12/27/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/12/02;	diagnosis date: 12/3/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/25/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/25/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: ? MS never proven;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
LNCaP-abl_siHIPK2_1,pert
CD4+ CD25- Foxp3- T cells,ctrl
BALB_Female_Control_rep1,ctrl
BP patient 92_biological replicate 2,pert
E14 - Lis1ko/+ 3,pert
a_NY34,pert
"siYAP RNA #2 transfected, biological rep 1",pert
Heart_KO_1,pert
GATA6 KO #3,pert
"Mice_c-myc trans, biological rep1",pert
"Normal subject (46 year old caucasian female, SAK_1280015703)",ctrl
Healthy individual of twinpair #3,ctrl
KO_d00_eX_vs_WT_d00_eX,pert
Genotype: p38alpha KO;	Age: E15.5,pert
pediatric AML S14,pert
tissue: Biceps muscle;	patient: P.b.7;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
strain: C57BL/6;	tissue: liver;	genotype/variation: wild type;	diet: high-fat diet fed starting at 3 months of age for eight weeks.,ctrl
LNCaP.FoxA1.3,pert
40SMOKEH,ctrl
Tendon;Flexor-Pronator_Lesional,pert
RO35,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP;	age: 3-4 months;	tissue: bone marrow;	cell type: bone marrow CD11b+Gr-1+ myeloid cells,ctrl
"Retina from NeuroD1 cKO mouse at ZT20, biological rep 1",pert
XBP1s_B_cells_spleen_20 weeks,pert
heart wild type replicate2,pert
AA_Case7_CD8,pert
age: 8 weeks;	genetic background: SV 129/C57BL/6;	genotype: control;	cell type: pancreatic beta-cell,ctrl
diseased_IL-13 1,pert
tissue: whole whisker pad;	genotype: wild-type;	age: E12.5,ctrl
WT-3 (Large PreB),ctrl
01LQJ_CTRL,ctrl
RAW_2.8mM_HOCl_#2,pert
E99-/+SRFdM-VP16-2,pert
Kidney_saline iv_mouse #005,ctrl
Run8.aUa.010615d.SkMInS1082D.CEL-IS basal,ctrl
ALI patient #9,pert
AA_135,pert
esophageal squamous cell carcinoma from patient E1635,pert
Age: 32;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
Trasnsformed Lymphocytes Bipolar Disorder Affected Twin Pair 2 (DCBD2.1)(TP7),pert
LNCaP-abl_siMED19_1,pert
"Patient  L, lesion, 4 week",pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 -/-;	tissue type: renal tissue",pert
Age: 46;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
MPM tumor 22,pert
"AD_FC, biological rep1",pert
SCD1 +/+ liver rep4,ctrl
"siRNA, plastic plate, rep3",pert
"prdm-control, biological rep1",pert
56SageA,pert
NoKD_SerumStarved->1hrEGF_rep2,pert
"Aorta, Ang II 14d, #5",pert
ES cells_OE_rep2,pert
Muscle 50 eccentric contractions 12 hours KO Adult 01032,pert
Ad-rep2,pert
"SKO-transduced MEFs, Vc untreated, lysed on D8",ctrl
BP29,pert
P0 - DCXko/Y 2,pert
Silberg2 (8) 021301BE,pert
PBMCs_IS_4 [IS],pert
"EBF1 d0, rep 4",pert
PGC-1alpha -/- differentiated brown fat cells (rep1),pert
coc-57_B,pert
hES_SA01_2,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep3",pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous adenoma (IPMA),pert
Individual_4397_PP_sample,pert
age: 31;	sex: F;	disease status: Marfan subject;	Filter number: 36;	Usage number: 1;	Exposures: 4,pert
EBS_3,pert
01LPH,pert
KO mouse heart under basal conditions,pert
B13 - non-infected BALB/cByJ fibroblasts,ctrl
TTP_WT_0ActD_BioRep1,ctrl
Transgenic nr 661,pert
"human failing LV myocardium, Ischemic86",pert
Obese rosiglitazone-3,pert
gallbladder-saline treated,ctrl
Human sorted B cells,pert
pMX-GFP no vitamin C GFPVc-_2,ctrl
"testis wt, 14dpp, Rep3",ctrl
Rat Hippocampus,pert
"disease group: Atopic Dermatitis;	Sex: f;	age: 40s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 11.3;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 430;	ige (kiu/l): normal (0-48.5 kIU/L): 319;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: pos",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: del5q plus other,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 38;	gender: male,pert
MA_282,pert
5_b,pert
HeLa cells transfected with UPF1 siRNA 2 (experiment),pert
9_1_MOE_430A_WT,ctrl
postmortem brain,ctrl
WT HPC Veh 6,ctrl
"human failing LV myocardium, Idiopathic16",pert
H441 transfected with scrambled siRNA 1,pert
FC 05,ctrl
"GI_canc, Col2",pert
colon_IBD_1537,pert
HEL_Control shRNA (Luc)_1,ctrl
Individual_4649_NN_sample,ctrl
RPE65_KO_6months_retina6,pert
Nonirradiated-ATM-Ko Replicative3,pert
GM19238_Kd_CREBBP_1,pert
Hippocampus_NaiveControl_rep1,ctrl
Cardiac Muscle_Cmah KO_rep2,pert
Muscle JDM (YJD-JDM-15UA-s2),pert
epithelium from colon of HDAC2 KO mouse no.3,pert
heart_co_14M_rep2,ctrl
"patient 044b, cancer, homogenized",pert
B2KO; No Treatment #5,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 54;	age-at-onset: 50;	geographical origin: Vila-Real;	clinical characteristics: Hypertension,pert
Rapid progressing fibrosis,pert
NALT_infected_24h_90-226_rep2,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 41;	maternal age: n/a,ctrl
"Gtf2i Mutant line, biological rep 2",pert
Errb mutant stria vascularis replicate 2,pert
SIN3A_siRNA_LIF1h_rep2,pert
"Patient 21, Atheroma plaque",pert
Bone-Marrow_MGUS_G693,pert
HMEC_50 vs BT474,pert
"control endometrium, patient 32",ctrl
Human cell line,ctrl
52 year old male,ctrl
tissue: liver;	gender: female;	disease status: type 2 diabetes,pert
Vitamin A,pert
PBMC_C3,ctrl
T4.02,ctrl
Brain from 59 days Npc1+/- mouse1,ctrl
DS2-iPS 2,pert
5_c,ctrl
mouse bladder,pert
asthma_saline_2,ctrl
NS4_NS010827,ctrl
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID337,pert
minor HCC3,pert
IRF8 KO 2,pert
"12 weeks anterior prostates, Pten deletion",pert
melanoma cell line,pert
KO striatum Veh,pert
disease state: normal (control);	tissue: liver,ctrl
Tissue: endothelial cells,pert
LRRK2 (G2019S) homozygous fibroblast sample 2,pert
brain tumor tissue,pert
tissue: Brain;	genotype: Npc1-/-;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 3",ctrl
patient: 29;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
ME180 6 hours rep 3,pert
homozygot FH P261 (human CD3 positive T cells),pert
KU_02N,ctrl
dermal fibroblast from healthy control,ctrl
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 151;	time: 0;	batch: 1,pert
tetO-Satb2 #2 +DOX,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 2,pert
"male sprague-dawley rat, 21 days saline",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.124;	OD280: 0.574;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 212;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
HL60-shGSK3A-Construct5-rep2,ctrl
Array Type: HG-U133A_2;	Ratio: 2.04;	RNA Integrity Number: 9.6;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Age: 55;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: Yes,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: no LPA (control),ctrl
"63B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
race: caucasian;	age (years): 55-60;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-2,ctrl
cell line: Y79;	passage: 27;	cell type: Retinoblastoma,pert
Bc_Mock_1,ctrl
F2,ctrl
chip number: 15;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.65;	rin: 9.6;	transfection date: 2012-03-26,pert
Adipose tissue,pert
HTH83 LAMC2 KO 1,pert
Muscle PCOS control 18,ctrl
mouselung_wt_control_rep02,ctrl
CTL2 AO 1hr,ctrl
P16_WT_pancreas_rep2,ctrl
dental pulp cell from control 4,ctrl
CyP 3hr 1,pert
"seminoma specimen, pT2, patient age: 40y",pert
tissue biopsy of normal skin from healthy control,ctrl
Cancer 19,pert
CD34+/CD38-,pert
duration of untreated disease in month:1.1;	age at onset:4.7,pert
"N-BMSCs, biological rep2",ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_12_4_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
"brain, cerebellum: KCx4w#3_e1_le1",pert
Yy1_siRNA_rep2,pert
Mist1KO saline rep3,ctrl
"KO mouse heart at 6-weeks old, biological rep1",pert
Control (C66),ctrl
Patient: B;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
subject: 2828 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
"SBC-5 cells, siEGFP (control), 72 hr after siRNA, duplicate sample 1",ctrl
DLBCL_FOXP1 siRNA,pert
"Rb null fetal liver 2, embryo at 12.5 days of development",pert
BALB/c d18 (bmsnmix2),pert
Tolerizing allografts 70 days No.3,ctrl
liver_STZ 0.1% quercetin diet_rep1,pert
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep2",pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 24;	maternal age: n/a,ctrl
sampleID: SAM630141;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
BT474-J4_GSK089_24-1,pert
control AU1165303,ctrl
UACC903 cell line,pert
"BMMCs from NTAL WT, NTAL shRNA infected, 2 h activated, biological rep2",pert
H23 Ctrl 24h 3,ctrl
antimicroRNA-140_rep2,pert
G93A mouse 802,pert
HT-KO-21B,pert
GFP-KD-2 (total RNA),ctrl
FcgKO Non stim 1,pert
Breast_cancer_cell_line,pert
Patient identifyier: C;	Sex: male;	Age of patient: 32 years;	Duration of psoriasis: 17 years;	Body surface area: 8 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
RNA-DHL4-R406-2H-2,pert
E2 24hr,pert
MPM tumor 33,pert
WT_3,pert
neuron_rep12,pert
BM CD34+ Pool III,ctrl
SeroTest-3,pert
Patient 10 after folic acid,pert
tissue: brain;	genotype: mutant 14-3-3 ko/ko inbred;	age: P0,pert
N40843,ctrl
"Uninvolved Skin, NS-5",pert
train: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
"ERRA WT ventricle, baseline",pert
Ainv15 ES0 replicate 1,ctrl
"CD14+ monocytes, by positive selection",pert
"diet: AIN-76A;	sodium arsenite added to drinking water: 100 ppb, 5wk",pert
"68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6.4;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"Heart, MAT1 CKO, 4 wk, sample 5",pert
Clinically localized primary prostate cancer P3,pert
microdissected breast cancer cells from case 633,pert
n6t24h,pert
male_alcoholic_303,pert
"human embryonic stem (hES) cells line VUB03_DM1, biological replicate  2",pert
HEK293 cell line #6 with uninduced HNF1beta mutant A263insGG,ctrl
Ad infected murine liver-MO30k-(228)-6hpi,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 19.666;	Ratio: 2.14,pert
hepatocellular carcinoma cell line,ctrl
PancreaticSample23-Tumor,pert
"34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
01UNB_PolyRF-,pert
PDAC_P_105,ctrl
1082-01-C,ctrl
PGA-RMM-30m-3aA-s2,pert
23d tg7,pert
HCC_28T,pert
"LCL GM19238, Kd BATF, 72hrs",pert
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 48 hours,ctrl
Zfx fl MA9 cells + Vehicle [10986],ctrl
WT P10 replicate 1,ctrl
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 62;	donor: 12;	disease state: Lesional,pert
LNCaP R1881 rep 3,ctrl
"Cell type: neuronal, age:34, gender:male, diagnostic group: control, PMI:22h",ctrl
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P5,pert
coc-14,pert
C3 Control None,ctrl
patient: 30068;	sample: normal,ctrl
ab050 IM,pert
MDS patient 51,pert
H13_S_B1,ctrl
SNB19 PARK2 siRNA#1 replicate 1,pert
MCF7,pert
CD4IncTp2-6,pert
Lamp3 KD 4d 2,pert
LJMJDW23,pert
cell type: Primary hepatocytes;	donor: 1;	agent: Wy14643;	time: 6h;	gender: Male;	age: 63 years old,pert
"fetal testis sample 19, 20 weeks gestation",pert
CTCF-depleted oocyte,pert
DBTRG 10 uM Y15 rep2,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: wildtype;	tissue: GIST Tumor,ctrl
Tumor_18w_vechicle_DEN_134,ctrl
control to Sample 11,ctrl
cell line: CUTLL1 (T lymphoblastic leukemia / lymphoma),ctrl
Mouse Bone Marrow,ctrl
REH_control_rep1,ctrl
siOGT 24 hours_1,pert
Disease_status: Down syndrome;	Age (years): 56;	Gender: Female;	Post mortem interval (hours): 6;	Braak stage: VI;	Cause of death: Unknown,pert
N41027,ctrl
HT29 derived clone with 2 vectorS expressing CD24 directed shRNA,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M4;	flt3 status: WT,pert
liver cells from wildtype 8wk male mouse 8 challenged with acetaminophen (APAP)_13,pert
"brain, hippocampus: C6-I_e1_le1",ctrl
HT29 resistant cells replicate 1,ctrl
Rat spinal dorsal horn,ctrl
unstimulated CD3+ T-cells from Wt C57BL/6 mice,ctrl
"human failing LV myocardium, Ischemic27",pert
MPM tumor 2,pert
RE550_KPL4_5-Medi5117,pert
Melanoma cells,ctrl
Female - caucasian - N-08-G,pert
early to medium response after cadmium treatment,pert
brain_DLPFC_bipolar C_mr545,ctrl
"Strain: Polg+/+ mice;	Gender: male;	Age: 9 months old;	Tissue: cochlea;	For additional details about the strain used please refer to the following r;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
rd1 mouse retina at age postnatal day 4,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
HWS22,pert
"endometrioma, patient 9",pert
human endothelial cells isolated from postmortem dorsolateral prefrontal cortex,pert
1064-03-A,pert
Individual_4344_PP_sample,pert
wild type; 10 months,ctrl
"p53-, rep2",pert
esophageal squamous cell carcinoma from patient E1709,pert
Run2.aUa.001206d.SkMInS1087D.CEL-IS stimulate,pert
oocyte_Brwd1_mutant_rep3,pert
5211 Normal Uninflamed terminal ileum,ctrl
control male replicate 5,ctrl
TRPM2-AS siRNA rep4,pert
sXBP1_1578Q,pert
HEK293 cells,pert
saline injected mouse lung,pert
06R009 Control,ctrl
age: 49;	sex: F;	disease status: control subject;	Filter number: 96;	Usage number: 1;	Exposures: 3,ctrl
E99-/+SRFVP16-1,pert
ALI patient #7,pert
"liver, PPAR KO_ctr_116",pert
KPW13_T2_PP_day0_050,ctrl
"brain, knock out",pert
erStress_twins_AA_1725twin2_DMSO_4h,ctrl
DNGM-8,pert
GB 4 65B +LPA,pert
Brain BA10 post-mortem schizophrenic,pert
13-0002A_Day1_35,pert
Mouse heart,pert
IRAK2 KO macrophages stimulated with MALP-2 for 2 h,pert
"MDA-MB-231/shNS, biological rep2",ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 55 days;	subject: Mouse1;	genetic background: BALB/c,pert
RNA from whole tissue section of case 871 labeled with Cy5,pert
Preglaucoma control rep3 (OHN),ctrl
infected MBT/Pas fibroblasts (9 h post inf),pert
WT30,ctrl
Control subject 116_biological replicate 1,ctrl
T4 U133p2,pert
PFR3_replicate_3,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 6h",pert
PGA-FVB_3m_3f-m5,ctrl
"differentiated U937 cells, ROS exposed, 4h",ctrl
HMEC_50 vs BT549,pert
5250 UC Uninflamed sigmoid colon,pert
Pooled_3,pert
cell type: Transcriptional 2 Follicular Progenitor (T2-FP) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: KAP1 KO,pert
06R019 RA,pert
"Patient  K, lesion, 12 week",pert
control rep 3,ctrl
"129P3/J Chronic morphine treated, biological replicate 1",pert
DNGM-6,pert
Brain from 25 days Npc1-/- mouse1,pert
G205,pert
mouse: 2;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
E18.5 E-cadherin cKO,pert
Leg 56 Day control rep 1,ctrl
liver western diet rep1,ctrl
Muscle PCOS pioglitazone 201,ctrl
NTG replicate 1,ctrl
gender: female;	genotype: Wild type for TWIST2;	ethnicity: Caucasian,ctrl
"control triceps, biological rep2",ctrl
"WT, LPS 5hr",pert
Severe rep6 (OHN),pert
hippocampus: Sample #2_e1_le2,pert
cell line: A549;	cell type: Lung adenocarcinoma,pert
WT-628,ctrl
PFR3K650E_replicate_2,pert
disease affected colon of an adult with Crohn's disease (CD). Replicate-2,pert
061J4: normal control,ctrl
1106-03-A,pert
5275 UC Uninflamed descending colon,pert
remitted schizophrenia patient  S15,pert
"AD_TC, biological rep9",pert
Z138-shSOX11.1,pert
whole lung,pert
Mouse palatal shelf tissue at E14.5,pert
MDS patient 53,pert
D_Ctrl_3,ctrl
dy/dy mouse,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: trachea;	donor sex: female,pert
Normal Pleura 3,ctrl
"seminoma specimen, pT1, patient age: 31y; W98 100",pert
Strain: C57BL/6;	Genotype: AMPK gamma3 mutant (R225Q) transgenic;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
"acutely admitted, severely psychotic schizophrenia patient",pert
Individual_4609_PP_sample,pert
4-HPR_LIVER_2,pert
source tissue: lung;	strain: Insig1 ∆/∆ /Insig2 -/- (AT2 cells obtained from 2 months old SpC-rTTA / Otet-CRE / Insig1 flox/flox / Insig2-/- mice treated with doxycycline from E6.5 to E12.5. Control animals lacked either SpC-rtTA or Otet-CRE);	cell type: Alveolar Type II,pert
whole tissue section from case 1093,ctrl
AR-CO-24-1-541,ctrl
"Control, biological rep5",ctrl
2095-03-A,pert
NPC9,pert
"Mouse embryonic stem cells, day 0, wild type",ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 6 weeks post infection 20 cercariae,pert
sirt7 allele: knock-out,pert
S027_Scz_M_77,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Brg1,pert
"Uninvolved Skin, NS-27",pert
Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours;	Treatment: D-penicillamine 150 mg/kg by oral gavage,pert
normal skin sample,ctrl
S026_Scz_M_72,pert
"BMMs, untreated control, wt, Replicate 2",ctrl
ADH4,ctrl
Cervical cancer_1900T,pert
HF1219_U133P2,pert
Day: 15; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 1,pert
Shn2_Wildtype_4,ctrl
alveolar macrophages obtained from bronchoalveolar lavage,ctrl
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 19.1, Strain:DBA/2J",ctrl
intestinal crypt cells isolated by laser capture microdissection,pert
"LNCaP cells, treated with R1881, biological rep 1",ctrl
siEGFP (48 hr) _1,ctrl
PGA-MAH-AJ_OVA6h-2aA-s2,pert
Replicate 2 - CDB4124,pert
HLA risk: Medium;	Height: 124.8 cm;	Weight: 26 kg;	BMI: 16.9;	Age: 7.21 years;	Gender: Female;	Race: White;	Glucose: 180 mg/dl;	HbA1c: 7.5%,pert
E10.5 wt3,ctrl
Sox9egfpneg_p23-3,ctrl
Cadherin-11 siRNA (RNAi 4A)_2of2,pert
T44,pert
472MM,pert
U937-derived cell line harboring TRIPZ-shRNAmir TetOn cassette (clone ID: V3THS-381738),ctrl
"PC-3 Gefitinib, biological rep2 [mRNA]",pert
patient E1546,ctrl
R6_Pseudomonas_wildtype_48,ctrl
"cervical cancer, SiHa, squamous cell cancer",pert
A HID B_B010,pert
Patient  22 appendix,pert
cell line: THP-1;	disease state: monocytic leukemia,ctrl
RNA-DHL4-R406-6H-1,pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
"non-AD_TC, biological rep4",ctrl
Parkinson's disease sample x193,pert
whole tissue section from case 547,pert
T30,pert
PND28 Rat Testis_Rat230-2_1hr Corn Oil_Animal#41_04005,ctrl
GM19238_Kd_IRF7_1,pert
Mist1KO saline rep1,pert
"disease group: Psoriasis;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 3;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 110;	ige (kiu/l): normal (0-48.5 kIU/L): 31.2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg / positive to Strep. Viridans",pert
Ppif-/- heart 2,pert
CDKI-73 CLL1,pert
"medulloblastoma, wt, rep3",ctrl
A2780+(2),pert
cerebellum_Pink1 knockout_18 month_replicate 1,pert
9-cis-retinoic-acid_LIVER_3,pert
Pax6 negative retinal progenitors,pert
A673 cell line that has been treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50).,pert
D_Kin_1,pert
Mock infected murine liver-MO30k-(790)-6 hpi,ctrl
Surgical Sham Control Tail Skin 1,ctrl
"A pool of two pure subsets of peripheral blood B cells (CD19+ CD3- CD4- CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
striatum_wild type_12 weeks_replicate 2,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 718,pert
407MM,pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
"wt muscle 1, biological rep 1",ctrl
"Patient  O, lesion, 2 week",pert
"BioBreeding DR+/+ rat, day 65, mast cells derived from pancreatic lymph node.",ctrl
atopic eczema P4,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 72 hr,pert
"Atm-/- untreated, A",ctrl
Pooled normal myocardium sold commercially (E),ctrl
"Patient CCo, stable renal transplant recipients, male, 38 years old, T0 (time of enrollment)",ctrl
1214-5C,ctrl
lungs were over expressing nmyc-gfp fusion protein using the lung surfactant  c promoter.,pert
CUTLL1 DNMAML1 GSIwash2h-rep2,pert
coronary smooth muscle cells control replicate 3,ctrl
CH2114,pert
"650nM MLN4924 after 2hr, replicate 3",pert
"tissue: whole brain;	strain: C57BL/6J;	genotype/variation: Sarm1-/-;	age: 8 weeks, 5 days;	infection: 107 pfu of VSV-Indiana strain",pert
0515-01-C,ctrl
hippocampi pool from 3 SHA rats,ctrl
MRF control Oligodendrocyte Replicate 1,ctrl
Dicer KO CD4 T cells 2,pert
07R084 Control,ctrl
"Pineal gland from control mouse at ZT20, biological rep 2",ctrl
Huh7_TGFbeta_plus_2,ctrl
Skinbiopsy_96hoursnickel_controlsubject_k4,ctrl
"G9a knockdown cells, rep2",pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EED. Sample C,pert
"ES cells: E14 (129P2/OlaHsd background), Genotype: Knockout (Phgdh-/-), C57BL/6J background, Gestation: 13.5 days, Tissue: head",pert
wild-type 2,ctrl
Run1.a10a.000607jd.2.SkMNor922.CEL-IS stimulate,pert
Control peripheral blood leukocytes - Biological Replicate 4 - Technical Replicate 1,ctrl
Animal 4,ctrl
erStress_twins_AA_1743twin1_DMSO_4h,ctrl
Retina homozygous KO 42 days 4,pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His plasmid,ctrl
chip number: 15;	transfection plate: 3A;	target gene: SP3;	kd level: 0.62;	rin: 9.6;	transfection date: 2012-03-26,pert
MCF10A 1.5days,ctrl
"seminoma specimen, pT1, patient age: 39y; W03 035",pert
135B,ctrl
sMPNST cells treated with vehicle (DMSO),ctrl
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Female;	Age: 9 weeks (Moderate stage);	WILD TYPE",ctrl
cell line: LKR13,pert
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Anoxia;	Tobacco Use: No;	2nd technical replicate,pert
"sebocyte cell line, SV-40 immortalized, ethanol treated",ctrl
NZM12_siPAX3_30hrs_rep1,pert
STAT6 KO bone marrow-derived macrophage,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 62;	donor: 12;	disease state: Non-lesional,ctrl
"Vehicle treated, no doxycycline; biological replicate 1",pert
"10mg/kg/day PFOA, Rep 4, Block 4, lung (high dose)",pert
"BOEC, normal 1",ctrl
MDS patient 76,pert
PE_D_508,pert
Emd KO male 5,pert
Atm+/+ untreated B,ctrl
"medulloblastoma, M2_scrambled, rep2",ctrl
Individual_3822_PN_sample,pert
Myoblast-GATA4-OE-day0-2,pert
remitted schizophrenia patient  S18,pert
21dpp Ubb knockout testis,pert
wildtype 2,ctrl
cells: spleen marginal zone B cells;	genotype: IRF8 KO;	genetic background: C57BL/6J-lrf8-/- x CD19-Cre,pert
(ca)MEK_1,pert
"Du145-PCAT1 cMyc siRNA #4, replicate 2",pert
E2 72hr,pert
cadmium_08hr,pert
RatLung_Con_2,ctrl
whole tissue section from case 605,ctrl
"SUDHL-1, control repl 1",ctrl
RatLung_H1h_1,pert
wild type; 2 months,ctrl
ILD Study Number S030,ctrl
HVS-CD4-control_unstim,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:58;	Sex: female, male:female;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=diffuse type",pert
"human peripheral blood derived monocytes, 8 hour LPS stimulation, biological rep1",pert
gender: Male;	tissue: Tendon;ECRB;	age: 55;	donor: 26;	disease state: Lesional,pert
"ALL_NDS, K35 011409",ctrl
strain: 129SV;	gender: female;	age: 6 months;	tissue: right ventricle;	genotype: wt,ctrl
"HepG2 cells at T18 Control, biological replicate 2",ctrl
3x'  Ez f/wt,ctrl
AJSHAM,ctrl
Lung of hemorrhaged animal 16h,pert
T104,pert
"genotype: Gata6-WT;	cell: Peritoneal resident (CD11b-high, MHCII-low/negative) macrophages",ctrl
Mammary Gland_Cav-3KO_rep2,pert
RNA from HCC_12N,ctrl
"NALT infected with 90-226att, 24h, biological rep4",pert
initial tumor increase/(-)decrease: n/a;	kit mutation: unknown;	tissue: GIST Tumor,pert
Subconfluent wild type primary mouse embryonic fibroblasts at passage 3.,ctrl
Arid3a OE-High replicate 1,pert
"brain, cerebellum: RNA#7S_le1",pert
colon_epithelium_C57 mouse_12weeks_rep2,ctrl
Mouse fetal liver_E14.5_KO_rep2,pert
COV434 Control [RR1021],ctrl
ARF1 siRNA knockdown MDA-MB-231 sample 7,pert
M474 SKM-Tg,pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 36;	maternal age: 36,pert
"Endothelial control cells, passage 7",ctrl
"fibroblast, MFS subject FB1627 rep 4",pert
e_NY16,pert
Vit A deficient 4a,pert
MDS9,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-6,pert
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 58y/male/caucasian. Cause of death: cancer,ctrl
control HMEC,ctrl
healthy control H14,ctrl
"DBA/2J Chronic morphine treated, biological replicate 2",pert
brain_DLPFC_bipolar C_mr538,ctrl
wild-type control 1,ctrl
Sarcoma cell line  - Dicer Null -rep2,pert
IP RNA_WT_rep2,ctrl
HT-WT-2A,ctrl
AVIC sample#2 treated with DAPT,pert
MGHU3 Cells_TAK1 siRNA_Biological Replicate 2,pert
Age: 54;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
Patient: M;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Disease_status: Healthy control;	Age (years): 55;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Neurointermediate lobe _control,ctrl
strain: Gata4tm1.1Sad/J;	infection: Nuclear β-galactosidase;	culture: Growth medium,ctrl
wt 13.5d replicate 1,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: post-UV,pert
SZ25,pert
human promyelocytic leukemia cells,ctrl
"shKDM4C 1, clone 1, rep 1",pert
Individual_4298_PP_sample,pert
ID4+/+TCL1-tg spleen CD19+ B cells,ctrl
BSKO 4,pert
age: 71;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
c48 is a clonal Nurr1 stably-expressing stem cell line,pert
HWC16,ctrl
PBMC sample from healthy volunteer,ctrl
EB_07_8d_143_HCHO_Nasal_Rat230_2_CIIT05024,pert
LN-T-3,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID234,pert
neocortex-30 months of age-control diet-biological replicate2,ctrl
"non-AD_TC, biological rep1",ctrl
Dermal fibroblasts from healthy individual,ctrl
b-catenin deficient BxPC3 clone 111,pert
tissue: white blood cells;	age: 15;	Sex: male,ctrl
age: 55;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
M229_B_PLX,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr",pert
genotype: PML Knockout;	treatment: Low Fat Diet;	gender: male;	tissue: liver,pert
Sample 2 Posterior  -/-,pert
12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24728,pert
"Crohn's Disease subject (28 year old black male, SAK_1313738586)",pert
A2058 Ctrl siRNA Rep2,ctrl
Karyotype: inv(14)(q11q32);	Age: 72 years;	Gender: male,pert
umbilical cord_nobpd: 2D,ctrl
WT-smoke-med-5 month+1d-R3,ctrl
LNCaP + ELK1-shRNA + R1881 rep 1,pert
Liver_WT_Rep1,ctrl
HA96-61A,pert
C2C-LU,ctrl
"endometrioma, patient 7",pert
Liver vehicle rep4,ctrl
6h_c3,ctrl
GV oocyte_Ring1 mut_rep1,pert
prostate_Klf5 wt_rep4,ctrl
KO Soleus at 4 weeks biological rep3,pert
MCF-7_TOX3 expression,pert
Control_pancreas_1,ctrl
A39 WT2	F5/53	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
APLP2_R6_rep2,pert
aa.3,pert
Methoxychlor (50uM) rep 3,pert
"Neuroretina 8-week lean non-diabetic, Biological replica_3",ctrl
"female Spargue-Dawley rats, diet only for 7 days,  tissue: mammary gland",ctrl
strain: Myd88 KO;	gender: n/a;	age: 4 month;	weight: 25-30g;	tissue: trachea,pert
5217 UC Inflamed sigmoid colon,pert
"blood, -LPS",ctrl
V5-P119,ctrl
Patient: F;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
LUC 20 KD #1,ctrl
S4B Sporadic-cerebellum,ctrl
Btk KO2,pert
B6C3F1 male,pert
A HID U_B015,pert
patient code: 117;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: PMA,pert
Normal cortex of patient 42,ctrl
Control_2months_retina11,ctrl
THRB bN mutant + T3 replicate 2,pert
"spleen marginal zone B in WT, biological rep6",ctrl
control_08hr_rep2,ctrl
HP-81c,pert
Individual_4165_PN_sample,pert
HeLa_06_21_04 TP-12,pert
CLL13-CD4,pert
EB_2_5d_215_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
RNA from A549 Cells - Static Control 1hr Replicate 1,ctrl
RNA from whole tissue section of case 1045 labeled with Cy5,ctrl
cell type: Embrionic stem cell line;	genotype: HPRT -/-: GTF2I +/-,pert
B-CLL PB P155,pert
phenotype: alcoholic;	gender: male;	case_id: 210;	age: 51;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 27;	brain ph at time of freezing: 5.58;	labeling_batch: 1,pert
C57BL/6J_Liver_rep2,ctrl
CD-33-un,pert
A263insGG_mut4a+,pert
"Mutator, biological rep2",pert
heart_Q10_14M_rep1,pert
genotype: mcad -/-;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: LPS;	tissue: liver,pert
Individual_3992_PN_sample,pert
uterus_P4_WT_40hrs_rep3,ctrl
lesion_midUV_patient12,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_12_9_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep2,pert
HEK293 F18_doxycycline treated,pert
gender: female;	age (years): 34;	evolution time (years): 14;	disease extension: Pancolitis;	treatment: Azathioprine,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 20.57534,pert
WFS1 KO USHT_08_316_ko,pert
266D0,pert
diseased cells stimulated,pert
"IkB, LPS 1hr",ctrl
PGA-RMM-8h-1aA-s2,pert
CD11b+Gr1+ cell sample_2 (derived from IL17RC Knock out mouse),pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: gastrocnemius,ctrl
cell line: SU8686;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
A549_Cisplatin_rep1,pert
A_AN17254_C,pert
Strain : 100% C57BL/6;	Gender: Female;	Age: 9 weeks (Moderate stage);	Transgene: Mutant ataxin-7,pert
Kyoto rat liver tissue following animal exposure to orotic acid for 1 day,ctrl
BM_02680,ctrl
SW480 Snail (2),pert
V5-P487,pert
C57BL10 TA sample 2,ctrl
tissue: Frontal cortex;	age: 77;	Sex: M,ctrl
Replicate 3 - R5020,pert
Subtype: RA;	Karyotype: normal,pert
Blood_Control 3,ctrl
Wild type_lung_2,ctrl
BALB/DBA F1 mouse treated with pristane for 3 days,pert
cDNA no 19,ctrl
astrocytes normoxia batch 2,ctrl
tissue: oropharyngeal carcinoma KB,pert
206_SIO,pert
"mouse lung, tamoxifen-treated Tmem1002loxP/2loxP;ROSA26+/CreER",pert
PGA-MLS-Dex-1aAv2-s1,pert
MDS30,pert
"Affymetrix chip HG-U133A, siPTHrP 2",pert
jzo026-rp1-v5-u74av2-met,pert
SKM-1 STK33-2081,pert
"Peripheral blood, normal control [N54]",ctrl
CTRL_2_CMP,ctrl
Sample 20 Kidney Normal Mouse - Low Phosphate Diet,ctrl
A HID U_B054,pert
MDS40,pert
heart-30 months of age-resveratrol diet-biological replicate2,pert
Wild type rep 3,ctrl
Calu3-GemR_Veh_4,pert
potilas_DC_E,pert
Liver sample from Alcoholic hepatitis group (CA82),pert
ko 13.5d replicate 10,pert
lung_myd88_mock_repA,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 12h",pert
kidney_co_14M_rep2,ctrl
Wildtype 2 (jos1524),ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,pert
DNGH-1,pert
Hippocampus 2005 2 month Old,ctrl
A11,pert
"granulocyte, patient. Mtx rep8",pert
erStress_twins_AA_1733twin2_DMSO_4h,ctrl
H18_P_B2,pert
chronic lymphocytic leukemia (CLL 525),pert
11a_b,pert
FHCRCAML16907,pert
skin.KO.replicate25,pert
DBTRG untreated,ctrl
"Sample Type: human cellular RNA, Cell Line: primary airway epithelial cells, Cell Type: tracheobronchial",ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 62 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
individual: Control3;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
cell line: SNU-398;	cell type: Hepatocellular carcinoma (HCC);	genotype/variation: SALL4 knockdown,pert
567.KO,pert
"non-AD_FC, biological rep7",ctrl
"Tsc2 wildtype mouse, cerebellum",ctrl
3883-2 E2F WT,pert
"n03, surgically resected from patient of gastric cancer.",ctrl
"Primary aortic endothelial cells, transgenic_PPARG_V290M",pert
age_years: 43;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
"Grape extract group, 6 months, patient number 14",ctrl
RNA from HCC_8T,pert
Gallbladder-leptin treated,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1. Sample C,pert
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 1, clone 2",pert
AGS_Celecoxib treated,pert
tissue: temporal lobe;	strain: 129SV;	genotype: WFS1 KO,pert
Large cell carcinoma 006,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep1,pert
Dengue Hemorrhagic Fever Patient 40,pert
"S1P2-KO-neocortex, biological rep10 (female)",pert
"MN1, 1",ctrl
"liver,6weeks,WT",ctrl
Contralateral 1,ctrl
gender: female;	age (years): 41;	evolution time (years): 7;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
Carbo Day14 (439R),pert
CME-Ctr_LaminA3d-2MA-S2,ctrl
Jejunum_Wild Type_1,ctrl
vastus lateralis biopsy,pert
"Untreated ES cells, Rep 2",ctrl
HEK001_pLKO_R3,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 43;	gender: male,ctrl
"wildtype white adipose tissue, biological rep 1",ctrl
LSK cells SRF wt 3,ctrl
3560-3 E2F2 Null,pert
PBMCs_IS_13 [IS],pert
"CRT knockout mouse embryonic stem cell, biological rep2",pert
"G42 cells from M1, Mecp2 null, biological replicate 3",pert
KU_29T,pert
"NF-YB KD ES cells 96hr, replicate 1",pert
Muscle-AMPKgamma3-wt-3,ctrl
High Glucose Transcriptome Profiling {rpt},pert
N40728,ctrl
PHM-DM-3aUA-s2,pert
whole blood,ctrl
Msgn1_48hMinDox-biological rep1,ctrl
male_control_190,ctrl
siSPDEF_5,pert
HCT 116 cells transfected with siControl,ctrl
cerebellum_PS-/-_ 10d_rep2,pert
L1 062502 Con1,ctrl
"brain, hippocampus: Wt #3405 Hippo_e1_le1",ctrl
NSC11,pert
cell type: mammary epithelial cells;	gender: female;	age: 8 weeks;	myc: WT;	p53: WT;	rb: WT,ctrl
Scd1-/- on chow diet replicate 1,pert
Run5.aUa.010110d.SkMDbt1153D.CEL-DB stimulate,pert
"Brain tissue from Fisher 344 male rat, Animal #261, 50mg/kg D-Serine",pert
Strain: B6129;	Gender: male;	Age: 12 weeks;	Tissue: liver;	Developmental stage: adult,pert
colon_IL10mouse_6weeks_rep5,pert
"A3_tumor, lung tissue",pert
C26_heart 1,pert
Individual_5579_NN_sample,ctrl
"Wild-type-hippocampus, biological rep3 (male)",ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 4",ctrl
control MLL_00111,ctrl
quiescent ulcerative colitis_UCN2,ctrl
8h 4OHT-treated-sample2,pert
race: caucasian;	age (years): 55;	stage: IB;	grade: 1;	histology: endometrioid,pert
patient id: T166;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3N1M0;	Stage: III;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
"Semitendinosus Muscle, Cerebral Palsy",pert
4mo tg2,pert
wild-type male mice angiotensin II treated,pert
background strain: C57Bl6;	genotype: wildtype,ctrl
Normal control 2,ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 5,ctrl
genotype/variation: Ghrh-KO;	tissue: liver;	gender: male;	strain: mixed C57BL6 and 129SV,pert
Esophagus cell line OE33 siRNA,pert
"control embryonic stem cells, biological replicate 3",ctrl
Cutaneous psoriasis without arthritis PsC 19,pert
HCV_Control_2,ctrl
miR122-KO-T2,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-2,pert
cell line: A549;	agent: decitabine;	dose: 3 uM,pert
"PBMC, healthy control, biological rep12",ctrl
RA_C,pert
"Control rat liver, snap frozen",ctrl
autism with dup(15q) 02-07,pert
Pre-Frontal cortex of naïve AChE-R mice,pert
condition: Normal;	patient: N_AJ1;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
"SIRT3KO, standard diet, rep1",pert
colon cancer cells,ctrl
Subject 1 Pre allergen challenge,ctrl
"Rat_Tracheal_Control_2hr, rep5",ctrl
01UP8_ERA,pert
MBD1 WT #1,ctrl
MCF-7ADR_multi-step_doxorubicin_selected_subline_rep_1,pert
whole tissue section from case 1260,ctrl
C2A-LU,ctrl
"Normal cervix epithelium, microdissected, Age 44",ctrl
healthy control sample x302,ctrl
Diaphragm 23 Day control rep 1,ctrl
PGA-lv_8w_340,ctrl
FmrWT1_brain,ctrl
Mutant_liver_1,pert
WT3-iPS 3,ctrl
Control (pCMV-GFP-2)_MDA-231,ctrl
H_Kin_1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Female,pert
"Embryonic stem cells, HERVH shRNA",pert
Cnah KO_heart_1,pert
"Patient 19, Macroscopically intact tissue",ctrl
GM19238_Kd_NS4_21B,ctrl
"Rat pups treated with saline, spinal cord",ctrl
NSC8,pert
sepsis patient #16,ctrl
Control,ctrl
ApoE-/- mouse infected wtih an adenovirus expressing dominant negative cJun,pert
"Liver from control mice, biological replicate 5",ctrl
"fibroblast, MFS subject GDO1051 rep 1",pert
Injured 3 day Rat Retina 1,pert
24 weeks male,pert
Age: 57;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: No,pert
male_control_366,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 3,ctrl
Extract:LOX-1:113402;	Extract Description:GFP_Untreated_12hr:113402;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.48;	Quality: Background Mean Dev.:0.18;	Quality: Absent (%):59.48;	Quality: Absent (%) Dev.:0.95;	Quality: Scaling Factor:0.7;	Quality: Scaling Factor Dev.:0.72;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113402;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295723,ctrl
chip number: 14;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.84;	rin: 9.6;	transfection date: 2012-03-26,pert
EA_Case5_CD20,pert
RNA-DHL6-DMSO-3,ctrl
LSK SRF-null 3,pert
DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma),pert
"HL-60 cell line, transduced with shSYK_1 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
01MHR_PolyRF+,pert
cell type: dental pulp cells,ctrl
Trib1 #1 Wild-type macrphages were treated with LPS,ctrl
AKR/J Vehicle liver sample batch 3,ctrl
M_LS_Wk12,pert
histology: chronice active plaque;	disease state: multiple sclerosis following demyelination-active inflammation;	tissue: multiple sclerosis brain lesion,pert
T1D-LU,pert
"brain, hippocampus: Aldh5a1-/- #3403 Hippo_e1_le1",pert
cells_ATCC 16 Lu _human lung fibroblasts_JCB_0_12_19_Lung_Fibroblast_Rcontrol_HG-U133A_2_IMFRT0014,ctrl
BALB/c_PBS Replicate 2,ctrl
healthy control H23,ctrl
Pancreatic Sample 27-Tumor,pert
HD2,pert
"B10 sham kidney, biological rep1",ctrl
hippocampus: Sample #1_e1_le1,pert
WT differentiated brown fat cells (rep2),ctrl
Bone-Marrow_MM_M906,pert
38SMOKEH,ctrl
genotype/variation: GATA3 KO;	cell type: Tregs,pert
H4-II-E-C3 cells exposed to 29 µM CoCl2 for 24 h,pert
"Mutatn in the absence of tetracycline, rep3",pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 70;	age-at-onset: 69;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, hypercholesterolemia",pert
"116, MUSCLE, Before",ctrl
Fetal heart control 5,ctrl
AtT20 cells treated with NSBP1 siRNA rep 1,pert
disease state: paediatric glioblastoma;	age: 13;	gender: M;	h3.3_status: G34R,pert
"EtOH, WT, set 4",ctrl
Subject #8024-Preinfection,pert
FU-OV-1-(2),ctrl
siHic5_2_24h_4,pert
MDS patient 66,pert
GSK3B shRNA replicate 3,pert
CH2110,pert
SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2),pert
"JCAM1 Lck negative 0 hours, #3",pert
genotype: Oga knockout;	gender: Female;	cell type: MEF,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep6,pert
brain_DLPFC_bipolar C_mr448,pert
MCAD 5,pert
"LSK (Lin-, Sca-1+, c-Kit+) cells sorted from Lkb1 WT bone marrow cells",ctrl
B-CLL PB P137,pert
"24hr Hic-5 siRNA, 16hr vehicle treatment replicate 1",pert
Adrenocortical adenoma with wild-type CTNNB1-1,ctrl
"CD11b DC Xbp1 KO (DC conditional KO), biological replicate 1",pert
MLL1-KO MEF CT30-2,pert
18A,pert
"nasopharyngeal carcinoma, specimen T23",pert
patient code: 138;	gender: Male;	age: 50;	tumor grade: 2;	t-stage: 2;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
HL60-shControl-rep1,ctrl
Second shYY2,pert
PBMC from T cell Large granular lymphocyte leukemia patient#112,pert
"AD_FC, biological rep12",pert
Bc_p60_2,pert
"knock out, lung",pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 24 hours,pert
WT rep1,ctrl
"nasopharyngeal carcinoma, specimen T4",pert
dental pulp cells obtained from milk teeth,pert
HeLa_TP082505_20_HG-U133A_2_IMFGN0023,ctrl
MZ1774 YAPshRNA rep 3,pert
"PC from MM patient, isolated using CD38-APC.",pert
"C57BL/6J Saline treated, biological replicate 1",ctrl
YFP-pos GMP Dicer het rep3,pert
H4 Ctrl 2h 4,ctrl
NZM12_media_control_30hrs_rep1,ctrl
Ishikawa_VeryHighDose_BPA_24h_rep1,pert
"Wild type mouse striatum, postnatal day 0",ctrl
"brain, hippocampus: KA-240h-P15-III_e1_le1",pert
01UMZ_PolyRF-,pert
Sample Group: control; Gender: female; Age: 30; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
muscle_Akt1+/-_35wk_rep3,pert
Oct4GipES_Luc_esiRNA_72h_rep1,ctrl
whole blood_100374,ctrl
Septic shock;	gender: Male;	Survivor;	organism: Adenovirus;	organism class: Viral,pert
DOV13-(2)b,ctrl
cell line: HeLa;	cell type: human Cervical Carcinoma;	genotype/variation: parental,ctrl
cell line: MDA-MB-231;	cell type: Breast cancer cells;	group: Control group,ctrl
"Postnatal day 11 Cerebellum, wildtype; replicate 3",ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle. Galgt2 Transgenic",pert
"Hdh knock-in embryonic stem cells, Q50 line, biological replicate 3",pert
"Immortalized MEFs WC, empty retroviral vector infected, rep1",ctrl
WildType_2_2,ctrl
Nrg4 KO mouse liver,pert
cell type: WAO9 human embryonic stem cells;	genotype/variation: shRNA-mediated HNF4a knockdown;	growth protocol: subjected to a hepatic differentiation protocol;	time: d20,pert
tissue: Brain;	genotype: Npc1-/-;	age: 37 days;	subject: Mouse1;	genetic background: BALB/c,pert
KU_40N,ctrl
MC3T3 cell line,pert
s4t2c,ctrl
Patient identifyier: L;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 22 years;	Body surface area: 10 percent;	Overall erythema: moderate;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
BP patient 81_biological replicate 2,pert
patient: EUR12;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
Jurkat with Nef Biological Replicate 1,pert
"BOEC, normal 18",ctrl
PGA-MAH-C3H_OVA6h-4aA-s2,pert
JGB-Post-2UP_Run2-S2,ctrl
strain: C57BL/6J;	tissue: E13.5 embryonic fibroblasts;	genotype/variation: wild type,ctrl
gender: male;	age: adult;	tissue: liver;	genotype: Rictor floxed;	treatment: fasted 16hr then given ad libitum access to food for 3 hr,pert
healthy control H26,ctrl
"Lymphoblastoid cell lines derived from family 1724, member 1",pert
Mouse_Klf5 KO_ES_clone 1,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 49 yr;	population: white;	dsm-iv: 296.54;	age of onset: 20 yr,pert
26 weeks female,pert
Huh7 cells_Mock Infected 6 hours_ rep2,ctrl
E_Ctrl_2,ctrl
MLL2 siRNA biological rep 2,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
treatment: baseline;	gender: F;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
Cutaneous psoriasis without arthritis PsC 2,pert
PFC R control 4,pert
01MJD_Oligo,pert
AR-CO-24-1-542,pert
"non-AD_HI, biological rep1",ctrl
Spleen_infected_4weeks_rep2,pert
CUTLL1 MigR1 GSIwash4h-rep2,pert
GIST882 Imatinib Rep1,pert
prefrontal cortex (BA10);	depression,pert
tissue: Temporal cortex;	age: 89;	Sex: M,ctrl
"MCF-10A cells, shRNA targetting p63 DBD",pert
C593,ctrl
S035_Scz_F_87,pert
Hep G2 treated with Cadmium chloride 2.5-hydrate,pert
scan batch: Batch 1;	group: autism;	subject age: 9;	paternal age: 27;	maternal age: 28,pert
cell line: MCF7;	treatment: Control,ctrl
Manca 2,pert
umbilical cord_nobpd: 5D,ctrl
MMP-8 KO control mouse,pert
E11_WT3,ctrl
brain_OFC_control C_mr96,ctrl
ILD Study Number S013,ctrl
patient: 31;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"5mg/kg/day PFOA, Rep 5, Block 4, liver (high dose)",pert
Nrl-ko-Gfp 4 weeks replicate 2,ctrl
"Ptenloxp/loxp + pBP-Cre, biological rep 2",pert
platelet_Ctrl_2,ctrl
cell line: U87;	tumor tissue source: Cell line established;	tumor organ site: Brain;	pathological diagonosis: Glioma,pert
Multiple sclerosis CD4+T cells 7-PM,pert
genotype/variation: mutant ThPOK,pert
NALM-1 non-treated,ctrl
11419 UC Uninflamed ascending colon,pert
pediatric AML PP7,pert
"Foxd3 conditional knockout cells treated with DMSO, biological rep3",ctrl
INS-1 cell line #3b with induced HNF1b mutant A263insGG,pert
microdissected breast cancer cells from case 749,ctrl
lymphocytes_ctl_M_46y,ctrl
BCell_resting_sample1,ctrl
KO2 PBS,pert
HTH83 cell lines,ctrl
tissue: full-thickness skin;	age: newborn (P0);	genotype/variation: Krt1+/+;	strain: C57BL/6,ctrl
ASC_morbidly-obese_bilogical rep3,pert
Cerebellum_nontransgenic control A39_4 months_replicate 2,ctrl
Squamous cell lung cancer X36nml,ctrl
MO32_7,pert
MCF-10A shATM-3 replicate 3 [set 5],pert
strain: C57BL/6J;	cell type: KLS;	genotype/varation: ∆Hmga2,pert
Kidney tissues from lean rats on diet with rosiglitazone,pert
brain microvessels,ctrl
E11_SostKOSostLKO_2,pert
"cerebellum,18month,WT",ctrl
scc_06,pert
LT 411 +/T after nicotine-induced seizures,pert
muscle_Wt_8wk_rep3,ctrl
ME180 1 hour rep 2,pert
U2OS_control_shRNA_pLenti_3,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: F;	age: 47,pert
siLRH-1_#3_rep_1,pert
"650nM MLN4924 after 24hr, replicate 1",pert
"Subject 15, Family 5, Control",ctrl
explanted neonatal cardiomyocyte,ctrl
"Lesion Skin, LS-27",pert
patient: EUR12;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
"alveolar macrophages, non-smoker 005",ctrl
LICR_HN1_CETU3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu1,pert
HeTH-4 rep-3,ctrl
GM8923,pert
microdissected epithelial cells from invasive cancer originating in IPMN 2,pert
IM71_case,pert
gender: female;	age (years): 30;	evolution time (years): 3;	disease extension: Pancolitis;	treatment: Systemic steroids,pert
lesion_postUV_patient3,pert
EB_2_6h_209_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
"Lesion Skin, LS-6",pert
"Lesion Skin, LS-5",pert
Normal Rat Retinal Müller Cells (biological replicate 2),ctrl
"liver, fed 0.1% quercetin diet for 14 days",pert
medium to late response after cadmium treatment,pert
K562 cells CREB Knock-out replicate 6,pert
MeCP2_2,pert
12489 UC Uninflamed ascending colon,pert
Runx1 wild-type,ctrl
Liver_normoglycima_no.7,ctrl
Waldenström’s macroglobulinemia (WM-PC 30866),pert
BC2 TC_NOC,pert
SRF silenced R1881 rep 1,pert
BMM,pert
strain: C57BL/6;	tissue: cerebellum;	genotype/variation: wildtype,ctrl
40A;pretreatment;female;breast tumor; responder,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep2,pert
HVS-CD4-ITK-R335W_unstim_rep2,pert
Multiple Myeloma Patient 2,pert
"Grape extract group, 6 months, patient number 29",ctrl
NICM pool 4 (n=4),pert
"HeLa, epithelial cells, adenocarcinoma (CCL-2; American Tissue Culture Collection ATCC, Manassas, VA, USA)",ctrl
"Normal subject (25 year old caucasian male, SAK_1280038056)",ctrl
Gfp purified cell,pert
Control (C278),ctrl
Striatum of 8-10 week old DBA/2J mice,pert
Run4.aUa.010110d.SkMDbt1148D.CEL-DB basal,ctrl
E2F WT,pert
5008-scrape,pert
MyD88_ZYM_A,pert
cell line: AT2 E/R positive leukemia;	treatment: treated with specific E/R targeting shRNA,pert
224 Day 0 Untransfected biological rep2,ctrl
OSCE-13T,pert
Knockout liver DEN-injected 12weeks repl1,pert
K562 cells CREB Knock-out replicate 2,pert
genotype: control;	strain: inbred 129;	cell line: E14;	cell type: embryonbic stem cells,ctrl
WT-sham-2 month-R3,ctrl
RAW_0.14mM_HOCl_#2,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-sp3,ctrl
V5-P568,pert
NZW/LacJ Vehicle liver sample batch 2,ctrl
EE_IB_3_cauc_lcm,pert
MDS patient 156,pert
WT biological replicate 3,ctrl
"Peripheral blood, normal control [N63]",ctrl
Wildtype liver DEN-injected 12weeks repl3,ctrl
S8,pert
L428+M_rep2,ctrl
subcutaneous fat,ctrl
"Pineal gland from control mouse at ZT6, biological rep 3",ctrl
SENS 3 0hr,ctrl
"G42 cells from Cerebellum, wild type control, biological replicate 3",ctrl
Liver sample from Alcoholic hepatitis group (CA92),pert
Brain CD8 T cells that are IL-10+ rep3,ctrl
BirA control replicate 2,ctrl
CLL18-CD8,pert
colon_CRC_1761,pert
"WT, PR01M001v0",ctrl
unstimulated CD3+ T-cells from Itk knockout C57BL/6 mice,pert
Control N2B27 sample 1,ctrl
8 wk old male mdx5cv soleus,pert
liver_wild type_12 weeks_replicate_2,ctrl
H19 siRNA (simH19) tranfected into C2C12 myoblasts rep1,pert
"72 hour-treated wild-type NB4, biological rep1",pert
DMN-CtrHippo10d-1bAv2-s2,ctrl
Lung tissue sample from lung transplant patient,ctrl
cell line: SC263;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
lesion_preUV_patient3,pert
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID341,pert
Snell 22 month Wild Type Liver 2c,ctrl
E12 ko.1,pert
patient: 263;	current medication: Azathioprine 75mg Fosomax 70mg;	birth date: 11/9/58;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/00;	diagnosis date: 6/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 7/8/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"HCT116 cells, control siRNA",ctrl
Adrenal CREMKO 0h batch 1 [AdKOh00.1],pert
WT - Cre Treated - 2 hrs - repeat 2 - Cy5 - mAdbID:62603,ctrl
mouse liver B1,ctrl
Huntington's disease 874H,pert
S/LV4,pert
HF0639_U133P2,pert
AL Chip#26,pert
cell line: HEK293 cells;	transgene: NPAP1/C15orf2;	treatment: uninduced,ctrl
PGA_MI_nilv_1w_662,pert
cell type: placental trophoblast;	developmental stage: E12.5;	genotype/variation: c-Met KO,pert
MPM tumor 5,pert
age: 24 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
4IDC_tumor ductal,pert
WT-control-1 (DFW),ctrl
injection: IP 8hr 1 mg/kg Dexamethasone in saline;	diet: AIN-76A,pert
Wildtype_TAC_Rep5,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 17",pert
"spleen follicular B in WT, biological rep6",ctrl
RNA from HCC_37N,ctrl
patient: 238;	current medication: Enalapril Zantac;	birth date: 9/27/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 9/25/03;	diagnosis date: 1/14/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: NEW;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: Hypertension Diverticular disease;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
race: caucasian;	age (years): 60-65;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
whole blood_101007,pert
24h kin- Cel.08,pert
rd1_P4_rep2,pert
Jurkat T-cells non transfected,ctrl
"ERRa ko baseline heart, sample 1",ctrl
Mock infected murine liver-MO30k-(211)-6hpi,ctrl
"Patient 116, 12 month of REBIF",pert
"Male, Wistar, 6hrs/day access to cocaine, lateral hypothalamus",pert
A_AN11989_T,pert
mdx5cv diaphragm sample 1,pert
RNA-DHL4-R406-6H-3,pert
primary normal lung tissue 1361,ctrl
control_0412-7,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:45;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=diffuse type",pert
Male 8week BL6 CBDLrep3,pert
tissue: prefrontal cortex from adult APP knock-out mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
"fibroblast, MFS subject FB890 rep 5",pert
Clint-Cont-2-011411,ctrl
mucosa collected and archived within 30 mins after surgery,pert
DBA d3 (183msn),pert
Rat fatty liver8,ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: Treg;	treatment: unstimulated;	genotype: WT,ctrl
P14 - nudelcko/ko 3,pert
erStress_twins_AA_1736twin2_DMSO_4h,ctrl
normal adjacent esophageal tissue from patient E1532,ctrl
cell line: Colo205 parental cell line;	cell type: colon cancer,ctrl
WT_Mstn_4,ctrl
"SBC-5 cells, siEGFP (control), 48 hr after siRNA, duplicate sample 2",ctrl
AZ-521_uninduced_24h_rep3,ctrl
"344SQ with PIK3CA shRNA, replicate 2",pert
"Gata4_S105Amut, PE treated whole heart",pert
age: 6 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
A673 cell line that has been treated with DMSO vehicle control for 3 days.,ctrl
EB_2_19d_232_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 49;	age-at-onset: 47;	geographical origin: Mirandela;	lifestyle characteristics: ever smoker, ever drinker",pert
"49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
231/ARF-1_3,pert
cell type: primary p53-null neural stem cells;	retroviral expression: PlagL2,pert
EBS_2,pert
"Aorta, saline 7d, #3",ctrl
tetracycline inducible Ngn3 ESC differentiated for 3 days without feeder cells or LIF and with doxycycline,pert
GEIM193-NORM,ctrl
MLL_00110,ctrl
"BMDC, Asc-/-, replicate 1",pert
0989-01-C,ctrl
cell type: PBMC;	disease state: Convalescence,pert
HeLa_TP082505_22_HG-U133A_2_IMFGN0023,ctrl
GFP-progerin Induction: day 0 Replicate B (4b_progerin_0d_B),pert
"metastasis: metastatic recurrence;	Stage: 3c;	tissue: cancer, homogenized",pert
cell line: H1299;	agent: azacitidine;	dose: 3 uM,pert
Sprague-Dawley Rat (male),pert
Aquaporin-11-/-_mouse P7 kidney #2-3,pert
PsOEt-18-LS,ctrl
"Spi-21, biological rep 2",pert
VIN_B077,pert
Diaphragm 28 Day mdx rep 1,pert
MCF7 cyclin D1 siRNA Vehicle Rep2,pert
Gene expression of murine fibroblast-like synoviocytes Grp1_C57BL6_3_FLS_TNFtg_plus_RSK2-KO,pert
Adipose-5 month-Myc heterozygous-technical replicate 1,pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"human nonfailing LV myocardium, NonFailing3",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.809;	OD280: 0.918;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 156;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Pediatric_GBM_43,ctrl
HaCaT_Control_ biological rep1,pert
cell line: ARPE-19;	clone: 23;	genotype: Wild type,ctrl
Cardian muscle Diabetic 5 week D5,pert
PFC R control 1,pert
cell line: HL-60;	shRNA construct: GSK3A Construct 6,pert
Psoriasis-Patient-J,pert
"patient 13, baseline",ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#6,pert
human pluripotent cells,ctrl
Patient 10,pert
K562 cells control replicate 10,ctrl
testis knock out replicate3,pert
siEGR4 (24 hr) _1,pert
"Sodium arsenite added to food: None; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: 10 ppb, 5wk",pert
HC-KO-10B,pert
VMH of KO3 mice,pert
WT - Cre Treated - 24 hrs - repeat 2 - Cy5 - mAdbID:61766,ctrl
UTX conditional knockout (cKO) cell line 2,ctrl
"liver,12weeks,WT",ctrl
Rat fatty liver2,pert
Vit A sufficient 3a,ctrl
Ls174T-L8 dox1,pert
t10,pert
PTEN+/-IKK2ca/ca ep_C,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_4mM_HG-U133A_2_YCHSUP501,pert
tissue: Biceps muscle;	patient: C.b.4;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Backskin_Get1_e18_WT1,ctrl
"Colitis 08, UC08",pert
MS patient 9,pert
Celecoxib_#4867,pert
GV oocyte_control_rep2,ctrl
Erythroblast_SOD2-/-_repKO31,pert
HMEC_50 vs SKBR3,pert
tissue: retina;	disease state: Diabetes,pert
non-treated WT_rep-2,ctrl
MacularDegen-healthy-10aAv2-s2,ctrl
"Cadmium 0.2 µM, biological rep3",pert
"129P3/J SAL, Rep2",ctrl
Prostate Cancer_MS 36A6,pert
Rsk2-KO Hippocampus - 3,pert
GFP Untreated 2hr 282295473,ctrl
gender: Male;	age (y): N/A;	tissue: normal pituitary,ctrl
CN2,ctrl
Undifferentiated Dicer -/- (27H) ES cell line replicate_1,pert
"cell line: MCF7;	disease state: Breast adenocarcinoma, estrogen receptor-positive;	genotype/variation: MTDH WT KD",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp2,pert
Universal Human Reference RNA,pert
heart of 1 week control male mouse,ctrl
Spleen_uninfected_control_rep1,ctrl
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
cell line: KCL-22;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
Strain: C57BL/6;	Gender:male;	Tissue:liver,ctrl
C2,ctrl
C024_Control_F_78,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Male,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 41.25205,pert
"106, MUSCLE, Before",ctrl
experiment I hTERT replicate 2,pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.417;	OD280: 1.217;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 337;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"IN1472 siPD treated, Biological replicate3",pert
"FVB/N genetic background. 4-month old;	virgin female mice were used, mice were kept on a 12-hour;	light/dark cycle with ad libitum access to chow and water",ctrl
quadriceps_muscle_Wt_female_35wk_rep1,ctrl
"gender: male;	batch: 1;	age (years): 32;	patient id: Severe_3;	fev1 (% predicted): 98;	fvc (% predicted): 113;	medication: prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od;	cell type: CD4+ T-cells",pert
MSE_D_33A,pert
"Cultured ovarian cancer cell line A2780, untreated",ctrl
Carboplatin treated cells Rep1,pert
scrambled control-2,ctrl
AT2_shG1_rep2,pert
CLL11-CD4,pert
Calu-3_SIN3A siRNA,pert
human esophageal squamous cell carcinoma cell line_KYSE30,pert
N11B Normal-cerebellum,ctrl
"mouse aorta cross strain comparison, C3H_T40_HF_03",pert
Gene expression of murine fibroblast-like synoviocytes Grp1_C57BL6_1_FLS_TNFtg_plus_RSK2-KO,pert
genotype: Wild Type;	stimulation: stimulated with LPS and mouse recombinant IL-4 (day 2);	cell type: B cells,ctrl
genotype: Emu-myc;Suv39h1-/-;	transduction: Bcl2;	cell type: primary lymphoma cells from lymph nodes;	treatment: Adriamycin (ADR),pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 51,ctrl
"spleen follicular B in IRF8 conditional KO, biological rep4",pert
transfected with control siRNA_4,ctrl
Kidney_saline iv_mouse #003,ctrl
"shCDK8, low glucose, replicate 3",pert
WKY12-4,ctrl
SW1736_t0h_rep3,ctrl
tissue: white blood cells;	age: 7.88;	Sex: male,pert
MSC_VUB03_DM1_3,pert
Wistar rat liver tissue following animal no exposure to orotic acid  (control),ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 20;	maternal age: 19,ctrl
tri_CH1_normoxia,ctrl
Muscle 50 eccentric contractions 12 hours KO Aged 1217,pert
lesion_preUV_patient12,pert
induced pluripotent stem cells obtained from dental pulp cells,ctrl
"brain, hippocampus: KA72-II_e1_le1",pert
Cbfb-deficient Treg,ctrl
"Chromium 10 µM, biological rep2",pert
Female - caucasian - N-02-G,ctrl
kidney_co_6M_rep3,ctrl
DS-Fibr 6,pert
"Rat_Tracheal_Dex_2hr, rep2",pert
expression array - O5,pert
"MGSKO, PR01M008v0",pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp3,pert
age: 6 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
CME-Emerin0d-1MA-S2,pert
umbilical cord_nobpd: 8C,ctrl
C023_Control_M_38,ctrl
"male,17,Caucasian",pert
Heart-Base_WT-1,ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_1,pert
db/m 16 wk1,ctrl
Mouse_ATF6aKO_colon_UT_rep1,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 5 - Technical Replicate 2,pert
RAW_2.1mM_HOCl_#2,pert
"Luc control esiRNA, biological rep1",ctrl
microdissected breast cancer cells from case 140,pert
coc-14_C,pert
"gene expression of wild type oocyte, replicate 2",ctrl
"affected status (disease state): control;	gender: male;	age-at-examination: 52;	age-at-onset: n/a;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever drinker",ctrl
"RWPE1 cells treated for 48 hours with 100 nM 1,25(OH)2D",pert
MGHU3 Cells_Control siRNA_Biological Replicate 2,ctrl
"Acute Myeloid Leukemia, sample 63",pert
cRNA;	postnatal day 16;	NFIA deficient,pert
Control_6months_retina2,ctrl
MCI-021,pert
"Gastrocnemius muscle, Smad4 KO mouse",pert
MGHU3 Cells_TAK1 siRNA_Biological Replicate 3,pert
siLMO3_oligo2_0_rep2,pert
"metastasis: metastatic recurrence;	Stage: 3b;	tissue: cancer, homogenized",pert
"Nickel 400 µM, biologcial rep1",pert
U138MG shVEGFR-2 3,pert
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-3,pert
Disease_status: Healthy control;	Age (years): 40;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 38;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
NZW/LacJTCE liver sample batch 3,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 33;	sex: M,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_24_20_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
Psoriasis-4 baseline,pert
microdissected breast cancer cells from case 469,ctrl
WT - Thymus - biological repeat 2,ctrl
SCC25_rep2,ctrl
GB 6 NTB +LPA,ctrl
"RPMI8226_shKDM3A#1, replicate2",pert
Bronchial Epithelial Cells control biological 1902T,ctrl
RS-first,ctrl
"GNMT knockout at 3 month age, biological replicate 4",pert
U2OS control shRNA_pLenti_2007,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 11.442;	Ratio: 2.08,pert
cerebellum_Pink1 knockout_6 weeks_replicate 2,pert
N12,ctrl
PancreaticSample11-Normal,ctrl
cell line: SUDHL-1 Cells derived from the a patient with Anaplastic Large Cell Lymphoma;	agent: ALK inhibitor CEP-14083,pert
MCF-10A shATR-3 replicate 2 [set 5],pert
Liver-Cpr-null_pool 2,pert
GM19238_Kd_IRF8_2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.899;	OD280: 1.476;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 56;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
midbrain_wild type_6 weeks_replicate 1,ctrl
VCaP/MYB siRNA #2,pert
Liver Tro1,pert
CF knockout LFCF CHN532,pert
cerebellum SNCA knockout 21 month replicate 3,pert
"Uninfected, replicate 3",ctrl
224 Day 0 Untransfected biological rep1,ctrl
NTG mouse heart left ventricl,ctrl
gender: male;	strain: C57B/6Jx129Sv;	genotype/variation: SRC-2 knockout (KO);	tissue: heart;	age: 10-12 weeks old,pert
Normal_1801,ctrl
shRNA-TAK1-1 (HuT-102 cells + shRNA-TAK1),pert
RV63.04_CONTROL_day19,ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, chow diet, liver",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 214,pert
TYK-nu+(3),pert
liver western diet 0.05% quercetin rep2,pert
ccRCC tumor of patient 1524,pert
subject: 5;	disease: TD;	muscle: GR;	gender: F;	age: 12.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Normal Tail Skin 1,ctrl
"WT mouse lung, biological rep3",ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14481;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
E12.5 heart_wildtype_sample c,ctrl
Array Type: HG-U133A_2;	Ratio: 1.96;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
"atRA RARaKO, set 4",pert
shNANOG_4,pert
"Subject 5, Family 2, Asymptomatic",pert
mESC_undifferentiated_Alkb1-/-_rep2,pert
A5_tumor,pert
CON - R18,ctrl
"cells treated with Scrambled siRNA, biological replicate 1",ctrl
skin,pert
Blood_Control 4,ctrl
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14440;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
"vastus lateralis biopsy, 76 year-old healthy sedentary male (#47)",pert
Carboplatin 36 hours set 1,pert
strain: C57BL6  X 129sv mixed;	tissue: liver;	genotype: sphingosine-1-phosphate (S1P) lyase knock-out,pert
J1_plus LIF_rep2r,ctrl
A549 vehicle control (3207),ctrl
Human prostate cancer tissue,pert
hippocampus: Sample #3_e1_le1,pert
diet_Lung_2,ctrl
Control LM2 Cell Replicate 3,ctrl
IkkβF/F_replicate1,ctrl
Hippocampus_Soman_24h_rep1,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 33;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
neurectoderm derived from embryonic stem cells,pert
OVE26_8W_4_7,pert
EA_Case21_CD4,pert
FO_spleen_KO_rep1,pert
B15 - infected BALB/cByJ fibroblasts (9 h post inf),pert
ERRa KO biological replicate 1,pert
brownfat_KO3_day3,pert
"Mouse, WT, colon, UT, rep2",ctrl
"CD44 siRNA, 2",pert
P1 mouse eyeball extracted total RNA_wildtype2,ctrl
jzo010-rp1-v5-u74av2-met,pert
c.3,ctrl
HWC14,ctrl
"gender: Female;	age: 67;	post-mortem delay: 3.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
MF-32,pert
gonadal white adipose tissue_Sfrp5 KO_8 weeks of high-fat diet,pert
NCCIT siTET1 rep1,pert
kidney_Q10_6M_rep1,pert
NEO-6_HG-U133 Plus 2,ctrl
C017_Control_M_72,ctrl
"Mesodermal Precursor Cells derived from hES cells line VUB03_DM1, biological replicate 2",pert
Mouse female ES cells PGK12.1 after double RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-2 in PGK12.1.,pert
LIVER_CONTROL_repl4,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.2, MOLM-13 cells",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 46 yr;	population: white;	dsm-iv: 295.9;	age of onset: 22 yr,pert
muscle Smad4KO 2 control,pert
"mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 38;	ld: ETOH;	creatnine: 1.4;	mdrd: 60;	gfr: 57;	protein: 0;	hematuria: 0;	c3: 1;	c4: 0;	rf: 30;	hcv: NEG;	htn: 0;	dm: NEG;	hba1c: 5.2;	meld: 11;	ana: NEG;	gp: normal parenchyma by LM and IF, limited sample;	mm (mesangial matrix expansion): 0;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 0;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 0;	if (interstital fibrosis): 0;	as (arteiosclerosis): 0;	igg: 0;	iga: 0;	igm: 1;	c: 1;	empe: 1;	bmwid: 1;	bmd: 0;	edd: P;	no of glomeruli: 3;	glomerulosclerosis: 0;	intact t: 1;	arteries: normal;	if: IGM+ mesangial;	mesangium ig: M;	tissue: Kidney_Biopsy_Liver_disease",pert
jzo007-rp1-v5-u74av2-met,ctrl
A518 Sham 7 day,ctrl
shRNA2-4-plusDox-rep1,pert
KO_lung_PBS_control,ctrl
Subject #8037-8hr Postinfection,pert
Normal-ERα-positive breast cancer 24,ctrl
gastrocnemius-30 months of age-control diet-biological replicate4,ctrl
Reh_IKK_2,pert
H295R _2OHBDE85_rep2,pert
AVC_mutant_rep1,pert
Anterior tibialis,pert
prefrontal cortex (BA10);	control,ctrl
Tissue: primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes,pert
Normal myocardium sold commercially (C),ctrl
patient: 223;	current medication: Prednisolone 20mg Asacol 2.4g;	birth date: 1/18/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/04;	diagnosis date: 3/15/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
RatLung_H48h_1,pert
GFP+ cells from Sox9-EGFP Mus Musculus pancreas at p23,pert
gender: Male;	tissue: Tendon;Patellar;	age: 41;	donor: 10;	disease state: Lesional,pert
Placenta_PE(LO)4 with Cy5,pert
"DMSO Control after 8hr, replicate 3",ctrl
CME-Ctr_LaminA0d-1MA-S2,ctrl
E100-/-SRFVP16-1,pert
wild-type naïve CD8 T cells KAI282,ctrl
ESCs_pCIP siRNA 2,pert
"Cervical cancer, squamous cell carcinoma, microdissected, stage IIIA, HPV 16",pert
T123 U133p2,pert
"Morphology: epithelial, Organ: lung, Disease: adenocarcinoma (pleural effusion), Gender: male, Ethnicity: caucasian",ctrl
cell type: pre-iPSCs;	sirna mediated knockdown: Cbx3 (HP1gamma),pert
U937_ROS_curcumin_18h_rep3,pert
"liver, conditional Keap1 knockout, Alb-Cre::Keap1(flox/-)",pert
cell line: prostate cancer cell line VCaP;	genotype/variation: negative control siRNA,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: HIGH;	genome/variation: KIT mutation detected,pert
2119-03-A,pert
"ALL_NDS, K52 011609",ctrl
PC3 cells treated with Wee1inhibitorII,pert
01LQD: normal control,ctrl
"DMSO-treated NRK-52E cells at 72h, biological rep 1",ctrl
SA_258,pert
coc-57_C,pert
C57BL/6J-ob/ob;	Pancreatic islets;	Age: 14 weeks;	Gender: Male,ctrl
cell line: PC-3;	treatment: siControl,ctrl
"Proximal, Small Intestine 21 days old",pert
CD11b+Gr1+ cell sample_5 (derived from IL17RC Knock out mouse),pert
"vestibualr organ at E18.5 of Igf1 +/+, biological rep 2",ctrl
lymphocytes_HD_M_55y,pert
"control mice, whole uterine tissues, replicate 2",ctrl
human umbilical vein endothelial cells,ctrl
"healthy breast 3, biological rep. 3",ctrl
16A;pretreatment;female;breast tumor; not assessable,ctrl
A431 WT 2,ctrl
AA_78,pert
9_2_MOE_430A_HE,pert
AF cell free mRNA from 2nd trimester Turners syndrome fetus,pert
a10a.000606jd.2.SkMNor908.CEL-IS stimulate,pert
"Csbm/m mouse, cerebellum, standard diet supplemented with resveratrol ad lib",pert
Emx2 KO mouse,pert
"brain, cerebellum: WCb12w#1_e1_le1",ctrl
"human failing LV myocardium, Ischemic69",pert
"Acute Myeloid Leukemia, sample 10",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.386;	OD280: 0.669;	Ratio: 2.01;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 308;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Y VIS _B030,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-sp1,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID67,ctrl
BASC-Myc-depletion-1 [mRNA],pert
Sample ID: TP25;	Twin Pair ID: CCN4.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 29;	Current Age (2007): 32;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
CON-3-COLLAGEN,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3WT;	age: 12 weeks;	nutrient state: 24h fasted;	diet: High-fat diet,ctrl
patient id: 1524;	tissue: Normal cortex;	gender: Male;	age: 70;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
Healthy control 6,ctrl
87 year old female,pert
hnf4KD_H9_d20_hepatic differentiated_2,pert
Carbo Day2 (355R),pert
CLL 119-09 Control,ctrl
MCF-7 cells treated with E2 for 3h.,pert
diagnosis: COP;	fvc-group: FVC3;	tissue: lung,pert
cell line: SCOV3,ctrl
"ZR-75-1, 12h, 3.0mM 5FU",pert
Mouse Left Ventricle,ctrl
shRNA-TAK1-2 (HuT-102 cells + shRNA-TAK1),pert
Extract:LOX-1:213203;	Extract Description:LOX1_Untreated_2hr:213203;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.04;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.76;	Quality: Background Mean Dev.:0.44;	Quality: Absent (%):57.87;	Quality: Absent (%) Dev.:0.3;	Quality: Scaling Factor:0.58;	Quality: Scaling Factor Dev.:0.29;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213203;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295553,pert
FoxO3null_1_2,pert
T cells,pert
"genotype: wild type (Wutz et al., 2000);	cell line: ES",ctrl
Mouse old heart w/ a-tocopherol aT-Ht-5,pert
SKBR3_1uM_Lapatinib_3,pert
CRC_nodrug_F4882,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Mnk_3204-T-B,ctrl
"Patient N, lesional skin",pert
KU_24N,ctrl
midbrain_Pink1 knockout_18 month_replicate 1,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: shPTK7 (PTK7 knockdown),pert
race: caucasian;	age (years): 58;	stage: IC;	grade: 3;	histology: endometrioid,pert
cell type: hepatocytes,pert
"Patient  A, lesion, time: 0",ctrl
FCHL patient #99-0712,pert
C5_transgenic but unaltered,pert
3DKD_rep3,ctrl
V5-P096,pert
"Distal and Proximal Large Intestine, 8week old Eeyore mouse 1",pert
induced pluripotent stem cells obtained from dental pulp cells,pert
Cbfb-deficient Treg,pert
muscle wild type replicate1,ctrl
breast epithelium from reduction mammoplasty,ctrl
cell line: NOMO-1;	genotype: ZFX wild type,ctrl
MCF-7 Control,ctrl
KN-smoke-low-5 month-R3,pert
WT1-iPS 4,ctrl
P1 mouse eyeball extracted total RNA_Brg1_cKO1_GSM618318,pert
Gene expression profiling of normal cortex of patient 111,ctrl
Msgn1_12hMinDox-biological rep1,ctrl
Parkinson's disease sample x187,pert
"cell type: PBMCs;	disease state: acutely admitted, severely psychotic schizophrenia patient;	gender: male",pert
HC-KO-10A,pert
Mock infected macrophages harvested at 6h post-treatment from donor 3,ctrl
"Lesion Skin, LS-19",pert
C022_Control_F_68,ctrl
Colon_Wild Type+Quercetin_2,pert
control shRNA replicate 2,ctrl
CLP1,pert
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 15days;	genotype/variation: WT,ctrl
liver-AHRWT-cornoil-rep2,ctrl
Huntington's disease 874B,pert
Biceps_Control_7,ctrl
"human failing LV myocardium, Ischemic7",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 58,pert
GM19238_Kd_DIP2B_1,pert
32/OVX/oil/6h/UTX 129 Hoxa-10-/-,pert
siEGR4 (72 hr) _2,pert
disease state: healthy control;	tissue: epidermis;	age: 33;	gender: female;	treatment: untreated;	time: control,ctrl
"IDC 4, biological rep. 4",pert
strain: Wistar;	gender: male;	tissue: sciatic nerve;	treatment: saline,ctrl
endothelial_rep1,pert
Nerve_Diabetic_Vehicle_709,ctrl
subject: 34;	disease: CP;	muscle: GR;	gender: M;	age: 15.2;	gmfcs: 2;	popliteal angle: 120,pert
sarcoma tissue,pert
Aquaporin-11-/-_mouse P7 kidney #1-2,pert
G643-lcm,pert
HeLa_06_21_04 TP-8,pert
"control, BA46-67",ctrl
agent: EphB2-Fc conjugate;	time: 1h,pert
AL Chip#34,pert
Experimental 5,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 63 dpi,pert
Dengue Hemorrhagic Fever Patient 34,pert
tissue: Frontal cortex;	age: 92;	Sex: F,pert
small_intestine_complete_24h_fasted,ctrl
Ulk1/2+/+ (untreated) 3,ctrl
renal_vesicle_wild_type_4,ctrl
Day: 18; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 3,pert
CLL12-CD4,pert
Md02h032,ctrl
pancreatic cancer cell line MiaPaCa2 containing AGR2 overexpressing vector pCEP4 -AGR2,pert
patient id: 26;	tissue: Normal cortex;	gender: Female;	age: 77;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
MEFs_unstimulated_4hours_rep1,ctrl
"Hdh knock-out embryonic stem cells, biological replicate 3",pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 51;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
CD19 selected B-cells,ctrl
HEK293_HNF1b_#2_uninduced,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.6137,pert
UM13_Wt_rep1,ctrl
Bone-Marrow_MM_M832,pert
wildtype (GFP-negative) kidney cells,ctrl
"human failing LV myocardium, Ischemic16",pert
Lamp3 KD 4d 1,pert
TTF=135min;	Race=Black or African American;	Sex=Female;	Group=B;	Prototype_N,pert
MLL_PTD12,pert
Rb-/- prostate epithelial cell line,pert
HWC17,ctrl
con-41_C,ctrl
Cre_day_5-1,pert
Disease_status: Healthy control;	Age (years): 46;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
"Kidney from MON exposed rats, biological rep 2",pert
NORMAL LIVER,pert
shScr replicate 3,ctrl
"MCF-7, 12h, sham B",ctrl
Snell 22 month Wild Type Liver 1c,ctrl
GM19238_Kd_TCF12_2,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep3,pert
CT3 vs PBS 4 hr pooled,ctrl
n9t7d,pert
Dengue Fever Patient 4,pert
F9 con sample #3,ctrl
"male;	CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery",pert
strain: FVB/N;	tissue: forebrain,ctrl
"tissue: kidney;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: monuron 72 hr",pert
uterus_P4_PRKO_40hrs_rep3,pert
NPC4,pert
Squamous cell lung cancer patient 35,pert
CD4+YFP+Ly5.2+ from Foxp3delta,pert
H1_SS8_01Nov07,pert
C13-(2),ctrl
"fibroblast, control subject NM2 rep 2",ctrl
microdissected breast cancer cells from case 289,pert
Teratozoospermic individual: Sample T5,pert
Wild-type standard cage Rep4,ctrl
"Cells: U2OS, Treatment: infected with PRC shRNA4_pLenti, blasticidin selection",pert
Human Non-progressor HIV Sample L015-CD4+ T cells,pert
"Patient R, lesional skin",pert
Ovalbumin-induced inflammation 1 hour,pert
01SAGEA2,pert
"Gastrin Knockout, 2 month old male mice parietal cell",pert
rat heart ventricle,ctrl
COLO829 cells with shMITF knockdown and DMSO treatment,ctrl
sciatic nerve of P60 Pmp22 knockout mice,pert
genotype/variation: wt;	age: E12.5;	tissue: whole eye,ctrl
01MHM_PolyRF-,pert
06R024 RA,pert
Sample 19 Kidney Normal Mouse - Control Diet,ctrl
"ID: MLL_00248;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
Tendon_non-lesional_rep20,ctrl
Hdh mutant (111/111-polyQ) 3,pert
Strain: B6SJL;	Age: 110 days;	,ctrl
COLO829_shMITF_PLX4032_A,pert
newborn (P0) Krt1-/- skin_replicate 2,pert
subject: 12B;	cohort: 12;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 49;	Sex: M;	batch: Batch_3,pert
whole kidney from WT mice,ctrl
Substantia nigra PD rep16,pert
8 wk old male mdx quad,pert
"breast tumor epithelium,34",pert
Y SIT_B074,ctrl
MCI-016,pert
JoMa1_2,ctrl
38 year old female,ctrl
Pediatric_GBM_49,ctrl
FmrKO1_blood,pert
"D425-shOTX2_1, t=96",pert
15KD_SerumStarved->1hrEGF_rep1,pert
cell line: prostate cancer cell line VCaP;	genotype/variation: MYB siRNA,pert
BE-rep6,pert
cell line: CUTLL1 (T lymphoblastic leukemia / lymphoma),pert
38GOBMUC2H,ctrl
Muscle 50 eccentric contractions 12 hours KO Aged 1106,pert
"brain, hippocampus: KA72-I_e1_le1",pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 352;	age-at-biopsy-years: 41,ctrl
adult hearts,pert
cell type: induced pluripotent stem cells,pert
"A673 treated with DMSO vehicle control for 3 days, biological rep4",ctrl
CRC_celecoxib_F4874,pert
MGHU3 Cells_Control siRNA + PD173074,ctrl
b7.2,pert
MCAD + LPS 4,pert
E14wt-SRFVP16-1,ctrl
A549_Nrf2 siRNA_biological rep2,pert
mdx quadriceps sample 1,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 29;	maternal age: 37,pert
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2-/-;	agent: untreated,pert
Early IPF_surgical biopsy_upper lobe_rep159,pert
GIST Pre Treatment Biopsy 16,ctrl
"Patient 3, Atheroma plaque",pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep3,pert
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 12/1/03,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.1, MV4-11 cells",pert
Muscle Pio2,pert
HET Brain 82d Mouse1,ctrl
pt. HCL B treated with DMSO for 48h,ctrl
5N,ctrl
primary human monocyte-derived macrophages,ctrl
Healthy12-CD4,ctrl
MDS47,pert
striatum_Pink1 knockout_6 weeks_replicate 2,pert
MA_305,pert
Treg WT rep2,ctrl
ctrl_513,ctrl
breast tumor 4,pert
"experiment II, hTERT, replicate 1",pert
sampleID: SAM630130;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"age at diagnosis: 25;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 25;	dfs-event: 1;	distant metastasis: 1",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 59.49589,pert
U937 cell line infected with GSK3B Construct 2 shRNA,pert
Mc3T3 control_ 5day_rep3,ctrl
"peripheral ganglion, unknown: nicotine 1hr_2",pert
135A,ctrl
MDS patient 52,pert
"heart, middle septum",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 81,pert
Bronchial Epithelial Cells SA biological 1683H,pert
"Lymphoblastoid cell lines derived from family 1725, member 2",ctrl
"Patient #6, Untreated",pert
strain: FVB/NCrIBR;	tissue type: ear skin,pert
Mouse C2C12 Myotubes treated with BSA for 16 hours,ctrl
Brain tissue from glioma patient,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.929;	OD280: 1.018;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 233;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
PE_N_M165,ctrl
147B,ctrl
Estrogen [H2],ctrl
01L4J_CTRL,ctrl
Nfix_depleted_rep3,pert
"gender: Male;	age: 60;	post-mortem delay: 16h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
strain background: mixed;	tissue: retina;	Stage: E14;	onecut genotype: WT,ctrl
Sedentary-13,ctrl
Patient 4 appendix,pert
CD4+_Tcells_healthy_donor_1,ctrl
EP55_adipose_pcos,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
0947-01-A-b,pert
"ShamC-60, biological rep 3",ctrl
"MLD, biallelic AML MLL_00248",pert
HT29 cell line,ctrl
MPM tumor 12,pert
P4_PMP22TG_3,pert
Barrett's esophagus (B7),pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
infection: Un-infected control;	cell type: cultured primary human lung epithelial cells,ctrl
CHB PBMC_sample 9,pert
Series 3; Young; 1 Week after fracture,pert
E100-/-SRFdM-VP16-2,pert
heterozygot FH P387,pert
OVCA429-(1),ctrl
dex4hr_3,pert
Normal mucosa 9,ctrl
D2-Gpnmb+ control rep4 (retina),ctrl
biopsy of undifferentiated NPC,pert
subject id: 49;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Treg Trim28 conditional KO rep4,pert
MPM tumor specimen 10,pert
brown adipose tissue,pert
Huh-7/IRF1 rep1,pert
cell type: hRPE;	disease state: 24h post-infection with WNV;	gender: male,pert
CD4+_Tcells_healthy_donor_5,ctrl
IM17_control,ctrl
Seltzer 14d replicate 2,pert
cell type: sorted LSK cells;	strain: C57BL/6;	genotype/variation: SRF wt,ctrl
Brg1 mutant 2 cell embryo rep3,pert
H295R _2OHBDE85_rep3,pert
THRA wt + T3 replicate 2,pert
Ramos pRTS-CA-IKK2 E+,pert
tissue: liver;	strain: C57BL/6JBomTac;	genotype/variation: wildtype,ctrl
Pancreatic Sample 19-Tumor,pert
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks;	Tissue: thymus,ctrl
Psoriatic arthritis PsA 4,pert
Mannitol control treated A549 human lung cancer cell cultures replicate B,ctrl
kidney biopsy from patient with NSC,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 64;	donor: 23;	disease state: Lesional,pert
wt-Gfp P6 replicate 3,ctrl
Placenta_nl4 with Cy5,ctrl
"testis wt, 17dpp, Rep2",ctrl
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: Ing1-/-;	cell type: mouse embryonic fibroblasts (MEF cells),pert
I_LS_Wk2,pert
Control caudate,ctrl
Src-overexpression - replicate 1,pert
HMEC X BC21,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,ctrl
"control, BA10-40",ctrl
CsA,pert
siSox2 replicate2,pert
"Control shRNA cells passage 11, rep 4",ctrl
subject: 07A;	cohort: 7;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 29kb;	age (y): 18;	Sex: F;	batch: Batch_2,pert
F23.05,ctrl
CON_A,ctrl
PND28 Rat Testis_Rat230-2_3hr MEHP_Animal#50_04005,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.9;	choa: 195;	fata: 28;	eea: 1310;	wtkg: 64.5;	perfat: 27;	lbm: 44.9;	fat_mass: 1741.5,ctrl
adenocarcinoma (ADC7),pert
Sample 10,ctrl
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-2,ctrl
Tobacco_abuse_5,pert
cell line: M24met melanoma cell-line;	genotype/variation: wild type;	treatment: control,ctrl
"Soleus, TMD",pert
8 wk old male mdx5cv quad,pert
patient E1610,pert
tissue: Hippocampus;	age: 80;	Sex: M,ctrl
cell type: embryonic stem cells;	genotype/variation: wild-type,ctrl
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: shPTK7 (PTK7 knockdown),pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 93;	Usage number: 4;	Exposures: 1,ctrl
del337TR replicate 2,pert
Control Treg_rep1,pert
subject: 30;	disease: CP;	muscle: ST;	gender: M;	age: 4.1;	gmfcs: 2;	popliteal angle: 125,pert
Control Endometrium Endothelial Cell_016.UC182+-new,ctrl
HD8,pert
tissue: skin;	individual: Patient P12;	condition: AL;	eczema severity: SCORAD: 91.1,pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14465;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
P0 - WT129s6 1,ctrl
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Injured 3 day Rat Retina 2,pert
BP patient 78_biological replicate 1,pert
c 1-2,pert
cell line: HL-60;	replicate: Replicate1;	treatment: shSYK_1,pert
"SS gland, moderate, patient 22, batch 2",pert
Dengue Hemorrhagic Fever Patient 45,pert
control sample 3,ctrl
Tendon_non-lesional_rep16,ctrl
OV90-(1),ctrl
HCC PBMC Sample 7,pert
healthy control H28_2,ctrl
Male 8week BL6 CBDLrep2,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 42;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Hdh mutant (111/111-polyQ) 2,pert
HC-KO-28B,pert
"PMA treated, doxycycline treated; biological replicate 2",ctrl
MRF control littermate cultured oligodendrocytes,ctrl
Pooled_2,pert
"lymphoblastoid cell line from T6.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
EVI_GFP negative Lin- cells replicate 1,ctrl
"age at diagnosis: 48;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 34;	dfs-event: 0;	distant metastasis: 0",pert
"11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
siRNA scramble_control  MDA-MB-231 sample 3,ctrl
Ad infected murine liver-MO30k-(233)-6hpi,pert
E2_ethanol_21,pert
Jurkat-J1d,ctrl
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 0,pert
"human failing LV myocardium, Idiopathic26",pert
CF knockout HMCF CHN537,pert
Macrophages,ctrl
Against CDK8-2 transfected HeLa S3 cell,pert
cell line: H4-II-E-C3,ctrl
ab106 IM,pert
"Strain: C57BL/6;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",pert
Bronchial Epithelial Cells control biological 1624R,ctrl
"U373-EGFP, rep 2",ctrl
Panc-1 Gli3T 1,pert
control participant P318,ctrl
MLL_00114,ctrl
"Strain: SPARC-null, C57Bl/6 background;	Gender: male;	Age: 28 days;	Eye: Left",pert
"Healthy volunteer, Control_11816",ctrl
"Acute Myeloid Leukemia, sample 15",pert
V5-P510,ctrl
CTRL_5_MEP,ctrl
Individual_4382_NN_sample,ctrl
Strain: Fischer 344;	Gender: Male ;	Age: 6 ;	Tissue: Liver of vehicle treated rat,ctrl
Barretts esophagus (B1),pert
"Human mononuclear cells were isolated by Ficoll-Paque centrifugation in a discontinuous gradient from buffy coats from healthy blood donors. Cells were differentiated in macrophage-SFM medium supplemented with 70 U/ml human granulocyte macrophage colony-stimulating factor. After 3 days, the medium was changed to macrophage-SFM without GM-CSF and cells were cultured up to 8 days",pert
Pancreatic Sample 37-Tumor,pert
OVCAR-3/mock cell line,ctrl
HT29 methotrexate-sensitive cells,ctrl
chip number: 16;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.3;	transfection date: 2011-10-17,ctrl
MCF7 cyclin D1 siRNA Vehicle Rep1,pert
Insm1 mutant #4,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 4h,ctrl
Bladder cancer cells,pert
liver_NEMO_KO,pert
cerebellum wild type 6 month replicate 2,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: E2;	time: 4h,pert
"Rescue pancreas, biological rep1",pert
"Chromium 1 µM, biological rep3",pert
"IFNAR2-/- BMMC, uninfected",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 45 yr;	population: white;	dsm-iv: 295.9;	age of onset: 15 yr,pert
array 7 minus E,pert
CLL7-CD4,pert
RNA from HCC_33T,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 60,pert
Mammary gland R1 NT rep2,ctrl
cell line: MOLM-14;	replicate: Replicate1;	treatment: shSYK_2,pert
siERK2E24h_2648,pert
striatum_6 month,pert
tissue: Temporal cortex;	age: 80;	Sex: M,ctrl
PGA_MI_nilv_48h_354,pert
a_B35B,pert
"Lymphoblastoid cell lines derived from family 1744, member 1",ctrl
0977-01-C,ctrl
01N3E_Oligo,pert
CD46+/STAT1-KO hippo - Untreated-C,pert
"Control ES cells 96hr, replicate 2",ctrl
C_AN10028_C,ctrl
"AZ521 dnSox2 cells, uninduced, 12h",ctrl
ME180 3 hours rep 3,pert
IRAK2 KO macrophages unstimulated,pert
wildtype 4,ctrl
Mut2_2,pert
EB_0_6_323_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_Con_HG-U133A_2_YCHSUP501,ctrl
disease state: paediatric glioblastoma;	age: 10;	gender: M;	h3.3_status: K27M,pert
quadriceps_muscle_Wt_female_8wk_rep3,ctrl
IPMC 2,pert
Arid3a OE-High replicate 2,pert
strain: 170;	Disorder: normal;	Condition: no hydrocortisone,ctrl
4013-2 E2F2 Null,pert
PBS Treated Cells 3,ctrl
Adipose-24 month-wild type-technical replicate 3,ctrl
Muscle WT Aged 0106,ctrl
Ecad_Con_2,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD4-FITC;	cell type: CD4 positive T cells,ctrl
"brain, hippocampus: KA-24h-P15-I_e1_le1",pert
S029_Scz_F_53,pert
disease state: normal;	biopsy type: surgical;	tissue: lung,ctrl
8 week old extraocular muscle,ctrl
"Pten null fibroblasts, biological rep1",pert
Subject 2 Pre allergen challenge,ctrl
passage: 10;	cell type: fibroblast;	cell line: GM00038,ctrl
chip number: 22;	transfection plate: 3A;	target gene: BATF;	kd level: 0.64;	rin: 9.8;	transfection date: 2012-03-26,pert
"Lens epithelium, SPARC KO, #7L",pert
"normal skeletal muscle, biological rep14",ctrl
siNS_0h_3,ctrl
T149 U133p2,pert
normal main pancreatic duct 5,ctrl
A HID I_B008,pert
"conditional Keap1 knockout Alb-Cre:Keap1(flox/-), gender- male, age- 9 weeks, n = 1, # of tissue = 1 tissue: Liver",pert
"human failing LV myocardium, Ischemic96",pert
P0 - lis1ko/+ Mix 2,pert
siNS_24h_2,ctrl
Thyroid_ unaffected_paired with PTC11T,ctrl
"Skin biopsy, lesional",pert
patient E1584,pert
"Patient S238, MSI colorectal tumor",pert
subject: 2824 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
"Normal, biological rep 2",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 71 years,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 135min;	race: White;	sex: Female,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119-;	genotype/variation: Klf3 KO,pert
Mouse female ES cells PGK12.1 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-3 in PGK12.1.,ctrl
C_AN00142_F,ctrl
adenocarcinoma (ADC4),pert
"SIRT1 LKO liver, ad lib, 4:00pm",pert
Normal cervix_05-446,ctrl
KO - 5 mo - repeat 1 - Cy5 - mAdbID:74107,pert
FCHL #98-1176,pert
Amoxicillin treated Colon 1 17 days old,pert
EOM 28 Day Control rep 3,ctrl
Knockout day 3 Air replicate 2,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 79,ctrl
L-540_CTRL_24hrs_1A,ctrl
Control osteoblastic lineage cells 5-6 weeks post doxycylin withdrawal,ctrl
4_day_old_wildtype_mouse_rep1,ctrl
M24met_control_3,ctrl
Dot1l -/- day 7 after transduction with cre,pert
"Subject 9, Family 3, Control",ctrl
"Endometrium, postmenopausal, control, 21",ctrl
"Frontal cerebrocortex, deltamethrin (0.3 mg/kg), 6 hours",pert
Control_AF_3,ctrl
KO Tibialis Anterior at 4 weeks biological rep2,pert
PsOEt-19-Week 12,pert
Mammary gland R1 24 hr rep2,pert
"HepG2 cells, control, rep2",pert
Normal Biological Replicate 3,ctrl
lateral hypothalamus long access to cocaine replicate 3,pert
E14.5 fetal liver TER119- Klf3 KO,pert
cell line: AST13;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: SNCA triplication,pert
Fetal heart 6 ug/kg TCDD rep1,pert
FVB_MMTV_Wnt1_3065_Rosen,ctrl
15_0002C_Day1_41,ctrl
3979-2 E2F1 Null,ctrl
FW_2a_BV8343,pert
INSENS 5 0hr,ctrl
RI47,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_287,pert
Brain_Aged_LPSip_4hr_mouse1 (OL1_#67),pert
colonic_mucosa_inflammation_30,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 87;	baseline tumor size (cm): 5x3;	patient id (to identify the 2 chips from the same patient): 19301950,ctrl
APLP2_R6,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 18h,pert
cell line: PC-3;	treatment: luteolin;	treatment duration: 24h,pert
Dysf -/- QF mouse muscle,pert
V5-P239,ctrl
S46 NLS 142Q TG3	F5/10	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
M452 SKM-Tg,ctrl
Individual_4216_PP_sample,pert
"Wild type, snap frozen, gastrocnemus muscle, 7month age animal",ctrl
"Acute Myeloid Leukemia, sample 69",ctrl
con_B149,ctrl
Strain: J1 Cell type: mouse embryonic stem culture,ctrl
sepsis patient #21,ctrl
28 Day Mouse Diaphragm muscle,pert
Tet cells with Tetracycline-repressible WT1(-KTS) expression,ctrl
tissue: Primary human lung fibroblasts;	treatment: None;	patient: 1;	time: Baseline,ctrl
AA_87,pert
Patient identifyier: N;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 20 years;	Body surface area: 25 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Endometrium-Normal 1,pert
Sample Group: control; Gender: female; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Untreated diabetic,ctrl
non-CF subject 29,ctrl
LRRK2 (G2019S) homozygous iPSC sample 1,pert
brain wild type replicate3,ctrl
mouse CD4+ T cells,ctrl
healthy control H15,ctrl
cells: spleen follicular B cells;	genotype: WT;	genetic background: C57BL/6J,ctrl
P0 - DCXko/Y 3,pert
WT CFTR unexposed replicate 2,ctrl
D1 patient,pert
CD34+ cells without fenretinide treatment from CML33,ctrl
MCAD 3,pert
ND_9,ctrl
WT_IL-6_100_rep2,ctrl
25uM_Zn_2,pert
Against CDK8-1 transfected HeLa S3 cell,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 6 months,ctrl
Normal_002,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,pert
subject: 9;	disease: CP;	muscle: GR;	gender: M;	age: 11.2;	gmfcs: 2;	popliteal angle: 110,pert
Control;	Survivor;	gender: Male,ctrl
Individual_4968_NN_sample,ctrl
Hippocampus_Soman_168h_rep3,pert
IDH2 R140Q mutant mice,pert
brain_QH2_14M_rep2,pert
tissue: Frontal cortex;	age: 77;	Sex: F,ctrl
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 24h,pert
"Healthy control mice, time point 1 week",ctrl
synovial fluid macrophages,pert
background strain: CD1;	age: p23;	tissue: pancreas;	genotype/variation: Sox9-EGFP;	facs: GFP+,pert
Leg 28 Day control rep 2,ctrl
Skin_Lox_Control_Rep2,ctrl
"CD4+ splenocytes at 6h, biological replicate 1 sham-3",ctrl
GEIM12-U133A-DM,pert
"3 uM EPZ004777 treated, DAY 6, biological rep.3, MOLM-13 cells",pert
Luciferase shRNA_3 Days knockdown_rep3,ctrl
lung_CLP_PPTA knockout_rep3,pert
WT mouse heart under basal conditions,ctrl
EOM 56 Day Control rep 3,ctrl
"104, MUSCLE, Before",ctrl
E9.0 embryo yolk sacs,ctrl
"MAT1A knockout at 8 month age, biological replicate 1",pert
tissue: atria;	genotype: COUP-TFIIflox/flox;	age: 2 months;	genetic background: C57BL/6,ctrl
patient: 40892;	sample: normal,ctrl
Embryonic lung at E18.5 days WT,ctrl
embryonic stage: E14;	cell type: embryonic stem cells;	genotype/variation: wild-type,ctrl
48SAGEA,pert
"RNF40 siRNA - 2 days adipocyte differentiation, rep3",pert
"Gata4_S105Amut, PE treated whole heart, individual 7",pert
Tumor_Ker50,pert
endothelial_rep15,ctrl
CA01-103B,ctrl
3T3-L1 1uM rosiglitazone,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 39 yr;	population: white;	dsm-iv: 295.3;	age of onset: 17 yr,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#4,pert
Normal mucosa 11,ctrl
WT-smoke-med-5 month+13d-R4,ctrl
"brain, hippocampus: KA6-I_e1_le1",pert
Array Type; Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,pert
fibroblast_Slow_D98_Media_11,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 24h,pert
normal control 6,ctrl
BT-20 cell line,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q plus monosomy7/del7q plus other,pert
SK-N-SH cell line infected with eGFP lenti,ctrl
Lung of hemorrhaged animal 6h,pert
Peripheral blood mononuclear cells (PBMC)-Patient CV T0,ctrl
liver_female wt_rep3,ctrl
remitted schizophrenia patient  S11,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: WT CTNNB1,ctrl
T59 dilated cardiomyopathy heart biopsy,pert
WT-PBS_rep-1,ctrl
Diseased individual (ulcerative colitis) of twinpair #2,pert
Kidney_200 mg/kg VCM ip_mouse #085,pert
8ILC_normal_ductal,ctrl
"RWPE1 cells, vehicle, 48h, biological rep1",ctrl
IKK2 KO tumor,pert
"male;	CABG patient, atrial tissue, propofol anesthesia, after CABG surgery",pert
LPS 4 HOURS,pert
Sox3 null Sample 3,pert
WT_rep_3,ctrl
Control [G2],ctrl
"MAT1A knockout at 8 month age, biological replicate 3",pert
cell line: cervical cancer (HeLa) cells;	agent: Cas II-gly,pert
Pancreas,pert
mouse TMJ-cartilage from wild type mouse WT_Tal4,ctrl
shRNA4-1-noDox-rep3,ctrl
KN-smoke-high-5 month-R1,pert
AAA neck (Sample 3),pert
T2-FP_spleen_wt_rep1,ctrl
Day2 Estrogen treatment replicate 2,pert
"BMDM, LPS 1hr",ctrl
Biopsy 4 from cystectomy 16,pert
Donor4_6h_Wy,pert
HF0303_U133P2,ctrl
jos1985,pert
4140-4 E2F3 Heterozygous,pert
C8 Control None,ctrl
PS-/- cerebrum at new born,pert
Md02h030,ctrl
striatum_wild type_18 month_replicate 1,ctrl
KO_d00_e0_vs_WT_d00_e0,pert
E12 wt.2,ctrl
Non failing,ctrl
patient: CLS14;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
Murine Lung,ctrl
Sex: female;	genotype: sst -/-;	tissue: liver;	genetic background: C57BL/6,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14475;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
tissue: Biceps muscle;	patient: C.b.8;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1y 9m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Strain: 129S2/SvPasCrlf;	Genotype: Wildtype,ctrl
HP-49,pert
subject: 13U;	cohort: 13;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 63;	Sex: F;	batch: Batch_3,ctrl
siHic5_2_0h_1,pert
HCC_30T,pert
disease state: heterozygous Nxnl1 null;	strain: BALB/c AJ,pert
HCC_22N,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 days;	Tissue: kidney,pert
Nerve_Control_Rosi_711,ctrl
Astrocytoma_2,pert
HDAC6_3,pert
ACC 3 cell line lacZ-RNAi replicate 3,ctrl
Wildtype mouse embryonic fibroblasts,ctrl
WT - Cre Control - 3 mo - repeat 1 - Cy5 - mAdbID:74586,ctrl
1095PBMC,ctrl
E12.5 heart,pert
scan batch: Batch 2;	group: control;	subject age: 5;	paternal age: 30;	maternal age: 27,ctrl
"alveolar macrophages, non-smoker 002",ctrl
"Grape extract group, 12 months, patient number 29",ctrl
ak 04,pert
cell type: Oct4-GiP ES cells,ctrl
"Aorta, saline 7d, #6",ctrl
sampleID: SAM630140;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 211,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Mirandela,ctrl
DMN-CtrHippo20d-2bAv2-s2,ctrl
52A;pretreatment;female;breast tumor; nonresponder,ctrl
genotype: TAF4b knockout,pert
healthy control C2,ctrl
LIRKO liver sample 1,pert
Liver-5 month-Myc heterozygous-technical replicate 2,pert
WT - Cre Treated - 24 hrs - repeat 1 - Cy3 - mAdbID:61769,ctrl
Small intestine,ctrl
"SWR/J Acute morphine treated, biological replicate 2",pert
IRAK2 KO macrophages stimulated with MALP-2 for 4 h,pert
P75 dilated cardiomyopathy heart biopsy,pert
wildtype strong 2,pert
"HEK293 cells siRNA control, biological rep2",ctrl
Klf9KO_jejunum_PND30_5,pert
Wild type_lung_1,ctrl
C_AN01125_C,ctrl
EA_Case15_CD8,pert
Dicer WT CD4 T cells 1,ctrl
NOD,ctrl
"3mg/kg/day PFOA, Rep 1, Block 3, lung (low dose)",pert
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep2",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 35.01096,pert
lateral hypothalamus long access to cocaine replicate 2,pert
M304 SKM-KO,pert
whole tissue section from case 871,pert
anti-FGFR1_rep3,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.783;	Ratio: 2.13,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 18.308;	Ratio: 2.12,pert
Human-ApoD transgenic gain of function mutant,pert
Extract:LOX-1:213103;	Extract Description:LOX1_0hr:213103;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.53;	Quality: Background Mean Dev.:1.32;	Quality: Absent (%):58.85;	Quality: Absent (%) Dev.:0.46;	Quality: Scaling Factor:0.54;	Quality: Scaling Factor Dev.:0.6;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213103;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295463,pert
"human failing LV myocardium, Ischemic82",pert
major non-tumor10,ctrl
tissue: leukemia;	genotype: Sh2b3-/- ΔE-NOTCH1,pert
"E18.5 ERRg -/- heart, biological rep 3",pert
heart of mouse subjected 1 week to chronic constant hypoxia,pert
healthy control C7,ctrl
siHic5_2_4h_1,pert
"Rat liver, left lateral lobe",ctrl
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID374,pert
"3T3-L1 siControl 48h, biological rep 2",ctrl
695-383_2hr,pert
Whole blood from children with septic shock.,pert
healthy control H04,ctrl
Saline T00278945,ctrl
1_CD34+_12h_TCDD+,pert
NSC_FBS_L1,pert
embryonic fibroblasts from female wild type Balb/c mice,ctrl
"breast tumor epithelium,44",pert
hOB695_shRB1383_16hr_IR,pert
Nonlesional Epithelium Psoriasis rep3,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_8_23_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: tamoxifen for 120 min,pert
V5-P237,pert
BIO586225,pert
"P208 HCT-116, DNMT3B knockout, non-treated",pert
A_AN17777_F,pert
Pancreatic Sample 30-Normal,ctrl
RNA from HCC_18N,ctrl
colon_CRC_1651,pert
"Ulcerative colitis patient, biopsy taken from the descending colon, no macroscopic signs of inflammation.",pert
WT P2 replicate 4,ctrl
pLenti transduced cell lines overexpressing canonical CDH1,pert
Mening SWB WB NP 24b,pert
age: 67;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"Lesion Skin, LS-4",pert
medicated bipolar patient,pert
C_AN19760_F,ctrl
"Atm-/- untreated, A",pert
HeLa_TP082505_21_HG-U133A_2_IMFGN0023,ctrl
"Normal T-cells, CD3+, donor 7",ctrl
3765-ls,pert
brain_DLPFC_bipolar C_mr871,pert
strain: Sprague-Dawley;	tissue: spinal cord (ipsilateral dorsal horn);	developmental stage: Adult (8-12wks);	treatment group: sham,ctrl
Patient no. 4: control,ctrl
51n,ctrl
Kidney_Aqp11-/-_P7_2-3,pert
"10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Untreated 979-CLA-25,ctrl
RAW_0.14mM_HOCl_#3,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: WT,ctrl
GIST882 Cell line,pert
condition: Normal;	patient: N_LJ_6;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Trasnsformed Lymphocytes Unaffected (Unaffected pateint of MZ twin pair 2),ctrl
P64 Non failing heart biopsy,ctrl
mdx EDL sample 1,pert
"Mouse LV, WT 1",ctrl
lumbar spinal cord,pert
Array Type: HG-U133A_2;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: excellent;	Sample Preservation: -70C,ctrl
treatment: untreated;	cell type: CLL B-cells,ctrl
Tslc1 -/- mice_rep2,pert
TP06-855,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 202,ctrl
Heart_KO_2,pert
"tissue sample from Bellevue Hospital, NY",ctrl
MDS45,pert
..SAL_II_3,ctrl
WT_Mstn_3,ctrl
"bipolar disorder, BA10-13(2)",pert
12474 UC Inflamed sigmoid colon,pert
WT_1,pert
129B,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID68,ctrl
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50), biological rep3",pert
"Patient  E, lesion, time: 0",ctrl
CAR.AH_CITCO_rep1,pert
"BPH adrenals, replicate 2",pert
jos1984,pert
mutant_crypt_day2_sample2,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 4;	psoriasis duration: 18.009582477755;	age of psoriasis onset: 20,pert
V5-P511,pert
"brain, ethanol-treated P70  male",pert
strain: C57BL/6;	tissue: mouse bone marrow;	genotype: wild type;	treatment: 1x10^6 cells in a 12-well plate co-cultured overnight with 1x10^6 E0771 tumor cells in an sterile insert,ctrl
b138,ctrl
IM70_control,ctrl
"DCIS 2, biological rep. 2",pert
2008-Ets1 cells_rep3,pert
cell line: BxPC3;	cell type: pancreatic cancer;	transfected vector: control,ctrl
C26_skeletal 1,pert
DU145/MYB siRNA #3,pert
wt 13.5d replicate 3,ctrl
SKI-DLCL cells_AraC 20nM_24h_rpt2,pert
Gastrocnemius Muscle mdx AAV-Galgt2-Treated rep1,pert
heart tissue from KD mouse,pert
cell type: Embryonic Stem Cells;	genotype/variation: WT,ctrl
SeV 3660,pert
Kidney_saline iv_mouse #002,ctrl
Pancreatic Sample 24-Tumor,pert
CD4+ cells IL1RN knockout 1 month rep2,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: HIGH;	genome/variation: PDGFRA mutation detected,pert
"human failing LV myocardium, Idiopathic5",pert
treatment: PLX4720;	time: Day10;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
"brain, hippocampus: C1-II_e1_le1",ctrl
PGA-MAH-C3H_OVA24h-4aA-s2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 42;	gender: male,ctrl
3496-lcm,pert
Muscle 50 eccentric contractions 12 hours WT Aged 12171,ctrl
PGA_MI_nilv_24h_360,pert
"seminoma specimen, pT2, patient age: 28y; W03 012",pert
"Fetal lung, CD-1 background",pert
"Lung, Familial Idiopathic Interstitial Pneumonia (F-IIP), Usual Interstitial Pneumonia (UIP)",pert
Ishikawa_Control_8h_rep3,ctrl
"mouse aorta cross strain comparison, C3H_T24_HF_01",pert
Pertuzumab treated after 4 days (P1_1),pert
Old neocortex,pert
heart of mouse subjected 4 week to chronic intermittent hypoxia (4A),pert
S5_sham_overexpressor_12,pert
strain: C57BL/6J;	genotype: non-transgenic;	tissue: aorta;	age: 32-34 weeks,ctrl
CD4DecTp1-2,pert
6h Kin- Cel.46,pert
coc-10,pert
cell line: LNCaP-abl;	transfection: siHIPK2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 44.0274,pert
4B,pert
"miR-148b-B (miR-148b-1+, biological replicate 2)",pert
Subject #8028-2d Postinfection,pert
DIA-t7-2; transgenic diaphragm 7 month,pert
NS2,ctrl
MDS21,pert
ID4+/-TCL1-tg spleen CD19+ B cells,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure",ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14508;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
homozygous_1,pert
90 year old female,pert
mouse liver C2,pert
C,ctrl
disease state: Control;	gender: Female,ctrl
Non_Target_3,ctrl
Nfkbiz-/- peritonial macrophages,pert
"gender: Female;	age: 75;	post-mortem delay: 3h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"NeuroD1 knockout mouse, P0 Pineal Tissue, Sample 3, 05-31-06",pert
Yolk sac tumor,pert
"fibroblast, MFS subject FB890 rep 3",pert
4140-1 E2F3 Heterozygous,pert
IRAK4-KD_BoneMarrowMacrophages_unstimulated_4hours_rep1,pert
"Hdh knock-out embryonic stem cells, biological replicate 1",pert
"P16 mutant OC apex, biological rep 1",pert
BE,pert
Mut+/- rep3,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#5,pert
gender: Male;	age: 83;	post-mortem delay: 11.5h;	ph: 6.1,pert
SA2,ctrl
P 27 Si RNA,pert
AO 4hr,ctrl
c42 is aclonal Nurr1 stably-expressing stem cell line,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID56,ctrl
"Healthy control mice, time point 5 week",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 33;	gender: male,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: 0;	clone: 0,ctrl
"alveolar macrophages, non-smoker 013",ctrl
"WT cells, replicate 5",ctrl
array 5 plus E,ctrl
gender: female;	cell type: peritoneal macrophages;	strain: Nfkbiz-/-,pert
NB4 CONTROL 1,ctrl
10 days sham-1,ctrl
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"A4_tumor, lung tissue",pert
tissue: lesional skin;	urticaria status: affected;	patient: 7,pert
Control siRNA rep1,ctrl
Colon_POR-null_2,pert
gender: male;	age (years): 40;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
Healthy,ctrl
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: Mock,ctrl
"female,20,Caucasian",ctrl
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14464;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Extract:LOX-1:113302;	Extract Description:GFP_Untreated_6hr:113302;	Quality: Classification:Medium;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.43;	Quality: Background Mean Dev.:1.03;	Quality: Absent (%):59.24;	Quality: Absent (%) Dev.:0.77;	Quality: Scaling Factor:0.87;	Quality: Scaling Factor Dev.:2.23;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113302;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295603,ctrl
M303 C,pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/111;	differentiation status: undifferentiated;	cell line: Q111,pert
no_19,ctrl
25A;pretreatment;female;breast tumor,ctrl
"seminoma specimen, pT1, patient age: 35y",pert
"Normal Skin, Normal-20",ctrl
MCF-7 cell_DMSO_12hr_biological rep1,ctrl
cell line: HL-60;	shRNA construct: GSK3A Construct 5,pert
Normal myocardium sold commercially (H),ctrl
"UM-UC-3 bladder cancer cells, stably transfected with GFP (control), biological replicate A",ctrl
MKK7D transgenic female replicate 14 late timepoint,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 41;	sex: M,ctrl
non-CF subject 30,ctrl
Uninfected control_4b,pert
HC CM 2 water,ctrl
Aorta_APOE-deficient and captopril treated_2,pert
MDS patient 35,pert
race: african american;	age (years): 79;	stage: IA;	grade: 2;	histology: endometrioid,pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep3,pert
COLO829_shSCR_PLX4032_B,pert
"vehicle treatment, 24 hour time point, biological replicate 3",ctrl
Cardiac Muscle_Cmah KO_rep3,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339032,ctrl
patient code: 105;	gender: Male;	age: 68;	tumor grade: 3;	t-stage: 2;	n-stage: 0;	ajcc classif. (2002): 1b,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-sp2,pert
Trastuzumab treated after 4 days (T1_2),pert
"Pten null epithelials cells, biological rep3",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 217,pert
HP-24,ctrl
SKMEL28_t1h_rep3,pert
Aorta-APOE-deficient and vitamin E treatment-rep2,pert
U87 10 uM Y15,pert
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 101;	Usage number: 4;	Exposures: 3,pert
"5mg/kg/day PFOA, Rep 2, Block 1, liver (high dose)",pert
HeLa cells transiently transfected with SON siRNA,ctrl
Control replicate 1,ctrl
Region of the left ventricle [lv] above the LAD artery of a sham operated mouse,ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 33;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
TMRI E2 2hr,pert
"DMSO Control after 4hr, replicate 1",ctrl
strain: Balb/C;	Sex: female;	tissue: pancreas;	age: 30 days old;	maternal diet: Control diet;	treatment: sham,ctrl
"brain, hippocampus: inhibitor-1 KO 1_e1_le1",pert
Nerve_Control_Rosi_711,pert
Csbm/m Mouse_cerebellum_Old_saline treatment_Replicate-3,ctrl
whole lung E18 sftpc-nmyc,pert
"DMSO Control after 24hr, replicate 3",ctrl
Adrenal WT 0h batch 3 [AdWTh00.22],ctrl
intestine_wildtype_control_rep3,ctrl
cell line: HEK293,pert
Kidney from mice treated with 7 daily ip injections of saline,ctrl
gender: Male;	strain: C57BL/6;	genotype/variation: B1-/-;	tissue: Epididymal fat;	age: 3 month-old,pert
"Liver, untreated, rep3, knockout mouse",pert
"RPMI8226_shLuc2, replicate2",ctrl
gender: male;	age (years): 51;	evolution time (years): 2;	disease extension: Pancolitis;	treatment: Azathioprine,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 4hr,ctrl
aa_NY226,pert
normal 2911,ctrl
R6/1 18 week transgenic_C627,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 22 months old; Tissue: Brain; Treatment: 4 hours post saline ip.,ctrl
cell type: Heptaocellular carcinoma cell line with HIF-1alpha knockdown,pert
S/SM3,pert
lesion_midUV_patient7,pert
phenotype: control;	gender: female;	case_id: 270;	age: 60;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: ?;	post-mortem-interval (hrs): 21;	brain ph at time of freezing: 6.8;	labeling_batch: 1,ctrl
"DCIS 9, biological rep. 9",pert
liver_male ko_rep1,pert
Subject 2 Post allergen challenge,pert
Patient 4 c,pert
coc-12_C,pert
Diseased individual (ulcerative colitis) of twinpair #9,pert
treatment: EtOH + cycloheximide;	genotype: WT;	cell line: F9,ctrl
KO - knock-out Untreated - 0 hrs - repeat 2 - Cy5 - mAdbID:61725,pert
Parkinson's disease sample x092,pert
P65 Non failing heart biopsy,ctrl
3557-ls,pert
Normal prostate stroma,ctrl
T161 U133p2,pert
pediatric AML PP3,pert
IFC 03,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 61,pert
CLL 378-01 LMP-420,pert
agent: ConA;	time point: 1 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Control PB C106,ctrl
S024_Scz_M_75,pert
EB_07_8d_145_HCHO_Nasal_Rat230_2_CIIT05024,pert
fasted liver lard diet 2,pert
SBVGA1 1,pert
MCF-10A shATM-1 replicate 2 [set 5],pert
tissue: blood;	patient: 4;	gender: female;	age: 28,pert
"JCAM1 Lck negative 0 hours, #2",pert
Liver_Nrf1 Control_rep1.,ctrl
Ad infected murine liver-MO30k-(468)-6 hpi,pert
protocol: Non-silencing control siRNA;	cell line: MCF7,ctrl
VPA Treated Rep 1,pert
"Gender: female, Age: 44 years, Tissue: VIN 3",pert
control virus-infected replicate 1 (MCF7),ctrl
cell line: A2058;	treatment: Control siRNA,ctrl
01LQQ_PolyRF-,pert
"fibroblast, control subject NM7 rep 1",ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-4;	Primary Site:Floor of the mouth;	Age:60;	Sex:M;	TNM:T4N1M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
HDAC1_G10-rep3,pert
A10_C10_nasal_stem_cell_rep1,ctrl
heart knock out replicate3,ctrl
MCL_IGHV_MUT (R1305),pert
Bronchial Epithelial Cells control biological 2096X,ctrl
TOV112D cells_untreated_biological rep3,ctrl
human liver; normal liver tissue,ctrl
No or early 2 rep10 (retina),pert
"BMMCs from NTAL WT, pLKO.1 infected, 2 h activated, biological rep3",ctrl
microdissected breast cancer cells from case 1037,ctrl
HCT116_rep1,ctrl
"PDK1 null CTL, biological replicate 2",pert
Control with WY14643 replicate 7,pert
cell line: KJD;	transformation: SV40 virus transformed;	cell type: epidermal keratinocyte;	treatment: doxorubicin,pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-Tg;	tissue: Skeletal muscle (quadriceps),pert
F_Kin_3,pert
"testis wt, 17dpp, Rep5",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 7,ctrl
WFS1 KO USHT_01_337_wt,ctrl
Postmenopausal female. Estradiol treated. Patient 3.,pert
MF-24,pert
human liver; very early HCC,pert
Cervical Cancer C524,pert
Normal testis 0140,ctrl
SLE5-TC,pert
CLS14_T6_PP_day14_060,pert
Alveolar epithelial cell line A549,ctrl
SW480 cells,ctrl
Haloperidol treated 12weeks AffyGC RMA rep3,pert
Control subject 25_biological replicate 1,ctrl
RNA from whole tissue section of case 849 labeled with Cy5,pert
Disease_status: Bipolar disorder;	Age (years): 45;	Gender: Male;	Age of onset (years): 16;	Duration of illness (years): 29;	Brain pH: 6.03;	Post mortem interval (hours): 35;	Side of brain: Left;	Fluphenazine mg. Equivalents: 20000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
lymphocytes_HD_F_61y,pert
high grade serous carcinoma_patient 3_sample 1,pert
Brain from 25 days Npc1+/- mouse1,ctrl
Macroscopically intact carotid tissue adjacent to the atheroma plaque,ctrl
"depression, BA10-57",pert
Cardiac Progenitor MUT2,pert
tg-1,pert
03 MINUS OHT 2,ctrl
ROS2,pert
RKO_rep_2,pert
ARF1 siRNA knockdown MDA-MB-231 sample 8,pert
WT_embryonic brain_posterior,ctrl
cell line: NCI-H716;	treatment: YAP mutant vector,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (6),pert
CH 2,ctrl
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
Strain: Long-Evans;	Gender: Male;	Age: Adult (PND62-PND64);	Tissue:  Cerebrocortex,ctrl
sample =XCGD4 treatment=Control time=360 (min),pert
age (days old): 10;	genotype: SC-RbKO,pert
CRC_celecoxib_F4880,pert
Mammary cell line,ctrl
Globin_C1,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: trisomy8,pert
FVB_skin_5dpn_2,ctrl
0979-01-C,ctrl
"NPTX1 shRNA Day 5, biological rep1",pert
"normal skeletal muscle, biological rep11",ctrl
injury stage: Spinal 21 days;	gender: male;	strain: Wistar,pert
female_alcoholic_304,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: control;	time: 24h;	gender: Male;	age: 4 months,ctrl
t20,pert
"C57BL/6J female number 3, untreated control ear (#3_Wt-C-7)",ctrl
PGA-HMO-MObese-7aUA-s2,pert
normal 1103,ctrl
S2_S010403,pert
WT - Cre Control - 3 mo - repeat 3 - Cy3 - mAdbID:74591,ctrl
GM19238_Kd_GTF2B_2,pert
Caco-2 ZNF658 siRNA 1,pert
Wild type LSK (2),ctrl
Nonlesional Epithelium Psoriasis rep1,pert
COP DES-treated replicate 1,pert
PGA-MAH-AJ_PBS6h-2aA-s2,ctrl
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 2",pert
cell line: U937;	replicate: Replicate2;	treatment: shSYK_2,pert
"human nonfailing LV myocardium, NonFailing10",ctrl
"brain, hippocampus: Ctr-1h-P15-II_e1_le1",ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 76;	time: 0;	batch: 4,pert
WT_P14_Naive_rep2,ctrl
siRNA scramble_control  MDA-MB-231 sample 1,ctrl
Human.BF.CP.FCU,pert
55SageA,pert
Infergen_6hr_rep1,pert
GIST_KIT_14,pert
"Lymphoblastoid cell lines derived from family 1717, member 1",ctrl
RNA from microdissected breast cancer cells from case 1085 labeled with Cy5,pert
"gender: Male;	age: 87;	post-mortem delay: 3.5h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
human skeletal muscle,ctrl
MacularDegen-injured-16aAv2-s2,pert
Eed KO E14 ESCs on day 0,pert
Control Braak α- synuclein Stage 0 C8SN,ctrl
BACH2+/+ ALL (Sample3),ctrl
iPSC control triplicate 1,ctrl
KO_0424-2,pert
"Brain tissue from Fisher 344 male rat, Animal #267, 5mg/kg D-Serine",pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 8 hrs,ctrl
BT474-J4_DMSO_24-1,ctrl
brain_DLPFC_bipolar B_mr281,pert
D1_non-transgenic,ctrl
S46 NLS 142Q TG6	F4/2	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
cerebellum_Pink1 knockout_12 weeks_replicate 1,pert
ME180 DMSO rep 3,ctrl
"RNF40 siRNA - 2 days adipocyte differentiation, rep1",pert
"Wt Gata4, Wt Gata6, heart, CRE transgenic, biological rep1",ctrl
Control 2 a,ctrl
"fibroblast, MFS subject FB969 rep 4",pert
uterus_P4_WT_40hrs_rep1,ctrl
U937_naive_untreated_4h_rep1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.468;	OD280: 1.278;	Ratio: 1.88;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 57;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
tissue: Biceps muscle;	patient: P.b.3;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
aneurysmal tissue: sample #3,pert
mdx Biological Replicate 2,ctrl
Bone-Marrow_MM_M988,pert
Murine lymph node,ctrl
whole blood_101832,pert
"Amoxicillin treated Proximal, Small Intestine 3 21 days old",pert
FVB_MMTV_Wnt1_2406.4R_Rosen,ctrl
"hepatic gene expression at ""0 hr"", rep3",ctrl
"Frontal Cerebrocortex, vehicle control (corn oil), 6 hours",ctrl
"adult male mouse colon, Hnf4a mutant",pert
strain: C57BL/6;	genotype: Ager null;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,pert
mdx5cv soleus sample 2,pert
Jejunum_POR-null+quercetin_3,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 360;	age-at-biopsy-years: 36,ctrl
"DMD skeletal muscle, biological rep6",pert
siERK1E24h_2659,pert
Age: 41;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
Diagnosis: AML M5;	Age: 62y ;	Gender: Male;	Blast %: 96;	Sourc: PB;	Cyto: No Data;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
db/m 8wk 2,ctrl
MDS patient 86,pert
Sex: male;	genotype: sst -/-;	tissue: liver;	genetic background: C57BL/6,pert
"WT, PE treated whole heart, individual 3",ctrl
testis wild type replicate1,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Jejunum",pert
Snell 6 month Dwarf Liver 85dw,pert
"Wild type used for GNMT 8 month, replicate 2",ctrl
male_alcoholic_290,pert
"testis, Repro9 mutant, 14dpp, Rep3",pert
"fibroblast, MFS subject FB881 rep 3",pert
B lymphocytes,ctrl
cell type: embryonic stem cells;	genotype/variation: Trim71 KD,pert
"Control pancreas, sample 1",ctrl
"PPARg d0, rep 1",pert
diaphram muscle,ctrl
06R031 Control,ctrl
Normal_Kidney_Biopsy_6,ctrl
RAW CstF-64 1,pert
"YWHAZ overexpressed CL1-0, biological rep3",pert
"ALL_NDS, K39 011509",ctrl
normal tissue from mastectomy specimen from postmenopausal patient with invasive lobular carcinoma (ILC),ctrl
BT474_DMSO_24-2,ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 1,pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14584;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
genotype: wild-type;	cell type: naive CD4 T cells;	genetic background: C57BL\6,ctrl
"FACS purified YFP+ muscle stem cells, harvest immediately after isolation",pert
Hippocampus_Soman_48h_rep1,pert
Bronchial Epithelial Cells MMA biological 2131Z,pert
cell line: ARPE-19;	clone: 30;	genotype: Knockout,pert
Polyamide1_3,ctrl
Primary neonatal keratinocytes,pert
"Wild-type-neocortex, biological rep5 (male)",ctrl
4-KO,pert
HCC016T,pert
Kidney_50 mg/kg VCM iv_mouse #012,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.023;	OD280: 1.564;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 322;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 686,ctrl
Healthy1-CD8,ctrl
Control MEF 2,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 6",ctrl
Whole Blood of healthy control,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock),ctrl
GC resistant clone C7H2-R19E5 treated for 6 hours with GC,pert
Subject #8022-8hr Postinfection,ctrl
APLP2_R6_rep3,pert
Mutant right atria,pert
"Control siRNA - 5 days osteoblast differentiation, rep2",ctrl
38SAGEA2,pert
FVB 129 mice were used as bone marrow donors,ctrl
"118, ADIPOOSE TISSUE, Before",ctrl
"Patient  O, lesion, 1 week",pert
mdx5cv soleus sample 1,pert
patient: 219;	current medication: Sulphasalazine 1.2g Colifoam;	birth date: 1/5/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/81;	diagnosis date: 1/1/81;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/7/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 3,pert
Cerebellum_nontransgenic control A39_8 months_replicate 3,ctrl
WT Soleus at 4 weeks biological rep1,ctrl
"seminoma specimen, pT2, patient age: 28y",pert
Brain from 59 days Npc1-/- mouse1,pert
"AD_TC, biological rep2",pert
Transfection Reagent Only Technical Replicate 2,ctrl
C33KD2_without doxycycline_1,ctrl
Young 5,ctrl
HepG2_HIF-2α knockdown,pert
Individual_4934_PP_sample,pert
"BMDM, LPS 0hr",pert
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: none,ctrl
BTBR_Muscle_rep1,pert
abl control at VEH rep 1,ctrl
ndf + progerin + FTI,pert
NK_cell_pool_melanoma_M07+M08,pert
ILD Study Number 1222,pert
MDS patient 151,pert
HL60-shGSK3A-Construct6-rep1,pert
01MJG_Oligo,pert
Muscle PCOS 11,pert
sample 1:;	age: 69;	gender: female;	sample 2: ;	age: 64;	gender: male;	sample 3:;	age: 75;	gender: male;	sample 4:;	age: 58;	gender: male,ctrl
breast tumor 3,pert
tissue: murine embryonic stem cells;	genotype: knockout;	strain: 129SV/C57BL/6,pert
"gender: Male;	age: 25;	post-mortem delay: 12h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Sample ID: TP36;	Twin Pair ID: CCE3.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-7;	Age at interview & blood sampling: 57;	Current Age (2007): 60;	Sex: MALE;	Medication at blood sampling : None,pert
"seminoma specimen, pT1, patient age: 55y; W03 011",pert
"cerebellum,18month,KO",pert
"DMSO-treated, 6h after UV, Replicate C",ctrl
SeroTest-6,pert
WFS1 KO USHT_02_323_ko,pert
untreated_24hr,ctrl
AIRE-ko-CD80lo-mTEC-sample2,pert
Individual_4362_PP_sample,pert
CML_4_GMP,pert
"brain, frontal cortex: Sample50_e1_le1",pert
S/SM5,pert
HF1167_U133P2,pert
brain_DLPFC_bipolar C_mr544,ctrl
WildType_1_1,ctrl
PGC-1alpha -/- differentiated brown fat cells expressing a control siRNA (rep2),pert
PGA-MAH-AJ_PBS24h-2aA-s2,ctrl
Turner_AF_5,pert
Bone Marrow Mononuclear Cells;	35y Male,ctrl
cell line: SKBR3 parental;	treatment: 0.1uM Lapatinib,pert
endothelial_rep12,pert
Gene expression profiling of normal cortex of patient 265,ctrl
LCL Unaffected MZ twin pair 1 (CCN1.1R)(TP15),ctrl
n2a-Pou3f3-kd-2,pert
S2-041129-SA,pert
UV-SeV 3478,ctrl
PND28 Rat Testis_Rat230-2_3hr Corn Oil_Animal#53_04005,ctrl
non-malignant FTEb_patient 11,ctrl
147A,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 4,ctrl
8DKD_SerumStarved->3hrEGF_rep2,pert
strain background: FVB;	genotype/variation: wild type;	tissue: whole skin,pert
"HCT116 shCDK19, normal growth",pert
"DMD skeletal muscle, biological rep3",pert
tissue: Brain;	genotype: Npc1+/+;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
ADHC2,pert
Blood,ctrl
CD4_T_cell_pool_healthy_H09+H10,ctrl
HeLa cells transduced shYY2 control lentivirus.,pert
ILD Study Number 660,pert
"Normal subject (31 year old asian male, SAK_1265931893)",ctrl
Wildtype H9 hESC derived NSC 1,ctrl
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 32;	maternal age: 27,ctrl
"U-87 glioma cell line with shp105, biological rep3",pert
siRNA LMG2 treated HeLa cells 1,pert
"brain, hippocampus: PH2_e1_le1",pert
Cerebellum_nontransgenic control A61_8 months_replicate 1,ctrl
thyroid_tumor_2,pert
"Ovol1 KO, biological rep1 (with calcium)",pert
NB42 U133p2,ctrl
"113, MUSCLE, Before",ctrl
11410 UC Inflamed descending colon,pert
chip number: 21;	transfection plate: 3A;	target gene: BATF;	kd level: 0.5;	rin: 9.8;	transfection date: 2012-03-26,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: SAMPLE-6A,pert
Thyroid_ unaffected_paired with PTC86T,ctrl
Scd1+/+ on chow diet replicate 2,ctrl
healthy control H01,ctrl
A510 MI 1 day,pert
A HID B_B021,pert
"Amoxicillin treated Distal, Small Intestine 2 17 days old",pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"BCL-3 vector, biological rep1",pert
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 2;	age: Post natal day 3-5,ctrl
C590,pert
"Lesional tail skin from K14-Areg mouse, biological replicate 2",pert
M15 - infected MBT/Pas fibroblasts (9 h post inf),pert
background strain: Derived from blastcysts from a 129 female crossed to a (129 X PGK)F1 male.;	cell line: PGK12.1;	cell type: ES cell;	passage: 14-18,pert
Irradiated-ATM-WT Replicative1,ctrl
Region of the left ventricle above the LAD artery of a sham operated mouse,ctrl
E_LS_Wk2,pert
"Pten F341V epithelials cells, biological rep4",pert
CDF1-p3 (178msn),pert
cell line: U937;	replicate: Replicate2;	treatment: shLuciferase,ctrl
PE_N_598,ctrl
treatment: baseline;	gender: F;	age (y): 21;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
Nfix_depleted_rep2,pert
Injured 30 day Rat Retina 3,pert
cell line: U937;	replicate: Replicate1;	treatment: shSYK_1,pert
cell line: MLL-AF9 AML cell line 10950 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
"ID:c 2-3, Genotype=(C57BL/6J), Treatment= none",pert
T-ALL1 NBD 1,pert
Individual_5414_PN_sample,pert
"schizophrenia, BA10-25",pert
Strain: C57BL6;	Transgenic ATF6-MER;	Gender: male;	Age: 40 weeks;	Tissue: left ventricle;	Treatment: tamoxifen,pert
"DBA/2J SAL, Rep3",ctrl
"medulloblastoma, wt",ctrl
RNA from HCC_21T,pert
Pt_6 Normal Skin,ctrl
WT14,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 3,ctrl
sample type: Sample;	cell line: H1;	cell type: embryonic stem cell;	protocol: OCT4 knockdown;	time: 2 Days,pert
cell type: R1/E ESC;	RNAi: Rad21,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: wildtype;	tissue: GIST Tumor,pert
cell line: CH1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
b23.2,pert
"LCL GM19238, Kd BCL3, 72hrs",pert
KN-smoke-high-5 month+1d-R4,pert
"MUSCLE, RES, After",pert
Normal Cervix N13,ctrl
RNA from HCC_19N,ctrl
"EtOH, WT, set 3",ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 24h,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 44;	ld: HCV;	creatnine: 2.8;	mdrd: 26;	gfr: 30;	protein: 0.3;	hematuria: 1;	c3: 0;	c4: 0;	rf: 29;	hcv: POS;	htn: 1;	dm: POS;	hba1c: 5.9;	meld: 16;	ana: NEG;	gp: Mesangial GN+ 2nd FSGS;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 1;	ii (interstitial inflammation): 1;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 2;	igm: 1;	c: 1;	empe: 1;	bmwid: 1;	bmd: 0;	edd: 1;	no of glomeruli: 16;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: normal;	if: IGG+IGM+IGA++C3+ mesangial;	mesangium ig: AMC;	tissue: Kidney_Biopsy_Liver_disease,pert
disease state: non-alcoholic steatohepatitis (NASH);	tissue: liver,pert
Floxed_Mstn_5,pert
siRNA Control1 scanned on 07/21/10,ctrl
thorax from embryo of OTT1 knockout E18.5 mouse,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/18/05;	# cells: 55;	Sex: male;	region: M1;	age: 40;	genotype: Y/X;YFPH/-,ctrl
cell type: Primary hepatocytes;	donor: 3;	agent: Wy14643;	time: 6h;	gender: Female;	age: 70 years old,pert
MDS patient 30,pert
"69B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57BL/6;	age: 1 year old;	tissue: liver,pert
male_alcoholic_210,pert
WT3-iPS 2,ctrl
ANL Chip#25,pert
Normal cortex of patient T79,ctrl
cumulus_PCOS_Obese_rep1,pert
MDA-MB-231 control clone #6,ctrl
gender: Male;	age: 63;	post-mortem delay: 30h;	ph: 6.5,pert
UC Inflamed descending colon,pert
PND28 Rat Testis_Rat230-2_12hr Corn Oil_Animal#62_04005,ctrl
LIVER_diclofenac_repl3,pert
Testis WT 0h batch 2 [TeWTh00.11],ctrl
CTL2 AO 72hr,ctrl
MCF7 Argyrin A treated 12h,pert
"colonic tissue from macrophage-specific PPARgamma-deficient mouse, biological rep3",pert
BMM_C3H/ARC_time0h,ctrl
Control Mouse Lungs,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 180min;	race: White;	sex: Female,pert
"Gender: female, Age: 38 years, Tissue: normal vulva,",ctrl
Argyrin A treated 24h_1,pert
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: phenobarbital;	tissue: liver,ctrl
Sample ID: TP14;	Twin Pair ID: CCN1.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.2R** ,ctrl
CAR.KO_CITCO_rep1,pert
patient: 134;	current medication: None;	birth date: 12/21/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/12/05;	indictation for procedure: Abdominal pain;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
S46 NLS 142Q TG2	F5/9	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
"Acute Myeloid Leukemia, sample 76",ctrl
subject: 39;	disease: CP;	muscle: GR;	gender: M;	age: 15.3;	gmfcs: 2;	popliteal angle: 120,pert
Cisplatin_24h_rep1,pert
age: 15;	sex: F;	disease status: control subject;	Filter number: 102;	Usage number: 1;	Exposures: 3,ctrl
Control male 1,ctrl
tissue: Hippocampus;	age: 100;	Sex: F,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: severe stress + saline vehicle,pert
Normal mouse,ctrl
Epidermal keratinocytes treated with EphB2 for 1h,pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 32;	maternal age: 38,ctrl
K562 AMN107 sample 2,pert
frozen surgical tissue,pert
Human prostate cancer primary culture C1dx,pert
cell line: U-87MG;	treatment: vector,ctrl
HCC827 WT 1,ctrl
"Normal subject (49 year old caucasian male, SAK_1254531863)",ctrl
OCI-Ly7 NTsiRNA,ctrl
CD11b+Gr-1+ myeloid cells sorted from the colon tumors of HDC-EGFP/HDC-KO transgenic mice induced with AOM/DSS,pert
FK2,ctrl
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: wild-type,ctrl
10590_WBS,pert
Pool Ts1Cje_P15_hyb2,pert
"Neuroblastoma SH-SY5Y cells, stably transfected with RNAi against DJ-1",ctrl
Cancer 20,pert
disease state: paediatric glioblastoma;	age: 11;	gender: M;	h3.3_status: K27M,pert
cell type: hepatoma cells;	cell line: Huh-7;	transfection: IRF1,pert
RNA from whole tissue section of case 289 labeled with Cy5,pert
Globin_C5,ctrl
Tissue: lung;;	Genetics: Familial IIP;;	Histology: Usual Interstitial Pneumonia,pert
Gender:M;	Age:33;	Tissue: Mucosa,pert
ST045849 12 hours_3,pert
Aged 1,pert
"72 hour-treated wild-type NB4, biological rep2",ctrl
EGF 12h replicate 2,pert
"Brown adipose tissue, WT",ctrl
Ramos cells,pert
tissue: esophageal squamous cell carcinoma,pert
"Typically Developing Control, Gracilis, Patient Replicate 5",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: retina;	time: ZT20,pert
"brain, hippocampus: CH7_e1_le1",ctrl
Carbo Day7 (320R),pert
H1P_5,ctrl
Anti-mir-210 replicate 3,pert
AZ-521_uninduced_8h_rep1,ctrl
U2OS_siNS_4h,ctrl
Nerve_Control_Vehicle_704,ctrl
AA_Case16_CD8,pert
cell line: MiaPaCa2;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
subject: 10;	disease: TD;	muscle: ST;	gender: M;	age: 14.9;	gmfcs: N/A;	popliteal angle: N/A,ctrl
CME-LaminA3d-2MA-S2,pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep6,pert
ESVJ (+/+ parental of Abca1 +/-),ctrl
01LQT_Oligo,pert
MDS patient 49,pert
"Vehicle, biological rep2",ctrl
Patient no. 10: control,ctrl
treatment: baseline;	gender: F;	age (y): 51;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
"vehicle, biological rep3",ctrl
GM19238_Kd_ARNTL2_1,pert
NSC_FOXO_NULL-2,pert
Cervical Cancer C477,pert
UC-38-un,pert
"Spi-60, biological rep 7",pert
CF CFTR unexposed,pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
"DCIS 1, biological rep. 1",pert
Patient 4 skin baseline,ctrl
nodex_1,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: FMR1 shRNA,pert
sampleID: SAM630145;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
"scr-Rosi, biological rep2",pert
Mouse old brain C30-Br-1,ctrl
"TAMs sorted from imatinib treated tumors, biological replicate#2",pert
Wild type rep 2,ctrl
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: JAK2 knockdown (Jak2-9 shRNA),pert
Ishikawa_LowDose_BPA_24h_rep3,pert
"LSD2 knockdown, replicate 1",ctrl
CD19_selected_B-cells_after_R_rep4,pert
Muscle PCOS after pioglitazone 162,pert
B6C3F1/JTCE liver sample batch 6,pert
XBP1s B cells 4,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK1;	agent: EtOH;	time: 4h,ctrl
tissue: mouse lung upper left lobe;	strain: C57BL/6;	genotype/variation: CC10-rtTA-IL13 transgenic (TG);	age: 6-10 weeks old mouse,pert
MDS patient 160,pert
MDS patient 59,pert
subject: 28;	disease: TD;	muscle: GR;	gender: M;	age: 14.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes,pert
"MaF pre-iPSC9P2, Vc-, D4",ctrl
C_C7,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 4 - Technical Replicate 1,pert
MCF7 cell line _vehicle (control)_biological replicate 1,ctrl
tissue: muscle;	sample group: resveratrol;	treatment: after;	gender: Female,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.36986,pert
Patient no. 19: treated,pert
patient: 28;	disease state: hypertension;	tissue: Atheroma plaque,pert
T51721,pert
WT Brain 60d Mouse1,ctrl
treatment: Vehicle;	time: 7,ctrl
siPsmd14 replicate2,pert
C4 Control None,ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticlee",pert
cell line: BL2;	transfection: LEF siRNA;	batch: 2,pert
"Prdm14(-/-): 2i, rep1",pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 72 hr,ctrl
0147-01-C,ctrl
normal donor,ctrl
Flp-In™ 293 T-Rex,ctrl
"EBF1 d2, rep 1",pert
Gene expression profiles of Lkb1 KO #6 HSCs,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.092;	OD280: 0.567;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 284;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
GEIM87-U133A-DM,pert
Healthy control c2,ctrl
ve_B5,pert
"PBMC, patient. Mtx rep4",pert
subject: 20A;	cohort: 20;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 28;	Sex: M;	batch: Batch_5,pert
204/4,ctrl
M323 C,pert
"schizophrenia, BA46-82",pert
A HID B_B009,pert
control participant P309,ctrl
Infergen_24hr_rep1,pert
HUVEC_TNF-stimulated experiment 1,pert
HCC_12T,pert
12_PAH,pert
"BOEC, normal 21",ctrl
"1833 control, biological replicate 1",ctrl
"Uninvolved Skin, NS-23",pert
NLGN3_1,pert
ethnic background: Caucasian;	gender: male;	age: 45-65 years;	tissue: vastus lateralis muscle,pert
"Uninvolved Skin, NS-1",pert
mouse liver B3,ctrl
Carbo Day2 (72L),pert
LOXL2 2,pert
DND41 NBD 2,pert
CLL10-CD8,pert
BC4 TC,ctrl
Patient: F;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
EA_Control3_CD4,ctrl
24h 4OHT-treated-sample3,pert
"human failing LV myocardium, Ischemic60",pert
cell line: U87MG;	treatment: control siRNA,ctrl
HCT116 human colon cancer cells with PTEN -/-,ctrl
Liver Pio2,pert
"twin pair: #10;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
MDA-LM2-shTARBP2,pert
tissue: skin;	individual: Patient N-2;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
"human failing LV myocardium, Ischemic25",pert
pediatric AML S28,pert
"Control 2, 16hrs",ctrl
BxPC3-KO4 rep 5,pert
A549_siRNA_STAT3_rep2,pert
"cell type: HVS-transformed T cells;	genotype/variation: ITK R335W mutant , homozygous",pert
patient: 11;	disease state: hypertension;	tissue: Atheroma plaque,pert
HTH83 SCR 2,ctrl
"Neuroretina 8-week diabetic, Biological replica_3",pert
L428-PAX5+M_rep3,ctrl
"HUVEC treated with ERG SiRNA , biological rep1",pert
SCD1 +/+ liver rep1,ctrl
TN 2,ctrl
Normal Uninflamed sigmoid colon,ctrl
LRRK2 mutant knockin H9 hESC derived NSC 1,pert
cell line: Panc0403;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
Peripheral blood mononuclear cells;	TTF=95min;	Race=White;	Sex=Male,pert
PBMCs_IS_11 [IS],pert
CCRPKO-PBS_rep-3,pert
E_Ctrl_3,ctrl
WT - Cre Treated - 12 hrs - repeat 3 - Cy5 - mAdbID:61755,ctrl
"N-33, NORM, M, GSF, 6 x 100nM DHT, 14d",ctrl
Whole testis RNA from Crem-/- mouse #151 at 0h,pert
"68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
WT BMDCs tumor-derived DNA stimulation,ctrl
coc-38,pert
DA rat jejunum treated 1 h,pert
tissue: freshly isolated human monocyte;	gender:male; age: 47 yr; weight: 80 kg,pert
D6,ctrl
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: multiple gunshot wounds,ctrl
HF1606_U133P2,pert
"Control, biological rep 3",ctrl
Liver sample of WT mouse 3,ctrl
"G42 cells from M1, Mecp2 null, biological replicate 1",pert
Bone Marrow Mononuclear Cells;	22y Male,ctrl
cell line: LNCaP;	overexpression vector: FOXA1,pert
Control-1 (HuT-102 cells + vector only),ctrl
Rosi-treated diabetic-4,pert
uterus_P4_PRKO_40hrs_rep2,pert
PsOEt-22-Week 2,pert
"age at diagnosis: 56;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1biii;	er: 0;	pgr: 0;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
468MM,pert
endothelial_rep13,pert
WT-SB replicate 1,ctrl
High Glucose Transcriptome Profiling,pert
heart knock out replicate1,pert
Tumor_Ker26,pert
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2+/+;	agent: untreated,ctrl
MDA-MB-231 breast cancer cell line,ctrl
"Ovol2 BT, biological rep1 (E17.5)",pert
strain: FVB;	cell type: 6 DIV cultured hippocampal neurons;	transfected with: Sindbis virus expressing myc-tagged Hes1 and GFP,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 50;	sex: M,ctrl
mixed background e18.5 male cardiac ventricle,pert
HSC-wildtype-2,ctrl
Ishikawa_LowDose_BPA_24h_rep2,pert
age	26;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.1;	hemoglobin (g/dl)	14.6;	platelet count (/nl)	217,ctrl
individual: patient5;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
4T1.2-IRF7-1,pert
BalbC_6h_Wy,pert
"Cultured ovarian cancer cell line OVCAR-8, Cisplatin treated",pert
CON8,ctrl
"-Rosi, -PPAR, 72hrs",ctrl
Strain: C57BL/6;	Age: 6 months;	Tissue: retina,ctrl
BE-rep4,pert
db/db 7-3,pert
Tendon_lesional_rep20,pert
Dengue Fever Patient 36,pert
BL306,pert
BACH2+/+ ALL + Imatinib (Sample1),pert
tissue: Frontal cortex;	age: 90;	Sex: M,pert
cell type: Primary neonatal keratinocytes,ctrl
scram_lo_2,ctrl
"SLE patient, 1019V1",pert
"Sodium arsenite added to food: None; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: 10 ppb, 5wk",pert
Liver_WildType_3,ctrl
"midbrain,24weeks,KO",pert
"Acute Myeloid Leukemia, sample 53",pert
race: african american;	age (years): unknown;	stage: IA;	grade: 2;	histology: papillary serous,pert
amygdala no access to cocaine replicate 4,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 8",pert
gender: male;	genotype: Alb-Cre/ TAK1 flox;	strain: C57BL/6;	tissue: liver;	age: 4 wk,pert
mammary_16wkWT_ker70,ctrl
LSK cells from heterozygous JAK2V617F mouse rep4,pert
"experiment 2, control 1",ctrl
human_hepatocyte_gatifloxacin_24hr,pert
Cochlea_D257A_9mo_3,pert
HEK293-cells,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 75,pert
Immortilised monocyte cell line,ctrl
Subject #8018-2d Postinfection,pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 1",pert
"Human male subjects with familial combined hyperlipidemia (FCH), peripheral blood monocytes",pert
WT_cells_rep1,ctrl
1 mt E11.5 heart,pert
tibialis anterior Muscle control,ctrl
HDC-expressing CD11b+Gr-1+ myeloid cells sorted from the bone marrow of HDC-EGFP transgenic mice,ctrl
1% dmso batch 3,ctrl
Amniocytes_euploid_1569,ctrl
BxPC3-WT rep 3,ctrl
ID4+/-TCL1-tg spleen CD19+ B cells collected from 3 mice 3,pert
mdx soleus sample 1,pert
"spleen follicular B in IRF8 conditional KO, biological rep1",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: internal tandem duplication (ITD)/D835 mutation,pert
"brain, hippocampus: KA6-II_e1_le1",pert
Control-2 (HuT-102 cells + vector only),ctrl
"cultured human airway smooth muscle, 24 hour dex treatment, replicate 3",pert
Normal-BM 8,ctrl
Cardiac Muscle_mdx_rep1,pert
"wild type, embryonic stem cells",ctrl
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",ctrl
monocyte derived DCs,pert
C13+(2),pert
patient: 29;	disease state: hypertension;	tissue: Atheroma plaque,pert
mouse B6xCF-1  Non-transgenic (control-3),ctrl
Nerve_Control_Rosi_713,ctrl
"Acute Myeloid Leukemia, sample 74",ctrl
Liver_POR-null+quercetin_2,pert
HepG2_wild type,ctrl
background strain: mixed (C57BL6/6J and 129);	genotype: Dmrt1 flox/flox with Dhh-cre;	gender: male;	tissue: testis;	age: postnatal day 28 (P28),pert
Jurkat Biological Replicate 2,ctrl
healthy control H29,ctrl
RNA-DHL6-R406-2H-1,pert
Oligodendrioglioma_6,pert
AKT_PLACEBO_48hours_2,pert
"38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
61SMOKEH,ctrl
Mouse old heart w/ a-tocopherol aT-Ht-1,pert
"IKK2 WT tumor, biological replicate 4",ctrl
EA_Case11_CD20,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-tu3,pert
N8C Normal-hippocampus,ctrl
"liver_LDLr-KO, biological replicate 4",ctrl
"Control cells unstimulated, biological rep1",ctrl
KU_27T,pert
"Cell type: neuronal, age:46, gender:male, diagnostic group: control, PMI:31h",ctrl
WT-GFP-lamin A Induction: day 10 Replicate A (3a_WT_10d_A),ctrl
"MGSKO, PR01M005v0",pert
NALT_infected_24h_90-226-dM_rep2,pert
Mening SWB WB SW 6b,pert
lesion_midUV_patient9,pert
PTEN deletion Replicate3,pert
treatment: PLX4720;	time: Day3;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
"mNB-A1, MLN8237",pert
Time 120 mins rep 2,pert
"P90_C-DGCR8 KO cones, replicate 2 [array]",pert
"RET-PTC, 2 months",pert
"Tet1 KD, rep1",pert
PFC S control 2,pert
2B1_empty_vector_replicate2,ctrl
18.5 dpc mouse small intestine pLagl2 knockout,pert
wild-type_rep1,ctrl
CHARACTERISTICS;	Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,pert
"HPRTKO, biological rep2",pert
scpk/ikLLtumor/163,pert
Day: 24; Drug: Saline; Phase: Withdrawal; Replicate: 1,ctrl
"RWPE1 cells treated for 24 hours with 100 nM 1,25(OH)2D",pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep3,pert
HD7,pert
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 70",pert
Gender: Female;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
"human failing LV myocardium, Ischemic80",pert
control_00hr_rep1,ctrl
WT MEFs at passage 3_biological replicate 2,ctrl
normal bone marrow NBM1,ctrl
Muscle 50 eccentric contractions 12 hours WT Aged 0123,ctrl
multiple myeloma (MM 517),pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 45 yr;	population: white;	dsm-iv: 295.3;	age of onset: 34 yr,pert
Control for EGF 4h replicate 3,ctrl
"fibroblast, control subject NF3 rep 1",ctrl
"BL from CLL patient, isolated using CD19-PE and CD5-APC",pert
oocyte_wildtype_rep3,ctrl
"A673 cell line, a human EWS/FLI translocated Ewing sarcoma cell line.",ctrl
braak stage: BR34;	rin: 62;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Control 874C,ctrl
Bmi1 embryoid body sample_2 (Bmi1_EB_2),pert
FmrKO4_brain,pert
"CD3+ T cells, peripheral blood derived, SAA patients",pert
IM13_control,ctrl
+7hr Wnt,ctrl
MCF-10A_sh53BP1-1,pert
MSE_N_610,ctrl
"Control, rep 1",ctrl
EA_Case9_CD4,pert
"SS gland, moderate, patient 7, batch 1",pert
age: 36;	gender: male;	ejection fraction: 64;	left ventricular end diastolic diameter: 50;	inflammation/PVB19: negative,ctrl
"FACS-sorted cones, P90 wild type mice",ctrl
TOM-1 non-treated,ctrl
braak stage: CTRL;	rin: 65;	tissue: substantia nigra;	disease state: control,ctrl
Squamous cell lung cancer patient 36,ctrl
GIST Pre Treatment Biopsy 23,ctrl
cell line: JURL-MK1;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
MCF-10A shCHK1-4 replicate 1 [set 5],pert
NIH3T3_4h_FGF_exp1,pert
Bone-Marrow_MGUS_G850,pert
Strain: B6.V-lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 50,ctrl
untreated,ctrl
EB_07_6h_131_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
PGC-1alpha -/- differentiated brown fat cells expressing a siRNA specific for PGC-1beta knockdown (rep1),pert
pRb+/+;p107-/-.2,pert
MDS patient 13,pert
"Colitis 07, UC07",pert
cell line: SKMEL28;	time point: 1h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 1 h,pert
"Control lung tissue, biological replicate 3",ctrl
disease state: healthy control;	tissue: epidermis;	age: 28;	gender: female;	treatment: untreated;	time: control,ctrl
"Peripheral blood, patient without recurrent events [N44]",pert
background strain: C57Bl/6;	genotype/variation: Notch1 wild type,ctrl
MO_CTb_SON_NCBI,ctrl
THRA aI mutant + vehicle replicate 1,pert
strain background: C57BL/6;	gender: male;	tissue: thymus;	cell type: CD4 single-positive thymocytes;	genotype/variation: Ly5.1+,ctrl
P0 - nudelko/+ 1,pert
wild type MEF,ctrl
cell line: IEC-6;	tissue: colon epithelium,pert
EA_Case17_CD4,pert
HeLa SCY1-like 1 knock down 3,pert
Brain_Wild-type_MiceNob4367,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 1,pert
"siRNA, plastic plate, rep1",pert
MF-22,pert
Control Day7 (388L),ctrl
Txnip deficient tumor 22 months sample 2,pert
GM19238_Kd_RELA_3,pert
tissue: embryonic fibroblasts,pert
"Lymphoblastoid cell lines derived from family 1757, member 2",pert
G_LS_Wk12,pert
11087 Normal Uninflamed descending colon,ctrl
"DMD skeletal muscle, biological rep19",pert
cell type: Oct4-Gip ES;	RNAi: Panct1;	treatment time: 72h,pert
B7m2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 165;	Sex: male;	region: LC;	age: 40;	genotype: Y/X;TH/-,ctrl
healthy control_2,ctrl
T9.01,ctrl
Patient 13,pert
patient: 40836;	sample: tumor,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
liver western diet 0.05% quercetin rep5,pert
E8.5 wt.2,ctrl
"foxp3 expression: NO;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 2T>C(mut);	gender: female;	treatment: anti-CD3, anti-CD28 for 72 h",pert
"PPARg d4, rep 3",pert
Primary MEF from 13.5 dpc wild type mouse,ctrl
1186-03-A-b,pert
isoflurane 04,pert
H1299 SC_rep 1,ctrl
siHIRA 3,pert
Healthy 3 weeks C3,ctrl
cell line: Hep G2;	genotype: wild-type THRA and;	treatment: with vehicle for 6h,ctrl
Heart left ventricle,ctrl
"CCALD patient fibroblast, biological rep1",pert
siRNA Smc3 + Estrogen [N3],pert
"brain, cochlea",ctrl
Ishikawa_VeryLowDose_BPA_48h_rep4,pert
patient: 262;	current medication: Asacol 2.4g co-codamol;	birth date: 7/17/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/87;	diagnosis date: 1/1/87;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 7/5/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/5/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Advanced IPF_explant_lower lobe_rep158,pert
"brain, hippocampus: Wt #3406 Hippo_e1_le1",ctrl
HCC_30N,ctrl
"129P3/J Acute morphine treated, biological replicate 1",pert
"gender: Male;	age: 44;	post-mortem delay: 4h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
P80 dilated cardiomyopathy heart biopsy,pert
wt Ang2,pert
Sample Group: control; Gender: female; Age: 60; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
MS brain lesion (after inflammation has subsided -late stage),pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 36;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 3,pert
CD4_T_cell_pool_healthy_H03+H04,ctrl
ICL670 treated K562 cells (10uM for 16hrs),pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G with 1.0% quercetin diet for 14 days,pert
gender: female;	age (years): 38;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Peripheral blood, patient with recurrent events [N47]",pert
V5-P517,pert
PancreaticSample38-Tumor,pert
The RNA samples from DHT 4hr treated LNCaP cells,pert
Cervical Cancer C555,pert
Patient no. 7: control,ctrl
whole splenic B-cells from adult CBA mice,ctrl
mir-26b overexpression 3,pert
chip number: 12;	transfection plate: 6;	target gene: RAD21;	kd level: 0.89;	rin: 9.3;	transfection date: 2012-03-26,pert
02B CF,pert
heterozygot FH P283 (human CD3 positive T cells),pert
CD positive WT T cell TCR-stimulated rep1,ctrl
NBD inhibitory peptide-treated KOPT-K 100mM 16h,pert
Bronchial Epithelial Cells MMA biological 2014V,pert
patient: 20;	disease state: hypertension;	tissue: Atheroma plaque,pert
EB_15_6_341_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
Brain (Inferior Olivary Nucleus)_Control_case4,ctrl
HEK293 cell line #4 with induced HNF1alpha,pert
HUVEC_control experiment 1,ctrl
CTL made from wild type splenocytes,ctrl
Normal Pleura 5,ctrl
HWS26,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 93;	Usage number: 4;	Exposures: 2,pert
WT-Nrf2-Male-2,ctrl
Liver control pool2 Affy,ctrl
SHANK3_1,pert
AtT20 cells overexpressing NSBP1SE protein rep3,pert
"Cell type: neuronal, age:48, gender:male, diagnostic group: bipolar disorder, PMI:23h",pert
human frontal cortex,pert
e_NY44,pert
"AZ521 dnSox2 cells, uninduced, 24h",ctrl
muscle_Akt1+/-_8wk_rep2,pert
1076-03-A,pert
RNA from HCC_22N,ctrl
fibroblast_5azacontrol_rep1,ctrl
TMRI AO 1hr,ctrl
"genotype: wild-type;	strain: C57BL/6;	gender: male;	age: 8 weeks, 3 days;	tissue: colon",pert
V5-P457,ctrl
01MK9_PolyRF-,pert
NALT_sham_24h_rep4,ctrl
myoblasts-expt1_lentiDUX4short-rep1,pert
chip number: 15;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.85;	rin: 9.4;	transfection date: 2012-03-26,pert
RL_siRNA_LIF1h_rep1,ctrl
Liver_Wild Type_2,ctrl
"A673 treated with DMSO vehicle control for 5 days, biological rep6",ctrl
"Patient H-c883T, MSI colorectal tumor",pert
Control (C280),ctrl
KU_24T,pert
"U87MG - control siRNA, biological rep2",ctrl
cell line: SW1736;	time point: 1h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 1 h,pert
MDS1,pert
Directly ex vivo brain CD8 T cells,pert
HUVEC,pert
T145,pert
V5-P249,pert
"DMD skeletal muscle, biological rep22",pert
renal vesicle from E12.5 wild type kidney,ctrl
transplanted heart,pert
MPM tumor 27,pert
"cochlea at P7, ko, biological rep 1",pert
Run2.aUa.001206d.SkMInS1088D.CEL-IS basal,ctrl
cell type: granulosa cells;	disease: normal,ctrl
WT_2,pert
Spleen & Lymph Node,pert
"Control, high-fat diet, rep2",ctrl
Advanced IPF_explant_lower lobe_rep160,pert
Disease_status: Bipolar disorder;	Age (years): 61;	Gender: Female;	Age of onset (years): 18;	Duration of illness (years): 43;	Brain pH: 6.5;	Post mortem interval (hours): 60;	Side of brain: Left;	Fluphenazine mg. Equivalents: 40000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: Yes (5 treatments);	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
tissue: Frontal cortex;	age: 99;	Sex: M,pert
age: 24 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
PBMCs_IS_19 [IS],pert
LNCaP cells treated with vehicle and ELK1-shRNA,pert
"Peripheral blood, normal control [N66]",ctrl
EA_Case11_CD4,pert
23 Day Mouse Diaphragm muscle,ctrl
Thyroid_ unaffected_paired with PTC67T,ctrl
"genetic modification: cells stably expressing the oncogenes c-myc and Ha-ras under the control of the Tet-off regulatable promoter, konstitutive expression of the estradiol activatabel IRF-1hER fusion protein;	tissue: fibroblast",pert
BATF_KO_P14_Naive_rep3,pert
IM27_case,pert
Wildtype 2 (jos0533),ctrl
"ALL_DS, K29 011509",pert
"Brain tissue from Fisher 344 male rat, Animal #245, control (0mg/kg) D-Serine",ctrl
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: Control construct,ctrl
8 Month FORKO Ovary_02,pert
OE control 15A,ctrl
Mammary gland R1 8 hr rep3,pert
Liver GPR120KO HFD #429,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T22,ctrl
PsOEt-23-Week 2,pert
3500-1 E2F2 Null,pert
DMN-NF1Hippo20d-1aAv2-s2,pert
Endometrium from untreated postmenopausal woman,ctrl
NCI-H716_YAP1.2,pert
tDEA002.CEL,pert
Allo-4-3,pert
strain: HNF4 loxP/- villin cre;	age: 1 month;	tissue: small intestine;	sex: male,pert
AKO-rep2,pert
V5-P283,pert
TMRI E2 4hr,pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-5,pert
chip number: 17;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.73;	rin: 9.7;	transfection date: 2012-03-26,pert
injury stage: Sham 21 days;	gender: male;	strain: Wistar,ctrl
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:knockout,Treatment:cornoil,Batch:Batch2",pert
Human Embryonic Stem Cells,pert
"brain, adrenal medulla: Sample#B3 (Ctrl Pt3)_e1_le1",ctrl
224 Day 1 siSC transfected biological rep3,ctrl
"Control group, replicate 1 [GY_Con1]",ctrl
Untreated WT - repeat 5 - mAdbID:102769,ctrl
GIST_KIT_9,pert
Healthy controls; individual=IF; time=2; beverage=water,ctrl
Evi1-4,pert
Hunk WT rep5,ctrl
Human Acute HIV Sample A051-CD8+ T cells,pert
"D4_non-transgenic mice, lung tissue",ctrl
Liver_Female_CF_rep1,pert
TLW18_T2_PP_day0_013,ctrl
Day: 24; Drug: Saline; Phase: Withdrawal; Replicate: 3,ctrl
control participant P333,ctrl
H441 transfected with scrambled siRNA 1,ctrl
esiOgt_rep1,pert
HEK293 F18 WTX inducible,ctrl
"spleen marginal zone B in IRF8 conditional KO, biological rep2",pert
Ero1-WT non-induced biological repC,ctrl
subject: 07A;	cohort: 7;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 29kb;	age (y): 18;	Sex: F;	batch: Batch_2,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
"whole liver, treated with saline (control)",ctrl
"IKK2 WT tumor, biological replicate 3",ctrl
WT STR Veh 1,ctrl
Kidney_Aqp11-/-_P7_4-4,pert
"Subject 11, Family 4, Asymptomatic",pert
hESC transduced with WT miR-122-expressing lentiviral vector,pert
"human failing LV myocardium, Ischemic15",pert
tissue: Frontal cortex;	age: 86;	Sex: F,ctrl
"Global gene expression of NASH patients, P51",pert
hOB695_shRB1383_8hr_IR,pert
BC2 TC,ctrl
neurectoderm derived from embryonic stem cells,ctrl
Subject 2 / lung subsegment instillated by LPS,pert
RNA from whole tissue section of case 356 labeled with Cy5,pert
Lmna H222P heterozygous male 7,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep2",pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #1,pert
"control, BA10-60",ctrl
Retina of 2 month old C57BL/6 mouse,ctrl
Normospermic individual: Sample N8,ctrl
3880-3 E2F WT,pert
Undifferentiated Dicer +/- (D4) ES cell line replicate_3,ctrl
MCI-007,ctrl
sample N term wt,ctrl
4L,pert
Human prostate cancer cell line,pert
"atRA WT, set 2",pert
"30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
Primary hepatocytes isolated from Donor 1 treated with DMSO for 6h,ctrl
Subject #8018-8hr Postinfection,pert
"LCL GM19238, Kd DIP2B, 72hrs",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 19 yr;	population: white;	dsm-iv: 295.9;	age of onset: 18 yr,pert
3491-1 E2F2 Null,pert
HEL_JAK2 knockdown (Jak2-10 shRNA)_3,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 45;	donor: 19;	disease state: Lesional,pert
cDNA no 21,ctrl
Subject 1_t=30days_resveratrol,pert
Subject #8012-2d Postinfection,pert
treatment: atRA + cycloheximide;	genotype: RARaKO;	cell line: F9,pert
"Autoimmune pancreatic islets, day 2 cyclophosphamide treatment, rep 2",pert
Human hepatocellular carcinoma cell line infected with GFP protein (control) 2,ctrl
"wild type CTL+AktI, biological replicate 2",pert
"t12, surgically resected from patient of gastric cancer.",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 49,pert
RTX4 T12,pert
"mouse, liver (CCl4) (week 18)",ctrl
"peripheral ganglion, unknown",pert
25 weeks male,ctrl
"heart-30 months of age, resveratrol diet-biological replicate5",pert
Wildtype_XY_2,ctrl
Brain (Inferior Olivary Nucleus)_Control_case3,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Liver",ctrl
"cell line: MDA-MB-231;	disease state: Breast adenocarcinoma, estrogen receptor-negative;	genotype/variation: Control",ctrl
Liver_Wild Type_1,ctrl
Endometrial stromal cell - control/vector 3,ctrl
PGA_Ras_3-m5,pert
"control embryonic stem cells, biological replicate 5",ctrl
"ALL_DS, K23 011409",pert
Gastric_cancer_patient_3,pert
HLA risk: Low;	Height: 170 cm;	Weight: 61.2 kg;	BMI: 21.1;	Age: 14.9 years;	Gender: Female;	Race: White;	Glucose: 86 mg/dl;	HbA1c: NA,ctrl
Murine bone marrow from C57bl/6 mice,pert
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: D,pert
HT29 parental cell line,ctrl
strain: C57BL/6;	tissue: mouse bone marrow;	genotype: E-FABP knockout;	treatment: 1x10^6 cells in a 12-well plate co-cultured overnight with 1x10^6 E0771 tumor cells in an sterile insert,pert
V5-P447,pert
NPC19,pert
wt_on_rep3,ctrl
"breast tumor epithelium,6",pert
liver_female ko_rep3,pert
Extract:LOX-1:113303;	Extract Description:GFP_Untreated_6hr:113303;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.13;	Quality: Absent (%):58.09;	Quality: Absent (%) Dev.:0.13;	Quality: Scaling Factor:0.63;	Quality: Scaling Factor Dev.:0.14;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113303;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295613,ctrl
"human embryonic stem (hES) cells line SA01, biological replicate  2",ctrl
status: Control;	gender: Female;	age: 48;	tissue: Blood,ctrl
Nerve_Control_Rosi_715,pert
MCF10A_Vehicle_rep4,ctrl
Pax_S2,pert
Primary hepatocytes isolated from Donor 3 treated with Wy14643 for 24h,pert
tetO-Satb1 #1,ctrl
DMSO Treated Control 1,ctrl
MCF7 control siRNA Vehicle Rep1,ctrl
AtT20 cells overexpressing NSBP1WT protein rep2,pert
07R058 RA,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Neurointermediate lobe of the Pituitary,ctrl
XBP1s_B_cells_spleen,pert
RV64.10_CHF_day25,pert
PGA-RMM-15m-2aA-s2,pert
ccRCC tumor of patient T127,ctrl
MOLM14_shSYK_2_Replicate1,pert
"Control 10, NC10",ctrl
"Patient C, uninvolved skin",ctrl
VGP1,pert
BCell_lymphoma_aggressive_sample2,pert
REST shRNA KD 2,pert
EB_2_24h_213_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
bone marrow derived mast cells,pert
Control bone marrow - Biological Replicate 5 - Technical Replicate 2,ctrl
Leg 23 Day mdx rep 2,pert
Liver sample from Alcoholic hepatitis group (CA5),pert
224 Day 3 siSC transfected biological rep1,ctrl
E14Tg2a ES Cells,pert
heart knock out replicate3,pert
G518,pert
CH1812,ctrl
ZMYM2/FGFR1 biological replicate 1,pert
Individual_3591_PP_sample,pert
phenotype: severe glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
cell line: MCF10A;	transduction: HER3,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_1_16_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 7.03;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
background strain: B6/129;	genotype/variation: mir-122 knockout;	tissue: Liver;	age: 2 Month,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	target lesion score (peasi): 6;	peasi reduction [%]: 0,ctrl
3886-1 E2F1 Null,ctrl
"fibroblast, MFS subject FB881 rep 1",pert
KO HPC Veh 29,pert
MDS patient 61,pert
strain: C57BL/6J;	gender: male,ctrl
HCT116 human colon cancer cells with PTEn -/-,ctrl
"Healthy control, biological rep5",ctrl
"Heart, MAT1 control, 4 wk, sample 2",ctrl
XpO15,pert
WT AA 1,ctrl
"Muscle from DS, biological rep2",pert
"1mg/kg/day PFOA, Rep 3, Block 4, liver (low dose)",pert
"Cbfb+/+, technical replicate 3",ctrl
"BT474-J4 breast cancer cell line, foretinib",pert
CD19_selected_B-cells_after_R_rep9,pert
CRC_celecoxib_M4867,pert
5242 UC Uninflamed sigmoid colon,pert
Phan_008_KO.saline rep2,ctrl
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14464;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
MDS patient 162,pert
"CCM3 shRNA cells passage 7, rep 2",pert
whole lungs overexpressing an nmyc-gfp fusion protein via the lung surfactant c promoter,pert
control AU0995302,ctrl
Individual_5144_NN_sample,ctrl
MKO_rep_2,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 2",pert
"Aorta, saline 14d, #1",ctrl
patient: 13;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
tissue: skin;	individual: Patient P5;	condition: ANL;	eczema severity: SCORAD: 0,pert
Sample 05 Kidney Normal Mouse - Control Diet,ctrl
Diaphragm 28 Day control rep 3,ctrl
"hepatic gene expression at ""3 hr"" (rep1)",pert
cbp+/- standard cage Rep1,pert
204/0,ctrl
MPM tumor specimen 16,pert
gemcitabine resistant Calu3 derivative generated from the parental Calu3 line by consecutive treatments with 50 nM gemcitabine over a period of 3 months,pert
Bone-Marrow_SMM_S1449,pert
"brain, control, 14 months",ctrl
MCF-10A_shControl,ctrl
"heart tissue, ad lib feeding, 10-12 weeks old",pert
HepG2_control_rep2,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,ctrl
tissue: white blood cells;	age: 13.07;	Sex: male,pert
SHR16-4,pert
gender: Male;	age: 38;	post-mortem delay: 6h;	ph: 6.9,ctrl
"HeLa cells, 72 hs after transfection",ctrl
VPA treated MC3T3 mice,pert
GIST_KIT_15,pert
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: DMSO,ctrl
whole blood_100346,pert
9-cis-retinoic-acid_mammary_1,pert
2827 TG,pert
"testis, Repro9 mutant, 17dpp, Rep1",pert
N14B Normal-cerebellum,ctrl
T175 U133p2,pert
INS-1 cell line #6a with induced HNF1b mutant P328L329del,pert
"ID:7-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
1156-03-A,pert
7-Mut_1,pert
cell line: MDA-MB-231 1833;	cell type: breast cancer cells,ctrl
whole heart,pert
control siRNA rep3,pert
2098-03-A,pert
OCI-Ly1_FOXP1 overexpression,pert
Mouse soleus,pert
CF knockout HMCF CHN538,pert
LSK cells SRF wt 1,ctrl
WT - Cre Control - 5 mo - repeat 1 - Cy5 - mAdbID:74097,ctrl
cell line: OVCA429;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
A61 WT1	F6/20	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
The Caco-2 cell line is derived from a male Caucasian with a colon tumor,ctrl
"Control skin, rep1",ctrl
Biceps_Control_2,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (13),pert
Mnk_3204-T-7,pert
Untreated diabetic-3,ctrl
siERK2Veh4h_2654,ctrl
"SW480, colon cancer cells",ctrl
P4 Ovary cultured for 48 hours with NT3,pert
mouse adipose tissue,ctrl
PGC-1a-/- rep4,ctrl
diagnosis: FU;	fvc-group: FVC1;	tissue: lung,pert
"nasopharyngeal carcinoma, specimen T14",pert
umbilical cord_bpd: 7C,pert
A5,pert
GM19238_Kd_NS2_11,ctrl
Untreated CCE embryonic stem cells (CCE_ESC_Control),ctrl
CD34-001,ctrl
NB69,ctrl
H1299 cells,ctrl
sex: Male;	Age: 36 months;	additional patient information found in Series supplementary file,ctrl
BCell_lymphoma_transitional_sample5,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Aldosterone;	genotype: WT CTNNB1,ctrl
WT_P_2,ctrl
"Patient  G, lesion, 12 week",pert
shSOX2_3,pert
patient: 8;	disease state: hypertension;	tissue: Atheroma plaque,pert
CDF1-c (197msn),ctrl
Ad infected murine liver-MO30k-(464)-6 hpi,pert
M464 Wt,pert
Human hepatoma cell line (HepG2),pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
AAA neck (Sample 2),pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_4mM_HG-U133A_2_YCHSUP501,pert
cell type: fibroblast;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P7;	clone: 0,pert
"Patient I-c226T, MSI colorectal tumor",pert
WT-sham-5 month+13d-R1,ctrl
HUVEC transfected with anti-miR-210-LNA,pert
CA96-116A,ctrl
Astrocytoma_1,pert
Normal_001,ctrl
jzo031-rp1-v5_u74av2-met,ctrl
Pooled mouse tissue,pert
thymic tumor IKL/L mouse,pert
01N3S_Oligo,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID63,ctrl
NPC15,pert
sex: Male;	Age: 14 months;	additional patient information found in Series supplementary file,pert
c.1,ctrl
"human failing LV myocardium, Ischemic40",pert
R6/1 18 week wildtype_DFFC,ctrl
"CTR-A (CTR-1, biological replicate 1)",ctrl
MDS34,pert
another 26 year old male,ctrl
"brain, hippocampus: LH3_e1_le1",pert
wild type MEF time 2 replicate 2,ctrl
Trasnsformed Lymphocytes Unaffected Twin Pair 2 (DCBD2.2)(TP8),ctrl
cell line: TF-1;	gender: male;	age: 35 years;	disease: erythroleukemia (AML M6);	sirna: anti-Evi1,pert
Keratinocytes_siANCR_rep1,pert
WT_Mstn_5,ctrl
3T3-L1 Day 0 (passage 21) 48h after siControl transfection,pert
36A,pert
"BOEC, normal 3",ctrl
E9.0 ko.3,pert
siNS_2h_4,ctrl
DNGM-11,pert
Ecad_Mut_1,pert
A2AR_WT_saline_24h_rep3,ctrl
RA_A,pert
DND41 Control 1,ctrl
Mouse fetal liver_E14.5_KO_rep4,pert
lesion_midUV_patient4,pert
"patient 030b, cancer, homogenized",pert
cell line: MCF-7;	cell type: Breast tumor cell line;	transfected with: pcDNA3-Pit-1 overexpression vector,pert
Targretin_mammary_1,pert
HUVEC_TNF-stimulated experiment 3,pert
PGA-RMM-1h-2aA-s2,pert
"schizophrenia, BA46-26",pert
KM_079N,ctrl
skin.KO.replicate17,pert
"schizophrenia, BA10-37(3)",pert
MS patient 6,pert
4472-2 E2F3 Heterozygous,pert
SV589_15Day KD_Serum Starved,pert
216/4,pert
"A673 treated with Puromycin for 5 days with concentration of 0.09 uM (EC50), biological rep1",pert
Gene expression profiling of normal cortex of patient 131,ctrl
KOC 55 PBS treated,ctrl
KO1 PBS,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep7,pert
fasted liver standard chow diet 2,ctrl
cerebrum_WT_0d_rep2,ctrl
GFP-progerin Induction: day 10 Replicate A (6a_progerin_10d_A),pert
tissue type: Bone Marrow;	cell type: Monoclonal Gammopathy of Undetermined Significance (MGUS) plasma cells,pert
DH 4,pert
"breast tumor epithelium,55",pert
Brain (Inferior Olivary Nucleus)_Control_case5,ctrl
MDA_Parental_1,ctrl
strain background: Mixed background;	genotype/variation: Otx2 k.o.;	developmental stage: E13;	gender: not determined,pert
Adrenocortical adenoma with wild-type CTNNB1-2,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID130,pert
race: caucasian;	age (years): 77;	stage: IA;	grade: 2;	histology: endometrioid,pert
Male mice from mdx (C57BL/10ScSn-Dmdmdx/J) line were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,pert
"Liver from STZ-treated mice, biological replicate 3",pert
PTEN_1,pert
"liver, genetic control Alb-Cre:Keap1(flox/+)",ctrl
"Transgenic, snap frozen, diaphragm muscle, 7 month age animal",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 31 yr;	population: white;	dsm-iv: 295.3;	age of onset: 22 yr,pert
HepG2 cells treated with 5-aza-dC,pert
"human failing LV myocardium, Idiopathic13",pert
brain_DLPFC_bipolar C_mr780,pert
6-month mouse dorsal prostate,ctrl
DC2 RSG,pert
HCT116 STAG2 knockout clone 21 (STAG2 deficient),pert
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 45;	gender: m;	treatment: NSAIDs,ctrl
Control Day1 (357R),ctrl
WT_1,ctrl
kidney_Q10_6M_rep2,pert
"Primary culture of dermal fibroblasts from normal scar, no hydrocortisone treatment",ctrl
"hepatic gene expression at ""3 hr"" (rep2)",pert
lineage: colorectal;	cell line: SW480;	treatment: treated with TNKS inhibitor for 16h,pert
cell line: DAOY M2.1;	cell type: medulloblastoma;	genetic modification: siRNA cMYC silenced,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 59, stage IIB, HPV 18",pert
RV16;	Age = 19;	Sex = F,pert
siLMO3_oligo2_0_rep1,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 1hr,pert
mature Ly-6G+ thioglycollate-elicited peritoneal neutrophils,ctrl
"44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"epidermis, healthy control",ctrl
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
KU_14N,ctrl
gender: female;	age (years): 41;	evolution time (years): 15;	disease extension: Pancolitis;	treatment: 5-ASA,pert
Expression data from BAT of the KRAP deficient mice (WT3),ctrl
P0 - lis1ko/+ Mix 1,pert
"breast, pre AFI treatment (H18_1930)",ctrl
Bronchial Epithelial Cells MMA biological 2063I,pert
SIRT1 LKO liver_4 pm_rep2,pert
cerebrum_PS-/-_ 20d_rep1,pert
24h_RA2,pert
"SLE patient, 1005V1",pert
rd1_P4_rep3,pert
ATCC HTB-30,pert
0511-01-c,ctrl
cell type: BMDM;	strain: C57BL/6;	genotype: wild-type;	infection status: uninfected,ctrl
wt #2. 462,ctrl
11443 UC Uninflamed sigmoid colon,pert
Cre_day_7-3,pert
MBD2_1,pert
Normal-N_LJ_8,ctrl
RNA from whole tissue section of case 342 labeled with Cy5,pert
Mouse Left Ventricle,pert
Mouse_ATF6aKO_colon_DSS_rep1,pert
Wt Mouse_cerebellum_Young_saline treatment_Replicate-3,ctrl
Ishikawa_LowDose_BPA_48h_rep1,pert
Individual_4339_PP_sample,pert
Control (C70),ctrl
S007_Scz_F_67,pert
disease group: osteoarthritis;	cell type: chondrocytes;	cell culture: monolayer,pert
testis knock out replicate2,pert
5320-scrape,pert
Cutaneous psoriasis without arthritis PsC 11,pert
Disease_status: Healthy control;	Age (years): 31;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.13;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
Carbo Day14 (453R),pert
R7E 11,pert
RNA from whole tissue section of case 1304 labeled with Cy5,pert
77_129_WT,ctrl
strain: CD-1;	genotype/variation: wild-type;	developmental stage: embryo;	age: E17.5;	tissue: kidney,ctrl
SKBR3-R_1uM_Lapatinib_1,pert
C57 72 ozone 1,ctrl
HEK293 stably pIRES2-EGFP-transfected,ctrl
NK_cell_pool_healthy_H01+H02,ctrl
OE Sirt1 2,pert
Brain (Inferior Olivary Nucleus)_control subject_#3,ctrl
B-CLL PB P138,pert
NSC_ DMSO_24h_biological rep3,ctrl
E16.5 Vax2-/- 2,pert
"Colitis 09, UC09",pert
subject: 21A;	cohort: 21;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 82;	Sex: F;	batch: Batch_5,pert
Untreated Control 12weeks AffyGC RMA rep6,ctrl
"Colitis 06, UC06",pert
"ES cell mutant, RNA 308",pert
5871841165_B,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.326;	OD280: 0.691;	Ratio: 1.83;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 292;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
braak stage: BR56;	rin: 69;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"Control 07, NC07",ctrl
17B,pert
liver 1.0% quercetin diet rep1,pert
NTG mouse_tamoxifen1,ctrl
4010-1 E2F2 Null,pert
MPM tumor specimen 29,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 2;	bead chip array sentrix code: 4421339033,pert
MPM tumor 30,pert
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-4,pert
Subject #8022-2d Postinfection,ctrl
BL Day 2 siMut10 transfected biological rep3,pert
MDS patient 42,pert
control sample 6,ctrl
BRCA1 KD #1,pert
neonatal cord blood mononunclear cells without LPS-treatment,ctrl
mouse jejunum_hnf1alphacontrol_rep2,ctrl
C_AN17425_T,ctrl
MO32_17,pert
AA_124,pert
"PBMC, patient. Mtx rep13",pert
Leg 14 Day Control rep 1,ctrl
"bipolar disorder, BA10-16",pert
IDCM4,pert
race: caucasian;	age (years): 63;	stage: IC;	grade: 1;	histology: endometrioid,pert
genotype: p300+/-;	replicate: 2;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
wild type mammary gland,ctrl
tissue: Temporal cortex;	age: 75;	Sex: F,ctrl
Normal mucosa 21,ctrl
E12 embryo proper,ctrl
Muscle PCOS 9,pert
VCaP/NC siRNA #2,ctrl
PWD/PhJTCE liver sample batch 4,pert
M322 SKM-KO,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis posterior;	age at biopsy: 52;	Sex: male,pert
Substantia nigra normal rep2,ctrl
normal control_CTL5,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 31;	sex: M,ctrl
HCC_17T,pert
"Brain tissue from Fisher 344 male rat, Animal #258, 50mg/kg D-Serine",pert
TFEB_Overexpression(S2),pert
Ngn3 EB3 OFF replicate 1,pert
"ME16C, 12h, 0.06mM 5FU B",pert
Healthy controls; individual=JL; time=2; beverage=water,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu2,pert
Subject #8045-8hr Postinfection,ctrl
major non-tumor9,ctrl
Substantia nigra PD rep7,pert
OSE4 cells,ctrl
primary normal lung tissue 2841,ctrl
Embryonic age 17.5 mutant rep4 (PKD1_12),pert
"Patient SE, stable renal transplant recipients, male, 31 years old, T0 (time of enrollment)",ctrl
strain background: C57Bl/6J;	gender: male;	strain background: wild type;	age: adult;	tissue: whole brain,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 145min;	race: White;	sex: Female,pert
A673 cell line that has been treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50).,pert
PGA-RMM-2h-3aA-s2,pert
Erythroblast_SOD2-/-_repKO39,pert
Human Neural Stem Cell Line F3 Overexpressing NGN1,pert
AKT_PLACEBO_12hours_4,pert
"liver, fed Western diet containing 0.05% quercetin for 20 weeks",pert
"healthy control fibroblast, biological rep3",ctrl
S3A Sporadic-frontal,ctrl
MH1C1_untreated_rep3,ctrl
E14 - nudelko/+ 1,pert
transgene: FTO;	treatment: 48h after induced espression of integrated copy of the FTO gene,pert
E81-/-SRFVP16-1,pert
wild type MEF(2),ctrl
gender: male;	tissue: heart;	tissue: Transmural sample taken from near the apex of the left ventricle,pert
3471-1 E2F3 Heterozygous,pert
Control 874G,ctrl
Primary hepatocytes isolated from FVB mouse strain treated with Wy14643 for 24h,pert
"ALL_NDS, K41 011509",ctrl
"human failing LV myocardium, Idiopathic2",pert
patient with Acute Lung Injury,pert
Subject #8030-8hr Postinfection,pert
P60_PMP22KO_2,pert
5871841165_D,ctrl
"SFM control cells (24hr), biological rep2",pert
Liver sample from Alcoholic hepatitis group (CA64),pert
12471 UC Inflamed sigmoid colon,pert
14 Day Mouse leg muscle,pert
Mammary Gland_WT_rep3,ctrl
Panc-1_Control,ctrl
subject: 12A;	cohort: 12;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 22;	Sex: F;	batch: Batch_3,pert
uterus_veh_PRKO_40hrs_rep3,pert
"breast, pre AFI treatment (H11_1610)",ctrl
Injured 1 day Rat Retina 2,pert
2-ONS76_b,pert
breast adenocarcinoma from 69yr old female caucasian,pert
Large cell carcinoma 008,pert
"1mg/kg/day PFOA, Rep 2, Block 3, liver (low dose)",pert
KO_d00_eX,pert
Mouse T cells,ctrl
n4t6h,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 5,pert
MKK7D control female replicate 3 early timepoint,pert
MDS patient 3,pert
strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E18.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
"schizophrenia, BA46-45",pert
cell type: Lin- Sca-1+ c-Kit+ (LSK);	age: six weeks old;	genotype/variation: Ott1 flox/null Tg-Mx1cre,pert
none provided,pert
M24met melanoma cell-line,ctrl
AGS control biological rep 3,ctrl
"Strain:Wistar, Gender: male, Tissue: cirrhotic liver, Induction of cirrhosis: CCl4",pert
gender: male;	age (years): 41;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
e1 Ez f/fMef2c-cre,pert
patient: 221;	current medication: Prednisolone 7mg Asacol Adcal Seretide Fe SO4;	birth date: 1/29/86;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/10/01;	diagnosis date: 12/10/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma Eczema;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
15d control,ctrl
01LN7: new onset sJIA,pert
GM19238_Kd_ARNTL2_2,pert
"TG mouse lung, biological rep1",pert
sciatic nerve of P60 Trembler mice,pert
Leg 14 day mdx rep 2,pert
Gata-1 Wild Type A,ctrl
"DMSO Control after 1hr, replicate 2",ctrl
"Cervical cancer cell line, ME-180",pert
homozygot FH P251,pert
tissue: testis;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
"Control, replicate 5",ctrl
wt_on_rep1,ctrl
HEK293T cell line,pert
OCI-Ly7 BCL6siRNA 3,pert
PGC-1a-/-bf/f/MerCre rep2,pert
SW480_control RNAi_luciferase_rep2,ctrl
Sample ID: TP16;	Twin Pair ID: CCN1.2R;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.2**,ctrl
"breast, post AFI treatment (H13_1647)",pert
92.1 cells,pert
c 4-1,pert
"TMD_TP, T6",pert
NORMAL #00-0267,ctrl
"Lymphoblastoid cell lines derived from family 1744, member 2",ctrl
Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 2,ctrl
MCL_IGHV_MUT (R1399_M),pert
Normoxic Adeno Treated Control N2,ctrl
REST shRNA KD 1,pert
PGA-RMM-4h-3aA-s2,pert
6-KO_RD3b,pert
NK_cell_pool_healthy_H03+H04,ctrl
"Patient 4, baseline",ctrl
Lmx1b -/- E11.5 129Sv,pert
GIST_WT_1,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID230,pert
Tobacco_abuse_1,pert
Jurkat 3,pert
primary normal lung tissue 3208,ctrl
MDA-MB-231 parental cells,ctrl
gender: female;	mean age: 41.3;	mean bmi: 28.9;	depot: abdomen;	type: white adipose tissue;	ethnicity: Caucasian,pert
Healthy controls; individual=JL; time=2; beverage=alcohol,pert
patient: 30582;	sample: tumor,pert
"S1P3-KO-hippocampus, biological rep2 (male)",pert
PGC-1a-/-bf/f/MerCre rep3,pert
NE-rep8,ctrl
12h Control (SAMPLE 1),ctrl
Trim33-KD-SB-2,pert
GM19238_Kd_GTF2B_3,pert
con-41,ctrl
"HEK cells transfected with TDP-43 siRNA, 24h after transfection",pert
28A;pretreatment;female;breast tumor; responder,ctrl
Sh-control-3,ctrl
Age: 41;	Cycle: NA;	BRCA1/2 mutation: Negative;	Family History: No,pert
PA-1+(1),pert
N/SM4,ctrl
age: adult;	gender: male;	tissue: lung,ctrl
Tk6 treated with cadmium rep2,pert
4 PC3 2hr,pert
14-0004A_Day1_37,pert
kidney tissues from obese rats on diet with rosiglitazone,pert
DNGH-3,pert
Stratagene reference,ctrl
"Pb-Cre+;PtenL/W;K-rasG12D/W, biological rep3",ctrl
HTH83 SCR 1,ctrl
"gender: Female;	age: 78;	post-mortem delay: 8h;	ph: 6.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Sample M539,pert
SeroTest-4,pert
Mammary Gland_WT_rep1,ctrl
"KARPAS-231, LITAF-specific siRNA, REP3",pert
"SKO-transduced MEFs, Vc untreated, lysed on D5",ctrl
HCC_37T,pert
OSE_552,ctrl
heart_KO_rep1,pert
Superior Frontal Gyrus from a 10 year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day1,pert
PND28 Rat Testis_Rat230-2_12hr MEHP_Animal#57_04005,pert
CD positive WT T cell unstimulated rep2,ctrl
KN-smoke-med-5 month-R4,pert
"CBFb-SMMHCd179-221 animal 2, replicate 2",pert
FW_16c_BV7565,ctrl
Benign prostate tissue NX1,ctrl
Control_Time_0_2,ctrl
cells origin: subcutaneous white adipose tissue;	individual characteristics: Non-obese individual,ctrl
WILDTYPE cerebrum at 4 weeks,ctrl
placebo treated ipsilateral to stroke,ctrl
Gastrocnemius muscle from transgenic mouse overexpressing PPARalpha,pert
"DMD skeletal muscle, biological rep4",pert
Saline_3,ctrl
Sirt1 siRNA KD1 1,pert
H720 MK886 1 micromole 24h serum free Sample 2,pert
Mnk_3213-S-7,pert
"Rescue pancreas, biological rep4",pert
Recent-onset T1D_sample2,pert
24h Kin Cel.47,pert
"Vitamin C treated ES cells, Rep 2",pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 1,pert
Age: 37;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Unknown,ctrl
Patient: K;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
RTX9 T0,ctrl
22: NORMAL #99-0694,ctrl
"Atm-/- untreated, B",ctrl
"genetic background: Cebpa-Cre;R26-LSL-Eyfp;Dicer1wt/fl/Dicer1fl/fl (donror), C57BL/6 (recipient);	genotype: Dicer wild type;	cell type: YFP-positive  granulocyte-macrophage progenitor",ctrl
Mouse_ATF6bKO_colon_UT_rep1,pert
mouse cerebellum at P7 wild type 1,ctrl
T60 dilated cardiomyopathy heart biopsy,pert
Sh-control-2,ctrl
brain_DLPFC_bipolar C_mr780,ctrl
"shRNA-PGC1a #66, rep-2",pert
prostate tumor 5,pert
gender: male;	strain: C57BL/6;	developmental stage: day 13.5 embryo;	genotype/variation: wild type (WT),ctrl
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep3",pert
ab199 IM,pert
IDCM5,pert
DUSP1-/- control replicate 2,pert
age: 66;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
SA_260,pert
Patient 2,ctrl
siOGT 24 hours_3,pert
CT-receptor-KO osteoclasts untreated 1,pert
GM19238_Kd_KLF13_3,pert
"150 pos, CD 48 neg, Lin neg Sca and c-kit pos BM cells",ctrl
"Prdm14(-/-): 2i, rep2",pert
diagnosis: UIP/IPF;	fvc-group: FVC2;	tissue: lung,pert
Cardian muscle Trained 3 week T3,ctrl
Human prostate cancer primary culture C38dx,pert
"Normal subject (50 year old caucasian male, SAK_1276059218)",ctrl
cDNA scc 06,pert
LNCaP/MYB siRNA #2,pert
brain_OFC_bipolar B_mr93,pert
Thymus,ctrl
Total RNA was extracted from omental adipose tissue from a control subject,ctrl
MLL_00106,ctrl
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
"blood, +Q10H2, +LPS",pert
"SKO-transduced MEFs, Vc+, D5",pert
C7med,ctrl
"IRF6 knockout, biological rep1",pert
shRNA 94 R7 T5,pert
HepG2 cells quercetin 4h,pert
695_383_4hr_repeat,pert
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 429,pert
"BMMCs from NTAL WT, NTAL shRNA infected, 2 h activated, biological rep1",pert
"normal mouse kidney E12.5, biological rep 2",ctrl
"ALL_NDS, K62 011409",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 76 years,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.536;	OD280: 0.766;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 299;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
MSE_D_645,pert
"cochlea at P60, wt, biological rep 2",ctrl
HET Brain 67d Mouse1,ctrl
SZ27,pert
age: E14.5;	gender: male;	tissue: dorsal telencephalon;	genotype: histone methyltransferase ESET KO;	genetic background: C57BL\6,pert
tissue: Fallopian tube;	cell type: epithelium;	cell line: OE-E6/E7,ctrl
P4_Ovary_Control_biological rep3,ctrl
control to Sample 19,ctrl
"ALL_NDS, K32 011609",ctrl
PA-1-(1),ctrl
RAW_2.8mM_HOCl_#3,pert
V5-P117,pert
81 year old female,pert
p53_siRNA_0b,pert
HC JL 2 water,ctrl
WT MEF CT30-3,ctrl
"breast tumor epithelium,16",pert
"patient: 119;	current medication: Salubtamol, Bricanyl;	birth date: 9/30/70;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/27/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"RKO colon carcinoma cells (ATCC #CRL-2577), cultured in DMEM (Invitrogen Catalog#10569) containing 10% FBS (Atlas Biologicals)",pert
KO - knock-out Treated - 0.5 hrs - repeat 3 - Cy5 - mAdbID:62540,pert
Sex: male;	Age at operation: 60 years;	Site: upper arm;	Size in cm: 9.9x7x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
Diagnosis: AML M2;	Age: 41y ;	Gender: Male;	Blast %: 70;	Source: PB;	Cyto: Normal;	FLT3 ITD: No Data;	FLT3 TKD: No Data,pert
"Ifitm1-deficient lung tissue, biological replicate 2",pert
Diabetic 1 week D1,pert
"Testosterone treated, HIV-1 positive male, day 14 (8)",pert
CD3+ T cells from healthy volunteers,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated, biological rep2",pert
Monocytes from buffy coat preparation,pert
"control, untreated muscle cells",ctrl
"vehicle, biological rep5",ctrl
"MIST1-null pancreas, biological rep1",pert
prefrontal cortex (collagen),pert
Individual_4344_PN_sample,pert
human glioblastoma cell line,ctrl
hNHEPS_10 μM_6 h_rep3,pert
"Patient 10, Macroscopically intact tissue",ctrl
2: FCHL patient #98-1103,pert
Sca+ SP (side population) bone marrow cells,pert
KN-sham-5 month+13d-R2,pert
"LNCaP cells, treated with R1881, biological rep 3",ctrl
cell line: E14;	treatment: REST knockdown,pert
"OuJ, air, biological rep 1",ctrl
FVB_MMTV_Wnt1_iFGFR1_4013_3L_ROSEN,pert
strain: C57BL/6J;	age: 4 months;	gender: male;	tissue: lung;	genotype/variation: Ifitm1 k.o.,pert
cell line: KM-H2;	treatment: CIITA-BX648577 knockdown,pert
Human Embryonic Stem Cells,ctrl
dorsal mouse skin,pert
hOB695_shEV_16hr_IR,ctrl
"t02, surgically resected from patient of gastric cancer.",pert
CD4DecTp2-6,pert
Human prostate cancer primary culture C27dx,pert
"AG825-treated, 24h after UV, Replicate B",pert
"Transgenic mice with water, replicate 3",pert
"cultured human airway smooth muscle, 4 hour dex treatment, replicate 2",pert
"Normal cervix, Age 56",ctrl
SKI-DLCL cells were treated with AraC alone in concentration 20nM for 24h. Total RNA was extracted,pert
DuodTumor0225AFBW_dtb.txt,pert
"twin pair: #1;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"PPARg d4, rep 7",pert
Patient: M;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
AA_Case15_CD8,pert
Subject #8013-8hr Postinfection,ctrl
Normal Cervix,ctrl
MCI-013,ctrl
cell type: AML blasts;	fab classification: M4,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 59,ctrl
CBA2,ctrl
"ES cell mutant, RNA 307",pert
U138MG shcontrol 1,ctrl
218/4,pert
100uM H2O2 rep 2,pert
BMM_C3H/HeJ_time21h,pert
K562 cells control replicate 1,ctrl
WT - Cre Control - 3 mo - repeat 2 - Cy3 - mAdbID:74589,ctrl
Pias1 null IFN-gamma 4 h,pert
"shCDK19, low glucose, replicate 1",pert
day 30 5-FU HSC 1,pert
patient E1589,ctrl
PGA-RMM-4h-1aA-s2,pert
siCtrl_0_rep1,ctrl
bone marrow,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.77534,pert
"HUVEC, untreated 2",ctrl
E100-/-SRFVP16-2,pert
"WT cells, replicate 3",ctrl
Eed KO E14 ESCs on day 3,pert
"brain, frontal cortex: Sample52_e1_le1",pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep3",ctrl
COLO829 cells with shScrambled knockdown and DMSO treatment,ctrl
nmMLCK-/- -VILI replicate 2,pert
"IGF-treated cells (3hr), biological rep2",pert
Mammary gland R1 16 hr rep2,pert
CF control DFW CHN312,ctrl
genetic background: CD1;	genotype: A2AR KO;	Sex: male;	age: 14 weeks;	tissue: ventricular myocardium;	treatment: saline,pert
REST shRNA KD 3,pert
H1299 cells,pert
Percutaneous biopsies of vastus lateralis,pert
AP-920050,pert
healthy,ctrl
A2008-(3),ctrl
Lung WT-PBS replicate 1,ctrl
treatment: 1 ug/ml doxycyline;	time: 36 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
RAW_00.35mM_HOCl_#2,pert
"Neuroblastoma SH-SY5Y cells, stably transfected with RNAi against DJ-1",pert
cultured MGP melanoma cells,pert
LY2 SRC1-siRNA untreated rep2,ctrl
Bach2 KO - Thymus - biological repeat 2,pert
3275-1 E2F WT,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 4;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
sepsis patient #5,ctrl
IRS-1 KO (jos0678),pert
OVCAR-8+(2),pert
"ID:3-1, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",ctrl
LNCaP.FoxA1.2,pert
gender: Male;	age (y): 48;	tissue: prolactinoma,pert
"Amoxicillin treated Proximal, Small Intestine 2 21 days old",pert
EA_Case21_CD20,pert
T15,pert
sample: #9;	subject: Control case #4;	brain: T-779;	age: 76;	sex: Female;	region: Dorsal motor nucleus of the vagus,ctrl
HaCaT_Control_ biological rep1,ctrl
HCC010T,pert
HepG2_5-aza_rep2,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 32;	maternal age: 38,ctrl
SCLC cell line Lu-130,pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 77;	Usage number: 1;	Exposures: 4,pert
strain background: C57Bl/6;	genotype/variation: Lrp5+/+;	cell type: primary calvarial osteoblasts;	time point: day 7 of differentiation,ctrl
WT Uterus_saline_24h_rep1,ctrl
WTT 164 bleomycin treated,ctrl
Ero1-WT induced biological repB,pert
Patient: E;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
Akt1 wild type 3,ctrl
11389 Normal Uninflamed sigmoid colon,ctrl
brain_Down_syndrome_sampleid_jg1741,pert
"brain, brainstem: PB3_e1_le1",pert
cumulus_nonPCOS_Lean_rep1,ctrl
Cervical cancer_1798T,pert
PancreaticSample17-Tumor,pert
cell line: Reh;	transfection: IKKb(EE);	malignancy: non-Hodgkin lymphoma,pert
05SAGEA,pert
Human muscle (vastus laterlis),ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.7;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 53;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Hep G2 treated with Arsenic (III) oxide,pert
healthy control_4,ctrl
PGA-HMO-MObese-4aUA-s2,pert
Infected Jurkat cells (replicate 2),pert
Un-stimulated CD4+CD25+high regulatory T cells from PBMCs,ctrl
cell type: Lin- Sca-1+ c-Kit+ (LSK);	age: six weeks old;	genotype/variation: Ott1 wild type,ctrl
siRNA-2-PLASTIC,pert
"Patient 27, Atheroma plaque",pert
E100-/-vector-2,pert
SA_114,pert
Control subject 33_biological replicate 2,ctrl
"Acute Myeloid Leukemia, sample 9",pert
Day: 1; Drug: Heroin; Phase: Drug treatment; Replicate: 3,pert
"non-AD_FC, biological rep17",ctrl
STHdhQ111/Q111-A,pert
"Global gene expression of NASH patients, Normal control A486",ctrl
TN 5,ctrl
cell line: HL-60;	shRNA construct: GSK3A Construct 5,ctrl
695_383_8hr_repeat,pert
MOLM14-shGSK3B-Construct2-rep2,pert
8 week old EOM control rep 5,ctrl
EA_Case13_CD8,pert
GIST_KIT_7,pert
siPin1.exp1,pert
"Human LIMA artery from patient 4, treatment: paclitaxel-eluting stent",pert
"patient: 126;	current medication: None;	birth date: 4/4/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: FH of Crohn's disease, Symtom free at procedure;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
A HID B_B011,pert
condition: control;	tissue: decidous teeth dental pulp;	gender: female,ctrl
subject id: c1;	infection: control;	status: control;	tissue: whole blood,ctrl
Brain_Wild-type_MiceNoLT340,ctrl
CH1+(2),pert
strain: C57/Bl6;	gender: N/A;	age: 4 months;	weight: 25-30g;	tissue: whole trachea,ctrl
age: 6 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
Liver_untreated_wild type_rep1,ctrl
colon_CRC_1556,pert
Young 10,ctrl
cell line: KGN;	transfection: FOXL2 stealth RNAi,pert
retina,ctrl
"MCF7 cells stably transfected with XBP1, passage 6",pert
DBA/2J Vehicle liver sample batch 3,ctrl
"BMMC, WT, activated,",ctrl
"SPC-c-raf transgenic mice, 10 month old, female, tumor",pert
Huh7 cells_Mock Infected 18 hours_ rep2,ctrl
CBMNC.LPS-.3,ctrl
Septic shock;	gender: Male;	Non survivor;	organism: None,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 7.1;	colon weight (mg): 151;	colon ratio (mg/mm): 2.127;	myeloperoxidase activity (u/mg): 0.082;	tissue: colon;	treatment: 5% DSS,pert
"dy/dy dystrophic diaphragm 2, 8 week",pert
LJMJDW1,ctrl
cell type: Osteoblastic lineage cell;	strain: C57BL/6;	phenotype: Scl-tTA::TRE-BCR/ABL;	time point: 5-6 weeks post doxycylcin withdrawal,pert
460MM,pert
Mock infected murine liver-MO30k-(B)-6 hpi,ctrl
"Spleen, CD4+CD25hi Tregs, wildtype",ctrl
"Amniocytes, trisomy 21, 1575",pert
tissue: prostate;	normal/tumor: tumor,pert
MCL_IGHV_MUT (R1610),pert
"HEK001, siNCSTN",pert
Animal 9,ctrl
quadriceps_muscle_Akt1+/-_female_8wk_rep3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 70min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 248,pert
race: caucasian;	age (years): 43;	stage: IB;	grade: 3;	histology: endometrioid,pert
hNHEPS_control_0 h_rep2,ctrl
THRB wt + vehicle replicate 2,ctrl
control to Sample 3,ctrl
treatment: baseline;	gender: F;	age (y): 77;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 40;	maternal age: 40,pert
PGA-lv_48h_520,ctrl
"RWPE1 cells, vehicle, 6h, biological rep1",ctrl
"Acute Myeloid Leukemia, sample 40",pert
Nonirradiated-ATM-KO Replicative1,pert
P53_cKO_3,pert
Tet2 KO LSK rep1,pert
"Control Proximal, Small Intestine 1 21 days old",ctrl
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 3",pert
n4t0h,pert
HUH-nonsense-#3,ctrl
sciatic nerve,ctrl
11_0008C_Day1_21,ctrl
wild-type #1,ctrl
Gsk-3b-/- ESCs Rep2,pert
subject: 13B;	cohort: 13;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 16kb;	age (y): 42;	Sex: F;	batch: Batch_3,pert
Peripheral blood mononuclear cells (PBMC)-Patient CCa T1,pert
patient: 266;	current medication: Prednisolone ciproxin mesalazine fosomax Fe SO4;	birth date: 8/12/40;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/22/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 700;	esr: 0;	crp: 20;	hb: 93;	wcc: 17;	neutrophils: 16;	albumin: 23;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 0;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: COPD-Previous severe pneumonia;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: MCF10A;	treatment protocol: Vehicle,ctrl
"Empty vector control, 72 hrs, No Rosiglitazone (NONE_72_1)",ctrl
db/db 13-5,ctrl
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 24hr,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: control;	time: 24h;	gender: Female;	age: 5 months,ctrl
WT V6.5 ESCs on day 3,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A04",pert
cell line ATCC,pert
E9.5 KLF1-/- erythroid-5,pert
4160M patient’s mucosa,pert
Brain_Wild-type_MiceNoLT345,ctrl
EF1a-control_1,ctrl
LNCaP-abl_siHIPK2_2,pert
gender: female;	batch: 2;	age (years): 23;	patient id: Non_severe_4;	fev1 (% predicted): 84;	fvc (% predicted): 81;	medication: Salbutamol;	cell type: CD4+ T-cells,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 57 years,ctrl
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p27;	strain: E14,pert
11377 Normal Uninflamed ascending colon,ctrl
brain_DLPFC_bipolar C_mr404,ctrl
minor HCC9,pert
age	43;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.8;	hemoglobin (g/dl)	14;	platelet count (/nl)	311,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: no LPA (control),ctrl
"gender: Male;	age: 38;	post-mortem delay: 6h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 2 - Technical Replicate 2,pert
whole tissue section from case 1206,pert
LCH5ani,pert
colon_adenoma_1312,pert
stomach_1h_rep1,pert
THRA aI mutant + T3 replicate 2,pert
"219, MUSCLE, Before",ctrl
cell type: HeLa;	genotype/variation: Transfected with wild type Neuroserpin,ctrl
HF0526_U133P2,ctrl
180D0,pert
Sex: female;	Age at operation: 58 years;	Site: pelvis retroperitoneal;	Size in cm: 4x7x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: metastasis;	Previous radiation: no;	Previous chemotherapy: no,ctrl
06_ADL,pert
MEF cells from female  Oga knock out embryo (D12.5),pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 31;	maternal age: 28,pert
tissue: skin;	individual: Patient P8;	condition: ANL;	eczema severity: SCORAD: 0,pert
day: d00;	strain: C57BL/6;	genotype: KO;	experimental run: eX,pert
"Hunk WT, Mammary gland",ctrl
BALB/c d18 (bmsnmix4),pert
"Vehicle treated, DAY 4, biological rep.1, MV4-11 cells",ctrl
A549_siScramble_rep.2,ctrl
sample =Healthy1 treatment=Stimulated time=180 (min),ctrl
C13+(3),pert
Extract:LOX-1:113502;	Extract Description:GFP_Untreated_24hr:113502;	Quality: Classification:Medium;	Quality: Gradient Severity:0.12;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.46;	Quality: Background Mean Dev.:0.06;	Quality: Absent (%):60.04;	Quality: Absent (%) Dev.:1.38;	Quality: Scaling Factor:0.87;	Quality: Scaling Factor Dev.:2.22;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113502;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295843,ctrl
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/22,ctrl
"WT mouse skin treated once with acetone and collected 24 hr later, replicate 2",pert
17A;pretreatment;female;breast tumor,ctrl
tissue: white blood cells;	age: 10.37;	Sex: male,pert
endothelial_rep16,ctrl
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P5,pert
ACC Xenograft X6,pert
A673_CloneAsp14_Dox_0h_1,ctrl
Bulun 2-3h-,ctrl
11n,ctrl
RAW CstF-64 2,pert
"Immortalized MEFs WC, v-src expression retroviral vector infected, rep3",pert
esophageal squamous cell carcinoma from patient E1603,pert
"AG825-treated, Sham UV, Replicate E",pert
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Wild-type;	treatment: Imatinib (2uM for 16h),pert
U937_ROS_untreated_18h_rep1,ctrl
Normal subject 2,ctrl
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
amygdala no access to cocaine replicate 1,ctrl
murine neural crest,pert
"SPC-c-raf transgenic mice, 10 month old, male, tumor",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 58;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
colon_CRC_1377,pert
control6,ctrl
RTX3 T12,pert
SLE CD4 T cells 4,pert
"age at diagnosis: 47;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 0;	pgr: NA;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
control-4,pert
Silberg2 (11) 130701NE,ctrl
GFP Zfx wt 3,ctrl
Pancreatic Cancer PBMC Sample 3,pert
WT-Fibr2 5,ctrl
Panc0403 rep-2,pert
cell line: bj-fib_1: BJ (CRL-2522) fibroblasts were purchased from ATCC.,ctrl
siHic5_2_2h_1,pert
"Normal subject (45 year old caucasian female, SAK_1290231506)",ctrl
WT 2 mon replicate 2,ctrl
pediatric AML S29,pert
"Male, 34 years old, HIV infection of 9 years",pert
RNA from microdissected breast cancer cells from case 1419 labeled with Cy5,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 47, stage IIB, HPV 16",pert
brain_control_sampleid_mr276,ctrl
SZ6,pert
disease unaffected colon of a adult with ulcerative colitis (UC).,pert
Klf9WT_jejunum_PND30_4,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Liver",pert
"Lymphoblastoid cell lines derived from family 1727, member 1",pert
Individual_4177_PP_sample,pert
"hepatic gene expression at ""0 hr"", rep2",ctrl
Weight:High;	CFstatus:knockout;	Sex:Male,pert
MIC5,ctrl
tDEA005.CEL,pert
gender: female;	age (years): 60;	evolution time (years): 29;	disease extension: Pancolitis;	treatment: 5-ASA,pert
HF1185_U133P2,pert
1000uM H2O2 rep3,pert
PTEN25+_rep2,pert
tissue: Hippocampus;	age: 77;	Sex: M,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-sp1,pert
"metastasis: none;	Stage: 1;	tissue: normal, homogenized",ctrl
A2_C2_nasal_stem_cell_rep1,ctrl
TL3 LAMC2 KO 2,pert
FVB_8W_2_2,ctrl
Ulk1/2+/+ + IFNβ 2,ctrl
"Patient  H, lesion, 12 week",pert
MDS patient 157,pert
Mouse liver tissue,ctrl
10.5 Months Heart Control rep 2,ctrl
"Exp A, Animal #243, control (0mg/kg) D-Serine",ctrl
Control spleen - Biological Replicate 5 - Technical Replicate 1,ctrl
"ALL_NDS, K48 011409",ctrl
MCF-7 cell_DMSO_12hr_biological rep2,ctrl
BAL_20a_A1B1,pert
genetic modification:;	tissue: breast adenocarcinoma,pert
phenotype: control;	gender: male;	case_id: 366;	age: 69;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 16;	brain ph at time of freezing: 6.6;	labeling_batch: 2,ctrl
"primary mucosal tissue,  colon",ctrl
14-0002A_Day1_36,pert
systolic heart failure due to ischemic cardiomyopathy,pert
cell type: HUVEC;	treatment: RAF1 WT,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 3,pert
"General population, Male",ctrl
colon_0h_rep2,ctrl
strain: C57BL/6;	tissue: Skin;	cell type: keratinocyte;	gender: female;	age: E18.5;	genotype/variation: Control;	treatment: calcium,ctrl
"Cultured ovarian cancer cell line TYK-nu, Cisplatin treated",pert
H13_S_B2,pert
Tumor_18w_erlotinib2_DEN_138,pert
age: 66;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"JAG1 overexpressed CL1-0, biological rep2",pert
"Liver, wt control",ctrl
Brain,ctrl
healthy control H05,ctrl
T115 U133p2,pert
"heart, atrial tissue, baseline",ctrl
"Atm-/- 30 min post IR, B",ctrl
Testis WT 0h batch 2 [TeWTh00.13],ctrl
APOE_KO_DM_9W_1,ctrl
whole blood_101872,pert
wt-Gfp 4 weeks replicate 1,ctrl
mouse NB N1E-115 cell line,pert
wild-type MEF 2,ctrl
"ALL_NDS, K51 011509",ctrl
n5t7d,pert
osteoblast_5azatreated_rep1,pert
"MCF7, shRNA knockdown PDEF, biological rep1",pert
EB_6_8d_300_HCHO_Nasal_Rat230_2_CIIT05024,pert
"H1 hESCs, control",ctrl
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: liver",pert
104A,ctrl
NMRI_6h_Wy,pert
B12 - non-infected BALB/cByJ fibroblasts,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: post-UV,pert
midbrain_wild type_12 weeks_replicate 1,ctrl
BM CD34 CELLS,ctrl
CAST/EiJTCE liver sample batch 1,pert
AL Chip#28,pert
ErbB2 2,pert
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_4,pert
RAW 264.7 macrophage cell line,ctrl
Psoriasis-9 baseline,pert
cell line: HL-60;	replicate: Replicate2;	treatment: shLuciferase,ctrl
heart-wt-2,ctrl
476MM,pert
RS-final,pert
"peripheral ganglion, unknown: nicotine 1hr",pert
H4-II-E-C3_high_rep2,pert
age: 37;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Liver_WildType_1,ctrl
HCC_12N,ctrl
Liver_nash metformin_no.3,pert
PBMC from T cell LGL leukemia patient #111 (TLGL111),pert
CD11b+Gr1+ cell sample_4 (derived from wild type mouse),ctrl
monocytes,ctrl
"fatty (fa/fa), liver",ctrl
Embryonal carcinoma 0502,pert
17beta estradiol: 60 pM,pert
JIA PBMC Pre treatment A235_L221,ctrl
Subject 1 Post allergen challenge,pert
"Pancreas from adult WT mice, biological replicate 2",pert
PGA-RMM-6h-1aA-s2,pert
C2C12 myotubes 1000uM H2O2 rep3,pert
"affected status (disease state): control;	gender: female;	age-at-examination: 65;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension, hypercholesterolemia",ctrl
NB4 PROMYELOCYTIC CELLS,ctrl
"CBFb-SMMHC animal 2, replicate 3",ctrl
gender: Male;	age (y): 36;	tissue: prolactinoma,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 62, stage IIIB, HPV 45",pert
"C5_transgenic but unaltered, lung tissue",pert
endothelial_rep6,pert
MA_63,pert
HepG2 human hepatocellular carcinoma cell line,pert
V5-P213,ctrl
"shCDK19, normal growth, replicate 2",pert
Time:0 day; condition:LaminA ko;,pert
age: 68;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Substantia nigra PD rep14,pert
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
NM3 healthy control,ctrl
subset: HDAC2 siRNA subset;	cell line: HCC cell line Huh7;	treatment: HDAC2 siRNA,pert
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 64",pert
human esophageal squamous cell carcinoma cell line_KYSE220,pert
fibroblast_Normal_D133_Media_3,ctrl
"Quadriceps muscle, control mouse",ctrl
cell line: HCT116;	clone: 28;	genotype: Knockout,pert
strain: 131;	Disorder: normal;	Condition: no hydrocortisone,ctrl
subject: 2;	disease: TD;	muscle: GR;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
sal-PVH_1,ctrl
9161PBMC,pert
cell line: H1299;	agent: decitabine;	dose: 1 uM,pert
KO - 5 mo - repeat 5 - Cy3 - mAdbID:74141,pert
Pfeiffer BCL6siRNA 2,pert
WT White adipose tissue (WAT)_HFD_rep5,ctrl
Liver_Nrf2 KO_rep1.,pert
Prostate cancer cell line,pert
Panc1 rep-2,ctrl
Nerve_Control_Vehicle_703,ctrl
"3 uM EPZ004777 treated, DAY 4, biological rep.1, MV4-11 cells",pert
N51294,ctrl
Universal Human Reference RNA - Cy3,ctrl
hOB695_shRB1383_4hr_IR,pert
"WT mice, 6 weeks old",ctrl
LKO_092612,pert
PolyRF-,pert
MacularDegen-healthy-11aAv2-s2,ctrl
heart_QH2_14M_rep3,pert
transfected with FoxP1 siRNA_3,pert
"Crohn's Disease subject (33 year old caucasian male, SAK_1288174788)",pert
Empty vector control (RNAi 1B)_1of3,ctrl
Neonatal mouse ovaries cultured in Methoxychlor (50uM),pert
Ishikawa_HighDose_BPA_8h_rep2,pert
IMR-32,ctrl
MLL_PTD11,pert
Karyotype: normal;	Age: unknown;	Gender: unknown,ctrl
H_LS_Wk4,pert
KM_075T,pert
"acutely admitted, severely psychotic schizophrenia patient  A12",pert
"P50_C-DGCR8 KO cones, replicate 1 [array]",pert
"Patient  L, lesion, 1 week",pert
2-3 month old animal with brain-specific IκBα deletion ( IκBαfl/-;Nestin-Cre),pert
Treg cells WT replicate 2,ctrl
H1 hESCs,pert
FRD1 1,pert
cell line: H69;	treatment: TGX221,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID293,pert
"9837, control, skin fibroblasts",ctrl
FVB_MMTV_Wnt1_iFGFR1_2549_4L_ROSEN,pert
tissue: Biceps muscle;	patient: C.b.2;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 1y 11m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
T4,pert
MCF7 cyclin D1 siRNA Estradiol Rep2,pert
"cultured human airway smooth muscle, no treatment, replicate 4",ctrl
erStress_twins_AA_1725twin1_DMSO_4h,ctrl
"2 months, ipsilateral group, biological replicate 2",pert
"fibroblast, MFS subject 60FR rep 2",pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 46;	donor: 29;	disease state: Lesional,pert
S6_Sham_wildtype_8,ctrl
B6C3F1/JTCE liver sample batch 5,pert
CUTLL1 wash2h-CHX_rep1,pert
gender: male;	age (years): 20;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Human hepatoma cell line (HepG2), grown for 6 or 12 hours, and then total RNA harvested with Trizol and Qiagen Rneasy kit.",ctrl
"C57BL/6, Female, CF",pert
Aldosterone-producing adenoma (APA13),pert
"Distal and Proximal Large Intestine, 8week old mouse",pert
Primary hepatocytes isolated from BalbC mouse strain treated with DMSO for 6h,ctrl
E14.5_Mutant_Kidney_array1,pert
cell line ATCC,ctrl
stomach_1h_rep2,pert
Obese rat 1,pert
cerebellum_KO_1,pert
"gender: Female;	age: 94;	post-mortem delay: 9.5h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
gender: Male;	strain: C57BL/10;	genotype: WT;	tissue: Kidney;	surgery: Sham;	reperfusion time: 4hr,ctrl
GM9017,ctrl
459MM,pert
"brain, hippocampus: Wt #3405 Cort_e1_le1",ctrl
Age: 35;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
"BCL-3 vector, biological rep3",pert
Wild-type standard cage Rep5,ctrl
Series 3; Young; 3 Days after fracture,pert
mRNA of substantia nigra from saline-treated mouse,ctrl
Ileum,pert
Control subject 26_biological replicate 1,ctrl
"pt. HCL A treated with Vemurafenib 1000 nM for 48h, replicate2",pert
Control subject 95_biological replicate 1,ctrl
"depression, BA10-2",pert
"maternal exposure to vehicle, pitM",ctrl
11_0012C_Day1_24,ctrl
control8,ctrl
HA00-13A,pert
57SMOKEH,ctrl
"gender: Male;	age: 54;	post-mortem delay: 12h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
AL Chip#41,pert
3DKD_SerumStarved_rep1,pert
"650nM MLN4924 after 4hr, replicate 3",pert
A673_CloneAsp14_Dox_0h_2,ctrl
"ID:12-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Grape extract group, 6 months, patient number 11",ctrl
race: caucasian;	age (years): 51;	stage: IA;	grade: 1;	histology: endometrioid,pert
"650nM MLN4924 after 24hr, replicate 2",pert
"brain, frontal cortex: Sample49_e1_le1",pert
IM CD34+ Pool II,pert
"hepatic gene expression at ""6 hr"" (rep3)",pert
tracheal tissue,pert
RV64.10_CHF_day25_Slide47,pert
p53R2 attenuated,pert
"5mg/kg/day PFOA, Rep 4, Block 3, liver (high dose)",pert
ES_Suz12KO_rep2,pert
Sample Group: HD patient; Gender: female; Age: 50; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,pert
CON7,ctrl
LSK cells SRF KO 2,pert
60A;pretreatment;female;breast tumor,ctrl
NoKD_SerumStarved->1hrEGF_rep4,pert
Eed KO J1 ESCs on day 0 #2,pert
Tendon_non-lesional_rep2,ctrl
MDA-MB-231_siScramble_rep.1,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: D;	experimental sample name: PC9-R,pert
"MaF pre-iPSC9P2, Vc+, D6",pert
"U373-MAML1-dn, rep 1",pert
129/BSw het2 heart,pert
F/F.ES. rep2,ctrl
Fibroblasts_HealthyControl_1,ctrl
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_5,ctrl
PC-3 human prostate cancer cell line,pert
L425-PAX5+MAT_rep1,pert
MOLM14_shSYK_2_Replicate2,pert
Elf4 KO2 naive CD8 T cells,pert
FVB; No Treatment #6,ctrl
OC1-WT embryo 2,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A19",pert
cell type: mouse embryonic stem cells 3x passaged without feeder cells;	genotype: TRPM7-/-;	genetic background: C57BL/6,pert
6B,pert
"ES cell line, RNA 68",pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 2",ctrl
B6.IL10 48 air 2,pert
"H1299 treated with PBS buffer, 24hr",ctrl
NALT_sham_24h_rep3,ctrl
Wild-type mice rep1,ctrl
Cervical cancer_892T,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 56;	baseline tumor size (cm): 8x7;	patient id (to identify the 2 chips from the same patient): 16281659,pert
BMM_BalbC_time21h,pert
CD4DecTp1-4,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,pert
"Gastrocnemius, mdx, 2 months old",pert
Pancreatic Sample 29-Tumor,pert
Ls174T-pTER-β-catenin dox1,pert
ic patient 2,pert
INS-1 cell line #4a with induced HNF1b mutant A263insGG,pert
Psoriatic,pert
"Placebo treated, HIV-1 positive male, day 14 (3)",ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: DMSO for 72h,ctrl
Leptin treated mouse gallbladder 6,ctrl
WFS1 WT USHT_05_318_ko,pert
LOX1 Untreated 2hr 282295543,pert
"Pancreatic tumor cells, replicate 3",pert
mouse cerebellar granule cells wild type 4,ctrl
8_c,ctrl
M10KOepi_infect_0h_rep2,pert
"Strain: PolgD257A/D257A mice;	Gender: male;	Age: 9 month-old ;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",pert
Dot1l flox/flox day 5 after transduction with control,ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",pert
Bone-Marrow_MM_M896,pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#3,ctrl
"3mg/kg/day PFOA, Rep 4, Block 4, lung (low dose)",pert
Wt Mouse_cerebellum_Young_saline treatment_Replicate-2,ctrl
subject: 21U;	cohort: 21;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 63kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
"Control #6, Untreated",ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 2,pert
"MCF-7 cells, siGL3 treatment 72h, 10 nM E2 for 24h",ctrl
Control_Time_30_1,ctrl
"MUSCLE, PLC, Before",ctrl
anterior pituitary,ctrl
V5-P420,pert
siLRH-1_#2_rep_2,pert
Nonlesional Epithelium Atopic Dermatitis rep4,pert
E14.5 cKO 2,pert
Series 2; Older; 3 days,pert
negative control inhibitor (NTC1)_24-10,ctrl
duration of untreated disease in month:6.6;	age at onset:6.1,pert
Subject #8019-8hr Postinfection,pert
"Total RNA purchased from ADMET Technologies (Durham, NC), extracted from healthy liver tissue.",ctrl
Cervical carcinoma,pert
siGL3Veh 2,ctrl
wildtype HUES6 3,ctrl
pancreatic cancer cell line MiaPaCa2 stabley transfected with AGR2 overexpressing vector pCEP4 -AGR2,pert
"Control, replicate 4",ctrl
Skin biopsy from upper nates taken 48 hours after exposure to 5% nickel sulfate,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 3",pert
WT osteoclasts treated 1,pert
Angiopoietin-1(confluent)-1,pert
01N14_PolyRF-,pert
KN-smoke-med-5 month-R2,pert
GB 6 NTB +LPA,pert
"Cell type: neuronal, age:32, gender:male, diagnostic group: control, PMI:13h",ctrl
"age at diagnosis: 37;	diagnosis: Adenocarcinoma of breast, ductal, medullary features;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 51;	dfs-event: 0;	distant metastasis: 0",pert
FTO2_D4_ni,ctrl
Cell line MCF-7_c-myc KD_expt2,pert
tissue: brain;	genotype: WT mix background B;	age: P14,ctrl
WT P10 replicate 4,ctrl
P0 Quadriceps Klhl40 WT 1,ctrl
patient: 460A;	disease state: LGSC;	component: Invasive,pert
11P-M4,pert
cell line: rtTA-Dmrt5;	differentiation: 9 days;	treatment: -Dox,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 1,ctrl
Gastric_cancer_patient_28,pert
"20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
brain_DLPFC_bipolar C_mr532,pert
PancreaticSample4-Tumor,pert
GIST_PDGFRA_4,pert
"Wild type fibroblasts, biological rep3",ctrl
"Control 11, NC11",ctrl
"LCL GM19238, Kd NFKB2, 72hrs",pert
siRNA-2-PLASTIC,ctrl
HTB58_controlsiRNA_2,ctrl
OSCE-9T,pert
Normal_Kidney,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: undifferentiated,ctrl
"S1P3-KO-hippocampus, biological rep4 (female)",pert
"LNCaP cells, treated with EtOH, biological rep 1",ctrl
pancreas,pert
patient: 51722;	sample: tumor,pert
Sirt1 siRNA control 2,ctrl
HepG2_Hg rep1,pert
mutant Ndel ko/cko,pert
strain: C57BL/6;	genotype/variation: RORasg/sg;	gender: male;	age: 5 Month old;	tissue: Liver;	diet: 35% Fat Diet (High Fat Diet; HFD),pert
Wt MEF cycling cells,ctrl
PPAR WT_ctr_53,ctrl
cerebellum_Pink1 knockout_12 weeks_replicate 3,pert
Low_M_2,pert
46B,pert
RNA from microdissected breast cancer cells from case 317 labeled with Cy5,pert
cell type: Primary hepatocytes;	donor: 4;	agent: control;	time: 6h;	gender: Female;	age: 54 years old,ctrl
V5-P347,pert
ILD_2,pert
A HID I_B044,pert
F-IIP(NSIP)2_Cy3,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 21;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Bronchial Epithelial Cells MMA biological 1708X,pert
"Peripheral blood, patient without recurrent events [N43]",pert
TREx_Flp_FTO_siRNA_1,pert
C57BL10 EDL sample 2,ctrl
biopsy of Barrett's esophagus from the same patient as a matched normal esophagus biposy,pert
V5-P575,pert
siEGR4 (48 hr) _1,pert
homozygous_TGFb_4hr_1,pert
"115, MUSCLE, After",pert
E9_Embryo_Wild Type_2,ctrl
ILD Study Number 545,pert
"Patient #8, Untreated",pert
A61 NES 142Q TG4	F5/1	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
disease state: paediatric glioblastoma;	age: NA;	gender: NA;	h3.3_status: wt,ctrl
"human failing LV myocardium, Ischemic24",pert
Muscle PCOS pioglitazon 251,ctrl
"Wild-type-neocortex, biological rep7 (female)",ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: phenobarbitol,pert
A549_Control_rep2,ctrl
"strain: C57BL/6;	tissue: heart, left ventricle;	gender: male;	genotype/variation: Hsp22 WT;	stress: control",ctrl
colon_Runx1-KO_Cy3_15514,pert
tissue: skin;	individual: Patient P7;	condition: ANL;	eczema severity: SCORAD: 0,pert
WT - Cre Control - 5 mo - repeat 5 - Cy5 - mAdbID:74105,ctrl
"brain, frontal cortex: Sample60_e1_le1",ctrl
LJMJDW18,pert
DUSP1+/+ control replicate 2,ctrl
EB_0_5d_61_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
Strain: Btk KO/CBA were created by back-crossing Btk KO/SW129 mice on CBA background strain for 9 generations,pert
WT-sham-1 day-R3,ctrl
"ES cells: E14 (129P2/OlaHsd background),;	Genotype: Wild (Phgdh+/+), C57BL/6J background,;	Gestation: 13.5 days,;	Tissue: head",ctrl
LT 342 +/T untreated,ctrl
Control Day14 (460L),ctrl
Individual_5093_NN_sample,ctrl
PGA_MI_nilv_4h_390,pert
DNGM-14,pert
adenosquamous carcinoma 001,pert
"8B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"Mouse LV, akt2-/- 1",pert
patient: 40875;	sample: tumor,pert
V5-P599,pert
age: 18 month postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 208,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day1,pert
t08,pert
gender: male;	individual: patient 2;	treatment: paclitaxel-eluting stent,pert
Fog2flox/delta; no Cre biological replicate 1,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 05/07/06;	# cells: 60;	Sex: male;	region: M1;	age: 45;	genotype: Y/X;G42/-,ctrl
T40875,pert
Calreticulin knockout of mouse embryonic stem cell line,pert
LRRK2 (G2019S) homozygous fibroblast sample 1,pert
"male,23,Caucasian",pert
Muscle JDM (YJD-JDM-1UA-s2),pert
A2780-(1),ctrl
"E2A CLP LY6D-, biological rep1",pert
"BMMCs from NTAL WT, NTAL shRNA infected, nonactivated, biological rep3",pert
YFP-pos GMP Dicer het rep1,pert
"Postnatal day 11 Cerebellum, wildtype",ctrl
E14-99+/-vector-2,pert
FVB_24h_DMSO,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 62 years,ctrl
01_PAH,pert
Monocytes from buffy coat preparation,ctrl
"129/B6 background, 6-10 weeks",ctrl
MDS41,pert
Post Transduction:12 hr; treatment:Mut;,pert
"1mg/kg/day PFOA, Rep 1, Block 2, liver (low dose)",pert
MEF E2F4 KO 4-rep2,pert
untreated AML 14 blasts,ctrl
siNS_2h_2,ctrl
"E12.5 Ret-deficient embryonic kidney, biological rep3",pert
MCF7 - Control_3,ctrl
gender: Male;	age: 82;	post-mortem delay: 5h;	ph: 6.2,pert
Panc1005 rep-1,pert
LT 344 +/T untreated,ctrl
cDNA scc 07,pert
V5-P502,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 3;	psoriasis duration: 3.8507871321013;	age of psoriasis onset: 30,pert
"Histidine decarboxylase null myeloid-derived suppressor cell from bone marrow, rep2",pert
Mouse E10.5 urogenital epithelium -/- #1,pert
"Exp A, Animal #248, 500mg/kg D-Serine",pert
Skin biopsy from upper nates taken 96 hours after exposure to 5% nickel sulfate,pert
high grade serous carcinoma_patient 1,pert
Sex: female;	genotype: sst +/+;	tissue: liver;	genetic background: C57BL/6,ctrl
batch: A;	knock-in: VEC;	cell line: MycCap prostate cancer cells,ctrl
MCI-002,pert
subject: 6;	disease: TD;	muscle: ST;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Ebs at Day2.5 were treated with SB431542 for 2 h,pert
tissue: Temporal cortex;	age: 87;	Sex: F,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID73,ctrl
HeTH-4 +DOX rep-2,pert
"Endometrium, postmenopausal, estradiol, 8",pert
whole tissue section from case 843,pert
11411 UC Inflamed sigmoid colon,pert
12478 UC Inflamed descending colon,pert
"liver, knock out",ctrl
midbrain_Pink1 knockout_12 weeks_replicate 1,pert
asthma_OVA24h_3,pert
cardiomyocyte SRF-null 2,pert
"Aorta, saline 7d, #4",ctrl
KO - knock-out Treated - 24 hrs - repeat 1 - Cy3 - mAdbID:61776,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 265,pert
KO_cycling_rep1,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: control hairpins targeting luciferase,ctrl
"E18.5 ERRg +/+ heart, biological rep 3",ctrl
HC-WT-15A,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_8_38_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Subject #8015-2d Postinfection,ctrl
sirt7 allele: wild-type,ctrl
P14 - nudelkoMix/+ 2,pert
"Aorta, Ang II 14d, #2",pert
Peripheral blood mononuclear cells;	TTF=120min;	Race=White;	Sex=Male,pert
Dysf +/+ control TA mouse muscle,ctrl
"PCB77 treated HepG2 cells at T0.5, biological replicate 1",pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with 100 nM T3 for 6h,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 2h,ctrl
"Crohn's Disease subject (62 year old caucasian female, SAK_1287995940)",pert
"vastus lateralis biopsy, 56 year-old healthy trained male (#56)",ctrl
Heart_WT_01,ctrl
"SWR/J Acute morphine treated, biological replicate 3",pert
Individual_4334_PP_sample,pert
Primary hepatocytes isolated from Donor 4 treated with DMSO for 6h,ctrl
A549_Nrf2 siRNA_biological rep3,pert
siNonTarget replicate1,ctrl
C_Ctrl_1,ctrl
"mouse aorta cross strain comparison, C3H_T00_NC_03",ctrl
E9.5 FVB/N erythroid cells-4,ctrl
HCT116 colon cancer cells,ctrl
"WT CD8 memory T cells, biological rep1",ctrl
Against CDK8-2 rep1,pert
iFGFR2 mammary gland 8 hrs AP20187,pert
EOM 28 Day mdx rep 1,pert
Mening UNSTIM WB SW 12b,ctrl
"SS gland, early, patient 20, batch 2",pert
C33KD2_with doxycycline_3,pert
"Mouse organ of Corti from cochlea, basal half, littermate control",ctrl
"Autism no regression, Female",pert
KN-smoke-high-5 month+1d-R3,pert
MCF7/c p.6,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep1",pert
Human skin biopsy from psoriatic patient (uninvolved skin),ctrl
Control subject 95_biological replicate 2,ctrl
ccRCC tumor of patient 26,ctrl
Biceps_Control_5,ctrl
A HID B_B014,pert
Rybp#15 (OHT+)_4d,pert
DU145/MYB siRNA #1,pert
patient: 40741;	sample: normal,ctrl
"SDC1-silenced group, replicate 3",pert
control participant P318 (human CD3 positive T cells),ctrl
KO 2 Quadriceps,pert
jzo034-rp1-v5_u74av2-met,pert
"72 hour-treated wild-type NB4, biological rep1",ctrl
Heart left ventricle WT-PBS replicate 2,ctrl
strain: C57Bl/6;	cell type: Regulatory T-cells CD4+CD25+;	genotype/variation: Foxp3cre control,ctrl
Anti-mir-210 replicate 1,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 3,pert
tissue: white blood cells;	age: 8.38;	Sex: male,pert
striatum SNCA knockout 6 month replicate 3,pert
"Control shRNA cells passage 7, rep 1",ctrl
treatment: control esiRNA;	cell line: HeLa,ctrl
age: 35;	sex: F;	disease status: Marfan subject;	Filter number: 33;	Usage number: 4;	Exposures: 2,pert
disease affected colon of an adult with Crohn's disease (CD). Replicate-1,pert
cell line: Huh7.5.1;	tissue: liver;	agent: PBS,ctrl
disease state: endometrioma;	patient: M4,pert
renal_vesicle_wild_type_1,ctrl
01N4H_PolyRF-,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 1;	dfs-event: 1;	distant metastasis: 1",pert
ILD_17,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 2",ctrl
Control treated cells Rep2,ctrl
2008 ovarian cancer cells,ctrl
cell line: MCF7 breast cancer cells;	genotype/variation: estrogen receptor alpha (ESR1) knockdown,pert
LY2 SRC1-siRNA tamoxifen treated rep3,pert
"control + L-Arg colon tissue, biological rep2",ctrl
"BOEC, normal 24",ctrl
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 2, clone 2",pert
SCD1 -/- liver rep4,pert
patient: 40899;	sample: normal,ctrl
ASO T00278949,pert
Insig1 ∆/∆ /Insig2 -/- InsigKO_E1,pert
19 saline,ctrl
Arid3a OE-Pool replicate 2,pert
Cal27_CETU2,pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P55;	clone: C11,ctrl
Dendritic cells generated from blood of donor 2,ctrl
MO32_11,pert
healthy control H19,ctrl
type 2 diabetes subject 06,pert
O_LS_Wk12,pert
H4-II-E-C3_high_rep4,pert
"Sfrp5 KO HFD 8 weeks, biological rep1",pert
Normal Uninflamed ascending colon,ctrl
MGHU3 Cells_TAK1 siRNA + PD173074_Biological Replicate 1,pert
type 2 diabetes subject 09,pert
iPSC derived from healthy control dermal fibroblast,ctrl
"shRNA-PGC1a #65, rep-1",pert
age: 21 month postnatal;	tissue: striatum;	genotype: SNCA knockout,pert
"Patient B, uninvolved skin",ctrl
PGA-HMO-Obese-1aUA-s2,pert
BAL_47c_A0B1,ctrl
Control (C88),ctrl
"fibroblast, MFS subject GDO1051 rep 3",pert
Normal Human Sperm,ctrl
RNA from whole tissue section of case 140 labeled with Cy5,pert
cell line: SUDHL-1 Cells derived from the a patient with Anaplastic Large Cell Lymphoma;	agent: control,ctrl
"NF-YB KD ES cells 96hr, replicate 3",pert
"SW480, control RNAi, luciferase",ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 5",pert
Phytohemagglutinin-activated PBMCs from normal control subject K (KAcPBMC),ctrl
"Mouse Embryonice Stem Cells, control si RNA, Rep2",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 93;	Sex: male;	region: M1;	age: 39;	genotype: Y/Mecp2-;YFPH/-,pert
"WT MEFs, biological rep2",ctrl
Trained diabetic 5 weeks DT5,pert
5407-lcm,pert
age: 28dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
N30308,ctrl
E12 distal retina progenitors_control_rep 1,ctrl
KO - knock-out Treated - 24 hrs - repeat 3 - Cy3 - mAdbID:54822,pert
CH2222,ctrl
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Spare nerve injury;	experimetal group: Adult Ipsilateral,pert
E10.5_otic_vesicle_mut_replicate1,pert
triplicate 3 of S. aureus infected HepG2 nt cells,ctrl
Control 874D,ctrl
array 4 plus E,ctrl
"cochlea at P3, wt, biological rep 3",ctrl
Aldosterone-producing adenoma (APA19),pert
Retina,pert
T51292,pert
Control for EGF 12h replicate 3,ctrl
White adipose tissue in Fsp27 knockout mice (rep2),pert
"vertebral bone, WT",ctrl
HA96-37A,pert
"strain: C57BL6/10J;	genotype: Cmah KO, mdx;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle",pert
scram_hi_7,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_Con_HG-U133A_2_YCHSUP501,ctrl
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
Kidney_50 mg/kg VCM ip_mouse #069,pert
KU_28T,pert
"Acute Myeloid Leukemia, sample 26",pert
T129 U133p2,pert
WA09 human embryonic stem cells,pert
HL60-shGSK3B-Construct1-rep1,pert
"LCL GM19238, Kd RXRA, 72hrs",pert
MacularDegen-healthy-11bAv2-s2,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, U0126-treated",pert
12 hr KLF4 Time Course Induced,pert
Carboplatin 24 hours set 2,pert
C26_skeletal 2,pert
normal mammary tissue,pert
THRA 6a mutant + vehicle replicate 2,pert
Tsc1-deficient CD4 naïve cells KAI273,pert
HF0201_U133P2,ctrl
cell line: MOLM-14;	replicate: Replicate2;	treatment: shSYK_2,pert
mouse_islets_VhlhKO_01,pert
Normal PBMC_sample 4,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: not treated,ctrl
PGC1-a KO striatum,pert
CLL15-CD8,pert
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: control (vehicle);	dose: n/a,ctrl
T16,pert
untreated AML 9 blasts,ctrl
Basal IFE cells isolated from 1 year old KO mice,pert
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"metastasis: none;	Stage: 3b;	tissue: normal, homogenized",ctrl
GM19238_Kd_STAT2_3,pert
Whole pancreas,pert
EB_6_6h_283_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
CRC_nodrug_M4868,ctrl
NOD2wt_0h_MDP_biological replicate 3,ctrl
"C57BL/6J female number 3, 2 months old, whole ear tissue, untreated control ear",ctrl
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-GFP control,pert
GIST_KIT_5,pert
MCL_IGHV_MUT (R1302),pert
Interleukin_6_2,pert
heart of mouse subjected 2 week to chronic intermittent hypoxia (2A),pert
HL60_shSYK_2_Replicate1,pert
female JAK2 KO liver sample 102,pert
erStress_twins_AA_1720twin2_DMSO_4h,ctrl
Liver GPR120KO ND #719,pert
"human failing LV myocardium, Ischemic54",pert
Liver_Wild Type+Quercetin_3,pert
sample =XCGD6 treatment=Control time=0 (min),pert
Kidney_KO_baseline_rep2,pert
"PPARg2 expression construct, 2 hrs, No Rosiglitazone (PPAR_2_1)",pert
aorta of wildtype mice,ctrl
B2KO; No Treatment #1,pert
Grid2 deleted mouse 2,pert
t19,pert
Gender: Female;	AJCC Stage: IV;	Pathological T: 4;	Pathological N: 0;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
brain_QH2_6M_rep1,pert
Gastric_cancer_patient_8_dye_swap,ctrl
HepG2_Cr rep2,pert
Kidney_400 mg/kg VCM iv_mouse #048,pert
Muscle PCOS 10,pert
HLA risk: High;	Height: 183 cm;	Weight: 93.5 kg;	BMI: 27.8;	Age: 57.76 years;	Gender: Male;	Race: White;	Glucose: 104 mg/dl;	HbA1c: NA,ctrl
OCT4 shRNA_2 Days knockdown_rep2,pert
Mening SWB WB SW 12a,pert
MA_303,pert
ATF2 KO-1,pert
cell type: HUVEC;	treatment: empty lentiviral vector pLVX-IRES-puro,ctrl
The Identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12. Sample A,pert
"dy/dy dystrophic diaphragm 4, 8 week",pert
patient: 51572;	sample: tumor,pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; 3h EGF,pert
HeLa_TP082505-30_HG-U133A_2_IMFGN0023,ctrl
SC263_CETU3,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 30 min after intravenous endotoxin challenge""",pert
Aortas isolated from atherosclerotic APOE-deficient mice,ctrl
"42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.644;	OD280: 1.383;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 68;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
RNA from HCC_17T,pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 12 hour",pert
HCC007T,pert
subject: 09A;	cohort: 9;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 25kb;	age (y): 31;	Sex: F;	batch: Batch_2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 52 yr;	population: white;	dsm-iv: 295.1;	age of onset: 28 yr,pert
PBMC CV T0,ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: tamoxifen for 120 min,pert
WT Brain 67d Mouse1,ctrl
02_C57_KO,pert
WT_cerebellum at P7,ctrl
AKR/J Vehicle liver sample batch 5,ctrl
SC263_PBS1,ctrl
El-Ashry 001.CEL,ctrl
"Healthy control, biological rep2",ctrl
HepG2 cells control 4h,ctrl
224 Day 3 siSC transfected biological rep3,ctrl
"strain: C57BL/Ka-CD45.2:Thy-1.1;	genotype: wild-type;	tissue: bone marrow from femoral and tibial bones;	cell type: LSK (Lin-, Sca-1+, c-Kit+) cells",ctrl
lesion_midUV_patient6,pert
chip number: 12;	transfection plate: 4;	target gene: IRF3;	kd level: 0.91;	rin: 9.5;	transfection date: 2011-10-17,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 2;	gender: male,ctrl
"Biceps, control, cohort 09, subject 09U",ctrl
Ishikawa_VeryHighDose_BPA_8h_rep4,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous carcinoma (IPMC),pert
Neural progenitor cells,pert
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 50 mg/kg,pert
PGA-MAH-C3H_PBS24h-3aA-s2,ctrl
NET1 knockdown AGS cells treated with 10 microM LPA for 4 hr,pert
WKY20-4,ctrl
age_years: 50;	sex: M;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"Fibroblasts from UIP histology lung tissue, IPF-19",pert
QK-knockdown U87 transduced with miR-20a,pert
genotype: Pxr knockout;	Sex: Male;	tissue: Liver;	compound: Vehicle;	route: IP;	dose: 0 mg/kg,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 5,pert
MEF,pert
tissue: retina;	age: postnatal day 8;	genotype: rd1,pert
Mut-/- rep2,pert
HL60-shControl-rep2,pert
"acutely admitted, severely psychotic schizophrenia patient  A05",pert
disease status: CML chronic phase (CP);	cell source: leukapheresis products (LP);	cell type: CD34+ mononuclear cells,pert
"schizophrenia, BA46-39",pert
siEGFP (24 hr) _1,ctrl
"LKR13, knockdown of Wt1 by shRNA",pert
"diet: AIN-76A;	sodium arsenite added to drinking water: 10 ppb, 5wk",pert
reduction mammoplasty patient 334,ctrl
NE-rep1,ctrl
Control subject 29_biological replicate 1,ctrl
C final PC3 AA 2hr,pert
"Normal diaphragm 1, 8 week",ctrl
SIRT4 WT liver_7591,ctrl
Strain: 129Sv/C57BL/6,pert
Wt1f/f MEFs were infected with adenoviral Cre to knockout Wt1,pert
CAST/EiJ Vehicle liver sample batch 4,ctrl
Parkinson's disease sample x019,pert
chondrocyte_control_rep3,ctrl
Mouse wt palatal shelf tissue at E14.5,ctrl
liver_QH2_14M_rep1,pert
"A673 treated with Puromycin for 5 days with concentration of 0.09 uM (EC50), biological rep2",pert
"brain, hippocampus: KA-1h-P15-II_e1_le1",pert
2008 cells_rep1,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: n/a;	maternal age: n/a,ctrl
cell line: HCC1954 cells;	subtype: HER2 Positive;	treatment type: TBK1 inhibitor II;	treatment time: 3 Days,pert
Pancreatic Sample 24-Normal,ctrl
siSox2 replicate1,pert
treatment: control;	cell line: CuFi;	genotype: Cystic Fibrosis deltaF508 mutation,ctrl
Wtepi_infect_0h_rep3,ctrl
SynovAcAr_022EACIE_151.txt,pert
Phan_004_WT.bleomycin rep1,ctrl
WM35 cell line,pert
"peripheral white blood cells, matched control",ctrl
Murine liver,pert
cell line: HEK293;	sirna: control;	condition: sparse,ctrl
"Patient C, lesional skin",pert
"Normal skin from lmq_control mouse, biological replicate 3",ctrl
P4 Patient None,pert
Gadd45a-/-_MEF_rep1,pert
BxPC3-WT rep 6,ctrl
strain: C57BL/6;	tissue: colon;	genotype: PPAR g fl/fl; Lysozyme M cre+;	phenotype: PPAR gamma deficient;	treatment: dextran sodium sulfate (DSS),pert
isoflurane 05,pert
Extract:LOX-1:113401;	Extract Description:GFP_Untreated_12hr:113401;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.56;	Quality: Background Mean Dev.:0.03;	Quality: Absent (%):57.6;	Quality: Absent (%) Dev.:0.5;	Quality: Scaling Factor:0.61;	Quality: Scaling Factor Dev.:0;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113401;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295713,ctrl
"Aorta, Ang II 7d, #2",pert
EB_0_6_352_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
LmnaG609G/G609G KI #1. 461,pert
Whole adrenal RNA from WT mouse #145 at 0h,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 54,pert
K562 cells control replicate 2,ctrl
24h Lipofection GAPDH siRNA (SAMPLE 12),pert
KO-Nrf2-Female-2,pert
GB 9 65A NO LPA,pert
cerebellum,pert
"brain, hippocampus: Wt #3396 Cort_e1_le1",ctrl
"control endometrium, patient 4",ctrl
iFGFR1 mammary gland 8 hrs AP20187,pert
pt. HCL F treated with DMSO for 48h,ctrl
Gene expression profiling of normal cortex of patient T166,ctrl
strain: C57BL/6;	cell type: bone marrow-derived mast cells;	treatment: interleukin 3,ctrl
"brain, hippocampus: Ctr-6h-P15-III_e1_le1",ctrl
cortex_WT_rep3,ctrl
CD4+_Tcells_non_severe_asthmatic_4,pert
siFOXM1Veh24h rep2,pert
iFGFR1 mammary gland 24 hrs AP20187,pert
Panc-1 Pancreatic Cancer Cells,ctrl
Mouse old heart w/ a-tocopherol aT-Ht-3,pert
cKO_P55,pert
"NF-YC KD ES cells 96hr, replicate 1",pert
"Pb-Cre+;PtenL/W;K-rasG12D/W, biological rep1",ctrl
"Normal subject (44 year old caucasian female, SAK_1279948644)",ctrl
Chemically-induced skin papillomas in K14CREER:SOX2fl/fl mice treated with tamoxifen for 1 week,pert
1% dmso batch 2,ctrl
placenta,pert
c-Kit + MA9 AML Zfx fl,ctrl
Txnip deficient tumor 24 months sample 2,pert
KN-smoke-low-5 month+1d-R1,pert
MCF10A cells in 3-D culture,pert
"patient 8, baseline",ctrl
HepG2_Vehicle_24hr_prep4,ctrl
age: 36;	gender: female;	ejection fraction: 68;	left ventricular end diastolic diameter: 47;	inflammation/PVB19: negative,ctrl
human esophageal squamous cell carcinoma cell line_KYSE150,pert
"Gender: male;	Age: 74;	Source: skin, left ear",pert
KO STR Veh 28,pert
1uM H2O2,pert
cell line: PC-3;	transfection: pre-miR-221,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: D835 mutation,pert
"Human breast, pre AFI treatment",ctrl
strain: C57BL/6J;	cell type: bone marrow derived macrophage,ctrl
healthy myeloid cells 1,ctrl
"Control Distal, Small Intestine 2 17 days old",ctrl
PFC FVB/N control 4,ctrl
"vehicle, biological rep4",ctrl
MF-36,pert
Control [G1],ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 8week,pert
"Cervical cancer, adenocarcinoma, microdissected, age 46, stage IB2, HPV 16",pert
Normal skin from Tgfbeta_control mouse,ctrl
tissue: freshly isolated human monocyte;	gender:female; age: 19 yr; weight: 65 kg,ctrl
PBMCs_Control_17 [IS],ctrl
DW91.2_Tg_M,pert
background strain: C57Bl6;	genotype: Polgtm1Lrsn-/-;	tissue: Mouse bone marrow;	age: 32 weeks;	gender: female,pert
siERK2Veh4h_2650,ctrl
patient: 23;	disease state: hypertension;	tissue: Atheroma plaque,pert
Cont subject 03,ctrl
Bronchial Epithelial Cells SA biological 1997E,pert
"anN1 P9 hair follicle, biological rep2",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_24_35_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
Rat fatty liver4,pert
"FOXP3, mut, REP2, 72h",pert
b105,ctrl
H295R_Group_C_Dose_100_TIMEPT1_031,pert
S017_Scz_F_85,pert
Strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E14.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
Atm+/+ untreated C,ctrl
"TNFa-OMe siRNA-B, replicate 4",pert
EP32_adipose_pcos,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 33,pert
HEK293_A263insGG_#5_uninduced,ctrl
murine colon epithelium,pert
AJCBDL,pert
1uM H2O2 rep 3,pert
"LCL GM19238, Kd ZBTB38, 72hrs",pert
NSC13,pert
"Strain: B6CF1 x C57BL/6, Tissue: Bone marrow, Age: 7 weeks",pert
"RWPE1 cells, vehicle, 24h, biological rep1",ctrl
HF0914_U133P2,pert
01LMJ: new onset sJIA,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 5",ctrl
V5-P366,pert
"MaF pre-iPSC9P2, Vc+, D3",pert
"normal nasopharyngeal tissue, specimen N3",ctrl
wt Ang4,pert
cadmium_16hr_rep1,pert
Mc3T3 cells_treated with AA_5 days,pert
A_AN08873_T,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 11",pert
"Frontal cerebrocortex, permethrin (10 mg/kg), 6 hours",pert
"Distal and Proximal Large Intestine, 8week old Winnie mouse 1",pert
ethnic background: Caucasian;	gender: male;	age: 45-65 years;	tissue: vastus lateralis muscle,ctrl
Lineagelow Sca1+cKit high Cells,pert
mock-3,ctrl
Clint-Dhh-1-011411,pert
EA_Case18_CD4,pert
Mtb infected-63d-2,ctrl
"Mbd3 KD, replicate B",pert
strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: corn oil,pert
4032-1 E2F3 Heterozygous,pert
Teratoma 1282,pert
Individual_3586_PP_sample,pert
phenotype: alcoholic;	gender: male;	case_id: 313;	age: 70;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 62;	brain ph at time of freezing: 6.82;	labeling_batch: 2,pert
"brain, cerebellum, Purkinje cells, Mecp2 null",pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep4,pert
"Donor 1, Ebola infected 1hr",pert
CUTLL1 wash2h-CHX_rep3,pert
571.KO,pert
e_M75,pert
mammary epithelial cells,pert
Bone-Marrow_MM_M1062,pert
strain: C57BL/6;	genotype: Ppif-/- (global gene knockout);	tissue: heart;	age: 8 weeks,pert
H2_SS11_01Nov07,pert
"Setd2 knockout mESCs, biological rep1",pert
01-0043A_Day1_2,pert
individual: patient8;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
0949-01-A,pert
06R006 Control,ctrl
"male,23,Caucasian",ctrl
"human nonfailing LV myocardium, NonFailing6",ctrl
coc-8,pert
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 6",ctrl
wild-type mouse 2,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 218,pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14533;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
Normal mucosa 16,ctrl
"Lens epithelium, WT, #6L",ctrl
CLL7-CD8,pert
siEGR4 (48 hr) _2,pert
27 weeks male,ctrl
13A;pretreatment;female;breast tumor; responder,ctrl
DMN-NF1Hippo15d-2dAv2-s2,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 2;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
21C-M4-ND,ctrl
humanMBC_ctrl overexpression_1,ctrl
liver_Pink1 knockout_12 weeks_replicate_3,pert
"Frontal cerebrocortex, permethrin (1 mg/kg), 6 hours",pert
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 6 hours,ctrl
"seminoma specimen, pT1, patient age: 56y; W02 151",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.808;	OD280: 0.956;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 77;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
B cells -  wildtype mice - influenza-infected,ctrl
04_NML,ctrl
patient: 34208;	disease state: LGSC;	component: Invasive,pert
"Foxd3 conditional knockout cells treated with Tamoxifen, biological rep1",pert
strain: BALB/c;	gender: female;	type: TSG-6 knockout;	treatment: none,pert
"eye, retina: Control 1_le1",ctrl
non-treated CCRPKO_rep-3,pert
"Rat_Tracheal_Dex_2hr, rep1",pert
P14 - nudelko/+ 2,pert
primary dermal fibroblasts untreated,ctrl
db/m 6-3,pert
PGA-HMO-Obese-3aUA-s2,pert
Low weight gainer KOZAK2_ABI_HYP_L3,ctrl
untreated_2,ctrl
HES2_Mir122Mut_rep2,ctrl
SLE7-TC,pert
"wildtype white adipose tissue, biological rep 3",ctrl
SRF Mut. IgM+IgD+ (GBF0552),pert
empty retroviral vector-infected immortalized mouse embryonic fibroblasts,ctrl
"Immortalized MEFs WC, v-src expression retroviral vector infected, rep2",pert
Breast cancer,ctrl
"Control group, replicate 3 [GY_Con3]",ctrl
Control_2h_rep1,ctrl
siCONTROL no DNA Damage experiment 2,ctrl
DMSO1_6H,ctrl
Adipose-5 month-Myc heterozygous-technical replicate 3,pert
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Lymph node B cell;	Noninfected;		,ctrl
DRG_DMSO_0.1%_Rep2,ctrl
ILD Study Number 1274,pert
WT fed  High Fat Diet,ctrl
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_5,pert
heart_Q10_6M_rep1,pert
"P50_wt cones, replicate 2 [array]",ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 4x1h exposure per day",pert
Btk KO1,pert
"ID:13-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue: gallbladder,pert
WT-EtOH-1 (DFW),pert
microdissected ovarian tumor,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-C104A/C131A cells, expression induced with doxycycline for 24 h",pert
sample =XCGD3 treatment=Control time=0 (min),pert
strain: HNF4LoxP/LoxP AlfpCre;	age: E18.5;	tissue: Fetal Liver,pert
Ezh2-Cre2,pert
Normal mucosa 6,ctrl
Untreated diabetic-4,ctrl
50SageA,pert
MDA_PR_Paclitaxel_4,pert
Human glioblastoma cell line U87MG treated with a siRNA against CASP2,pert
"human ES cells line from AZ-VUB laboratory, Belgium; derived from normal embryos;	Karyotype: X,Y",ctrl
S004_Scz_F_88,pert
Day: 18; Drug: Saline; Phase: Withdrawal; Replicate: 2,ctrl
"human nonfailing LV myocardium, NonFailing13",ctrl
Squamous cell carcinoma 006,pert
cell line: LNCaP-abl (abl) prostate cancer cells;	genotype/variation: transfected with control siRNA;	treatment protocol: under hormone depleted conditions,ctrl
Squamous cell carcinoma 023,pert
patient: 51315;	sample: normal,ctrl
T92 U133p2,pert
individual: Control10;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
PND28 Rat Testis_Rat230-2_2hr Corn Oil_Animal#7_04005,ctrl
Normal liver control,ctrl
Ischemic cardiomyopathy_G42,pert
cell type: dermal fibroblast;	genotype: healthy control,ctrl
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 5",ctrl
MCI-011,pert
Normal mucosa 7,ctrl
Day6 Estrogen treatment replicate 2,pert
Primary hepatocytes isolated from Donor 6 treated with DMSO for 24h,ctrl
WT-VILI replicate 1,ctrl
"brain, hippocampus: Ctr-72h-P15-III_e1_le1",ctrl
Mouse RSK2 mutant mandibular molar,pert
P61 Non failing heart biopsy,ctrl
T162 U133p2,pert
Sample 03 Kidney Hyp Mouse - Control Diet,pert
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: MEDIUM;	genome/variation: PDGFRA mutation detected,pert
WKY20-2,ctrl
PBMCs_Control_5 [IS],ctrl
m1-adenoma2,pert
D2-Gpnmb+ control rep9 (retina),ctrl
BP28,pert
Muscle PCOS 4,pert
"brain, frontal cortex: Sample51_e1_le1",pert
K562 cells control replicate 9,ctrl
OSCE-12T,pert
siRNA Med12 [K1],pert
Mouse_WT_ES_clone 1,ctrl
Gnmt_WT_2,ctrl
Mouse Megakaryocytes,pert
strain: C57BL/6;	tissue type: back skin,ctrl
HCC002T,pert
organ: Liver;	age: 14-week-old;	genotype: Wild-Type,ctrl
8 week old H3f3b KO,pert
SeroNeg-3,ctrl
0196-01-C,ctrl
Treg cells Ptenfl/flFoxp3-Cre replicate 1,pert
HNF6_2+,pert
AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 3,pert
"cochlea at P7, wt, biological rep 1",ctrl
Exercised-7,pert
"mouse liver sample, KO strain, biological replicate 1",pert
"10mg/kg/day PFOA, Rep 5, Block 5, liver (high dose)",pert
cerebellum SNCA knockout 6 month replicate 3,ctrl
5A;pretreatment;female;breast tumor,ctrl
Aged 8,pert
strain: 129SV;	gender: male;	age: 6 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
ab069 IM,pert
"DMSO Control after 8hr, replicate 2",ctrl
"P30_C-DGCR8 KO cones, replicate 1 [array]",pert
Superior Frontal Gyrus from 2year-old normal girl,ctrl
"brain, frontal cortex: Sample58_e1_le1",ctrl
PTC BRAF mut 6,pert
tissue: skin;	individual: Patient N-6;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
cell line: A549;	cell type: adenocarcinomic human alveolar basal epithelial cells;	transfected with: siRNA against STAT3,pert
INS-1 cell line #6a with non-induced HNF1b mutant P328L329del,ctrl
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
s42,ctrl
Individual_4162_PP_sample,pert
Empty vector replicate 3,ctrl
age: 13.5 day;	strain: 129;	genotype/variation: Chsy-1 knockout,pert
"mNSC nucleofected with miR-128l, replicate",pert
Diseased individual (ulcerative colitis) of twinpair #3,pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50), biological rep2",pert
"Gender: Female, Age: 27, BMI: 29, Tissue: luteinized cumulus cells",pert
Muscle WT Adult 07271,ctrl
normal adjacent esophageal tissue from patient E1796,ctrl
"Wild type used for MAT1A 3 month, replicate 1",ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14508;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"SLE patient, 1015V1",pert
KU_37N,ctrl
Macrophages obtained from a contralateral lung segment challenged with LPS,pert
liver_WT_replicate2,ctrl
1 with Cy5,pert
Endometrium-Normal 2,ctrl
Individual_5295_NN_sample,ctrl
BP patient 48_biological replicate 1,pert
hES_VUB01_2,ctrl
"brain, brainstem: CB1_e1_le1",ctrl
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14455;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
tissue: white blood cells;	age: 15.15;	Sex: male,pert
"Control siRNA - 5 days adipocyte differentiation, rep2",ctrl
Low weight gainer Kozak1_ABI_ING_L1,ctrl
3T3F442A-shGFP-rep2,ctrl
30 year old female,ctrl
Embryonic Cardiac Progenitors - wild type,ctrl
astrocytes normoxia batch 1,ctrl
cell type: Bone marrow cells;	genotype: control rtTA mouse;	strain: C57BL/6,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 1,pert
NIXKO2 SPLEEN,pert
C8161 cell line,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
BTBR_Liver_rep2,pert
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Mesenchymal Cell,ctrl
Low Glucose Transcriptome Profiling,ctrl
GIST_PDGFRA_7,pert
MDA-MB-231,ctrl
PsOEt-13-LS,ctrl
mouse TMJ-cartilage from DDR-1-KO mouse KO_Tal5,pert
Primary hepatocytes isolated from DBA mouse strain treated with Wy14643 for 6h,pert
Errb mutant stria vascularis replicate 3,pert
"10590, WBS, skin fibroblasts",pert
"Control, biological rep4",ctrl
Ileum_POR-null_2,ctrl
Ero1-WT non-induced biological repA,ctrl
Phan_006_WT.bleomycin rep3,ctrl
patient: CAB10;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
"Patient 8, Atheroma plaque",pert
"sirna: siRNA2 (Dhamacon);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",pert
CTL2 AO 48hr,ctrl
Waldenström’s macroglobulinemia (WM-BL 32131),pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 63;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
tg-2,pert
peripheral blood mononuclear cells,pert
IRF4-mut_Th17_cells_42hr,pert
Untreated 979-CLA-26,ctrl
"DHL6, R406, 48h",pert
kontrolli_DC_A,ctrl
"Patient  F, lesion, 4 week",pert
01LPM,pert
c 2-1,pert
gender: male;	batch: 1;	age (years): 56;	patient id: Control_8;	fev1 (% predicted): 111;	fvc (% predicted): 111;	medication: None;	cell type: CD8+ T-cells,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 48.0;	age of psoriasis onset: 19,pert
MDS patient 50,pert
Dgcr8 KO replicate 1,pert
RNAi -Transgenic replicate 12,pert
"RWPE1 cells, vehicle, 24h, biological rep4",ctrl
B10.H2g7_S1,ctrl
Muscle control 18,ctrl
Fetal heart 3.0 ug/kg TCDD rep3,pert
CD8-IGF1R Transfected 3T3 cells treated with A-928605 for 24 h,pert
Rat heart ventricle,pert
Strain: C57BL/6J;	Gender: male;	Age: 2-3 months;	Tissue: heart,pert
Pool Eu_P30_hyb2,ctrl
LPS-PVH_2,pert
age	54;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	5.1;	hemoglobin (g/dl)	13.8;	platelet count (/nl)	284,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 3 (untreated with resveratrol)",ctrl
WT3-2,ctrl
"human failing LV myocardium, Idiopathic55",pert
NOD/LtJ Vehicle liver sample batch 2,ctrl
"striatum,18month,KO",pert
10_MLN8237-1,pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep1,pert
E17.5 preB cells_Smchd1 wildtype_Rep 1,ctrl
EB_07_19d_154_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
5237 UC Uninflamed ascending colon,pert
L-540_Perifosine 10µM_24hrs_2C,pert
RNA from microdissected breast cancer cells from case 1343 labeled with Cy5,pert
Time 120 mins rep 1,pert
"Untreated, biological rep5",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
WT_lung_PBS_control,ctrl
VehVeh1,ctrl
Patient no. 4: treated,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep4",pert
sex: Male;	Age: 22 months;	additional patient information found in Series supplementary file,pert
HET Brain 25d Mouse1,ctrl
MDS50,pert
THP1-shGSK3B-Construct1-rep1,pert
CLS14_T3_PP_day1_057,pert
primary chondrocytes untreated,ctrl
wt-Gfp P6 replicate 4,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: P2,pert
harmane 1uM batch 2,pert
"PBMC, patient. Mtx rep11",pert
wt-Gfp P6 replicate 1,ctrl
"breast, flash-frozen, microdissected normal ductal cells",ctrl
bladder cancer cells treated 48 hr,pert
colon_adenoma_1138,pert
mouse,ctrl
E3C,ctrl
Whisker pad WT biological rep1,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 73;	baseline tumor size (cm): 7x6;	patient id (to identify the 2 chips from the same patient): 15751594,pert
HCC_3N,ctrl
S-IIP(UIP)15_Cy3,pert
"Reh, control",ctrl
H05_S_B1,ctrl
"control, BA10-55",ctrl
n3_lo_6,pert
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate1,ctrl
wild type MEF time 48 replicate 2,ctrl
"fibroblast, MFS subject FB1040 rep 1",pert
tissue: Fallopian tube;	cell type: epithelium;	cell line: OE-E6/E7,pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
NSC_FBS_L3,pert
"patient 032b, normal, homogenized",ctrl
11384 Normal Uninflamed ascending colon,ctrl
Knockdown Cell on HMVEC-L Replicate 1,pert
disease: AML;	bcor mutation: wild-type;	karyotype: normal karyotype,ctrl
"array 17, xenograft, 0.3% Tween-20 vehicle",pert
"Biceps, control, cohort 03, subject 03U",ctrl
"Lesion Skin, LS-9",pert
"Patient  A, lesion, 2 week",pert
Ischemic cardiomyopathy_G55,pert
lung_control_2,ctrl
MDS patient 174,pert
02SAGEA2,pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 34;	Duration of illness (years): 16;	Brain pH: 6.1;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: 12000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
fibroblast_5azatreated_rep2,pert
autism with FMR1-FM AU039305,pert
"Uninvolved Skin, NS-21",pert
disease state: control;	patient: 12,ctrl
"Control siRNA, 2",ctrl
Ebola-infected macrophages harvested at 1h post-treatment from donor 2,pert
"Patient 108, baseline",ctrl
Cbx2_KO_XY_3,pert
condition: Psoriasis;	patient: PS-H;	tissue: LS skin biopsy;	kit: Affy,pert
Aire WT,ctrl
TTE3 cells treated with BPA for 0 h-2,ctrl
PE_N_M169,ctrl
strain: C57BL/6J;	genotype/variation: Asc -/-;	cell type: bone marrow derived dendritic cells,pert
DLBCL_ctrl siRNA,ctrl
"metastasis: metastatic recurrence;	Stage: 3b;	tissue: normal, homogenized",ctrl
Strain: C57BL/6J;	Gender: F;	Age: 7 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
HeLa-LAMP3siRNA-4d,pert
Placebo treated ipsilateral to stroke replicate P6IC-2a,ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: lung;	age: 12 weeks,ctrl
"Mature proximal small intestine, first 5 cm immediately adjacent to the pylorus",ctrl
"NTERA2/D1 cells, Vamp7 knockdown siRNA",pert
DMN-CtrHippo15d-2cAv2-s2,ctrl
Array Type: HG-U133A_2;	Ratio: 2.01;	RNA Integrity Number: 9.5;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Ngn3 EB10 ON replicate 1,pert
cell line: SV589;	knockdown (days): 8;	treatment: no treatment,ctrl
"1833 expressing Tet1, biological replicate 3",pert
tissue: blood;	control: 2;	gender: male;	age: 48,ctrl
Bronchial Epithelial Cells SA biological 1987B,pert
Early Secretory Phase Normal,ctrl
Kidney_200 mg/kg VCM iv_mouse #026,pert
platelet_sickle_6,pert
2795-lcm,pert
MeCP2_3,pert
EB_2_6h_207_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
FW_8a_BV8865,pert
AZ-521_doxycycline_8h_rep1,pert
individual: patient14;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
RA6,ctrl
Ls174T-pTER-β-catenin con1,pert
"Bone Marrow sorted Zfx-cko HSC (Lin-, Sca1+, c-Kit+)",pert
neuron_rep3,ctrl
"PC-3, untreated",ctrl
EDL-n7; normal extensor digitorum longus 7 month,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Male,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 126;	genotype/variation: WT;	age: 8 weeks,ctrl
BACH2+/+ ALL (Sample1),ctrl
LNCaP + AR-shRNA rep2,pert
RNA from whole tissue section of case 823 labeled with Cy5,pert
cell line: MDA-MB-231 1833;	cell type: breast cancer cells;	genotype/variation: expressing HMGA2 shRNA,pert
MIY_day_3-3,ctrl
"human failing LV myocardium, Ischemic76",pert
t07,pert
Nfix_depleted_rep1,pert
cell type: Immortalized human neural stem cell;	cell line: HB-1;	treatment: Nurr1 overexpression,pert
Strain: DBA/2J;	Sex: Male;	Age: 8-10 weeks;	Treatment: Control,ctrl
"gender: Male;	age: 81;	post-mortem delay: 5h;	ph: 6.1;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
wt-Gfp E16 replicate 3,ctrl
microdissected epithelial cells from IPMA 5,pert
"striatum,6weeks,WT",ctrl
WT J1 ESCs on day 7 #2,ctrl
INSENS 5 4hr,pert
NSC miR-Control 3,ctrl
"Mice_non trans, biological rep3",ctrl
Normospermic individual: Sample N6,ctrl
C57BL/6J Mouse Male Kidney,pert
cell type: tumor nodule cells;	ikk2 status: WT,ctrl
TL3 SCR 3,ctrl
Healthy control 10,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (1),pert
cRNA;	embryonic day 18;	WT,ctrl
Tissue: HepG2 Cells;	Gender: male;	Source: ATCC;	Vehicle Treated 0.1N KOH (at equivalent volume as treated) in media,ctrl
PBMC from T cell LGL leukemia patient #113 (TLGL113),pert
EA_Case9_CD8,pert
Control peripheral blood leukocytes - Biological Replicate 3 - Technical Replicate 2,ctrl
brain_DLPFC_bipolar C_mr539,ctrl
CD34+ hemopoietic progenitors purified from peripheral blood of Idiopathic Myelofibrosis (IM) patients,pert
genotype: tg/wt;	treatment: CaNrf2;	gender: female;	background strain: FVB/N/C57BL/6 mixed,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 226;	age-at-biopsy-years: 61,pert
Injured 7 day Rat Retina 3,pert
"Control cell, Replicate 3",ctrl
cell line: AT2 E/R positive leukemia;	treatment: treated with non targeting lacZ shRNA,ctrl
"Age: 8 months, Sex: Female, Retina: right, Final IOP (mm Hg): 26.5, Strain:DBA/2J",pert
WT_bone marrow cells,ctrl
Pediatric_GBM_15,pert
normal control 1,ctrl
P4_Ovary_NT3_biological rep3,pert
G392E_off_rep3,pert
Tendon_non-lesional_rep5,ctrl
WT - Thymus - biological repeat 1,ctrl
Tendon_lesional_rep11,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 19; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.,pert
IR-KO_Rep3,pert
159B,ctrl
bleomycin injected mouse lung,ctrl
Head RNA of Phgdh Knockout@E13.5 No.2,pert
Tissue: normal thyroid; Gender:female; Age:43,ctrl
Mouse lungs infected with Mtb for 63days,pert
"brain, cerebellum: RNA#12S_le1",ctrl
CD19_selected_B-cells_after_R_rep6,pert
"Liposarcoma culture from tumor 379, doxorubicin treated",pert
"Patient 97N, normal colonic mucosa",ctrl
sex: Male;	Age: 18 months;	additional patient information found in Series supplementary file,ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
R6/1 18 week wildtype_15E8,ctrl
Normal Cervix N8,ctrl
Spleen_wt_1m_rep1,ctrl
H3f3b WT 3966,ctrl
disease group: normal;	cell type: chondrocytes;	cell culture: 3-D,ctrl
"mature (CD44+, NK1.1+) thymic natural killer T cells",ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-Tg;	tissue: Skeletal muscle (quadriceps),ctrl
HUVEC infected by retroviral vectors bearing pre-miR-210 sequence,pert
strain: 131;	Disorder: normal scar;	Condition: +hydrocortisone,pert
T8,pert
"brain, cochlea: [6] Sample #6_le1",pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID233,pert
"SIRT7 Knockout Liver, replicate3",pert
MacularDegen-healthy-7aAv2-s2,ctrl
chip number: 12;	transfection plate: 5;	target gene: TAF1;	kd level: 0.73;	rin: 9;	transfection date: 2011-10-17,pert
KO_72_O3_3,pert
CLL13-CD8,pert
ancestral background: African-American (AA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,ctrl
NTG replicate 3,ctrl
ILD Study Number 998,pert
Aldosterone-producing adenoma (APA4),pert
E10.5 ko.3,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 29;	sex: M,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T166,pert
"Bmi1 shRNA, biological rep3",pert
Luciferase shRNA_3 Days knockdown_rep1,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 10",ctrl
Replicate 1 - R5020,pert
Subject #8041-2d Postinfection,pert
PGA_MI_nilv_48h_351,pert
4010-2 E2F2 Null,pert
tumor cell line HepG2 rep4,ctrl
WT_cerebellum at P30,ctrl
Strain: FVB/N;	Genotype:mCftr+|+,ctrl
gender: male;	age (years): 58;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: No treatment,pert
MKK7D transgenic female replicate 15 late timepoint,pert
"G42 cells from M1, wild type control, biological replicate 2",ctrl
diet: AIN-76A,ctrl
V5-P418,pert
"Pou4f1-/- cells, transduced with control virus",pert
tibialis anterior muscle,pert
control participant P307,ctrl
sepsis patient #7,ctrl
A431 PR 1,pert
"Autism with regression, Female",pert
hNHEPS_10 μM_6 h_rep4,pert
"Biceps, control, cohort 12, subject 12U",ctrl
ab134 N,ctrl
age: 57;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
neonatal cord blood mononunclear cells after LPS-treatment,pert
OE-E6/E7 cells,pert
"121, ADIPOOSE TISSUE, Before",ctrl
"age at diagnosis: 81;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T1b;	n (lymph node metastasis): N3a;	er: 1;	pgr: 1;	dfs-month: 31;	dfs-event: 1;	distant metastasis: 1",pert
80 year old male,pert
MF-26,pert
Testicular seminoma 1748,pert
cbp+/- standard cage Rep4,pert
NE-rep7,ctrl
healthy control sample x044a,ctrl
"Neural precursor cells derived from hES cells line VUB01, biological replicate  3",ctrl
mouse_islets_VhlhKO_03,pert
F9 WT treated 8hr with atRA,pert
Lmna H222P homozygous male 2,pert
treatment: treated with R1881 and ELK1-shRNA;	cell line: LNCaP,pert
HDAC2_B10-rep1,pert
Septic shock;	gender: Male;	Survivor;	organism: Staph aureus,pert
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: 33;	maternal age: 29,pert
extensor digitorum longus muscle,ctrl
subject: 18U;	cohort: 18;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 37;	Sex: M;	batch: Batch_4,ctrl
Muscle 50 eccentric contractions 12 hours KO Adult 0713,pert
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; PtenF341V/loxP,pert
Strain: C3HeB/FeJ;	Age: 10-12 weeks at the beginning of the feeding regimen,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 29;	sex: M,ctrl
HEL_Control shRNA (GFP)_1,ctrl
primary normal lung tissue 1037,ctrl
A375P cells expressing Control shScr,ctrl
MDS patient 81,pert
3278-scrape,pert
cell type: embryonic stem cells;	genetic modification: Dgcr8 knockout,pert
"brain, lateral and medial ganglionic eminences: Arx-/Y #2_le1",pert
Brain from 40 days Npc1-/- mouse1,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: none,ctrl
Wt1-null MEFs-1,pert
gender: male;	batch: 1;	age (years): 56;	patient id: Control_8;	fev1 (% predicted): 111;	fvc (% predicted): 111;	medication: None;	cell type: CD4+ T-cells,ctrl
Muscle PCOS 16,pert
HC JL 2 alcohol,pert
5P-ER,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 50;	baseline tumor size (cm): missing;	patient id (to identify the 2 chips from the same patient): 22332259,ctrl
Treated with 50uM Zinc for 4 hrs -- replicate #1,pert
cell line: non-clonal BMSC cultures;	transfection: negative control (siNC) construct,ctrl
Subject #8008-2d Postinfection,ctrl
DBA control (124-5msn),ctrl
genotype/variation: Fbn1 wild-type;	tgfbr2 status: intact TGF-β signaling;	tissue: ascending aorta;	age: 6 weeks,ctrl
m1-adenoma4,pert
c 2-2,pert
Phan_005_WT.bleomycin rep2,ctrl
WT - Cre Treated - 12 hrs - repeat 1 - Cy3 - mAdbID:61756,ctrl
"BMDC, Asc-/-, replicate 2",pert
Wild type C2C12 cells,ctrl
MDS patient 167,pert
prostate tumor 6,pert
P60 Vax2-/- 1,pert
"BMMC, NTAL KD, nonactivated",pert
Embryonal carcinoma 0564,pert
Cdh1_cKO_2,pert
RE550_DU145_Un1,ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14509;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
CD8 T cells isolated from tumor,ctrl
Tumor_Ker52,pert
19SAGEA,pert
"Mepenzolate treatment, 25 hours (replication 2)",pert
Scrapings of the distal colon mucosa,pert
Healthy-9 baseline,ctrl
"C3H/HeJBir, sample-1",ctrl
WT_P57,ctrl
C2C12 myotubes 1000uM H2O2 rep1,pert
sample: #14;	subject: PD case #2;	brain: T-1982;	age: 79;	sex: Male;	region: Inferior olivary nucleus,pert
Thymuse,pert
"Autoimmune pancreatic islets, day 3 cyclophosphamide treatment, rep 2",pert
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E16.5 embryo;;	Gender: female;;	Tissue: whole brain,pert
Control_2,ctrl
Sedentary-16,ctrl
Day: 12; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 3,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 18Q x50_16 months_replicate 1,pert
Hippocampus_Soman_96h_rep3,pert
patient: 22;	disease state: hypertension;	tissue: Atheroma plaque,pert
Bone Marrow Mononuclear Cells;	24y Female,ctrl
IFN_Gamma_24hr_rep2,pert
secondary glioblastoma_1,pert
control liver,ctrl
cell line: HL-60;	shRNA construct: GSK3B Construct 1,pert
"mouse aorta cross strain comparison, C3H_T04_HF_01",pert
chronic lymphocytic leukemia (CLL 13651),pert
Skeletal muscle tibialis anterior (TA) from fiona transgenic line,pert
B_Kin_2,pert
pooled skins,ctrl
24h 4OHT-treated-sample2,pert
strain: C57BL6/J;	Sex: female;	genotype: WT;	cell type: mouse embryonic fibroblasts,ctrl
GM19238_Kd_WHSC1_3,pert
colonic_mucosa_inflamation_125,pert
Cancer 9,pert
Adrenal WT 0h batch 4 [AdWTh00.26],ctrl
tissue: heart;	gender: male;	genotype: VAChT KD;	age: 3 months;	strain: C57BL/6,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: control;	time: 24h;	gender: Male;	age: 2 months,ctrl
"Crohn's Disease subject (50 year old caucasian female, SAK_1288040656)",pert
HMEC_50 vs MDA_MB_468,pert
15_0001C_Day1_40,ctrl
OVCA420-(3),ctrl
TTP_KO_0ActD_BioRep4,ctrl
P1 mouse eyeball extracted total RNA_Snf2h_cKO1,pert
lesion_preUV_patient4,pert
GIST_KIT_6,pert
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Spare nerve injury;	experimetal group: Adult Contralateral,pert
"breast adenocarcinoma, cell line",pert
"10mg/kg/day PFOA, Rep 5, Block 5, lung (high dose)",pert
H69_Ctr_3,ctrl
"110, ADIPOOSE TISSUE, Before",ctrl
Squamous cell carcinoma 022,pert
HEK293_hCdc73siRNAConfluent_rep1,pert
LJMJDW7,pert
background strain: C57BL/6J;	cell type: Lin- hematopoietic progenitors,ctrl
total cellular RNA from Jurkat T cells,pert
OSE_475,ctrl
status: autism,pert
HCT 116 control rep2,ctrl
cultured LNCaP cells;	refer to ATTC,ctrl
healthy control H11,ctrl
Cell line: MDA-MB-231,pert
Bronchial Epithelial Cells control biological 1925F,ctrl
HP-12,pert
RNA from HCC_32N,ctrl
genotype: Smad3-/-;	strain: mixed strains of C57BL/6 and NIH Black Swiss females (Taconic);	treatment: regular diet,pert
At Risk: -;	Age: 17;	Sex: M,pert
GFP Zfx ko 2,pert
TGFb1 treated experiment A (10ng/ml 24 hours),pert
"Pineal gland from NeuroD1 cKO mouse at ZT20, biological rep 1",pert
155B,ctrl
P6 Patient None,pert
wt_P8_rep1,ctrl
RA1,ctrl
Large cell carcinoma 004,pert
GBM_stem_4 days_3,ctrl
PGC-1a-/-bf/f/MerCre rep1,pert
"Lymphoblastoid cell lines derived from family 1743, member 1",ctrl
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.40;	Post mortem interval (hours): 9;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
braak stage: BR12;	rin: 66;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
ccRCC tumor of patient 260,ctrl
TP07-726B,ctrl
Mtb infected-42d-3,pert
uterus,pert
0h Kin Cel.40,pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 3,ctrl
"RNF40 siRNA - 5 days osteoblast differentiation, rep2",pert
N/A,ctrl
HCC_19N,ctrl
V5-P508,pert
"Crohn's Disease subject (54 year old caucasian male, SAK_1316666829)",pert
cell line: 344SQ lung cancer cell line;	genotype.variation: PIK3CA knockdown,pert
T-ALL1 Control 2,ctrl
"EBF1 d10, rep 2",pert
minor non-tumor10,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID58,ctrl
Subtype: RAEB1;	Karyotype: other,pert
Myoblast-GATA4-KO-day3-1,pert
ex-iTreg,pert
SV589_15Day KD_Serum Starved -> 3hr EGF,pert
BCell_activated_sample1,ctrl
"Peripheral blood, patient without recurrent events [N50]",pert
Trastuzumab treated after 4 days (T1_1),pert
E9.5 FVB/N erythroid cells-1,ctrl
endothelial_rep5,pert
brain_DLPFC_bipolar C_mr682,pert
c17.2 mouse neural stem cell line,pert
rear leg muscle,ctrl
T40726,pert
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: Vehicle treated,ctrl
tissue: colon;	genotype/variation: control,ctrl
23GOBMUC2H,ctrl
"PC-3, AA treated 2hr",pert
"ShamC-21, biological rep 5",ctrl
"human failing LV myocardium, Idiopathic80",pert
wt_off_rep2,ctrl
E9.0 wt.1,ctrl
Healthy control,ctrl
RNA-DHL6-R406-2H-3,pert
whole blood_100923,pert
LICR_HN2_PBS3,ctrl
220C6,ctrl
human neurons isolated from postmortem dorsolateral prefrontal cortex,pert
G007,pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 1953348002;	hybridization batch: III,pert
C3H/HeJTCE liver sample batch 2,pert
"Fetal liver, CD-1 background",pert
ICR MEF infected  with pMX-GFP retrovirus,pert
Liver tumor,pert
Primary CLL cells (treated with 0.1 μM CDKI-73 for 4h),pert
T7B-LU,pert
NSC_FOXO_NULL-1,pert
Sample: nontransgenic control (NTG);	Replicate: 2;	Pool: NP,ctrl
Age: 37;	Sex: F;	Ancestry: African;	Smoking status: non-smoker,ctrl
"Control, sample 4",ctrl
liver 1.0% quercetin diet rep5,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.16712,pert
"siRNA, plastic plate, rep2",pert
"Knockout Heart with no treatment, biological rep2",pert
Peripheral blood mononuclear cells;	TTF=117min;	Race=White;	Sex=Male,pert
anterior pituitary,pert
N1C Normal-hippocampus,ctrl
non-CF subject 41,ctrl
L425-PAX5+MAT_rep2,pert
NPC_p5ko_rep4,pert
8DKD_SerumStarved->1hrEGF_rep3,pert
P 29 Si RNA,pert
"NPTX1 shRNA Day 5, biological rep3",pert
striatum_wildtype_1,ctrl
Hep G2 treated with Potassium dichromate,pert
"SDC1-silenced group, replicate 1",pert
Skin biopsy from upper nates taken 48 hours after exposure to 5% nickel sulfate,pert
mixed reference (CRG + FR),pert
"patient 033b, normal, homogenized",ctrl
39SAGEA,pert
"eye, cornea: TRizol Extraction_le1 6",ctrl
"Gender: female, Age: 45 years, Tissue: VIN 3",pert
"WT, PR04M002v0",ctrl
"human failing LV myocardium, Ischemic39",pert
CML_3_CMP,pert
P0 - nudelcko/ko 2,pert
ccRCC tumor of patient 324,ctrl
HeyC2-(1),ctrl
Tendon_non-lesional_rep13,ctrl
H02_P_B1,ctrl
Reh_mock2,ctrl
2908-lcm,pert
peripheral blood,ctrl
"amnion mesenchymal cells, no treatment, biological rep1",ctrl
5269 UC Uninflamed terminal ileum,pert
sepsis patient #14,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: UKmin;	race: White;	sex: Male,ctrl
"gender: Female;	age: 28;	post-mortem delay: 11h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
strain: v6.5;	cell_type: ES cells;	transfection protocol: GFP shRNA transfected;	culture media: ES,ctrl
A9,pert
cumulus_nonPCOS_Lean_rep5,ctrl
Ovarian Cancer xenograft,ctrl
TTE3 cells treated with BPA for 12 h-1,pert
vMyb virus-infected replicate 2 (MCF7),pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 13.0;	age of psoriasis onset: 31,pert
Pool 2 Acute stage,ctrl
"heart tissue, ad lib feeding, 10-12 weeks old",ctrl
multiple myeloma (MM 36),pert
LOX1 0hr 282295463,pert
A549_NS siRNA_biological rep3,ctrl
diseased_media 2,ctrl
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus",pert
pSUPER-scramble replicate 1,ctrl
U937-shGSK3A-Construct6-rep2,pert
CD46+ hippo - Untreated-D,ctrl
E11_SostKOSostLKO_1,pert
WT11,pert
WT GMP rep2,ctrl
KN-smoke-high-5 month+1d-R2,pert
"CA2, parental control SOX17 HESC- clone1",ctrl
"CTLA-4 KO 5C.C7 T cells, biological rep3",pert
Ileum_POR-null_3,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 60;	tissue: Blood,pert
GIST_KIT_8,pert
"Biceps, control, cohort 07, subject 07U",ctrl
"CCALD patient fibroblast, biological rep4",pert
cell type: Peripheral blood leukocytes;	strain: DBA/2,pert
control IgG_rep4,ctrl
Liver_Wild Type+Quercetin_1,pert
"Ulcerative Colitis (41 year old black female, SAK_1304707354)",pert
ATP-treated AML 9 blasts,pert
"H1 hESCs, EF1a-control",ctrl
"Mouse, ATF6aKO, colon, UT, rep2",pert
RNA from whole tissue section of case 260 labeled with Cy5,pert
Placenta Adra2bWT 1,ctrl
U-87MG-V8 set 1,ctrl
strain background: C57BL/6J;	genotype/variation: Nod2-/-;	age: 8 weeks;	tissue: small intestine;	cell type: laser captured Paneth cells,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 43;	Usage number: 1;	Exposures: 3,pert
RV64.09_CHF_day25,pert
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate A,pert
Series 3; adult; 3 days after fracture,pert
LJMJDW6,pert
patient E1603,ctrl
VMM-WT_MyoD12h-2MP-s2,ctrl
"58B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
age_years: 47;	sex: F;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
Human Leukemia cell line RS4.11,ctrl
Parkinson's disease sample x029,pert
"tissue: liver;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: control 72 hr",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.29041,pert
Bone-Marrow_NPC_N1362,ctrl
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/8,ctrl
"Male, 43 years old",ctrl
scan batch: Batch 2;	group: control;	subject age: n/a;	paternal age: n/a;	maternal age: n/a,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): R1881,pert
"Mouse brain, Aged, 4hr post LPS ip injection",pert
T119 U133p2,pert
ovary_cultured_progesterone_rep1,pert
NME2 induced A549 cell Replicate2,pert
hOB695_shRB1383_0hr,pert
Sample Group: control; Gender: male; Age: 38; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
race: caucasian;	age (years): 57;	stage: IB;	grade: 2;	histology: endometrioid,pert
4041-4 E2F3 Heterozygous,pert
"0mg/kg/day PFOA, Rep 2, Block 1 lung (high dose)",ctrl
"HCT116 cells, CD44 siRNA",pert
Strain: B6.V-lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,ctrl
Common Myeloid Progenitors,ctrl
Hunk Knock-Out rep 6,pert
HT29 PLX Day3 rep1,pert
"t08, surgically resected from patient of gastric cancer.",pert
Gastrocnemius Muscle_WT_rep3,ctrl
"Heart, KO3",pert
EB_07_5d_138_Formaldehyde_RatNasal_Rat230_2_CIIT05024,pert
sample =Healthy2 treatment=Stimulated time=360 (min),ctrl
Pancreatic Sample 9-Tumor,pert
"CD44 siRNA, 1",pert
lung fibroblasts from a patient (FASSc2) with fibrosing alveolitis associated with systemic sclerosis,pert
Age: 50;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
220C1,ctrl
Cancer 3,pert
heart wild type replicate3,pert
Leg 7 Day Control rep 1,ctrl
Liver_POR-null+quercetin_3,pert
TTF=120min;	Race=Asian;	Sex=Female;	Group=A;	Prototype_N,pert
Bone-Marrow_SMM_S1384,pert
"cell line: hgps-fib_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository",pert
H1993 BRMS1 KD_1,pert
MOLM14-shGSK3B-Construct2-rep1,pert
ko 13.5d replicate 2,pert
CTRL_5_CMP,ctrl
individual: patient3;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
WT liver_HFD_rep2,ctrl
EOM 14 Day Control rep 1,ctrl
WT heart 1,ctrl
T6F-LU,pert
"Patient 6, lesion tissue",pert
MDS39,pert
Mesangial Cells,ctrl
agent: pristane;	time: 3 days;	strain: BALB/c;	tissue: mesentery,pert
microdissected breast cancer cells from case 1205,ctrl
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: control (none);	timepoint: 24 hours,ctrl
human_LIMA_artery_patient4_paclitaxel-eluting_stent,pert
treatment: DMNQ;	cell line: NuLi;	genotype: no-Cystic Fibrosis deltaF508 mutation,pert
"Pou4f1-/- cells, transduced with control virus_KO_MSCV_86",pert
PFR3K650E_replicate_3,pert
CUTLL1 DNMAML1 GSI-rep2,ctrl
"Crohn 04, CD04",pert
B4_pseudomonas_overexpressor_422,pert
"patient: 202;	current medication: Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118;	birth date: 10/3/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/68;	diagnosis date: 1/1/69;	joint problems: TRUE;	uc flare up: TRUE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Polymyalgia rheumatica;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",pert
sex: Male;	Age: 33 months;	additional patient information found in Series supplementary file,ctrl
cell line: MOLM-14;	shRNA construct: GSK3A Construct 6,pert
brain_DLPFC_bipolar C_mr544,pert
NOD Aire KO MEC rep1,pert
"gender: Male;	age: 25;	post-mortem delay: 17h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"mouse aorta cross strain comparison, C3H_T00_NC_01",ctrl
strain: FVB;	developmental stage: adult (3-month-old);	tissue: hippocampus;	genotype/variation: Prnp0/0,pert
jzo033-rp1-v5_u74av2-met,ctrl
WT J1 ESCs on day 3 #1,ctrl
TF_1_control_d2.5_rep2,ctrl
11104 UC Uninflamed descending colon,pert
Fat FC2,ctrl
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 40;	Usage number: 1;	Exposures: 3,pert
"Acute Myeloid Leukemia, sample 22",pert
Cardiac Muscle_mdx_rep2,pert
"Fourth ventricular choroid plexus from wildtype mice at E13, biological replicate 3",ctrl
23A,pert
28_C57_WT,ctrl
"105, ADIPOOSE TISSUE, Before",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 30,pert
"human failing LV myocardium, Idiopathic78",pert
CON17,ctrl
cell line: Raji;	cell type: human Burkitt's lymphoma;	gender: male;	treatment: expression of control mimic;	treatment duration: 24 hrs,ctrl
NPC_p5ko_rep1,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep11,ctrl
4_CD34+_12h_TCDD+,pert
"Patient 29, Atheroma plaque",pert
patient E1535,pert
tumor cell line HepG2 with knockdown of HIF-2α rep4,pert
Mouse heart with no DOX treatmeant,pert
"S1P2-KO-hippocampus, biological rep5 (male)",pert
"mouse aorta cross strain comparison, C3H_T04_HF_02",pert
patient16,pert
RatLung_H6h_1,pert
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID342,pert
"control pancreas, biological rep3",ctrl
17A;pretreatment;female;breast tumor; responder,ctrl
brain microvessels,pert
129S1/SvImJTCE liver sample batch 2,pert
Control Endometrium Epithelial Cell_014.UC182_EpCAM,ctrl
"WT caudal vertebral bone, rep3",ctrl
Wild Type nr 663,ctrl
Seguin_IDR_BrownNorway_Liver_treated4,pert
Jejunum_POR-null_2,ctrl
Caco2-siRNA2-rep2,pert
BL6SHAM,ctrl
patient: 237;	current medication: Omep 20mg Losartan 50mg Bisoprolol 5mg Prav 40mg;	birth date: 11/12/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/95;	diagnosis date: 11/13/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/18/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/5/03;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/52;	smoking amount: 0-4;	other illnesses: Hypercholesteremia Prev CABG;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Human normal pituitary -N6,ctrl
Neo-1 Ctl HG-U133 Plus 2.0,ctrl
peripheral blood CD4 T cells,ctrl
"DOCK8 knockout, thymic, NK1.1+ NKT cells replicate2",pert
06R029 RA,pert
"WT mouse skin treated once with acetone and collected 24 hr later, replicate 1",pert
umbilical cord_nobpd: 9A,ctrl
"brain, hippocampus: Aldh5a1-/- #3363 Hippo_e1_le1",pert
"control E14, rep2",ctrl
heart_co_14M_rep3,ctrl
cell line: MCF7 breast cancer;	treatment: RL silenced and LIF-stimulated,ctrl
cell line: MCF7;	treatment: PDEF knockdown,pert
9-cis-retinoic-acid_mammary_2,pert
HWS23,pert
n04,ctrl
THRB 15b mutant + vehicle replicate 2,pert
Subtype: RARS;	Karyotype: del(5q),pert
17 saline,ctrl
Empty control #1,ctrl
n9t0h,pert
tissue: Liver;	genotype/variation: Hmgn1-/-;	treatment: injection of 10 µg/g body weight of saline,pert
WT S49 cells 24h cAMP treatment,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-9;	Primary Site:Tongue;	Age:66;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
BL6_24h_Wy,pert
NHE3+/+ replicate 3,ctrl
BP patient 55_biological replicate 1,pert
tissue type: Bone Marrow;	cell type: Smoldering Multiple Myeloma (SMM) plasma cells,pert
Insm1 control #5_pituitary gland,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 39 yr;	population: white,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-tu2,pert
"DMSO Control after 2hr, replicate 2",ctrl
"0mg/kg/day PFOA, Rep 4, Block 4, lung (low dose)",ctrl
"C57BL/6 BMDM infected with WA(pTTS,pP60)",pert
Md02h027,pert
BATF_KO_P14_D3_Effector_rep4,pert
Primary hepatocytes isolated from BalbC mouse strain treated with DMSO for 24h,ctrl
tissue: Frontal cortex;	age: 100;	Sex: F,ctrl
HDAC2 KO E17.5 Ventricle 1B,pert
A673 cell line that has been treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50).,pert
MO32_15,ctrl
DMN-NF1Hippo10d-1aAv2-s2,pert
CUTLL1 wash2h-CHX,pert
strain: 129SvEv;	developmental stage: E11.5;	tissue: ventricle,ctrl
"Control at ZT20, retina",ctrl
"TAMs sorted from vehicle control tumors, biological replicate#1",ctrl
SZ1,pert
long-Rif1 KD rep1,pert
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 72;	gender: f;	treatment: -,ctrl
ANL Chip#33,pert
BT474_Lap_24-3,pert
SLE CD4 T cells 2,pert
482 cells Sox2shRNA-rep2,pert
"vector d4, rep 3",ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 4,ctrl
Insm1 mutant #6,pert
n7t0h,pert
INSENS 7 4hr,pert
whole uterus,pert
TTF=120min;	Race=Black or African American;	Sex=Female;	Group=A;	Prototype_Y,pert
Control Endometrium Endothelial Cell_ETB65 +-,ctrl
NSC_FBS_V1,ctrl
ColonProx_0227AFAS_070.txt,ctrl
Whole liver,pert
0651-01-C,ctrl
"human failing LV myocardium, Ischemic50",pert
"liver, QH2, 6 months",pert
lymphocytes_ctl_M_50y,ctrl
Hodgkin lymphoma cell line KM-H2,pert
Normal cortex of patient 1393,ctrl
brownfat,pert
CEMC1 cells treated with 10 nm rapamycin for 3 hours,pert
genotype/variation: Wildtype_XY;	tissue: gonads;	age: E11.5,ctrl
Pancreatic Cancer PBMC Sample 1,pert
"WT CD8 memory T cells, biological rep2",ctrl
SA_292,pert
"C2 corrected_A2_tumor, lung tissue",pert
"brain, hippocampus: inhibitor-1 KO 2_e1_le1",pert
treatment: vehicle;	genotype: wild type;	treatement time: 40 hours,ctrl
testis wild type replicate1,pert
"FACS-sorted cones, P40 wild type mice",ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Jejunum",ctrl
T21.01,ctrl
atopic eczema P1,pert
normal 1473,ctrl
U133A_G1,ctrl
Retina ko/ko rep3,pert
CD positive WT T cell TCR-stimulated rep3,ctrl
"AD_TC, biological rep4",pert
humanMBC_ctrl overexpression_2,ctrl
MDS patient 130,pert
Normal-BM 4,ctrl
OCI-Ly10_FOXP1 overexpression,ctrl
MDS patient 106,pert
"PCB153 treated HepG2 cells at T1.5, biological replicate 2",pert
Head RNA of littermate wild@E13.5 No.1,ctrl
"CCM3 shRNA cells passage 7, rep 3",pert
48 hrs sham-1,ctrl
KO PBS3,pert
NSC_ DMSO_24h_biological rep1,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-sp3,pert
Control gray matter 3,ctrl
diet_LIVER_1,ctrl
BS2011051054_2,ctrl
AL Chip#24,pert
ME180 3 hours rep 4,pert
tissue: Brain;	genotype: Npc1-/-;	age: 54 days;	subject: Mouse5;	genetic background: BALB/c,pert
"Trip12 mut/mut, biological rep1",pert
mouse NB N1E-115 cell line,ctrl
"metastasis: metastasis;	Stage: 4;	tissue: normal, homogenized",ctrl
"Retina, 30 days old homozygous Egr-1 knock-out mice",pert
DC1 RSG,pert
Murine Cells (Macrophages),ctrl
S2B Sporadic-cerebellum,ctrl
Endometrial stromal cell - control/vector 2,ctrl
Primary hepatocytes isolated from NMRI mouse strain treated with DMSO for 6h,ctrl
female_control_477,ctrl
"brain, brainstem: LB1_e1_le1",pert
Sox3 null Sample 1,pert
3886-2 E2F1 Null,pert
Rb-/-PrE serumfree 2,pert
tissue: skeletal muscle;	status: diabetic;	agent: insulin,pert
Aquaporin-11-/-_mouse P7 kidney #4-3,pert
Untreated CHOP-/- A,pert
"NB4 cell line, TG2 knockout, untreated",pert
BL121,ctrl
gastrocnemius-30 months of age-resveratrol diet-biological replicate4,pert
M325 C,pert
cerebellum SNCA knockout 6 month replicate 2,pert
Control 1 at age 35-day,ctrl
"Lesion Skin, LS-29",pert
Knockout CS_2_15_KO_2,pert
Gene expression profiling of normal cortex of patient 209,ctrl
Control pool 3 (n=5),ctrl
Run1.a10a.000607jd.2.SkMNor920.CEL-IS stimulate,pert
Run5.aUa.010110d.SkMDbt1152D.CEL-DB basal,ctrl
MDS patient 43,pert
Seltzer 21d replicate 1,pert
3598,pert
"Control fetal heart (vehicle treated with corn oil on gd14.5 via oral gavage, collected on gd17.5)",ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures,T3 (treated with resveratrol)",pert
remitted schizophrenia patient  S22,pert
"Spi-60, biological rep 2",pert
Akt1-deficient 1,pert
HEL_JAK2 knockdown (Jak2-9 shRNA)_3,pert
"testis, wild type",ctrl
gender: Male;	age: 71;	post-mortem delay: 6.5h;	ph: 6,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 2,pert
Mouse embryonic stem cell line E14,ctrl
"C57BL/6J SAL, Rep1",ctrl
0844-01-A,pert
"ADAM17 cKO skin, rep2",pert
NIH3T3,pert
"NeuroD1 knockout mouse, P0 Pineal Tissue, Sample 2, 05-23-06",pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T127,ctrl
PsOEt-19-Week 2,pert
age_years: 59;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep4,pert
Gene expression profiling of normal cortex of patient T158,ctrl
ACI control replicate 3,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 1 day;	treatment: fresh air, treatment over 1 day, 3x1h exposure per day",ctrl
RNA from whole tissue section of case 1218 labeled with Cy5,pert
Bone-Marrow_SMM_S1259,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 14 months,pert
lesion_midUV_patient5,pert
"Wild type used for MAT1A 8 month, replicate 1",ctrl
"Lesional skin biopsy from psoriasis patient, Week12_etanercept",pert
hBSMC_vitamin D_rep1,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 60;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
colon_IBD_1670,pert
heart female CVD3 10 dpi rep2,pert
MA_94,pert
"fibroblast, MFS subject FB881 rep 2",pert
Diaphragm 7 day control rep 3,ctrl
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.93;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Pou4f1-/- cells, transduced with control virus_KO_MSCV_83",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Female,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 1524,pert
gender: Female;	age: 46;	post-mortem delay: 4h;	ph: 6.6,ctrl
"SS gland, moderate, patient 9, batch 1",pert
Striatum of 8-10 week old C57BL/6J mice,ctrl
BM_02303,ctrl
AVC_mutant_rep4,pert
"10mg/kg/day PFOA, Rep 2, Block 1, lung (high dose)",pert
8 hour tunicamycin CHOP-/- A,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep6,ctrl
"ERRa wt baseline heart, sample 2",pert
Run1.a10a.000607jd.2.SkMNor915.CEL-IS basal,ctrl
CAB10_T2_PP_day0_032,ctrl
Lesional skin from K5-Stat3c mouse,pert
cell line: GIST882;	agent: DMSO (control);	replicate: Rep1,ctrl
T130 U133p2,pert
E81-/-vector-1,pert
mouse intestine pLagl2 knockout 1,pert
MF_II_3,pert
"non-AD_FC, biological rep8",ctrl
11425 UC Uninflamed ascending colon,pert
vacht KD 1,pert
mouse heart,pert
brain knock out replicate1,ctrl
kidney from control mouse,ctrl
"brain, cerebellum",pert
genotype: mcad -/-;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: vehicle;	tissue: liver,pert
cell line: KYSE270;	cell type: squamous cell carcinoma,pert
Silberg2 (10) 130701BE,pert
Healthy control 17,ctrl
BP2,pert
T4C-LU,pert
C2 patient,ctrl
"Neurons overexpressing Hes1 and GFP, biological rep3",pert
JIA PBMC Pre treatment A235_L003,ctrl
"U937 cell line, transduced with shSYK_1 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
GM19238_Kd_E2F6_3,pert
"fibroblast, MFS subject FB1211 rep 2",pert
"Male, 25 years old, HIV infection of ~2 months",pert
PBMC from T cell LGL leukemia patient #128 (TLGL128),pert
RNA-DHL6-R406-48H-3,pert
"Liver from Nrf2 wt mice, biological replicate 3",ctrl
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 32;	maternal age: n/a,ctrl
P60_PMP22TG_2,pert
"genetic background/strain: C57BL/6;	genotype: wild type;	cell type: embryonic stem cells;	developmental stage: day 0, undifferentiated;	passage: 8",ctrl
Trizol extracted total RNA from uterine fibroid tissue.,pert
brain_DLPFC_bipolar C_mr444,pert
Cells: HCT116 colon cancer cell line,pert
whole mouse lung homogenate,pert
"disease group: Nonatopic Control;	Sex: m;	age: 40s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 160;	ige (kiu/l): normal (0-48.5 kIU/L): 2.9;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-1,pert
age: 31;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
heart control 1,ctrl
HEK293_A08_R3,pert
hypothalamus,pert
Ischemia-reperfusion #2,pert
HEK-293,ctrl
wt_P2_rep1,ctrl
Tissue: striatum;	Age: 6 months;	Gender: F,ctrl
C57BL10 gastroc sample 2,ctrl
HW_475,pert
patient: 12;	disease state: hypertension;	tissue: Atheroma plaque,pert
"Total RNA, WT GMP",ctrl
B4 365 b4-/- untraeted,pert
BP patient 51_biological replicate 2,pert
SFM,pert
"IkB, LPS 0hr",ctrl
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
UM1_Mut_rep1,pert
U138MG shVEGFR-2 1,pert
Paraventricular nucleus_3d dehydrated,pert
CML cell line: KCL-22,ctrl
51A;pretreatment;female;breast tumor,ctrl
VMM-MUT_MyoD12h-2MP-s2,pert
parental biological replicate 2,ctrl
1118-01-C,ctrl
gender: M;	age at blood draw: 57;	tissue: whole blood,ctrl
H720 cell line control 2,ctrl
ES_WT_rep1,ctrl
"human failing LV myocardium, Idiopathic30",pert
SD rat femur,ctrl
"K562, 250nM1R-Chl, 24hrs, rep1",pert
U2OS_control_shRNA_pLenti_1_2007,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.38904,pert
HaCat cells infected with a BCL-3-expressing  lentiviral construct. Replicat 3,pert
Genotype: C57Bl/6 mice;	Age: 8-12 weeks old,ctrl
patient: 9;	disease state: hypertension;	tissue: Atheroma plaque,pert
LT-HSC Zbtb7a F/+ Mx1-Cre+ #1,ctrl
T145 U133p2,pert
Subject 3_t=30days_placebo,ctrl
"WT mouse heart at 6-weeks old, biological rep1",ctrl
44A;pretreatment;female;breast tumor; nonresponder,ctrl
01LR3_ERA,pert
chip number: 9;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.9;	transfection date: 2011-03-29,ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: heart;	age: 8 weeks,ctrl
control lung fibroblasts,ctrl
Squamous cell lung cancer patient 42,pert
CSTB KO_cerebellar granule cells at P5+2 DIV,pert
strain: Ts65Dn;	tissue: skeletal muscle;	Sex: male;	age: 5 months,pert
"non-AD_FC, biological rep13",ctrl
"ALL_DS, K30 012109",pert
"215, MUSCLE, Before",ctrl
GEIM195-U133A-DM,pert
KO - 3 mo - repeat 4 - Cy5 - mAdbID:74670,pert
HP-81,pert
"EBF1 d2, rep 2",pert
HC IF 2 water,ctrl
PB_DON086,ctrl
WT HSC 3,ctrl
"Endometrium, postmenopausal, control, 12-2",ctrl
DS2-iPS 5,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 10. Replicate B,ctrl
Brain of BSKO mice,pert
BC1 TC,ctrl
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 1",ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 45;	donor: 5;	disease state: Lesional,pert
5259 UC Inflamed sigmoid colon,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 1,pert
EB_07_19d_152_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Normal myocardium sold commercially (G),ctrl
TP06-963,ctrl
CD4IncTp1-9,pert
human_LIMA_artery_patient1_paclitaxel-eluting_stent,pert
Mouse_Retina_P7_Rs1h_KO 3,pert
WT - Cre Treated - 0.5 hrs - repeat 1 - Cy3 - mAdbID:62541,ctrl
TN3b-control,ctrl
"SKO-transduced MEFs, Vc-, D5",ctrl
Biceps_Pompe_6,pert
RatLung_H48h_3,pert
PancreaticSample36-Normal,ctrl
SKBR3 WT 1,ctrl
high grade serous carcinoma_patient 10,pert
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
CH2124,ctrl
HUVEC/NmenMC58_WT_4h_rep3_1117,pert
Human normal pituitary -N1,ctrl
15C-ER-D,ctrl
Squamous cell carcinoma 021,pert
whole blood_100537,pert
"BMDM, LPS 5hr",pert
MLL1-KO MEF CT18-1,pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-KO;	tissue: Skeletal muscle (quadriceps),pert
strain background: Mixed;	genotype/variation: wild type;	tissue: ventromedial hypothalamus (VMH),ctrl
Carrier-inj_Mip-1a-KO_rep1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.475;	OD280: 0.755;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 155;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 4x1h exposure per day",ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_1mM_HG-U133A_2_YCHSUP501,pert
Placenta_PE(LO)1 with Cy5,pert
disease state: Schizophrenic;	gender: Male,pert
U-87MG-PK25 set 3,pert
Moderate rep2 (retina),pert
N40726,ctrl
Biopsy 4 from cystectomy 10,pert
"human failing LV myocardium, Ischemic58",pert
Ainv15 EB10 replicate 1,ctrl
HNF1b_1a+,pert
age: 71;	sex: M;	disease status: control subject;	Filter number: 100;	Usage number: 1;	Exposures: 3,ctrl
tissue: 2B1 cell line;	genotype/variation: N/A;	age: 4 days post-differentiation in-vitro,ctrl
Individual_5936_NN_sample,ctrl
M229_R5_A_PLX,pert
Mouse fetal liver_E14.5_WT_rep1,ctrl
"DMD skeletal muscle, biological rep18",pert
strain background: C57BL/6;	gender: male;	tissue: thymus;	cell type: CD4 single-positive thymocytes;	genotype/variation: Bach2 knock out;	genotype/variation: Ly5.1-,pert
Hippocampus_Soman_3h_rep3,pert
PGA-RMM-48h-2aA-s2,pert
transfection: control shRNA;	cell line: Stable F1 Rif1 knockdown ES cells at passage 16;	background strain: C57BL/6xC3H,ctrl
Sample from retroviral MSCV-GFP control infected cyclin D1 knockout 3T3 cells (line 1).,pert
"C57BL/6J SAL, Rep2",ctrl
GM19238_Kd_NS2_23,ctrl
normal;	Adjacent pair of T7,ctrl
Bronchial Epithelial Cells control biological 1818E,ctrl
db/db 11-1,pert
8 wk old male mdx TA,pert
JIA PBMC Pre treatment A235_L027,ctrl
PKBa-/- MEF time 48 replicate 1,pert
16SAGEA2,pert
CD8+_Tcells_severe_asthmatic_2,pert
Large cell carcinoma 007,pert
Wild type day 3 Air replicate 1,ctrl
Liver_normoglycima_no.2,ctrl
Knockout cre_ppar_beta_floxed_rep3,pert
both ventricles of heart,pert
"tissue: lung, lower lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 68",pert
"Neural precursor cells derived from hES cells line SA01, biological replicate  3",ctrl
age: 45;	gender: female,pert
"Ovol2 KO, biological rep1",pert
age: 65;	gender: female,pert
181C0,ctrl
"C57BL6J-backcrossed, male",ctrl
T40836,pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:73;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
strain: E14Tg2A;	cell type: mouse ES cells;	knockdown: control;	overexpression: none,ctrl
GFP Zfx ko 1,pert
Hunk WT rep4,ctrl
CTRL_siRNA_rep2,ctrl
LCCS sample 20 weeks,pert
Mammary Gland_WT_rep2,ctrl
Control2,ctrl
Human colon biopsies from UC patient with active disease (involved mucosa),ctrl
Infected Jurkat cells (replicate 1),pert
triplicate 1 of uninfected HepG2 nt cells,ctrl
Age: 39;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
"liver,fasted,refed, 3hr",ctrl
p53_siRNA_0c,pert
Saline treated mouse gallbladder 4,ctrl
"brain, cerebellum: KCb12w#1_e1_le1",pert
RNA-DHL6-R406-24H-1,pert
S25 WT3	F41/391	S25	wild type	Mouse	2.5 months	Cerebellum	Female,ctrl
tissue: white blood cells;	age: 9.78;	Sex: female,pert
"sodium arsenite added to food: 10 ppb, 5wk;	diet: AIN-76A",pert
"IN1760 siPD treated, Biological replicate1",pert
"MHC class II high thymic medullary epithelial cells, NODaireWT",ctrl
"Sh2b3 KO, biological rep1",pert
T10,pert
PGC-1a KO 2,pert
Papilloma_tumour_epithelial_cells_Sox2cKO_rep3,pert
plasma;	patient with Acute Lung Injury,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 63, stage IB, HPV 16, HPV 18",pert
Huh7 cells_Mock Infected 24 hours_ rep3,ctrl
Mouse_WT_ES_clone 2,ctrl
Haloperidol treated 12weeks AffyGC RMA rep2,pert
KU_21N,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 3,pert
CC1 21d replicate 1,pert
CEPI_IIIc_242,pert
Huh-7/IRF1 rep2,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.86;	choa: 161;	fata: 49;	eea: 1360;	wtkg: 52;	perfat: 39.5;	lbm: ;	fat_mass: 2054,ctrl
Neuroblastoma SH-SY5Y cells_cloneB_stably transfected with RNAi against DJ-1_replicate1,pert
marginal E-mu-BRD2 mediated lymphoma,pert
WT HSC 1,ctrl
HCC009N,ctrl
Male 8week AJ CBDLrep3,pert
RORasg/sg WAT_HFD_rep3,pert
DU145/MYB siRNA,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 29.490;	Ratio: 2.12,ctrl
genetic modification: Cd19-cre mediated deletion of the SRF Gene;	tissue:  spleen: FACS sorted IgM+IgD+ cells,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
ND_7,ctrl
C57BL6_lung,pert
WT 2 sample A,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, mock",ctrl
liver 0.1% quercetin diet rep1,pert
cell line: cervical cancer (HeLa) cells;	agent: control,ctrl
Diagnosis: MDS/AML;	Age: 83y ;	Gender: Female;	Blast %: 90;	Source: PB;	Cyto: tris8;	FLT3 ITD: 1;	FLT3 TKD: 1,pert
X_p4_rep1,pert
Insm1 control #6,ctrl
MDS patient 10,pert
"Empty vector, plastic plate, rep1",ctrl
RNA from HCC_30N,ctrl
KN-sham-5 month+1d-R4,pert
"Uninvolved Skin, NS-29",pert
"Gender: Female, Age: 30, BMI: 24, Tissue: luteinized cumulus cells",ctrl
patient: 460A;	disease state: LGSC;	component: Borderline,ctrl
"Normal Skin, Normal-10",ctrl
TREx_Flp_FTO_siRNA_2,pert
4T1.2-BV-2,ctrl
Kyoto rat liver tissue following animal exposure to orotic acid for 3 days,pert
cell line: THP-1;	shRNA construct: GSK3B Construct 2,pert
subject: 38;	disease: CP;	muscle: ST;	gender: M;	age: 9.4;	gmfcs: 2;	popliteal angle: 100,pert
"non-AD_TC, biological rep8",ctrl
Soleus muscles from male BERKO ( estrogen receptor beta knockout),pert
Sample Group: control; Gender: male; Age: 46; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
SC263_CETU2,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 6,pert
"AZ521 dnSox2 cells, induced, 24h",pert
SCHT control 3,ctrl
D_LS_Wk4,pert
8h 4OHT-treated-sample1,pert
KO - knock-out Treated - 12 hrs - repeat 3 - Cy5 - mAdbID:61761,pert
"Ls174T, β-catenin siRNA, uninduced",ctrl
microdissected epithelial cells from normal main pancreatic duct 2,ctrl
Vehicle-Control;	Vehicle-Control 24 hours set 1,ctrl
Tumor-KO-rep3,pert
Oga_WT_MEF_E8_rep2,ctrl
"Normal tail skin from control mouse, biological replicate 1",ctrl
BAL_18_A1B0,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/18/05;	# cells: 65;	Sex: male;	region: M1;	age: 40;	genotype: Y/Mecp2-;YFPH/-,pert
"Cell line:  Fibroblast TTP KO cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",ctrl
Ileum_POR-null+quercetin_2,pert
H12 HA 6h 2,pert
B7m6,pert
sex: Male;	Age: 5 months;	additional patient information found in Series supplementary file,ctrl
scan batch: Batch 2;	group: autism;	subject age: 2;	paternal age: 28;	maternal age: 31,pert
aa.2,pert
strain: C57BL6;	genotype: WT;	tissue: striatum;	treatment: PDE10i,pert
"BMDC, wt, replicate 1",ctrl
race: african american;	age (years): 47;	stage: IA;	grade: 2;	histology: endometrioid,pert
BP13,pert
"Normal subject (56 year old caucasian female, SAK_1290052750)",ctrl
CD4+T cells,pert
imanitib1,pert
FVB_MMTV_Wnt1_iFGFR1_3851_5L_ROSEN,pert
AO 1hr,ctrl
colonic_mucosa_non_inflamed_744,pert
MSE_N_G98A,ctrl
NOMO-1 acute myeloid leukemia cells,ctrl
"EAE, placebo-treated #1",pert
SCC-40_siZMPSTE24_rep.2,pert
"transgene: none;	treatment: treated with scrambled siRNA, after 48h",ctrl
Sample ID:DCBD2.1;	Twin Pair ID:TP8 ;	Clinical Status:Control;	Age of Onset:-;	Age at interview & blood sampling:20 ;	Current Age (2007):24;	Sex: Male ;	Medication at interview (duration) :none,ctrl
FK1,ctrl
Cbx2_KO_XY_2,pert
striatum_Pink1 knockout_12 weeks_replicate 2,pert
EB_0_5d_62_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
strain: mixed C57BL6;	genotype/variation: Rptrflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: BaCl2 muscle injury;	tissue: hindlimb muscle contralateral to BaCl2 muscle injury;	cell type: CSC;	time: 2.5 days post injury,pert
"ME16C, 12h, sham",ctrl
IFC 02,pert
"Sfrp5 KO HFD 8 weeks, biological rep8",pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: healthy,ctrl
peripheral blood cell,pert
Osteoblasts_Lrp5_Control_Day7_rep3,ctrl
phenotype: alcoholic;	gender: female;	case_id: 304;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 58.5;	brain ph at time of freezing: 6.4;	labeling_batch: 1,pert
Colonic mucosal endoscopic pinch biopsy,pert
cell line: um-uc-3 (atcc# crl-1749);	cell type: bladder cancer cells;	genotype/variation: transfected with gfp-tagged rhogdi2,pert
PFR3_replicate_1,ctrl
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
220D6,pert
"human nonfailing LV myocardium, NonFailing7",ctrl
Pediatric_GBM_4,pert
19A;pretreatment;female;breast tumor; responder,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 12h,pert
cell type: dermal fibroblast;	genotype: CCALD patient,pert
triplicate 2 of S. aureus infected HepG2 HIF-1-/- cells,pert
siControl_5,ctrl
11: FCHL patient #99-0308,pert
"knockout liver, biological rep 1",pert
57A;pretreatment;female;breast tumor,ctrl
c-Met KO CD9+ trophoblasts,pert
HF0510_U133P2,pert
Pool 4 Convalescent stage,pert
microdissected breast cancer cells from case 1363,ctrl
MOLM14_luc_Replicate3,ctrl
RNA from microdissected breast cancer cells from case 651 labeled with Cy5,pert
genotype: WT;	strain: C57BL/6;	treatment: regular diet,ctrl
"brain, Entorhinal Cortex: 99-28 normal_e1_le1",ctrl
CF (D508) subject7,pert
heart,ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: WT,ctrl
SLE CD4 T cells 14,pert
cumulus_PCOS_Lean_rep1,pert
Nrl-ko-Gfp 4 weeks replicate 4,ctrl
quadriceps muscle tissue of normal controls,ctrl
CLL5-CD4,pert
Dengue Fever Patient 42,pert
C57BL10 soleus sample 2,ctrl
T178,pert
PBMC of Rhesus Macaque Mnk_3133-S-7,pert
MDS11,pert
42A;pretreatment;female;breast tumor; nonresponder,ctrl
lymphoblast cell line,ctrl
HCT116_shBgal-rep1,ctrl
"Acute Myeloid Leukemia, sample 30",ctrl
"wildtype pancreas, biological rep1",ctrl
tissue: white blood cells;	age: 9.84;	Sex: male,pert
scrambled biological rep2,ctrl
Olfactory mucosa,pert
Epididymal adipose WT ND #686,ctrl
"vector d0, rep 2",ctrl
"Spi-21, biological rep 6",pert
IM122_case,pert
R3,pert
treatment: siRNA LMG2,pert
"mouse aorta cross strain comparison, C3H_T04_NC_03",ctrl
V5-P051,pert
"FA6 transiently transfected with non-targeting siRNA, transfection C",ctrl
BCell_lymphoma_marginal_sample6,pert
"ALL_NDS, K33 011609",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 78 years,ctrl
"Rb null MEFs with cisplatin treatment (16microM, 24hrs)",pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 4,pert
"Untreated TG2 knockout NB4, biological rep3",ctrl
tissue: Brain;	genotype: Npc1+/+;	age: 60 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
whole uterus,ctrl
HDAC1_G10-rep2,pert
P60 Vax2-/- 2,pert
cell line: A2780;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 7.03;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
Expression data from liver of the KRAP deficient mice (KO1),pert
M24met_Wnt1_5,pert
Healthy controls; individual=CM; time=2; beverage=alcohol,pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 29;	maternal age: 30,ctrl
siERK2Veh24h_3500,ctrl
"Runx1KO, biological replicate 2",pert
Liver_untreated_wild type_rep2,ctrl
"Normal T-cells, CD3+, donor 8",ctrl
liver_co_6M_rep3,ctrl
WT_PLACEBO_12hours_4,ctrl
newborn (P0) Krt1-/- skin_replicate 1,pert
F1 ES Cells,pert
"Undifferentiated Dicer -/- ES cell line, passage 18",pert
3560-2 E2F2 Null,pert
MH1C1_low_rep4,pert
"DHL6, DMSO",ctrl
"Wild type used for MAT1A 8 month, replicate 5",ctrl
cell type: BMDM;	strain: C57BL/6;	genotype: No2 -/-;	infection status: uninfected,pert
Ecad_Mut_3,pert
4_Hr_No_MGd_1,ctrl
CD4+/CD25- T effector cells 72h after activation,pert
KU_18N,ctrl
Wild_Type Circadian_Time_14,ctrl
"Patient 5, Atheroma plaque",pert
shGFP-rep-2,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),pert
coMCF-7_2,ctrl
Nrl-ko-Gfp P10 replicate 2,pert
"DBA/2J Saline treated, biological replicate 2",ctrl
"650nM MLN4924 after 4hr, replicate 2",pert
K562 cells CREB Knock-out replicate 3,pert
020112-2,pert
Healthy individual of twinpair #8,ctrl
puroB replicate 1,ctrl
"Cardiac, ventricular tissue",ctrl
CD34+ cells from the patient (CML33),pert
treatment: siRNA against ETS2;	cell line: H441,ctrl
Sodium arsenite added to food: None; Injection: IP 8hr 1 mg/kg sodium arsenite in saline; Diet: AIN-76A; Sodium arsenite added to drinking water: None,pert
"control endometrium, patient 3",ctrl
10-0021A_Day1_19,pert
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate2,pert
P28 testes,ctrl
lung_E18_sftpc-nmyc_rep1,pert
microdissected epithelial cells from IPMC 1,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.63562,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
"Normal Cervix, microdissected epithelium, Age 54",ctrl
"spc-c-raf transgenic mice, age: 6 month old, Gender: male, Tissue: tumor",pert
Subject 2 / lung subsegment instillated by Saline,ctrl
BV2_Curcumin_rep2,pert
Human.AT.CP.ECRB,pert
Ishikawa_VeryLowDose_BPA_8h_rep2,pert
Thyroid_ unaffected_paired with PTC69T,ctrl
"cell line: Hec50co endometrial cancer cell line;	cell line traits: Loss of p53, loss of hormone receptors ER and PR;	disease state: Grade 3 endometrioid adenocarcinoma;	genotype/variation: MTDH knockdown",pert
ko 13.5d replicate 1,pert
L1 062502 Rosi2,pert
pt. HCL E treated with DMSO for 48h,ctrl
control KD mouse ES cells,ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 178-day-old male;	40 mg liver used for RNA extraction",pert
human CD14 positive monopcytes,ctrl
EA_Control2_CD4,ctrl
463MM,pert
"DBA/2J SAL, Rep1",ctrl
LY2 control-siRNA tamoxifen treated rep2,ctrl
"SWR/J Saline treated, biological replicate 3",ctrl
strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 3 months;	tissue: liver;	disease status: steatosis,pert
"shControl clone 2, rep 1",ctrl
Haloperidol treated 4weeks AffyGC RMA rep1,pert
A VIS _B031,pert
myoblasts transduced with lentivirus carrying DUX4-s,pert
cell type: neuron progenitor cells (NPC);	disease group: healthy control,ctrl
"Control siRNA - 2 days adipocyte differentiation, rep1",ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: female;	age: 20 weeks;	genotype/variation: VhlhKO",pert
HeLa_06_21_04 TP-4,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 14 months,pert
patient: 26;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
ko 13.5d replicate 5,pert
lesion_postUV_patient8,pert
Healthy control_sample7,ctrl
ab064 N,ctrl
Zmpste24+/+ mouse embryonic fibroblasts (P3),ctrl
Patient: I;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
4T1.2-BV-1,ctrl
cell line: A549;	cell type: Lung adenocarcinoma,ctrl
MDS patient 9,pert
striatum SNCA knockout 6 month replicate 2,pert
"203, MUSCLE, Before",ctrl
tissue: peripheral blood from 8-10 E12.5 embryos;	genotype: Cbfb+/+;	progeny from cross: Cbfb+/- x Cbfb+/-,ctrl
L_LS_Wk2,pert
diagnosis: HP;	fvc-group: FVC3;	tissue: lung,pert
01LRK_ERA,pert
"P60_C-DGCR8 KO cones, replicate 2 [array]",pert
monocytes_T14,pert
"Uninvolved Skin, NS-9",pert
cell type: PBMC;	disease state: Acute,ctrl
SKNSH eGFP3,ctrl
Normal-ERα-positive breast cancer 36,ctrl
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: 4-hydroxytamoxifen;	dose: 100 nM,pert
MPM tumor specimen 11,pert
PGA-MAH-C3H_OVA6h-3aA-s2,pert
Subject #8017-8hr Postinfection,ctrl
"liver, Q10, 14 months",pert
CME-LaminA3d-3MA-S2,pert
"EBF1 d2, rep 4",pert
"human failing LV myocardium, Ischemic107",pert
4010-4 E2F2 Null,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA)",pert
"Cerebral Palsy, Gracilis, Patient Replicate 4",pert
genetic background: FVB;	cell type: DN2;	genotype: E2A deficient,pert
"Acute Myeloid Leukemia, sample 2",pert
CML Patient 5 before therapy,ctrl
GM19238_Kd_POU2F1_2,pert
FHCRCAML169017,pert
Knockout day 3 Air replicate 1,pert
wildtype Tcof1 [B],ctrl
"human failing LV myocardium, Ischemic23",pert
Gingiva tissue,ctrl
CH2125,ctrl
IMR-32_pCMV-SQSTM1_48hr_rep 2,pert
CTRL_3_CMP,ctrl
MCL_IGHV_MUT (R1301),pert
Sample ID: TP28;	Twin Pair ID: CCN5.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 34;	Current Age (2007): 37;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 26/47,pert
Pertuzumab treated after 4 days (P2_1),pert
"liver, Q10, 6 months",pert
GEIM58-U133A-DM,pert
"Patient 24, Macroscopically intact tissue",ctrl
WT-smoke-high-5 month-R1,ctrl
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50), biological rep2",pert
X_p4_rep3,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 4;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
"C57BL/6 mice, thymus and spleen pooled",ctrl
HMEC culture,ctrl
"IKK2 WT cell line, biological replicate 2",ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MeCP2 shRNA,pert
"Healthy volunteer, Control_11695",ctrl
Superior Frontal Gyrus_2y_normal,ctrl
LCL Unaffected MZ twin pair 4 (CCN4.2)(TP26),ctrl
hair follicles from wild-type,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L014,pert
genotype/variation: Gsk-3a-/-;	cell type: embryonic stem cells,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 41.51233,pert
"Liver from Nrf2 wt mice, biological replicate 2",pert
"Patient  E, lesion, 2 week",pert
"non-AD_TC, biological rep13",ctrl
whole blood_101369,pert
129_Sv_2_Runx1_Ko_d6_4302,pert
"Wild-type-neocortex, biological rep3 (male)",ctrl
GM19238_Kd_GTF2B_1,pert
RNA from microdissected breast cancer cells from case 1125 labeled with Cy5,ctrl
race: african america;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
GM19238_Kd_CEBPG_3,pert
Fibroblasts isolated from wild type mouse mammary glands,ctrl
tumor cell line HepG2 with knockdown of HIF-2α rep2,pert
N40741,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 27.26575,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: ;	fata: ;	eea: ;	wtkg: 69.9;	perfat: 10.4;	lbm: 61.2;	fat_mass: 726.96,ctrl
DUSP1+/+ control replicate 1,ctrl
Muscle PCOS pioglitazone 271,ctrl
control virus-infected replicate 2 (monocytes),ctrl
Skin_Control E16.5_rep1,ctrl
BALB/c d3 (191msn),pert
69A;pretreatment;female;breast tumor; responder,ctrl
"103, ADIPOOSE TISSUE, Before",ctrl
Bronchial Epithelial Cells MMA biological 2156P,pert
34A;pretreatment;female;breast tumor; responder,ctrl
patient code: 123;	gender: Male;	age: 74;	tumor grade: 3;	t-stage: 1;	n-stage: 1;	ajcc classif. (2002): 2b,pert
SCLC cell line Lu-134a,pert
Patient 3,ctrl
"shCDK8, low glucose, replicate 1",pert
CH1804,pert
"Patient 8, Macroscopically intact tissue",ctrl
KO621,pert
Normal Pleura 4,ctrl
"SFM control cells (24hr), biological rep_1",ctrl
DNGM-5,pert
KOC 67 PBS treated,ctrl
Parkinson's disease sample x001,pert
"Subject 12, Family 4, Control",ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 1 hour",pert
K562 STI sample 8,pert
THP1-shGSK3B-Construct2-rep1,pert
NPC2,pert
Liver_hyperglycima_no.3,pert
gender: Male;	age: 58;	post-mortem delay: 15h;	ph: 6.5,ctrl
Muscle control 12,ctrl
RNA from HCC_11T,pert
"siThoc5-2, biological rep2",pert
R6/1 22 week wildtype_C835,ctrl
D4 patient,pert
"non-AD_FC, biological rep15",ctrl
Seguin_IDR_BrownNorway_Liver_treated1,pert
Intestine_Ctrl_biological rep4,ctrl
GM19238_Kd_IRF3_1,pert
"tissue: heart;	strain: mixed background of C57BL/6, 129/sv, and Balb/c",pert
"Lymphoblastoid cell lines derived from family 1734, member 1",ctrl
WT Primary Hepatocytes - Pooled -Cy3,pert
Spleen_wt_4m_rep3,ctrl
gastrocnemus muscle,ctrl
condition: Psoriasis;	patient: PS-A;	tissue: LS skin biopsy;	kit: Affy,pert
Group4: 6 days differentiated Flk1+ Runx1-/- ES cells,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
DIA-n7-2; normal diaphragm 7 month,ctrl
"disease group: Psoriasis;	Sex: m;	age: 30s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 34;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 360;	ige (kiu/l): normal (0-48.5 kIU/L): 224;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 22.80822,pert
01LQH: normal control,ctrl
EosKOCD25+#1,pert
Colon 21 days old,ctrl
Sex: female;	Age at operation: 76 years;	Site: thigh;	Size in cm: 38.5x17.5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
pediatric AML S31,pert
WT Hippocampus - 1,ctrl
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Wild-type,ctrl
tissue: white blood cells;	age: 7;	Sex: female,ctrl
U87-mC1,ctrl
KM_053T,pert
cell type: HeLa;	genotype/variation: nucleofacted with Dharmacon control siRNA,ctrl
"wildtype (GFP-negative) kidney cells, biological rep1",ctrl
disease state: mPIN (mouse prostatic intraepithelial neoplasia);	age: 20 weeks;	tissue: ventral prostate;	strain: FVB,pert
TB 3,pert
"sirna: Dhamracon negative siGENOME Non-Targeting siRNA;	cell line: Human epithelial colonic adenocarcinoma, Caco-2",ctrl
Normal-ERα-positive breast cancer 31,ctrl
SEB-1 treated biological replicate 2,pert
MEF E2F4 KO 1-rep1,pert
Rsk2-KO Hippocampus - 1,pert
MPM tumor 26,pert
"Transgenic mice with water, replicate 1",pert
V5-P101,pert
"AD_TC, biological rep10",pert
disease status: controls;	tissue (brain region): Cerebellum,ctrl
colon_IBD_1118,pert
Normal Adrenal Gland (AN14),ctrl
"breast tumor epithelium,40",pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 6 months,ctrl
cell type: breast cancer cells;	agent: none,ctrl
"miR-148b-C (miR-148b-2+, biological replicate 3)",pert
"granulocyte, healthy control, biological rep4",ctrl
"Carcinoma in situ_1 (CIS, double transgene)",pert
Control d10 (3),ctrl
"Wildtype luminal mammary epithelial cells, MD642",ctrl
A505 Sham 1 day,ctrl
454MM,pert
erStress_twins_AA_1734twin2_500nM_thapsigargin_4h,pert
Pias1 null IFN-beta 2 h,pert
Wild-type retina at P15,ctrl
intestine_PPARa-knockout_control_rep3,pert
Normal_2169,ctrl
"cochlea at P3, wt, biological rep 1",ctrl
cell line: KGN;	transfection: GC matched control,ctrl
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 89;	Usage number: 5;	Exposures: 3,pert
"NALT infected with 90-226 deltaM, 24h, biological rep2",pert
Allo-14-2,pert
CLL10-CD4,pert
Against CDK19-2 transfected HeLa S3 cell,pert
"LSD2 knockdown, replicate 2",ctrl
695_EV_4hr_repeat1,ctrl
Postnatal 3 weeks control heart biological rep2,ctrl
con-13_A,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 3,pert
KN-smoke-med-1 day-R4,pert
EOM 14 Day mdx rep 1,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep6,pert
D2-Gpnmb+ control rep10 (retina),ctrl
WT liver_HFD_rep3,ctrl
MDS patient 24,pert
BxPC3-KO111 rep 5,pert
siCtrlVeh24h rep2,ctrl
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-1,ctrl
Individual_5143_NN_sample,ctrl
01J43_Systemic,pert
No or early 2 rep6 (retina),pert
siNEG replicate 1,ctrl
human liver,ctrl
"DMSO treated THP-1 cells, biological replicate 1",ctrl
"control, BA10-43",ctrl
BT474-J4_Lap_24-2,pert
Muscle FC2,ctrl
"MaF pre-iPSC9P2, Vc-, D3",ctrl
3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24715,pert
HCC005T,pert
shRNA6-16-plusDox-rep1,pert
sample 1:;	age: 32;	gender: female;	sample 2;	age: 47;	gender: male;	sample 3;	age: 75;	gender: female,ctrl
CON14,ctrl
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	Weight: 20-25g;	Wild type,ctrl
Human skeletal muscle biopsy sample;	Patient #57 with NORM,ctrl
M473 SKM-Tg,ctrl
Gata4Loxp/-VillinCre adult male jejunum (6-8wk). Gata4 conditional knockout (mutant) sample.,pert
"acutely admitted, severely psychotic schizophrenia patient  A16",pert
Cervical Cancer C542,pert
"cochlea at P60, ko, biological rep 1",pert
LOXL2 3,pert
"U937 cell line, transduced with a control luciferase and selected with  1 µg/ml puromycin 48 hours post-infection",ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 9,pert
"108, ADIPOOSE TISSUE, After",pert
"Exp A, Animal #257, 50mg/kg D-Serine",pert
Neo6 cell line,pert
"Tibialis Anterior Muscle, Wildtype, Aged",ctrl
"neocortex, 30 months of age, resveratrol diet",pert
Mic33_muscle_control,ctrl
whole blood_101611,pert
F_LS_Wk2,pert
Human Acute HIV Sample A144-CD8+ T cells,pert
liver_co_14M_rep2,ctrl
12B,pert
"testis, Repro9 mutant, 14dpp, Rep5",pert
Tendon;Quadriceps_Non-lesional,ctrl
treatment: naïve;	transgenic variant: FVB/N;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,ctrl
RNA from HCC_26N,ctrl
B10.H2g7 Idd3_S2,ctrl
Sample: nontransgenic control (NTG);	Replicate: 1;	Pool: NP,ctrl
7: NORMAL #00-0267,ctrl
tissue: normal colonic mucosa,ctrl
CTRL_siRNA,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day2,pert
Mouse TCF-1-deficient memory CD8 T cells,pert
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 7,pert
"ICR10 mouse strain (Nrf2-/-)  gender- female, age- 2 months, n = 1, # of tissue = 1, tissue: Lung, Cell:Type II.",pert
non-CF subject 32,ctrl
"brain, control, 6 months",ctrl
LNCaP-MED1 overexpressed,pert
"NC1, biological replicate 5",ctrl
"-Rosi, +PPAR, 24hrs",pert
"atRA WT, set 4",pert
Itk knockout CD4+ unstimulated 2,pert
patient: 801B;	disease state: LGSC;	component: Invasive,pert
ve_NY26,pert
siControl_3,ctrl
siTNIK+7hr Wnt (Experiment 2; dye swap),pert
MSC_VUB01_3,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-tu2,pert
race: caucasian;	age (years): 75-80;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
Phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject C (CAcCD8),ctrl
"Autoimmune pancreatic islets, day 3 cyclophosphamide treatment, rep 1",pert
mdx5cv EDL sample 1,pert
MOLT4_ctrl_A,ctrl
Disease_status: Bipolar disorder;	Age (years): 51;	Gender: Male;	Age of onset (years): 23;	Duration of illness (years): 28;	Brain pH: 6.67;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: 1200;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
RNA from HCC_33N,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 210min;	race: White;	sex: Male,pert
Gene expression profiles of Lkb1 KO #4 HSCs,pert
"patient 6, left arm treated with pimecrolimus until day 22",pert
Rejecting allografts 7 days No.2,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.54;	age of onset: 21 yr,pert
"breast tumor epithelium,18",pert
Individual_5905_NN_sample,ctrl
Male mouse 60 day old,ctrl
01-0058A_Day1_4,pert
3550-1 E2F WT,ctrl
6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24722,pert
"Tibialis anterior, healthy control",ctrl
patient: 40843;	sample: normal,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 2,pert
con-50,ctrl
"spleen follicular B in WT, biological rep4",ctrl
HT29,ctrl
striatum_Pink1 knockout_24 weeks_replicate 1,pert
SCLC cell line DMS79,pert
Superior Frontal Gyrus from a 6 year-old girl suffering from Rett Syndrome.,pert
OSCE-15T,pert
ROS1,pert
Pool Ts1Cje_P15,pert
"Cells: U2OS, Treatment: infected with control shRNA_pLenti, blasticidin selection",ctrl
triplicate 1 of S. aureus infected HepG2 HIF-1-/- cells,pert
patient: 235;	current medication: Asacol Predfoam Lanzoprazole;	birth date: 1/9/47;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/24/97;	diagnosis date: 8/26/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/11/05;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/11/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/97;	smoking amount: 15-24;	other illnesses: TURP;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
OSE_563,ctrl
"Huh7 cells, JFH-1 Infected, 6 hours.",pert
SZ12,pert
"Donor 1, mock infected 1hr",ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-1502;	gender: male;	passage: P11;	clone: C29,ctrl
NFIA E18WT1,ctrl
wild type control tissue  3,ctrl
KO - knock-out Treated - 2 hrs - repeat 2 - Cy5 - mAdbID:62609,pert
5284 UC Uninflamed ascending colon,pert
E18.5 control,ctrl
MSI colorectal tumor,pert
2-3 month old littermate control animal (IκBαfl/-),ctrl
Female - caucasian - E-03-G,pert
"whole-blood leukocytes, placebo, 4hr",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 6,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 42 yr;	population: white;	dsm-iv: 296.8;	age of onset: 18 yr,pert
sample =Healthy1 treatment=Control time=0 (min),ctrl
DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma) Replicate 2,pert
CME-Ctr_LaminA4d-1MA-S2,ctrl
WT STR Veh 5,ctrl
RelA_siRNA_0a,pert
CML Patient 1 7 days therapy,pert
KU_04T,pert
Mening UNSTIM WB NP 6b,ctrl
"Patient  F, lesion, 2 week",pert
4112-2 E2F WT,ctrl
strain: C57/Bl6;	gender: male;	genotype: Egr-1 wildtype;	age: 30 days;	tissue: retina,ctrl
GLY replicate 6,pert
SHANK3_3,pert
con-50_B,ctrl
Normal_2222,ctrl
VPA Treated Rep 3,pert
"Mature proximal small intestine with intestinal epithelium-specific Pdx1 inactivation, first 5 cm immediately adjacent to the pylorus",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 64 yr;	population: white;	dsm-iv: 295.7;	age of onset: 19 yr,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 80;	time: 0;	batch: 2,ctrl
gfp control sample 1,ctrl
Gsk-3a-/- ESCs Rep2,pert
MCF7_Control_Array_1,ctrl
CD19_selected_B-cells_before_R_rep10,ctrl
cell line: NALM1;	tissue: Human B cell precursor leukemia,ctrl
Primary hepatocytes isolated from Donor 2 treated with Wy14643 for 6h,pert
SUBSTANCE P 24 HOURS,pert
WT(Rnh1+/+) -2,ctrl
strain: C57/Bl6;	genotype: Akt1+/+;	gender: PND70 female,ctrl
WT_R6_rep3,ctrl
14dpp Ubb knockout testis,pert
"NASP Overexpression, sample #4",pert
Brain from 55 days Npc1+/- mouse1,ctrl
123B,ctrl
Hunk Knock-Out rep 2,pert
KO - knock-out Treated - 12 hrs - repeat 3 - Cy3 - mAdbID:61764,pert
BMM,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A02",pert
"Spi-21, biological rep 1",pert
"disease group: Psoriasis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 9.1;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 10;	ige (kiu/l): normal (0-48.5 kIU/L): 49.3;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
gender: Female;	age: 54;	post-mortem delay: 4h;	ph: 6.5,ctrl
Stain: RPE65-/-;	Age: 2 months;	Tissue: retina,pert
siCITED1#1 replicate3,pert
Esophagus CTR replicate 1,ctrl
cell line: SCC-40;	cell line origin: Oral cancer;	genotype/variation: control,ctrl
strain: C57BL/6J;	gender: male,pert
cell line: OVCAR3;	transfection: eukaryotic expression vector pcDNA3.1 containing no insert,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 32 yr;	population: white;	dsm-iv: 295.9;	age of onset: 29 yr,pert
Primary hepatocytes isolated from Donor 6 treated with DMSO for 6h,ctrl
Biopsy 1 from cystectomy 18,pert
HeLa cells transfected with siSp1 rep 3,pert
NORMAL #99-1053,ctrl
Brain_nAChRbeta4SubunitDeficent_MiceNob4363,pert
BCell_lymphoma_aggressive_sample4,pert
expression array - O2,pert
PGC-1a-/-bf/f/MerCre rep4,pert
CA1 hippocampus,ctrl
SCLC cells,pert
"seminoma specimen, pT1, pN1, patient age: 34y",pert
Tobacco abuse,pert
"cultured PBMC, nontreated",ctrl
C2C12 myotubes 1000uM H2O2 rep 4,pert
genetic background: FVB;	cell type: DN2;	genotype: wild type,ctrl
"Monuron-treated NRK-52E cells at 72h, biological rep 3",pert
STV_G,pert
MIC4,ctrl
"MDA-MB231 cells, G9a knockdown",pert
"19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"gender: male;	batch: 2;	age (years): 35;	patient id: Non_severe_3;	fev1 (% predicted): 77;	fvc (% predicted): 89;	medication: Becotide, Ventolin;	cell type: CD4+ T-cells",pert
p107-/-;	age: newborn;	strain: FVB;	tissue: skin,pert
AQA C,ctrl
HeTH-4 rep-1,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A;	cell line: GM00038,pert
"pancreas, control diet, replicate 3",ctrl
"Ulcerative Colitis (55 year old caucasian female, SAK_1319013894)",pert
166-01-C,ctrl
BE-rep3,pert
GM19238_Kd_IKZF3_3,pert
MCF-10A shATM-3 replicate 2 [set 5],pert
lrrk2 genotype: WT / LRRK2 GS,pert
11380 Normal Uninflamed ascending colon,ctrl
CON - LV22,ctrl
"human failing LV myocardium, Ischemic41",pert
male_control_211,ctrl
Clcn5 knockout,pert
Patient 6 skin treated,pert
"treatment: control;	batch: 7;	donor: 53;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
8 week old EOM MDX rep 3,pert
"Tumor sample from patient with p53 wild type, replicate 3",ctrl
HF0615_U133P2,pert
NHE3-/- replicate 3,pert
MPM tumor specimen 2,pert
Map3k7 (TAK1) knockout replicate 3,pert
Clozapine treated 12weeks AffyGC RMA rep4,pert
Neocortex_Eomes_WT.2,ctrl
wt_P6_rep4,ctrl
tissue: cerebellum;	strain: wild type;	age: 3 months;	genetic background: C57Bl/6,ctrl
Pt38_Post,pert
ctrl- rep2,ctrl
"Cell line SLM2, mutant status WT, condition Control 1",ctrl
"vestibualr organ at E18.5 of Igf1 -/-, biological rep 2",pert
NINDS-RHS-Kainate_240h-1aUA-s2,pert
28dpp wild type testis,ctrl
B6_Pseudomonas_overexpressor_48,pert
EA_Control_CD8,ctrl
Wildtype 1 (jos0677),ctrl
NFIA E18KO1,pert
A YOKE_B027,pert
KM_028T,pert
E17.5 preB cells_Smchd1 wildtype_Rep 3,ctrl
TscWT3_brain,ctrl
heart_co_14M_rep1,ctrl
mESCs_EGFPcontrol_rep2,ctrl
"125, MUSCLE, Before",ctrl
KO_cycling_rep3,pert
HeLa cells transiently transfected with a Stau1 siRNA.,pert
WSD-first,ctrl
liver_wild type_24 weeks_replicate_3,ctrl
Bone-Marrow_SMM_S1340,pert
"Control #4, Untreated",ctrl
BS2011051055,ctrl
"Acute Myeloid Leukemia, sample 7",pert
ventricular tissue,pert
Moderate rep7 (retina),pert
Leptin treated mouse gallbladder 8,pert
PBMCs from normal control subject C,ctrl
"Sham NALT (PBS), biological replicate 3",ctrl
HepG2_VehicleA_24hr,ctrl
strain: C57BL/6;	tissue: Spleen;	genotype: WT,ctrl
"fibroblast, wild-type, untreated, biological replicate 2",ctrl
Individual_5849_PP_sample,pert
sample: #11;	subject: PD case #1;	brain: T-243;	age: 77;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
L-540_Perifosine 10µM_24hrs_2B,pert
CD4+/CD25- T effector cells 72h after activation,ctrl
CTL made from PDK1fl/fl TamoxCre splenocytes and treated with 4OHT,pert
patient id: 42;	tissue: Normal cortex;	gender: Male;	age: 45;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
NMRI_24h_Wy,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L003,pert
Muscle PCOS after pioglitazone 102,pert
Untreated wild type C,ctrl
CCRPKO-PBS_rep-2,pert
TF1_controlsiRNA_2,ctrl
disease state:NHM;,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#106,pert
"208, ADIPOOSE TISSUE, Before",ctrl
CD4DecTp1-8,pert
"Control 1, biological rep4",ctrl
HD 4,ctrl
BAT_KO_1,pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 4;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: NO,ctrl
BM_02300,ctrl
Undifferentiated Dicer -/- (27H) ES cell line replicate_2,pert
E9.5 embryo_Cop1KO_rep1,pert
quiescent ulcerative colitis_UCN1,ctrl
GLIP1,pert
KO PGC rep1,pert
MDS patient 32,pert
UC-55-un,pert
myotubes from control subject,ctrl
A7,pert
chip number: 16;	transfection plate: 5;	target gene: TAF1;	kd level: 0.68;	rin: 9.4;	transfection date: 2011-10-17,pert
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: STAG2 knockout clone 7 (STAG2 deficient),pert
FACS-purified B cells_129SV/EV_influenza-infected_rep4,ctrl
"PDK1 null CTL, biological replicate 1",pert
BAL_27b_A2B1,pert
Gata4LoxP/+VillinCre adult male jejunum (6-8 wk). Control sample.,ctrl
BC9 TC,ctrl
normal 3370,ctrl
Replication 2 Aldosterone,pert
HSL-null 2,pert
cell line: SKBR3 parental;	treatment: basal conditions,ctrl
shCypB3,pert
A_AN17138_F,pert
Sprague Dawley rats;	Gender: male;	Weight: 250-350 g,pert
Cav3 knockout,pert
miR122-WT-103,ctrl
MPM tumor 40,pert
Control Endometrium Stromal Cell_ETB65 -+,ctrl
10A;pretreatment;female;breast tumor; responder,ctrl
p300+/- Rep3,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: none;	vector: none;	activation: 2 h 100 ng/ml TNP-BSA,ctrl
knockdown: estrogen receptor alpha KD;	cell line: MCF7,pert
cell line: U251;	transduction: stably expressing shRNA against cyclophilin B,pert
"Endometrium, postmenopausal, estradiol, 28",pert
R26Pax3/Pax3 E14.5 palatal shelves 1,pert
C027_Control_M_90,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 132;	genotype/variation: WT;	age: 8 weeks,ctrl
8 hour tunicamycin wild type C,ctrl
Strain: C57BL/6: PGC1beta mutant; Tissue: liver,pert
"white adipose tissue, KSR2-/-",pert
braak stage: BR56;	rin: 81;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Directly ex vivo brain CD8 T cells,ctrl
HUVEC,ctrl
heart_QH2_14M_rep1,pert
non-transgenic,ctrl
0516-01-C,ctrl
H295R _Control_rep3,ctrl
WT2,ctrl
"45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
KM_066N,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 69 years,pert
Exon3_T3,pert
non-malignant FTEb_patient 12,ctrl
FSH-NHM-4UA-s2,ctrl
Hippocampus 1981 15 month Old,pert
"scr-Rosi, biological rep2",ctrl
colon_IL10mouse_12weeks_rep2,pert
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	Wild type,ctrl
"Affymetrix chip HG-U133A, siPTHrP 3",pert
Normal-N_LJ_2,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 5",ctrl
Liver_hyperglycima_no.4,pert
K14deltaNB-cateninER  Time 1 replicate 3,pert
MDA_Parental_4,ctrl
Cavin-1/PTRF KO #237,pert
siTNIK+7hr Wnt (Experiment 1; dye swap),pert
PGA-HMO-NonObese-8aUA-s2,ctrl
Total RNA from bone marrow derived macrophage from C3H/ARC mice,ctrl
BCells_Transgenic_day0_REP2,pert
CDK9 Knock Down,pert
WT_IL-6_100_rep3,ctrl
background mouse strain: C57BL/6;	source: liver;	genotype: wildtype,ctrl
scan batch: Batch 1;	group: autism;	subject age: 8;	paternal age: 34;	maternal age: 37,pert
5246 UC Uninflamed sigmoid colon,pert
Age: 45;	Sex: M;	Ancestry: Hispanic;	Smoking status: non-smoker,ctrl
"MDA-MB-231 (human, Caucasian, breast, adenocarcinoma)",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: A;	experimental sample name: PC1-R,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 214,pert
"SR-A mutant, 6 weeks old",pert
HEK293_hCdc73siRNASparse_rep1,pert
Dental pulp cells control sample triplicate 2,ctrl
PA-1-(2),ctrl
mock C,ctrl
transfected with FoxP1 siRNA_2,pert
Nrl-ko-Gfp P10 replicate 1,pert
background strain: Derived from BL6 blastcysts.;	cell line: WD44;	cell type: ES cell;	passage: 14-18,ctrl
S4-040517-SA,pert
P0 - epsilon129s6 3,pert
Caco2-siRNA-control2-rep2,ctrl
ILD Study Number 1235,pert
Subject #8041-8hr Postinfection,pert
MSE_N_659,ctrl
HSF1+/+ T cells at 37oC replicate #2,ctrl
PCOS Endometrium Endothelial Cell_103.PC01+-,pert
strain: mixed background of 129/SV and C57BL/6;	cell type: macrophage;	genotype/variation: PPARg KO,pert
RE550_DU145_7-Medi5117,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 3;	psoriasis duration: 8.89390828199863;	age of psoriasis onset: 38,pert
211/4,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep4",pert
G392E_off_rep2,pert
nmd untreated 3,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P5,pert
T7,pert
Synovium_SynoAcAr,pert
C4_HypM,ctrl
"MaF pre-iPSC9P2, Vc treated, lysed on D5",pert
Tumor_18w_vechicle_DEN_129,ctrl
cell type: Endothelial cells,ctrl
"Wild type used for MAT1A 15 month, replicate 5",ctrl
strain: CD-1;	genotype/variation: Pkd1null/null mutant;	developmental stage: embryo;	age: E14.5;	tissue: kidney,pert
age	52;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	4.4;	leukocyte count (/nl)	30.5;	hemoglobin (g/dl)	12.8;	platelet count (/nl)	359,pert
PC-3M/NC siRNA #1,ctrl
"AG825-treated, 6h after UV, Replicate E",pert
XmO1,pert
MCL_IGHV_MUT (R1341),pert
"OuJ, air, biological rep 3",ctrl
"Cbfb-/-, technical replicate 1",pert
cell line: prostate cancer cell line DU145;	genotype/variation: MYB siRNA,pert
4mo tg8,pert
0561-01-A,pert
"human peripheral blood derived monocytes, 24 hour LPS stimulation, biological rep2",pert
age: 12 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
1203-03-A,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 52;	gender: male;	tumor grade: IV,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 22;	maternal age: 23,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.748;	OD280: 0.861;	Ratio: 2.01;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 76;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
whole tissue section from case 1363,ctrl
WT-Fibr1 1,ctrl
PBMCs_IS_15 [IS],pert
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 8/1/03,ctrl
"mouse lung, tamoxifen-treated Tmem1002loxP/2loxp",ctrl
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14501;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"U373-MAML1-dn, rep 3",pert
"vector d0, rep 3",ctrl
Brain area 8/9_6y_RTT,pert
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 2",pert
"human failing LV myocardium, Ischemic14",pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (14),pert
Nerve_Diabetic_Rosi_717,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID221,pert
siWTAP 1,pert
695_EV_24hr_repeat,ctrl
"cell line: hgps-fib_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository",pert
t09,pert
cell line: MH1C1,ctrl
double mutant,pert
N11A Normal-frontal,ctrl
Diagnosis: AML M5;	Age: 41y ;	Gender: Male;	Blast %: 90;	Source: BM;	Cyto: Complex;	FLT3 ITD: 1;	FLT3 TKD: No Data,pert
patient E1507,ctrl
PND28 Rat Testis_Rat230-2_1hr MEHP_Animal#37_04005,pert
Genotype: Mdr2-KO homozygous mouse;	Age: 12 month,pert
Run7.aUa.001206d.SkMInS1072D.CEL-IS basal,ctrl
RNAi -Transgenic replicate 11,pert
"schizophrenia, BA46-88",pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: untreated,ctrl
Pooled litter samples were collected 24 hrs after the final compound dose.,pert
Ishikawa_VeryLowDose_BPA_24h_rep1,pert
untreated-sample3,ctrl
cell type: lymphoblastic leukemia;	gc resistant: TRUE;	treatment: EtOH,ctrl
Retina of 4 month old RPE65 -/- mouse,pert
pancreatic cancer cell line MiaPaCa2 stabley transfected with empty vector pCEP4,ctrl
Mouse old heart w/ a-tocopherol aT-Ht-4,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
WT_R6_rep2,ctrl
1163-03-A,pert
Normal subject 1,ctrl
"SLE patient, 1021V1",pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14502;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
RI59,pert
Strain: C57BL;	Gender: male;	Age: 9-10 weeks;	Tissue: liver;	Developmental stage: adult;	Cell type: Primary hepatocytes,ctrl
HMEC X BC1257,pert
LJMJDW17,ctrl
Control N2B27 sample 3,ctrl
H10 Ctrl 6h 4,ctrl
c57BL/6J Vehicle liver sample batch 2,ctrl
Wt_ liver_fasted_refed_3hr_ rep3,ctrl
brain_DLPFC_bipolar B_mr304,pert
U-87MG-PK19 set 2,pert
WT mouse (WT_Tal3),ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID218,pert
CUTLL1 MigR1 GSIwash2h-rep3,pert
"MIST1-null pancreas, biological rep3",pert
PancreaticSample22-Tumor,pert
A549 cultured cell,ctrl
strain: ICR;	cell type: bronchoalveolar stem cells (BASC);	genotype/variation: Myc-depleted,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,pert
RNA mix 5 of nomarl lungs,ctrl
Subject #8041-Preinfection,pert
PC-3M/NC siRNA #3,ctrl
MEF Wild Type 1-rep3,ctrl
CTL2 AO 24hr,ctrl
"patient 16, right arm treated with pimecrolimus until day 22",pert
3172-scrape,pert
112 Day Mouse leg muscle,ctrl
strain/background: C57B6SJL;	genotype/variation: GNMT knockout;	age: 8 months;	tissue: liver;	disease status: hepatocellular carcinoma,pert
cell line: MCF7 breast cancer;	treatment: RL silenced and LIF-stimulated,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 65min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 242,pert
"cochlea at P3, ko, biological rep 2",pert
"5B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"HepG2 cells; (HB-8065; ATCC, Manassas, VA)",ctrl
THRB wt + vehicle replicate 3,ctrl
pediatric AML S12,pert
04_ADL,pert
Strain: C57BL/6J;	Gender: M;	Age: 9 weeks;	Treatment: untreated,pert
LRRK2 (G2019S) heterozygous fibroblast sample 2,pert
231/ARF-4_2,pert
GFP Untreated 6hr 282295593,ctrl
4_Hr_No_MGd_3,ctrl
heart MHC-Plin5 3,pert
PBMCs_Control_16 [IS],ctrl
Gender: Male;	Age: 32;	Ethnicity: Hispanic,pert
Adipose-5 month-wild type-technical replicate 2,ctrl
SEB-1 vehicle control biological replicate 3,ctrl
MCF10A 5days,ctrl
subject: 40;	disease: CP;	muscle: GR;	gender: M;	age: 10.1;	gmfcs: 2;	popliteal angle: 120,pert
Phan_010_KO.bleomycin rep1,pert
WT_rep_4,ctrl
MDS31,pert
human thyroid,ctrl
b93,ctrl
heart control 2,ctrl
Human squamous cell lung cancer cells,ctrl
Muscle 50 eccentric contractions 12 hours WT Adult 07271,ctrl
cell type: B220+ cells from preB colonies;	genotype/variation: Hspa9+/+,ctrl
Total RNA from LM2 cells labeled with Cyanine-5 (red).,pert
colon_CRC_1146,pert
chip number: 22;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.84;	rin: 9.5;	transfection date: 2012-03-26,pert
3T3-L1 20uM pioglitazone,pert
strain: 116;	Disorder: normal;	Condition: no hydrocortisone,ctrl
HOX424 Carbo Day1,pert
liver_Pink1 knockout_6 weeks_replicate_2,pert
subset: HDAC2 siRNA subset;	cell line: HCC cell line Huh7;	treatment: scrambled siRNA,ctrl
Control siRNA rep3,ctrl
Fetal heart 1.5 ug/kg TCDD rep3,pert
PGA-HMO-NonObese-6aUA-s2,ctrl
Klf9KO_jejunum_PND30_3,pert
Halothane 10 exposures-3,pert
Total skin,ctrl
sample I 18.5 wt,ctrl
JURL-MK1 non-treated,ctrl
INS-1 cell line #2 with induced HNF6,pert
cell line: U2OS;	cell type: human osteosarcoma cells;	transfected with: shCHK1-3,pert
HEK293 transiently EWS-FLI1-transfected 1,pert
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 3",pert
HepG2_DMNQ rep1,pert
E14wt-SRFdM-VP16-2,ctrl
Fibroblasts_DBApatient_3,pert
Discoid Lupus-L3,pert
Mouse No Cldn16 B9 451,pert
colon_IBD_1665,pert
10 week mutant OMN rep 3,pert
"CD14+ at baseline, biological replicate 1",ctrl
blood_day6_patient5,pert
mouselung_scid_control_rep01,pert
HO_1,pert
Healthy control_sample1,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: luciferase shRNA,ctrl
U937_shSYK_2_Replicate2,pert
"patient 047b, normal, homogenized",ctrl
P60_TR_2,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 30;	maternal age: 21,pert
Individual_4269_PN_sample,pert
MCF-10A shCHK2-2 replicate 3 [set 5],pert
Run1.a10a.000607jd.2.SkMNor919.CEL-IS basal,ctrl
RNA from whole tissue section of case 25 labeled with Cy5,pert
wildtype_hypoxia,pert
breast tumor 6,pert
condition: Normal;	patient: N_LJ_9;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Braak α-synuclein stages 5-6  BR56_8SN,pert
A2780+(3),pert
"healthy control fibroblast, biological rep1",ctrl
tissue: Hippocampus;	age: 80;	Sex: F,ctrl
Heart_WT_03,ctrl
Pt_6 Acne Lesion,pert
42B,pert
Olfactory mucosa,ctrl
Sex: male;	Age: 7;	SL: 3.37;	House: -;	Severity: C;	Ashworth: 1;	Zancolli: 0;	PEFF: 90;	PESF: 90;	AEFF: 90,ctrl
cumulus_nonPCOS_Obese_rep1,ctrl
"postnatal 3~5 days, mixed gender, C57BL6/129 mixed background",pert
male;	38 yr old;	White,ctrl
KL5_muscle_control,ctrl
HCC011N,ctrl
untreated AML 8 blasts,ctrl
RNA from MLL1-KO MEF (18h after serum shock),pert
JoMa1-MYCN-induced tumor,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: other,pert
siERK5Veh 1,pert
disease: type 1 diabetes;	gender: male;	cell type: endothelial progenitor cell,ctrl
ApoD transgenic mouse rep_2 (CTG2),pert
"Exp A, Animal #263, 20mg/kg D-Serine",pert
Treated with 25uM Zinc for 4 hrs -- replicate #2,pert
B-CLL PB P255,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID217,pert
KM_051N,ctrl
"Vehicle treated, DAY 6, biological rep.2, MOLM-13 cells",ctrl
treatment: naïve;	transgenic variant: AChE-R;	tissue: Caudate-Putamen;	genetic background: FVB/N,pert
PGK12.1_Kdm6a RNAi-4,pert
microdissected epithelial cells from IPMC 4,pert
"ALL_DS, K56 011409",pert
GC resistant clone C7H2-R19E7 treated for 6 hours with EtOH,ctrl
Ada3FL/FL MEFs_control adenovirus,ctrl
OA 4,pert
DA rat stomach control,ctrl
Individual_5660_NN_sample,ctrl
in vitro differentiated DCs,ctrl
3D-cultured chondrocytes from normal donor 3,ctrl
Panc-1 Gli3T 2,pert
159A,ctrl
tissue: bone marrow;	genotype: E2A-KO;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),pert
H441 transfected with ETS2-specific siRNA 3,pert
strain: C57BL/6J;	cell type: MEP;	genotype/varation: wildtype,ctrl
KGN Control  [RR1003],ctrl
T38,pert
P123,ctrl
MDS patient 131,pert
HDAC2 siRNA_1_Huh7 [HDAC2 siRNA subset],pert
dental pulp cells obtained from milk teeth,ctrl
WT CFTR unexposed replicate 3,ctrl
"Wild type fibroblasts, biological rep1",ctrl
MCF7 cells that were transfected by siRNA targeting estrogen receptor alpha (ESR1).,pert
tissue: sciatic nerve;	age: 2 months;	genotype: MPZ-Tfam KO,pert
PB_preTherapy_IIa,pert
Peripheral Mononuclear Blood Cells,ctrl
"EBF1 d4, rep 7",pert
Severe rep4 (retina),pert
strain: FVB/NHsd;	tissue type: back skin,ctrl
"Cultured ovarian cancer cell line CH1, untreated",ctrl
CEM11_T6_PP_day14_042,pert
m1-adenoma5,pert
heart-30 months of age-control diet-biological replicate2,ctrl
S006_Scz_M_79,pert
"MaF pre-iPSC9P2, Vc treated, lysed on D4",pert
V5-P536,pert
"Wild type, biological rep4",ctrl
A_LS_Wk12,pert
122A,ctrl
RatLung_H6h_4,pert
NoKD_SerumStarved_rep3,pert
Syracuse High Avoidance (SHA) learing rats 2,ctrl
"Patient  M, lesion, 2 week",pert
brain_DLPFC_bipolar C_mr523,ctrl
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate to poor;	Tumor Site: Descending;	Drug Treatment: YES,pert
wildtype murine HSCs,ctrl
Wildtype iPSC sample 1,ctrl
"Peripheral blood, normal control [N75]",ctrl
RNA from whole tissue section of case 655 labeled with Cy5,ctrl
"DU145, Untreated",ctrl
Primary hepatocytes isolated from SV129 mouse strain treated with Wy14643 for 24h,pert
CML cell line: JURL-MK1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 36;	maternal age: 30,pert
Ovalbumin-induced inflammation 4 hours,pert
mouse intestine pLagl2 knockout 4,pert
uterus_veh_PRKO_4hrs_rep3,pert
cMetKO QSC Technical Rep.1,pert
HCC_6N,ctrl
acne skin sample,pert
E8.5 embryo proper,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 38 yr;	population: white,ctrl
48h_c1,ctrl
healthy control sample x169,ctrl
MLL_00116,ctrl
Erythroblast_SOD2+/+_repWT33,ctrl
Cortex,pert
cerebellum_WT_12w_rep2,ctrl
Telencephalon cKO 3,pert
tissue: freshly isolated human monocyte;	gender:male; age: 41 yr; weight: 92 kg,ctrl
wildtype 3,ctrl
NPC Brain 25d Mouse1,pert
Heart sample5,pert
MDS patient 5,pert
"Spleen homogenate, infected, 4 weeks",pert
BP patient 88_biological replicate 2,pert
"wdNHBE uninfected at 36hpi, biological rep1",ctrl
B final PC3 ctrl,ctrl
disease state: Chronic hepatitis B;	cell type: Peripheral blood mononuclear cells,pert
Atm+/+ untreated C,pert
mouse hippocampus,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 29;	gender: male,ctrl
fibroblast_Slow_D123_Media_10,pert
HF0816_U133P2,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case1,pert
tissue: retina;	age: postnatal day 6;	genotype: rd1,pert
KN-smoke-med-5 month+13d-R3,pert
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 4h",pert
GM19238_Kd_IRF3_3,pert
PC12 line PFR3K650E,pert
RNA from whole tissue section of case 1085 labeled with Cy5,pert
non-malignant FTEb_patient 6,ctrl
heart female pbs 10 dpi rep3,ctrl
11m2,ctrl
HCC_24N,ctrl
DBA control (121msn),ctrl
Lung-normal-rep3,ctrl
c.4,ctrl
HT29 PLX Day8 rep2,pert
No or early 1 rep9 (OHN),pert
subject id: c8;	infection: control;	status: control;	tissue: whole blood,ctrl
cell type: human peripheral blood memory B cells (MBCs);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
WT MEFs at passage 3_biological replicate 4,ctrl
genotype/variation: Cbx2_KO_XY;	tissue: gonads;	age: E11.5,pert
sample type: HeLa-Ctrl-siRNA-3d;	cell line: HeLa;	knockdown: Ctrl-siRNA;	time: 3d interferon alpha;	treatment: interferon alpha,ctrl
Control subject,ctrl
HCC_26N,ctrl
C57BL10 soleus sample 1,ctrl
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50), biological rep2",pert
"Mepenzolate treatment, 25 hours (replication 1)",pert
n2a-Pou3f3-cont-2,ctrl
whole tissue section from case 297,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous saline challenge""",ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 41;	maternal age: 40,ctrl
"genotype/variation: ApoE-/- RAGE-/-;	strain: C57BL/6;	mouse provider: Ann Marie Schmidt laboratory, Columbia University;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: diabetic",pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: C,pert
Cbx2_KO_XY_1,pert
b8.2,pert
primary cell culture,pert
RNA from HCC_11N,ctrl
Epididymal adipose WT ND #687,ctrl
"Patient 20, Macroscopically intact tissue",ctrl
"Mouse LV, WT 3",ctrl
"Cnr1-/-/Cnr2-/- female number 2, untreated control ear (#8_Ko-C-5)",pert
"C26, whole gastrocnemius",pert
Lmx1b -/- E11.5 proximal hindlimb pool 3,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 60,pert
Pooled litter samples were collected 24 hrs after the final compound dose.,ctrl
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: liver",pert
"Mice_non trans, biological rep2",ctrl
"LCL GM19238, Kd TAF1, 72hrs",pert
Silberg2 (S4) 23100NE,ctrl
HSF1+/+ T cells activated at 37oC,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 4 weeks post infection 20 cercariae,pert
P1 mouse eyeball extracted total RNA_Snf2h_cKO2,pert
SIRT4 KO liver_7211-2,pert
"NeuroD1 cKO at ZT20, pineal gland",pert
Pediatric_GBM_37,ctrl
"Patient  M, lesion, 4 week",pert
PGA-MAH-OuJO3-1aAv2-s1,ctrl
"cell type: Human mammary epithelial cells infected with retrovirus carrying hTERT and the oncogenic allele of H-Ras, H-RasV12 described in (Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65)",ctrl
"Control 03, NC03",ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
uterus - Mid secretory endometrium from normal patient,ctrl
tissue: small intestine;	genotype/variation: wildtype,ctrl
Rat Hippocampus,ctrl
Braak α-synuclein stages 5-6  BR56_2SN,pert
"age at diagnosis: 50;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N1mi;	er: 1;	pgr: NA;	dfs-month: 8;	dfs-event: 0;	distant metastasis: 0",pert
"cell line: prostate cancer, PPC1",pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14584;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
S6_Sham_wildtype_12,ctrl
Healthy control 9,ctrl
MDS patient 110,pert
hippocampus: Sample #4_e1_le1,ctrl
chip number: 8;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.86;	rin: 9.1;	transfection date: 2011-03-29,pert
"Diclofenac treated THP-1 cells, biological replicate 1",pert
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Male;	Age: 9 weeks (Moderate stage);	WILD  TYPE",ctrl
2i/LIF maintained Usp-22 depleted Embryonic Stem Cell,pert
cumulus_PCOS_Obese_rep4,pert
ACC Xenograft X16,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 4,pert
"EtOH, RARaKO, set 4",pert
OSCE-7T,pert
YFP+Foxp3+ r2,ctrl
Amniocytes_trisomy 21_1575,pert
fetal liver with p38alpha knock out,pert
"Mouse heart, control, replicate 3",ctrl
Individual_3140_PP_sample,pert
25SMOKEH,ctrl
strain: Mixed;	genotype/variation: Nrf1 Control;	gender: Female;	tissue: Liver;	age: 6weeks,ctrl
"Mkl2-/-, embryonic stem cells",pert
Phan_004_WT.bleomycin rep1,pert
"spinal cord, ventral spinal cord: EP132/L - hSOD1(Chan)/e14-wildtype hSOD1_le2",ctrl
Tissue:tumor; Gender:female; Age:48  Tumor stage:T3N1bMx,pert
"genotype Cldn16 +/-, renal tissue",pert
"ME180 cells, DMSO-treated",ctrl
healthy CD19 B cells 1,ctrl
"medulloblastoma, M2_cMYC_silenced, rep1",pert
"non-AD_TC, biological rep9",ctrl
Kidney_Aqp11-/-_P7_1-2,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T2N2,pert
"Wild-type, biological rep2",ctrl
Rat left ventricle,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.44;	age of onset: 18 yr,pert
Mnk_3214-S-7,pert
Heart_WT_1,ctrl
colon_epithelium_C57 mouse_12weeks_rep1_2,ctrl
"ME16C, 12h, 0.06mM 5FU",pert
terminal end buds from mice,pert
MDS42,pert
65A;pretreatment;female;breast tumor; nonresponder,ctrl
BxPC3_Ctrl_rep3,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 59 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Thyroid_papillary carcinoma 14,pert
"frontal cortex, bipolar disorder",pert
"twin pair: #6;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50), biological rep3",pert
vehicle treated rep 2,ctrl
LSK cells SRF KO 3,pert
"BOEC, not_at_risk 3",pert
24h WT Cel.04,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#3,pert
G519-lcm,pert
"Normal Skin, Normal-16",ctrl
type 2 diabetes subject 05,pert
RNA from microdissected breast cancer cells from case 1363 labeled with Cy5,ctrl
N40977,ctrl
Frozen sarcoidosis lung tissue,pert
KM_076N,ctrl
Cervical cancer_1721T,pert
B6 Control R4,ctrl
"Huh7 cells, JFH-1 Infected, 18 hours.",pert
major non-tumor5,pert
GFP-progerin Induction: day 10 Replicate B (6b_progerin_10d_B),pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 1,ctrl
LNCaP R1881 rep 1,pert
U937_shSYK_1_Replicate1,pert
cell type: Normal Human Epidermal Keratinocytes (NHEK);	transfected with: scrambled siRNA (control),ctrl
"Normal subject (47 year old caucasian female, SAK_1289248024)",ctrl
CON-3-COLLAGEN,ctrl
age: 6 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
Rat fatty liver9,pert
MDS patient 89,pert
sepsis patient #10,ctrl
FTO2_D4_48h,pert
MCF 7 cell line drug resistant cell subline,pert
gender: Female;	age: 68;	post-mortem delay: 6h;	ph: 6.4,ctrl
cell line: LNCaP-abl;	transfection: siControl,ctrl
age: 55;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
wild-type_corn oil_rep2,ctrl
FmrWT3_brain,ctrl
Liver-Cpr-null_pool 3,pert
Mouse RSK2 mutant mandibular molar [AZN_MolairesMutant1],pert
"array 24, xenograft, DBP 500 mg/kg/d",pert
Gata4loxP/+VillinCre adult male jejunum (6-8 wk). Control sample.,ctrl
"PBMC, healthy control, biological rep5",ctrl
Healthy individual of twinpair #7,ctrl
genotype: EFLmDREAM;	stimulation: stimulated with LPS and mouse recombinant IL-4 (day 2);	cell type: B cells,pert
061J3_CTRL,ctrl
human ccRCC cell line,ctrl
cell line: Breast carcinoma cell line Cal51;	genotype/variation: control;	agent: untreated,ctrl
HCT 116  siChe-1 rep1,pert
healthy CD19 B cells 9,ctrl
major HCC4,ctrl
5258 UC Uninflamed terminal ileum,pert
1194-03-A,pert
"RES-enriched Grape extract group, 12 months, patient number 22",pert
"Cadmium 1.2 µM, biological rep2",pert
OA 5,pert
10 days sham-2,ctrl
"human failing LV myocardium, Idiopathic85",pert
PC-3 human prostate cancer cell line,ctrl
alveolar epithelial cell line exposed to cyclic stretch 20% elongation for 4hr,pert
cell type: Embryonic Stem Cell;	genotype: Mkl2-/-;	strain: C57BL/6,pert
1138-03-A-b,pert
Normal heart,ctrl
Gallbladder - leptin treated,ctrl
Cardiac biventricle of Tamoxifen injected PGC-1a-/-bf/f/MerCre mouse,pert
Strain: FVB/N;	Genotype: SP-C-hCFTR+|+/mCftr+|+,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: none,pert
colon_IBD_1175,pert
Series 3; adult; 1 week after fracture,pert
224 Day 2 siMut10 transfected biological rep1,pert
OC1-KO embryo 2,pert
3 h-control (EtOH),ctrl
"EtOH, WT, set 2",ctrl
Muscle control (YJD-JDM-50UA-s2),ctrl
Whisker pad mutant biological rep2,pert
Differentiation of hES cells line SA01 towards MPC-like cells;	Mesenchymal stem cells phenotype,ctrl
cell type: granulocytes;	group: Patient;	patient treatment: Mtx,pert
brain_DLPFC_bipolar C_mr869,ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 5.8;	colon weight (mg): 159;	colon ratio (mg/mm): 2.741;	myeloperoxidase activity (u/mg): 0.442;	tissue: colon;	treatment: 5% DSS,pert
cell line: MCF-7;	cell line: breast cancer cells;	transfected with: TOX3 Vector,pert
Polyamide1_2,ctrl
06R038 Control,ctrl
"human failing LV myocardium, Idiopathic3",pert
MEF Wild Type 1-rep1,ctrl
3T3 cells from cyclin D1KO mice infected with MSCV-GFP control.,pert
sex: Female;	Age: 6 months;	additional patient information found in Series supplementary file,ctrl
"liver, STZ-treated fed 0.5% quercetin diet for 14 days",pert
RV83.09_CHF_day10,pert
Fertility Status: Infertile,pert
M24met melanoma cell-line,pert
Thyroid_ unaffected_paired with PTC71T,ctrl
01LMV_Oligo,pert
"siRNA, collagen plate, rep2",pert
mononuclear cells after Ficoll purification,ctrl
Raji_mi-142-3p_2,pert
LPS + CyP 3hr 1,pert
Tendon;Flexor-Pronator_Non-lesional,ctrl
Silberg3 ( S1) 120902NE,ctrl
E14.5 Tgfbr2 Wildtype Mouse Model Palate 4,ctrl
FHCRCAML2619,pert
Cy3: Human Common Reference,ctrl
"48 hour-treated wild-type NB4, biological rep2",pert
total RNA,pert
ccRCC tumor of patient T166,pert
"ShamC-21, biological rep 1",ctrl
RNA from whole tissue section of case 749 labeled with Cy5,ctrl
Control liver_4 pm_rep1,ctrl
NCI-H716_Control.3,ctrl
Gender:female,pert
Wtepi_infect_0h_rep2,ctrl
liver 1.0% quercetin diet rep4,pert
CHF NYHA III-IV pts,pert
gender: female;	age (years): 63;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
"CTR-C (CTR-2+, biological replicate 3)",ctrl
"Uninvolved Skin, NS-19",pert
Sex: male;	Age at operation: 74 years;	Site: thigh;	Size in cm: 16.5x9x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
treatment: scrambled vector;	cell line: Esophagus cell line OE33;	array id: 5617835005,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 168;	fata: 71;	eea: 1780;	wtkg: 89.3;	perfat: 27.6;	lbm: 62.9;	fat_mass: 2464.68,ctrl
RatLung_Con_1,ctrl
background strain: C57Bl/6;	developmental stage: E11.5;	tissue: fore-limb;	genotype/variation: wild-type,ctrl
FIH null MEFs,pert
"breast, pre AF treatment (H23_2233)",ctrl
10SAGEA2,pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 2;	histology: papillary serous,pert
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate B,pert
V5-P271,pert
Bronchial Epithelial Cells MMA biological 1780F,pert
cDNA scc 14,pert
Dengue Fever Patient 66,pert
CD4DecTp2-7,pert
B6.IL10 72 O3 2,pert
Wt_ liver_fasted_refed_3hr_ rep2,ctrl
Total RNA from Monkey PBMC labeled with cyanine-5 (red),ctrl
Liver_WT_Vehicle_Rep3,ctrl
Globin_C2,ctrl
U937_naive_untreated_4h_rep3,ctrl
cell line: A375 melanoma cell-line;	genotype/variation: wild type;	treatment: control,ctrl
mortality: alive;	ethnicity: White;	gender: F;	age (yrs): 32;	tissue: Normal_Kidney_Biopsy,ctrl
ColonTum_022AAFC8_cta.txt,pert
P1 mouse eyeball extracted total RNA_wildtype1,ctrl
Intima media; type 2 diabetic patient,pert
endothelial_rep11,pert
PGA-MAH-AJ_OVA6h-3aA-s2,pert
Parkinson's disease sample x188,pert
231/ARF-2_3,pert
tissue: heart;	genotype: ClpP KO;	genetic background: C57BL/6,pert
U937_naive_curcumin_4h_rep3,pert
293TsiLL-4,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep2",pert
Colon 17 days old,pert
Human LRRK2 (G2019S) heterozygous patient fibroblast,pert
"normal nasopharyngeal tissue, specimen N10",ctrl
siRNA-140_rep2,pert
IRAK2 KO_macrophages_8h,pert
"0mg/kg/day PFOA, Rep 3, Block 2, liver (low dose)",ctrl
HC12E4,pert
Bone marrow derive macrophage,pert
Untreated Control 12weeks AffyGC RMA rep10,ctrl
RV83.02_CONTROL_day10_Slide52,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 58;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
TGF-alpha 979-CLA-33,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: Vemurafenib 1000 nM for 72h,pert
"female,21,Caucasian",pert
CD4IncTp1-8,pert
Gastrocnemius Muscle Galgt2 Transgenic rep1,pert
"Creatine-treated, biological rep5",pert
"p38alpha knock out fetal liver E13.5, biological rep3",pert
kidney tissues from obese rats on control diet,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 59 yr;	population: white;	dsm-iv: 296.5;	age of onset: 48 yr,pert
HGPS Fibroblast replicate 2,pert
mouse full-thickness skin,pert
Tissue: lung,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 131;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
HEK293 cells + control siRNA 72h,ctrl
8 hr KLF4 Time Course Control,ctrl
"human nonfailing LV myocardium, NonFailing9",ctrl
MLL_00134,pert
MDS51,pert
RWPE1 cells treated for 6 hours with vehicle (0.1% ethanol),ctrl
Sample ID: TP35;	Twin Pair ID: CCE3.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-7;	Age at interview & blood sampling: 57;	Current Age (2007): 60;	Sex: MALE;	Medication at blood sampling : Epilim,pert
Control 3 a,ctrl
"Control, biological rep 2",ctrl
Mnk_3213-S-B,ctrl
breast normal 6,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID64,ctrl
Bronchial Epithelial Cells SA biological 2118H,pert
E16.5 Vax2-/- 1,pert
3 day LAD ligated heart from C57BL/6 strain,pert
"lymphoblastoid cell line from T4.02, one out of seven of insensitive group, 50*10e6 cells",ctrl
DP (CD4+/8+) cells from Normal Thymus,ctrl
HCC017T,pert
Mus musculus tissue,ctrl
"Heart, MAT1 CKO, 4 wk, sample 2",pert
GC resistant clone C7H2-R3B5 treated for 6 hours with EtOH,ctrl
Normospermic individual: Sample N12,ctrl
"9B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"Lesional skin from K5-Tgfbeta mouse, biological replicate 1",pert
"liver, control, 6 months",ctrl
Tk6 untreated controls for cadmium exposure rep1,ctrl
INS-1 cell line #5a with non-induced HNF1b mutant P328L329del,ctrl
WT-smoke-high-5 month-R3,ctrl
Brain from 60 days Npc1+/+ mouse2,ctrl
"control, BA46-103",ctrl
individual: patient10;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 147;	genotype/variation: WT;	age: 8 weeks,ctrl
"Male Nrf2 Wild-type mice, liver sample",ctrl
Age: 47;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
EA_Control5_CD4,ctrl
Human colon biopsies from UC patient with active disease (non-involved mucosa),pert
3DKD_SerumStarved->3hrEGF_rep1,pert
KO2,pert
normal adjacent esophageal tissue from patient E1635,ctrl
PancreaticSample54-Normal,ctrl
"Age: 48;	Sex: M;	Ancestry: European;	Smoking status: smoker, 15 pack-years",pert
Human hepatocellular carcinoma cell line infected with GFP protein (control) 1,ctrl
TAF4b knockout 2,pert
"HME-CC, 12h, 0.01mM 5FU",pert
"granulocyte, healthy control, biological rep9",ctrl
Large cell carcinoma 009,pert
optineurin expression-a02,pert
colon_epithelium_C57 mouse_12weeks_rep1_1,ctrl
Double_positive_thymocytes_Dexamethasone (1E-07M) _3h_rep2,pert
"schizophrenia, BA46-10",pert
liver_Akt1+/-_8wk_rep2,pert
RV82.01_CONTROL_day10_Slide53,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 4",ctrl
Ero1-WT non-induced biological repB,ctrl
striatum_21 month,ctrl
Pancreatic Sample -Tumor,pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ shNotch3;	treatment: Ca 0.09mM, 72 h",pert
autism with dup(15q) AU010604,pert
first-episode BP patient 74_biological replicate 2,pert
Subject 9_t=30days_placebo,ctrl
"BioBreeding DR+/+ rat, day 65, mast cells derived from pancreatic lymph node",ctrl
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
"depression, BA10-3",pert
ILD Study Number 1226,pert
RTX1 T12,pert
Patient no. 16: treated,pert
tissue: white blood cells;	age: 8;	Sex: male,ctrl
Ngn3 EB3 ON replicate 2,pert
Cardiac Muscle_Cmah KO_mdx_rep2,pert
siRNA scramble_control  MDA-MB-231 sample 2,ctrl
01LKV_CTRL,ctrl
N40899,ctrl
B_Ctrl_3,ctrl
"n12, surgically resected from patient of gastric cancer.",ctrl
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: shRNA against β-catenin;	time: 72hr,pert
coc-57,pert
CD4IncDec-test-3,pert
"BMDM, Tpl2 KO, unstimulated, biological replicate 1",pert
Mouse liver tissue,pert
"Crohn's Disease subject (20 year old caucasian female, SAK_1287906498)",pert
"nasopharyngeal carcinoma, specimen T12",pert
"breast tumor epithelium,54",pert
5922012038_F,ctrl
U937_ROS_untreated_18h_rep3,ctrl
Normal cervix epithelium_03-5438,ctrl
Nonspecific siRNA1,ctrl
"cell type: MYC negative B-cell;	transgene: MycEGFP (a Myc reporter allele, in which a MYC-EGFP fusion protein (MYCEGFP) is expressed from the endogenous Myc locus);	genetic background: C57/Bl6",ctrl
Trasnsformed Lymphocytes Bipolar Disorder Affected (Affected pateint of MZ twin pair 3),pert
DC-7,ctrl
Liver_Nrf1 Control_rep2.,ctrl
HeLa cells were treated with the siRNAs for 72 hrs,ctrl
"LCL GM19238, Kd GTF2B, 72hrs",pert
NESG1-negative C6-5-8F NPC cells rep1,ctrl
rheumatoid arthritis 9252,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD)/D835 mutation,pert
Retina wildtype 42 days 3,ctrl
G4D_Sham_Rep1,pert
"peripheral ganglion, unknown: nicotine 24 hr_2",pert
"Ishikawa cell line, control, 24hr",ctrl
Multiple sclerosis CD4+T cells 15-US,pert
"Lymphoblastoid cell lines derived from family 1727, member 2",pert
Liver of pup from control group rep2,ctrl
NOD Aire WT MEC rep3,ctrl
lung fibroblasts from patient with fibrosing alveolitis associated with systemic sclerosis,pert
"Whole ovary from 8 Month Old FORKO mice_01, biological rep1",pert
MCF7 cells treated with 2uM Sangivamycin,pert
11_0018C_Day1_27,ctrl
"Lesional skin from K5-Stat3c mouse, biological replicate 1",pert
Large cell neuroendocrine carcinoma 002,pert
Liver from C57BL/6 mouse,ctrl
"vector d2, rep 4",ctrl
"Mouse, ATF6aKO, colon, UT, rep1",pert
Homogenized lung tissue,pert
Bone-Marrow_SMM_S1336,pert
umbilical cord_bpd: 5H,pert
BP patient 56_biological replicate 2,pert
patient: 5;	disease state: hypertension;	tissue: Atheroma plaque,pert
PBMC from T cell Large granular lymphocyte leukemia patient#101,pert
WT-smoke-med-5 month+1d-R2,ctrl
brain_DLPFC_bipolar C_mr537,pert
HLA risk: Low;	Height: 171.7 cm;	Weight: 66.4 kg;	BMI: 22.5;	Age: 13.4 years;	Gender: Female;	Race: White;	Glucose: 101 mg/dl;	HbA1c: NA,ctrl
c 4-4,pert
"Exp A, Animal #269, 5mg/kg D-Serine",pert
treatment: ethanol,pert
"normal skeletal muscle, biological rep10",ctrl
ve_NY6,pert
EA_SLE_CD4,pert
tissue: Frontal cortex;	age: 72;	Sex: F,ctrl
"E18.5 lung WT1, biological rep2",ctrl
Bone-Marrow_MM_M1070,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: PMA,pert
primary normal lung tissue 1502,ctrl
Adult Sham; Biological replicate 1,ctrl
control participant P306wdh,ctrl
Txnip deficient tumor 27 months sample 3,pert
GEIM177-U133A-DM,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 1;	time: 6h,pert
HW_450,pert
"WT, untreated whole heart, individual 2",ctrl
AAA neck (Sample 4),pert
Velcade I2,pert
HDC-expressing CD11b+Gr-1+ myeloid cells sorted from the bone marrow of HDC-EGFP/HDC-KO transgenic mice,pert
"mouse aorta cross strain comparison, C3H_T08_HF_02",pert
1IDC_tumor_ductal,pert
Heart sample from 8-week-old C57BL/6 mice,ctrl
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: non-recombinant clone 27 (STAG2 wild-type),ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_8_3_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
SV589_8DayKD_SerumStarved,pert
Subject #8030-2d Postinfection,pert
"brain, hippocampus: CH3_e1_le1",ctrl
MCF-10A sh53BP1-1 replicate 3 [set 5],pert
cell type: hepatoma cells;	cell line: Huh7,pert
"BOEC, normal 27",ctrl
0h WT Sample 16,ctrl
ovary_cultured_control_rep2,ctrl
MCF7_Sangivamycin_Array_2,pert
control endometrium,ctrl
Thyroid_ unaffected_paired with PTC14T,ctrl
HT29 resistant cells replicate 3,pert
cell line: MDA-MB-231;	cell line origin: Breast cancer;	genotype/variation: control,ctrl
Murine lymph node,pert
"ADIPOSE TISSUE, RES, Before",ctrl
Subject #8028-8hr Postinfection,pert
Xid primary splenic B-cells (sample1),pert
fresh tissue: splenocytes;	strain: DBA/2,pert
age: 24 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
RNA from HCC_14N,ctrl
HET Brain 37d Mouse1,ctrl
cell type: embryonic stem cells;	genetic modification: Dicer knockout,pert
E14 +/+ wiltype ES cell line (control for Cdk4+/- ES cell line),ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 1,pert
RNA from HCC_5T,pert
"Deltoid, FSHD, cohort 13, subject 13B",pert
"MGSKO, PR03M008v0",pert
Replication 3 Control,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.318;	OD280: 1.187;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 66;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
4112-1 E2F WT,pert
HD12E1,ctrl
VillinCreERT2-_Rep3,ctrl
E100-/-SRFdM-VP16-1,pert
MDS patient 112,pert
"brain, cochlea: [16] Sample #16_le1",ctrl
"CCM3 shRNA cells passage 11, rep 4",pert
Normal cortex of patient T166,ctrl
cell line: D3;	genotype/variation: scrambled sequence control (siSCR);	cell type: undifferentiated embryonic stem cells,ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: control;	time: 6h;	gender: Male;	age: 73 years old,ctrl
"D425-control, t=48",ctrl
"LckCre Dicer lox/lox KO, biological rep3",pert
MDS4,pert
Muscle JDM (YJD-JDM-2UA-s2),pert
"Crohn's Disease subject (27 year old caucasian female, SAK_1275500386)",pert
gastrocnemius muscle,pert
normal B lymphocytes (NBL 534),ctrl
"Patient SE, stable renal transplant recipients, male, 31 years old, T1 (3 months after the switching of the therapy)",pert
Muscle 50 eccentric contractions 12 hours WT Aged 0121,ctrl
No or early 1 rep6 (OHN),pert
"peripheral ganglion, unknown: control 1 hr",ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 3",ctrl
N51628,ctrl
HET Brain 81d Mouse1,ctrl
WT-Fibr2 6,ctrl
"Patient #7, Untreated",pert
NIH3T3_0h_exp1_rep1,ctrl
microdissected breast cancer cells from case 1507,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 14",pert
Septic shock;	gender: Male;	Survivor;	organism: Staph aureus;	organism class: Gram pos,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-SOX2,pert
NCCIT-Mock-rep1,ctrl
Temporal cortex of AD brain,pert
wild type rep-1,ctrl
tissue: Terminal end bud (mammary gland);	gender: female;	age: 4.5 week old;	genotype: Ovol2flox/-;K14-Cre;	strain: C57/BL6,pert
"Endometrium, postmenopausal, control, 22",ctrl
spinal cord,pert
Wild type LSK (3),ctrl
"MCF-10A cells, shRNA targetting p63 TA, biological rep1",pert
HVS-CD4-control_unstim_rep2,ctrl
CD19_selected_B-cells_before_R_rep9,ctrl
LCH1ani,pert
HEK001_pLKO_R2,ctrl
LY2 control-siRNA untreated rep1,ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 12961346,ctrl
Cerebellum_nontransgenic control A39_10 months_replicate 1,ctrl
Lung WT-PBS replicate 3,ctrl
HE_2,pert
MDS patient 65,pert
Wt1-null MEFs-5,pert
"Lesional ear skin from K14-Areg mouse, biological replicate 2",pert
"Gastrocnemius-soleus muscles, basal status, integrin alpha7 transgenic mouse",pert
Patient: A;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
ErbB3 DOX-KO,pert
Erythroblast_SOD2-/-_repKO35,pert
Aldosterone-producing adenoma,pert
amnion mesenchymal cells treated with interleukin-1-beta for 1h,pert
Tendon_lesional_rep3,pert
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep1,pert
con-15,ctrl
jzo003-v5-u74av2-met,ctrl
"HCT116 cells, parental",ctrl
patient: 40645;	sample: tumor,pert
Fiona Biological Replicate2,pert
"IDC 5, biological rep. 5",pert
"brain, brainstem",pert
Mutant_liver_4,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3KO;	age: 12 weeks;	nutrient state: 24h fasted;	diet: Standard diet,pert
Control 2 b,ctrl
Ishikawa_LowDose_BPA_8h_rep3,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 3,ctrl
BAL_20b_A1B1,pert
siRNA treated MCF-7 breast carcinoma cell line,ctrl
"mouse back skin, K5-IKKbeta transgenic",pert
"spinal cord, ventral spinal cord: EP142/L - G93R(Roth)/e14-mutant hSOD1_le2",pert
MIY_day_7-4,ctrl
A507 Sham 1 day,ctrl
Kidney_200 mg/kg VCM ip_mouse #090,pert
"ALL, Non-Down syndrome",ctrl
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 0;	agent: none,ctrl
LECs from cirrhotic rats 2,pert
The Caco-2 cell line is derived from a male Caucasian with a colon tumor,pert
Retina of 2 month old RPE65 -/- mouse,pert
Heart RNA,ctrl
"fibroblast, wild-type, untreated, biological replicate 4",ctrl
CON-1-COLLAGEN,pert
"MCF7/BUS, 0 pM E2, 48 hours, biological replication 1",ctrl
whole tissue section from case 1405,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5a;	flt3 status: WT,pert
Run1.a10a.000608jd.2.SkMNor926.CEL-IS stimulate,pert
DBA/2JTCE liver sample batch 6,pert
siLMO3_oligo2_FM_rep2,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: Wy14643;	time: 24h;	gender: Male;	age: 4 months,pert
BAL_27a_A0B0,ctrl
Gender: male;	Age: 40;	Ethnicity: black,ctrl
gender: Female;	age: 97;	post-mortem delay: 3.5h;	ph: 6.2,pert
siNEG replicate 4,ctrl
SKM-1 acute myeloid leukemia cells,ctrl
GB 8 63B NO LPA,pert
CAR.AH_CITCO_rep2,pert
Mock infected macrophages harvested at 6h post-treatment from donor 2,ctrl
"liver, wild type",pert
cell type: Embryonic stem cells;	genotype: wild type;	culture condition: 3 days in N2B27,ctrl
WT 2 cerebellum 3 month,ctrl
Kidney_Aqp11+/+_P7_2-2,ctrl
rd1_P6_rep1,pert
Control gray matter 2,ctrl
"PTEN inducible MEFs at T0, biological rep2",pert
MPM tumor specimen 15,pert
patient5,pert
"granulocyte, healthy control, biological rep1",ctrl
MCF-7 cell line treated with control siRNA and vehicle (control),ctrl
CD11b+Gr1- cell sample_2 (derived from IL17RC Knock out mouse),pert
"Male, Wistar, 0 access to cocaine, amygdala",ctrl
WT(Rnh1+/+) -1,ctrl
GIST Pre Treatment Biopsy 27,pert
"Ager/Rage null C57BL/6 mice, liver, 10-12 weeks old, sacrificed 2 hours after 85% liver resection",pert
whole tissue section from case 662,pert
HLA risk: High;	Height: 125 cm;	Weight: 23.3 kg;	BMI: 14.7;	Age: 8.02 years;	Gender: Female;	Race: White;	Glucose: 328 mg/dl;	HbA1c: 6.5%,pert
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: dexamethasone for 24 hr,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P3,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 51 yr;	population: white,ctrl
cumulus_nonPCOS_Obese_rep4,ctrl
strain: C57BL/6;	diet: normal chow (normal);	tissue: liver,ctrl
MDS20,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 52;	gender: m;	treatment: NSAIDs,ctrl
WT - Cre Treated - 0.5 hrs - repeat 2 - Cy3 - mAdbID:62542,ctrl
Placenta_PE(LO)4,pert
whole tissue section from case 420,pert
Ls174T-pTER-β-catenin con3,ctrl
strain: C57BL/6;	tissue: visceral_fat;	gender: female;	age: 8week,ctrl
cerebellum_PSNA_ 12w_rep1,pert
"mammary epithelial cells, p53-",pert
Normal - no fibrosis,ctrl
E2_ethanol_36,pert
"Control siRNA - 5 days osteoblast differentiation, rep1",ctrl
SKMEL28_t48h_rep2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 35;	gender: male,ctrl
wt-Gfp E16 replicate 2,ctrl
A HID B_B017,pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep3",pert
Kidney_50 mg/kg VCM ip_mouse #070,pert
"age at diagnosis: 64;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3a;	er: 1;	pgr: 1;	dfs-month: 26;	dfs-event: 0;	distant metastasis: 0",pert
MDA-MB-231_TR6194,pert
01UN2_Systemic,pert
strain: C57BL/6;	tissue: Spleen;	genotype: Xbp1 KO,pert
MCF7/XBP1 p.3,pert
condition: Discoid Lupus;	patient: L5;	tissue: LS skin biopsy;	kit: Ovation,pert
CD34-920082,ctrl
HUVEC/NmenMC58_pilD_1h_rep2_1107,pert
RTX7 T12,pert
"A673 treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50), biological rep1",pert
5SC-nbc,pert
AtT20 cells overexpressing NSBP1SE protein rep1,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: control;	time: 6h;	gender: Female;	age: 5 months,ctrl
Female - caucasian - E-05-M,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 69,pert
PGA-MAH-HeJO3-1bAv2-s1,pert
reduction mammoplasty patient 347,ctrl
"siNC-BMSCs , biological rep3",ctrl
"human post-mortem brain tissue, bipolar disorder",pert
11090 Normal Uninflamed descending colon,ctrl
"CFU-PreB colonies Hspa9+/-, biological replicate 3",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 19.40822,pert
Large cell carcinoma 016,pert
cell line: SUM149,ctrl
cell line: MCF10A;	gender: female;	tissue: breast;	expression: HER2 over-expression,pert
"Endometrium, postmenopausal, tibolone, 11",pert
PBMCs_IS_7 [IS],pert
CEPI_IV_542,pert
MDS48,pert
Wild type IFN-beta 2 h,ctrl
sample =Healthy1 treatment=Stimulated time=90 (min),ctrl
Pancreatic Sample 16-Normal,ctrl
subject: 33;	disease: TD;	muscle: ST;	gender: M;	age: 13;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shControl.1,ctrl
"human post-mortem brain tissue, healthy control",ctrl
"control for Abca1 +/- ES, RNA 78",ctrl
SKMEL28_t48h_rep3,pert
WT #187,ctrl
GM19238_Kd_YY1_1,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-sp3,pert
BT474-J4_DMSO_24-3,ctrl
sample E 18.5 homo,pert
con-41_B,ctrl
E81-/-SRFdM-VP16-2,pert
Septic shock;	gender: Male;	Non survivor;	organism: Group B Strep;	organism class: Gram pos,pert
Human Chronic HIV Sample C101-CD4+ T cells,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 14.0;	age of psoriasis onset: 11,pert
TGF-alpha 979-CLA-31,pert
"HCT116 cells with enforced miR-34a expression, technical replicate 2",pert
V5-P354,pert
postnatal 3 weeks pitx2 cko heart,pert
Caco2-siRNA2-rep3,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 1,ctrl
"220, ADIPOOSE TISSUE, Before",ctrl
"PMA treated, no doxycycline; biological replicate 3",pert
sample =Healthy1 treatment=Control time=360 (min),ctrl
Pediatric_GBM_27,ctrl
tissue: testis;	gestational age: 22 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: 0.3% Tween-20 vehicle,pert
"hMSC-Tert, RNF40 siRNA, undifferentiated",pert
CD4+/CD25- T effector cells in resting phase,ctrl
PGA-MAH-AJ_PBS6h-4aA-s2,ctrl
murine whole heart tissue,ctrl
"sh3293 (to target ERBB3) T47D cell line, replicate 1",pert
T61 dilated cardiomyopathy heart biopsy,pert
157_SIO,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep5,ctrl
Kidney,pert
"normal colorectal mucosa, biological rep 2",ctrl
C13-(3),ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATM-3,pert
"gender: Female;	age: 87;	post-mortem delay: 14.5h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Time:0 day; condition:ctr;,ctrl
AA_Case21_CD8,pert
con-37_B,ctrl
genotype: Btk KO;	strain: CBA;	cell type: Splenic B-cells;	developmental stage: Transitional Type 1,pert
"Control 09, NC09",ctrl
cell type: F442A cultured adipocyte;	cell line: 3T3L1;	back ground strain: Swiss,ctrl
Untreated Melan-Ink4a #1,ctrl
ILD Study Number 1239,pert
"mental retardation or developmental delay, Male",pert
chip number: 20;	transfection plate: 4;	target gene: HCST;	kd level: 0.88;	rin: 9.7;	transfection date: 2011-10-17,pert
coc-51,pert
Bone-Marrow_MM_M687,pert
Trasnsformed Lymphocytes Unaffected Twin Pair 1(DCBD1.2)(TP6),ctrl
Pediatric_GBM_40,ctrl
SKMEL28_t1h_rep2,pert
cell line: IOSE80pc;	knockdown: ARID1A;	cell type: ovarian surface epithelial cells,pert
"liver_LDLr-KO, biological replicate 1",ctrl
Replication 2 Control,ctrl
colorectum,ctrl
"2 months, contralateral group, biological replicate 2",pert
"IkB, LPS 5hr",ctrl
HSC-3_TAT-2_48hr culture_ rep2,pert
"Cultured ovarian cancer cell line DOV13, Cisplatin treated",pert
Normal_MS 36D4,ctrl
HF12E1,pert
B_Kin_3,pert
"WT Heart with no treatment, biological rep2",ctrl
"129/B6 background, 6-10 weeks",pert
BE-rep9,pert
12P-ER,pert
"Epidydimal white adipose tissue from Casp1-/- after 16 weeks of high fat diet feeding, replicate 1",pert
KU_08N,ctrl
PCOS Endometrium Stromal Cell_134.UC271-+,pert
35/OVX/oil/6h/UTX 129 Hoxa-10+/+,ctrl
type 2 diabetes subject 10,pert
liver knock out replicate1,pert
cell type: tumor nodule cells;	ikk2 status: IKK2 -/-,pert
"FOXP3, mut, REP1, 0h",pert
SV589_15Day KD,ctrl
cell line: MCF7;	treatment: none,ctrl
"Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:37h",pert
WT-Nrf2-Female-1,ctrl
Keratinocytes_siRNA control_rep2,ctrl
"Control KD, rep1",ctrl
"CD3+ T cells, peripheral blood derived, healthy volunteers",ctrl
Lung of hemorrhaged animal 3h,pert
gender: Female;	age: 90;	post-mortem delay: 12.5h;	ph: 5.7,ctrl
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 26;	maternal age: 27,ctrl
primary normal lung tissue 1112,ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 9",pert
SUM149_siTIG1_rep2,pert
MA_13,pert
"whole brain, nicotinic acetylcholine receptor subunit mutant mice and littermate controls",ctrl
tissue: brain;	genotype: WT inbred background;	age: P0,ctrl
Day: 1; Drug: Saline; Phase: Drug treatment; Replicate: 3,ctrl
cadmium_32hr_rep1,pert
hair follicles from anagen-deleted area (presence of functional Notch1),pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 1",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_24_5_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
c 4-5,pert
Strain : 100% C57BL/6;	Gender: Male;	Age: 9 weeks (Moderate stage);	Transgene: Mutant ataxin-7,pert
aortic valve cells treated with DMSO,ctrl
8L,pert
cell type: ovarian cancer;	ets-1 expression status (western blot): High levels of Ets-1 protein expression,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 35;	maternal age: 36,ctrl
PPAR WT_ctr_54,ctrl
Gb5 KO,pert
"Human LIMA artery from patient 2, treatment: paclitaxel-eluting stent",pert
C3H10T1/2 cell line,pert
Control accumbens,ctrl
Age: 44;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 5382insC;	Family History: Yes,ctrl
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Male;	Age of onset (years): 21;	Duration of illness (years): 20;	Brain pH: 6.60;	Post mortem interval (hours): 39;	Side of brain: Left;	Fluphenazine mg. Equivalents: 4000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Patient 10,ctrl
6-C_1,ctrl
"fibroblast, MFS subject FB773 rep 3",pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
sal-PVH_2,ctrl
"breast, pre AFI treatment (H9_1575)",ctrl
SLE CD4 T cells 8,pert
muscle WT 2 control,ctrl
chip number: 20;	transfection plate: 6;	target gene: RAD21;	kd level: 0.9;	rin: 9.7;	transfection date: 2012-03-26,pert
MPM tumor specimen 41,pert
PHM-DM-1aUA-s2,pert
"B6, HFD 2wks",ctrl
treatment: control;	cell line: MCF7-FR,ctrl
Mening UNSTIM WB SW 0a,ctrl
Extract:LOX-1:213501;	Extract Description:LOX1_Untreated_24hr:213501;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.65;	Quality: Background Mean Dev.:0.43;	Quality: Absent (%):59.43;	Quality: Absent (%) Dev.:0.91;	Quality: Scaling Factor:0.75;	Quality: Scaling Factor Dev.:1.18;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213501;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295893,pert
HMEC,pert
"Frontal cerebrocortex, vehicle control (corn oil), 6 hours",ctrl
ColonDistal0224AC3G_071.txt,ctrl
"MCF-10A cells, shRNA targetting p63 DBD, biological rep2",pert
cell line: L-540;	cell type: Human Hodgkin Lymphoma,ctrl
MDA-MB-231_TR20003: transfected with the original vector plasmid,ctrl
J_LS_Wk4,pert
CAR.KO_CITCO_rep2,pert
"2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Injured 7 day Rat Retina 2,pert
06SAGEA,pert
P14 - nudelcko/ko 2,pert
"Pancreas from adult WT mice, biological replicate 2",ctrl
"HeLa treated with Cas-II-gly, biological rep2",pert
CRC_celecoxib_M4861,pert
"Amniocytes, euploid, 1563",ctrl
MCF7 Control cells Array 1,ctrl
HeLa cells nucleofacted with HIRA siRNA,pert
KM_019T,pert
"Patient  I, lesion, 12 week",pert
CD4+_Tcells_severe_asthmatic_3,pert
DBA control (203msn),ctrl
RTX11 T0,ctrl
"mouse aorta cross strain comparison, C3H_T24_HF_03",pert
cell line: AGS;	tissue origin: stomach;	cell type: human gastric carcinoma cells;	treated with: 20μM celecoxib for 24hrs,pert
INHA2,pert
liver_wild-type,ctrl
pt. HCL A treated with DMSO for 72h,ctrl
Patient no. 3: control,ctrl
GIST 2,pert
"Testes, 8 hours after cadmium treatment, biological rep 2",pert
Run4.aUa.010110d.SkMDbt1141D.CEL-DB stimulate,pert
"MAT1A knockout at 3 month age, biological replicate 1",pert
MZ1774 mock rep 2,ctrl
"MCF-10A cells, shRNA targetting p63 TA",pert
Wt Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-1,pert
"Patient #3, Untreated",pert
IMR-32_pCMV-SQSTM1_48hr,pert
Targretin_mammary_2,pert
MDS38,pert
WT 3 cerebellum 3 month,ctrl
Unaffected MZ twin pair 3 (Unaffected patient of MZ twin pair CCN3),ctrl
Msgn1_24hPlusDox-biological rep3,pert
PsOEt-18-Week 1,pert
cell line: LNCap;	sirna transfection: siRNA COP1,pert
genotype: wild type;	strain: CBA;	cell type: Splenic B-cells;	developmental stage: Transitional Type 1,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET3 transcript,pert
WT mouse 1_heart_basal,ctrl
CT-receptor-KO osteoclasts untreated 3,ctrl
"medulloblastoma, M2, cMYC silenced",pert
tissue: skin;	individual: Patient N-3;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
T2_pitM,pert
HeTH-4 +DOX rep-3,pert
Gastrocnemius Muscle_mdx_rep3,pert
Time of Surgery:Post;,ctrl
Normal cervix_05-1981,ctrl
CD4_T_cell_pool_melanoma_M11+M12,pert
3702-1 E2F3 Heterozygous,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: LSD1;	transfection time: 48h,ctrl
DN2 replicate 3,ctrl
OE-NANOG_2,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 361;	age-at-biopsy-years: 57,ctrl
gender: male;	agent: E2;	cell type: Hematopoietic stem cells,pert
"uterine sample from cKO female mouse, 24h vehicle treated",pert
"fibroblast, MFS subject FB837 rep 1",pert
minor HCC5,pert
"Liver, Intermittent Hypoxia 2",pert
RL_siRNA_LIF1h_rep1,pert
affected status (disease state): IS patient;	gender: male;	age-at-examination: 74;	age-at-onset: 72;	geographical origin: Mirandela;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
cardiomyocyte control 3,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: TL3 LAMC2 shRNA;	cell line: TL3,pert
"mouse liver, RNA B6999A",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.789;	OD280: 0.949;	Ratio: 1.83;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 132;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Vit A sufficient 1a,ctrl
"107, ADIPOOSE TISSUE, Before",ctrl
Seguin_IDR_BrownNorway_Liver_treated2,pert
"CCM3 shRNA cells passage 11, rep 3",pert
"Calu3 human non-small lung cancer cells, parental (ATCC)",ctrl
Monocyte human familial combined hyperlipidemia (FCH) sample,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: vehicle,pert
Individual_5325_PN_sample,pert
hdh genotype: Q111/Q111;	tissue: striatum;	age: 3~10 weeks,pert
rtTA-Dmrt5 day 7 -Dox,ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 48 hrs,ctrl
Endometrium-Normal 10,pert
Placenta Adra2bWT 2,ctrl
Cochlea_D257A_9mo_1,pert
"GNMT knockout at 8 month age, biological replicate 4",pert
Rat heart ventricle,ctrl
con-41_A,ctrl
ANL Chip#40,pert
Strain: C57BL/6J;	Gender: male;	Age: 2-3 months;	Tissue: heart,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 16.848;	Ratio: 2.11,pert
3589-1 E2F1 Null,ctrl
Wild-type postnatal day 10,ctrl
"AD_TC, biological rep3",pert
treatment: vehicle;	genotype: progesterone receptor knockout;	treatement time: 4 hours,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.92;	choa: 190;	fata: 15;	eea: 1160;	wtkg: 71.1;	perfat: 33.2;	lbm: 45.3;	fat_mass: 2360.52,ctrl
lymphoma_9250_ADR,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 110min;	race: White;	sex: Female,pert
"Deltoid, control, cohort 22, subject 22U",ctrl
BirA control replicate 1,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
model: Fischer 344;	gender: Male;	age: 7 to 8 months old,pert
E17.5 preB cells_Smchd1 null_Rep 3,pert
baseline control 06,ctrl
Liver_PXR KO_Vehicle_Rep4,pert
460A.INV,pert
Rat skeletal muscle (gas),ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep1",pert
Carboplatin 30 hours set 2,pert
"fibroblast, MFS subject FB837 rep 3",pert
WKY16-1,ctrl
P910,ctrl
disease state: ovarian adenocarcinoma;	specimen: ovarian cancer epithelia cells,pert
Ulk1/2+/+ + IFNβ 1,ctrl
Mononcyte-healthy-untreated-4,ctrl
438: control mouse 3,ctrl
high grade serous carcinoma_patient 3_sample 2,pert
control sample 5,ctrl
"KM-H2 cells, CIITA-BX648577 knockdown, replicate 1",pert
WIld-type control 3,ctrl
GM19238_Kd_ZHX2_2,pert
mouse cerebellar granule cells knockout 1,pert
OC1-WT embryonic retina at E14,ctrl
SW1736_t1h_rep1,pert
AtT20 cells infected with empty vector rep3,ctrl
"HSCs from male mice treated with oil, replicate 3",ctrl
Vehicle 12 hours_1,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Strep pneumo,pert
T147 U133p2,pert
affected status (disease state): control;	gender: female;	age-at-examination: 47;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension;	lifestyle characteristics: ever smoker,ctrl
T1E-LU,pert
"MHC class II high thymic medullary epithelial cells, NODaireKO",pert
phytohemagglutinin-activated PBMCs from normal control subject K,ctrl
CRC_celecoxib_F4871,pert
whole blood,pert
PS_IA_2_cauc_lcm,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 24.0;	age of psoriasis onset: 31,pert
NB83,ctrl
"human peripheral blood derived monocytes, 24 hour LPS stimulation, biological rep1",pert
tDEA001.CEL,pert
P54 Non failing heart biopsy,ctrl
"Patient 18, Macroscopically intact tissue",ctrl
ACC Xenograft X9,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 12h,ctrl
sirna: control;	plate: plastic;	cell line: MCF10A,pert
KM_103T,pert
GEIM17-PM,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 76,pert
Gastric_cancer_patient_1_dye_swap,ctrl
pancreatic beta-cells,ctrl
EB_0_6_325_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
"Liposarcoma culture from tumor 391, doxorubicin treated",pert
tDEA004.CEL,pert
Patient 7 skin treated,pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 54;	age-at-onset: 49;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"Liver, Normoxia 4",ctrl
TB 8,pert
CHB PBMC_sample 1,pert
race: caucasian;	age (years): 61;	stage: IB;	grade: 1;	histology: endometrioid,pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
"Lesion Skin, LS-31",pert
sex: Male;	Age: 60 months;	additional patient information found in Series supplementary file,ctrl
"Vldlr knockout saline, biological rep2",pert
11388 Normal Uninflamed descending colon,ctrl
GEIM179-U133A-DM,pert
colon_adenoma_1700,pert
cell line: Huh7.5.1;	tissue: liver;	agent: Ribavirin,pert
WILDTYPE cerebellum at 10 days,ctrl
Total RNA from Gsk-3a-/- ESCs,pert
"HCT116 shCDK8, normal growth",pert
N9_Cy3,ctrl
Tissue:Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	2nd technical replicate,pert
FoxM1 B,pert
"'cervical cancer cell line C4-I' , 'squamous cell cancer'",pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case5,pert
prefrontal cortex (control),ctrl
T2-FP_spleen_KO_rep1,pert
BCell_lymphoma_marginal_sample1,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 38;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Subject #8027-Preinfection,ctrl
siLRH-1_#3_rep_2,pert
E16.5 wt1,ctrl
Extract:LOX-1:213302;	Extract Description:LOX1_Untreated_6hr:213302;	Quality: Classification:Bad;	Quality: Gradient Severity:0.08;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.67;	Quality: Background Mean Dev.:0.99;	Quality: Absent (%):60.73;	Quality: Absent (%) Dev.:1.92;	Quality: Scaling Factor:1.1;	Quality: Scaling Factor Dev.:4.2;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213302;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295663,pert
MH1C1_high_rep3,pert
IL8 human transgenic mouse colon cancer tumor (control),pert
Wild-type mice rep3,ctrl
"MCF7, shRNA knockdown PDEF, biological rep2",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
HUVEC treated with 1 nM for 24 h,pert
tissue: Terminal end bud (mammary gland);	gender: female;	age: 4.5 week old;	genotype: Ovol2flox/+;	strain: C57/BL6,ctrl
MDS patient 101,pert
Sprague-Dawley Rat retina (male); 7d post injury,pert
INS-1 cell line (FLP-In T-REx clone #1-1.16),ctrl
protocol: Transfection Reagent;	cell line: MCF7,ctrl
wildtype 5,ctrl
"MOLM-14 cell line, transduced with a control luciferase and selected with  1 µg/ml puromycin 48 hours post-infection",ctrl
whole tissue section from case 1507,ctrl
heart-wt-1,ctrl
CUTLL1 wash4h-CHX_rep2,pert
"brain, frontal cortex: Sample62_e1_le1",ctrl
wt 13.5d replicate 9,ctrl
cell line: SLM2;	mutation: WT;	treatment: Control,ctrl
b44-,pert
"brain, frontal cortex: Sample44_e1_le1",pert
HeLa treated with water (mock experiment),ctrl
GEIM128-U133A-Norm,ctrl
Empty vector control embryoid body sample_1 (Vector_EB_1),ctrl
tissue: Temporal cortex;	age: 89;	Sex: M,pert
BP patient 101_biological replicate 1,pert
Male 6-8 week BALB/c trachea,ctrl
HF1348_U133P2,pert
Trib1 #1 KO macrophage treated with LPS,pert
Pax_C1,ctrl
HCC_16T,pert
PancreaticSample9-Normal,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 1 day;	treatment: fresh air, treatment over 1 day, 3x1h exposure per day",pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #2,pert
protocol: NGN1 overexpression;	cells: Human Neural Stem Cell Line F3,pert
"S1P3-KO-hippocampus, biological rep3 (female)",pert
MF-14,ctrl
"ERRa wt ventricle, baseline",pert
Epididymal adipose GPR120KO ND #720,pert
cell line: D3;	treatment: siPRMT1,pert
"65B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"jejunum, control, 1",ctrl
brain_QH2_14M_rep1,pert
WT_P14_D3_Effector_rep2,ctrl
Human.AZ.CTRL.FCU,ctrl
Immature dendritic cells cultivated in medium for 6h,ctrl
"patient 032b, cancer, homogenized",pert
Nrl-ko-Gfp 4 weeks replicate 3,pert
AO 8hr,ctrl
WT S49 Cells 6 h cAMP treatment,ctrl
"brain, hippocampus",pert
11091 Normal Uninflamed descending colon,ctrl
U87 10 uM Y15 rep1,pert
HeLa cell line,ctrl
tissue: gastrointestinal stromal tumor (GIST);	cell type: freshly sorted tumor associated macrophages (TAMs),ctrl
"Dermatomyositis, biological rep4",pert
Mut-/- rep1,pert
gender: female;	age (years): 46;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
DBA mouse treated with pristane for 18 days,pert
sciatic nerve,pert
cell type: Primary hepatocytes;	donor: 5;	agent: Wy14643;	time: 6h;	gender: Male;	age: 73 years old,pert
n24,ctrl
"Vehicle treatment, 7 hours (replication 1)",ctrl
Muscle_control_3,ctrl
E15.5 K14-Cre;Tgfbr2 fl/fl Conditional Knockout Mutant Mouse Model,pert
GAS-t7; transgenic gastrocnemus 7 month,pert
Kidney_200 mg/kg VCM ip_mouse #088,pert
Individual_4213_PP_sample,pert
"TNFa-OMe-P siRNA-C, replicate 3",pert
KN-smoke-low-5 month+1d-R3,pert
subject: 15A;	cohort: 15;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 28kb;	age (y): 66;	Sex: M;	batch: Batch_5,pert
11A;pretreatment;female;breast tumor; nonresponder,ctrl
"MEKi 4 days, biological rep1",pert
"Cell line SLM2, mutant status WT, condition Treated with Sorafenib 1",pert
HUVEC_control_rep3,ctrl
healthy control H09,ctrl
Huh7 cells_Mock Infected 6 hours_ rep3,ctrl
GM19238_Kd_RXRA_2,pert
"brain, cerebellum: KCx12w#1_e1_le1",pert
whole blood_100409,ctrl
ATF2 WT-1,ctrl
Cardian muscle Healthy 5 week C5,ctrl
Cervical Cancer C564,pert
Peripheral blood mononuclear cells;	TTF=150min;	Race=Black/African American;	Sex=Male,pert
DMN-NF1Hippo15d-1dAv2-s2,pert
"WT liver, biological rep3",ctrl
multiple sclerosis_7,pert
LSK cells from wild type mouse rep4,ctrl
jejunum_1h_rep2,pert
"650nM MLN4924 after 2hr, replicate 2",pert
Recent-onset T1D_sample12,pert
Hippocampus of of AD brain,pert
midbrain_Pink1 knockout_12 weeks_replicate 3,pert
E14wt-vector-2,ctrl
siRNA treated MCF-7 breast carcinoma cell line,pert
DMSO Control 3,ctrl
Barrett's esophagus (B4),pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.  . The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
WT 0h TPA rep3,ctrl
"ALL_NDS, K50 011409",ctrl
chip number: 17;	transfection plate: 4;	target gene: IRF8;	kd level: 0.64;	rin: 9.7;	transfection date: 2011-10-17,pert
V5-P291,pert
Skinbiopsy from healthy controls,ctrl
Pancreatic Sample 15-Tumor,pert
Hypothalamus,ctrl
"BMDM, Nod2 KO, uninfected",pert
patient id: 233;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 79;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
sample =XCGD1 treatment=Stimulated time=90 (min),pert
GLY replicate 1,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: p400,pert
KJD+doxorubicin_rep2,pert
day16 ES derived neuron,ctrl
"PPARg d4, rep 4",pert
subject id: 45;	infection: DENV;	status: DHF;	tissue: whole blood,pert
ET 27,pert
GM19238_Kd_YY1_2,pert
Amniocytes_euploid_1563,ctrl
"human ES cells line from Cellartis, Sweden; commercial line derived from normal embryos;	Karyotype: X,Y",ctrl
Human LRRK2 (G2019S) heterozygous induced pluripotent stem cells,pert
"human ES cells line from AZ-VUB laboratory, Belgium; derived from a blastocyst obtained after an in vitro fertilization carried out during a PGD procedure for DM1;	Karyotype: X,X",pert
Neocortex E14.5 mouse Eomes KO,pert
disease state: Healthy;	cell type: CD4+T;	twin: U,ctrl
"T47D, sh3293",pert
"Control ES cells 96hr, replicate 3",ctrl
HeLa_TP090705_29_HG-U133A_2_IMFGN0023,ctrl
array 6 minus E,pert
KOT 81 bleomycin treated,pert
RNA from HCC_36N,ctrl
Mouse embryonic fibroblasts,ctrl
DNGM-10,pert
"E18.5 lung KO2, biological rep2",pert
con-50_A,ctrl
M559_WT,ctrl
Glucosamine Transcriptome Profiling,pert
Individual_4688_PP_sample,pert
128A,ctrl
Adult 7d SNI; Biological replicate 6,pert
jzo030-rp1-v5_u74av2-met,pert
EB_07_24h_134_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
ILD Study Number S011,ctrl
"Patient  I, lesion, 2 week",pert
cerebellum_wild type_18 month_replicate 3,ctrl
EA_Control_CD4,ctrl
vehicle treated experiment B (4mM HCL/1% BSA) 24 hours,ctrl
Colo-205 DMSO Day 1,ctrl
THRB 15b mutant + vehicle replicate 3,pert
Normal_MS 36A4,ctrl
Human peripheral blood mononuclear cells,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A11",pert
siRNA Smc3 [M1],pert
H4-II-E-C3 cells,pert
LNCaP prostate cancer epithelial cell line,ctrl
"Embryonic stem cells, control shRNA",ctrl
"Wild type used for GNMT 8 month, replicate 5",ctrl
microdissected breast cancer cells from case 280,pert
TMRI AO 72hr,ctrl
L4/L5 dorsal root ganglia from adult rats (2 months old) 7 days after sham surgery,ctrl
"Pineal gland from NeuroD1 cKO mouse at ZT6, biological rep 2",pert
Huntington's disease 820D,pert
RNA from whole tissue section of case 868 labeled with Cy5,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#5,ctrl
SeroTest-1,pert
RNA,ctrl
"control, BA46-27",ctrl
con-13,ctrl
PB_DON034,ctrl
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 3 months;	tissue: liver;	disease status: healthy,ctrl
LmnaG609G/G609G KI #3. 463,pert
"seminoma specimen, pT1, patient age: 25y; W01 075",pert
"imr-32,",pert
Pt34_Post,pert
cell type: ovarian cancer;	ets-1 expression status (western blot): No detectable Ets-1 protein expression,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_8_33_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
Control Day7 (335R),ctrl
Primary hepatocytes isolated from BL6 mouse strain treated with DMSO for 24h,ctrl
CD71+ bone marrow cells from CD70TG (clone F13) mouse 2,pert
"Keratinocytes untreated control, 24h",ctrl
Individual_4934_PN_sample,pert
Patient: B;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
EB_0_5d_63_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
Uninfected NT mouse brain at 5 d.p.i.,ctrl
IRS-1 KO (jos0669),pert
Unaffected MZ twin pair 2 (Unaffected patient of MZ twin pair CCN2),ctrl
Sample isolated from loxP flanked Foxp3 CD4+YFP+Ly5.2+ T cells following treatment with HR-MMPCreGFP and six week adoptive transfer.,pert
N18,ctrl
4 hour tunicamycin CHOP-/- B,pert
"Monuron-treated NRK-52E cells at 24h, biological rep 3",pert
MacularDegen-healthy-14aAv2-s2,ctrl
Cell line HeLa_control_expt2,ctrl
male_alcoholic_274,pert
subject: 28;	disease: TD;	muscle: ST;	gender: M;	age: 14.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Squamous cell carcinoma 026,pert
6h WT Cel.03,ctrl
TF1_antiEvi1siRNA_1,pert
E14 +/+ wildtype ES cell line (control for Cdk4 +/- ES cell line),ctrl
Sex: female;	Age at operation: 57 years;	Site: thorax;	Size in cm: 4.9x4x3;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,ctrl
"Wild-type HFD 8 weeks, biological rep5",ctrl
CD8+_Tcells_severe_asthmatic_7,pert
N51677,ctrl
Wild type_kidney_2,ctrl
SCD1 -/- liver rep1,pert
"214, ADIPOOSE TISSUE, Before",ctrl
Muscle PCOS after pioglitazone 252,pert
whole blood_100652,pert
FmrKO3_blood,pert
3896-1 E2F1 Null,pert
Pancreatic Sample 16-Tumor,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.588;	OD280: 0.789;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 127;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Cultured ovarian cancer cell line PA-1, Cisplatin treated",pert
control11,ctrl
Mouse WT mandibular molar [AZN_MolairesWT2],ctrl
MO32_16,ctrl
8 week old EOM control rep 1,ctrl
"gene expression of CTCF-depleted oocyte, replicate 5",pert
RNA from microdissected breast cancer cells from case 1218 labeled with Cy5,pert
"Wild type, snap frozen, tibialis anterior muscle, 10 month age animal",ctrl
SIRT4 WT liver_7577,ctrl
A HID B_B012,pert
"MCF7 silenced Estrogen receptor, biological rep1",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 195min;	race: White;	sex: Male,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: wild type;	cell subtype: 10 days old tumor spheroids,ctrl
liver_Akt1+/-_female_35wk_rep3,pert
BALB/c_PBS Replicate 4,ctrl
"ID:9-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"S1P2-KO-neocortex, biological rep8 (female)",pert
"SKO-transduced MEFs, Vc-, D4",ctrl
WT_lung_bleomycin,pert
Wild type CD8+ unstimulated,ctrl
J1_minus LIF_rep1,ctrl
Phan_003_WT.saline rep3,ctrl
Pt_5 Acne Lesion,pert
"tissue: Cardiac, ventricular tissue;	genotype: caAkt;	age: 8 weeks-old",pert
developmental stage: E14.5;	genotype: Prmt5F/FNes;	genetic background: mixed C57BL/6 X 129S1/SvlmJ;	cell type: NPC;	treatment: Prmt5 depletion,pert
"patient 7, baseline",ctrl
NORMAL #99-0636,ctrl
KO - knock-out Untreated - 0 hrs - repeat 1 - Cy5 - mAdbID:61724,pert
XBP1s B cells 3,pert
Control F344 RAT penis,ctrl
"sh2608 (to target ERBB3) T47D cell line, replicate 2",pert
HF0822_U133P2,pert
Mut_P_2,pert
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 3;	age: Post natal day 3-15,pert
EOM 28 Day mdx rep 2,pert
cell line: A549;	cell type: human lung cancer;	sirna: FAM60A targeting,pert
BxPC3-KO4 rep 3,pert
MLL_00135,ctrl
BS2011051056,pert
HWC13,ctrl
RPE25,pert
"Whole blood - Autism with regression, Female",pert
pMX-Oct4 and pMX-jhdm1b(jmjc) no vitamin C O+JMJCVc-_1,ctrl
cell culture,ctrl
"control_B2, empty vector",ctrl
Healthy chondroctyes 2,ctrl
female JAK2 WT liver sample 147,ctrl
treatment: si222;	cell line: MCF7-FR,pert
FASSc1 medium only,pert
Discoid Lupus-L4,pert
disease state: healthy;	tissue: tibialis posterior;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
CML cell line: JURL-MK1,pert
Psoriasis-Patient-K,pert
age: 58;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
control_0525-1,ctrl
WT_01,ctrl
ALS gray matter 3 Sporadic,pert
"glioblastoma stem cells, differentiation, 4 days",pert
ME180 3 hours rep 2,pert
MDA-MB-231 cells siRhoGDIbeta transfected rep1 HG-U133A,pert
optineurin expression-b03,ctrl
"MDA-MB-231/shDBC1, biological rep2",pert
disease state: control;	patient: 3,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
Ring1b_KD_1,pert
lox62 control mouse,ctrl
wild type control tissue  5,ctrl
HF0141_U133P2,ctrl
JIA PBMC Post treatment A235_L014(2),pert
KN-smoke-med-1 day-R3,pert
OA5,ctrl
WT HPC Veh 2,ctrl
2 hr KLF4 Time Course Induced,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous saline challenge""",ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: kidney;	age: 12 weeks,ctrl
Normal PBMC Sample 9,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 97min;	race: White;	sex: Female,pert
"Setd2 knockout mESCs, biological rep2",pert
whole blood_100354,ctrl
Nerve_Control_Rosi_714,ctrl
Nrl ko 2 mon replicate 1,pert
postmortem brain tissue,ctrl
"non-AD_FC, biological rep14",ctrl
WT 541 L3,ctrl
L1 062502 Rosi1,pert
Bronchial Epithelial Cells MMA biological 1751Y,pert
minor non-tumor6,pert
"Gender: Female, Age: 32, BMI: 30, Tissue: luteinized cumulus cells",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.381;	OD280: 0.716;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 222;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
ab061a IM,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.843;	OD280: 0.95;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 52;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
b158,ctrl
"healthy breast 1, biological rep. 1",ctrl
pSuper vector control 3,ctrl
100uM H2O2,pert
strain: C57BL/6;	tissue: visceral_fat;	gender: female;	age: 8week,pert
treatment group: air;	tissue: left lung lobe;	gender: Male;	strain: C3H/ HeOuJ,ctrl
Kidney_Biopsy_Liver_Disease_1,pert
"Pancreatic islets, VhlhKO, 03",pert
Disease_status: Bipolar disorder;	Age (years): 35;	Gender: Female;	Age of onset (years): 21;	Duration of illness (years): 14;	Brain pH: 6.10;	Post mortem interval (hours): 17;	Side of brain: Right;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 35.43014,pert
m1-WT3,ctrl
E14 - WTMixB 3,ctrl
"Control, Liver, 11M",ctrl
chip number: 13;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.67;	rin: 9.5;	transfection date: 2011-10-17,pert
cell type: umbilical cord endothelial cells (HUVEC);	passage: 4,pert
control female replicate 2,ctrl
RENT1-2,pert
genetic background strain: C57BLKS/J;	tissue: Neuroretina;	age: 8-week old;	genotype: db/db;	phenotype: diabetic,pert
FHCRCAML16908,pert
HEK293 cells unstimulated,ctrl
mRNA of substantia nigra from 10mg/kg methylphenidate-treated mouse,pert
32n,ctrl
"Immortalized MEFs WA, v-src expression retroviral vector infected, rep1",pert
Soleus muscles from male BERKO ( estrogen receptor beta knockout).,pert
05_NOR,ctrl
Mouse WT mandibular molar [AZN_MolairesWT],ctrl
Colonic_mucosa_inflammation_26,pert
coc-14_B,pert
"P30_C-DGCR8 KO cones, replicate 2 [array]",pert
NESG1-negative C6-5-8F NPC cells rep2,ctrl
HCC_29T,pert
amnion mesenchymal cells with no treatment,ctrl
"Vehicle treated, doxycycline treated; biological replicate 1",pert
db/db 12-2,pert
6-KO,pert
RNA from HCC_18T,pert
Healthy individual of twinpair #2,ctrl
Wild-type_macrophages_4h,ctrl
17A,pert
"BMMs, untreated control, ko, Replicate 3",pert
patient: 219;	current medication: Sulphasalazine 1.2g Colifoam;	birth date: 1/5/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/81;	diagnosis date: 1/1/81;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/7/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"mouse aorta cross strain comparison, C3H_T08_HF_03",pert
sampleID: SAM630144;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
strain: Myd88 KO;	gender: n/a;	weight: 25-30g;	age: 4 month;	tissue: whole trachea,pert
cadmium_32hr,pert
SARRC-0248-01-A,pert
RA_D,pert
patient: 13;	disease state: hypertension;	tissue: Atheroma plaque,pert
INSENS 3 0hr,ctrl
12473 UC Inflamed sigmoid colon,pert
tissue: inner ear;	genotype/variation: Dlx5-null;	age: E10,pert
"breast tumor epithelium,15",pert
Grhl2 downregulation in MLE 15 cells 1,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 46;	donor: 32;	disease state: Lesional,pert
Placenta_PE(EO)1,pert
KU_25N,ctrl
EOM 14 Day mdx rep 2,pert
Placenta_PE(EO)2 with Cy5,pert
8 week old mouse extraocular muscle,pert
c48 is a clonal Nurr1 stably-expressing stem cell line,ctrl
Tmod3 KO-2,pert
L-540_Perifosine 10µM_24hrs,pert
"patient 028b, normal, homogenized",ctrl
Dexamethasone 2,pert
"metastasis: metastatic recurrence;	Stage: 2b;	tissue: cancer, homogenized",pert
HeLa_06_21_04 TP-11,pert
3-ONS76_c,pert
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
midbrain_wild type_18 month_replicate 1,ctrl
01UP5_ERA,pert
"A549 cells (lung epithelial cells, a common cell line used in IFN assays)",pert
U-87MG-V22 set 1,ctrl
CLL5-CD8,pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His-ZNF217 plasmid,ctrl
strain: C57Bl/6;	genotype: Myc(F/F);	cell type: CD8+ T cells,ctrl
T40741,pert
heart_QH2_6M_rep2,pert
umbilical cord_nobpd: 8F,ctrl
C57BL/6J_Islet_rep1,ctrl
erStress_twins_AA_1744twin2_DMSO_4h,ctrl
GC13_skin_5dpn_3,pert
wildtype luminal mammary epithelial cells,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep5",pert
Patient identifyier: R;	Sex: male;	Age of patient: 56 years;	Duration of psoriasis: 16 years;	Body surface area: 30 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 27,ctrl
"cell line: 5850, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
Retina RNA,ctrl
Md02h033,pert
5850_CNTL,ctrl
cell line: HepG2;	genotype/variation: HNF4a knockdown,ctrl
3716-lcm,pert
PBMC from T cell LGL leukemia patient #116 (TLGL116),pert
R1/E ESC,ctrl
Patient: A;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Embryonic Cardiac Progenitors - mutant,pert
"heart, control, 6 months",ctrl
Liver_untreated_HESKOL_rep1,pert
cell line: HEK293T;	transfection: si-control;	induction agent: CM;	induction time: 7 hours,ctrl
"brain, hippocampus: Aldh5a1-/- #3389 Hippo_e1_le1",pert
strain: myd88 KO;	weight: 25-30g;	age: 4 month;	gender: n/a;	tissue: whole trachea,pert
Control male 3,ctrl
11376 Normal Uninflamed ascending colon,ctrl
Gastrocnemius Muscle_mdx_rep1,pert
CML Patient 1 before therapy,ctrl
"Liposarcoma culture from tumor 340, untreated",ctrl
KO - 5 mo - repeat 5 - Cy5 - mAdbID:74140,pert
breast adenocarcinoma from 69yr old female caucasian,ctrl
cell line: MCF-7 breast cancer cell line;	agent: SFM (control);	time: 3hr,ctrl
"HEK293T human embryonic kidney cells, Wnt3A, si-TNIK",pert
ab156 IM,pert
061K3_CTRL,ctrl
HF0920_U133P2,pert
cell culture: grade VI GBM short term cultures,ctrl
PTEN_3,pert
Chronic plaque 2 (CP2),pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATR-3,pert
Healthy individual of twinpair #6,ctrl
BJ-fib_1,ctrl
liver 0.1% quercetin diet rep3,pert
"control, BA46-43",ctrl
01N27_Oligo,pert
Kidney_colistin_2,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 359;	age-at-biopsy-years: 48,pert
"Cell type: neuronal, age:49, gender:female, diagnostic group: control, PMI:45h",ctrl
background strain: C57Bl6;	genotype/variation: WT;	age: 9 weeks old;	tissue: whole heart ventricle,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 218,pert
4_day_old_wildtype_mouse_rep3,ctrl
V5-P604,pert
Mouse male ES cells WD44 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-2 in WD44.,pert
female_control_299,ctrl
"vehicle treatment, 72 hour time point, biological replicate 2",ctrl
E18.5 top2b-/- brain,pert
Normal-ERα-positive breast cancer 29,ctrl
GIST Pre Treatment Biopsy 47,ctrl
human CF cell lines airway with 24 hours of DMNQ treatment,pert
homozygot FH P270wh,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 147;	time: 0;	batch: 2,ctrl
Bronchial Epithelial Cells SA biological 1744B,pert
cell line: prostate cancer cell line PC-3;	telomere status: Short;	exogenous htert: absent,ctrl
"Postnatal day 11 Cerebellum, knockout for L1CAM, replicate 3",pert
Human PBMC,ctrl
NE-rep4,ctrl
BL Day 2 siMut12 transfected biological rep4,pert
Huh7,pert
"patient: 203;	current medication: Asacol 800mg BD, Simvastatin;	birth date: 1/10/35;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/92;	diagnosis date: 3/23/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/1/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 14;	crp: 0;	hb: 147;	wcc: 6;	neutrophils: 4;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: HISTOLOGICAL;	diagnosis recto sigmoid: HISTOLOGICAL;	diagnosis splen flex: HISTOLOGICAL;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/57;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: None,ctrl
sample =XCGD6 treatment=Stimulated time=360 (min),pert
"Chromium 10 µM, biological rep3",pert
"age at diagnosis: 53;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
patient: 3;	disease state: hypertension;	tissue: Atheroma plaque,pert
n8t0h,pert
EB_07_24h_133_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"age at diagnosis: 42;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1bi;	er: 0;	pgr: NA;	dfs-month: 15;	dfs-event: 1;	distant metastasis: NA",pert
U-87MG-V22 set 2,ctrl
HLA risk: Low;	Height: 181.1 cm;	Weight: 76 kg;	BMI: 23.2;	Age: 16.82 years;	Gender: Male;	Race: White;	Glucose: 75 mg/dl;	HbA1c: NA,ctrl
bone marrow-derived macrophages,pert
background mouse strain: C57B16;	genotype: WT;	treatment: Vehicle,ctrl
"PPARg d4, rep 1",pert
strain: C57/BL6;129Ola mixed;	genotype/variation: Insm1 +/-;	developmental stage: embryo;	age: E17.5;	tissue: pituitary gland,ctrl
U133A_G2,ctrl
01LR0_PolyRF+,pert
A509 Sham 1 day,ctrl
"pooled adult mouse intestine, kidney, and liver plus fetus tissue",ctrl
"Autism no regression, Male",pert
gender: Female;	age (y): N/A;	tissue: normal pituitary,ctrl
"brain, brainstem: LB6_e1_le1",pert
MIY_day_3-2,ctrl
"primary cortical neurons, luciferase shRNA",ctrl
V5-P503,pert
SLE patient,pert
WT_PMΦ_rep3,ctrl
patient: 116;	current medication: Clomiprimine;	birth date: 1/19/56;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: FH Colon cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
ve_NY41,pert
Liver antiangiogenic-treatment rep2,pert
"H69 tumor untreated, biological rep3",ctrl
WT-control-3 (DFW),ctrl
"granulocyte, patient. Mtx rep10",pert
"human nonfailing LV myocardium, NonFailing8",ctrl
GB 7 63A NO LPA,ctrl
"psoriatic epidermis, phototherapy, 2 months",pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: overexpression control,pert
Normal Chip#1,ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: wild-type;	age: 32 weeks,pert
con_B043,ctrl
B2KO; No Treatment #4,pert
P0 - WTMixB 2,ctrl
"ZR-75-1, 12h, 3.0mM 5FU B",pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 32, stage IIIB, HPV 16",pert
V5-P364,pert
Glioma cells not expressing Cyr61,ctrl
OC1-KO embryo 1,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 6",pert
WT_Mstn_1,ctrl
sparse HUVECs stimulated with Angiopoietin for 1 hour after overnight starvation,pert
S010_Scz_M_82,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 7",pert
endothelial_rep2,pert
NOD_T1,pert
WT / Reference_13425630,ctrl
12476 UC Inflamed sigmoid colon,pert
95 year old male,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 0, Units of Harvest Time Point: hr",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu2,pert
heart of 4 week control male mouse,ctrl
cell line: JCRB0033 [CEM];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
08SE1181,pert
A61 NES 142Q TG2	F6/22	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
Discoid Lupus-L2,pert
Mening SWB WB SW 1a,pert
Run1.a10a.000606jd.2.SkMNor912.CEL-IS stimulate,pert
POAG-TM-A,pert
patient id: 324;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 60;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"C57BL/6J female number 1, untreated control ear (#1_Wt-C-3)",ctrl
"liver_ABCA1-TG, biological replicate 3",pert
"Vehicle treated, DAY 6, biological rep.1, MOLM-13 cells",ctrl
"fibroblast, MFS subject FB1234 rep 1",pert
Prostate Cancer_MS 36A1,pert
Arid3a KD replicate 2,pert
Carboplatin treated cells Rep2,pert
456MM,pert
"E2A CLP LY6D-, biological rep3",pert
individual: Control1;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A13",pert
G_LS_Time0,ctrl
"53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
gender: male;	age (years): 39;	evolution time (years): 3;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
H24 Ctrl 24h 4,ctrl
MCF7 fulvestrant-resistant cell line,ctrl
background strain: Derived from BL6 blastcysts.;	cell line: WD44;	cell type: ES cell;	passage: 14-18,pert
SCC-40_siScramble_rep.1,ctrl
U2OS_PRC_shRNA1_pLenti_1_2007,pert
PGA-RMM-Ctr-4aA-s2,ctrl
PBMC_S2,pert
OVCAR-8-(2),ctrl
"PC-3 Luteolin, biological rep1 [mRNA]",pert
PsOEt-19-Week 1,pert
Bone Marrow MGUS patient,pert
Dot1l flox/flox day 7 after transduction with control,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 288;	age-at-biopsy-years: 52,ctrl
"WT cells, replicate 1",ctrl
age: 7dpp;	genotype/variation: wild type;	tissue: testis,ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 46;	donor: 29;	disease state: Non-lesional,ctrl
n2a-Pou3f3-kd-3,pert
Wild Type B cells Spleen 3,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 140min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 311,pert
Mouse cardiac left ventricle,pert
"BALB/c BMDM infected with WA(pTTS, pP60)",pert
RNA from whole tissue section of case 1037 labeled with Cy5,ctrl
"human failing LV myocardium, Idiopathic35",pert
"HCT116 cells, XIAP shRNA, early passage",pert
0810A-01_scrambled control-2,ctrl
1116-03-A,pert
HCC011T,pert
Sample from retroviral MSCV-GFP control infected cyclin D1 knockout 3T3 cells (line 7).,pert
FR-si221-3,pert
8 wk old male C57BL10,ctrl
cell line: HL-60;	replicate: Replicate2;	treatment: shSYK_1,pert
8 Week cardiac muscle,ctrl
tissue: embryonic fibroblasts,ctrl
hiPSC-derived 6-week-old neurons,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 3,ctrl
Mening SWB WB NP 1a,pert
"siPRMT1 ES, biological rep2",pert
54_129_KO,pert
CON21,ctrl
"skin fibroblasts, passage #1",ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: wild-type;	age: 32 weeks,ctrl
Individual_4990_NN_sample,ctrl
Healthy 1 week C1,ctrl
chip number: 11;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.79;	rin: 9.6;	transfection date: 2012-03-26,pert
"Normal subject (42 year old caucasian male, SAK_1265954246)",ctrl
Control 820B,ctrl
colonic_mucosa_inflamation_95,pert
P8 wt2,ctrl
cell line: prostate cancer cell line DU145;	genotype/variation: negative control siRNA,ctrl
"brain, Entorhinal Cortex: 97-01 normal_e1_le1",ctrl
CON_B,ctrl
"Sciatic nerve, acrylamide treated, biological rep2",pert
astrocyte,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: HIGH;	genome/variation: KIT mutation detected,pert
subject: 38;	disease: CP;	muscle: GR;	gender: M;	age: 9.4;	gmfcs: 2;	popliteal angle: 100,pert
batch: B;	knock-in: Twist-DQD;	cell line: MycCap prostate cancer cells,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: normal,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID288,pert
15L,pert
Heart tissues,pert
patient: 228;	current medication: None;	birth date: 11/22/48;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/80;	diagnosis date: 1/1/82;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Migraines;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"TNFa siRNA-A, replicate 2",pert
normal adjacent esophageal tissue from patient E1542,ctrl
"ShamC-21, biological rep 6",ctrl
MDA-MB-231 control clone #1,ctrl
New El-Ashry 007.CEL,ctrl
"Dicer lox/lox control, biological rep3",ctrl
Gata1WT25+#2,ctrl
HCT116_shBgal-rep3,ctrl
"Healthy volunteer, Control_11694",ctrl
C8161 cell line,ctrl
FVB_MMTV_Wnt1_iFGFR2_2960_5L_ROSEN,pert
mutant 14-3-3 ko/ko,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 30,ctrl
RTX10 T12,pert
K562_1R-Chl_24hrs_rep2,pert
db/db 14-5,ctrl
V5-P307,pert
"runx1-null luminal mammary epithelial cells, MD640",pert
S020_Scz_F_82,pert
OVCA433+(3),pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 27;	maternal age: 24,pert
hnf4KD_H9_d20_hepatic differentiated_3,pert
lymphocytes_HD_M_62y,pert
Ad+TOT replicate2,pert
remitted schizophrenia patient,pert
Normal-ERα-positive breast cancer 62,ctrl
"120, ADIPOOSE TISSUE, Before",ctrl
heart wild type replicate3,ctrl
"HSCs from male mice treated with E2, replicate 3",pert
NK_cell_pool_melanoma_M09+M10,pert
Monocyte-RCC-untreated-1,pert
"gender: Female;	age: 46;	post-mortem delay: 4h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"Undifferentiated C2C12 myoblasts, passage #11;	",pert
erStress_twins_AA_1720twin2_500nM_thapsigargin_4h,pert
Astrocytoma_8,pert
explanted neonatal cardiomyocyte,pert
"213, MUSCLE, Before",ctrl
gallbladder-saline treated,pert
224 Day 3 siMut10 transfected biological rep2,pert
Parkinson's disease sample x185,pert
Ad+TOT replicate1,pert
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 25y/female/caucasian. Cause of death: pneumonia.,ctrl
microdissected breast cancer cells from case 1370,ctrl
GATA-1deltaNeodeltaHS mutant E12.5 fetal liver derived megakaryocytes,pert
Diaphragm 56 Day mdx rep 1,pert
SIRT1 LKO liver_4 pm_rep1,pert
MOLM-14 cell line infected with GSK3A Construct 5 shRNA,pert
No_abuse_5,ctrl
"NTera-2 cells SOX2 siRNA, biological replicate 3",pert
Sample Group: HD patient; Gender: female; Age: 41; Tissue: lymphocytes (blood); IT15 CAG repeats: 24/49,pert
"wild type CTL, biological replicate 1",ctrl
92.1 - siBAP1 - replicate3,pert
age: 21 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),pert
AZ-521_uninduced_18h_rep1,ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
PGA-MAH-HeJAir-1aAv2-s1,pert
Mutator,pert
brain_DLPFC_bipolar C_mr545,pert
"spinal cord, ventral spinal cord: EP141/L - G93R(Roth)/e14-mutant hSOD1",pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#2,pert
cell type: Follicular (FO) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: WT,ctrl
"SUDHL-1, Treated by ALK inhibitor repl 2",pert
E_Kin_1,pert
EB_0_8d_67_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
Control_1_intestine_30days,ctrl
H12_SS10_01Nov07,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep4",pert
"Nrl-ko, purified Gfp+ photoreceptor cell",ctrl
"control embryonic stem cells, biological replicate 6",ctrl
J1 ES Cells,pert
Leptin treated mouse gallbladder 8,ctrl
Human umbilical vein endothelial cell,ctrl
diet_Lung_3,ctrl
"CCM3 shRNA cells passage 11, rep 5",pert
BATF_KO_P14_D3_Effector_rep2,pert
strain/background: mixed B6/129/FVB;	genotype: MMTV-Cre;Runx1L/L;R26Y;	gender: female;	developmental stage: adult virgin;	cell type: mammary gland luminal epithelial cells,pert
"nasopharyngeal carcinoma, specimen T25",pert
12A;pretreatment;female;breast tumor; responder,ctrl
"siSCR neuron, biological rep3",ctrl
hematopoietic stem cells transduced with control,ctrl
EA_Case16_CD20,pert
208/0,ctrl
ILD_15,pert
"patient 024b, cancer, homogenized",pert
Cochlea_WT_9mo_5,ctrl
"Fmr1 knockout mouse, blood",pert
GIST_PDGFRA_8,pert
Squamous cell lung cancer X42nml,ctrl
"Deltoid, FSHD, cohort 20, subject 20A",pert
BB Rat day 65 female diabetic prone mast cells from pancreatic lymph node,pert
MDS patient 75,pert
chip number: 17;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.4;	transfection date: 2012-03-26,pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC,ctrl
Biceps_Control_10,ctrl
patient: 242;	current medication: Salazopyrin Folic acid;	birth date: 10/18/39;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/75;	diagnosis date: 1/1/75;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/22/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"brain, Entorhinal Cortex: 96-18 normal_e1_le1",ctrl
lung tissue,ctrl
"Nickel 40 µM, biological rep3",pert
transgene strong 2,ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 7",pert
HEK293 cell line #2 with induced HNF1beta,pert
aa_NY234,pert
"brain, hippocampus: PH6_e1_le1",pert
GEIM19-U133A-DM,pert
Control spleen - Biological Replicate 4 - Technical Replicate 2,ctrl
Lmna H222P homozygous male 5,pert
"MCF-7 cells, siERK2 treatment 60h, 10 nM E2 for 4h",pert
"KO mouse heart at 6-weeks old, biological rep3",pert
microdissected breast cancer cells from case 823,pert
P4_PMP22TG_2,pert
Human glioblastoma cell line U87MG treated with a control siRNA,ctrl
"Untreated wild-type NB4, biological rep1",ctrl
"cochlea at P13, wt, biological rep 2",ctrl
"1833 shHMGA2, biological replicate 2",pert
chip number: 11;	transfection plate: 4;	target gene: IRF9;	kd level: 0.77;	rin: 9.1;	transfection date: 2011-10-17,pert
"Testosterone treated, HIV-1 positive male, day 14 (7)",pert
Bronchial Epithelial Cells MMA biological 0211F,pert
HCC PBMC Sample 10,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 49;	gender: male,pert
intestine_PPARa_kockout_24hfasted_rep1,pert
gender: male;	disease state: healthy,ctrl
B_cell_pool_healthy_H01+H02,ctrl
Insm1 control #7,ctrl
"lung homogenates, AhR KO, PBS control",pert
Gastrocnemius Muscle_Cmah KO_rep3,pert
NSCLC cell line H157. Transfected with siRNA oligomers targeting DJ-1 - #1,pert
DOV13-(1)b,ctrl
knockout rep-4,pert
E14.5 WT 2,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
V5-P055,pert
siOGT 12 hours_3,pert
brain_DLPFC_bipolar B_mr288,pert
Txnip deficient tumor 22 months sample 1,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#4,pert
M249_B_PLX,pert
1uM H2O2 rep 4,pert
Normal Chip#6,ctrl
01N1N_PolyRF-,pert
Cpr-low_pool 3,pert
8 wk old male mdx soleus,pert
Healthy-5 baseline,ctrl
"WT HSC, biological rep1",ctrl
neocortex-30 months of age-resveratrol diet-biological replicate2,pert
11099 UC Uninflamed descending colon,pert
"human failing LV myocardium, Idiopathic36",pert
Mock infected macrophages harvested at 6h post-treatment from donor 1,ctrl
R,pert
PIK3CA.DMSO.3,pert
Control subject 32_biological replicate 2,ctrl
siCtrlE24h_2656,pert
"mouse aorta cross strain comparison, C3H_T04_HF_03",pert
CD19_selected_B-cells_after_R_rep7,pert
mESCs_EGFPcontrol_rep4,ctrl
Diagnosis: AML M5;	Age: 38y;	Gender: Female;	Blast %: 97;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 1,pert
"Kidney from control rats, biological rep 2",ctrl
Keratinocytes treated with EFNA4 for 48h,pert
"shCDK19, normal growth, replicate 3",pert
"spleen marginal zone B in IRF8 conditional KO, biological rep1",pert
MDS patient 57,pert
Cervical Cancer C512,pert
"LCL GM19238, Kd IRF3, 72hrs",pert
cell type: MEF derived stable cell line;	genotype/variation: Tet-off control cells,ctrl
ICL670 10uM for 16hrs,pert
Muscle-24 month-wild type-technical replicate 2,ctrl
WT-EtOH-5 (DFW),pert
PS_IA_3_aa_lcm,pert
BP6,pert
S25 WT2	F41/390	S25	wild type	Mouse	2.5 months	Cerebellum	Female,ctrl
Biceps_Control_3,ctrl
"MAT1A knockout at 3 month age, biological replicate 2",pert
"- Rosiglitazone, - PPARg, 24 hrs",ctrl
XX19_InX,ctrl
newborn (P0) Krt1+/+ skin_replicate 1,ctrl
PancreaticSample14-Normal,ctrl
Gastrocnemius muscle wild-type mouse,ctrl
Control biological rep3,ctrl
HF0523_U133P2,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 4,ctrl
457MM,pert
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 48 hours",pert
"white adipose tissue, wild type",ctrl
Lineagelow Sca1+cKit high Cells,ctrl
RTX3 T0,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 24h",pert
"1mg/kg/day PFOA, Rep 3, Block 4, lung (low dose)",pert
tissue type: Malignant prostate tissue;	tmprss2: ERG fusion status: negative,pert
CD4_T_cell_pool_melanoma_M07+M08,pert
AFFS084-2-291004,ctrl
HCC_13T,pert
SIRT4 KO liver_7245,pert
IFC 04,pert
no_02+05+08,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIb;	Sex: F;	age: 52,pert
race: african american;	age (years): 37;	stage: IA;	grade: 2;	histology: endometrioid,pert
Strain C57BL/6;	Tissue: Backskin;	Age: e18,ctrl
Muscle PCOS case 31,pert
BL Day 1 siMut10 transfected biological rep1,pert
(ca)Raf_1,pert
Extract:LOX-1:213503;	Extract Description:LOX1_Untreated_24hr:213503;	Quality: Classification:Bad;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0.03;	Quality: Outlier Area (%):0.02;	Quality: 3'/5' Mean:1.74;	Quality: Background Mean Dev.:2.24;	Quality: Absent (%):61.27;	Quality: Absent (%) Dev.:2.34;	Quality: Scaling Factor:1.66;	Quality: Scaling Factor Dev.:9.07;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213503;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295913,pert
01LS8_PolyRF-,pert
siCtrl.exp3,ctrl
V5-P155,pert
"Benign, Prostate tissue",ctrl
Rybp#15 (OHT-)_4d,ctrl
non-CF subject 34,ctrl
whole tissue section from case 648,ctrl
EB_15_6_342_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
HGPS-fib_1,pert
EB_2_19d_233_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 40;	gender: male;	tumor grade: IV,pert
H20 HA 12h 4,pert
Day3 Estrogen treatment replicate 1,pert
KU_02T,pert
Individual_5293_NN_sample,ctrl
disease state: control;	patient: 18,ctrl
"Biological Material: Cell line, grown invitro; Tissue derivation: Adenoid cystic carinoma of the parotid gland",pert
AA_Case8_CD8,pert
CD4+T cells,ctrl
"A673 treated with DMSO vehicle control for 5 days, biological rep1",ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: moderate;	Ig clonality: oligoclonal,pert
"normal skeletal muscle, biological rep9",ctrl
Treated with 5% mannitol for 4 hrs -- replicate #2,ctrl
Fat Tro2,pert
SU8686 rep-2,ctrl
ShKdm2b replicate 2,pert
CD70Tg biological rep 2,pert
ESE_N_650,ctrl
VMM-WT_MyoD24h-1MP-s2,ctrl
V5-P065,pert
tissue: Brain;	genotype: Npc1+/-;	age: 81 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB without doxycycline,pert
"breast tumor epithelium,48",pert
NINDS-RHS-Kainate_24h-2aUA-s2,pert
Individual_5849_PN_sample,pert
St6gal1-/- tumor #3151,pert
Fetal heart 6 ug/kg TCDD rep3,pert
Liver_D3T _Rep1,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 23;	gender: male,ctrl
tissue: isolated from spleen;	cell type: memory CD8 T cells;	strain: C57/BL6;	genome/variation: TCF-1-deficient;	age: over 80 days after infection,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep6",pert
cell line: MDA-MB231;	treatment: control shRNA;	media: DMEM,pert
strain: C57BL/6J;	tissue: skin;	cell type: melanocyte;	genotype/variation: Ink4a-ARF1 null,pert
HeLa treated with siRNA specific for optineurin mRNA,pert
NZW/LacJ Vehicle liver sample batch 4,ctrl
MOLT4_GSI_C,pert
Strain: C57BL/6;	Gender:male;	Tissue:liver,pert
transfection: CDK8-2;	cell line: HeLa S3,pert
KD control 21A n,ctrl
thyroid_normal_4,ctrl
Kidney_Aqp11-/-_P7_2-4,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 49 yr;	population: white,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 6,pert
MDS patient 2,pert
WT Mouse spleen Ter19+CD71high sorted cells,ctrl
patient: 125;	current medication: OCP;	birth date: 3/17/78;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: Diarrhoea predominant IBS;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
WT Thymus,ctrl
3 wks TAC-4,pert
SENS 2 4hr,pert
Rnh1 Knock out  embryo yolk sac,pert
0192-01-C,ctrl
Labeled microRNA,ctrl
FVB_MMTV_Wnt1_iFGFR1_4004_3L_ROSEN,pert
age: 15;	sex: F;	disease status: control subject;	Filter number: 95;	Usage number: 1;	Exposures: 3,ctrl
B_cell_pool_healthy_H11+H12,ctrl
lesion_preUV_patient9,pert
Bronchial Epithelial Cells MMA biological 1945L,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep1,pert
"fibroblast, MFS subject FB773 rep 2",pert
HOX424 Carbo Day2,pert
435MM,ctrl
"patient 047b, cancer, homogenized",pert
"acutely admitted, severely psychotic schizophrenia patient  A23",pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P4,pert
Clinically localized primary prostate cancer tissue pool PX2,pert
Sham 14 replicate 1,ctrl
Sh2b-/-  NOTCH1 induced tumors,pert
KO_PMΦ_rep3,pert
triplicate 2 of uninfected HepG2 nt cells,ctrl
"Fibroblasts, baseline, time 0, patient 2, rep 1",ctrl
"wild type, prenatal stress, biological rep3",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_4_2_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
V5-P221,ctrl
"Sample Type: tissue, Tissue: testis",pert
CAR.KO_corn oil_rep1,pert
Nrf2 KO rep2,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: LSD1;	transfection time: 48h,pert
"CD8 DC wild type, biological replicate 3",ctrl
10 week mutant spinal cord rep 1,pert
MO_CTa_SON_NCBI,ctrl
H2 Ctrl 2h 2,ctrl
3587-1 E2F1 Null,ctrl
reduction mammoplasty patient 328,ctrl
"embryonic stem cells, KD replicate A",pert
cell type: peripheral blood mononuclear;	disease state: healthy,ctrl
HP-2,ctrl
EA_Case20_CD20,pert
sample =XCGD6 treatment=Control time=180 (min),pert
R6/1 18 week transgenic_5D42,pert
Brain from 54 days Npc1-/- mouse1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 13.666;	Ratio: 2.07,ctrl
Normal-ERα-positive breast cancer 33,ctrl
strain: C57Bl6;	gender: female;	age: 6 months;	tissue: white adipose tissue;	genotype: KSR2-/-,pert
43SAGEA,pert
tissue: skin;	cell line: NZM12;	tumour stage: metastatic melanoma;	tumour site: small intestine;	treatment: media-only control,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
cDNA no 02+05+08,ctrl
"Patient 28, Atheroma plaque",pert
PND28 Rat Testis_Rat230-2_1hr Corn Oil_Animal#40_04005,ctrl
"4302_CD133+, laminin treated",pert
Nonlesional Epithelium Nonatopic Control rep1,ctrl
C5star_CLP_wildtype_8,ctrl
gender: male;	strain: C57BL/6J;	genotype/variation: Scd1 knockout (SKO);	tissue: Dorsal skin;	age: 8-9 wks old,pert
Control_R_-Dox_rep3,ctrl
EA_Control1_CD4,ctrl
ndf + FTI,pert
heart wild type replicate2,ctrl
RO36,ctrl
MCF7_ARC_Array_2,pert
"cochlea at P13, ko, biological rep 1",pert
"iPSC derived from healthy control fibroblast WT2, biological rep7",ctrl
H17 Ctrl 12h 3,ctrl
Gender:M;	Age:44;	Tissue: Mucosa;	,pert
wild type MEF time 24 replicate 4,ctrl
Cancer 15,pert
WT heart 2,ctrl
age_years: 58;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
strain: B6/C3H hybrid;	gender: male;	age: 30-month-old,ctrl
gastrointestinal stromal tumor,ctrl
Strain: C57BL/6;	Gender: male;	Age: 9 - 12 weeks;	Tissue: liver;	Treatment: vehicle only (5% DMSO in corn oil),ctrl
whole right lung,pert
PND28 Rat Testis_Rat230-2_6hr Corn Oil_Animal#36_04005,ctrl
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep2",pert
Luciferase shRNA_2 Days knockdown_rep1,ctrl
01LLB: normal control,ctrl
Pax3 WT E14.5 palatal shelves 6,ctrl
"Inclusion body myositis, biological rep3",pert
cell line: H1;	cell type: embryonic stem cells;	shRNA: control,ctrl
TTF=127min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
"HL-60 cell line, transduced with shSYK_2 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
"A673 treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50), biological rep3",pert
APOE_KO_RAGE_KO_NODM_9W_15,pert
breast cancer cell line transduced with GATA3,pert
ADH1,ctrl
"Liver, fasted, phenobarbital",pert
disease state: endometrioma;	patient: 9,pert
Control Day0 (76L),ctrl
HepG2 cell line from ATCC at 8th generation.,ctrl
normal esophageal epithelium (N2),ctrl
"breast tumor epithelium,3",pert
"1833 expressing Tet1, biological replicate 1",pert
"Aorta, Ang II 14d, #3",pert
PPAR WT_ctr_55,ctrl
REH E/R positive leukemia cell line,pert
"human failing LV myocardium, Idiopathic74",pert
"gender: Female;	age: 89;	post-mortem delay: 5h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
C_AN00544_F,ctrl
SeroNeg-2,ctrl
"SKO-transduced MEFs, Vc treated, lysed on D8",pert
tissue: heart;	developmental stage: E10.5;	genotype/variation: Dbh+/+,ctrl
"Patient 18, Atheroma plaque",pert
genotype:Rb null;	Age: e12.5,ctrl
Human.BP.CTRL.FCU,ctrl
cell line: DOV13;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Colon",pert
"Setd2 wild type mESCs, biological rep1",ctrl
Human prostate cancer primary culture C11sx,pert
LIVER_CONTROL_repl3,ctrl
brain_DLPFC_bipolar C_mr283,pert
HUVEC monolayer,pert
N3+4,ctrl
long-Rif1 KD rep2,pert
PBMC from T cell LGL leukemia patient #102 (TLGL102),pert
Gastrocnemius Muscle_mdx_rep2,pert
"Normal Skin, Normal-13",ctrl
tissue type: normal esophageal tissue of surgically resected human esophagus;	cell type: fibroblast,ctrl
Individual_5142_NN_sample,ctrl
6 h-apra-2 nM,pert
THRA 6a mutant + vehicle replicate 3,ctrl
8_b,pert
treatment: control;	cell line: NuLi;	genotype: no-Cystic Fibrosis deltaF508 mutation,ctrl
"AD_HI, biological rep7",pert
"fibroblast, MFS subject FB992 rep 2",pert
Z5_TA,ctrl
ADHD_MPH,pert
Vector control 1,ctrl
PlagL2WT2,ctrl
Mnk_3214-S-B,ctrl
"Aorta, Ang II 7d, #1",pert
male_control,ctrl
Aorta_non-transgenic C57BL/6J control_1,ctrl
"spleen follicular B in IRF8 conditional KO, biological rep5",pert
"Distal and Proximal Large Intestine, 8week old Eeyore mouse 2",pert
Isolated PBMCs from diabetic male patient_RES-enriched Grape extract_12 months,pert
3765-1 E2F1 Null,ctrl
CD11b+Gr1+ cell sample_3 (derived from wild type mouse),ctrl
myotubes from type 2 diabetes subject,pert
Bronchial epithelium,pert
"patient: 254;	current medication: Asacol 800mg TDS, Predfoam;	birth date: 7/25/59;	gender: F;	ethnicity: ASIAN;	symptoms onset date: 1/1/00;	diagnosis date: 11/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
RNA from HCC_15N,ctrl
C57BL/6 heart left ventrical (LAD ligation 3 day),pert
"Endometrium, postmenopausal, tibolone, 6",pert
"Acute Myeloid Leukemia, sample 12",pert
ku86(ko)_Terc(wt)_1,pert
Sox9egfpneg_p23-1,ctrl
DE1483_muscle_mutation,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 4",pert
"Wild type, snap frozen, tibialis anterior muscle, 7month age animal",ctrl
tissue: brain;	genotype: WT mix background A;	age: P14,ctrl
MCE301 cells treated with SB for 24 h-1,pert
Panc-1 Gli3T 3,pert
Waldenström’s macroglobulinemia (WM-BL 30639),pert
8wk old male mdx diaphragm,pert
Nrl-ko-Gfp P6 replicate 2,pert
HepG2_Sb rep3,pert
Mouse_Klf5 KO_ES_clone 2,pert
Tk6 untreated controls for cadmium exposure rep2,ctrl
WT V6.5 ESCs on day 7 #1,ctrl
Ramos Cells,pert
R7E 7,pert
"C2C12 Myotubes treated with BSA, rep3",ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 74;	age-at-onset: 73;	geographical origin: Mirandela;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
mdx Biological Replicate 4,ctrl
M535_WT,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 47 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
WT-control-4,ctrl
"human failing LV myocardium, Idiopathic7",pert
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 4",ctrl
"D425-shOTX2_2, t=96",pert
Mesangial Cells,pert
C57BL/6 BMDM naive,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 32;	maternal age: n/a,pert
A375 melanoma cells treated with vehicle (0.1% DMSO) batch A,ctrl
HepG2-PARP2 depleted-2,pert
"non-AD_TC, biological rep19",ctrl
umbilical cord_nobpd: 5A,ctrl
platelet from control,ctrl
glioma cell line,pert
High weight gainer Kozak1_ABI_ING_H1,pert
MLL_00131,pert
Prdm14 knockout 2,pert
..SAL_II_1,ctrl
Waldenström’s macroglobulinemia (WM-BL 32833),pert
Diseased individual (ulcerative colitis) of twinpair #10,pert
M_LS_Wk4,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-C104A/C131A cells, expression not induced",ctrl
FHCRCAML16906,pert
65A;pretreatment;female;breast tumor,ctrl
CD11b+Gr1- cell sample_3 (derived from IL17RC Knock out mouse),pert
RNA from RAW 264.7,pert
A_AN17777_T,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: C,ctrl
"Liposarcoma culture from tumor 388, untreated",ctrl
NS2-031009-SA,ctrl
Individual_4688_PN_sample,pert
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 42;	tissue: Normal_Kidney_Biopsy,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 1;	gender: male,ctrl
FBooth-CON-3Av2-s2,ctrl
VEC A,pert
Individual_4165_PP_sample,pert
SPC KO lung adult,pert
33A;pretreatment;female;breast tumor; nonresponder,ctrl
cell type: Erythroid progenitors on day 6 of differentiation;	genotype/variation: transduced with control empty vector,ctrl
HSC-3_vector_48hr culture_rep3,ctrl
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID354,ctrl
Whisker pad WT biological rep3,ctrl
Disease_status: Down syndrome;	Age (years): 76;	Gender: Female;	Post mortem interval (hours): 18;	Braak stage: VI;	Cause of death: Unknown,pert
"SRF silenced, treated with EtOH, biological rep 3",ctrl
5285 UC Inflamed ascending colon,pert
cell type: PBMCs;	disease state: remitted schizophrenia patient;	gender: male,pert
cell line: OVCA433;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Severe rep7 (OHN),pert
colon_epithelium_C57mouse_6weeks_rep2,ctrl
Liver_normoglycima_no.3,ctrl
MCI-006,pert
Pten cKO rep2,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
LCH2ani,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L016,ctrl
genotype/variation: Wildtype_XX;	tissue: gonads;	age: E11.5,ctrl
Psoriasis-Patient-B,pert
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep1",ctrl
"18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
03SAGEA,pert
Control ITP chip B,ctrl
Rap1 knockout liver,pert
"Ad(moi10)-infected, vehicle-treated for 24hr",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.088;	OD280: 0.579;	Ratio: 1.8;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 289;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Ad+veh replicate2 b,ctrl
Wild type_liver _2,ctrl
cMyb virus-infected replicate 2 (MCF7),pert
Mouse_ESC_Pcl2_shRNA_sample 2,pert
475MM,pert
08SE1180,ctrl
"patient: 204;	current medication: AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin;	birth date: 8/15/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 7/1/02;	diagnosis date: 8/1/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/1/04;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 0;	nod 702: 0;	nod 908: 0;	dlg5 133a: 0;	nod 1007 fs: 0;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/58;	smoking stop date: 1/1/01;	smoking amount: 25+;	other illnesses: Type 2 DM 02/2004.-Gout.;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed",pert
cell line: HCT116;	clone: 21;	genotype: Knockout,pert
Liver CTR replicate 2,ctrl
TOV112D NT-1,ctrl
liver_control_diet_rep2,ctrl
Gene expression profiling of Phgdh knockout embryo KO2,pert
Oct4 KD replicate 1,pert
subject: 34;	disease: CP;	muscle: ST;	gender: M;	age: 15.2;	gmfcs: 2;	popliteal angle: 120,pert
Control + LPS 5,ctrl
human preadipocytes+siCtrl_day0_rep2,ctrl
strain: BALB/C;	age: 8-10 weeks;	treatment: PBS;	gender: Female;	time: 10 dpi;	tissue: heart,ctrl
"Nod2-UN3,experimental replicate 3",pert
Gene expression data spleen follicular B in WT,ctrl
HCC_3T,pert
Untreated WT - repeat 2 - mAdbID:102766,ctrl
CML_4_HSC,pert
Primary combined SCLC-AD 1870,pert
"3T3-L1 siLSD1 24h, biological rep 1",pert
+/+ mouse liver,ctrl
11428 UC Inflamed ascending colon,pert
E14 molar TCDD 2,pert
healthy CD19 B cells 2,ctrl
A549 non-small cell lung cancer (NSCLC) cell line,pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: Myc over-expression,pert
Muscle PCOS pioglitazone 31,ctrl
GM19238_Kd_NFE2L1_2,pert
"ALL_NDS, K13 011609",ctrl
major non-tumor9,pert
Age: 41;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
"twin pair: #2;	individual: healthy individual, non-inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",ctrl
Mammary gland R1 24 hr S rep1,pert
Capan2_siLLGL1-2 biological rep1,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with vehicle for 6h,ctrl
129/BSw wt1 heart,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.222;	OD280: 1.139;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 64;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
mucosa collected and archived within 30 mins after sugery,pert
Wild type mouse pDCs,ctrl
NZM15_siPAX3_30hrs_rep1,pert
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
Psoriatic arthritis PsA 13,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 7",pert
total RNA from testis,pert
"wild type, control, biological rep3",ctrl
cell line: C13;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
"heart tissue, untreated controls",pert
"normal mouse kidney E12.5, biological rep 1",ctrl
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 35;	dfs-event: 0;	distant metastasis: 0",pert
liver_male ko_rep2,pert
Liver_TAK1KO_Rep3,pert
transgene strong 3,ctrl
ERRa KO kidneys,pert
OSCE-10T,pert
Insm1 mutant #2_pituitary gland,pert
CLL8-CD8,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case2,pert
Mutated-ERα-positive breast cancer 57,pert
RNA-DHL6-R406-24H-3,pert
"BOEC, normal 26",ctrl
TGF-alpha 979-CLA-32,pert
"spleen marginal zone B in IRF8 conditional KO, biological rep3",pert
genotype: Fog2flox/delta;	treatment: alpha MHC Cre;	age: 6-7 wks old;	gender: male;	tissue: heart,pert
CXCL4_A,pert
Sarcoma cell line  - Dicer Null -rep3,pert
Patient no. 5: control,ctrl
X_p8_rep3,pert
Amniocytes_Euploid_1559,ctrl
"colonic tissue from floxed mouse, biological rep2",ctrl
chip number: 21;	transfection plate: 5;	target gene: RXRA;	kd level: 0.86;	rin: 9.1;	transfection date: 2011-10-17,pert
"disease state: Nasopharyngeal carcinoma;	stage: I, T1, N0, M0, G4",pert
Cerebellum_nontransgenic control S25_3 months_replicate 3,ctrl
"brain, hippocampus: wildtype 3_e1_le1",ctrl
FCHL patient #98-1405,pert
CO_2,ctrl
"Patient M030-55B, MSI colorectal tumor",pert
KU_12T,pert
N65s2,ctrl
Panc1 rep-3,ctrl
sample L 18.5 wt,ctrl
Waldenström’s macroglobulinemia (WM-PC 30381),pert
cell line: MCF-7;	cell type: Breast Cancer Cells,pert
Skinbiopsy_48hoursnickel_nickel_allergic_subject_P4,pert
cerebellum wild type 21 month replicate 1,pert
U87 20 uM Temozolomide rep1,pert
A2058 CT16 siRNA Rep3,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 48 hr,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 1,pert
"vestibualr organ at E18.5 of Igf1 +/+, biological rep 1",ctrl
44A;pretreatment;female;breast tumor,ctrl
Gastrocnemius muscle from integrin alpha7 transgenic mouse;	Strain: SJ6/C57BL6 background;	Genotype: integrin alpha7 transgenic;	Gender: Female;	Age: 5 week;	Tissue: gastrocnemius and soleus muscle;	Feeding condition: non-fasted,pert
"FVB/N genetic background. 4-month old;	virgin female mice were used, mice were kept on a 12-hour;	light/dark cycle with ad libitum access to chow and water",pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep7,pert
Z138-shSOX11.3,pert
HNF6_1-,ctrl
"seminoma specimen, pT1, patient age: 36y; W03 014",pert
siRNA-96_rep3,ctrl
RAW Untreated 1,ctrl
"Wild type used for MAT1A 3 month, replicate 5",ctrl
chip number: 16;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.55;	rin: 7.8;	transfection date: 2011-10-17,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: post-UV,pert
Control A549 cell Replicate3,ctrl
HP-9C,pert
normal control,pert
Wild type mice on a high fat diet (CH 2),ctrl
Rat Adipose Tissue,ctrl
"human failing LV myocardium, Ischemic55",pert
T92,pert
chronic lymphocytic leukemia (CLL 45205),pert
PolyRF+,pert
MCF10A_HER3_2,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse, liver sample",ctrl
Multiple Myeloma Patient 1,pert
aorta from ApoE-/- mouse with diabetes sacrificed at 9 weeks.,ctrl
ILD Study Number 1078,pert
umbilical cord_bpd: 9C,pert
erlot5_CT37,pert
"C3H/HeJBir-Il10tm1Cgn, sample 1",pert
cell line: NCI-H716;	treatment: none,ctrl
Tissue:tumor; Gender:female; Age:31; Tumor stage:T4aN1bMx,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, U0126-treated",pert
8 Ko,pert
Cervical cancer_1875T,pert
E10.5 ko.1,pert
MPM tumor specimen 39,pert
normal control 5,ctrl
VIN_B017,pert
Normal urothelium_1 (Wild-type),ctrl
Sample 6,pert
HCC004N,ctrl
Subject 6 Post allergen challenge,pert
Nasal Epithelium Inhalation Formaldehyde 15ppm 6h ID338,pert
strain: C57BL/6;	genotype/variation: Wildtype;	tissue: whole embryonic kidney;	age: gestational day 12.5 (E12.5),ctrl
Parkinson's disease sample x108,pert
"brain, cerebellum: RNA#4S_le1",ctrl
genotype/variation: K14CREER:SOX2fl/fl mice treated with tamoxifen for 1 week;	tumour stage: Benign tumour,pert
brain_DLPFC_bipolar C_mr538,pert
"brain, wild type",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.408;	OD280: 1.228;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 342;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"gene expression of wild type oocyte, replicate 4",ctrl
FCHL patient #99-1225,pert
"breast tumor epithelium,23",pert
airway epithelial brushing,ctrl
OVCA420+(2),pert
SV129_24h_Wy,pert
normal B lymphocytes (NBL 004),ctrl
Normal-ERα-positive breast cancer 47,ctrl
Ngn3 EB10 ON replicate 2,pert
Sarcoma cell line - Dicer Null -rep1,pert
strain: C57BL/6J;	genotype/variation: CD70TG;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),pert
AZ-521_doxycycline_18h_rep3,pert
HT29 sensitive cells replicate 3,ctrl
DU145_NCsh_rep1,ctrl
WT1-iPS 1,ctrl
11081 Normal Uninflamed descending colon,ctrl
Mening SWB WB SW 24b2,pert
skin.wt.replicate4,ctrl
V5-P504,pert
D2-Gpnmb+ control rep7 (retina),ctrl
Atm+/+ untreated A,ctrl
HEK293_HNF1b_#1_induced,pert
KU_48N,ctrl
"vestibualr organ at P15 of Igf1 +/+, biological rep 1",ctrl
b12.2,pert
strain: Ola129;	cell type: Embryonic Stem Cells;	genotype/variation: control,ctrl
TMRI AO 8hr,ctrl
WT5,pert
wild-type_phenobarbitol_rep1,ctrl
V5-P255,pert
mRNA from Gastric tissue,ctrl
BC4 TC_NOC,pert
"brain, motor cortex, layer 5 thick tufted pyramidal neurons, wild type",ctrl
Control gray matter 4,ctrl
LJMJDW13,ctrl
U937 cell line infected with scrambled control shRNA,ctrl
"NPTX1 shRNA Day 0, biological rep2",pert
cell type: Melanoma cell line;	cell line name: A375P;	expression: PGC1a shRNA 65,pert
Gastric tissue tumor region,pert
TAF4b knockout 1,pert
"mutant triceps, biological rep4",pert
patient: 40730;	sample: tumor,pert
"human failing LV myocardium, Idiopathic10",pert
U2OS_siHic5_2_4h,pert
Pool Ts1Cje_P0_hyb2,pert
Hodgkin lymphoma cell line,ctrl
"55B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"shKDM4C 1, clone 2, rep 1",pert
0195-01-C,ctrl
SPC WT lung adult,ctrl
CD4+_Tcells_healthy_donor_4,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 4 - Technical Replicate 2,pert
"Quercetin, sample 1",pert
Liver wildtype ND,ctrl
retina_DBA_1026L_3mo_rep3,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 99;	Sex: male;	region: M1;	age: 39;	genotype: Y/X;YFPH/-,ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 100,pert
control IgG_rep2,ctrl
clone 42 replicate 1,pert
IRS-2 KO (jos0929),pert
Keratinocytes treated with EphB2 for 4h,pert
"wild type Treg, replicate 4",ctrl
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: sensitive,ctrl
Hes6_Castrated OWJ72,pert
health control_2,ctrl
"human whole blood, PAXgene",ctrl
gender: male;	strain: BALB/c;	tissue: liver;	diet: Western diet containing 0.05% quercetin for 20 weeks,pert
CUTLL1 MigR1 GSIwash2h-rep2,pert
A with Cy5,ctrl
C57BL10 diaphragm sample 1,ctrl
HDAC1_A3-rep1,pert
"IKK2 -/- tumor, biological replicate 3",pert
"heart, 30 months of age, control diet",ctrl
"endometrial stromal cell - control/vector1, 3 days post infection",ctrl
EA_Control4_CD4,ctrl
Wt_cycling_rep2,ctrl
HF0232_U133P2,ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA1+dox,pert
T5C-LU,pert
48h_c2,ctrl
shRNA4-1-noDox-rep1,ctrl
normal control 3,ctrl
heart-30 months of age-resveratrol diet-biological replicate3,pert
>95% CD3+ T cells negatively isolated with Dynal kit,ctrl
"Patient 112, 3 month of REBIF",pert
SynovCTRL_022HACIZ_150.txt,ctrl
siControl_rep_4,ctrl
untreated_24hr_rep4,ctrl
E10_otic_vesicle_wt_replicate1,ctrl
ASC_lean_biological rep3,ctrl
health control_3,ctrl
sample type: Primary culture of typeII cells collected from SPC KO lung adult;	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C KO;	genetic background: 129S6/SvEvTac,pert
"macrophages, 4 days post UV-SeV inoculation",ctrl
wt_on_rep2,ctrl
Nrl-ko-Gfp E16 replicate 3,pert
B6.IL10 72 O3 3,pert
"Crohn's Disease subject (43 year old black male, SAK_1287548671)",pert
CONTROL;	Age = 22;	Sex = M,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 1",ctrl
Tumor-WT-rep2,ctrl
C26_heart 3,pert
Human mammary epithelial MCF10A cells,ctrl
Total RNA from MDA-MB-231 cells infected with a lentivirus shLOXL2,pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: U2OS;	cell type: human osteosarcoma cells;	transfected with: shControl,ctrl
ILD_14,pert
"Mouse brain, Adult, 4hr post saline ip injection",ctrl
tissue: white blood cells;	age: 17.74;	Sex: female,pert
EB_15_6_337_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
TTF=103min;	Race=Caucasian/White;	Sex=Female;	Group=A;	Prototype_N,pert
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
SLE CD19 B cells 11,pert
cerebrum_PS-/-_ 0d_rep2,pert
patient: 10;	disease state: hypertension;	tissue: Atheroma plaque,pert
treatment protocol: control,ctrl
Individual_4164_PP_sample,pert
"PIO, subject 15",pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 16 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
"left ventricle,Hsp22 WT,basal condition",ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 2,ctrl
KM_001T,pert
"Subject 2, Family 1, Asymptomatic",pert
HMEC X BC1369,pert
K562 DMSO sample 11,ctrl
uterus_P4_PRKO_4hrs_rep3,pert
Pooled PBMC sample from normal control subjects (139PBMC),ctrl
"RES-enriched Grape extract group, 6 months, patient number 41",pert
Cochleae from wild type mice at P13,ctrl
breast cancer patient 258,pert
erStress_twins_AA_1733twin1_DMSO_4h,ctrl
HD 6,ctrl
GM19238_Kd_NS_P6_12,ctrl
E2A-deficient DN2 replicate 3,pert
CH 3,ctrl
X6752318020 F MYC negative#3397,ctrl
PDAC_3,pert
genotype: wild type;	tissue: triceps muscle;	age: 3 months,ctrl
G_LS_Wk1,pert
heart_co_6M_rep3,ctrl
siCtrl.exp1,ctrl
MCF-10A shATR-3 replicate 3 [set 5],pert
X6752318020 E MYC positive#3397,pert
MacularDegen-healthy-8bAv2-s2,ctrl
CON-1-COLLAGEN,ctrl
M24met_Wnt1_2,pert
chip number: 14;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.83;	rin: 9.5;	transfection date: 2012-03-26,pert
iFGFR1 mammary gland 16 hr AP20187,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.72;	Post mortem interval (hours): 45;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
tissue type: Malignant prostate tissue;	tmprss2: ERG fusion status: positive,pert
Cas 1,pert
Adult Sham; Biological replicate 4,ctrl
strain background: BALB/c;	cell line: 4T1.2;	stably transfected with: pMSCV retroviral expression vector system the base vector (BV);	expressing: base vector (BV);	tissue: Mammary Tumour,ctrl
Glioblastoma_12,pert
ESCs_control siRNA,ctrl
cell type: bone marrow cells;	strain: DBA/2,ctrl
GFP-kd_ES_rep2,ctrl
Nasal Epithelium,pert
nmMLCK-/- -SB replicate 1,pert
OVCAR3_rep2/CD157_norm,pert
B6C3F1/J Vehicle liver sample batch 1,ctrl
"T3 fetal heart (treated on gd14.5 via oral gavage, collected on gd 17.5)",pert
"Nickel 40 µM, biological rep1",pert
MDA-MB-231 RRP1B over-expressing clone #10,pert
Cell line established from CA2 HESC using pClip vector,ctrl
expression array - O3,pert
tMLL09,ctrl
mESC_undifferentiated_Alkb1-/-_rep3,pert
"patient 044b, normal, homogenized",ctrl
"Primary, localized, pooled tissue, prostate cancer",pert
3T3-L1 0.1% DMSO,ctrl
"treatment: diclofenac;	batch: 2;	donor: 28;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
C57BL,ctrl
SKBR3_0.1uM_Lapatinib_1,ctrl
K14deltaNB-cateninER Time 0 replicate 1,pert
ATF2 WT-3,ctrl
"fibroblast, MFS subject GDO32 rep 2",pert
"AD_HI, biological rep6",pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 23;	maternal age: 22,pert
Control 4 b,ctrl
"mNSC nucleofected with miR-Control, replicate",ctrl
HA96-61B,pert
agent: Chromium 1 µM,pert
tissue: aorta;	genetic background: C57BL/6J;	genotype: APOE-deficient;	treatment: vitamin E;	sample type: aortas from vitamin E-treated APOE-deficient mice,pert
db/db 8wk 2,pert
"HEK293 cell, MIF Knockdown",pert
tissue: liver;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
chip number: 18;	transfection plate: 3A;	target gene: SP3;	kd level: 0.62;	rin: 9.7;	transfection date: 2012-03-26,pert
"Donor 2, mock infected 1hr",ctrl
PBMCs_Control_7 [IS],ctrl
RKO_liver_fasted_refed_3hr_rep2,pert
chondrocyte_5azatreated_rep1,pert
Trib1 #1 KO macrophages were treated with LPS,pert
strain/background: C57BL/6N;	genotype: Ctnnb1 flox(ex3)/+;	tissue: tumor,pert
WT_24A_2,ctrl
Lung WT-PBS replicate 2,ctrl
"human failing LV myocardium, Ischemic45",pert
Genotype: MMTV-c-myc/Hunk KO; Gender: Female; Tissue: Mammary gland tumors; Strain: FVB,pert
"subjects: heart-beating, brain-dead donor;	tissue type: normal aortic tissue",ctrl
Intestine_Ctrl_biological rep1,ctrl
Allo-14-3,pert
Clozapine treated 4weeks AffyGC RMA rep1,pert
tissue: Temporal cortex;	age: 90;	Sex: M,pert
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 1,ctrl
14-week-old Trim24-/- liver_395M,pert
cMetKO CSC Technical Rep.1,pert
mutant_ANT_PDE_9-1,pert
Mut+/- rep2,pert
"WT CD8 memory T cells, biological rep3",ctrl
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
H1P_8,ctrl
MDS patient 180,pert
striatum SNCA knockout 6 month replicate 1,pert
laser-captured pancreatic islets,pert
RNA from whole tissue section of case 651 labeled with Cy5,pert
MPM tumor 41,pert
high grade serous carcinoma_patient 6,pert
tissue: pancreas;	genotype: Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 9 weeks-old,ctrl
Diaphragm 112 Day control rep 3,ctrl
GIST_WT_3,ctrl
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with acetaminophen (APAP)_2,pert
Skin_Tcfap2c Mutant E16.5_rep2,pert
1IDC_normal_ductal,ctrl
MPA 6,pert
pediatric AML S35,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: abiraterone,pert
ab147 N,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 15",pert
RNA-DHL4-R406-24H-1,pert
HF0931_U133P2,pert
Waldenström’s macroglobulinemia (WM-PC 33161),pert
Untreated Myd88 knockout - repeat 3 - mAdbID:102773,pert
"brain, Entorhinal Cortex: 00-28 tangle_e1_le1",pert
tissue: non-neoplastic salivary gland;	organ site at which tumor arose: submandibular salivary gland;	donor sex: unknown,ctrl
RptorKO CSC Technical Rep.2,pert
3449-1 E2F WT,pert
BCR-ABL1-control rep 2,pert
Subject 5 Post allergen challenge,pert
MLL_00120,pert
Mutc-Met_1,pert
Blood_Control 7,ctrl
Skinbiopsy_96hoursnickel_nickel_allergic_subject_P7,pert
a10a.000606jd.2.SkMNor911.CEL-IS basal,ctrl
"human failing LV myocardium, Idiopathic57",pert
Prdm14(+/+) ESCs,ctrl
human_hepatocyte_400uM_Trovafloxacin_donorB_24hr_prep2,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 68;	baseline tumor size (cm): 8x8;	patient id (to identify the 2 chips from the same patient): 12781328,ctrl
HepG2,pert
KO_IL-6_100_rep3,pert
24A;pretreatment;female;breast tumor,ctrl
"A673 treated with DMSO vehicle control for 24 hours, biological rep6",ctrl
Wildtype iPSC sample 2,ctrl
"SKO-transduced MEFs, Vc-, D6",ctrl
SKMEL28_t6h_rep2,pert
TAMs sorted from imatinib treated tumors,pert
Trnp1 knockdown tissue,pert
gender: male;	age (years): 50;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Endometrium, postmenopausal, control, 33",ctrl
MCF7_E2_24h_rep2,pert
GM19238_Kd_RXRA_3,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 4x1h exposure per day",ctrl
DND41 NBD 1,pert
25 uM cyfluthrin batch 2,pert
208/4,ctrl
K562_ICL670_10uM_dup1,pert
PGK12.1_control RNAi-1,ctrl
EA_Case16_CD4,pert
Epididymal adipose GPR120KO ND #718,pert
cell type: Primary hepatocytes;	donor: 6;	agent: control;	time: 6h;	gender: Male;	age: 73 years old,ctrl
Normal mucosa 15,ctrl
cell line: HuT-102;	cell type: human cutaneous T cell lymphoma cells;	transfection vector: shRNA expression vector against TAK1,pert
"human failing LV myocardium, Idiopathic29",pert
osteoblast_5azatreated_rep2,pert
MCF7_CHX_EtOH_24h_rep3,pert
TTE3 cells treated with BPA for 6 h-1,pert
Primary human erythroid progenitor cells expressing HDAC1 G10 shRNA,pert
subject: 12;	disease: TD;	muscle: GR;	gender: M;	age: 15.6;	gmfcs: N/A;	popliteal angle: N/A,ctrl
"seminoma specimen, pT1, patient age: 51y",pert
cell type: Primary hepatocytes;	strain: SV129;	agent: control;	time: 24h;	gender: Male;	age: 4 months,ctrl
F9 con sample #1,ctrl
CD34+ cells from the patient (CML34),pert
"patient 027b, normal, homogenized",ctrl
cell line: Du145-PCAT1 (HTB-81);	age: < 20 cell passages from derivation,pert
2826 TG,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 87;	Usage number: 5;	Exposures: 3,ctrl
sXBP2_1578R,pert
"from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
"49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 18h,ctrl
0198-01-c,ctrl
2h 4OHT-treated-sample3,pert
"E12.5 wild-type embryonic kidney, biological rep2",ctrl
LY2 SRC1-siRNA untreated rep1,ctrl
tissue: colon;	cell line: HT29,pert
mdx Biological Replicate 5,pert
breast cancer patient 316,pert
"brain, cerebellum: RNA#1S_le1",pert
ko 13.5d replicate 11,pert
Old heart,pert
Normal cervix epithelium_CaCx5,ctrl
age: 67;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
CME-LaminA0d-2MA-S2,pert
ME180 1 hour rep 4,pert
G93A mouse 1262,pert
Day: 6; Drug: Saline; Phase: Drug treatment; Replicate: 2,ctrl
Cutaneous psoriasis without arthritis PsC 13,pert
CONTROL;	Age = 24;	Sex = F,ctrl
strain: C57 BL6NCr;	tissue: Distal colon;	genotype: Myd88-/-,pert
MPM tumor specimen 9,pert
"t21, surgically resected from patient of gastric cancer.",pert
Gata-1 Knock Down B,pert
"age at diagnosis: 66;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 25;	dfs-event: 1;	distant metastasis: 1",pert
HEK001_A08_R1,pert
"p63shRNA_B1, p63-depleted",pert
"WM35, no treatment",ctrl
source: Breast adenocarcinoma;	cell line: MCF-7;	treatment: ethanol;	knockdown: FOXM siRNA,pert
Sample ID: TP23;	Twin Pair ID: CCN3.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 25;	Current Age (2007): 28;	Sex: MALE;	Medication at blood sampling : None,ctrl
"AD_FC, biological rep8",pert
cell type: CFBE41o-  wt-CFTR,ctrl
heart_WT_rep2,ctrl
LNCaP + vehicle rep 1,ctrl
MCI-018,pert
"Patient 6, Atheroma plaque",pert
human embryonic stem cells cultured with mouse embryonic fibroblasts,ctrl
12487 UC Uninflamed ascending colon,pert
thyroid sample containing tumor cells,pert
"Control cells, rep3",ctrl
genetic background: c57/bl;	gender: male;	tissue: heart;	genotype: control,ctrl
PBMCs_Control_2 [IS],ctrl
P62 Non failing heart biopsy,ctrl
Mouse WT mandibular molar,ctrl
liver_Wt_35wk_rep2,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 4,ctrl
AhR-KO2 melanocytes,pert
HEK293 cells transfected with SIRT6 construct  and unstimulated,pert
RAW_3.5mM_HOCl_#2,pert
R2_saline_wildtype_48,ctrl
E14 - 14-3-3Epsilon 3,pert
Control liver sample 3,ctrl
Individual_5030_NN_sample,ctrl
C_AN00142_C,ctrl
C57BL6,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A07",pert
NPC25,pert
32 with Cy5,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 72h",pert
AAA neck (Sample 1),pert
Tissue: brain (frontal cortex);	Disease state: HIVE,pert
Genotype: p38alpha KO;	Age: E13.5,pert
A HID U_B016,pert
MGHU3 Cells_TAK1 siRNA + PD173074_Biological Replicate 3,pert
A_Ctrl_1,ctrl
Normal Sample 1,ctrl
"alveolar macrophages, smoker 041",pert
3880-1 E2F WT,pert
RF- polyarthritis,pert
"Pineal gland from control mouse at ZT20, biological rep 1",ctrl
"seminoma specimen, pT3, patient age: 42y; W00 048",pert
SLE CD19 B cells 4,pert
129_Sv_3_Runx1_Ko_d6_4302,pert
"TNFa-OMe siRNA-B, replicate 3",pert
Muscle KO Adult 01031,pert
Kidney_KO_baseline_rep1,pert
VGLL4 HUES6 3,pert
Individual_5281_NN_sample,ctrl
NCI-H69 human small cell lung cancer,pert
"Deltoid, control, cohort 15, subject 15V",ctrl
murine lymph node,pert
male_control_335,ctrl
H14_P_B1,ctrl
Squamous cell carcinoma 010,pert
AP-920051,pert
PND28 Rat Testis_Rat230-2_12hr MEHP_Animal#59_04005,pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 46;	maternal age: 42,pert
tissue: brain;	genotype: mutant Ndel ko/cko;	age: E14,pert
HDAC2 WT E17.5 Ventricle 2A,ctrl
Itk knockout unstimulated 1,pert
"endometrial stromal cell - control/vector2, 3 days post infection",ctrl
TAp63 alpha 24h without induction s3,ctrl
Vehicle-Control 24 hours set 1,ctrl
"prdm-control, biological rep2",ctrl
"PCB77 treated HepG2 cells at T0.5, biological replicate 2",pert
condition: Psoriasis;	patient: PS-B;	tissue: LS skin biopsy;	kit: Affy,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep1,pert
36/OVX/oil/6h/UTX 129 Hoxa-10-/-,pert
patient: 17;	disease state: hypertension;	tissue: Atheroma plaque,pert
"DP thymocytes, control",ctrl
cell line: A549;	agent: azacitidine;	dose: 0.3uM,pert
"fibroblast, MFS subject FB836 rep 2",pert
brain_DLPFC_bipolar B_mr547,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 4;	gender: male,pert
Tgfbr2 fl/fl Control Posterior Palate 6,ctrl
RNA from NCCIT human cells treated with a control non-targeting siRNA,ctrl
Endometrium/Ovary-Disease 7,pert
Ls174T-L8 con1,ctrl
Peripheral blood from healthy individuals,ctrl
sample: #19;	subject: PD case #4;	brain: T-9;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
uninfected hRPE cells,ctrl
"DHL4, R406, 24h",pert
TG mouse left ventricle treated with tamoxifen,pert
chip number: 16;	transfection plate: 4;	target gene: HCST;	kd level: 0.86;	rin: 9.2;	transfection date: 2011-10-17,pert
PGC-1a-/-bf/f/MerCre rep5,pert
Liver Experiment 3,pert
UC-71-Aff,pert
rtTA-Dmrt5_d9_-Dox_rep_1,ctrl
MDS patient 71,pert
"Quercetin, sample 3",pert
"LCL GM19238, Kd CEBPG, 72hrs",pert
Normal Adrenal Gland (AN26),ctrl
APLP2_R6_rep1,pert
BALB-RAG_PBS Replicate 3,pert
Pediatric_GBM_2,pert
TG mouse left ventricle,pert
BP7,pert
Msgn1_24hPlusDox-biological rep1,pert
human peripheral blood derived monocytes,pert
3T3F442A-shTRPV4-rep2,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siNonTarget,ctrl
"Lymphoblastoid cell lines derived from family 1727, member 2",ctrl
"2 months, sham group, biological replicate 2",ctrl
430: control mouse 1,ctrl
"Peripheral blood mononuclear cells, RF+ polyarthritis",pert
"Lymphoblastoid cell lines derived from family 1734, member 1",pert
subjectid: 5258;	imatinib: NoIM;	lbh589: NoLBH,ctrl
GM19238_Kd_KLF13_2,pert
Control (0.1% DMSO) rep 1,ctrl
"KARPAS-231, non-targeting siRNA, REP3",ctrl
HCC_39T,pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 49;	age-at-onset: 48;	geographical origin: Porto;	clinical characteristics: Diabetes, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
Normal-N_LJ_10,ctrl
WT7,pert
SeroTest-10,pert
34n,ctrl
M249_R4_A_PLX,pert
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate B,pert
strain background: C57BL/6N;	genotype/variation: Sta1 Wildtype (wt);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),ctrl
MLL_PTD03,pert
chip number: 12;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.82;	rin: 9.2;	transfection date: 2012-03-26,pert
coc-51_A,pert
"Sv129/C57B6 hybrid strain, 12 week old male",pert
4-HPR_LUNG_1,pert
"ME180 cells, 10μM ATRA, 3 hours",pert
mouse liver D1,pert
brain_DLPFC_bipolar B_mr520,pert
Patient 9 appendix,pert
Patient 7,pert
"wt total RNA LSK, rep 1",ctrl
B-lymphoid,ctrl
STAT1-deficient naïve T cells stimulated for 3 hours with medium alone 3,pert
MSE_D_678,pert
imanitib8,pert
"breast, pre AFI treatment (H2_1279)",ctrl
"control, subject 4",ctrl
Aortas isolated from non-transgenic C57BL/6J control mice,ctrl
CD8 KLF13 WT 1,ctrl
Ls174T-pTER-β-catenin dox2,pert
Nonspecific siRNA4,ctrl
MS25_5B_MEK5_220307,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 3,pert
cell line: HepG2;	genotype/variation: control,pert
PBMC,pert
"Csbm/m mouse, cerebellum, young, saline treatment",ctrl
C2C12 myotubes 1000uM H2O2 rep 2,pert
MV4-11 cells,ctrl
"Undifferentiated C2C12 myoblasts, passage #11",ctrl
strain: C57BL/6;	genotype/variation: Wild type;	cell type: Regulatory T cells,ctrl
pediatric AML S09,pert
BL Day 1 siSC transfected biological rep4,ctrl
sample 1:;	age: 51;	gender: male;	sample 2;	age: 84;	gender: female;	sample 3:;	age: 74;	gender: female,pert
"5 x 10^4 Zfx-cko LSK (Lin-, Sca1+, c-Kit+) cells were sorted directly into Trizol Reagent (Invitrogen) form pooled bone marrow cells from Zfx-cko mice.",pert
V5-P355,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of EED. Sample A,pert
KU-812 Imatinib-treated,pert
cell line: SCC25;	tissue: tongue;	cell type: epidermal keratinocyte,ctrl
cell line: HEK293 cells WTX inducible clone F18;	agent: doxycycline,pert
OE-NANOG_1,pert
Run3.aUa.010110d.SkMDbt1136D.CEL-DB basal,ctrl
"schizophrenia, BA46-40",pert
scan batch: Batch 1;	group: autism;	subject age: 8;	paternal age: 33;	maternal age: 29,pert
short-Rif1 KD rep1,pert
"normal skeletal muscle, biological rep3",ctrl
Severe rep2 (retina),pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 99min;	race: White;	sex: Female,pert
c-Kit + MA9 AML Zfx wt,ctrl
normal plasma cells (NPC 545),ctrl
"Mouse liver, GNMT knockout, non-alcoholic steatohepatitis, 3 months",pert
ALS gray matter 6 Sporadic,pert
VEC C,pert
224 Day 2 siSC transfected biological rep2,ctrl
Severe asthma,pert
15DKD_SerumStarved->3hrEGF_rep2,pert
BCell_lymphoma_transitional_sample1,pert
18.5 dpc mouse small intestine wild type,ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: Ctr MCF10A.B2,ctrl
"ALL, Down syndrome",pert
ve_M47,pert
strain: C57BL/6N;	genotype: wildtype;	tissue: liver;	age: 5-6 months;	gender: male;	treatment: streptozotocin,pert
FU-OV-1+(2),pert
"CD8 DC Xbp1 KO (DC conditional KO), biological replicate 1",pert
Sex: female;	Age at operation: 69 years;	Site: lower arm;	Size in cm: 4.5x3.5x2.2;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,pert
"MGSKO, PR03M006v0",pert
MDS patient 19,pert
shRNA4-1-plusDox-rep1,pert
C2C12 myotubes 10uM H2O2 rep 3,pert
Monocyte-RCC-untreated-4,pert
Klf9 wild type (Klf9WT) and mutant (Klf9KO) mice jejunum; Age: PND 30,pert
Sample 9,ctrl
0978-01-C,ctrl
"DHL4, DMSO",ctrl
Wt_ liver_fasted_refed_3hr_ rep4,ctrl
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: standard AIN-93G diet (SD; carbohydrate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum for 8 months,ctrl
NOD Aire WT MEC rep2,ctrl
Strain: NMRI mouse;	Age: 14 d embryo;	Tissue: molar tooth germs,ctrl
V5-P343,pert
WT_IL-6_400_rep1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 37;	maternal age: 32,pert
"Histidine decarboxylase null myeloid-derived suppressor cell from bone marrow, rep1",pert
"A673 treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50), biological rep2",pert
HRas-v12 transgenic male replicate 1 early timepoint,pert
"jejunum, GATA4 mutant, 2",pert
PTC BRAF mut 4,pert
"liver, PPAR WT_ctr_54",ctrl
Infergen_6hr_rep4,pert
non-malignant FTEb_patient 2,ctrl
treatment: siThoc5;	cell line: HeLa,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 10",ctrl
BALB/c BMDM infected with WA(pYV),pert
wt #4. 464,ctrl
shRNA6-16-plusDox-rep2,pert
plantaris muscle,ctrl
Mouse fetal liver_E14.5_WT_rep2,ctrl
"Uninvolved Skin, NS-3",pert
Ulk1/2+/+ + IFNβ 3,ctrl
NALM-1 Imatinib-treated,pert
tissue: white blood cells;	age: 13.87;	Sex: female,pert
UV-inactivated Sendai virus infected mouse tracheal epithelial cells.,ctrl
THP1-shGSK3A-Construct5-rep2,pert
hair bulbs only from 9-day-old mice,pert
remitted schizophrenia patient  S16,pert
mouse NB N1-115 cell line,ctrl
Male wild-type BALB/c,pert
"Liver, fasting",pert
MCF7 - MTDH_WT_KD_1,pert
cell line: HEK293E,pert
HeyC2-(3),ctrl
male;	36 yr old;	Hispanic,pert
Liver_normoglycima_no.5,ctrl
DP AA4+ replicate 2,pert
original diagnosis: PolyRF+;	cell type: Peripheral blood mononuclear cells,pert
OCI-Ly7_ctrloverexpression,ctrl
"NALT infected with wild type 90-226, biological rep3",pert
"vestibualr organ at E18.5 of Igf1 +/+, biological rep 3",ctrl
disease state: endometrioma;	patient: 14,pert
disease affected colon of an adult with bacterial infectious colitis (INF).,pert
38n,ctrl
N_LS_Wk2,pert
ku86(wt)_Terc(ko)_1,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID322,ctrl
neocortex-30 months of age-resveratrol diet-biological replicate3,pert
"brain, knock out",ctrl
SKI-DLCL cells_untreated_24h_1rpt,ctrl
HUVEC/NmenMC58_WT_6h_rep2_1108,pert
heart-30 months of age-control diet-biological replicate5,ctrl
CTL2 AO 8hr,ctrl
OA 2,pert
"nasopharyngeal carcinoma, specimen T7",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: monosomy7/del(7q),pert
Bone Marrow MM patient,pert
H1299 AZA 1 uM (3231),pert
"patient 7, right arm treated with pimecrolimus until day 22",pert
cell line: MCF7 breast cancer;	treatment: SIN3A silenced,pert
Patient: O;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
"VHL null MEFs, biological rep1",pert
human normal cell lines airway,ctrl
HNF4loxp/-,ctrl
MOLM14-shGSK3B-Construct1-rep2,pert
K562_ICL670_untreated_dup2,ctrl
strain: FVB;	genotype/variation: ErbB3 DOX-KO;	tissue: Mammary epithelial organoids;	treatment: DOX,pert
microdissected breast cancer cells from case 1389,ctrl
Muscle PCOS pioglitazone 231,ctrl
Normal myocardium sold commercially,ctrl
"Biceps, control, cohort 22, subject 22U",ctrl
mouse embryo forelimbs,ctrl
Large PreB,pert
nucleus accumbens long access to cocaine replicate 1,pert
MDS37,pert
tissue: retina;	age: postnatal day 2;	genotype: wild type,ctrl
HEK293 cell line #2 with uninduced HNF1beta,ctrl
BMM_C3H/ARC_time21h,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 1",ctrl
"liver, wild type",ctrl
Cervical Cancer C538,pert
CKO Wild Type V3,ctrl
13,pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #3,pert
Phan_008_KO.saline rep2,pert
EVI_GFP positive Lin- cells replicate 1,pert
Liver-5 month-wild type-technical replicate 2,ctrl
New El-Ashry 010.CEL,pert
"72 hour-treated TG2 knockout NB4, biological rep3",pert
"fibroblast, control subject NF6 rep 2",ctrl
CME-Ctr_LaminA4d-2MA-S2,ctrl
36M2 cell line from ovarian serous carcinoma cells,pert
Seguin_IDR_BrownNorway_Liver_control4,ctrl
Hippocampus 2001 2 month Old,ctrl
F9 RARaKO treated 8hr with atRA,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 70 years,pert
WT - Cre Treated - 12 hrs - repeat 1 - Cy5 - mAdbID:61753,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (4)",pert
SZ5,pert
Liver sample of p14 KO mouse 2,pert
5270 UC Inflamed sigmoid colon,pert
tissue: Brain;	genotype: Npc1+/-;	age: 40 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Bronchial Epithelial Cells control biological 1070A,ctrl
MacularDegen-injured-3cAv2-s2,pert
bronchoalveolar stem cells,ctrl
S1,pert
DOV13-(1),ctrl
control sample 4,ctrl
siGL3E2 2,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_1mM_HG-U133A_2_YCHSUP501,pert
CIS,pert
NOD2-L1007fsinsC_0h_MDP_biological replicate 3,pert
BA osteoblastic lineage cells 5-6 weeks post doxycylin withdrawal,pert
pediatric AML S23,pert
Heart sample2,pert
Normal-N_AJ1,ctrl
Mnk_3201-R-B,ctrl
"Male, 27 years old, HIV infection of ~1 months",pert
NPC 5-8F cells with NESG1 overexpression,pert
E8.5 ko.2,pert
V5-P451,pert
Wild Type Mice fed Low fat diet 1,ctrl
GLIP3,pert
"Ishikawa cell line, BPA, 1pM, 24hr",pert
Jejunum_Wild Type_2,ctrl
Liver_Female_WT_rep4,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 21.1863,ctrl
HC JR 2 alcohol,pert
"52B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
465MM,pert
"H1299 treated with PTD-DRBD GAPDH siRNA, 24hr",pert
aa_NY224,pert
strain: C57BL6 mixed FVB;	genotype/variation: cMetflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
C_AN19760_T,ctrl
control MCF-7 cells,ctrl
CD4_Tcells_non_severe_asthma,pert
"seminoma specimen, pT3, patient age: 42y",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 24 hr AP20187,pert
"3mg/kg/day PFOA, Rep 3, Block 5, liver (low dose)",pert
heart tissue,ctrl
"ES cell control, RNA 296",ctrl
cell type: Immortalized lung epithelial cells,pert
CLL21-CD4,pert
"Genetic background: mixed 129 and C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow, non-fasted; Genetic modification: Scd1 -/-.",pert
wild_type_embryonic_stem cells_biological_rep3,ctrl
2107-03-A,pert
reduction mammoplasty patient 288,ctrl
SLE myeloid cells 7,pert
"Ishikawa cell line, BPA, 1uM, 48hr",pert
F_LS_Wk1,pert
H441 transfected with scrambled siRNA 2,pert
Sirt1 siRNA KD2 3,pert
lesional skin bioposy obtained from patient after 7 days of treatment,pert
Contralateral 2,ctrl
4: FCHL patient #98-1056,pert
HeLa SCY1-like 1 knock down 2,pert
KrasG12D Pten L/+ PDEC,pert
Normal esophageal epithelium (N8),ctrl
SP-C-rtTA/(tetO)7CMV-Cre/Stat3flx/flx triple-transgenic mice,pert
"non-AD_FC, biological rep1",ctrl
Fiona Biological Replicate 1,pert
PBMCs_IS_18 [IS],pert
Kidney_200 mg/kg VCM iv_mouse #028,pert
"JCAM1 Lck negative 0 hours, #1",pert
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: mammary gland",pert
Subject 6 Pre allergen challenge,ctrl
scpk/ikLLtumor/90,pert
PBMCs from normal control subject J (JPBMC),ctrl
"liver sample of Wistar rat fed for 12 weeks with lard diet, after overnight fast",pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 49;	donor: 35;	disease state: Non-lesional,ctrl
tissue: skeletal muscle;	disease status: dermatomyositis,pert
shRNA6-16-noDox-rep3,ctrl
Wild-type postnatal day 10 rep 1,ctrl
Vitamin A fed at age 35-days,pert
41A;pretreatment;female;breast tumor,ctrl
"Exp A, Animal #246, control (0mg/kg) D-Serine",ctrl
human glioblastoma cell line,pert
S46 WT3	F5/11	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
mdx5cv quadriceps sample 2,pert
Extract:LOX-1:113201;	Extract Description:GFP_Untreated_2hr:113201;	Quality: Classification:Medium;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.1;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.56;	Quality: Background Mean Dev.:1.93;	Quality: Absent (%):59.17;	Quality: Absent (%) Dev.:0.71;	Quality: Scaling Factor:0.64;	Quality: Scaling Factor Dev.:0.22;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113201;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295473,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep5",pert
"age at diagnosis: 33;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1mi;	er: 0;	pgr: 0;	dfs-month: 51;	dfs-event: 0;	distant metastasis: 0",pert
MDS patient 67,pert
P60_WT_3,ctrl
PGA-MAH-AJ_PBS6h-3aA-s2,ctrl
Patient no. 17: control,ctrl
32SAGEA,pert
"Neurons overexpressing Hes1 and GFP, biological rep2",pert
"Zen-Bio, Inc. (Research Triangle Park, NC) - SL0044",ctrl
MDS36,pert
db/db 8-4,pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
58_129_KO,pert
Individual_4298_PN_sample,pert
"Peripheral blood, patient with recurrent events [N38]",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 2,pert
T-REx293-NPAP1-uninduced-2,ctrl
Z6_Cont_TA,pert
subject: 8;	disease: CP;	muscle: GR;	gender: M;	age: 16.7;	gmfcs: 5;	popliteal angle: 90,pert
"Patient  H, lesion, 2 week",pert
biopsy of non-malignant nasopharyngeal control,ctrl
"G9a knockdown cells, rep3",pert
A2CNT2,ctrl
MCF7 cell line_resveratrol_150mM_biological replicate 3,pert
KU_41N,ctrl
Jurkat Biological Replicate 3,ctrl
RNA from HCC_40N,ctrl
"Monuron-treated NRK-52E cells at 6h, biological rep 1",pert
MEF.WT.E,ctrl
14SC-pbo,ctrl
NB4 INFECTED 2,pert
cell line: HEK293;	genotype/variation: tranfected with SNRK-pEGFPN3,pert
"RPMI8226_shKDM3A#2, replicate2",pert
minor non-tumor7,pert
cell line: JCRB0086 [TALL-1];	cell type: human T-ALL cell line;	agent: control,ctrl
"nasopharyngeal carcinoma, specimen T13",pert
chip number: 12;	transfection plate: 3A;	target gene: BATF;	kd level: 0.52;	rin: 9.9;	transfection date: 2012-03-26,pert
"Normal cervix, microdissected epithelium, Age 45",ctrl
MKK3bE transgenic male replicate 2 late timepoint,pert
sample: #7;	subject: Control case #3;	brain: T-638;	age: 78;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
esophageal squamous cell carcinoma from patient E1614,pert
"A673 treated with DMSO vehicle control for 3 days, biological rep6",ctrl
VCaP/MYB siRNA #3,pert
"ID:14-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
cell type: bone marrow derived mast cells;	genotype: NTAL knock out;	genetic background: C57BL/6;	treatment: none;	vector: none;	activation: 2 h 100 ng/ml TNP-BSA,pert
cell line: A549;	cell type: human lung cancer;	sirna: non-targeting,ctrl
hNHEPS_control_6 h_rep4,ctrl
"Lesion Skin, LS-22",pert
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
MPM tumor specimen 5,pert
"BOEC, normal 17",ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: Sham (intact) control,ctrl
Primary hepatocytes isolated from DBA mouse strain treated with Wy14643 for 24h,pert
Nerve_Diabetic_Vehicle_709,pert
"non-AD_HI, biological rep8",ctrl
HepG2 human hepatocellular carcinoma cell line,ctrl
"knockout white adipose tissue, biological rep 2",pert
"cell type: Primary chondrocytes;	genotype: Mir140 KO;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant",pert
"CCM3 shRNA cells passage 11, rep 1",pert
CXCR4 knockout 3,pert
"EGFP KD, replicate A",ctrl
Cervical Cancer C525,pert
"344SQ with control shRNA, replicate 1",ctrl
SIRT4 WT liver_7213,ctrl
control IgG_rep6,ctrl
NK_cell_pool_melanoma_M11+M12,pert
"control mouse cerebral microvascular fragments, biological rep2",ctrl
Genotype: Wild type,ctrl
cell line: MDA-MB-231 breast cancer cell line;	genotype/variation: ARF1 siRNA,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 23;	maternal age: 19,pert
"WT epithelium, uninfected, 0h",ctrl
blank_6,ctrl
Sample 13 Kidney Hyp Mouse - Control Diet,pert
Jurkat T-cells transfected with siRNA #6 for Sp3 for 48 hours,pert
Aquaporin-11-/-_mouse P7 kidney #3-3,pert
P16_exPKO_pancreas_rep2,pert
Placenta_nl4,ctrl
Gata3_Cdx2_null_11,pert
NOMO-1 cells infected with GFP lentivirus,ctrl
genotype: Wildtype;	Sex: Male;	tissue: Liver;	compound: vehicle;	route: IP;	dose: 0 mg/kg,ctrl
shRNA6-16-noDox-rep3,pert
GEIM175-PM,pert
"mouse strain: C57B/SV129;	genotype: Nrf2 wt;	tissue: mouse liver, 10 weeks",ctrl
WM35 cell line,ctrl
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 720,pert
LJMJDW10,pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14583;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
GEIM133-NORM,ctrl
"RET-PTC, 10 months",pert
NORMAL LUNG TISSUE,pert
MH1C1_high_rep2,pert
thorax from embryo of OTT1 null/wt E18.5 mouse,ctrl
"Neuroretina 8-week lean non-diabetic, Biological replica_1",ctrl
"IGF-treated cells (24hr), biological rep1",pert
HCT116 cells,ctrl
Ls174T-L8 con2,ctrl
cell line: KM-H2;	treatment: Non-silencing control,ctrl
6112 KSR2-/- Mouse White Adipose Tissue,pert
T151 U133p2,pert
Control Endometrium Stromal Cell_013.UC182-+,ctrl
3L,pert
"SWR/J ACU, Rep3",pert
"MUSCLE, CR, Before",ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
FVB; No Treatment #2,ctrl
Severe rep3 (OHN),pert
7d-IR-47,pert
U2OS_shCHK1-3,pert
tissue: brain;	strain: C57/BL6 Vert-X;	genotype: IL-10eGFP;	age: 6-8 weeks;	cell type: CD8 T cells that are IL-10+,ctrl
"Normal skin from Tgfbeta_control mouse, biological replicate 2",ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14480;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 50 mg/kg,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: PMA,ctrl
Human_macrophages_normoxia_repA,ctrl
"TNFa siRNA-A, replicate 5",pert
5266 UC Uninflamed sigmoid colon,pert
DMN-CtrHippo18d-1dAv2-s2,ctrl
WKY16-3,ctrl
t14,pert
rheumatoid arthritis,pert
IR-WT_Rep3,ctrl
chip number: 20;	transfection plate: 4;	target gene: IRF9;	kd level: 0.75;	rin: 9.2;	transfection date: 2011-10-17,pert
RV83.10_CHF_day10,pert
Control Replicate 2,ctrl
"SBC-5 cells, siEGR4 (target), 48 hr after siRNA, duplicate sample 2",pert
42 year old male,ctrl
Monocyte FCH rep 2,ctrl
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch3",ctrl
Subject #8002-2d Postinfection,ctrl
Sample 16 Kidney Normal Mouse - Low Phosphate Diet,ctrl
Parkinson's disease sample x020a,pert
3586-1 E2F1 Null,ctrl
PPARg KO macrophages rep 1,pert
HUVECs transfected with FoxP1 siRNA,pert
Celecoxib_#4858,pert
Placenta_nl2 with Cy5,ctrl
T4D-LU,pert
"lymphoblastoid cell line from P910, one out of seven of sensitive group, 50*10e6 cells",pert
BTBR_Islet_rep2,pert
S9A Sporadic-frontal,ctrl
control tissue,ctrl
WT Primary Hepatocytes - Pooled -Cy3,ctrl
MCF-7 Pit-1 overexpression,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: 5HTT +/-;	treatment: control,pert
220C0,ctrl
con-56_C,ctrl
Mock infected murine liver-MO30k-(210)-6hpi,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: no,pert
"G42 cells from Cerebellum, wild type control, biological replicate 1",ctrl
CD positive WT T cell unstimulated rep1,ctrl
"Patient  N, lesion, 1 week",pert
"CD11b DC Xbp1 KO (DC conditional KO), biological replicate 2",pert
tissue: bone marrow;	genotype: Wild type;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),ctrl
"Pten F341V epithelials cells, biological rep3",pert
Jejunum_POR-null_1,pert
Ctr MCF10A.B2 3,ctrl
Clozapine treated 12weeks AffyGC RMA rep9,pert
Panc-1 Untreated Control 3,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure.",ctrl
CUTLL1 wash4h-CHX_rep1,pert
HCC827 WT 2,ctrl
AA_Case1_CD8,pert
"Hippocampus, soman, 3h",pert
"gender: Female;	age: 65;	post-mortem delay: 3h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Adipose-5 month-wild type-technical replicate 1,ctrl
Gene expression of murine fibroblast-like synoviocytes Grp2_C57BL6_1_FLS_TNFtg,ctrl
"Mouse liver, wild type, healthy, 15 months",ctrl
heart wild type replicate1,ctrl
wild type rep-3,ctrl
"S1P2-KO-hippocampus, biological rep8 (female)",pert
cell line: HCT116;	clone: 23;	genotype: Wild type,ctrl
0991-01-C,ctrl
KO - knock-out Treated - 24 hrs - repeat 2 - Cy3 - mAdbID:61777,pert
"mouse strain: C57B/SV129;	genotype: Nrf2 ko;	tissue: mouse liver, 10 weeks",pert
genotype/variation: Tsc2 wildtype;	tissue: cerebellum;	gender: Female,ctrl
WAT from Ahnak knockout fed high fat diet Replicate 3,pert
WTGFP QSC Biological Rep.2 Technical Rep.1,ctrl
Subject #8023-Preinfection,ctrl
Skeletal muscle biopsy,ctrl
jzo025-rp1-v5-u74av2-met,ctrl
Patient no. 12: control,ctrl
"P40_C-DGCR8 KO cones, replicate 2 [array]",pert
pediatric AML S07,pert
"Cell type: neuronal, age:51, gender:male, diagnostic group: bipolar disorder, PMI:23h",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 125min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 94,pert
protocol: hsa-mir-30a/30d depletion,pert
BT-20 cells,pert
"vestibualr organ at P90 of Igf1 -/-, biological rep 1",pert
Normal Chip#5,ctrl
B-CLL PB P33,pert
lymphocytes,pert
KM_008N,ctrl
OCT4 shRNA_2 Days knockdown_rep1,pert
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): nTreg,ctrl
5 wt,ctrl
tissue: whole whisker pad;	genotype: homozygous Trps1 mutant;	age: E12.5,pert
"Postnatal day 11 Cerebellum, knockout for L1CAM, replicate 2",pert
ctrl_509,ctrl
R7E 10,pert
Peripheral blood mononuclear cells (PBMC)-Patient CCo T1,pert
Muscle control 9,ctrl
Capan2_NC-2 biological rep1,ctrl
Colon_POR-null_3,pert
GM19238_Kd_CREBBP_2,pert
cell type: Mouse embryonic fibroblasts (MEFs);	genome/variation: wild type,ctrl
27 weeks male,pert
XX2_Paf,ctrl
Liver_WildType_4,ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: untreated,ctrl
E9.5 KLF1-/- erythroid-8,pert
PZA treated-63d-1,pert
57 wt E11.5 heart,ctrl
Severe rep6 (retina),pert
genotype: WT;	genetic background: Balb/c;	cell type: Regulatory T-cells CD4+CD25+,ctrl
Hippocampus 2007 2 month Old,ctrl
unstimulated(sparse)-1,ctrl
sirna: Syk siRNA knockdown;	plate: collagen coated;	cell line: MCF10A,ctrl
FACS-purified B cells_wildtype_influenza-infected_rep1,pert
NB58,ctrl
"64B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Retina homozygous KO 42 days 1,pert
"Wild type fetal liver 1, embryo at 12.5 days of development",ctrl
Total RNA Mir140 KO-2,pert
Ishikawa_VeryHighDose_BPA_8h_rep1,pert
P1 mouse eyeball extracted total RNA_Brg1_cKO2_GSM618319,pert
"NCI-H460, control, 24 hr",ctrl
Gender:M;	Age:44;	Tissue: Mucosa,ctrl
Ring1b_KD,pert
Tendon_lesional_rep21,pert
SeroNeg-6,ctrl
"Normal tail skin from control mouse, biological replicate 2",ctrl
"Control cell, Replicate 2",ctrl
cell line: HepG2;	genotype/variation: control,ctrl
"Control, biological rep. 2",ctrl
"mutant triceps, biological rep1",pert
Treg cell,pert
0986-01-C,ctrl
trained plakoglobin (+/-),pert
"BOEC, at_risk 1",pert
liver_Pink1 knockout_6 weeks_replicate_3,pert
genotype/variation: Gfi1b wt,ctrl
"HepG2 cells; (HB-8065; ATCC, Manassas, VA)",pert
F9 RARaKO treated 8hr with EtOH,pert
Normal Rat Retina 2,ctrl
minor non-tumor9,pert
WT-GFP-lamin A Induction: day 5 Replicate A (2a_WT_5d_A),ctrl
Skeletal muscle biopsy,pert
Cerebellum_nontransgenic control A39_4 months_replicate 1,ctrl
Control 4 a,ctrl
normal donors XCH1,ctrl
5091212024_B,pert
"brain, adrenal medulla: Sample#B1(Ctrl Pt1)_e1_le1",ctrl
RatLung_H16h_2,pert
MO_DH3a_SON_NCBI,pert
1705-EV_16hr,pert
Primary hepatocytes isolated from SV129 mouse strain treated with Wy14643 for 6h,pert
Scd1+/+ on very low fat diet (TD03045 from Harlan Teklad) replicate 4,ctrl
mouse strain: C57BL/6J;	genotype/variation: AhR-d,pert
Liver_normal_no.4,ctrl
MCF7/XBP1 p.2,pert
Normospermic individual: Sample N4,ctrl
cell type: Primary neonatal keratinocytes;	genotype/variation: control,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L016,pert
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
UC Uninflamed ascending colon,pert
01LRH_ERA,pert
siHic5_2_2h_4,pert
"Distal and Proximal Large Intestine, 8week old Eeyore mouse 3",pert
HE_1,pert
AAA neck (Sample 11),pert
8 week old EOM MDX rep 4,pert
F4,pert
Hippocampus 1983 15 month Old,pert
"NTera-2 cells negative control, biological replicate 2",ctrl
"Male, 40 years old, HIV infection of 7 years",pert
AA_Case2_CD8,pert
CD4_T_cell_pool_healthy_H07+H08,ctrl
WT STR Veh 3,ctrl
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-2,pert
"depression, BA10-28(2)",pert
B with Cy5,ctrl
HCC_10N,ctrl
myoblasts-expt1_lentiDUX4fl-rep2,pert
MDS patient 161,pert
lesion_postUV_patient9,pert
genotype/variation: Pou4f1+/+;	agent: MSCV-Pou4f1 virus;	tissue type: fetal liver,pert
NOD.scid,ctrl
"Ptenloxp/loxp + pBP-Cre, biological rep 1",pert
"Wild Type, 1",ctrl
"48 hour-treated wild-type NB4, biological rep2",ctrl
"Brain tissue from Fisher 344 male rat, Animal #269, 5mg/kg D-Serine",pert
"siCFIm68-1, biological rep1",pert
SENS 6 4hr,pert
"Age: 50;	Sex: M;	Ancestry: European;	Smoking status: smoker, 38 pack-years",pert
V5-P433,pert
"HL-60 + 10 nM TCDD, biological replicate 2",pert
treatment: progesterone;	genotype: wild type;	treatement time: 40 hours,ctrl
LRRK2 (G2019S) heterozygous iPSC sample 1,pert
H295R adrenocortical carcinoma cells,pert
"fibroblast, MFS subject FB783 rep 3",pert
cell line: HUES6;	treatment: VGLL4 overexpression,pert
WT 2,ctrl
3510-lcm,pert
sample =XCGD5 treatment=Stimulated time=180 (min),pert
affected status (disease state): control;	gender: male;	age-at-examination: 53;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever smoker,ctrl
HUVECs transfected with control siRNA,ctrl
MDA-MB-231 breast cancer cell line,pert
MCF-7_ethanol_ethanol,ctrl
HCaRG-9_HG-U133_Plus_2_Rep2,pert
heterozygot FH P266,pert
AZ-521_doxycycline_12h_rep1,pert
PTC BRAF mut 12,pert
E10.5 ko.2,pert
Low_M_1,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 30;	maternal age: 27,pert
CON23,ctrl
H26 HA 24h 2,pert
patient: 214;	current medication: NONE;	birth date: 1/10/37;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/59;	diagnosis date: 1/10/61;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 11/12/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/9/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: CENTRAL RETINAL VEIN OCCLUSION 01/04;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
microdissected breast cancer cells from case 420,pert
C1C-LU,ctrl
UACC903 cell line,ctrl
atopic eczema P2,pert
hepatoma cells,pert
cell line: ARPE-19;	clone: parental;	genotype: Wild type,ctrl
92.1 - control #1 - replicate1,ctrl
cell line: H1299;	agent: decitabine;	dose: 0.3 uM,pert
"650nM MLN4924 after 8hr, replicate 1",pert
"Subject 10, Family 4, Affected",pert
"transfected with pSuper-shMTDH, cultured with HMVEC-L and then purified by FACS",pert
2h Kin- Cel.45,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 37;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
WFS1 KO USHT_06_333_wt,ctrl
Ngn3 ES3 ON replicate 2,pert
Hippocampus Control group 1,ctrl
treatment: Overexpression Control;	cell line: Caco-2,ctrl
CTRL_1_GMP,ctrl
Patient no. 14: treated,pert
"kidney, Q10, 6 months",pert
con-50_C,ctrl
LNCaP/NC siRNA #3,ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA;	treated with: 100nM PD173074 for 48 hrs,ctrl
Patient identifyier: E;	Sex: male;	Age of patient: 51 years;	Duration of psoriasis: 24 years;	Body surface area: 8 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"IRF6 wt, biological rep3",ctrl
Setleis Syndrome patient 3,pert
12484 UC Inflamed sigmoid colon,pert
"Xenograft of Panc-1 (Human pancreatic carcinoma) cell line, in mouse",pert
chronic lymphocytic leukemia (CLL 26212),pert
Myoblast-GATA4-Wt-day0-1,ctrl
"human failing LV myocardium, Ischemic19",pert
"HEK293T human embryonic kidney cells, Wnt3A, si-control",ctrl
"KO, Tumor, 14M",pert
"Lesion Skin, LS-8",pert
Ebs at Day2.5 were treated with Activin for 2 h,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 55 years,ctrl
E14.5_Control_Kidney_array2,ctrl
"ME16C, 12h, sham B",ctrl
MCF7 CHX+EtOH,pert
"Gracilis Mucle, Control",ctrl
IR-WT_Rep1,ctrl
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: empty vector,ctrl
Plate vs. Nail:  3 Day Plate,pert
Tmod3 WT-3,ctrl
"patient 6, baseline",ctrl
platelet_sickle_13,pert
Menadione (5uM) rep 1,pert
Wtepi_infect_0h_rep1,ctrl
sMPNST_shBrd4.552_3day_rep1,pert
MSC_SA01_2,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 42;	maternal age: 32,pert
cell line: LNCaP-abl;	transfection: siMED19,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous endotoxin challenge""",pert
sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta;	agent: control (saline);	time: 7d,ctrl
"shKDM4C 1, clone 1, rep 2",pert
Liver sample from Control group (C7),ctrl
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
"3T3-L1 siControl 24h, biological rep 2",ctrl
4194-2 E2F3 Heterozygous,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: arteriosclerotic cardiovascular disease,ctrl
HMEC X Matrigel,ctrl
"Exp A, Animal #251, 500mg/kg D-Serine",pert
age_years: 61;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Bone-Marrow_SMM_S1586,pert
"COP strain, male, age 21 weeks",ctrl
HCC_13N,ctrl
MS patient 5,pert
CML-BM 6,pert
brain_DLPFC_bipolar C_mr276,pert
C589,ctrl
76_129_WT,ctrl
EA_Control2_CD8,ctrl
Anti-scramble replicate 3,ctrl
V5-P340,ctrl
patient skin sample-Acne Lesion,pert
180C1,ctrl
"MDA-MB-231/shDBC1, biological rep1",pert
"Acute Myeloid Leukemia, sample 52",pert
11N,ctrl
6114 KSR2-/- Mouse White Adipose Tissue,pert
1053-03-A,pert
"Peripheral blood, patient without recurrent events [N34]",pert
"C57BL/6 mice, thymus and spleen pooled",pert
THP-1 AML cells,ctrl
"CD4+ splenocytes at 6h, biological replicate 1 sham-1",ctrl
Ramos pRTS-GFP A+,ctrl
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: control hairpins targeting luciferase,ctrl
tissue: liver;	genotype: IR flox/flox albumin:CRE -,ctrl
strain: HNF4 null;	age: 1 month;	tissue: small intestine;	sex: female,pert
A_AN08166_C,pert
129A,ctrl
"CD3+ T cells, bone marrow derived, SAA patients",pert
Placental tissue from normal pregnancy,ctrl
Whole brain hemispheres,pert
MDS patient 94,pert
Brain_nAChRbeta4SubunitDeficent_MiceNob4398,pert
treatment: Mepenzolate;	time: 25,pert
array 8 minus E,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T183,pert
strain: C57/Bl6;	genotype/variation: Caspase 1 null;	gender: male;	tissue: epididymal white adipose tissue,pert
A673 cell line that has been treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50).,pert
Normal Chip#3,ctrl
"Total colon, pooled sample",ctrl
HCC PBMC_sample 9,pert
treatment: after Rituximab,pert
pcdh12-deficient placenta embryonic day 12.5,ctrl
Human skeletal muscle biopsy sample;	Patient #16 with PM,pert
"Distal and Proximal Large Intestine, 8week old Winnie mouse 2",pert
Tet2 KO GMP rep1,pert
MBD1 KO #1,pert
C_AN17425_F,ctrl
phenotype: alcoholic;	gender: male;	case_id: 303;	age: 67;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 48;	brain ph at time of freezing: 6.4;	labeling_batch: 2,pert
4P-M4-ND,pert
1052-03-A,pert
SOCS3 Cre plus A,pert
V5-P303,pert
"Mouse Embryonice Stem Cells, pCIP siRNA 2, Rep1",pert
"imr-32,cdk4 siRNA,t=48,3",pert
"Mdr2-KO heterozygous mouse, 3 month old mouse 1",ctrl
CD8_T_cell_pool_healthy_H03+H04,ctrl
Control (C285),ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 130min;	race: White;	sex: Female,pert
IL8.3,pert
Genotype: KO,pert
Peripheral blood mononuclear cells;	TTF=65min;	Race=White;	Sex=Female,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep4",pert
TTP_KO_0ActD_BioRep3,ctrl
subject: 18A;	cohort: 18;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 21kb;	age (y): 36;	Sex: F;	batch: Batch_4,pert
BCR/FGFR1 biological replicate 3,pert
12GOBMUC2A,pert
"eye, cornea: TRizol Extraction_le1 7",ctrl
Dicer KO replicate 2,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1. Sample A,pert
umbilical cord_nobpd: 3D,ctrl
Wildtype_TAC_Rep2,pert
WAT from wild-type control fed high fat diet Replicate 3,ctrl
S46 NLS 142Q TG5	F4/1	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
IFN_Gamma_6hr,pert
Strain: C57BL/6J;	Gender: Male;	Tissue: primary culture tracheal epithelial cells,pert
"brain, cochlea: [18] Sample #18_le1",ctrl
"Ulcerative Colitis (65 year old caucasian male, SAK_1291908052)",pert
"schizophrenia, BA46-17",pert
Hippocampus 2008 2 month Old,ctrl
T73 U133p2,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 79,pert
A_AN08873_C,pert
WT-smoke-low-5 month-R4,ctrl
Bone-Marrow_MGUS_G417,pert
cell line: H4-II-E-C3,pert
"Healthy volunteer, Control_11817",ctrl
tissue: skeletal muscle;	status: diabetic;	agent: untreated,ctrl
subject: 30;	disease: CP;	muscle: GR;	gender: M;	age: 4.1;	gmfcs: 2;	popliteal angle: 125,pert
ES2 COUP-TFII-4 25nM,pert
"DMSO-treated, 24h after UV, Replicate C",ctrl
Gata-1 Wild Type C,ctrl
mouse TMJ-cartilage from wild type mouse WT_Tal6,ctrl
Ishikawa_LowDose_BPA_8h_rep1,pert
Dental pulp cells idipopathic autistic patient triplicate 2,pert
heart from beta1-Gly389 transgenic mice,pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 0;	dose: 0;	agent: none,ctrl
healthy control H18,ctrl
isoflurane 02,pert
HCC_41T,pert
PGA-MAH-AJ_OVA6h-4aA-s2,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 24 hours;	agent: air;	exposure dose: 0 ppm O3",pert
Control sample 23 weeks,ctrl
"N-56, NORM, M, GSF, 1 x 1000nM DHT, 24h",ctrl
"Acute Myeloid Leukemia, sample 64",pert
Ad infected murine liver-MO30k-(466)-6 hpi,pert
BxPC3-WT rep 2,ctrl
"Rat_Tracheal_Control_2hr, rep3",ctrl
LCH6ani,pert
5922012047_C,pert
"MCF-10A cells, shRNA targetting p63 DBD, biological rep1",pert
F-IIP(NSIP)1_Cy3,pert
PGA-lv_24h_517,ctrl
control male replicate 2,ctrl
Clinically localized primary prostate cancer P5,pert
disease state: healthy;	tissue: extensor digitorum longus;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
Normal skin 3,ctrl
8003PBMC,pert
C57 48 air 2,ctrl
P8 wt1,ctrl
PCOS Endometrium Mesenchymal Cell_102.PC01++,pert
chip number: 13;	transfection plate: 3B;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2012-03-26,ctrl
C57BL10 diaphragm sample 2,ctrl
Pool 1 Acute stage,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.975;	OD280: 1.082;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 338;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
C4,ctrl
Dengue Fever Patient 68,pert
CTL2 E2 48hr,pert
"GFPMYC positive GC B cells, Biological replicate 4",pert
LJMJDW15,pert
Endometrium/Ovary-Disease 4,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G48,ctrl
PCOS Endometrium Epithelial Cell_109.PC08_EpCAM,pert
HeLa_TP082505_24_HG-U133A_2_IMFGN0023,ctrl
HSC,ctrl
Mock infected murine liver-MO30k-(209)-6hpi,ctrl
PBMCs from Crohn's Disease subject,pert
Buffy Coat blood of healthy donors,ctrl
A_2m25,pert
wild-type_rep2,ctrl
14-week-old WT liver_616WT,ctrl
"wild type naïve CD4 positive cell, unstimulated, replicate 1",ctrl
"Colitis 10, UC10",pert
ctrl_504,ctrl
HeyA8-(1)b,ctrl
"disease status: non allergic non asthmatic subject, without any stimulation;	tissue: bronchial biopsies",ctrl
Wildtype_XY_3,ctrl
CD8_T_cell_pool_melanoma_M07+M08,pert
CD4IncTp2-7,pert
skin from mice,pert
GM19238_Kd_SP3_1,pert
RNA from microdissected breast cancer cells from case 1206 labeled with Cy5,pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, chow diet, liver",ctrl
"t05, surgically resected from patient of gastric cancer.",pert
"PCB77 treated HepG2 cells at T0, biological replicate 1",ctrl
Sham 2,ctrl
Normal bladder 272-99,ctrl
"schizophrenia, BA10-26",pert
7dpp Ubb knockout testis,pert
Endometrium-Normal 6,ctrl
"Strain: Bl6, Tissue: Bone marrow, Age: 7 weeks",pert
CME-LaminA4d-1MA-S2,pert
Conditional Sample 4,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl; Wnt1-Cre;	tissue: Tongue;	age: E14.5;	gender: Not determined,pert
Mouse old heart C30-Ht-4,ctrl
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 2",ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA2-dox,ctrl
"Control animal, biological repeat 3",ctrl
Normal mucosa 14,ctrl
NALT_infected_24h_90-226-dM_rep4,pert
"IRF6 wt, biological rep1",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#104,pert
"Lesional skin biopsy from psoriasis patient, Pre-dose",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.469;	OD280: 1.802;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 355;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
S49 WT Cells 6 h cAMP treatment,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 215,pert
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P12;	clone: C11,pert
WT J1 ESCs on day 0 #1,ctrl
Liver_untreated_HESKOL_rep2,pert
N6,ctrl
Cisplatin-treated wildtype MEFs-b,pert
"HEK293E cells, scrambled siRNA, replicate 4",ctrl
"Placebo treated, HIV-1 positive male, day 14 (7)",ctrl
Patient 5,ctrl
Ngn3 EB10 OFF replicate 1,ctrl
31A;pretreatment;female;breast tumor,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 05/07/06;	# cells: 39;	Sex: male;	region: M1;	age: 44;	genotype: Y/Mecp2-;G42/-,pert
MCI-019,ctrl
hES_VUB01_1,ctrl
"202, ADIPOOSE TISSUE, Before",ctrl
"Pineal gland from NeuroD1 cKO mouse at ZT20, biological rep 3",pert
Mouse WT mandibular molar [ABH_12A],ctrl
Strain: C57BL/6J;	Gender: Male;	Age: 16 weeks;	Tissue: testis,pert
GAS-n10; normal gastrocnemus 10 month,ctrl
"Line A39 control cerebellum, mouse, male, 10 months",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 40;	gender: male,pert
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 0;	dfs-event: 1;	distant metastasis: 1",pert
RNA from microdissected breast cancer cells from case 1368 labeled with Cy5,ctrl
20 hour after cadmium treatment,pert
genotype: C57BL/6;	gender: male;	age: 10 weeks;	tissue: Liver;	diet: chow diet,ctrl
Normal PBMC Sample 4,ctrl
"hepatic gene expression at ""6 hr"" (rep1)",pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: G;	transfectant type: stably transfected with RNAi against DJ-1,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep3",pert
Cutaneous psoriasis without arthritis PsC 12,pert
HepG2_DMNQ rep3,pert
"FA6 transiently transfected with AGR2 siRNA, transfection A",pert
RPE23,ctrl
patient code: 105;	gender: Male;	age: 68;	tumor grade: 3;	t-stage: 2;	n-stage: 0;	ajcc classif. (2002): 1b,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu3,pert
treatment: SCY1-like 1 esiRNA;	cell line: HeLa,pert
"Control siRNA, 1",ctrl
"JAG1 overexpressed CL1-0, biological rep3",pert
original diagnosis: ExtendedOligo;	cell type: Peripheral blood mononuclear cells,pert
MLL_00261,pert
"Human LIMA artery from patient 5, control (unstented)",ctrl
MBD1 KO #3,pert
cerebellum_Pink1 knockout_24 weeks_replicate 2,pert
ab074 IM,pert
PC-3_basalhTERT_ShortTelomeres_mockcre_4,ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 69;	age-at-onset: n/a;	geographical origin: Lisboa,ctrl
"0mg/kg/day PFOA, Rep 5, Block 5, lung (high dose)",ctrl
epithelium from colon of HDAC2 KO mouse no.1,pert
R2_saline_wildtype_422,ctrl
Cerebellum_nontransgenic control S46_10 months_replicate 2,ctrl
COLO829_shSCR_PLX4032_A,pert
Normal PBMC Sample 5,ctrl
B_Ctrl_2,ctrl
Heart-Base_KO-3,pert
race: caucasian;	age (years): 70-75;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
TF_1_control_d2.5_rep1,ctrl
pt. HCL E treated with Vemurafenib 1000 nM for 48h,pert
siEGR4 (24 hr) _2,pert
AZ-521_doxycycline_8h_rep2,pert
chip number: 7;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.79;	rin: 9.7;	transfection date: 2011-03-29,pert
Cervical cancer_103-04T,pert
CD4+ cells IL1RN knockout 1 month rep1,pert
EE_IA_2_aa_lcm,pert
Squamous cell lung cancer X31sqm,pert
LKR13_Control-2,ctrl
cell type: Heptaocellular carcinoma cell line (non-target control cells),ctrl
"E2A-deficient (E2AKO) DP cells, biological rep 2",pert
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep2",pert
"Biceps, FSHD, cohort 03, subject 03A",pert
CLL16-CD4,pert
patient: 30162;	sample: tumor,pert
EOM 56 Day Control rep 2,ctrl
Exercised-1,pert
Ago2-IP RNA Mir140 KO-1,pert
"ALL_DS, K16 011409",pert
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage_3",ctrl
Kidney_Aqp11+/+_P7_2-1,ctrl
Allo-25-1,pert
MCF-7 cell_tRA_12hr_biological rep2,pert
control untransduced myoblasts,ctrl
ESC Cultured in 15% KO + LIF without feeders,pert
"treatment: diclofenac;	batch: 7;	donor: 53;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-15;	Primary Site:Floor of Mouth;	Age:51;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
12mo APPSw #1,pert
BP patient 88_biological replicate 1,pert
"schizophrenia, BA46-41",pert
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: poor;	Tumor Site: Cecum;	Drug Treatment: YES,pert
DP AA4+ replicate 1,pert
T56 Non failing heart biopsy,ctrl
HCT116 human colon cancer cells with PTEN -/-,pert
TAF4b knockout 3,pert
mutant_ANT_PDE_22,pert
murine adult bone marrow,ctrl
"Cell type: neuronal, age:35, gender:male, diagnostic group: bipolar disorder, PMI:35h",pert
"seminoma specimen, pT2, patient age: 35y",pert
Wild Type 9,ctrl
Disease_status: Bipolar disorder;	Age (years): 42;	Gender: Male;	Age of onset (years): 18;	Duration of illness (years): 24;	Brain pH: 6.65;	Post mortem interval (hours): 32;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: yes,pert
Diaphragm 28 Day mdx rep 3,pert
"Crohn's Disease subject (47 year old caucasian female, SAK_1263249533)",pert
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: foretinib,pert
cell line: MOLM-14;	replicate: Replicate3;	treatment: shLuciferase,ctrl
cell line: A375 melanoma cell-line;	genotype/variation: Wnt-1 overexpressing;	treatment: control,pert
wild type MEF time 0 replicate 1,ctrl
WT_R6,ctrl
MCF10A-Her2-rep1,pert
Kin- S49 Cells 0h,pert
heart fasted,ctrl
"Cbfb-/-, technical replicate 2",pert
N30364,ctrl
1-WT_RD1a,ctrl
postnatal 12 weeks pitx2 cko heart,pert
C6,ctrl
Mening SWB WB SW 3a,pert
control esophagus,ctrl
HF0211_U133P2,ctrl
PsOEt-18-Week 12,pert
ctrl_untreat,ctrl
17_C57_KO,pert
9-cis-retinoic-acid_Lung_3,pert
tissue: murine embryonic stem cells;	genotype: Wild type;	strain: 129SV/C57BL/6,ctrl
"Tg brain, biological rep5",pert
"K562, 250nM1R-Chl, 24hrs, rep2",pert
KCL-22 Imatinib-treated,pert
MCF10A-Her2-rep3,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 3,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 54;	tissue: Blood,pert
"human failing LV myocardium, Ischemic53",pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep2,pert
"Animal id 544, right retina, 8 months, female, DBA/2J",pert
"Heart, MAT1 CKO, 2 wk, sample 3",pert
32023.INV,pert
Floxed_Mstn_2,pert
SW480_ezrin RNAi_rep1,pert
strain: C57BL/6J;	cell type: LSK cells;	genotype/variation: wt,ctrl
erStress_twins_AA_1717twin1_DMSO_4h,ctrl
"Patient D, uninvolved skin",ctrl
Normal-ERα-positive breast cancer 26,ctrl
PGA-MLS-RA-1bAv2-s1,pert
ku86(wt)_Terc(ko)_2,pert
Time:3 day; condition:Emerin ko;,pert
Scd1-/- on chow diet replicate 5,pert
"FACS-sorted cones, P30 wild type mice",ctrl
"Deltoid, control, cohort 19, subject 19U",ctrl
Bl6_Mock_1,ctrl
A2058 CT16 siRNA Rep2,pert
hdh genotype: Q7/Q7;	tissue: striatum;	age: 3~10 weeks,ctrl
"Donor 1, Ebola infected 6hr",pert
"wild type, prenatal stress, biological rep2",pert
"12-week-old Wistar Kyoto (WKY), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",ctrl
K14deltaNB-cateninER  Time 1 replicate 1,pert
Cont subject 08,ctrl
quiescent p27KO MEFs 2,pert
5922012038_C,ctrl
Rosi-treated diabetic-1,pert
status: Control;	gender: Female;	age: 63;	tissue: Blood,ctrl
Cervical Cancer C482,pert
Muscle PCOS control 10,ctrl
genotype: WT;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,ctrl
U-87MG-PK25 set 2,pert
mdx quadriceps sample 2,pert
Day: 12; Drug: Saline; Phase: Drug treatment; Replicate: 2,ctrl
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P6,pert
Liver_Wildtype_Rep1,ctrl
Day 4 (T29),pert
nucleus accumbens,pert
phenotype: control;	gender: male;	case_id: 339;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 37;	brain ph at time of freezing: 6.76;	labeling_batch: 1,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 43;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
BATF_KO_P14_Naive_rep1,pert
heart of male mouse subjected 2 week to chronic intermittent hypoxia,pert
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 4 hours,pert
Waldenström’s macroglobulinemia (WM-BL 32395),pert
OVCAR-10-(1),ctrl
Wt Mouse_cerebellum_Old_saline treatment_Replicate-2,ctrl
KU_05T,pert
Lung tissue,pert
C9 Control None,ctrl
GM19238_Kd_IKZF3_1,pert
Untreated Myd88 knockout - repeat 6 - mAdbID:102776,pert
homozygot FH P254,pert
Pancreatic Sample 54-Normal,ctrl
T1+2,pert
"empty vector, biological rep1",ctrl
Cervical Cancer C451,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_1_6_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Omental adipose tissue,ctrl
heart_Q10_14M_rep2,pert
cerebrum_PS-/-_ 20d_rep2,pert
Cervical Cancer C348,pert
WT-sham-5 month+13d-R3,ctrl
Peripheral Mononuclear Blood Cells,pert
CD34+ cells from normal donor after in vitro TCDD exposure,pert
Txnip deficient normal 24 months sample 3,ctrl
individual: patient12;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
.SAL_II_1,ctrl
kidney_QH2_6M_rep3,pert
P60_PMP22KO_1,pert
Normal BM CD34 cells,ctrl
HDAC1_A3-rep3,pert
TB 4,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 6,ctrl
"breast tumor epithelium,37",pert
Gastrocnemius muscle wild-type mouse: control mouse for integrin alpha7 overexpressing;	Strain: SJ6/C57BL6 background;	Genotype: wild type;	Gender: Female;	Age: 5 week;	Tissue: gastrocnemius and soleus muscle;	Feeding condition: non-fasted,ctrl
healthy CD4 T cells 6,ctrl
Metastatic prostate cancer W3,pert
patient: 214;	current medication: NONE;	birth date: 1/10/37;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/59;	diagnosis date: 1/10/61;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 11/12/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/9/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: CENTRAL RETINAL VEIN OCCLUSION 01/04;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
disease state: B-CLL;	tissue: peripheral blood,pert
chip number: 2;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.79;	rin: 9.7;	transfection date: 2011-03-29,pert
"empty vector, biological rep2",ctrl
"Mutator, biological rep1",pert
Cy5 labeled Liver RNA,ctrl
"FOXP3, WT, REP3, 72h",ctrl
Control day 10 sample 2,ctrl
MDS patient 140,pert
"TMD_TA, T7",pert
Normal mucosa 19,ctrl
Human Chronic HIV Sample C062-CD4+ T cells,pert
wildtype Tcof1 [A],ctrl
T40728_rep,pert
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 560,ctrl
Genotype: B6.Pdss2loxP/loxP;	Age: 209-day-old male (concurrent control to Alb73);	90 mg liver used for RNA extraction,ctrl
"CD14+ after 2 wk quercetin supplementation, biological replicate 1",pert
Fibroid_2540B,pert
HRas-v12 transgenic male replicate 1 late timepoint,pert
HCC_39N,ctrl
normal brain_2,ctrl
P328L329_del6a+,pert
"650nM MLN4924 after 1hr, replicate 1",pert
Wild-type control 1,ctrl
"Fmr1 wildtype mouse, blood",ctrl
24h Control (SAMPLE 8),ctrl
Aorta from ApoE-/-  RAGE-/- mouse without diabetes sacrificed at 9 weeks.,pert
COV434 Wildtype [RR1018],pert
Pooled PBMC sample enriched for CD8+ cells from normal control subjects,ctrl
U87-mC2,ctrl
"Cultured ovarian cancer cell line OV90, untreated",ctrl
brain_OFC_control C_mr131,ctrl
Itk knockout CD4+ unstimulated 3,pert
Non_Target_1,ctrl
"LCL GM19238, Kd EP300, 72hrs",pert
strain: C57BL/6;	age: 1 year old;	tissue: liver,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 328;	age-at-biopsy-years: 39,ctrl
MLL_00115,ctrl
HK12B7,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (33),pert
"brain, hippocampus: Ctr-240h-P15-III_e1_le1",ctrl
Liver_normal_no.1,ctrl
Waldenström’s macroglobulinemia (WM-PC 32131),pert
Normal cervix_05-31,ctrl
HMEC X NB2,pert
IEC_GF-HDAC3ΔIEC -2,pert
KD control replicate 1,ctrl
2B1 Otic vesicle cell line over-expressing Dlx5 and GFP,pert
Nerve_Control_Vehicle_705,pert
"Resveratrol treatment exp 3T3-L1 cells, CT2",ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype squamoid cell;	matched/unmatched: unmatched,pert
Wildtype fibroblast sample 1,ctrl
Cutaneous psoriasis without arthritis PsC 8,pert
"skin fibroblasts, passage #3",pert
CONTROL;	Age = 19;	Sex = F,ctrl
AR-CO-24-3-571,pert
WT2R2,pert
YFP-pos GMP Dicer wt rep2,ctrl
microdissected breast cancer cells from case 1343,pert
gender: male;	age: 6 months old;	genotype: Pdx1flox/flox (Ctrl);	litter: brother of the same litter,ctrl
E4C,ctrl
human lung,pert
C2C12 myotubes 1uM H2O2 rep2,pert
CD11b+Gr1+ cell sample_2 (derived from wild type mouse),ctrl
c_NY106,ctrl
strain: B6129SF2/J;	tissue: lung;	genotype: wild-type,ctrl
"experiment II, untransduced, replicate 2",ctrl
umbilical cord_nobpd: 3G,ctrl
patient: 27;	disease state: hypertension;	tissue: Atheroma plaque,pert
siRNA LMG2 treated HeLa cells 2,pert
"Lens epithelium, WT, #5L",ctrl
APLP2_R1_rep1,pert
cell type: myoblast;	transduction: untransduced,ctrl
CF (D508) subject2,pert
eNOS Knockout Mice-M140,pert
"Patient 150N, normal colonic mucosa",ctrl
"Overexpress TFPIbeta, biological rep. 2",pert
patient: 11;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
after 30 days intervention with placebo,ctrl
MCF10A_Empty vector_2,ctrl
LNCaP/NC siRNA #1,ctrl
genotype: Villin-Cre - / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 63,ctrl
"Rat_Tracheal_Dex_2hr, rep3",pert
patient: 51104;	disease state: LGSC;	component: Borderline,ctrl
WT_IL-6_100_rep1,ctrl
"ID: MLL_00261;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"Diabetic mice, time point 1 week",pert
n2a-Pou3f3-cont-3,ctrl
dex24hr_3,pert
At Risk: +;	Age: 16;	Sex: F,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: control; biological replicate: 2,ctrl
gender: female;	genotype: Homozygous for the Q119X mutation in the TWIST2 gene;	ethnicity: Puerto Rican,pert
cell line: MDA-MB231;	treatment: control shRNA;	media: SCM,ctrl
Sarcoma cell line  - Dicer Heterozygote -rep3,ctrl
"brain, hippocampus: wildtype 1_e1_le1",ctrl
s2t2c,ctrl
pcdh12-deficient mice rep3,pert
LOX1_Untreated_24hr,pert
primary osteoblasts untreated,ctrl
pancreatic islets,ctrl
disease state: paediatric glioblastoma;	age: 5.4;	gender: M;	h3.3_status: wt,ctrl
Alb67 mutant mouse,pert
LT 436 +/T untreated,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.169;	Ratio: 2.11,pert
"MCF-7, 12h, 0.9uM DOX B",pert
midbrain_wild type_18 month_replicate 3,ctrl
"ALL_DS, K12 012109",pert
"ICR10 mouse strain (WT,)  gender- female, age- 2 months, n = 1, # of tissue = 1, tissue: Lung, Cell:Type II.",ctrl
MCF-7 breast cancer cells,pert
"Gender: Female, Age: 28, BMI: 17.1, Tissue: luteinized cumulus cells",pert
C020_Control_M_25,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, non-treated",ctrl
striatum_wild type_24 weeks_replicate 2,ctrl
Individual_5223_NN_sample,ctrl
"Gata4_S105Amut, untreated whole heart, individual 6",pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 65;	age-at-onset: 65;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia",pert
444MM,pert
L-540_CTRL_24hrs,ctrl
01-0059A_Day1_5,pert
Cas 3,pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14504;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
liver-AHRWT-cornoil-rep1,ctrl
Cervical Cancer C502,pert
Tissue: normal thyroid; Gender:male; Age:43,ctrl
CONTROL 3,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 3,ctrl
"Liposarcoma culture from tumor 338, doxorubicin treated",pert
"ACC3 cell line, Sox4 RNAi knockdown with lacZ as control",ctrl
pediatric AML S24,pert
RV63.04_CONTROL_day19_Slide35,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 3x1h exposure per day",ctrl
SLE myeloid cells 2,pert
BAL_13_A0B0,ctrl
genotype/variation: Fmr1 knockout;	tissue: cerebellum;	gender: Female,pert
MED1 overexpression #1,pert
VIN_B027,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_4mM_HG-U133A_2_YCHSUP501,pert
16GOBMUC2A,pert
SCLC cell line SBC-2,pert
control participant P338 (human CD3 positive T cells),ctrl
Control subject 34_biological replicate 2,ctrl
Sham 50d replicate 1,ctrl
PBMCs_IS_8 [IS],pert
scpk/ikLLtumor/77,pert
H08_P_B1,ctrl
Mouse testis,pert
"control, subject 6",ctrl
Leg 28 Day mdx rep 3,pert
wild-type naïve CD4 T cells,ctrl
"NPCxhIPSC SCZP, replicate 5",pert
liver western diet rep3,ctrl
V5-P048,pert
RptorKO QSC Technical Rep.1,pert
Kidney_Aqp11-/-_P7_3-3,pert
MLL_00259,pert
jos1988,ctrl
"Normal cervix epithelium, Age 53",ctrl
KGN Knockdown [RR1007],pert
IEC_GF-HDAC3ΔIEC -3,pert
Histopathological diagnostic: non-tumor,ctrl
siRNA Control Duplicate 1,ctrl
"Biceps, control, cohort 12, subject 12V",ctrl
DNGL-2,pert
Patient no. 12: treated,pert
optineurin expression-a01,pert
"cell type: Primary chondrocytes;	genotype: Mir140 KO;	antibody: Ago2 antibody;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant;	antibody manufacturer: Wako biochemicals;	antibody catalog #: 292-67301;	antibody lot #: PEK486",pert
RPE65_KO_2months_retina2,pert
"Wild type used for MAT1A 8 month, replicate 3",ctrl
MKK7D control female replicate 9 late timepoint,pert
tissue: heart;	developmental stage: E10.5;	genotype/variation: Dbh-/-,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: nasal cavity;	donor sex: male,pert
Intestinal Epithelial Cells (IECs),ctrl
"non-transgenic mice, 7 month old, female",ctrl
"Nrl-ko-Gfp, Gfp+ photoreceptor cells",ctrl
HCaRG-8_HG-U133 Plus 2,pert
Human Chronic HIV Sample C080-CD8+ T cells,pert
Patient: F;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
5224 UC Uninflamed sigmoid colon,pert
sirna: control (siSTABLE V2 non-targeting siRNA#1);	treated with tnfα: YES,ctrl
scpk/ikLLtumor/126,pert
patient: 51084;	sample: tumor,pert
Bone-Marrow_SMM_S1306,pert
cerebellum_6 month,ctrl
"RNF40 siRNA - 5 days adipocyte differentiation, rep1",pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep2",pert
OVCA420+(1),pert
age: 18 month postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: SCM,pert
Against CDK8-1 rep1,pert
T-REx293-NPAP1-induced-1,pert
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Inferior olivary nucleus,ctrl
MCL_IGHV_UNMUT (R1306),ctrl
Bronchial Epithelial Cells SA biological 1941D,pert
cell type: Primary hepatocytes;	donor: 1;	agent: control;	time: 24h;	gender: Male;	age: 63 years old,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK2-2,pert
"Patient 23, Macroscopically intact tissue",ctrl
brain_DLPFC_bipolar C_mr448,ctrl
colonic_mucosa_non_inflamed_93,pert
Klf9 mutant (Klf9KO) mouse jejunum; Age: PND 30,pert
"seminoma specimen, pT2, patient age: 34y",pert
"HL-60 + 100 µM curcumin, biological replicate 1",pert
PGA-RMM-Ctr-2aA-s2,ctrl
Embryonic Stem Cells,pert
Cav3KO 1505,pert
"Control 06, NC06",ctrl
No or early 1 rep4 (OHN),pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp3,pert
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 12/1/03,ctrl
WildType_1_2,ctrl
pcDNA3(CT2),ctrl
3560-4 E2F2 Null,pert
"wild-type control (littermate) of ""P16_exPKO_pancreas""; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #2.",ctrl
KO - knock-out Treated - 24 hrs - repeat 2 - Cy5 - mAdbID:61773,pert
GFP_Untreated_12hr,ctrl
"Patient  F, lesion, 12 week",pert
VMH of KO2 mice,pert
"Spi-60, biological rep 3",pert
Cav1KO 1758,pert
BC7 TC,ctrl
"U-87 glioma cell line with shcontrol, biological rep1",ctrl
SCC11,pert
Control 2 appendix,ctrl
"A673 treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50), biological rep2",pert
HaCaT_Control_ biological rep2,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 5 months;	genotype: Myc heterozygous,pert
WT Control Sample B,ctrl
shCDK8_Time_0_2,pert
GIST Pre Treatment Biopsy 29,pert
"Liposarcoma culture from tumor 338, untreated",ctrl
cumulus_PCOS_Lean_rep5,pert
ku86(ko)_Terc(wt)_2,pert
diet_mammary_1,ctrl
Cbfb-deficient Treg_rep3,pert
mutant Lis1 ko/cko,pert
pediatric AML GP2,pert
vehicle treated rep 3,ctrl
gender: F;	age at blood draw: 59;	tissue: whole blood,pert
C_C6,ctrl
V5-P090,ctrl
MDS patient 132,pert
FGF21KO.DMSO_2,pert
Y YOKE_B022,ctrl
RNA from RAW 264.7 Cells,ctrl
BM_02619,ctrl
WT Primary Hepatocytes - Pooled -Cy5,ctrl
PGA-HMO-MObese-1aUA-s2,pert
KO MEF 2,pert
V5-P332,pert
"non-SS control gland, patient 18, batch 2",ctrl
HEK293_SNRK,pert
wild-type male mice angiotensin II treated,ctrl
H720 cell line control 3,ctrl
Mouse lung Gata5 knockout,pert
LNCaP EtOH rep 1,ctrl
01LNK_CTRL,ctrl
ND_3,ctrl
THRB bN mutant + vehicle replicate 1,pert
human late-stage OA repair tissue,pert
brain_Down_syndrome_sampleid_jg1737,pert
"human failing LV myocardium, Ischemic59",pert
HL-60 cells treated for 24h with 0.5 % DMSO as control,ctrl
AIRE-ko-CD80hi-mTEC-sample2,pert
Human skin biopsy from psoriatic patient (lesional skin),pert
affected status (disease state): IS patient;	gender: male;	age-at-examination: 46;	age-at-onset: 45;	geographical origin: Vila-Real;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P7,pert
m1-adenoma3,pert
erStress_twins_AA_1725twin1_500nM_thapsigargin_4h,pert
N51572,ctrl
Leg 23 Day mdx rep 1,pert
3_2_MOE_430A_HO,pert
subject: 03U;	cohort: 3;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >40kb;	age (y): 42;	Sex: F;	batch: Batch_1,ctrl
control1,ctrl
"experiment 1, control 1",ctrl
"Patient 998, 12 month of BETAFERON",pert
"Nuclear RNA, HuR KO MEFs",pert
Patient identifyier: W;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 27 years;	Body surface area: 6 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
condition: Normal;	patient: N_AJ2;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
siERK2Veh24h_3495,ctrl
Sample 3 Posterior  -/-,pert
Human prostate cancer primary culture C22dx,pert
"RNF40 siRNA - 2 days osteoblast differentiation, rep2",pert
cell line: HCT116 Human colon cancer;	shRNA expressing: B-Galactosidase,ctrl
KN-smoke-med-5 month-R3,pert
hES_VUB01_3,ctrl
patient E1614,pert
siRNA-1-COLLAGEN,ctrl
3036,pert
"Sorted erythroblasts, Sod2-/-",pert
TOV112D NT-2,ctrl
"tissue: whole brain;	strain: C57BL/6J;	genotype/variation: wild type;	age: 8 weeks, 5 days;	infection: 107 pfu of VSV-Indiana strain",ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: corn oil,pert
"ALL_NDS, K59 011509",ctrl
"41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"brain, Entorhinal Cortex: 97-01 tangle_e1_le1",pert
GV oocyte_control_rep3,ctrl
patient: 51294;	sample: normal,ctrl
PGA-MPF-C57-saline-24h-2aAv2-s1,ctrl
murine Satb1-/- ES cells,pert
treatment: baseline;	gender: F;	age (y): 47;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
"brain, hippocampus: Ctr-24h-P15-III_e1_le1",ctrl
"Subject 3, Family 1, Control",ctrl
Myh11-CreERT2.Tgfbr2f/f Control 2,ctrl
5: FCHL patient #98-1281,pert
"Huh7 cells, JFH-1 Infected, 48 hours",pert
cell type: Primary hepatocytes;	donor: 3;	agent: Wy14643;	time: 24h;	gender: Female;	age: 70 years old,pert
Leg 7 Day mdx rep 3,pert
Wildtype_XX_2,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing progerin;	cell line: GM00038,pert
HeLa_06_21_04 TP-3,pert
brain_DLPFC_bipolar B_mr420,pert
E9_Embryo_Heterozygous_1,pert
ubb_d14_ko_2,pert
"ONS76, KDM5A siRNA",pert
8 Weeks Heart MDX rep 2,pert
C033_Control_M_81,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 24h ID57,ctrl
BIO586224,pert
Cadherin-11 siRNA (RNAi 6A)_1of2,pert
CML_2_MEP,pert
"control, BA46-59",ctrl
wt_P2_rep3,ctrl
Primary hepatocytes isolated from Donor 2 treated with DMSO for 6h,ctrl
Endometrial stromal cell - Jag1 retrovirus infected 2,pert
med2d_2,pert
Normal mucosa 18,ctrl
Primary hepatocytes isolated from Donor 5 treated with DMSO for 24h,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID219,pert
Subject 6_t=30days_placebo,ctrl
"LNCaP cells, treated with R1881, biological rep 2",pert
NSCL/P sample 2,pert
wt_TGFb_4hr_2,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 58y",ctrl
HP-54,ctrl
SF539 PARK2 siRNA#1 replicate 2,pert
OE33 Control rep3,ctrl
"Wild-type retina, biological rep4",ctrl
platelet_Ctrl_7,ctrl
BL Ramos cell line,ctrl
GM19238_Kd_WHSC1_2,pert
C2 Control None,ctrl
SeroTest-9,pert
testis,ctrl
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 2",pert
sample P term wt,ctrl
CTRL_2_MEP,ctrl
Haloperidol treated 12weeks AffyGC RMA rep4,pert
Velcade I3,pert
human frontal cortex,ctrl
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
protocol: AP-2 gamma targetting siRNA 1;	cell line: MCF7,pert
IGROV-1+(1),pert
PBMC CCa T0,ctrl
"mouse, liver (control) (week 18)",ctrl
Psoriasis-Patient-H,pert
age: 51;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
HCV_Core_3,pert
Healthy controls; individual=CM; time=2; beverage=water,ctrl
"Male, 33 years old, HIV infection of >3 years",pert
Dengue Fever Patient 35,pert
cell type: Primary hepatocytes;	donor: 4;	agent: control;	time: 24h;	gender: Female;	age: 54 years old,ctrl
ccRCC tumor of patient T165,pert
miR122-WT-104,ctrl
LJMJDW8,pert
KGN Knockdown [RR1004],pert
mutant Lis1 ko/+,pert
condition: Psoriasis;	patient: 252;	tissue: LS skin biopsy;	kit: Ovation,pert
cell line: HeLa,pert
colon_CRC_1486,pert
sal-PVH3_1,ctrl
"Gender: Female, Age: 37, BMI: 31, Tissue: luteinized cumulus cells",pert
mouse cerebellar granule cells knockout 2,pert
"t18, surgically resected from patient of gastric cancer.",pert
HeLa_01-04-05 TP12_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 4",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	RNA Integrity Number: 9.6;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 41;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
AVC_control_rep1,ctrl
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 3;	age: Post natal day 3-12,pert
Wild Type B cells Spleen 2,ctrl
MCF10A-Vector-rep2,ctrl
WT sham kidney,ctrl
3765-2 E2F1 Null,ctrl
5922012038_D,pert
transfection: CDK8-1;	cell line: HeLa S3,pert
age: 12 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
Paraventricular nucleus_control,ctrl
Psoriatic arthritis PsA 12,pert
A549 lung cancer cells,pert
Brain_Aged_Salineip_4hr_mouse1 (OP1_#61),ctrl
"twin pair: #4;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
Age: 66 yrs Gender: Female  Ethnicity: Caucasian,pert
"A673 treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50), biological rep1",pert
"Lesional skin from imiquimod-treated mouse, biological replicate 2",pert
"Kinin B1 receptor knockout, biological rep2",pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 4",pert
microdissected breast cancer cells from case 1093,ctrl
race: caucasian;	age (years): 52;	stage: IB;	grade: 1;	histology: endometrioid,pert
maternal diet: Control;	genotype/variation: Wildtype;	strain: C57BL6/J;	developmental stage: Embryonic (8.5 days post coitum),ctrl
RNA from whole tissue section of case 607 labeled with Cy5,ctrl
MacularDegen-injured-7bAv2-s2,pert
Fibroblasts_HealthyControl_3,ctrl
coc-42_B,pert
"SiRNA-scrambled, replicate 6",ctrl
Patient 10 appendix,pert
cell line: LN229;	expression: control,ctrl
Carbo Day1 (397L),pert
BP patient 54_biological replicate 2,pert
whole tissue section from case 1047,ctrl
"Patient CCa, stable renal transplant recipients, female, 70 years old, T1 (3 months after the switching of the therapy)",pert
CD8-IGF1R Transfected 3T3 cells treated with DMSO for 24 h,ctrl
Myoblast-GATA4-OE-day0-1,pert
Murine skeletal muscle,pert
Control Treg,ctrl
N30162_rep,ctrl
Series 1; adult; no fracture,ctrl
SLE CD4 T cells 10,pert
subject: 31;	disease: TD;	muscle: ST;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Animal 3,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 4;	psoriasis duration: 19.0;	age of psoriasis onset: 17,pert
CBMNC.LPS+.3,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 47 yr;	population: white;	dsm-iv: 295.3;	age of onset: 20 yr,pert
"Liposarcoma culture from tumor 393, doxorubicin treated",pert
"Peripheral blood, normal control [N52]",ctrl
umbilical cord_bpd: 2I,pert
PTC BRAF mut 5,pert
"10 week, mutant;	SOD1(G93A);	Male",pert
AL Chip#45,pert
MEF.FHL2mutJ,pert
MCL_IGHV_UNMUT (R1338),ctrl
"2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",ctrl
"schizophrenia, BA10-14(2)",pert
CuFi cell line treated at DMNQ biological rep3,pert
"A pool of two pure subsets of peripheral blood CD4+ T cells (CD19- CD3+ CD4+ CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
condition: Normal;	patient: N_AJ3;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
129S1/SvImJTCE liver sample batch 1,pert
ATP-treated AML 7C blasts,pert
Rat fatty liver1,pert
"dy/dy dystrophic diaphragm 1, 8 week",pert
Control subject 24_biological replicate 1,ctrl
Normal heart_G16,ctrl
con-11_B,ctrl
Disease_status: Healthy control;	Age (years): 55;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Endometrium, postmenopausal, tibolone, 1",pert
"AD_FC, biological rep11",pert
HA99-96B,pert
Mouse female ES cells PGK12.1 after double RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-1 in PGK12.1.,ctrl
Testis CREMKO 0h batch 4 [TeKOh00.5],pert
WT_cells_rep2,pert
timepoint: Pre-Cediranib treatment,ctrl
MIY_day_3-1,ctrl
CHB PBMC_sample 7,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with vehicle (saline)_4,pert
"S1P2-KO-neocortex, biological rep3 (male)",pert
TTF=70min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
Disease_status: Down syndrome;	Age (years): 47;	Gender: Female;	Post mortem interval (hours): 8;	Braak stage: II;	Cause of death: Unknown,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 100min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 118,pert
mixed reference (CRG + FR),ctrl
HEK-293,pert
B2KO; No Treatment #10,pert
Healthy6-CD4,ctrl
Cervical cacner_654T,pert
Msgn1_48hPlusDox-biological rep3,pert
siHic5 VC 2,pert
normally functioning myocardium from unused donor heart,ctrl
3872-1 E2F WT,pert
Md02h021,ctrl
Bladder urothelium,ctrl
Wild Type Control for Pit-1 mutant (Snell) resulting in long lived dwarf pheontype,ctrl
injection: IP 8hr 1 mg/kg sodium arsenite in saline;	diet: AIN-76A,pert
Psoriatic arthritis PsA 3,pert
"MCF7 cells stably transfected with pCDNA3.1, passage 1",ctrl
"Inclusion body myositis, biological rep2",pert
WT HPC PDE10i 13,pert
MLL_00235,pert
"brain, hippocampus: Aldh5a1-/- #3389 Cort_e1_le1",pert
ROS3,pert
NRG Melan-Ink4a #3,pert
E-mu-BRD2 resting B-Cells,pert
Jurkat with Nef Biological Replicate 2,pert
HO_2,pert
"AD_HI, biological rep4",pert
male_alcoholic,pert
REH_control_rep3,ctrl
"KO VSV infected, biological replicate 3",pert
Sample ID: TP15;	Twin Pair ID: CCN1.1R;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.1**,ctrl
"Crohn's Disease subject (54 year old caucasian male, SAK_1275522739)",pert
CHF - R11,pert
GATA6 KO #2,pert
"Foxd3 conditional knockout cells treated with Tamoxifen, biological rep2",pert
"Crohn's Disease subject (27 year old caucasian male, SAK_1313693880)",pert
Allo-4-2,pert
"neocortex, 30 months of age, control diet",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
cell type: Mouse embryonic fibroblasts;	genotype: wild type;	time: CT30,ctrl
12h Lipofection GAPDH siRNA (SAMPLE 6),pert
"hippocampus, SSS",pert
11402 Normal Inflamed sigmoid colon,ctrl
"0mg/kg/day PFOA, Rep 2, Block 1 liver (low dose)",ctrl
race: african american;	age (years): 74;	stage: IA;	grade: 2;	histology: endometrioid,pert
CML Patient 4 7 days therapy,pert
No or early 2 rep3 (OHN),pert
RNA from HCC_1T,pert
organ: Liver;	age: 14-week-old;	genotype: Trim24-/-,pert
strain: FVB;	developmental stage: newborn (4-day-old);	tissue: hippocampus;	genotype/variation: Prnp0/0,pert
MOLM14-shControl-rep2,ctrl
tissue: breast;	disease state: healthy,ctrl
"normal breast epithelium,3",ctrl
SKBR3_1uM_Lapatinib_2,ctrl
WT - Cre Control - 5 mo - repeat 3 - Cy5 - mAdbID:74101,ctrl
Intronic WT control rep3,ctrl
SUM149_siTIG1_rep1,pert
"midbrain,6weeks,KO",pert
E14 molar DMSO 2,ctrl
blood_day0_patient4,pert
HEK293 cells siRNA BAHD1 biological rep2,pert
"Male, 27 years old",ctrl
Patient 9,ctrl
striatum wild type 6 month replicate 3,ctrl
Leukemia,pert
MDS24,pert
Cell line MCF-7_control_expt2,ctrl
Ischemic cardiomyopathy,pert
"Pb-Cre+;PtenL/W;K-rasG12D/W, biological rep2",ctrl
MDS patient 82,pert
Patient 6 after folic acid,pert
"Muscle from DS, biological rep4",pert
NFIA P16KO3,pert
D425,pert
HT1080,ctrl
"BMMCs from NTAL WT, NTAL shRNA infected, 2 h activated, biological rep3",pert
"Liposarcoma culture from tumor 385, doxorubicin treated",pert
SW1736_t1h_rep3,pert
coronary smooth muscle cells control replicate 2,ctrl
Brain_Aged_LPSip_4hr_mouse3 (OL3_#69),pert
U-87MG-PK19 set 1,pert
Mammary gland R1 8 hr rep4,pert
"MaF pre-iPSC9P2, Vc-, D5",ctrl
CRC_nodrug_F4864,ctrl
WT_TER119-_rep2,ctrl
PGA-RMM-30m-1aA-s2,pert
EB_07_5d_137_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"striatum,24weeks,KO",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 70min;	race: White;	sex: Female,pert
"Liver from Nrf2 k.o. mice, biological replicate 3",pert
CD11b+Gr1- cell sample_1 (derived from IL17RC Knock out mouse),pert
"PIO, subject 10",pert
whole tissue section from case 1218,pert
"nasopharyngeal carcinoma, specimen T24",pert
"non-AD_FC, biological rep9",ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: fresh air, treatment over 5 month + 1 day recovery, 4x1h exposure per day",ctrl
CD8+_Tcells_severe_asthmatic_8,pert
MDS patient 155,pert
"wild type CTL+AktI, biological replicate 3",pert
lung_E18_wildtype_rep1,ctrl
MDS52,pert
"48 hour-treated wild-type NB4, biological rep3",pert
patient id: 260;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: n/a;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
Gender: Male; Tissue: prostate.,pert
Cmah KO_lung_1,pert
PsOEt-17-LS,ctrl
"wild type naïve CD4 positive cell, unstimulated, replicate 4",ctrl
8 week old EOM control rep 2,ctrl
Individual_4391_NN_sample,ctrl
RA_z,pert
prostate_Klf5 ko_rep3,pert
PancreaticSample16-Normal,ctrl
Colo-205 PLX Day 3,pert
OC1-KO embryo 3,pert
Untreated Control 4weeks AffyGC RMA rep2,ctrl
PC-3_basalhTERT_ShortTelomeres_mockcre_1,ctrl
"DBA/2J Saline treated, biological replicate 1",ctrl
"Control, biological rep3",ctrl
Control_liver_4,ctrl
Patient: E;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Bc_WAP_2,pert
"Wild-type-hippocampus, biological rep2 (male)",ctrl
C597,ctrl
Substantia nigra PD rep6,pert
Lmna H222P heterozygous male 2,pert
"scr-Rosi, biological rep1",ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,pert
A2780+(1),pert
"KO liver, biological rep3",pert
Whole adrenal RNA from Crem-/- mouse #143 at 0h,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep7,pert
WT mouse (WT_Tal4),ctrl
lung fibroblasts from a patient (FASSc3) with fibrosing alveolitis associated with systemic sclerosis,pert
"wild type; BMDM; IFNgamma and  1alpha,25(OH)2D3 treated",ctrl
genotype: MLL partial tandem duplication,pert
mouse liver B2,ctrl
RNA from HCC_4T,pert
Mixed_E14.5_Whole_Kidney,pert
Normal bladder 81-99,ctrl
umbilical cord_bpd: 4I,pert
5261 UC Uninflamed descending colon,pert
SNRK_3,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L221,pert
"human failing LV myocardium, Ischemic102",pert
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 49;	donor: 35;	disease state: Lesional,pert
Wildtype 3 (jos0534),ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID286,pert
"WT, PR02M003v0",ctrl
K_LS_Wk1,pert
INCB18424 Persistent 3,pert
Isoflurane 10 exposures-2,pert
Brain_Wild-type_MiceNoB4394,ctrl
genotype: WT;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Male,ctrl
"UACC903, no treatment",ctrl
Genotype: Genotype: FORKO (FSH Recptor Knock Out). FORKO mice was generated by deleting all variants of FSH-Receptor,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: WT;	treatment: DSS for 3 days,ctrl
N79s,ctrl
5922012038_B,pert
Pancreatic Sample 54-Tumor,pert
31GOBMUC2A,pert
"D425-shOTX2_3, t=16",pert
8DKD_SerumStarved_rep3,pert
MCF-7,pert
"BMDM, 1alpha,25(OH)2D3 treated, KO Vdr -/-",pert
"Entire small intestine, CF, control",ctrl
age: 6 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,pert
CA01-103A,ctrl
"ID: MLL_00255;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
H07_S_B1,ctrl
heart_QH2_6M_rep3,pert
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 1",pert
"genetic background/strain: C57BL/6;	genotype: Alkbh1-/-;	cell type: embryonic stem cells;	developmental stage: day 0, undifferentiated;	passage: 8",pert
Mammary gland R1 NT rep3,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.377;	OD280: 0.716;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 211;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Kidney_saline_5,ctrl
Patient: G;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
autism with FMR1-FM AU046703,pert
Control 60 days sample 3,ctrl
patient: 258;	current medication: Azathioprine 200mg Pentaza 1g TDS;	birth date: 10/26/64;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/1/87;	diagnosis date: 6/1/88;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"Knockout sham, biological rep3",pert
PsOEt-19-LS,ctrl
5871841165_C,pert
tissue: small intestine;	genotype/variation: E-cadherin cKO,pert
"Normal cervix epithelium, Age 52",ctrl
8 hour tunicamycin CHOP-/- B,pert
5197 Normal Uninflamed sigmoid colon,ctrl
Spleen_infected_4weeks_rep1,pert
OCI-Ly7 BCL6siRNA 2,pert
Vastus lateralis muscle,ctrl
"PCOS, biological rep 6",pert
"P16 mutant OC apex, biological rep 2",pert
RAW LPS 1,pert
"wildtype white adipose tissue, biological rep 2",ctrl
ADHC3,pert
U2OS shControl replicate 3 [set 4],ctrl
Discoid Lupus-L8,pert
Snell 6 month Wild Type Liver 88c,ctrl
Testis_Taf7l knockout_rep2,pert
PyV-mT wild-type tumor,ctrl
"SFM control cells (3hr), biological rep_2",ctrl
PancreaticSample5-Tumor,pert
"human failing LV myocardium, Idiopathic15",pert
KO mouse 2_heart_basal,pert
Control LM2 Cell Replicate 1,ctrl
G93A 60 days sample 1,pert
Mouse female ES cells PGK12.1 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-3 in PGK12.1.,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.5;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"P209 HCT-116, DNMT3B knockout, DMSO-treated",pert
Mist1KO saline rep1,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 57, stage IIB, HPV 18",pert
"fibroblast, MFS subject FB783 rep 1",pert
Huh7 cells_JFH-1 Infected 18 hours_ rep2,pert
"P205 HCT-116, DNMT1 knockout, non-treated",pert
"Liposarcoma culture from tumor 391, untreated",ctrl
Sample ID: TP24;	Twin Pair ID: CCN3.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 25;	Current Age (2007): 28;	Sex: MALE;	Medication at blood sampling : None,ctrl
CD4DecTp2-11,pert
"Deltoid, FSHD, cohort 18, subject 18A",pert
"C57BL/6 male 3w, 100",pert
Brain from 37 days Npc1+/- mouse1,ctrl
Tissue: normal thyroid; Gender: male; Age:42,ctrl
RNA from whole tissue section of case 1437 labeled with Cy5,ctrl
Vit A deficient 1a,pert
control-3,pert
DS1-iPS 2,pert
A1_tumor,pert
Strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue:  gallbladder,ctrl
Human_Hepatocyte_trovafloxacin,pert
K562_NoTreatmentControl_24hrs_rep2,ctrl
Endometrium/Ovary-Disease 3,pert
U87-20.2,pert
CLL6-CD8,pert
Ex1_cells_rep3,pert
thyroid_tumor_7,pert
"Estradiol, rep 2",pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,ctrl
Sox2-shRNA-2,pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F7;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
HSC cells from control rtTA mouse rep1,ctrl
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,ctrl
"GFPMYC positive GC B cells, Biological replicate 7",pert
E10_otic_vesicle_mut_replicate1,pert
"Transgenic, snap frozen, tibialis anterior muscle, 10 month age animal",pert
KU_22T,pert
112B,ctrl
18: FCHL patient #98-1479,pert
PBMCs_Control_6 [IS],ctrl
T119,pert
"ID:13-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Tendon;Suspraspinatus_Lesional,pert
"brain, adrenal medulla: Sample#B4(Ctrl Pt4)_e1_le1",ctrl
T118 U133p2,pert
"RWPE1 cells, vehicle, 48h, biological rep2",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 6h",pert
"129P3/J Acute morphine treated, biological replicate 2",pert
"siRNA, collagen plate, rep3",ctrl
WT_24A_1,ctrl
"human nonfailing LV myocardium, NonFailing2",ctrl
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 1;	age: Post natal day 3-13,pert
heterozygot FH P249,pert
liver_wild type_6 weeks_replicate_3,ctrl
Sample: nontransgenic control (NTG);	Replicate: 3;	Pool: P;	Sample: nontransgenic control (NTG);	Replicate: 3;	Pool: P,ctrl
"Patient  C, lesion, time: 0",ctrl
aa_NY31,pert
"liver_ABCA1-TG, biological replicate 2",pert
saline injected mouse lung,ctrl
4-HPR_mammary_3,pert
strain: wt;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 7-9 wk,ctrl
MCF7 cells that were transfected by control siRNA.,ctrl
patient: 249;	current medication: Azathioprine 150mg Salazopyrine;	birth date: 1/12/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/90;	diagnosis date: 3/24/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/8/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 4/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
shSOX2_2,pert
Mock infected murine liver-MO30k-(A)-6 hpi,ctrl
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep1",pert
phenotype: alcoholic;	gender: male;	case_id: 274;	age: 81;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Ex;	post-mortem-interval (hrs): 36;	brain ph at time of freezing: 6.44;	labeling_batch: 1,pert
Mouse inner ear,pert
"Ls174T, dominant-negative Tcf4, induced",pert
tissue: Spleen;	genotype: TRAF3flox/flox-CD19+/cre (B-TRAF3-/-),pert
CH2117,pert
cervical spinal cord,ctrl
MiaPaCa2 pCEP4 clone 3,ctrl
"human failing LV myocardium, Idiopathic45",pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His-ZNF217 plasmid,pert
hOB1705_shRB1383_16hr_IR,pert
Brain (Inferior Olivary Nucleus)_control subject_#4,ctrl
"midbrain,12weeks,KO",pert
231/ARF-1,pert
mouse CD4+ T cells,pert
"Acute Myeloid Leukemia, sample 8",pert
"C57BL/10-SJL.Dysf TA, replicate 2",pert
C57 24 air 2,ctrl
"RNF40 siRNA - 2 days adipocyte differentiation, rep2",pert
TTP_KO_60ActD_BioRep3,pert
pMX-Oct4 and pMX-jhdm1b(jmjc) vitamin C O+JMJCVc+_2,pert
whole tissue section from case 829,ctrl
"LCL GM19238, Kd RELA, 72hrs",pert
reduction mammoplasty patient 360,ctrl
"normal skeletal muscle, biological rep1",ctrl
224 Day 1 siSC transfected biological rep1,ctrl
Parkinson's disease sample x153,pert
ILD Study Number 1259,pert
"brain, brainstem: CB5_e1_le1",ctrl
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 1,pert
A HID U_B007,pert
thyroid_tumor_5,pert
CLL2-CD4,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 209,ctrl
model: Fischer 344;	gender: Male;	age: 21 to 22 months old,ctrl
B6.IL10 48 air 1,pert
placenta (E 10.5),ctrl
Liver_Nrf1 Control_rep3.,ctrl
PTC BRAF mut 7,pert
SF539 GBM cell line,pert
Keratinocytes_siRNA control_rep1,ctrl
patient: 51783;	sample: tumor,pert
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",pert
heterozygot FH P560,pert
Y YOKE_B060,ctrl
cell type: fibroblast;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: 0;	clone: 0,ctrl
WT-Fibr1 2,ctrl
10 week control spinal cord rep 3,ctrl
Mouse whole brain,ctrl
Wild type C2C12 cells,pert
Uninfected control_4a,pert
1199-01-A,pert
puroD replicate 1,pert
cell line: HM1 embryonic stem cell line;	genotype/variation: control,ctrl
Control 1 medium only,ctrl
A549_Nrf2 siRNA_biological rep1,pert
12mo Control #1,ctrl
H04_P_B2,pert
untreated 24 hr,ctrl
CD8-IGF1R 3T3 Vehicle 1,ctrl
"72 hour-treated wild-type NB4, biological rep3",pert
s9129_2,pert
siLRH-1_#2_rep_4,pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p31;	strain: E14,ctrl
"NALT infected with 90-226 deltaM, 24h, biological rep1",pert
Lung-normal-rep4,ctrl
minor non-tumor8,pert
tissue: colon biopsie,pert
Control 5,ctrl
mouse bone marrow-derived mast cells treated with IL3,ctrl
Adipose-24 month-Myc heterozygous-technical replicate 1,pert
"Strain: C57BL/6, Tissue: Airway Epithlium, Culture: Organotypic Air Liquid Interface",ctrl
RNA from HCC_29T,pert
Tendon_non-lesional_rep23,ctrl
MDS patient 80,pert
AVC_control_rep3,ctrl
HUVEC culture,pert
Muscle-AMPKgamma3-mutant(R225Q)transgenic-1,pert
thyroid cancer cell line,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post saline ip.,ctrl
"seminoma specimen, pT1, patient age: 37y",pert
LIVER_CONTROL_repl1,ctrl
ubb_d28_wt_1,ctrl
3_month_old_wildtype_mouse_rep2,ctrl
WT1-iPS 2,ctrl
OCI-Ly10_sictrl,ctrl
HEK293_HNF1a_#1_induced,pert
PBMC from T cell LGL leukemia patient #106 (TLGL106),pert
blood_day6_patient2,pert
Mc3T3_untreated_5 days,ctrl
RNA from whole tissue section of case 59 labeled with Cy5,pert
ME180 6 hours rep 4,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Liver",pert
HCT116_shN91_rep2,pert
MOLM-14 cell line infected with GSK3A Construct 6 shRNA,pert
LSK cell from Gfi1 wildtype mice,ctrl
TN 3,ctrl
skeletal muscle (quadriceps); fasted 18h,ctrl
cells origin: subcutaneous white adipose tissue;	individual characteristics: Morbidly obese patient,pert
wt-Gfp 4 weeks replicate 2,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 4h,ctrl
"heart, knock out",pert
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 7 weeks-old,pert
Muscle control (YJD-JDM-48UA-s2),ctrl
cell line: HeLa,ctrl
CD4+_Tcells_healthy_donor_2,ctrl
Trizol extracted total RNA from uterine fibroid tissue.,ctrl
"MCF7/BUS, 30 pM E2, 48 hours, biological replication 4",pert
spinal cord,ctrl
"mouse aorta cross strain comparison, C3H_T08_NC_02",ctrl
WT HPC Veh 3,ctrl
"gender: Female;	age: 70;	post-mortem delay: 4.5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Disease_status: Bipolar disorder;	Age (years): 63;	Gender: Female;	Age of onset (years): 43;	Duration of illness (years): 20;	Brain pH: 6.97;	Post mortem interval (hours): 32;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"control + L-Arg colon tissue, biological rep3",ctrl
SW1736_t48h_rep1,pert
"P200 HCT-116, DNMT wildtype, non-treated",ctrl
PancreaticSample11-Tumor,pert
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: PBS;	tissue: liver,ctrl
mdx EDL sample 2,pert
B4 424 b4-/- untreated,ctrl
Wild type unstimulated 1,ctrl
Animal 11,ctrl
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep3,pert
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"PBMC, patient. Mtx rep3",pert
rat hippocampus (CA1 region)_IntermediateCort,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 5d ID62,ctrl
AtT20 cells treated with control siRNA rep 3,ctrl
"tissue: bone marrow;	disease status: B-precursor acute lymphoblastic leukemia, Down syndrome",pert
NCI-H716_YAP1.1,pert
HUVEC_TSA_rep2,pert
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,ctrl
PTC BRAF wt 5,pert
"Wild type, snap frozen, diaphragm muscle,10 month age animal",ctrl
WT S49 cells 2 h cAMP treatment,ctrl
peripheral blood cell,ctrl
"D5_non-transgenic mice, lung tissue",ctrl
MO_DH1b_SON_NCBI,pert
"The Identification of gene expression changes in human embryonic fibroblast cells, background. Sample A",ctrl
"Nod2-UN1,experimental replicate 1",pert
Clozapine treated 12weeks AffyGC RMA rep8,pert
"control, BA46-53",ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 5",pert
3116-scrape,pert
chip number: 23;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.86;	rin: 9.6;	transfection date: 2012-03-26,pert
LCL Unaffected MZ twin pair 1 (CCN1.2)(TP14),ctrl
HF0835_U133P2,pert
MOLM14-shControl-rep1,ctrl
rheumatoid arthritis 1032,pert
"Heart, mdx, 2 months old",pert
Cell line MCF-7_c-myc KD_expt1,pert
NPC12,pert
"55B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
postmortem brain,pert
"PMA treated, no doxycycline; biological replicate 1",ctrl
c42 is aclonal Nurr1 stably-expressing stem cell line,pert
GIST_PDGFRA_5,pert
"healthy control fibroblast, biological rep2",ctrl
siTNIK+4hr Wnt (dye swap),pert
"Placebo treated, HIV-1 positive male, day 14 (9)",ctrl
Psoriasis-2 baseline,pert
si FoxA1 and vehicle replicate 3,pert
INCB18424 Persistent 1,pert
gender: female;	age (years): 36;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
array type: Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,ctrl
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Female;	Age of onset (years): 33;	Duration of illness (years): 15;	Brain pH: 6.50;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
1: FCHL #98-1176,pert
genetic background: B6/129;	genotype: Tet2 KO;	cell type: Tet2 deficient CD150+ sorted LSKs,pert
WT MEF CT18-1,ctrl
MCF10A-HER2(+) 5days,pert
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T1N0,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: myocardium,pert
WT #3,ctrl
"Vehicle treatment, 25 hours (replication 2)",ctrl
Ls174T-L8 con3,ctrl
"Patient  N, lesion, 12 week",pert
liver control diet rep2,ctrl
MEF E2F4 KO 4-rep1,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 2,ctrl
EOM 112 Day mdx rep 1,pert
"650nM MLN4924 after 2hr, replicate 1",pert
H_LS_Time0,ctrl
Normal cortex of patient 265,ctrl
K562 DMSO sample 9,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 12h,ctrl
CD47 null Endothelial cells 3,pert
NCCIT siTET2 rep1,pert
Normal bladder biopsy,ctrl
Healthy control 12,ctrl
DBA/2J Vehicle liver sample batch 2,ctrl
Individual_4247_PP_sample,pert
Aurka_R_-Dox_rep1,ctrl
01MH9_PolyRF+,pert
Mening SWB WB NP 24a,pert
"Acute Myeloid Leukemia, sample 61",pert
"Untreated, biological rep1",ctrl
293TsiScram-4,ctrl
patient E1796,pert
"Mouse Sciatic Nerve, Diabetic Vehicle",pert
healthy control H25,ctrl
"Hippocampus, naïve control",ctrl
5922012008_B,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/15/07;	# cells: 84;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
"brain, brainstem: LB5_e1_le1",pert
"Xenograft of Panc-1 (Human pancreatic carcinoma) cell line, in mouse",ctrl
pool of thyroids from 10 months old wild type mice,ctrl
ACC Xenograft X11,pert
"105, MUSCLE, Before",ctrl
MSC_SA01_1,ctrl
H12_P_B1,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 151;	colon ratio (mg/mm): 2.52;	myeloperoxidase activity (u/mg): 1.06;	tissue: colon;	treatment: 5% DSS,ctrl
wildtype strong 1,pert
MRF CKO Oligodendrocyte Replicate 3,pert
"K562, NoTreatmentControl, 24hrs, rep1",ctrl
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: Dicer1 conditional knockout, Atoh1-Cre;Dicer1(flox/flox);	tissue: organ of Corti from cochlea, apical half;	age: postnatal day 16",pert
mESCs_Tip60KD_rep1,pert
"ventricular myocardium, wild-type, saline, 24h",ctrl
14 with Cy5,pert
Z4_TA,ctrl
"human failing LV myocardium, Ischemic13",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 1,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep2",pert
Kidney_50 mg/kg VCM iv_mouse #007,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 27;	sex: M,ctrl
"+Rosi, -PPAR, 2hrs",pert
ILD_10,pert
18SAGEA2,pert
HEK293_HNF1a_#4_uninduced,ctrl
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-WT;	overexpression induced with doxycline: Yes,pert
126KD 14A n,pert
treatment group: untreated in parallel to arsenic treated cells;	cell line: TK6 cells,ctrl
Human colon biopsies from UC patient with active disease (involved mucosa),pert
whole tissue section from case 342,pert
PS_IB_3_aa_lcm,pert
Untreated Jurkat cells (replicate 1),ctrl
HCC PBMC Sample 5,pert
8 wk old male mdx EDL,pert
"Patient  J, lesion, 4 week",pert
Lung-normal-rep1,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu1,pert
"heart, control, 14 months",ctrl
T3C-LU,pert
cell type: embryonic stem cells;	genotype/variation: Satb1 knockout,pert
status: Rapid;	age: 48;	gender: male;	tissue: cultured human fibroblasts,pert
Fibroid_2525C,pert
"CD11b DC wild type, biological replicate 2",ctrl
"brain, cerebellum: WCb4w#2_e1_le1",ctrl
RAW_3.5mM_HOCl_#3,pert
214/4,pert
"Human LIMA artery from patient 5, treatment: paclitaxel-eluting stent",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 34.37808,pert
Mut1,pert
Wild type naïve T cells stimulated for 3 hours with medium alone 3,ctrl
t13,pert
SLE9-TC,pert
MCF-10A shCHK1-3 replicate 2 [set 5],pert
57SageA2,pert
tissue: Biceps muscle;	patient: P.b.1;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
4_KO_1,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,ctrl
11424 UC Uninflamed ascending colon,pert
"human failing LV myocardium, Ischemic83",pert
Individual_4378_NN_sample,ctrl
5280 UC Uninflamed ascending colon,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 6hr.",pert
293TsiScram-3,ctrl
HepG2 cells quercetin 12h,pert
"mouse aorta cross strain comparison, C3H_T24_NC_02",ctrl
mock B,ctrl
Knockout day 3 Air replicate 3,pert
FW_14c_BV5933,ctrl
01MLB_Systemic,pert
Wild Type 12,ctrl
wild type mouse,ctrl
alveolar macrophages obtained from bronchoalveolar lavage,pert
PGA-lv_8w_339,ctrl
485MM,ctrl
Chondrogenic progenitor cells from OA female 2,pert
Uninfected control_4c,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-7;	Primary Site:Floor of mouth;	Age:48;	Sex:M;	TNM:;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
LNCaP EtOH rep 3,ctrl
Sample: alpha-TM180;	Replicate: 2;	Pool: NP,pert
FTO2_D4_24h,pert
"27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
K562_1R-Chl_24hrs_rep1,pert
colon_adenoma_1832,pert
NSCL/P sample 4,pert
Whole skin tissue,pert
HaCat cells infected with a BCL-3-expressing  lentiviral construct. Replicat 1,pert
PBMC from T cell LGL leukemia patient #136 (TLGL136),pert
CD11b+Gr1+ cell sample_5 (derived from wild type mouse),ctrl
Arid3a OE-Pool replicate 1,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
A HID U_B053,pert
Control mouse 2,ctrl
scan batch: Batch 2;	group: autism;	subject age: n/a;	paternal age: 25;	maternal age: n/a,pert
NoKD_SerumStarved_rep1,pert
K562 cells CREB Knock-out replicate 1,pert
cerebellum SNCA knockout 21 month replicate 4,pert
Germinal center B-cells,ctrl
HEK293T cell line,ctrl
peripheral blood from E12.5 Cbfb+/+  embryos,ctrl
HaCat cells infected with a control lentiviral construct. Replicat 3,ctrl
WT_rep_5,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, mock (24h post-infection)",ctrl
sex: Male;	Age: 3 months;	additional patient information found in Series supplementary file,pert
Y HID_B037,ctrl
"Lesion Skin, LS-21",pert
Neuroblastoma SH-SY5Y cells_cloneM_scramble control_replicate1,pert
"Benign, prostate tissue",ctrl
tissue: lymph node;	genotype: Dicer KO;	cell type: CD4+CD62L- resting T cells,pert
B6_Female_Control_rep2,ctrl
Md02h035,pert
ADH3,ctrl
triplicate 2 of uninfected HepG2 HIF-1-/- cells,pert
Kidney_colistin_6,pert
Control Treg_rep2,ctrl
Muscle 50 eccentric contractions 12 hours WT Adult 0629,ctrl
"Empty vector, plastic plate, rep2",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.301;	OD280: 0.666;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 136;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Hippocampus 2010 2 month Old,ctrl
GIST Pre Treatment Biopsy 18,ctrl
SKMEL28_t1h_rep1,pert
breast cancer patient 320,pert
age: 45;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
non-malignant FTEb_patient 9,ctrl
Tendon;ECRL_Non-lesional,ctrl
V5-P399,pert
Atxn1L null murine HSCs,pert
E14.5_Control_Kidney_array1,ctrl
Cardian muscle Healthy 3 week C3,ctrl
EA_SLE_CD20,pert
"Frontal cerebrocortex, permethrin (100 mg/kg), 6 hours",pert
PBMCs enriched for CD8+ cells from normal control subject J (JCD8),ctrl
"siTERC-BMSCs, biological rep1",pert
HUVEC/NmenMC58_pilD_4h_rep2_1107,pert
A3243G-MELAS subject 2,pert
"KPL4, Untreated",ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: RNAi-1B,ctrl
strain/background: C57BL/6;	genotype/variation: Wnt7aCre+;Esr1f/f (uterine epithelial ERα conditional knockout);	age: 8-10 weeks;	gender: female;	tissue: uterus;	treatment: saline;	time point: 24h,pert
AT2 E/R positive leukemia cell line,ctrl
Muscle-AMPKgamma3-wt-4,ctrl
"human failing LV myocardium, Ischemic87",pert
subject: 12V;	cohort: 12;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 45;	Sex: F;	batch: Batch_3,ctrl
"Wt mouse, cerebellum, standard diet supplemented with resveratrol ad lib",pert
Gender: F;	Age: 49;	Tissue: Mucosa,pert
gender: F;	age at blood draw: 49;	tissue: whole blood,ctrl
"H1 hESCs, SOX2 shRNA",pert
Strain: BALB/c;	Age: postnatal day 0;	Genotype: Wild type,ctrl
K14deltaNB-cateninER  Time 1 replicate 2,pert
Bone-Marrow_MGUS_G1356,pert
"brain, cerebellum: RNA#39*_le1",pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 27;	gender: male,ctrl
Sex: female;	Age at operation: 58 years;	Site: pelvis retroperitoneal;	Size in cm: 4x7x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: metastasis;	Previous radiation: no;	Previous chemotherapy: no,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 1;	time: 3h,pert
MNR 6-2 KO 3,pert
chronic lymphocytic leukemia (CLL 528),pert
RNA from HCC_28T,pert
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus_WT-POU_87",pert
"Heart, MAT1 CKO, 4 wk, sample 4",pert
ID4+/+TCL1-tg spleen CD19+ B cells collected from 3 mice 2,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 2",pert
CD8_T_cell_pool_healthy_H01+H02,ctrl
OCI-Ly7_sictrl,ctrl
449MM,pert
"12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Mouse_E14 ES cell_Undifferentialted,ctrl
"bipolar disorder, BA10-5",pert
11442 UC Uninflamed descending colon,pert
Amoxicillin treated Colon 2 21 days old,pert
Sample ID: TP21;	Twin Pair ID: CCE1.1;	Clinical Status:  Childhood Absence Epilepsy;	Age of Onset:-5;	Age at interview & blood sampling: 22;	Current Age (2007):25;	Sex: FEMALE;	Medication at blood sampling : Epilim,pert
AP-2 gamma targetting siRNA 1: AAUGAGAUGGCAGCUAGGAAG Technical Replicate 2,pert
Jak2VF vehicle (7991003040_F),pert
Wild-type postnatal day 10 rep 3,ctrl
RV82.09_CHF_day10_Slide58,pert
Mouse heart with no DOX treatmeant,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: non-treated;	tissue: liver,pert
"LCL GM19238, Kd NFYC, 72hrs",pert
CON5,ctrl
age: 42;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
normal lung,ctrl
07R060 RA,pert
CuFi cell line biological rep2,ctrl
BCells_Transgenic_day2_REP1,pert
Rybp#10 (OHT-)_12d_rep2,ctrl
s2t4c,ctrl
thyroid_tumor_1,pert
F1.02,ctrl
Time:3 day; condition:LaminA ko;,pert
T8B-LU,pert
LPS 1 HOUR,pert
cell type: Melanoma cell line;	cell line: A375,ctrl
HW_1090,pert
nmd untreated 1,pert
"Acute Myeloid Leukemia, sample 24",pert
genotype/variation: Vax2-/-;	age: P8;	tissue: Whole eye,pert
"24hr non-specific siRNA, 16hr vehicle treatment replicate 2",ctrl
tissue: heart;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
SKI-DLCL cells untreated,ctrl
cell line: HEK-293;	genotype: NOD2 wt;	stimulation: Muramyl-dipeptide (MDP) 10 µg/ml;	time point: 0 h,ctrl
cell line: HEK293;	genotype/variation: tranfected with pEGFPN3,ctrl
CTR 1,ctrl
Psoriasis-10 baseline,pert
jejunum_GATA4mutant_1,pert
Primary chondroyctes; Wt; Ago2-IP,ctrl
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"Patient 16, Atheroma plaque",pert
c-Kit + MA9 AML Zfx KO,pert
amygdala no access to cocaine replicate 2,ctrl
"WT HSC, biological rep2",ctrl
P67 Non failing heart biopsy,ctrl
XX1_InX,ctrl
Mouse male ES cells WD44 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-1 in WD44.,pert
Control Endometrium Stromal Cell_033.UC-209-+,ctrl
P60_WT_1,ctrl
"breast, post AF treatment (H14_1659)",pert
Run7.aUa.001206d.SkMInS1077D.CEL-IS stimulate,pert
"NB4 cell line, wild-type, ATRA, 48hr",ctrl
expression array - O1,pert
Wild-type Rep3,ctrl
CD71+ bone marrow cells from Ifng-/- mouse 1,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 5",pert
tissue: Frontal cortex;	age: 81;	Sex: F,ctrl
0 h (control sample),ctrl
"fibroblast, MFS subject 60FR rep 4",pert
The caudate nucleus from an XDP Filipino (aged 52 yr) .,pert
sample =Healthy4 treatment=Stimulated time=180 (min),ctrl
genotype: Sox3 null;	cell line: R1;	cell type: Embryonic stem cells differentiated into neural progenitor cells,pert
tissue: Melanoma Lymph node Metastasis;	cell line: WM164;	treatment: 500nM PLX4032 for 16 days,pert
NBD inhibitory peptide-treated CEM 100mM 16h,pert
"Tissue: peripheral blood, Subject:Healthy Control",ctrl
Panc-1 Ctrl 3,ctrl
181C6,ctrl
Cancer 21,pert
"breast tumor epithelium,26",pert
"human failing LV myocardium, Ischemic52",pert
"Acute Myeloid Leukemia, sample 16",pert
A39 NES 142Q TG1	F5/51	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Female,pert
T21 U133p2,pert
"BOEC, normal 6",ctrl
Control subject 43_biological replicate 1,ctrl
SCARKO d 10 (5),pert
triplicate 1 of uninfected HepG2 HIF-1-/- cells,pert
cell type: splenic CD11c+ dendritic cells;	strain: C57Bl/6strain: C57Bl/6;	genotype/variation: Map3k7CreER;	treatment: tamoxifen,pert
Vehicle-Control 36 hours set 1,ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: DMSO (Vehicle);	treatment time: NA",ctrl
"Gata4_S105Amut, untreated whole heart, individual 5",pert
Hippocampus 2006 2 month Old,ctrl
involved skin from cases,pert
cell type: Mouse embryonic fibroblasts (MEFs);	genome/variation: Wt1-null,pert
Mnk_3220-S-B,ctrl
cerebellum_wildtype_3,ctrl
Tissue: tumor; Gender: male; Age:42  Tumor stage: T3NxMx,pert
KO PBS4,ctrl
Mutant_liver_3,pert
cell line: Y79;	passage: 25;	cell type: Retinoblastoma,pert
"Polyamide 1 treated LNCaP cells not stimulated with DHT, biological replicate 2",ctrl
Run4.aUa.010110d.SkMDbt1142D.CEL-DB basal,ctrl
Barrett's esophagus (B2),pert
"ESCs overexpressed Foxd3, biological rep3",pert
"ID:c 1-2, Genotype=(C57BL/6J), Treatment= none",pert
"brain, brainstem: LB3_e1_le1",pert
PC-3_basalhTERT_ShortTelomeres_mock_1,ctrl
BALB/cByJTCE liver sample batch 1,pert
MLL1-KO MEF CT18-2,pert
tissue: amnion;	cell type: mesenchymal;	agent: vehicle;	time: control,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.226;	OD280: 1.154;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 223;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
M238_A_DMSO,ctrl
Adrenal WT 0h batch 1 [AdWTh00.4],ctrl
RKO cells transfected with HSF1 Stealth siRNA treated 6 h with DMSO 0.5%,pert
MCF-10A shCHK1-4 replicate 2 [set 5],pert
heart of male mouse subjected 2 week to chronic intermittent hypoxia.,pert
NORMAL #99-0739,ctrl
chip number: 17;	transfection plate: 6;	target gene: NS;	kd level: NA;	rin: 9.1;	transfection date: 2012-03-26,ctrl
human ccRCC cell line,pert
GFP-progerin Induction: day 5 Replicate A (5a_progerin_5d_A),pert
Control subject 107_biological replicate 2,ctrl
AZ-521_doxycycline_24h_rep2,pert
MDA-MB-231_TR6196: transfected with a vector containing a shRNAs against CD146,pert
"SFM control cells (24hr), biological rep1",pert
Cardiac Progenitor MUT1,pert
Individual_4294_PN_sample,pert
EA_Case8_CD20,pert
40A;pretreatment;female;breast tumor,ctrl
siHic5_2_4h_3,pert
pt. HCL D treated with Vemurafenib 1000 nM for 48h,pert
TEx15ni,pert
cell line: SNB19;	transfection: PARK2 siRNA#2,pert
WT1R2,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID308,pert
Ishikawa_HighDose_BPA_8h_rep4,pert
UC-32-un,pert
D1,pert
"fibroblast, MFS subject FB837 rep 4",pert
Individual_4247_PN_sample,pert
Striatum of 6-10 week old C57BL/6J mice,pert
chip number: 22;	transfection plate: 5;	target gene: STAT2;	kd level: 0.64;	rin: 9.2;	transfection date: 2011-10-17,pert
MCF-10A_shATR-4,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
strain background: B6/C3H;	genotype/variation: wildtype;	developmental stage: germinal vesicle (GV) stage;	tissue: oocytes (100 cells),ctrl
"control pancreas, biological rep1",ctrl
"ES cell mutant, RNA 306",pert
bone marrow cells,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 4",pert
P0 Quadriceps Klhl40 WT 2,ctrl
"A673 treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50), biological rep3",pert
Normospermic individual: Sample N1,ctrl
HCC_2T,pert
cell line: L428;	treatment: Mifepristone + 5-aza-2′-deoxycytidine + Trichostatin A (MAT);	duration of treatment: 5 days,pert
"Acute Myeloid Leukemia, sample 11",pert
FSH-NHM-1UA-S2,ctrl
A549 Stretch 1hr Jan 31 2003,pert
"3T3-L1 siLSD1 48h, biological rep 3",pert
"A673 treated with DMSO vehicle control for 5 days, biological rep2",ctrl
01LKZ_ERA,pert
"Trained mice, time point 1 week",ctrl
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 3,pert
WTC 157 PBS treated,ctrl
oligoarthritis,pert
BL307,pert
control AU1348302,ctrl
REH_control_rep2,ctrl
e5 Ez f/wt,ctrl
Ecad_Con_1,ctrl
Retina ko/wt rep1,pert
293TsiLL-2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 42.82192,pert
Sprague Dawley rats;	Gender: male;	Weight: 250-350 g,ctrl
DEX4_24H,pert
ubb_d7_wt_1,ctrl
RTX5 T12,pert
"S1P3-KO-neocortex, biological rep2 (male)",pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 7.9;	colon weight (mg): 167;	colon ratio (mg/mm): 2.11;	myeloperoxidase activity (u/mg): 0.088;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: prefrontal cortex from adult APPsa knock-in mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
INCB18424 Acute 1,pert
07R068 Control,ctrl
Leptin treated mouse gallbladder 7,pert
IL22KO_T. gondii-infected_5dpi_ileum,pert
"F348, WBS, skin fibroblasts",pert
Igf1 -/- mouse vestibular organs at embrionic stage E18.5,pert
cell type: B220+ cells from preB colonies;	genotype/variation: Hspa9+/-,pert
"Patient H-c558T, MSI colorectal tumor",pert
"4 weeks old PS-NA mice, cerebrum",pert
"brain, frontal cortex",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 75min;	race: White;	sex: Male,ctrl
Bone-Marrow_MM_M1105,pert
CD11b+Gr1+ cell sample_1 (derived from IL17RC Knock out mouse),pert
cell type: WAO9 human embryonic stem cells;	growth protocol: subjected to a hepatic differentiation protocol;	time: d15,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (29),pert
"nasopharyngeal carcinoma, specimen T29",pert
"P90_C-DGCR8 KO cones, replicate 1 [array]",pert
26 weeks male,ctrl
Eed KO BM LT-HSC,pert
3T3 cells,ctrl
"FOXP3, WT, REP2, 0h",ctrl
"Untreated, biological rep6",ctrl
whole tissue section from case 687,ctrl
5218 UC Inflamed descending colon,pert
"Lymphoblastoid cell lines derived from family 1733, member 2",ctrl
wild type control tissue  2,ctrl
R1 ES cells expressing mouse Cdx2 T2ER fusion,ctrl
agent: untreated;	time point: 0 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
strain: C57Bl/6;	genotype/variation: WT;	cell type: cDC;	cell type subset: CD11b+,ctrl
E_LS_Wk1,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
MIC2,ctrl
"control + L-Arg colon tissue, biological rep1",ctrl
siRNA Med12 + Estrogen [L1],pert
Ring1b_KD_3,pert
CML_6_MEP,pert
24B,pert
SKM WT4,ctrl
"Uninvolved Skin, NS-17",pert
age: 48;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.732;	OD280: 0.907;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 138;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
MB231 con-DMEM,pert
LNT-2,ctrl
Eed KO J1 ESCs on day 3 #2,pert
Papilloma_tumour_epithelial_cells_Sox2cKO_rep1,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 144;	time: 0;	batch: 4,pert
T81,pert
"LY2 cell line, SRC-1 scrambled untreated, biological rep4",ctrl
SV589_3DayKD_SerumStarved,pert
Control (C282),ctrl
ILD Study Number S010,ctrl
Control_2months_retina10,ctrl
wtPrE serum 2,ctrl
"lung adenocarcinoma, cell line",pert
"Gender: female, Age: 48 years, Tissue: VIN 3",pert
"213, ADIPOOSE TISSUE, After",pert
"Spleen homogenate, infected, 6 weeks",pert
liver_Q10_14M_rep2,pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: Rb KO;	age: 3-month,pert
gastrocnemius-30 months of age-control diet-biological replicate5,ctrl
agent: Chromium 10 µM,pert
RNA from microdissected breast cancer cells from case 843 labeled with Cy5,pert
Psoriatic arthritis PsA 19,pert
Rat fatty liver5,pert
age: 40;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: siDsRed;	cell line: HeLa,ctrl
patient id: 83;	tissue: Normal cortex;	gender: Female;	age: 85;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: other,pert
"A673 treated with DMSO vehicle control for 5 days, biological rep3",ctrl
sample G term homo,pert
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: valproic acid (VPA);	treatment time: 4 hours,pert
cumulus_nonPCOS_Obese_rep5,ctrl
"brain, cerebellum: KCb12w#2_e1_le1",pert
OVCAR-10+(3),pert
CD4+ cells IL1RN wild type 1 month rep2,ctrl
"TGCT cell line 2102Ep/clone 2A6, treated 3 days with retinoic acid, undifferentiated",pert
race: african american;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
Control_Time_30_2,ctrl
"Control siRNA - 2 days adipocyte differentiation, rep3",ctrl
genotype: MBD2–/–;	genetic background: Balb/c;	cell type: Regulatory T-cells CD4+CD25+,pert
"Typically Developing Control, Gracilis, Patient Replicate 6",ctrl
non-malignant FTEn_patient 11,ctrl
Backskin_Get1_e18_WT2,ctrl
quiescent ulcerative colitis,ctrl
C2C12 myotubes,ctrl
cell line: MCF7;	condition: Estrogen,ctrl
Gastrocnemius Muscle mdx PBS-Treated rep2,ctrl
Multiple Myeloma Patient 4,pert
treatment: Sirt1 siRNA Knockdown 2;	cell line: Caco-2,pert
HDAC6_1,ctrl
Donor (Sample 15),ctrl
Strain: C57BL/6;	Gender: mixed;	Age:E9;	Tissue: whole embryonic body  ,ctrl
HRas-v12 transgenic male replicate 3 late timepoint,pert
C4_CLP_wildtype_8,ctrl
human pluripotent cells,pert
Total RNA from Ph+ ALL (C57Bl6),ctrl
Postmenopausal female. Estradiol treated. Patient 28.,pert
cell type: Primary hepatocytes;	donor: 6;	agent: control;	time: 24h;	gender: Male;	age: 73 years old,ctrl
strain: 58;	Disorder: normal;	Condition: no hydrocortisone,ctrl
"brain, cochlea: [12] Sample #12_le1",ctrl
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	nmMLCK-/-,pert
5922012038_A,ctrl
Normal B cell 2,ctrl
15-0012A_Day1_39,pert
"spinal cord, ventral spinal cord: EP134/L - hSOD1(Chan)/e14-wildtype hSOD1_le2",ctrl
Muscle-AMPKgamma3-wt-12,ctrl
"219, ADIPOOSE TISSUE, Before",ctrl
GC resistant clone C7H2-R19F2 treated for 6 hours with GC,pert
RNA from whole tissue section of case 317 labeled with Cy5,pert
ACI control replicate 2,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 14 months,ctrl
Irradiated-ATM-KO Replicative2,pert
Control 4 c,ctrl
106B,ctrl
PGA_MI_nilv_48h_355,pert
MDS3,pert
Tumor from MYF-5 CRE/SSM2 mouse CC17-B,pert
HCC_20T,pert
Dilated cardiomyopathy,pert
Hippocampus from mouse Rasgrf1 knockout,pert
Animal 12,ctrl
"Patient 30, Macroscopically intact tissue",ctrl
"Cerebral Palsy, Semitendinosus, Patient Replicate 3",pert
Vehicle 12 hours_2,ctrl
LPS-PVH3_2,pert
MDA_PR_3,pert
"cirrhotic liver, vehicle treatment",ctrl
"ALL_DS, K31 012109",pert
"PMVEC isolated from mice carrying TetO7-Bmpr2-delx4, immortomouse and Rosa26-rtTA transgenes",pert
"S1P3-KO-hippocampus, biological rep1 (male)",pert
gender: Male;	age: 82;	post-mortem delay: 19.5h;	ph: 5.8,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 39.807665982204;	age of psoriasis onset: 25,pert
"LY2 cell line, SRC-1 scrambled untreated, biological rep1",ctrl
A_AN16641_C,pert
DC-8,ctrl
Healthy individual of twinpair #4,ctrl
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage _3",ctrl
"healthy control fibroblast, biological rep4",ctrl
CLL 164-02 Control,ctrl
Subject #8007-8hr Postinfection,pert
pediatric AML S34,pert
HeLa control knock down 1,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 72h",pert
shRNA2-4-noDox-rep2,pert
"Acute Myeloid Leukemia, sample 36",ctrl
Mouse_ESC_Pcl2_mismatch_control_sample 1,ctrl
VehVeh3,ctrl
"age at diagnosis: 48;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2;	er: 1;	pgr: 1;	dfs-month: 58;	dfs-event: 0;	distant metastasis: 0",pert
"treatment with MDBP, replicate 3",pert
PC-3M/NC siRNA #2,ctrl
"human failing LV myocardium, Idiopathic25",pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 93;	Usage number: 1;	Exposures: 3,ctrl
rheumatoid arthritis 121102,pert
HO_3,pert
Huh7 cells_JFH-1 Infected 48 hours_ rep2,pert
No_drug_#4870,ctrl
H5_SS11_01Nov07,pert
strain: mixed C57BL6;	genotype/variation: Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,ctrl
A VIS _B069,pert
treatment: baseline;	gender: F;	age (y): 33;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
mESC_undifferentiated_wild type_rep2,ctrl
EB_6_19d_310_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
CEPI_IIIc_588,pert
"non-AD_HI, biological rep3",ctrl
Bronchial Epithelial Cells MMA biological 2154L,pert
"liver, STZ-treated fed 0.1% quercetin diet for 14 days",pert
TTP_KO_0ActD_BioRep2,pert
ic patient 6,pert
cerebellum SNCA knockout 21 month replicate 1,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 3,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 59;	donor: 17;	disease state: Lesional,pert
B10.H2g7_S2,ctrl
Pt_5 Normal Skin,ctrl
healthy control sample x050,ctrl
"Sv129/C57B6 intercrossed hybrid strain, 12 week old male",pert
"SIRT3KO, high-fat diet, rep2",pert
Mature mice skeletal muscle sample from the hind limb,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: no,ctrl
MDS23,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 3;	psoriasis duration: 37.0;	age of psoriasis onset: 11,pert
"NALT infected with 90-226att, 24h, biological rep1",pert
sample type: HeLa-LAMP3siRNA-4d;	cell line: HeLa;	knockdown: LAMP-3 siRNA;	time: 4d interferon alpha;	treatment: interferon alpha,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID212,pert
U133A_B3,pert
GFP Zfx wt 1,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: E2;	time: 4h,pert
siDdb1 replicate2,pert
treatment: DMNQ;	cell line: CuFi;	genotype: Cystic Fibrosis deltaF508 mutation,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 24;	gender: male,ctrl
NSC_ X5050_24h_biological rep2,pert
"D425-shOTX2_3, t=96",pert
del337TR replicate 7,pert
Plate vs. Nail:  1 Day Sham,ctrl
whole splenic B-cells from adult Xid mice,pert
Transgenic 3,pert
memory HD-/- P14 T cells #2,pert
EOM 112 Day Control rep 1,ctrl
MS brain lesion (following demyelination-active inflammation),pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: P55;	clone: C32,ctrl
SZ8,pert
Lung from SM22-dnBMPR2 inducible transgenic males activated 8 weeks,pert
"Patient  J, lesion, 2 week",pert
11SAGEA2,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection;	vector: pLKO.1;	activation: 2 h 100 ng/ml TNP-BSA,ctrl
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: JAK2 knockdown (Jak2-10 shRNA),pert
CON - R22,ctrl
EA_Case14_CD4,pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P7;	clone: C16,ctrl
T1F-LU,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ,pert
pediatric AML S01,pert
Human.AI.CP.FCU,pert
Disease_status: Down syndrome;	Age (years): 61;	Gender: Female;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
MCF7 control siRNA Estradiol Rep2,ctrl
Nuclear RNA_WT_rep1,ctrl
"NPCxhIPSC SCZP, replicate 4",pert
brain_QH2_14M_rep3,pert
patient: 1;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Adult Sham; Biological replicate 3,ctrl
Subject #8045-Preinfection,ctrl
GFP1_1578G,ctrl
Huntington's disease 874F,pert
Cochleae from wild type mice at P60,ctrl
intestine_wildtype_control_rep1,ctrl
confluent HUVECs stimulated with Angiopoietin for 1 hour,pert
Patient 2 a,pert
"AD_FC, biological rep7",pert
HEK cell lines expressing mutant channel,ctrl
Total RNA from MDA-MB-231 cells infected with a lentivirus shControl,ctrl
SLE CD4 T cells 13,pert
Postmenopausal female. Tibolone treated. Patient 6.;	Replicate,pert
HP-11,pert
mouse intestine pLagl2 wild type 4,ctrl
"BMDM, IFNgamma treated, KO Vdr -/-",pert
"Normal subject (53 year old caucasian male, SAK_1288621868)",ctrl
PA-1+(3),pert
"LCL GM19238, Kd WHSC1, 72hrs",pert
Karyotype: no inv(14)(q11q32);	Age: 62 years;	Gender: male,pert
U937_naive_curcumin_4h_rep1,pert
"Acute Myeloid Leukemia, sample 39",ctrl
individual: patient1;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
Jejunum_Wild Type_3,ctrl
control siRNA (siCon) tranfected into C2C12 myoblasts rep3,ctrl
T30364,pert
34A;pretreatment;female;breast tumor,ctrl
FACS-purified B cells_IFNAR1-/-_influenza-infected_rep1,pert
"Amoxicillin treated Distal, Small Intestine 1 21 days old",pert
"WT, biological rep1",ctrl
"treatment: control;	batch: 3;	donor: 29;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
"Lesion Skin, LS-24",pert
HeLa_01-04-05 TP6_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
strain: C57BL/6;	genotype: Klhl40 knock out;	age: 0 days;	tissue: muscle;	muscle type: Quadriceps,pert
ME180 DMSO rep 2,ctrl
Mouse old heart C30-Ht-3,ctrl
NFIA P16WT1,ctrl
control-control rep 3,ctrl
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 4,pert
Placenta_nl1 with Cy5,ctrl
GEIM176-U133A-Norm,ctrl
Muscle control 13,ctrl
"spinal cord, ventral spinal cord: EP143/L - G93R(Roth)/e14-mutant hSOD1_le2",pert
"C2C12 Myotubes treated with Palmitate, rep2",pert
cell line: HCT116;	shRNA: CDK8;	treatment: untreated,pert
"granulocyte, healthy control, biological rep11",ctrl
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, Harlan Teklad TD03045 diet, liver",pert
Patient: G;	Time: 0;	Group: responder;	Condition: lesional,ctrl
reference: whole mouse total RNA,pert
cervical spinal cord,pert
"10 days old prosaposin knockout mice, cerebrum",pert
"brain, hippocampus: PH5_e1_le1",pert
WT-sham-5 month-R4,ctrl
SKI-DLCL cells treated with Aplidin (3nM) for 24h. Total RNA was extracted.,pert
testis wild type replicate3,ctrl
"t20, surgically resected from patient of gastric cancer.",pert
EP18_adipose_pcos,pert
"3 uM EPZ004777 treated, DAY 6, biological rep.3, MV4-11 cells",pert
PGA_MI_nilv_4h_389,pert
cell type: peripheral blood mononuclear cells;	disease state: multiple sclerosis,pert
"Neurod1 KO, 129 mouse pineal glands from postnatal day zero.",pert
"LCL GM19238, Kd CREBBP, 72hrs",pert
"Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:18h",pert
"BOEC, not_at_risk 4",pert
CML_4_MEP,pert
Skin biopsy from upper nates taken 96 hours after exposure to 5% nickel sulfate,ctrl
GB 1 63A +LPA,pert
Healthy-7 baseline,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK1-3,pert
AT2 E/R positive leukemia cell line,pert
scan batch: Batch 2;	group: autism;	subject age: 14;	paternal age: 30;	maternal age: 32,pert
Bone marrow CD34+ cells,ctrl
WT_d00_e0_vs_WT_d21_e9,ctrl
NFIA E18KO3,pert
Healthy10-CD4,ctrl
MKK7D control female replicate 1 early timepoint,pert
"breast tumor epithelium,42",pert
PGA-HMO-MObese-5aUA-s2,pert
DU145/NC siRNA,ctrl
ctrl_507,ctrl
nmMLCK-/- -VILI replicate 3,pert
wild type mammary stroma,ctrl
M249_R4_B_DMSO,ctrl
01UMY_PolyRF-,pert
U937_naive_curcumin_18h_rep2,pert
3DKD_SerumStarved->1hrEGF_rep3,pert
Gender: Male;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: YES,pert
WT_PMΦ_rep2,ctrl
fully differentiated (day 6) myotubes,pert
"fibroblast, MFS subject 60FR rep 1",pert
3749-lcm,pert
tissue: skin;	individual: Patient P3;	condition: ANL;	eczema severity: SCORAD: 0,pert
Control Colon 1 21 days old,ctrl
RV64.09_CHF_day25_Slide40,pert
Parkinson's disease sample x014,pert
15d Dicer cKO_Pool 12,pert
U87-20.1,pert
"Patient I-c406T, MSI colorectal tumor",pert
"Pten null epithelials cells, biological rep4",pert
Thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age; RNA was pooled before synthesis of cDNA,pert
siCtrlVeh24h_3490,ctrl
Th17 cells,ctrl
Cutaneous psoriasis without arthritis PsC 5,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: n/a;	maternal age: 27,pert
non-malignant FTEn_patient 1,ctrl
"mouse aorta cross strain comparison, C3H_T00_NC_02",ctrl
MDS27,pert
A549 RNA Static Control 4hr Jan 31 2003,ctrl
LSK cells from wild type mouse rep1,ctrl
ABH4,ctrl
"WT BM LT-HSC, biological rep2",ctrl
129S1/SvImJTCE liver sample batch 3,pert
Sodium arsenite added to food: None; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: None,ctrl
"Patient 6, Macroscopically intact tissue",ctrl
cell line: HEK293T;	transfection: si-TNIK;	induction agent: Wnt3A;	induction time: 7 hours,pert
"alveolar macrophages, smoker 033",pert
Bronchial Epithelial Cells SA biological 1970K,pert
Diabetic untreated rats 2,pert
"N-56, NORM, M, GSF, 1 x ETOH, 24h",ctrl
Snell 6 month Wild Type Liver 82c,ctrl
tissue: Biceps muscle;	patient: C.b.7;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y 3m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
"fatty (fa/fa), liver, Rosiglitazone",pert
B_LS_Wk2,pert
GV oocyte_Ring1 mut_rep3,pert
Bone-Marrow_SMM_S1495,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 5,ctrl
HL-60 cell line infected with scrambled control shRNA,pert
Liver-24 month-Myc heterozygous-technical replicate 2,pert
muscle_Akt1+/-_35wk_rep4,pert
cell type: Immortalized lung epithelial cells,ctrl
B7n,ctrl
heart tissue,pert
"bipolar disorder, BA10-49",pert
PGA-RMM-1h-3aA-s2,pert
healthy control sample x171,ctrl
Yolk sac tumor 0307,pert
STHdhQ7/Q7-A,ctrl
Patient 7,ctrl
MKO_rep_3,pert
Human peripheral blood mononuclear cells,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 55,ctrl
12h_RA1,pert
batch: A;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,pert
"wild-type control (littermates) of ""P32_exPKO_pancreas""; mixed genetic background; postnatal day 32; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.",ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-tu2,pert
H5_SS9_01Nov07,pert
Transgenic 2,pert
nTreg cells Foxo1KO,pert
trained wt,ctrl
Gata3 overexpression line,ctrl
Nrl ko P2 replicate 1,pert
Rb Mouse spleen Ter19+CD71high sorted cells,pert
"seminoma specimen, pT3, patient age: 48y; W00 023",pert
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticle",pert
sex: Male;	family: 4;	age: 12;	disease status: Affected;	tissue: Muscle: Biceps,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with vehicle for 6h,pert
SLE3,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
"Control siRNA - 5 days adipocyte differentiation, rep3",ctrl
EDL-n7-2; normal extensor digitorum longus 7 month,ctrl
Naive (control) #3,ctrl
Plate vs. Nail:  1 Day Plate,pert
RO36,pert
KO 1 Quadriceps,pert
brain_DLPFC_bipolar C_mr871,ctrl
WT-Fibr1 7,ctrl
"brain, frontal cortex: Sample45_e1_le1",pert
ESE_D_489,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 54 yr;	population: white;	dsm-iv: 296.89;	age of onset: 45 yr,pert
Tak1_1,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: LPA,pert
agent: ConA;	time point: 3 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"patient 042b, cancer, homogenized",pert
118B,ctrl
Prostate,pert
cell line: SCC25;	tissue: tongue;	cell type: epidermal keratinocyte;	treatment: doxorubicin,pert
Differentiation of hES cells line SA01 towards neural rosettes;	Neural precursor phenotype,ctrl
MRL/MpJ heart left ventrical (LAD ligation 3 day),pert
Parkinson's disease sample x110,pert
11_0009C_Day1_22,ctrl
Ileum_POR-null+quercetin_1,pert
siRNA Med12 + Estrogen [L2],pert
"Immortalized MEFs WB, v-src expression retroviral vector infected, rep3",pert
ubb_d21_wt_2,ctrl
"Pancreatic islets, control, 02",ctrl
Strain: C57BL/6 wildtype;	P7,ctrl
"alveolar macrophages, non-smoker 003",ctrl
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Rosiglitazone,pert
NPC22,pert
liver_male wt_rep3,ctrl
colon_C57 mouse_12weeks_rep5,ctrl
CD34+ cells with fenretinide treatment from CML32,ctrl
cell line: DAOY;	cell type: medulloblastoma;	genetic modification: none (wildtype),ctrl
NSCLC cell line H157. Transfected with scrambeled control non-targetting oligomer siRNA - #1,ctrl
47A;pretreatment;female;breast tumor; responder,ctrl
"Animal id 543, left retina, 8 months, female, DBA/2J",pert
HT29 resistant cells replicate 2,ctrl
Dengue Fever Patient 54,pert
ATF2 WT-2,ctrl
tissue: Pancreas;	cell line: Panc-1;	treatment group: TGFβ Treated 48 hr,pert
Severe rep8 (retina),pert
KU_30T,pert
A_AN16115_C,pert
Control mouse 1,ctrl
Control ppar_beta_floxed_rep1,ctrl
Tia-1 122973 cerebellum 3 month,pert
patient: 1;	disease state: hypertension;	tissue: Atheroma plaque,pert
MF-45,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 9.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 34;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
MEF E2F4 KO 3-rep1,pert
Choriocarcinoma,pert
"skin, no treatment",ctrl
Monocyte derived dendritic cells,ctrl
M_LS_Wk1,pert
"vector control cells, biological rep2",ctrl
CD positive WT T cell unstimulated rep3,ctrl
KU_48T,pert
ANL Chip#44,pert
WT / Reference_13425676,ctrl
Native ko biological replicate 2,pert
reduction mammoplasty patient 350,ctrl
"fatty (fa/fa), skeletal muscle (gastrocnemius), Pioglitazone",pert
N30277,ctrl
ADH2,ctrl
PBMCs_Control_19 [IS],ctrl
MDS patient 54,pert
AZ-521_doxycycline_24h_rep3,pert
Reference RNA e17.5 embryo,pert
"breast, pre AF treatment (H12_1628)",ctrl
age_years: 32;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
Individual_4093_PN_sample,pert
Diabetes 1a,pert
G_Ctrl_3,ctrl
Control_liver_5,ctrl
shCON2,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (1)",pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; 1h EGF,pert
cell line: MCF7;	treatment: control,ctrl
liver; fasted 18h,ctrl
Normal PBMC Sample 6,ctrl
Normal cortex of patient 260,ctrl
neuron_rep13,pert
M16 - infected MBT/Pas fibroblasts (9 h post inf),pert
"DMSO-treated NRK-52E cells at 24h, biological rep 2",ctrl
DS-Fibr 4,pert
"AG825-treated, 24h after UV, Replicate C",pert
Sex: female;	Age at operation: 67 years;	Site: thigh;	Size in cm: 35x15x12;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Heart sample6,ctrl
JIA PBMC Post treatment A235_L003(2),pert
1N,ctrl
"TMD_SOL, T5",pert
V5-P259,pert
T7C-LU,pert
"bipolar disorder, BA10-31",pert
Gastrocnemius Muscle_Cmah KO_mdx_rep2,pert
LIVER_diclofenac_repl4,pert
D2-Gpnmb+ control rep2 (retina),ctrl
"acutely admitted, severely psychotic schizophrenia patient  A10",pert
"A673 treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50), biological rep3",pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: DMSO (control);	dose: n/a;	time: 3 hr,ctrl
Patient: K;	Time: 0;	Group: responder;	Condition: lesional,ctrl
MDS5,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
Whole body,pert
"lymphoblastoid cell line from R, one out of seven of sensitive group, 50*10e6 cells",ctrl
PPAR KO_ctr_118,pert
WFS1 KO USHT_01_337_wt,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 96 hrs,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Epithelial Cell,ctrl
3879-1 E2F WT,ctrl
GEIM197-PM,pert
H1993 shRNA Control _1,ctrl
"PCB153 treated HepG2 cells at T18, biological replicate 3",pert
chip number: 21;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
colon_normal_1456,ctrl
CD4DecTp2-13,pert
V5-P281,pert
CKO V4,pert
bone marrow macrophages from 1 female and 2 male wild type Balb/c mice,ctrl
Muscle Tro2,pert
Human CD34+ cord blood cells expressing the empty MIG control vector,ctrl
"brain, hippocampus: KA1-III_e1_le1",pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: E2f8 KO;	age: 3-month,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 39;	age of psoriasis onset: 7,pert
Liver_untreated_HESKOL_rep3,pert
"WT BM LT-HSC, biological rep3",ctrl
wild type proximal tubules of mouse kidney,ctrl
01LLX_CTRL,ctrl
3T3-L1 Day 0 (passage 19) 24h after siControl transfection,ctrl
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit and Sca1 (LSK) positive expressing bone marrow progenitors",pert
age: 15;	sex: M;	disease status: control subject;	Filter number: 82;	Usage number: 1;	Exposures: 3,ctrl
"E18.5 brain, wild-type, rep 2",ctrl
HCC_11T,pert
mouse cerebellum at P30 wild type 1,pert
control participant P335,ctrl
VIN_B040,pert
Balb/c WT_3,ctrl
n9t30m,pert
aneurysmal tissue: sample #1,pert
Discoid Lupus-L9,pert
SBVGA1 3,pert
brain_DLPFC_bipolar C_mr532,ctrl
Cpr-lox_pool 2,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 24 hour",ctrl
S/SM4,pert
VMH of WT-2 mice,ctrl
AA_SLE_CD8,pert
"Gender: Female, Age: 28, BMI: 34, Tissue: luteinized cumulus cells",ctrl
Human Non-progressor HIV Sample L004-CD8+ T cells,pert
"Pineal gland from control mouse at ZT6, biological rep 2",ctrl
TGFBeta Transcriptome Profiling,pert
BALB_Male_CF_rep2,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 1;	gender: male,pert
ATF2 Genotype: WT,ctrl
brain knock out replicate3,pert
sample =XCGD4 treatment=Stimulated time=360 (min),pert
Panc-1 TGFβ Treated 3 48 hr,pert
Septic shock;	gender: Male;	Survivor;	organism: None;	organism class: None,pert
29SAGEA,pert
"Patient G, uninvolved skin",ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 8.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 47;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
21GOBMUC2H,ctrl
"array 22, xenograft, abiraterone 75 mg/kg/d",pert
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
"Mouse, WT, colon, DSS, rep1",ctrl
Vit-KO,pert
ct-1,ctrl
"Kidney, AGTR1A-KO mice, control",pert
19SAGEA2,pert
original diagnosis: PolyRF-;	cell type: Peripheral blood mononuclear cells,pert
cumulus_nonPCOS_Lean_rep3,ctrl
age: 49;	sex: M;	disease status: Marfan subject;	Filter number: 92;	Usage number: 5;	Exposures: 3,pert
NS5-040401-SA,ctrl
"heart, QH2, 14 months",pert
Genetic background: mixed 129 and C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow; Non-fasted; Genetic modification: Scd1 -/-.,pert
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: DMEM,ctrl
Gastrocnemius Muscle_Cmah KO_rep1,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 63,ctrl
RE550_H1650_un2,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_4mM_HG-U133A_2_YCHSUP501,pert
strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue: gallbladder,ctrl
Isolated PBMCs from diabetic male patient_Grape extract group_6 months,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 35;	sex: M,ctrl
PGA-RMM-72h-2aA-s2,pert
treatment: shVEGFR-2;	cell line: U138MG,pert
Control Endometrium Stromal Cell_029.UC208-+,ctrl
WT fed  regular chow,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient B;	treatment: DMSO for 48h,ctrl
aa_NY218,pert
"RWPE-PCAT1 cMyc siRNA #3, replicate 2",pert
siRNA Control Duplicate 2,ctrl
PLT-n7-2; normal plantaris 7 month,ctrl
RNA from HCC_26T,pert
SNRK_2,pert
E16.5 top2b-/- brain,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: knockdown control,ctrl
"SRC-2 null mouse, liver",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 95min;	race: White;	sex: Female,ctrl
db/m 3-1,ctrl
MDS patient 68,pert
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
MBD2_2,pert
mdx TA sample 2,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 24 hr,ctrl
Wildtype H9 hESC derived NSC 2,ctrl
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
Surgical sample,ctrl
FR-si222-2,pert
"twin pair: #3;	individual: diseased individual, inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",pert
PancreaticSample13-Tumor,pert
phenotype: control;	gender: male;	case_id: 211;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 29;	brain ph at time of freezing: 6.68;	labeling_batch: 2,ctrl
WT - Cre Control - 3 mo - repeat 1 - Cy3 - mAdbID:74587,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_24_25_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
U937_ROS_untreated_4h_rep1,ctrl
tissue: white blood cells;	age: 12;	Sex: male,ctrl
No or early 2 rep4 (retina),pert
miR122-KO-91,pert
tissue: Peripheral blood;	disease status: patient without recurrent events,pert
"DMD skeletal muscle, biological rep16",pert
age: 7 weeks old;	strain: C57Bl/6;	phenotype markers: CD4+ Foxp3+ CD25+;	separation method: FACSAria;	Sex: Female,pert
A3243G-MELAS subject 4,pert
BL Ramos cell line,pert
512MM,pert
El-Ashry 005.CEL,pert
Whole testis RNA from Crem-/- mouse #76 at 0h,pert
P3,pert
Control5,ctrl
mammary stoma-4w-wt-rep1,ctrl
scpk/ikLL/192,pert
NB4 CONTROL 3,ctrl
Sex: female;	Age: 12;	SL: 5.31;	House: 6;	Severity: SM;	Ashworth: 3;	Zancolli: 2A;	PEFF: 85;	PESF: 85;	AEFF: 55,pert
Subject 8_t=30days_resveratrol,pert
gender: male;	strain: SV129;	tissue: heart;	genotype: PKCZ -/-;	age: 32 weeks,ctrl
A61 WT2	F6/21	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
01LNH: normal control,ctrl
CLL11-CD8,pert
HeLa-Ctrl-siRNA-4d,ctrl
liver_control_diet_rep1,ctrl
V5-P421,pert
SZ21,pert
"BMMs, untreated control, ko, Replicate 1",pert
"brain, adrenal medulla: Sample#A3 (Exp pt 3)_e1_le1",pert
Squamous cell lung cancer patient 33,pert
Liver of pup from control group rep6,ctrl
Pool Eu_P30,ctrl
wild-type anterior prostate 3,ctrl
"Hdh knock-out embryonic stem cells, biological replicate 6",pert
"Affymetrix chip HG-U133A, siPTHrP 1",pert
tMLL06,ctrl
"sebocyte cell line, SV-40 immortalized, 13-cis retinoic acid treated",pert
ccRCC tumor of patient 233,pert
PDAC_T_138,pert
11436 UC Inflamed descending colon,pert
"Healthy volunteer, Control_11690",ctrl
human_LIMA_artery_patient2_control,ctrl
CME-Emerin4d-1MA-S2,pert
HNF4 Null_1195,pert
patient: 40975;	sample: normal,ctrl
LY2 SRC1-siRNA untreated rep3,ctrl
sample =Healthy3 treatment=Stimulated time=180 (min),ctrl
"patient: 212;	current medication: Pred 10mg, AZA150mg, ADCAL D3;	birth date: 8/3/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/97;	diagnosis date: 9/1/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/9/04;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 0;	igr2198: 11;	igr2230: 12;	octn1: 11;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/9/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
"brain, hippocampus: C1-III_e1_le1",ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 30;	gender: male,ctrl
"Dicer lox/lox control, biological rep1",ctrl
Cervical cancer_98-04T,pert
FGF21KO.DMSO_4,pert
Healthy1-CD4,ctrl
PGA-RMM-Ctr-1aA-s2,ctrl
GAS-t10; transgenic gastrocnemus 10 month,pert
ACC 3 cell line Sox4-RNAi replicate 1,pert
PGA-HMO-MObese-2aUA-s2a,pert
"Wt mouse, cerebellum, old, nicotinamide riboside treatment",pert
skin.wt.replicate29,ctrl
strain: C57BL/6;	tissue: Skin;	cell type: keratinocyte;	gender: female;	age: E18.5;	genotype/variation: Ovol1 KO;	treatment: calcium,pert
WT mouse 3_heart_basal,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated",ctrl
NS1,ctrl
"mouse strain: C57B/SV129;	genotype: Nrf2 wt;	tissue: mouse liver, 10 weeks",pert
patient3,pert
CLL4-CD4,pert
"Liver from Nrf2 k.o. mice, biological replicate 3",ctrl
"Crohn's Disease subject (33 year old caucasian male, SAK_1280753352)",pert
uterus_veh_WT_40hrs_rep1,ctrl
Ifng-/- biological rep 1,pert
Tia-1 122970 cerebellum 3 month,pert
2008 cells_rep3,ctrl
KM_009T,pert
FVB_skin_5dpn_1,ctrl
Supraoptic nucleus_3d dehydrated,pert
wt testis at 17dpp,ctrl
monolayer chondrocytes from OA donor 1,pert
TOV112D cells_untreated_biological rep2,ctrl
Subject #8034-8hr Postinfection,pert
cell line: HL-60;	shRNA construct: GSK3A Construct 6,ctrl
"Lesion Skin, LS-3",pert
"array 26, xenograft, corn oil vehicle",pert
t04,pert
2091N,ctrl
Rybp#10 (OHT+)_4d,pert
Cardiac Progenitor WT3,ctrl
GEIM80-PM,pert
CUTLL1 MigR1 GSIwash4h,pert
Substantia nigra normal rep4,ctrl
Oral Squamous Cell Epithelium Tissue,ctrl
M473 SKM-Tg,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 3;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case1,ctrl
"Retina from NeuroD1 cKO mouse at ZT6, biological rep 1",pert
EBS_1,pert
Brain from 25 days Npc1+/+ mouse1,ctrl
"SKI-DLCL cells untreated, cultured for 24h, total RNA was isolated using RNeasy kit",ctrl
MDS2,pert
"age at diagnosis: 71;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1c;	er: 1;	pgr: 1;	dfs-month: 36;	dfs-event: 0;	distant metastasis: 0",pert
10 days TAC-2,pert
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-4,pert
"N-33, NORM, M, GSF, 6 x ETOH, 14d",ctrl
Nonirradiated-ATM-KO Replicative2,pert
ndf control 2,ctrl
"WT in the presence of tetracycline, rep2",ctrl
BS2011051059,ctrl
"Gender: female, Age: 54 years, Tissue: normal vulva,",ctrl
Jurkat cell line,pert
EB_400_6_365_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 1",pert
ccRCC tumor of patient T22,ctrl
Tolerizing allografts 7 days No.1,ctrl
"NRVM, Fibronectin-coated plates",pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 1,ctrl
WT-smoke-med-1 day-R3,ctrl
APLP2_R1_rep3,pert
"patient 006b, normal, homogenized",ctrl
"G42 cells from M1, Mecp2 null, biological replicate 2",pert
STAT3-deficient naïve T cells stimulated for 3 hours with medium alone 2,pert
"brain, Entorhinal Cortex: 96-31 normal_e1_le1",ctrl
whole tissue section from case 763,ctrl
Donor3_24h_DMSO,ctrl
Human LRRK2 (G2019S) homozygous patient fibroblast,pert
@52055800697862121408403718160409,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 44 yr;	population: white;	dsm-iv: 296.74;	age of onset: 26 yr,pert
OA 1,pert
"H69 tumor untreated, biological rep1",ctrl
patient: 257;	current medication: 6MP 50mg;	birth date: 5/16/64;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 2/1/05;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"KM-H2 PTPN1 Knockdown, technical rep1",pert
"amnion mesenchymal cells, 1h interleukin-1-beta, biological rep2",pert
colon_epithelium_IL10mouse_12weeks_rep2,pert
No_abuse_6,ctrl
Left ventricle,ctrl
Shn2_Wildtype_1,ctrl
Atrioventricular canal,pert
adult male,pert
Z138-shControl,ctrl
"wild-type control (littermate) of ""P16_exPKO_pancreas""; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #1.",ctrl
Kidney_saline_1,ctrl
"D425-shOTX2_1, t=0",pert
array 2 plus E,ctrl
1119-03-A,pert
Strain: C57BL/6;	Gender: female;	Age: 110 days;	Tissue: mammary tumor;	Days after tumor onset: 14 days,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
ErbB2  3,pert
disease state: paediatric glioblastoma;	age: 7;	gender: F;	h3.3_status: wt,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ and Rosiglitazone,pert
THRA aI mutant + vehicle replicate 2,pert
PBMC sample from hepatocellular carcinoma patient,pert
Untreated Control 12weeks AffyGC RMA rep2,ctrl
ku86(wt)_Terc(wt)_1,ctrl
LPS-PVH3_1,pert
Vehicle-Control;	Vehicle-Control 24 hours set 2,ctrl
BM_02347,ctrl
Clozapine treated 12weeks AffyGC RMA rep3,pert
Kidney_saline_2,ctrl
PBMCs_IS_20 [IS],pert
array 9 minus E,pert
GIST Pre Treatment Biopsy 45,ctrl
PancreaticSample53-Normal,ctrl
Control with WY14643 replicate 5,pert
Globin_S4,pert
Strain: NMRI mouse;	Age: 14 day embryo;	Tissue: molar tooth germ,ctrl
2 Ctrl 2,ctrl
14 olanzapine,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14474;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
PBMC from T cell LGL leukemia patient #104 (TLGL104),pert
Patient: E;	Time: 0;	Group: responder;	Condition: lesional,ctrl
chip number: 23;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.53;	rin: 9.8;	transfection date: 2011-10-17,pert
AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 2,pert
"S1P3-KO-neocortex, biological rep4 (female)",pert
CON26,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 16",pert
healthy control sample x182,ctrl
SHR16-2,pert
ANL Chip#42,pert
AGS control biological rep 1,ctrl
Brown Norway DPA-Treated Liver,pert
kidney_Q10_14M_rep3,pert
cell line: Embryonic kidney cell line HEK;	genotype/variation: WT channel;	agent: tetracycline,ctrl
Nuclear RNA_KO_rep3,pert
"DHL4, R406, 2h",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 63 yr;	population: white;	dsm-iv: 296.89;	age of onset: 43 yr,pert
brain_DLPFC_bipolar B_mr946,pert
E14.5 fetal liver TER119+ wildtype,ctrl
genotype/variation: ACTL6a knock down,pert
ILD Study Number S032,ctrl
HP-87,pert
"RNF40 siRNA - 5 days adipocyte differentiation, rep2",pert
"CBFb-SMMHC animal 2, replicate 2",ctrl
"MTDH knockdown, biological replicate 2",pert
"AALE-Vector + shTBK1, biological rep3",pert
siRNA Med12 [K2],pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_24_40_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Sample ID:DCBD2.1;	Twin Pair ID:TP7 ;	Clinical Status:BD1 with psychotic features ;	Age of Onset:19 ;	Age at interview & blood sampling:20 ;	Current Age (2007):24;	Sex: Male ;	Medication at interview (duration) :lithium & olanzapine (64 weeks),pert
Control + LPS 1,ctrl
D425,ctrl
"differentiated U937 cells, ROS exposed, 1uM curcumin treated, 18h",pert
MZ1774 mock rep 3,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 5 months;	genotype: Wild type,ctrl
HeyA8+(3),pert
"cultured human airway smooth muscle, 24 hour dex treatment, replicate 1",pert
Dengue Fever Patient 41,pert
"Ring1B deficient ES cells, biological replicate 1",pert
cell line: COLO829 melanoma cell line;	genotype/variation: control;	agent: control,ctrl
RatLung_H48h_2,pert
"KO liver, biological rep1",pert
subject: 15A;	cohort: 15;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 28kb;	age (y): 66;	Sex: M;	batch: Batch_5,pert
"Patient 4, Atheroma plaque",pert
HeLa_06_21_04 TP-9,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_5;	fev1 (% predicted): 44;	fvc (% predicted): 61;	medication: Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn;	cell type: CD4+ T-cells",pert
"brain, hippocampus: Aldh5a1-/- #3403 Cort_e1_le1",pert
11393 Normal Uninflamed ascending colon,ctrl
"suprarenal aorta, aneurysm, Ang II treated 14d",pert
cell type: prostate cancer cell;	cell line: LNCaP;	transfection: empty vector,ctrl
Sham 4,ctrl
"brain, cerebellum: RNA#11*_le1",ctrl
healthy control sample x177,ctrl
BxPC3-KO111 rep 4,pert
EE_IC_3_cauc_lcm,pert
WT-control-5,ctrl
Healthy control_sample13,ctrl
"Crohn 05, CD05",pert
microdissected epithelial cells from normal main pancreatic duct 3,ctrl
rat distal colon,ctrl
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: none;	disease: atherosclerosis;	age: 32-34 weeks,ctrl
Ad-rep3,pert
INS-1,ctrl
pediatric AML S33,pert
1834 cells with Tet1-expression,pert
normal liver,ctrl
GM19238_Kd_BATF_1,pert
RNA prepared from fibroblast cell lines treated with 10% serum for 90 min followed by 0.5 µg/ml actinomycin D for 60 minutes,pert
mdx diaphragm sample 2,pert
PS_IA_2_aa_lcm,pert
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",ctrl
Fetal heart control 7,ctrl
genotype variation: Nrf+/+;	treatment: air;	developmental stage: neonate,ctrl
P60_TR_1,pert
NPC16,pert
"ALL_DS, K15 011509",pert
"H69 tumor post-PDT, biological rep3",pert
WT1-null mouse embryonic fibroblasts,pert
"39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
n11t0h,pert
"SRF silenced, treated with EtOH, biological rep 1",pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: matched to N16,pert
sample description: pool of total RNA from 10 human cell lines,pert
Conditional Sample 2,ctrl
Ls174T-pTER-β-catenin con2,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 8week,ctrl
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor Low CD34 positive expressing bone marrow progenitors CMP",pert
KM_065N,ctrl
E10.5 embryo yolk sacs,ctrl
"liver, untreated",ctrl
normal adjacent esophageal tissue from patient E1709,ctrl
"Rat pups treated with saline, sciatic nerve",ctrl
Cre_day_5-5,pert
liver_SHP-/-,pert
whole blood_101074,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-sp1,ctrl
Mouse Retina at P7,ctrl
AA_Case4_CD8,pert
"siPRMT1 neuron, biological rep2",pert
#2,ctrl
S034_Scz_F_70,pert
ErbB3 DOX-KO,ctrl
"Patient 113, baseline",ctrl
RNA from microdissected breast cancer cells from case 655 labeled with Cy5,ctrl
spleens from mice on C57/Bl6 x 129 Sv background,ctrl
C_Ctrl_3,ctrl
patient E2644,pert
"fibroblast, MFS subject GDO32 rep 1",pert
435_CreER: mutant mouse 2,pert
Embryonal carcinoma 1838,pert
"Cervical cancer cell line, HeLa, adenocarcinoma",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 30.888;	Ratio: 2.10,pert
patient code: 117;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,ctrl
Intestine_Ctrl_biological rep3,ctrl
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: PMA,ctrl
tissue type: Lesional skin;	time: Week12_etanercept,pert
age	69;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	8.2;	leukocyte count (/nl)	9;	hemoglobin (g/dl)	14.3;	platelet count (/nl)	283,pert
"patient 13, right arm treated with pimecrolimus until day 22",pert
monocytes_T14_rep1,pert
KO MEF 1,pert
Subject 2_t=30days_placebo,ctrl
Control ppar_beta_floxed_rep2,ctrl
Sample M548,ctrl
NESG1-overexpressed 2F4-5-8F NPC cells rep2,pert
"Mouse heart, IDH2 R140Q mutant, replicate 2",pert
ES_Suz12KO_rep1,pert
Dot1l -/- day 5 after transduction with cre,pert
hematopoietic stem cells transduced with Cre,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 65 years,ctrl
Septic shock;	gender: Female;	Non survivor;	organism: Staph aureus,pert
Control Day0 (425L),ctrl
5871841165_F,pert
HeLa cells transfected with siSp1 rep 2,pert
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 4",pert
MCF7_siRNA_ESR1_24h_AM0009_9.1,pert
Gsk-3b-/- ESCs Rep3,pert
Grhl2 downregulation in MLE 15 cells 2,pert
ES2 NT-4 25nM,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 8d ID65,ctrl
"GM9023, unaffected brother",ctrl
HL60_shSYK_1_Replicate1,pert
Patient: F;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
"Peripheral blood, patient without recurrent events [N37]",pert
E14 cells_control RNAi,ctrl
Mut_P_1,pert
strain: C57BL/6;	cell type: MACS-purified mature B cells;	genotype: irf4-/-,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 30.0411,pert
Cervical cancer_CC128,pert
renal tissue from Nrf2 KO mice,pert
X50 NLS 18Q TG2	F2/35	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
Mammary Gland_Cav-3KO_rep3,pert
major HCC7,ctrl
U2OS_siHic5_2_0h,pert
SLE CD19 B cells 8,pert
pt. HCL C treated with Vemurafenib 1000 nM for 72h,pert
tissue: heart;	genotype: WT;	genetic background: C57BL/6,ctrl
Syngen,ctrl
ILD Study Number S031,ctrl
IRS-2 KO (jos0698),pert
heterozygot FH P276 (human CD3 positive T cells),pert
"Mouse heart, control, replicate 2",ctrl
UC-55-Aff,pert
AA_Case17_CD8,pert
Individual_3937_PP_sample,pert
H11_S_B2,pert
Subtype: RARS;	Karyotype: other,pert
01LL3_ERA,pert
GM19238_Kd_HCST_2,pert
"liver, genetic control, Nrf2(+/+)",ctrl
P0 - lis1ko/+ Mix 3,pert
V5-P374,pert
control participant P328wh (human CD3 positive T cells),ctrl
GM19238_Kd_ESRRA_1,pert
Transfection Reagent Only Technical Replicate 1,ctrl
Bronchial Epithelial Cells SA biological 2177X,pert
MacularDegen-injured-7cAv2-s2,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: naïve,ctrl
ANL Chip#46,pert
"T1.5 fetal heart (treated on gd1.45 via oral gavage, collected on gd17.5)",pert
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 2",pert
H1299 AZA 1 uM (3230),pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.39726,pert
colon_IBD_1060,pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 23;	maternal age: 24,pert
Flexor carpi ulnaris from cerebral palsy patient,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,pert
HeLa cells transduced LKO control lentivirus.,ctrl
"p38alpha knock out fetal liver E15.5, biological rep1",pert
Strain: C57BL/6 wildtype P7,ctrl
Brain CD8 T cells that are IL-10- rep3,pert
Wild-type mice following nicotine-induced seizures,pert
"acutely admitted, severely psychotic schizophrenia patient  A15",pert
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro technologies;	Cause of Death: Hypoxia;	Tobacco Use: None,ctrl
HF0295_U133P2,ctrl
"AD_TC, biological rep1",pert
Genotype: MMTV-c-myc/Hunk WT; Gender: Female; Tissue: Mammary gland tumors; Strain: FVB,ctrl
"A673 treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50), biological rep2",pert
strain: C57BL6/J;	genotype/variation: wildtype;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,ctrl
"IRF6 wt, biological rep2",ctrl
SEB-1 treated biological replicate 3,pert
DS-Fibr 1,pert
Tendon_lesional_rep8,pert
Vehicle 24 hours_3,ctrl
"p53-, rep1",pert
Human Umbilical Vein Endothelial Cells (HUVEC),ctrl
DNMT1-1,pert
SynovAcAr_022HACJ0_151.txt,pert
patient code: 138;	gender: Male;	age: 50;	tumor grade: 2;	t-stage: 2;	n-stage: 1;	ajcc classif. (2002): 2b,pert
"breast tumor epithelium,4",pert
Female - caucasian - N-06-G,ctrl
wild type,ctrl
pooled reference mRNA from 4 harvests of MCF-7 cells,ctrl
3T3F442A-shTRPV4-rep1,pert
NIH3T3,ctrl
RNA from whole tissue section of case 829 labeled with Cy5,ctrl
Bulun 3-3h-,ctrl
DU145_NCsh_rep2,ctrl
Dysf +/+ control mouse muscle,ctrl
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep4,ctrl
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Vehicle-Control 36 hours set 2,ctrl
Run5.aUa.010110d.SkmDbt1959D.CEL-DB basal,ctrl
Supraoptic nucleus_1d Dehydrated,pert
Bone-Marrow_MGUS_G1720,pert
untreated AML 13 blasts,ctrl
human skeletal muscle from insulin sensitive individuals after insulin therapy,pert
control MLL_00118,ctrl
3987-1 E2F1 Null,pert
Macrophages obtained from a contralateral lung segment challenged with saline,ctrl
"human failing LV myocardium, Ischemic28",pert
"23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
05_ADL,pert
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 1,pert
REH_shG1_rep3,pert
Cy5 labeled Liver RNA,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: Wy14643;	time: 24h;	gender: Male;	age: 2 months,pert
Liver-24 month-Myc heterozygous-technical replicate 1,pert
Ad infected murine liver-MO30k-(465)-6 hpi,pert
tissue: brain;	genotype: mutant Ndel ko/+;	age: P14,pert
chip number: 17;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.67;	rin: 8.7;	transfection date: 2011-10-17,pert
"Spi-21, biological rep 7",pert
WT kidney pool 2,ctrl
"skin fibroblasts, passages #3 and 5",pert
NPC21,pert
Healthy donor_biological replicate6,ctrl
cell line: SV589;	knockdown (days): 15;	treatment: no treatment,ctrl
"BOEC, not_at_risk 7",pert
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case5,ctrl
hNHEPS human hepatocytes not exposed to VX at 6 h,ctrl
normal B lymphocytes (NBL 531),ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 1;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
RKO_rep_5,pert
KO - knock-out Treated - 2 hrs - repeat 1 - Cy3 - mAdbID:62610,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: B,pert
con_B132,ctrl
"B cells, wild type, unstimulated",ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Knockout 1,pert
"Control 1, biological rep3",ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep6",ctrl
"brain, motor cortex, fast spiking interneurons, Mecp2 null",pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shSYK_1,pert
Human Chronic HIV Sample C138-CD8+ T cells,pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 8",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 216,pert
"frontal cortex, schizophrenia",pert
ApoE-/- mouse infected with a control adenovirus expressing GFP,ctrl
56 Day Mouse extraocular muscle,pert
Healthy control_sample15,ctrl
wild-type male mice non-treated,ctrl
wild type MEF time 0 replicate 2,ctrl
WT 2 mon replicate 4,ctrl
Oga_KO_MEF_E7_rep1,pert
RNA from HCC_23N,ctrl
"testis, Repro9 mutant, 14dpp, Rep4",pert
Frontal_Cerebrocortex_Vehicle_6hr_rep8,ctrl
age_years: 34;	sex: F;	ethnicity: Black;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
skeletal muscle myoblast_OE_day0,pert
cell type: T cell;	disease state: control participant,ctrl
Paclitaxel-sensitive,ctrl
Seguin_IDR_BrownNorway_Liver_control2,ctrl
"t10, surgically resected from patient of gastric cancer.",pert
"cell line: HEK293 human embryonic kidney cell line;	protocol: MIF depletion, siRNA-mediated;	siRNA concentration = 100pmol/ml",pert
Endometrium-Normal 3,ctrl
Nerve_Diabetic_Vehicle_707,pert
strain: mixed background;	age: 4 months;	genotype: wildtype;	tissue: jejunum;	sample type: control littermate,ctrl
Du145-PCAT1 cells transfected with non-targeting siRNA,ctrl
N30057,ctrl
Muscle PCOS 14,pert
GM19238_Kd_SREBF2_3,pert
migratory cells only found in diseased OA tissue with stem cell characteristics,pert
CBMNC.LPS+.2,pert
"Mouse bone marrow-derived mast cells treated with IL3, rep 3",ctrl
PZA treated-42d-2,pert
control_bronchial biopsies,ctrl
mouse wild-type lung 8 h after cecal ligation and puncture surgery,ctrl
"disease group: Atopic Dermatitis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 4.5;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 100;	ige (kiu/l): normal (0-48.5 kIU/L): 36;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
treatment: transfected with Ambion Silencer Select Negative Control #1;	cell type: embryonal carcinoma;	cell line: 2102Ep;	passage: 35-50,ctrl
Bone-Marrow_MM_M1042,pert
B4 398 b4-/- untreated,pert
CML_2_GMP,pert
Rat liver,pert
DuodTumor022YAFBV_dtb.txt,pert
normal 1319,ctrl
HL60-shControl-rep2,ctrl
3_CD34+_12h_TCDD-,ctrl
4P-ER-ND,pert
Testicular seminoma,pert
alveolar macrophages from bronchoalveolar lavage,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.86027,pert
cell line: SW1736;	time point: 48h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 48 h,pert
muscle knock out replicate2,pert
"CFU-PreB colonies Wildtype littermate, biological replicate 2",ctrl
"2102Ep cells negative control, biological replicate 2",ctrl
THRA aI mutant + vehicle replicate 3,ctrl
"Male, 39 years old, HIV infection of 2 years",pert
"brain, forebrain: WCx4w#1_e1_le1",ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 35;	maternal age: 28,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 1",ctrl
Gender: female;	Age: 63;	Source: left lower leg,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 103;	Usage number: 1;	Exposures: 3,ctrl
"imr-32,t=0,2",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 39.88219,pert
71_129_WT,ctrl
Bronchial Epithelial Cells control biological 2170J,ctrl
Muscle-24 month-Myc heterozygous-technical replicate 1,pert
"37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
affected status (disease state): control;	gender: male;	age-at-examination: 72;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever drinker,ctrl
Mock infected murine liver-MO30k-(275)-6hpi,ctrl
"Trained mice, time point 5 week",ctrl
Csbm/m Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-2,pert
Ing1-/-_MEF_rep2,pert
race: caucasian;	age (years): 57;	stage: IA;	grade: 1;	histology: endometrioid,pert
"breast tumor epithelium,10",pert
mouse colon_hnf4control_rep1,ctrl
THRB bN mutant + vehicle replicate 1,ctrl
MCE301 cells treated with SB for 24 h-2,pert
"Human lung adenocarcinoma A549 cells treated with TNFα, in presence of control siRNA",ctrl
07_PAH,pert
sample =XCGD2 treatment=Control time=360 (min),pert
Individual_4093_PP_sample,pert
WT_laser captured Paneth cells,ctrl
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 3,ctrl
liver wild type replicate1,pert
"brain, brainstem: CB7_e1_le1",ctrl
5210 Normal Uninflamed terminal ileum,ctrl
Kidney_colistin_3,pert
Brain (Inferior Olivary Nucleus)_Control_case2,ctrl
Yy1_siRNA_rep1,pert
"proband k, past exhaustive exercise",pert
patient: 120;	current medication: Minicycline;	birth date: 5/6/54;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
A375 control-2,ctrl
Disease_status: Healthy control;	Age (years): 54;	Gender: Male;	Post mortem interval (hours): 10;	Braak stage: II;	Cause of death: Aortic aneurysm,ctrl
WT - Cre Untreated - 0 hrs - repeat 2 - Cy5 - mAdbID:61714,ctrl
"Female (age range 33-49), skin biopsy from upper nates. No nickel exposure",ctrl
sex: Male;	family: 2;	age: 66;	disease status: Asymptomatic;	tissue: Muscle: Deltoid,pert
10 week mutant spinal cord rep 3,pert
SCLC cell line SBC-3,pert
BP patient 92_biological replicate 1,pert
HDAC1_knock_out_embryonic_stem_cells_biological_rep3,pert
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 0,pert
"211, MUSCLE, Before",ctrl
PBMC RNA from a healthy control,ctrl
"Tip60 KD, replicate B",pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 143;	time: 0;	batch: 3,pert
Retina wildtype 42 days 2,ctrl
liver_NEMO_KO_replicate1,pert
genotype: DTG;	diet: high fat;	muscle hypertrophy: +;	sex: male;	tissue: liver;	treatment: doxycycline 3wks,pert
siAgo1,pert
Exon3_T4,pert
BASC-Control-1 [mRNA],ctrl
Control (C270),ctrl
Large cell carcinoma 018,pert
Individual_3059_PN_sample,pert
SHEP-SF neuroblastom,ctrl
EA_Case8_CD8,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 48 yr;	population: white,ctrl
ILD Study Number S037,ctrl
"PMA treated, doxycycline treated; biological replicate 2",pert
Muscle control 8,ctrl
subjects: patient with AAA undergoing open surgery to treat AAA;	tissue type: non-aneurysmal AAA neck tissue,pert
prostate_Klf5 wt_rep3,ctrl
control_crypt_day2_sample1,ctrl
treatment: control siRNA;	cell line: PC3,ctrl
CO_1,ctrl
Sh-control-1,ctrl
"p38alpha wild type fetal liver E13.5, biological rep1",ctrl
PsOEt-16-LS,ctrl
Wt CD9+ trophoblasts,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_12_34_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
CHF - R10,pert
Primary brain tumor tissue,pert
C594,pert
"Donor 3, Ebola infected 6hr",pert
"human failing LV myocardium, Ischemic88",pert
"DMD skeletal muscle, biological rep9",pert
Klf9KO_jejunum_PND30_4,pert
knockdown: Control;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 7.7;	colon weight (mg): 157;	colon ratio (mg/mm): 2.04;	myeloperoxidase activity (u/mg): 0.038;	tissue: colon;	treatment: 5% DSS,ctrl
nodex_4,ctrl
Pancreatic Sample 4-Normal,ctrl
treatment: Sirt1 siRNA Knockdown 1;	cell line: Caco-2,pert
Lmna H222P heterozygous male 1,pert
primary osteoblasts treated,pert
WT_BoneMarrowMacrophages_unstimulated_4hours_rep1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 66,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.042;	OD280: 1.079;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 216;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 5",pert
"WT, PR03M003v0",ctrl
"Ovol2 BT, biological rep2 (E17.5)",pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 96;	Usage number: 4;	Exposures: 3,pert
"Pou4f1+/+ cells, transduced with control virus",ctrl
CD8+_Tcells_severe_asthmatic_6,pert
Gender: female;	Age: 10 weeks,ctrl
cerebellum_WT_4w_rep2,ctrl
"Empty vector control, 72 hrs, No Rosiglitazone (NONE_72_2)",ctrl
01N0Z_ERA,pert
Airway epithelial cells,ctrl
race: asian;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
transfection: shPARP-2 transfected,pert
COLO829 cells with shMITF knockdown and PLX4032 treatment,pert
MCF10A_Vehicle_rep2,ctrl
Leptin treated mouse gallbladder 5,ctrl
"BOEC, normal 19",ctrl
siCONTROL no DNA Damage experiment 1,ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 73;	baseline tumor size (cm): 7x6;	patient id (to identify the 2 chips from the same patient): 15751594,ctrl
Sample 02 Kidney Normal Mouse - Low Phosphate Diet,ctrl
55SageA2,pert
strain background: Sprague Dawley;	gender: male;	diet: isocaloric control diet without EtOH for 6wks;	sample group: Control;	cell type: Alveolar type 2 cells,ctrl
RAW_2.1mM_HOCl_#3,pert
BCells_WildType_day0_REP2,ctrl
"Bicalutamide treated LNCaP cells not stimulated with DHT, biological replicate 3",pert
1202-03-A,pert
FACS-purified B cells_wildtype_non-infected_rep2,ctrl
cell line: Breast carcinoma cell line Cal51;	genotype/variation: IPMK depletion;	agent: MMC,pert
"human failing LV myocardium, Ischemic103",pert
"brain, hippocampus: KA240-III_e1_le1",pert
genotype: p300+/-;	replicate: 3;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
CRG,ctrl
sirna: Claudin 1;	treated with tnfα: YES,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: A,ctrl
sample type: Sample;	cell line: H1;	cell type: embryonic stem cell;	protocol: OCT4 knockdown;	time: 3 Days,pert
01N6Z: normal control,ctrl
NALT_sham_24h_rep2,ctrl
C2_HypM,ctrl
"NASP Overexpression, sample #2",pert
cell line: H1993;	tissue: Lung adenocarcinoma,pert
NTG replicate 6,ctrl
"Patient #4, Untreated",pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",pert
KU_20N,ctrl
disease state: normal skin,ctrl
BP5,pert
"JurkatNegative (Mock stim)  0 hours, #2",ctrl
MDS10,pert
"runx1-null luminal mammary epithelial cells, MD869",pert
"testis, Repro9 mutant, 17dpp, Rep5",pert
PancreaticSample16-Tumor,pert
Recent-onset T1D_sample8,pert
disease status: autism;	tissue (brain region): Temporal cortex,pert
Patient identifyier: D;	Sex: male;	Age of patient: 61 years;	Duration of psoriasis: 21 years;	Body surface area: 12 percent;	Overall erythema: mild;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
type 2 diabetes subject 08,pert
mT6,pert
HeLa_06_21_04 TP-7,pert
Cervical carcinoma,ctrl
6n,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 52;	age-at-onset: 48;	geographical origin: Mirandela;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 4",pert
SKGT4 cell line,ctrl
coc-12_B,pert
IEC_GF-HDAC3ΔIEC -1,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 69,pert
NTac_liver_vehicle 0 mg/kg_96 hr_4,pert
t18,pert
WT1-iPS 3,ctrl
PGA-lv_8w_329,ctrl
hBSMC_control_rep2,ctrl
Normal cervix_03-5657,ctrl
P5A Progranulin-frontal,pert
hOB1705_shEV_24hr_IR,pert
Allo-25-3,pert
Cmah KO_liver _2,pert
IGROV-1-(3),ctrl
"Acute Myeloid Leukemia, sample 72",ctrl
Muscle JDM (YJD-JDM-21UA-s2),pert
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 1,ctrl
A HID B_B043,pert
individual: patient9;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: non-recombinant clone 24 (STAG2 wild-type),ctrl
"SBC-5 cells, siEGFP (control), 48 hr after siRNA, duplicate sample 1",ctrl
JIA PBMC Post treatment A235_L010(2),pert
Panc0504 rep-3,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: rosiglitazone at 1uM,pert
"Huh7 cells, Mock Infected, 48 hours.",ctrl
Adult WT mouse whole brain,ctrl
KM_056N,ctrl
"Strain: Mixed genetic background, predominantly (>87.5%) C56BL/6 with some CD1. Genotype: Mx1-Cre negative: PTENfx/+. Sex: Female;	Age: eight and a half weeks (at tissue isolation). Tissue: Small Intestine (jejunum/ileum region). ",ctrl
HepG2_Sb rep1,pert
Mock infected murine liver-MO30k-(270)-6hpi,ctrl
strain: C57BL/6J;	genotype/variation: WT;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),ctrl
MEFs,pert
"Cadmium 1.2 µM, biological rep1",pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/16;	differentiation status: undifferentiated;	cell line: Q20,pert
Bone-Marrow_NPC_N1610,ctrl
"Normal subject (54 year old caucasian female, SAK_1276103927)",ctrl
Lrp5 Retina Rep3,pert
NS3-040213-SA,ctrl
"maternal exposure to dioxin, HypM",pert
DNGL-1,pert
Mouse spleen at 4 month,pert
3010-lcm,pert
"Mouse brain, Adult, 4hr post Saline ip injection",ctrl
C_AN17425_C,ctrl
H29 Ctrl 6h 3,ctrl
HCaRG-9_HG-U133 Plus 2_Rep,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: wild type;	treatment: prenatal stress,pert
LECs from control rats,ctrl
Mouse_Retina_P7_Control 3,ctrl
heart_Q10_6M_rep3,pert
"FACS-sorted cones, P90 C-DGCR8 KO mice",pert
mir-26b overexpression 2,pert
PBMCs_Control_8 [IS],ctrl
"brain, locus coeruleus neurons, Mecp2 null",pert
siNEG replicate 2,ctrl
Silberg2 (S1) 021101BE,pert
Healthy controls; individual=CJ; time=2; beverage=alcohol,pert
"Hippocampus, soman, 96h",pert
RNA from microdissected breast cancer cells from case 605 labeled with Cy5,ctrl
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2+/+;	agent: IFNβ,ctrl
KO_TER119-_rep3,pert
KO - 3 mo - repeat 3 - Cy3 - mAdbID:74674,pert
P1,pert
Cell line MCF-7_c-myc KD_expt3,pert
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 2,ctrl
A HID U_B089,pert
Cultured trabecular meshwork cells,ctrl
gender: Male;	tissue: Tendon;Quadriceps;	age: 41;	donor: 10;	disease state: Non-lesional,ctrl
CD4DecTp2-3,pert
Rarb null mammary stroma,pert
Mtb infected-42d-3,ctrl
"DMSO Control after 24hr, replicate 1",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: pineal gland;	time: ZT20,ctrl
phytohemagglutinin-activated PBMCs from normal control subject J,ctrl
brain_Down_syndrome_sampleid_jg1734,pert
E10.5 Vax2-/- 1,pert
Individual_4213_PN_sample,pert
HL60-shGSK3A-Construct5-rep1,pert
"brain, hippocampus: KA-240h-P15-I_e1_le1",pert
11429 UC Inflamed descending colon,pert
Patient 2 b,pert
"E2-treated cells (24hr), biological rep_2",pert
"MN1VP16, 2",pert
cell line: H1299;	agent: decitabine;	dose: 3 uM,pert
subject: 12V;	cohort: 12;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 45;	Sex: F;	batch: Batch_3,ctrl
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Pioglitazone,pert
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: YES,pert
microdissected muscle fibers,ctrl
"human failing LV myocardium, Idiopathic60",pert
Targretin_Lung_2,pert
CTIP 20 #1,pert
"0mg/kg/day PFOA, Rep 1, Block 2 lung (high dose)",ctrl
"nasopharyngeal carcinoma, specimen T2",pert
E14 - DCXko/Y 1,pert
heart-30 months of age-resveratrol diet-biological replicate1,pert
DN4 cells sorted from mouse n°131 (Cre-),ctrl
T2,pert
Muscle JDM (YJD-JDM-8UA-s2),pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep4",pert
HeLa_06_21_04 TP-10,pert
kidney_co_14M_rep1,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 9.7;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 54;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Mouse colonic epithelial cell line MCE301,pert
tumor cell line HepG2 with knockdown of HIF-1α rep3,pert
"Control #9, Untreated",ctrl
heart-30 months of age-control diet-biological replicate4,ctrl
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,ctrl
"infected primary RPE, biological replicate 4",pert
DC3,ctrl
1212-1heart_OTT1KO,pert
Kyoto Rat liver tissue following animal exposure to orotic acid for 3 days,pert
"WT mouse cortex, P29",ctrl
A375 Wnt1-1,pert
Msgn1_48hPlusDox-biological rep2,pert
major non-tumor7,ctrl
Bronchial Epithelial Cells MMA biological 1926H,pert
IEC_GF-HDAC3FF -2,ctrl
age_years: 35;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
HEK001_A08_R3,pert
ak_12,pert
condition: Normal;	patient: N_LJ_7;	tissue: Normal skin biopsy;	kit: Affy,ctrl
normal adjacent esophageal tissue from patient E1614,ctrl
"fibroblast, MFS subject FB837 rep 2",pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Colon",ctrl
Bone-Marrow_MM_M828,pert
STAT1-deficient naïve T cells stimulated for 3 hours with medium alone 1,pert
"PMA treated, no doxycycline; biological replicate 1",pert
DBA d18 (120msn),pert
"human embryonic stem (hES) cells line VUB01, biological replicate  3",ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 0.770020533880903;	age of psoriasis onset: 39,pert
LIRKO liver sample 2,pert
0201-01-C-RR,ctrl
WT 1,ctrl
Cardian muscle Diabetic 1 week D1,pert
"DOX, rep3",pert
construct: HDAC1 A3 shRNA;	cell type: Primary human erythroid progenitor cells,pert
KO - knock-out Treated - 0.5 hrs - repeat 2 - Cy5 - mAdbID:62539,pert
ST045849 24 hours_3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu1,ctrl
GM19238_Kd_CEBPG_1,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 75,pert
"control, rep2",ctrl
Control subject 97_biological replicate 2,ctrl
3589-1 E2F1 Null,pert
Cell line MDA-MB-231_control_expt1,ctrl
4x' Ez f/fMef2c-cre,pert
11394 Normal Uninflamed descending colon,ctrl
cell lines HUVEC (human umbilical vein EC),ctrl
gallbladder -saline treated,ctrl
"mouse liver sample, WT strain, biological replicate 2",ctrl
B_LS_Wk12,pert
"S1P2-KO-hippocampus, biological rep1 (male)",pert
Haloperidol treated 4weeks AffyGC RMA rep3,pert
skin derived melanocyte cell line_21day NRG1 treated,pert
cell line: SF539;	transfection: PARK2 siRNA#1,pert
D1,ctrl
477MM,pert
COLO829_shMITF_DMSO_B,ctrl
"Gender: male;	Age: 75;	Source: skin, left heel",pert
Peripheral blood mononuclear cells (PBMC)-Patient CCo T0,ctrl
RWPE1 cells treated for 24 hours with vehicle (0.1% ethanol),ctrl
tissue: Brain;	genotype: Npc1+/+;	age: 60 days;	subject: Mouse2;	genetic background: BALB/c,ctrl
Bone-Marrow_SMM_S1415,pert
Gender: male;	Age: 46;	Source: back,pert
"Age: 45;	Sex: M;	Ancestry: African;	Smoking status: smoker, 70 pack-years",pert
Hippocampus_Soman_72h_rep3,pert
O_LS_Wk1,pert
mammary_16wkLH_ker74,pert
"seminoma specimen, pT1, patient age: 31y",pert
wt_P4_rep1,ctrl
WT-smoke-med-5 month-R2,ctrl
Prostate,ctrl
patient id: T22;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 67;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3N0M0;	Stage: III;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
splenocytes,ctrl
"Mouse invivo nTreg cells, replicate pool 1",ctrl
"C8161, no treatment",ctrl
MGP2,pert
Subject 8_t=30days_placebo,ctrl
wild-type+PQ rep_2 (PQWT2),ctrl
GFP-progerin Induction: day 0 Replicate A (4a_progerin_0d_A),pert
Nrl-ko-Gfp P2 replicate 1,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1+/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: esophagus,ctrl
Moderate rep4 (OHN),pert
Hereditary gingival fibromatosis(HGF) patient Gingiva replicate1,pert
"Kidney from control rats, biological rep 1",ctrl
brownfat,ctrl
muscle_Wt_35wk_rep2,ctrl
cell type: Embryonic stem cells;	genotype: Bmpr1a-/-;	culture condition: 3 days in N2B27,pert
Individual_4294_PP_sample,pert
3_month_old_Prnp_knockout_mouse_rep2,pert
Control for EGF 4h replicate 1,ctrl
Liver_WT_Vehicle,ctrl
67 y/o female,ctrl
non-malignant FTEn_patient 2,ctrl
Tissue: lung;;	Genetics: Sporadic IIP;;	Histology: Nonspecific Interstitial Pneumonia,pert
C33KD2_without doxycycline_3,ctrl
gender: male;	genetic background: C57BL/6x129;	age: 6.5 months;	tissue: Crhr2+/+;	genotype: Gastrocnemius and Soleus muscles,ctrl
gender: Male;	tissue: Tendon;ECRB;	age: 52;	donor: 30;	disease state: Lesional,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep1",ctrl
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"nasopharyngeal carcinoma, specimen T15",pert
MDS patient 176,pert
"Patient H-137-N, normal colonic mucosa",ctrl
1198-03-A,pert
WT2 CD11b,ctrl
midbrain_Pink1 knockout_24 weeks_replicate 1,pert
14C-ER,ctrl
"Endometrium, postmenopausal, tibolone, 26",pert
"Lung tissue of CD-1 wildtype mouse, control group",ctrl
"ARD291, CAIS, F, GOF, 6 x ETOH, 14d",pert
U2OS_control_shRNA_pLenti_2_2007,ctrl
DA rat stomach treated 1 h,pert
WT littermat3,ctrl
ATM_siRNA_0a,pert
Bone-Marrow_MM_M1089,pert
Liver_D3T _Rep3,pert
"cardiac muscle, left ventricle",ctrl
CPU FVB/N control 1,ctrl
GM19238_Kd_WHSC1_1,pert
patient: 30057;	sample: normal,ctrl
Age: 42;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 5382insC;	Family History: Yes,ctrl
MDA-MB-231 - Control-3,ctrl
gender: male;	individual: patient 4;	treatment: control,ctrl
Wild type_heart_1,ctrl
Btk KO primary splenic B-cells (sample1),pert
race: caucasian;	age (years): 46;	stage: IB;	grade: 1;	histology: endometrioid,pert
patient id: T144;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 74;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N1M0;	Stage: III;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"skin, 1 week isotretinoin treatment",pert
strain: FVB/NHsd;	tissue type: back skin,pert
5871841165_E,ctrl
ethanol_ethanol_91,ctrl
tissue: neocortex;	developmental stage: E14.5;	genotype: Eomes WT;	genetic background: C57BL\6,ctrl
224 Day 1 siSC transfected biological rep2,ctrl
HeLa cells transiently transfected with control siRNA,pert
dental pulp cell from control 3,ctrl
OSE_541,ctrl
BATF_KO_P14_D3_Effector,pert
"medulloblastoma, wt, rep1",ctrl
renal_vesicle_wild_type_3,ctrl
Total RNA Mir140 KO-1,pert
ALI patient #2,pert
Brain_Aged_Salineip_4hr_mouse3(OP3_#63),ctrl
"WKY adrenals, replicate 2",ctrl
Igf1 -/- mouse vestibular organs 15day old (P15),pert
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 67",pert
Contusion - 35 Day Epicenter Rep1,pert
Subject #8002-8hr Postinfection,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep1",pert
siNS_4h_2,ctrl
Wildtype 3 (jos0928),ctrl
"metastasis: metastasis;	Stage: 4;	tissue: cancer, homogenized",pert
WT mix background B,ctrl
E10.5 Vax2-/- 3,pert
strain: CD-1;	age: 20 week;	genotype: Wild type;	tissue: heart left ventricle,ctrl
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: Cd4-Cre_C57BL6-STAT3<tm1Dlv> (STAT3KO);	treatment: stimulated for 3 hours with medium alone,pert
AtT20 cells treated with NSBP1 siRNA rep 3,pert
"MTDH control, biological replicate 1",ctrl
lung_wt_mock_repB,ctrl
non-malignant FTEn_patient 9,ctrl
"Pou4f1+/+ cells, transduced with control virus_Wt-MSCV_79",ctrl
Mut+/- rep1,pert
A_AN08166_T,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_6;	fev1 (% predicted): 55;	fvc (% predicted): 69;	medication: Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd;	cell type: CD8+ T-cells",pert
"Sodium arsenite added to food: 10 ppb, 5wk; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: None",pert
A375 melanoma cells treated with vemurafenib,pert
U-87MG-V17 set 3,ctrl
strain/background: mix of 129Sv and C57BL/6;	genotype: control;	tissue: back skin;	age: 10 days,ctrl
Tumor_18w_erlotinib2_DEN_126,pert
extensor digitorum longus muscle,pert
brain_co_6M_rep2,ctrl
"Cells transfected with sirtuin 6, biological rep2",pert
PU.1 KD HSC 1,pert
Phan_009_KO.saline rep3,ctrl
"brain, hippocampus: Aldh5a1-/- #3403 Cereb_e1_le1",pert
lung_CLP_wildtype_rep1,ctrl
WT thymocytes,ctrl
WT_72_O3_3c,ctrl
Bone-Marrow_MM_M856,pert
Control 6,ctrl
3894-2 E2F WT,ctrl
Control 3,ctrl
RWPE-PCAT1 cells transfected with non-targeting siRNA,ctrl
KM_066T,pert
HWS17,pert
"WT mouse lung, biological rep1",ctrl
age: 65;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Kidney_saline ip_mouse #064,ctrl
cell line: HEK293E,ctrl
"BMDM, LPS 0 hr",ctrl
07R083 RA,pert
6h WT cel.38,ctrl
RNA from microdissected breast cancer cells from case 280 labeled with Cy5,pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 31;	gender: f;	treatment: -,pert
tissue type: hepatocellular carcinoma,pert
Ishikawa_VeryLowDose_BPA_24h_rep4,pert
Human skeletal muscle,ctrl
"NCI-H460, control, 2 hr",ctrl
siEGFP (24 hr) _2,ctrl
CML_4_CMP,pert
HLA risk: High;	Height: 170.2 cm;	Weight: 63.9 kg;	BMI: 21.8;	Age: 30.94 years;	Gender: Female;	Race: White;	Glucose: 93 mg/dl;	HbA1c: NA,ctrl
2h 4OHT-treated-sample1,pert
background: C57BL/6x129Sv/B6 hybrid;	genotype: Prkaca+/-;	age: 9 months;	tissue: caudal vertebral bone,pert
STING tumor DNA II,pert
aortic biopsy,pert
Tissue: brain (frontal cortex);	Disease State: HIVE,pert
LKR13_Kras sh-4,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6;	colon weight (mg): 167;	colon ratio (mg/mm): 2.78;	myeloperoxidase activity (u/mg): 0.056;	tissue: colon;	treatment: 5% DSS,pert
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 3",pert
8 week old leg control rep 4,ctrl
HCC_21T,pert
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep5",pert
Sirt1 siRNA KD2 2,pert
CD19_selected_B-cells_after_R_rep8,pert
Dilated cardiomyopathy_G63,pert
siCONTROL + MMC experiment 3,ctrl
SeroNeg-11,ctrl
whole blood_100190,ctrl
Scrambled 24 hours_1,ctrl
U937-shGSK3B-Construct2-rep2,pert
Gender: Male;	Age: 34;	Ethnicity: White,pert
subject: 9;	disease: CP;	muscle: ST;	gender: M;	age: 11.2;	gmfcs: 2;	popliteal angle: 110,pert
liver_female wt_rep1,ctrl
"MCF7, non specific control, biological rep2",ctrl
"proband k, before exhaustive exercise",ctrl
control siRNA rep4,ctrl
human breast tumor tissue RNA,pert
GFP 0hr 282295423,ctrl
NOD non-transgenic islet rep1,ctrl
shOCT4_2,pert
Shn2_Mutant_3,pert
Liver-24 month-Myc heterozygous-technical replicate 3,pert
"Patient H-s124T, MSI colorectal tumor",pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 61;	donor: 16;	disease state: Lesional,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 16 hrs AP20187,pert
cell line: sh3293 T47D;	sherbb3: +,pert
H441 transfected with ETS2-specific siRNA 1,ctrl
Neocortex E14.5 mouse Eomes WT,ctrl
ndf + preLA,pert
"Ulcerative Colitis (57 year old caucasian female, SAK_1286542779)",pert
CUTLL1 DNMAML1 GSIwash2h-rep3,pert
1212-5heart_Control,ctrl
Placenta Adra2bKO 2,pert
AP-2 gamma targetting siRNA 3: CCACACUGGAGUCGCCGAAUA Technical Replicate 1,pert
A39 WT4	F25/17	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
NoKD_SerumStarved->3hrEGF_rep1,pert
Array Type; Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,ctrl
V5-P120,pert
retinal,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 2 (untreated with resveratrol)",ctrl
braak stage: CTRL;	rin: 81;	tissue: substantia nigra;	disease state: control,ctrl
BxPC3-KO4 rep 1,pert
1000uM H2O2,pert
treatment: Control siRNA Vehicle;	cell line: MCF7,ctrl
HF0512_U133P2,ctrl
Untreated WT - repeat 6 - mAdbID:102770,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with PBS;	,ctrl
"TGCT cell line NTera2/clone D1, treated 3 days with retinoic acid, differentiated",pert
Bmpr1a-/- ESC media sample 3,pert
WT_d00_eX_vs_KO_d00_eX,ctrl
wildtype 8,ctrl
T65 dilated cardiomyopathy heart biopsy,pert
Endometrium/Ovary-Disease 6,pert
Normal Lung,ctrl
Wild type Retina Rep2,ctrl
tissue type: Lesional skin;	time: Pre-dose,ctrl
Murine cell culture,ctrl
sample =Healthy3 treatment=Control time=360 (min),ctrl
"KARPAS-231, LITAF-specific siRNA, REP1",pert
Tumor_setB_Ker80,pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#4,ctrl
sampleID: SAM630135;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
FCHL patient #98-1103,pert
EA_Case7_CD4,pert
"Patient  E, lesion, 4 week",pert
55A;pretreatment;female;breast tumor; responder,ctrl
Normal esophageal epithelium (N4),ctrl
"Ada3FL/FL MEF, Cre, biological replicate 1",pert
"Oral Squamous cell epithelium tissue;	Patient code:OSCC-2;	Age:58;	Sex:F;	TNM:T2N0M0;	;	ABBREVIATION:TNM,TUMOR-NODE-METASTASIS",pert
"eye, cornea: TRizol Extraction_le1 1",pert
TAF4b knockout,pert
CF CFTR unexposed replicate 2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 83;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
2075N,ctrl
cell type: Embryonic stem cells;	genotype: Bmpr1a-/-;	culture condition: ESC media,pert
LJMJDW5,ctrl
brain_Down_syndrome_sampleid_jg1742,pert
LacZ control_4b,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 4,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 34;	maternal age: n/a,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 79;	Usage number: 4;	Exposures: 2,pert
Skinbiopsy_96hoursnickel_controlsubject_k1,ctrl
Control LM2 Cell on HMVEC-L Replicate 1,ctrl
"Brain tissue from Fisher 344 male rat, Animal #244, control (0mg/kg) D-Serine",ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep4",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 58 yr;	population: white;	dsm-iv: 296.54;	age of onset: 27 yr,pert
major HCC1,ctrl
JGB-Pre-3UP_Run2-S2,pert
DU145/NC siRNA #2,ctrl
V5-P397,pert
protocol: control;	cells: Human Neural Stem Cell Line F3,ctrl
Bronchial Epithelial Cells control biological 2034B,ctrl
SU8686 rep-1,ctrl
"brain, adrenal medulla",pert
Bc_p60_1,pert
"MCF-7 cells-40mM g-T3, biological rep 1",pert
Wild-type mice rep5,ctrl
V5-P381,ctrl
WT_MEF_rep1,ctrl
Vastus lateralis muscle,pert
"Acute Myeloid Leukemia, sample 60",pert
iA50clone6+,ctrl
C1E-LU,ctrl
8N,ctrl
colonic_mucosa_non_inflamed_722,ctrl
"Data 2, overnight control",ctrl
Itk knockout CD4+ CD3-stimulated 2,pert
heart of mouse subjected 4 week to chronic intermittent hypoxia (4B),pert
TAC 3,pert
"Peripheral blood, patient without recurrent events [N29]",pert
M452 SKM-Tg,pert
GEIM50-U133A-Norm,ctrl
age: 69;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: Vemurafenib 1000 nM for 72h,pert
"adenocarcinoma at 20wk, biological rep 3",pert
"FIH null MEFs, biological rep1",pert
Manca 3,pert
HMEC_control experiment 3,ctrl
"human embryonic stem (hES) cells line VUB03_DM1, biological replicate  3",pert
Skinbiopsy_48hoursnickel_controlsubject_k5,ctrl
"105, ADIPOOSE TISSUE, After",pert
hTNFtg;Rsk2-/y FLS,pert
"Adherent lung cancer cell line, anti-Evi1 siRNA",pert
ES2 COUP-TFII-3 25nM,pert
patient E1520,pert
5282 UC Uninflamed ascending colon,pert
uterus - Proliferative endometrium from patient with  endometriosis,pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 7.2;	colon weight (mg): 154;	colon ratio (mg/mm): 2.14;	myeloperoxidase activity (u/mg): 0.019;	tissue: colon;	treatment: 5% DSS,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.652;	OD280: 0.857;	Ratio: 1.92;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 215;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
T51091,pert
"Csbm/m mouse, cerebellum, old, saline treatment",ctrl
HNF4 CONTROL_277,ctrl
KO PBS3,ctrl
lymphoblast cell line,pert
autism with FMR1-FM AU046706,pert
foxp3 expression: NO;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 2T>C(mut);	gender: female;	treatment: none,pert
Whole adrenal RNA from WT mouse #80 at 0h,ctrl
GFP Untreated 24hr 282295833,ctrl
@52055800697862121408403718160364,ctrl
HP-9,pert
U2-OS-ERa E2 4 hrs 2,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 5,pert
"Endometrium, postmenopausal, tibolone, 11-2",pert
NRG Melan-Ink4a #2,pert
UV-SeV 3480,ctrl
MDS patient 33,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 36, stage IIB, HPV 16",pert
ab119 IM,pert
Individual_5242_PP_sample,pert
WT-PB_rep-1,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T2N2,pert
human neurons isolated from postmortem dorsolateral prefrontal cortex,ctrl
CONTROL 2,ctrl
rat liver,pert
scan batch: Batch 2;	group: control;	subject age: 5;	paternal age: 35;	maternal age: 34,ctrl
"heart of mouse, 1 week control (1B)",ctrl
"control colon tissue, biological rep2",ctrl
Fog2flox/delta; no Cre biological replicate 2,ctrl
DQD A,pert
"MCF-7 breast cancer cell, transfected, pcDNA3.2",ctrl
COV434,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 26.040;	Ratio: 2.11,pert
BP patient 79_biological replicate 2,pert
liver_STZ treated diabetic_rep4,pert
Muscle-AMPKgamma3-wt-11,ctrl
pediatric AML PP9,pert
liver control diet rep5,ctrl
"gene expression of CTCF-depleted oocyte, replicate 2",pert
"primary cortical neurons, MeCP2 shRNA",pert
B11 - non-infected BALB/cByJ fibroblasts,ctrl
age_years: 46;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Diabetic untreated rats 1,pert
32023.LMP,ctrl
PWD/PhJ Vehicle liver sample batch 2,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 4h,pert
206/0,ctrl
"kidney, control, 14 months",ctrl
11-0057A_Day1_33,pert
HSC-wildtype-1,ctrl
Tendon;Patellar_Lesional,pert
Subject #8038-8hr Postinfection,pert
agent: control (untreated);	time: 48h,ctrl
cell line: HEK293 cells WTX inducible clone F18;	agent: control,pert
92.1 - control #1 - replicate2,ctrl
MDA-MB-231_siScramble_rep.2,ctrl
"C26, whole heart",pert
normal human salivary gland,ctrl
Systemic,pert
Parkinson's disease,pert
AIRE-ko-CD80lo-mTEC-sample1,pert
B2KO; No Treatment #3,pert
Human PBMC,pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 62;	donor: 13;	disease state: Non-lesional,ctrl
platelet_sickle_15,pert
Tet2 KO LSK rep2,pert
KU_31T,pert
Individual_4339_PN_sample,pert
Alpha7 nAChR subunit L250T heterozygous mice without treatment,ctrl
WT mouse skin treated once with TPA and collected 24 hr later,ctrl
tissue: bone marrow;	cell type: macrophage;	genotype/variation: IFNAR2-/-;	infection: uninfected,pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_12_39_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
Ishikawa_VeryHighDose_BPA_24h_rep2,pert
Individual_4136_PP_sample,pert
LKR13_Kras sh-2,pert
THRB 15b mutant + T3 replicate 3,pert
WTGFP QSC Biological Rep.1 Technical Rep.1,ctrl
"PBMC, patient. Mtx rep9",pert
SIN3A_siRNA_NS_rep1,pert
cell line: TF-1;	gender: male;	age: 35 years;	disease: erythroleukemia (AML M6);	sirna: control,ctrl
"treatment with MDBP, replicate 1",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.592;	OD280: 1.273;	Ratio: 2.03;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 341;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
THRA aI mutant + vehicle replicate 3,pert
MCF-7 cells from ATCC,pert
sample =Healthy4 treatment=Control time=0 (min),ctrl
"Setd2 wild type mESCs, biological rep3",ctrl
MCF-7 +ER siRNA + vehicle rep2 (MD38),pert
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep2",ctrl
K562 cells CREB Knock-out replicate 4,pert
Muscle-AMPKgamma3-ko-1,pert
Diagnosis: AML M1;	Age: 54y ;	Gender: Female;	Blast %: 89;	Source: PB;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
Gastric_cancer_patient_1,pert
CUTLL1 MigR1 GSI-rep3,ctrl
genotype: ILKS343D Tg;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,pert
E14.5 Tgfbr2 Wildtype Mouse Model Palate 2,ctrl
FVB; No Treatment #3,ctrl
high grade serous carcinoma_patient 2_sample 1,pert
RNA from microdissected breast cancer cells from case 297 labeled with Cy5,ctrl
NOMO-1 cells infected with ZFX shRNA SH1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.615;	OD280: 0.851;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 73;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Fibroblasts isolated from mouse mammary glands with Pten deletion in fibroblasts,pert
cell type: Primary human epidermal melanocytes (neonatal),pert
A HID U_B042,pert
"human peripheral blood derived monocytes, 8 hour LPS stimulation, biological rep2",pert
V5-P566,pert
Splenic T1 cells,pert
Series 3; adult; 4 weeks after fracture,pert
Pt_2 Acne Lesion,pert
Lung tissue from male control mice,ctrl
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: dexamethasone for 4 hr,pert
"Liposarcoma culture from tumor 314, untreated",ctrl
TF_1_shTRAF6_d2.5_rep1,pert
Ulk1/2-/- (untreated) 1,pert
"A673 treated with DMSO vehicle control for 3 days, biological rep2",ctrl
01N72_CTRL,ctrl
tissue: brain;	genotype: mutant 14-3-3 ko/ko;	age: E14,pert
KU_26T,pert
sample type: fvb control;	strain: fvb/nj;	gender: Male;	age: 8 weeks;	tissue: glomerulus;	disease state: Nondiabetic,ctrl
"Cell line SLM2, mutant status WT, condition Control 2",ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_4mM_HG-U133A_2_YCHSUP501,pert
whole blood_101644,ctrl
striatum_wild type_12 weeks_replicate 3,ctrl
Liver antiangiogenic-treatment rep4,pert
DMSO Control 2,ctrl
11m1,ctrl
"C57BL/6, Female, Contol",ctrl
whole tissue section from case 878,ctrl
A2AR_WT_saline_24h_rep2,ctrl
"Wild-type-hippocampus, biological rep8 (female)",ctrl
shRNA6-16-noDox-rep2,ctrl
Control ITP chip A,ctrl
"Mouse Sciatic Nerve, Control Rosi",pert
MCF-7_trans-retinoic acid_12hr,pert
Control subject 29_biological replicate 2,ctrl
MCF10A 3days,ctrl
wt-Gfp E16 replicate 1,ctrl
age_years: 51;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
cell line: L428-PAX5;	treatment: Mifepristone (M);	duration of treatment: 5 days,ctrl
tissue: white blood cells;	age: 9.66;	Sex: male,pert
CDF1-p3 (177msn),pert
VillinCreERT2-_Rep1,ctrl
patient: 428;	disease state: LGSC;	component: Borderline,ctrl
"Embryoid bodies, 12h,Plus Dox",pert
Rap1 mutant mouse embryonic fibroblasts,pert
Wild Type B cells Spleen 5,ctrl
cell line: C13;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
"Gender: female, Age: 32 years, Tissue: VIN 3",pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 39;	Usage number: 4;	Exposures: 3,pert
"Cbfb+/+, technical replicate 2",ctrl
"peripheral ganglion, unknown: nicotine 24 hr",pert
tisue: cleared mammary fat pad;	genotype: Rarb +/+;	age: four weeks,ctrl
PDAC_P_138,ctrl
50A;pretreatment;female;breast tumor,ctrl
MPM tumor specimen 37,pert
THRB 15b mutant + vehicle replicate 3,ctrl
RCC patient,pert
Bone-Marrow_MGUS_G492,pert
T30162_rep,pert
PsOEt-17-Week 1,pert
"3T3-L1 siControl 48h, biological rep 2",pert
"fetal testis sample 23L, 20 weeks gestation",ctrl
Treg WT rep3,ctrl
HT29 PLX Day3 rep2,pert
Muscle 50 eccentric contractions 12 hours KO Aged 1215,pert
Gender:M;	Age:28;	Tissue: Mucosa,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, DMSO-treated",ctrl
patient id: T183;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxM1;	Stage: IV;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
S032_Scz_M_77,pert
H295R adrenocortical carcinoma cells,ctrl
ic21 -- mockAPF on membrane A,ctrl
Akt1 wild type 1,ctrl
cerebellum_WT_0d_rep1,ctrl
white blood cells,pert
Aurka_R_-Dox_rep3,ctrl
A511 MI 1 day,pert
KN-sham-2 month-R3,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siDdb1,pert
Individual_5305_NN_sample,ctrl
"Sfrp5 KO HFD 8 weeks, biological rep6",pert
HC JR 2 water,ctrl
SZ4,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.469;	OD280: 0.766;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 139;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
total RNA from testis,ctrl
MDS patient 17,pert
strain: C57/Bl6;	genotype/variation: ASC1 null;	gender: male;	tissue: epididymal white adipose tissue,pert
KU_09T,pert
FW_15c_BV5830,ctrl
P0 - lis1cko/ko Mix 1,pert
Normal Chip#4,ctrl
"mutant triceps, biological rep3",pert
cell line: HL-60;	replicate: Replicate3;	treatment: shLuciferase,ctrl
Gallbladder- leptin treated,pert
CD8-IGF1R 3T3 Vehicle 2,ctrl
7 Day Mouse Diaphragm muscle,ctrl
C4_transgenic but unaltered,pert
Normal_Kidney_Biopsy_1,ctrl
strain: 21;	Disorder: normal;	Condition: no hydrocortisone,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 1 (untreated with resveratrol)",ctrl
strain/background: C57BL6J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: sham surgery,ctrl
EA_Case17_CD8,pert
Sample ID: TP32;	Twin Pair ID: CCE2.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-5;	Age at interview & blood sampling: 34;	Current Age (2007): 36;	Sex: FEMALE;	Medication at blood sampling : None,pert
Liver_TAK1KO_Rep1,pert
c57BL/6JTCE liver sample batch 5,pert
small_intestine_complete,ctrl
ATF2 Genotype: KO,pert
"SKO-transduced MEFs, Vc treated, lysed on D10",pert
"Oct4-Gip ES cells, Panct1 RNAi, 72h post transfection",pert
tissue: Whole pancreas;	genotype: Rkip-1 KO;	background: C57BL/6;	age: 8 weeks,pert
01J48_PolyRF-,pert
Control Braak α- synuclein Stage 0 C2SN,ctrl
10 week control spinal cord rep 2,ctrl
"in vivo,2 cell stage, embryo",ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 1,pert
PancreaticSample24-Normal,ctrl
"Patient  O, lesion, 12 week",pert
WM1205 cell line,pert
"Rat Schwannoma cell line that express genes associated with glial characteristics including Sox10, p75, GFAP, and S100.  For additional information please see: Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I.;	(2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 69:497–.508.",pert
TA-t10; transgenic tibialis anterior 10 month,pert
E14.5 WT 3,ctrl
"S1P3-KO-neocortex, biological rep5 (female)",pert
Skin removed from back region of embryonic day 16.5 mouse,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 48 hours,ctrl
Postmortem human substantia nigra,ctrl
brownfat_WT4_day3,ctrl
tissue: xenograft tumor,ctrl
cell line: HEK293,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: control;	time: 24h;	gender: Male;	age: 44 years old,ctrl
tissue: lung;	strain: CD-1;	age: 20 week;	genotype: Wild type,ctrl
IKK2 WT cell line,ctrl
strain: FVB;	genotype/variation: ErbB3 DOX-KO;	tissue: Mammary epithelial organoids;	treatment: control,ctrl
c_NY101,ctrl
GM19238_Kd_IRF9_1,pert
CD-53-Aff,pert
XBP1s Tumor 5,pert
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Stromal Cell,pert
WT.DMSO.3,ctrl
24 hr KLF4 Time Course Control,ctrl
chip number: 18;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.5;	transfection date: 2012-03-26,pert
Embryonic age 14.5 wild-type rep1 (PKD1_57),ctrl
"GNMT knockout at 3 month age, biological replicate 2",pert
MLL1-KO MEF CT18-3,pert
Time:4 day; condition:LaminA ko;,pert
"t11, surgically resected from patient of gastric cancer.",pert
A61 WT4	F24/5	A61	wild type	Mouse	8 months	Cerebellum	Female,ctrl
OTT1 knock out,pert
BP25,pert
TLR4 knockout normoxia,pert
"Dumbo retina, biological rep4",pert
"normal nasopharyngeal tissue, specimen N4",ctrl
"wildtype MEFs with cisplatin treatment (16microM, 24hrs)",pert
"60B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
LP50 cells treated with vehicle and AR-shRNA,pert
"ID:6-4, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 16 hrs AP20187,pert
Normal cortex of patient T164,ctrl
Psoriasis-Patient-I,pert
Zfx fl MA9 cells + 4-OHT [10986],pert
cell line: ACC483 [HPB-ALL];	cell type: human T-ALL cell line;	agent: control,ctrl
"Patient  A, lesion, 1 week",pert
Patient: A;	Time: 1 week;	Group: responder;	Condition: lesional,pert
healthy control H13,ctrl
CD4+YFP+Ly5.2+ from Foxp3+,ctrl
MLL_00252,pert
erStress_twins_AA_1743twin2_500nM_thapsigargin_4h,pert
"IGF-treated cells (3hr), biological rep3",pert
CD25+Xbp1KO,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 4, Units of Harvest Time Point: hr",pert
Amoxicillin treated Colon 3 17 days old,pert
Ishikawa_Control_8h_rep1,ctrl
Insm1 mutant #5_pituitary gland,pert
BP patient 57_biological replicate 1,pert
ccRCC tumor of patient T158,pert
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep5,pert
"wild type saline, biological rep4",ctrl
GIST Pre Treatment Biopsy 15,pert
Whole brain hemispheres,ctrl
IGROV-1+(3),pert
ILKS343D2,pert
Insm1 control #1,ctrl
Sample 18 Kidney Hyp Mouse - Low Phosphate Diet,pert
ILD_19,pert
Adult Sham; Biological replicate 2,ctrl
brain_control_sampleid_mr523,ctrl
pMX-Oct4 and pMX-jhdm1b(jmjc) vitamin C O+JMJCVc+_1,pert
"Cell type: endothelial, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h",pert
gender: female;	batch: 2;	age (years): 23;	patient id: Non_severe_4;	fev1 (% predicted): 84;	fvc (% predicted): 81;	medication: Salbutamol;	cell type: CD8+ T-cells,pert
A HID B_B086,pert
"Biceps, FSHD, cohort 15, subject 15A",pert
chip number: 22;	transfection plate: 3B;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2012-03-26,ctrl
"Pancreas from adult WT mice, biological replicate 1",ctrl
CD-59-un2,pert
Against CDK8-1 rep3,pert
endothelial_rep14,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 90min;	race: White;	sex: Female,ctrl
cell type: iPSC;	genotype: CCALD patient,pert
Advanced IPF_explant_upper lobe_rep157,pert
3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24718,pert
RNA from HCC_30T,pert
BACH2-/- ALL (Sample3),pert
human liver,pert
Bone-Marrow_MM_M1093,pert
A_AN00764_F,pert
433MM,ctrl
H1299 RBP2 KD2_rep 2,pert
Human prostate cancer primary culture C40dx,pert
patient13,pert
"fibroblast, wild-type, untreated, biological replicate 1",ctrl
"Uninvolved Skin, NS-24",pert
LSK cells from heterozygous JAK2V617F mouse rep3,pert
sciatic nerve of P4 wild type mouse,ctrl
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50), biological rep3",pert
tissue: white blood cells;	age: 16.13;	Sex: male,pert
diet_mammary_4,ctrl
"pancreas, ethanol diet, replicate 3",pert
Female - caucasian - E-02-M,pert
pMX-Oct4 and pMX-jhdm1b no vitamin C O+Jhdm1BVc-_2,ctrl
minor non-tumor1,pert
PGA-lv_1w_674,ctrl
"2 month old, double transgenic (InsMycER+,RIP-BclXL+)",ctrl
"LCL GM19238, Kd KLF13, 72hrs",pert
siCITED1#1 replicate1,pert
"4302_CD133+, untreated",ctrl
GEIM30-U133A-DM,pert
GFP Untreated 24hr 282295843,ctrl
tissue: Pancreas;	cell line: Panc-1;	treatment group: Untreated Control,ctrl
BP patient 53_biological replicate 2,pert
G_Ctrl_1,ctrl
gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6.4,pert
Sex: female;	Age: 13;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
"expression at 0hr, bio rep2",ctrl
GM19238_Kd_SP3_3,pert
181D0,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 46;	tissue: Blood,pert
cell line: HEK293T,ctrl
MO_DH1a_SON_NCBI,pert
Control spleen - Biological Replicate 3 - Technical Replicate 1,ctrl
tissue: white blood cells;	age: 14.58;	Sex: male,pert
4332-1 E2F2 Null,pert
age: 35;	sex: F;	disease status: control subject;	Filter number: 97;	Usage number: 4;	Exposures: 3,ctrl
SA_201,pert
control AU060003,ctrl
Insm1 mutant #3_pituitary gland,pert
disease state: paediatric glioblastoma;	age: 9;	gender: F;	h3.3_status: wt,ctrl
Kidney_50 mg/kg VCM iv_mouse #011,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 71;	age-at-onset: 65;	geographical origin: Porto;	clinical characteristics: Hypertension;	lifestyle characteristics: ever smoker, ever drinker",pert
M833 / Reference_13425475,pert
IPMC 6,pert
S4A Sporadic-frontal,ctrl
strain: C57BL6  X 129sv mixed;	tissue: liver;	genotype: WT,ctrl
H3_SS11_01Nov07,pert
"Gift Prof Dr Olivier De Wever, Ghent University Hospital, Ghent, Belgium)",ctrl
untreated_6hr_rep1,ctrl
08SE1178,ctrl
N40730,ctrl
DLBCL_FOXP1 overexpression,ctrl
Human skeletal muscle biopsy sample;	Patient #175 with PM,pert
strain: B6/129;	gender: male;	age: 6 months;	tissue: dorsal prostate;	genotype: Klf5-/-; Pten-/-;PB-Cre4,pert
tissue: thymus;	genotype: E2Aflox/flox Cd4-cre+;	age: 8 weeks,pert
"Animal id 1025, left retina, 3 months, female, DBA/2J",ctrl
Nasal Epithelium Instilation Formaldehyde 0mM 6h ID356,ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P15 postnatal stage,pert
Mouse lungs infected with Mtb for 42 days,pert
genotype: p300+/-;	replicate: 1;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
HN_97,ctrl
Naive (control) #4,ctrl
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
GM9023,ctrl
wild-type macrophages stimulated with MALP-2 for 4 h,ctrl
APOE_KO_RAGE_KO_DM_9W_12,pert
ApoD transgenic mouse+PQ rep_3 (PQTG3),pert
Lrp5 Retina Rep2,pert
a10a.000606jd.2.SkMNor907.CEL-IS basal,ctrl
BE-rep8,pert
mn cells sample 3,pert
CD19_selected_B-cells_before_R_rep7,ctrl
pediatric AML GP8,pert
H2bt5,pert
IFN_Gamma_24hr_rep1,pert
"Subject 14, Family 5, Asymptomatic",pert
Wild type day 3 Air replicate 3,ctrl
"MCF-7 transfected with pcDNA3.2, rep.2",ctrl
"Peripheral blood was obtained by venipuncture from healthy adult volunteers. Blood samples from umbilical cords of the placentas of healthy, full-term infants after scheduled caesarean section or vaginal delivery were obtained by puncture of the cord immediately after delivery",ctrl
Y YOKE_B023,ctrl
NTG replicate 4,ctrl
"vestibualr organ at P15 of Igf1 -/-, biological rep 3",pert
Kidney_50 mg/kg VCM ip_mouse #071,pert
cell type: splenic CD11c+ dendritic cells;	strain: C57Bl/6strain: C57Bl/6;	genotype/variation: WT;	treatment: tamoxifen,ctrl
10: NORMAL #00-0386,ctrl
GEIM57-NORM,ctrl
E2 1hr,pert
Run1.a10a.000609jd.2.SkMNor910.CEL-IS stimulate,pert
A502 Sham 7 day,ctrl
Cardiac Progenitor WT1,ctrl
Retina wt/wt rep2,ctrl
chip number: 11;	transfection plate: 6;	target gene: USF1;	kd level: 0.77;	rin: 9.3;	transfection date: 2012-03-26,pert
FTO1_C1_24h,pert
"human failing LV myocardium, Idiopathic27",pert
SIRT4 KO liver_7235,pert
heart of mouse subjected 1 week to chronic constant hypoxia (C1B),pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M0;	flt3 status: WT,ctrl
age_years: 31;	sex: M;	ethnicity: Asian;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Parkinson's disease sample x184,pert
patient: 30;	disease state: hypertension;	tissue: Atheroma plaque,pert
C57_LF_3,ctrl
disease: psoriasis;	skin: non-lesional,pert
Control 894B,ctrl
DC1,ctrl
CON9,ctrl
SKBR3_1uM_Lapatinib_3,ctrl
"BMMCs from NTAL WT, pLKO.1 infected, nonactivated, biological rep1",ctrl
"40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
patient: 51681;	sample: tumor,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 2,ctrl
Chondrocyte_control_rep2,ctrl
"seminoma specimen, pT2, patient age: 30y; W03 036",pert
"Human breast, pre AF treatment",ctrl
Strain: DBA/2J Sex: Male Age: 8-10 weeks Treatment: Fluoxetine,pert
KOC 53 PBS treated,pert
HA96-37B,pert
"Cervical cancer cell line, SiHa",pert
Brain hemisphere,pert
"344SQ with control shRNA, replicate 3",ctrl
DBTRG 10 uM Y15,pert
"Muscle from WT, biological rep3",ctrl
Y YOKE_B058,ctrl
T6.01,pert
"218, ADIPOOSE TISSUE, Before",ctrl
MH1C1 cells exposed to 160 µM CoCl2 for 24 h,pert
6 weeks old,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 3,pert
RORasg/sg liver_HFD_rep2,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: control; biological replicate: 3,ctrl
Gender:F;	Age:44;	Tissue: Mucosa,pert
"p400 KD, replicate A",pert
microdissected breast cancer cells from case 843,pert
GIST Pre Treatment Biopsy 19,ctrl
muscle Smad4KO 3 control,pert
human subcultured chondrocytes (passage 2) from normal donors maintained for 14 days in scaffold culture,ctrl
age: 29;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
FW_5a_BV8411,pert
ICM pool 4 (n=4),pert
A673 cell line that has been treated with DMSO vehicle control for 24 hours.,ctrl
B-CLL PB P143,pert
mES cells TR71 KD rep3,pert
"Wild type epithelials cells, biological rep4",ctrl
Patient: O;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
8 weeks cardiac muscle,pert
PsOEt-22-Week 1,pert
"Uninvolved Skin, NS-18",pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (34),pert
BCells_WildType_day2_REP2,ctrl
Untreated CHOP-/- D,pert
ILD Study Number S036,ctrl
LNCaP + ELK1-shRNA rep 2,pert
hESC transduced with mutant miR-122-expressing lentiviral vector,ctrl
colon_CRC_1293,pert
Patient 1 skin baseline,ctrl
BM_preTherapy_I,pert
"YAP-overexpressing cells, biological rep1",pert
Control 120 days sample 2,ctrl
tissue: Frontal cortex;	age: 87;	Sex: F,ctrl
"alveolar macrophages, smoker 002",pert
BAL_47a_A0B0,ctrl
BL6CBDL,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 10",pert
HEK001_pLKO_R1,ctrl
Bone-Marrow_SMM_S1329,pert
CEPI_IIIc_528,pert
breast precancerous tissue,pert
Hippocampus 1982 15 month Old,pert
"vector d2, rep 3",ctrl
"Liposarcoma culture from tumor 398, doxorubicin treated",pert
Y VIS _B065,ctrl
Mouse fetal liver_E14.5_WT_rep3,ctrl
HCC1954 Cell Control 1,ctrl
s9129_1,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
"NF-YB KD ES cells 96hr, replicate 2",pert
liver knock out replicate2,ctrl
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-WT;	overexpression induced with doxycline: No,ctrl
3T3-L1 Day 0 (passage 21) 48h after siControl transfection,ctrl
Vector control 2,ctrl
siHic5_2_2h_3,pert
RNA from whole tissue section of case 1125 labeled with Cy5,ctrl
"airway epithelium, small airways, obtained by bronchoscopy and brushing",ctrl
Bone-Marrow_MM_M758,pert
duration of untreated disease in month:30.6;	age at onset:1.0,pert
Gender: Male;	Age: 38;	Ethnicity: Black,pert
liver_female ko_rep1,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: kidney;	age: 12 weeks,pert
Scd1-/- on very low fat diet (TD03045 from Harlan Teklad) replicate 1,pert
"control, BA46-83",ctrl
Kin- S49 Cells 2h cAMP treatment,pert
"Lymphoblastoid cell lines derived from family 1720, member 1",ctrl
P0 - nudelcko/ko 1,pert
695_EV_0hr_repeat,ctrl
"fibroblast, MFS subject FB1234 rep 4",pert
Cardiac Progenitor MUT3,pert
"Proximal, Small Intestine 17 days old",ctrl
patient: 51104;	disease state: LGSC;	component: Invasive,pert
ILD_7,pert
Muscle PCOS control 11,ctrl
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep2,pert
mouse ventral prostate,pert
NPC6,pert
"Normal T-cells, CD3+, donor 1",ctrl
HLA risk: High;	Height: 157.7 cm;	Weight: 54.5 kg;	BMI: 21.9;	Age: 57.96 years;	Gender: Female;	Race: White;	Glucose: 83 mg/dl;	HbA1c: NA,ctrl
prostate tumor 3,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep3,pert
PBMC sample from pancreatic cancer patient,pert
Array Type: HG-U133A_2;	Ratio: 2.02;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Hippocampus_NaiveControl_rep3,ctrl
MCF-7 cell_tRA_12hr_biological rep1,pert
Knock-out postnatal day 10 rep 1,pert
MPM tumor 11,pert
Gastrocnemius Muscle_Cmah KO_mdx_rep3,pert
"breast, post AFI treatment (H10_1594)",pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case6,pert
hOB695_shRB1383_0hr,ctrl
chronic lymphocytic leukemia (CLL 34297),pert
ME180 6 hours rep 1,pert
IM29_control,ctrl
"3mg/kg/day PFOA, Rep 2, Block 1, lung (low dose)",pert
SLE myeloid cells 6,pert
untreated AML 6B blasts,ctrl
VillinCreERT2-_Rep2,ctrl
9A;pretreatment;female;breast tumor,ctrl
VMM-WT_MyoD12h-1MP-s2,ctrl
"p38alpha knock out fetal liver E13.5, biological rep2",pert
PBMCs from CIS patient before IFNb-1a in-vivo treatment,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Primary palate mesenchyme;	age: E13.5  + P2,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 26;	maternal age: 23,ctrl
E2F1 Null,pert
8 hour tunicamycin wild type B,ctrl
IRF8 KO 1,pert
Whole skin tissue,ctrl
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Male;	Age of onset (years): 31;	Duration of illness (years): 17;	Brain pH: 6.90;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
"3mg/kg/day PFOA, Rep 2, Block 1, liver (low dose)",pert
Lymphedema Tail Skin 2,pert
CH2126,ctrl
phenotype: no or early glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
Phan_007_KO.saline rep1,ctrl
A2008-(1),ctrl
"Crohn's Disease subject (22 year old caucasian female, SAK_1316756241)",pert
F3-WT-1st,ctrl
"Epidydimal white adipose tissue from Casp1-/- after 16 weeks of high fat diet feeding, replicate 3",pert
Patient no. 2: control,ctrl
Mut1_2,pert
Mammary Gland,ctrl
ATM_siRNA_0c,pert
"Sorted erythroblasts, Sod2+/+",ctrl
"CCALD patient fibroblast, biological rep3",pert
Osteoblasts_Lrp5_Control_Day7,ctrl
SUM149_siTIG1_rep3,pert
disease state:DM;,pert
Het-pDC1,pert
MCL_IGHV_MUT (R1941),pert
"SFM control cells (24hr), biological rep_2",ctrl
"adult female mouse colon, Hnf4a mutant",pert
"ID:7-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
"Liver from Nrf2 k.o. mice, biological replicate 1",ctrl
Fibroid_2192,pert
"Gender: Female, Age: 28, BMI: 17, Tissue: luteinized cumulus cells",ctrl
"Cultured ovarian cancer cell line OVCA420, Cisplatin treated",pert
10uM H2O2 rep 3,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: angiotensin II;	dose: 100 nM;	time: 3 hr,pert
PGA-RMM-7h-2aA-s2,pert
PND28 Rat Testis_Rat230-2_2hr Corn Oil_Animal#47_04005,ctrl
neuron_rep2,pert
Patient: C;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
cell line: SKMEL28;	time point: 0h;	mutation: BRAFV600E;	treatment: untreated,ctrl
status: Control;	gender: Male;	age: 47;	tissue: Blood,ctrl
colon_C57mouse_6weeks_rep3,ctrl
BalbC_6h_DMSO,ctrl
gender: Female;	tissue: Tendon;Subscapularis;	age: 63;	donor: 20;	disease state: Non-lesional,ctrl
Trasnsformed Lymphocytes Unaffected (Unaffected pateint of MZ twin pair 3),ctrl
01LP7_PolyRF-,pert
DBA_24h_DMSO,ctrl
"human failing LV myocardium, Ischemic106",pert
A520 MI 7 day,pert
ESCs_pCIP siRNA 1,pert
"G42 cells from Cerebellum, Mecp2 null, biological replicate 2",pert
Control bone marrow - Biological Replicate 5 - Technical Replicate 1,ctrl
Leg 14 Day mdx rep 3,pert
V5-P251,pert
Individual_5815_NN_sample,ctrl
"Gender: female, Age: 33 years, Tissue: normal vulva,",ctrl
WTGFP QSC Biological Rep.1 Technical Rep.2,ctrl
P55 Non failing heart biopsy,ctrl
"gender: male;	batch: 1;	age (years): 32;	patient id: Severe_3;	fev1 (% predicted): 98;	fvc (% predicted): 113;	medication: prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od;	cell type: CD8+ T-cells",pert
Sprague-Dawley rat femoral diaphysis,ctrl
"A549, -TNFα, Claudin 1 siRNA, rep1",pert
"Strain: Sprague-Dawley, Gender: male, Weight: 350 g",ctrl
diagnosis: HP;	fvc-group: FVC2;	tissue: lung,pert
Skinbiopsy_48hoursnickel_nickel_allergic_subject_P1,pert
35A;pretreatment;female;breast tumor; nonresponder,ctrl
wt 13.5d replicate 5,ctrl
"Empty vector control, 2 hrs, Rosiglitazone (ROS_2_2)",pert
Md02h026,pert
A_AN08166_F,pert
Epididymal adipose GPR120KO ND #719,pert
E.8 DBA-C57BL/6 whole embryo,ctrl
Raji cells transfected with miR-142-3p mimic at 24 hours,pert
adenocarcinoma (ADC2),pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 7;	gender: male,pert
A537 MI 1 day,pert
FCHL patient #98-1281,pert
T40656,pert
Strain: C57BL/6; Tissue: quadricpes muscle,ctrl
GEIM176-NORM,ctrl
tissue: rectal mucosal epithelia;	genotype: CFTR D508,pert
MEF Wild Type 3-rep4,ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep2,pert
P0 - WT129s6 3,ctrl
"WT, PR03M002v0",ctrl
PsOEt-21-Week 2,pert
tissue: Biceps muscle;	patient: P.b.9;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 90,ctrl
glaucoma: glaucoma;	phenotype: no or early glaucoma;	radiation: No radiation treatment;	strain: DBA/2J;	gender: Female;	age (mos): 10.5,pert
N/SM2,ctrl
"Subject 4, Family 2, Affected",pert
3950M patient’s mucosa,pert
Wild type Mice-M125,ctrl
"PIO, subject 14",pert
Normal Uninflamed terminal ileum,ctrl
Flp-In™ T-REx™ 293,pert
Heart-Base_WT-2,ctrl
hur status: WT;	rna subtype: nuclear RNA after HnRNPA1 Immunoprecipitation,ctrl
266D6,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: Wy14643;	time: 24h;	gender: Male;	age: 6 months,pert
3P-M4-ND,pert
231/ARF-1_2,pert
"Benign, Pooled, prostate tissue",ctrl
"bcatGOF  mouse kidney E12.5, biological rep 3",pert
"liver, PPAR WT_ctr_55",ctrl
"fatty (fa/fa), skeletal muscle (gastrocnemius), Troglitazone",pert
"experiment 1, ethanol-treated 2",pert
"9B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Scd1-/- on chow diet replicate 2,pert
"BOEC, normal 13",ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID155,pert
L1 062502 Pio2,pert
"-Rosi, +PPAR, 2hrs",pert
Recent-onset T1D_sample11,pert
C2C12 myotubes,pert
Individual_4216_PN_sample,pert
"GSL30, PR04M010v0",pert
Placenta_nl1,ctrl
"0mg/kg/day PFOA, Rep 4, Block 4, lung (high dose)",ctrl
9L,pert
Insm1 control #6_pituitary gland,ctrl
U937_luc_Replicate2,ctrl
RKO_rep_4,pert
41A;pretreatment;female;breast tumor; responder,ctrl
THRB bN mutant + vehicle replicate 3,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 59;	donor: 34;	disease state: Lesional,pert
No or early 2 rep1 (OHN),pert
CD8 KLF13 WT,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 6,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 5",pert
RNA from whole tissue section of case 638 labeled with Cy5,ctrl
"Normal cervix, commercial_Stratagene",ctrl
WT-Fibr1 8,ctrl
LKR13_Control-1,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
EB_07_6h_127_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
brain_DLPFC_bipolar C_mr682,ctrl
LCCS sample 23 weeks,pert
strain: C57BL/6 (B6);	genotype: WT;	cell type: leukemia stem cells (LSCs);	age: 8 weeks,ctrl
Ulk1/2+/+ (untreated) 1,ctrl
"granulocyte, patient. Mtx rep3",pert
NHE3+/+ replicate 1,ctrl
IRS-2 KO (jos0952),pert
AQA B,pert
N7,ctrl
"Cervical cancer cell line, C-33A",pert
Mouse heart at 6-weeks old,pert
control-control rep 4,ctrl
ctrl_512,ctrl
strain: C57BL6/J;	age: 12 weeks;	gender: female,pert
whole blood_100240,pert
HCC_38T,pert
"Acute Myeloid Leukemia, sample 77",ctrl
liver_Wt_8wk_rep2,ctrl
SIN3A_siRNA_LIF1h_rep1,pert
cell line: Raji;	cell type: human Burkitt's lymphoma;	gender: male;	treatment: expression of miR-142-3p mimic;	treatment duration: 24 hrs,pert
Normal bladder 61-99,ctrl
sample =XCGD5 treatment=Stimulated time=360 (min),pert
quadriceps_muscle_Akt1+/-_female_35wk_rep1,pert
"SPC-c-raf transgenic mice, 12 month old, female, tumor",pert
3007-ls,pert
"SFM control cells (3hr), biological rep2",ctrl
"Hif1a-/- LSC, biological rep2",pert
Mening UNSTIM WB NP 1a,ctrl
Subject #8002-Preinfection,ctrl
Patient: N;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Strain: B6SJL;	Age: 75 days,ctrl
"Patient H-661-N, normal colonic mucosa",ctrl
Cell line established from CA1 HESC using pClip vector,ctrl
Whole testis,ctrl
heart MHC-Plin5 2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.31781,pert
Tendon_lesional_rep2,pert
PTC BRAF wt 3,pert
A4_LEF1,pert
Laser-capture microdissected non-malignant FTE from normal control patient,ctrl
Spleen_ko_4m_rep3,pert
ubb_d7_ko_1,pert
"vehicle, biological rep6",ctrl
female JAK2 KO liver sample 131,pert
PGA-MAH-C3H_PBS6h-2aA-s2,ctrl
tissue: brain;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
PC3 Control Rep2 (weak signal),ctrl
HD12,pert
Spleen_wt_4m_rep1,ctrl
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr.",pert
23 weeks male,pert
VMM-MUT_MyoD24h-2MP-s2,pert
major HCC5,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 55 days;	subject: Mouse4;	genetic background: BALB/c,ctrl
SARRC-1021-01-A,pert
Muscle WT Adult 07273,ctrl
SA_259,pert
"Whole brain hemispheres, harvested at 8 weeks",ctrl
OV1002 Control Day7,ctrl
cell line: KU-812;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
F9 RA sample #3,pert
unaffectd brother,ctrl
"BN strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
KN-smoke-low-5 month-R1,pert
cell type: hepatoma cells;	cell line: Huh7,ctrl
patient id: T79;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 59;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
control to Sample 15,ctrl
01_0053A_Day1_15,pert
"208, MUSCLE, Before",ctrl
Mouse C57/bl6,ctrl
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep2",pert
0820-01-A,pert
PancreaticSample29-Tumor,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.",ctrl
control participant P316 (human CD3 positive T cells),ctrl
01UNR_ERA,pert
tissue: lung adenocarcinoma;	cell line: A549;	transfection: pcDNA-MYC (control),ctrl
umbilical cord_nobpd: 6D,ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.59;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
Patient identifyier: F;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 28 years;	Body surface area: 15 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Diseased individual (ulcerative colitis) of twinpair #1,pert
cell type: granulocytes;	group: Healthy control;	patient treatment: not applicable,ctrl
HB1.F5-Nurr1,pert
HeLa_TP082505-27_HG-U133A_2_IMFGN0023,ctrl
"MCF-10A cells, overexpression ΔNp63α, biological rep2",pert
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-1,ctrl
NOMO-1_LEN-GFP,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: fresh air, treatment over 5 month, 4x1h exposure per day",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 52.78082,pert
Wild type Mice-M128,ctrl
"BMDC, Asc-/-",pert
MEFs,ctrl
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 6,pert
"Retina from control mouse at ZT20, biological rep 2",ctrl
G93A non transgenic littermate 1264,ctrl
L1 062502 Pio1,pert
siZMPSTE24-treated MDA-MB-231,pert
HEK293 F5 WTX inducible,ctrl
"Transgenic, snap frozen, diaphragm muscle, 10 month age animal",pert
wild-type_TCPOBOP_rep2,ctrl
"seminoma specimen, pT2, pN2, pM1, patient age: 37y; W00 111",pert
U937_ROS_untreated_4h_rep3,ctrl
ACI DES-treated replicate 4,pert
Individual_3822_PP_sample,pert
NB87,ctrl
"seminoma specimen, pT1, patient age: 56y",pert
"brain, hippocampus: wildtype 2_e1_le1",ctrl
EB_0_6_321_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
"DSS colon tissue, biological rep3",pert
wt_P2_rep2,ctrl
HEK001_A08_R2,pert
"209, MUSCLE, Before",ctrl
"GFPMYC negative GC B cells, Biological replicate 2",ctrl
B7hi mTEC B6/129 aire-/- 1,pert
colon_epithelium_IL10mouse_6weeks_rep6,pert
AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 1,pert
"T1.5 fetal heart (treated on gd14.5 via oral gavage, collected on gd17.5)",pert
Series 1; older; 3 days,pert
liver_Pink1 knockout_12 weeks_replicate_1,pert
231_GATA3_rep1,pert
Mannitol_1,ctrl
105B,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
DU145_VprBPsh_rep2,pert
"Trained diabetic mice, time point 5 week",pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 131,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 74 years,ctrl
GhrhKO_005,pert
Both ventricles of heart,pert
"Tg brain, biological rep3",pert
Jejunum_Wild Type+Quercetin_1,pert
"DMSO-treated, 24h after UV, Replicate B",ctrl
RAW_0.35mM_HOCl_#1,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
H5med,ctrl
MCF7_siRNA_GCMedControl_24h_AM0011_97.1,ctrl
Severe rep4 (OHN),pert
colorectum,pert
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 12",pert
Usp22 depleted replicate 1,pert
genotype/variation: Usp2-KO;	strain: C57BL6/N,pert
siControl_4,ctrl
"SKO-transduced MEFs, Vc+, D6",pert
RNA from HCC_5N,ctrl
Insm1 control #10_pituitary gland,ctrl
striatum SNCA knockout 21 month replicate 1,pert
"Runx1KO, biological replicate 1",pert
"human failing LV myocardium, Ischemic90",pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,ctrl
"PDAC, sample 1",pert
GFP Untreated 6hr 282295613,ctrl
lung tissue,pert
strain: C57BL/6;	tissue: small intestine;	genotype: wild type;	treatment: lubiprostone,pert
patient E1635,pert
Mening UNSTIM WB NP 12a,ctrl
"Bicalutamide treated LNCaP cells not stimulated with DHT, biological replicate 1",pert
Control AGS cells (transduced with non targetting shRNA),ctrl
control normoxia,ctrl
gastrocnemius-30 months of age-resveratrol diet-biological replicate3,pert
Control d10 (2),ctrl
chip number: 4;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.84;	rin: 9.1;	transfection date: 2011-03-29,pert
P77 dilated cardiomyopathy heart biopsy,pert
F_Ctrl_3,ctrl
"breast tumor epithelium,8",pert
age: 6 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
SKM-1 acute myeloid leukemia cells,pert
IR-WT_Rep2,ctrl
Thyroid_ papillary carcinoma 50,pert
"Peripheral blood, patient without recurrent events [N36]",pert
"Muscle from DS, biological rep3",pert
subject: 10;	disease: TD;	muscle: GR;	gender: M;	age: 14.9;	gmfcs: N/A;	popliteal angle: N/A,ctrl
CLL 377-01 Control,ctrl
midbrain_wild type_12 weeks_replicate 2,ctrl
female_control_410,ctrl
H1 hESCs,ctrl
"Skin removed from back region of embryonic day 16.5 mouse, Tcfap2c mutation",pert
B_lymphoma_1,pert
strain background: C57BL/6J;129S5/Brd mixed hybrid;	genotype/variation: wild type control;	tissue: uterine;	age: 15 days,ctrl
3895-2 E2F1 Null,ctrl
mutant_ANT_PDE_A4,pert
"control endometrium, patient 24",ctrl
WTT 160 bleomycin treated.,ctrl
21A;pretreatment;female;breast tumor,ctrl
OSCE-2N,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.13151,pert
17-0001A_Day1_44,pert
LCCS sample 18 weeks,pert
A375 Wnt1-3,pert
protocol: control;	cells: Neural Neural Stem Cell Line F3,ctrl
monocytes_Q10H2_2,pert
"ATP7B -/- Ko mice, 6 weeks old",pert
KN-smoke-med-5 month+1d-R4,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: Vemurafenib 1000 nM for 48h,pert
"patient 036b, normal, homogenized",ctrl
gender: Male;	age: 74;	post-mortem delay: 4.5h;	ph: 6,pert
MDS patient 111,pert
24SMOKEH,ctrl
WT-smoke-med-5 month+13d-R3,ctrl
Ex1_cells_rep3,ctrl
vulva biopsy of normal tissue,ctrl
A2058 CT16 siRNA,pert
"Peripheral blood, normal control [N57]",ctrl
"Whole ovary from 8 Month Old FORKO mice_02, biological rep2",pert
BxPC3-KO4 rep 4,pert
"ID:6-2, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
"BMMs, untreated control, wt, Replicate 3",ctrl
cumulus_nonPCOS_Obese_rep3,ctrl
Patient 4 after folic acid,pert
H4-II-E-C3_untreated_rep1,ctrl
isolated keratinocytes from mouse skin,ctrl
race: caucasian;	age (years): 62;	stage: IB;	grade: 1;	histology: endometrioid,pert
"nasopharyngeal carcinoma, specimen T27",pert
"brain, hippocampus: KA240-I_e1_le1",pert
tissue: skin;	cell line: NZM15;	tumour stage: metastatic melanoma;	tumour site: neck nodule;	treatment: media-only control,ctrl
Kidney_400 mg/kg VCM ip_mouse #104,pert
Extract:LOX-1:113403;	Extract Description:GFP_Untreated_12hr:113403;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.04;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.7;	Quality: Background Mean Dev.:1.04;	Quality: Absent (%):57.99;	Quality: Absent (%) Dev.:0.2;	Quality: Scaling Factor:0.48;	Quality: Scaling Factor Dev.:1.14;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113403;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295733,ctrl
MCF10A cells,pert
gender: female;	batch: 1;	age (years): 31;	patient id: Control_7;	fev1 (% predicted): 85;	fvc (% predicted): 96;	medication: None;	cell type: CD4+ T-cells,ctrl
Sciatic nerves from GNMT-KO mice,ctrl
"Sh2b3 WT, biological rep2",ctrl
Testis_KO_rep5,pert
"1833 control, biological replicate 2",ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated, biological rep1",pert
KO_48A_1c,pert
cell line: OV90;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
"Wild-type-hippocampus, biological rep4 (male)",ctrl
"ES cell line, RNA 70",pert
Sample 4 Posterior  -/-,pert
MDS patient 69,pert
3P-ER-ND,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 4,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: normal,pert
Epithelial prostate primary cells from fresh tumor explant.,pert
Brain from 20 days Npc1+/+ mouse1,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: c-jun knock out;	cell type: B-lymphoid,pert
10.5 Months Heart MDX rep 2,pert
"brain, adrenal medulla: Sample#A2 (Exp pt 2)_e1_le1",pert
wild-type Jurkat cells,ctrl
SA1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 104min;	race: White;	sex: Female,ctrl
gender: male;	batch: 1;	age (years): 46;	patient id: Control_4;	fev1 (% predicted): 92;	fvc (% predicted): 105;	medication: None;	cell type: CD8+ T-cells,ctrl
"brain, Entorhinal Cortex: 00 28 normal_e1_le1",ctrl
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA) post therapy / in hematological remission",pert
Mutated-ERα-positive breast cancer 17,pert
PFC S control 3,pert
MDA cells resistant to paclitaxel were treated with 30 nM Paclitaxel,pert
A673_CloneAsp14_Dox_96h_2,pert
HUVEC monolayer,ctrl
transgene: FTO;	treatment: noninduced,ctrl
Cell line established from CA2 HESC using pClip vector,pert
5247 UC Uninflamed sigmoid colon,pert
tissue: white blood cells;	age: 14.51;	Sex: female,pert
Cbx2_KO_XX_3,pert
Parkinson's disease sample x175,pert
sample =XCGD2 treatment=Stimulated time=360 (min),pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 5,ctrl
tissue: freshly isolated human monocyte;	gender:female; age: 19 yr; weight: 65 kg,pert
Fibroblasts_DBApatient_2,pert
EB_400_6_369_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
"ERbKO mouse aorta with placebo, biological rep1",pert
Nerve_Diabetic_Rosi_716,pert
12491 UC Inflamed sigmoid colon,pert
"granulocyte, patient. Mtx rep4",pert
CA99-43B,ctrl
n3_hi_11,pert
CD4DecTp2-9,pert
strain background: Mixed; mostly C57BL/6 with some 129S/SvImJ (from CJ7 ES cells).;	genotype/variation: Eed KO;	age: 9-day old;	tissue: bone marrow;	cell type: long-term hematopoietic stem cells (LT-HSC);	cell type: Lin-Sca1+CD48-CD150+,pert
"brain, cerebellum: WCb4w#3_e1_le1",ctrl
209/4,ctrl
ICR MEF infected  with pMX-Oct4 retrovirus,pert
HF0312_U133P2,ctrl
06_NOR,ctrl
RNA from HCC_20N,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,pert
"PBMC, healthy control, biological rep7",ctrl
LacZ control_0c,ctrl
tissue: Hippocampus;	age: 99;	Sex: M,pert
Pancreatic Sample 5-Tumor,pert
sampleID: SAM630147;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 6",ctrl
whole tissue section from case 1279,ctrl
Control 1a,ctrl
Raji_mi-142-3p_1,pert
5199 Normal Uninflamed sigmoid colon,ctrl
"shCDK19, low glucose, replicate 2",pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease_case6,pert
strain: Wistar;	gender: male;	tissue: spinal cord;	treatment: saline,ctrl
No or early 2 rep7 (OHN),pert
51104.LMP,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.93699,pert
cell line: HeyC2;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
Sample ID: TP13;	Twin Pair ID: CCN1.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.1R** ,ctrl
BAL_15a_A0B1,ctrl
7021.31PBMC,ctrl
"shControl clone 2, rep 2",ctrl
Itk knockout CD4+ CD3-stimulated 1,pert
runx1-null luminal mammary epithelial cells,pert
Day: 18; Drug: Heroin; Phase: Withdrawal; Replicate: 3,pert
cell line: NOMO-1,pert
Contralateral 4,ctrl
"patient 11, baseline",ctrl
B2KO; No Treatment #2,pert
01LMB_Oligo,pert
KO Soleus at 4 weeks biological rep2,pert
VIN_B090,pert
OVCAR-8+(1),pert
siUbr5,pert
"Wild-type-hippocampus, biological rep9 (female)",ctrl
genotype: C57BL/6 WT,ctrl
AA_Case6_CD8,pert
PGA-RMM-5h-2aA-s2,pert
LNCaP + ELK1-shRNA + R1881 rep 2,pert
"liver,6weeks,KO",pert
Carbo Day4 (71L),pert
"Untreated TG2 knockout NB4, biological rep1",ctrl
background strain: B6/129;	genotype/variation: wild type;	age: 11 Month;	tissue type: Liver,ctrl
normal scar treated with hydrocortisone-2,pert
Treatment 4,pert
rtTA-Dmrt5_d7_-Dox_rep_1,ctrl
Gastric_cancer_patient_3_dye_swap,ctrl
"Patient 2, Macroscopically intact tissue",ctrl
Pancreatic Sample 14-Tumor,pert
"Kinin B1 receptor knockout, biological rep1",pert
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject J,ctrl
Endometrial stromal cell - Jag1 retrovirus infected 1,pert
CD19_selected_B-cells_after_R_rep3,pert
Genotype: wildtype MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,ctrl
Subject #8032-2d Postinfection,pert
"endometrioma, patient 6",pert
patient: 7;	disease state: hypertension;	tissue: Atheroma plaque,pert
PGA-lv_4h_507,ctrl
"sebocytes cultured from M, 55, normal preauricular sebaceous glands and SV-40 immortalized",ctrl
Disease_status: Healthy control;	Age (years): 50;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.75;	Post mortem interval (hours): 49;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
A549 DAC 1 uM (3221),pert
cerebellum_wild type_6 weeks_replicate 2,ctrl
"schizophrenia, BA46-3",pert
"schizophrenia, BA46-93",pert
BP21,pert
RE550_H1650_5-Medi5117,pert
"DMD skeletal muscle, biological rep2",pert
"TAMs sorted from imatinib treated tumors, biological replicate#1",pert
F_Kin_1,pert
Ppif-/- heart 3,pert
"Primary culture of dermal fibroblasts from normal scar, treated with 1.5uM hydrocortisone",pert
cultured human melanoma cancer cell BL,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Atypical antipsychotic Clozapine, Dose: 12mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking water, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with vehicle for 6h,pert
Lesional skin from K5-Tie2 mouse,pert
CLC5 ko rep 2,pert
"BOEC, normal 2",ctrl
"IN1472 siNT treated, Biological replicate1",ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID207,pert
gender: female;	age (years): 60;	evolution time (years): 22;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
Psoriatic arthritis PsA 8,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 58, stage IIA, HPV 16",pert
"non-SS control gland, patient 17, batch 2",ctrl
"Knock-out Nrf2 mice, liver sample",pert
WT HPC PDE10i 11,pert
Bone-Marrow_MM_M1028,pert
gfp control sample 3,ctrl
liver control diet rep1,ctrl
"Rat liver, left lateral lobe",pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 2x1h exposure per day",ctrl
Bronchial Epithelial Cells SA biological 2047K,pert
"Luc control esiRNA, biological rep2",ctrl
Bronchial Epithelial Cells MMA biological 2003Q,pert
Pancreatic Cancer PBMC Sample 2,pert
microdissected breast cancer cells from case 68,pert
Donor (Sample 22),ctrl
RNA-DHL6-DMSO-2,ctrl
48 hrs TAC-2,pert
"immortalized cells derived from brown fat tissue of PGC-1alpha KO mouse (mixed background), expressing a control siRNA.",pert
GC13_skin_5dpn_1,pert
CLL16-CD8,pert
genotype: Wild type;	strain: C57BL6,pert
"CD8 DC, WT",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 10.008;	Ratio: 2.11,pert
MBD2_3,pert
01LMR,pert
"ALL_NDS, K54 011509",ctrl
"alveolar macrophages, non-smoker 006",ctrl
"eye, retina: Control 2_e1_le1",ctrl
HMEC,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 35 yr;	population: white;	dsm-iv: 295.3;	age of onset: 14 yr,pert
Age (mean +- SE),ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 68 years,ctrl
gender: Male;	age: 41;	post-mortem delay: 8h;	ph: 6.3,pert
Gata3_Cdx2_null_3,pert
infection: GFP protein (control),ctrl
db/db 12-3,ctrl
64A;pretreatment;female;breast tumor; responder,ctrl
tissue: kidney;	protocol: intravenous;	agent: saline;	dose: 0 mg/kg,ctrl
11101 UC Uninflamed descending colon,pert
sample: #24;	subject: PD case #6;	brain: T-227;	age: 76;	sex: Female;	region: Inferior olivary nucleus,pert
MOLT4_GSI_A,pert
Wild_type_control,ctrl
"mouse, mutant, liver, RNA B8877",pert
V5-P241,ctrl
Sham 50d replicate 2,ctrl
Braak α-synuclein 3-4 BR34_7SN,pert
3798M patient’s mucosa,pert
BaF3 cell line transduced MPLW515L3 mutant,pert
Snai1 knock out ESCs,pert
diagnosis: UIP/IPF;	fvc-group: FVC1;	tissue: lung,pert
Psoriatic arthritis PsA 16,pert
tetO-Satb1 #1 +DOX,pert
"Normal T-cells, CD3+, donor 5",ctrl
fibroblast_Slow_D72_Media_8,pert
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 2 hrs;	Drug: No Rosiglitazone present,pert
Mutated-ERα-positive breast cancer 46,pert
brain wild type replicate2,pert
U937-shGSK3A-Construct6-rep1,pert
Gastrocnemius Muscle_WT_rep2,ctrl
"Embryoid bodies, 24h,Min Dox",ctrl
siCtrlVeh4h_2657,ctrl
HeLa cells control 2 (Luciferase siRNA transfection),ctrl
PancreaticSample12-Tumor,pert
PDAC_P_123,ctrl
A YOKE_B061,pert
sample =XCGD2 treatment=Stimulated time=90 (min),pert
gallbladder saline treated,pert
ctrl_506,ctrl
KN-smoke-low-5 month+1d-R2,pert
subject: 21A;	cohort: 21;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 82;	Sex: F;	batch: Batch_5,pert
esophageal squamous cell carcinoma from patient E1796,pert
Peripheral Blood Mononuclear Cells,ctrl
XBP1s B cells 5,pert
Pancreatic Sample 25-Normal,ctrl
PBMC from T cell LGL leukemia patient #108 (TLGL108),pert
"CA1, parental control SOX7 HESC- clone2",ctrl
SUP-B15 Imatinib-treated,pert
"siRNA, plastic plate, rep1",ctrl
pre-iPSC- siRNA to Cbx3- biological replicate2,pert
Dicer KO CD4 T cells 3,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_10 months_replicate 1,pert
Subject #8023-8hr Postinfection,ctrl
"Patient  C, lesion, 12 week",pert
sample O term wt,ctrl
Rybp#15 (OHT+)_12d_rep2,pert
normal 1546,ctrl
"nasopharyngeal carcinoma, specimen T31",pert
216/0,pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14503;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"shZBP-89, biological rep1",pert
"NPTX1 shRNA Day 0, biological rep1",pert
Cav3KO 1504,pert
Untreated CHOP-/- B,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID127,pert
Experimental 2,pert
"brain, Entorhinal Cortex: 95-08 tangle_e1_le1",pert
"KO+Empty, biological rep1",pert
"MDA-MB-231/shNS, biological rep1",ctrl
4421-1 E2F3 Heterozygous,pert
Strain: a mixed C57BL6/129 genetic background,ctrl
quadriceps_muscle_Akt1+/-_female_35wk_rep3,pert
"strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 15 months;	tissue: liver, tumoral tissue;	disease status: hepatocellular carcinoma",pert
"Cultured ovarian cancer cell line C13, untreated",ctrl
OSCE-14T,pert
5248 UC Uninflamed sigmoid colon,pert
E12.5 heart_Sp3 knockout_sample a,pert
Sample 15 Kidney Normal Mouse - Control Diet,ctrl
"IKK2 -/- tumor, biological replicate 1",pert
PGA-MAH-C3H_OVA24h-5aA-s2,pert
"Strain: Wistar, Sex: male",pert
10SC-pbo,ctrl
U937_shSYK_2_Replicate1,pert
Mouse forebrain primary cell cultue of astrocytes,pert
AIRE-ko-CD80hi-mTEC-sample1,pert
Donor2_6h_Wy,pert
"G392E, 2 ug/ml doxycycline",pert
HN_64,ctrl
"liver, ABCA1-TG",pert
individual: patient15;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 3;	histology: endometrioid,pert
Human prostate cancer primary culture C41sx,pert
hippocampal tissue from wild-type mice (standard cage),ctrl
"control mouse cerebral microvascular fragments, biological rep3",ctrl
"LY2 cell line, SRC-1 siRNA untreated, biological rep1",pert
GIST_PDGFRA_3,pert
Mutant biological rep2,pert
INCB18424 Acute 3,pert
CD11b+Gr1- cell sample_4 (derived from wild type mouse),ctrl
23d wt4,ctrl
P0 - nudelcko/ko 3,pert
age: adult;	gender: female;	tissue: lung,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-tu3,pert
"vector d10, rep 1",ctrl
Sample ID:TP9;	Twin Pair ID:DCBD3.1;	Clinical Status:BD1 with psychotic features ;	Age of Onset:18 ;	Age at interview & blood sampling:35 ;	Current Age (2007):38 ;	Sex: Female ;	Medication at interview (duration) :sodium valproate (5 years),pert
patient E1520,ctrl
RNA from HCC_34N,ctrl
Mammary cell line,pert
siRNA LMG4 treated HeLa cells 2,pert
cell type: embryonic stem cells;	genotype/variation: Satb1 overexpression,pert
"fibroblast, MFS subject FB1627 rep 3",pert
KU_40T,pert
"CFU-PreB colonies Hspa9+/-, biological replicate 1",pert
"WT mouse heart at 6-weeks old, biological rep3",ctrl
GM19238_Kd_IRF5_1_rep,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-NANOG,pert
"FOXP3, mut, REP3, 0h",pert
Subject #8015-Preinfection,ctrl
A8_C8_nasal_stem_cell_rep1,ctrl
"72 hour-treated wild-type NB4, biological rep2",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 85min;	race: White;	sex: Female,pert
Subject 5 Pre allergen challenge,ctrl
lesion_preUV_patient8,pert
sMPNST cells treated with 500 nM JQ1,pert
phenotype: control;	gender: male;	case_id: 257;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 12;	brain ph at time of freezing: 6.46;	labeling_batch: 2,ctrl
Liver_nash_no.4,ctrl
Cont G2,ctrl
Mening Unstim WB SW 24a,ctrl
HT29siRNAc.833,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.131;	Ratio: 2.11,pert
Snell 6 month Dwarf Liver 83dw,pert
PPAR KO_ctr_116,pert
PGA-HMO-NonObese-1aUA-s2,ctrl
HLA risk: Low;	Height: 160 cm;	Weight: 53.4 kg;	BMI: 20.7;	Age: 22.84 years;	Gender: Female;	Race: White;	Glucose: 88 mg/dl;	HbA1c: NA,ctrl
Mouse No Cldn16 B9 439,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: unmatched,pert
patient: 19;	disease state: hypertension;	tissue: Atheroma plaque,pert
treatment: BCL-3 vector;	cell line: HaCaT;	tissue: Immortalized keratinocytes;	cell type: Immortalized cell line,pert
skeletal muscle Crhr2-/- replicate1,pert
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 24h",ctrl
Control_24h_rep2,ctrl
T6C-LU,pert
prefrontal cortex (BA46);	control,ctrl
No or early 2 rep11 (OHN),pert
Muscle control 2,ctrl
"t06, surgically resected from patient of gastric cancer.",pert
"Wild type used for MAT1A 15 month, replicate 1",ctrl
Subtype: RAEB1;	Karyotype: del(5q),pert
TTP_KO_0ActD_BioRep4,pert
CLL24-CD4,pert
"breast tumor epithelium,39",pert
homozygot FH P262,pert
control siRNA (siCon) tranfected into C2C12 myoblasts rep1,ctrl
WT / Reference_13425477,ctrl
Individual_5177_PP_sample,pert
mTert 2,pert
Bmpr1a-/- ESC media sample 2,pert
HGF patient gingiva tissue,pert
patient E1603,pert
COLO829 cells with shScrambled knockdown and PLX4032 treatment,pert
"Peripheral blood, patient without recurrent events [N45]",pert
M465 Wt,pert
PE_D_26A,pert
"cultured human airway smooth muscle, no treatment, replicate 3",ctrl
heterozygot FH P278,pert
double positive thymocytes,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 90;	ige (kiu/l): normal (0-48.5 kIU/L): 70.8;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
CUTLL1 DNMAML1 GSIwash2h,pert
ICR MEF infected  with pMX-Oct4 retrovirus,ctrl
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 19;	maternal age: 19,pert
cell type: Oct4-GiP ES cells,pert
"36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
age: 6 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
CD8_T_cell_pool_melanoma_M09+M10,pert
DOV13-(3),ctrl
colon_IBD_1802,pert
"SPC(+)Cre(-), Dox E6.5-12.5, PN15; knockout",pert
St6gal1-/- tumor #3376,pert
Diagnosis: MDS/AML;	Age: 51y ;	Gender: Female;	Blast %: 72;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
Wild-type Rep1,ctrl
WT1 naive CD8 T cells,ctrl
"PBMC, patient. Mtx rep6",pert
GM19238_Kd_NFE2L1_1,pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu2,pert
normal lung tissue,ctrl
db/db mice (stock 000642 Jackson lab),ctrl
major non-tumor2,pert
lymphocytes (blood),pert
Bone Marrow Mononuclear Cells;	31y Male,ctrl
Control Day7 (313R),ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.54;	age of onset: 19 yr,pert
condition: Discoid Lupus;	patient: L9;	tissue: LS skin biopsy;	kit: Ovation,pert
PC3 Wee1 Rep2,pert
strain background: CD1;	genotype/variation: Raldh2 null mutant; Raldh2 -/-;	tissue: embryonic brain;	tissue region: Rostral/Anterior;	developmental stage: 14 somite stage,pert
"Ulcerative Colitis (29 year old caucasian female, SAK_1305780306)",pert
CLL14-CD8,pert
"wild type naïve CD4 positive cell, unstimulated, replicate 3",ctrl
T5.02,ctrl
"SKO-transduced MEFs, Vc treated, lysed on D3",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 71,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: no mutation detected,ctrl
CLDN18_KnockOut_3,pert
cerebellum_WT_20d_rep2,ctrl
GB 8 63B NO LPA,ctrl
G93A-SOD1 mouse spinal cord 75 day,pert
Severe rep2 (OHN),pert
Cervical cancer_CC214,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 1hr,ctrl
H295R_Group_A_Dose_NA_TIMEPT1_003,ctrl
DMSO4_24H,ctrl
GB 12 NTB NO LPA,ctrl
Murine prostate,ctrl
Disease_status: Bipolar disorder;	Age (years): 35;	Gender: Male;	Age of onset (years): 19;	Duration of illness (years): 16;	Brain pH: 6.30;	Post mortem interval (hours): 35;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
"Cervical cancer cell line, MS751",pert
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate2,ctrl
"whole ear tissue, untreated control ear",pert
"129P3/J Chronic morphine treated, biological replicate 2",pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 45, stage IIIB, HPV 16",pert
Etoh 2,ctrl
wt #6. 466,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L112,ctrl
siOGT 12 hours_2,pert
"airway epithelium, small airways, obtained by bronchoscopy and brushing",pert
antimicroRNA-449_rep3,ctrl
Itk knockout CD4+ unstimulated 1,pert
Eed KO E14 ESCs on day 0 #1,pert
Subject #8031-Preinfection,ctrl
Argyrin A treated 24h_2,pert
tissue: mouse lung upper left lobe;	strain: C57BL/6;	genotype/variation: wildtype;	age: 6-10 weeks old mouse,ctrl
"All mice (C57BL/6) were free of Helicobacter species, housed in a specific pathogen free facility with 12-h light/dark cycles with free access to standard food and water.",ctrl
WT-smoke-low-5 month-R3,ctrl
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: captopril;	treatment time: 7 months;	age: 32-34 weeks,pert
T2E-LU,pert
LOX1 0hr 282295443,pert
"CD8 DC wild type, biological replicate 1",ctrl
"MS patient 12, technical replicate 1",pert
13A;pretreatment;female;breast tumor,ctrl
RAW_2.8mM_HOCl_#1,pert
HCC014N,ctrl
patient code: 104;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
KO - knock-out Treated - 0.5 hrs - repeat 1 - Cy5 - mAdbID:62538,pert
Beta4 nAChR subunit null mice without treatment,ctrl
"brain, QH2, 14 months",pert
LICR_HN2_PBS2,ctrl
age: 54;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
3N,ctrl
Embryonic Stem Cell,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: M;	age: 58,ctrl
"t03, surgically resected from patient of gastric cancer.",pert
chip number: 15;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.55;	rin: 9.5;	transfection date: 2011-10-17,pert
"C57BL/10 control TA, replicate 3",ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 3 hours",pert
WILDTYPE cerebrum at 20 days,ctrl
"non-AD_TC, biological rep11",ctrl
MCF-10A sh53BP1-1 replicate 2 [set 5],pert
Bcl6 KO 1 sample A,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 25;	gender: male,ctrl
tissue: testis;	gender: male;	age: 2-3 months;	genotype: wild-type,ctrl
"liver,24weeks,KO",pert
Huh7 cells_Mock Infected 24 hours_ rep2,ctrl
CD70Tg biological rep 3,pert
DMSO2_6H,ctrl
"p400 KD, replicate B",pert
Mouse old heart C30-Ht-2,ctrl
Lmna H222P homozygous male 4,pert
H295R adrenocortical carcinoma cell line,ctrl
pt. HCL C treated with DMSO for 72h,ctrl
Rex-1 KO_minus LIF_rep3,pert
"SS gland, early, patient 6, batch 1",pert
CAR.AH_corn oil_rep2,pert
HMEC X BC17,pert
HF1235_U133P2,pert
Kidney_Biopsy_Liver_Disease_5,pert
CRC_nodrug_F4872,ctrl
mouse skin,ctrl
pt. HCL D treated with DMSO for 72h,ctrl
siGL3Veh 1,ctrl
age: 57;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Control #1,ctrl
tissue: LNCaP-LM NSG xenografts;	expression: Hes6 overexpression,pert
"strain: C57BL6/10J;	genotype: Cmah KO, mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle",pert
"3T3-L1 siLSD1 24h, biological rep 2",ctrl
"Retina from NeuroD1 cKO mouse at ZT20, biological rep 3",pert
RNA from whole tissue section of case 763 labeled with Cy5,ctrl
34GOBMUC2H,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 7 hours after nickel exposure",pert
Normal testis 9013,ctrl
subject: 35;	disease: CP;	muscle: GR;	gender: M;	age: 5.9;	gmfcs: 5;	popliteal angle: 130,pert
background strain: B6/129;	genotype/variation: WT;	tissue: Liver;	age: 2 Month,ctrl
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PBMC;	molecule: RNA extracted from PBMC,pert
Control subject 117_biological replicate 2,ctrl
colon_epithelium_C57 mouse_12weeks_rep3,ctrl
subject id: 574328;	infection: DENV;	status: DHF;	tissue: whole blood,pert
jzo024-rp1-v5-u74av2-met,pert
VehLPS1,pert
Subject 5_t=30days_resveratrol,pert
"ESCs overexpressed Foxd3, biological rep2",pert
NIH3T3_0h_exp2,ctrl
age: 12 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 10. Replicate A,ctrl
12mo Control #2,ctrl
LC1003ni,pert
"Patient C-c145T, MSI colorectal tumor",pert
"BOEC, normal 7",ctrl
normal control_CTL2,pert
BL6_24h_DMSO,ctrl
RTX9 T12,pert
umbilical cord_nobpd: 3I,ctrl
PancreaticSample33-Tumor,pert
tissue: Hippocampus;	age: 55;	Sex: M,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 62;	donor: 13;	disease state: Lesional,pert
A549_NS siRNA_biological rep1,ctrl
diet_LIVER_2,ctrl
GM19238_Kd_IRF3_2,pert
Zfx fl MA9 cells + 4-OHT [10949],pert
Nerve_Diabetic_Rosi_719,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 55,pert
splenic CD11c+ dendritic cells,ctrl
3451-1 E2F WT,ctrl
PMVEC isolated from mice carrying immortomouse and Rosa26-rtTA transgenes,ctrl
"Infected with H37Rv, replicate 3",ctrl
Lung myd88 mock repB,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 30,pert
cell line: Hep3B;	treatment: transfection with nonsense siRNA,ctrl
"BMDC, wt, replicate 2",ctrl
primary normal lung tissue 1090,ctrl
C5bt5,pert
D890_WBS,pert
Knock-out postnatal day 10 rep 2,pert
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 87;	baseline tumor size (cm): 5x3;	patient id (to identify the 2 chips from the same patient): 19301950,pert
sample =XCGD2 treatment=Control time=0 (min),pert
Genotype: wild type;	not differentiated,ctrl
non-malignant FTEn_patient 4,ctrl
PKBa-/- MEF time 0 replicate 2,pert
Jurkat T-cells transfected with siRNA #2 for Sp3 for 48 hours,pert
TP06-727-993,ctrl
"RISC-free control transfected, biological rep 2",ctrl
MCL_IGHV_UNMUT (R1595),ctrl
"medulloblastoma, M2_cMYC_silenced, rep2",pert
tissue: white blood cells;	age: 4;	Sex: male,ctrl
ILD Study Number 1319,pert
"human failing LV myocardium, Ischemic67",pert
U2OS_control_shRNA_pLenti_2,ctrl
H1_SS11_01Nov07,pert
Day: 18; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 1,pert
"Epidydimal white adipose tissue from ASC-/- after 16 weeks of high fat diet feeding, replicate 2",pert
strain: C57BL/6;	cell type: MEFs;	genotype/variation: Cebpg-/-,pert
LCL Unaffected MZ twin pair 1 (CCN1.2R)(TP16),ctrl
"human failing LV myocardium, Idiopathic12",pert
lymphocytes_ctl_M_38y,ctrl
Human sorted B cells,ctrl
Tissue:tumor; Gender: male; Age:43; Tumor stage:T2NxMx,pert
"Peripheral blood, patient without recurrent events [N49]",pert
Pool Eu_P0,ctrl
"proband g, past exhaustive exercise",pert
"TNFa-OMe-P siRNA-C, replicate 1",pert
HF0377_U133P2,ctrl
Normal_Kidney_Biopsy_7,ctrl
normal adjacent esophageal tissue from patient E1584,ctrl
LJMJDW11,pert
06R017 Control,ctrl
23A;pretreatment;female;breast tumor; responder,ctrl
sex: Male;	family: 4;	age: 54;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
01N71: normal control,ctrl
Normal Uninflamed descending colon,ctrl
Ishikawa_LowDose_BPA_8h_rep4,pert
"kidney, Q10, 14 months",pert
N5,ctrl
Tissue: lung;	Genetics: Sporadic IIP;	Histology: Usual Interstitial Pneumonia,pert
"breast tumor epithelium,49",pert
WT 3,ctrl
THRA 6a mutant + vehicle replicate 1,ctrl
unstimulated CD8+ T-cells from Itk knockout C57BL/6 mice,pert
ZNF395 knock-down (shZNF395-2),pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.945;	Ratio: 2.12,pert
strain/background: C57BL/6;	genotype/variation: Zbtb7a Flox/+ Mx1-Cre+ (LRF heterozygous);	age: 4 weeks;	cell type: FACS-sorted LT-HSCs (LSK IL7Ra-Flt3-CD150+CD48-);	time point: 9 days after 1st pIpC injection,ctrl
"U373-DTX1-myc, rep 3",pert
tissue: Temporal cortex;	age: 72;	Sex: F,ctrl
sidroshaB-transfected sample,pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 2,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 183;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.298;	tissue: colon;	treatment: 5% DSS,ctrl
"ID:c 2-1, Genotype=(C57BL/6J), Treatment= none",pert
0968-01-C,ctrl
"LCL GM19238, Kd IKZF3, 72hrs",pert
Run1.a10a.000609jd.2.SkMNor909.CEL-IS basal,ctrl
5213 UC Inflamed sigmoid colon,pert
MA_302,pert
PCOS Endometrial Biopsy,pert
"Primary, Prostate cancer, localized",pert
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 3,ctrl
SHR20-2,pert
"Uninvolved Skin, NS-30",pert
thyroid sample containing normal cells,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.977;	OD280: 0.478;	Ratio: 1.99;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 300;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
TTP_KO_0ActD_BioRep1,pert
WT_liver_vehicle 0 mg/kg_96 hr_4,ctrl
Aldosterone-producing adenoma (APA15),pert
Csbm/m Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-2,pert
08_PAH,pert
Oct4GipES_Panct1_esiRNA_72h_rep1,pert
treated with TGF-beta,ctrl
patient: 135;	current medication: none;	birth date: 8/14/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/28/05;	indictation for procedure: bloody diahorrea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
age_years: 70;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
"Acute Myeloid Leukemia, sample 73",ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 35week,pert
PS-NA cerebrum at 4 weeks,pert
Squamous cell carcinoma 035,pert
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"eye, cornea: TRizol Extraction_le1 2",pert
tissue: skin;	individual: Patient P13;	condition: ANL;	eczema severity: SCORAD: 0,pert
platelet_sickle_3,pert
KO - 5 mo - repeat 4 - Cy5 - mAdbID:74138,pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep2,pert
SON siRNA rep1,pert
CF_lubiprostone,pert
1214-3C,pert
Healthy controls; individual=MB; time=2; beverage=alcohol,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"mouse liver sample, WT strain, biological replicate 3",ctrl
U-87MG-V17 set 1,ctrl
OVCAR-3/CD157 cell line,pert
SKBR3 PR 2,pert
WT - Cre Control - 3 mo - repeat 5 - Cy5 - mAdbID:74668,ctrl
22A;pretreatment;female;breast tumor,ctrl
AKT_PLACEBO_12hours_1,pert
subject id: 37;	infection: DENV;	status: DF;	tissue: whole blood,pert
WT_BoneMarrowMacrophages_unstimulated_4hours_rep2,ctrl
"E18.5 ERRg -/- heart, biological rep 1",pert
HeLa cells nucleofacted with Dharmacon control siRNA,ctrl
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 10 weeks-old,pert
Barrett's esophagus (B6),pert
SK-N-SH cell line infected with MECP2_e1 lenti,pert
"Mutant in the presence of tetracycline, rep2",ctrl
strain: C57BL/6J;	age: 4 months;	gender: male;	tissue: lung;	genotype/variation: control,ctrl
"SKO-transduced MEFs, Vc-, D10",ctrl
5200 Normal Uninflamed sigmoid colon,ctrl
HCaRG-9 HG-U133 Plus 2.0,pert
"cochlea at P60, ko, biological rep 2",pert
Dilated cardiomyopathy_G2,pert
"NeuroD1 cKO at ZT20, retina",pert
braak stage: BR34;	rin: 77;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
HNF1b_2b-,ctrl
Human skeletal muscle biopsy sample;	Patient #197 with PM,pert
background strain: B6/129;	genotype/variation: wild type;	age: 14 Month;	tissue type: Liver,ctrl
H6PDH WT,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L014,ctrl
BCell_resting_sample5,ctrl
"Control shRNA cells passage 11, rep 3",ctrl
SeroTest-8,pert
Hippocampus of of non-AD brain,ctrl
siSPDEF_2,pert
gender: male;	genetic background: C57BL/6x129;	age: 6.5 months;	tissue: Crhr2-/-;	genotype: Gastrocnemius and Soleus muscles,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
cell type: Human melanoma cell line;	cell line: M238_R1;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
phenotype: alcoholic;	gender: male;	case_id: 212;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.59;	labeling_batch: 2,pert
Normal-ERα-positive breast cancer 3,ctrl
colon_epithelium_C57mouse_6weeks_rep6,ctrl
Colo205 parental cell line,ctrl
strain: BALB/C;	age: 8-10 weeks;	treatment: CVB3;	gender: Female;	time: 10 dpi;	tissue: heart,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14535;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
coc-8_B,pert
age: 6 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),pert
umbilical cord_nobpd: 6A,ctrl
tissue: glomeruli of human kidney;	disease state: nephrosclerosis,pert
PGA_MI_nilv_8w_326,pert
Normal Biological Replicate 4,ctrl
"Control siRNA - Undifferentiated, rep3",ctrl
"Pancreatic islets, control, 03",ctrl
"Liposarcoma culture from tumor 400, doxorubicin treated",pert
MPM tumor specimen 36,pert
Liver_normoglycima_no.4,ctrl
Tretinoin3,pert
Benign prostate tissue NX2,ctrl
GM9013,pert
Bone-Marrow_MGUS_G588,pert
"Tissue: peripheral blood, Subject:Sickle cell patient",pert
THRB wt + T3 replicate 4,pert
"Patient  H, lesion, 1 week",pert
HCC_33T,pert
"urogenital ridge epithelium, E10.5, -/-",pert
Sex: male;	Age at operation: 70 years;	Site: thigh;	Size in cm: 9x3x6;	Histological Subtype: atypical lipoma;	Responder type: medium;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
liver_STZ treated diabetic_rep1,pert
normal adjacent esophageal tissue from patient E1520,ctrl
Strain:J1 Cell type: mouse embryonic stem cell,ctrl
Emd KO male 1,pert
Primary human lung fibroblasts,pert
KN-sham-1 day-R3,pert
0966-01-C,ctrl
KN-sham-5 month+1d-R1,pert
"Ifitm1-deficient lung tissue, biological replicate 5",pert
01LN7_Systemic,pert
12492 UC Inflamed descending colon,pert
b36-,pert
3 wks TAC-3,pert
Liver_Female_WT_rep2,ctrl
patient E1521,pert
jzo022-rp1-v5-u74av2-met,pert
Mammary gland R1 8 hr rep1,pert
reference: whole mouse total RNA,ctrl
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"Control, biological rep1 (with calcium)",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 145min;	race: White;	sex: Female,ctrl
mESCs_EGFPcontrol_rep1,ctrl
KO-517,pert
strain: BALB/c;	cell type: CD8 T;	genotype/variation: KLF13 KO,pert
"MCF-7 human cell line, siControl",ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 44;	donor: 33;	disease state: Lesional,pert
Strain: C57BL;	Gender: male;	Age: 9-10 weeks;	Tissue: liver;	Developmental stage: adult;	Cell type: Primary hepatocytes,pert
T50 U133p2,pert
"NPTX1 shRNA Day 2, biological rep2",pert
.SAL_II_2,ctrl
wild-type rep_1 (CWT1),ctrl
HaCat cells infected with a BCL-3-expressing  lentiviral construct. Replicat 2,pert
thyroid cancer cell line,pert
"brain, hippocampus: C24-III_e1_le1",ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure.",pert
116A,ctrl
n6t7d,pert
CON25,ctrl
"Age: 40;	Sex: M;	Ancestry: African;	Smoking status: smoker, 24 pack-years",pert
liver_QH2_6M_rep3,pert
cerebellum wild type 21 month replicate 4,ctrl
lymphoma_4936_nt,ctrl
mouse B6xCF-1  Non-transgenic (control-1),ctrl
Moderate rep8 (OHN),pert
IP RNA_KO_rep3,pert
BP patient 75_biological replicate 2,pert
Moderate rep3 (OHN),pert
NLGN1_2,pert
Gender: Male; Tissue: Prostate.,ctrl
platelet_sickle_12,pert
cell line: IGROV-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 28.81096,ctrl
CLL23-CD4,pert
E10_otic_vesicle_wt_replicate2,ctrl
Melanoma cells,pert
"LKR13, knockdown of K-ras by shRNA",pert
intestine_wildtype_control_rep2,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 61 years,ctrl
Normal-ERα-positive breast cancer 37,ctrl
sepsis patient #15,ctrl
microdissected ovarian tumor,ctrl
EpiAdip wildtype ND,ctrl
U2OS shCHK1-4 replicate 3 [set 4],pert
Liver_normal_no.2,ctrl
SW480_control RNAi_luciferase_rep1,ctrl
Brain from 37 days Npc1-/- mouse1,pert
MEF Wild Type 2-rep1,ctrl
"murine kidney, cystic epithelial tissue,  Fh1 knockout mouse",pert
A2058 CT16 siRNA Rep1,pert
SLE CD4 T cells 12,pert
Caco-2 ZNF658 siRNA 2,pert
full thickness aortic wall biopsy,pert
liver knock out replicate3,ctrl
Normal patient platelets,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 63;	gender: male;	tumor grade: AIII,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case3,pert
Hunk Knock-Out rep 1,pert
memory HD-/- P14 T cells #1,pert
"male,17,Caucasian",ctrl
2B1_Dlx5_replicate2,pert
0205-01-C,ctrl
Braak α-synuclein 3-4 BR34_5SN,pert
Spleen_infected_6weeks_rep1,pert
cell type: mouse embryonic fibroblasts (MEF);	phase: cycling,pert
mn cells sample 2,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 30 min after intravenous endotoxin challenge""",pert
"RWPE-PCAT1 NT siRNA, replicate 1",ctrl
V5-P069,pert
"Primary aortic endothelial cells, Non_transgenic_control",ctrl
strain: 129SV;	gender: male;	age: 6 months;	tissue: right ventricle;	genotype: wt,ctrl
chip number: 23;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.84;	rin: 9.7;	transfection date: 2012-03-26,pert
Jurkat-KD1,pert
Alpha7 L250T heterozygous mice following nicotine-induced seizures,pert
A549 AZA 3 uM (3215),pert
tissue: white blood cells;	age: 10.6;	Sex: male,pert
wild-type_corn oil_rep1,ctrl
Prostate Cancer_MS 36C3,pert
individual: patient6;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
platelet_Ctrl_6,ctrl
"SiRNA-scrambled, replicate 7",ctrl
Skinbiopsy_7hoursnickel_controlsubject_k4,ctrl
"HEK cells transfected with scrambled siRNA, 24h after transfection",ctrl
A2008+(3),pert
Pool Ts1Cje_P30,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.848;	OD280: 0.434;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 207;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
H6_SS11_01Nov07,pert
genotype/variation: Tpl2 deficient;	treatment: unstimulated,pert
Disease_status: Healthy control;	Age (years): 40;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 38;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Normal mucosa 8,ctrl
"TMD_EHL, T1",pert
MDS patient 115,pert
Integrin alpha7 transgenic mouse rep1,pert
WT_72_O3_1,ctrl
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
R6/2 (untreated) 5227,pert
cell type: mouse embryonic fibroblasts (MEFs);	genotype: KSR1 -/-;	expression: GFP;	background strain: DBA,pert
Bone-Marrow_MM_M1142,pert
"Heart, MAT1 control, 4 wk, sample 3",ctrl
5871841165_A,pert
C_LS_Wk12,pert
"56B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
"striatum,12weeks,KO",pert
"GFPMYC negative GC B cells, Biological replicate 4",ctrl
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep1,pert
MKK3bE transgenic female replicate 3 late timepoint,pert
Bronchial Epithelial Cells MMA biological 1821T,pert
Retina severe glaucoma,pert
CA1,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 30;	maternal age: 29,pert
renal tissue from WT mice,ctrl
NFIA P16KO1,pert
1_WT_2,ctrl
Livers of WT mice sacrificed at 4 weeks,ctrl
CD3+ T cells from patients with sarcoidosis,pert
TN1,pert
"D425-shOTX2_1, t=48",pert
"129P3/J CHR, Rep2",pert
F191G B,pert
"HME-CC, 12h, 0.2uM DOX B",pert
MF_II_2,pert
56A;pretreatment;female;breast tumor,ctrl
Nr2_pre221,pert
XmO7,pert
R1 ES cells expressing human Gata3 T2ER fusion,ctrl
RWPE-PCAT1 cells transfected with cMyc siRNA #3,pert
E17.5 preB cells_Smchd1 wildtype_Rep 2,ctrl
Monocyte-RCC-untreated-5,pert
49A;pretreatment;female;breast tumor; responder,ctrl
Pt25_Post,pert
"p38alpha wild type fetal liver E15.5, biological rep2",ctrl
ILD_5,pert
"thymus, control",ctrl
terminal end buds from mice,ctrl
Individual_511_PN_sample,pert
Transfected MCF-7 cell line (siRNA targeting SPDEF),pert
Wildtype liver_saline-injected 12weeks repl3,ctrl
V5-P187,pert
"Ulcerative Colitis (40 year old caucasian female, SAK_1285156893)",pert
Muscle 50 eccentric contractions 12 hours KO Adult 01031,pert
Tumor from MYF-5 CRE/SSM2 mouse,pert
siIPMK + MMC experiment 2,pert
SC263_PBS2,ctrl
"22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
SHR20-3,pert
HCC1937_3,ctrl
"Hunk Knock-Out, Mammary gland",pert
"liver, knock out",pert
CD4+_Tcells_non_severe_asthmatic_1,pert
Muscle JDM (YJD-JDM-14UA-s2),pert
patient: 135;	current medication: none;	birth date: 8/14/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/28/05;	indictation for procedure: bloody diahorrea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"MCF-7 cells, siERK5 treatment 72h, 10 nM E2 for 24h",pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6aKO;	treatment: DSS for 3 days,pert
Braak α-synuclein stages 5-6  BR56_5SN,pert
WT-pDC2,ctrl
"Control Distal, Small Intestine 1 17 days old",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 24h,ctrl
"Control, biological replicate 1",ctrl
Mouse old brain w/ a-tocopherol aT-Br-1,pert
S6-041001-SA,pert
tissue: large intestine;	genotype: HDAC3FF;	strain: C57BL/6,ctrl
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: NO,ctrl
cell line: HEK293 cells WTX inducible clone F18;	agent: control,ctrl
Mouse RSK2 mutant mandibular molar [ABH_14A],pert
APBMNC.LPS-.2,ctrl
"human failing LV myocardium, Idiopathic53",pert
"P206 HCT-116, DNMT1 knockout, DMSO-treated",pert
Patient 2 skin baseline,ctrl
Disease_status: Bipolar disorder;	Age (years): 54;	Gender: Male;	Age of onset (years): 45;	Duration of illness (years): 9;	Brain pH: 6.50;	Post mortem interval (hours): 44;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
Fiona Biological Replicate3,pert
age_years: 63;	sex: F;	ethnicity: Latino;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Fetal heart control 1,ctrl
MDS patient 164,pert
RNA from HCC_37T,pert
RNA from RAW 264.7 Cells,pert
Sample 04 Kidney Mouse Hyp - Low Phosphate Diet,pert
wt testis at 14dpp,ctrl
"KARPAS-231, non-targeting siRNA, REP2",ctrl
HP-1,pert
cell type: Primary hepatocytes;	strain: DBA;	agent: control;	time: 6h;	gender: Female;	age: 3 months,ctrl
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 11+16=27;	Sex: male;	region: M1;	age: 37,40;	genotype: Y/Mecp2-;G42/-",pert
"H69 tumor post-PDT, biological rep1",pert
Sox9egfp_p23-2,pert
"Wildtype, biological rep1",ctrl
"H1299 treated with PBS buffer, 12hr",ctrl
B2KO; No Treatment #6,pert
Male C57Bl/6  Mice were 10.5 weeks old at time of sacrifice.,ctrl
patient: 51628;	sample: normal,ctrl
BP patient 49_biological replicate 1,pert
ic patient 5,pert
SeroNeg-1,ctrl
background strain: C57BL/6J;	cell type: Lin- hematopoietic progenitors,pert
"DCIS 8, biological rep. 8",pert
Dorsal Skin_SKO,pert
Cortex,ctrl
patient: 211;	current medication: Predfoam Adcal D3 Alendronate;	birth date: 11/10/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 6/7/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/5/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/5/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Coeliac disease 1991;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
MDS patient 29,pert
Cebpg-/- MEFs at passage 3_biological replicate 2,pert
"mouse aorta cross strain comparison, C3H_T04_NC_01",ctrl
Tumor-WT-rep4,ctrl
"INS-1 cell line, clone #5-3.19",ctrl
diet_LIVER_4,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp1,pert
cell line: MOLM-14;	shRNA construct: GSK3B Construct 1,pert
MyD88_ZYM_B,pert
Subject 9_t=30days_resveratrol,pert
Brain from 82 days Npc1-/- mouse1,pert
KOT 80 bleomycin treated,pert
"ACI strain, male, age 21 weeks",ctrl
"650nM MLN4924 after 1hr, replicate 3",pert
"Wild type used for MAT1A 3 month, replicate 3",ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N3, G4",pert
RPE65_KO_4months_retina25,pert
HMEC X HMEC + TGFbeta 24hrs,ctrl
hiPSC-derived 6-week-old neurons,pert
Backskin_Get1_e18_KO2,pert
HEK293 cell line #5 with uninduced HNF1beta mutant A263insGG,ctrl
PGA-MAH-OuJO3-1bAv2-s1,ctrl
"HEK293 cells siRNA control, biological rep3",ctrl
1-ONS76_a,pert
liver_co_14M_rep3,ctrl
Bronchial Epithelial Cells MMA biological 2119J,pert
MDS patient 87,pert
Series 3; old; 6 weeks after fracture,pert
chip number: 22;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.82;	rin: 9.3;	transfection date: 2011-10-17,pert
H02_P_B2,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 55;	sex: M,ctrl
"PTEN mutant 3 intestinal polyp, polyI:C, 30 days",pert
tissue: normal adjacent esophageal tissue,ctrl
Large cell carcinoma 010,pert
non-malignant FTEn_patient 6,ctrl
"14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
HT29siRNAc.E,pert
PBMC_S4,pert
P4_Ovary_NT3_biological rep2,pert
"Animal id 1024, left retina, 3 months, female, DBA/2J",ctrl
"brain, hippocampus: C72-II_e1_le1",ctrl
"DCIS 6, biological rep. 6",pert
age: 71;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cell line: HT144;	transfection: negative control non-targeting siRNA,ctrl
GM19238_Kd_RAD21_2,pert
MCL_IGHV_MUT (R1970),pert
Diaphragm 14 Day control rep 2,ctrl
Glioblastoma_4,pert
WT_P14_D3_Effector_rep4,ctrl
Knockout liver DEN-injected 12weeks repl2,pert
VillinCreERT2+_Brg1fl/fl_Rep3,pert
microdissected breast cancer cells from case 605,ctrl
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: E,ctrl
CML-BM 3,pert
sex: Male;	family: 1;	age: 49;	disease status: Affected;	tissue: Muscle: Biceps,pert
"Huh7 cells, Mock Infected, 12 hours.",ctrl
striatum wild type 6 month replicate 1,pert
U133A_B0_dv,pert
"Ctrl OBCs, post doxycyclin withdrawal, rep3",ctrl
condition: Psoriasis;	patient: PS-G;	tissue: LS skin biopsy;	kit: Affy,pert
treatment: siCFIm68;	cell line: HeLa,pert
short term cultures of epidermal melanocytes,ctrl
siGFP-transfected sample 2,ctrl
"Peripheral blood, normal control [N58]",ctrl
PKBa-/- MEF time 0 replicate 4,pert
"glioma cell line U373, DTX1 over-expressing",pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.86;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"brain, hippocampus: Aldh5a1-/- #3363 Cort_e1_le1",pert
SU8686 rep-3,ctrl
Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,ctrl
06R014 Control,ctrl
"Nod2-UN2,experimental replicate 2",pert
Patient 4,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 1,ctrl
race: caucasian;	age (years): 67;	stage: IC;	grade: 1;	histology: endometrioid,pert
muscle_Wt_8wk_rep2,ctrl
"new born prosaposin knockout mice, cerebrum",pert
S-IIP(UIP)12_Cy3,pert
"tissue sample from Bellevue Hospital, NY",pert
Disease_status: Healthy control;	Age (years): 37;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
MDS46,pert
"proband g, before exhaustive exercise",ctrl
bipolar disorder,pert
GC resistant clone C7H2-R10E7 treated for 6 hours with GC,pert
HEL_Control shRNA (Luc)_3,ctrl
Normal cervix_05-4602,ctrl
age	31;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	8.3;	hemoglobin (g/dl)	14.9;	platelet count (/nl)	269,ctrl
Lin- Rosa26rtTA cells transduced with pRRL.TET.EVI1.IRES.EGFP,pert
"Normal subject (42 year old caucasian male, SAK_1276036865)",ctrl
cell line: H1299 lung cancer cell line;	genotype/variation: RBP2 depletion;	shRNA: RBP2 KD1,pert
Adipose-24 month-Myc heterozygous-technical replicate 2,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Untreated-Control, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",ctrl
Patient no. 15: control,ctrl
Carboplatin;	Carboplatin 30 hours set 1,pert
48SAGEA2,pert
genotype/variation: Vax2-/-;	age: P60;	tissue: Whole eye,pert
Run5.aUa.010110d.SkmDbt2448D.CEL-DB stimulate,pert
Isoflurane 5 exposures-2,pert
N51176,ctrl
epithelium from colon of control mouse no.3,ctrl
"cerebellum,24weeks,KO",pert
MacularDegen-healthy-4cAv2-s2,ctrl
strain: C57BL/6;	genotype/variation: wild type;	gender: male;	age: 5 Month old;	tissue: White adipose tissue (WAT);	diet: 35% Fat Diet (High Fat Diet; HFD),ctrl
wt_off_rep3,ctrl
MZ1774 YAPshRNA rep 4,pert
"Frontal Cerebrocortex, permethrin (1 mg/kg), 6 hours",pert
Wild type day 3 Air replicate 2,ctrl
IEC_GF-HDAC3FF -1,ctrl
Peripheral blood mononuclear cells (PBMC)-Patient SE T1,pert
C_AN00142_T,ctrl
CD8_T_cell_pool_healthy_H11+H12,ctrl
CON_D,ctrl
"SFM control cells (24hr), biological rep1",ctrl
age: 71;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
01LNH_CTRL,ctrl
P0 - nudelko/+ 3,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_10 months_replicate 3,pert
"Patient  K, lesion, 2 week",pert
iPSC control triplicate 3,ctrl
double positive thymocytes,pert
Spleen_ko_1m_rep1,pert
erStress_twins_AA_1720twin1_DMSO_4h,ctrl
tissue: blood;	control: 1;	gender: male;	age: 41,ctrl
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6bKO;	treatment: untreated,pert
Untransduced Wild Type DAOY Cells;	,ctrl
T175,pert
INS-1 cell line (FLP-In T-REx clone #5-3.14),ctrl
Uninfected control_0b,ctrl
SCC-2_siZMPSTE24_rep.2,pert
SV589_3Day KD_Serum Starved -> 3hr EGF,pert
Ngn3 EB10 OFF replicate 2,ctrl
Trib1 #2 Wild-type macrophage LPS,ctrl
age: 77;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 60,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 3,pert
HLA risk: Low;	Height: 178.5 cm;	Weight: 71.2 kg;	BMI: 22.4;	Age: 25.25 years;	Gender: Female;	Race: White;	Glucose: 80 mg/dl;	HbA1c: NA,ctrl
patient: 116;	current medication: Clomiprimine;	birth date: 1/19/56;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: FH Colon cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
BAL_41_A1B0,ctrl
MH1C1_untreated_rep2,ctrl
Subject #8046-2d Postinfection,ctrl
BAL_19_A0B0,ctrl
"Normal subject (53 year old caucasian male, SAK_1287347487)",ctrl
Mtb infected-42d-1,ctrl
224 Day 1 siMut12 transfected biological rep1,pert
K562 cell line,pert
Pool Eu_P0_hyb2,ctrl
Jurkat Biological Replicate 1,ctrl
PB_DON056,ctrl
Huh7 cells_JFH-1 Infected 24 hours_ rep1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.208;	Ratio: 2.10,pert
disease affected colon of an adult with Crohn's disease (CD).,pert
gender: M;	age at blood draw: 58;	tissue: whole blood,ctrl
disease status: CML chronic phase (CP);	cell source: bone marrow (BM);	cell type: CD34+ mononuclear cells,pert
KPW13_T5_PP_day7_053,pert
cKO 24h V1::1,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
SC-RbKO 1,pert
"N-58, NORM, M, GSF, 6 x 100nM DHT, 14d",ctrl
allergic_asthmatic_bronchial biopsies,pert
cell type: Melanoma cell line;	cell line: A375,pert
"kidney, control, 6 months",ctrl
RKO human colorectal carcinoma cells,pert
gender: male;	age: 8 weeks;	strain: Sprague Dawley rats;	tissue: lumbar dorsal root ganglia,pert
"Acute Myeloid Leukemia, sample 34",ctrl
"650nM MLN4924 after 8hr, replicate 3",pert
Total Prefrontal cortex RNA,pert
cell type: MEFs;	genotype/variation: p27KO,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 314;	age-at-biopsy-years: 49,ctrl
H157 siDJ-1 #1,pert
cell type: Normal Human Epidermal Keratinocytes (NHEK);	transfected with: MLL2 siRNA,pert
Kidney_WT_baseline_rep1,ctrl
Placenta_PE(LO)2 with Cy5,pert
"brain, hippocampus: Ctr-72h-P15-II_e1_le1",ctrl
"fibroblast, MFS subject FB1040 rep 2",pert
esophageal squamous cell carcinoma from patient E1532,pert
11434 UC Inflamed descending colon,pert
Subject #8031-8hr Postinfection,ctrl
"patient 14, right arm treated with pimecrolimus until day 22",pert
agent: EphB2-Fc conjugate;	time: 4h,pert
Caco2-siRNA-control2-rep3,ctrl
Recent-onset T1D_sample3,pert
treatment: Vehicle;	time: 25,ctrl
"Lymphoblastoid cell lines derived from family 1744, member 2",pert
"fibroblast, control subject NF10 rep 2",ctrl
"GTF2iTrap line, biological rep 2",pert
EA_Case4_CD20,pert
Tslc1 +/+ mice_rep1,ctrl
Strain:  B6.V-Lep ob;	Gender: female;	Age:  12 weeks;	Tissue:  gallbladder,pert
sex: female;	tissue: liver,pert
Mouse brown preadipocyte cell line,pert
"brain, cochlea: [11] Sample #11_le1",ctrl
cell line: E14;	treatment: control,ctrl
"age at diagnosis: 55;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1b;	er: EV;	pgr: EV;	dfs-month: 22;	dfs-event: 0;	distant metastasis: 0",pert
Whisker pad WT biological rep2,ctrl
SA_253,pert
Clozapine treated 4weeks AffyGC RMA rep3,pert
Mouse forebrain primary cell cultue of astrocytes,ctrl
NPC_wt_rep4,ctrl
liver; fasted 18h,pert
wild type stria vascularis replicate 3,ctrl
cerebellum SNCA knockout 6 month replicate 1,pert
tissue: white blood cells;	age: 15.59;	Sex: male,pert
HEK293_HNF1a_#1_uninduced,ctrl
C57BL/10-SJL.Dysf QF replicate 1,pert
10SAGEA,pert
34A,pert
WT3-iPS 1,ctrl
age_years: 63;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
020112-5,ctrl
Biceps_Control_1,ctrl
Hippocampus_Soman_6h_rep3,pert
"t19, surgically resected from patient of gastric cancer.",pert
HEL_Control shRNA (Luc)_2,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 44;	gender: male;	tumor grade: IV,pert
cDNA no 17,ctrl
Wild-type standard cage Rep2,ctrl
RKO_NEGsiRNA_6hDMSO_REP2,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 72;	Usage number: 1;	Exposures: 4,pert
"Acute Myeloid Leukemia, sample 66",pert
HVS-CD4-ITK-R335W_unstim,pert
LT489 wild-type after nicotine-induced seizures,pert
"Testosterone treated, HIV-1 positive male, day 14 (10)",pert
22SMOKEH,ctrl
NPC_p5ko_rep2,pert
Lung of hemorrhaged animal 1h,pert
Pancreatic Sample 11-Normal,ctrl
ACC Xenograft X4,pert
3879-1 E2F WT,pert
CON-3-PLASTIC,pert
"Normal subject (57 year old caucasian male, SAK_1290276212)",ctrl
A HID B_B046,pert
Large cell carcinoma 011,pert
HaCaT_ZNF750i_ biological rep3,ctrl
AKT_PLACEBO_48hours_3,pert
hNHEPS_0.1 μM_6 h_rep2,pert
PTC BRAF mut 8,pert
cell line: H1;	cell type: embryonic stem cells;	shRNA: HERVH,pert
"INS-1 cell line, clone #5-3.14",ctrl
strain background: C57Bl/6;	genotype/variation: P14 TCR transgenic C57Bl/6;	cell state: Day 0 Naïve CD8+ T cells,ctrl
01LKS,pert
"patient 041b, cancer, homogenized",pert
"8 wk old BALB/c (or BALB-RAG) mice were sensitized to ovalbumin (or PBS)]on days 1 and 7, and challenged with aerosolized ovalbumin (or PBS) on days 15-21, and samples harvested on day 22",pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/+;	tissue type: renal tissue",ctrl
"experiment IV, hTERT, replicate 2",pert
SKBR3_1uM_Lapatinib_1,pert
blood_day6_patient1,pert
Luciferase shRNA_3 Days knockdown_rep2,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 2",ctrl
Keratinocytes treated with EFNA4 for 24h,pert
S46 WT1	F5/3	S46	wild type	Mouse	3.5 months	Cerebellum	Male,ctrl
"Lens epithelium, WT, #2L",ctrl
WT_48A_4,ctrl
HD 2,ctrl
sampleID: SAM630142;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
tissue: liver;	gender: male;	disease status: type 2 diabetes,pert
Psoriasis-Patient-C,pert
RNA from HCC_20T,pert
U2-OS-ERa E2 4 hrs 1,pert
Cre_day_3-3,pert
WT V6.5 ESCs on day 0 #1,ctrl
Gsk-3b-/- ESCs Rep1,pert
14 saline,ctrl
Mature mice skeletal muscle sample from the forelimb,ctrl
P8 Vax2-/- 1,pert
cell type: mammary epithelial cells;	gender: female;	age: 8 weeks;	myc: WT;	p53: KO;	rb: WT,pert
normal main pancreatic duct 7,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 21.40548,pert
subject id: c6;	infection: control;	status: control;	tissue: whole blood,ctrl
brain_DLPFC_bipolar C_mr276,ctrl
NORMAL #00-0504,ctrl
Luciferase control 1,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: Vemurafenib 1000 nM for 48h,pert
strain: Wistar;	gender: male;	tissue: sciatic nerve;	treatment: acrylamide,pert
phenotype: alcoholic;	gender: female;	case_id: 443;	age: 49;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 56;	brain ph at time of freezing: 6.11;	labeling_batch: 1,pert
"Amniocytes, trisomy 21, 1551",pert
tissue: Hippocampus;	age: 2-3 months;	genotype/variation: IκBαfl/-;Nestin-Cre,pert
A549_Cisplatin_rep2,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1+/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: liver,ctrl
"lymphoblastoid cell line from F6.01, one out of seven of sensitive group, 50*10e6 cells",pert
AZ-521_uninduced_12h_rep1,ctrl
3_month_old_Prnp_knockout_mouse_rep3,pert
Placenta_nl3 with Cy5,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 17.7488021902806;	age of psoriasis onset: 21,pert
"human peripheral blood derived monocytes, no stimulation, biological rep2",ctrl
Normal Biological Replicate 2,ctrl
452MM,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID292,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 36;	maternal age: 27,pert
cell line: NAS2;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: wild-type,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L027,pert
EB_2_24h_214_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
scrambled biological rep1,ctrl
Liver from a 24 month old wild type mouse,ctrl
PancreaticSample38-Normal,ctrl
cell type: Primary hepatocytes;	strain: BL6;	agent: control;	time: 6h;	gender: Male;	age: 2 months,ctrl
CA4,pert
"wildtype liver, biological rep 1",ctrl
6-ONS76 Mock_c,ctrl
Strain: C57BL/6;	Gender: female;	Age: 110 days;	Tissue: mammary tumor;	Days after tumor onset: 14 days,ctrl
Day3 Genistein treatment replicate 1,pert
"control triceps, biological rep4",ctrl
Run8.aUa.010615d.SkMInS1086D.CEL-IS basal,ctrl
Sex: female;	Age: 12;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
MCL_IGHV_MUT (R1589),pert
"mouse liver, RNA B9216",pert
"Creatine-treated, biological rep1",pert
"schizophrenia, BA10-12(3)",pert
Mening SWB WB NP 12a,pert
"control mice, whole uterine tissues, replicate 3",ctrl
G93A 120 days sample 1,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID298,pert
MIY_day_5-1,ctrl
HF0088_U133P2,ctrl
patient: 30617;	sample: tumor,pert
strain: C57BL6;	genotype: PDE10A KO;	tissue: hippocampus;	treatment: vehicle control,pert
HaCaT cells at day 12 of in-vitro calcium induced differentiation,pert
THRB 15b mutant + vehicle replicate 2,ctrl
"sirna: Sense Control siRNA (Ambion);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",ctrl
KU_17T,pert
2828 WT,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 28;	gender: male,ctrl
BL Day 1 siMut10 transfected biological rep4,pert
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 200 mg/kg,pert
MCF-10A shATR-4 replicate 1 [set 5],pert
PBMCs_IS_10 [IS],pert
"Patient S-316-N, normal colonic mucosa",ctrl
Placenta_PE(EO)5 with Cy5,pert
Series 3; young; 2 weeks after fracture,pert
KU_31N,ctrl
HSC cells from MSI2-inducible mouse rep2,pert
human preadipocytes+oligo1_day0_rep1,pert
heart_WT_rep1,ctrl
Untreated Myd88 knockout - repeat 1 - mAdbID:102771,pert
N2A Normal-frontal,ctrl
0975-01-C,ctrl
SP-WT-Nrf2-Female-1,ctrl
"Estradiol, rep 1",pert
Braak α-synuclein 3-4 BR34_6SN,pert
BS2011051062,pert
"skin fibroblasts, passages #14 and 15",ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 3,pert
10uM H2O2 rep 2,pert
condition: Normal;	patient: N_LJ_4;	tissue: Normal skin biopsy;	kit: Affy,ctrl
HCC_10T,pert
3269-lcm,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 155;	colon ratio (mg/mm): 2.58;	myeloperoxidase activity (u/mg): 1.35;	tissue: colon;	treatment: 5% DSS,ctrl
Neural progenitor cells,ctrl
chip number: 4;	transfection plate: 1;	target gene: E2F1;	kd level: 0.77;	rin: 9.8;	transfection date: 2011-03-29,pert
source tissue: lung;	strain: Insig1 flox/flox /Insig2 -/- ( AT2 cells obtained from 2 months old SpC-rTTA / Otet-CRE / Insig1 flox/flox / Insig2-/- mice treated with doxycycline from E6.5 to E12.5. Control animals lacked either SpC-rtTA or Otet-CRE);	cell type: Alveolar Type II,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK1-4,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 8.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 45;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
A549_Control_rep3,ctrl
male_alcoholic_313,pert
"VPA 1, 16hrs",pert
GM19238_Kd_SREBF2_2,pert
"PPARg2 expression construct, 72 hrs, No Rosiglitazone (PPAR_72_1)",pert
18GOBMUC2A,pert
heart fasted,pert
Dengue Fever Patient 33,pert
MDS patient 25,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 76;	baseline tumor size (cm): 7x8;	patient id (to identify the 2 chips from the same patient): 13491389,ctrl
MOLM14_luc_Replicate1,ctrl
S003_Scz_F_89,pert
"Gender: female, Age: 43 years, Tissue: normal vulva,",ctrl
70 year old male,pert
01N0R_PolyRF-,pert
ROS4,pert
C6star_CLP_wildtype_8,ctrl
Rybp#15 (OHT+)_12d,pert
phenotype: moderate glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
RNA from whole tissue section of case 280 labeled with Cy5,pert
"human failing LV myocardium, Idiopathic20",pert
"Biceps, FSHD, cohort 21, subject 21A",pert
ventricular tissue,ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14481;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
KOC 55 PBS treated,pert
10.5 months Heart Control rep 1,ctrl
FmrWT2_brain,ctrl
"disease group: Psoriasis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 6.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 140;	ige (kiu/l): normal (0-48.5 kIU/L): 18.2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
92.1 - siBAP1 - replicate1,pert
E12.5 heart,ctrl
F9 TSA sample #3,pert
P0 Quadriceps Klhl40 KO 1,pert
Knockdown Cell Replicate 3,pert
WT2 PBS,ctrl
adenosquamous carcinoma 003,pert
"endometrioma, patient M1",pert
agent: Control,ctrl
Teratozoospermic individual: Sample T4,pert
2 hr KLF4 Time Course Control,ctrl
NPC Brain 59d Mouse1,pert
gender: Male;	tissue: Tendon;ECRB;	age: 48;	donor: 9;	disease state: Lesional,pert
mT5,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 145;	time: 0;	batch: 4,ctrl
PGA-RMM-12h-1aA-s2,pert
"Tibialis anterior, TMD",pert
"KARPAS-231, LITAF-specific siRNA, REP2",pert
SHR20-1,pert
disease state: healthy (non EBS);	cell type: Keratinocytes;	tissue origin: skin biopsies with no stimulation,ctrl
4 hour tunicamycin wild type B,ctrl
WT-sham-2 month-R2,ctrl
Patient identifyier: P;	Sex: male;	Age of patient: 76 years;	Duration of psoriasis: 56 years;	Body surface area: 15 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: minimal (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
HF1380_U133P2,pert
sample 1:;	age: 58;	gender: male;	sample 2;	age: 64;	gender: male,ctrl
Oga_WT_MEF_E8_rep3,ctrl
mononuclear cells isolated from bone marrow,ctrl
PB_DON058,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#110,pert
"RES-enriched Grape extract group, 12 months, patient number 28",pert
8SC-pbo,ctrl
15SAGEA,pert
subject id: 6;	infection: DENV;	status: DF;	tissue: whole blood,pert
10-0029A_Day1_20,pert
AL Chip#37,pert
Hep G2 treated with Nickel (II) chloride hexahydrate,pert
CON16,ctrl
male JAK2 WT liver sample 112,ctrl
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: Rap1 knockout,pert
"LY2 cell line, SRC-1 scrambled untreated, biological rep3",ctrl
WT tumor DNA,ctrl
Pre-Frontal cortex of naïve AChE-S mice,pert
Mouse Retina at P7,pert
A3243G-MELAS subject 3,pert
lesion_midUV_patient1,pert
M238_B_PLX,pert
cell line: Reh;	transfection: control shRNA;	malignancy: non-Hodgkin lymphoma,ctrl
"Alk2 cKO mice, whole uterine tissues, replicate 1",pert
sample =Healthy3 treatment=Stimulated time=90 (min),ctrl
Cadmium_00hr,pert
cell line: Lung Epithelial Cell Line MLE15;	genotype/variation: Grhl2 knockdown,pert
ARF1 siRNA knockdown MDA-MB-231 sample 5,pert
tissue: Biceps muscle;	patient: P.b.4;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 10m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
knockdown: Control;	cell line: 92.1,ctrl
8 wk old male mdx gastroc,pert
"fibroblast, control subject NM9 rep 2",ctrl
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b retrovirus,ctrl
Cervical Cancer C567,pert
"metastatic, prostate cancer",pert
12466 UC Inflamed descending colon,pert
mouse intestine pLagl2 wild type 1,ctrl
PsOEt-14-Week 1,pert
"endometrial stromal cell - Jag1 retrovirus infected2, 3 days post infection",pert
b-catenin deficient BxPC3 clone 4,pert
"BPH adrenals, replicate 1",pert
B6C3F1/JTCE liver sample batch 4,pert
GM19238_Kd_TCF12_1,pert
cell line: SUM149,pert
neuron_rep10,pert
Liver Pio3,pert
"ID:5-3, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",ctrl
HeLa_06_21_04 TP-6,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 3",pert
Gender: Male;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
WT-smoke-high-5 month+1d-R1,ctrl
"SFM control cells (24hr), biological rep3",pert
"Ctip2 knockout mouse striatum, postnatal day 0",pert
"PCB77 treated HepG2 cells at T24, biological replicate 2",pert
strain: C57BL/6;	Sex: Female;	age: 3-weeks old;	genotype: CF,pert
HEK293_A263insGG_#6_induced,pert
tissue: Liver;	genotype/variation: Hmgn1-/-;	treatment: injection of 10 µg/g body weight of N-nitrosodiethylamine,pert
Liver phenobarbital pool2 Affy,pert
PBMC CCo T0,ctrl
"Control 2, biological rep1",ctrl
ccRCC tumor of patient 75,pert
At Risk: +;	Age: 18;	Sex: M,pert
Vector expression uninfected,ctrl
Muscle control 6,ctrl
"breast, flash-frozen, microdissected ductal tumor cells",pert
"Female (age range 33-49), skin biopsy taken from upper nates no nickel exposure",ctrl
major non-tumor2,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),ctrl
MPM tumor 37,pert
renal_vesicle_Lim1_mutant_3,pert
phenotype: alcoholic;	gender: male;	case_id: 322;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 30;	brain ph at time of freezing: 6.13;	labeling_batch: 1,pert
Gender: Female;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 2;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: NO,ctrl
SV589 15 Day KD Serum Starved-> 1hr EGF,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 63;	sex: F,ctrl
subject id: 43;	infection: DENV;	status: DF;	tissue: whole blood,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.72;	Post mortem interval (hours): 45;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
untreated untrMurine 3T3-L1 cells,ctrl
braak stage: BR34;	rin: 75;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
3_KO_2,pert
"shControl cells, rep3",ctrl
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep3",pert
Control day 10 sample 1,ctrl
"MCF-10A cells, overexpression vector control",ctrl
A263insGG_mut3b-,ctrl
"cochlea at P13, wt, biological rep 1",ctrl
cerebellum SNCA knockout 6 month replicate 3,pert
strain background: C57BL/6;	genotype/variation: WT;	cell type: sorted Ter119+CD71+ bone marrow cells,ctrl
Stroma associated to prostate invasive tumor,pert
M24met_Wnt1_1,pert
"Atm+/+ 120 min post IR, B",pert
Substantia nigra,pert
E1 clone infected with control retrovirus.,ctrl
Murine prostate,pert
Peripheral blood mononuclear cells;	TTF=105min;	Race=White;	Sex=Female,pert
Tendon_non-lesional_rep10,ctrl
Src-overexpression - replicate 3,pert
SV589 NoKD Serum Starved-> 1hr EGF,pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/+;	tissue type: renal tissue",ctrl
EA_Control_CD20,ctrl
4T1.2-BV-3,ctrl
"44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Control_4months_retina17,ctrl
Mening SWB WB SW 3b,pert
"t16, surgically resected from patient of gastric cancer.",pert
control-control rep 1,ctrl
HUH-nonsense-#1,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: Treg;	treatment: unstimulated;	genotype: WT,ctrl
Third shYY2,pert
Bc_WAP_1,pert
"WT mouse embryonic fibroblasts, unstimulated, 4 hours",ctrl
S2,pert
CLC5 ko rep 3,pert
"PPARg d0, rep 3",pert
"Gastrocnemius, Cmah KO, 2 months old",pert
status: Control;	gender: Male;	age: 67;	tissue: Blood,ctrl
RNA-DHL6-R406-24H-2,pert
"2 months, contralateral group, biological replicate 1",pert
C_AN03217_C,ctrl
sepsis patient #1,ctrl
FVB; No Treatment #8,ctrl
No or early 2 rep2 (retina),pert
"alveolar macrophages, smoker 069",pert
NE-rep2,ctrl
status: Control;	gender: Female;	age: 55;	tissue: Blood,ctrl
"P40_wt cones, replicate 2 [array]",ctrl
"Deltoid, control, cohort 18, subject 18U",ctrl
early HCC,pert
strain background: C57BL/6N;	genotype/variation: Stat1 delta alpha (da);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
Wild type,ctrl
nt S. aureus 11,ctrl
EB_0_6h_52_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
HCC_18N,ctrl
"brain, Entorhinal Cortex: 99-21 normal_e1_le1",ctrl
SW1736_t48h_rep3,pert
WT S49 Cells 24h cAMP treatment,ctrl
tissue: Frontal cortex;	age: 55;	Sex: M,ctrl
"shControl, low glucose, replicate 1",ctrl
"Immortalized MEFs WA, empty retroviral vector infected, rep2",ctrl
B4 365 b4-/- untraeted,ctrl
"Wild type, snap frozen, diaphragm muscle, 7month age animal",ctrl
Mnk_3142-T-7,pert
"ESCs overexpressed CA-NFATc3, biological rep1",pert
441MM,pert
Recent-onset T1D_sample7,pert
LOX1 Untreated 24hr 282295903,pert
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: no,pert
"vehicle treatment, 24 hour time point, biological replicate 1",ctrl
Advanced IPF_explant_upper lobe_rep160,pert
kidney_colistin_treated,pert
HEK293-cells,pert
mouse cerebellar granule cells wild type 7,ctrl
brain_DLPFC_bipolar B_mr426,pert
Intima media; control subject,ctrl
NHEK_scrambled siRNA_1.8mM Ca_48hr,ctrl
Normal-BM 7,ctrl
"C57BL/6J female number 1, 2 months old , whole ear tissue, untreated control ear",ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,pert
"P50_wt cones, replicate 1 [array]",ctrl
treatment: EtOH + cycloheximide;	genotype: RARaKO;	cell line: F9,pert
Etoh 4,ctrl
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 1957998115;	hybridization batch: I,ctrl
BJ-iPSC replicate 2,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID209,pert
Mouse otic vesicle at E10 mut,pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"Acute Myeloid Leukemia, sample 25",pert
thyroid_tumor_3,pert
"brain, lateral and medial ganglionic eminences",pert
"Patient #2, Untreated",pert
Characteristics:;	Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours,ctrl
M833,pert
braak stage: CTRL;	rin: 72;	tissue: substantia nigra;	disease state: control,ctrl
NeuroD1 transgenic animals die very shortly after birth.,pert
nTreg,ctrl
OVCA433-(2),ctrl
agent: untreated;	time point: 0 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
"proband f, past exhaustive exercise",pert
KM_019N,ctrl
del337TR replicate 3,pert
MA_294,pert
GM19238_Kd_NS_P1_21B,ctrl
K14deltaNB-cateninER Time 0 replicate 2,pert
braak stage: BR12;	rin: 51;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
"vehicle treatment, 72 hour time point, biological replicate 3",ctrl
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 2",pert
disease: cardiopathy;	gender: male;	age: 2 years;	tissue: thymus,ctrl
GM19238_Kd_NS_P2_24,ctrl
CT1 vs PBS 4 hr pooled,ctrl
Tendon_lesional_rep19,pert
FoxM1 C,pert
C1 clone infected with control retrovirus.,ctrl
Diaphragm 56 Day control rep 3,ctrl
Muscle PCOS control 17,ctrl
Bronchial Epithelial Cells MMA biological 2001M,pert
A549_control_rep1,ctrl
Liver_POR-null_2,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: LPA,ctrl
WAT from Ahnak knockout fed high fat diet Replicate 1,pert
"ZR-75-1, 12h, 0.4uM DOX",pert
Dengue Fever Patient 47,pert
NonIR-WT_Rep1,ctrl
PND28 Rat Testis_Rat230-2_3hr Corn Oil_Animal#52_04005,ctrl
cell type: lineage depleted cord blood cells;	culture: liquid culture day 11;	transduction 1: BCR-ABL1;	transduction 2: control,pert
"breast, pre AF treatment (H7_1349)",ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#5,pert
"Control KD, rep2",ctrl
PGA-MAH-AJ_PBS24h-4aA-s2,ctrl
cell line: MLL-AF9 AML cell line 10980 (Zfx wt);	treatment protocol: vehicle;	genotype/variation: wt,ctrl
"schizophrenia, BA46-85",pert
Braak α-synuclein stage 1-2 BR12_2SN,pert
normal tissue,ctrl
"ALL_NDS, K42 011509",ctrl
miR122-KO-03,pert
age: adult;	gender: female;	tissue: lung,pert
WT osteoclasts untreated 1,ctrl
14-week-old Trim24-/- liver_411M,pert
0705-01-A,pert
CD4+_Tcells_non_severe_asthmatic_3,pert
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,pert
control participant P302,ctrl
"PCB153 treated HepG2 cells at T6, biological replicate 2",pert
"spleen follicular B in IRF8 conditional KO, biological rep6",pert
15d Dicer cKO,pert
"patient: 113;	current medication: OCP;	birth date: 8/17/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Recurrant abcess, ?IBD;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.04384,pert
MLL_PTD01,pert
WKY12-3,ctrl
"mouse embryonic fibroblasts, unstimulated, 4 hours",ctrl
genotype: wildtype;	cell-type: resting;	splenomegaly: none;	Ig clonality: polyclonal,ctrl
Normal urothelium_2 (Wild-type),ctrl
"wdNHBE with BN/59 at 36hpi, biological rep3",pert
Oct4GipES_Panct1_esiRNA_72h_rep2,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep2,pert
No or early 2 rep5 (OHN),pert
Healthy3-CD4,ctrl
cell line: shEGFP T47D;	sherbb3: -;	sample type: control,ctrl
cell line: THP-1;	shRNA construct: GSK3A Construct 6,pert
PGA-MAA-IL4-1cAv2-s2,pert
A39 NES 142Q TG4	F7/5	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Male,pert
CD4_T_cell_pool_melanoma_M05+M06,pert
"Myeloid cell line, anti-Evi1 siRNA",pert
T140 U133p2,pert
"Scarmbled control knockdown, replicate 2",pert
"E18.5 brain, wild-type, rep 3",ctrl
"suprarenal aorta, non-dissected aneurysm, Ang II treated 7d",pert
KO (Rnh1-/-) -1,pert
2h WT Cel.17,ctrl
clone type: AtT20 clone types overexpressing NSBP1SE protein rep3,pert
N/SM3,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID50,ctrl
TAC 1,pert
Insm1 control #1_pituitary gland,ctrl
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
"126 (221), ADIPOOSE TISSUE, Before",ctrl
"Mouse bone marrow-derived mast cells treated with IL3, rep 1",ctrl
Pax_C3,ctrl
E_Kin_2,pert
chip number: 18;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.9;	rin: 9.4;	transfection date: 2011-10-17,pert
SeroNeg-4,ctrl
Jak2VF vehicle (7991003028_B),pert
race: caucasian;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
disease status: autism;	tissue (brain region): Cerebellum,pert
Raji_mi-Ctrl_3,ctrl
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.93;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Tumor_Ker24,pert
Cervical cancer_2035T,pert
"Human LIMA artery from patient 4, control (unstented)",ctrl
"female Spargue-Dawley rats, diet only for 7 days,  tissue: lung",ctrl
Ishikawa_Control_24h_rep1,ctrl
Bone-Marrow_MM_M1094,pert
E81-/-SRFdM-VP16-1,pert
"Mdr2-KO homozygous mouse, 3 month old mouse, liver sample",pert
remitted schizophrenia patient  S19,pert
WKY16-4,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 3",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 221,pert
H1299 DAC 3 uM (3240),pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/-;	tissue type: renal tissue",pert
PB_DON102,ctrl
A_AN19511_C,pert
"Patient GM, stable renal transplant recipients, female, 53 years old, T0 (time of enrollment)",ctrl
"Extensor digitorum longus, TMD",pert
brain_DLPFC_bipolar C_mr284,ctrl
Laser Capture Microdissection (LCM) to isolate tissue sections of the hippocampus area of Rasgrf1 knockout mice brains,pert
"Normal cervix epithelium, microdissected, Age 43",ctrl
GNMT-KO mouse hepatocytes (sample 2),pert
Postnatal 3 weeks mutant heart biological rep3,pert
Neocortex_Eomes_WT.7,ctrl
Brain CD8 T cells that are IL-10- rep1,pert
background strain: C57Bl6;	genotype/variation: Gata4_S105A_homozygous mutant;	age: 9 weeks old;	tissue: whole heart ventricle,pert
Retina homozygous KO 30 days 2,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 69;	gender: female;	tumor grade: IV,pert
32054.LMP,ctrl
WT-EtOH-3 (DFW),pert
14.5_KO_540G,pert
"brain, motor cortex, fast spiking interneurons, wild type",ctrl
MGHU3 Cells_TAK1 siRNA + PD173074,pert
cultured human melanoma cancer cell 224,pert
WT mouse lung,ctrl
Actinomycin D treated A549 human lung cancer cell cultures replicate C,pert
"male,15,Caucasian",ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Atypical antipsychotic Clozapine, Dose: 12mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
PKCZ -/- male mice non-treated,pert
"PIO, subject 11",pert
Cochleae from wild type mice at P3,ctrl
"human hepatoma cell line, Hep G2",ctrl
N51084,ctrl
HEL cell line_JAK2 knockdown (Jak2-10 shRNA),pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep3,pert
Myc(F/F);CreER CD8 T cells,pert
CA99-43A,ctrl
OVCAR-8-(1),ctrl
MPA 3,pert
LNCaP-abl_siControl_1,ctrl
db/db 13-1,ctrl
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 2",pert
Seguin_IDR_BrownNorway_Liver_treated7,pert
Head RNA of Phgdh KO@E13.5 No.1,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
MDA-MB-231 - MTDH-WT-KD-1,pert
KU_22N,ctrl
T51783,pert
gender: M;	age at blood draw: 32;	tissue: whole blood,ctrl
HF0137_U133P2,ctrl
colon_adenoma_1141,pert
NB4 PROMYELOCYTIC CELLS,pert
"WT CLP LY6D-, biological rep2",ctrl
"LCL GM19238, Kd ARNTL2, 72hrs",pert
esophageal squamous cell carcinoma from patient E1610,pert
PTEN+/-IKK2ca/ca ep_B,pert
LICR_HN1_CETU2,pert
"granulocyte, healthy control, biological rep3",ctrl
Ishikawa_HighDose_BPA_24h_rep1,pert
No or early 1 rep10 (OHN),pert
ALI patient #6,pert
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Aurka;	condition: -Dox,ctrl
Day: 12; Drug: Saline; Phase: Drug treatment; Replicate: 1,ctrl
"striatum,18month,WT",ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 400 mg/kg,pert
EOM 56 Day Control rep 1,ctrl
"HUVEC treated with ERG SiRNA , biological rep2",ctrl
NPC_VUB01_3,ctrl
FHCRCAML169020,pert
Caco2-siRNA1-rep3,pert
THRA aI mutant + T3 replicate 3,pert
Skin_WT_2,ctrl
endothelial_rep3,pert
KN-sham-5 month-R2,pert
MPM tumor specimen 31,pert
healthy control sample x058,ctrl
Wild-type_macrophages_8h,ctrl
APOE_KO_NODM_9W_5,ctrl
"brain, hippocampus: Ctr-1h-P15-I_e1_le1",ctrl
PDAC_P_91,ctrl
adenocarcinoma (ADC8),pert
jzo027-rp1-v5_u74av2-met,ctrl
OV1002 Control Day1,ctrl
Csbm/m Mouse_cerebellum_Young_nicotinamide riboside treatment_Replicate-3,pert
erStress_twins_AA_1727twin2_500nM_thapsigargin_4h,pert
0153-01-C,ctrl
Control_R_-Dox_rep1,ctrl
V5-P102,ctrl
Wild type CD4+ unstimulated 1,ctrl
"ALL_DS, K19 011409",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_1_21_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
M833 / Reference_13425519,pert
SGK1-IL23 rep1,pert
"Lung, Familial Idiopathic Interstitial Pneumonia (F-IIP), Nonspecific Interstitial Pneumonia (NSIP)",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 2;	psoriasis duration: 18.0;	age of psoriasis onset: 29,pert
Control Replicate 3,ctrl
Dominant negative cJun  VZ18,pert
Subject #8024-8hr Postinfection,pert
RTX2 T12,pert
Nrf2 KO rep3,pert
KO - knock-out Treated - 2 hrs - repeat 1 - Cy5 - mAdbID:62608,pert
expression array - AO2,pert
major non-tumor6,pert
Donor3_6h_DMSO,ctrl
mdx Biological Replicate 5,ctrl
patient: 30308;	sample: tumor,pert
strain: C57BL/6;	genotype/variation: KLF5 KO;	cell type: LSK BM cells,pert
disease status: CML chronic phase (CP);	cell source: leukapheresis products (LP);	cell type: CD34+ mononuclear cells,ctrl
"Normal Skin, Normal-3",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 35;	gender: male,pert
Bone-Marrow_MM_M1134,pert
VCaP/MYB siRNA #1,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 45 yr;	population: white;	dsm-iv: 296.44;	age of onset: 35 yr,pert
Pancreatic Sample 9-Normal,ctrl
V5-P478,pert
"treatment with BZP, replicate 1",pert
2975,pert
sex: Male;	Age: 12 months;	additional patient information found in Series supplementary file,pert
WT-IL23 rep1,ctrl
HeLa cells control 1 (Luciferase siRNA transfection),ctrl
32SAGEA2,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 35week,pert
Pediatric_GBM_26,ctrl
Luciferase-rep1,ctrl
"Macrophage cultures were prepared from C57BL/6J, male, mouse peripheral blood by Optiprep (Accurate Chemical and Scientific, Westbury, NY) gradient centrifugation.",ctrl
Human Sperm from an infertile male with a consistent severe teratozoospermia,pert
Brown Norway Control Liver,ctrl
strain: CD1;	tissue type: back skin,pert
normal donors,ctrl
Proximal hindlimb bud tissue (~500um from base of limb bud) pooled from 3 embryos (6 limbs total).,ctrl
patient: 32;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
microdissected breast cancer cells from case 607,ctrl
Gene expression profiling of normal cortex of patient T127,ctrl
Treatment 5,pert
primary normal lung tissue 1144,ctrl
MPM tumor 25,pert
MDS patient 113,pert
liver_STZ 0.1% quercetin diet_rep6,pert
patient: 18;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Cisplatin-treated Rb-/- MEFs-b,pert
HCC_2N,ctrl
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: well;	Tumor Site: Ascending;	Drug Treatment: NO,ctrl
Wild type 618,ctrl
3210-lcm,pert
V5-P415,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: post-UV,pert
"Acute Myeloid Leukemia, sample 21",pert
MKK7D transgenic female replicate 7 early timepoint,pert
BCell_lymphoma_marginal_sample4,pert
"S1P2-KO-neocortex, biological rep5 (male)",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 211,ctrl
"WT, PR01M003v0",ctrl
"t13, surgically resected from patient of gastric cancer.",pert
"human failing LV myocardium, Ischemic18",pert
treatment: Arid3a overexpression pool;	cell line: J1 ES cells;	sample type: pool,pert
8 wt,ctrl
"29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Control_liver_1,ctrl
BxPC3_JMJD3KD_rep2,pert
Cont G1,ctrl
Embryonic day 14.5 wild type (WT) mouse fetal liver,ctrl
age: 36;	sex: M;	disease status: control subject;	Filter number: 99;	Usage number: 5;	Exposures: 3,ctrl
Corl51 SCLC cel line,pert
cell line: SCC-2;	cell line origin: Oral cancer;	genotype/variation: ZMPSTE24 silencing,pert
BACH2+/+ ALL + Imatinib (Sample2),pert
"Total RNA, Tet2 KO CMP",pert
HUVEC_4h_rep2_1107,ctrl
C57BL/6J_Islet_rep2,ctrl
"peripheral white blood cells, baseline",pert
"Bone marrow-derived macrophages, MyD88 -/-, Zymosan stimulated, 120 minutes",pert
WAT from wild-type control fed regular chow diet Replicate 3,ctrl
Wild type no tumor 2,ctrl
"E2f8 KO, biological rep3",pert
strain: BALB/cByJ;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: infected,pert
"cell line: HeTH-4;	genotype/variation: THOC1-depletion;	comments: HeLa cell line with inducible THOC1-depletion, induced",pert
"Lymphoblastoid cell lines derived from family 1724, member 1",ctrl
CD3-stimulated CD4+ T-cells from Wt C57BL/6 mice,ctrl
Tissue: normal thyroid; Gender:male; Age:56,ctrl
striatum wild type 21 month replicate 2,ctrl
"MCF7/BUS, 10 pM E2, 48 hours, biological replication 2",pert
Trasnsformed Lymphocytes Unaffected Twin Pair 3 (DCBD3.2)(TP10),ctrl
Ramos pRTS-CA-IKK2 H+,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous saline challenge""",ctrl
E1-GemKD,pert
48 hrs sham-4,ctrl
HIF-1-/- S. aureus 6,pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
KO - 5 mo - repeat 1 - Cy3 - mAdbID:74108,pert
age_years: 63;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
No_drug_#4876,ctrl
Retina ko/ko rep2,pert
erStress_twins_AA_1712twin1_DMSO_4h,ctrl
PC-3 cells,ctrl
"siRNA, collagen plate, rep3",pert
"HeLa treated with Cas-II-gly, biological rep3",pert
"ID:8-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Proximal, Small Intestine 17 days old",pert
E10.5 wt1,ctrl
gender: female;	age (years): 40;	evolution time (years): 13;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
"Cultured ovarian cancer cell line IGROV-1, untreated",ctrl
Aquaporin-11-/-_mouse P7 kidney #3-2,pert
E17.5 preB cells_Smchd1 null_Rep 1,pert
"MOLM-14 cell line, transduced with shSYK_1 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
age: 69;	gender: male;	ejection fraction: 35;	left ventricular end diastolic diameter: 60;	inflammation/PVB19: positive,pert
MEFs-3,ctrl
gender: male;	batch: 1;	age (years): 39;	patient id: Control_1;	fev1 (% predicted): 78;	fvc (% predicted): 76;	medication: None;	cell type: CD8+ T-cells,ctrl
Sample M558,pert
HepG2 cell line from ATCC at 8th generation after 24 hours of PCB77 treatment.,pert
Clock_mutant Circadian_Time_02,pert
CXCR4 knockout 2,pert
Peripheral Blood Mononuclear Cell (PBMC),ctrl
SKM-1 control 1,ctrl
Control subject 44_biological replicate 1,ctrl
Ago2-IP RNA Wildtype-2,ctrl
Liver WT4,ctrl
"Vehicle treated, DAY 4, biological rep.2, MV4-11 cells",ctrl
New 3 hr 3,pert
D2-Gpnmb+ control rep3 (retina),ctrl
V5-P556,pert
subjectid: 5278;	imatinib: NoIM;	lbh589: NoLBH,ctrl
chip number: 1;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.78;	rin: 9.8;	transfection date: 2011-03-29,pert
MCF10A-HER2(+) 3days,pert
"Patient CV, stable renal transplant recipients, male, 58 years old, T0 (time of enrollment)",ctrl
"Soleus muscle, basal state, Ts65Dn",pert
cerebellum SNCA knockout 21 month replicate 3,ctrl
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 6h,pert
normal adjacent esophageal tissue from patient E1610,ctrl
"non-AD_TC, biological rep12",ctrl
lymphoma_4936_ADR,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 51;	gender: f;	treatment: NSAIDs,ctrl
undifferentiated,pert
FACS-purified B cells_129SV/EV_influenza-infected_rep3,ctrl
siFOXM1Veh24h rep1,pert
"Nickel 400 µM, biologcial rep2",pert
cerebellum_PSNA_ 18w_rep2,pert
"NB4 cell line, wild-type, ATRA, 72hr",pert
bladder epithelial cells,ctrl
Wild-type E11.5 proximal hindlimb pool 1,ctrl
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 4",pert
"A pool of two pure subsets of peripheral blood CD4+ T cells (CD19- CD3+ CD4+ CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
Gastrin Knockout parietal cell replicate 3,pert
control virus-infected replicate 2 (MCF7),ctrl
"Soleus, healthy control",ctrl
strain: C57BL/6;	cell type: MACS-purified mature B cells;	genotype: irf4+/+,ctrl
"Mouse heart, IDH2 R140Q mutant, replicate 4",pert
"TF-1 cells, shTRAF6, d2.5",pert
DC-5,ctrl
"rat hippocampus (CA1 region), IntermediateCort, 18 months old, subject 13",pert
Ileum_POR-null_3,pert
C_LS_Wk2,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 3,pert
P3A Progranulin-frontal,pert
Tumor from MYF-5 CRE/SSM2 mouse CC23,pert
EB_6_19d_308_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
healthy control C3,ctrl
Rat spinal dorsal horn,pert
KO_cycling_rep2,pert
race: caucasian;	age (years): 60;	stage: IA;	grade: 3;	histology: endometrioid,pert
strain: C57BL/6;	tissue: cerebral microvascular fragments;	genotype/variation: wildtype;	age: 2 months,ctrl
BM_healthyControl_III,ctrl
"PIO, subject 16",pert
CD8+_Tcells_severe_asthmatic_1,pert
colon_epithelium_C57mouse_6weeks_rep5,ctrl
liver cells from wildtype 8wk male mouse 8 challenged with vehicle (saline)_8,ctrl
OE-SOX2_1,pert
"Untreated LNCaP cells not stimulated with DHT, biological replicate 1",ctrl
diseased_media 1,ctrl
Testis_Taf7l knockout_rep1,pert
EOM 28 Day Control rep 1,ctrl
tissue: dorsal skin;	genotype/variation: GR+/+;	strain: B6D2/F1;	age: E18.5,ctrl
9ILC_normal_ductal,ctrl
3T3 cells from cyclin D1KO mice infected with MSCV-D1a,ctrl
patient: 240;	current medication: Asacol 800mg BD;	birth date: 1/10/59;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 8/2/04;	diagnosis date: 12/14/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
disease status: controls;	tissue (brain region): Temporal cortex,ctrl
PBMC from T cell LGL leukemia patient #131 (TLGL131),pert
"brain, cerebellum: RNA#40_le1",ctrl
Bone-Marrow_SMM_S1215,pert
"13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"PPARg2 expression construct, 24 hrs, No Rosiglitazone (PPAR_24_1)",pert
WT15,pert
Mening UNSTIM WB NP 1b,ctrl
"Patient  M, lesion, 12 week",pert
"fibroblast, TSG6-knockout, untreated, biological replicate 2",pert
HP-45,ctrl
HepG2_Hg rep3,pert
control participant P331,ctrl
WKY12-1,ctrl
"SS gland, early, patient 21, batch 2",pert
bladder cancer cells treated 48 hr,ctrl
patient: 40728;	sample: normal,ctrl
IRS-1 KO (jos1534),pert
gender: Male;	tissue: Tendon;Biceps;	age: 41;	donor: 28;	disease state: Non-lesional,ctrl
Vehicle-Control 30 hours set 2,ctrl
cerebellum wild type 21 month replicate 3,pert
cell line: LNCaP-abl (abl) prostate cancer cells;	genotype/variation: depleted of EZH2;	treatment protocol: under hormone depleted conditions,pert
"NIH3T3, 0 h",ctrl
Control_Castrated OWJ52,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Supraoptic nucleus,pert
"SiRNA-scrambled, replicate 2",ctrl
E13.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Primary Palate Mesenchyme collected after 2 passages in culture,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 52;	gender: male,ctrl
strain: C57BL/6;	genotype: Wild Type;	replicate: 2,ctrl
8 with Cy5,pert
heart of mouse subjected 4 week to chronic constant hypoxia (4B),pert
T51308,pert
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 24 months;	genotype: Myc heterozygous,pert
Mutated-ERα-positive breast cancer 28,pert
695-383_8hr,pert
"MAT1A knockout at 3 month age, biological replicate 5",pert
duration of untreated disease in month:13.6;	age at onset:2.5,pert
esophageal squamous cell carcinoma from patient E1542,pert
U-87MG-PK7 set 2,pert
"HUVEC treated with ERG SiRNA , biological rep2",pert
MCF7 - Control_1,ctrl
H1299_shPTK7-1,pert
"nasopharyngeal carcinoma, specimen T1",pert
cell type: Primary human epidermal melanocytes (neonatal),ctrl
Liver phenobarbital pool4 Affy,pert
DMN-NF1Hippo15d-2cAv2-s2,pert
"Patient 11, Atheroma plaque",pert
8 wk old male C57BL10 quad,ctrl
C2F-LU,ctrl
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVA, T4, N2b, M0, G4",pert
"epidermoid carcinoma, cell line",ctrl
"treatment with TFMPP, replicate 1",pert
Bl6_p60_1,pert
human subcultured chondrocytes (passage 2) from OA donors,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 5d ID140,pert
Bone Marrow,ctrl
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep3,ctrl
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: mild stress + saline vehicle,pert
HCC PBMC Sample 6,pert
NALT_infected_24h_90-226_rep4,pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu2,pert
MDS patient 102,pert
"Control, replicate 9",ctrl
15A;pretreatment;female;breast tumor,ctrl
"age: 41;	sex: M;	ancestry: African;	smoking status: smoker, 20 pack-years",pert
splenic CD11c+ dendritic cells,pert
strain: Hnf4LoxP/+AlfpCre;	age: E18.5;	tissue: Fetal Liver,ctrl
Age: 39;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
NS1_NS010112,ctrl
"ID:14-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug TAK1 siRNA,pert
Tendon_lesional_rep15,pert
"wild type CTL, biological replicate 2",ctrl
Muscle PCOS case 251,pert
695-EV_2hr,ctrl
normal skin sample,pert
Ad infected murine liver-MO30k-(229)-6hpi,pert
HRas-v12 transgenic male replicate 2 early timepoint,pert
N41027_rep,ctrl
Wt,ctrl
wild type mouse retina at age postnatal day 6,ctrl
rapamycin treated_3 3h,pert
human bronchial smooth muscle cell_vehicle_24h,ctrl
strain: ICR;	agent: AOM/DSS;	time point (week end): 20;	disease state: colorectal adenocarcinoma,pert
"72 hour-treated TG2 knockout NB4, biological rep2",pert
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 33;	Usage number: 1;	Exposures: 4,pert
HEK cell lines non-expressing WT channel,pert
Cerebellum_nontransgenic control S25_3 months_replicate 1,ctrl
"G392E, no doxycycline",pert
"PC-3 Ctrl, biological rep2 [mRNA]",ctrl
KM_032T,pert
autism with dup(15q) 98-19,pert
Ero1-C104A/C131A induced biological repB,pert
Capan2_siLLGL1-2 biological rep2,pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A treated with FTI;	cell line: GM00038,pert
pt. HCL C treated with Vemurafenib 1000 nM for 48h,pert
Mus musculus liver - wildtype,pert
sample =XCGD1 treatment=Control time=180 (min),pert
"striatum,12weeks,WT",ctrl
treatment: 1 ug/ml doxycyline;	time: 72 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
cell type: embryonic stem cells;	genotype/variation: Satb2 overexpression,pert
wild type mouse stria vascularis,ctrl
parental HeLa cells rep 2,ctrl
"Calu3 human non-small lung cancer cells, gemcitabine resistant (Ligand)",pert
age	42;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	5.4;	leukocyte count (/nl)	180;	hemoglobin (g/dl)	12.1;	platelet count (/nl)	476,pert
Cav3KO 1506,pert
CAR.AH_phenobarbitol_rep2,pert
r7,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_6h_1mM_HG-U133A_2_YCHSUP501,pert
"alveolar macrophages, smoker 040",pert
MCF7 cells treated with 2uM ARC for 24 hours Array 1,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 33.34247,pert
Female - caucasian - N-05-G,ctrl
IM12_case,pert
3 wks sham-2,ctrl
MCL_IGHV_UNMUT (R1329),ctrl
"human failing LV myocardium, Ischemic73",pert
"human failing LV myocardium, Ischemic5",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 95min;	race: Asian;	sex: Female,pert
Dengue Fever Patient 6,pert
Injured 30 day Rat Retina 2,pert
"HtrA2 KO mouse cortex, P29",pert
"Lesional skin from K5-Tgfbeta mouse, biological replicate 2",pert
AQA B,ctrl
Akt1 double transgenic mice on a high fat diet (DH 2),pert
APBMNC.LPS+.2,pert
ctrl_515,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 98;	Usage number: 4;	Exposures: 3,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 15.0;	age of psoriasis onset: 32,pert
Normal cervix epithelium_03-4986,ctrl
Normal_MS 36D3,ctrl
Pancreatic Sample 13-Tumor,pert
CTR 2,ctrl
01MCY: new onset sJIA,pert
IRS-3 KO (jos1528),pert
NM18 healthy control,ctrl
pediatric AML S18,pert
patient: KPW13;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Gender:male,ctrl
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
MCF-7cells treated with 100 nM 4-hydroxytamoxifen and scrambled siRNA,pert
mouse cerebellum at P30 wild type 2,ctrl
human_LIMA_artery_patient2_paclitaxel-eluting_stent,pert
MDS29,pert
HWC7,ctrl
cumulus_nonPCOS_Lean_rep6,ctrl
transitional E-mu-BRD2 mediated lymphoma,pert
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 3",pert
colon_C57mouse_6weeks_rep4,ctrl
genotype/variation: Pou4f1-/-;	agent: control virus;	tissue type: fetal liver,pert
DBA control (201msn),ctrl
Embryonic Stem Cell,pert
TYK-nu-(2),ctrl
KSL cells from Runx1-knockout mice (Runx1floxed/floxedMxCre+/-),pert
"brain, hippocampus: KA72-III_e1_le1",pert
Human Fresh Bronchial Epithelial cells,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep5,pert
"Uninvolved Skin, NS-8",pert
A375 cells 24h Control rep2,ctrl
"Liver, untreated, rep2",ctrl
"suprarenal aorta, control, saline treated 14d",ctrl
"Frontal cerebrocortex, deltamethrin (3 mg/kg), 6 hours",pert
SUDHL-1 cell line,ctrl
Du145-PCAT1 cells transfected with cMyc siRNA #4,pert
siERK1Veh4h_2665,ctrl
"DBA/2J CHR, Rep1",pert
UC Uninflamed sigmoid colon,pert
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shSOX11.1,pert
Primary human monocytes,pert
heart of mouse subjected 4 week to chronic constant hypoxia (4A),pert
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
CD4+_Tcells_non_severe_asthmatic_2,pert
Tg77,pert
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: phenobarbital;	tissue: liver,pert
NONE_72,ctrl
Myoblast-GATA4-KO-day3-3,pert
Nrl ko P10 replicate 4,pert
Heart of 10 weeks old mice,ctrl
"WT male mice, water",ctrl
30 day LAD ligated heart from MRL/MpJ strain,pert
"proband a, past exhaustive exercise",pert
SKBR3-R_0.1uM_Lapatinib_3,pert
WT_M_1,ctrl
Young 7,ctrl
non-malignant FTEn_patient 8,ctrl
hNHEPS_10 μM_6 h_rep2,pert
control to Sample 5,ctrl
Amniocytes_euploid_1561,ctrl
"MDA-MB231 cells, control",ctrl
"glioma cell line U373, EGFP expressing",ctrl
age: 69;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
sample =XCGD3 treatment=Stimulated time=360 (min),pert
Squamous cell carcinoma 033,pert
Pool Ts1Cje_P30_hyb1,pert
V5-P335,ctrl
MOLM-13 cells,ctrl
Cervical Cancer C495,pert
KM_012T,pert
Old Control;	male,ctrl
RNA from microdissected breast cancer cells from case 342 labeled with Cy5,pert
coronary smooth muscle cells metoprolol replicate 3,pert
MRF CKO Oligodendrocyte Replicate 2,pert
M303 C,ctrl
IRF4_1,pert
"HSCs from female mice treated with oil, replicate 3",ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,ctrl
"Normal 15, control tissue",ctrl
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
tissue: skin;	individual: Patient P13;	condition: AL;	eczema severity: SCORAD: 51,pert
46A;pretreatment;female;breast tumor,ctrl
"brain, Entorhinal Cortex: 99-28 tangle_e1_le1",pert
"BOEC, at_risk 11",pert
treatment: Oct4 knockdown;	cell line: J1 ES cells,pert
57_129_KO,pert
"breast tumor epithelium,41",pert
pMX-jhdm1b no vitamin C Jhdm1BVc-_1,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 40;	maternal age: 38,ctrl
Normal cortex of patient 83,ctrl
01N15: new onset sJIA,pert
mouse liver A3,pert
RTX2 T0,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 24h,pert
HCC013N,ctrl
4040-2 E2F3 Heterozygous,pert
control_08hr_rep1,ctrl
"testis wt, 17dpp, Rep1",ctrl
1L,pert
BV2_rep2,ctrl
Wild type caerulein rep2,pert
strain: C57BL/6;	cell type: mononuclear bone marrow cells;	treatment protocol: Evi1 retroviral transduction,pert
HeyA8-(3),ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5a;	flt3 status: WT,pert
"Lymphoblastoid cell lines derived from family 1717, member 2",pert
"MCF10A cells, Her2 and Myc over-expression",pert
UTX conditional knockout (cKO) cell line 1,ctrl
breast cancer patient 359,pert
0-KO,pert
"gender: female;	batch: 1;	age (years): 42;	patient id: Severe_8;	fev1 (% predicted): 33;	fvc (% predicted): 94;	medication: Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium;	cell type: CD4+ T-cells",pert
"Autoimmune pancreatic islets, day 1 cyclophosphamide treatment, rep 1",pert
Primary neonatal keratinocytes_control_rep1,ctrl
"Normal ear skin from control mouse, biological replicate 3",ctrl
Lmna H222P heterozygous male 6,pert
M465 Wt,ctrl
"IDC 3, biological rep. 3",pert
Head RNA of Phgdh Knockout@E13.5 No.4,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 5 - Technical Replicate 1,pert
background strain: B6/129;	genotype/variation: mir-122 knockout;	age: 14 Month;	tissue type: Tumor,pert
Alveolar type 2 cells_Alcohol ingestion,pert
SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2,pert
con-37,ctrl
1164-03-A,pert
Skinbiopsy_0h_controlsubject_k2,ctrl
Primary lung tumor,pert
15 saline,ctrl
duration of untreated disease in month:1.1;	age at onset:6.8,pert
"Patient 8, control tissue",ctrl
ALS gray matter 1 Familial,pert
"brain, hippocampus: C6-III_e1_le1",ctrl
Normal-ERα-positive breast cancer 51,ctrl
tissue: breast cancer;	cell line: MDA-MB-231,pert
rat heart ventricle,pert
HT29 PLX Day8 rep1,pert
HEL_Control shRNA (GFP)_3,ctrl
KU_09N,ctrl
jzo008-rp1-v5-u74av2-met,pert
"normal colorectal mucosa, biological rep1",ctrl
"STZ pancreas, biological rep3",pert
5 Ko,pert
strain background: 129/SvEv;	genotype/variation: STING knockout;	cell type: bone marrow derived dendritic cells (BMDCs);	stimulated with: purified tumor-cell derived DNA,pert
patient: 40975;	sample: tumor,pert
tissue type: normal thyroid;	matched/unmatched: unmatched,ctrl
normal with no hydrocortisone treatment-3,ctrl
Control subject 107_biological replicate 1,ctrl
WT CD80hi mTEC sample1,ctrl
colonic_mucosa_non_inflamed_75,pert
Hdh knock-in mice striatal cells,ctrl
liver,pert
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: P0,pert
RNA from whole tissue section of case 1206 labeled with Cy5,pert
patient: 51176;	sample: normal,ctrl
Disease_status: Healthy control;	Age (years): 51;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
PGA-RMM-1h-1aA-s2,pert
pSUPER-mir-210 replicate 1,pert
"array 14, xenograft, abiraterone 75 mg/kg/d",pert
HMEC_50 vs T47D,pert
GM19238_Kd_NS_P1_22,ctrl
HCC PBMC_sample 3,pert
chip number: 16;	transfection plate: 6;	target gene: USF1;	kd level: 0.79;	rin: 9.4;	transfection date: 2012-03-26,pert
wild-type double positive cells sorted from thymus of 8 week old mouse,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 53;	sex: F,ctrl
"hepatic gene expression at ""1 hr"", rep3",pert
brain_co_6M_rep3,ctrl
"Control, biological rep2",ctrl
Liver vehicle rep2,ctrl
Sample 07 Kidney Hyp Mouse - Control Diet,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: Vemurafenib 1000 nM for 48h,pert
cell line: KYSE70;	cell type: squamous cell carcinoma,pert
cell type: granulosa cells;	disease: Polycystic ovary Syndrome,pert
SLE CD4 T cells 5,pert
colon_epithelium_IL10mouse_6weeks_rep4,pert
rd1 mouse retina at age postnatal day 6,pert
Adipose from a 5 month old wild type mouse,ctrl
"Reh, transient knockdown of CBFA2T3",pert
source: JAX stock # 000664;	strain: C57BL/6J;	tissue: retina;	age: P8;	genotype: wild type,ctrl
10A;pretreatment;female;breast tumor,ctrl
mutant Ndel ko/+ mix background,pert
KO - knock-out Treated - 0.5 hrs - repeat 3 - Cy3 - mAdbID:62537,pert
"10mg/kg/day PFOA, Rep 4, Block 4, liver (high dose)",pert
C57BL/6J_Muscle_rep1,ctrl
normal plasma cells (NPC 625),ctrl
ns DHT 3,ctrl
gastrocnemius muscle wild-type mouse,ctrl
cell type: Primary hepatocytes;	strain: NMRI;	agent: control;	time: 6h;	gender: Male;	age: 4 months,ctrl
GIST Pre Treatment Biopsy 37,ctrl
Untreated Myd88 knockout,pert
E12.5 wt2,ctrl
Recent-onset T1D_sample6,pert
Heart_WT_2,ctrl
Peripheral blood mononuclear cells;	TTF=85min;	Race=White;	Sex=Male,pert
"brain, frontal cortex: Sample54_e1_le1",pert
01N70: normal control,ctrl
A HID B_B090,pert
"alveolar macrophages, smoker 027",pert
"brain, lateral and medial ganglionic eminences: Arx+/Y #2_le1",ctrl
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: P14,pert
HF0171_U133P2,ctrl
LDLR_LF_3,pert
HepG2 cells quercetin 2h,pert
U2-OS-ERb,pert
07-0006A_Day1_18,pert
Cerebellum_nontransgenic control A39_10 months_replicate 2,ctrl
Klf9KO_jejunum_PND30_1,pert
MCF10A_Vehicle_rep1,ctrl
condition: Psoriasis;	patient: PS-J;	tissue: LS skin biopsy;	kit: Affy,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: hypertensive cardiomyopathy,ctrl
Sample Group: control; Gender: female; Age: 68; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 1,ctrl
"gender: female;	batch: 1;	age (years): 45;	patient id: Severe_7;	fev1 (% predicted): 71;	fvc (% predicted): 105;	medication: Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline;	cell type: CD4+ T-cells",pert
cell type: Embryonic Stem Cells;	genotype/variation: Suz12KO,pert
fibroblast_Normal_D160_Media_5,ctrl
GEIM110-NORM,ctrl
Normal-N_LJ_4,ctrl
"Kidney from control rats, biological rep 4",ctrl
myoblasts-expt1_untransduced-rep4,ctrl
kidney_saline_control,ctrl
"IN1760 siPD treated, Biological replicate3",pert
Rat skeletal muscle (gas),pert
"Acute Myeloid Leukemia, sample 78",ctrl
C3H/HeJTCE liver sample batch 3,pert
2.5-4.5 month old ovarioectomized female mouse,pert
MCF-7 control rep 2,ctrl
Braf 2,pert
nt control 9,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: mid-UV,pert
CTRL_2_GMP,ctrl
"patient: 126;	current medication: None;	birth date: 4/4/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: FH of Crohn's disease, Symtom free at procedure;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"MCF7 cells, shRNA targetting PDEF",pert
B7hi mTEC B6/129 wt2,ctrl
phenotype: no glaucoma;	gender: female;	strain: D2-Gpnmb+;	tissue: retina;	age: 10.5 months,ctrl
MCF-7 +scrambled siRNA + 100 nM 4-hydroxytamoxifen rep2 (MD34),pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Supraoptic nucleus,ctrl
WT-2 (EPLM),ctrl
"schizophrenia, BA46-22",pert
0178-01-C,ctrl
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50), biological rep1",pert
"TNFa-OMe-P siRNA-C, replicate 7",pert
Normal-ERα-positive breast cancer 45,ctrl
4_CD34+_12h_TCDD-,ctrl
race: caucasian;	age (years): 61;	stage: IC;	grade: 2;	histology: endometrioid,pert
OVCAR-8-(3),ctrl
blood_day6_patient4,pert
B-CLL PB P86,pert
BT474-J4_DMSO_24-2,ctrl
CHF - R12,pert
cell line: D3;	treatment: siPRMT8,pert
MOLT4_ctrl_C,ctrl
KN-sham-2 month-R1,pert
"human failing LV myocardium, Idiopathic52",pert
tissue: Frontal cortex;	age: 78;	Sex: F,ctrl
"seminoma specimen, pT1, patient age: 36y; W00 223",pert
Mouse_ATF6aKO_colon_DSS_rep2,pert
5272 UC Uninflamed sigmoid colon,pert
DRG_DMSO_0.1%_Rep1,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5b;	flt3 status: D835 mutation,pert
Gene expression profiling of normal cortex of patient T163,ctrl
sample 1:;	age: 45;	gender: female;	sample 2;	age: 46;	gender: female;	sample 3:;	age: 64;	gender: male,pert
control to Sample 9,ctrl
Transgenic male mouse 120 day old,pert
Mouse E10.5 urogenital epithelium +/+ #2,ctrl
C3H/HeJ Vehicle liver sample batch 5,ctrl
RA_F,pert
"Cell type: neuronal, age:52, gender:male, diagnostic group: schizophrenia, PMI:16h",pert
"BOEC, at_risk 4",pert
shRNA6-16-noDox-rep1,ctrl
patient15,pert
normal muscle replicate 2,ctrl
"Global gene expression of NASH patients, P40",pert
"Mesodermal Precursor Cells derived from hES cells line SA01, biological replicate 2",ctrl
OCI-Ly10_FOXP1 overexpression,pert
MDS patient 36,pert
patient: 30617;	sample: normal,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 44;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
M454 SKM-Tg,pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp3,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-10;	Primary Site:Tongue;	Age:64;	Sex:M;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
"treatment: diclofenac;	batch: 5;	donor: 5;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
erStress_twins_AA_1727twin1_DMSO_4h,ctrl
normal plasma cells (NPC 642),ctrl
"Hep G2 treated with 2,3-Dimethoxy-1,4-naphthoquinone",pert
APOE_KO_DM_9W_4,ctrl
CML Patient 4 before therapy,ctrl
HP-27,pert
"brain, Entorhinal Cortex: 95-08 normal_e1_le1",ctrl
"Male, 44 years old, HIV infection of 12 years",pert
human preadipocytes+oligo2_day0_rep1,pert
nfia E18KO3,pert
Recent-onset T1D_sample10,pert
high grade serous carcinoma_patient 5,pert
8 Month Wild Type Ovary_01,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 19d ID232,pert
SZ10,pert
(ca)MEK_3,pert
"T3 fetal heart (treated on gd14.5 via oral gavage, collected on gd17.5)",pert
LM2 cells cultured with HMVEC-L and then purified by FACS,ctrl
cell type: Erythroid progenitors on day 6 of differentiation;	genotype/variation: transduced with lentivirus expressing short hairpins against ZBP-89,pert
blood_day0_patient2,pert
Day: 24; Drug: Heroin; Phase: Withdrawal; Replicate: 3,pert
Bronchial Epithelial Cells MMA biological 1790I,pert
Cancer 17,pert
MDS patient 139,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 66;	donor: 31;	disease state: Lesional,pert
CTRL_4_CMP,ctrl
WT-sham-5 month+13d-R4,ctrl
"PIO, subject 13",pert
Genotype: FGF23 TG on C57Bl strain;	Age: 8 weeks,ctrl
race: caucasian;	age (years): 63;	stage: IC;	grade: 3;	histology: endometrioid,pert
EA_Control1_CD8,ctrl
MEKi 4h biological replicate 2,pert
COV434 Control [RR1023],ctrl
cbp+/- standard cage Rep5,pert
cell line: COLO829 melanoma cell line;	genotype/variation: MITF knockdown;	agent: control,ctrl
01LLR_CTRL,ctrl
Skin_Control E16.5_rep3,ctrl
"Mdr2-KO heterozygous mouse, 3 month old mouse, liver sample",ctrl
Patient identifyier: J;	Sex: female;	Age of patient: 54 years;	Duration of psoriasis: 48 years;	Body surface area: 9 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
HCC_36T,pert
"Embryonic cerebral cortex, Trnp1 knockdown, biological replicate 3",pert
osteoblast_control_rep2,ctrl
Wildtype fibroblast sample 2,ctrl
SHEP-SF neuroblastoma,pert
MLL_PTD13,pert
tissue type: brown adipose;	gender: male;	genotype/variation: ob/ob;	harvest time: 4 day post injection;	age: 3 months,ctrl
Wild Type B cells Spleen 4,ctrl
F191G C,ctrl
subject: 32;	disease: CP;	muscle: GR;	gender: F;	age: 7.9;	gmfcs: 2;	popliteal angle: 95,pert
mIMCD3 cells,ctrl
224 Day 0 Untransfected biological rep3,ctrl
EB_2_5d_217_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
ancestral background: European-American (EA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,ctrl
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 0,ctrl
01LM6_Systemic,pert
BL Day 1 siMut12 transfected biological rep1,pert
01LM2_ERA,pert
Lung-sarcoidosis-rep3,pert
mammary gland,ctrl
MPM tumor 28,pert
lung,pert
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/22,pert
BV-173 non-treated,ctrl
BAL_45b_A2B0,pert
"wdNHBE with KY/136 at 36hpi, biological rep1",pert
Mouse testicular Sertoli cell line TTE3,ctrl
KO - 3 mo - repeat 1 - Cy5 - mAdbID:74593,pert
RNA pool from MPH-treated LCLs generated from ADHD patients,pert
transfection: Rif1 shRNA;	cell line: J1 ES Cells;	background strain: 129S4/SvJae,pert
"iPSC derived from healthy control fibroblast WT2, biological rep5",ctrl
"NC1, biological replicate 2",ctrl
N14,ctrl
clone type: AtT20 clone types treated with control siRNA rep 2,ctrl
melanoma in situ,pert
Vehicle-Control;	Vehicle-Control 36 hours set 2,ctrl
18A;pretreatment;female;breast tumor; responder,ctrl
phytohemagglutinin-activated PBMCs from normal control subject C,ctrl
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 19;	Brain pH: 6.71;	Post mortem interval (hours): 70;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
Luciferase-rep2,ctrl
"Control, sample 3",ctrl
No or early 2 rep9 (OHN),pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep4",pert
NFIA E18WT3,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 53 yr;	population: white;	dsm-iv: 295.9;	age of onset: 29 yr,pert
visceral_fat_Wt_female_8wk_rep3,ctrl
NZM15 metastatic melanoma cells treated with PAX3 siRNA,pert
mdx5cv EDL sample 2,pert
gender: Male;	age: 87;	post-mortem delay: 3.5h;	ph: 6,pert
"brain, hippocampus: KA-6h-P15-II_e1_le1",pert
cerebellum_PSNA_ 0d_rep2,pert
"Cervical cancer, squamous cell carcinoma, microdissected, stage IIB1, HPV 18, HPV 45",pert
Control peripheral blood leukocytes - Biological Replicate 1 - Technical Replicate 2,ctrl
Healthy11-CD8,ctrl
"MCF-10A cells, shRNA targetting p63 TA, biological rep2",pert
0120-01-C,ctrl
siRNA mediated WTAP knockdown in HUVEC,ctrl
genotype/variation: Fmr1 wildtype;	tissue: blood;	gender: Female,ctrl
H441 transfected with ETS2-specific siRNA 2,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: myocardium,ctrl
MCF10A_SFN_rep1,pert
cell line: U937;	replicate: Replicate1;	treatment: shLuciferase,ctrl
age: 8 weeks;	genetic background: SV 129/C57BL/6;	genotype: PPAR-beta deletion;	cell type: pancreatic beta-cell,pert
15_0003C_Day1_42,ctrl
M238_R1_B_PLX,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 39;	gender: male;	tumor grade: AII,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, T2 (treated with resveratrol)",pert
PsOEt-22-Week 12,pert
WT-1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.72;	OD280: 0.901;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 206;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
BALB/c control (bmsnmix7),ctrl
cell line: JCRB0086 [TALL-1];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
G392E_on_rep3,pert
Gata-1 Knock Down A,pert
Sedentary-23,ctrl
"Wild-type retina, biological rep3",ctrl
HCC003T,pert
P4_TR_1,pert
age_years: 40;	sex: M;	ethnicity: Asian;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
age: 24 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
BP patient 53_biological replicate 1,pert
strain/background: C57B6SJL;	genotype/variation: GNMT knockout;	age: 3 months;	tissue: liver;	disease status: non-alcoholic steatohepatitis,pert
ERα-positive breast tumors without PIK3CA mutation,ctrl
RatLung_H6h_2,pert
"UM-UC-3 bladder cancer cells, stably transfected with GFP-tagged RhoGDI2, biological replicate A",pert
MCF7 control siRNA Vehicle Rep2,ctrl
H9 Ctrl 6h 3,ctrl
"depression, BA10-22(4)",pert
Whole blood from normal children.,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: JQ1 treated,pert
129_Sv_2_WT_d6_4302,ctrl
IRS-4 KO (jos0954),pert
OVCA420-(1),ctrl
tissue: adipose tissue;	sample group: calorie restrictive;	treatment: before;	gender: Female,ctrl
chip number: 17;	transfection plate: 5;	target gene: STAT2;	kd level: 0.7;	rin: 9.7;	transfection date: 2011-10-17,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 57;	tissue: Blood,pert
NM9 healthy control,ctrl
Donor (Sample 18),ctrl
OE33 siRNA rep2,pert
BALB/c mouse treated with pristine for 3 days,pert
C57BL/6J-ob/ob;	Soleus muscle;	Age: 14 weeks;	Gender: Male,ctrl
Ishikawa_Control_8h_rep2,ctrl
Txnip deficient tumor 27 months sample 1,pert
wild-type macrophages stimulated with MALP-2 for 8 h,ctrl
10 weeks old,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 59;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 16101647,pert
"Normal subject (40 year old caucasian male, SAK_1254688334)",ctrl
30A,pert
cMetKO QSC Technical Rep.2,pert
PBMC RNA from a patient who achieved remission on MTX,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: C,ctrl
Barrett's esophagus (B8),pert
wildtype activated B-Cells,ctrl
HT29 resistant cells replicate 1,pert
OCI-Ly7 NTsiRNA 3,ctrl
"human failing LV myocardium, Ischemic30",pert
Ficoll/PBMC,pert
EE_IB_2_unkwn_lcm,pert
skeletal muscle (quadriceps); fasted 18h,pert
"human failing LV myocardium, Ischemic98",pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/lacZ; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 14.5; Tissue: whole kidneys from 17 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",pert
"Normal skin from Tgfbeta_control mouse, biological replicate 1",ctrl
Aorta control,ctrl
Wild Type Time 7 replicate 2,ctrl
NCCIT-SNF5sh-rep2,pert
Liver sample from Alcoholic hepatitis group (CA51),pert
01LPL_ERA,pert
460A.LMP,ctrl
strain: C57BL/6;	gender: male;	cell type: ESCs;	genotype/variation: No genetic modification;	culture conditions: 2i,ctrl
gender: Male;	tissue: Tendon;Brachialis;	age: 45;	donor: 5;	disease state: Non-lesional,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-tu1,pert
siHic5_2_24h_2,pert
postnatal 3 weeks control heart,ctrl
"2 months, contralateral group, biological replicate 3",pert
Vector Control Transfected 3T3 cells treated with A-928605 for 24 h,pert
"Typically Developing Control, Gracilis, Patient Replicate 10",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
SLE4-TC,pert
Kidney_400 mg/kg VCM ip_mouse #105,pert
PC-3_basalhTERT_ShortTelomeres_mock_3,ctrl
CD8+_Tcells_healthy_donor_2,ctrl
Weight:Low;	CFstatus:knockout;	Sex:Female,pert
E81-/-vector-2,pert
01LM3_Oligo,pert
Striatum of 8-10 week old 129P3/J mice,ctrl
Sex: male;	Age: 15;	SL: 4.01;	House: 7;	Severity: M;	Ashworth: 2;	Zancolli: 2B;	PEFF: 80;	PESF: 80;	AEFF: -50,pert
genetic background: hybrid C57BL/6J and 129S5/SvEvBrd;	genotype: control,ctrl
"2102Ep cells SOX2 siRNA, biological replicate 3",pert
m1-carcinoma2,pert
"Wistar Han;	Crl:Wi(Han), Male, tissue: Heart",pert
NSC miR-128 2,pert
E14 - DCXko/Y 3,pert
type 2 diabetes subject 01,pert
ZNF395 knock-down (shZNF395-3),pert
P1A Progranulin-frontal,pert
HT29 DMSO Day1 rep1,ctrl
"PIO, subject 9",pert
subject: 6;	disease: TD;	muscle: GR;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
WT1-iPS 6,ctrl
E10.5 embryo yolk sacs,pert
MCF-7-Pit-1 rep 2,pert
"metastasis: none;	Stage: 3b;	tissue: cancer, homogenized",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 219,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
15: NORMAL #99-0693,ctrl
imanitib2,pert
ColTum_022GAFD8_g8.txt,pert
BL Day 0 Untransfected biological rep2,ctrl
"hMSC-Tert, control siRNA, 5 days adipocyte differentiation",ctrl
human esophageal squamous cell carcinoma cell line,pert
del337TR replicate 4,pert
SNB19 scramble siRNA replicate 2,ctrl
Esophagus CTR replicate 3,ctrl
N6A Normal-frontal,ctrl
ILD_6,pert
genotype: WT;	cell type: Th17,ctrl
colonic_mucosa_non_inflamed_76,pert
Liver_hyperglycima_no.7,pert
Contusion - 35 Day Epicenter Rep3,pert
human esophageal squamous cell carcinoma cell line_KYSE140,pert
FR-si222-1,pert
cell line: MCF-7;	cell line: breast cancer cells;	transfected with: Empty vector,ctrl
"P16 control OC apex, biological rep 1",ctrl
"Untreated TG2 knockout NB4, biological rep3",pert
H19 siRNA (simH19) tranfected into C2C12 myoblasts rep2,pert
"Gastrocnemius-soleus muscles, basal status, wild type mouse",ctrl
Control + LPS 2,ctrl
cKO_P67,pert
HSC_Zfx-cko_Replicate2,pert
minor non-tumor2,pert
MCI-001,ctrl
GM19238_Kd_ESRRA_3,pert
"P60_wt cones, replicate 1 [array]",ctrl
WT_3,ctrl
"50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
EB_400_6_374_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
5215 UC Uninflamed ascending colon,pert
Kidney_WT_baseline_rep3,ctrl
patient code: 91;	gender: Female;	age: 51;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,ctrl
HeLa_01-04-05 TP10_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
CDK9 Knock Down1,pert
"MTDH control, biological replicate 2",ctrl
HN_125,ctrl
mouselung_scid_control_rep02,pert
SKBR3_0.1uM_Lapatinib_1,pert
GM19238_Kd_HCST_3,pert
"DMSO Control after 1hr, replicate 3",ctrl
"G9a knockdown cells, rep1",pert
4_DMSO-4,ctrl
NTB_skeletal 3,ctrl
patient: 262;	current medication: Asacol 2.4g co-codamol;	birth date: 7/17/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/87;	diagnosis date: 1/1/87;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 7/5/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/5/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"N-58, NORM, M, GSF, 1 x ETOH, 24h",ctrl
"Dermatomyositis, biological rep3",pert
primary MEFs,pert
AtT20 cells treated with control siRNA rep 1,ctrl
cell type: Human melanoma cell line;	cell line: M229;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
PND28 Rat Testis_Rat230-2_2hr MEHP_Animal#45_04005,pert
strain: CD-1;	age: 20 week;	tissue: heart left ventricle;	genotype: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-? promoter,pert
hBSMC_control_rep3,ctrl
ab117 N,ctrl
antimicroRNA-449_rep2,ctrl
"gender: female;	batch: 1;	age (years): 21;	patient id: Severe_2;	fev1 (% predicted): 105;	fvc (% predicted): 101;	medication: Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn;	cell type: CD8+ T-cells",pert
Mouse embryonic kidney,pert
renal_vesicle_Lim1_mutant_4,pert
"SRF silenced, treated with R1881, biological rep 2",pert
Muscle PCOS case 271,pert
11382 Normal Uninflamed ascending colon,ctrl
Wild-type postnatal day 10 rep 2,ctrl
Extract:LOX-1:213101;	Extract Description:LOX1_0hr:213101;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.02;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.53;	Quality: Background Mean Dev.:1.12;	Quality: Absent (%):58.17;	Quality: Absent (%) Dev.:0.07;	Quality: Scaling Factor:0.51;	Quality: Scaling Factor Dev.:0.89;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213101;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295443,pert
FCHL patient #98-1479,pert
"fibroblast, control subject NM2 rep 1",ctrl
24h Control (SAMPLE 7),ctrl
scan batch: Batch 1;	group: control;	subject age: 5;	paternal age: 29;	maternal age: 29,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.93;	choa: 330;	fata: 22;	eea: 1930;	wtkg: 84.5;	perfat: 35.2;	lbm: 54;	fat_mass: 2974.4,ctrl
MIC1,ctrl
HLA risk: High;	Height: 147.8 cm;	Weight: 52.9 kg;	BMI: 24.1;	Age: 12.2 years;	Gender: Female;	Race: White;	Glucose: 83 mg/dl;	HbA1c: 8.1%,pert
MCF7_E2_24h_rep4,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T2N1,pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: ApoD knock-out,pert
human fibroblasts overexpressing progerin treated with FTI,pert
D4_non-transgenic,ctrl
"Exp A, Animal #249, 500mg/kg D-Serine",pert
IM14_case,pert
SHP-/-_rep2,pert
GM19238_Kd_EP300_2,pert
"liver sample of Wistar rat fed for 12 weeks with standard chow diet, after overnight fast",ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 224-day-old male;	40 mg liver used for RNA extraction",pert
RNA from microdissected breast cancer cells from case 687 labeled with Cy5,ctrl
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ Tal-1-/-  ES cells,pert
wild-type replicate 3,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 6h ID131,pert
Waldenström’s macroglobulinemia (WM-PC 32395),pert
Cont subject 05,ctrl
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/+; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 18.5; Tissue: whole kidneys from 14 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",ctrl
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 26;	maternal age: n/a,pert
Rybp#10 (OHT+)_4d_rep2,pert
iA50clone9+,ctrl
siNEG replicate 3,ctrl
GIST_PDGFRA_11,pert
AIRE ko CD80hi mTEC sample1,pert
normal 1345,ctrl
"WT4_ileum, 5 days post-infection with T. gondii",ctrl
Bronchial Epithelial Cells MMA biological 2012R,pert
PGA-MAH-C3H_OVA24h-1aA-s2,pert
BAL_44a_A0B0,ctrl
sample =Healthy1 treatment=Control time=90 (min),ctrl
kidney,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
"Rad21 esiRNA, biological rep3",pert
C2C12 myotubes 1uM H2O2 rep 3,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 64;	tissue: Blood,pert
MDS patient 40,pert
"GSL30, PR04M006v0",pert
LJMJDW21,ctrl
Plate vs. Nail:  4 Week Nail,pert
Tumor_18w_vechicle_DEN_123,ctrl
RNA from HCC_40T,pert
XX1_Paf,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 9",ctrl
T133,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 57.34247,ctrl
S3_S010809,pert
Female - caucasian - E-01-M,pert
"ID:11-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
KD control 17A n,ctrl
sample =XCGD1 treatment=Control time=90 (min),pert
M558_KO,pert
Lesional tail skin from K14-Areg mouse,pert
mammary epithelial cells,ctrl
BxPC3-KO111 rep 1,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID154,pert
"202, ADIPOOSE TISSUE, After",pert
CH2121,ctrl
"Csbm/m mouse, cerebellum, young, nicotinamide riboside treatment",pert
"ShamC-60, biological rep 1",ctrl
"E18.5 brain, Meg3 knock-out, rep 6",pert
5922012047_F,pert
Integrin alpha7 transgenic mouse rep2,pert
R1 differentiated controls,ctrl
patient E1507,pert
CD71+ bone marrow cells from WT mouse 3,ctrl
"patient 12, baseline",ctrl
11386 Normal Uninflamed ascending colon,ctrl
"205, ADIPOOSE TISSUE, Before",ctrl
erStress_twins_AA_1744twin2_500nM_thapsigargin_4h,pert
Heart_KO_4,pert
surgically resected material,pert
gender: male;	strain: C57BL/6;	developmental stage: day 13.5 embryo;	genotype/variation: DUSP5 knockout (KO),pert
Treated with 25uM Zinc for 4 hrs -- replicate #1,pert
"brain, cerebellum: KCx4w#2_e1_le1",pert
patient: 6;	disease state: hypertension;	tissue: Atheroma plaque,pert
race: caucasian;	age (years): 63;	stage: IA;	grade: 3;	histology: endometrioid,pert
"AG825-treated, 6h after UV, Replicate B",pert
5283 UC Inflamed ascending colon,pert
strain: mixed 129/Ola-C57BL/6 background;	genotype/variation: Junf/f,ctrl
caudate nucleus,ctrl
"Control animal, biological repeat 2",ctrl
IMR-32_pCMV-SQSTM1_48hr_rep 1,pert
No_abuse_3,ctrl
"PC-3 cells, 60μM luteolin (Lut), 24h",pert
ab139 N,ctrl
ab057 IM,pert
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b retrovirus,ctrl
"Normal Skin, Normal-4",ctrl
MDS patient 41,pert
Parkinson's disease sample x115,pert
Healthy control 11,ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Endothelial Cell,pert
strain: C57BL/6;	genotype/variation: Zmpste24+/+;	cell type: mouse embryonic fibroblasts,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with MEK inhibitor for 4h,pert
cell type: monocytes;	disease state: healthy,ctrl
"TNFa-OMe siRNA-B, replicate 2",pert
NTB_skeletal 1,ctrl
Gastric_cancer_patient_2,pert
GM19238_Kd_NFKB2_2,pert
"Whole blood - General population, Female",ctrl
"cultured human airway smooth muscle, no treatment, replicate 2",ctrl
Liver CTR replicate 3,ctrl
strain: 21;	Disorder: normal scar;	Condition: +hydrocortisone,pert
"Acute Myeloid Leukemia, sample 32",ctrl
chip number: 6;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.83;	rin: 9.1;	transfection date: 2011-03-29,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.83;	choa: 148;	fata: 78;	eea: 1590;	wtkg: 84.3;	perfat: 20.7;	lbm: 62.7;	fat_mass: 1745.01,ctrl
CLL9-CD8,pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12. Sample B,pert
PGA-MAH-C3H_PBS6h-4aA-s2,ctrl
PsOEt-21-Week 1,pert
Control 2,ctrl
"25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Peripheral blood, patient without recurrent events [N23]",pert
Mock infected macrophages harvested at 1h post-treatment from donor 1,ctrl
minor non-tumor4,pert
cell line: HuT-102;	cell type: human cutaneous T cell lymphoma cells;	transfection vector: shRNA expression vector against Luc,ctrl
tissue: Biceps muscle;	patient: C.b.3;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2y 1m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
"Mesodermal Precursor Cells derived from hES cells line SA01, biological replicate 1",ctrl
disease status: allergic asthmatic subjects;	tissue: bronchial biopsies,pert
KU_44N,ctrl
scan batch: Batch 2;	group: autism;	subject age: 10;	paternal age: 26;	maternal age: 24,pert
WT-EtOH-4 (DFW),pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 40.17808,pert
colon_IBD_939,pert
MDS patient 127,pert
PND28 Rat Testis_Rat230-2_1hr MEHP_Animal#38_04005,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14476;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
strain: C57BL/6;	genotype/variation: B6.Sle1a.1;	gender: female;	sample type: experimental,pert
"344SQ with control shRNA, replicate 2",ctrl
AKR/J Vehicle liver sample batch 6,ctrl
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 24 hours;	agent: air;	exposure dose: 0 ppm O3",ctrl
Allo-4-1,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14477;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
control siRNA rep3,ctrl
"Mut, biological rep2",pert
Irradiated-ATM-WT Replicative2,ctrl
patient: 51681;	sample: normal,ctrl
Normal cortex of patient 1524,ctrl
MPM tumor 10,pert
db/db 8-3,ctrl
tissue: primary skin cells;	genotype/variation: Adam10 knockout,pert
cell line: A549;	cell line origin: Lung cancer;	genotype/variation: control,ctrl
microdissected breast cancer cells from case 342,pert
"48 hour-treated wild-type NB4, biological rep3",ctrl
Kidney_200 mg/kg VCM iv_mouse #027,pert
sciatic nerve of P4 wild type mice,ctrl
JIA PBMC Pre treatment A235_L009,ctrl
Retina wildtype 30 days 4,ctrl
Diaphragm 23 Day mdx rep 1,pert
Disease_status: Bipolar disorder;	Age (years): 45;	Gender: Male;	Age of onset (years): 35;	Duration of illness (years): 10;	Brain pH: 6.35;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: 10000;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): Unknown,pert
Carbo Day7 (416L),pert
day16 ES derived neuron,pert
"Human LIMA artery from patient 1, control (unstented)",ctrl
mouse pituitary gland cells,pert
Nod2-/- 2,pert
genotype: C57BL/6 Ptenfl/flFoxp3-Cre,pert
M454 SKM-Tg,ctrl
Patient no. 9: treated,pert
"Mouse ex-iTreg cells, replicate pool 1",pert
treatment protocol: depleted BRCA1,pert
Control [G3],ctrl
EB_2_8d_223_HCHO_Nasal_Rat230_2_CIIT05024,pert
patient id: 131;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 51;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"Control subject, biopsy taken from the colon, no macroscopic signs of inflammation.",ctrl
p300_2,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 9",ctrl
"35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 43;	gender: f;	treatment: -,ctrl
RNA from microdissected breast cancer cells from case 878 labeled with Cy5,ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#3,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: HIF-1α knockdown;	cell subtype: 10 days old tumor spheroids,pert
platelet_sickle_7,pert
Squamous cell carcinoma 032,pert
L1 062502 Tro1,pert
BalbC_24h-DMSO,ctrl
Subject #8030-Preinfection,pert
tissue: blood;	patient: 3;	gender: male;	age: 59,pert
1015-01-A,pert
long-Con rep2,ctrl
01LR6_ERA,pert
PBMC CV T1,pert
MCF-7 +scrambled siRNA + vehicle rep1 (MD39),ctrl
HMEC_50 vs HMEC_41,ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: sham,ctrl
strain background: Mixed; mostly C57BL/6 with some 129S/SvImJ (from CJ7 ES cells).;	genotype/variation: wild type;	age: 9-day old;	tissue: bone marrow;	cell type: long-term hematopoietic stem cells (LT-HSC);	cell type: Lin-Sca1+Kit+CD48-CD150+,ctrl
"eye, retina",pert
Jejunum_POR-null+quercetin_2,pert
HGPS-iPSC replicate 2,pert
Lung-sarcoidosis-rep4,pert
"Lesion Skin, LS-7",pert
lesion_postUV_patient2,pert
RatLung_H16h_3,pert
"patient 15, baseline",ctrl
CTL2 E2 24hr,pert
control peptide-treated T-ALL1 100mM 16h,ctrl
"CCM3 shRNA cells passage 7, rep 1",pert
A2008-(2),ctrl
HCC_38N,ctrl
Seguin_IDR_BrownNorway_Liver_treated6,pert
RTX6 T0,ctrl
CD43+/41+/235+ progenitors generated from euploid iPSCs,ctrl
SKI-DLCL cells cultured for 24h,ctrl
25SAGEA,pert
Placenta_PE(EO)4 with Cy5,pert
Patient identifyier: C;	Sex: male;	Age of patient: 32 years;	Duration of psoriasis: 17 years;	Body surface area: 8 percent;	Overall erythema: moderate;	Induration: severe (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 41 yr;	population: white,ctrl
cell type: PBMCs;	disease state: healthy control;	gender: male,ctrl
CTRL_3_MEP,ctrl
patient: 40843;	sample: tumor,pert
TTE3 cells treated with BPA for 0 h-1,ctrl
tissue: brain;	genotype: mutant Dcx ko/Y;	age: E14,pert
"Gender: Female, Age: 29, BMI: 22, Tissue: luteinized cumulus cells",ctrl
GIST Pre Treatment Biopsy 03,ctrl
Wild-type E11.5 proximal hindlimb pool 3,ctrl
T47D breast cancer cells,pert
Stratagene Human Universal Reference Pool,ctrl
age: 11;	sex: F;	disease status: control subject;	Filter number: 94;	Usage number: 1;	Exposures: 3,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 8 hour",pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 1.5,ctrl
Sample 3 Posterior  +/+,ctrl
Adult 7d SNI; Biological replicate 5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.681;	OD280: 0.848;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 219;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell line: HCT116;	clone: 20;	genotype: Wild type,ctrl
B5_Pseudomonas_overexpressor_48,pert
agent: ConA;	time point: 3 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Pancreatic Sample 31-Tumor,pert
HTB58_antiEvi1siRNA_1,pert
treatment: control knockdown;	cell line: J1 ES cells,ctrl
host strain: nude mice;	injected with: iNRAS-475 mouse melanoma cells;	tissue: Melanoma allograft;	treated with: vehicle,ctrl
Muscle PCOS control 6,ctrl
Parkinson's disease sample x045,pert
No_drug_#4863,ctrl
"Wild type used for GNMT 8 month, replicate 1",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day0,ctrl
"seminoma specimen, pT2, patient age: 37y",pert
erStress_twins_AA_1734twin2_DMSO_4h,ctrl
Female - caucasian - E-08-G,pert
Cervical Cancer C517,pert
multiple myeloma (MM 370),pert
"Heart, MAT1 CKO, 4 wk, sample 1",pert
control participant P317,ctrl
"0mg/kg/day PFOA, Rep 5, Block 3, lung (low dose)",ctrl
WT osteoclasts untreated 2,ctrl
"proband i, before exhaustive exercise",ctrl
normal main pancreatic duct 6,ctrl
KU-812 non-treated,ctrl
WT P2 replicate 3,ctrl
4010-3 E2F2 Null,pert
"DBA/2J ACU, Rep2",pert
Patient no. 18: control,ctrl
R6/1 22 week transgenic_BD1Bv1,pert
BCR/ABL1 biological replicate 2,pert
CTRL_4_HSC,ctrl
COV434 Wildtype [RR1020],pert
LCL Unaffected MZ twin pair 1 (CCN1.1)(TP13),ctrl
WT-sham-5 month+1d-R4,ctrl
strain/background: C57BL/6;	genotype/variation: wild type;	tissue: lung;	treatment: PBS control,ctrl
HVS-CD4-control_unstim_rep1,ctrl
chip number: 21;	transfection plate: 4;	target gene: IRF9;	kd level: 0.7;	rin: 9.5;	transfection date: 2011-10-17,pert
3975-1 E2F1 Null,ctrl
pB  is a clonal control (puromycin resitant) stably-expressing stem cell line,ctrl
SIRT4 WT liver_7587,ctrl
AFFS084-6-291004,pert
14-week-old Trim24-/- liver_463M,pert
KO (Rnh1-/-) -2,pert
Macrophages derived from pheripheral blood,pert
gender: F;	age at blood draw: 37;	tissue: whole blood,ctrl
BP patient 60_biological replicate 1,pert
U2-OS-ERa,ctrl
Gender: Male;	Age: 25;	Ethnicity: White,pert
"human nonfailing LV myocardium, NonFailing15",ctrl
Frontal_Cerebrocortex_Permethrin_10mg/kg_6hr_rep2,pert
H3med,ctrl
"Heart, MAT1 control, 2 wk, sample 3",ctrl
"Other: Equal quantities of total RNA from each cell line (brain, breast, B-lymphocyte, cervix, liver, liposarcoma, macrophages, skin, testis, Y-lymphocyte) were pooled together.",ctrl
A HID B_B041,pert
01LNJ: normal control,ctrl
"WT, PR04M001v0",ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
ASO T00278947,pert
Normal skin from Tie2_control mouse,ctrl
sample =XCGD6 treatment=Stimulated time=180 (min),pert
0577-01-A,pert
cerebrum_PSNA_ 0d_rep2,pert
tissue: Brain;	genotype: Npc1+/-;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
s2t0c,ctrl
"Frontal cerebrocortex, permethrin 100 mg/kg, 6 hours",pert
HepG2_Phenol rep2,pert
brown fat cells differentiated for seven days,pert
Placenta_PE(LO)1,pert
"ESCs overexpressed vector control, biological rep3",ctrl
Mouse otic vesicle at E10 wt,ctrl
EBS_5,pert
11391 Normal Uninflamed ascending colon,ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 74;	Usage number: 1;	Exposures: 4,pert
Wild type_heart_3,ctrl
CHB PBMC_sample 8,pert
MDS patient 159,pert
IPMA 6,pert
OVCAR-10+(1),pert
Brain from 67 days Npc1+/- mouse1,ctrl
Mtb infected mouse lungs treated with PZA-42 days post infection,pert
NTG 1,ctrl
IPMC 3,pert
epithelium from colon of control mouse no.1,ctrl
HT29 resistant cells replicate 3,ctrl
n4t30m,pert
WT_POST_PDE_059,ctrl
"Retina from NeuroD1 cKO mouse at ZT20, biological rep 2",pert
DMN-CtrHippo28d-1aAv2-s2,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 260,ctrl
mutant_embryonic brain_rostral,pert
breast cancer patient 232,pert
U2OS_control_shRNA_pLenti_1,ctrl
"Biceps, FSHD, cohort 07, subject 07A",pert
ic6 -- mock APF#1 on cell line 1,ctrl
"Patient 16, Macroscopically intact tissue",ctrl
tissue: heart;	genotype: Gata4_KO;	age: 8 week adult mice,pert
Normal-ERα-positive breast cancer 66,ctrl
sciatic nerve of P4 Trembler mice,pert
E9.5 embryo_wild-type_rep2,ctrl
tissue: tumor tissue from cancer patients;	genotype: p53 wild type;	disease state: Microsatellite Stable Stage III Colorectal adenocarcinoma,ctrl
tissue: testis;	gestational age: 16 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: DBP,pert
MCE301 cells treated with SB for 0 h-1,ctrl
striatum_Pink1 knockout_24 weeks_replicate 3,pert
Substantia nigra PD rep1,pert
Cdx2_H2,ctrl
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
EB_07_5d_140_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"control, BA10-42",ctrl
G93A mouse 799,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 22.31507,pert
Empty Vector Control for transient transfection replicate 2,ctrl
"Crohn's Disease subject (41 year old caucasian female, SAK_1277825109)",pert
"PBMC, healthy control, biological rep8",ctrl
"RWPE1 cells, vehicle, 6h, biological rep4",ctrl
osteoblast_control_rep3,ctrl
"NASP siRNA treatment, sample #2",ctrl
genotype: wild type;	cell type: colon epithelial cells;	gender: male;	treatment: water,ctrl
Txnip deficient normal 24 months sample 2,ctrl
ab180 N,ctrl
"human failing LV myocardium, Ischemic81",pert
"knockout white adipose tissue, biological rep 1",pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T163,pert
24 hr KLF4 Time Course Induced,pert
Osteoblasts_Lrp5_Knockout_Day7_rep4,pert
"normal skeletal muscle, biological rep2",ctrl
WT4-iPS 1,ctrl
lymphocytes_HD_F_36y,pert
cbp+/- standard cage Rep2,pert
22B,pert
"Mesodermal Precursor Cells derived from hES cells line VUB01, biological replicate 1",ctrl
"brain, hippocampus: Ctr-72h-P15-I_e1_le1",ctrl
WAT from wild-type control fed regular chow diet Replicate 2,ctrl
"Retina from NeuroD1 cKO mouse at ZT6, biological rep 2",pert
"Deltoid, control, cohort 03, subject 03U",ctrl
6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24724,pert
ANCR knockdown,pert
cell line: ACC525 [DND41];	cell type: human T-ALL cell line;	agent: control,ctrl
MO32_18,ctrl
Human Acute HIV Sample A051-CD4+ T cells,pert
patient: 242;	current medication: Salazopyrin Folic acid;	birth date: 10/18/39;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/75;	diagnosis date: 1/1/75;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/22/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
92.1 - siBAP1 - replicate2,pert
pediatric AML PP8,pert
DS2-iPS 3,pert
HC MB 2 alcohol,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 225min;	race: White;	sex: Male,pert
gender: male;	tissue: gastrocnemius muscle;	age: 7.5 months;	genotype: Mstn ko,pert
phenotype: alcoholic;	gender: male;	case_id: 351;	age: 42;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 41;	brain ph at time of freezing: 6.5;	labeling_batch: 2,pert
431MM,ctrl
3783-lcm,pert
"Spleen, SRBC immunized mouse, 12 days post-immunization",ctrl
"male, 275-300g",pert
Control 60 days sample 2,ctrl
"Uninvolved Skin, NS-13",pert
HepG2_Cd rep1,pert
CPU R control 2,pert
HCT116 colon cancer cells,pert
"age at diagnosis: 76;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIB;	t (extent of primary tumor): T4;	n (lymph node metastasis): N1a;	er: NA;	pgr: NA;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
genotype/variation: Tsc2 +/- mouse;	tissue: cerebellum;	gender: Female,pert
ACC Xenograft X1,pert
strain: FVB/NCrIBR;	tissue type: tail skin,ctrl
"human failing LV myocardium, Idiopathic75",pert
LCL Unaffected MZ twin pair 2 (CCN2.2)(TP18),ctrl
SKI-DLCL cells,ctrl
LNCaP R1881 rep 3,pert
HF0251_U133P2,pert
"Kidney from MON exposed rats, biological rep 4",pert
DBA d3 (185msn),pert
HCV_Core_1,pert
H2_SS12_01Nov07,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	1st technical replicate,pert
11437 UC Inflamed sigmoid colon,pert
"ATP7B -/- KO mice, 6 weeks old",pert
Strain CD-1,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_24_10_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
whole brain,pert
"brain, lateral and medial ganglionic eminences: Arx+/Y #1_le1",ctrl
"Ulcerative Colitis (37 year old caucasian female, SAK_1286609838)",pert
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-2;	Primary Site:Floor of Mouth;	Age:58;	Sex:F;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",ctrl
"A549, -TNFα, control siRNA, rep1",ctrl
subject: 2825 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
"Lymphoblastoid cell lines derived from family 1734, member 2",pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep2",ctrl
Early IPF_surgical biopsy_upper lobe_rep149,pert
MCF-7 +scrambled siRNA + 100 nM 4-hydroxytamoxifen rep1 (MD33),pert
control mice colon rep 3,ctrl
clone 42 replicate 1,ctrl
3 weeks TAC-2,pert
06 PLUS OHT 3,pert
"Peripheral blood, patient without recurrent events [N46]",pert
0970-01-C,ctrl
"Trim28 conditional KO mice Treg cell, replicate 2",pert
"B10 sham kidney, biological rep3",ctrl
"MCF7 cells stably transfected with XBP1, passage 2",pert
brain_DLPFC_bipolar C_mr645,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day7,pert
Cerebellum_nontransgenic control A39_10 months_replicate 3,ctrl
lymphoma_5783_nt,ctrl
"103, MUSCLE, Before",ctrl
PBMCs_Control_3 [IS],ctrl
B_LS_Wk1,pert
D_LS_Wk1,pert
CLDN18_KnockOut_lung,pert
1197-03-A,pert
cell type: monocytes;	disease state: renal cell carcinoma (RCC),pert
sample type: HeLa-LAMP3siRNA-3d;	cell line: HeLa;	knockdown: LAMP-3 siRNA;	time: 3d interferon alpha;	treatment: interferon alpha,pert
nucleus accumbens ctrl replicate 2,ctrl
16L,pert
SLE myeloid cells 4,pert
NCI-H1650 + Medi5117,pert
RO38,ctrl
"Mouse Sciatic Nerve, Non-diabetic Vehicle",ctrl
"Lymphoblastoid cell lines derived from family 1743, member 2",ctrl
5264 UC Uninflamed sigmoid colon,pert
Adrenocortical adenoma with wild-type CTNNB1-3,ctrl
Normal-BM 3,ctrl
"Patient 17, Atheroma plaque",pert
HP-65,pert
JoMa1_1,ctrl
Retina wildtype 30 days 3,ctrl
"BMMCs from NTAL KO, noninfected, 2 h activated, biological rep3",pert
"testis, knock out",pert
Embryonic day 14.5 Zfp36l2 knockout (KO) mouse fetal liver,pert
subject id: 4;	infection: DENV;	status: DF;	tissue: whole blood,pert
Postmenopausal female. Untreated control. nr 12.;	Replicate,ctrl
brain_Down_syndrome_sampleid_jg1740,pert
normal 1502,ctrl
Plate vs. Nail:  3 Day Nail,pert
WT vehicle (7991003028_E),ctrl
Etoh 6,ctrl
ns VC 1,ctrl
SLE CD19 B cells 13,pert
100uM H2O2 rep 4,pert
Recent-onset T1D_sample9,pert
12472 UC Uninflamed ascending colon,pert
"Lymphoblastoid cell lines derived from family 1733, member 1",ctrl
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
"GFPMYC positive GC B cells, Biological replicate 5",pert
Parkinson's disease sample x032,pert
"MCF-7, 12h, 0.3mM 5FU",pert
tissue: liver;	gender: female;	disease status: normal glucose tolerance,ctrl
Mouse_ESC_Pcl2_mismatch_control_sample 3,ctrl
"EAE, 1,25(OH)2D3-treated #8",pert
C3_CLP_overexpressor_12,pert
CD8+ T cells derived by negative selection from leukopheresed blood sample,pert
Normal Puerto Rican control 3,ctrl
Liver_POR-null_3,ctrl
Colon,pert
"4302_CD133-, untreated",ctrl
vacht KD 3,pert
Disease_status: Bipolar disorder;	Age (years): 43;	Gender: Female;	Age of onset (years): 29;	Duration of illness (years): 14;	Brain pH: 5.92;	Post mortem interval (hours): 57;	Side of brain: Left;	Fluphenazine mg. Equivalents: 10000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Ad-rep1,pert
"WT Heart with no treatment, biological rep3",ctrl
"uninfected primary RPE, biological replicate 4",ctrl
7d-Sham-81,ctrl
S-IIP(UIP)4_Cy3,pert
"Patient  A, lesion, 12 week",pert
MCL_IGHV_UNMUT (R1328),ctrl
16C-M4-D,ctrl
PB_healthyControl_III,ctrl
P4_Ovary_Control_biological rep1,ctrl
"cell line: prostate cancer, PPC1",ctrl
"Lesional tail skin from K14-Areg mouse, biological replicate 1",pert
Postmenopausal female. Untreated control. nr 38.,ctrl
BALB/c control (bmsnmix9),ctrl
PTC BRAF wt 7,pert
cell type: human peripheral blood memory B cells (MBCs);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
HCC_8N,ctrl
age: 5;	sex: F;	disease status: control subject;	Filter number: 105;	Usage number: 1;	Exposures: 3,ctrl
EGFP control KD mouse embryonic stem cells,ctrl
clone 48 replicate 1,ctrl
SKBR3-R_1uM_Lapatinib_3,pert
cell type: epithelial cells,ctrl
liver_co_6M_rep1,ctrl
sepsis patient #17,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 80;	time: 0;	batch: 3,ctrl
"57B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
gender: female;	batch: 1;	age (years): 33;	patient id: Control_6;	fev1 (% predicted): 116;	fvc (% predicted): 115;	medication: None;	cell type: CD4+ T-cells,ctrl
11432 UC Uninflamed sigmoid colon,pert
chip number: 15;	transfection plate: 4;	target gene: IRF8;	kd level: 0.65;	rin: 9.3;	transfection date: 2011-10-17,pert
tissue: bone marrow;	cell type: macrophage;	genotype/variation: WT;	infection: uninfected,ctrl
"RWPE1 cells, vehicle, 6h, biological rep2",ctrl
NFIA P16WT3,ctrl
14.5_WT_522C,ctrl
wildtype MEFs,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,ctrl
Lung,ctrl
Myc(F/F) CD8 T cells,ctrl
231/ARF-2,pert
"control, BA46-24",ctrl
Y HID_B038,ctrl
normal adjacent esophageal tissue from patient E1507,ctrl
lesion_preUV_patient10,pert
"Empty vector, collagen plate, rep1",pert
Liver sample of p14 KO mouse 1,pert
CF (D508) subject9,pert
WFS1 WT USHT_11_326_wt,ctrl
GEIM39-U133A-DM,pert
"Wt mouse, cerebellum, old, saline treatment",ctrl
Irradiated-ATM-WT Replicative3,ctrl
T118,pert
"acutely admitted, severely psychotic schizophrenia patient  A06",pert
-DOX/-E2_2,ctrl
Subject #8040-Preinfection,pert
status: Control;	gender: Female;	age: 47;	tissue: Blood,ctrl
BN DES-treated replicate 3,pert
"BOEC, not_at_risk 6",pert
5249 UC Uninflamed sigmoid colon,pert
Kidney_200 mg/kg VCM iv_mouse #030,pert
Substantia nigra PD rep10,pert
CD4+/CD25- T effector cells in resting phase,pert
"siRNA, plastic plate, rep3",ctrl
LY2 control-siRNA tamoxifen treated rep2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 36;	gender: male,ctrl
Wildtype_XY_1,ctrl
brain_DLPFC_bipolar B_mr678,pert
WT-pDC1,ctrl
"breast tumor epithelium,24",pert
12490 UC Inflamed descending colon,pert
DBA/2JTCE liver sample batch 4,pert
Bone Marrow Mononuclear Cells;	24y Male,ctrl
"Wild-type-neocortex, biological rep9 (female)",ctrl
pRb+/+.2,ctrl
MDA-MB-231 - Control,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.242;	OD280: 1.1;	Ratio: 1.97;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 288;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
LCL Unaffected MZ twin pair 4 (CCN4.1)(TP25),ctrl
A375 Wnt1-2,pert
Calu3-GemR_Veh_3,pert
"in vivo,2 cell stage, embryo",pert
skin,ctrl
"AD_FC, biological rep5",pert
GIST Pre Treatment Biopsy 39,pert
GFP A,ctrl
CD4+_Tcells_severe_asthmatic_4,pert
Mut-/- rep4,pert
tissue: Temporal cortex;	age: 84;	Sex: F,ctrl
HeyC2+(2),pert
Non-silencing control siRNA: AAUUCUCCGAACGUGUCACGU Technical Replicate 1,ctrl
Bone-Marrow_MM_M1155,pert
brain_DLPFC_bipolar C_mr701,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 24 hr,pert
"Exp A, Animal #262, 20mg/kg D-Serine",pert
"MaF pre-iPSC9P2, Vc untreated, lysed on D4",ctrl
110B,ctrl
CD4+ CD25+ Foxp3- T cells,ctrl
E_LS_Time0,ctrl
HCT 116  siChe-1 rep3,pert
EosKOCD25+#2,pert
"breast tumor epithelium,11",pert
tissue: Frontal cortex;	age: 89;	Sex: M,pert
strain: FVB/NCrIBR;	tissue type: ear skin,ctrl
major HCC8,ctrl
patient id: T166;	tissue: Normal cortex;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: oral cavity;	donor sex: male,pert
V5-P157,ctrl
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: TFPI alpha,pert
PBMC normal sample RNA for Control,ctrl
siControl_rep_2,ctrl
Wild-type CS_2_16_WT_3,ctrl
PFR3K650E_replicate_4,pert
"heart of mouse, 2 week control (1A)",ctrl
miR122-KO-94,pert
Empty vector control (RNAi 1B)_3of3,ctrl
coc-12,pert
HSC-3_vector_48hr culture_rep2,ctrl
Control (C275),ctrl
WT A,pert
"Patient W, uninvolved skin",ctrl
MLL_00111,ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 4, Units of Harvest Time Point: hr",ctrl
"Crohn's Disease subject (61 year old caucasian male, SAK_1316018592)",pert
cell type: T cell;	disease state: heterozygote FH,pert
WKY16-2,ctrl
Mouse Bone Marrow,pert
BC6 TC,ctrl
"Pineal gland from control mouse at ZT6, biological rep 1",ctrl
coMCF-7_1,ctrl
H295R_Group_A_Dose_NA_TIMEPT1_002,ctrl
WT C,pert
V5-P256,pert
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep2",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: retina;	time: ZT6,ctrl
Normal B cell 1,ctrl
221/4,pert
brain_DLPFC_bipolar C_mr951,ctrl
KU_07N,ctrl
CON 3,ctrl
Cell line BT-474_c-myc KD_expt1,pert
21: NORMAL #99-0636,ctrl
Pt_4 Normal Skin,ctrl
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 27;	maternal age: 27,ctrl
"3 uM EPZ004777 treated, DAY 6, biological rep.2, MV4-11 cells",pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 38;	maternal age: 31,pert
PsOEt-11-Week 1,pert
patient id: 265;	tissue: Normal cortex;	gender: Female;	age: 43;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 95min;	race: White;	sex: Male,pert
MCF-7 +scrambled siRNA + 500 nM 4-hydroxytamoxifen rep1 (MD35),pert
Tetracycline-inducible glioma cells no dox 2,ctrl
cell line: GIST882;	agent: DMSO (control);	replicate: Rep2,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep3",ctrl
Prostate Cancer_MS 36D7,pert
CLS14_T2_PP_day0_056,ctrl
266D3,pert
KN-sham-5 month+1d-R3,pert
"A pool of RNA from lung from three male mice with SM22-rtTA transgene on an FVB/N background, raised at Denver altitude (nearly normoxic), fed doxycycline for 8 weeks and sac'd at 12 weeks of age.",ctrl
Scrambled 24 hours_2,ctrl
Ad infected murine liver-MO30k-(6697)-6 hpi,pert
normal control 2,ctrl
NOMO-1 cells infected with ZFX shRNA SH3,pert
"Patient  L, lesion, 12 week",pert
RNA mix 3 of nomarl lungs,ctrl
HeLa-Ctrl-siRNA-3d,ctrl
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.434;	OD280: 1.353;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 7.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 140;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CD34+ cells from untreated normal donor,ctrl
MacularDegen-healthy-8aAv2-s2,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 11,ctrl
HT29 DMSO Day3 rep1,ctrl
coc-8_C,pert
Mutant_liver_2,pert
CD19_selected_B-cells_before_R_rep8,ctrl
cell line: LN229;	expression: Cyr61,pert
non-malignant FTEb_patient 10,ctrl
NB83 U133p2,ctrl
Phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject K (KAcCD8),ctrl
BL6_6h_DMSO,ctrl
Heart-Base_KO-1,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 19;	maternal age: n/a,pert
"Control 1, 16hrs",ctrl
PLT-t7-2; transgenic plantaris 7 month,pert
"Patient  K, lesion, 1 week",pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
GIST Pre Treatment Biopsy 13,pert
colon_1h_rep1,pert
Gender:F;	Age:41;	Tissue: Mucosa,ctrl
pediatric AML S26,pert
CTRL_5_HSC,ctrl
KM_050N,ctrl
Muscle-AMPKgamma3-mutant(R225Q)transgenic-3,pert
"KO, Tumor, 11M",pert
INS-1 cell line #1 with induced HNF6,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	RNA Integrity Number: 9.2;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
PGA-RMM-18h-1aA-s2,pert
strain: B6EiC3SnF1/J (mix of B6 and C3H background);	genotype: wild-type;	tissue: skeletal muscle;	Sex: male;	age: 5 months,ctrl
"Cultured ovarian cancer cell line FU-OV-1, Cisplatin treated",pert
"seminoma specimen, pT1, patient age: 37y; W03 023",pert
V5-P465,pert
CD4IncTp2-3,pert
RE550_KPL4_un2,ctrl
"primary cortical neurons, PTEN shRNA",pert
Control 60 days sample 1,ctrl
"expression at 16hr, bio rep2",pert
control7,ctrl
"A549, -TNFα, control siRNA, rep3",ctrl
colon_0h_rep1,ctrl
vMyb virus-infected replicate 1 (MCF7),pert
Caco2-siRNA-control1-rep3,ctrl
1204-03-A-b,pert
Muscle-AMPKgamma3-ko-2,pert
"SKO-transduced MEFs, Vc+, D4",pert
Hunk Knock-Out rep 5,pert
MCF7 breast cancer cells,pert
"Uninvolved Skin, NS-14",pert
unstimulated HMEC culture experiment 1,ctrl
Hippocampus 1997 15 month Old,pert
strain background: BALB/c;	cell line: 4T1.2;	stably transfected with: pMSCV retroviral expression vector system with IRF7;	expressing: IRF7;	tissue: Mammary Tumour,pert
Invasive cancer originating in IPMN 2,pert
mdx soleus sample 2,pert
"Atm+/+ 120 min post IR, A",pert
Mutated-ERα-positive breast cancer 7,pert
WT differentiated brown fat cells (rep1),ctrl
9-cis-retinoic-acid_mammary_4,pert
40_C57_WT,ctrl
Primary hepatocytes isolated from Donor 6 treated with Wy14643 for 6h,pert
Shn2_Mutant_2,pert
strain: C57BL/6J;	genotype/variation: wild type;	cell type: bone marrow derived dendritic cells,ctrl
FC 02,ctrl
"TNFa-OMe-P siRNA-C, replicate 4",pert
RL_siRNA_NS_rep3,ctrl
Plate vs. Nail:  2 Week Plate,pert
Knockout CS_MA_5_11_KO_3,pert
Leg 7 Day mdx rep 2,pert
2-WT,ctrl
"Macrophage cultures were prepared from C57BL/6J, male, mouse peripheral blood by Optiprep (Accurate Chemical and Scientific, Westbury, NY) gradient centrifugation.",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: insulin,pert
BaF3 cell line transduced MPLW515L3 mutant,ctrl
"Biceps, control, cohort 21, subject 21U",ctrl
Control subject 47_biological replicate 1,ctrl
WT648,ctrl
"Strain: C57BL/6 Ly5.1+, tissue: CD45.2+ transplanted bone marrow",ctrl
abl siEZH2 at VEH rep 1,pert
Normal cortex of patient T142,ctrl
human_hepatocyte_vehicle_donorA_24hr_prep1,ctrl
striatum_ctip2_KO_3,pert
Individual_5177_PN_sample,pert
CUTLL1 MigR1 GSIwash2h-rep1,pert
WT replicate 1,ctrl
THRB wt + T3 replicate 3,pert
V5-P043,pert
cell line: U-87 MG;	cell type: glioma,pert
AA_Case13_CD8,pert
Total RNA,pert
Postmenopausal female. Tibolone treated. Patient 11.;	Replicate,pert
"fibroblast, MFS subject FB836 rep 1",pert
Wild-type iPSCs,ctrl
"Normal subject (31 year old caucasian female, SAK_1265864834)",ctrl
"non-AD_TC, biological rep18",ctrl
Seltzer 14d replicate 1,pert
colonic_mucosa_inflamation_94,pert
"Rat_Tracheal_Dex_2hr, rep6",pert
microdissected epithelial cells from IPMC 6,pert
tissue: thymus;	genotype: wild-type cd4-cre+;	age: 8 weeks,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 165min;	race: White;	sex: Female,pert
T147,pert
DN4 cells sorted from mouse n°137 (Cre-),ctrl
H1P_2,ctrl
C1A-LU,ctrl
Mnk_3201-R-7,pert
PHM-DM-4aUA-s2,pert
Wt Mouse_cerebellum_Young_saline treatment_Replicate-4,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: III, T1, N2, M0, G4",pert
Gata1KO25+#1,pert
"brain, brainstem: PB2_e1_le1",pert
"brain, forebrain: WCx4w#3_e1_le1",ctrl
Klf9WT_jejunum_PND30_2,ctrl
"Neural precursor cells derived from hES cells line VUB01, biological replicate  1",ctrl
"Male, 39 years old, HIV infection of 11 years",pert
Control Day0 (306R),ctrl
gender: female;	agent: control;	cell type: Hematopoietic stem cells,ctrl
cell line: MCF10A;	transduction: HER2,pert
"Control Day 2, biological rep2",ctrl
genetic background: 129SV;	genotype: WFS1 KO;	tissue: hypothalamus,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 7x6x4;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"brain, cerebellum: RNA#2S_le1",ctrl
Silberg3 ( S4) 191102-1NE,ctrl
cell line: MCF7;	treatment: velcade stimulated,pert
Msgn1_12hPlusDox-biological rep1,pert
F9 RA sample #2,pert
Mouse male ES cells WD44 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-1 in WD44.,ctrl
"mouse aorta cross strain comparison, C3H_T08_HF_01",pert
WAT from wild-type control fed high fat diet Replicate 1,ctrl
Ker,ctrl
Mature mice skeletal muscle sample from the hind limb 2,ctrl
72_129_WT,ctrl
B6_Male_CF_rep1,pert
GM19238_Kd_CEBPG_2,pert
SV129_6h_DMSO,ctrl
SKNSH eGFP1,ctrl
B4 391 b4-/- after nicotine-induced seizures,pert
22SAGEA,pert
"Cadmium 0.55 µM, biological rep1",pert
H1299 vehicle control (3225),ctrl
123A,ctrl
siRNA Med12 + Estrogen [L3],pert
Hif1a-/- leukemia stem cell,pert
Muscle PCOS pioglitazone 121,ctrl
WT-Nrf2-Male-1,ctrl
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: Control shRNA infection,ctrl
JGB-Post-3UP_Run2-S2,ctrl
MB231 PIAS1 shRNA-SCM,ctrl
patient: 51292;	sample: normal,ctrl
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed CA-NFATc3,pert
"human failing LV myocardium, Ischemic10",pert
H19 siRNA (simH19) tranfected into C2C12 myoblasts rep3,pert
"embryonic stem cells, KD replicate B",ctrl
Genotype: FORKO (FSH Recptor Knock Out). FORKO mice was generated by deleting all variants of FSH-Receptor,pert
XDP nucleus accumbens,pert
Bone-Marrow_MM_M1117,pert
SIN3A_siRNA_NS_rep2,pert
HaCaT_ZNF750i_ biological rep2,pert
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"NF-YA KD ES cells 96hr, replicate 1",pert
"GI, Duo",ctrl
"Creatine-treated, biological rep2",pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep5",pert
Placebo treated ipsilateral to stroke P6IC-1a,ctrl
GLIP4,pert
esophageal squamous cell carcinoma from patient E1507,pert
8 week mouse extraocular muscle,ctrl
Gadd45a-/-_MEF_rep2,pert
"H69 tumor post-PDT, biological rep2",pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 71;	gender: f;	treatment: NSAIDs,ctrl
"PC-3 Ctrl, biological rep1 [mRNA]",ctrl
"D425-control, t=8",ctrl
MCL_IGHV_MUT (R1304),pert
"MN1VP16, 1",pert
WI-38 cells exposed to 1 uM BPDE for 24 h,pert
Amniocytes_euploid_1565,ctrl
"BOEC, normal 9",ctrl
gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.1,pert
HSL-null 1,pert
cell type: HeLa;	genotype/variation: nucleofacted with CABIN1 siRNA,pert
Eed KO E14 ESCs on day 3 #1,pert
LCL Unaffected MZ twin pair 2 (CCN2.1)(TP17),ctrl
siRNA-3-PLASTIC,pert
AAA neck (Sample 8),pert
EB_6_24h_288_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Liver Rosi2,pert
MPM tumor 31,pert
MGHU3 Cells_Control siRNA,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 85min;	race: White;	sex: Female,pert
EB_0_5d_60_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
C3H/HeJ Vehicle liver sample batch 1,ctrl
memory P14 T cells #2,ctrl
"granulocyte, healthy control, biological rep7",ctrl
LC1008ni,pert
"RPMI8226_shLuc, replicate2",ctrl
PGA-MAA-IL4-1bAv2-s2,pert
"patient 16, arm treated with pimecrolimus",pert
Wild type LSK (1),ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L010,ctrl
Trim33-KD-ac-2,pert
Csbm/m Mouse_cerebellum_Old_saline treatment_Replicate-2,ctrl
sirna: NT control;	cell line: ES2;	cell type: Ovarian cancer cell line,ctrl
Primary hepatocytes isolated from BL6 mouse strain treated with DMSO for 6h,ctrl
18C-M4,ctrl
C_Kin_2,pert
"Control 2, biological rep4",ctrl
VMM-MUT_MyoD24h-1MP-s2,pert
RNA from microdissected breast cancer cells from case 180 labeled with Cy5,ctrl
Empty vector control embryoid body sample_2 (Vector_EB_2),ctrl
genetic background: 129/SVE;	genotype: wild type;	tissue: tibialis anterior;	age: 12-14 mo;	strain: 129/SVE;	treatment: 50 eccentric contractions 12 hours,ctrl
Control with WY14643 replicate 2,pert
6ILC_normal_ductal,ctrl
6h_c2,ctrl
MCL_IGHV_MUT (R1400),pert
"Liver, untreated, rep1",ctrl
strain: C57BL/6 (B6);	genotype: Hif1a-/-;	cell type: leukemia stem cells (LSCs);	age: 8 weeks,pert
2a_c,ctrl
"expression at 4hr, bio rep1",pert
Primary human lung fibroblasts,ctrl
Pediatric_GBM_14,pert
t16,pert
"metastasis: none;	Stage: 3c;	tissue: normal, homogenized",ctrl
b38-,pert
Chondrogenic progenitor cells from OA female 1,pert
5922012038_E,pert
NME2 induced A549 cell,pert
"depression, BA10-48",pert
ASO T00278951,pert
patient: 267;	current medication: Mesalazine 800mg TDS;	birth date: 8/16/74;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: 5/10/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/15/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/20/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 9/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 5/1/03;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
normal adult rat testis,ctrl
RNA-DHL4-R406-24H-3,pert
5178-scrape,pert
Preglaucoma control rep7 (OHN),ctrl
N40875,ctrl
"n22, surgically resected from patient of gastric cancer.",ctrl
n5t0h,pert
LOX1 Untreated 6hr 282295673,pert
b106,ctrl
PWD/PhJ Vehicle liver sample batch 1,ctrl
"C57BL/6N, adult, male",pert
"SDC1-silenced group, replicate 2",pert
Carbo Day4 (336R),pert
M229_R5_A_DMSO,ctrl
"Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h",pert
Bronchial Epithelial Cells MMA biological 2139P,pert
hES_VUB03_DM1_2,pert
63A;pretreatment;female;breast tumor; responder,ctrl
Mut_M_1,pert
Negative Control 3,ctrl
lesion_midUV_patient2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
Control (C54),ctrl
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6aKO;	treatment: untreated,pert
Cavin-1/PTRF KO #192,pert
Mouse otic vesicle at E10.5 wt,ctrl
colon_epithelium_C57mouse_6weeks_rep3,ctrl
shOCT4_1,pert
tissue: Lung Epithelium,pert
age_years: 55;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
untreated with TGF-beta,pert
MSE_D_543,pert
Ulk1/2+/+ (untreated) 2,ctrl
"control embryonic stem cells, biological replicate 2",ctrl
siHic5 VC 3,pert
3894-2 E2F WT,pert
DNGM-13,pert
"Patient M030-258N, normal colonic mucosa",ctrl
"control, BA46-91",ctrl
"amniocytes, euploid, 1565",ctrl
after 30 days intervention with resveratrol,pert
overexpressed Tcof1 [A],pert
"Please refer to Lilly et al., Am J Respir Crit Care Med. 2005 Mar 15;171(6):579-86",ctrl
Human Non-progressor HIV Sample L004-CD4+ T cells,pert
Common Reference 2 round amplification 2 ug,pert
HCC PBMC Sample 9,pert
Sample Group: HD patient; Gender: male; Age: 59; Tissue: lymphocytes (blood); IT15 CAG repeats: 21/45,pert
First shYY1,pert
gender: female;	batch: 1;	age (years): 25;	patient id: Control_2;	fev1 (% predicted): 103;	fvc (% predicted): 107;	medication: None;	cell type: CD8+ T-cells,ctrl
Sex: male;	Age: adult (11-12 weeks),ctrl
phenotype: control;	gender: male;	case_id: 225;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.53;	labeling_batch: 1,ctrl
"BMDC, Asc-/-, replicate 3",pert
striatum_wild type_18 month_replicate 2,ctrl
"Lox control liver, ad lib, 4:00pm",ctrl
Ishikawa_VeryHighDose_BPA_8h_rep3,pert
EB_0_8d_65_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
Waldenström’s macroglobulinemia (WM-BL 30381),pert
Pt_1 Acne Lesion,pert
PDAC_T_123,pert
Tissue: normal thyroid; Gender: female; Age:31,ctrl
KO1 CD11b,pert
"Tracheal explants, Dex, 2hr",pert
"Amoxicillin treated Proximal, Small Intestine 2 17 days old",pert
HEK293_ControlsiRNASparse_rep1,ctrl
GM19238_Kd_NS4_12,ctrl
cell type: glioma stem cells;	treatment: DMSO,ctrl
"Control Distal, Small Intestine 2 21 days old",ctrl
Bronchial Epithelial Cells SA biological 2102S,pert
A_Kin_1,pert
ccRCC tumor of patient T144,ctrl
"0mg/kg/day PFOA, Rep 5, Block 5, liver (high dose)",ctrl
THP1-shGSK3A-Construct6-rep1,pert
healthy control H21,ctrl
GFP Untreated 12hr 282295723,ctrl
T3.02,pert
treatment: Arid3a knockdown;	cell line: J1 ES cells,pert
CLL 141-08 Control,ctrl
Bronchial Epithelial Cells SA biological 2111T,pert
WT 3 Quadriceps,ctrl
"SNCA triplication iPSCs, AST13",pert
"primary cortical neurons, MEF2A shRNA",pert
LC1022ni,pert
Mutant biological rep4,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 172;	fata: 63;	eea: 1500;	wtkg: 70;	perfat: 21.2;	lbm: 51.4;	fat_mass: 1484,ctrl
NSC miR-128 3,pert
sirna: control;	plate: collagen coated;	cell line: MCF10A,ctrl
29A,pert
OVCA433-(3),ctrl
MDS patient 122,pert
"Dumbo retina, biological rep1",pert
RTX8 T0,ctrl
ILD_1,pert
genotype/variation: TRPV4 knockdown,pert
"peripheral ganglion, unknown: nicotine 1hr_3",pert
first-episode bipolar patient,pert
KO-control-5,pert
Series 1; older; no fracture,ctrl
Keratinocytes treated with EphB2 for 24h,pert
GFP Zfx wt 2,ctrl
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Sham;	experimetal group: Adult Sham,ctrl
020112-1,ctrl
HEK cell lines non-expressing mutant channel,pert
TREx_Flp_Scrambled_siRNA_2,ctrl
Ls174T-pTER-β-catenin con2,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M1;	flt3 status: WT,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis anterior;	age at biopsy: 52;	Sex: male,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 8week,pert
Frozen disease-free lung tissue,ctrl
"Deltoid, FSHD, cohort 21, subject 21B",pert
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
"72 hour-treated TG2 knockout NB4, biological rep1",pert
Strain: Mix 129X1/SvJ and C57BL/6J and Sjl;	Gender: Mix;	Age: 4Wks;	Tissue: retina,pert
HEK293_HNF1a_#4_induced,pert
H441 transfected with ETS2-specific siRNA 2,ctrl
MOLF/EiJTCE liver sample batch 1,pert
Vector Control Transfected 3T3 cells treated with DMSO for 24 h,ctrl
normal with no hydrocortisone treatment-5,ctrl
agent: resveratrol_250mM;	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,pert
4-HPR_LIVER_4,pert
"Fibroblasts, baseline, time 0, patient 2, rep 2",ctrl
RA_E,pert
ILD Study Number 1245,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 205min;	race: White;	sex: Male,pert
53SageA,pert
NCCIT-SNF5oe-rep2,pert
"PPARg d4, rep 6",pert
KO Tibialis Anterior at 4 weeks biological rep3,pert
Glioblastoma_2,pert
"genotype: mutation in the NOTCH 1 gene (Weng et al., 2004, Science, 306, 269-271)",pert
"spleen follicular B in WT, biological rep2",ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
ApoD KO+PQ rep_3 (PQKO3),pert
transfection: Control siRNA;	cell line: HeLa S3,ctrl
Donor2_24h_Wy,pert
LOXL2 1,pert
MH1C1_high_rep4,pert
background mouse strain: C57BL/6;	source: white adipose tissue;	genotype: wildtype,ctrl
"DCIS 7, biological rep. 7",pert
"Lung tissue of CD-1 wildtype mouse, smoke treated",ctrl
Rybp#15 (OHT-)_4d_rep1,ctrl
C33KD2_with doxycycline_2,pert
tissue: brain;	genotype: WT mix background A;	age: E14,ctrl
"Mouse embryonic stem cells, day 0, Alkb1-/-",pert
69A;pretreatment;female;breast tumor,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: D835 mutation,pert
"brain, hippocampus: C24-I_e1_le1",ctrl
CD46+/STAT1-KO hippo - Untreated-D,pert
"colonic tissue from macrophage-specific PPARgamma-deficient mouse, biological rep1",pert
Knockout liver_saline-injected 12weeks repl1,pert
26_C57_WT,ctrl
Control sample 19 weeks,ctrl
"65B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
HP-64,pert
skeletal muscle myoblast_WT_day0,ctrl
lateral hypothalamus no access to cocaine replicate 4,ctrl
PC3 Wee1 Rep1,pert
dental pulp cell from control 6,ctrl
INS-1 cell line #2 with non-induced HNF6,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 57,pert
liver_wildtype,ctrl
Patient: N;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Mock_cells_rep1,ctrl
"HME-CC, 12h, 0.01mM 5FU B",pert
90 year old male,pert
ns VC 2,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 3,ctrl
695_EV_16hr_repeat,ctrl
Braak α-synuclein 3-4 BR34_2SN,pert
anti-FGFR1_rep4,pert
cell type: CD4+CD25+;	strain: C57BL6;	genotype/variation: Wild type,ctrl
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,pert
Sex: male;	Age at operation: 38 years;	Site: knee;	Size in cm: 8.3x4x7;	Histological Subtype: myxoid liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: yes;	Previous chemotherapy: no,pert
WT-sham-1 day-R2,ctrl
"Exp A, Animal #261, 50mg/kg D-Serine",pert
N/LV3,ctrl
F-IIP(UIP)8_Cy3,pert
Erythroblast_SOD2+/+_repWT17,ctrl
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/-;	tissue type: renal tissue",pert
BT474_DMSO_24-1,ctrl
PGA_Ras_2-m5,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, non-treated",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 2,pert
Treg cells from Ptenfl/flFoxp3-Cre mouse,pert
V5-P212,ctrl
patient id: T164;	tissue: Normal cortex;	gender: Male;	age: 75;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
IGROV-1-(1),ctrl
Male mice from fiona transgenic line (dystrophin-deficient with a transgene expressing high level of full length utrophin) were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,pert
TN1b-control,ctrl
14 Day Mouse Diaphragm muscle,pert
SCLC cell line MS-1,pert
Patient: G;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Psoriasis-Patient-G,pert
CSTB KO_cerebellum at P30,ctrl
Knockout liver_saline-injected 12weeks repl3,pert
Braak α-synuclein stages 5-6  BR56_6SN,pert
RV64.11_CHF_day25_Slide46,pert
NCCIT-SNF5sh-rep1,pert
scram_hi_8,ctrl
"Acute Myeloid Leukemia, sample 47",pert
Myh11-CreERT2.Tgfbr2f/f Control 1,ctrl
Mus musculus embryonic stem cells derived from HDAC1 knock out embryos,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 45;	donor: 19;	disease state: Non-lesional,ctrl
SV589_NoKD,ctrl
tissue: testis;	genotype: WT;	genetic background: C57BL/6,pert
Cell line expressing inducible GFP-progerin. Induction: day 5. Replicate B,pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
P4_Ovary_Control_biological rep2,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: control,ctrl
disease status: autism;	tissue (brain region): Frontal cortex,pert
"array 29, xenograft, corn oil vehicle",pert
uterus_P4_PRKO_4hrs_rep2,pert
Day: 6; Drug: Methamphetamine; Phase: Drug treatment; Replicate: 2,pert
Heart left ventricle dnCREB-PBS replicate 3,pert
p300_1,pert
murine colon epithelium,ctrl
R6/2 (untreated) 5270,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 28;	gender: f;	treatment: -,ctrl
01-0066A_Day1_9,pert
4_Hr_+MGd_2,pert
HCC PBMC_sample 4,pert
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: littermate control, Atoh1-Cre;Dicer1(flox/wt);	tissue: organ of Corti from cochlea, apical half;	age: postnatal day 16",ctrl
liver_Akt1+/-_female_8wk_rep2,pert
GFPRhoGDI2 Replicate B,pert
Usp22 depleted replicate 2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.64384,pert
KO_TER119-_rep2,pert
KU_49N,ctrl
genotype: WT;	sample type: DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma);	genetic background: WT C57/BLACK6;	cell type: DP (CD4+/8+) cells,ctrl
muscle_Wt_35wk_rep1,ctrl
scan batch: Batch 2;	group: control;	subject age: 3;	paternal age: 22;	maternal age: 22,ctrl
Whole testis RNA from Crem-/- mouse #144 at 0h,pert
MacularDegen-injured-6aAv2-s2,pert
mouse whole lung,pert
BCell_lymphoma_aggressive_sample1,pert
MPM tumor specimen 18,pert
695_383_0hr,pert
HL60-shGSK3A-Construct5-rep1,ctrl
SA_101,pert
"PCB153 treated HepG2 cells at T0, biological replicate 3",ctrl
2826,pert
affection: unaffected;	treatment: untreated;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 6 unaffected controls,ctrl
patient: 231;	current medication: prednisolone 40mg heparin clarithromycin;	birth date: 10/29/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/00;	diagnosis date: 11/19/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/28/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"shCDK8, normal growth, replicate 1",pert
Mouse old brain C30-Br-3,ctrl
Insm1 mutant #1,pert
14 Day Mouse extraocular muscle,ctrl
BALB_Male_CF_rep1,pert
batch: B;	knock-in: VEC;	cell line: MycCap prostate cancer cells,pert
Vehicle-Control;	Vehicle-Control 30 hours set 1,ctrl
"Distal and Proximal Large Intestine, 8week old Wild-type mouse 2",ctrl
Human.AN.CP.ECRB,pert
Dengue Fever Patient 3,pert
"rat hippocampus (combined dorsal and ventral apsects), aged control, subject 8",ctrl
1030-03-A-b,pert
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 1",pert
"Prkaca+/- caudal vertebral bone, rep4",pert
"Patient 4, 24 month of BETAFERON",pert
DNGM-4,pert
induction of AICD,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.03;	OD280: 1.028;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 218;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
SZ18,pert
pediatric AML S25,pert
Sham3,ctrl
Papilloma_tumour_epithelial_cells_CTRL_rep2,ctrl
MSE_D_G72A,pert
WT_PLACEBO_48hours_3,ctrl
iPSC idiopathic autistic patient triplicate 1,pert
ESE_D_575,pert
"D425-shOTX2_1, t=8",pert
"HCT116 shCDK8, low glucose",pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: vehicle,pert
LJMJDW20,pert
Patient: H;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
disease state: tibial muscular dystrophy (TMD);	tissue: extensor digitorum longus;	age at biopsy: 53;	Sex: male,pert
TMRI E2 8hr,pert
HW_476,ctrl
PC-3_overexpresshTERT_LongTelomeres_LhTERTL_1,pert
"FACS-sorted Lin-, c-kit+, Sca-1+ HSC from the bone marrow of PU.1 knockdown mice with targeted disruption of the distal enhancer (URE) –14kb upstream of the PU.1 gene.",ctrl
5258-lcm,pert
Sample 7,pert
cell line: HCT116;	shRNA: non-target;	treatment: low glucose,ctrl
48h_RA1,pert
B6-rep2,ctrl
"AD_TC, biological rep5",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 2,pert
U2-OS-ERb E2 4 hours,pert
Mouse No Cldn16 B9 452,pert
NM14 healthy control,ctrl
MEF E2F4 KO 3-rep2,pert
tissue: LNCaP-LM NSG xenografts;	expression: vector control,ctrl
Wt Mouse_cerebellum_Standard diet Ad Lib_Replicate-3,ctrl
ME180 6 hours rep 2,pert
pLenti transduced cell lines overexpressing canonical CDH1,ctrl
PancreaticSample36-Tumor,pert
heart/muscle-specific MnSOD-deficient mouse (f/f)(control),ctrl
1295-2C,pert
VMM-WT_MyoD12h-3MP-s2,ctrl
WILDTYPE cerebrum at new born,ctrl
"Nickel 140 µM, biological rep1",pert
Control AGS cells (transduced with non targetting shRNA) treated with 10 microM LPA for 4 hr,ctrl
age: 60;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
PTC BRAF wt 2,pert
LacZ control_4a,ctrl
mouse colon_hnf4mutant_rep2,pert
"colonic tissue from floxed mouse, biological rep1",ctrl
"Human lung adenocarcinoma A549 cells treated without TNFα, in presence of control siRNA",ctrl
Glioblastoma_7,pert
Pt_2 Normal Skin,ctrl
healthy control H17,ctrl
Healthy control 7,ctrl
age: 34;	sex: F;	disease status: control subject;	Filter number: 96;	Usage number: 5;	Exposures: 3,ctrl
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 39;	gender: f;	treatment: -,ctrl
HF0828_U133P2,pert
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ Runx1-/- ES cells,pert
BP patient 104_biological replicate 1,pert
chip number: 23;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.81;	rin: 9.7;	transfection date: 2012-03-26,pert
Mening UNSTIM WB NP 6a,ctrl
CLL 161-04 LMP-420,pert
liver_Wt_35wk_rep1,ctrl
"mouse liver sample, KO strain, biological replicate 3",pert
Cre_day_5-2,pert
Pediatric_GBM_17,ctrl
colon_IBD_1110,pert
blood_day0_patient7,pert
RatLung_H1h_3,pert
WT - Cre Treated - 24 hrs - repeat 3 - Cy5 - mAdbID:54724,ctrl
Ad infected murine liver-MO30k-(232)-6hpi,pert
Brain from 67 days Npc1-/- mouse1,pert
Pcgf6_4_shRNA2-dox,ctrl
Leg 7 Day Control rep 2,ctrl
Tgfbr2 fl/fl Control Posterior Palate 5,ctrl
"Immortalized MEFs WB, empty retroviral vector infected, rep1",ctrl
NSCLC cell line H157. Transfected with siRNA oligomers targeting DJ-1 - #2,pert
Methoxychlor (50uM) rep 1,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 44;	maternal age: 40,pert
whole tissue section from case 295,pert
P63 Non failing heart biopsy,ctrl
Mesenchymal derived mouse cell line,pert
Male mouse 120 day old,ctrl
HL60 cell line,ctrl
"Ulcerative colitis patient, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.",pert
monocytes_-LPS_2,ctrl
"ShamC-21, biological rep 4",ctrl
Normal male wistar rat,ctrl
"imr-32,t=0,3",ctrl
mouse liver A2,pert
cerebellum SNCA knockout 21 month replicate 1,ctrl
T84 U133p2,pert
INS-1 cell line #2 with non-induced HNF4a2,ctrl
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 5,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: None,pert
CAST/EiJTCE liver sample batch 2,pert
RO35,pert
Patient: D;	Time: 1 week;	Group: responder;	Condition: lesional,pert
NIXKO10 SPLEEN,pert
BP24,pert
48 year old female,ctrl
tissue: dental pulp cells;	genotype: control;	passages: 7,ctrl
"xenograft: Panc-1 human pancreatic carcinoma cell line, grown in mice;	treatment: control shRNA",ctrl
S014_Scz_M_74,pert
ApoD transgenic mouse+PQ rep_2 (PQTG2),pert
KO STR Veh 25,pert
"strain: C57BL/Ka-CD45.2:Thy-1.1;	genotype: Lkb1 knockout;	tissue: bone marrow from femoral and tibial bones;	cell type: LSK (Lin-, Sca-1+, c-Kit+) cells",pert
Normal-ERα-positive breast cancer 74,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",pert
skin derived melanocyte cell line,ctrl
striatum wild type 6 month replicate 3,pert
TYK-nu-(3),ctrl
"human failing LV myocardium, Idiopathic64",pert
Human prostate cancer primary culture C43dx,pert
Day: 1; Drug: Heroin; Phase: Drug treatment; Replicate: 1,pert
race: caucasian;	age (years): 48;	stage: IB;	grade: 2;	histology: endometrioid,pert
"Liver, Normoxia 1",ctrl
"S1P3-KO-neocortex, biological rep1 (male)",pert
"210, MUSCLE, Before",ctrl
"wild type CTL+AktI, biological replicate 1",pert
TTF=115min;	Race=Caucasian/White;	Sex=Male;	Group=C;	Prototype_N,pert
"Peripheral blood, normal control [N64]",ctrl
HEL_JAK2 knockdown (Jak2-9 shRNA)_1,pert
brownfat_KO2_day3,pert
"Mdr2-KO heterozygous mouse, 3 month old mouse 3",ctrl
liver_Pink1 knockout_24 weeks_replicate_1,pert
Csbm/m Mouse_cerebellum_Young_saline treatment_Replicate-2,ctrl
BCR/ABL1 biological replicate 1,pert
"Peripheral blood, normal control [N69]",ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 1,ctrl
Wild-type mice rep4,ctrl
Karyotype: inv(14)(q11q32);	Age: 49 years;	Gender: male,pert
C006_Control_F_71,ctrl
WT J1 ESCs on day 3,ctrl
astrocytes hypoxia batch 2,pert
HP-13C,ctrl
Cervical Cancer C366,pert
PBMC from T cell LGL leukemia patient #120 (TLGL120),pert
"vector d4, rep 6",ctrl
hOB695_shRB1383_2hr_IR,pert
heterozygot FH P279,pert
Bronchial Epithelial Cells SA biological 2147O,pert
microdissected breast cancer cells from case 356,pert
44n,ctrl
"C4_transgenic but unaltered, lung tissue",pert
Obese 2,pert
db/db 7-4,pert
"gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
human_hepatocyte_trovafloxacin_24hr,pert
01MJT_PolyRF+,pert
Monocyte control rep 2,ctrl
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
tissue: Hippocampus;	age: 72;	Sex: F,ctrl
Mouse_E14 ES cell_Undifferentialted,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 3;	psoriasis duration: 13;	age of psoriasis onset: 25,pert
Subject #8039-Preinfection,ctrl
BALB_Female_Control_rep3,ctrl
condition: Discoid Lupus;	patient: L4;	tissue: LS skin biopsy;	kit: Ovation,pert
"Normal subject (40 year old caucasian male, SAK_1265820128)",ctrl
Advanced IPF_explant_lower lobe_rep146,pert
PS-NA cerebellum at 18 weeks,pert
VehLPS2,pert
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 29;	maternal age: 29,ctrl
cell line: U87;	tumor tissue source: Cell line established;	tumor organ site: Brain;	pathological diagonosis: Glioma,ctrl
cell line: FU-OV-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.6;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Wild type epithelials cells, biological rep2",ctrl
C_AN12240_F,ctrl
Expression data from BAT of the KRAP deficient mice (WT1),ctrl
WT J1 ESCs on day 7 #1,ctrl
"MCF7 silenced Estrogen receptor, biological rep2",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 111min;	race: White;	sex: Male,pert
48h_c4,ctrl
siNS_0h_4,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 2 - Technical Replicate 2,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 54,ctrl
wt 13.5d replicate 4,ctrl
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: Human-ApoD transgenic gain of function mutant,pert
Osteoblasts_Lrp5_Knockout_Day7,pert
"Patient 2, control tissue",ctrl
"SRF silenced, treated with EtOH, biological rep 3",pert
CD4+ T cells derived by negative selection from leukopheresed blood sample,ctrl
Bronchial Epithelial Cells MMA biological 0168R,pert
wt PBS3,pert
IP RNA_WT_rep1,ctrl
"wildtype pancreas, biological rep3",ctrl
genetic background: 129/SVE;	genotype: wild type;	tissue: tibialis anterior;	age: 7-9 wk;	strain: 129/SVE;	treatment: 50 eccentric contractions 12 hours,ctrl
Myoblast-GATA4-Wt-day0-2,ctrl
EmptyVector 2,ctrl
"12 weeks anterior prostates, wild-type",ctrl
PBMC,ctrl
control AU016703,ctrl
Blood_Control 2,ctrl
FTO1_C1_ni,ctrl
B6 Control R1,ctrl
"59B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Large cell carcinoma 005,pert
age_years: 66;	sex: F;	ethnicity: Latino;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
MDA-MB-231 RRP1B over-expressing clone #9,pert
HNF4loxp/+villin cre,ctrl
"BMMC, WT pLKO.1, nonactivated",ctrl
Nrl-ko-Gfp E16 replicate 1,pert
"Hdh knock-out embryonic stem cells, biological replicate 2",pert
breast tumor 2,pert
Leg 112 Day mdx rep 2,pert
Aldosterone-producing adenoma (APA1),pert
Patient: M;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: mid-UV,pert
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 1",pert
Mic26_muscle_control,ctrl
"Wild type, snap frozen, plantaris muscle, 7 month age animal",ctrl
T51294,pert
"Normal subject (54 year old caucasian male, SAK_1289963270)",ctrl
breast cancer patient 297B,pert
Obese rosiglitazone-1,pert
erStress_twins_AA_1744twin1_DMSO_4h,ctrl
CGR8 embryonic stem cells,pert
WT2R1,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 2",ctrl
HEK293_GFP,ctrl
gender: Female;	age (y): 52;	tissue: prolactinoma,pert
A YOKE_B063,pert
"Brown adipose tissue, KO",pert
ubb_d21_ko_2,pert
"schizophrenia, BA46-94",pert
RNA from whole tissue section of case 1093 labeled with Cy5,ctrl
Control 1,ctrl
BCells_Transgenic_day2_REP2,pert
cell: ES cells;	genotype/variation: UTX conditional knockout,ctrl
agent: ConA;	time point: 6 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"Liposarcoma culture from tumor 399, untreated",ctrl
ERA,pert
Muscle JDM (YJD-JDM-25UA-s2),pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep5",ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 3",ctrl
"experiment 1, control 2",ctrl
Peripheral blood mononuclear cells;	TTF=105min;	Race=White;	Sex=Male,pert
Age: 38;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 A1959T;	Family History: Yes,ctrl
1218-4C,pert
tissue: Temporal cortex;	age: 71;	Sex: F,ctrl
cell line: COV434;	transfection: pFOXL2m,pert
"WT brain, biological rep2",ctrl
Epidermal keratinocytes treated with EFNA4 for 4h,pert
CT-receptor-KO osteoclasts untreated 3,pert
PBMC from T cell Large granular lymphocyte leukemia patient#133,pert
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14509;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Strain: mixed;	Tissue: liver;	Age: 28 days,ctrl
control participant P316,ctrl
Msgn1_24hMinDox-biological rep2,ctrl
"wildtype mouse embryonic fibroblast, biological rep 1",ctrl
"3T3-L1 siControl 48h, biological rep 3",pert
Y HID_B040,ctrl
age	26;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	9.3;	leukocyte count (/nl)	25.7;	hemoglobin (g/dl)	13.9;	platelet count (/nl)	915,pert
E14.5 WT 1,ctrl
E10.5 wt.3,ctrl
No_drug_#4868,ctrl
diaphram muscle,pert
U2OS_siHic5_2_2h,pert
"Brain tissue from Fisher 344 male rat, Animal #259, 50mg/kg D-Serine",pert
cell line: SCOV3,pert
adult HSC 1 (untreated),ctrl
"fibroblast, MFS subject FB1627 rep 1",pert
P3 Patient None,pert
"Gift Prof Dr Sandra Nuyts (University Hospital Leuven, Leuven, Belgium)",ctrl
T37,pert
P1 mouse eyeball extracted total RNA_Snf2h_cKO3,pert
2d-IR-73,pert
blood_day6_patient3,pert
Mouse spleen at 1 month,pert
cultured skin fibroblasts from control subjects,ctrl
"C2C12 Myotubes treated with Palmitate, rep3",pert
"control, BA46-54",ctrl
"breast tumor, Cyp27b1 knockout",pert
MLL_00118,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-sp1,pert
"breast, pre AF treatment (H15_1682)",ctrl
"2 months, ipsilateral group, biological replicate 1",pert
Series 2; Older; no fracture,ctrl
CyP 1hr 1,pert
Expression data from liver of the KRAP deficient mice (WT1),ctrl
DS1-iPS 1,pert
Heart left ventricle,pert
KO kidney pool 1,pert
Healthy control_sample3,ctrl
C008_Control_F_94,ctrl
HEK293 cell line #4 with uninduced HNF1alpha,ctrl
"lymphoblastoid cell line from F6.06, one out of seven of sensitive group, 50*10e6 cells",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day4,pert
P14 - Lis1ko/+ 3,pert
Control Braak α- synuclein Stage 0 C3SN,ctrl
KN-smoke-med-5 month+1d-R2,pert
transfected with pSuper-shMTDH,pert
normal 1144,ctrl
mutant_POST_PDE_053,pert
H1299 AZA 0.3 uM (3229),pert
HD 5,ctrl
Neocortex_Eomes_WT.3,ctrl
HMEC_50,pert
"8 weeks old sex age matched littermates, lung typeII cells",ctrl
"brain, cerebellum: WCx12w#2_e1_le1",ctrl
PDE1C siRNA treated for 10 days,pert
Dorsal Skin_Lox_Control,ctrl
HaCaT_ZNF750i_ biological rep2,ctrl
"PBMC, healthy control, biological rep2",ctrl
BP patient 110_biological replicate 2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 59.3726,pert
Postmenopausal female. Estradiol treated. Patient 13.,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 39;	maternal age: 33,ctrl
chip number: 16;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.57;	rin: 9.5;	transfection date: 2012-03-26,pert
CHB PBMC_sample 11,pert
"Control #5, Untreated",ctrl
Control liver sample 2,ctrl
111A,ctrl
Kidney_colistin_4,pert
4T1.2-IRF7-3,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 44;	Usage number: 1;	Exposures: 3,pert
Cutaneous psoriasis without arthritis PsC 6,pert
cell line: A2058;	treatment: CT16 siRNA,pert
GM19238_Kd_TAF1_3,pert
FRD440 4,pert
Pancreatic Sample 26-Tumor,pert
"control, BA46-95",ctrl
Control 3 c,ctrl
SEB-1 treated biological replicate 1,pert
colon_epithelium_C57mouse_6weeks_rep1,ctrl
No or early 1 rep9 (retina),pert
SUM149 cells transfected with siRNA targeting TIG1 (NM_002888),pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 3,ctrl
"cirrhotic liver, antiangiogenic treatment",pert
17C-M4,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 80min;	race: White;	sex: Female,ctrl
wtPrE serum 1,ctrl
"patient 030b, normal, homogenized",ctrl
HepG2 cells,pert
HA01-149A,pert
MPM tumor 34,pert
"twin pair: #12;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
Dengue Hemorrhagic Fever Patient 48,pert
MDS patient 124,pert
"breast tumor epithelium,17",pert
strain: C57Bl/6;	genotype: AIRE ko;	treatment: Freshly isolated cells,pert
MOLF/EiJ Vehicle liver sample batch 6,ctrl
ILD Study Number 1000,pert
lung fibroblasts,ctrl
Ad infected murine liver-MO30k-(467)-6 hpi,pert
Eed KO E14 ESCs on day 7 #2,pert
MA_290,pert
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 5,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#115,pert
"Empty vector, collagen plate, rep3",ctrl
sampleID: SAM630137;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
MCL_IGHV_MUT (R1585),pert
E10.5 wt2,ctrl
Human prostate tumor,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 6h ID206,pert
chip number: 9;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.2;	transfection date: 2011-03-29,pert
Diagnosis: AML M5;	Age: 69y ;	Gender: Male;	Blast %: 93;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
Ero1-C104A/C131A induced biological repC,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379004;	hybridization batch: V,ctrl
BC3 TC,ctrl
"Human Umbilical Vein Endothelial Cell, TSA (500nM, 24h, Sigma)",pert
"Alk shRNA, biological rep2",pert
Akt1 wild type 2,ctrl
YFP-pos GMP Dicer wt rep1,ctrl
"IL22KO1_ileum, 5 days post-infection with T. gondii",pert
5281 UC Inflamed ascending colon,pert
"PCB153 treated HepG2 cells at T0, biological replicate 2",ctrl
"PMVEC isolated from mice carrying TetO7-Bmpr2-R899X, immortomouse and Rosa26-rtTA transgenes",pert
tissue: adipose tissue;	sample group: resveratrol;	treatment: before;	gender: Female,ctrl
Fetal heart 1.5 ug/kg TCDD rep1,pert
344SQ with PIK3CA shRNA,pert
3_month_old_wildtype_mouse_rep1,ctrl
"Male, 42 years old",ctrl
Patient 19 appendix,pert
s9129_3,pert
"brain, brainstem: LB4_e1_le1",pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: control,pert
"patient: 213;	current medication: PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI;	birth date: 11/1/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/82;	diagnosis date: 2/2/83;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/12/04;	followup rectum: COLONOSCOPIC;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/74;	smoking amount: unknown;	other illnesses: ISCHEAMIC HEART DISEASE;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
PsOEt-14-LS,ctrl
Series 1; young; no fracture,ctrl
control participant P302 (human CD3 positive T cells),ctrl
GM19238_Kd_RDBP_2,pert
Age: 49;	Sex: F;	Ancestry: European;	Smoking status: non-smoker,ctrl
"HUVEC, atorvastatin",pert
"20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Human CD34+ cord blood cells expressing ZMYM2/FGFR1,pert
"51B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
A SIT_B098,pert
condition: Psoriasis;	patient: PS-K;	tissue: LS skin biopsy;	kit: Affy,pert
liver_Pink1 knockout_12 weeks_replicate_2,pert
jejunum_1h_rep1,pert
SLE myeloid cells 14,pert
P0 - nudel129s6 3,pert
cell line: U87MG;	treatment: siRNA against CASP2,pert
1051-03-A-b,pert
tissue: freshly isolated human monocyte;	gender:male; age: 41 yr; weight: 92 kg,pert
"1mg/kg/day PFOA, Rep 1, Block 2, lung (low dose)",pert
"Ctrl OBCs, post doxycyclin withdrawal, rep2",ctrl
MDS patient 116,pert
Nonlesional Epithelium Atopic Dermatitis rep2,pert
"Liver from control mice, biological replicate 6",ctrl
strain: B6/129;	gender: male;	age: 6 months;	tissue: dorsal prostate;	genotype: Klf5+/+; Pten-/-;PB-Cre4,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 102;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
"SiRNA-scrambled, replicate 3",ctrl
X50 NLS 18Q TG1	F2/34	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 4",pert
"liver RNA, wt mouse",ctrl
Surgical Sham Control Tail Skin 2,ctrl
aa_NY79,pert
ILD Study Number 1299,pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 690,ctrl
AA_Case10_CD8,pert
"t01, surgically resected from patient of gastric cancer.",pert
CON22,ctrl
5113-scrape,pert
Rybp#10 (OHT+)_12d_rep1,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	target lesion score (peasi): 5;	peasi reduction [%]: 0,pert
MCF-7ADR_multi-step_doxorubicin_selected_subline_rep_2,pert
E99-/+SRFdM-VP16-1,pert
age: 13.5 day;	strain: 129;	genotype/variation: wild type,ctrl
patient: 40656;	sample: tumor,pert
N5B Normal-cerebelum,ctrl
"control, subject 5",ctrl
gender: Male;	tissue: Tendon;ECRL;	age: 52;	donor: 30;	disease state: Non-lesional,ctrl
NM24 healthy control,ctrl
Benign prostate tissue N4,ctrl
normal control_CTL1,pert
GM19238_Kd_RELA_1,pert
Kidney HEK293 cells,pert
Age: 43;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
age: 18 month postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
"HERVH shRNA, rep1",pert
Donor4_24h_Wy,pert
"Patient 31, Macroscopically intact tissue",ctrl
MV 5,pert
"Mouse heart, IDH2 R140Q mutant, replicate 1",pert
D2-Gpnmb+ control rep8 (retina),ctrl
"E2f8 KO, biological rep1",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 2,pert
WT Soleus at 4 weeks biological rep2,ctrl
"HepG2 cells, HNF4a RNAi treated,  rep1",ctrl
liver_STZ 0.5% quercetin diet_rep5,pert
HUH-YAP-#1,pert
WT_PLACEBO_48hours_1,ctrl
"WT in the presence of tetracycline, rep3",ctrl
infection: 2009 pandemic H1N1 Influenza virus;	cell type: cultured primary human lung epithelial cells,pert
"DMSO treated HL60 cells, biological replicate 2",ctrl
"S1P2-KO-hippocampus, biological rep7 (female)",pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 5",pert
patient skin sample-Normal Skin,ctrl
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 25;	Brain pH: 6.51;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 15000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
"Semitendinosus Muscle, Control",ctrl
male_control_282,ctrl
"Pten WT/null epithelials cells, biological rep4",pert
T40892,pert
"non-AD_HI, biological rep10",ctrl
"RPMI8226_shKLF2#2, replicate1",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.98;	RNA Integrity Number: 8.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 48;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
primary chondrocytes treated,pert
Akt1 double transgenic mice on a high fat diet (DH 4),pert
"Donor 2, Ebola infected 6hr",pert
RNA from whole tissue section of case 1419 labeled with Cy5,ctrl
Fog2flox/delta; alpha MHC Cre biological replicate 2,pert
"Acute Myeloid Leukemia, sample 65",pert
"Normal subject (39 year old caucasian female, SAK_1265797775)",ctrl
age	29;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	7.3;	hemoglobin (g/dl)	12.9;	platelet count (/nl)	257,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 7 hours,ctrl
cerebrum_WT_10d_rep2,ctrl
"PMA treated, no doxycycline; biological replicate 2",ctrl
parental HeLa cells rep 3,ctrl
"ALL_DS, K57 011509",pert
"WT, LPS 0hr",pert
retina_DBA_552R_8mo_rep3,pert
Subject #8027-8hr Postinfection,ctrl
Biceps_Control_9,ctrl
"human failing LV myocardium, Ischemic91",pert
LNCaP/NC siRNA #2,ctrl
N7B Normal-cerebellum,ctrl
chip number: 19;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.87;	rin: 9.2;	transfection date: 2011-10-17,pert
strain background: C57BL/6J;	genotype/variation: WT;	age: 8 weeks;	tissue: small intestine;	cell type: laser captured Paneth cells,ctrl
12479 UC Uninflamed sigmoid colon,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 24.450;	Ratio: 2.11,ctrl
WT HSC 2,ctrl
EA_Case14_CD20,pert
"Patient C-c691T, MSI colorectal tumor",pert
6SC-PBO,ctrl
Liver_PXR KO_Vehicle,pert
Mutated-ERα-positive breast cancer 14,pert
HLA risk: Medium;	Height: 167 cm;	Weight: 65 kg;	BMI: 23.3;	Age: 33.7 years;	Gender: Male;	Race: Asian;	Glucose: 85 mg/dl;	HbA1c: NA,ctrl
C5_CLP_overexpressor_12,pert
"Mdr2-KO homozygous mouse, 12 month old mouse, liver sample",pert
CuFi cell line biological rep3,ctrl
CD4IncDec-test-2,pert
07R055 RA,pert
Teratozoospermic individual: Sample T7,pert
race: american indian;	age (years): 60;	stage: IC;	grade: 2;	histology: endometrioid,pert
INS-1 cell line #3b with non-induced HNF1b mutant A263insGG,ctrl
HCV_Core_2,pert
r13,pert
midbrain_Pink1 knockout_24 weeks_replicate 2,pert
224 Day 2 siSC transfected biological rep3,ctrl
HL60_luc_Replicate1,ctrl
Mening SWB WB SW 1b,pert
HEK293 cells + BAHD1 siRNA 72h,pert
Strain: C57BL/6; PGC1beta mutant; Tissue: liver,pert
"WI-38 cells, at 24 h after exposure to 1 uM BPDE, biological rep2",pert
strain: C57BL/6;	cell type: Lineagelow Sca1+cKit high Cells;	genotype/variation: Wild type,ctrl
colon,ctrl
Injured 7 day Rat Retina 1,pert
"Adult mouse, C57black background, left ventricle of heart",pert
Carbo Day7 (368L),pert
Total RNA from bone marrow derived macrophage from C3H/HeJ mice,ctrl
untrained plakoglobin (+/-),pert
"Transgenic, snap frozen, extensor digitorum longus muscle, 7 month age animal",pert
Mouse embryonic fibroblasts (MEFs),ctrl
"brain, hippocampus: Aldh5a1-/- #3363 Cereb_e1_le1",pert
"Lesion Skin, LS-18",pert
ONH severe glaucoma,pert
gender: M;	age at blood draw: 48;	tissue: whole blood,pert
K562_ICL670_10uM_dup2,pert
Untreated wild type D,ctrl
wt_P4_rep3,ctrl
"ID:14-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
MCI-009,pert
Intestine_Ctrl_biological rep2,ctrl
iFGFR1 mammary gland 24 hr solvent,pert
"Quadricpes muscle, PGC1beta mutant mouse",pert
"brain, hippocampus: Wt #3396 Cereb_e1_le1",ctrl
Monocyte FCH rep 3,ctrl
LT-HSCs of control mouse,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 08/23/05;	# cells: 38;	Sex: male;	region: M1;	age: 47;	genotype: Y/X;G42/-,ctrl
Cardiac Muscle_Cmah KO_mdx_rep1,pert
Md02h036,pert
"Mouse LV, akt2-/- 3",pert
"gender: Female;	age: 54;	post-mortem delay: 4h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Mild asthma,pert
VMH of KO1 mice,pert
"Hdh knock-in embryonic stem cells, Q91 line, biological replicate 3",pert
S/SM1,pert
"119, MUSCLE, Before",ctrl
KU_39N,ctrl
n5t30m,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 1 - Technical Replicate 1,pert
"A pool of two pure subsets of peripheral blood CD56dim natural killer cells (CD19- CD3- CD56dim Cd16+), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),pert
whole tissue section from case 469,ctrl
Bmi1 embryonic stem cells sample_1 (Bmi1_ESC_1),pert
A_AN09730_T,pert
Tsc1-deficient CD4 naïve cells,pert
"Patient 12, Macroscopically intact tissue",ctrl
brain_DLPFC_bipolar C_mr418,pert
"Human lung carcinoma H1299 cells (p53 null, no p63 expression) Tet-on",ctrl
HEK293 F18_doxycycline treated,ctrl
"LCL GM19238, Kd IRF9, 72hrs",pert
"HeJ, air, biological rep 1",pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Tip60,pert
Large cell carcinoma 001,pert
EOM 112 Day mdx rep 3,pert
"GFP Alone, Replicate 3",pert
MCF7_Sangivamycin_Array_1,pert
KN-smoke-med-5 month+13d-R2,pert
"Alk2 cKO mice, whole uterine tissues, replicate 3",pert
RNA from microdissected breast cancer cells from case 648 labeled with Cy5,ctrl
MDA_Parental_3,ctrl
"Cell type: endothelial, age:32, gender:male, diagnostic group: control, PMI:13h",ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.3;	Post mortem interval (hours): 25;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Age: 44;	Sex: F;	Ancestry: European;	Smoking status: smoker, 30 pack-years",pert
12h_RA3,pert
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: 32;	maternal age: 33,pert
Regulatory T-cells CD4+CD25+,pert
N40836,ctrl
intestine_PPARa-knockout_control_rep2,pert
age: 67;	gender: male;	ejection fraction: 43;	left ventricular end diastolic diameter: 59;	inflammation/PVB19: positive,pert
Wildtype_XX_3,ctrl
MCF7 cell line_resveratrol_150mM_biological replicate 2,pert
"P90_wt cones, replicate 1 [array]",ctrl
4031-3 E2F3 Heterozygous,pert
"Rad21 esiRNA, biological rep4",pert
PTEN+/- ep_B,ctrl
iPSC idiopathic autistic patient triplicate 3,pert
INS-1 cell line (parental),ctrl
ubb_d21_ko_1,pert
cumulus_nonPCOS_Obese_rep2,ctrl
NL_cauc_lcm,ctrl
"fibroblast, control subject NF11 rep 2",ctrl
"twin pair: #3;	individual: healthy individual, non-inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",ctrl
"human failing LV myocardium, Ischemic42",pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
"TH cells from LC, Mecp2 null, young time point, biological replicate 2",pert
"Typically Developing Control, Semitendinosus, Patient Replicate 7",ctrl
wild type CBA (sample2),ctrl
Bmpr2-R899X 2,pert
WT-smoke-med-5 month+13d-R1,ctrl
Parkinson's disease sample x124,pert
"human failing LV myocardium, Idiopathic32",pert
"SLE patient, 1014V2",pert
gender: male;	batch: 1;	age (years): 39;	patient id: Control_1;	fev1 (% predicted): 78;	fvc (% predicted): 76;	medication: None;	cell type: CD4+ T-cells,ctrl
cell line: MCF-7;	expression: BP1-overexpressor,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: Asian;	sex: Male,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p30;	strain: E14,pert
NINDS-RHS-Kainate_240h-2aUA-s2,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: WT,pert
T149,pert
Dumbo retina at P15,pert
"Epidermal keratinocytes untreated control, 48h",ctrl
Tgfbr2 Wildtype Mouse Model MEPM 2,ctrl
V5-P280,pert
KO3 CD11b,pert
A375P cells expressing Control shGFP,ctrl
cell line: Normal bone cell line 1705;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),pert
"fetal testis sample 25, 20 weeks gestation",ctrl
brain_OFC_control C_mr217,ctrl
sampleID: SAM630138;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
liver western diet rep6,ctrl
gender: Female;	age: 94;	post-mortem delay: 9.5h;	ph: 6.3,ctrl
murine total uterus,pert
"48 hour-treated wild-type NB4, biological rep1",pert
control participant P300,ctrl
"C57BL/10-SJL.Dysf TA, replicate 3",pert
pooled reference mRNA from 4 harvests of ZR-75-1 cells,ctrl
multiple myeloma (MM 412),pert
sMPNST_JQ1_2day_rep3,pert
"control, BA10-50(2)",ctrl
CD4+_Tcells_severe_asthmatic_5,pert
transfection: CDK19-1;	cell line: HeLa S3,pert
Testis_wild type_rep2,ctrl
HEL_JAK2 knockdown (Jak2-9 shRNA)_2,pert
transfection: CDK19-2;	cell line: HeLa S3,pert
chip number: 19;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.59;	rin: 9.6;	transfection date: 2012-03-26,pert
A/JTCE liver sample batch 6,pert
Nerve_Diabetic_Vehicle_707,ctrl
cell line: COLO829 melanoma cell line;	genotype/variation: control;	agent: BRAF inhibitor PLX4032 (Vemurafenib),pert
RNA from microdissected breast cancer cells from case 638 labeled with Cy5,ctrl
Cirrhotic_Liver_Kidney,pert
T3B-LU,pert
Squamous cell carcinoma 013,pert
GFP-progerin Induction: day 5 Replicate B (5b_progerin_5d_B),pert
human_hepatocyte_vehicle_24hr,ctrl
"113, ADIPOOSE TISSUE, Before",ctrl
cell line: BxPC3;	cell type: pancreatic cancer;	transfected vector: shJMJD3-expressing,pert
PlagL2KO4,pert
ME180 DMSO rep 4,ctrl
PsOEt-11-LS,ctrl
Untreated after 4 days (C3_2),ctrl
U937_luc_Replicate1,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 28;	gender: male,pert
cell type: LSK;	tissue: hematopoietic stem cell enriched fraction from bone marrow,pert
231/ARF-4_3,pert
RTX12 T0,ctrl
Severe rep1 (OHN),pert
Embryoid body formation (10 days) of empty vector transduced embryonic stem cells (CCE ES cells).,ctrl
Ischemic cardiomyopathy_G43,pert
AKO-rep1,pert
"N-58, NORM, M, GSF, 1 x 100nM DHT, 24h",ctrl
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.6;	Post mortem interval (hours): 27;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
RORasg/sg liver_HFD_rep4,pert
GM19238_Kd_STAT6_2,pert
Sham2,ctrl
Lung Tissue,pert
race: caucasian;	age (years): 62;	stage: IB;	grade: 2;	histology: endometrioid,pert
strain: Des(-/-)/129/SVE;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 7-9 wk,pert
t22,pert
KO_TER119-_rep1,pert
M AA S45P,pert
brain_DLPFC_bipolar C_mr275,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 8",ctrl
Strain: C57BL/6;	Genotype: AMPK gamma3 knock-out;	Generation: F7;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
OE control 2,ctrl
Gender: Male;	Age: 25;	Ethnicity: Black,ctrl
LJMJDW2,pert
At Risk: +;	Age: 9;	Sex: F,pert
"cerebellum,12weeks,WT",ctrl
"CD8 DC Xbp1 KO (DC conditional KO), biological replicate 3",pert
Lung tissue from male Ifitm1-deficient mice,pert
race: unknown;	age (years): 64;	stage: IB;	grade: 2;	histology: endometrioid,pert
disease state: paediatric glioblastoma;	age: 14;	gender: M;	h3.3_status: wt,ctrl
"203, ADIPOOSE TISSUE, Before",ctrl
Wt Mouse_cerebellum_Young_saline treatment_Replicate-1,ctrl
LNCaP R1881 rep 2,pert
Gender:F;	Age:42;	Tissue: Mucosa,ctrl
"Normal T-cells, CD3+, donor 3",ctrl
Scrambled 12 hours_1,ctrl
Mtb infected-42d-4,ctrl
ESC_Zfx-null_Replicate2,pert
Monocyte derived dendritic cells were generated by culturing human monocytes isolated from buffy coats using CD14 microbeads (Miltenyi),pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 70 years,ctrl
Muscle Experiment 3,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 217,pert
Muscle PCOS control 2,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: untreated,ctrl
baseline control 05,ctrl
Carbo Day2 (376R),pert
Primary hepatocytes isolated from DBA mouse strain treated with DMSO for 24h,ctrl
MelJuSo cell line,pert
tissue: adipose tissue;	sample group: placebo;	treatment: before;	gender: Female,ctrl
microdissected breast cancer cells from case 1437,ctrl
Untreated after 4 days (C3_1),ctrl
MDA-MB-231 - Control-2,ctrl
Nonlesional Epithelium Nonatopic Control rep5,ctrl
phenotype: control;	gender: male;	case_id: 282;	age: 82;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 36;	brain ph at time of freezing: 6.24;	labeling_batch: 1,ctrl
short-Con rep2,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 6 months,pert
LSK SRF-null 2,pert
0952-01-A,pert
Littermate Control,ctrl
CD4IncTp2-1,pert
"G42 cells from M1, Mecp2 null, biological replicate 4",pert
normal muscle replicate 3,ctrl
"human failing LV myocardium, Ischemic22",pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
PGA-lv_4h_506,ctrl
Myoblast-GATA4-Wt-day3-3,ctrl
E5C,ctrl
443MM,pert
Hippocampus_Soman_6h_rep1,pert
Aorta from ApoE-/- RAGE -/- mouse with diabetes sacrificed at 9 weeks.,pert
3_month_old_wildtype_mouse_rep4,ctrl
"gender: Male;	age: 91;	post-mortem delay: 4.5h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"Neuroretina 8-week diabetic, Biological replica_1",pert
6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24720,ctrl
lung_silica_3,pert
ColonTumor022RAFBU_cta.txt,pert
"PBMC, patient. Mtx rep7",pert
Pool Ts1Cje_P0_hyb1,pert
genotype variation: Nrf-/-;	treatment: air;	developmental stage: neonate,pert
Gene expression profiling of Phgdh knockout embryo wild1,ctrl
GM19238_Kd_NS3_12,ctrl
"Patient N, uninvolved skin",ctrl
PPC1_CBFbeta shRNA replicate 1,pert
"Acute Myeloid Leukemia, sample 43",pert
age: 7 weeks old;	strain: C57Bl/6;	phenotype markers: CD4+ Foxp3+ CD25+;	separation method: FACSAria;	Sex: Female,ctrl
Genotype: HDAC1 knock out;	not differentiated,pert
ref,ctrl
Insm1 control #3_pituitary gland,ctrl
Leg 56 Day mdx rep 1,pert
Liver Control 3,ctrl
HUVEC culture,ctrl
"C57BL/10 QF, replicate 3",ctrl
MPM tumor specimen 38,pert
visceral_fat_Wt_female_8wk_rep2,ctrl
Bone-Marrow_MM_M995,pert
Yolk sac tumor 0216,pert
Myoblast-GATA4-OE-day3-1,pert
FW_7a_BV8479,pert
EP31_adipose_control_rep1,ctrl
"A673 treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50), biological rep2",pert
104B,ctrl
"Wildtype mouse, liver",ctrl
eNOS Knockout Mice-M10,pert
"control, BA46-65",ctrl
"Fibroblasts from normal histology lung tissue, NL-5",ctrl
MMTV-neu mouse mammary tumor,pert
WT-GFP-lamin A Induction: day 0 Replicate B (1b_WT_0d_B),ctrl
Liver_WT_Vehicle_Rep1,ctrl
platelet_Ctrl_10,ctrl
CTL made from wild type splenocytes and treated with AktI,pert
Diaphragm 14 Day mdx rep 1,pert
Subject #8008-Preinfection,ctrl
MDA-MB-231 RRP1B over-expressing clone #7,pert
genotype: Tsc1-deficient;	cell type: CD4 naive cells;	genetic background: C57BL\6,pert
"Wild type, snap frozen, extensor digitorum longus muscle, 7month age animal",ctrl
normal main pancreatic duct 4,ctrl
"ESCs overexpressed CA-NFATc3, biological rep2",pert
CRC_celecoxib_F4859,pert
C2C12 myotubes 100uM H2O2 rep 4,pert
"Mkl2-/-, sample 1",pert
"Cell culture. A549 treated by MK886, control 3",ctrl
"Wild type,pancreas",pert
"Male, Wistar, 0 access to cocaine, nucleus accumbens",ctrl
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 67",pert
Hippocampus_Soman_72h_rep2,pert
vehicle treated rep 1,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 30.4411,pert
EA_SLE_CD8,pert
Normal-ERα-positive breast cancer 50,ctrl
Human squamous cell lung cancer cells,pert
pediatric AML S11,pert
tissue: skin;	individual: Patient N-4;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
695_383_16hr_repeat,pert
01LNM: normal control,ctrl
tissue: liver;	genotype: IR flox/flox albumin:CRE +,pert
Muscle JDM (YJD-JDM-23UA-s2),pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 2",pert
Dendritic cells generated from blood of donor 1,ctrl
"Patient 1, Macroscopically intact tissue",ctrl
patient E1535,ctrl
treatment: RISC-free control transfected;	cell type: Primary cell line,ctrl
P4_WT_2,ctrl
WT-smoke-med-1 day-R1,ctrl
Plate vs. Nail:  1 Week Nail,pert
Normal cervix epithelium_03-4216,ctrl
"Liver, untreated, rep2, knockout mouse",pert
Sex: female;	Age at operation: 69 years;	Site: lower arm;	Size in cm: 4.5x3.5x2.2;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,ctrl
HMEC_50 vs MCF7,pert
rd1_P8_rep2,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 40,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 24 hours,ctrl
RNA from WT MEF (18h after serum shock),ctrl
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: FIZZ2 knockout,pert
Normal cervix_05-4615,ctrl
SBVGA3 3,ctrl
C16-4,pert
microdissected epithelial cells from IPMC 2,pert
source: Breast adenocarcinoma;	cell line: MCF-7;	treatment: ethanol;	knockdown: control,ctrl
"colonic tissue from floxed mouse, biological rep3",ctrl
CD4+_Tcells_severe_asthmatic_7,pert
Huh-7/Fluc rep3,ctrl
S/LV1,pert
SC-RbKO 4,pert
Murine Hippocampus,ctrl
chip number: 5;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2011-03-29,ctrl
Wild Type Time 0 replicate 1,ctrl
Cancer 6,pert
Liver_Female_WT_rep3,ctrl
MKK3bE transgenic male replicate 3 late timepoint,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 84;	Usage number: 1;	Exposures: 3,ctrl
"human failing LV myocardium, Idiopathic11",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 95;	Sex: male;	region: LC;	age: 41;	genotype: Y/Mecp2-;TH/-,pert
8 week old EOM MDX rep 2,pert
TTE3 cells treated with BPA for 3 h-2,pert
"Cnr1-/-/Cnr2-/- female number 1, 2 months old, whole ear tissue, untreated control ear",pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_0.4mM_HG-U133A_2_YCHSUP501,pert
HeTH-4  stable cell lines,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.163;	OD280: 0.612;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 60;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 112;	genotype/variation: WT;	age: 8 weeks,ctrl
Sample 01 Kidney Normal mouse - Control diet,ctrl
"strain: FVB/C57B6 mixed backgroud;	cell type: primary KrasG12D pancreatic ductal epithelial cells, P7;	genotype/variation: Pdx1-Cre;LSL-KrasG12D L/+",ctrl
Mouse_Retina_P7_Rs1h_KO 2,pert
age: 53;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
age: 77;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
rd1_P2_rep3,pert
b146,ctrl
OSE4 cells,pert
Nasal Epithelium Inhalation Formaldehyde 0ppm 19d ID75,ctrl
Bone-Marrow_MM_M1081,pert
inguinal fat,ctrl
CD34+ cells from the patient (CML33),ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 59 days;	subject: Mouse1;	genetic background: BALB/c,pert
WFS1 WT USHT_17_315_ko,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 55 yr;	population: white,ctrl
HeyC2-(2),ctrl
microdissected breast cancer cells from case 319,pert
11387 Normal Uninflamed descending colon,ctrl
"Mutant, biological rep1",pert
11395 Normal Uninflamed sigmoid colon,ctrl
Experimental 3,pert
KU_41T,pert
"BALB/c, Male, CF",pert
N_LS_Time0,ctrl
human MBC_empty vector overexpression,ctrl
"age at diagnosis: 76;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
AA_Case20_CD8,pert
3T3 Vector Control Vehicle 3,ctrl
CAR.KO_corn oil_rep2,pert
UC Inflamed ascending colon,pert
"Eed KO BM LT-HSC, biological rep3",pert
patient: 30364;	sample: normal,ctrl
"SFM control cells (24hr), biological rep2",ctrl
patient: 51572;	sample: normal,ctrl
heart of mouse subjected 2 week to chronic constant hypoxia,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep12,ctrl
CD19_selected_B-cells_after_R_rep2,pert
3975-1 E2F1 Null,pert
pB  is a clonal control (puromycin resitant) stably-expressing stem cell line,pert
224 Day 2 siMut10 transfected biological rep2,pert
3T3 Vector Control A-928605 1,pert
KO1,pert
01MKC_PolyRF-,pert
cell line: RWPE-1-PCAT-1 (CRL-11609);	age: < 20 cell passages from derivation,ctrl
MCL_IGHV_MUT (R1940),pert
"siYAP RNA #1 transfected, biological rep 3",pert
3507-scrape,pert
"control endometrium, patient 12",ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 64,pert
WT liver_HFD_rep1,ctrl
(ca)Raf_3,pert
WFS1 KO USHT_04_319_ko,pert
Pool 1 Convalescent stage,pert
STHdhQ111/Q111-B,pert
"E2F-1, #2 repeat",pert
Dot1l flox/flox day 3 after transduction with control,ctrl
GLY replicate 5,pert
DMSO1,ctrl
FHCRCAML723,pert
"58B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"patient 042b, normal, homogenized",ctrl
PsOEt-10-Week 1,pert
Endometrium-Normal 7,pert
Sham 6,ctrl
NSC_FBS_V2,ctrl
Monocyte FCH rep 2,pert
Panc-1 TGFβ Treated 1 48 hr,pert
FBooth-CON-5Av2-s2,ctrl
DUSP1-/- control replicate 1,pert
BCR/ABL1 biological replicate 3,pert
BP18,pert
patient: 250;	current medication: Asacol 2.4g/d;	birth date: 1/27/58;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 1/1/94;	diagnosis date: 5/30/94;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/29/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 4/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
age: 63;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Gastrocnemius Muscle_Cmah KO_rep2,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: A,pert
"Cultured ovarian cancer cell line HeyA8, Cisplatin treated",pert
Muscle PCOS pioglitazone 81,ctrl
RTX10 T0,ctrl
"Embryonic cerebral cortex, control, biological replicate 3",ctrl
fibroblast_Normal_D139_Media_4,ctrl
quiescent p27WT MEFs 1,ctrl
HUVEC_control_rep1,ctrl
cell line: HCT116;	shRNA: CDK8;	treatment: low glucose,pert
"shCDK19, normal growth, replicate 1",pert
MH1C1 cells exposed to 310 µM CoCl2 for 24 h,pert
testis knock out replicate1,pert
"proband i, past exhaustive exercise",pert
MDA-231 cells,ctrl
Patient 4 skin treated,pert
CEM-C1 cells treated with DMSO,ctrl
Common Myeloid Progenitors,pert
sMPNST_JQ1_2day_rep2,pert
cell type: Primary hepatocytes;	donor: 6;	agent: Wy14643;	time: 24h;	gender: Male;	age: 73 years old,pert
Frontal_Cerebrocortex_Permethrin_1mg/kg_6hr_rep7,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: mir126 knockdown,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T84,pert
Wild-type E11.5 129Sv,ctrl
iPSC control triplicate 2,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Neurointermediate lobe of the Pituitary,pert
PGA-MAH-C3H_PBS6h-5aA-s2,ctrl
"29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
MDA-MB-231_TR6196,pert
"Global gene expression of NASH patients, normal control A643",ctrl
T143 U133p2,pert
XBP1s Tumor 2,pert
"Cnr1-/-/Cnr2-/- female number 3, untreated control ear (#9_Ko-C-7)",pert
Donor (Sample 20),ctrl
E9.5 FVB/N erythroid cells-3,ctrl
heart_KO_rep3,pert
"GFPMYC positive GC B cells, Biological replicate 6",pert
6: FCHL patient #98-1174,pert
cell type: umbilical cord endothelial cells (HUVEC);	passage: 4,ctrl
kidney_QH2_6M_rep2,pert
"DMSO Control after 4hr, replicate 2",ctrl
Bronchial Epithelial Cells SA biological 1578K,pert
DNGM-9,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 18.18082,ctrl
TB 1,pert
"mouse embryonic fibroblasts derived from WT mice, E",ctrl
"Gender: Female, Age: 31, BMI: 21, Tissue: luteinized cumulus cells",ctrl
strain: HNF4LoxP/+AlfpCre;	age: E18.5;	tissue: Fetal Liver,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#102,pert
PCOS Endometrium Stromal Cell_118.PC11-+,pert
Muscle PCOS case 161,pert
"Pineal gland from NeuroD1 cKO mouse at ZT6, biological rep 3",pert
"shCDK19, low glucose, replicate 3",pert
transplanted heart,ctrl
TGFb1 treated experiment B (10ng/ml 24 hours),pert
status: control,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Colon",pert
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 8/1/03,ctrl
RNA from HCC_23T,pert
"WT VSV infected, biological replicate 2",ctrl
Human LRRK2 (G2019S) homozygous induced pluripotent stem cells,pert
Aquaporin-11+/+_mouse P7 kidney #2-1,ctrl
Gastric_cancer_patient_2_dye_swap,ctrl
Subtype: RAEB1;	Karyotype: normal,pert
normal scar treated with hydrocortisone-4,pert
Osteoblasts_Lrp5_Control_Day7_rep1,ctrl
"5 x 10^4 Zfx-flox LSK (Lin-, Sca1+, c-Kit+) cells were sorted directly into Trizol Reagent (Invitrogen) form pooled bone marrow cells from Zfx-flox mice.",ctrl
KU_17N,ctrl
Primary hepatocytes isolated from Donor 3 treated with DMSO for 24h,ctrl
"glioblastoma stem cells, stem, 4 days",ctrl
Patient identifyier: P;	Sex: male;	Age of patient: 76 years;	Duration of psoriasis: 56 years;	Body surface area: 15 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
HEK293_A263insGG_#5_induced,pert
cell line: MDA-MB-231 breast cancer cell line;	genotype/variation: scramble,ctrl
gastrointestinal stromal tumor,pert
WT-3 (EPLM),ctrl
Mouse fetal liver_E14.5_WT_rep5,ctrl
D2-Gpnmb+ control rep6 (retina),ctrl
mouse pituitary gland cells,ctrl
Insm1 mutant #2,pert
Lung of control animal,ctrl
"Wild type, snap frozen, diaphragm muscle, 10 month age animal",ctrl
KU_16N,ctrl
Normal skin from lmq_control mouse,ctrl
DU145/NC siRNA #3,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 93min;	race: White;	sex: Female,pert
"human failing LV myocardium, Ischemic70",pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 32;	maternal age: 27,ctrl
4-Vinylcyclohexene Diepoxide (50uM) rep 2,pert
Paclitaxel-resistant,pert
HL-60 cell line infected with GSK3A Construct 5 shRNA,pert
"Cnr1-/-/Cnr2-/- female number 2, 2 months old, whole ear tissue, untreated control ear",pert
chip number: 11;	transfection plate: 3B;	target gene: EP300;	kd level: 0.62;	rin: 9.4;	transfection date: 2012-03-26,pert
Fiona Biological Replicate 4,pert
Control male 4,ctrl
JIA PBMC Post treatment A235_L009(2),pert
MCF-10A shATR-4 replicate 2 [set 5],pert
Total RNA from bone marrow derived macrophage from BalbC mice after 10ug/ml LPS (S. minnesota) stimulation for 21 hours,pert
WT-smoke-low-5 month+1d-R3,ctrl
Muscle WT Adult 0629,ctrl
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
"male;	CABG patient, atrial tissue;	propofol anesthesia, after CABG surgery",pert
Cutaneous psoriasis without arthritis PsC 1,pert
4194-1 E2F3 Heterozygous,pert
"Setd2 knockout mESCs, biological rep3",pert
STING knock out BMDCs tumor-derived DNA stimulation,pert
"Well-differentiated human lung epithelial cells, infected with KY/180 (pdmH1N1) for 36h",pert
platelet_sickle_10,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-14;	Primary Site:Floor of Mouth;	Age:60;	Sex:F;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
RNA from microdissected breast cancer cells from case 547 labeled with Cy5,pert
HES2_Mir122WT_rep2,pert
HEK293_HNF1b_#1_uninduced,ctrl
MV 6,pert
"CCALD patient fibroblast, biological rep5",pert
Isoflurane 5 exposures-1,pert
Skin_SKO_Rep2,pert
day 2 5-FU HSC 2,pert
"brain, cerebellum: RNA#21*_le1",ctrl
01LS6_Oligo,pert
AJ3251_muscle_mutation,pert
"Lymphoblastoid cell lines derived from family 1727, member 1",ctrl
Muscle Tro1,pert
R1 control ES cells,ctrl
batch: A;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,pert
con_B130,ctrl
BAT_WT_4,ctrl
"Lymphoblastoid cell lines derived from family 1725, member 1",ctrl
nodex_3,ctrl
siEGFP (48 hr) _2,ctrl
"runx1-null luminal mammary epithelial cells, MD643",pert
mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 28;	tissue: Normal_Kidney_Biopsy,ctrl
sirna: control (siSTABLE V2 non-targeting siRNA#1);	treated with tnfα: NO,ctrl
CAR.KO_TCPOBOP_rep2,pert
A549 cells,ctrl
non-malignant FTEb_patient 8,ctrl
Parkinson's Disease;	male,pert
Immature dendritic cells cultivated together with Aspergillus fumigatus germ tubes for 6h,pert
disease: cardiopathy;	gender: female;	age: 200 days;	tissue: thymus,ctrl
EE_IB_1_cauc_lcm,pert
AL,pert
M537_KO,pert
T2_HypM,pert
"Strain: MRL/MpJ;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",ctrl
"sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta, non-dissected aneurysm;	agent: Ang II;	time: 7d",pert
"HEB CLP LY6D-, biological rep1",pert
Retina moderate glaucoma,pert
V5-P063,pert
LKR13_Control-3,ctrl
Cervical Cancer_1981T,pert
DOV13+(1),pert
Mouse fetal liver_E14.5_KO_rep3,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 221,pert
"G42 cells from M1, wild type control, biological replicate 1",ctrl
31SAGEA2,pert
"218, ADIPOOSE TISSUE, After",pert
T3A-LU,pert
Muscle WT Adult 0701,ctrl
THP-1 cell line infected with GSK3B Construct 1 shRNA,pert
cell line: Breast carcinoma cell line Cal51;	genotype/variation: IPMK depletion;	agent: untreated,pert
MDS patient 123,pert
MDA-MB-231 - MTDH-WT-KD-3,pert
WAT from Ahnak knockout fed high fat diet Replicate 2,pert
DMN-CtrHippo15d-1aAv2-s2,ctrl
A_Kin_2,pert
"BOEC, at_risk 3",pert
treatment: baseline;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
liver_STZ 0.5% quercetin diet_rep4,pert
"WI-38 cells, at 24 h after exposure to DMSO vehicle control, biological rep3",ctrl
Wildtype 2 (jos0950),ctrl
astrocytes hypoxia batch 1,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 2,ctrl
disease state: endometrioma;	patient: 19,pert
"mNB-A1, DMSO",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 170min;	race: White;	sex: Female,pert
"Wild type, biological rep1",ctrl
HL-60 cell line infected with GSK3A Construct 5 shRNA,ctrl
CPU FVB/N control 2,ctrl
patient: 30582;	sample: normal,ctrl
C3H/HeJTCE liver sample batch 1,pert
in situ 1,pert
Bronchial Epithelial Cells SA biological 1969Z,pert
"P30_wt cones, replicate 2 [array]",ctrl
V5-P562,pert
"strain background: mixed 129S6/SvEvTac, C57BL/6J, Balb/c;	genotype/variation: CLDN18_KnockOut;	age: 3-4 months;	gender: Male;	tissue: whole lung tissue",pert
F16.01,pert
Gastric biopsies,ctrl
HP-28,ctrl
"126 (221), MUSCLE, Before",ctrl
"siYAP RNA #1 transfected, biological rep 1",pert
scpk/ikLL/192,ctrl
C1_pitM,ctrl
"Mouse brain, Aged, 4hr post saline ip injection",ctrl
3497-1 E2F2 Null,pert
BB Rat day 65 female diabetic resistant mast cells from pancreatic lymph node,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate 2,pert
48B,pert
transgene: none;	treatment: siRNA trasfected - 48h of depletion from FTO,pert
MDS patient 126,pert
Vit A deficient 3a,pert
SV589_8Day KD,ctrl
heart_KO_rep2,pert
P73 dilated cardiomyopathy heart biopsy,pert
T-ALL,pert
strain: Sprague-Dawley;	cell type: aortic valve interstitial cells,pert
LNCaP cells treated with R1881 and ELK1-shRNA,pert
"experiment 1, ethanol-treated 1",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 26.8,pert
pMX-GFP no vitamin C GFPVc-_1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 210min;	race: White;	sex: Female,pert
"breast, pre AFI treatment (H3_1296)",ctrl
NSC_FOXO_WT-2,ctrl
PBMC sample from Chronic hepatitis B carriers,pert
"human peripheral blood derived monocytes, no stimulation, biological rep1",ctrl
testis wild type replicate2,pert
ctrl_501,ctrl
"Peripheral blood, normal control [N59]",ctrl
TAC 5,pert
07R062 Control,ctrl
cultured LNCaP cells;	refer to ATTC,pert
P0 Quadriceps Klhl40 KO 3,pert
Tumor from MYF-5 CRE/SSM2 mouse SSM5,pert
"IL22KO5_ileum, 5 days post-infection with T. gondii",pert
patient E1610,ctrl
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 4,pert
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: T,pert
Post Transduction:12 hr; treatment:WT;,ctrl
Mutated-ERα-positive breast cancer 10,pert
EUR12_T5_PP_day7_047,pert
PPAR KO_ctr_117,pert
"MCF-7 cells, siCtrl treatment 60h, 0.1%EtOH for 24h",ctrl
renal vesicle from E12.5 Lim1 mutant kidney,pert
U138MG shcontrol 2,ctrl
mouse cerebellum at P30 knockout 3,ctrl
T116 U133p2,pert
Vehicle 24 hours_1,ctrl
"Normal subject (48 year old caucasian female, SAK_1289292737)",ctrl
V5-P121,ctrl
"WT3_ileum, 5 days post-infection with T. gondii",ctrl
RTX11 T12,pert
Treated with 25uM Zinc for 4 hrs -- replicate #3,pert
monocytes_-LPS_3,ctrl
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 718,pert
Lung; wild type; VILI,ctrl
L1 062502 Con2,ctrl
long-Con rep1,ctrl
B2_saline_overexpressor_422,pert
HCC_32N,ctrl
VCaP/NC siRNA,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, DMSO-treated",pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed Foxd3,pert
"BPL adrenals, replicate 3",ctrl
"fibroblast, control subject NF10 rep 3",ctrl
"Kidney from MON exposed rats, biological rep 3",pert
"seminoma specimen, pT3, pN1, pM1, patient age: 23y",pert
HCT116_rep2,ctrl
Dendritic cells generated from blood of donor 1 + A. fumigatus germ tubes,pert
8 wk old male mdx5cv TA,pert
"PBMC, patient. Mtx rep5",pert
HeLa_06_21_04 TP-2,pert
266C3,ctrl
tissue: PBMCs;	treatment: after IFNb-1a in-vivo treatment,pert
N2,ctrl
JIA PBMC Pre treatment A235_287,ctrl
01UNP_Systemic,pert
Mouse embryo fibroblast,pert
Postnatal 12 weeks mutant heart biological rep3,pert
Strain: C3HeB/FeJ;	Age: 10-12 weeks at the beginning of the feeding regimen,ctrl
MF-41,pert
heterozygot FH P283,pert
chip number: 22;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.77;	rin: 9.4;	transfection date: 2012-03-26,pert
KN-sham-1 day-R1,pert
Knockout 3,pert
wtPrE serumfree 2,ctrl
lymphoma_9250_nt,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 16 weeks;	Tissue: testis;	;	,ctrl
Cervical Cancer C579,pert
13GOBMUC2A,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed vector control,ctrl
Cancer 8,pert
HEK293 cell line #1 with induced HNF1beta,pert
MDA-MB-231 cells siRhoGDIbeta transfected rep3 HG-U133A,pert
Wild type (untreated) 5296,ctrl
HeLa cells transiently transfected with a nonspecific control siRNA,ctrl
Zfx fl MA9 cells + Vehicle [10949],ctrl
tissue: lymph node;	genotype: Dicer WT;	cell type: CD4+CD62L- resting T cells,ctrl
strain: C57BL6/J;	Sex: female;	genotype: Pdpn-/-;	cell type: mouse embryonic fibroblasts,pert
"57B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: JCRB0033 [CEM];	cell type: human T-ALL cell line;	agent: control,ctrl
GM19238_Kd_HCST_1,pert
B4 437 b4-/- untreated,ctrl
Total RNA from Gsk-3b-/- ESCs,pert
WT-Fibr1 4,ctrl
autism with dup(15q) AU010603,pert
RatLung_H72h_2,pert
"lymphoblastoid cell line from T3.02, one out of seven of insensitive group, 50*10e6 cells",ctrl
"Mepenzolate treatment, 7 hours (replication 2)",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 60,pert
Low Glucose Transcriptome Profiling {rpt 2},ctrl
"U-87 glioma cell line with shcontrol, biological rep2",ctrl
01UNG_Oligo,pert
Control bone marrow - Biological Replicate 2 - Technical Replicate 2,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.42192,pert
"C2C12 myoblasts, untreated",ctrl
"FA6 transiently transfected with non-targeting siRNA, transfection A",ctrl
23d wt12,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: KIT mutation detected,pert
C_LS_Wk1,pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: Her2 and Myc over-expression,pert
T38 U133p2,pert
Total skin,pert
EB_2_8d_220_HCHO_Nasal_Rat230_2_CIIT05024,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"Hdh knock-in embryonic stem cells, Q111 line, biological replicate 2",pert
patient id: 325;	tissue: Normal cortex;	gender: Female;	age: 80;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
CF (D508) subject5,pert
LICR_HN2_CETU3,pert
Early IPF_surgical biopsy_upper lobe_rep140,pert
Setdb1 2lox/1lox/Cre minus tamoxifen 3,ctrl
"spleen marginal zone B in WT, biological rep2",ctrl
"Patient #5, Untreated",pert
Parkinson's disease sample x076,pert
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: curcumin,pert
coc-10_C,pert
Rybp#10 (OHT+)_12d,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,ctrl
WT_TER119-_rep1,ctrl
"Du145-PCAT1 cMyc siRNA #3, replicate 1",pert
"seminoma specimen, pT1, patient age: 51y; W02 116",pert
FHCRCAML1970,pert
NALT_infected_24h_90-226_rep1,pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
sirna: Syk siRNA knockdown;	plate: collagen coated;	cell line: MCF10A,pert
Ramos Cells,ctrl
liver_Akt1+/-_female_8wk_rep3,pert
"mouse aorta cross strain comparison, C3H_T40_HF_01",pert
Adipose tissue from male wild-type animal (C57/Bl6 background),ctrl
LCH3ani,pert
Postnatal 3 weeks mutant heart biological rep2,pert
LY2 control-siRNA tamoxifen treated rep4,pert
"NCI-H460, cisplatin, 2 hr",pert
Cutaneous psoriasis without arthritis PsC 7,pert
"Gender: Female, Age: 25, BMI: 23, Tissue: luteinized cumulus cells",pert
"array 18, xenograft, abiraterone 75 mg/kg/d",pert
"Gender: female, Age: 35 years, Tissue: VIN 3",pert
Muscle_Rpt3 null_3,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 31.0;	age of psoriasis onset: 23,pert
"array 28, unimplanted",ctrl
WT-smoke-med-5 month-R3,ctrl
Panc1005 rep-3,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 50;	sex: F,ctrl
K562 cells,ctrl
41B,pert
siPin1.exp2,pert
embryonic stem cell,ctrl
cells_ATCC 16Lu_human lung fibroblasts_JCB_10_12_24_Lung_Fibroblast_V2O5_HG-U133A_2_IMFRT0014,pert
R6/1 18 week transgenic_BC91,pert
treatment: siRNA against ETS2;	cell line: H441,pert
Subject #8024-2d Postinfection,pert
"Normal ear skin from control mouse, biological replicate 2",ctrl
"HeJ, air, biological rep 3",pert
siTNIK+7hr Wnt (Experiment 2),pert
Etoh 3,ctrl
PDAC_T_91,pert
"SBC-5 cells, siEGR4 (target), 24 hr after siRNA, duplicate sample 2",pert
brain_co_14M_rep1,ctrl
Irradiated-ATM-KO Replicative3,pert
tissue: lung;	strain: Balb/c;	genotype: wild-type;	treatment: cecal ligation and puncture surgery;	age: 8-10 weeks,ctrl
129S1/SvImJ Vehicle liver sample batch 6,ctrl
WTC 158 PBS treated,ctrl
SCC3,pert
Bone-Marrow_MM_M724,pert
normal 1074,ctrl
Frontal cortex brain tissue from HIVE-control patient,ctrl
Primary hepatocytes isolated from FVB mouse strain treated with DMSO for 24h,ctrl
strain background: C57BL;	genotype/variation: wild-type;	tissue: liver,ctrl
Infergen_24hr_rep4,pert
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/+,ctrl
Control siRNA rep2,ctrl
"Cell type: endothelial, age:47, gender:male, diagnostic group: control, PMI:11h",ctrl
female_alcoholic_285,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
male_control_507,ctrl
Wild type_lung_3,ctrl
subject id: 47;	infection: DENV;	status: DF;	tissue: whole blood,pert
IM CD34+ progenitors cells,pert
Sprague-Dawley Rat retina (male); 3d post injury,pert
"N-58, NORM, M, GSF, 6 x ETOH, 14d",ctrl
CD71+ bone marrow cells from CD70TG (clone F13) mouse 3,pert
WT mouse 2_heart_basal,ctrl
healthy CD19 B cells 6,ctrl
Pooled PBMC sample from normal control subjects,ctrl
Rat fatty liver7,ctrl
C_AN10833_T,ctrl
NTac_liver_vehicle 0 mg/kg_96 hr_2,pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 22;	maternal age: 20,pert
M229_R5_B_PLX,pert
"Amoxicillin treated Distal, Small Intestine 3 17 days old",pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days. The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
IRF4_3,pert
Control 8,ctrl
Healthy volunteer blood,ctrl
Nrl-ko-Gfp P6 replicate 4,pert
cell line: A549;	cell line origin: Lung cancer;	genotype/variation: ZMPSTE24 silencing,pert
"mature (CD44+, NK1.1+) thymic natural killer T cells",pert
T129,pert
m1-carcinoma3,pert
Wild type Mice-M158,ctrl
tissue: skin;	individual: Patient P4;	condition: ANL;	eczema severity: SCORAD: 0,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 340;	age-at-biopsy-years: 41,ctrl
Endometrium from estradiol-treated postmenopausal woman,pert
"Lymphoblastoid cell lines derived from family 1743, member 1",pert
Human.AO.CP.FCU,pert
NSC14,pert
Parkinson's disease sample x007,pert
"patient 035b, normal, homogenized",ctrl
WT hippocampus Veh,ctrl
"Vehicle treated, no doxycycline; biological replicate 1",ctrl
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.40;	Post mortem interval (hours): 9;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
RAW_0mM_HOCl_#2,ctrl
OCI-Ly7 BCL6siRNA,pert
mortality: alive;	ethnicity: White;	gender: F;	age (yrs): 65;	tissue: Normal_Kidney_Biopsy,ctrl
7d-sham-82,ctrl
sip53mut.exp1,pert
SK-BR-3 breast cancer cells stably overexpressing TFPIbeta,pert
N_LS_Wk1,pert
Cerebellum_nontransgenic control S46_10 months_replicate 1,ctrl
t02,pert
Placental tissue from early onset Preeclampsia,pert
GM19238_Kd_TAF1_1,pert
Healthy control_sample4,ctrl
"control, BA46-99",ctrl
XmO2,pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",pert
GC resistant clone C7H2-R9C10 treated for 6 hours with GC,pert
Retina homozygous KO 30 days 3,pert
CLP3,pert
Control (0.1% DMSO) rep 2,ctrl
WT-MEFs_unstimulated_4hours_rep2,ctrl
BC3 TC_NOC,pert
PC-3M/NC siRNA,ctrl
0943-01-A,pert
Tissue: normal thyroid; Gender:female; Age:48,ctrl
liver_Q10_6M_rep1,pert
age	54;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	5.7;	leukocyte count (/nl)	52.2;	hemoglobin (g/dl)	9.3;	platelet count (/nl)	388,pert
"E18.5 brain, Meg3 knock-out, rep 3",pert
"ASC, obese patient (ASCmo)",pert
wild-type naïve CD4 T cells KAI267,ctrl
8: NORMAL #00-0074,ctrl
P53_cKO_2,pert
TNKSi 16h biological replicate 1,pert
subject: 15V;	cohort: 15;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 107kb;	age (y): 60;	Sex: F;	batch: Batch_5,ctrl
"liver, STZ-treated fed AIN93G diet for 14 days",pert
Bone-Marrow_NPC_N1588,ctrl
Hippocampus_WildType_rep2,ctrl
age: 31;	gender: male;	ejection fraction: 52;	left ventricular end diastolic diameter: 57;	inflammation/PVB19: positive,pert
non-infected MBT/Pas fibroblasts,ctrl
siLRH-1_#3_rep_3,pert
"shKDM4C 2, clone 1, rep 1",pert
Human.AO.CP.ECRB,pert
Bone-Marrow_MGUS_G800,pert
b72,ctrl
TMRI AO 4hr,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 3,pert
"Age: 8 months, Sex: Female, Retina: right, Final IOP (mm Hg): 30.4, Strain:DBA/2J",pert
TMRI E2 24hr,pert
Allo-14-1,pert
cerebellum,ctrl
cell line: A549;	agent: decitabine;	dose: 1 uM,pert
ASC_morbidly-obese_biological rep1,pert
"Normal subject (36 year old caucasian male, SAK_1782763706)",ctrl
age: 71;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Carboplatin;	Carboplatin 24 hours set 2,pert
Control subject 41_biological replicate 1,ctrl
"BMMCs from NTAL WT, pLKO.1 infected, 2 h activated, biological rep1",ctrl
rtTA-Dmrt5_d9_-Dox_rep_2,ctrl
muscle knock out replicate3,pert
Double_positive_thymocytes_medium _3h_rep1,ctrl
Rex KO_minus LIF_rep3r,pert
Dengue Fever Patient 55,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 68,pert
Normal bladder,ctrl
Control subject 42_biological replicate 1,ctrl
48A;pretreatment;female;breast tumor; responder,ctrl
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
MiaPaCa2 pCEP4 - AGR2 clone 15,pert
tissue: lung;	genotype: PPTA knockout;	treatment: cecal ligation and puncture surgery;	age: 8-10 weeks,pert
Postmenopausal female. Tibolone treated. Patient 26.,pert
APP_R6_rep3,pert
H1299 AZA 3 uM (3232),pert
Ainv15 EB10 replicate 2,ctrl
Individual_3690_PP_sample,pert
N12A Normal-frontal,ctrl
A_Ctrl_2,ctrl
AKT_PLACEBO_48hours_5,pert
Healthy individual of twinpair #9,ctrl
lean control-3,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.054;	OD280: 1.504;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 365;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
T58 Non failing heart biopsy,ctrl
EB_0_6h_50_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
non-transgenic spleen B cells,ctrl
EB_2_19d_230_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
CD4DecTp1-9,pert
K562 STI sample 7,pert
Kidney_200 mg/kg VCM iv_mouse #025,pert
CD8 T cells isolated from tumor,pert
PBMCs_Control_4 [IS],ctrl
Genotype: wildtype MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,pert
nucleus accumbens long access to cocaine replicate 2,pert
PGA-lv_48h_518,ctrl
"BT474-J4 breast cancer cell line, lapatinib",pert
PsOEt-12-Week 1,pert
Healthy individual of twinpair #12,ctrl
GM19238_Kd_BATF_2,pert
pre-iPSC- siRNA to luciferase- biological replicate1,ctrl
treatment: DMSO (control);	cell line: K562,ctrl
tissue: Gastrocnemius muscle;	genotype: WT;	age: YOUNG,ctrl
treatment: Sirt1 siRNA Knockdown Control;	cell line: Caco-2,ctrl
"DMSO-treated, 6h after UV, Replicate G",ctrl
"depression, BA10-9",pert
LNCaP-abl_siMED19_2,pert
OV1002 Control Day14,ctrl
8 Month Wild Type Ovary_03,ctrl
CD4_Tcells_healthy_donor,ctrl
"FA6 transiently transfected with non-targeting siRNA, transfection B",ctrl
"WI-38 cells, at 24 h after exposure to 0.1 uM BPDE, biological rep1",pert
"WT+Empty, biological rep2",ctrl
Mouse WT mandibular molar [AZN_MolairesWT1],ctrl
Cardiac muscle,ctrl
Mouse female ES cells PGK12.1 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-4 in PGK12.1.,pert
"2102Ep cells negative control, biological replicate 1",ctrl
erStress_twins_AA_1724twin1_500nM_thapsigargin_4h,pert
"brain, brainstem: LB2_e1_le1",pert
Akt1-deficient 3,pert
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB without doxycycline,ctrl
H3_SS9_01Nov07,pert
"Distal and Proximal Large Intestine, 8week old Wild-type mouse 1",ctrl
"10 days normal mice, cerebrum",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: E;	experimental sample name: PC3-R,ctrl
colonoscopic biopsy from adult with unaffected colon with Crohn's disease,pert
"schizophrenia, BA46-101",pert
IGROV-1+(2),pert
Panc-1_Gli3T,pert
mouse cerebellum at P7 wild type 4,ctrl
GEIM168-U133A-DM,pert
"fetal testis sample 26, 20 weeks gestation",ctrl
01UN1_PolyRF-,pert
Human polymorphonuclear (PMN) leukocytes,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp3,ctrl
C57BL/10-SJL.Dysf QF replicate 3,pert
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 5",ctrl
"schizophrenia, BA10-45",pert
Cbx2_KO_XX_1,pert
DMN-NF1Hippo10d-1bAv2-s2,pert
Liver vehicle rep3,ctrl
genotype/variation: AhR knockout;	strain: AhRtm1Bra;	gender: female;	cell type: skin melanocytes,pert
"A pool of two pure subsets of peripheral blood CD8+ T cells (CD19- CD3+ CD4- CD8+ CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
"wild type Treg, replicate 3",ctrl
6N,ctrl
Untreated HeLa cells,ctrl
Genotype: Homo sapiens,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu3,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-16;	Primary Site:Mandible;	Age:50;	Sex:F;	TNM:T4N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
0510-01-C,ctrl
clone 2-2,pert
H18_P_B1,ctrl
12463 UC Inflamed descending colon,pert
Beta4 nAChR subunit null mice without treatment,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 48h, biological rep3",pert
shCypB1,pert
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1-/-Rnf2F/F (Ring1 mutant),pert
..SAL_II_2,ctrl
liver_QH2_14M_rep3,pert
PKBa-/- MEF time 48 replicate 2,pert
"Liver, Intermittent Hypoxia 5",pert
"shControl clone 1, rep1",ctrl
Huntington's disease 820C,pert
A HID U_B081,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep1,pert
Mock infected murine liver-MO30k-(D)-6 hpi,ctrl
5239 UC Uninflamed sigmoid colon,pert
PsOEt-13-Week 2,pert
U2OS_PRC_shRNA1_pLenti_2_2007,pert
ctrl_508,ctrl
ATL-3 - mAdbID:91660,pert
EB_2_19d_234_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"Liver from control exposed rats, biological rep 1",ctrl
GFP3_1578I,ctrl
"paraventricular nucleus of the hypothalamus, LPS, 10 micrograms, 1 hours",pert
C57BL/10 QF replicate 2,ctrl
CON4,ctrl
PC-3M/MYB siRNA,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 73 years,ctrl
"DMSO treated THP-1 cells, biological replicate 2",ctrl
FRD1 4,pert
gender: Female;	age: 52;	cell type: PBMC;	individual: Patient 13;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
HF0960_U133P2,pert
Human skeletal muscle biopsy sample;	Patient #186 with NORM,ctrl
"WT, untreated whole heart",ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 4 - Technical Replicate 1,pert
07R059 RA,pert
Dental pulp cells idipopathic autistic patient triplicate 1,pert
cell type: IMR90 (Normal human diploid lung fibroblast);	gender: Female;	overexpression: H-RasV12;	treatment: Metformin,pert
MCF10A-Her2Myc-rep1,pert
Sham1,ctrl
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119+;	genotype/variation: Klf3 KO,pert
remitted schizophrenia patient  S05,pert
peripheral blood mononuclear cells,ctrl
CH2115,pert
mammary_16wkLH_ker72,pert
strain background: C57BL/6;	gender: female;	genotype/variation: MMA wild type;	tissue: kidney;	diet: high protein diet for 2 months,ctrl
THRA wt + T3 replicate 1,pert
breast cancer cell line transduced with eGFP,ctrl
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
"siRNA, collagen plate, rep1",ctrl
brain_Q10_14M_rep2,pert
MCL_IGHV_UNMUT (R1388),ctrl
phenotype: preglaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 4.5 months,ctrl
primary mouse embryonic fibroblasts,ctrl
Embryonic stem cell,pert
LNCaP/MYB siRNA,pert
"age at diagnosis: 47;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 35;	dfs-event: 0;	distant metastasis: 0",pert
MCF7 breast cancer cells,ctrl
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 7,pert
"MUSCLE, RES, Before",ctrl
MF_II_1,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P6,pert
"A549, +TNFα, Claudin 1 siRNA, rep1",pert
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep1",pert
RORasg/sg WAT_HFD_rep1,pert
BTBR+tf/J Vehicle liver sample batch 3,ctrl
age: 40;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Skinbiopsy_48hoursnickel_nickel_allergic_subject_P7,pert
HT29 PLX Day1 rep2,pert
"10 week, control;	SOD1(G93A);	Male",ctrl
Bronchial Epithelial Cells control biological 1325H,ctrl
HT29 DMSO Day8 rep2,ctrl
01LSM_Oligo,pert
HF1136_U133P2,pert
wild type mouse stria vascularis postnatal 3~5 days,ctrl
KM_008T,pert
"Hdh knock-in embryonic stem cells, Q20 line, biological replicate 1",pert
"brain, hippocampus: Wt #3405 Cereb_e1_le1",ctrl
KL4_muscle_control,ctrl
age: 11;	sex: F;	disease status: control subject;	Filter number: 81;	Usage number: 1;	Exposures: 3,ctrl
01LQK_CTRL,ctrl
whole blood_100812,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 9",ctrl
MDS patient 121,pert
"Endometrium, postmenopausal, tibolone, 30",pert
"50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
HEK293 cells,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated, biological rep1",ctrl
cell line: Normal bone cell line 1705;	phenotype: Parental;	cell type: human osteoblast (hOB),pert
LKR13_Wt1 sh-2,pert
ColonDistal0220AFAR_071.txt,ctrl
aortic valve cells treated with DAPT,pert
SKM KO6,pert
age: 3 wk;	tissue: whole heart;	genotype: MCKcre Pitx2 Flox/Flox,pert
MiaPaCa2 pCEP4 - AGR2 clone 16,pert
HeLa cells transiently transfected with a Stau1 siRNA,pert
"Normal cervix epiethelium, microdissected, Age 48",ctrl
ILD Study Number S038,ctrl
"FIH null MEFs, biological rep2",pert
Control4,ctrl
LT 339 +/T untreated,pert
2102Ep cells transfected with Ambion Silencer Select SOX2 siRNA,pert
strain: E14Tg2A;	cell type: mouse ES cells;	knockdown: Tet1;	overexpression: none,pert
HCC PBMC_sample 2,pert
WT heart 3,ctrl
tissue: Pancreas;	strain: C57BL/6;	genotype: Mist1Cre-ER/Cre-ER; LSL-MIST1myc;	age: 8 weeks,pert
Human Chronic HIV Sample C138-CD4+ T cells,pert
"Data 1, Valpha2",pert
"siRNA, collagen plate, rep2",ctrl
mononuclear cells after Ficoll purification,pert
Pooled total RNAs from lymphoblastoid cells of 14 individuals,pert
"patient: 208;	current medication: Prednisolone 25mg/d, Pentaza 1g BD, Fosomax weekly;	birth date: 8/16/85;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 6/1/04;	diagnosis date: 6/25/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/14/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 17;	crp: 3;	hb: 121;	wcc: 8;	neutrophils: 5;	albumin: 39;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
STHdhQ7/Q7-C,ctrl
Day: 24; Drug: Heroin; Phase: Withdrawal; Replicate: 1,pert
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-5,pert
"ShamC-60, biological rep 2",ctrl
2880,pert
strain background: C57BL/6;	genotype/variation: control mice (Runx1floxed/floxedMxCre-/-);	tissue: bone marrow;	cell type: sorted c-Kit+/Sca-1+/Lin-/IL7Ra- (KSL) cells;	experimental procedure: 3 months after poly IC treatment,ctrl
non-CF subject 39,ctrl
array 1 plus E,ctrl
hNHEPS_0.1 μM_6 h_rep4,pert
diseasedl_IL-13,pert
The control subjects had normal glucose tolerance and no family history of diabetes.,ctrl
"Immortalized MEFs WB, v-src expression retroviral vector infected, rep2",pert
"HEK293, Control RNA treatment",ctrl
Mixed_E18.5_Whole_Kidney,ctrl
T6D-LU,pert
tissue: resected non-tumor liver tissue;	genotype: major [rs8099917 TT],ctrl
"NASP siRNA treatment, sample #1",ctrl
NZW/LacJTCE liver sample batch 1,pert
MF-44,pert
PPC1_CBFbeta shRNA replicate 3,pert
HaCaT_Control_ biological rep3,pert
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep4",pert
cell line: L428;	treatment: Mifepristone (M);	duration of treatment: 5 days,ctrl
LNCaP + R1881 rep 2,ctrl
MCF7_CHX_EtOH_24h_rep1,pert
3979-1 E2F1 Null,pert
MCF7 fulvestrant-resistant cell line transfected by antisense hsa-miR-221,pert
"LNCaP cells, treated with R1881, biological rep 2",ctrl
normal 1090,ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P13,ctrl
HEK293_Control RNA_24h_Illumina,ctrl
"brain, hippocampus: Ctr-6h-P15-I_e1_le1",ctrl
Gender: male;	Source tissue: lymph node of the scalp/neck,pert
tetO-Satb1 #3 +DOX,pert
tissue: Cop1 control embryos,ctrl
PPC1_non-target shRNA_replicate 3,ctrl
"ALL_DS, K26 011609",pert
F191G A,pert
"DMSO-treated, Sham UV, Replicate B",ctrl
RT4D6_mutant Sox10 siRNA_rep2,ctrl
"heart of mouse, 4 week control (4A)",ctrl
Severe rep9 (OHN),pert
murine Pb-Cre+;PtenL/W;K-rasG12D/W prostate,ctrl
OVE26_8W_2_5,pert
cell type: glioma stem cells;	treatment: SIO,pert
sepsis patient #13,ctrl
neocortex-30 months of age-resveratrol diet-biological replicate1,pert
KO_IL-6_400_rep2,pert
S7C Sporadic-hippocampus,ctrl
Cell line established from CA1 HESC using pClip vector,pert
Bone-Marrow_SMM_S1485,pert
cerebellum wild type 21 month replicate 2,pert
gender: F;	age at blood draw: 62;	tissue: whole blood,pert
EP23_adipose_control,ctrl
"brain, hippocampus: KA1-II_e1_le1",pert
24h_RA3,pert
FO_spleen_KO_rep3,pert
KO,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 77;	time: 0;	batch: 4,pert
Muscle 50 eccentric contractions 12 hours WT Aged 12172,ctrl
MDA-MB-231 cells siRhoGDIbeta transfected rep2 HG-U133A,pert
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): iTreg,pert
Severe rep10 (retina),pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-8;	Primary Site:Tongue;	Age:77;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
Psoriasis-252,pert
phenotype: alcoholic;	gender: male;	case_id: 417;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 20;	brain ph at time of freezing: 6.64;	labeling_batch: 2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.23288,pert
tissue: microsatellite instability (MSI) colorectal tumor,pert
whole mouse lung homogenate,ctrl
43SAGEA2,pert
"strain background: mixed C57BL/6, FVB, 129 background;	genotype/variation: BrafV600E::Pten-/-::Pdk+/+, Pdk1 wild-type;	tissue: tumor",ctrl
CDKI-73 CLL2,pert
CD8+_Tcells_non_severe_asthmatic_3,pert
CXCR4 knockout 6,pert
Left ventricular myocardium in patients with Dilated cardiomyopathty (8),pert
New 3 hr 2,pert
BT474-J4_GSK089_24-2,pert
INS-1 cell line #2b with non-induced HNF1b,ctrl
10uM H2O2,pert
umbilical cord_nobpd: 8B,ctrl
mouse cerebellum at P7 wild type 3,ctrl
"Liver, Intermittent Hypoxia 3",pert
"ShamC-60, biological rep 5",ctrl
NALT_infected_24h_90-226att_rep2,pert
Bronchial biopsies from lung tissue,ctrl
tissue: heart;	genotype: Gata6_KO;	age: 8 week adult mice,pert
Cell line: human ES cell HES2,ctrl
Adult Sham; Biological replicate 5,ctrl
Muscle-5 month-wild type-technical replicate 3,ctrl
A549_siScramble_rep.1,ctrl
CML Patient 3 7 days therapy,pert
"Liposarcoma culture from tumor 386, untreated",ctrl
CD-49-un1,pert
"normal nasopharyngeal tissue, specimen N7",ctrl
Diaphragm 23 Day control rep 3,ctrl
"Gender: female, Age: 36 years, Tissue: VIN 3",pert
Normal cortex of patient 324,ctrl
sample: #12;	subject: PD case #1;	brain: T-243;	age: 77;	sex: Female;	region: Inferior olivary nucleus,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 2,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 5.8;	colon weight (mg): 174;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.238;	tissue: colon;	treatment: 5% DSS,ctrl
"experiment 2, ethanol-treated 2",pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue 3,pert
strain: FVB/N;	genotype/variation: KLF1-/-;	age: embryonic day 9.5;	cell type: erythroid cells,pert
KO HPC Veh 25,pert
Series 2; adult; no fracture,ctrl
immortalized mouse brown preadipocyte,pert
RNA from whole tissue section of case 295 labeled with Cy5,pert
"brain, Entorhinal Cortex: 98-18 tangle_e1_le1",pert
HepG2_As rep2,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 46;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"Endometrium, postmenopausal, estradiol, 3",pert
C_AN01125_F,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: DMSO for 72h,ctrl
"Liver from Nrf2 k.o. mice, biological replicate 2",ctrl
MPM tumor specimen 25,pert
PGA-RMM-30h-2aA-s2,pert
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E18.5 embryo;;	Gender: male;;	Tissue: whole brain,pert
CH 1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 140min;	race: White;	sex: Female,pert
Balb/c WT_2,ctrl
"FOXP3, WT, REP5, 0h",ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID312,pert
Patient: I;	Time: 1 week;	Group: responder;	Condition: lesional,pert
CD8-IGF1R 3T3 A-928605 2,pert
CEM11_T3_PP_day1_039,pert
tissue: colon;	cell line: HT29,ctrl
agent: control;	strain: BALB/DBA F1 hybrid;	tissue: mesentery,ctrl
agent: control (untreated);	time: 4h,ctrl
"Human breast, post AF treatment",pert
ME180 1 hour rep 3,pert
Nonlesional Epithelium Nonatopic Control rep3,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 19.67397,pert
Substantia nigra PD rep2,pert
FHCRCAML72,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 105min;	race: White;	sex: Female,pert
Cultured HTM cells-B,ctrl
RptorKO QSC Technical Rep.2,pert
"Vitamin C treated ES cells, Rep 1",pert
p300+/- Rep2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 38 yr;	population: Hispanic;	dsm-iv: 295.9;	age of onset: 17 yr,pert
agent: control (untreated);	time: 24h,ctrl
N/SM1,ctrl
ET 3,pert
"Immortalized MEFs WA, empty retroviral vector infected, rep3",ctrl
B6_Female_Control_rep1,ctrl
"Lesion Skin, LS-33",pert
normal plasma cells (NPC 389),ctrl
"Contralateral knee articular cartilage, 4 weeks following OA surgery",ctrl
tissue: Brain;	genotype: Npc1+/+;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
GIST Pre Treatment Biopsy 22,ctrl
"ICL670 50uM 16hrs, K562 cells",pert
HeLa cells transfected with UPF1 siRNA 1 (experiment),pert
"Untreated TG2 knockout NB4, biological rep2",ctrl
MCF-7 +scrambled siRNA + 500 nM 4-hydroxytamoxifen rep2 (MD36),pert
Cerebellum_nontransgenic control A39_8 months_replicate 4,ctrl
subject: 2827 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
No or early 1 rep1 (retina),pert
Human lung adenocarcinoma cell line,ctrl
gender: F;	age at blood draw: 63;	tissue: whole blood,pert
"brain, hippocampus: KA-1h-P15-I_e1_le1",pert
"Crohn 02, CD02",pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: Mx1-Cre negative: PTENfx/+. Sex: Female. Age:;	Eight and a half weeks (at tissue isolation). Tissue: small intestine (jejunum/ileum).",ctrl
whole brain,ctrl
Human colon biopsies from UC patient in remission (involved mucosa),pert
3T3-L1 Day 0 (passage 21) 48h after siLSD1 transfection,ctrl
CAR.AH_TCPOBOP_rep1,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P15;	genotype: Igf1 -/-,pert
"Amniocytes, trisomy 21, 1549",pert
GEIM4-U133A-DM,pert
FRD440 2,pert
GC resistant clone C7H2-R19E5 treated for 6 hours with EtOH,ctrl
whole tissue section from case 638,ctrl
"fibroblast, MFS subject GDO21 rep 1",pert
db/db 10-1,ctrl
BDC2.5/NOD.scid,pert
Gsk-3a-/- ESCs Rep1,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep9",ctrl
12464 UC Inflamed sigmoid colon,pert
A HID B_B088,pert
strain:C57BL/6; VillinCRE-HNF4loxp; male; tissue colon; mutant,pert
"Cultured ovarian cancer cell line C13, Cisplatin treated",pert
"seminoma specimen, pT1, patient age: 35y; W03 030",pert
"Lesional ear skin from K14-Areg mouse, biological replicate 1",pert
platelet_sickle_18,pert
"10 days old prosaposin knockout mice, cerebellum",pert
Kdm2b KD E14,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 88;	Usage number: 4;	Exposures: 3,pert
"cochlea at P60, wt, biological rep 3",ctrl
"1833 shHMGA2, biological replicate 3",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day14,ctrl
"Normal Skin, Normal-8",ctrl
Extract:LOX-1:213502;	Extract Description:LOX1_Untreated_24hr:213502;	Quality: Classification:Good;	Quality: Gradient Severity:0.07;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.58;	Quality: Background Mean Dev.:1.06;	Quality: Absent (%):57.27;	Quality: Absent (%) Dev.:0.76;	Quality: Scaling Factor:0.47;	Quality: Scaling Factor Dev.:1.26;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213502;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295903,pert
microdissected breast cancer cells from case 547,pert
A549 Stretch 4hr Nov 21 2002,pert
4-HPR_LIVER_1,pert
Kidney_Biopsy_Liver_Disease_4,pert
BT474_Lap_24-1,pert
"UM-UC-3 bladder cancer cells, stably transfected with GFP (control), biological replicate B",ctrl
BS2011051060,ctrl
NALT_sham_24h_rep1,ctrl
GFP2_1578H,ctrl
WT AA 3,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 2",ctrl
IMR-32_pCMV-DPP3_48hr_rep 1,pert
tDEA003.CEL,pert
"Notch3 knockout mouse cerebral microvascular fragments, biological rep1",pert
Itk knockout CD8+ unstimulated 2,pert
PGA-RMM-6h-2aA-s2,pert
GFP Untreated 2hr 282295493,ctrl
WT osteoclasts treated 3,pert
Control bone marrow - Biological Replicate 1 - Technical Replicate 2,ctrl
control (day 0) replicate 2,ctrl
Healthy4-CD8,ctrl
MEF.WT.F,ctrl
At Risk: -;	Age: 8;	Sex: M,pert
cell line: MCF7 breast cancer cells;	genotype/variation: control,ctrl
N/LV5,ctrl
"ID:c 1-1, Genotype=(C57BL/6J), Treatment= none",pert
strain: C57BL/6;	genotype: wildtype,ctrl
BC-920079,ctrl
b148,ctrl
UnInfected-4,ctrl
MacularDegen-injured-13aAv2-s2,pert
"1833 expressing Tet1, biological replicate 2",pert
Superior Frontal Gyrus from 5 year-old normal girl,ctrl
M AA T41A,pert
Aquaporin-11+/+_mouse P7 kidney #3-1,ctrl
"Skin biopsy, non-lesional",pert
lymphocytes (blood),ctrl
OC1-WT embryo 1,ctrl
Placenta_PE(EO)1 with Cy5,pert
A_AN00764_T,pert
CML cell line: KCL-22,pert
genotype/variation: C56B/6 and CD-1 mixed;	strain background: Shh mutant;	age: E9.5;	tissue: E9.5 embryos;	microdissection: posterior second heart field,pert
Aortas isolated from captopril-treated APOE-deficient mice,pert
H12_P_B2,pert
SNB19 GBM cell line,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 2,ctrl
UIP lung explant,pert
gender: Female;	age: 85;	post-mortem delay: 3.5h;	ph: 5.9,pert
"LNCaP cells, treated with R1881, biological rep 1",pert
ndf control1,ctrl
Monocyte FCH rep 1,ctrl
sample 1:;	age: 58;	gender: male;	sample 2;	age: 69;	gender: female,ctrl
Run3.aUa.010110d.SkMDbt1139D.CEL-DB stimulate,pert
bladder cell with APF,ctrl
"A5_tumor, lung tissue",pert
R5_Pseudomonas_wildtype_48,ctrl
New El-Ashry 004.CEL,pert
"wildtype liver, biological rep 3",ctrl
ES cells_OE_rep3,pert
BP patient 83_biological replicate 1,pert
"RPMI8226_shKDM3A#2, replicate1",pert
whole blood_101339,ctrl
Control (C284),ctrl
Bone Marrow SMM patient,pert
12A,pert
Diaphragm 112 Day mdx rep 3,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 3",pert
"Lymphoblastoid cell lines derived from family 1717, member 1",pert
"genotype: mutation in the NOTCH 1 gene (Weng et al., 2004, Science, 306, 269-271)",ctrl
Txnip deficient tumor 24 months sample 3,pert
"alveolar macrophages, smoker 057",pert
92.1 cells,ctrl
BSKO 3,pert
CON15,ctrl
HaCaT_Control_ biological rep3,ctrl
strain: FVB;	genotype: E2F1 null;	tissue: mammary gland tumor,ctrl
CD34-003,ctrl
PGA-HMO-Obese-7aUA-s2,pert
C_AN15566_C,ctrl
MDA_PR_2,ctrl
MDS patient 169,pert
"Hif1a-/- LSC, biological rep1",pert
Hdh mutant (111/111-polyQ) 1,pert
Patient: J;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
NPC7,pert
"Normal 14, control tissue",ctrl
Hippocampus_Soman_3h_rep1,pert
Genotype: Mdr2-KO homozygous mouse;	Age: 3 month,pert
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
T4E-LU,pert
MSE_N_M163,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID134,pert
Brain from 67 days Npc1+/+ mouse1,ctrl
Hippocampus Fluoxetine Group 1,pert
"PCOS, biological rep 3",pert
1 hr KLF4 Time Course Induced,pert
Tendon_non-lesional_rep6,ctrl
HUVEC/NmenMC58_pilD_4h_rep1_1103,pert
"Liver, untreated, rep1, knockout mouse",pert
AO 2hr,ctrl
cell line: rtTA-Dmrt5;	differentiation: 7 days;	treatment: -Dox,ctrl
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 3,pert
KO 541 L1,pert
tissue: tumor tissue from cancer patients;	genotype: p53 mutant;	disease state: Microsatellite Stable Stage III Colorectal adenocarcinoma,pert
"Cell type: endothelial, age:54, gender:male, diagnostic group: schizophrenia, PMI:38h",pert
Patient: M;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
HeLa_01-04-05 TP7_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
genotype: wildtype;	cell-type: activated;	splenomegaly: none;	Ig clonality: polyclonal,ctrl
SIN3A_siRNA_NS_rep3,pert
"BMDM, 1alpha,25(OH)2D3 and IFNgamma treated, KO Vdr -/-",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.54;	age of onset: 22 yr,pert
3872-1 E2F WT,ctrl
whole blood_100801,ctrl
Native wt biological replicate 2,ctrl
PGA-MAH-C3H_OVA24h-3aA-s2,pert
GM19238_Kd_ZHX2_3,pert
WT-CD80hi-mTEC-sample2,ctrl
HCC_25T,pert
brain_DLPFC_bipolar C_mr801,ctrl
"HSCs from male mice treated with E2, replicate 1",pert
CH1813,ctrl
15KD_rep2,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.94;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Primary hepatocytes isolated from Donor 3 treated with Wy14643 for 6h,pert
"Crohn's Disease subject (32 year old caucasian male, SAK_1287459252)",pert
wt-Gfp 4 weeks replicate 4,ctrl
P60_PMP22TG_1,pert
cerebellum_PSNA_ 4w_rep1,pert
strain: 129;	cell type: EBs;	genotype/variation: WT,ctrl
GBM_differentiation_4 days_1,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P7,pert
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: sensitive,pert
EA_Case18_CD20,pert
14-week-old WT liver_393WT,ctrl
RE550_DU145_8-Medi5117,pert
KO - knock-out Treated - 24 hrs - repeat 3 - Cy5 - mAdbID:54820,pert
"RNA was prepared from papilomas of 2-3 mice (2 for WT and 3 for Knockout) and this was pooled to perform the array. Each pooled sample was run in triplicates.   The mice were treated once with DMBA, followed by TPA application for 30 wks.",ctrl
cell line: MDA-MB231;	treatment: control shRNA;	media: SCM,pert
Glioblastoma_10,pert
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep5",pert
MDA-MB-231 cells siLuc (control) transfected rep3 HG-U133A,ctrl
"eye, cornea",pert
H7 HA 2h 3,pert
Teratozoospermic individual: Sample T6,pert
CON3,ctrl
DBTRG untreated rep1,ctrl
Disease_status: Bipolar disorder;	Age (years): 30;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 8;	Brain pH: 6.1;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: 60000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
control AU1038304,ctrl
GM19238_Kd_ZBTB38_2,pert
F9 embryonal Carcinoma cells,ctrl
"healthy breast 5, biological rep. 5",ctrl
"SKO-transduced MEFs, Vc+, D8",pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 12.6235455167693;	age of psoriasis onset: 37,pert
saline ctr002,ctrl
"Mammary gland, control, biological repl 2",ctrl
V5-P387,ctrl
Adipose-5 month-wild type-technical replicate 3,ctrl
ovary_cultured_control_rep1,ctrl
t11,pert
MDA_PR_Paclitaxel_3,pert
Z4_Cont_TA,pert
Aorta from ApoE-/- mouse with diabetes sacrificed at 9 weeks.,ctrl
MPM tumor specimen 7,pert
Z138-shControl.2,ctrl
"T47D cell line, replicate 1",ctrl
E10.5_otic_vesicle_mut_replicate2,pert
Pancreatic Sample 36-Normal,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 14.5x7.5x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
MDS patient 172,pert
Gata-1 Wild Type B,ctrl
MGHU3 Cells_Control siRNA + PD173074_Biological Replicate 3,ctrl
V5-P056,pert
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PAXgene;	molecule: total RNA,pert
"septic CD4+ splenocytes at 6h, biological replicate 2",pert
217/4,pert
patient E2644,ctrl
AA_98,pert
MLL_PTD10,pert
Huh7 cells_Mock Infected 12 hours_ rep1,ctrl
strain: C57BL/6J;129S5/SvEvBrd;	genome/variation: wild type;	cell type: granulosa cell;	treatment group: 44-46hr PMSG,ctrl
scan batch: Batch 1;	group: control;	subject age: n/a;	paternal age: 32;	maternal age: n/a,ctrl
CD34+ cells without fenretinide treatment from CML32,ctrl
Ezh2-Cre1,pert
V5-P103,pert
Rat fatty liver12,pert
race: caucasian;	age (years): 54;	stage: IB;	grade: 1;	histology: endometrioid,pert
"28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Gene expression profiling of normal cortex of patient T164,ctrl
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 56;	gender: m;	treatment: -,ctrl
"prostate cancer cell line, non-target control",ctrl
GEIM9-U133A-DM,pert
Male 8week AJ sham rep3,ctrl
11403 Normal Uninflamed terminal ileum,ctrl
"WM 266.4 metastatic melanoma cell line, siPIR",pert
source tissue: lymphoid;	cell type: Splenic CD11b+Gr-1 cells;	disease state: no tumor;	genotype: IRF8 KO;	genetic background: H-2b,pert
HCC_5N,ctrl
Transfection Reagent Only Technical Replicate 3,ctrl
Osteoblasts_Lrp5_Knockout_Day7_rep3,pert
SCD1 +/+ liver rep2,ctrl
K562 cells CREB Knock-out replicate 7,pert
"Liposarcoma culture from tumor 400, untreated",ctrl
NSC miR-128 1,pert
E13.5 Tgfbr2 Wildtype Mouse Model Primary Palate Mesenchyme collected after 2 passages in culture,ctrl
"RKO colon carcinoma cells (ATCC #CRL-2577), cultured in DMEM (Invitrogen Catalog#10569) containing 10% FBS (Atlas Biologicals)",ctrl
Whisker pad mutant biological rep3,pert
DLBCL_FOXP1 overexpression,pert
V5-P054,pert
SKM-KO,ctrl
Diabetic Rat Retinal Müller Cells,pert
cell line: SKBR3 resistant;	treatment: 0.1uM Lapatinib,pert
Time:0 day; condition:Emerin ko;,pert
del337TR replicate 1,pert
gender: Male;	age: 79;	post-mortem delay: 4h;	ph: 6.2,pert
tissue: Gastrocnemius muscle;	genotype: KO;	age: YOUNG,pert
Paclitaxel-resistant,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T1N1,pert
Untreated native HeLa cells 1,ctrl
skNAC knockout heart,pert
healthy myeloid cells 3,ctrl
68A;pretreatment;female;breast tumor; nonresponder,ctrl
"metastatic, pooled, prostate cancer",pert
cell line: L428-PAX5;	treatment: Mifepristone + 5-aza-2′-deoxycytidine + Trichostatin A (MAT);	duration of treatment: 5 days,pert
"1104, control, skin fibroblasts",ctrl
striatum_Pink1 knockout_6 weeks_replicate 3,pert
U937 cell line infected with GSK3A Construct 5 shRNA,pert
Pool 3 Convalescent stage,pert
temporal lobe,pert
Subtype: RA;	Karyotype: del(5q),pert
Halothane 5 exposures-2,pert
"Kdm2b KD E14, rep1",pert
HF1489_U133P2,pert
"Control_SOL, C5",ctrl
Braak α-synuclein stage 1-2 BR12_1SN,pert
RAW 264.7 macrophage cell line,pert
strain background: C57Bl/6J;	gender: male;	strain background: Glo1 overexpression;	age: adult;	tissue: whole brain,pert
N7_Cy3,ctrl
Male 8weekBL6 shamrep3,ctrl
"PPARg2 expression construct, 2 hrs, No Rosiglitazone (PPAR_2_2)",pert
foxp3 expression: YES;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 wild type;	gender: female;	treatment: none,ctrl
Substantia nigra PD rep12,pert
C57_LF_1,ctrl
Bronchial Epithelial Cells SA biological 1841Z,pert
Erythroblast_SOD2+/+_repWT37,ctrl
Female - caucasian - N-04-M,ctrl
GM19238_Kd_IKZF3_2,pert
Carbo Day14 (455R),pert
"Mouse, ATF6bKO, colon, UT, rep2",pert
"Gastrocnemius, 2 months old",ctrl
Ulk1/2-/- (untreated) 3,pert
cell line: MCF-7 breast cancer cell line;	agent: estradiol (E2);	time: 24hr,pert
Strain: 129SV/EV IFNAR1-/-;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,pert
hsa-mir-30a/30d inhibitor_24-8,pert
m1-WT5,ctrl
Treatment 2,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: LPA,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 1",ctrl
rheumatoid arthritis 1152,pert
BCR/FGFR1 biological replicate 2,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
MDS patient 22,pert
"U373-EGFP, rep 1",ctrl
"liver, PPAR KO_ctr_117",pert
subject: 8;	disease: CP;	muscle: ST;	gender: M;	age: 16.7;	gmfcs: 5;	popliteal angle: 90,pert
22A;pretreatment;female;breast tumor; responder,ctrl
brain_DLPFC_bipolar B_mr282,pert
WT - Cre Control - 3 mo - repeat 5 - Cy3 - mAdbID:74673,ctrl
INS-1 cell line #2 with induced HNF4a2,pert
"Spleen homogenate, infected, 7 weeks",pert
treatment: baseline;	gender: F;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
A5_C5_nasal_stem_cell_rep1,pert
"HepG2 cells, HNF4a RNAi treated, rep2",ctrl
"knockout mouse embryonic fibroblast, biological rep 2",pert
Panc1005 cell line,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.32603,pert
"Strain: C57BL/6 Ly5.1+, tissue: CD45.2+ transplanted bone marrow",pert
"MCF-7 breast cancer cell, transfected, pcDNA3.2-BP1",pert
spleen,ctrl
CD8+_Tcells_healthy_donor_1,ctrl
"GNMT knockout at 8 month age, biological replicate 1",pert
IOSE80pc Cells,ctrl
tissue: blood;	patient: 5;	gender: male;	age: 38,pert
murine neural crest,ctrl
KO Ang3,pert
duration of untreated disease in month:6.5;	age at onset:7.7,pert
BL Day 2 siMut10 transfected biological rep2,pert
Aurka_R_+Dox_rep2,pert
Array Type: HG-U133A_2;	Ratio: 2.01;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Disease_status: Healthy control;	Age (years): 34;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.87;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 3;	age: Post natal day 3-6,ctrl
OE control 1,ctrl
brain_OFC_control C_mr231,ctrl
"DMSO Control after 2hr, replicate 1",ctrl
Trained 1 week T1,ctrl
Pancreatic Sample 21-Tumor,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).,ctrl
ICR MEF infected  with pMX-jhdm1b retrovirus,pert
DRG_DMSO_0.1%_Rep4,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 72;	gender: m;	treatment: -,ctrl
"Huh7 cells, Mock Infected, 24 hours",ctrl
tissue: Frontal cortex;	age: 88;	Sex: F,pert
Wildtype_Sham_Rep1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 185min;	race: Asian;	sex: Female,pert
NBD inhibitory peptide-treated DND41 100mM 16h,pert
"mouse skin, Tcfap2c mutant",pert
genetic background: 129SV;	genotype: WFS1 WT;	tissue: hypothalamus,pert
scan batch: Batch 1;	group: control;	subject age: 4;	paternal age: 28;	maternal age: 27,ctrl
Human prostate cancer primary culture C19dx,pert
Bmpr1a-/- N2B27 sample 2,pert
strain: FVB;	genotype: wild-type;	tissue: mammary gland tumor,pert
14.5_KO_540C,pert
Day: 15; Drug: Heroin; Phase: Withdrawal; Replicate: 1,pert
U2OS PRC shRNA4_pLenti,pert
Rat Heart,ctrl
Healthy controls; individual=JR; time=2; beverage=water,ctrl
NSCL/P sample 3,pert
"human failing LV myocardium, Ischemic61",pert
Patient 5 after folic acid,pert
B_cell_pool_melanoma_M03+M04,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK1;	agent: E2;	time: 4h,pert
NOD RIP-Aire27 islet rep2,pert
"Liver from control mice, biological replicate 4",ctrl
WT_IL-6_400_rep2,ctrl
PsOEt-20-Week 1,pert
"PPARg d4, rep 2",pert
Bronchial Epithelial Cells SA biological 1743Z,pert
HUVEC exposure no colchicine 12 hr_1,ctrl
PBMC from Rhesus Macaque,pert
Day2 Estrogen treatment replicate 1,pert
ACC Xenograft X2,pert
Strain:  B6.V-Lep ob;	Gender: female;	Age:  12 weeks;	Tissue:  gallbladder,ctrl
CF CFTR unexposed replicate 4,pert
"A673 treated with DMSO vehicle control for 5 days, biological rep4",ctrl
Normal_Kidney_Biopsy_5,ctrl
CUTLL1 GSI-rep3,ctrl
VIN_B105,pert
"seminoma specimen, pT1, patient age: 39y",pert
Patient 9,pert
treatment: shcontrol;	cell line: U138MG,ctrl
"genetic background: B6;	genotype/variation: Eos (Ikzf4) knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
HCC_27N,ctrl
"HSCs from male mice treated with oil, replicate 1",ctrl
gender: male;	strain: BALB/c;	tissue: liver,pert
32m1,pert
B4 424 b4-/- untreated,pert
mutant Ndel ko/+,pert
injury stage: Spinal 60 days;	gender: male;	strain: Wistar,pert
BCells_Transgenic_day0_REP1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 27.167;	Ratio: 2.13,pert
Cell line: human ES cell HES2,pert
Globin_C3,ctrl
BALB/cByJTCE liver sample batch 3,pert
Sham 21 replicate 3,ctrl
KU_30N,ctrl
Squamous cell lung cancer patient 36,pert
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep2",pert
"40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 350;	age-at-biopsy-years: 47,ctrl
"Acute Myeloid Leukemia, sample 67",pert
RKO_HSF1siRNA_6hDMSO_REP3,pert
mouse embryonic fibroblasts,pert
Wild-type bone marrow-derived macrophage,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 30 minutes after intravenous saline challenge""",ctrl
tissue: heart;	genotype: WT;	genetic background: C57BL/6,pert
28B,pert
"dy3K/dy3K, mouse model for congenital muscular dystrophy type 1 A",pert
Series 3; old; 1 week after fracture,pert
SHR20-4,pert
"PCB77 treated HepG2 cells at T24, biological replicate 1",pert
CD4_Tcells_severe_asthma,pert
BS2011051058,pert
OVCA420-(2),ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 5 months;	genotype: Wild type,ctrl
Control subject 23_biological replicate 2,ctrl
NCI-H716,ctrl
0833-01-C,ctrl
Day 4 (T34),pert
oocyte,ctrl
OCT4 shRNA_3 Days knockdown_rep1,pert
C57BL6_lung,ctrl
Severe rep3 (retina),pert
51_129_KO,pert
"Cells transfected with sirtuin 6, biological rep1",pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: F;	age: 50,ctrl
strain: C57BL/6;	genotype: Cmah knockout;	tissue: liver;	age: 12 weeks,pert
CEPI_IIIc_229,pert
tissue: testis;	gestational age: 22 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
gender: Female;	age: 87;	post-mortem delay: 14.5h;	ph: 6.5,ctrl
Kidney_WT_baseline_rep2,ctrl
liver_Wt_8wk_rep1,ctrl
"human embryonic stem (hES) cells line VUB01, biological replicate  1",ctrl
THP-1 cell line infected with scrambled control shRNA,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 47;	gender: male;	tumor grade: AIII,pert
HF0616_U133P2,ctrl
microdissected breast cancer cells from case 59,pert
"Microdissected normal cervical epithelium, Age 38",ctrl
uterus_veh_PRKO_40hrs_rep1,pert
hsa-mir-30a/30d inhibitor_24-6,pert
IPMC 5,pert
Parent 1,ctrl
TTP_KO_60ActD_BioRep1,pert
"D425-shOTX2_2, t=48",pert
murine whole heart tissue,pert
"Heart, mdx, 2 months old",ctrl
brain_DLPFC_bipolar C_mr951,pert
ET patient,pert
umbilical cord_nobpd: 3A,ctrl
HepG2 cells control 12h,ctrl
"spleen follicular B in IRF8 conditional KO, biological rep3",pert
immortalized cells derived from brown fat tissue of mouse of mixed background. passage number: 4.,ctrl
Msgn1_24hMinDox-biological rep1,ctrl
MCF10A-HER2-FKBP-HA cells,ctrl
"liver, conditional Nrf1 knockout, Nrf1(dN/-)::Alb-Cre",pert
4m2,ctrl
Mouse jejunum PND30,pert
WD44_control RNAi-1,ctrl
PGA-RMM-72h-1aA-s2,pert
"Rat_Tracheal_Dex_2hr, rep5",pert
Placenta Adra2bWT 3,ctrl
LT 435 +/T after nicotine-induced seizures,pert
age: 15;	sex: M;	disease status: control subject;	Filter number: 98;	Usage number: 1;	Exposures: 3,ctrl
HL60 AML cells,pert
"NCI-H460, cisplatin, 24 hr",pert
VehLPS,pert
Human hepatocellular carcinoma cell line infected with MIR517A and GFP protein 1,pert
RNA from HCC_24N,ctrl
PKCZ -/- male mice angiotensin II treated,ctrl
"Prdm14(+/+): 2i, rep1",ctrl
GFP_0hr,ctrl
Subject #8037-2d Postinfection,pert
full thickness aortic wall biopsy,ctrl
3765-2 E2F1 Null,pert
CLL 379-01 LMP-420,pert
GSK-3 inhibitor effect on MLL leukemia cells - 2,pert
CT-receptor-KO osteoclasts treated 1,pert
Brain (Inferior Olivary Nucleus)_control subject_#5,ctrl
"Patient  G, lesion, time: 0",ctrl
Caco2-siRNA1-rep2,pert
KO - 3 mo - repeat 3 - Cy5 - mAdbID:74669,pert
8 week old EOM control rep 3,ctrl
2861-scrape,pert
Non-Transgenic replicate 1,ctrl
Male Sprague-Dawley (Crl:CD(SD)IGS Br;	Age: between 5 and 6 weeks old,ctrl
"non-AD_TC, biological rep5",ctrl
saline ctr001,ctrl
"Peripheral blood, patient without recurrent events [N74]",pert
cell line: neuro 2A (N2A);	cell type: neuroblastoma cell line;	genotype/variation: transiently transfected with non-targeting vector,ctrl
"Lesional skin from K5-Tie2 mouse, biological replicate 3",pert
coc-8_A,pert
ES cells_control_rep3,ctrl
"Patient 11, Macroscopically intact tissue",ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 31;	maternal age: 28,pert
"breast tumor epithelium,28",pert
WT HPC PDE10i 12,pert
TscWT2_brain,ctrl
"fibroblast, control subject NF7 rep 2",ctrl
Jejunum_POR-null_1,ctrl
"Liposarcoma culture from tumor 379, untreated",ctrl
HaCat cells infected with a control lentiviral construct. Replicat 2,ctrl
B cells -  wildtype mice - influenza-infected,pert
H20_S_B1,ctrl
APOE_KO_DM_9W_3,ctrl
Tendon_lesional_rep10,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 72 years,pert
"Atm-/- 120 min post IR, A",ctrl
disease state: healthy control;	tissue: epidermis;	age: 47;	gender: female;	treatment: untreated;	time: control,ctrl
CME-LaminA4d-3MA-S2,pert
treatment: transfected with Ambion Silencer Select Negative Control #1;	cell type: embryonal carcinoma;	cell line: NTera-2;	passage: 40-50,ctrl
"Normal subject (35 year old caucasian female, SAK_1265842481)",ctrl
Human Acute HIV Sample A044-CD4 T cells,pert
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 4051964034;	hybridization batch: II,ctrl
cell line: U87;	treatment: 10 uM Y15;	cell type: glioblastoma cancer cell line,pert
muscle wild type replicate3,ctrl
mammary_16wkWT_ker71,ctrl
"100-200 motor neurons, sacral spinal cord, 21 days post injury",pert
Fetal heart 1.5 ug/kg TCDD rep2,pert
Disease_status: Bipolar disorder;	Age (years): 58;	Gender: Female;	Age of onset (years): 27;	Duration of illness (years): 31;	Brain pH: 6.50;	Post mortem interval (hours): 35;	Side of brain: Left;	Fluphenazine mg. Equivalents: 12000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
"Crohn's Disease subject (47 year old caucasian male, SAK_1263137700)",pert
B_LS_Time0,ctrl
MIY_day_5-2,ctrl
Kidney_50 mg/kg VCM iv_mouse #0078,pert
GFP_1,ctrl
HCC1954 Cell Control 2,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-1,pert
"E18.5 lung KO1, biological rep1",pert
strain: 129SV;	gender: male;	genotype/variation: SIRT4 WT;	tissue: liver,ctrl
"Patient Z, uninvolved skin",ctrl
PKBa-/- MEF time 6 replicate 3,pert
HSF1-/- T cells at 37oC replicate #1,pert
"Normal Skin, Normal-17",ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 16 hr AP20187,pert
"tissue: Cardiac, ventricular tissue;	genotype: wild-type;	age: 8 weeks-old",ctrl
EmptyVector 1,ctrl
race: caucasian;	age (years): 65;	stage: IA;	grade: 2;	histology: endometrioid,pert
"Normal subject (54 year old caucasian male, SAK_1287392193)",ctrl
ES_WT_rep2,ctrl
5192-scrape,pert
"Gender: Female, Age: 358, BMI: 30, Tissue: luteinized cumulus cells",pert
"S1P2-KO-neocortex, biological rep7 (female)",pert
wild-type replicate 1,ctrl
Undifferentiated mouse embryonic stem cells,ctrl
PFC FVB/N control 3,ctrl
"medulloblastoma, wt, rep2",ctrl
H05_S_B2,pert
Female - caucasian - N-01-M,pert
"SNCA triplication iPSCs, AST18",pert
platelet_sickle_1,pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 95;	Sex: male;	region: LC (locus coeruleus);	age: P23;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
"Donor 1, mock infected 6hr",ctrl
cell line: LNCaP,ctrl
Setleis Syndrome patient 1,pert
bone marrow,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.881;	OD280: 0.457;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 310;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 24h",pert
normal bone marrow NBM4,ctrl
Muscle PCOS case 81,pert
Peripheral Blood Mononuclear Cell (PBMC),pert
kidney_QH2_14M_rep3,pert
Control treated cells Rep1,ctrl
cell line: SKMEL28;	time point: 48h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 48 h,pert
normal muscle replicate 4,ctrl
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 2hr,pert
"ID:3-3, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
FHCRCAML169014,pert
BJ fibroblast replicate 2,ctrl
2A;pretreatment;female;breast tumor; responder,ctrl
Muscle KO Aged 1217,pert
WT-SB replicate 3,ctrl
Patient no. 8: control,ctrl
Trim28CKO unstimulated CD4 positve T cell rep2,pert
Ishikawa_LowDose_BPA_24h_rep4,pert
sip53mut.exp3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 145;	time: 0;	batch: 3,ctrl
Csbm/m Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-2,pert
"FACS-sorted cones, P50 C-DGCR8 KO mice",pert
"SFM control cells (3hr), biological rep_1",ctrl
"Patient H-c1027T, MSI colorectal tumor",pert
"pt. HCL A treated with Vemurafenib 1000 nM for 72h, replicate2",pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch2",ctrl
THRA 6a mutant + T3 replicate 1,pert
Frontal_Cerebrocortex_Vehicle_6hr_rep4,ctrl
"Uninfected TG at 5 d.p.i., rep1",pert
Gsk-3a-/- ESCs Rep3,pert
Fibroblasts_DBApatient_4,pert
patient: 251;	current medication: Bumetanide Asprin Lisinopril Colifoam;	birth date: 5/22/21;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/05;	diagnosis date: 6/6/05;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/6/05;	indictation for procedure: ;	ucss: 9;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Vaginal Prolapse-Angina;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Primary human monocytes,ctrl
tissue: Hippocampus;	age: 84;	Sex: F,ctrl
C2C12 myotubes 100uM H2O2 rep 2,pert
"affected status (disease state): control;	gender: male;	age-at-examination: 50;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",ctrl
9264PBMC,pert
"Deltoid, FSHD, cohort 21, subject 21A",pert
Targretin_LIVER_1,pert
27SAGEA2,pert
P19_WT_pancreas,ctrl
GFP+ one marrow cells transduced with pSF91-MN1-IRES-GFP 4  weeks after Tx,ctrl
"granulocyte, patient. Mtx rep9",pert
thymic tumor IkL/L mouse,pert
EA_Case3_CD20,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 37;	gender: f;	treatment: NSAIDs,ctrl
wild type embryo MEF cells,ctrl
umbilical cord_bpd: 9I,pert
HSC cells from control rtTA mouse rep2,ctrl
WT Brain 60d Mouse2,ctrl
lymphocytes_HD_F_44y,pert
"Endometrium, postmenopausal, estradiol, 24",pert
Pediatric_GBM_9,pert
Dominant negative cJun  VZ20,pert
No or early 1 rep5 (retina),pert
"Vehicle treated, DAY 4, biological rep.3, MV4-11 cells",ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 65;	donor: 21;	disease state: Lesional,pert
"BN strain, male, age 21 weeks",ctrl
H2_SS8_01Nov07,pert
FVB; No Treatment #4,ctrl
tissue: skin;	individual: Patient P1;	condition: ANL;	eczema severity: SCORAD: 0,pert
Parkinson's disease sample x114,pert
n5t24h,pert
"Liposarcoma culture from tumor 337, untreated",ctrl
wild_type_embryonic_stem cells_biological_rep1,ctrl
mouse: 5;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
Lmna H222P homozygous male 1,pert
Lima1A_case,pert
Hippocampus_Soman_48h_rep3,pert
"21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Individual_582_PP_sample,pert
"endometrioma, patient 14",pert
SKI-DLCL cells_Aplidin 3nM_24h_rpt1,pert
WILDTYPE cerebellum at 20 days,ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: H;	transfectant type: stably transfected with scramble control,pert
age: 35;	sex: F;	disease status: Marfan subject;	Filter number: 32;	Usage number: 4;	Exposures: 3,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P13,pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
endothelial_rep8,ctrl
"TH cells from LC, wild type control, young time point, biological replicate 3",ctrl
Muscle-24 month-Myc heterozygous-technical replicate 2,pert
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IV;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1biii;	er: 0;	pgr: 1;	dfs-month: 16;	dfs-event: 1;	distant metastasis: 1",pert
1 Ctrl 1,ctrl
Mouse striatum,pert
striatum_6 month,ctrl
tissue type: Primary lung tumor;	histology: AS,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: Foxd3 conditional knockout cells treated with DMSO,ctrl
01N3C_Systemic,pert
tissue: Temporal cortex;	age: 86;	Sex: F,ctrl
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: TCDD,pert
3880-2 E2F WT,pert
patient: 8;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Gender: male;	Age: 34;	Ethnicity: white,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 33, stage IV, HPV 16",pert
"array 13, xenograft, 0.3% Tween-20 vehicle",pert
B6 wild type;	Age: 4-8 wks,ctrl
Colon_Wild Type_1,ctrl
"Brain tissue from Fisher 344 male rat, Animal #247, 500mg/kg D-Serine",pert
"Neo6, 48h treatment with 5 AzadC",pert
79_129_WT,ctrl
cell line: RT112;	transduced: EGFP shRNA;	doxycycline treatment: no,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 116;	genotype/variation: WT;	age: 8 weeks,ctrl
Age: 50;	Cycle: NA;	BRCA1/2 mutation: BRCA1 917delTT;	Family History: Yes,pert
"RWPE1 cells, vehicle, 24h, biological rep2",ctrl
P53_cKO_1,pert
Patient: H;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
cell type: Endothelial cells,pert
"A673 treated with DMSO vehicle control for 5 days, biological rep5",ctrl
LY2 control-siRNA tamoxifen treated rep3,ctrl
HepG2-PARP2 depleted-1,pert
wild-type_CITCO_rep1,ctrl
DP (CD4+/8+) cells from Normal Thymus Replicate 2,ctrl
T44 U133p2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 82min;	race: White;	sex: Female,pert
Trim28CKO TCR-stimulated CD4 positve T cell rep4,pert
"fibroblast, TSG6-knockout, untreated, biological replicate 1",pert
microdissected breast cancer cells from case 518,ctrl
cell line: MCF7;	condition: control,ctrl
HUVEC/NmenMC58_pilD_6h_rep2_1107,pert
EOM 56 Day mdx rep 2,pert
SKI-DLCL cells_untreated_24h_rpt3,ctrl
disease: cardiopathy;	gender: male;	age: 9 years and 10 months;	tissue: thymus,ctrl
"nasopharyngeal carcinoma, specimen T8",pert
strain background: C57BL/6J;129S5/Brd mixed hybrid;	genotype/variation: Cre knockout of Dicer;	tissue: uterine;	age: 15 days,pert
erStress_twins_AA_1734twin1_500nM_thapsigargin_4h,pert
P14 - nudelcko/ko 1,pert
YFP-pos GMPs,pert
tissue: Temporal cortex;	age: 88;	Sex: M,pert
human breast cancer cell line,ctrl
"Transgenic, brain hemisphere",pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep1",ctrl
Tissue:tumor; Gender:female; Age:43; Tumor stage:T1N1aMx,pert
"CL1-0 mock control, biological rep2",ctrl
"iPSC derived from CCALD patient fibroblast CCALD1, biological rep2",pert
DBA mouse treated with pristane for 3 days,pert
"Patient  J, lesion, time: 0",ctrl
48 hrs sham-2,ctrl
CD71+ bone marrow cells from WT mouse 1,ctrl
"BMDM, WT, uninfected",ctrl
KO mouse 3_heart_basal,pert
tissue: Biceps muscle;	patient: P.b.5;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
Phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject J (JAcCD8),ctrl
OV90+(1),pert
482 cells Sox2shRNA-rep3,pert
healthy CD4 T cells 7,ctrl
06R021 RA,pert
H6 HA 2h 2,pert
"seminoma specimen, pT2, patient age: 27y; W03 021",pert
"Wt mouse, cerebellum, young, saline treatment",ctrl
strain: F1 (C57BL6 X 129/SvEv);	genotype: wild type mice;	tissue: kidney;	gender: male;	treatment: NS diet,ctrl
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep4",pert
5208 Normal Uninflamed sigmoid colon,ctrl
"cochlea at P7, ko, biological rep 3",pert
"Transgenic, snap frozen, gastrocnemus muscle, 10 month age animal",pert
Vit A deficient 4b,pert
"gender: male;	batch: 2;	age (years): 23;	patient id: Non_severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 98;	medication: Becotide, Ventolin;	cell type: CD8+ T-cells",pert
rd1 mouse retina at age postnatal day 8,pert
C005_Control_M_91,ctrl
MCF-10A_shCHK2-2,pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_3-sp1,pert
"AD_FC, biological rep4",pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 48 hr,ctrl
4013-1 E2F2 Null,pert
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P55;	clone: C11,pert
HF0962_U133P2,pert
strain: C57BL/6;	diet: methionine- and choline-deficient diet+ high fat diet (NASH);	tissue: liver,ctrl
Cardiac Muscle_Cmah KO_rep1,pert
normal;	Adjacent pair of T10,ctrl
patient id: T165;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 40;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Gastric_cancer_patient_9,pert
01N1B_ERA,pert
Ainv15 EB3 replicate 1,ctrl
3898-1 E2F1 Null,ctrl
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: untreated;	treatment time: 16 hours,ctrl
BAL_1_A0B0,ctrl
Subject #8035-2d Postinfection,pert
primary normal lung tissue 1455,ctrl
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
KOC 53 PBS treated,ctrl
shSOX2_4,pert
heart_QH2_14M_rep2,pert
"Heart, Cmah KO, mdx, 2 months old",pert
JIA PBMC Post treatment A235_L016(2),pert
12482 UC Inflamed ascending colon,pert
B-CLL PB P136,pert
Neuroblastoma SH-SY5Y cells_cloneH_scramble control_replicate1,pert
resected liver tumor,pert
short-Con rep1,ctrl
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 2h,pert
H_Ctrl_2,ctrl
patient: 32;	disease state: hypertension;	tissue: Atheroma plaque,pert
liver cells from txnrd1 liver-null 8wk male mouse 8 challenged with acetaminophen (APAP)_3,pert
C2_CLP_overexpressor_12,pert
B1_saline_overexpressor_422,pert
MKK7D transgenic female replicate 6 early timepoint,pert
genotype: MLL translocation,ctrl
Liver sample of p14 KO mouse 3,pert
5_CD34+_12h_TCDD-,ctrl
Synovium_Synov,ctrl
PGK12.1_Kdm6a RNAi-3,pert
"Crohn's Disease subject (65 year old caucasian female, SAK_1280909823)",pert
"MCF-10A cells, overexpression TAp63γ, biological rep1",pert
Age: 47;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
b10.2,pert
Liver control pool4 Affy,ctrl
Wildtype pancreatic RNA 36 hours post-tamoxifen,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 24 hour",pert
WT_P58,ctrl
cell line: CAL27;	treatment: PBS,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: F;	experimental sample name: PC11-R,pert
disease state: paediatric glioblastoma;	age: 9;	gender: M;	h3.3_status: wt,ctrl
Parkinson's disease sample x103,pert
29 with Cy5,pert
Day: 15; Drug: Saline; Phase: Withdrawal; Replicate: 2,ctrl
RatLung_H1h_2,pert
patient: 51783;	sample: normal,ctrl
MDA-MB-231 control clone #3,ctrl
EOM 14 Day COntrol rep 3,ctrl
striatum_Pink1 knockout_6 weeks_replicate 1,pert
KSL cells from control mice (Runx1floxed/floxedMxCre-/-),ctrl
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P90;	genotype: Igf1 -/-,pert
Healthy control_sample12,ctrl
3DKD_SerumStarved->1hrEGF_rep2,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.54521,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
age_years: 67;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 2,pert
BP patient 104_biological replicate 2,pert
CD-53-un,pert
"WT mouse bone marrow macrophages, unstimulated, 4 hours",ctrl
Sex: male;	Age at operation: 53 years;	Site: thigh;	Size in cm: 10x3x5;	Histological Subtype: atypical liposarcoma;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
DNGM-1,pert
A517 Sham 7 day,ctrl
GBM_differentiation_4 days_3,pert
"control, subject 3",ctrl
control-plusDox-rep2,ctrl
Control_5,ctrl
healthy control sample x191,ctrl
KM_053N,ctrl
Ileum_POR-null+quercetin_3,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVC, T4, N3, M1, G4",pert
Substantia nigra PD rep4,pert
minor non-tumor5,pert
age: 24 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
RE550_KPL4_8-Medi5117,pert
U937 cell line infected with GSK3B Construct 1 shRNA,pert
Nerve_Control_Vehicle_702,pert
Tumor_Pdk1 WT,ctrl
"Huh7 cells, Mock Infected, 6 hours.",ctrl
3978-1 E2F1 Null,pert
Cultured cell line,ctrl
major HCC9,ctrl
V5-P171,pert
A512 MI 1 day,pert
disease state: paediatric glioblastoma;	age: 16;	gender: F;	h3.3_status: wt,ctrl
control female replicate 1,ctrl
CHB PBMC_sample 2,pert
CON-4--71602,ctrl
12493 UC Inflamed sigmoid colon,pert
"wild type, control, biological rep1",ctrl
KO Soleus at 4 weeks biological rep1,pert
Backskin_Get1_e18,pert
cells: CD8+ cells;	tissue: spleen;	strain: C57BL/6,ctrl
Human umbilical vein endothelial cell,pert
WT619,ctrl
GEIM86-U133A-DM,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 53 years,ctrl
CD11b+Gr1- cell sample_3 (derived from wild type mouse),ctrl
PsOEt-17-Week 12,pert
"hippocampus, SSM",pert
Strain: C57BL/6JNIA;	Age: 2 months;	Gender: Male;	Tissue: Whole hippocampus,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 3,ctrl
Contusion - 35 Day Epicenter Rep2,pert
KO.ES. rep1,pert
strain: FVB;	developmental stage: adult (3-month-old);	tissue: hippocampus;	genotype/variation: Prnp+/+,ctrl
USF1 replicate 1,pert
Laser-capture microdissected high grade serous carcinoma,pert
"MCF7, biological rep2",ctrl
Mouse_WT_colon_UT_rep1,ctrl
Wild type CD4+ unstimulated 2,ctrl
fibroblast_Rapid_D56_Media_16,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 51;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 19d ID310,pert
Mouse inner ear,ctrl
TR71 KD mES,pert
gastric bipsies,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 43.0;	age of psoriasis onset: 15,pert
CML Patient 3 before therapy,ctrl
wild_type_embryonic_stem cells_biological_rep2,ctrl
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep7",ctrl
"LY2 cell line, SRC-1 siRNA untreated, biological rep4",pert
IM18_control,ctrl
"Wild-type-neocortex, biological rep10 (female)",ctrl
K562_ICL670_untreated_dup1,ctrl
"Peripheral blood, normal control [N68]",ctrl
157A,ctrl
Waldenström’s macroglobulinemia (WM-BL 33325),pert
Subject #8037-Preinfection,pert
Jurkat-J2,ctrl
Control (C276),ctrl
Muscle FC3,ctrl
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep1,pert
Untreated Control 12weeks AffyGC RMA rep9,ctrl
umbilical cord_bpd: 8A,pert
"Gender: Female, Age: 25, BMI: 16, Tissue: luteinized cumulus cells",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Male,ctrl
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14583;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
NB69 U133p2,ctrl
HET Brain 54d Mouse1,ctrl
"LCL GM19238, Kd NR3C1, 72hrs",pert
Control replicate 7,ctrl
Nerve_Control_Rosi_713,pert
Cell culture. A549 treated by MK886 3,pert
"Liposarcoma culture from tumor 386, doxorubicin treated",pert
Normal_Kidney_Biopsy_4,ctrl
Btk KO primary splenic B-cells (sample2),pert
Nerve_Control_Rosi_714,pert
MycCap prostate cancer cells,ctrl
C_LS_Time0,ctrl
"CFU-PreB colonies Wildtype littermate, biological replicate 3",ctrl
CD8_T_cell_pool_melanoma_M03+M04,pert
hippocampal CA1 tissue,ctrl
cell line: MLL-AF9 AML cell line 10950 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
Carbo Day7 (419L),pert
Human.BF.CP.ECRB,pert
"WT VSV infected, biological replicate 1",ctrl
MA_307,pert
"testis, Repro9 mutant, 14dpp, Rep2",pert
tissue: Spleen;	cell type: B lymphocytes;	gfpmyc status: negative,ctrl
Human Leukemia cell line RS4.11,pert
cell line: prostate cancer cell line PC-3M;	genotype/variation: MYB siRNA,pert
"ESCs overexpressed vector control, biological rep1",ctrl
ccRCC tumor of patient 265,pert
Shn2_wild type,ctrl
malignant tissue_TMPRSS2:ERG fusion positive,pert
LPS + CyP 3hr 2,pert
5922012008_A,ctrl
liver-AHRWT-cornoil-rep4,ctrl
6_c,ctrl
FCHL patient #99-0562,pert
BL Day 2 siMut12 transfected biological rep3,pert
MDA-MB-231_TR20003,ctrl
GIST Pre Treatment Biopsy 31,ctrl
E18.5_Mutant_Kidney_array1,pert
"E2f8 KO, biological rep2",pert
1083-03-A,pert
"control, BA10-58",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 29.459;	Ratio: 2.10,pert
"HepG2 cells, control, rep2",ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID49,ctrl
"RWPE-PCAT1 cMyc siRNA #3, replicate 1",pert
subject id: 48;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Control male replicate1,ctrl
Moderate rep2 (OHN),pert
Normospermic individual: Sample N13,ctrl
subject: 39;	disease: CP;	muscle: ST;	gender: M;	age: 15.3;	gmfcs: 2;	popliteal angle: 120,pert
Mature mice skeletal intercostal muscle sample,ctrl
E14 cells_Zfp322a RNAi-rep1,pert
Control rep 2,ctrl
HSC cells from control rtTA mouse rep3,ctrl
whole blood_100981,ctrl
"D425-control, t=96",ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 10",pert
"Brain tissue from Fisher 344 male rat, Animal #256, 200mg/kg D-Serine",pert
Sample Group: HD patient; Gender: female; Age: 56; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/43,pert
"metastasis: none;	Stage: 2b;	tissue: cancer, homogenized",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 48.09041,pert
25 uM chlorpyrifos batch 3,pert
WT 1 Quadriceps,ctrl
BxPC3-KO4 rep 2,pert
WD44_Kdm6a RNAi-2,pert
ColTum_022NAFD9_g8.txt,pert
patient: 245;	current medication: Pentaza 1g BD;	birth date: 11/4/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/4/04;	diagnosis date: 3/16/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/16/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/16/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 6/3/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
WM164 Melanoma cell Line,ctrl
wt_P6_rep3,ctrl
"fibroblast, MFS subject FB1286 rep 1",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 351;	age-at-biopsy-years: 35,pert
G_Kin_1,pert
Human prolactinoma 131,pert
age_years: 60;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"Liver from control exposed rats, biological rep 4",ctrl
34208.INV,pert
"Aorta, Ang II 7d, #3",pert
WT #188,ctrl
CEPI_Ic_336,pert
tissue: skin;	cell line: NZM12;	tumour stage: metastatic melanoma;	tumour site: small intestine;	treatment: PAX3 siRNA,pert
"hippocampus, MSS",pert
"Primary aortic endothelial cells, transgenic_PPARG_V290M_2",pert
human_hepatocyte_levofloxacin_24hr,pert
"disease group: Atopic Dermatitis;	Sex: m;	age: 50s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 34.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 510;	ige (kiu/l): normal (0-48.5 kIU/L): 710;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
"Kidney from MON exposed rats, biological rep 1",pert
GFP+ one marrow cells transduced with pSF91-MN1VP16-IRES-GFP 4  weeks after Tx,pert
Heart sample7,pert
age: 38;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
microdissected epithelial cells from IPMA 6,pert
day: d00;	strain: C57BL/6;	genotype: WT;	experimental run: eX,ctrl
B_Ctrl_1,ctrl
BE-rep5,pert
Vehicle-Control;	Vehicle-Control 36 hours set 1,ctrl
Normal bladder 16-99,ctrl
Control 26 appendix,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 24 months;	genotype: Wild type,ctrl
"Peripheral blood, normal control [N62]",ctrl
DA rat colon treated 1 h,pert
"eye, cornea: TRizol Extraction_le1 4",pert
"SIRT3KO, standard diet, rep2",pert
colon biopsy,pert
CD3-stimulated CD8+ T-cells from Itk knockout C57BL/6 mice,pert
genetic background: 129/SVE;	genotype: Des(-/-);	tissue: tibialis anterior;	age: 12-14 mo;	strain: Des(-/-)/129/SVE;	treatment: 50 eccentric contractions 12 hours,pert
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 4",pert
5196 Normal Uninflamed sigmoid colon,ctrl
03_ADL,pert
treatment: PLX4720;	time: Day1;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
S46 WT4	F5/13	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
Individual_4124_NN_sample,ctrl
"Biceps, FSHD, cohort 20, subject 20A",pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 103;	Usage number: 5;	Exposures: 3,pert
MDA-MB-231 control clone #5,ctrl
J1_minus LIF_rep1r,ctrl
"cell line: 10590, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
colon_1h_rep2,pert
Embryonic age 14.5 mutant rep2 (PKD1_35),pert
"Fetal liver, CD-1 background",ctrl
ICR MEF infected  with pMX-GFP retrovirus,ctrl
sMPNST_Vehicle_2day_rep3,ctrl
"eye, retina: Myoc 2_e1_le1",pert
Bone-Marrow_SMM_S1412,pert
"IGF-treated cells (24hr), biological rep3",pert
CUTLL1 wash4h-CHX_rep3,pert
CON - R17,ctrl
prostate from wild-type model,ctrl
"patient 11, left arm treated with pimecrolimus until day 22",pert
ns VC 3,ctrl
T140,pert
MPM tumor 3,pert
Tet2 KO CFU 5th rep2,pert
Primary neonatal keratinocytes_ACTL6a_i_rep1,pert
"Lens epithelium, SPARC KO, #1L",pert
AMWT_Ker40,ctrl
Hippocampus_Soman_72h_rep4,pert
race: african american;	age (years): 59;	stage: IC;	grade: 2;	histology: endometrioid,pert
U87 10 uM Y15 rep2,pert
tissue type: Primary lung tumor;	histology: LCNEC,pert
potilas_DC_D,pert
"wild type; BMDM; 1alpha,25(OH)2D3 treated",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.221;	OD280: 0.621;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 152;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Heart, wild type1",ctrl
Control ESC media sample 2,ctrl
dex24hr_1,pert
systolic heart failure due to idiopathic dilated cardiomyopathy,pert
Wild_type_lubiprostone,pert
"E2-treated cells (3hr), biological rep_1",pert
knockdown: shLOXL2;	cell line: MDA-MB-231,pert
0h WT Sample 36,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 42;	gender: m;	treatment: colchicine,ctrl
cell type: mouse embryonic stem cells 3x passaged without feeder cells;	genotype: WT;	genetic background: C57BL/6,ctrl
liver_Q10_14M_rep1,pert
CUTLL1 DNMAML1 GSIwash2h-rep1,pert
monolayer chondrocytes from normal donor 2,ctrl
"Trim28 conditional KO mice Treg cell, replicate 3",pert
"Strain: SPARC-null, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Right",pert
whole blood_101446,pert
"non-AD_FC, biological rep11",ctrl
cell line: rtTA-Dmrt5;	differentiation: 9 days;	treatment: +Dox,pert
Testis_KO_rep1,pert
Biceps_Control_6,ctrl
Embryonic age 17.5 wild-type rep3 (PKD1_2),ctrl
ACC 3 cell line lacZ-RNAi replicate 1,ctrl
NALT_infected_24h_90-226att_rep4,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 36 yr;	population: white;	dsm-iv: 295.9;	age of onset: 33 yr,pert
patient: 125;	current medication: OCP;	birth date: 3/17/78;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: Diarrhoea predominant IBS;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
11SAGEA,pert
C1 patient,ctrl
"STZ pancreas, biological rep1",pert
SLE CD4 T cells 1,pert
Trizol extracted total RNA from myometrium tissue.,ctrl
"Mesodermal Precursor Cells derived from hES cells line VUB03_DM1, biological replicate 3",pert
platelet_Ctrl_1,ctrl
kontrolli_DC_C,ctrl
strain: mixed background of C57BL/6;	genotype: Ezh2f/f;Mef2cAHF::Cre;	tissue: heart;	developmental stage: adult,pert
heart control 4,ctrl
liver_Wt_female_8wk_rep1,ctrl
MacularDegen-injured-12aAv2-s2,pert
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
major non-tumor3,pert
PsOEt-24-LS,ctrl
Zfx wt MA9 cells + Vehicle [10977],ctrl
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Carbo Day14 (378R),pert
E31,pert
breast cancer patient 251,pert
EB_6_24h_290_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell line: PC3;	treatment: Wee1 inhibitor II,pert
"Liver, fasted",ctrl
male_alcoholic_417,pert
129_Sv_2_Tal1_Ko_d6_4302,pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Post mortem interval (hours): 24;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
gender: female;	genotype: Homozygous for the Q65X mutation in the TWIST2 gene,pert
Embryonic day 14.5 pancreas,ctrl
cell line: OVCAR-8;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
Liver_Wildtype_Rep2,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 24h ID289,pert
KM_065T,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-OCT4,pert
"WT-UN3,experimental replicate 3",ctrl
15KD_SerumStarved_rep2,pert
TRPM7-/- mESC,pert
"Ptenloxp/loxp + pBP-Cre, biological rep 3",pert
"seminoma specimen, pT2, patient age: 27y",pert
"Uninfected NT at 5 d.p.i., rep1",ctrl
Untreated 979-CLA-27,ctrl
age: 46;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
lung_CLP_PPTA knockout_rep2,pert
"Cultured ovarian cancer cell line OVCA433, untreated",ctrl
"human failing LV myocardium, Idiopathic9",pert
9m1,ctrl
"Lymphoblastoid cell lines derived from family 1712, member 2",ctrl
"Peripheral blood, normal control",ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: control; biological replicate: 1,ctrl
"whole right lung, 3 weeks after a bleomycin dose of 125mg/kg, given by osmotic minipump.",pert
Rb null MEFs without cisplatin treatment,pert
HCT116,ctrl
BP10,pert
428B.INV,pert
4 hr KLF4 Time Course Induced,pert
"Uninvolved Skin, NS-4",pert
CTL2 E2 2hr,pert
gender: male;	agent: control;	cell type: Hematopoietic stem cells,ctrl
Sox9egfpneg_p23-2,ctrl
"C57BL/10 Control QF, replicate 1",ctrl
P83 dilated cardiomyopathy heart biopsy,pert
RAW LPS 3,pert
"Liver, Intermittent Hypoxia 1",pert
Kin- S49 Cells,pert
BIO586223,pert
"strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
"mouse control, liver, RNA B6477A",ctrl
"human failing LV myocardium, Idiopathic43",pert
cell line: HCT 116;	treatment: siChe-1,pert
Mouse E10.5 urogenital epithelium +/+ #3,ctrl
T1alpha (-/-) fetal lung dpc 18.5,pert
"NALT infected with wild type 90-226, biological rep2",pert
EE_IA_1_cauc_lcm,pert
Large cell carcinoma 017,pert
16A,pert
Patient no. 11: control,ctrl
11_MLN8237-2,pert
"seminoma specimen, pT1, patient age: 43y",pert
strain: 129/Sv,pert
TTE3 cells treated with BPA for 3 h-1,pert
D_Ctrl_2,ctrl
CH2116,pert
EA_Case18_CD8,pert
Renal vesicles from Lim1 mutant E12.5 embryos isolated by laser capture microdissection.,pert
Gender: Male;	Age: 37;	Ethnicity: White,pert
Insm1 control #8,ctrl
Mening UNSTIM WB SW 1a,ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 1 - Technical Replicate 2,pert
cell line: mda-mb-231;	transfectant: siRNA for p53,pert
Testis WT 0h batch 2 [TeWTh00.9],ctrl
SIRT4 WT liver_7583,ctrl
cell line: NOMO-1;	genotype: ZFX knock-down,pert
"JAG1 overexpressed CL1-0, biological rep1",pert
Normal Rat Retina,ctrl
NSC2,pert
Mouse_ESC_Pcl2_shRNA_sample 1,pert
Individual_4874_NN_sample,ctrl
EA_Case1_CD8,pert
RNA from microdissected breast cancer cells from case 823 labeled with Cy5,pert
pcdh12-deficient mice rep1,pert
Gender: Male;	AJCC Stage: II;	Pathological T: 4;	Pathological N: 0;	Pathological M: 0;	Grade: poor;	Tumor Site: Hepatic Flexure;	Drug Treatment: NO,ctrl
IMR-32_pCMV_48hr_rep 1,ctrl
SON siRNA rep2,pert
patient: 221;	current medication: Prednisolone 7mg Asacol Adcal Seretide Fe SO4;	birth date: 1/29/86;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/10/01;	diagnosis date: 12/10/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma Eczema;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"alveolar macrophages, non-smoker 035",ctrl
patient id: T26;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 73;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM1;	Stage: IV;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: EF1a-control,ctrl
"Acute Myeloid Leukemia, sample 4",pert
"wild type ES cells, biological replicate 2",ctrl
E14 - DCXko/Y 2,pert
NOD_S1,pert
"granulocyte, patient. Mtx rep5",pert
"Rescue pancreas, biological rep3",pert
strain: CB6F1;	tissue: Skin;	gender: female;	age: E17.5;	genotype/variation: Control,ctrl
201/4,ctrl
34SAGEA,pert
strain background: C57Bl/6;	genotype/variation: Lrp5-/-;	cell type: primary calvarial osteoblasts;	time point: day 7 of differentiation,pert
"Amoxicillin treated Proximal, Small Intestine 1 17 days old",pert
Cdh1 knock-out,pert
NME2 induced A549 cell Replicate3,pert
3881-1 E2F WT,ctrl
tissue: Mouse heart;	genotype: akt2-/-;	strain: C57BL/6,pert
RNA from whole tissue section of case 547 labeled with Cy5,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P2,pert
Cervical cancer_CC140,pert
"Spleen, CD4+CD25hi Tregs, Xbp1 knockout",pert
E14.5 Tgfbr2 Wildtype Mouse Model Palate 1,ctrl
NTB_heart 2,ctrl
"TG mouse lung, biological rep2",pert
"human post-mortem brain tissue, Down syndrome",pert
CD4_T_cell_pool_healthy_H11+H12,ctrl
11441 UC Uninflamed ascending colon,pert
HMEC X BC23 : 0090-5k,pert
PGK12.1_Kdm6a RNAi-1,pert
Gastric_cancer_patient_5,pert
IRF4-control_Th17_cells_42hr_rep3,ctrl
"shControl, low glucose, replicate 3",ctrl
T3+4,pert
OV1002 Carbo Day1,pert
control-2,ctrl
Normal bladder 283-99,ctrl
Liver_WT_Vehicle_Rep4,ctrl
CUTLL1 wash2h-CHX_rep2,pert
"cervical cancer cell line, MS751",pert
strain: C57BL/6;	cell type: mononuclear bone marrow cells;	treatment protocol: mock retroviral transduction,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day2,pert
strain: F1 littermate of TCL1 (C3H/B6) and ID4+/- (CD1) mice;	genotype/variation: ID4+/-TCL1-tg;	tissue type: spleen;	cell type: CD19+ B;	age of the mice: 1 month old,pert
"gender: male;	batch: 2;	age (years): 35;	patient id: Non_severe_3;	fev1 (% predicted): 77;	fvc (% predicted): 89;	medication: Becotide, Ventolin;	cell type: CD8+ T-cells",pert
"cell line: hgps-ipsc_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below.",pert
striatum_wild type_6 weeks_replicate 3,ctrl
Pfeiffer BCL6siRNA 1,pert
age: 48;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
A504 MI 7 day,pert
MDS13,pert
PIK3CA.DMSO.1,pert
age: 28dpp;	genotype/variation: wild type;	tissue: testis,ctrl
sample =XCGD1 treatment=Stimulated time=360 (min),pert
"patient 6, arm treated with pimecrolimus",pert
Diaphragm 7 Day mdx rep 2,pert
PGA-HMO-NonObese-4aUA-s2,ctrl
Control biological rep2,ctrl
"MCF-7 cells-control, biological rep 3",ctrl
patient: 40875;	sample: normal,ctrl
Tmod3 WT-1,ctrl
heterozygot FH P282,pert
heart of male mouse subjected 1 week to chronic constant hypoxia,pert
5251 UC Uninflamed sigmoid colon,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 46 years,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 1",ctrl
EB_07_5d_139_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Chemically-induced skin papillomas in control mice treated with tamoxifen for 1 week,ctrl
Individual_4977_NN_sample,ctrl
E12.5 heart_Sp3 knockout_sample c,pert
liver_Akt1+/-_female_8wk_rep1,pert
brain_OFC_control C_mr206,ctrl
EBS_6,pert
"BMMCs from NTAL WT, noninfected, 2 h activated, biological rep3",ctrl
Msgn1_12hPlusDox-biological rep2,pert
03_NOR,ctrl
THRA aI mutant + vehicle replicate 1,ctrl
peripheral blood CD4 T cells,pert
Sarc_2,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: E18.5;	genotype: Igf1 +/+,ctrl
KN-smoke-high-5 month+1d-R1,pert
155A,ctrl
P14 - Lis1cko/ko 3,pert
"acutely admitted, severely psychotic schizophrenia patient  A03",pert
Haloperidol treated 12weeks AffyGC RMA rep7,pert
Modified MCF10A Cells,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.27123,pert
liver_QH2_6M_rep1,pert
KO_IL-6_400_rep1,pert
Untreated CLL1,ctrl
"LCL GM19238, Kd SREBF2, 72hrs",pert
WFS1 KO USHT_18_330_wt,ctrl
220/4,pert
age_years: 31;	sex: F;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
TRPM2-AS siRNA,pert
Control Day1 (328R),ctrl
"ALL_NDS, K40 012109",ctrl
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: yes,pert
KU_26N,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 67 years,pert
Sex: female;	Age at operation: 85 years;	Site: lower arm;	Size in cm: 11x8x4;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
whole tissue section from case 140,pert
CME-LaminA0d-1MA-S2,pert
"Lens epithelium, wild-type mouse",ctrl
Primary hepatocytes isolated from Donor 2 treated with Wy14643 for 24h,pert
strain: C57BL/6J;	genotype/variation: wild type,ctrl
V5-P596,pert
wt Ang4,ctrl
NIH3T3_0h_exp1_rep2,ctrl
E12.5 heart_wildtype_sample b,ctrl
Subject #8012-8hr Postinfection,pert
BM_030065,ctrl
DS1-iPS 5,pert
PFC S control 4,pert
ApoD KO+PQ rep_2 (PQKO2),pert
FCHL patient #99-1191,pert
"Human breast, post AFI treatment",pert
cell type: prostate cancer cell;	cell line: LNCaP;	transfection: MED1 expression vector,pert
PBMC from HC,ctrl
HepG2-control-1,ctrl
Parkinson's disease sample x186,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-sp2,pert
Hepatic reductase null N8,pert
"skin fibroblasts, passage #3",ctrl
7ILC_normal_ductal,ctrl
Strain: C57BL/6; PGC1beta mutant mouse; Tissue: quadriceps muscle,pert
Human heart,pert
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Normal Adrenal Gland (AN18),ctrl
Cavin-1/PTRF KO #157,pert
PS-/- cerebellum at 10 days,pert
unaffected brother,ctrl
Myoblast-GATA4-Wt-day3-1,ctrl
"wdNHBE with BN/59 at 36hpi, biological rep2",pert
SKM WT3,ctrl
background strain: C57Bl6;	genotype: Polgtm1Lrsn+/+;	tissue: Mouse bone marrow;	age: 32 weeks;	gender: female,ctrl
"Quadricpes muscle, control mouse",ctrl
"siNC-BMSCs , biological rep1",ctrl
H1299_shPTK7-2,pert
oocyte,pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep5,pert
BN DES-treated replicate 1,pert
A549_siZMPSTE24_rep.1,pert
"wildtype pancreas, biological rep4",ctrl
IGF,pert
1083PBMC,ctrl
"Patient M030-161C, MSI colorectal tumor",pert
PBMC from T cell LGL leukemia patient #115 (TLGL115),pert
SeroNeg-8,ctrl
Heart sample 10,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 24 months;	genotype: Wild type,ctrl
non-CF subject 37,ctrl
Heart sample 12,pert
cell type: Transcriptional 2 Follicular Progenitor (T2-FP) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: WT,ctrl
BP patient 96_biological replicate 2,pert
gender: female;	age (years): 54;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
monolayer chondrocytes from normal donor 1,ctrl
MF-25,pert
B-lymphoid,pert
blood-derived macrophages,ctrl
"KM-H2 cells, CIITA-BX648577 knockdown, replicate 2",pert
Silberg2 (S10) 25091NE,ctrl
Normal cortex of patient 111,ctrl
EA_Case17_CD20,pert
ILD_22,pert
cell type: AML blasts;	fab classification: M4,pert
nt control 8,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 48h",pert
Brain_Adult_LPSip_4hr_mouse3 (YL3_#66),pert
MPM tumor specimen 23,pert
gender: Male;	tissue: Tendon;Patellar;	age: 32;	donor: 15;	disease state: Lesional,pert
Insm1 control #4_pituitary gland,ctrl
"strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
EOM 28 Day mdx rep 3,pert
umbilical cord_nobpd: 2C,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 5 days osteoblast differentiation,ctrl
siHic5_2_0h_2,pert
S-IIP(UIP)8_Cy3,pert
31SAGEA,pert
tissue: prostate tumor;	genotype: Pten null;	age: older than 20 weeks,pert
TTE3 cells treated with BPA for 12 h-2,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 48 hours,pert
Wildtype (untreated) 5176,ctrl
PBMCs_Control_11 [IS],ctrl
Diaphragm 112 Day mdx rep 2,pert
ICL670 50uM 16hrs,pert
brain_DLPFC_bipolar B_mr867,pert
"Patient 116, 24 month of REBIF",pert
BL150,ctrl
"Vehicle treated,  doxycycline treated; biological replicate 3",pert
02_NOR,ctrl
R6/1 18 week wildtype_F272,ctrl
"Crohn's Disease subject (41 year old caucasian female, SAK_1304662648)",pert
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 32;	maternal age: n/a,pert
695_383_0hr,ctrl
RNA from HCC_39T,pert
"spinal cord, ventral spinal cord: EP144/L - G93R(Roth)/e14-mutant hSOD1_le2",pert
Empty Vector Control for transient transfection replicate 1,ctrl
GFP Zfx ko 3,pert
Leg 23 Day mdx rep 3,pert
3433-lcm,pert
"human failing LV myocardium, Idiopathic51",pert
04SAGEA2,pert
"8 weeks old sex age matched littermates, lung typeII cells",pert
"Mdr2-KO homozygous mouse, 12 month old mouse 3",pert
0-WT,ctrl
Healthy Donors 3,ctrl
3264-lcm,pert
BL Day 2 siMut12 transfected biological rep1,pert
"106, ADIPOOSE TISSUE, Before",ctrl
siCtrl_FM_rep2,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L017,ctrl
"brain, hippocampus: KA-6h-P15-III_e1_le1",pert
Retina of 2 month old RPE65-/- mouse,pert
c_NY102,ctrl
LNCaP cells treated with vehicle and control shRNA,ctrl
"Sodium arsenite added to food: 10 ppb, 5wk; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: None",pert
MCF10A cells in 3-D culture,ctrl
231_Empty_rep2,ctrl
siZMPSTE24-treated SCC-40,pert
VHL null MEFs,pert
Rb heterozygous 129sv matings,ctrl
CCE embryonic stem cells (CCE ES cells).,ctrl
tissue: retina;	age: postnatal day 6;	genotype: wild type,ctrl
"human failing LV myocardium, Idiopathic42",pert
"DMD skeletal muscle, biological rep1",pert
patient id: 209;	tissue: Normal cortex;	gender: Male;	age: 63;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
WT Hippocampus - 2,ctrl
Disease_status: Bipolar disorder;	Age (years): 19;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 2;	Brain pH: 5.97;	Post mortem interval (hours): 12;	Side of brain: Right;	Fluphenazine mg. Equivalents: 2000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 24hr,ctrl
batch: A;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,ctrl
Rybp#15 (OHT-)_4d_rep2,ctrl
"DMD skeletal muscle, biological rep14",pert
LT-HSC Zbtb7a F/F Mx1-Cre+ #2,pert
strain: C57BL/6N;	genotype: wildtype;	tissue: liver;	age: 5-6 months;	gender: male;	treatment: mock,ctrl
SKMEL28_t6h_rep3,pert
strain: C57BL6J;	genotype: H3f3b WT/WT;	age: E12.5;	tissue: 1 of 2 mouse testes,ctrl
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 1, clone 1",pert
E8.5 ko.1,pert
Brain,pert
strain/background: C57BL/6;	genotype: wild-type;	tissue: anterior prostate;	age: 12 weeks,ctrl
condition: Psoriasis;	patient: PS-M;	tissue: LS skin biopsy;	kit: Affy,pert
Individual_4607_NN_sample,ctrl
brain knock out replicate2,ctrl
strain: C57BL/6;	genotype: Nrf2 KO;	gender: Male;	age: 9 weeks;	tissue: kidney;	treatment: intraperitoneally injected with a single dose of vehicle (saline),pert
Prostate Cancer_MS 36C9,pert
Control male 8,ctrl
healthy control sample x117,ctrl
OVCA433+(1),pert
Individual_3059_PP_sample,pert
Mtb infected-42d-5,pert
pMX-jhdm1b no vitamin C Jhdm1BVc-_2,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#131,pert
Tet2 KO CFU 5th rep1,pert
prostate normal 6,ctrl
KGN Control  [RR1009],ctrl
PGA-MAH-AJ_OVA6h-1aA-s2,pert
SR-A mutant olfactory epithelium 0 h replicate1,pert
Normal heart from C57BL/6 strain,ctrl
whole tissue section from case 25,pert
"Neural precursor cells derived from hES cells line VUB03_DM1, biological replicate  1",pert
"fibroblast, MFS subject 60FR rep 3",pert
01MLF_PolyRF+,pert
"RNF40 siRNA - Undifferentiated, rep3",pert
GM19238_Kd_IRF9_2,pert
Human Uninfected Sample N001-CD8+ T cells,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID222,pert
"ADIPOSE TISSUE, RES, After",pert
tissue: brain;	genotype: mutant Ndel ko/+ inbred;	age: P0,pert
cerebellum wild type 21 month replicate 3,ctrl
"control, BA46-35",ctrl
cerebellum_WT_18w_rep2,ctrl
Muscle from a 5 month old Myc heterozygous mouse,pert
DMN-CtrHippo20d-2aAv2-s2,ctrl
BM CD34+ Pool II,ctrl
7N,ctrl
S9,pert
CTL2 E2 8hr,pert
"Brain tissue from Fisher 344 male rat, Animal #263, 20mg/kg D-Serine",pert
CON-2-PLASTIC,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: WT,pert
wild-type tumor #3152,ctrl
01LSD_ERA,pert
pool of thyroids from 10 months old RET-PTC transgenic mice,pert
Normal-ERα-positive breast cancer 5,ctrl
"proband a, before exhaustive exercise",ctrl
cerebellum_PS-/-_ 20d_rep2,pert
Cre-negative (control),ctrl
"lymphoblastoid cell line from T9.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
09_C57_KO,pert
Mening SWB WB NP 1b,pert
Normal-ERα-positive breast cancer 25,ctrl
"human failing LV myocardium, Idiopathic76",pert
cell type: CD43+/41+/235+ progenitors generated from euploid iPSCs,ctrl
chip number: 13;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.64;	rin: 9.4;	transfection date: 2012-03-26,pert
cell line: THP-1;	disease state: monocytic leukemia,pert
SON siRNA rep3,ctrl
tissue: skin;	individual: Patient P6;	condition: ANL;	eczema severity: SCORAD: 0,pert
AA_Control4_CD8,ctrl
GIST Pre Treatment Biopsy 28,pert
HCC_4T,pert
liver-AHRKO-cornoil-rep2,pert
HK12B5,ctrl
"siSCR neuron, biological rep1",ctrl
"Empty vector control, 24 hrs, No Rosiglitazone (NONE_24_2)",ctrl
THRB bN mutant + vehicle replicate 2,ctrl
Lesional skin from imiquimod-treated mouse,pert
"Strain: C57BL/6 X SV129, Age: Embryonic Day 14.5, Tissue: Palatal Shelves",pert
HTH83 LAMC2 KO 3,pert
6-month mouse dorsal prostate,pert
Primary human erythroid progenitor cells expressing a luciferase control shRNA,ctrl
"WT, PR03M004v0",ctrl
Aorta_non-transgenic C57BL/6J control_2,ctrl
tissue: Aorta;	genotype/variation: SRF-flex2neo;	genotype/variation: SRF-flex2neo littermates (control);	age: 4 month-old,ctrl
"Patient  G, lesion, 4 week",pert
MCF-10A shATM-1 replicate 1 [set 5],pert
Control (C286),ctrl
ALI patient #4,pert
whole tissue section from case 868,ctrl
prostate_Klf5 wt_rep2,ctrl
T41027_rep,pert
Hippocampus_NaiveControl_rep2,ctrl
E2A-deficient DN2 replicate 1,pert
shRNA2-4-noDox-rep3,pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 1",pert
med2d_3,pert
EE_IB_2_cauc_lcm,pert
"primary cortical neurons, SHANK3 shRNA",pert
"human failing LV myocardium, Ischemic64",pert
MDS patient 97,pert
Testis CREMKO 0h batch 2 [TeKOh00.12],pert
MDS patient 166,pert
colonic_mucosa_non_inflamed_881,pert
FHCRCAML_2762,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_6h_Con_HG-U133A_2_YCHSUP501,ctrl
Liver Pio1,pert
HN_122,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 12,ctrl
"Patient 25, Atheroma plaque",pert
Wild Type 612,ctrl
Carbo Day1 (408R),pert
IkL/L thymocytes,pert
Ero1-WT induced biological repC,pert
jzo004-v5-u74av2-met,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 334;	age-at-biopsy-years: 42,ctrl
ILD Study Number S012,ctrl
"Frontal Cerebrocortex, permethrin (100 mg/kg), 6 hours",pert
PBMCs enriched for CD8+ cells from normal control subject J,ctrl
Normal Caucasian control 4,ctrl
SLE CD19 B cells 12,pert
BCell_lymphoma_marginal_sample5,pert
"Normal cervix epithelium, microdissected, Age 42",ctrl
WT_TER119+_rep3,ctrl
Cutaneous psoriasis without arthritis PsC 18,pert
MDS patient 179,pert
"Patient CCo, stable renal transplant recipients, male, 38 years old, T1 (3 months after the switching of the therapy)",pert
Healthy control_sample9,ctrl
RNA,pert
LT 436 +/T untreated,pert
DRG_Capsaicin_10microM_Rep1,pert
CA95-198A,ctrl
"RWPE-PCAT1 NT siRNA, replicate 2",ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 2 - Technical Replicate 1,pert
11105 UC Uninflamed descending colon,pert
CH1802,pert
human_hepatocyte_400uM_grepafloxacin_donorA_24hr_prep2,pert
CD34+ cells isolated from the bone marrow of a normal control,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: severe;	Ig clonality: oligoclonal,pert
0175-01-C,ctrl
466MM,pert
fully differentiated (day 6) myotubes,ctrl
EA_Case19_CD8,pert
03_C57_KO,pert
6_DMSO-6,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 72,pert
male;	48 yr old;	White,pert
B137+,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 5;	gender: male,ctrl
prostate normal 4,ctrl
Monocyte control rep 1,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 4",ctrl
chip number: 19;	transfection plate: 5;	target gene: RELA;	kd level: 0.68;	rin: 8.9;	transfection date: 2011-10-17,pert
JIA PBMC Post treatment A235_L015(2),pert
Kidney_saline iv_mouse #006,ctrl
Tolerizing allografts 7 days No.2,ctrl
Preglaucoma control rep2 (OHN),ctrl
Control + LPS 4,ctrl
PGA-MPF-C57-bleo-24h-3bAv2-s2,pert
genotype/variation: MBD1 KO;	tissue type: thymus;	cell type: medullary thymic epithelial cell (mTECs),pert
MDS patient 177,pert
Psoriasis-5 baseline,pert
Embryonic age 17.5 wild-type rep3 (PKD1_41),ctrl
4-HPR_LUNG_3,pert
"CD11b, WT",ctrl
individual: patient16;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"Pou4f1+/+ cells, transduced with control virus_Wt-MSCV_81",ctrl
C018_Control_F_67,ctrl
"Hippocampus, soman, 24h",pert
H10_P_B2,pert
224 Day 3 siMut10 transfected biological rep1,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 92;	Usage number: 1;	Exposures: 3,ctrl
minor salivary gland,pert
"Retina from NeuroD1 cKO mouse at ZT6, biological rep 3",pert
OTT1 null/wt mouse;	sacrificed at gestational age,ctrl
WT4,ctrl
Testicular seminoma 1113,pert
E9.5 FVB/N erythroid cells-2,ctrl
Wild type olfactory epithlium 0 h replicate1,ctrl
fibroblast_Slow_D223_Media_12,pert
anti-FGFR1_rep2,pert
Pax_C2,ctrl
BxPC3_JMJD3KD_rep1,pert
control mouse WT8,ctrl
Pancreatic Sample 25-Tumor,pert
"Liposarcoma culture from tumor 388, doxorubicin treated",pert
EO1389_muscle_mutation,pert
A673 cell line that has been treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50).,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,pert
maternal diet: Control;	genotype/variation: Cited2 -/-;	strain: C57BL6/J;	developmental stage: Embryonic (8.5 days post coitum),pert
01-0033A_Day1_10,pert
"2 months, ipsilateral group, biological replicate 3",pert
chip number: 19;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.79;	rin: 9.4;	transfection date: 2012-03-26,pert
left hippocampus,pert
PML Knockout Mice fed Low Fat Diet 2,pert
"WT, rep3",ctrl
07R069 Control,ctrl
A549_siRNA_STAT3_rep1,pert
control participant P310 (human CD3 positive T cells),ctrl
Nanog overexpressing esophagus,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Post mortem interval (hours): 28;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
HF0453_U133P2,pert
RE550_DU145_Un2,ctrl
db/db 16 wk 1,pert
gender: male;	disease state: healthy;	tissue: peripheral blood;	cell type: white blood cells;	sample type: matched control,ctrl
siRNA Smc3 + Estrogen [N2],pert
cell line: Hep3B;	treatment: transfected with YAP-specific siRNA,pert
"P60_C-DGCR8 KO cones, replicate 1 [array]",pert
Liver sample from Alcoholic hepatitis group (CA47),pert
Wild type no tumor 1,ctrl
erStress_twins_AA_1744twin1_500nM_thapsigargin_4h,pert
control_32hr_rep2,ctrl
strain: FVB/N;	tissue: Skin;	gender: female;	age: E17.5;	genotype/variation: Ovol2 overexpression (Ovol2 BT),pert
clone type: AtT20 clone types infected with empty vector rep3,ctrl
GIST_KIT_10,pert
subject: 18;	disease: TD;	muscle: ST;	gender: F;	age: 17.4;	gmfcs: N/A;	popliteal angle: N/A,ctrl
VCaP/MYB siRNA,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 27,ctrl
UC-33-un,pert
mouse cerebellum at P7 knockout 2,pert
cell line: HCT116;	clone: 15;	genotype: Wild type,ctrl
race: caucasian;	age (years): unknown;	stage: IA;	grade: 3;	histology: papillary serous,pert
PGA-RMM-30m-2aA-s2,pert
tissue: Liver;	genotype/variation: Hmgn1+/+;	treatment: injection of 10 µg/g body weight of N-nitrosodiethylamine,ctrl
umbilical cord_bpd: 5C,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 47;	gender: male;	tumor grade: IV,pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G diet for 14 days,ctrl
"CA2, SOX17 expressing HESC - clone2",pert
Individual_4992_NN_sample,ctrl
T30 U133p2,pert
PCOS Endometrium Epithelial Cell_119.PC11_EpCAM,pert
FRD1 3,pert
Isolated PBMCs from diabetic male patient_Grape extract group_12 months,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 2",pert
HCC_15N,ctrl
"ACI strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
"Control_EHL, C4",ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 45;	age-at-onset: n/a;	geographical origin: Vila-Real,ctrl
MCF-10A_shCHK1-4,pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
MiaPaCa2 pCEP4 - AGR2 clone 2,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID143,pert
NL B,ctrl
NHE3-/- replicate 1,pert
Control Day0 (451R),ctrl
platelet_Ctrl_12,ctrl
"cultured human airway smooth muscle, 4 hour dex treatment, replicate 1",pert
"Strain: C57BL/10J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle Treated with Phosphate-Buffered Saline, Deficient in Dystrophin",ctrl
H69_TGX221_3,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Post mortem interval (hours): 18;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
cell type: myeloid monocytic cells;	protocol: 28h medium,ctrl
WT STR PDE10i 12,pert
Mouse E10.5 urogenital epithelium -/- #2,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu3,pert
"Cultured ovarian cancer cell line CH1, Cisplatin treated",pert
genotype/variation: Pou4f1+/+;	agent: control virus;	tissue type: fetal liver,ctrl
MDS patient 48,pert
"Muscle from DS, biological rep1",pert
"Human male subjects with familial combined hyperlipidemia (FCH), peripheral blood monocytes",ctrl
"Placebo treated, HIV-1 positive male, day 14 (8)",ctrl
Left ventricle,pert
adult male,ctrl
"brain, cerebellum: RNA#36_le1",pert
ILD Study Number 1098,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: normal,ctrl
Whole testis RNA from WT mouse #147 at 0h,ctrl
A3_scrb,ctrl
"210, ADIPOOSE TISSUE, After",pert
Aortas isolated from vitamin E-treated APOE-deficient mice,pert
CD4_T_cell_pool_melanoma_M03+M04,pert
BATF_KO_P14_Naive,pert
HL60 cell line,pert
Trabecular meshwork tissue,pert
HeyA8+(1),pert
HCC018T,pert
CF knockout HMCF CHN310,pert
CEM11_T2_PP_day0_038,ctrl
8 Weeks  Heart MDX rep 1,pert
BTBR-ob/ob;	Soleus muscle;	Age: 14 weeks;	Gender: Male,pert
CDF1-p3 (179msn),pert
Female - caucasian - N-05-M,ctrl
T40899,pert
patient: 4;	disease state: hypertension;	tissue: Atheroma plaque,pert
Liver endothelial cells,ctrl
Primary epithelial cell culture from esophageal biopsies,pert
"Chromium 1 µM, biological rep1",pert
2933-ls,pert
5091212024_C,ctrl
age: 48;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 69, stage IIB, HPV 16",pert
Whole Brain,ctrl
autism with FMR1-FM AU039304,pert
MDA-MB-231_TR6194: transfected with a vector containing a shRNAs against CD146,pert
Empty vector control (RNAi 1B)_2of3,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#120,pert
Gender: female;	Age: 10 weeks,pert
Individual_5258_PP_sample,pert
TOV112D cells_untreated_biological rep1,ctrl
con-11_C,ctrl
B6 Control R2,ctrl
wild-type mouse 1,ctrl
Cochlea_WT_9mo_2,ctrl
PC12 line PFR3,ctrl
Infected Jurkat cells (replicate 3),pert
nucleus accumbens ctrl replicate 1,ctrl
striatum_wild type_6 weeks_replicate 2,ctrl
Chronic plaque 1 (CP1),pert
reduction mammoplasty patient 368,ctrl
Mouse Soleus 4 weeks post birth,pert
untrained wt,ctrl
WT1(-KTS) expression induced for 4 hrs 01-14-03_Lee_U133A_4_2,ctrl
Against CDK19-2 rep2,pert
"MCF7/BUS, 100 pM E2, 48 hours, biological replication 1",pert
Mtb infected-42d-6,ctrl
IFN_Gamma_24hr_rep4,pert
"ALL_NDS, K61 011509",ctrl
"expression at 16hr, bio rep1",pert
"Deltoid, FSHD, cohort 12, subject 12B",pert
ES2 COUP-TFII-5 25nM,pert
duration of untreated disease in month:6.1;	age at onset:1.8,pert
GFP (control) shRNA-transfected ES cells in ES cell culture,ctrl
"Wild type, biological rep 3",ctrl
mutant_POST_PDE_046,pert
V5-P522,pert
Hodgkin lymphoma cell line,pert
NOD/LtJTCE liver sample batch 4,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 13,ctrl
CDKI-73 CLL3,pert
cell line: OVCA420;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Endometrial stromal cell - control/vector 1,ctrl
Muscle JDM (YJD-JDM-6UA-s2),pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M1;	flt3 status: WT,ctrl
Wild-type CS_12_29_1_WT_1,ctrl
"BMMs, untreated control, ko, Replicate 2",pert
"twin pair: #12;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID215,pert
Normal esophageal epithelium (N5),ctrl
Native-0-5,ctrl
Day: 18; Drug: Saline; Phase: Withdrawal; Replicate: 3,ctrl
WT #1,ctrl
Conditional Sample 3,ctrl
12_MLN8237-3,pert
293TsiScram-1,ctrl
Flp-In™ 293 T-Rex,pert
01N0Y: new onset sJIA,pert
NB4 CONTROL 2,ctrl
TP06-987,ctrl
C4 patient,ctrl
INHA1,pert
"Cervical cancer cell line, ME-180, Human, squamous cell cancer",pert
Group3: 6 days differentiated Flk1+ WT ES cells,ctrl
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: lung",pert
disease state: endometrioma;	patient: 6,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 48 yr;	population: white;	dsm-iv: 296.7;	age of onset: 33 yr,pert
DS1-iPS 3,pert
WT Littermate2,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 14 months,ctrl
Cardiac Muscle_WT_rep3,ctrl
Skinbiopsy_7hoursnickel_controlsubject_k3,ctrl
Healthy donor_biological replicate5,ctrl
"human failing LV myocardium, Ischemic8",pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 2, Units of Harvest Time Point: hr",pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 8,ctrl
control MLL_00106,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M1;	flt3 status: WT,pert
"DMD skeletal muscle, biological rep8",pert
10.5 months cardiac muscle,ctrl
affected status (disease state): IS patient;	gender: female;	age-at-examination: 47;	age-at-onset: 43;	geographical origin: Vila-Real;	clinical characteristics: Hypercholesterolemia,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
Subject 10_t=30days_resveratrol,pert
jos1983,pert
9P-M4-ND,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.08;	RNA Integrity Number: 9.1;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
Human polymorphonuclear (PMN) leukocytes,ctrl
"treatment: control;	batch: 4;	donor: 30;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
RNA from microdissected breast cancer cells from case 607 labeled with Cy5,ctrl
SCC2,pert
del337TR replicate 6,pert
n03,ctrl
Muscle PCOS 24,pert
BxPC3-WT rep 1,ctrl
T5A-LU,pert
PGA-MAH-HeJO3-1aAv2-s1,pert
Huh7 cells_Mock Infected 24 hours_ rep1,ctrl
age: 20;	sex: M;	disease status: Marfan subject;	Filter number: 85;	Usage number: 4;	Exposures: 3,pert
Healthy control c9,ctrl
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14465;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
fluorescent activated cell sorter (FACS)-selected cells,pert
"brain, cerebellum: RNA#31_le1",pert
TP02-478,ctrl
Untreated WT,ctrl
"A673 treated with DMSO vehicle control for 24 hours, biological rep4",ctrl
shScr replicate 2,ctrl
A HID B_B091,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
Individual_4616_PN_sample,pert
"B cells, transgenic, stimulated",pert
"BOEC, not_at_risk 8",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M0;	flt3 status: internal tandem duplication (ITD),ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 2,pert
GFP_Untreated_6hr,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous saline challenge""",ctrl
FVB 129 mice were used as bone marrow donors,pert
scram_hi_9,ctrl
"5-FU-primed bone marrow mononuclear cells, Evi1-transduction",pert
tissue: heart;	genotype: CRE;	age: 8 week adult mice,ctrl
"GI_canc, Duo1",pert
PGA-lv_48h_519,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 25;	gender: male,pert
sampleID: SAM630131;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
RNA prepared from fibroblast cell lines treated with 10% serum for 90 min,pert
"Cell type: endothelial, age:44, gender:male, diagnostic group: schizophrenia, PMI:9h",pert
Papilloma_tumour_epithelial_cells_CTRL_rep3,ctrl
50uM_Zn_2,pert
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with vehicle for 6h,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: HTH83 LAMC2 shRNA;	cell line: HTH83,pert
platelet from sickle cell patient,pert
Strain: J1 Cell type: mouse embryonic stem cell,pert
"Mouse heart, control, replicate 1",ctrl
Sedentary-21,ctrl
"Rat liver, treated with DMN, 15 mg/kg in water per orally, extrated 48 hours after treatment, biological rep4",pert
"Monuron-treated NRK-52E cells at 72h, biological rep 1",pert
A YOKE_B093,pert
Esophagus TG replicate 3,pert
0982-01-c,ctrl
"Amoxicillin treated Proximal, Small Intestine 1 21 days old",pert
H30 Ctrl 6h 4,ctrl
Cancer 4,pert
wild type mouse retina at age postnatal day 2,ctrl
Mononcyte-healthy-untreated-2,ctrl
affected status (disease state): IS patient;	gender: male;	age-at-examination: 68;	age-at-onset: 66;	geographical origin: Mirandela;	lifestyle characteristics: ever drinker,pert
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,pert
chip number: 17;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.54;	rin: 9.6;	transfection date: 2012-03-26,pert
ic7 -- cell line 1 treated with APF#2,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET2 transcript,pert
disease state: paediatric glioblastoma;	age: 6;	gender: M;	h3.3_status: wt,ctrl
embryons of mice at 14.5 days.,ctrl
tissue: Embrionic stem cell line;	genotype/variation: Δexon2/+,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"Neural precursor cells derived from hES cells line VUB03_DM1, biological replicate  2",pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: DMSO,ctrl
MPA 2,pert
cell type: B-cell;	cell line: Pfeiffer DLBCL,pert
CAST/EiJ Vehicle liver sample batch 5,ctrl
Subtype: RA;	Karyotype: other,pert
"Postnatal day 11 Cerebellum, knockout for L1CAM",pert
Tetracycline-inducible glioma cells no dox 1,ctrl
KO Ang3,ctrl
E2_ethanol_96,pert
"p38alpha wild type fetal liver E15.5, biological rep1",ctrl
13 wt E11.5 heart,ctrl
HD1,pert
cell line: HEK-293;	genotype: NOD2 L1007fsinsC;	stimulation: Muramyl-dipeptide (MDP) 10 µg/ml;	time point: 0 h,pert
age: 51;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Control_R_-Dox_rep2,ctrl
M833 / Reference_13431198,pert
NonIR-WT_Rep2,ctrl
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.20;	Post mortem interval (hours): 10;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
gender: F;	age at blood draw: 58;	tissue: whole blood,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 2 hrs;	Drug: No Rosiglitazone present,ctrl
rtTA-Dmrt5_d7_-Dox_rep_2,ctrl
CDK9 Knock Down4,pert
"control, BA46-52",ctrl
Control replicate 3,ctrl
SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3,pert
H4-II-E-C3_low_rep2,pert
HUH-nonsense-#2,ctrl
GATA6 KO lung E18.5 mixed strain,pert
Spleen_infected_6weeks_rep2,pert
colon biopsy,ctrl
"Cadmium 0.2 µM, biological rep1",pert
E10.5 wt.2,ctrl
Z138-shControl.1,ctrl
Sample from retroviral MSCV-D1a infected cyclin D1 knockout 3T3 cells (line 12).,ctrl
A YOKE_B094,pert
Normal heart from MRL/MpJ strain,ctrl
"Ulcerative colitis patient, biopsy taken from the colon, no macroscopic signs of inflammation.",pert
PGA-MAH-AJ_PBS24h-3aA-s2,ctrl
CD3-purified cells from normal peripheral blood sample. >95% purity,ctrl
3025-lcm,pert
"G42 cells from Cerebellum, Mecp2 null, biological replicate 3",pert
age	24;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	4.7;	hemoglobin (g/dl)	14.2;	platelet count (/nl)	192,ctrl
"Tg brain, biological rep2",pert
brain wild type replicate1,ctrl
patient: 256;	current medication: None;	birth date: 10/16/44;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 4/1/05;	diagnosis date: 6/2/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 10;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
DNGH-4,pert
lung_CLP_wildtype_rep2,ctrl
Neonatal mouse ovaries cultured in4-Vinylcyclohexene Diepoxide (50uM),pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: B,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 days;	Tissue: kidney,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 428,pert
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.7;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
RTX6 T12,pert
"3mg/kg/day PFOA, Rep 3, Block 5, lung (low dose)",pert
BCR-ABL1-control rep 3,pert
cell type: R1 mouse embryonic stem cells stably transfected with shRNA mismatch control sequence,ctrl
INS-1 cell line #5a with induced HNF1b mutant P328L329del,pert
PGC-1alpha -/- differentiated brown fat cells expressing a siRNA specific for PGC-1beta knockdown (rep2),pert
liver biopsy sample,ctrl
diet: LRD-5001,ctrl
midbrain_wild type_6 weeks_replicate 3,ctrl
HeLa cells were treated with the siRNAs for 72 hrs,pert
cell line: MCF-7 breast cancer cell line;	agent: estradiol (E2);	time: 3hr,pert
minor HCC2,pert
"Mouse liver tumoral tissue, MAT1A knockout, hepatocellular carcinoma, 15 months",pert
"Male, 26 years old, HIV infection of ~5 months",pert
MCF7 cell line _vehicle (control)_biological replicate 3,ctrl
healthy control sample x097,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 51 yr;	population: white;	dsm-iv: 295.9;	age of onset: 23 yr,pert
PDAC_2,pert
strain: C57BL/6;	genotype/variation: Ret Deficient;	tissue: whole embryonic kidney;	age: gestational day 12.5 (E12.5),pert
"Patient  B, lesion, 12 week",pert
OVCAR3_rep1/CD157_norm,pert
tissue: Hippocampus;	age: 2-3 months;	genotype/variation: IκBαfl/-,ctrl
chip number: 18;	transfection plate: 4;	target gene: IRF7;	kd level: 0.71;	rin: 9;	transfection date: 2011-10-17,pert
"GFPMYC negative GC B cells, Biological replicate 1",ctrl
CF (D508) subject11,pert
"BMMs, untreated control, wt, Replicate 1",ctrl
tMLL03,ctrl
Muscle-5 month-wild type-technical replicate 2,ctrl
age: 6 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
Sarcoma cell line  - Dicer Heterozygote -rep2,ctrl
"breast tumor epithelium,12",pert
"SLE patient, 1024V1",pert
INS-1 cell line #2b with induced HNF1b,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 50;	gender: male;	tumor grade: IV,pert
P0 - nudel129s6 1,pert
neocortex-30 months of age-control diet-biological replicate1,ctrl
HSC-3 cell line with control vector,ctrl
CD8-IGF1R 3T3 A-928605 3,pert
"NB4 cell line, wild-type, ATRA, 72hr",ctrl
"Normal diaphragm 2, 8 week",ctrl
Whole adrenal RNA from Crem-/- mouse #2 at 0h,pert
male_alcoholic_351,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L010,pert
F-IIP(UIP)4_Cy3,pert
"Patient  F, lesion, 1 week",pert
liver_wild type_24 weeks_replicate_2,ctrl
knockdown: BAP1;	cell line: 92.1,pert
GIST_PDGFRA_1,pert
Run3.aUa.010110d.SkMDbt1137D.CEL-DB stimulate,pert
10L,pert
WT HPC Veh 1,ctrl
KO HPC Veh 28,pert
cell line: MCF-7 breast cancer cell line;	sirna: ER siRNA;	agent: control (vehicle);	dose: n/a,pert
erStress_twins_AA_1717twin2_500nM_thapsigargin_4h,pert
S/LV2,pert
BAL_3_A1B0,ctrl
"C2C12 myoblasts, treated with 50 mM sodium pyruvate for 72 hr",pert
MycCap prostate cancer cells,pert
THRB bN mutant + T3 replicate 1,pert
Amoxicillin treated Colon 1 21 days old,pert
Whole lung tissue_early IPF_biopsy,pert
COLO829_shMITF_DMSO_A,ctrl
CD4DecTp1-3,pert
MCF7 Argyrin A treated 24h,pert
"Nickel 140 µM, biological rep3",pert
CA1 NoCre Sox7I,ctrl
MSE_D_540,pert
WT1(-KTS) expression induced for 12 hrs 01-14-03_Lee_U133A_12_2,pert
Ngn3 EB3 OFF replicate 2,pert
strain background: mixed;	tissue: retina;	Stage: E14;	onecut genotype: OC1-KO,pert
T141 U133p2,pert
dental pulp cell from control 1,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: doxycycline,ctrl
12h control (1);HT-29;colon:carcinoma;NONE;42994,ctrl
A2_LEF1,pert
"age at diagnosis: 60;	diagnosis: Adenocarcinoma of breast, lobular;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 1;	pgr: NA;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
N/SM5,ctrl
whole tissue section from case 1368,ctrl
"E18.5 brain, Meg3 knock-out, rep 4",pert
Frontal_Cerebrocortex_Deltamethrin_0.3mg/kg_6hr_rep8,pert
"rat, hepatocellular carcinoma (DEN 50mg), treated with vehicle (week 18)",ctrl
WT-CD80hi-mTEC-sample1,ctrl
PGA-HMO-MObese-3aUA-s2,pert
14-week-old WT liver_611WT,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 4,pert
cell line: LNCaP;	overexpression vector: GFP,ctrl
CTRL_3_GMP,ctrl
N5_Cy3,ctrl
"Brain tissue from Fisher 344 male rat, Animal #246, control (0mg/kg) D-Serine",ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 4",pert
control participant P332wh (human CD3 positive T cells),ctrl
Retina wt/wt rep3,ctrl
Gastrocnemius Muscle mdx AAV-Galgt2-Treated rep2,pert
"Liver, Normoxia 2",ctrl
"112, ADIPOOSE TISSUE, Before",ctrl
liver_STZ 0.1% quercetin diet_rep3,pert
brain_OFC_bipolar B_mr233,pert
Tolerizing allografts 7 days No.3,ctrl
Squamous cell carcinoma 018,pert
Panc-1 Ctrl 1,ctrl
"Cell type: endothelial, age:34, gender:male, diagnostic group: control, PMI:22h",ctrl
Adult Tg mouse whole brain,pert
ND_2,ctrl
35/1-22 - Dox +48h E2_1,pert
cell type: embryonic stem cell;	genetic background: C57BL/6;	genotype: wild-type control,ctrl
platelet_sickle_11,pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: wild type;	agent: Akt inhibitor AktI-1/2,pert
tibialis anterior Muscle homo,pert
epithelium from colon of control mouse no.2,ctrl
PTC BRAF wt 9,pert
"medulloblastoma, M2_scrambled, rep3",ctrl
LOX1 Untreated 12hr 282295773,pert
midbrain_Pink1 knockout_6 weeks_replicate 1,pert
T40645,pert
Normoxic Control N1,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 8 hours,pert
"HUVEC infected with Control Vector , biological rep1",ctrl
Nerve_Diabetic_Vehicle_706,ctrl
5201 Normal Uninflamed sigmoid colon,ctrl
"Lesion Skin, LS-26",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-sp3,pert
triplicate 1 of S. aureus infected HepG2 nt cells,ctrl
MPM tumor specimen 22,pert
4140-3 E2F3 Heterozygous,pert
cerebellum_WT_12w_rep1,ctrl
LICR_HN1_CETU1,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 28;	maternal age: 27,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,pert
tissue: skin;	individual: Patient P6;	condition: AL;	eczema severity: SCORAD: 70,pert
GM19238_Kd_NFYC_2,pert
WILDTYPE cerebellum at 18 weeks,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: Brd4 shRNA,pert
Control (C83),ctrl
Healthy control c8,ctrl
35B,pert
CD4DecTp1-7,pert
strain/background: mixed B6/129;	tissue: thymus;	cell type: CD4+CD8+ thymocytes;	genotype/variation: Dicer lox/lox control,ctrl
NPC_SA01_3,ctrl
PC-3_basalhTERT_ShortTelomeres_mock_4,ctrl
GC resistant clone C7H2-R3B5 treated for 6 hours with GC,pert
BALB/cByJTCE liver sample batch 2,pert
CD-45-un,pert
wt-Gfp P10 replicate 4,ctrl
Subject #8039-2d Postinfection,ctrl
PsOEt-23-Week 1,pert
Heart_caAkt_01,pert
siIPMK + MMC experiment 3,pert
tissue: Liver;	strain: C57BL/6;	genotype/variation: PXR+/+;	treatment group: vehicle 0 mg/kg,ctrl
"alveolar macrophages, non-smoker 019",ctrl
agent: ConA;	time point: 1 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"SRF silenced, treated with EtOH, biological rep 2",pert
"MaF pre-iPSC9P2, Vc+, D4",pert
UM15_Mtu_rep2,pert
"IGF-treated cells (3hr), biological rep1",pert
Abca1 +/- ES cell line,pert
S46 NLS 142Q TG1	F5/2	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Male,pert
ApoD knock-out,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 41.5589,pert
Oga_WT_MEF_E8_rep1,ctrl
A549 DAC 0.3 uM (3219),pert
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
CD34+ cells with fenretinide treatment from CML33,pert
EUR12_T4_PP_day3_046,pert
"TGCT cell line 2102Ep/clone 2A6, untreated, undifferentiated",pert
Human Non-progressor HIV Sample L134-CD4+ T cells,pert
LRRK2 (G2019S) heterozygous fibroblast sample 1,pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 24 months;	genotype: Myc heterozygous,pert
"Crohn's Disease subject (34 year old caucasian female, SAK_1288197141)",pert
HT29 methotrexate-resistant cells,pert
midbrain_Pink1 knockout_18 month_replicate 3,pert
cumulus_PCOS_Obese_rep5,pert
RNA from HCC_3T,pert
06R016 Control,ctrl
Sample: alpha-TM180;	Replicate: 3;	Pool: NP,pert
RNA-DHL4-R406-2H-3,pert
human adenoid cystic carcinoma grown as xenograft in mouse host,pert
"fetal testis sample 18L, 22 weeks gestation",ctrl
Primary hepatocytes isolated from SV129 mouse strain treated with DMSO for 24h,ctrl
Turner_AF_4,pert
(ca)erbB-2_3,pert
sample type: Primary culture of typeII cells collected from SPC WT lung (adult);	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C WT;	genetic background: 129S6/SvEvTac,ctrl
Liver sample from Control group (N52),ctrl
Cardiac Muscle_mdx_rep1,ctrl
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
tissue: lesional skin;	urticaria status: affected;	patient: 4,pert
Diagnosis: MDS/AML;	Age: 53y ;	Gender: Male;	Blast %: 77;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
"Dicer lox/lox control, biological rep2",ctrl
Rejecting allografts 7 days No.3,pert
"human failing LV myocardium, Ischemic6",pert
cell line: HL-60;	shRNA construct: Scrambled Control,pert
CON - LV21,ctrl
Normal skin 2,ctrl
"human failing LV myocardium, Idiopathic41",pert
YFP-pos GMP Dicer het rep2,pert
Time 0 mins rep 1,ctrl
microdissected breast cancer cells from case 1047,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 35;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 80;	tissue: Blood,pert
Pt_1 Normal Skin,ctrl
"left ventricle,Hsp22 KO,basal condition",pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of saline for one week,ctrl
"Retina from control mouse at ZT6, biological rep 3",ctrl
XpO18,pert
atopic eczema P9,pert
HepG2_Sb rep2,pert
liver_Wt_8wk_rep3,ctrl
NIXKO3 SPLEEN,pert
diagnosis: NSIP;	fvc-group: FVC2;	tissue: lung,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P90;	genotype: Igf1 +/+,ctrl
RTX7 T0,ctrl
Y VIS _B029,ctrl
52_129_KO,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: other,pert
S2_sham_overexpressor_12,pert
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 4 - Technical Replicate 2,pert
Bone-Marrow_MM_M1037,pert
CEPI_II_367,pert
A9_C9_nasal_stem_cell_rep1,pert
tissue biopsy of urticaria lesion from CIU patient,pert
"CD8 DC, KO",pert
cells_ATCC 16Lu_human lung fibroblasts_JCB_0_1_31_Lung_Fibroblast_control_HG-U133A_2_IMFRT0014,ctrl
MPM tumor 13,pert
cell type: primary p53-null neural stem cells;	retroviral expression: vector,ctrl
EP3_adipose_control,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.4;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
MCL_IGHV_UNMUT (R1332),ctrl
PancreaticSample34-Tumor,pert
ko 13.5d replicate 7,pert
HEL cell line_Control shRNA (GFP),ctrl
"WT C57BL/6 mice, liver, 10-12 weeks old, sacrificed 2 hours after 85% liver resection",ctrl
Expression data from liver of the KRAP deficient mice (KO3),pert
Mut+/- rep4,pert
"WM35, 48h treatment with 5 AzadC",pert
tissue: Breast adenocarcinoma,pert
colonoscopic biopsy from adult with affected colon from adult with INF,pert
"LCL GM19238, Kd YY1, 72hrs",pert
P32_WT_pancreas,ctrl
Trasnsformed Lymphocytes Bipolar Disorder Affected Twin Pair 3 (DCBD3.1)(TP9),pert
CD-51-un,pert
"ID:10-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
EP37_adipose_control,ctrl
"patient 028b, cancer, homogenized",pert
cell line: HepG2,pert
MCF7_EtOH_24h_rep3,ctrl
217/0,pert
"control, BA46-79",ctrl
RatLung_H16h_1,pert
3799-lcm,pert
"seminoma specimen, pT1, pN1, patient age: 34y; W99 113",pert
Extract:LOX-1:213402;	Extract Description:LOX1_Untreated_12hr:213402;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.55;	Quality: Background Mean Dev.:0.39;	Quality: Absent (%):57.62;	Quality: Absent (%) Dev.:0.49;	Quality: Scaling Factor:0.55;	Quality: Scaling Factor Dev.:0.52;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213402;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295783,pert
microdissected breast cancer cells from case 655,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 58;	gender: male,pert
"control, BA46-56",ctrl
HEK293 cell line #1 with induced HNF1alpha,pert
GhrhKO_004,pert
"cell type: Human mammary epithelial cells infected with retrovirus carrying hTERT and the oncogenic allele of H-Ras, H-RasV12 described in (Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65)",pert
"control, BA46-38",ctrl
GM19238_Kd_ARNTL2_3,pert
hNHEPS human hepatocytes exposed to 10 μM VX 6 h after exposure,pert
cell type: embryonic fibroblasts (MEFs);	genotype: wild type,ctrl
HUVEC/NmenMC58_frpC/frpA_4h_rep1_1108,pert
Fetal heart control 3,ctrl
Tet2 KO CMP rep1,pert
11423 UC Uninflamed ascending colon,pert
Gastric_cancer_patient_8,pert
Cancer 5,pert
5922012008_E,pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep4",ctrl
Normal donor Lung,ctrl
NK_cell_pool_healthy_H09+H10,ctrl
"non-AD_HI, biological rep4",ctrl
cell line: SUP-B15;	tissue: Human B cell precursor leukemia,pert
"Patient 2, lesion tissue",pert
GFP Untreated 12hr 282295713,ctrl
"VPA 1, 4hrs",pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 72h",pert
platelet_sickle_2,pert
Mtb infected-42d-2,ctrl
GAS-n10-2; normal gastrocnemus 10 month,ctrl
U-87MG-V22 set 6,ctrl
"YWHAZ overexpressed CL1-0, biological rep1",pert
CRC_nodrug_F4862,ctrl
M833 / Reference_13425673,pert
CD4+CD8+ double positive (DP) thymocytes 3h medium treated,ctrl
5276 UC Uninflamed descending colon,pert
normal muscle replicate 5,ctrl
Array Type: HG-U133A_2;	Ratio: 1.96;	RNA Integrity Number: 9.8;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
"siCFIm68-2, biological rep2",pert
Age: 42;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
mouse_islets_ctrl_02,ctrl
3492-ls,pert
NOD1,ctrl
KU_46T,pert
cell line: SV589;	knockdown (days): 3;	treatment: no treatment,ctrl
age: 50;	sex: M;	disease status: control subject;	Filter number: 101;	Usage number: 1;	Exposures: 3,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 6 months,pert
Embryonic age 14.5 mutant rep2 (PKD1_65),pert
INSENS 3 4hr,pert
OE-OCT4_2,pert
strain: C57BL6,pert
"human failing LV myocardium, Ischemic62",pert
LECs from control rats 3,ctrl
LPS 3hr 1,pert
striatum_Pink1 knockout_18 month_replicate 3,pert
U133A_B2,pert
Liver TG replicate 1,pert
Type II cells from Nrf2-/- mouse.,pert
"BioBreeding DRlyp/lyp rat, day65, mast cells derived form pancreatic lymph node",pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: DBP,pert
Muscle-5 month-Myc heterozygous-technical replicate 3,pert
WT - Cre Untreated - 0 hrs - repeat 1 - Cy3 - mAdbID:61715,ctrl
patient id: 75;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 48;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0M0;	Stage: II;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.60;	Post mortem interval (hours): 11;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Well-differentiated human lung epithelial cells, un-infected for 36h",ctrl
PGA-MLS-RA-1aAv2-s1,pert
Experiment TOX3 transient transfection replicate 1,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14455;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
6 hr KLF4 Time Course Induced,pert
PGA-RMM-15m-3aA-s2,pert
"RORalpha1delDE, 3",pert
patient: 239;	current medication: Asacol Fybogel Amitriptiline;	birth date: 4/10/41;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/1/63;	diagnosis date: 12/12/64;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
tissue: lesional skin;	urticaria status: affected;	patient: 6,pert
treatment: naïve;	transgenic variant: FVB/N;	tissue: Caudate-Putamen;	genetic background: FVB/N,ctrl
CAST/EiJ Vehicle liver sample batch 6,ctrl
shRNA-PGC1a #65 rep-2,pert
SHR12-4,pert
"gastrocnemius-30 months of age, resveratrol diet-biological replicate5",pert
Sample ID:TP6;	Twin Pair ID:DCBD1.2;	Clinical Status:Control ;	Age of Onset:-;	Age at interview & blood sampling:55 ;	Current Age (2007):58 ;	Sex: Female ;	Medication at interview (duration) :None,ctrl
RNA from microdissected breast cancer cells from case 1045 labeled with Cy5,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: doxycycline,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: Wy14643;	time: 6h;	gender: Male;	age: 4 months,pert
cell line: PC-3;	treatment: none;	treatment duration: 0h,ctrl
"ALL_DS, K21 011509",pert
Control MEF 1,ctrl
8A;pretreatment;female;breast tumor; nonresponder,ctrl
cerebrum_WT_20d_rep1,ctrl
WT-sham-5 month-R1,ctrl
FMR1_4,pert
BCell_lymphoma_marginal_sample2,pert
KO SPC Type II 9_27_04,pert
"Neural precursor cells derived from hES cells line SA01, biological replicate  2",ctrl
genotype/variation: Fmr1 wildtype;	tissue: cerebellum;	gender: Female,ctrl
PKBa-/- MEF time 24 replicate 1,pert
NPC Brain 62d Mouse1,pert
Testis CREMKO 0h batch 1 [TeKOh00.6],pert
T5B-LU,pert
"wild type saline, biological rep3",ctrl
Severe rep5 (retina),pert
Control_pancreas_2,ctrl
GIST Pre Treatment Biopsy 36,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 110min;	race: White;	sex: Female,pert
liver western diet 0.05% quercetin rep3,pert
Skin_Lox_Control_Rep3,ctrl
cell line: MDA-MB-231,ctrl
individual: Control8;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
strain/background: A/J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: sham surgery,ctrl
EDL-t7-2; transgenic extensor digitorum longus 7 month,pert
27A;pretreatment;female;breast tumor; nonresponder,ctrl
LNCaP.FoxA1.4,pert
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: LSD1;	transfection time: 24h,pert
Elf4 KO1 naive CD8 T cells,pert
lesion_postUV_patient11,pert
MCF10A-Vector-rep1,ctrl
cell type: hepatoma cells;	cell line: Huh-7;	transfection: luciferase,ctrl
BP patient 111_biological replicate 2,pert
Dendritic cells generated from blood of donor 2 + A. fumigatus germ tubes,pert
"AML blasts from bone marrow (at diagnosis), wild-type NPM",ctrl
"Resveratrol treatment exp 3T3-L1 cells, CT1",ctrl
"The Identification of gene expression changes in human embryonic fibroblast cells, background. Sample C",ctrl
DC1 AM,pert
DH 1,pert
@52055800697862121408403718160371,pert
"age at diagnosis: 54;	diagnosis: Adenocarcinoma of breast, ductal, lobular features;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 15;	dfs-event: 0;	distant metastasis: 0",pert
microdissected epithelial cells from invasive cancer originating in IPMN 3,pert
Cell line MDA-MB-231_control_expt2,ctrl
HCC009T,pert
gender: female;	batch: 1;	age (years): 26;	patient id: Control_3;	fev1 (% predicted): 105;	fvc (% predicted): 115;	medication: None;	cell type: CD8+ T-cells,ctrl
"5mg/kg/day PFOA, Rep 1, Block 5, liver (high dose)",pert
Chronic active plaque 2 (CAP2),pert
patient: 16;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 42;	Usage number: 1;	Exposures: 3,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
KM_049N,ctrl
Fibronectin 1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 1,pert
"MLD, biallelic AML MLL_00230",pert
"fibroblast, MFS subject FB773 rep 1",pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
full differentiated 3T3F422A adipocyte,pert
"Normal subject (54 year old caucasian female, SAK_1289203312)",ctrl
liver_Pink1 knockout_6 weeks_replicate_1,pert
OV90-(2),ctrl
db/db 8wk 3,pert
HeLa cells treat with luciferase siRNA,ctrl
platelet_sickle_14,pert
"5mg/kg/day PFOA, Rep 2, Block 1, lung (high dose)",pert
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 2,pert
control participant P336 (human CD3 positive T cells),ctrl
GM19238_Kd_NS2_24,ctrl
major non-tumor4,pert
E14.5 cKO 1,pert
181C1,ctrl
MeCP2_4,pert
"MCF7/BUS, 60 pM E2, 48 hours, biological replication 2",pert
Against CDK19-1 transfected HeLa S3 cell,pert
CD8_Tcells_severe_asthma,pert
status: Slow;	age: 68;	gender: female;	tissue: cultured human fibroblasts,pert
220C3,ctrl
A HID I_B087,pert
Cervical Cancer C496,pert
APP_R6_rep1,pert
subject id: 39;	infection: DENV;	status: DHF;	tissue: whole blood,pert
No_drug_#4879,ctrl
ACC 3 cell line lacZ-RNAi replicate 2,ctrl
CF (D508) subject6,pert
"Primary aortic endothelial cells, Non_transgenic_control_1",ctrl
Psoriasis-3 baseline,pert
Carbo Day2 (352L),pert
lymphoma_7890_ADR,pert
"psoriatic epidermis, before phototherapy",pert
cell type: Primary hepatocytes;	strain: SV129;	agent: control;	time: 6h;	gender: Male;	age: 4 months,ctrl
"brain, lateral and medial ganglionic eminences: Arx+/Y #4_le1",ctrl
chip number: 3;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-03-29,ctrl
skin from mice,ctrl
KU_10N,ctrl
multiple myeloma (MM 513),pert
chronic lymphocytic leukemia (CLL 532),pert
"Wild type mouse aorta with placebo, biological rep3",ctrl
BP patient 56_biological replicate 1,pert
G392E_off_rep1,pert
"lateral prostate, PTEN+/- IKK2ca/ca epithelium, 12 months",pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G63,ctrl
"Pancreatic tumor cells, replicate 6",pert
scan batch: Batch 1;	group: autism;	subject age: 11;	paternal age: 24;	maternal age: 24,ctrl
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep4,pert
201/0,ctrl
3838M patient’s mucosa,pert
INS-1 cell line #1 with induced HNF4a2,pert
"GM9018, unaffected brother",ctrl
MDA-MB-231 breast cancer cells,ctrl
"Patient S-855-N, normal colonic mucosa",ctrl
Cochlea_D257A_9mo_4,pert
Liver_nash metformin_no.2,pert
H10_P_B1,ctrl
disease state: control;	patient: 4,ctrl
"Nickel 40 µM, biological rep2",pert
white blood cells,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4e;	flt3 status: WT,ctrl
Muscle control 7,ctrl
renal_vesicle_wild_type_5,ctrl
control_0530-1,ctrl
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: 0.3% Tween-20 vehicle,pert
"AD_TC, biological rep8",pert
primary human monocyte-derived macrophages,pert
race: caucasian;	age (years): 66;	stage: IB;	grade: 2;	histology: endometrioid,pert
KO 569 R4,pert
"Total colon, pooled sample",pert
"strain background: F2 of C57BL/6J and DBA;	gender: female;	genotype/variation: cbp+/-  (CBP deficient, heterozygous);	age: 3 months;	tissue: hippocampus",pert
H4bt5,pert
Six week old male C57BL/6 mouse with conditional liver p14 knock out.,pert
MPM tumor 29,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"spleen marginal zone B in WT, biological rep3",ctrl
MCF-10A shControl replicate 3 [set 5],ctrl
11094 Normal Uninflamed descending colon,ctrl
Biopsy 7 from cystectomy 5,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 39;	maternal age: 36,pert
human promyelocytic leukemia cells,pert
"AALE-Vector + shGFP, biological rep1",ctrl
RNA from RAW Cells,pert
"fatty (fa/fa), skeletal muscle (gastrocnemius)",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 24h",pert
"TLR4 null sham kidney, biological rep2",pert
The RNA samples from DHT 16hr treated LNCaP cells,pert
"SHR adrenals, replicate 2",pert
Embryonic age 17.5 wild-type rep3 (PKD1_38),ctrl
Bone-Marrow_SMM_S1313,pert
Normal Rat Retinal Müller Cells,ctrl
8DKD_SerumStarved_rep2,pert
"MEKi 4 days, biological rep2",pert
"FACS-sorted cones, P30 C-DGCR8 KO mice",pert
MCL_IGHV_UNMUT (R1897),ctrl
E12.5 Vax2-/- 2,pert
Control_2h_rep3,ctrl
CON28,ctrl
U937-shGSK3A-Construct5-rep2,pert
pediatric AML S21,pert
"Frontal Cerebrocortex, permethrin (10 mg/kg), 6 hours",pert
224 Day 3 siSC transfected biological rep2,ctrl
"whole liver, treated with IL-6",pert
3112-lcm,pert
disease state: sarcoidosis;	biopsy type: surgical;	tissue: lung,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.8;	choa: 88;	fata: 71;	eea: 1480;	wtkg: 67.1;	perfat: 21.8;	lbm: 50.8;	fat_mass: 1462.78,ctrl
Dicer KO replicate 3,pert
tissue: Gastrocnemius muscle;	genotype: KO;	age: OLD,pert
"ShamC-60, biological rep 4",ctrl
"Pool of three samples (n=3);;	cells: CD3+ T cells, peripheral blood;;	healthy volunteers; gender: two females, one male; age: 25 and 37 years old ",ctrl
01LLE: normal control,ctrl
25 uM cyfluthrin batch 1,pert
wt_P4_rep2,ctrl
Control LM2 Cell Replicate 2,ctrl
GM19238_Kd_CLOCK_1,pert
"Patient  N, lesion, time: 0",ctrl
MCF-10A shCHK1-3 replicate 1 [set 5],pert
C,pert
siPsmd14,pert
SBVGA3,ctrl
EE_IB_2_aa_lcm,pert
CP Pool,pert
Zucker rats,ctrl
Liver GPR120KO HFD,pert
P4_WT_3,ctrl
HTH83 LAMC2 KO 2,pert
healthy myeloid cells 10,ctrl
Mel,ctrl
"Tibialis Anterior Muscle, Desmin Knockout, Aged",pert
WT 0h TPA rep1,ctrl
age: 63;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
control_16hr_rep1,ctrl
"breast tumor epithelium,47",pert
Mammary gland R1 24 hr rep3,pert
12mo APPSw #2,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: mild;	Ig clonality: oligoclonal,pert
lean rosiglitazone-3,pert
LNCaP + R1881 rep 1,ctrl
CH1800,pert
D_Kin_3,pert
"DOCK8 knockout, thymic, NK1.1+ NKT cells replicate1",pert
healthy CD19 B cells 8,ctrl
ST045849 24 hours_2,pert
"Lymphoblastoid cell lines derived from family 1736, member 2",ctrl
pcdh12-deficient mice rep4,pert
SKM KO8,pert
ASC_morbidly-obese_biological rep2,pert
myoblasts-expt1_lentiDUX4short-rep2,pert
4A;pretreatment;female;breast tumor; not assessable,ctrl
muscle knock out replicate1,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 24;	gender: male,pert
PDAC_P_117,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 3,pert
pMX-Oct4 and pMX-jhdm1b no vitamin C O+Jhdm1BVc-_1,ctrl
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of saline for one week,ctrl
High weight gainer KOZAK2_ABI_HYP_H4,pert
CD8 KLF13 KO 1,pert
Individual_3171_PP_sample,pert
"Untreated wild-type NB4, biological rep3",ctrl
Syracuse Low Avoidance (SLA) learning rats 1,pert
Thyroid_ papillary carcinoma 69,pert
SIRT4 KO liver_7232,pert
0810A-01_scrambled control-1,ctrl
wt 13.5d replicate 2,ctrl
cell type: primary human monocyte-derived macrophages;	differentiation factor: CXCL4,pert
ILD Study Number 1040,pert
patient2,pert
chip number: 14;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.1;	transfection date: 2011-10-17,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 7 days;	Tissue: kidney,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 79;	Usage number: 5;	Exposures: 3,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 5,ctrl
"1mg/kg/day PFOA, Rep 4, Block 1, lung (low dose)",pert
"SKO-transduced MEFs, Vc untreated, lysed on D3",ctrl
WFS1 KO USHT_15_329_wt,ctrl
ColonTumor022KAFBT_cta.txt,pert
"Pten WT/null epithelials cells, biological rep2",pert
MCF7_ARC_Array_1,pert
"DMSO Control after 2hr, replicate 3",ctrl
strain background: C57BL/6;	genotype/variation: WT;	infected with: ME49 strain of T. gondii;	time point: at day 5 post-infection;	tissue: ileum,ctrl
CAR.KO_phenobarbitol_rep2,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 56 yr;	population: white;	dsm-iv: 296.54;	age of onset: 28 yr,pert
BJ-iPSC_1,ctrl
PPAR KO_ctr_115,pert
Normal Puerto Rican control 2,ctrl
"hippocampus, CC",ctrl
Control_7,ctrl
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with 100 nM T3 for 6h,pert
fibroblast_Rapid_D10_Media_13,pert
SLE CD19 B cells 5,pert
tissue: Hippocampus;	age: 87;	Sex: F,ctrl
"atRA WT, set 3",pert
control siRNA rep2,ctrl
T-REx293-NPAP1-induced-2,pert
BxPC3_Ctrl_rep2,ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
V5-P463,pert
APOE_KO_RAGE_KO_DM_9W_9,pert
Control 25,ctrl
cerebellum_Pink1 knockout_24 weeks_replicate 3,pert
Cre_day_7-1,pert
Pool Eu_P15,ctrl
sample: #20;	subject: PD case #1;	brain: T-9;	age: 74;	sex: Male;	region: Inferior olivary nucleus,pert
"Lesion Skin, LS-25",pert
"human failing LV myocardium, Ischemic78",pert
mature Ly-6G+ thioglycollate-elicited peritoneal neutrophils,pert
Murine Heart Apex,pert
Individual_999027_NN_sample,ctrl
"brain, cerebellum: RNA#6S_le1",ctrl
Kidney_saline_3,ctrl
fat_Akt1+/-_8wk_rep2,pert
major non-tumor10,pert
"HEK293 stably EWS-FLI1-transfected, clone",pert
wild-type MEF 3,ctrl
J_LS_Wk2,pert
female_control_393,ctrl
NSC miR-Control 2,ctrl
nmMLCK-/- -SB replicate 2,pert
"Hdh knock-out embryonic stem cells, biological replicate 4",pert
tumor cell line HepG2 with knockdown of HIF-1α rep2,pert
Nrl ko P10 replicate 3,pert
PPARg WT macrophages rep 2,ctrl
WT AA 2,ctrl
non-treated WT_rep-3,ctrl
"Pten null, biological rep1",pert
Hippocampus_Soman_1h_rep2,pert
"GATA6 knockout, biological rep 1",pert
clone type: AtT20 clone types treated with NSBP1 siRNA rep 1,pert
WT_liver_vehicle 0 mg/kg_96 hr_2,ctrl
MCF7 cell line_resveratrol_250mM_biological replicate 2,pert
01L4N_CTRL,ctrl
"Embryonic cerebral cortex, Trnp1 knockdown, biological replicate 2",pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 12h",pert
Csbm/m Mouse_cerebellum_Young_saline treatment_Replicate-1,ctrl
e4 Ez f/wt,ctrl
CD8+_Tcells_healthy_donor_6,ctrl
rd1_P8_rep3,pert
"Toral RNA, commercial",ctrl
tissue: adipose tissue (epididymal);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
Gene expression profiles of Lkb1 WT #6 HSCs,ctrl
Kidney_Biopsy_Liver_Disease_8,pert
PKBa-/- MEF time 6 replicate 4,pert
Hep G2 treated with Mercury (II) chloride,pert
age: 21dpp;	genotype/variation: wild type;	tissue: testis,ctrl
KO - 3 mo - repeat 2 - Cy3 - mAdbID:74594,pert
SeroNeg-7,ctrl
"primary cortical neurons, naïve",ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 40 yr;	population: white;	dsm-iv: 295.9;	age of onset: 21 yr,pert
S46 WT5	F5/53	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
Normal-ERα-positive breast cancer 59,ctrl
C57BL/6 heart left ventrical,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-tu2,pert
Trasnsformed Lymphocytes Bipolar Disorder Affected (Affected pateint of MZ twin pair 1),pert
cell line: A2008;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
chronic lymphocytic leukemia (CLL 529),pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_1mM_HG-U133A_2_YCHSUP501,pert
"EBF1 d0, rep 2",pert
"BMMCs from NTAL WT, pLKO.1 infected, nonactivated, biological rep3",ctrl
untreated_6hr_rep3,ctrl
Emd KO male 6,pert
PBMC from TB,pert
knockdown Tcof1 [B],pert
RE550_KPL4_6-Medi5117,pert
strain: C57BL6;	genotype: WT;	tissue: hippocampus;	treatment: vehicle control,ctrl
"human failing LV myocardium, Idiopathic34",pert
V5-P052,pert
Mock infected murine liver-MO30k-(272)-6hpi,ctrl
4mo wt10,ctrl
A VIS _B097,pert
Rybp#10 (OHT-)_4d_rep1,ctrl
IRF4-mut_Th17_cells_42hr_rep3,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P9;	clone: 0,ctrl
"breast, post AFI treatment (H19_1935)",pert
male JAK2 KO liver sample 114,pert
LDLR_LF_1,pert
KPW13_T6_PP_day14_054,pert
subject: 1;	disease: TD;	muscle: GR;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
"vehicle treatment, 24 hour time point, biological replicate 2",ctrl
"mouse aorta cross strain comparison, C3H_T08_NC_03",ctrl
"ID:1-2, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
subject: 22U;	cohort: 22;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 60kb;	age (y): 43;	Sex: F;	batch: Batch_5,ctrl
NEO-1_HG-U133_Plus_2_Rep2,ctrl
coc-42_C,pert
strain: 129/Sv;	genotype/variation: wild type;	tissue: madibular condyle cartilage,ctrl
tissue: glioblastoma xenografts,ctrl
KU_50N,ctrl
hNHEPS_0.1 μM_6 h_rep3,pert
deletion in 337TR,pert
Pit-1 mutant (Snell) resulting in long lived dwarf pheontype,pert
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
Peripheral Blood,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.435;	OD280: 0.745;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 287;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
SUM149_siControl_rep3,ctrl
60 day LAD ligated heart from MRL/MpJ strain,pert
13P-ER-ND,pert
"eye, cornea",ctrl
WT9,pert
"Control Day 2, biological rep1",ctrl
3986-lcm,pert
"experiment 2, control 2",ctrl
MDS patient 11,pert
"WT in the absence of tetracycline, rep1",pert
"HCT116 cells with empty vector, technical replicate 1",ctrl
HNF4 Null_61,pert
"NPCxhIPSC CON, replicate 1",ctrl
Eed KO J1 ESCs on day 3,pert
Runx1  knockout,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 19.758;	Ratio: 2.11,pert
cell line: U2OS;	treatment: shControl,ctrl
Sorted DN2 cells from fetal thymus,pert
genotype/variation: C56B/6 and CD-1 mixed;	strain background: wild type;	age: E9.5;	tissue: E9.5 embryos;	microdissection: posterior second heart field,ctrl
H3 Ctrl 2h 3,ctrl
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus_WT-POU_82",pert
sample: #2;	subject: Control case #1;	brain: T-199;	age: 82;	sex: Female;	region: Inferior olivary nucleus,ctrl
"strain background: C57BL/6J;	genotype/variation: IRF4 -/-;	tissue: spleen;	cell type: Naïve CD4+, CD62L hi, CD25 - T cells;	differentiation condition: Th17;	timepoint: 42 hrs",pert
erythroblast transduced with shZBP-89,pert
11379 Normal Uninflamed ascending colon,ctrl
LKR13_Kras sh-3,pert
Teratoma 0691,pert
MDS patient 129,pert
"MTDH knockdown, biological replicate 3",pert
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 3;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
ANL Chip#36,pert
quadriceps_muscle_Akt1+/-_female_8wk_rep2,pert
Bronchial Epithelial Cells MMA biological 2230B,pert
non-malignant FTEn_patient 12,ctrl
siCONTROL + MMC experiment 1,ctrl
"Typically Developing Control, Semitendinosus, Patient Replicate 8",ctrl
WT tumor DNA II,ctrl
OSCE-4T,pert
phenotype: control;	gender: female;	case_id: 299;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 23;	brain ph at time of freezing: 6.65;	labeling_batch: 2,ctrl
minor HCC4,pert
"Wild type mouse aorta with placebo, biological rep4",ctrl
Control_6,ctrl
WT-sham-5 month-R2,ctrl
genotype/variation: Snf2h lens-conditional knockout;	strain: C57BL/6;	age: newborn,pert
"human failing LV myocardium, Ischemic71",pert
Control Day0 (356L),ctrl
cell line: Abelson B cell line,ctrl
CH1810,ctrl
Liver_TAK1KO_Rep5,pert
normal B lymphocytes (NBL 005),ctrl
t05,pert
H1299 AZA 0.3 uM (3228),pert
MLL_PTD06,pert
Aldosterone-producing adenoma (APA11),pert
brain_DLPFC_bipolar B_mr403,pert
G016,pert
N66s1,ctrl
224 Day 1 siMut12 transfected biological rep3,pert
RAW_0mM_HOCl_#1,ctrl
U2-OS-ERa vehicle control 1,ctrl
Control subject 39_biological replicate 1,ctrl
B6_pseudomonas_overexpressor_422,pert
CCI 14d replicate 1,pert
Peripheral blood mononuclear cells (PBMC)-Patient GM T0,ctrl
"Embryonic stem cells, untreated",ctrl
Plate vs. Nail:  No Fracture,ctrl
Adipose from a 24 month old wild type mouse,ctrl
lung_control_3,ctrl
brown fat cells differentiated for seven days,ctrl
Knockdown Cell Replicate 2,pert
50_129_KO,pert
Whole adrenal RNA from WT mouse #78 at 0h,ctrl
strain: 129SV;	gender: female;	age: 10 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
"Healthy volunteer, Control_11693",ctrl
PB_DON005,ctrl
"U87MG - control siRNA, biological rep1",ctrl
"Wild-type Liver, replicate2",ctrl
"Atm-/- 30 min post IR, A",ctrl
cell type: B-cell;	cell line: OCI-Ly7 DLBCL,pert
"Wild type sham, biological rep2",ctrl
disease state: healthy;	tissue: extensor digitorum longus;	age at biopsy: 80;	Sex: male;	individual identifier: 2,ctrl
MacularDegen-healthy-3cAv2-s2b,ctrl
Cebpg-/- MEFs at passage 3_biological replicate 4,pert
Control PB C104,ctrl
SP-WT-Nrf2-Female-2,ctrl
"MCF-7 cells, siERK1 treatment 60h, 10 nM E2 for 4h",pert
BALB/c control (199msn),ctrl
platelet_sickle_16,pert
"human failing LV myocardium, Idiopathic22",pert
HDAC2_B10-rep2,pert
"A673 treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50), biological rep3",pert
"Control 2, 4hrs",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 106;	Sex: male;	region: LC (locus coeruleus);	age: P23;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
Liver_SRC-2 Knockout_Rep2,pert
BN control replicate 3,ctrl
cell type: Bladder cancer;	treatment: VprBP-depleted,pert
V5-P029,ctrl
Dicer KO CD4 T cells 1,pert
Weight:High;	CFstatus:knockout;	Sex:Female,pert
"S1P2-KO-hippocampus, biological rep4 (male)",pert
Kidney_Aqp11+/+_P7_5-1,ctrl
"Right brain hemisphere ,C57BL male mouse,Haloperidol treated,Orally,4 weeks",pert
whole tissue section from case 356,pert
cell line: mOS482;	cell type: osteosarcoma,ctrl
G425,pert
HCC_16N,ctrl
Sorted DN2 cells from fetal thymus,ctrl
WT_POST_PDE_049,ctrl
MCF10A-HER2(+) 7days,pert
healthy control sample x201,ctrl
"This allele contains a deletion of the second coding exon of Gata4, including the start codon and the Nterminal 46% of the coding region. The mice used in this study were all male and on a uniform F1 genetic background resulting from the cross of Gata4WT/Δex2 (abbreviated;	G4D) mice, backcrossed for greater than 8 generations into C57BL6/J, to wild-type FVB/N mice. G4D progeny from this cross were present at weaning at the expected Mendelian ratio (104/218, 48%), survived normally to 18 months of age, and had no evidence of structural heart disease (0 out of 15 embryos examined histologically at E15.5-E18.5). Gata4WT/WT littermates (WT) from these crosses were used as controls.",ctrl
Monocyte FCH rep 1,pert
siERK2E224h_3496,pert
Healthy control c6,ctrl
1 hr KLF4 Time Course Control,ctrl
ILD_13,pert
SNCA triplication iPSCs,pert
breast precancerous tissue,ctrl
Normal-BM 2,ctrl
Disease_status: Healthy control;	Age (years): 46;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
Patient: E;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
"Mut, biological rep1",pert
Control Endometrium Mesenchymal Cell_015.UC182++new,ctrl
ME180 1 hour rep 1,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 5,pert
WILDTYPE cerebrum at 12 weeks,ctrl
"Cbfb-/-, technical replicate 3",pert
"Crohn's Disease subject (21 year old caucasian male, SAK_1260634232)",pert
human skin biopsy,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 6,ctrl
E12 distal retina progenitors_mutant_rep 3,pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
"PCB153 treated HepG2 cells at T18, biological replicate 1",pert
cerebellum_wild type_24 weeks_replicate 2,ctrl
"fetal testis sample 26, 20 weeks gestation",pert
Age: 42;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 26,ctrl
M238_B_DMSO,ctrl
"Bicalutamide treated LNCaP cells not stimulated with DHT, biological replicate 2",pert
PGC-1a-/- rep5,ctrl
GM19238_Kd_RDBP_3,pert
A/J Vehicle liver sample batch 1,ctrl
A549_NS siRNA_biological rep2,ctrl
"brain, lateral and medial ganglionic eminences: Arx-/Y#1_le1",pert
Pancreatic islets,ctrl
"gender: Female;	age: 53;	post-mortem delay: 11h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: parotid salivary gland;	donor sex: female,pert
"ESCs overexpressed CA-NFATc3, biological rep3",pert
Obese rosiglitazone-2,pert
genotype/variation: K5-IKKbeta transgenic;	tissue: skin;	age: 32 days;	sex: male;	strain: C57BL6 X DBA2,pert
Tetracycline-inducible glioma cells dox 3,pert
A HID U_B045,pert
"Sciatic nerve, saline control, biological rep1",ctrl
adenosquamous carcinoma 004,pert
SON siRNA rep3,pert
liver biopsy sample,pert
"rat hippocampus (CA1 region), sham, 18 months old, subject 2",ctrl
Control 4,ctrl
MZ1774 YAPshRNA rep 1,pert
KO-021,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 24 hrs;	Drug: No Rosiglitazone present,ctrl
"seminoma specimen, pT2, patient age: 45y; W99 037",pert
V5-P083,pert
MKK7D transgenic female replicate 5 early timepoint,pert
Thyroid_ papillary carcinoma 11,pert
DS fibroblast-derived iPSC,pert
PsOEt-24-Week 12,pert
Subtype: normal;	Karyotype: normal,ctrl
MCF-10A_shATM-3,pert
CKO V3,pert
IM66_control,ctrl
Heart-Base_KO-2,pert
"DMSO-treated NRK-52E cells at 6h, biological rep 2",ctrl
HCC_29N,ctrl
"Autoimmune pancreatic islets, no cyclophosphamide treatment, rep 1",ctrl
strain: 4th Gen. FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/+,ctrl
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14474;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID211,pert
MDS patient 120,pert
D6,pert
Msgn1_48hPlusDox-biological rep1,pert
SF539 scramble siRNA replicate 1,ctrl
NCCIT-Consh-rep1,ctrl
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep4",pert
KU_06N,ctrl
Array Type: HG-U133A_2;	Ratio: 2.04;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
M833 / Reference_13431197,pert
brain_DLPFC_bipolar B_mr648,pert
MF-34,pert
WT-470,ctrl
482 cells scrambledshRNA rep1,ctrl
sigmoid colon biopsy,pert
Whole testis,pert
3379-scrape,pert
heart of mouse subjected 2 week to chronic constant hypoxia (2B),pert
estrogen treated ipsilateral to stroke replicate,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 5,pert
01L4G_CTRL,ctrl
KN-smoke-low-5 month-R4,pert
Amoxicillin treated Colon 2 17 days old,pert
sirna: Claudin 1;	treated with tnfα: NO,pert
ab077 IM,pert
"Biceps, FSHD, cohort 22, subject 22A",pert
"Lesional skin from imiquimod-treated mouse, biological replicate 3",pert
"p38alpha knock out fetal liver E15.5, biological rep2",pert
WT-sham-5 month+13d-R2,ctrl
sMPNST_Vehicle_2day_rep1,ctrl
HUVEC_1h_rep1_1103b,ctrl
astrocytes hypoxia batch 3,pert
"Normal skin from Tie2_control mouse, biological replicate 2",ctrl
HeTH-4 rep-2,ctrl
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep1,pert
Mutated-ERα-positive breast cancer 52,pert
tissue: Lung;	strain: Lewis;	treatment: exposed to silica,pert
Knockout CS_2_9_KO_1,pert
RNA from HCC_7N,ctrl
Tendon_lesional_rep1,pert
Rat fatty liver11,pert
normal colonic mucosa,ctrl
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 2,pert
pt. HCL E treated with Vemurafenib 1000 nM for 72h,pert
K562 Cell line,pert
"Ptenloxp/loxp + pBP-Cre, biological rep 4",pert
GM19238_Kd_BCL3_2,pert
PsOEt-15-Week 2,pert
peripheral blood CD8 T cells,pert
MRL/MpJ heart left ventrical,ctrl
umbilical cord_bpd: 3E,pert
Gata4Loxp/-VillinCre adult male jejunum (6-8wk). GATA4 conditional knockout (mutant) sample.,pert
AA_Control5_CD8,ctrl
WT B,pert
MiaPaCa2 rep-2,ctrl
Individual_4626_NN_sample,ctrl
mn cells sample 1,pert
Muscle PCOS 27,pert
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep4",pert
"midbrain,12weeks,WT",ctrl
DQD B,pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 76;	Usage number: 1;	Exposures: 4,pert
"liver,24weeks,WT",ctrl
uterus,ctrl
Pancreatic Sample 33-Tumor,pert
agent: Control;	selection protocol: negatively selected cells,ctrl
cerebellum wild type 6 month replicate 1,ctrl
Wistar-derived-Liverpool John Moores University rats,pert
Parent 3,ctrl
55_129_KO,pert
"650nM MLN4924 after 24hr, replicate 3",pert
CML_1_MEP,pert
Treated with 50uM Zinc for 4 hrs -- replicate #3,pert
ILD_8,pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep4",pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp2,ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep3",ctrl
E12 distal retina progenitors_control_rep 2,ctrl
n7t30m,pert
MDS patient 99,pert
Vehicle-Control;	Vehicle-Control 30 hours set 2,ctrl
strain: Wistar;	agent (mother exposed to): TCDD;	gender (pup): male;	age (pup): PND70;	tissue (pup): hypothalamus,pert
Neo6 cell line,ctrl
CD19 selected B-cells,pert
THRB 15b mutant + T3 replicate 1,pert
Kidney_saline iv_mouse #004,ctrl
3_1_MOE_430A_HE,pert
"Pten WT/null epithelials cells, biological rep1",pert
disease state: paediatric glioblastoma;	age: 15;	gender: M;	h3.3_status: wt,ctrl
Mc3T3 control_ 5day_rep2,ctrl
Day: 24; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 3,pert
strain background: Mixed background;	genotype/variation: Wildtype;	developmental stage: E13;	gender: not determined,ctrl
"Histidine decarboxylase null myeloid-derived suppressor cell from colon tumor, rep2",pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: lung bronchus;	donor sex: female,pert
Hippocampus Control group 2,ctrl
NSC7,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 19.96712,pert
Bl6 - Control - rep1,ctrl
"E-FABP knockout GM-BMMs, biological rep2",pert
striatum_Pink1 knockout_18 month_replicate 2,pert
Hes6_Castrated OWJ40,pert
T1B-LU,pert
Muscle PCOS 19,pert
P14 - Lis1cko/ko 2,pert
Parkinson's disease sample x199,pert
"TH cells from LC, Mecp2 null, young time point, biological replicate 1",pert
"age at diagnosis: 70;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: NA;	pgr: NA;	dfs-month: 58;	dfs-event: 0;	distant metastasis: 0",pert
Untreated after 4 days (C1_2),ctrl
"MGSKO, PR02M001v0",pert
Myoblast-GATA4-Wt-day3-2,ctrl
FO_spleen_wt_rep2,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu3,ctrl
"3T3-L1 siControl 24h, biological rep 1",ctrl
Scd1-/- on chow diet replicate 2,ctrl
OVCA429+(2),pert
pooled reference mRNA from 4 harvests of HME-CC cells,ctrl
Bone Marrow Mononuclear Cells;	Unknown Age/Unknown Gender,ctrl
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 15days;	genotype/variation: NSun2 KO,pert
"vestibualr organ at E18.5 of Igf1 -/-, biological rep 1",pert
"Cerebral Palsy, Gracilis, Patient Replicate 7",pert
Donor (Sample 19),ctrl
mef2a_3,pert
Wild-type E11.5 proximal hindlimb pool 2,ctrl
Staggererer mice fed with a HFD for 6 weeks,pert
genetic background: C57BL/6;	gender: male;	cell type: primary murine fibroblast-like synoviocytes (FLS);	genotype: human TNF transgenic without knockout (Rsk2+/y FLS);	flow cytometric cell sorting: CD90.2pos/VCAM1pos/CD11bneg,ctrl
phenotype: no or early glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 324,ctrl
Mnk_3226-T-B,ctrl
"human failing LV myocardium, Ischemic20",pert
"Fibroblasts, formoterol, time 3h, patient 1, rep 1",pert
siDdb1,pert
gender: Female;	tissue: Tendon;Biceps;	age: 59;	donor: 34;	disease state: Non-lesional,ctrl
CON-1-PLASTIC,ctrl
"brain, hippocampus: LH2_e1_le1",pert
"Liver, wt control",pert
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: yes,pert
liver_STZ 0.5% quercetin diet_rep3,pert
gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.2,pert
brain_DLPFC_bipolar C_mr945,pert
Run5.aUa.010110d.SkmDbt1961D.CEL-DB basal,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IB;	age:66;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=advanced gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=not determined",pert
"FOXP3, mut, REP5, 0h",pert
Non -Transgenic replicate 7,ctrl
431: control mouse 2,ctrl
cell line: MDA-231;	transfection: pCMV-GFP,ctrl
"cell line: D890, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
tissue: brain;	genotype: mutant Lis1 ko/+;	age: P14,pert
41SAGEA2,pert
hepatocellular carcinoma,pert
450MM,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.371;	OD280: 0.727;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 283;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
MDS patient 45,pert
PGA_MI_nilv_24h_361,pert
U937_ROS_untreated_4h_rep2,ctrl
Strain: FVB/N;	Genotype: SP-C-hCFTR+|-/mCftr+|+,pert
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
race: african american;	age (years): 73;	stage: IB;	grade: 3;	histology: endometrioid,pert
Subtype: RAEB2;	Karyotype: other,pert
HUVEC_4h_rep1_1103,ctrl
gender: F;	age at blood draw: 50;	tissue: whole blood,pert
"Typically Developing Control, Semitendinosus, Patient Replicate 5",ctrl
wild type mouse retina at age postnatal day 4,ctrl
patient: 5;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with TNKS inhibitor for 4h,pert
Transgenic ATF6-MER mouse;	Strain: C57BL6;	Gender: male;	Age: ~30 weeks;	Tissue: heart LV;	Treatment: tamoxifen,pert
Human Umbilical Vein Endothelial Cells (HUVEC),pert
SF539 GBM cell line,ctrl
"cochlea at P7, wt, biological rep 2",ctrl
wt PBS5,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: C;	tissue: Skeletal muscle (quadriceps),ctrl
EP10_adipose_pcos,pert
MSE_D_G73A,pert
ESC_Zfx-flox_Replicate2,ctrl
"Patient 12, Atheroma plaque",pert
GNMT-KO mouse hepatocytes (sample 1),pert
adenocarcinoma (ADC1),pert
Normal esophageal epithelium (N6),ctrl
R6/1 22 week transgenic_BBB4,pert
race: african american;	age (years): 65;	stage: IA;	grade: 2;	histology: endometrioid,pert
HDAC1_knock_out_embryonic_stem_cells_biological_rep2,pert
"Female Nrf2 Knock-out mice, spleen sample",pert
P53 knock-out,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: gastrocnemius,pert
"TNFa siRNA-A, replicate 3",pert
Strain: RPE65-/-;	Age: 6 months;	Tissue: retina,pert
Aortas isolated from atherosclerotic APOE-deficient mice,pert
control participant P312 (human CD3 positive T cells),ctrl
sample J 18.5 wt,ctrl
"SIRT3KO, high-fat diet, rep1",pert
WT4,pert
"patient 14, arm treated with pimecrolimus",pert
9-cis-retinoic-acid_LIVER_2,pert
Fat Tro1,pert
strain background: ICR;	genotype/variation: alpha-cre;	developmental stage: E12;	tissue: Embryonic retina/optic cup,ctrl
WT_P59,ctrl
A549_EGFplus_rep1,ctrl
"MAT1A knockout at 8 month age, biological replicate 4",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
PsOEt-16-Week 2,pert
status: Slow;	age: 64;	gender: female;	tissue: cultured human fibroblasts,pert
primary normal lung tissue 2911,ctrl
Cervical cancer_1898T,pert
DMSO4_6H,ctrl
P53 Non failing heart biopsy,ctrl
Control PB C107,ctrl
Extract:LOX-1:213303;	Extract Description:LOX1_Untreated_6hr:213303;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.1;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.96;	Quality: Background Mean Dev.:0.14;	Quality: Absent (%):57.57;	Quality: Absent (%) Dev.:0.53;	Quality: Scaling Factor:0.44;	Quality: Scaling Factor Dev.:1.44;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213303;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295673,pert
Extract:LOX-1:213301;	Extract Description:LOX1_Untreated_6hr:213301;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.02;	Quality: 3'/5' Mean:1.62;	Quality: Background Mean Dev.:0.52;	Quality: Absent (%):57.11;	Quality: Absent (%) Dev.:0.88;	Quality: Scaling Factor:0.53;	Quality: Scaling Factor Dev.:0.69;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213301;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295653,pert
strain/background: C57BL/6;	genotype/variation: hsp70 transgenic;	tissue: brain (right cerebral hemisphere);	age: 7 days;	treatment: PBS control;	time post-infection: 5,pert
muscle wild type replicate2,ctrl
Airway epithelial cells,pert
"fibroblast, control subject NF8 rep 1",ctrl
Age: 39;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 1293del40;	Family History: Yes,ctrl
NSC_FBS_L2,pert
"Primary lymphoma cells, isolated from lymph nodes of Emu-myc,Suv39h1-/- mice and retrovirally transduced by Bcl2, ADR treated",pert
strain/background: mixed B6/129;	tissue: thymus;	cell type: CD4+CD8+ thymocytes;	genotype/variation: LckCre Dicer lox/lox knockout,pert
cell type: HeLa cells,ctrl
061J3: normal control,ctrl
1_DMSO-1,ctrl
HMEC culture,pert
"Acute Myeloid Leukemia, sample 68",ctrl
Transgenic nr 614,pert
11106 UC Uninflamed descending colon,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 2,pert
"ID:14-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
human preadipocytes+siCtrl_day6_rep2,ctrl
RKO_rep_6,pert
HEK293_pLKO_R3,ctrl
Muscle from a 24 month old Myc heterozygous mouse,pert
"Brain tissue from Fisher 344 male rat, Animal #271, 5mg/kg D-Serine",pert
"Aorta, saline 7d, #2",ctrl
strain: Wistar;	gender: male;	tissue: spinal cord;	treatment: acrylamide,pert
disease state: tuberculosis;	tissue: PBMC,pert
CML_7_CMP,pert
HT29 sensitive cells replicate 1,pert
BAL_31_A0B1,ctrl
"MAT1A knockout at 3 month age, biological replicate 4",pert
gender: Male;	age: 90;	post-mortem delay: 6.75h;	ph: 6.2,ctrl
Bronchial Epithelial Cells control biological 1734Y,ctrl
WT3,ctrl
PGA-RMM-2h-2aA-s2,pert
age: 49;	sex: F;	disease status: control subject;	Filter number: 88;	Usage number: 1;	Exposures: 3,ctrl
tissue: skin;	individual: Patient N-5;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
cell type: mouse embryonic fibroblasts (MEFs);	genotype: KSR1 -/-;	expression: KSR1 and GFP;	background strain: DBA,ctrl
"mammary epithelial cells, WT",ctrl
Untreated WT - repeat 3 - mAdbID:102767,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",ctrl
R5_Pseudomonas_wildtype_422,ctrl
"Biceps, FSHD, cohort 13, subject 13B",pert
high grade serous carcinoma_patient 8,pert
Bmi1 transduced embryonic stem cells (Bmi1 ES cells).,pert
Granulocyte-Macrophage Progenitors,ctrl
pt. HCL E treated with DMSO for 72h,ctrl
"LCL GM19238, Kd USF1, 72hrs",pert
"Pten null, biological rep2",pert
GEIM63-U133A-Norm,ctrl
Diaphragm 14 Day control rep 3,ctrl
S259A-4,pert
healthy control_3,ctrl
"Hippocampus, soman, 168h",pert
normal;	Biopsy Negative Control,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: TL3 SCR shRNA;	cell line: TL3,ctrl
ICL670-treated K562 cells,pert
"gastrocnemius, 30 months of age, control diet",ctrl
human subcultured chondrocytes (passage 2) from normal donors,ctrl
CD4+_Tcells_healthy_donor_3,ctrl
strain: c57/bl6;	weight: 25-30g;	age: 4 month;	gender: n/a;	tissue: whole trachea,ctrl
cell line: prostate cancer cell line LNCaP;	genotype/variation: negative control siRNA,ctrl
Sample isolated from wild type Foxp3 CD4+YFP+Ly5.2+ T cells following treatment with HR-MMPCreGFP and six week adoptive transfer.,ctrl
PND28 Rat Testis_Rat230-2_12hr Corn Oil_Animal#61_04005,ctrl
PancreaticSample31-Normal,ctrl
TP06-872-lcm,ctrl
age_years: 35;	sex: M;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
MCF-7_vector control,ctrl
"brain, hippocampus: CH4_e1_le1",ctrl
ES2 NT-3 25nM,ctrl
"MAT1A knockout at 15 month age, tumoral tissue, biological replicate 5",pert
parental biological replicate 1,ctrl
cell line: MCF10A;	treatment protocol: SFN,pert
normal B lymphocytes (NBL 533),ctrl
CD8 KLF13 KO 2,pert
Full-thickness epidermis,ctrl
BT474-J4_GSK089_24-3,pert
MacularDegen-injured-5aAv2-s2,pert
"DMSO-treated NRK-52E cells at 6h, biological rep 3",ctrl
"ID: MLL_00235;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"lymphoblastoid cell line from T5.02, one out of seven of sensitive group, 50*10e6 cells",ctrl
jzo020-rp1-v5-u74av2-met.TXT,pert
MCF7_siRNA_ESR1_24h_AM0003_8.1,pert
strain: backcrossed 3-5 generations on C57BL/6 from FVB;	rna: TRAP;	driver: S100a10;	line: ES691/p11 KO;	tissue: cortex;	treatment: vehicle,ctrl
genotype:Rb null;	Age: e12.5,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50).,pert
strain: BALB/c;	cell type: CD8 T;	genotype/variation: wild type,ctrl
Wild Type Time 0 replicate 2,ctrl
SV cells isolated from inguinal White adipose tissue,ctrl
A2AR_KO_saline_24h_rep4,pert
disease state: control;	patient: 20,ctrl
"Global gene expression of NASH patient, P34",pert
muscle_Akt1+/-_8wk_rep1,pert
WT,ctrl
expression array - BRAIN 3,ctrl
"breast tumor epithelium,5",pert
Peripheral blood mononuclear cells (PBMC)-Patient CV T1,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 1 day;	treatment: 2R4F whole mainstream smoke 125 µg/ml, treatment over 1 day, 3x1h exposure per day",pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 7.8;	colon weight (mg): 158;	colon ratio (mg/mm): 2.03;	myeloperoxidase activity (u/mg): 0.043;	tissue: colon;	treatment: 5% DSS,ctrl
Lung tissue,ctrl
"Patient 23, Atheroma plaque",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q plus other,pert
H5bt5,pert
Thoracic mammary glands were collected from three virgin wild type F1 CF-1/FVB mice at 16 weeks of age; RNA was pooled before synthesis of cDNA.,ctrl
SRF Mut. IgM+IgD+ (GBF0611),pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: cisplatin;	timepoint: 24 hours,pert
PBMCs_Control_12 [IS],ctrl
Mut2,pert
Bronchial Epithelial Cells SA biological 2040W,pert
whole tissue section from case 260,pert
colon_epithelium_IL10mouse_12weeks_rep3,pert
3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24717,pert
Lung of hemorrhaged animal 24h,pert
Aquaporin-11+/+_mouse P7 kidney #2-2,ctrl
Control_6months_retina1,ctrl
cortex_HtrA2_KO_rep2,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
HEK293_A08_R1,pert
"patient 038b, normal, homogenized",ctrl
esophageal squamous cell carcinoma from patient E1535,pert
"WT mouse lung, biological rep2",ctrl
SV589_8Day KD_Serum Starved,pert
mouse cerebellum at P7 knockout 5,pert
Mening SWB WB NP 3a,pert
NZW/LacJ Vehicle liver sample batch 5,ctrl
n3_lo_5,pert
Cisplatin-treated Rb-/- MEFs-c,pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: ZNF750 gene silencing,pert
"peripheral ganglion, unknown: control 24 hr _3",ctrl
432MM,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_6h_Con_HG-U133A_2_YCHSUP501,ctrl
IPMA 1,pert
Disease_status: Healthy control;	Age (years): 34;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.87;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Individual_4394_NN_sample,ctrl
subject: 19A;	cohort: 19;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 22kb;	age (y): 65;	Sex: M;	batch: Batch_4,pert
CHB PBMC_sample 4,pert
Fat FC1,ctrl
P1 mouse eyeball extracted total RNA_wt1_GSM618315,ctrl
tissue: peripheral blood;	subject: Control;	rna prep: PAXgene;	molecule: total RNA,ctrl
uterine leiomyoma,pert
X50 WT1	F2/8	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
"SHR adrenals, replicate 3",pert
HF0285_U133P2,pert
Adrenocortical adenoma with CTNNB1 mutation (S45P),pert
CyP 1hr 2,pert
"IL22KO3_ileum, 5 days post-infection with T. gondii",pert
"cell type: Normal human diploid WI-38 lung fibroblasts, CCL-75(TM), passage 7-12.",ctrl
D5_non-transgenic,ctrl
CLL 379-01 Control,ctrl
293T cells stably transfected with 1 scramble shRNA construct. Control cell line for 293TsiLL cell line (LEDGF transcript knockdown - PSIP1 gene).,ctrl
Huh7_TGFbeta_minus_1,pert
P0 - epsilon129s6 2,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 24h ID136,pert
"Control Day 0, biological rep2",ctrl
"GNMT knockout at 3 month age, biological replicate 3",pert
"GM8830, MS-proband",pert
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep5,pert
"ARD842, CAIS, F, GOF, 1 x ETOH, 24h",pert
pMX-Oct4 and pMX-jhdm1b vitamin C O+Jhdm1BVc+_1,pert
cell line: Breast carcinoma cell line Cal51;	genotype/variation: control;	agent: MMC,ctrl
Patient: J;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
Normal cortex of patient 131,ctrl
"MCF7 cells, RL silenced, LIF 1h",ctrl
CD25+Xbp1WT#2,ctrl
Gene expression profiling of normal cortex of patient 1524,ctrl
"LCL GM19238, Kd POU2F1, 72hrs",pert
Sodium arsenite added to food: None; Injection: IP 8hr 1 mg/kg Dexamethasone in saline; Diet: AIN-76A; Sodium arsenite added to drinking water: None,pert
"Cell line:  Fibroblast TTP KO cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",pert
K562 DMSO sample 12,ctrl
Biceps_Control_4,ctrl
DBA_6h_DMSO,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.5;	Post mortem interval (hours): 8;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
12483 UC Inflamed descending colon,pert
cell line: KU-812;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L112,pert
cell type: myoblast;	transduction: lentiDUX4fl,pert
control (day 0) replicate 1,ctrl
"breast tumor epithelium,32",pert
LSK cells SRF KO 1,pert
PancreaticSample26-Tumor,pert
brown fat cells differentiated for 7 days,ctrl
genotype: Sgk1-/-;	cell type: Th17,pert
COV434 Mutant [RR1017],pert
Normal myocardium sold commercially (A),ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.74;	age of onset: 14 yr,pert
tissue: Frontal cortex;	age: 82;	Sex: M,ctrl
N9,ctrl
untreated_1,ctrl
"Patient S196, MSI colorectal tumor",pert
"S1P2-KO-hippocampus, biological rep2 (male)",pert
"Liver RNA, WT mice",ctrl
Nr4_ctrl,ctrl
The nucleus accumbens from a neurologically normal Jpanese male (aged 60 yr).,ctrl
OCI-Ly1_ctrloverexpression,ctrl
Cervical Cancer C484,pert
UC-38-Aff,pert
Whisker pad mutant biological rep1,pert
"Cultured ovarian cancer cell line A2008, Cisplatin treated",pert
sampleID: SAM630129;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
Scd1+/+ on chow diet replicate 5,ctrl
Mutated-ERα-positive breast cancer 9,pert
Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model MEPM 2,pert
colon_CRC_1739,pert
n4t24h,pert
"MCF-10A cells, overexpression ΔNp63α, biological rep3",pert
Psoriasis-Patient-F,pert
Ishikawa_VeryLowDose_BPA_48h_rep3,pert
liver control diet rep4,ctrl
PTEN+/-IKK2ca/ca ep_A,pert
whole blood_100683,pert
testis wild type replicate3,pert
"Liposarcoma culture from tumor 392, doxorubicin treated",pert
266C0,ctrl
MOLF/EiJ Vehicle liver sample batch 4,ctrl
LNT-4,pert
Normal Tail Skin 2,ctrl
9N,ctrl
5720 Wild Type Mouse White Adipose Tissue,ctrl
ic24 -- APF on membrane B,ctrl
"age at diagnosis: 44;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
muscle WT 1 control,ctrl
S2_Sham_wildtype_8,ctrl
"brain, hippocampus: Ctr-6h-P15-II_e1_le1",ctrl
age_years: 48;	sex: M;	ethnicity: Black;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Advanced IPF_explant_lower lobe_rep152,pert
LCL Concordant for Epilepsy twin pair 2 (CCE2.2)(TP32),pert
control participant P303,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 201,ctrl
"non-AD_TC, biological rep14",ctrl
healthy control sample x112,ctrl
"Heart, MAT1 CKO, 2 wk, sample 2",pert
Control Endometrium Endothelial Cell_032.UC208+-,ctrl
"mouse embryonic fibroblasts derived from FHL2-/- mice, FHL2mutE",pert
"Strain: C57BL/6;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",ctrl
whole tissue section from case 856,ctrl
cardiac allograft,pert
Sox2-shRNA-3,pert
BALB/c mouse treated with pristane for 18 days,pert
Strain: 129S2/SvPasCrlf;	Sex: male;	Genotype: L1CAM knockout (-/Y),pert
Mnk_3149-R-7,pert
GFP Untreated 2hr 282295483,ctrl
"P50_C-DGCR8 KO cones, replicate 2 [array]",pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/43;	differentiation status: undifferentiated;	cell line: Q50,pert
BxPC3-WT rep 4,ctrl
MPA 4,pert
chondrocyte_control_rep1,ctrl
Frontal_Cerebrocortex_Vehicle_6hr_rep1,ctrl
Genotype: p38alpha wt;	Age: E15.5,ctrl
Septic shock;	gender: Male;	Survivor;	organism: None,pert
BL308,pert
"Lesional skin from imiquimod-treated mouse, biological replicate 1",pert
10 days TAC-3,pert
Liver-5 month-wild type-technical replicate 1,ctrl
CUTLL1 GSI,ctrl
VEC B,pert
RNA from HCC_39N,ctrl
"Ulcerative Colitis (49 year old caucasian female, SAK_1286431014)",pert
braak stage: BR34;	rin: 65;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Normal Inflamed sigmoid colon,ctrl
clone type: AtT20 clone types overexpressing NSBP1SE protein rep1,pert
Wild type mice on a high fat diet (CH 3),ctrl
Squamous cell lung cancer X33nml,ctrl
nucleus accumbens ctrl replicate 3,ctrl
Control (shControl-4),ctrl
WT_d00_eX_vs_WT_d21_eX,ctrl
Parkinson's disease sample x015,pert
Ischemic cardiomyopathy_G12,pert
Ishikawa_HighDose_BPA_8h_rep3,pert
Human Chronic HIV Sample C101-CD8+ T cells,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post Saline ip.,ctrl
16B,pert
"Healthy control mice, time point 3 week",ctrl
"FOXP3, mut, REP4, 72h",pert
Pancreatic Sample 31-Normal,ctrl
dorsal skin from GR-/- E18.5 embryo,pert
"Wild type used for GNMT 3 month, replicate 5",ctrl
62SmokeH,ctrl
treatment: EtOH + cycloheximide;	genotype: RARaKO;	cell line: F9,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.94;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
LJMJDW9,ctrl
strain: C57BL/6J;	tissue: skin;	cell type: melanocyte;	genotype/variation: Ink4a-ARF1 null,ctrl
genotype/variation: Wild-type (E14K);	cell type: embryonic stem cells,ctrl
shCDK8_Time_0_1,pert
"Peripheral blood, normal control [N55]",ctrl
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 2",pert
11089 Normal Uninflamed descending colon,ctrl
Bmpr1a-/- in ESC media,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 2;	time: 6h,pert
Control replicate 6,ctrl
control-noDox-rep3,ctrl
"Crohn's Disease subject (31 year old caucasian female, SAK_1313134987)",pert
"Mut, biological rep3",pert
"Aorta, saline 14d, #4",ctrl
CH1+(3),pert
Vehicle 12 hours_3,ctrl
R1_saline_wildtype_422,ctrl
UC-35-Aff,pert
V5-P313,pert
Liver_hyperglycima_no.9,pert
WT-CD80lo-mTEC-sample1,ctrl
GV oocyte_control_rep1,ctrl
Normal cortex of patient T163,ctrl
HeLa control knock down 3,ctrl
cell type: bone marrow cells;	strain: DBA/2,pert
A549 lung cancer cells,ctrl
"experiment 2, control 3",ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P3,ctrl
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 19;	gender: f;	treatment: NSAIDs,pert
chronic lymphocytic leukemia (CLL 32489),pert
SENS 1 4hr,pert
transfection with nonsense siRNA,ctrl
"age at diagnosis: 50;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T3;	n (lymph node metastasis): N3a;	er: NA;	pgr: NA;	dfs-month: 17;	dfs-event: 1;	distant metastasis: 1",pert
Treatment 1,pert
HepG2_Hg rep2,pert
"MCF-7 cells, siERK1 treatment 60h, 0.1%EtOH for 4h",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 10. Replicate B,pert
DK-first,ctrl
scc_07,pert
23 wt E11.5 heart,ctrl
"MCF-7 cells, siGL3 treatment 72h, 0.1%EtOH for 24h",ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
quadriceps femoris,ctrl
5 STAT6KO control macrophage,pert
e2 Ez f/f Mef2c-cre,pert
Liver_normoglycima_no.6,ctrl
Subject #8017-2d Postinfection,ctrl
"Data 1, overnight control",ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 11,pert
13a_b,pert
HCV_Control_1,ctrl
Igf1 +/+ mouse vestibular organs 90 days old (P90),ctrl
V5-P079,ctrl
"Patient  M, lesion, 1 week",pert
cell type: embryonic stem cells [E14];	transfected with: pooled non-specific siRNAs (control),ctrl
HMEC X BC14 : 0096-5k,pert
status: Normal;	age: 59;	gender: female;	tissue: cultured human fibroblasts,ctrl
M24met_control_5,ctrl
PGC-1alpha -/- differentiated brown fat cells expressing a control siRNA (rep1),pert
genotype: Wild-type;	replicate: 3;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
HT-WT-9B,ctrl
wt_P6_rep2,ctrl
Tendon_non-lesional_rep1,ctrl
jzo011-rp1-v5-u74av2-met,ctrl
P 25 Si RNA,pert
MEFs-2,ctrl
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ scramble;	treatment: Ca 0.09mM, 72 h",ctrl
KM-H2 with PTPN1 siRNA knockdown,pert
Rat fatty liver6,pert
APOE_KO_RAGE_KO_DM_9W_11,pert
Postmortem human substantia nigra,pert
FmrKO3_brain,pert
primary MEFs,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
tissue: white blood cells;	age: 16.94;	Sex: female,pert
"Liver from STZ-treated mice, biological replicate 4",pert
NORMAL #99-0160,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 1,pert
0810A-01_clone 3-1,pert
HEK293 cells siRNA BAHD1 biological rep1,pert
"WT in the absence of tetracycline, rep2",pert
"Benign, pooled tissue, prostate",ctrl
gender: female;	batch: 2;	age (years): 44;	patient id: Non_severe_2;	fev1 (% predicted): 87;	fvc (% predicted): 92;	medication: flixotide;	cell type: CD4+ T-cells,pert
treatment: control scrambled siRNA;	cell line: H441,ctrl
MacularDegen-healthy-7bAv2-s2,ctrl
Wt1-null MEFs-2,pert
WT25+_rep3,ctrl
Individual_4164_PN_sample,pert
pediatric AML S16,pert
"Patient 1, control tissue",ctrl
Nonirradiated-ATM-WT Replicative2,ctrl
Rat Dorsal Root Ganglia,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 1,pert
Subject #8010-2d Postinfection,ctrl
nasopharynx,pert
"p53-null NSC, PlagL2",pert
"Cbfb+/+, technical replicate 1",ctrl
subject id: c2;	infection: control;	status: control;	tissue: whole blood,ctrl
MOLM-14 cell line infected with scrambled control shRNA,ctrl
"Normal Skin, Normal-7",ctrl
PBMC from T cell LGL leukemia patient #121 (TLGL121),pert
"lung, from control",ctrl
1212-3heart_OTT1KO,pert
11A;pretreatment;female;breast tumor,ctrl
CEM Control 1,ctrl
MCAD + LPS 2,pert
S021_Scz_M_71,pert
CEM11_T5_PP_day7_041,pert
mdx5cv TA sample 1,pert
"heart, wild type",ctrl
unstimulated CD4+ T-cells from Itk knockout C57BL/6 mice,pert
"brain, brainstem: PB6_e1_le1",pert
Adipose-5 month-Myc heterozygous-technical replicate 2,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep8",ctrl
8 Month FORKO Ovary_03,pert
Age: 59;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: No,pert
Control 3_Huh7 [HDAC2 siRNA subset],ctrl
Heart_WT_02,ctrl
ic12 -- cell line 2 treated with mock APF#2,ctrl
RNA from HCC_2T,pert
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 99;	Usage number: 4;	Exposures: 3,pert
Genotype: Wild Type,ctrl
3D-cultured chondrocytes from normal donor 1,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: fresh air, treatment over 5 month, 4x1h exposure per day",pert
TAp63 alpha Q540L 24h without induction s3,pert
Peripheral blood mononuclear cells;	TTF=140min;	Race=White;	Sex=Male,pert
"brain, hippocampus: KA24-III_e1_le1",pert
r19,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.7726,pert
HT29 derived clone with vector expressing CD24 directed shRNA,pert
Etoh 1,ctrl
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 690,ctrl
Normospermic individual: Sample N5,ctrl
A2058 Ctrl siRNA Rep1,ctrl
human MBC_FOXP1 overexpression,pert
race: african american;	age (years): 51;	stage: IB;	grade: 3;	histology: papillary serous,pert
cell line: HeLa cervical carcinoma,ctrl
SRF silenced EtOH rep 3,ctrl
E14 - Lis1cko/ko 3,pert
"RWPE1 cells, 100 nM of 1,25(OH)2D, 24h, biological rep3",pert
Leg 56 Day control rep 2,ctrl
intestine_PPARa-knockout_control_rep1,pert
Tendon_lesional_rep14,pert
NOD RIP-Aire27 islet rep3,pert
WT-smoke-med-5 month+1d-R4,ctrl
Heterozygous mouse pDCs,pert
25 uM chlorpyrifos batch 1,pert
normal scar treated with hydrocortisone-1,pert
"Mouse, WT, colon, DSS, rep2",ctrl
Control subject 23_biological replicate 1,ctrl
Skin_Lox_Control_Rep1,ctrl
At Risk: +;	Age: 13;	Sex: F,pert
Liver KO8,pert
Muscle KO Aged 1106,pert
mouse whole lung,ctrl
RT4D6_mutant Sox10 siRNA_rep1,ctrl
N69s,ctrl
CD4DecTp2-8,pert
"Mel18 shRNA, biological rep3",pert
basolateral amygdala,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 23;	sex: F,ctrl
Wild type CD4+ CD3-stimulated 1,ctrl
FU-OV-1-(3),ctrl
cell type: preadipocytes;	tissue: white adipose tissue,pert
MLL_00112,ctrl
"BL from CLL patient, isolated using CD19-PE and CD5-APC.",pert
11B,pert
HNF4 Null_190,pert
Plate vs. Nail:  6 Week Plate,pert
DLBCL cell line KARPAS-231 transfected with a non-targeting siRNA,ctrl
"human peripheral blood derived monocytes, 4 hour LPS stimulation, biological rep1",pert
Treg cells WT replicate 1,ctrl
patient: 30;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Carbo Day7 (417L),pert
sample =XCGD2 treatment=Control time=90 (min),pert
aorta from ApoE-/- mouse with diabetes sacrificed at 9 weeks,ctrl
3335M patient’s mucosa,pert
"human failing LV myocardium, Idiopathic17",pert
S022_Scz_M_44,pert
N1_Cy3,ctrl
WT-080,ctrl
chronic lymphocytic leukemia (CLL 35513),pert
gastrocnemius-30 months of age-control diet-biological replicate2,ctrl
"brain, hippocampus: C240-III_e1_le1",ctrl
Individual_4208_PP_sample,pert
139A,ctrl
Celecoxib_#4871,pert
BJ-iPSC replicate 1,ctrl
V5-P524,pert
"ALL_NDS, K36 011609",ctrl
New El-Ashry 006.CEL,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: DMSO for 48h,ctrl
shRNA4-1-plusDox-rep2,pert
shScr replicate 4,ctrl
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 1 - Technical Replicate 2,pert
"PCB77 treated HepG2 cells at T6, biological replicate 1",pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: Western diet for 20 weeks,ctrl
10 weeks old,pert
NM22 healthy control,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 85min;	race: White;	sex: Female,ctrl
Panc-1 Ctrl 2,ctrl
Ishikawa_Control_24h_rep2,ctrl
Carbo Day7 (311R),pert
09EXPLANTH,ctrl
tissue: cervical cancer cell line HeLa,ctrl
Male 6-8 week BALB/c grafts in Male 6-8 week C57Bl/6 host,pert
strain/background: C57BL/6;	genotype/variation: AhR-deficient knockout (AhR-/-);	tissue: lung;	treatment: PBS control,pert
"non-AD_FC, biological rep12",ctrl
Against CDK19-1 rep3,pert
Psoriatic arthritis PsA 7,pert
mouse heart,ctrl
sepsis patient #4,ctrl
"cell line: 9837, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
HUVEC_6h_rep1_1103,ctrl
Young 4,ctrl
"human failing LV myocardium, Idiopathic54",pert
Parkinson's disease sample x123,pert
gastrocnemius muscle,ctrl
IPMA 2,pert
Manca 1,pert
coronary smooth muscle cells metoprolol replicate 1,pert
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
WT - Cre Treated - 12 hrs - repeat 2 - Cy5 - mAdbID:61754,ctrl
db/db 10-4,ctrl
Control Braak α- synuclein Stage 0 C4SN,ctrl
01LMN: new onset sJIA,pert
cell line: HT1080;	clone: 9;	genotype: Wild type,ctrl
"fetal testis sample 25, 20 weeks gestation",pert
lean control-1,ctrl
PGA-RMM-4h-2aA-s2,pert
cerebellum_KO_2,pert
MCF7 DMSO+EtOH,ctrl
PGA-MAH-AJ_PBS24h-1aA-s2,ctrl
"ID:c 4-3, Genotype=(C57BL/6J), Treatment= none",pert
WT - Cre Untreated - 0 hrs - repeat 3 - Cy5 - mAdbID:54710,ctrl
0h Kin Cel.05,pert
CD4+ T cells from B6 mice,ctrl
myoblasts-expt1_untransduced-rep2,ctrl
2073N,ctrl
"cell line: Hec50co endometrial cancer cell line;	cell line traits: Loss of p53, loss of hormone receptors ER and PR;	disease state: Grade 3 endometrioid adenocarcinoma;	genotype/variation: control",ctrl
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 3",ctrl
wild-type heart,ctrl
patient7,pert
patient: 51308;	sample: normal,ctrl
SCD1 -/- liver rep5,pert
HeLa cells;	(cervical cancer cells),ctrl
R7E 9,pert
01-0007A_Day1_0,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 08/23/05;	# cells: 48;	Sex: male;	region: M1;	age: 48;	genotype: Y/Mecp2-;G42/-,pert
Bronchial Epithelial Cells MMA biological 1781H,pert
lymphocytes_HD_F_41y,pert
C57BL/6J Mouse Female Kidney,ctrl
Sex: male;	Age at operation: 60 years;	Site: upper arm;	Size in cm: 9.9x7x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
"LY2 cell line, SRC-1 siRNA treated 120min, biological rep3",pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p28;	strain: E14,pert
LOX1 0hr 282295453,pert
R7E 6,pert
8 week old EOM control rep 4,ctrl
HOX424 Carbo Day7,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
"array 20, unimplanted",ctrl
"Endometrium, postmenopausal, control, 12",ctrl
K562 STI sample 5,pert
GB 5 NTA +LPA,pert
Frontal_Cerebrocortex_Deltamethrin_3mg/kg_6hr_rep8,pert
Esophagus TG replicate 1,pert
Control subject 46_biological replicate 1,ctrl
Alpha7 nAChR subunit L250T heterozygous mice without treatment,pert
Braak α-synuclein stages 5-6  BR56_1SN,pert
"P10 mouse back skin, control",ctrl
B6C3F1/J Vehicle liver sample batch 3,ctrl
HCC_28N,ctrl
01L4M: normal control,ctrl
disease: type 1 diabetes;	gender: female;	cell type: endothelial progenitor cell,pert
prostate tumor 4,pert
52A;pretreatment;female;breast tumor,ctrl
Untreated Myd88 knockout - repeat 5 - mAdbID:102775,pert
WT-Fibr1 6,ctrl
Parkinson's disease sample x006,pert
mdx Biological Replicate 6,pert
Errb mutant stria vascularis replicate 1,pert
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 547,ctrl
"Control lung tissue, biological replicate 2",ctrl
"Cultured ovarian cancer cell line OVCA420, untreated",ctrl
Pediatric_GBM_47,ctrl
Multiple sclerosis CD4+T cells 3-TE,pert
34B,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: M;	transfectant type: stably transfected with scramble control,pert
"PTEN mutant 2 intestinal polyp, polyI:C, 30 days",pert
OE control 23A n,ctrl
GFP Untreated 6hr 282295603,ctrl
3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24713,ctrl
"TH cells from LC, wild type control, young time point, biological replicate 2",ctrl
"MN1, 2",ctrl
3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24716,pert
Run7.aUa.001206d.SkMInS1085D.CEL-IS stimulate,pert
"Liver from STZ-treated mice, biological replicate 2",pert
LJMJDW19,pert
SKM-KO,pert
Primary hepatocytes isolated from Donor 1 treated with DMSO for 24h,ctrl
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting luciferase (control),ctrl
RPEshp,ctrl
inflammatory Cardiomyopathy,pert
8 week old dy/dy dystrophic mouse diaphragm,pert
121-01-C,ctrl
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
S10,pert
control_crypt_day2_sample2,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
Mouse_WT_colon_DSS_rep1,ctrl
Dilated cardiomyopathy_G6,pert
CD46+ hippo - Untreated-A,ctrl
SLE CD19 B cells 2,pert
Subject #8013-Preinfection,ctrl
"mutant mouse embryonic fibroblast, biological rep 2",pert
Vit A sufficient 2a,ctrl
KU_13T,pert
Murine liver,ctrl
Disease_status: Down syndrome;	Age (years): 55;	Gender: Male;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
SKM-1 STK33-2077,pert
granulocyte RNA from healthy control,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 67,pert
Normal mucosa 10,ctrl
non-treated CCRPKO_rep-1,pert
gender: male;	age (years): 30;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
condition: Discoid Lupus;	patient: L8;	tissue: LS skin biopsy;	kit: Ovation,pert
PGA-MAA-IL4-1aAv2-s2,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: pre-UV,pert
Mouse embryonic kidney,ctrl
5046-lcm,pert
NuLi cell line treated at DMNQ biological rep2,pert
"ACC3 cell line, Sox4 RNAi knockdown with lacZ as control",pert
"skin fibroblasts, passages #2 and 4",ctrl
GATA6 KO #1,pert
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
AKT_PLACEBO_48hours_4,pert
"Proximal, Small Intestine 21 days old",ctrl
SZ9,pert
"Cell type: neuronal, age:41, gender:female, diagnostic group: bipolar disorder, PMI:28h",pert
Control subject 117_biological replicate 1,ctrl
24A;pretreatment;female;breast tumor; not assessable,ctrl
hES_SA01_1,ctrl
RBP2-/- MEF(1),pert
AtT20 cells treated with NSBP1 siRNA rep 2,pert
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 7;	Brain pH: 6.39;	Post mortem interval (hours): 48;	Side of brain: Left;	Fluphenazine mg. Equivalents: 9000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
Astrocytoma_5,pert
duration of untreated disease in month:105.6;	age at onset:2.6,pert
Healthy control 2,ctrl
MDS patient 64,pert
cell line: T47D;	treatment: contol,ctrl
Osteoblasts_Lrp5_Control_Day7_rep4,ctrl
SZ17,pert
H14 HA 6h 4,pert
HF1325_U133P2,pert
Bone Marrow Healthy Donor,ctrl
sample 1:;	age: 58;	gender: male;	sample 2;	age: unknown;	gender: unknown,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),ctrl
"Ulcerative Colitis (63 year old caucasian female, SAK_1318991541)",pert
"brain, frontal cortex: Sample61_e1_le1",ctrl
CML-BM 7,pert
"Mouse, WT, colon, UT, rep1",ctrl
MCF10A_HER3_1,pert
C014_Control_M91,ctrl
unstimulated CD8+ T-cells from Wt C57BL/6 mice,ctrl
"p38alpha wild type fetal liver E13.5, biological rep2",ctrl
RA4,ctrl
miR122-KO-69-T,pert
cRNA;	embryonic day 18;	NFIA deficient,pert
FmrWT4_brain,ctrl
"Male F344 rats, sacrificed at the age 18 weeks",ctrl
G392E_on_rep1,pert
genotype: T-ALL;	sample type: DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma);	genetic background: WT C57/BLACK6;	cell type: DP (CD4+/8+) cells,pert
U87 20 uM Temozolomide,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 6,ctrl
Waldenström’s macroglobulinemia (WM-BL 33161),pert
"patient: 102;	current medication: Movicol 1 sachet daily;	birth date: 9/5/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: RIF pain, persistent anaemia.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
BL Day 0 Untransfected biological rep3,ctrl
phenotype: control;	gender: male;	case_id: 507;	age: 52;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 32;	brain ph at time of freezing: 6.76;	labeling_batch: 2,ctrl
"Tibialis posterior, TMD",pert
N11,ctrl
3871-1 E2F WT,ctrl
normal sigmoid colon of adult,ctrl
Normal cervix_05-4959,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep3,pert
WT - Cre Treated - 24 hrs - repeat 1 - Cy5 - mAdbID:61765,ctrl
HeTH-4  THOC1-depleted,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 25;	maternal age: 24,pert
HT29 DMSO Day1 rep2,ctrl
S-IIP(UIP)7_Cy3,pert
shNANOG_5,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 24h,pert
Testis WT 0h batch 3 [TeWTh00.20],ctrl
"Bmi1 shRNA, biological rep2",pert
MCF7_E2_24h_rep3,pert
"LCL GM19238, Kd IRF8, 72hrs",pert
cell line: mOS482;	cell type: osteosarcoma,pert
NORMAL #99-0694,ctrl
"Patient  C, lesion, 1 week",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
age: 10-week old;	sex: male;	strain: C57BL6;	tissue: liver,ctrl
"RPMI8226_shKLF2#1, replicate1",pert
race: caucasian;	age (years): 68;	stage: IA;	grade: 3;	histology: endometrioid,pert
brain knock out replicate3,ctrl
mESCs_Tip60KD_rep2,pert
b44+,pert
"WT caudal vertebral bone, rep1",ctrl
"control endometrium, patient 20",ctrl
pD  is a clonal control (puromycin resitant) stably-expressing stem cell line,ctrl
MCF7_EtOH_24h_rep4,ctrl
0199-01-C,ctrl
"KO+Empty, biological rep2",pert
"ES cell line, RNA 73",pert
cell type: Anaplastic thyroid carcinoma;	expression: HTH83 SCR shRNA;	cell line: HTH83,ctrl
race: caucasian;	age (years): 80;	stage: IC;	grade: 2;	histology: endometrioid,pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 8",pert
2h Kin- Cel.41,pert
"array 19, unimplanted",ctrl
PE_D_594,pert
Colon_POR-null_1,ctrl
midbrain_wild type_24 weeks_replicate 2,ctrl
Brain_Adult_LPSip_4hr_mouse1 (YL1_#64),pert
BDC2.5/NOD.scid_1,pert
mouse cerebellum at P30 wild type 3,pert
Nuclear RNA_KO_rep2,pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
EB_0_8d_66_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
B10.H2g7 Idd3_T1,ctrl
DEX treated rep 2,pert
"Lesional skin from K5-Tgfbeta mouse, biological replicate 3",pert
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 35week,ctrl
Huh7_TGFbeta_minus_2,pert
disease: AML;	bcor mutation: BCOR mutation;	karyotype: normal karyotype,pert
5262 UC Inflamed sigmoid colon,pert
"skeletal muscle, quadriceps",pert
CA1 hippocampus,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
Bronchial Epithelial Cells MMA biological 1973Q,pert
2d-IR-76,pert
Liver_Nrf2 KO_rep3.,pert
MCE301 cells treated with SB for 6 h-1,pert
RNA from HCC_15T,pert
type 2 diabetes subject 02,pert
cell line: MCF-7 breast cancer cell line;	agent: SFM (control);	time: 24hr,ctrl
HCC PBMC_sample 7,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1tetO-Nanog/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: liver,pert
U-87MG-PK25 set 1,pert
glioma cell line,ctrl
"10 days old normal mice, cerebellum",ctrl
H295R_Group_B_Dose_100_TIMEPT1_008,pert
"Liver from control exposed rats, biological rep 3",ctrl
Parkinson's Disease;	female,pert
"differentiated U937 cells, 1uM curcumin treated, 4h",pert
"DMSO-treated, sham UV exposed",ctrl
Bronchial Epithelial Cells control biological 2052D,ctrl
HepG2_control_rep3,ctrl
chip number: 16;	transfection plate: 4;	target gene: IRF5;	kd level: 0.63;	rin: 9.3;	transfection date: 2011-10-17,pert
Nrl-ko-Gfp P10 replicate 3,pert
Ex1_cells_rep1,pert
SRF Wt. IgM+IgD+ (GBF0610),ctrl
Individual_5023_NN_sample,ctrl
NOD non-transgenic islet rep2,ctrl
V5-P357,pert
SCC-2_siScramble_rep.2,ctrl
"shControl cells, rep2",ctrl
"BT474 breast cancer cell line, lapatinib",pert
cell line: HeyA8;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
tissue: oropharyngeal carcinoma KB,ctrl
"primary cortical neurons, MEF2D shRNA",pert
"breast, post AF treatment (H4_1328)",pert
KO - knock-out Treated - 24 hrs - repeat 1 - Cy5 - mAdbID:61772,pert
5025-scrape,pert
CLC5 ko rep 1,pert
"Mouse invivo nTreg cells, replicate pool 2",ctrl
Diaphragm 23 Day mdx rep 2,pert
"E18.5 ERRg +/+ heart, biological rep 2",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 73;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
NHE3-/- replicate 2,pert
"BMMCs from NTAL WT, noninfected, 2 h activated, biological rep1",ctrl
IM19_case,pert
PKBa-/- MEF time 0 replicate 1,pert
patient: 28;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
02 CF,pert
BL Day 1 siMut10 transfected biological rep2,pert
Wild Type Skeletal Muscle Sample (Intercostal),ctrl
AKR/JTCE liver sample batch 3,pert
pancreatic cancer cell line MiaPaCa2 containing empty vector pCEP4,ctrl
Saline treated mouse gallbladder 1,pert
NPC_wt_rep3,ctrl
GV oocyte_Rnf2 mut_rep3,pert
219/0,pert
"SUDHL-1, Treated by ALK inhibitor repl 3",pert
T55 Non failing heart biopsy,ctrl
NK_cell_pool_healthy_H11+H12,ctrl
CLL 69-04 LMP-420,pert
fibroblast cultured from normal esophageal tissue_HEF_75,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: control shRNA,ctrl
Nrl ko 2 mon replicate 4,pert
PS_IB_3_cauc_lcm,pert
"Gender: Female, Age: 25, BMI: 32, Tissue: luteinized cumulus cells",pert
MCF7 control siRNA Estradiol Rep1,ctrl
"PCOS, biological rep 1",pert
"acutely admitted, severely psychotic schizophrenia patient  A24",pert
MelJuSo cell line,ctrl
Wild-type anterior prostate 2,ctrl
01N41_ERA,pert
2008-Ets1 cells_rep2,pert
"lymphoblastoid cell line from T21.01, one out of seven of insensitive group, 50*10e6 cells",pert
sample =Healthy4 treatment=Stimulated time=360 (min),ctrl
"AG825-treated, 24h after UV, Replicate A",pert
P0 - WTMixB 3,ctrl
wt_TGFb_24hr_2,ctrl
HW_1089,ctrl
L_LS_Wk4,pert
"schizophrenia, BA46-25",pert
"age at diagnosis: 68;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3;	er: 0;	pgr: NA;	dfs-month: 5;	dfs-event: 1;	distant metastasis: 1",pert
sample 1:;	age: 41;	gender: male;	sample 2;	age: 66;	gender: female,pert
H08_P_B2,pert
V5-P057,pert
ab164 IM,pert
E12 distal retina progenitors_mutant_rep 1,pert
TLR4 null sham kidney,pert
"brain, cerebellum: WCb4w#1_e1_le1",ctrl
HE_3,pert
11_0027C_Day1_30,ctrl
KO - 3 mo - repeat 5 - Cy5 - mAdbID:74671,pert
"fibroblast, control subject NM4 rep 2",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
PFC R control 2,pert
MEFs were treated with an nonspecific adenoGFP virus.,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 63;	donor: 20;	disease state: Lesional,pert
"Du145-PCAT1 NT siRNA, replicate 2",ctrl
mouse TMJ-cartilage from wild type mouse WT_Tal3,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Tongue;	age: E14.5;	gender: Not determined,ctrl
"21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 2,ctrl
ONH moderate glaucoma,pert
C57BL6,pert
Male wild-type (C57BL/10SnJ) mice were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,ctrl
MDS patient 128,pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 8hr,ctrl
age: 50;	sex: M;	disease status: control subject;	Filter number: 89;	Usage number: 1;	Exposures: 3,ctrl
PsOEt-20-LS,ctrl
"brain, cerebellum: RNA#34*_le1",ctrl
Subject 1_t=30days_placebo,ctrl
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: Regular chow diet,pert
hippocampus,ctrl
human_hepatocyte_400uM_Trovafloxacin_donorA_24hr_prep1,pert
hES_VUB03_DM1_1,pert
HDAC1_knock_out_embryonic_stem_cells_biological_rep1,pert
OBF-1 overexpression BCS-1 (EPLM),pert
Run5.aUa.010110d.SkmDbt2447D.CEL-DB basal,ctrl
4_day_old_wildtype_mouse_rep2,ctrl
"Neural precursor cells derived from hES cells line SA01, biological replicate  1",ctrl
Keratinocytes_siANCR_rep2,pert
Muscle-24 month-wild type-technical replicate 3,ctrl
control-plusDox-rep3,ctrl
remitted schizophrenia patient  S20,pert
Eed KO J1 ESCs on day 7 #2,pert
E99-/+SRFVP16-2,pert
KU_01N,ctrl
"fibroblast, MFS subject FB969 rep 3",pert
disease: Down syndrome;	gender: female;	age: 1 year and 6 months;	tissue: thymus,pert
45 year old male,ctrl
SOCS3 Cre minus C,ctrl
KU_11T,pert
At Risk: +;	Age: 4;	Sex: F,pert
BP4,pert
status: Normal;	age: 58;	gender: female;	tissue: cultured human fibroblasts,ctrl
OVCA429-(3),ctrl
"midbrain,18month,WT",ctrl
lrrk2 genotype: GS / GS,pert
Human skeletal muscle biopsy sample;	Patient #80 with PM,pert
mouselung_wt_control_rep01,ctrl
cell line: MDA-MB231;	treatment: control shRNA;	media: DMEM,ctrl
Tsc1-deficient CD4 naïve cells KAI276,pert
"AZ521 dnSox2 cells, uninduced, 8h",ctrl
lrrk2 genotype: GS / WT,pert
cell type: Pancreatic ductal adenocarcinoma;	cell line: CAPAN2;	transfection: lentivirus carrying shRNAs targeting LLGL1 transcript,pert
0167-01-C,ctrl
Human Uninfected Sample N071-CD4+ T cells,ctrl
cell type: Human melanoma cell line;	cell line: M229;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
cerebellum_WT_10d_rep2,ctrl
"schizophrenia, BA46-55",pert
cell line: Normal bone cell line 695;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),ctrl
MLL_00124,pert
1132-03-A,pert
"iPSC derived from healthy control fibroblast WT3, biological rep8",ctrl
"mouse back skin, wild type",ctrl
PBMC from T cell LGL leukemia patient #133 (TLGL133),pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep2",ctrl
"Control Proximal, Small Intestine 3 21 days old",ctrl
patient: 51315;	sample: tumor,pert
"Fetal lung, CD-1 background",ctrl
"Peripheral blood, normal control [N67]",ctrl
CON19,ctrl
n7t7d,pert
PB_DON088,ctrl
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 1;	age: Post natal day 3-7,pert
Diagnosis: AML M2;	Age: 44y ;	Gender: Female;	Blast %: 75;	Source: BM;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
0653-01-C,ctrl
CRC_nodrug_F4881,ctrl
RV63.12_CHF_day19,pert
Total RNA from cervix,ctrl
Waldenström’s macroglobulinemia (WM-PC 31098),pert
INCB18424 Persistent 2,pert
prostate tumor 1,pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep2",ctrl
"Data 1, Vbeta5",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.50137,pert
128B,ctrl
"D425-control, t=0",ctrl
"nasopharyngeal carcinoma, specimen T22",pert
RNA from whole tissue section of case 374 labeled with Cy5,pert
HCT116_shBgal-rep2,ctrl
"LNCaP cells, treated with R1881, biological rep 3",pert
Healthy9-CD4,ctrl
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 35;	maternal age: 24,ctrl
"Uninfected TG at 5 d.p.i., rep4",pert
status: Control;	gender: Female;	age: 53;	tissue: Blood,ctrl
brain_DLPFC_bipolar B_mr646,pert
"Peripheral blood, patient without recurrent events [N32]",pert
"Acute Myeloid Leukemia, sample 48",pert
T151,pert
NSC_ X5050_24h_biological rep1,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 28, stage IIIB, HPV 45",pert
Septic shock;	gender: Female;	Survivor;	organism: Neisseria,pert
3449-1 E2F WT,ctrl
t17,pert
NSCL/P sample 1,pert
NPC Brain 67d Mouse1,pert
SV cells isolated from inguinal White adipose tissue,pert
Kidney_saline ip_mouse #066,ctrl
A549 siRNA FAM60A CNTRL 1,ctrl
short-Rif1 KD rep2,pert
"Ls174T, β-catenin siRNA, uninduced",pert
left hippocampus of control mice,ctrl
cerebellum_PSNA_ 4w_rep2,pert
NMRI_24h_DMSO,ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, mannitol (5% final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",ctrl
Subject 3 / lung subsegment instillated by Saline,ctrl
WT_TER119+_rep4,ctrl
A263insGG_mut3b+,pert
Cervical cancer_CC126,pert
A/J Vehicle liver sample batch 3,ctrl
tissue: blood;	patient: 7;	gender: male;	age: 25,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P2,ctrl
Sarcoma cell line  - Dicer Heterozygote -rep1,ctrl
genotype/variation: c-Myb deficient;	age: 4-5weeks,pert
N15,ctrl
"thymus, DS",pert
HCC_21N,ctrl
HT29 sensitive cells replicate 3,pert
MPM tumor specimen 30,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.9;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
"Spinal Cord, Epicenter (~T8)",pert
sample =Healthy2 treatment=Control time=0 (min),ctrl
Human skeletal muscle biopsy sample;	Patient #133 with NORM,ctrl
Bronchial Epithelial Cells MMA biological 1815Y,pert
total cellular RNA from Jurkat T cells,ctrl
KO - knock-out Untreated - 0 hrs - repeat 1 - Cy3 - mAdbID:61726,pert
Biceps_Pompe_5,pert
CD-48-un2,pert
homozygot FH P253,pert
"Hdh knock-in embryonic stem cells, Q111 line, biological replicate 3",pert
Human cell line,pert
CML_5_CMP,pert
GLY replicate 2,pert
BL Day 2 siMut10 transfected biological rep1,pert
Brain_Wild-type_MiceNoLT346,ctrl
Brain_Adult_Salineip_4hr_mouse3(YP3_#60),ctrl
"Chromium 10 µM, biological rep4",pert
BxPC3-KO111 rep 6,pert
Control 11,ctrl
19 olanzapine,pert
Postnatal 12 weeks mutant heart biological rep1,pert
whole kidney from KO mice,pert
WT-control-1,ctrl
genotype/variation: control;	tissue: skin;	age: 32 days;	sex: male;	strain: C57BL6 X DBA2,ctrl
"Wild-type retina, biological rep2",ctrl
disease state: hepatocellular carcinoma;	cell type: Peripheral blood mononuclear cells,pert
Nasal Epithelium Inhalation Formaldehyde 2ppm 8d ID220,pert
AtT20 cells infected with empty vector rep1,ctrl
strain: C57BL6;	genotype: PDE10A KO;	tissue: striatum;	treatment: vehicle control,pert
mdx5cv TA sample 2,pert
lesion_preUV_patient6,pert
MCF7 cells,pert
WT - Cre Control - 5 mo - repeat 4 - Cy3 - mAdbID:74104,ctrl
Colon_POR-null+quercetin_3,pert
No or early 1 rep3 (OHN),pert
Sample 10 Kidney Hyp Mouse - Low Phosphate Diet,pert
Huh7 cells_JFH-1 Infected 12 hours_ rep2,pert
Supraoptic nucleus_1d dehydrated,pert
APLP2_R1_rep2,pert
"gender: Female;	age: 87;	post-mortem delay: 5.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Normal_MS 36C6,ctrl
appendix sample removed from patient who went to the operating room with the diagnosis of acute appendicitis,pert
sMPNST_Vehicle_2day_rep2,ctrl
genotype: HDAC6 knock out,ctrl
Sex: female;	Age at operation: 70 years;	Site: thorax;	Size in cm: 1.9x1.3x1;	Histological Subtype: pleomorphic liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: residual tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"10 week, mutant;	SOD1(G93A)",pert
Carboplatin 30 hours set 1,pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: wild type;	agent: control,ctrl
con-7_B,ctrl
n11t6h,pert
CML_2_HSC,pert
"Tg brain, biological rep1",pert
Liver GPR120KO HFD #427,pert
"A673 treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50), biological rep2",pert
MPM tumor 16,pert
SA2117_muscle_mutation,pert
Clcn5 knockout in proximal tubules of mouse kidney,pert
Carbo Day2 (410L),pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Ileum",pert
Colorectal cancer cell line HT29,ctrl
cell line: COLO829 melanoma cell line;	genotype/variation: MITF knockdown;	agent: BRAF inhibitor PLX4032 (Vemurafenib),pert
"fibroblast, MFS subject FB969 rep 1",pert
cell line: HUVEC,pert
Seguin_IDR_BrownNorway_Liver_treated3,pert
wt-Gfp 4 weeks replicate 3,ctrl
"human failing LV myocardium, Ischemic31",pert
RTX1 T0,ctrl
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
28 Day Mouse extraocular muscle,pert
"Nickel 400 µM, biologcial rep3",pert
12 h-apra-10 nM,pert
HF1334_U133P2,pert
INF-156,pert
CT-receptor-KO osteoclasts treated 3,pert
Run1.a10a.000607jd.2.SkMNor917.CEL-IS basal,ctrl
KM_076T,pert
PBMC from T cell LGL leukemia patient #1375 (TLGL1375),pert
KL6_muscle_control,ctrl
"granulocyte, patient. Mtx rep1",pert
HCC_18T,pert
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: no,ctrl
"Mdr2-KO heterozygous mouse, 12 month old mouse 2",ctrl
normal lung tissue,pert
"fibroblast, MFS subject GDO1051 rep 2",pert
Normal cervix epithelium_CaCX3,ctrl
colon_normal_1081,ctrl
Tgfbr2 fl/fl Control Posterior Palate 3,ctrl
V5-P390,ctrl
MLL_00248,pert
LNCaP cells treated with R1881 and control shRNA,ctrl
"lymphoblastoid cell line from F1.02, one out of seven of sensitive group, 50*10e6 cells",ctrl
0466-01-C,ctrl
wild type primary mef,ctrl
Haloperidol treated 12weeks AffyGC RMA rep1,pert
SIRT1 LKO liver_4 pm_rep3,pert
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 15.3, Strain:DBA/2J",ctrl
tracheal tissue,ctrl
S-IIP(UIP)11_Cy3,pert
Age: 42;	Cycle: NA;	BRCA1/2 mutation: BRCA1 3875delGTCT;	Family History: No,pert
MCE301 cells treated with SB for 12 h-1,pert
"Rat liver, treated with ANIT, 125 mg/kg in corn oil per orally, extrated 48 hours after treatment, biological rep5",pert
MGHU3 Cells_TAK1 siRNA + PD173074_Biological Replicate 2,pert
Mouse: strain C57,pert
"650nM MLN4924 after 1hr, replicate 2",pert
Muscle control 11,ctrl
strain: FVB/N;	genotype/variation: Bmpr2-delx4+ mutation;	cell type: pulmonary vascular microendothelial cells (PMVEC),pert
"heart, middle septum",ctrl
colon_epithelium_C57mouse_6weeks_rep4,ctrl
RNA from whole tissue section of case 772 labeled with Cy5,pert
Pt32_Pre,ctrl
Muscle JDM (YJD-JDM-13UA-s2),pert
LDLR_HF_1,pert
Embryonic stem cell,ctrl
primary mouse embryonic fibroblasts,pert
"BOEC, not_at_risk 9",pert
Patient identifyier: B;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 15 years;	Body surface area: 6 percent;	Overall erythema: severe;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"P10 mouse back skin, ADAM17 cKO",pert
33SMOKEH,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, mock",ctrl
BALB/c d18 (bmsnmix1),pert
"vehicle, biological rep1",ctrl
colonic_mucosa_non_inflamed_125,pert
H69_TGX221_2,pert
remitted schizophrenia patient  S21,pert
Human Neural Stem Cell Line F3 Overexpressing NGN1 (replicate),pert
fibroblast_5azatreated_rep3,pert
Untreated Melan-Ink4a #3,ctrl
"postnatal 3~5 days, mixed gender, C57BL6/129 mixed background",ctrl
age: 29;	sex: F;	disease status: Marfan subject;	Filter number: 93;	Usage number: 5;	Exposures: 3,pert
SD rat femur,pert
Skinbiopsy from patient with atopic eczema,pert
5265 UC Inflamed sigmoid colon,pert
Early IPF_surgical biopsy_upper lobe_rep145,pert
"ID:1-1, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
A_AN08792_T,pert
37 year old male,ctrl
"Primary lymphoma cells, isolated from lymph nodes of Emu-myc,Suv39h1-/- mice and retrovirally transduced by Bcl2, untreated",ctrl
age_years: 51;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
"Global gene expression of NASH patients, P35",pert
"GFP Alone, Replicate 2",pert
"Normal cervix epithelium, Age 50",ctrl
IPMA 5,pert
Nasal Epithelium Instilation Formaldehyde 400mM 6h ID369,pert
FR-control-3,ctrl
MLL_PTD07,pert
genetic background strain: C57BLKS/J;	tissue: Neuroretina;	age: 8-week old;	genotype: db/+;	phenotype: lean non-diabetic,ctrl
10.5 Months Heart Control rep 3,ctrl
human fibroblasts overexpressing progerin,pert
M13 - non-infected MBT/Pas fibroblasts,ctrl
erlot5_CT36,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
PBMC normal sample RNA,ctrl
neuron_rep4,ctrl
Bone-Marrow_SMM_S1220,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 72,pert
ATF6-MER TG mouse_tamoxifen2,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, DMSO-treated",pert
"RNA from Cell line SLM2, mutant status WT, condition Treated with Sorafenib",pert
heart of mouse subjected 1 week to chronic intermittent hypoxia (1B),pert
Liver_experimental mouse,pert
genotype: Tsc1-deficient;	cell type: CD8 naive cells;	genetic background: C57BL\6,pert
"DMD skeletal muscle, biological rep17",pert
Backskin_Get1_e18,ctrl
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. PMID: 12888219 [PubMed - indexed for MEDLINE]",pert
"seminoma specimen, pT2, patient age: 34y; W03 031",pert
"Ishikawa cell line, BPA, 1pM, 48hr",pert
control IgG,ctrl
Diaphragm 112 Day mdx rep 1,pert
mutant testis at 17dpp,pert
Series 3; adult; 6 weeks after fracture,pert
17beta estradiol: 30 pM,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: Wy14643;	time: 6h;	gender: Female;	age: 5 months,pert
PsOEt-18-Week 2,pert
TTP_WT_60ActD_BioRep1,pert
56 Day Mouse Diaphragm muscle,pert
normal liver tissue,pert
tissue: testis;	genotype: ClpP KO;	genetic background: C57BL/6,pert
E18.5 Embryonic Liver,pert
Squamous cell carcinoma 011,pert
normal adjacent esophageal tissue from patient E1535,ctrl
"Pten F341V epithelials cells, biological rep1",pert
race: caucasian;	age (years): unknown;	stage: IC;	grade: 2;	histology: endometrioid,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Kidney_Biopsy_Liver_Disease_2,pert
multiple sclerosis_3,pert
CHF - LV15,pert
cell line: HL60;	disease state: promyelocytic leukemia,ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 24h ID214,pert
human lung,ctrl
Transgenic 1,pert
Tmod3 KO-1,pert
age: 60;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
CF CFTR unexposed replicate 1,pert
P0 - epsilon129s6 1,pert
Human umbilical vein endothelial cells (HUVEC),pert
Dilated cardiomyopathy_G9,pert
Control gray matter 1,ctrl
female_alcoholic,pert
Thyroid_ unaffected_paired with PTC50T,ctrl
timepoint: Post-Cediranib treatment,pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 72hr,pert
"Cervical cancer cell line, CaSki",pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14533;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Crohn's Disease subject (52 year old caucasian female, SAK_1307747342)",pert
cell line: MDA-MB231;	treatment: none;	cell type: metastatic breast cancer cells,ctrl
"ALL_DS, K17 011409",pert
strain: C57BL/6;	genotype: Wild Type;	replicate: 3,ctrl
CH2122,ctrl
VillinCreERT2+_Brg1fl/fl_Rep4,pert
RatLung_H3h_1,pert
MCF-7_parental_cell_rep_1,ctrl
Healthy7-CD4,ctrl
CF knockout LFCF CHN309,pert
"transfection: pRTS-GFP;	cell type: human Burkitt lymphoma;	dsmz no.: ACC 603;	origin: established from the ascitic fluid of a 3-year-old boy with American-type Burkitt lymphoma in 1972; cells were described to be EBV-negative but EBV infectible, to carry the (8;14) translocation and p53 mutations",ctrl
"MEKi 4 days, biological rep6",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 1,pert
"Wild-type Liver, replicate3",ctrl
cell type: T cell;	treatment: 37C;	genotype: HSF1-/-;	genetic background: mixed 129Sv.BALB/c background,pert
genotype/variation: control mice treated with tamoxifen for 1 week;	tumour stage: Benign tumour,ctrl
"CL1-0, biological rep2",ctrl
OCI-Ly7 NTsiRNA 1,ctrl
WFS1 WT USHT_19_320_ko,pert
cell line: OVCAR-10;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
wild-type+PQ rep_1 (PQWT1),ctrl
"Wildtype, thymic, NK1.1+ NKT cells replicate1",ctrl
gender: female;	batch: 1;	age (years): 33;	patient id: Control_6;	fev1 (% predicted): 116;	fvc (% predicted): 115;	medication: None;	cell type: CD8+ T-cells,ctrl
Preglaucoma control rep8 (OHN),ctrl
hepatoma cells,ctrl
"U373-EGFP, rep 3",ctrl
MacularDegen-injured-7dAv2-s2,pert
WT4-iPS 2,ctrl
"BALB/c, Female, Control",ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: Rosiglitazone,ctrl
Cervical cancer_CC207,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 33;	maternal age: 27,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 97;	Usage number: 5;	Exposures: 3,pert
"control colon tissue, biological rep3",ctrl
C57 72 ozone 3,ctrl
CD34+ cells of CML patient before therapy,ctrl
pcDNA3(CT3),ctrl
B6 Control R3,ctrl
Embryonic age 14.5 wild-type rep1 (PKD1_34),ctrl
Pool 5 Convalescent stage,pert
Ishikawa_HighDose_BPA_24h_rep3,pert
ATCC CRL-1555,pert
PGA-HMO-Obese-6aUA-s2,pert
3DKD_rep2,ctrl
control AU055103,ctrl
LSK cells from heterozygous JAK2V617F mouse rep1,pert
"DOX, rep2",pert
pRb+/+;p107-/-.1,pert
IFNAR_uninf_2,pert
HF0897_U133P2,pert
Age: 48;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
c57BL/6J Vehicle liver sample batch 3,ctrl
NALT_infected_24h_90-226-dM_rep3,pert
cerebrum_PS-/-_ 10d_rep2,pert
normal mouse embryonic kidney day 12.5,ctrl
SeroNeg-5,ctrl
Braak α-synuclein 3-4 BR34_1SN,pert
KO STR Veh 29,pert
KOPT-K NBD 1,pert
braak stage: CTRL;	rin: 74;	tissue: substantia nigra;	disease state: control,ctrl
P4 Ovary cultured for 48 hours with no treatment,ctrl
CON 1,ctrl
wild-type naïve CD4 T cells KAI264,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.68219,pert
Aorta_APOE-deficient with atherosclerosis_1,ctrl
Tumor,pert
"Acute Myeloid Leukemia, sample 13",pert
cell line: HEK293;	sirna: hCdc73;	condition: sparse,pert
Muscle PCOS after pioglitazone 232,pert
minor HCC8,pert
LP50 cells treated with vehicle and control shRNA,ctrl
cell line: non-clonal BMSC cultures;	transfection: siTERC-RNA (siTERC) construct,pert
Sex: male;	Age at operation: 76 years;	Site: thigh;	Size in cm: 3.5x3x3;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
Subject #8040-2d Postinfection,pert
ab161 N,ctrl
Prostate Cancer_MS 36C2,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.2;	colon weight (mg): 159;	colon ratio (mg/mm): 2.56;	myeloperoxidase activity (u/mg): 0.391;	tissue: colon;	treatment: 5% DSS,pert
C57BL/6 heart left ventrical (LAD ligation 60 day),pert
Diabetes 2,pert
Raji_mi-142-3p_3,pert
parental HeLa cells,ctrl
sample =XCGD1 treatment=Control time=360 (min),pert
Ishikawa_Control_48h_rep2,ctrl
Control Colon 2 17 days old,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 57;	baseline tumor size (cm): 5x5;	patient id (to identify the 2 chips from the same patient): 19101935,pert
mdx Biological Replicate 6,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#1375,pert
normal 2266,ctrl
SA4,ctrl
vacht KD 2,pert
KO2 CD11b,pert
FVB 129 mice used as bone marrow donors,pert
Human prostate cancer primary culture C14sx,pert
Tissue:tumor; Gender:male; Age:56; Tumor stage:T4N0M1,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 5,ctrl
"expression at 16hr, bio rep3",pert
no_18,ctrl
HLA risk: Medium;	Height: 162.5 cm;	Weight: 53.4 kg;	BMI: 20.2;	Age: 13.03 years;	Gender: Female;	Race: White;	Glucose: 81 mg/dl;	HbA1c: 7.8%,pert
Male 8week AJ sham rep2,ctrl
WT-GFP-lamin A Induction: Day 0 Replicate A (CBGE_Hsapiens_WG_progerin1),ctrl
"Patient  D, lesion, 1 week",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 184;	fata: 69;	eea: 2080;	wtkg: 109.2;	perfat: 30.1;	lbm: 68.9;	fat_mass: 3286.92,ctrl
RNA from microdissected breast cancer cells from case 871 labeled with Cy5,pert
control_16hr,ctrl
Muscle PCOS 3,pert
Ishikawa_HighDose_BPA_24h_rep4,pert
coc-51_B,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 42 yr;	population: white;	dsm-iv: 295.3;	age of onset: 18 yr,pert
VIN_B060,pert
3898-1 E2F1 Null,pert
Insm1 control #2,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, T1 (treated with resveratrol)",pert
Bc_Mock_2,ctrl
CA95-198B,ctrl
K562 cells control replicate 3,ctrl
SCD1 +/+ liver rep3,ctrl
"NC1, biological replicate 4",ctrl
WT AA 4,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 35, stage IB1, HPV 18, HPV 45",pert
"vestibualr organ at P90 of Igf1 -/-, biological rep 2",pert
cortex_HtrA2_KO_rep3,pert
NOD_S2,pert
subject: 37;	disease: CP;	muscle: GR;	gender: M;	age: 8.7;	gmfcs: 2;	popliteal angle: 95,pert
knockdown: Control;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 7.7;	colon weight (mg): 169;	colon ratio (mg/mm): 2.19;	myeloperoxidase activity (u/mg): 0.039;	tissue: colon;	treatment: 5% DSS,ctrl
strain background: Sprague Dawley;	gender: male;	diet: Lieber-DeCarlie diet containg EtOH for 6 wk;	sample group: Alcohol ingestion;	cell type: Alveolar type 2 cells,pert
Pfeiffer NTshRNA 3,ctrl
Amniocytes_euploid_1567,ctrl
CH1-(3),ctrl
DMSO treated CEM-C1 cells_3,ctrl
"D425-shOTX2_3, t=8",pert
WT kidney pool 1,ctrl
"human failing LV myocardium, Ischemic100",pert
"E-FABP knockout GM-BMMs, biological rep3",pert
Endometrium-Normal 8,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_6h_1mM_HG-U133A_2_YCHSUP501,pert
treatment: baseline;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
"Control, biological rep1",ctrl
HepG2_Cd rep2,pert
E2F2 Null,pert
NICM pool 2 (n=2),pert
"E12.5 wild-type embryonic kidney, biological rep3",ctrl
AZ-521_doxycycline_12h_rep2,pert
wt Ang2,ctrl
Cyclophosphamide-treated bone marrow 1 day - Biological Replicate 2 - Technical Replicate 1,pert
RNA from whole tissue section of case 319 labeled with Cy5,pert
Sham 7,ctrl
"Control fetal heart (vehicle treated with corn oil via oral gavage on gd14.5, collected on gd17.5)",ctrl
"BOEC, normal 20",ctrl
cortex_WT_rep2,ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 2,ctrl
WT-smoke-med-1 day-R4,ctrl
"human embryonic stem (hES) cells line VUB01, biological replicate  2",ctrl
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle,ctrl
mouse spinal cord,pert
cell line: U87;	treatment: 20 uM Temozolomide;	cell type: glioblastoma cancer cell line,pert
Ileum_POR-null_2,pert
0137-01-C,ctrl
MDS patient 175,pert
"100-200 motor neurons, sacral spinal cord, 60 days post injury",pert
WT - Cre Control - 3 mo - repeat 4 - Cy3 - mAdbID:74672,ctrl
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,pert
"Dumbo retina, biological rep3",pert
iFGFR1 mammary gland 8 hr AP20187,pert
AA_Control2_CD8,ctrl
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 0.1 μM;	agent: VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothiolate),pert
APP_R6,pert
HCC007N,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
Primary hepatocytes isolated from NMRI mouse strain treated with Wy14643 for 6h,pert
control participant P350 (human CD3 positive T cells),ctrl
phenotype: alcoholic;	gender: male;	case_id: 290;	age: 51;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 46;	brain ph at time of freezing: 6.35;	labeling_batch: 1,pert
T141,pert
"lateral prostate, PTEN+/- epithelium, 12 months",ctrl
Human normal prostate tissue,ctrl
Human prostate cancer primary culture C29dx,pert
"fetal liver, wild type",ctrl
G93A mouse 801,pert
Liver experimental mouse,pert
NORMAL #99-0583,ctrl
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
M249_R4_A_DMSO,ctrl
miR122-WT-163,ctrl
cell line: U937;	replicate: Replicate1;	treatment: shSYK_2,pert
RNA from HCC_36T,pert
control5,ctrl
NSC5,pert
Control bone marrow - Biological Replicate 4 - Technical Replicate 2,ctrl
Mutated-ERα-positive breast cancer 71,pert
Mouse Reference,pert
Skin_WT_1,ctrl
HT29RC PLX4720 resistant cell line,pert
KO Ang4,pert
Estrogen [H3],ctrl
T62 dilated cardiomyopathy heart biopsy,pert
"Epididymal fat, knockout",pert
"Normal skin from lmq_control mouse, biological replicate 1",ctrl
Day: 6; Drug: Saline; Phase: Drug treatment; Replicate: 3,ctrl
multiple myeloma (MM 500),pert
EB_0_6_322_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 67;	baseline tumor size (cm): 9x7;	patient id (to identify the 2 chips from the same patient): 12791332,pert
P91,ctrl
MPM tumor specimen 4,pert
A673_CloneAsp14_Dox_72h_2,pert
Ebola-infected macrophages harvested at 6h post-treatment from donor 3,pert
DU145_VprBPsh_rep1,pert
prostate_Klf5 wt_rep1,ctrl
KO_72_O3_4,pert
Individual_4160_PN_sample,pert
NLGN1_3,pert
Gene expression profiling of normal cortex of patient 260,ctrl
Sex: male;	Age: adult (11-12 weeks),pert
AGS_control,ctrl
B9_092612,ctrl
Muscle PCOS control 9,ctrl
MO_DH3b_SON_NCBI,pert
Squamous cell carcinoma 015,pert
PancreaticSample24-Tumor,pert
pediatric AML PP2,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.01644,ctrl
DNGH-2,pert
0514-01-C,ctrl
"human failing LV myocardium, Idiopathic47",pert
"Normal 11, control tissue",ctrl
"eye, retina",ctrl
Against CDK19-2 rep3,pert
NPC Brain 54d MOuse1,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 230min;	race: White;	sex: Female,pert
Control replicate 4,ctrl
liver_STZ 0.5% quercetin diet_rep1,pert
"treatment with TFMPP, replicate 3",pert
IRS-4 KO (jos0931),pert
"Lung, Sporadic Idiopathic Interstitial Pneumonia (S-IIP), Usual Interstitial Pneumonia (UIP)",pert
Trasnsformed Lymphocytes Bipolar Disorder Affected (Affected pateint of MZ twin pair 2),pert
shNANOG_7,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep4",ctrl
control9,ctrl
Frontal_Cerebrocortex_Vehicle_6hr_rep7,ctrl
chip number: 23;	transfection plate: 3A;	target gene: SP3;	kd level: 0.59;	rin: 9.4;	transfection date: 2012-03-26,pert
MOLF/EiJTCE liver sample batch 3,pert
HMEC_50 vs BT20,pert
"Epidydimal white adipose tissue from ASC-/- after 16 weeks of high fat diet feeding, replicate 3",pert
Bone-Marrow_MGUS_G991,pert
Strain: C57BL/6J;	Gender: F;	Age: 7 weeks;	Treatment: untreated,ctrl
wildtype resting B-Cells,ctrl
Wildtype_TAC_Rep1,pert
"cell line: F348, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
cell type: HUVEC;	treatment: RAF1 S259A,pert
Against CDK19-2 rep1,pert
"Deltoid, FSHD, cohort 15, subject 15A",pert
mammary_16wkLH_ker73,pert
ExtendedOligo,pert
WT osteoclasts untreated 3,ctrl
CTL2 AO 2hr,ctrl
WT_MEF_un.2,ctrl
"Empty vector control, 24 hrs, No Rosiglitazone (NONE_24_1)",ctrl
P0 - WTMixA 1,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: Wy14643;	time: 24h;	gender: Male;	age: 44 years old,pert
T152,pert
DBTRG untreated rep2,ctrl
Cbfb-deficient Treg_rep2,pert
Aged 6,pert
Liver_Nrf1 CKO_rep2.,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#1,pert
RNA from whole tissue section of case 1368 labeled with Cy5,ctrl
K562 AMN107 sample 3,pert
KJD+doxorubicin_rep1,pert
DA rat colon control,ctrl
patient id: 111;	tissue: Normal cortex;	gender: Female;	age: 72;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
C_AN19760_C,ctrl
WT_liver_vehicle 0 mg/kg_96 hr_5,ctrl
potilas_DC_B,pert
Contralateral 5,ctrl
SV129_24h_DMSO,ctrl
U-87MG-PK7 set 3,pert
Muscle JDM (YJD-JDM-3UA-s2),pert
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 81;	Usage number: 4;	Exposures: 3,pert
Mouse old brain C30-Br-4,ctrl
Bone-Marrow_MM_M1049,pert
"MaF pre-iPSC9P2, Vc treated, lysed on D3",pert
Bone Marrow.,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
NTera-2 cells transfected with Ambion Silencer Select SOX2 siRNA,pert
"Wild-type myeloid-derived suppressor cell from colon tumor, rep2",ctrl
"Atria, Control, biological replicate 2",ctrl
Klf9WT_jejunum_PND30_1,ctrl
7118.3PBMC,ctrl
day 6 5-FU HSC 2,pert
Patient: M;	Time: 0;	Group: responder;	Condition: lesional,ctrl
MCI-003,ctrl
"Wild type mouse embryonic stem cell, biological rep2",ctrl
01JE9_ERA,pert
patient6,pert
strain: wt;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 12-14 mo,ctrl
1009-03-A,pert
"vector control cells, biological rep1",ctrl
A_AN06420_C,pert
TTP_KO_0ActD_BioRep1,ctrl
HF1150_U133P2,pert
A_AN06420_T,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14454;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
B4 422 wild-type after nicotine-induced seizures,pert
2 Wild-type control macrophage,ctrl
Atrioventricular canal,ctrl
Hippocampus 1980 15 month Old,pert
ALI patient #5,pert
HCC1937_1,ctrl
age_years: 41;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: Vemurafenib 1000 nM for 72h,pert
"Extensor digitorum longus, healthy control",ctrl
"Control at ZT20, pineal gland",ctrl
pooled reference mRNA from 4 harvests of HME-CC cells,pert
RNA from microdissected breast cancer cells from case 319 labeled with Cy5,pert
DMN-CtrHippo15d-1bAv2-s2,ctrl
control-plusDox-rep1,ctrl
HEK293 F18_doxycycline untreated,ctrl
EA_Case20_CD8,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: metastasis to lung;	organ site at which tumor arose: oral cavity;	donor sex: male,pert
"cochlea at P13, ko, biological rep 2",pert
Whole adrenal RNA from Crem-/- mouse #77 at 0h,pert
PBMCs from normal control subject J,ctrl
Bone-Marrow_MM_M1051,pert
race: caucasian;	age (years): 83;	stage: IB;	grade: 3;	histology: endometrioid,pert
"Distal and Proximal Large Intestine, 8week old Winnie mouse 3",pert
"Patient  G, lesion, 1 week",pert
"seminoma specimen, pT1, patient age: 36y; W01 145",pert
affected status (disease state): control;	gender: female;	age-at-examination: 73;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
cell line: MCF-7;	sirna knockdown: siLRH-1_#3,pert
Murine bone marrow from C57bl/6 mice,ctrl
Tissue: Primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use:  Yes,ctrl
0652-01-C,ctrl
Kidney from mice treated with 7 daily iv injections of vancomycin at 200 mg/kg,pert
"E2A-deficient (E2AKO) DP cells, biological rep 1",pert
"Mouse organ of Corti from cochlea, apical half, littermate control",ctrl
"lymphoblastoid cell line from P910, one out of seven of sensitive group, 50*10e6 cells",ctrl
THRB wt + T3 replicate 5,pert
"non-AD_HI, biological rep6",ctrl
Nasal Epithelium Inhalation Formaldehyde 2ppm 5d ID216,pert
"HPRTKO, biological rep1",pert
ATM_siRNA_4a,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep3",ctrl
WT1-iPS 5,ctrl
MCF7 - MTDH_WT_KD,pert
CA97-14B,ctrl
Skinbiopsy_0h_controlsubject_k5,ctrl
BAL_12_A1B0,ctrl
"Age: 37;	Sex: F;	Ancestry: African;	Smoking status: smoker, 23 pack-years",pert
CON24,ctrl
sample =Healthy2 treatment=Stimulated time=90 (min),ctrl
sample K 18.5 wt,ctrl
"A673 treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50), biological rep1",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-tu1,pert
SKBR3_0.1uM_Lapatinib_2,ctrl
MGHU3 Cells_TAK1 siRNA_Biological Replicate 1,pert
"Mouse stable invitro iTreg cells, replicate pool 2",pert
BCell_activated_sample3,ctrl
"sh2608 (to target ERBB3) T47D cell line, replicate 1",pert
subject: 12U;	cohort: 12;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 24;	Sex: F;	batch: Batch_3,ctrl
bone marrow derived mast cells,ctrl
"breast tumor epithelium,21",pert
patient: 17;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
LNCaP-LM xenograft with Hes6 overexpression,pert
cell line: KARPAS-231;	cell type: diffuse large B-cell lymphoma (DLBCL) cells;	treatment: non-targeting siRNA,ctrl
RI46,pert
OCI-Ly1_siFOXP1,pert
"patient 035b, cancer, homogenized",pert
GC resistant clone C7H2-R10E7 treated for 6 hours with EtOH,ctrl
Embryonic age 17.5 mutant rep4 (PKD1_40),pert
cell line: D3;	genotype/variation: PRMT1 knockdown (siPRMT);	cell type: undifferentiated embryonic stem cells,pert
Transgenic nr 652,pert
WT_P_1,ctrl
"NPCxhIPSC SCZP, replicate 1",pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 3",pert
"macrophages, 4 days post SeV inoculation",pert
M323 C,ctrl
B2KO; No Treatment #8,pert
Monocyte derived dendritic cells were generated by culturing human monocytes isolated from buffy coats using CD14 microbeads (Miltenyi),ctrl
"bcatGOF  mouse kidney E12.5, biological rep 2",pert
Normal cervix_05-5007,ctrl
patient: 250;	current medication: Asacol 2.4g/d;	birth date: 1/27/58;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 1/1/94;	diagnosis date: 5/30/94;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/29/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 4/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Muscle PCOS case 41,pert
"0mg/kg/day PFOA, Rep 3, Block 3, liver (high dose)",ctrl
56 y/o male,ctrl
wild-type tumor #3375,ctrl
Patient 1 skin treated,pert
"Mice_c-myc trans, biological rep2",pert
control MLL_00114,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 3",pert
"control E14, rep1",ctrl
BP15,pert
RNAi -Transgenic replicate 5,pert
"CRT knockout mouse embryonic stem cell, biological rep3",pert
Primary hepatocytes isolated from Donor 1 treated with Wy14643 for 24h,pert
3976-3 E2F1 Null,ctrl
"brain, frontal cortex: Sample46_e1_le1",pert
cell line: COV434;	transfection: empty vector,ctrl
pediatric AML S27,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 24hr",ctrl
HL-60 cell line infected with GSK3B Construct 1 shRNA,pert
Th17 cells,pert
04 PLUS OHT 2A,pert
HNF4a2_1-,ctrl
"NRK-52E cells (DeLarco and Todaro, 1978) (ATCC, CRL-1571)",ctrl
PBMC;	Age: day 4,pert
"OuJ, air, biological rep 2",ctrl
"A549, +TNFα, Claudin 1 siRNA, rep2",pert
Cancer 11,pert
"35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
GATA3KO_1,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age: 12 weeks;	Tissue:  Gallbladder,ctrl
HeLa cells were transfected with siRNA specific for optineurin mRNA,pert
"brain, Entorhinal Cortex: 01-22 normal_e1_le1",ctrl
"human failing LV myocardium, Ischemic93",pert
strain: B6/C3H F1 hybrid;	gender: male;	age: 30-month-old,ctrl
"Endometrium, postmenopausal, estradiol, 36",pert
cell line: FOXO WT,ctrl
"650nM MLN4924 after 8hr, replicate 2",pert
T134 U133p2,pert
"Ls174T, dominant-negative Tcf4, uninduced",ctrl
TIG3 embryonic diploid fibroblasts,ctrl
Sample 11 Kidney Normal Mouse - Control Diet,ctrl
HB1.F3-Nurr1,pert
scrambled siRNA biological rep 1,ctrl
treatment: shRNA against DBC1 (shDBC1);	cell line: MDA-MB-231,pert
wild-type #2,ctrl
Bone-Marrow_MGUS_G736,pert
EOM 14 Day mdx rep 3,pert
E.8 DBA-C57BL/6 whole embryo,pert
MDS patient 168,pert
cell line: SK-N-SH;	lentivirus: eGFP,ctrl
monocytes_T0,ctrl
sample: #13;	subject: PD case #1;	brain: T-1982;	age: 79;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
"normal nasopharyngeal tissue, specimen N5",ctrl
"Frontal cerebrocortex, deltamethrin (1 mg/kg), 6 hours",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 24 hrs Solvent,pert
subject id: c3;	infection: control;	status: control;	tissue: whole blood,ctrl
MCF7/XBP1 p.6,pert
visceral_fat_Akt1+/-_female_8wk_rep2,pert
"schizophrenia, BA10-15",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),ctrl
"Strain: D3, mouse embryonic stem cell",ctrl
shRNA-PGC1a #66 rep-1,pert
adult HSC 2 (untreated),ctrl
cell type: embryonic stem cells;	genotype/variation: transfected with yy1-specific siRNA,pert
RAW_0mM_HOCl_#3,ctrl
T116,pert
"Crohn's Disease subject (46 year old caucasian female, SAK_1316845653)",pert
Carbo Day2 (65R),pert
brain_DLPFC_bipolar C_mr645,ctrl
Muscle 50 eccentric contractions 12 hours WT Adult 0701,ctrl
colon_epithelium_IL10mouse_6weeks_rep2,pert
"Lymphoblastoid cell lines derived from family 1724, member 2",pert
"brain, Q10, 14 months",pert
patient4,pert
cell line: CH1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: WT,ctrl
HDAC6_2,ctrl
AL Chip#35,pert
ic25 -- mock APF on membrane A,ctrl
DBA control (202msn),ctrl
Mening SWB WB NP 6b,pert
cell line: KYSE220;	cell type: squamous cell carcinoma,pert
strain background: B6/C3H;	genotype/variation: Brwd1 mutant;	developmental stage: germinal vesicle (GV) stage;	tissue: oocytes (100 cells),pert
knockout rep-1,pert
Liver_WT_Rep2,ctrl
PS-final,pert
Liver sample from Alcoholic hepatitis group (CA79),pert
PS-/- cerebrum at 20 days,pert
"Control, standard diet, rep1",ctrl
"YPFH cells from M1, Mecp2 null, biological replicate 3",pert
Map3k7 (TAK1) knockout replicate 2,pert
mdx Biological Replicate 1,pert
"T47D cell line, replicate 2",ctrl
CD4+ CD25lo Foxp3+ T cells,pert
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep2,pert
SHR12-1,pert
DEX2_24H,pert
kidney_co_14M_rep3,ctrl
"Ulcerative Colitis (41 year old caucasian female, SAK_1285223952)",pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S46_3 months_replicate 4,pert
B_cell_pool_healthy_H09+H10,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: gastrocnemius medialis;	age at biopsy: 62;	Sex: male,pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 -/-;	tissue type: renal tissue",pert
Extract:LOX-1:213102;	Extract Description:LOX1_0hr:213102;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.58;	Quality: Background Mean Dev.:1.4;	Quality: Absent (%):59.09;	Quality: Absent (%) Dev.:0.65;	Quality: Scaling Factor:0.6;	Quality: Scaling Factor Dev.:0.13;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213102;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295453,pert
colon_C57 mouse_12weeks_rep3,ctrl
"BOEC, at_risk 9",pert
"BOEC, not_at_risk 5",pert
cell type: Mouse embryonic fibroblasts;	genotype: MLL1 KO;	time: CT30,pert
cell line: mNB-A1;	strain/background: mixed C57BL/6 x 129X1/SvJ;	cell type: MYCN-driven neuroblastoma;	treatment: MLN8237,pert
Muscle JDM (YJD-JDM-9UA-S2),pert
genotype/variation: WT;	cell type: Tregs,ctrl
E14wt-SRFVP16-2,ctrl
mouse jejunum_hnf1alphacontrol_rep3,ctrl
Lymphedema Tail Skin 3,pert
T-ALL cell line treated with DMSO,ctrl
"Eed KO BM LT-HSC, biological rep2",pert
cell line: HepG2,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.315;	OD280: 0.668;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 312;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
WT biological rep 2,ctrl
WT - Cre Treated - 2 hrs - repeat 2 - Cy3 - mAdbID:62606,ctrl
P50 Non failing heart biopsy,ctrl
Bronchial Epithelial Cells control biological 1705R,ctrl
"WT, PR02M002v0",ctrl
"Acute Myeloid Leukemia, sample 45",pert
Replicate 3 - CDB4124,pert
"Patient J, lesional skin",pert
H157 siMOCK,ctrl
"JurkatNegative (Mock stim)  0 hours, #3",ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Lisboa;	lifestyle characteristics: ever smoker,ctrl
"12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",pert
tissue: skin;	individual: Patient P3;	condition: AL;	eczema severity: SCORAD: 81,pert
patient: 40741;	sample: tumor,pert
"Patient 27, Macroscopically intact tissue",ctrl
E11_WT1,ctrl
SZ15,pert
Control1,ctrl
CC1 21d replicate 2,pert
"brain, hippocampus: PH3_e1_le1",pert
SeroNeg-10,ctrl
Rat fatty liver13,pert
age_years: 56;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
WT659,ctrl
Prostate-specific Pten deletion anterior prostate tumor 1,pert
PBMC from T cell LGL leukemia patient #110 (TLGL110),pert
"Cerebral Palsy, Semitendinosus, Patient Replicate 1",pert
Untreated Y79 cells,ctrl
tissue: liver;	strain: C57BL/6JBomTac;	genotype/variation: ACBP-/- (KO),pert
PBMCs_Control_10 [IS],ctrl
"Uninfected NT at 5 d.p.i., rep4",ctrl
A_AN17138_T,pert
"ARD842, CAIS, F, GOF, 1 x 100nM DHT, 24h",pert
"A673 treated with DMSO vehicle control for 24 hours, biological rep1",ctrl
Sox9egfp_p23-3,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 159;	colon ratio (mg/mm): 2.607;	myeloperoxidase activity (u/mg): 0.477;	tissue: colon;	treatment: 5% DSS,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 3,pert
liver_control_diet_rep4,ctrl
Normal Adrenal Gland,ctrl
wild type stria vascularis replicate 1,ctrl
lung_silica_2,pert
"heart, subendocardial left ventricle",ctrl
3976-1 E2F1 Null,pert
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
A2780-(3),ctrl
ko 13.5d replicate 6,pert
106 year old female,pert
PGA-MAH-C3H_PBS6h-1aA-s2,ctrl
ubb_d7_ko_2,pert
uterus_P4_WT_4hrs_rep2,ctrl
"IMR-32 ,T=0, 1",ctrl
ILD Study Number 1021,pert
clone type: AtT20 clone types treated with control siRNA rep 1,ctrl
strain: C57BL/6;	genotype/variation: WT;	cell type: Peritoneal MF,ctrl
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: R,pert
HDAC6_3,ctrl
IM67_case,pert
Individual_649_PN_sample,pert
"coronary smooth muscle cells (hcaSMC), treated with metoprolol for 72 hours",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 37.0;	age of psoriasis onset: 24,pert
Low weight gainer Kozak1_ABI_ING_L2,ctrl
RNA-DHL4-R406-48H-1,pert
cell line: RUES2;	cell type: human embryonic stem cells;	transduced with: shRNA targeting TMEM88;	time point: Day 5 of cardiac differentiation; cardiovascular progenitor cell stage,pert
BATF_KO_P14_D3_Effector_rep1,pert
Rosiglitazone treated cells Rep1,pert
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 35;	maternal age: n/a,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.7;	colon weight (mg): 168;	colon ratio (mg/mm): 2.51;	myeloperoxidase activity (u/mg): 0.474;	tissue: colon;	treatment: 5% DSS,ctrl
KOPT-K control 2,ctrl
agent: EFNA4-Fc conjugate;	time: 1h,pert
"diet: LRD-5001;	sodium arsenite added to drinking water: 10 ppb, 5wk",pert
"Endometrium, postmenopausal, estradiol, 23",pert
7149.3PBMC,ctrl
Cerebellum_nontransgenic control X50_16 months_replicate 1,ctrl
"Crohn's Disease subject (34 year old caucasian female, SAK_1307702704)",pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 35;	maternal age: 32,ctrl
WT MEFs at passage 3_biological replicate 1,ctrl
Human skeletal muscle biopsy sample;	Patient #164 with PM,pert
"Colitis 01, UC01",pert
CTRL_1_MEP,ctrl
Pancreatic Sample 14-Normal,ctrl
3T3 Vector Control A-928605 3,pert
"Ulcerative Colitis (33 year old hispanic female, SAK_1285179246)",pert
01N4B_PolyRF-,pert
"3 uM EPZ004777 treated, DAY 4, biological rep.3, MV4-11 cells",pert
cell type: ESC;	genotype/variation: Snai1 knockout,pert
"lymphoblastoid cell line from F6.04, one out of seven of sensitive group",ctrl
disease state: Mantle Cell Lymphoma;	cell type: B cell lymphocyte;	ighv status: UNMUT,ctrl
parental cell line: WB;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
WT.DMSO_3,ctrl
Esophagus TG replicate 2,pert
genotype/variation: wildtype;	strain: C57Bl/6;	gender: female;	cell type: skin melanocytes,ctrl
b66+,pert
"testis wt, 14dpp, Rep1",ctrl
CON - R20,ctrl
chip number: 15;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.72;	rin: 9.7;	transfection date: 2012-03-26,pert
AAA neck (Sample 12),pert
PFC R control 3,pert
"primary fibroblasts expressing a control shRNA construct, clone 2",ctrl
21A;pretreatment;female;breast tumor; responder,ctrl
"Biceps muscle, Control patient",ctrl
ATM_siRNA_4c,pert
pre-iPSC- siRNA to luciferase- biological replicate2,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 43 yr;	population: white;	dsm-iv: 295.9;	age of onset: 18 yr,pert
"BMMCs from NTAL WT, NTAL shRNA infected, nonactivated, biological rep2",pert
tissue: atria;	genotype: Myh6-cre; COUP-TFIIflox/flox;	age: 2 months;	genetic background: C57BL/6,pert
"Infected with H37Rv, replicate 1",ctrl
"nasopharyngeal carcinoma, specimen T16",pert
infected BALB/cByJ fibroblasts (9 h post inf),pert
age: 6 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep5",ctrl
Calf muscle complex,pert
tissue: PBMCs;	treatment: before IFNb-1a in-vivo treatment,ctrl
"neocortex-30 months of age, resveratrol diet-biological replicate5",pert
liver sample group: : Control,ctrl
"RWPE1 cells, vehicle, 24h, biological rep3",ctrl
tissue: prostate;	normal/tumor: normal,ctrl
"Gata6-KO heart, CRE, biological rep1",pert
"Wild type, brain hemisphere",ctrl
midbrain_wild type_24 weeks_replicate 3,ctrl
tissue: glomeruli of human kidney;	disease state: control,ctrl
brownfat_wt3_day3,ctrl
Cell culture. A549 treated by MK886 4,pert
Rapamycin treated_2 3h,pert
GM19238_Kd_BCL3_3,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 25.68219,ctrl
FoxO deficient LSK (5),pert
Kidney from mice treated with 7 daily iv injections of vancomycin at 50 mg/kg,pert
RV63.09_CHF_day19_Slide45,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 1,ctrl
YFP-pos GMP Dicer wt rep3,ctrl
"56B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
NPC20,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 54.32329,pert
Ishikawa_VeryLowDose_BPA_24h_rep3,pert
strain: C57BL6;	genotype: WT;	tissue: striatum;	treatment: vehicle control,ctrl
"strain: FVB;	transduction: transformed by v-src gene;	tissue: Primary prostate epithelial cell culture, oncogene-transduced",pert
lymphocytes,ctrl
P2 Patient None,pert
4 hr unpooled 1 vs PBS 4hrpooled,pert
liver_Akt1+/-_8wk_rep3,pert
CA1 NoCre Sox7H,ctrl
PTC BRAF mut 11,pert
GM19238_Kd_DIP2B_2,pert
OSCE-2T,pert
"wild type 5C.C7 T cells, biological rep1",ctrl
OBF-1 overexpression BCS-3 (EPLM),pert
Ileum,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 297B;	age-at-biopsy-years: 46,pert
E14 - Lis1cko/ko 2,pert
Bronchial Epithelial Cells MMA biological 1863J,pert
"Liver, Nrf2 deficient",ctrl
"C57BL/6J SAL, Rep3",ctrl
mouse spinal cord,ctrl
MED1 overexpression #2,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T144,ctrl
SLE patient blood,pert
KO_d00_eX_vs_KO_d21_eX,pert
CRC_nodrug_F4879,ctrl
BAL_45a_A1B0,ctrl
EA_Case12_CD20,pert
race: caucasian;	age (years): 64;	stage: IC;	grade: 1;	histology: endometrioid,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 33.0;	age of psoriasis onset: 26,pert
A536 Sham 1 day,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 47 yr;	population: white,pert
"A549 human adenocarcinoma cell line, cisplatin-treated",pert
Oligodendrioglioma_5,pert
"NIH3T3, FGF 4 h",pert
"Acute Myeloid Leukemia, sample 31",ctrl
"Mouse Embryonice Stem Cells, control si RNA, Rep1",ctrl
"Undifferentiated C2C12 myoblasts, passage #11;	",ctrl
JGB-Pre-2UP_Run2-S2,pert
Prostate Cancer_MS 36C8,pert
C_AN15566_T,ctrl
N51721,ctrl
"TNFa-OMe siRNA-B, replicate 5",pert
T4_pitM,pert
siZMPSTE24-treated A549,pert
mef2a_4,pert
MDS patient 79,pert
"Patient 116, 3 month of REBIF",pert
"P90_wt cones, replicate 2 [array]",ctrl
"Tfrc-/- (GFP-positive) kidney cells, biological rep1",pert
PS-NA cerebellum at new born,pert
RNA from NCCIT human cells depleted of TET2 by siRNA,pert
PBMC sample from healthy patient,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 1,pert
LCL Concordant for Epilepsy twin pair 4 (CCE4.1)(TP39),pert
sample =XCGD6 treatment=Control time=360 (min),pert
brain_OFC_control C_mr216,ctrl
KU_45N,ctrl
IFC 01,pert
V5-P084,ctrl
S033_Scz_M_83,pert
"8B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 8week,ctrl
MDS patient 125,pert
"IN1472 siNT treated, Biological replicate2",ctrl
XBP1s_B_cells_spleen_20_weeks,pert
Extract:LOX-1:113102;	Extract Description:GFP_0hr:113102;	Quality: Classification:Medium;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.62;	Quality: Background Mean Dev.:0.83;	Quality: Absent (%):60.38;	Quality: Absent (%) Dev.:1.65;	Quality: Scaling Factor:0.75;	Quality: Scaling Factor Dev.:1.2;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113102;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295423,ctrl
MacularDegen-healthy-5bAv2-s2,ctrl
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14439;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 31;	sex: F,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: PTD-DRBD-mediated siRNA delivery;	time: 12hr,pert
Individual_4389_PP_sample,pert
genetic background: 129/SVE;	genotype: Des(-/-);	tissue: tibialis anterior;	age: 7-9 wk;	strain: Des(-/-)/129/SVE;	treatment: 50 eccentric contractions 12 hours,pert
tissue: white blood cells;	age: 13;	Sex: female,ctrl
cell line: MCF-7;	cell type: Breast tumor cell line;	transfected with: pcDNA3 (control vector),ctrl
Bc_WAP_3,pert
Septic shock;	gender: Male;	Non survivor;	organism: None;	organism class: None,pert
"metastasis: metastatic recurrence;	Stage: 3c;	tissue: normal, homogenized",ctrl
CML_1_GMP,pert
T138,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_287,ctrl
wild-type mouse 3,ctrl
patient: 236;	current medication: None;	birth date: 11/20/53;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/18/05;	indictation for procedure: ;	ucss: 15;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 2/18/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: 1/1/71;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
37/OVX/oil/6h/UTX 129 Hoxa-10+/+,ctrl
Nasal Epithelium Inhalation Formaldehyde 0ppm 6h ID53,ctrl
strain: HNF4LoxP/- no Cre;	age: 1 month;	tissue: small intestine;	sex: male,ctrl
"206, MUSCLE, Before",ctrl
ES cells_control_rep2,ctrl
Nrl-ko-Gfp P6 replicate 1,pert
cell type: Human melanoma cell line;	cell line: M238_R1;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
tissue: prefrontal cortex from adult wild-type mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,ctrl
healthy myeloid cells 9,ctrl
C8,ctrl
2L,pert
Postmenopausal female. Estradiol treated. Patient 8.,pert
Female - caucasian - N-08-G,ctrl
MLL_00125,pert
MCF7_siRNA_ESR1_24h_AM0006_7.1,pert
optic nerve head astrocyte,ctrl
Healthy untreated rats 1,ctrl
DIA-t10; transgenic diaphragm 10 month,pert
KGN Control  [RR1006],ctrl
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; no EGF,pert
AT2_control_rep2,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate,pert
Cultured hESC H1,ctrl
MPM tumor specimen 13,pert
disease state: healthy;	tissue: soleus;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
erStress_twins_AA_1734twin1_DMSO_4h,ctrl
M249_A_PLX,pert
01-P,ctrl
MCF-10A shCHK2-1 replicate 3 [set 5],pert
Mouse testicular Sertoli cell line TTE3,pert
Setdb1 2lox/1lox/Cre plus tamoxifen 1,pert
Akt1 double transgenic mice on a high fat diet (DH 1),pert
PsOEt-13-Week 1,pert
Diaphragm 7 Day control rep 1,ctrl
SHR-vehicle pool sample2,pert
H720 MK886 1 micromole 24h serum free Sample 4,pert
Nrl-ko-Gfp P2 replicate 4,pert
Wild type unstimulated 3,ctrl
CON-1-PLASTIC,pert
Healthy9-CD8,ctrl
27GOBMUC2H,ctrl
Rybp#15 (OHT-)_12d_rep2,ctrl
HMEC X NB1,pert
"Brain tissue from Fisher 344 male rat, Animal #254, 200mg/kg D-Serine",pert
subject id: 41;	infection: DENV;	status: DF;	tissue: whole blood,pert
Uninfected_control_0a,ctrl
30 day LAD ligated heart from C57BL/6 strain,pert
20C-ER-D,ctrl
tissue: brain;	genotype: mutant Ndel ko/cko;	age: P0,pert
PPC1_non-target shRNA_replicate 2,ctrl
35/1-22 - Dox_1,ctrl
KO 0h TPA rep3,pert
KU_44T,pert
T40730,pert
healthy control H22,ctrl
CML-BM 9,pert
agent: ConA;	time point: 3 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Untreated CHOP-/- C,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 19d ID152,pert
hOB695_shEV_0hr,ctrl
Endometrium/Ovary-Disease 9,pert
HEL cell line_Control shRNA (Luc),ctrl
"PPARg d10, rep 3",pert
"Liposarcoma culture from tumor 401, doxorubicin treated",pert
HEK293 F5 WTX inducible,pert
Mutated-ERα-positive breast cancer 73,pert
WT-Fibr2 4,ctrl
"PCB77 treated HepG2 cells at T6, biological replicate 3",pert
The Identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1. Sample B,pert
"Whole blood - mental retardation or developmental delay, Female",pert
KPW13_T3_PP_day1_051,pert
Wild Type Time 1 replicate 3,ctrl
AO 24hr,ctrl
ALI patient #1,pert
Gender:male,pert
ATCC HTB-30,ctrl
"Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications.",pert
13L,pert
"fetal sex: female;	karyotype: 46,XX",ctrl
Cochleae from a9 null mice at P60,pert
4 hr unpooled 3 vs PBS 4hrpooled,pert
RPE65_KO_4months_retina31,pert
Preglaucoma control rep6 (OHN),ctrl
Control subject 97_biological replicate 1,ctrl
cell line: HT144;	transfection: siRNA targeting CITED1,pert
Liver WT2,ctrl
KO - knock-out Treated - 12 hrs - repeat 1 - Cy3 - mAdbID:61762,pert
BP17,pert
"Endometrium, postmenopausal, tibolone, 6-2",pert
BATF_KO_P14_Naive_rep2,pert
esophageal squamous cell carcinoma from patient E1584,pert
fibroblast_Slow_D76_Media_9,pert
CHB PBMC_sample 10,pert
cell line: PC-3;	treatment: siAgo1,pert
"PCB77 treated HepG2 cells at T24, biological replicate 3",pert
"T1.5 fetal heart (treated on gd14.5 via oral gavage, collected on gd 17.5)",pert
"5B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
HL60-shGSK3A-Construct5-rep2,pert
"GM9013, proband-MS",pert
M238_R1_A_DMSO,ctrl
Bronchial Epithelial Cells SA biological 1566D,pert
HW_449,ctrl
Whole blood,pert
CUTLL1 MigR1 GSIwash4h-rep3,pert
397MM,pert
Human normal prostate primary culture N1,ctrl
MPM tumor 21,pert
"strain background: 129/B6 mixed;	cell type: Ada3FL/FL MEF, immortalized;	infected with: Cre adenovirus",pert
strain: C57BL/6;	cell type: hepatocytes;	genotype/variation: GNMT-WT;	agent: aflatoxin B1 (AFB1),ctrl
"U937 cell line, transduced with shSYK_2 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
E12 distal retina progenitors_mutant_rep 2,pert
"liver, SCD+/+",ctrl
NALT_infected_24h_90-226att_rep1,pert
"DMD skeletal muscle, biological rep7",pert
Gfp purified photoreceptors,pert
Control Day14 (441L),ctrl
"Whole ovary from 8 Month Old Wild Type mice_02, biological rep2",ctrl
MDA-MB231 control shRNA cells,pert
strain CD-1 mouse. RV was isolated by laser capture microdissection.,ctrl
RNA from HCC_3N,ctrl
"Wildtype, thymic, NK1.1+ NKT cells replicate2",ctrl
"Wildtype luminal mammary epithelial cells, MD638",ctrl
KU_47T,pert
SCC-2_siZMPSTE24_rep.1,pert
PancreaticSample20-Tumor,pert
25A;pretreatment;female;breast tumor; responder,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 48 yr;	population: white;	dsm-iv: 296.53;	age of onset: 31 yr,pert
cell type: Mouse embryonic fibroblasts;	genotype: wild type;	time: CT18,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 39;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
ZMYM2/FGFR1 biological replicate 2,pert
Muscle-AMPKgamma3-ko-6,pert
ccRCC tumor of patient 42,pert
CD4+_Tcells_healthy_donor_8,ctrl
primary normal lung tissue 1074,ctrl
"schizophrenia, BA46-66",pert
cerebellum_PS-/-_ 10d_rep1,pert
"Mmp10-/- epithelium, uninfected, 0h",pert
myoblast_untreated_rep3,ctrl
control participant P328wh,ctrl
1122-03-A,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 71;	tissue: Blood,pert
Tet2 KO GMP rep2,pert
A673_CloneAsp14_Dox_0h_3,ctrl
"MCF-7, 12h, 0.3mM 5FU B",pert
WildType_2_1,ctrl
"Vehicle treatment, 25 hours (replication 1)",ctrl
"PMA treated, no doxycycline; biological replicate 3",ctrl
H720 cell line control 4,ctrl
MCF7 cyclin D1 siRNA Estradiol Rep1,pert
"Huh7 cells, JFH-1 Infected, 24 hours.",pert
Lung of hemorrhaged animal 72h,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: corn oil,ctrl
treatment: 1 ug/ml doxycyline;	time: 53 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
20SMOKEH,ctrl
8 Etoh 4,pert
PE_N_M182,ctrl
intestine_wildtype_24hfasted_rep3,ctrl
HET Brain 62d Mouse1,ctrl
PGC-1a-/- rep1,ctrl
cell type: Sarcoma cell line;	strain: C57BL6/J;	genotype/variation: Dicer Heterozygote,ctrl
agent: Cadmium 0.2 µM,pert
WT_PLACEBO_12hours_2,ctrl
WT-sham-2 month-R4,ctrl
control to Sample 1,ctrl
Glioblastoma_9,pert
"Fibroblasts from UIP histology lung tissue, IPF-20",pert
ZNF395 knock-down (shZNF395-1),pert
cell line: HeLa cervical carcinoma,pert
WT CMP rep1,ctrl
NPC_wt_rep2,ctrl
Day6 Genistein treatment replicate 1,pert
Ebola-infected macrophages harvested at 1h post-treatment from donor 1,pert
"Normal subject (42 year old caucasian female, SAK_1289918632)",ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_4-sp3,pert
KU_23N,ctrl
LacZ control_0a,ctrl
liver cells from wildtype 8wk male mouse 8 challenged with acetaminophen (APAP)_12,pert
neuron_rep6,pert
MPM tumor 38,pert
DNGL-3,pert
Huh7 cells_JFH-1 Infected 48 hours_ rep1,pert
skin: normal,ctrl
8 wk old male C57BL10 diaphragm,ctrl
Placenta Adra2bKO 1,pert
MCF7 Control cells Array 2,ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
Squamous cell carcinoma 019,pert
Ileum epithelials cells,ctrl
Myh11-CreERT2.Tgfbr2f/f Knockout 2,pert
Array Type: HG-U133A_2;	Ratio: 1.97;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
B4 437 b4-/- untreated,pert
GM19238_Kd_IRF5_2_rep,pert
K14-Cre;Tgfbr2 fl/fl Mutant Posterior Palate 2,pert
"A2BAR -/- mouse heart, control, rep3",pert
mouse NB N1E-115 cell lines,pert
Pediatric_GBM_35,ctrl
siCABIN1 1,pert
"Control mouse for dy/dy, 8 week",ctrl
erStress_twins_AA_1724twin2_DMSO_4h,ctrl
"GM9016, affected brother",pert
"Normal skin from Tie2_control mouse, biological replicate 1",ctrl
colon_epithelium_IL10mouse_6weeks_rep5,pert
Psoriatic arthritis PsA 5,pert
CLL3-CD8,pert
healthy control sample x027,ctrl
NL_aa_lcm,ctrl
TMRI E2 72hr,pert
"brain, hippocampus: Wt #3406 Cort_e1_le1",ctrl
22C-M4-D,ctrl
age: 72;	sex: M;	disease status: control subject;	Filter number: 94;	Usage number: 4;	Exposures: 3,ctrl
48 hrs TAC-3,pert
subject: 19A;	cohort: 19;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 22kb;	age (y): 65;	Sex: M;	batch: Batch_4,pert
"TNFa-OMe siRNA-B, replicate 1",pert
WT_d00_e0_vs_KO_d00_e0,ctrl
amygdala,pert
569.KO,pert
batch: B;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 3",ctrl
MDS patient 62,pert
"CD4+ splenocytes at 6h, biological replicate 1 sham-2",ctrl
"HL-60 + 0.5 % DMSO, biological replicate 2",ctrl
11431 UC Uninflamed terminal ileum,pert
"Exp A, Animal #265, 20mg/kg D-Serine",pert
12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24729,pert
Rat eft ventricle,pert
405MM,pert
"brain, brainstem: LB7_e1_le1",pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-tu3,pert
Skinbiopsy_7hoursnickel_controlsubject_k2,ctrl
NSCL/P sample 7,pert
AAA neck (Sample 14),pert
PsOEt-12-LS,ctrl
Healthy6-CD8,ctrl
"Crohn's Disease subject (65 year old caucasian female, SAK_1280798058)",pert
KO - knock-out Treated - 2 hrs - repeat 3 - Cy3 - mAdbID:51964,pert
patient: 40726;	sample: normal,ctrl
infection: seasaonal H1N1 Influenza virus;	cell type: cultured primary human lung epithelial cells,pert
GM19238_Kd_DIP2B_3,pert
monocytes_-LPS_1,ctrl
Testis_WT_rep1,ctrl
liver_WT_replicate3,ctrl
"metastasis: none;	Stage: 2a;	tissue: normal, homogenized",ctrl
s1,ctrl
Tendon_lesional_rep7,pert
gender: Female;	age: 89;	post-mortem delay: 5h;	ph: 6.5,ctrl
tissue: arterial;	status: normal,ctrl
Day6 Genistein treatment replicate 2,pert
CML cell line: KU-812,ctrl
secondary glioblastoma_3,pert
PGA-lv_24h_515,ctrl
Itk knockout CD8+ CD3-stimulated,pert
No_abuse_9,ctrl
multiple sclerosis_8,pert
"patient 038b, cancer, homogenized",pert
Against CDK19-1 rep1,pert
Tetracycline-inducible glioma cells dox 1,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 41;	maternal age: 39,pert
remitted schizophrenia patient  S17,pert
patient: 7;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
normal arterial tissue: sample #1,ctrl
platelet_Ctrl_5,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.749;	OD280: 0.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 220;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
chip number: 13;	transfection plate: 5;	target gene: RELA;	kd level: 0.62;	rin: 9.3;	transfection date: 2011-10-17,pert
"Spi-60, biological rep 1",pert
Leg 28 Day control rep 3,ctrl
CD4IncTp1-7,pert
cerebrum_PS-/-_ 10d_rep1,pert
rtTA-Dmrt5_d7_+Dox_rep_1,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: pineal gland;	time: ZT6,ctrl
Fat Tro3,pert
P28 testes Dhh Cre,pert
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: lapatinib,pert
Healthy Pulp 1,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 7 weeks post infection 20 cercariae,pert
Superior Frontal Gyrus from a 5 year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
asthma_saline_1,ctrl
uterus_veh_WT_40hrs_rep2,ctrl
B4 527 wild-type after nicotine-induced seizures,pert
EA_Case10_CD4,pert
566.B6,ctrl
Treg Trim28 conditional KO rep2,pert
H1299 RBP2 KD1_rep 2,pert
Bone Marrow CD34+ progenitors cells,ctrl
"NOD islets, non-transgenic",ctrl
HUVEC cell culture,ctrl
"Crohn's Disease subject (56 year old caucasian male, SAK_1263271818)",pert
TYK-nu-(1),ctrl
Ileum_POR-null_1,pert
Hepatic Reductase null N7,pert
WT_liver_vehicle 0 mg/kg_96 hr_3,ctrl
shOCT4_3,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 31;	maternal age: 30,ctrl
"Mouse Sciatic Nerve, Control Rosi",ctrl
"Control 2, biological rep3",ctrl
cell line: THP-1,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep4,pert
cell line: H1993;	tissue: Lung adenocarcinoma,ctrl
Hippocampus_Soman_1h_rep1,pert
tibialis anterior muscle,ctrl
MDS patient 181,pert
Control pool 1 (n=2),ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 24.21096,ctrl
siSox2,pert
human esophageal squamous cell carcinoma cell line_KYSE170,pert
rtTA-Dmrt5 day 7 +Dox,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 4,ctrl
cell line: U20S;	tissue type: osteosarcoma,pert
MPM tumor specimen 1,pert
IM32_control,ctrl
MDS patient 72,pert
gender: female;	agent: E2;	cell type: Hematopoietic stem cells,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.442;	OD280: 1.248;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 205;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
S023_Scz_F_97,pert
mir-26b overexpression 1,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: Vemurafenib 1000 nM for 72h,pert
CCRPKO-PBS_rep-1,pert
TTP_KO_60ActD_BioRep2,pert
strain: C57BL/6;	gender: male;	cell type: ESC-like cells;	genotype/variation: Prdm14 Knockout;	culture conditions: 2i,pert
WM-266 knock-down of Pirin by siRNA - Replica 1,pert
"P40_C-DGCR8 KO cones, replicate 1 [array]",pert
strain: C57BL/6;	genotype: Myd88 null;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,pert
"Runx1KO, biological replicate 3",pert
RNA from whole tissue section of case 843 labeled with Cy5,pert
Native-0-2,ctrl
Human Acute HIV Sample A044-CD8+ T cells,pert
S10B Sporadic-cerebellum,ctrl
"BOEC, normal 15",ctrl
P4_WT_1,ctrl
H295R _Control_rep2,ctrl
Strain: Inbred C57BL/6J;;	 Gender: male;;	 Age: day of life 3;;	 Tissue: liver,ctrl
brain_DLPFC_bipolar B_mr667,pert
monolayer chondrocytes from OA donor 3,pert
Leg 56 Day mdx rep 3,pert
liver from control mouse,ctrl
"45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
APOE_KO_NODM_9W_8,ctrl
WTT 164 bleomycin treated,pert
"Pou4f1+/+ cells, transduced with control virus_Wt-MSCV_85",ctrl
Lung wt mock repB,ctrl
Pediatric_GBM_29,ctrl
HL60-shGSK3B-Construct2-rep2,pert
tissue: white blood cells;	age: 16.02;	Sex: male,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 5.3;	colon weight (mg): 149;	colon ratio (mg/mm): 2.811;	myeloperoxidase activity (u/mg): 0.208;	tissue: colon;	treatment: 5% DSS,pert
Substantia nigra normal rep1,ctrl
B16 - infected BALB/cByJ fibroblasts (9 h post inf),pert
cell line: BL2;	transfection: scrb siRNA;	batch: 3,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 310;	age-at-biopsy-years: 60,ctrl
patient9,pert
WT V6.5 ESCs on day 0,ctrl
aa_NY216,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Male;	Age of onset (years): 27;	Duration of illness (years): 21;	Brain pH: 6.1;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: 200;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
LICR_HN2_CETU2,pert
wild type; BMDM; not treated,ctrl
rd1_P6_rep2,pert
Bronchial Epithelial Cells control biological 1733W,ctrl
treatment group: inorganic arsenic 0.1 uM;	cell line: TK6 cells,pert
TA-t7-2; transgenic tibialis anterior 7 month,pert
TL3 SCR 1,ctrl
db/m 16 wk 2,ctrl
knockdown: control;	cell line: MCF7,ctrl
Extract:LOX-1:213403;	Extract Description:LOX1_Untreated_12hr:213403;	Quality: Classification:Good;	Quality: Gradient Severity:0.1;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.08;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.79;	Quality: Background Mean Dev.:0.74;	Quality: Absent (%):59.36;	Quality: Absent (%) Dev.:0.86;	Quality: Scaling Factor:0.66;	Quality: Scaling Factor Dev.:0.42;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213403;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295793,pert
JoMa1_GFP,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: pre-UV,pert
tissue: skin;	cell line: NZM15;	tumour stage: metastatic melanoma;	tumour site: neck nodule;	treatment: PAX3 siRNA,pert
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 1953348007;	hybridization batch: III,ctrl
adult hearts,ctrl
genotype/variation: C57BL/KLS-leprdb/leprdb (db/db),pert
chip number: 3;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.4;	transfection date: 2011-03-29,pert
TK6 cells,ctrl
RNA from microdissected breast cancer cells from case 1093 labeled with Cy5,ctrl
Mening UNSTIM WB NP 0b,ctrl
treated Murine 3T3-L1 cells,pert
"Monuron-treated NRK-52E cells at 24h, biological rep 1",pert
"BMDM, Tpl2 KO, unstimulated, biological replicate 2",pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 23;	Brain pH: 6.2;	Post mortem interval (hours): 19;	Side of brain: Left;	Fluphenazine mg. Equivalents: 60000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
cell type: Dorsal skin Basal IFE epidermal stem cells;	genotype: Bmal1 KO,pert
"RPMI8226_shKDM3A#1, replicate1",pert
model: Fischer 344;	gender: Male;	age: 21 to 22 months old,pert
liver_QH2_6M_rep2,pert
microdissected breast cancer cells from case 878,ctrl
patient: 30162;	sample: normal,ctrl
Gata3_D3,ctrl
RPE65_KO_6months_retina5,pert
Insig1 ∆/∆ /Insig2 -/-,pert
3409-lcm,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 46;	maternal age: 42,pert
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b retrovirus,pert
tissue: brain;	genotype: ClpP KO;	genetic background: C57BL/6,pert
Primary hepatocytes isolated from Donor 3 treated with DMSO for 6h,ctrl
chip number: 14;	transfection plate: 4;	target gene: HCST;	kd level: 0.87;	rin: 9.6;	transfection date: 2011-10-17,pert
"Rat liver, untreated (control), extrated 48 hours after treatment (no treatment in this case), biological rep1",ctrl
Mtb infected-63d-2,pert
Biceps_Pompe_2,pert
b147,ctrl
"B10 sham kidney, biological rep2",ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#1,ctrl
p53r2 siRNA 1,pert
TLW18_T5_PP_day7_017,pert
OC1-WT embryo 3,ctrl
"muscle, knock out",pert
ILKS343D,pert
"Patient D, lesional skin",pert
erStress_twins_AA_1757twin2_DMSO_4h,ctrl
"Csbm/m mouse, cerebellum, old, nicotinamide riboside treatment",pert
A673 cell line that has been treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50).,pert
WT_Regulatory T-cells CD4+CD25+,ctrl
ID: MLL_00117;	cell type: PBMC;	disease state: control,ctrl
TTP_WT_60ActD_BioRep3,pert
"A2BAR -/- mouse heart, control, rep1",pert
cell line HCT-116,pert
normal donors TA1,ctrl
VillinCreERT2+_Brg1fl/fl_Rep2,pert
Trim28CKO unstimulated CD4 positve T cell rep4,pert
Ishikawa_LowDose_BPA_8h_rep2,pert
Subject 7_t=30days_placebo,ctrl
"HEK293E cells, TDP-43 siRNA, replicate 3",pert
siERK5E2 1,pert
RNA from microdissected breast cancer cells from case 1260 labeled with Cy5,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 146;	time: 0;	batch: 3,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 83;	Sex: male;	region: M1;	age: 38;	genotype: Y/X;YFPH/-,ctrl
subject: 09U;	cohort: 9;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 47kb;	age (y): 57;	Sex: F;	batch: Batch_2,ctrl
"brain, cerebellum: RNA#12_le1",ctrl
sex: male;	tissue: liver,ctrl
"HSCs from male mice treated with oil, replicate 2",ctrl
"Patient 1, Atheroma plaque",pert
Normal Tail Skin 3,ctrl
tMLL10,ctrl
"brain, brainstem: PB1_e1_le1",pert
12h_c2,ctrl
P1 Patient None,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 2;	psoriasis duration: 38.0;	age of psoriasis onset: 7,pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. ;	PMID: 12888219 [PubMed - indexed for MEDLINE]",pert
"siSCR neuron, biological rep2",ctrl
DS2-iPS 1,pert
LSK SRF-null 1,pert
Severe rep9 (retina),pert
PGA-MLS-Dil-1aAv2-s1,ctrl
sample =XCGD3 treatment=Control time=360 (min),pert
SKBR3_0.1uM_Lapatinib_3,pert
microdissected epithelial cells from IPMA 3,pert
Scd1-/- on chow diet replicate 4,ctrl
"new born normal mice, cerebellum",ctrl
"Ishikawa cell line, BPA, 10nM, 24hr",pert
CLL4-CD8,pert
Angiopoietin-1(sparse)-1,pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His plasmid,pert
DEX2_6H,pert
cell line: MCF-7 breast cancer cells,ctrl
HMEC X BC1498,pert
OCI-Ly7_siFOXP1,pert
2096-03-A,pert
Exon3_T2,pert
"Well-differentiated human lung epithelial cells, infected with BN/59 (seasonal H1N1) for 36h",pert
heart-30 months of age-control diet-biological replicate1,ctrl
OA4,ctrl
tissue: inner ear;	genotype/variation: Wild-type;	age: E10,ctrl
H14_P_B2,pert
"Crohn 09, CD09",pert
"patient 16, baseline",ctrl
colonoc_mucosa_non_inflamed_30,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 73;	gender: f;	treatment: -,ctrl
NoKD_SerumStarved->3hrEGF_rep2,pert
Sample Group: HD patient; Gender: female; Age: 61; Tissue: lymphocytes (blood); IT15 CAG repeats: 19/44,pert
MPM tumor specimen 19,pert
061K3: normal control,ctrl
"MCF7, biological rep3",ctrl
Brain from 62 days Npc1-/- mouse1,pert
HCC_36N,ctrl
"hepatic gene expression at ""1 hr"", rep2",pert
race: african american;	age (years): 55-60;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
GIST Pre Treatment Biopsy 04,ctrl
LUC KD #2,ctrl
N40892,ctrl
treatment: progesterone;	genotype: wild type;	treatement time: 4 hours,ctrl
"Crohn's Disease subject (64 year old caucasian female, SAK_1260745997)",pert
PBMC from T cell LGL leukemia patient #100 (TLGL100),pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 33;	gender: male,ctrl
KJD_rep1,ctrl
"E18.5 lung WT1, biological rep1",ctrl
12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24730,pert
"Sham NALT (PBS), biological replicate 4",ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 9,ctrl
age: 21 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),ctrl
Wild type CD8+ CD3-stimulated,ctrl
KU_04N,ctrl
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: ZNF750 gene silencing,ctrl
GB 5 NTA +LPA,ctrl
Bronchial Epithelial Cells SA biological 0658D,pert
"EBF1 d4, rep 4",pert
wild-type macrophages stimulated with MALP-2 for 2 h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.607;	OD280: 0.846;	Ratio: 1.83;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 213;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Lung myd88 mock repC,pert
hBSMC_control_rep1,ctrl
Isoflurane 5 exposures-3,pert
mouse TMJ-cartilage from DDR-1-KO mouse KO_Tal2,pert
"Strain: Sprague-Dawley, Gender: male, Weight: 350 g",pert
Disease_status: Healthy control;	Age (years): 50;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.75;	Post mortem interval (hours): 49;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
V5-P393,ctrl
Diagnosis: MDS/AML;	Age: 79y ;	Gender: Male;	Blast %: 87;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 3,pert
tissue: gastrointestinal stromal tumor (GIST);	cell type: freshly sorted tumor associated macrophages (TAMs),pert
MEF Wild Type 3-rep1,ctrl
EA_Case10_CD20,pert
"CD4+ splenocytes at 6h, biological replicate 1 sham-4",ctrl
HLA risk: Low;	Height: 157.3 cm;	Weight: 54.4 kg;	BMI: 21.9;	Age: 24.43 years;	Gender: Female;	Race: White;	Glucose: 95 mg/dl;	HbA1c: NA,ctrl
"DCIS 5, biological rep. 5",pert
"scr-control, biological rep1",ctrl
FACS-purified B cells_129SV/EV_influenza-infected_rep3,pert
reduction mammoplasty patient 361,ctrl
shRNA2-4-noDox-rep1,ctrl
chip number: 12;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.8;	rin: 9.2;	transfection date: 2011-10-17,pert
MacularDegen-healthy-1cAv2-s2,ctrl
MCAD 4,pert
M479 Wt,ctrl
A HID I_B047,pert
Bc_Mock_4,ctrl
ventral prostate,pert
WT-2,ctrl
Muscle PCOS after pioglitazone 82,pert
GIST882 DMSO Rep3,ctrl
CRC_nodrug_F4860,ctrl
Scd1-/- on chow diet replicate 4,pert
"WM 266.4 metastatic melanoma cell line, siCTR",ctrl
A39 WT1	F5/50	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
liver_Q10_6M_rep3,pert
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticle",ctrl
Intestinal Epithelial Cells (IECs),pert
CLL9-CD4,pert
01UPD_ERA,pert
"RT4D6 Schwannoma cells, treated with mutant siRNA for Sox 10, 48 hours",ctrl
Run2.aUa.001206d.SkMInS1089D.CEL-IS stimulate,pert
"Wild type GM-BMMs, biological rep1",ctrl
"Age: 8 months, Sex: Female, Retina: left, Final IOP (mm Hg): 25.3, Strain:DBA/2J",pert
skeletal muscle Crhr2+/+ replicate2,ctrl
Healthy control_sample8,ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
Ctrl siRNA 3d 1,ctrl
cell line: MDA-MB-231;	cell line origin: Breast cancer;	genotype/variation: ZMPSTE24 silencing,pert
Cont subject 06,ctrl
patient E1566,pert
"Gastrocnemius medialis, TMD",pert
0523-01-C,ctrl
myoblasts-expt1_untransduced-rep3,ctrl
shRNA-control-rep-2,ctrl
Mouse male ES cells WD44 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-2 in WD44.,ctrl
"Mesodermal Precursor Cells derived from hES cells line VUB01, biological replicate 2",ctrl
"Mdr2-KO heterozygous mouse, 3 month old mouse 2",ctrl
A549 cells exposed to cyclic stretch 20% elongation for a total of 4hrs experiemnt performed on Nov 21 2002,pert
Gata3_F2,ctrl
5209 Normal Uninflamed sigmoid colon,ctrl
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 687,ctrl
nt control 7,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 1,pert
HD3,pert
NPC14,pert
"KO total RNA LSK, rep 4",pert
B6_Female_CF_rep3,pert
tissue: Brain;	genotype: Npc1+/+;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
heterozygot FH P250,pert
Normal PBMC Sample 3,ctrl
Bronchial Epithelial Cells MMA biological 2198F,pert
HTH83 cell lines,pert
EB_6_24h_289_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
NM16 healthy control,ctrl
"pooled adult mouse intestine, kidney, and liver plus fetus tissue",pert
Run4.aUa.010110d.SkMDbt1144D.CEL-DB basal,ctrl
MDA-MB-231 - MTDH_WT_KD,pert
A2AR_WT_saline_24h_rep4,ctrl
treatment: baseline;	gender: M;	age (y): 44;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
Subject #8011-Preinfection,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: DMSO for 72h,ctrl
cell type: Primary hepatocytes;	strain: FVB;	agent: Wy14643;	time: 24h;	gender: Female;	age: 5 months,pert
SA_71,pert
imanitib3,pert
"Neuroretina 8-week diabetic, Biological replica_2",pert
EB_07_6h_129_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
AO C3,ctrl
14_PAH,pert
"liver,12weeks,KO",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 34.13425,pert
PGK12.1_control RNAi-3,ctrl
"Mouse jejunum, PND30",ctrl
multiple myeloma (MM 48),pert
"Human lung adenocarcinoma A549 cells treated with TNFα, in presence of Claudin 1 siRNA",pert
Strain: C57BL/6J;	Gender: M;	Age: 6 weeks;	Treatment: untreated,pert
0170-01-C,ctrl
"medulloblastoma, M2_scrambled, rep1",ctrl
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Pioglitazone,pert
cell line: HCT116;	cell type: colon cancer;	sirna: CD44,pert
liver_female ko_rep2,pert
"kn muscle 1, biological rep 1",pert
CFU-PreB colonies Hspa9+/-,pert
FoxO3null_2_2,pert
r04,ctrl
"seminoma specimen, pT2, patient age: 37y; W00 025",pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: B;	transfectant type: stably transfected with RNAi against DJ-1,ctrl
HUVEC_control experiment 2,ctrl
gonadal white adipose tissue_wild-type_8 weeks of high-fat diet,ctrl
"brain, cerebellum: KCx4w#1_e1_le1",pert
microdissected breast cancer cells from case 1304,pert
LNT-5,pert
ALS gray matter 4 Sporadic,pert
SRF silenced EtOH rep 2,pert
"disease state: Nasopharyngeal carcinoma;	stage: III, T2, N2, M0, G4",pert
imanitib6,pert
E14.5 Tgfbr2 Wildtype Mouse Model Tongue,ctrl
disease status: controls;	tissue (brain region): Frontal cortex,ctrl
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PAXgene Globin reduced;	molecule: Globin-depleted RNA,pert
Teratoma 2201,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 41 yr;	population: Native American;	dsm-iv: 296.53;	age of onset: 22 yr,pert
tissue: breast cancer;	cell line: MDA-MB-231,ctrl
Cell line HeLa_control_expt3,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.232;	OD280: 0.618;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 230;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Postmenopausal female. Untreated control. nr 37.,ctrl
myoblasts-expt1_lentiDUX4fl-rep1,pert
strain/background: C57BL/6;	genotype/variation: Zbtb7a Flox/Flox Mx1-Cre+ (LRF homozygous knockout);	age: 4 weeks;	cell type: FACS-sorted LT-HSCs (LSK IL7Ra-Flt3-CD150+CD48-);	time point: 9 days after 1st pIpC injection,pert
SC263_PBS3,ctrl
"65 y/o male 46,XY",pert
hNHEPS_control_6 h_rep1,ctrl
CRC_celecoxib_M4877,pert
TOV112D cells_untreated,ctrl
quadriceps_muscle_Akt1+/-_female_35wk_rep2,pert
Xid primary splenic B-cells (sample2),pert
tissue: brain;	genotype: WT mix background B;	age: P0,ctrl
chip number: 20;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.71;	rin: 9.8;	transfection date: 2012-03-26,pert
DIA-t7; transgenic diaphragm 7 month,pert
Human.AQ.CP.FCU,pert
Mouse_WT_colon_UT_rep2,ctrl
DUSP1-/- control replicate 3,pert
Mening UNSTIM WB NP 24b,ctrl
"Patient 113, 12 month of REBIF",pert
"Mutant, biological rep3",pert
PTC BRAF wt 1,pert
LY2 control-siRNA tamoxifen treated rep4,ctrl
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
Panc1 cell line,ctrl
Patient 1,ctrl
17beta estradiol: 100 pM,pert
"P16 control OC apex, biological rep 2",ctrl
Patient: D;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
"Pten null epithelials cells, biological rep1",pert
healthy control sample x072,ctrl
"Amoxicillin treated Distal, Small Intestine 3 21 days old",pert
female,pert
"Biceps, control, cohort 19, subject 19U",ctrl
"SiRNA-scrambled, replicate 1",ctrl
PBMCs_IS_12 [IS],pert
NOD/LtJ Vehicle liver sample batch 1,ctrl
Adipose-24 month-Myc heterozygous-technical replicate 3,pert
Sodium arsenite added to food: None; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: None,ctrl
"Patient I-c1034T, MSI colorectal tumor",pert
BV-173 Imatinib-treated,pert
"0mg/kg/day PFOA, Rep 3, Block 3 lung (high dose)",ctrl
b89,ctrl
osteoblast_5azatreated_rep3,pert
strain CD-1,ctrl
"Mbd3 KD, replicate A",pert
NK_cell_pool_melanoma_M05+M06,pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 1",ctrl
Control A549 cell,ctrl
"Liposarcoma culture from tumor 387, doxorubicin treated",pert
"vector d10, rep 2",ctrl
SeroNeg-9,ctrl
Control (shControl-3),ctrl
H295R_Group_C_Dose_100_TIMEPT1_033,pert
cell type: late passage (LP50) LNCaP,ctrl
Treated with 5% mannitol for 4 hrs -- replicate #3,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_6-tu3,pert
NM19 healthy control,ctrl
"Human LIMA artery from patient 1, treatment: paclitaxel-eluting stent",pert
HL60_shSYK_1_Replicate2,pert
nucleus accumbens,ctrl
"shKDM4C 2, clone 1, rep 2",pert
5-ONS76 Mock_b,ctrl
HT-WT-2B,ctrl
Extract:LOX-1:213201;	Extract Description:LOX1_Untreated_2hr:213201;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.67;	Quality: Background Mean Dev.:0.2;	Quality: Absent (%):57.28;	Quality: Absent (%) Dev.:0.75;	Quality: Scaling Factor:0.54;	Quality: Scaling Factor Dev.:0.59;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213201;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295533,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.88;	choa: 240;	fata: 58;	eea: 1750;	wtkg: 85.6;	perfat: 23.1;	lbm: 58.3;	fat_mass: 1977.36,ctrl
F3-WT-2nd,ctrl
130B,ctrl
erStress_twins_AA_1712twin1_500nM_thapsigargin_4h,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14475;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
coc-16_C,pert
"Acute Myeloid Leukemia, sample 28",pert
"WT caudal vertebral bone, rep2",ctrl
pMX-GFP vitamin C GFPVc+_2,pert
"E14 embryonic stem cells, untreated",ctrl
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 29;	maternal age: 24,ctrl
patient: 15;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
S25 WT1	F4/27	S25	wild type	Mouse	3 months	Cerebellum	Male,ctrl
Glioblastoma_5,pert
r18,pert
10_c,ctrl
RNA from whole tissue section of case 297 labeled with Cy5,ctrl
Diagnosis: MDS/AML;	Age: 45y ;	Gender: Male;	Blast %: 85;	Source: PB;	Cyto: Complex;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
Brain from 81 days Npc1+/- mouse1,ctrl
dental pulp stem cells extracted from deciduos tooth,ctrl
"C57BL/6 female, fasted 18h (overnight), age 4-5 months",pert
MDS patient 146,pert
"control, subject 7",ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 57;	baseline tumor size (cm): 5x5;	patient id (to identify the 2 chips from the same patient): 19101935,ctrl
lean rosiglitazone 2,pert
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD4-FITC;	cell type: CD4 positive T cells,pert
cell line: um-uc-3 (atcc# crl-1749);	cell type: bladder cancer cells;	genotype/variation: transfected with gfp,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 2,pert
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
"Acute Myeloid Leukemia, sample 3",pert
health control_4,ctrl
C57BL10 gastroc sample 1,ctrl
NCCIT-Consh-rep2,ctrl
"23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Age: 66 yrs Gender: Female  Ethnicity: Caucasian,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 33 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
"Transgenic, snap frozen, plantaris muscle, 7month age animal",pert
3491-2 E2F2 Null,pert
A_AN11989_F,pert
"Wild type used for MAT1A 3 month, replicate 2",ctrl
age: 49;	gender: female,pert
Insig1 flox/flox /Insig2 -/- InsigKO_C2,ctrl
"Patient  D, lesion, 12 week",pert
Ileum_Wild Type+Quercetin_1,pert
"HEK293E cells, scrambled siRNA, replicate 3",ctrl
Paraquat Human-ApoD transgenic gain of function mutant,pert
Skinbiopsy_0hoursnickel_nickel_allergic_subject_P4,ctrl
Myd88 KO control tissue  4,pert
Kidney HEK293 cells,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 1,pert
12N,ctrl
Day: 24; Drug: Methamphetamine; Phase: Withdrawal; Replicate: 2,pert
Control Endometrium Mesenchymal Cell_ETB65 ++,ctrl
chip number: 13;	transfection plate: 6;	target gene: USF1;	kd level: 0.79;	rin: 9.5;	transfection date: 2012-03-26,pert
con-52,ctrl
s5t2c,ctrl
skin total,pert
strain: SW129/C57BL/6J  cells;	genotype/variation: wild type;	cell type: B-lymphoid,pert
developmental stage: E14.5;	genotype: Pax2Cre/+;PtenloxP/loxP,pert
"differentiated U937 cells, untreated, 4h",ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 3",ctrl
EGF 4h replicate 1,pert
01N15_Systemic,pert
"triceps, control mouse",ctrl
HCC SNU-398_SALL4 knockdown,pert
coc-16_B,pert
array 10 minus E,pert
Control #2,ctrl
r07,pert
CD8+ cells isolated from spleen,pert
MDA-MB-231ER+ Breast Cancer Cells,ctrl
WT striatum,ctrl
Bone marrow.,pert
si Control and vehicle replicate 1,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp2,pert
shOCT4_5,pert
AA_Case5_CD8,pert
CON31,ctrl
"TMD_TA, T3",pert
PBMCs_IS_14 [IS],pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
Kidney_50 mg/kg VCM ip_mouse #068,pert
Wildtype liver,ctrl
MDS16,pert
"Animal id 552, right retina, 8 months, female, DBA/2J",pert
EA_Case2_CD20,pert
"1mg/kg/day PFOA, Rep 4, Block 1, liver (low dose)",pert
"human failing LV myocardium, Idiopathic40",pert
"MCF-7 transfected with pcDNA3.2-BP1, rep.2",pert
Patient 22,pert
Ls174T-L8 dox2,pert
Placenta_PE(EO)3 with Cy5,pert
Healthy controls; individual=JR; time=2; beverage=alcohol,pert
GFAP-negative lamina cribrosa cells,ctrl
"Exp A, Animal #245, control (0mg/kg) D-Serine",ctrl
"Patient I-c671T, MSI colorectal tumor",pert
Angiopoietin-1(sparse)-2,pert
Ero1-C104A/C131A induced biological repA,pert
Snell 6 month Dwarf Liver 87dw,pert
tissue: dorsal skin;	genotype/variation: GR-/-;	strain: B6D2/F1;	age: E18.5,pert
WT_PMΦ_rep1,ctrl
Subject #8023-2d Postinfection,ctrl
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
Subject 3 / lung subsegment instillated by LPS,pert
"28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
Cervical cancer_88-04T,pert
PHM-DM-5aUA-s2,pert
"Patient 9, Macroscopically intact tissue",ctrl
mESCs_EGFPcontrol_rep3,ctrl
PGA-RMM-18h-2aA-s2,pert
B7hi mTEC B6/129 aire-/- 2,pert
major non-tumor1,ctrl
"Crohn's Disease subject (23 year old caucasian male, SAK_1316577485)",pert
tissue: isolated from spleen;	cell type: memory CD8 T cells;	strain: C57/BL6;	genome/variation: wild type;	age: over 80 days after infection,ctrl
"Global gene expression of NASH patients, P53",pert
Allo-4-4,pert
muscle_Akt1+/-_8wk_rep3,pert
race: african american;	age (years): 50;	stage: IA;	grade: 1;	histology: endometrioid,pert
"patient 024b, normal, homogenized",ctrl
"eye, cornea: TRizol Extraction_le1 5",ctrl
"Colitis 03, UC03",pert
"Mammary gland, IGF1R-overexpressed, biological rep1",pert
Wt Mouse_cerebellum_Old_saline treatment_Replicate-3,ctrl
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 42;	gender: m;	treatment: -,ctrl
Human Non-progressor HIV Sample L128-CD8+ T cells,pert
66 mt E11.5 heart,pert
Nonlesional Epithelium Atopic Dermatitis rep1,pert
patient: 34208;	disease state: LGSC;	component: Borderline,ctrl
Donor1_6h_DMSO,ctrl
LNCaP.GFP.1,ctrl
Leg 28 Day mdx rep 1,pert
uterus_P4_PRKO_40hrs_rep1,pert
14 Day Mouse Diaphragm muscle,ctrl
tissue: skeletal muscle;	disease status: inclusion body myositis,pert
"C57BL/6 female 6 weeks, 125",pert
H1P_6,ctrl
"Crohn's Disease subject (21 year old caucasian female, SAK_1261327175)",pert
microdissected epithelial cells from IPMA 2,pert
"Rat_Tracheal_Control_2hr, rep1",ctrl
"Donor 3, mock infected 1hr",ctrl
Embryonic day 14.5 pancreas,pert
P2A Progranulin-frontal,pert
V5-P594,pert
Hep G2 treated with Phenol,pert
MEF Wild Type 2-rep2,ctrl
EB_0_24h_56_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
WT-sham-5 month+1d-R1,ctrl
LCL Concordant for Epilepsy twin pair 3 (CCE3.2)(TP36),pert
endothelial_rep4,ctrl
4mo wt9,ctrl
MCF10A 9days,ctrl
Macrophages,pert
CLL 164-02 LMP-420,pert
PND28 Rat Testis_Rat230-2_3hr Corn Oil_Animal#54_04005,ctrl
Colo-205 DMSO Day 10,ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Mesenchymal Cell,pert
"Whole blood - Autism no regression, Male",pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 36;	maternal age: 36,pert
"IκBα-deficient animal, biological repeat 3",pert
female heart 10 days post cvb3 injection,pert
CXCR4 knockout 5,pert
"Patient H-c587T, MSI colorectal tumor",pert
Subject #8001-8hr Postinfection,pert
"Control, replicate 6",ctrl
2_DMSO-2,ctrl
brain_Down_syndrome_sampleid_jg1739,pert
28dpp Ubb knockout testis,pert
cell type: embryonic stem cells;	genotype/variation: transfected with scrampled-control siRNA,ctrl
CBMNC.LPS-.1,ctrl
"Control at ZT6, pineal gland",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 85min;	race: White;	sex: Male,pert
major HCC10,ctrl
SLE CD4 T cells 11,pert
PBMC_C1,ctrl
8 week old Nix null mice (Nix-/-) spleen,pert
36 year old female,ctrl
"AALE-Vector + shGFP, biological rep2",ctrl
Day: 18; Drug: Saline; Phase: Withdrawal; Replicate: 1,ctrl
neocortex,pert
Tissue: lung;;	Genetics: Sporadic IIP;;	Histology: Usual Interstitial Pneumonia,pert
Leukemic mice 3 weeks after birth,pert
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 1,pert
B6C3F1/J Vehicle liver sample batch 2,ctrl
Lung-normal-rep6,ctrl
c57/BL,ctrl
S46 WT6	F5/54	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
"wt total RNA LSK, rep 5",ctrl
Gender:M;	Age:35;	Tissue: Mucosa,ctrl
cell line: THP-1;	shRNA construct: GSK3A Construct 5,pert
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Bronchial biopsies from lung tissue,pert
"EtOH, RARaKO, set 3",ctrl
KO - 5 mo - repeat 3 - Cy5 - mAdbID:74137,pert
IFNAR_uninf_1,pert
Dissociated dorsal root ganglia treated for 30 min with capsaicin,pert
wild-type E18.5,ctrl
Wild type olfactory epithlium 0 h replicate2,ctrl
HLA risk: Medium;	Height: 166.3 cm;	Weight: 64.5 kg;	BMI: 23.2;	Age: 18.16 years;	Gender: Female;	Race: Other;	Glucose: 114 mg/dl;	HbA1c: 7.4%,pert
siZMPSTE24-treated SCC-2,pert
"Acute Myeloid Leukemia, sample 75",ctrl
FmrKO5_blood,pert
WT623,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 55.27671,pert
short-hairpin rna: shCDK8;	cell line: HCT116,pert
Aged 7,pert
Liver sample from Control group (C9),ctrl
BV2_rep3,ctrl
Pancreatic Sample 4-Tumor,pert
KO-control-1,pert
cerebellum_KO_3,pert
116B,ctrl
human_hepatocyte_400uM_levofloxacin_donorA_24hr_prep1,pert
sex: Male;	Age: 8 months;	additional patient information found in Series supplementary file,pert
PGA-MAH-AJ_PBS24h-5aA-s2,ctrl
MMA heterozygote,pert
FASSc2 medium only,pert
patient: 120;	current medication: Minicycline;	birth date: 5/6/54;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Female,pert
male_control_367,ctrl
"fibroblast, control subject NM7 rep 2",ctrl
HEL_JAK2 knockdown (Jak2-10 shRNA)_1,pert
"BMMC, NTAL KD, activated",pert
SCARKO d10 (1),pert
CTRL,ctrl
FVB_24h_Wy,pert
midbrain_wild type_18 month_replicate 2,ctrl
"seminoma specimen, pT2, patient age: 31y",pert
HD6,pert
tissue: testis;	gestational age: 22 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: abiraterone,pert
t12,pert
si Control and vehicle replicate 2,ctrl
"brain, cerebellum: KCb4w#3_e1_le1",pert
"Lymphoblastoid cell lines derived from family 1717, member 2",ctrl
"Control, replicate 7",ctrl
LmnaG609G/G609G KI #5. 465,pert
age: 42;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P0 postnatal stage,ctrl
Aorta_APOE-deficient with atherosclerosis_2,ctrl
"Lesional skin from K5-Tie2 mouse, biological replicate 1",pert
siNS_24h_3,ctrl
0155-01-c,ctrl
H441 transfected with ETS2-specific siRNA 3,ctrl
liver western diet 0.05% quercetin rep6,pert
GM19238_Kd_NFKB2_1,pert
"Cultured ovarian cancer cell line TYK-nu, untreated",ctrl
patient id: T142;	tissue: Normal cortex;	gender: Female;	age: 56;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
patient id: 83;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 85;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: loss;	vhl status: mutant,pert
"LY2 cell line, SRC-1 scrambled treated 120min,  biological rep3",pert
"nasopharyngeal carcinoma, specimen T18",pert
8 week old leg MDX rep 1,pert
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 0,ctrl
NPC Brain 20d Mouse1,pert
control-1,pert
5268 UC Inflamed sigmoid colon,pert
tissue: Biceps muscle;	patient: C.b.9;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y 11m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
colon_C57 mouse_12weeks_rep1,ctrl
n2a-Pou3f3-kd-1,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 4hr,pert
"Crohn's Disease subject (33 year old caucasian female, SAK_1275455680)",pert
Leptin treated mouse gallbladder 6,pert
Brain_Aged_LPSip_4hr_mouse2 (OL2_#68),pert
Pool Ts1Cje_P15_hyb1,pert
Cisplatin_2h_rep1,pert
112 Day Mouse extraocular muscle,pert
cell line: MCF-10A,ctrl
T3_HypM,pert
"vehicle, biological rep2",ctrl
Knockdown Cell on HMVEC-L Replicate 3,pert
cell type: E14 murine embryonic stem cells;	genotype: Mock knock-down cells,ctrl
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Tumor-KO-rep4,pert
Glomeruli from diabetic male OVE26 mouse sacrificed at 8 weeks,pert
S1-030626-SA,pert
"TG male mice, water",pert
tissue: testis;	genotype: wt;	age: 14dpp,ctrl
Diagnosis: AML M1;	Age: 52y ;	Gender: Female;	Blast %: 88;	Source: BM;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
ctrl.1,ctrl
T30277,pert
U937_ROS_curcumin_4h_rep3,pert
primary normal lung tissue 1546,ctrl
sirna: NR2F2 knockdown;	cell line: TOV112D;	cell type: Ovarian cancer cell line,pert
AP-2 gamma targetting siRNA 2: GCGGCCCAGCAACUGUGUAAA Technical Replicate 3,pert
knockout rep-3,pert
"mouse embryonic fibroblasts derived from FHL2-/- mice, FHL2mutH",pert
"A1_tumor, lung tissue",pert
Mc3T3 AA_ 5day_rep1,pert
con-15_B,ctrl
"HeLa control, biological rep2",ctrl
"tissue: whole lung;	strain: SPC(+)Cre(-), Dox E6.5-12.5, PN15;	genotype/variation: wildtype, control",ctrl
"gender: Male;	age: 82;	post-mortem delay: 5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
TTP_WT_0ActD_BioRep5,ctrl
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1+/+Rnf2F/F (control),ctrl
"Mutant in the presence of tetracycline, rep3",ctrl
WT 569 R3,ctrl
Hippocampus_Soman_96h_rep1,pert
Cmah KO_lung_2,pert
hNHEPS_control_6 h_rep2,ctrl
Tendon_non-lesional_rep18,ctrl
3551-1 E2F WT,ctrl
Disease_status: Bipolar disorder;	Age (years): 44;	Gender: Male;	Age of onset (years): 33;	Duration of illness (years): 11;	Brain pH: 6.74;	Post mortem interval (hours): 19;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous saline challenge""",ctrl
HepG2_Cd rep3,pert
"A549 cells (lung epithelial cells, a common cell line used in IFN assays)",ctrl
"Autoimmune pancreatic islets, day 2 cyclophosphamide treatment, Rep 1",pert
KN-sham-5 month-R3,pert
BIO586226,pert
Healthy controls; individual=IF; time=2; beverage=alcohol,pert
Nerve_Diabetic_Rosi_718,pert
condition: Normal;	patient: N_LJ_2;	tissue: Normal skin biopsy;	kit: Affy,ctrl
WM-266 knock-down of Pirin by siRNA - Replica 2,pert
Muscle-24 month-wild type-technical replicate 1,ctrl
Bronchial Epithelial Cells MMA biological 1691G,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T158,pert
"ventricular myocardium, A2AR knockout, saline, 24h",pert
scpk/ikLLtumor/21,pert
"PPARg d0, rep 4",pert
Huh7 cells_Mock Infected 18 hours_ rep3,ctrl
Bronchial Epithelial Cells control biological 1579M,ctrl
genotype: tg/g;	treatment: CaNrf2;	gender: female;	background strain: FVB/N/C57BL/6 mixed,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 54;	age-at-onset: 53;	geographical origin: Mirandela;	clinical characteristics: Diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: liver",pert
S-IIP(UIP)6_Cy3,pert
Bronchial Epithelial Cells SA biological 1568H,pert
NALT_infected_24h_90-226-dM_rep1,pert
EDL-n10; normal extensor digitorum longus 10 month,ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep4",ctrl
BCells_WildType_day0_REP1,ctrl
human peripheral blood mononuclear cells (healthy subject),ctrl
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14477;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
Aire KO,pert
Bone-Marrow_SMM_S1365,pert
"NF-YA KD ES cells 96hr, replicate 3",pert
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
colon_adenoma_1830,pert
HF1677_U133P2,pert
patient8,pert
X50 WT2	F2/9	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
"ID:9-2, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
WT_ANT_PDE_B1,ctrl
AVIC sample#2 treated with DMSO,ctrl
"WT mouse lung, biological rep4",ctrl
"wild type 5C.C7 T cells, biological rep2",ctrl
NIH3T3_4h_FGF_exp2,pert
Retina of 6 month old C57BL/6 mouse,ctrl
cell line: U373;	cell type: glioma;	vector: Deltex1 (Myc-tagged),pert
"control, BA46-77",ctrl
"Control subject, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.",ctrl
human fibroblasts overexpressing prelamin A treated with FTI,pert
EB_07_8d_146_HCHO_Nasal_Rat230_2_CIIT05024,pert
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-GFP,pert
"BOEC, normal 25",ctrl
tissue: Biceps muscle;	patient: P.b.6;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
fibroblast_5azatreated_rep1,pert
WT Uterus_saline_24h_rep2,ctrl
tissue: tumor;	disease state: DCIS,pert
OSCE-9N,ctrl
HF0087_U133P2,pert
"Retina from control mouse at ZT6, biological rep 2",ctrl
"Lesion Skin, LS-30",pert
SLE CD4 T cells 3,pert
phenotype: control;	gender: male;	case_id: 510;	age: 60;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 21.5;	brain ph at time of freezing: 6.66;	labeling_batch: 1,ctrl
Retina homozygous KO 42 days 2,pert
SRF silenced R1881 rep 3,pert
Fog2flox/delta; no Cre biological replicate 3,ctrl
TTP_WT_60ActD_BioRep2,pert
oculomotor nucleus,ctrl
"tissue: neurectoderm derived from embryonic stem cells;	treatment: control, shRNAmir #11;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",ctrl
cerebellum_PSNA_ 12w_rep2,pert
cell line: MOLM-14;	shRNA construct: GSK3A Construct 5,pert
Exon3_T1,pert
Retina homozygous KO 30 days 1,pert
Normal_1975,ctrl
cardiomyocyte SRF-null 3,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 70;	gender: male,pert
129_Sv_1_Runx1_Ko_d6_4302,pert
GM19238_Kd_STAT2_1,pert
Diaphragm 28 Day control rep 2,ctrl
Transgenic nr 619,pert
23B,pert
PancreaticSample54-Tumor,pert
siCtrlVeh4h_2663,ctrl
Bone-Marrow_MM_M1018,pert
E9.0 wt.3,ctrl
sample: #17;	subject: PD case #3;	brain: T-3321;	age: 77;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
REH_shG1_rep1,pert
Cont subject 01,ctrl
ccRCC tumor of patient 131,ctrl
BAT_KO_2,pert
RV64.02_CONTROL_day25_Slide41,ctrl
U937_ROS_untreated_18h_rep2,ctrl
"shCDK8, low glucose, replicate 2",pert
437_CreER: mutant mouse 3,pert
Sample ID:TP5;	Twin Pair ID:DCBD1.1;	Clinical Status:BD1 with psychotic features;	Age of Onset:19;	Age at interview & blood sampling:55;	Current Age (2007):58;	Sex: Female;	Medication at interview (duration) :lithium & citalopram (22.5 years),pert
major HCC2,ctrl
U2OS shCHK1-3 replicate 3 [set 4],pert
control AU1086301,ctrl
cell type: NPC 5-8F cells;	genotype/variation: NESG1 overexpression,pert
"MDA-MB-231 (human, Caucasian, breast, adenocarcinoma)",pert
NCI-H69 human small cell lung cancer,ctrl
H3f3b KO 3967,pert
sex: Male;	Age: 11 months;	additional patient information found in Series supplementary file,pert
subject: 13U;	cohort: 13;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 63;	Sex: F;	batch: Batch_3,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 4",pert
Patient no. 8: treated,pert
patient with sepsis only,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 22.0;	age of psoriasis onset: 23,pert
Individual_777_PN_sample,pert
P105,ctrl
liver_STZ treated diabetic_rep4,ctrl
HSC_Zfx-cko_Replicate1,pert
SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2),ctrl
PGA-RMM-330m-3aA-s2,pert
WT 2 mon replicate 3,ctrl
10 week control OMN rep 3,ctrl
SLE2,pert
Kidney_Biopsy_Liver_Disease_6,pert
T144,pert
"BT474 breast cancer cell line, DMSO",ctrl
MCF7 cells,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 3,pert
Murine Heart Apex,ctrl
cell line: NAS9;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: wild-type,ctrl
strain: 129/Sv;	genotype/variation: DDR-1-KO;	tissue: madibular condyle cartilage,pert
PTEN_mutant_1_intestinal_polyp_30days,pert
NET1 knockdown AGS cells,pert
"cell line: HEK293 human embryonic kidney cell line;	protocol: MIF depletion, siRNA-mediated;	siRNA concentration = 50pmol/ml",pert
Neonatal mouse ovaries cultured in DMSO (0.1%),ctrl
cell line: derived from JoMa1-MYCN-induced tumor,pert
"Acute Myeloid Leukemia, sample 58",pert
Nonlesional Epithelium Nonatopic Control rep4b,ctrl
"Atria, Control, biological replicate 3",ctrl
gender: male;	age: 7.5 mo +/-2.5 weeks;	genotype/variation: PPAR KO;	treatment: control,pert
EGFR+EGF_3,pert
treatment group: air;	tissue: left lung lobe;	gender: Male;	strain: C3H/HeJ,pert
3769,pert
"strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
"Cells: U2OS, Treatment: infected with PRC shRNA1_pLenti, blasticidin selection",pert
"siYAP RNA #2 transfected, biological rep 4",pert
M10KOepi_infect_0h_rep3,pert
8 week old leg MDX rep 4,pert
Diabetic 5 weeks D5,pert
Strain: C57BL/6 Rs1h knockout P7,pert
The placenta (E 10.5) of a congenic adra2B-/- mouse embryo (maternal genotype Adra2b+/-) was rapidly dissected and flash frozen.,pert
Low weight gainer KOZAK2_ABI_HYP_L2,ctrl
human_hepatocyte_400uM_clinafloxacin_donorA_24hr_prep1,pert
subject: 20U;	cohort: 20;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 39kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
cell: Cultured oligodendrocytes;	genotype: Myelin-gene Regulatory Factor control littermate,ctrl
MCL_IGHV_MUT (R1640),pert
scpk/ikLL/57,pert
"Uninvolved Skin, NS-25",pert
prostate_Klf5 ko_rep2,pert
strain: HNF4LoxP/+  Villin Cre;	age: 1 month;	tissue: small intestine;	sex: female,ctrl
"H1 hESCs, NANOG shRNA",pert
Normal-ERα-positive breast cancer 72,ctrl
"human failing LV myocardium, Ischemic94",pert
MDS patient 170,pert
"Spi-60, biological rep 4",pert
"20 days normal mice, cerebrum",ctrl
age_years: 40;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"Exp A, Animal #266, 20mg/kg D-Serine",pert
liver knock out replicate1,ctrl
RNA from whole tissue section of case 1205 labeled with Cy5,ctrl
Choriocarcinoma 0915,pert
Epidermal keratinocytes treated with EFNA4 for 48h,pert
"Mammary gland, control, biological repl 1",ctrl
healthy donor,ctrl
"differentiated U937 cells, ROS exposed, 18h",ctrl
cell line: SCC-40;	cell line origin: Oral cancer;	genotype/variation: ZMPSTE24 silencing,pert
"A673 treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50), biological rep1",pert
patient: 20;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
APOE_KO_NODM_9W_6,ctrl
DMSO Treated Control 2,ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 58;	tissue: Blood,pert
Liver of pup exposed to 0.2 mg/kg BW BDE-47 rep4,pert
control siRNA rep1,pert
HCC_4N,ctrl
coc-53_C,pert
C10,ctrl
ATP-treated AML 14 blasts,pert
Cal27_CETU1,pert
NS5_NS010926,ctrl
Liver_hyperglycima_no.8,pert
HSC_Zfx-flox_Replicate1,ctrl
MS25_4B_MEK5_220307,pert
cell type: Primary hepatocytes;	strain: DBA;	agent: control;	time: 24h;	gender: Female;	age: 3 months,ctrl
PDAC_1,pert
Ishikawa_VeryLowDose_BPA_24h_rep2,pert
A503 MI 7 day,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379020;	hybridization batch: IV,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous endotoxin challenge""",pert
Mouse No Cldn16 B9 458,ctrl
Exercised-5,pert
lymphocytes_ctl_F_51y,ctrl
GM19238_Kd_IRF7_2,pert
"PTEN inducible MEFs at T1 = 24hr, biological rep1",pert
"MAT1A knockout at 8 month age, biological replicate 2",pert
Ctrl siRNA 4d 1,ctrl
Fibroblasts_HealthyControl_2,ctrl
"HERVH shRNA, rep2",pert
Extract:LOX-1:113101;	Extract Description:GFP_0hr:113101;	Quality: Classification:Bad;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.12;	Quality: Defective Area (%):0.08;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.61;	Quality: Background Mean Dev.:6.14;	Quality: Absent (%):61.21;	Quality: Absent (%) Dev.:2.29;	Quality: Scaling Factor:0.45;	Quality: Scaling Factor Dev.:1.4;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113101;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295413,ctrl
SA_252,pert
strain: C57BL/6J;	cell type: KLS;	genotype/varation: wildtype,ctrl
Native-0-1,ctrl
primary normal lung tissue 1050,ctrl
Postmenopausal female. Untreated control. nr 22.,ctrl
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: control hairpins targeting GFP,ctrl
BCell_lymphoma_transitional_sample4,pert
Skinbiopsy_7hoursnickel_nickel_allergic_subject_P4,pert
kidney_QH2_6M_rep1,pert
wild-type rep_2 (CWT2),ctrl
"human failing LV myocardium, Idiopathic69",pert
n3_hi_10,pert
dental pulp cell from control 2,ctrl
P14 - nudelko/+ 1,pert
jejunum_GATA4mutant_2,pert
AKT_PLACEBO_48hours_1,pert
Scd1-/- on chow diet replicate 5,ctrl
Wild type mouse embryonic stem cells,ctrl
"control, BA46-90",ctrl
CONTROL;	Age = 21;	Sex = F,ctrl
H1299 DAC 1 uM (3239),pert
lung_myd88_mock_repB,pert
THRA aI mutant + T3 replicate 1,pert
liver_control_diet_rep3,ctrl
"4105_CD133-, laminin treated",pert
"patient 10, baseline",ctrl
subject: 09A;	cohort: 9;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 25kb;	age (y): 31;	Sex: F;	batch: Batch_2,pert
treatment: PLX4720;	time: Day8;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 1",pert
"Crohn's Disease subject (39 year old caucasian female, SAK_1261237763)",pert
gender: male;	age (years): 33;	evolution time (years): 8;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
"P16 control OC base, biological rep 2",ctrl
Female - caucasian - E-02-G,pert
patient: 21;	disease state: hypertension;	tissue: Atheroma plaque,pert
Normal skin 1,ctrl
"EBF1 d0, rep 3",pert
NCCIT siTET1 rep2,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 60 years,ctrl
"2 month old, double transgenic (InsMycER+,RIP-BclXL+)",pert
"ARD531, CAIS, F, GOF, 6 x ETOH, 14d",pert
SKBR3_0.1uM_Lapatinib_2,pert
striatum wild type 6 month replicate 2,ctrl
NPC_VUB03_DM1_1,pert
cell line: Calu-3;	cell type: airway epithelia cells;	treated with: SIN3A siRNA,pert
C57/BL6 murine Liver RNA- 6 hours post-injection with PBS,ctrl
WT 1 1508,ctrl
Individual_5749_NN_sample,ctrl
LC1025ni,pert
disease state: cocaine addiction;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: cocaine related,pert
strain: C57BL/6;	cell type: Lineagelow Sca1+cKit high Cells;	genotype/variation: mutant JAK2V617F (heterozygous),pert
normal arterial tissue: sample #2,ctrl
"shControl, low glucose, replicate 2",ctrl
cell type: Sarcoma cell line;	strain: C57BL6/J;	genotype/variation: Dicer Null,pert
39SAGEA2,pert
A673 cell line that has been treated with DMSO vehicle control for 5 days.,ctrl
condition: Psoriasis;	patient: PS-O;	tissue: LS skin biopsy;	kit: Affy,pert
"Pancreatic tumor cells, replicate 4",pert
KN-smoke-med-1 day-R2,pert
"wildtype pancreas, biological rep2",ctrl
KN-smoke-med-5 month+13d-R1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 4.08;	OD280: 2.003;	Ratio: 2.01;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 325;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
ab129 IM,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 2,ctrl
con-56,ctrl
age: 21 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,pert
MCF-10A shControl replicate 1 [set 5],ctrl
"Human mononuclear cells were isolated by Ficoll-Paque centrifugation in a discontinuous gradient from buffy coats from healthy blood donors. Cells were differentiated in macrophage-SFM medium supplemented with 70 U/ml human granulocyte macrophage colony-stimulating factor. After 3 days, the medium was changed to macrophage-SFM without GM-CSF and cells were cultured up to 8 days",ctrl
53A;pretreatment;female;breast tumor; nonresponder,ctrl
Wild type olfactory epithlium 0 h replicate3,ctrl
GM19238_Kd_ZHX2_1,pert
Squamous cell lung cancer patient 31,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 58,ctrl
5B,pert
EB_0_8d_64_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
"primary fibroblasts expressing a control shRNA construct, clone 1",ctrl
KM_050T,pert
Gfp+ photoreceptor cells,ctrl
570.B6,ctrl
224 Day 2 siSC transfected biological rep1,ctrl
B_cell_pool_melanoma_M07+M08,pert
Floxed_Mstn_4,pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.80;	Post mortem interval (hours): 47;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"BOEC, normal 23",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.37534,pert
cell line: HT29 parental cell line;	cell type: colon cancer,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Female,pert
"Right brain hemisphere ,C57BL male mouse,Un-treated Control,12 weeks",ctrl
pMX-jhdm1b vitamin C Jhdm1BVc+_2,pert
race: african american;	age (years): 71;	stage: IA;	grade: 1;	histology: endometrioid,pert
Individual_5242_PN_sample,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A61_8 months_replicate 1,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,ctrl
Heart,ctrl
LOX1_Untreated_6hr,pert
EA_Case15_CD20,pert
age: 63;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
DIA-n7; normal diaphragm 7 month,ctrl
whole lung E18 normal,ctrl
Bronchial Epithelial Cells SA biological 2254P,pert
"patient 011b, normal, homogenized",ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H511_2h_1mM_HG-U133A_2_YCHSUP501,pert
MPM tumor specimen 20,pert
type_of_rx: AFG;	pre_or_post_treatment: post;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 12961346,pert
Wildtype 1 (jos0668),ctrl
frozen surgical tissue,ctrl
T73,pert
A673 cell line that has been treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50).,pert
Teratozoospermic individual: Sample T8,pert
EB_0_19d_75_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
"ID:6-3, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
G630,pert
HT-KO-8A,pert
21dpp wild type testis,ctrl
rd1_P6_rep4,pert
DQD C,pert
tissue: Brain;	genotype: Npc1-/-;	age: 62 days;	subject: Mouse1;	genetic background: BALB/c,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).,ctrl
"seminoma specimen, pT2, pN1, patient age: 43y",pert
disease: type 1 diabetes;	gender: male;	cell type: endothelial progenitor cell,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 21;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
Fibronectin 2,pert
5922012008_F,ctrl
Adam10 knockout mouse,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 2,pert
"C57BL/6J, sample 1",ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID287,pert
Ishikawa_VeryLowDose_BPA_48h_rep1,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 31 yr;	population: white,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Ileum",ctrl
Skin biopsy from upper nates no nickel exposure,ctrl
phenotype: control;	gender: female;	case_id: 460;	age: 49;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: ?;	post-mortem-interval (hrs): 15;	brain ph at time of freezing: 6.93;	labeling_batch: 2,ctrl
sampleID: SAM630134;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep2,pert
Psoriasis-287,pert
"Patient  B, lesion, 1 week",pert
Strain: RPE65-/-;	Age: 2 months;	Tissue: retina,pert
31wk FVB(87.5%)/CF-1 (12.5%) mammary gland,ctrl
Wt Mouse_cerebellum_Standard diet supplemented with resveratrol_Ad Lib_Replicate-5,pert
WKY-vehicle pool sample1,ctrl
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 3",pert
shRNA2-4-plusDox-rep2,pert
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 41;	Usage number: 1;	Exposures: 3,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 4;	psoriasis duration: 4;	age of psoriasis onset: 24,pert
PancreaticSample21-Tumor,pert
"CBFb-SMMHCd179-221 animal 1, replicate 1",pert
Kidney_Aqp11-/-_P7_4-3,pert
0983-01-C,ctrl
MCF-10A sh53BP1-2 replicate 1 [set 5],pert
"cell line: hgps-ipsc_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below",pert
Anti-mir-210 replicate 2,pert
PA-1-(3),ctrl
siLMO3_oligo1_FM_rep2,pert
Preglaucoma control rep1 (OHN),ctrl
"fibroblast, MFS subject FB783 rep 4",pert
Monocyte ATV rep 2,pert
Pt_3 Normal Skin,ctrl
H2009_shPTK7,pert
siOGT 12 hours_1,pert
"RES-enriched Grape extract group, 6 months, patient number 13",pert
Untreated Control 4weeks AffyGC RMA rep1,ctrl
OSE_463,ctrl
"BOEC, normal 16",ctrl
Ctrl PGC rep1,ctrl
"ID:13-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
strain: Gata4tm1.1Sad/J;	infection: Cre recombinase;	culture: Differentiation medium for 3 days,pert
Healthy8-CD4,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 216,pert
"SW480, colon cancer cell",pert
"eye, retina: Control 1_e1_le1",ctrl
Spleen_infected_7weeks_rep2,pert
"Epidermal keratinocytes untreated control, 24h",ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 2;	time: 0;	batch: 2,pert
"human failing LV myocardium, Idiopathic82",pert
gender: Male;	age: 91;	post-mortem delay: 9.5h;	ph: 6.3,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 57;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
ICL670 10uM for 16hs,pert
Cas 2,pert
M_LS_Time0,ctrl
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"C57BL/6N, adult, female",pert
HL60-shGSK3B-Construct1-rep2,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue 2,pert
HeLa_01-04-05 TP4_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
SKI-DLCL cells treated with Aplidin 3.0nM for 24h. Total RNA was isolated using RNeasy kit.,pert
A673_CloneAsp14_Dox_0h_4,ctrl
Control8,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#117,pert
M249_B_DMSO,ctrl
Wild type 2,ctrl
Liver from a 5 month old wild type mouse,ctrl
"MS patient 11, technical replicate 1",pert
"Data 2, Valpha2",pert
Control_AF_1,ctrl
cell line: Y79;	passage: 27;	cell type: Retinoblastoma,ctrl
MCSF_A,ctrl
RNA from microdissected breast cancer cells from case 1437 labeled with Cy5,ctrl
Ishikawa_VeryHighDose_BPA_48h_rep2,pert
Skeletal muscle,ctrl
Endothelial cells 1,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.3;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
LNCaP R1881 rep 2,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T1, N1, M0, G4",pert
"Neurons overexpressing GFP, biological rep3",ctrl
WT Littermate1,ctrl
"human failing LV myocardium, Idiopathic28",pert
age: 47;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Peripheral blood,ctrl
"wild type 5C.C7 T cells, biological rep3",ctrl
WT osteoclasts treated 2,pert
"ALL_NDS, K43 012109",ctrl
"Mouse jejunum, PND30",pert
first-episode BP patient 74_biological replicate 1,pert
control_32hr,ctrl
strain: C57BL/6J;	genotype/variation: Rsk2-KO,pert
control 1,ctrl
8 week old leg MDX rep 2,pert
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease_case5,pert
cKO 24h V1::2,pert
c17.2 mouse neural stem cell line,ctrl
strain: mixed background of C57BL/6;	genotype: Ezh2f/f;	tissue: heart;	developmental stage: adult,ctrl
Muscle control 10,ctrl
"wild-type control (littermates) of ""P19_exPKO_pancreas""; mixed genetic background; postnatal day 19; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.",ctrl
Bone-Marrow_SMM_S1519,pert
Rex KO_plus LIF_rep4,pert
Array Type: HG-U133A_2;	RNA Integrity Number: 9.2;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
GFP B,ctrl
whole tissue section from case 655,ctrl
G93A non transgenic littermate 800,ctrl
Msgn1_24hMinDox-biological rep3,ctrl
NSCLC adenocarcinoma cell line,ctrl
Disease_status: Healthy control;	Age (years): 49;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 46;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Empty vector, collagen plate, rep2",pert
tissue: Whole Brain;	developemental stage: E 18.5;	genotype/variation: Wild-type,ctrl
shRNA2-4-plusDox-rep3,pert
patient: KPW13;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
1000uM H2O2 rep 4,pert
HD4,pert
WT 1 sample A,ctrl
Cadherin-11 siRNA (RNAi 6A)_2of2,pert
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Posterior Palate;	age: E15.5;	gender: Not determined,ctrl
jzo017-rp1-v5-u74av2-met,ctrl
"ME180 cells, 10μM ATRA, 6 hours",pert
ID4+/-TCL1-tg spleen CD19+ B cells collected from 3 mice 2,pert
"breast tumor, control",ctrl
BAL_44b_A0B0,ctrl
chip number: 14;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.7;	rin: 9.7;	transfection date: 2012-03-26,pert
cell type: tumor-derived cell line;	ikk2 status: IKK2 -/-,pert
5202 Normal Uninflamed sigmoid colon,ctrl
5-KO,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 278;	age-at-biopsy-years: 44,ctrl
n2a-Pou3f3-cont-1,ctrl
MCF 7 parental cell line,ctrl
Wild type rep 1,ctrl
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.7;	colon weight (mg): 172;	colon ratio (mg/mm): 3.02;	myeloperoxidase activity (u/mg): 0.932;	tissue: colon;	treatment: 5% DSS,pert
71 year old female,pert
wild type 2 cell embryo rep4,ctrl
age	40;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	9.5;	leukocyte count (/nl)	129;	hemoglobin (g/dl)	9.4;	platelet count (/nl)	261,pert
Normal Rat Retina 3,ctrl
PGA-HMO-Obese-8aUA-s2,pert
cMyb virus-infected replicate 1	(monocytes),pert
MDA-MB-231 cells transfected with negative control siRNA,ctrl
HCT116,pert
E14 - WTMixB 2,ctrl
cell line: L-540;	cell type: Human Hodgkin Lymphoma;	treatment: 10 µM Perifosine for 24hrs,pert
CML_6_CMP,pert
Gender:F;	Age:33;	Tissue:Mucosa,pert
Run3.aUa.010110d.SkMDbt1135D.CEL-DB stimulate,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 50 yr;	population: white;	dsm-iv: 296.54;	age of onset: 25 yr,pert
patient E1542,ctrl
tissue: liver;	treatment: CCl4;	strain: A/J,ctrl
"Normal skin from Stat3c_control mouse, biological replicate 2",ctrl
BALB/c d18 (bmsnmix3),pert
"A673 treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50), biological rep2",pert
Placenta_PE(LO)3,pert
M322 SKM-KO,pert
HEK293 F5_doxycycline untreated,ctrl
IR-KO_Rep1,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 74,pert
Plate vs. Nail:  1 Day Nail,pert
R26Pax3/Pax3 E14.5 palatal shelves 7,pert
trypsin-2 overexpressing HSC-3 cell line,pert
non-malignant FTEb_patient 3,ctrl
PBMCs_IS_3 [IS],pert
"treatment with MeOPP, replicate 2",pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
X6752318096 F MYC negative#3394,ctrl
R6/1 22 week wildtype_O7A2,ctrl
Untreated Jurkat cells (replicate 2),ctrl
"disease state: Nasopharyngeal carcinoma;	stage: II, T2, N0, M0, G4",pert
RNA from microdissected breast cancer cells from case 763 labeled with Cy5,ctrl
Healthy control 5,ctrl
C57BL/6 male control,ctrl
"gender: male;	batch: 2;	age (years): 23;	patient id: Non_severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 98;	medication: Becotide, Ventolin;	cell type: CD4+ T-cells",pert
major non-tumor1,pert
Pooled healthy pulpal tissue,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp1,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M4;	flt3 status: WT,ctrl
WT-CD80lo-mTEC-sample2,ctrl
liver_female wt_rep2,ctrl
ATL-2 - mAdbID:91502,pert
Panc0403 cell line,pert
"bipolar disorder, BA10-47",pert
"Crohn's Disease subject (46 year old caucasian female, SAK_1313783292)",pert
"schizophrenia, BA46-75",pert
affection: unaffected;	treatment: MPH;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 6 unaffected controls,pert
KN-smoke-low-5 month-R2,pert
esophageal squamous cell carcinoma from patient E1546,pert
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Male;	Age: 9 weeks (Moderate stage);	WILD TYPE",ctrl
C019_Control_F_46,ctrl
gender: female;	age (years): 22;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
tissue: liver;	genotype: p14 WT;	genetic background: C57BL/6,ctrl
A_AN19511_F,pert
Normal_Kidney_Biopsy_3,ctrl
pool of wild type thyroids from 2 months old wild type mice,ctrl
WT_POST_PDE_041,ctrl
construct: HDAC1 G10 shRNA;	cell type: Primary human erythroid progenitor cells,pert
"AALE-KRAS uninfected, biological rep2",pert
Muscle JDM (YJD-JDM-5UA-s2),pert
"ID: MLL_00259;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
CD70Tg biological rep 1,pert
OSE_440,ctrl
WT-sham-5 month+1d-R2,ctrl
"human peripheral blood derived monocytes, 4 hour LPS stimulation, biological rep2",pert
subject id: 54;	infection: DENV;	status: DF;	tissue: whole blood,pert
"SPC-c-raf transgenic mice, 6 month old, male, unaltered",pert
mixed reference (FR + CRG),ctrl
scan batch: Batch 1;	group: control;	subject age: n/a;	paternal age: n/a;	maternal age: n/a,ctrl
01N1E_Systemic,pert
10 mg/kg MPH tr1001,pert
HB1.A4-Nurr1,pert
WT Littermate3,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 8,pert
Control treated with WY14643,pert
Human skeletal muscle biopsy sample;	Patient #193 with NORM,ctrl
23 weeks female,ctrl
MacularDegen-injured-11aAv2-s2,pert
"PCB153 treated HepG2 cells at T1.5, biological replicate 1",pert
Normal-N_LJ_3,ctrl
FASSc3 medium only,pert
FHCRCAML2429,pert
"DBA/2J Acute morphine treated, biological replicate 2",pert
"Diabetic mice, time point 5 week",pert
wild-type naïve CD8 T cells KAI284,ctrl
Estrogen treated ipsilateral to stroke replicate E6IC-2a,pert
"SWR/J Chronic morphine treated, biological replicate 1",pert
mIMCD3 cells,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: Foxd3 conditional knockout cells treated with Tamoxifen,pert
Low Glucose Transcriptome Profiling {rpt 3},ctrl
age: 65;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 12.21;	Ratio: 2.08,pert
"SWR/J SAL, Rep2",ctrl
HDAC2 KO mice colon rep 3,pert
Liver_nash metformin_no.1,pert
"Peripheral blood, normal control [N73]",ctrl
CD8-IGF1R 3T3 A-928605 1,pert
"alveolar macrophages, non-smoker 001",ctrl
male,ctrl
Hippocampus_Soman_24h_rep3,pert
3_month_old_wildtype_mouse_rep3,ctrl
Run3.aUa.010110d.SkMDbt1133D.CEL-DB stimulate,pert
Crx-Nr2e3-Nrl-ko-Gfp4W-4,pert
Bone-Marrow_SMM_S1410,pert
Sample from retroviral MSCV-D1a infected cyclin D1 knockout 3T3 cells (line 1).,ctrl
A549 non-small cell lung cancer (NSCLC) cell line,ctrl
cell type: Bone marrow cells;	genotype: MSI2-inducible mice;	strain: C57BL/6,pert
control to Sample 23,ctrl
Wild-type ES cells,ctrl
WAT from Ahnak knockout fed regular chow diet Replicate 2,pert
cell type: Pancreatic ductal adenocarcinoma;	cell line: CAPAN2;	transfection: control lentivirus,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: Lipofection-mediated siRNA delivery;	time: 24hr,pert
Subject #8039-8hr Postinfection,ctrl
NPC24,pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",pert
"DOX, rep1",pert
EB_2_8d_221_HCHO_Nasal_Rat230_2_CIIT05024,pert
Sprague-Dawley rat femoral diaphysis,pert
Pool Ts1Cje_P0,pert
colon_normal_1114,ctrl
CTRL_5_GMP,ctrl
undifferentiated,ctrl
"control, BA10-54",ctrl
R,ctrl
WT-smoke-high-5 month-R4,ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-9;	Primary Site:Tongue;	Age:66;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",ctrl
"pt. HCL A treated with Vemurafenib 1000 nM for 48h, replicate1",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day7,pert
BP patient 55_biological replicate 2,pert
X50 NLS 18Q TG3	F2/49	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
Cre_day_3-1,pert
U937-shControl-rep2,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L221,ctrl
"control, BA10-44",ctrl
human_hepatocyte_400uM_ciprofloxacin_prep1,pert
H3_SS12_01Nov07,ctrl
VGP melanoma,pert
"testis wt, 17dpp, Rep3",ctrl
EA_Case2_CD4,pert
mouse liver C3,pert
Nasal Epithelium Inhalation Formaldehyde 6ppm 5d ID294,pert
"SRF silenced, treated with R1881, biological rep 1",pert
U2-OS-ERb vehicle 2,ctrl
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
"control, BA10-1",ctrl
8 hour tunicamycin wild type A,ctrl
Patient identifyier: J;	Sex: female;	Age of patient: 54 years;	Duration of psoriasis: 48 years;	Body surface area: 9 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Disease_status: Healthy control;	Age (years): 29;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 42;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty (32),pert
Pool Eu_P15_hyb2,ctrl
"brain, hippocampus: Wt #3396 Hippo_e1_le1",ctrl
SHR16-3,pert
uterus_P4_WT_40hrs_rep2,ctrl
"NCI-H69 xenografts, PDT treated and control untreated",pert
Liver_SRC-2 Knockout_Rep3,pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: untreated,ctrl
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID144,pert
diagnosis: RB-ILD;	fvc-group: FVC3;	tissue: lung,pert
"gene expression of wild type oocyte, replicate 5",ctrl
Leukemai,pert
"skeletal muscle, quadriceps",ctrl
"E14 molar teeth, TCDD exposure",pert
genotype: SIRT3 KO;	tissue: brown adipose;	genetic background: 129,pert
Tendon_lesional_rep9,pert
"wdNHBE with BN/59 at 36hpi, biological rep1",pert
B6-rep3,ctrl
Prdm14 knockout 3,pert
Lmna H222P heterozygous male 3,pert
Pancreatic Sample 12-Tumor,pert
"Wild-type iPSCs, NAS9",ctrl
Individual_4426_PP_sample,pert
AP-920039,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 7,pert
"Tumor sample from patient with p53 mutant, replicate 1",pert
434_CreER: mutant mouse 1,pert
PGA-MAH-AJ_PBS6h-1aA-s2,ctrl
cell type: R1 mouse embryonic stem cells stably transfected with Pcl2 shRNA sequence,pert
RV16;	Age = 20;	Sex = F,pert
"AG825-treated, 6h after UV, Replicate A",pert
Untreated native HeLa cells 2,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 70min;	race: White;	sex: Male,ctrl
01LN0_PolyRF-,pert
Basal IFE epidermal stem cells from KO mice 1,pert
primary leukemic cells purified from peripheral blood,ctrl
MIY_day_7-2,ctrl
Emx2 KO mouse,ctrl
Intima media,pert
day 1 5-FU HSC 1,pert
cell line: OVCAR3;	transfection: eukaryotic expression vector pcDNA3.1 containing the full-length cDNA for CD157,pert
"Biceps, control, cohort 20, subject 20U",ctrl
whole tissue section from case 749,ctrl
TOV112D COUP-TFII-2,pert
"H69 tumor untreated, biological rep2",ctrl
"PTEN inducible MEFs at T0, biological rep1",pert
HaCaT_ZNF750i_ biological rep3,pert
WT3-1,ctrl
E2F1 Null,ctrl
Brain from 60 days Npc1+/+ mouse1,ctrl
Snell 6 month Wild Type Liver 84c,ctrl
"Typically Developing Control, Gracilis, Patient Replicate 4",ctrl
"gender: female;	batch: 1;	age (years): 42;	patient id: Severe_8;	fev1 (% predicted): 33;	fvc (% predicted): 94;	medication: Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium;	cell type: CD8+ T-cells",pert
Phan_009_KO.saline rep3,pert
healthy control H08,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
NOMO-1_ZFX-SH1,pert
11SC-nbc,pert
OSE_437,ctrl
Subject #8035-Preinfection,pert
normal donors XH1,ctrl
UC Uninflamed descending colon,pert
Mouse_ESC_Pcl2_shRNA_sample 3,pert
C57/BL,pert
"SLE patient, 1001V2",pert
RE550_KPL4_un3,ctrl
cell line: T47D;	treatment: Telpristone [1µM],pert
Trastuzumab treated after 4 days (T2_1),pert
"Ishikawa cell line, BPA, 100pM, 48hr",pert
U937_naive_curcumin_18h_rep3,pert
wildtype HUES6 4,ctrl
TNKSi 4h biological replicate 2,pert
TF1_antiEvi1siRNA_3,pert
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
SCLC cells,ctrl
"SWR/J CHR, Rep3",pert
"TH cells from LC, Mecp2 null, biological replicate 1",pert
24h_RA4,pert
non-CF subject 38,ctrl
hur status: WT;	rna subtype: nuclear RNA,ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siPsmd14,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: EtOH;	time: 24h,ctrl
shRNA6-16-plusDox-rep3,pert
Female - caucasian - N-02-M,ctrl
cell line: MOLM-14;	replicate: Replicate2;	treatment: shLuciferase,ctrl
"Patient 29, Macroscopically intact tissue",ctrl
LRRK2 (G2019S) homozygous iPSC sample 2,pert
Neuroretina 8-week old db/db mouse: BKS.Cg- + Leprdb/+ Leprdb/OlaHsd,pert
iFGFR1 mammary gland 16 hrs AP20187,pert
strain background: FVB;	genotype/variation: wild type;	tissue: whole skin,ctrl
CEPI_IIIc_369,pert
CF (D508) subject16,pert
MLL_00133,pert
cell line: THP-1,pert
H_Ctrl_1,ctrl
agent: resveratrol_150mM;	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,pert
Human_macrophages_normoxia_repB,ctrl
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: 4-hydroxytamoxifen;	dose: 500 nM,pert
SCC8,pert
-DOX/+E2 48h_2,pert
MDS patient 152,pert
striatum_Pink1 knockout_18 month_replicate 1,pert
Ramos pRTS-GFP D+,ctrl
"Control, high-fat diet, rep3",ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T4, N3, M0, G4",pert
isoflurane 03,pert
Universal Human Reference RNA - Cy3,pert
8_2,pert
H295R _Control_rep1,ctrl
CEM NBD 2,pert
MDS patient 47,pert
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Rectosigmoid;	Drug Treatment: NO,ctrl
CPU S control 2,pert
first-episode BP patient 77_biological replicate 1,pert
S/LV3,pert
GM19238_Kd_USF1_3,pert
Carbo Day1 (396L),pert
MiaPaCa2 cell line,ctrl
cell line: BT474;	cell type: breast cancer;	lapatinib sensitivity: lapatinib-sensitive;	her2 status: HER2-positive;	treatment: lapatinib,pert
Postmenopausal female. Tibolone treated. Patient 11.,pert
68A;pretreatment;female;breast tumor,ctrl
siERK2Veh4h_2660,pert
RNA from microdissected breast cancer cells from case 140 labeled with Cy5,pert
Bone-Marrow_SMM_S1535,pert
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 32+26=58;	Sex: male;	region: M1;	age: 47,48;	genotype: Y/Mecp2-;G42/-",pert
PKBa-/- MEF time 2 replicate 2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 120min;	race: UK;	sex: Female,ctrl
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 2hr,ctrl
genetic background: C57BL/6-129Sv hybrid background;	genotype: Setdb1 2lox/1lox/Cre;	treatment: tamoxifen;	cell type: embryonic stem cell,pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
tissue: white blood cells;	age: 16.28;	Sex: male,pert
cell line: GIST882;	agent: DMSO (control);	replicate: Rep3,ctrl
MEF E2F4 KO 5-rep2,pert
NORMAL #00-0386,ctrl
NB87 U133p2,ctrl
Strain: C57BL/6 Gender: mixed Age:E9 Tissue: whole embryonic body;	,ctrl
Peripheral blood mononuclear cells;	TTF=92min;	Race=White;	Sex=Female,pert
MDS patient 141,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 33.53973,pert
RNA-DHL6-R406-6H-2,pert
Tgfbr2 fl/fl Control Posterior Palate 4,ctrl
"CTLA-4 KO 5C.C7 T cells, biological rep1",pert
U2OS_siNS_0h,ctrl
cell type: Human melanoma cell line;	cell line: M249;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
"Control, standard diet, rep2",ctrl
MPM tumor specimen 33,pert
"Wild-type HFD 8 weeks, biological rep1",ctrl
strain background: C57BL;	genotype/variation: SHP knockout; SHP-/-;	tissue: liver,pert
0h WT Sample 13,ctrl
Adipose tissue from male ASC-/- animal (C57/Bl6 background),pert
cPuro,ctrl
Superior Frontal Gyrus from 10 year-old normal girl,ctrl
V5-P165,ctrl
Murine Cells (Macrophages),pert
LSK control 3,ctrl
Bronchial Epithelial Cells control biological 1546X,ctrl
Squamous cell lung cancer X31nml,ctrl
Mening SWB WB SW 12b,pert
Leg 7 Day mdx rep 1,pert
"brain, hippocampus: CH6_e1_le1",ctrl
"BOEC, at_risk 10",pert
Multiple sclerosis CD4+T cells 9-RS,pert
"array 23, xenograft, corn oil vehicle",pert
WT mESC,ctrl
Trained 3 weeks T3,ctrl
"PBMC, patient. Mtx rep8",pert
tissue: Temporal cortex;	age: 95;	Sex: F,pert
CD8+_Tcells_healthy_donor_4,ctrl
"2102Ep cells negative control, biological replicate 3",ctrl
Endometrium-Normal 3,pert
erlot2_CT42,pert
CME-Emerin3d-1MA-S2,pert
status: Control;	gender: Male;	age: 49;	tissue: Blood,ctrl
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.  The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
"Female (age range 33-49), skin biopsy taken from upper nates 96 hours after nickel exposure",ctrl
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with vehicle for 6h,ctrl
Carbo Day2 (409R),pert
subject: 33;	disease: TD;	muscle: GR;	gender: M;	age: 13;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Bmpr2-R899X 1,pert
T162,pert
"age: Embryonic day 14.5;	genotype: Zfp36l2 knockout (KO);	tissue type: fetal liver;	strain: b6, 129 mixed background strain",pert
IRS-2 KO (jos1527),pert
142A,ctrl
"Biceps, FSHD, cohort 12, subject 12A",pert
tissue: white blood cells;	age: 14.5;	Sex: male,pert
111B,ctrl
cell type: Human melanoma cell line;	cell line: M238;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
08SE1182,pert
striatum_ctip2_KO_4,pert
12A;pretreatment;female;breast tumor,ctrl
Wt Mouse_cerebellum_Old_nicotinamide riboside treatment_Replicate-4,pert
25uM_Zn_3,pert
1833 cells with HMGA2-depletion,pert
"Fourth ventricular choroid plexus from Otx2ko mice at E13, biological replicate 4",pert
Replication 1 Aldosterone,pert
human_hepatocyte_400uM_gatifloxacin_donorA_24hr_prep2,pert
SKM WT2,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,pert
Normal bladder 7-99,ctrl
human normal cell lines airway with 24 hours of DMNQ treatment,pert
chip number: 14;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.65;	rin: 9.8;	transfection date: 2012-03-26,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_1-tu1,ctrl
Young 8,ctrl
disease state: Healthy;	cell type: CD4+T;	twin: R,ctrl
"Gender: Female, Age: 32, BMI: 25, Tissue: luteinized cumulus cells",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
gender: male;	individual: patient 5;	treatment: paclitaxel-eluting stent,pert
MDS33,pert
Transgenic 4,pert
strain: Des(-/-)/129/SVE;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 12-14 mo,pert
AL Chip#39,pert
B17 - infected BALB/cByJ fibroblasts (9 h post inf),pert
E14.5 Tgfbr2 Wildtype Mouse Model Palate 3,ctrl
c 1-1,pert
5-C_1,ctrl
P4A Progranulin-frontal,pert
gender: male;	strain: C57B/6Jx129Sv;	genotype/variation: wild type;	tissue: heart;	age: 10-12 weeks old,ctrl
Muscle_mutation,pert
Background: mixed genetic backgroud of C57Bl/6 and 129/SvJ;	Genotype: IRF6 wt;	Age: Embryonic day 17.5,ctrl
Pre-Frontal contex of naïve AChE-S mice,pert
lymphocytes_ctl_M_60y,ctrl
B lymphocytes,pert
"T-cell prolymphocytic leukemia, inv(14)(q11q32), case 5",pert
liver_STZ treated diabetic_rep2,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated, biological rep3",pert
cell type: AML blasts;	fab classification: M2,ctrl
CD4+_Tcells_severe_asthmatic_2,pert
N16,ctrl
"breast tumor epithelium,27",pert
HEK 293,pert
cerebrum_PSNA_ 4w_rep1,pert
disease state: paediatric glioblastoma;	age: 14;	gender: F;	h3.3_status: wt,ctrl
DEX treated rep 1,pert
Mouse old heart w/ a-tocopherol aT-Ht-2,pert
S001_Scz_F_75,pert
tissue: Brain;	genotype: Npc1-/-;	age: 40 days;	subject: Mouse2;	genetic background: BALB/c,pert
"Resveratrol treatment exp 3T3-L1 cells, T2",pert
Male C57Bl/6  Mice were 10.5 weeks old at time of sacrifice.,pert
Endometrium/Ovary-Disease 8,pert
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 23;	maternal age: n/a,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: pre-UV,pert
MEF cells from female  WT embryo (D12.5),ctrl
Whole Blood of Dengue infected patient at acute infection time point,pert
"Endometrium, postmenopausal, tibolone, 16",pert
"Distal, Small Intestine 21 days old",pert
agent: pristane;	time: 3 days;	strain: BALB/DBA F1 hybrid;	tissue: mesentery,pert
34/OVX/oil/6h/UTX 129 Hoxa-10-/-,pert
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
LNCaP + ELK1-shRNA rep 1,pert
"endometrial stromal cell - Jag1 retrovirus infected1, 3 days post infection",pert
strain: C57BL/6;	tissue: cerebral microvascular fragments;	genotype/variation: Notch3 knockout;	age: 2 months,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
colonic_mucosa_non_inflamed_122,pert
5072-scrape,pert
Tetracycline-inducible glioma cells dox 2,pert
Heart left ventricle dnCREB-PBS replicate 1,pert
E14 - WTMixA 1,ctrl
8DKD_SerumStarved->3hrEGF_rep1,pert
hur status: KO;	rna subtype: nuclear RNA,pert
"NOD islets, RIP-Aire27 transgenic",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 51,pert
44m2,ctrl
MDA-MB-231 RRP1B over-expressing clone #8,pert
1049-03-A,pert
mTert 1,pert
phenotype: moderate glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 36.00274,pert
siRNA Stau1,pert
SV589_3Day KD,ctrl
"metastasis: none;	Stage: 1;	tissue: cancer, homogenized",pert
Mammary gland R1 NT rep1,ctrl
Subject #8010-Preinfection,ctrl
"Ada3FL/FL MEF, control, biological replicate 2",ctrl
"nasopharyngeal carcinoma, specimen T30",pert
OE33 siRNA rep3,pert
Myoblast-GATA4-OE-day0-3,pert
"Embryoid bodies, 24h,Plus Dox",pert
NM20 healthy control,ctrl
5256 UC Uninflamed terminal ileum,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H465_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
"MEKi 4 days, biological rep5",pert
kidney_Q10_6M_rep3,pert
Emd KO male 3,pert
U2OS shCHK1-4 replicate 2 [set 4],pert
BM CD34+ Pool I,ctrl
liver_control_diet_rep6,ctrl
N30582,ctrl
tissue: Spleen;	cell type: B lymphocytes;	gfpmyc status: positive,pert
"Normal diaphragm 3, 8 week",ctrl
SCARKO d 10 (3),pert
Untransfected Jurkat cell line,ctrl
Muscle FC1,ctrl
Muscle control (YJD-JDM-51UA-s2),ctrl
testis knock out replicate3,ctrl
Subject #8034-2d Postinfection,pert
12-0002A_Day1_34,pert
siCITED1#3 replicate1,pert
"Lymphoblastoid cell lines derived from family 1720, member 2",pert
cell type: Osteoblastic lineage cell;	strain: C57BL/6;	phenotype: Control;	time point: 5-6 weeks post doxycylcin withdrawal,ctrl
"BALB/c, Male, Contol",ctrl
genotype/variation: Zfx wt/y CreER;	treatment: infected with control retrovirus with GFP selectable marker,ctrl
patient id: T158;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 82;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM1;	Stage: IV;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Muscle 50 eccentric contractions 12 hours WT Adult 07272,ctrl
11422 UC Uninflamed ascending colon,pert
T40977,pert
"Wild Type, biological rep2",ctrl
NLGN3_4,pert
EB_2_5d_216_HCHO_Nasal_Rat230_2_CIIT05024,pert
HepG2_Phenol rep1,pert
T30582,pert
PGA_MI_nilv_4h_391,pert
M AA S37C,pert
"DHL4, R406, 48h",pert
WTC 76 PBS treated,ctrl
PTEN-22 (-/-),pert
WT_TER119-_rep4,ctrl
Individual_4257_PP_sample,pert
"3 uM EPZ004777 treated, DAY 4, biological rep.2, MV4-11 cells",pert
hOB695_shEV_4hr_IR,ctrl
MCF10A-Her2Myc-rep3,pert
cell line: mda-mb-231;	transfectant: siRNA for Pin1,pert
01J43: new onset sJIA,pert
Untreated diabetic-2,ctrl
Braak α-synuclein stage 1-2 BR12_4SN,pert
Hippocampus,pert
gender: Male;	age: 25;	post-mortem delay: 17h;	ph: 6.9,ctrl
"normal nasopharyngeal tissue, specimen N6",ctrl
COP control replicate 2,ctrl
0990-01-C,ctrl
8 week old leg control rep 3,ctrl
imanitib4,pert
wild type; BMDM; IFNgamma treated,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.448;	OD280: 0.781;	Ratio: 1.85;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 309;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Nuclear RNA_KO_rep1,pert
"Prkaca+/- caudal vertebral bone, rep1",pert
"bipolar disorder, BA10-19",pert
C025_Control_F_88,ctrl
IP RNA_WT_rep3,ctrl
19C-ER,ctrl
Ecad_Mut_2,pert
EB_6_5d_296_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
224 Day 1 siMut12 transfected biological rep2,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 4",pert
"paraventricular nucleus of the hypothalamus, saline, 3 hour",ctrl
transfection: Rif1 shRNA;	cell line: Stable F1 Rif1 knockdown ES cells at passage 16;	background strain: C57BL/6xC3H,pert
HGPS iPSC replicate 1,pert
T117 U133p2,pert
Patient no. 14: control,ctrl
KO PBS2,ctrl
"RWPE1 cells, 100 nM of 1,25(OH)2D, 6h, biological rep1",pert
43SMOKEH,ctrl
Individual_5248_NN_sample,ctrl
"Acute Myeloid Leukemia, sample 46",pert
"Knockout sham, biological rep1",pert
Superior Frontal Gyrus_10y_normal,ctrl
n6t0h,pert
"Untreated TG2 knockout NB4, biological rep1",pert
"ZR-75-1, 12h, 3.0mM 5FU C",pert
MCF7_EtOH_24h_rep1,ctrl
MDS patient 85,pert
TTP_WT_0ActD_BioRep3,ctrl
07R057 RA,pert
PBMCs_IS_16 [IS],pert
Cisplatin_2h_rep3,pert
"U87MG - CASP2siRNA, biological rep2",pert
209/0,ctrl
"siPRMT8 neuron, biological rep3",pert
"LY2 cell line, SRC-1 siRNA treated 120mins, biological rep1",pert
MDA_PR_Paclitaxel_2,pert
BATF_KO_P14_D3_Effector_rep3,pert
Whole lung tissue_healthy donor lung,ctrl
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_2-tu1,pert
"CCM3 shRNA cells passage 11, rep 2",pert
RKO_rep_1,pert
no_21,ctrl
A_LS_Wk2,pert
0959-01-A,pert
NRG Melan-Ink4a #1,pert
"Rat_Tracheal_Dex_2hr, rep4",pert
B6-WT1 melanocytes,ctrl
autism with FMR1-FM AU046708,pert
RUES2_shRNA TMEM88,pert
FGF21KO.DMSO_3,pert
"Fibroblasts from normal histology lung tissue, NL-6",ctrl
Non-Transgenic replicate 8,ctrl
A549_siZMPSTE24_rep.2,pert
"LCL GM19238, Kd STAT6, 72hrs",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 20.0;	age of psoriasis onset: 19,pert
Patient 2 after folic acid,pert
BL Day 2 siSC transfected biological rep3,ctrl
age: 31;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"Wild type, biological rep2",ctrl
Patient no. 6: control,ctrl
lymphocytes_ctl_F_39y,ctrl
H09_S_B2,pert
Normal heart_G66,ctrl
Gastrocnemius muscle wild-type mouse - control mouse for PPARalpha overexpressing,ctrl
P4C Progranulin-hippocampus,pert
FGF21KO.DMSO_1,pert
cell line: Colo205RC PLX4720 resistant cell line;	cell type: colon cancer,pert
cumulus_PCOS_Obese_rep6,pert
Individual_4284_PP_sample,pert
cell line: H69;	treatment: none,ctrl
Total RNA from bone marrow derived macrophage from BalbC mice,ctrl
race: caucasian;	age (years): unknown;	stage: IA;	grade: 2;	histology: endometrioid,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
Carbo Day7 (374L),pert
gender: Male;	age: 72;	post-mortem delay: 20h;	ph: 6.6,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L017,pert
Male wild-type BALB/c,ctrl
MDS patient 90,pert
Early Secretory Phase Endometriosis,pert
MEF Wild Type 1-rep2,ctrl
B-CLL PB P250,pert
DS-Fibr 5,pert
M_LS_Wk2,pert
Human prostate tumor tissue,pert
Lesional ear skin from K14-Areg mouse,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.782;	OD280: 1.422;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 54;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Celecoxib_#4877,pert
RNA from whole tissue section of case 1507 labeled with Cy5,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.01;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
ATF6-MER TG mouse_tamoxifen3,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 2,ctrl
kidney_QH2_14M_rep2,pert
pSUPER-mir-210 replicate 3,pert
Turner_AF_2,pert
Bmpr1a-/-  ESCs cultured 3 days in N2B27,pert
"cell line: SW480-Snail, Snail expressing stable line",pert
Human prostate cancer primary culture  sample C2dx,pert
SZ16,pert
MB231 PIAS1 shRNA-DMEM,pert
heterozygot FH P276,pert
esophageal squamous cell carcinoma from patient E1589,pert
Pool 4 Acute stage,ctrl
ALI patient #12,pert
GB 2 63B +LPA,pert
E9.5 embryo_Cop1KO_rep2,pert
AtT20 cells overexpressing NSBP1SE protein rep2,pert
A375 control-1,ctrl
neuron_rep11,ctrl
myoblast_treated_rep2,pert
Mouse T cells,pert
AVIC sample#3 treated with DMSO,ctrl
strain/background: C57BL6J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: cholestatic intestinal injury,pert
"Liposarcoma culture from tumor 398, untreated",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 44.58082,pert
"MS patient 12, technical replicate 2",pert
PBMCs from normal control subject C (CPBMC),ctrl
"siPRMT1 ES, biological rep3",pert
"Ott1 knock out, biological rep 3",pert
E14.5 fetal liver TER119+ Klf3 KO,pert
4112-1 E2F WT,ctrl
cell line: LNCap;	sirna transfection: siRNA Control1,ctrl
Day: 1; Drug: Saline; Phase: Drug treatment; Replicate: 2,ctrl
"control colon tissue, biological rep1",ctrl
U133A_G0,ctrl
Huntington's disease 874A,pert
"brain, cochlea: [4] Sample #4_le1",pert
LZ11,ctrl
strain: v6.5;	cell_type: ES cells;	transfection protocol: Tet1 shRNA transfected;	culture media: ES,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q plus monosomy7/del7q plus other,pert
PBMCs_IS_5 [IS],pert
tissue: prefrontal cortex from adult APLP2 knock-out mouse with mixed genetic background;	genetic background: back-crossed to C57BL/6 for 1 generation;	gender: male,pert
FRD440 3,pert
AQA A,pert
Murine osteoclasts,ctrl
cell line: KCL-22;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
"fibroblast, MFS subject FB773 rep 4",pert
striatum wild type 6 month replicate 2,pert
06-0009A_Day1_17,pert
"n23, surgically resected from patient of gastric cancer.",ctrl
Control + LPS 3,ctrl
Control_1,ctrl
8 hr KLF4 Time Course Induced,pert
BS2011051064,pert
"Spinal cord, saline control, biological rep2",ctrl
"D890, WBS, skin fibroblasts",pert
"brain, forebrain",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/15/07;	# cells: 60;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
Normal cervix_05-15,ctrl
Plate vs. Nail:  2 Week Nail,pert
"FACS-sorted cones, P60 wild type mice",ctrl
HLA risk: High;	Height: 184.1 cm;	Weight: 77 kg;	BMI: 22.7;	Age: 17.16 years;	Gender: Male;	Race: White;	Glucose: 260 mg/dl;	HbA1c: 6.3%,pert
"Untreated, biological rep4",ctrl
"Cultured ovarian cancer cell line FU-OV-1, untreated",ctrl
siHic5_2_24h_3,pert
OCT4 shRNA_3 Days knockdown_rep3,pert
N/LV1,ctrl
IFNb-treated MEF 1,pert
WT6 SPLEEN,ctrl
Celecoxib_#4859,pert
Nasal Epithelium Inhalation Formaldehyde 07ppm 8d ID145,pert
HLA risk: Low;	Height: 157 cm;	Weight: 52 kg;	BMI: 21.1;	Age: 27.24 years;	Gender: Female;	Race: White;	Glucose: 79 mg/dl;	HbA1c: NA,ctrl
CF CFTR unexposed replicate 3,pert
cell type: Follicular (FO) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: KAP1 KO,pert
S5,pert
"Patient 999, 12 month of BETAFERON",pert
PBMC SE T0,ctrl
subject: 12A;	cohort: 12;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 22;	Sex: F;	batch: Batch_3,pert
tissue: Murine small intestine (jejunum);	genotype/variation: VillinCreERT2-,ctrl
Gender: Female;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
"NPCxhIPSC SCZP, replicate 3",pert
CD4DecTp2-5,pert
"wdNHBE uninfected at 36hpi, biological rep3",ctrl
Md02h024,ctrl
LOX1 Untreated 12hr 282295793,pert
Gastrocnemius Muscle mdx PBS-Treated rep1,ctrl
Normal myocardium sold commercially (D),ctrl
Paraquat ApoD knock-out,pert
"seminoma specimen, pT1, patient age: 33y; W01 231",pert
age: 10-week old;	sex: male;	strain: C57BL6;	tissue: liver,pert
VPA Treated Rep 2,pert
10 week control OMN rep 2,ctrl
Individual_4598_NN_sample,ctrl
Transgenic male mouse 60 day old,pert
cell type: lineage depleted cord blood cells;	culture: liquid culture day 11;	transduction 1: control;	transduction 2: control,ctrl
RV82.03_CONTROL_day10,ctrl
1uM H2O2 rep2,pert
CD-51-Aff,pert
Pt38_Pre,ctrl
"PCB153 treated HepG2 cells at T18, biological replicate 2",pert
HL-60 cell line infected with GSK3B Construct 2 shRNA,pert
"IDC 1, biological rep. 1",pert
HET Brain 20d Mouse1,ctrl
Nerve_Diabetic_Vehicle_710,ctrl
liver_Q10_6M_rep2,pert
disease state: Healthy;	cell type: CD4+T;	twin: P,ctrl
tissue: white blood cells;	age: 17.45;	Sex: female,pert
SUBSTANCE P 1 HOUR,pert
Jejunum_Wild Type+Quercetin_2,pert
DNGM-3,pert
"IN1760 siNT treated, Biological replicate3",ctrl
day: d00;	strain: C57BL/6;	genotype: WT;	experimental run: e0,ctrl
non-treated WT_rep-1,ctrl
"seminoma specimen, pT1, patient age: 35y; W00 222",pert
healthy CD19 B cells 4,ctrl
CT-receptor-KO osteoclasts treated 2,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G52,pert
ct-2,ctrl
"Resveratrol treatment exp 3T3-L1 cells, CT3",ctrl
Parkinson's disease sample x100,pert
MEKi 4h biological replicate 1,pert
cell line: U87;	treatment: untreated;	cell type: glioblastoma cancer cell line,ctrl
HMEC -EGF for 2days,ctrl
"Peripheral blood, patient without recurrent events [N25]",pert
No_DHT_control_1,ctrl
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 54",pert
"WT CLP LY6D-, biological rep1",ctrl
sMPNST_shBrd4.552_3day_rep2,pert
"Wild-type HFD 8 weeks, biological rep3",ctrl
subject: 12;	disease: TD;	muscle: ST;	gender: M;	age: 15.6;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Primary hepatocytes isolated from Donor 5 treated with Wy14643 for 24h,pert
brain_DLPFC_bipolar C_mr537,ctrl
CTL2 E2 4hr,pert
cell line: U937;	replicate: Replicate3;	treatment: shLuciferase,ctrl
112 Day Mouse leg muscle,pert
"Creatine-treated, biological rep6",pert
Splenic CD11b+Gr-1 high cell populations,pert
Klf9 mutant (Klf9KO) mice jejunum; Age: PND 30,pert
Muscle PCOS after pioglitazone 32,pert
genetic background: C57Bl/6;	genotype: wildtype;	cell type: Osteoclasts;	treatment: untreated,ctrl
Liver_Nrf2 KO_rep2.,pert
P328L329_del5a+,pert
"Mouse liver peritumoral tissue, MAT1A knockout, hepatocellular carcinoma, 15 months",pert
10 mg/kg MPH tr1002,pert
"HEK293 cells siRNA control, biological rep1",ctrl
"Crohn 06, CD06",pert
"Empty vector, collagen plate, rep3",pert
mdx gastroc sample 1,pert
tumor,pert
ID: MLL_00107;	cell type: PBMC;	disease state: control,ctrl
"seminoma specimen, pT1, patient age: 43y; W02 003",pert
"WildType mice with water, replicate 3",ctrl
KU_33N,ctrl
Bone-Marrow_MM_M1137,pert
Patient: G;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
Kidney_400 mg/kg VCM ip_mouse #103,pert
ccRCC tumor of patient 83,pert
WT / Reference_13425561,ctrl
tissue: peripheral blood;	subject: Control;	rna prep: PAXgene Globin reduced;	molecule: Globin-depleted RNA,ctrl
10ILC_normal_ductal,ctrl
strain: Swiss Webster;	treatment: 10mg/kg MPH;	tissue: substantia nigra,pert
"seminoma specimen, pT2, patient age: 35y; W03 032",pert
Normal Biological Replicate 5,ctrl
180C6,ctrl
LIRKO liver sample 3,pert
M24met_control_1,ctrl
Normoxic Control N2,pert
U2OS_shControl,ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 33;	maternal age: 36,ctrl
CON1,ctrl
HMEC_50 vs HMEC_21,ctrl
pooled reference mRNA from 4 harvests of ME16C cells,ctrl
tissue: Frontal cortex;	age: 80;	Sex: F,ctrl
5221 UC Uninflamed sigmoid colon,pert
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shGFP,ctrl
"Gastrocnemius, 2 months old",pert
HB1.A4,ctrl
age: 26;	gender: female;	ejection fraction: 74;	left ventricular end diastolic diameter: 47;	inflammation/PVB19: negative,ctrl
Squamous cell carcinoma 024,pert
"C57Bl/6, CD-1",ctrl
3339-lcm,pert
male_alcoholic_252,pert
v-src retroviral vector-infected immortalized mouse embryonic fibroblasts,pert
tissue: freshly isolated human monocyte;	gender:male; age: 47 yr; weight: 80 kg,ctrl
KO_0525-2,pert
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: ErbB2,pert
Bronchial Epithelial Cells SA biological 2166S,pert
mouse colon_hnf4mutant_rep1,pert
"human failing LV myocardium, Ischemic104",pert
"human failing LV myocardium, Ischemic77",pert
monocytes_T0_rep1,ctrl
hNHEPS human hepatocytes exposed to 0.1 μM VX 6 h after exposure,pert
COLO829_shMITF_PLX4032_B,pert
"Control 1, biological rep2",ctrl
cell line: HL-60;	shRNA construct: Scrambled Control,ctrl
"3T3-L1 siLSD1 48h, biological rep 2",ctrl
ctrl.3,ctrl
"Acute Myeloid Leukemia, sample 27",pert
Bronchial Epithelial Cells MMA biological 0114X,pert
Mouse No Cldn16 B9 461,pert
MDS patient 60,pert
liver_wild type_24 weeks_replicate_1,ctrl
PGK12.1_control RNAi-4,ctrl
DMN-NF1Hippo15d-1cAv2-s2,pert
"acutely admitted, severely psychotic schizophrenia patient  A18",pert
36M2 cell line from ovarian serous carcinoma cells,ctrl
"SBC-5 cells, siEGFP (control), 72 hr after siRNA, duplicate sample 2",ctrl
HCT116 human colon cancer cells with intact PTEN,ctrl
G93A non transgenic littermate 1265,ctrl
HCC_23N,ctrl
cell type: hepatocytes,ctrl
8 week old leg control rep 2,ctrl
"Testosterone treated, HIV-1 positive male, day 14 (5)",pert
"A pool of two pure subsets of peripheral blood B cells (CD19+ CD3- CD4- CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
Ischemia-reperfusion #3,pert
tMLL02,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 26 weeks;	genotype/variation: control",ctrl
MDS patient 56,pert
FoxO3null_1_1,pert
Pooled mouse tissue,ctrl
"proband f, before exhaustive exercise",ctrl
"normal mouse kidney E12.5, biological rep 3",ctrl
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 82;	Usage number: 5;	Exposures: 3,pert
A1,pert
liver knock out replicate3,pert
Discoid Lupus-L5,pert
"brain, cerebellum: RNA #1_le1",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 71,pert
FW_1a_BN1544,pert
Zfx wt MA9 cells + 4-OHT [10980],pert
15DKD_rep1,ctrl
"Liver, Normoxia 5",ctrl
IM CD34+ Pool III,pert
Pcgf6_1_shRNA1+dox,pert
adrenergic-deficient,pert
sepsis patient #8,ctrl
miR122-KO-105-T,pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 4051964045;	hybridization batch: II,pert
"ShamC-21, biological rep 2",ctrl
"CTR-D (CTR-3, biological replicate 4)",ctrl
Control 3 medium only,ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 176-day-old male;	70 mg liver used for RNA extraction",pert
gender: Male;	tissue: Tendon;Patellar;	age: 32;	donor: 15;	disease state: Non-lesional,ctrl
Isoflurane 10 exposures-1,pert
3T3-L1 Day 0 (passage 19) 24h after siLSD1 transfection,pert
braak stage: BR56;	rin: 72;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"iPSC derived from healthy control fibroblast WT2, biological rep4",ctrl
tissue: brain;	genotype: mutant Ndel ko/+;	age: P0,pert
MDS55,pert
patient: CAB10;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
HC-WT-20B,ctrl
HF0533_U133P2,ctrl
"48 hour-treated wild-type NB4, biological rep1",ctrl
tissue: prostate tumor;	genotype: Pb-Cre+;PtenL/W;K-rasG12D/W;	age: older than 20 weeks,ctrl
strain: FVB;	cell type: 6 DIV cultured hippocampal neurons;	transfected with: Sindbis virus expressing GFP alone,ctrl
ic8 -- cell line 1treated with mock APF #2,ctrl
HF1502_U133P2,pert
whole tissue section from case 1304,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 35;	maternal age: 30,pert
Male mice from fiona transgenic line (dystrophin-deficient with a transgene expressing high level of full length utrophin) were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction. Biological Replicate 1.,pert
Mnk_3206-R-7,pert
H19_P_B1,ctrl
monocytes_T0_rep3,ctrl
Patient 5 appendix,pert
patient id: T163;	tissue: Normal cortex;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
BP patient 48_biological replicate 2,pert
G026-lcm,pert
heart of male mouse subjected 1 week to chronic constant hypoxia (C1BM),pert
LJMJDW24,pert
Wild type_liver _3,ctrl
WT_liver_vehicle 0 mg/kg_96 hr_1,ctrl
oculomotor nucleus,pert
"Retina, 42 days old wildtype mice",ctrl
CA5,pert
GIST_KIT_1,pert
age: 8 month;	strain: FVB/N;	genotype: wide type;	tissue: normal urothelium,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
Patient 6,ctrl
NOD.scid1,ctrl
AAA neck (Sample 10),pert
10B,pert
Yolk sac tumor 0738,pert
"CFU-PreB colonies Wildtype littermate, biological replicate 4",ctrl
Snell 22 month Dwarf Liver 4dw,pert
Carrier-inj_Mip-1a-KO_rep2,pert
Wild-type mouse embryonic stem cell,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: none,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 63;	gender: male,pert
neuron_rep9,pert
01-0045A_Day1_11,pert
mock A,ctrl
colon_C57 mouse_12weeks_rep4,ctrl
Control peripheral blood leukocytes - Biological Replicate 2 - Technical Replicate 2,ctrl
CD8 T cells isolated from spleen,pert
brownfat_WT1_day3,ctrl
heterozygot FH P250 (human CD3 positive T cells),pert
J1 mouse embryonic stem cell,pert
wild-type placenta embryonic day 12.5,pert
Individual_4163_PP_sample,pert
MEF Wild Type 3-rep2,ctrl
AQA A,ctrl
K14deltaNB-cateninER  Time 7 replicate 3,pert
HCC005N,ctrl
CD4+_Tcells_severe_asthmatic_6,pert
Jurkat with Nef Biological Replicate 3,pert
sample H term homo,pert
SRF silenced EtOH rep 1,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: not treated,ctrl
C4_CLP_overexpressor_12,pert
Treg WT rep1,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.87;	choa: 154;	fata: 45;	eea: 1280;	wtkg: 79.3;	perfat: 44.9;	lbm: 40.9;	fat_mass: 3560.57,ctrl
29A;pretreatment;female;breast tumor,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: SAMPLE-1B,ctrl
Control N2B27 sample 2,ctrl
"male;	CABG patient, atrial tissue, ;	baseline before CABG surgery",ctrl
EOM 14 Day Control rep 2,ctrl
"LCL GM19238, Kd JUND, 72hrs",pert
miR122-WT-349,ctrl
EE_IB_3_aa_lcm,pert
H4med,ctrl
"S1P2-KO-neocortex, biological rep1 (male)",pert
Cochlea_WT_9mo_4,ctrl
siRNA Control,ctrl
Pcgf6_3_shRNA2+dox,pert
siCtrl_0_rep2,ctrl
Cancer 14,pert
"CBFb-SMMHC animal 1, replicate 1",ctrl
"Control Distal, Small Intestine 3 17 days old",ctrl
IRS-3 KO (jos0930),pert
"cochlea at P13, wt, biological rep 3",ctrl
THRA 6a mutant + vehicle replicate 3,pert
HepG2_DMNQ rep2,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 74 years,pert
"Liver, fasted, PBS",ctrl
B2_saline_overexpressor_48,pert
Ezh2-Vec2,ctrl
"Uninfected NT at 5 d.p.i., rep2",ctrl
Metastatic prostate cancer tissue pool WX1,pert
061J5_CTRL,ctrl
P60_WT_2,ctrl
"eye, cornea: TRizol Extraction_le1 8",ctrl
cell line: SF539;	transfection: PARK2 siRNA#2,pert
H1299 DAC 0.3 uM (3237),pert
No abuse,ctrl
colonoscopic biopsy from adult with unaffected colon from adult with UC,pert
Early IPF_surgical biopsy_lower lobe_rep149,pert
MCK-PPARa rep 2,pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
RL_siRNA_NS_rep2,ctrl
age: 43;	sex: M;	disease status: control subject;	Filter number: 95;	Usage number: 4;	Exposures: 3,ctrl
"Grape extract group, 12 months, patient number 11",ctrl
"24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; not assessable",pert
"female Spargue-Dawley rats, diet only for 7 days,  tissue: liver",ctrl
cell line: M24met melanoma cell-line;	genotype/variation: Wnt-1 overexpressing;	treatment: control,pert
cell line: LICR HN2;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
Trastuzumab treated after 4 days (T2_2),pert
HepG2_100uM_Trovafloxacin_24hr_Prep2,pert
4 hour tunicamycin wild type C,ctrl
puroB replicate 1,pert
Liver GPR120KO ND,pert
"Cardiac, ventricular tissue",pert
DMN-CtrHippo28d-1bAv2-s2,ctrl
TN3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: mid-UV,pert
C010_Control_F_90,ctrl
tissue: cardiac biventricle;	genotype/variation: PGC-1a KO/PGC-1b KO,pert
8DKD_rep2,ctrl
K_LS_Wk2,pert
LPS 24 HOURS,pert
Adoptive transfer of OT-I derived T cells transduced with shRNA into B16 tumor bearing mice_5-tu3,pert
MPM tumor 9,pert
WT S49 Cells,ctrl
control,ctrl
Mononcyte-healthy-untreated-1,ctrl
N1B Normal-cerebellum,ctrl
"n16, surgically resected from patient of gastric cancer.",ctrl
Control with WY14643 replicate 3,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: untreated,pert
cell line: HeLa;	cell type: human Cervical Carcinoma;	transfected with: siRNA directed against Sp1 mRNA (siSp1),pert
3_month_old_Prnp_knockout_mouse_rep4,pert
microdissected epithelial cells from normal main pancreatic duct 1,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 7,ctrl
Basal IFE cells isolated from 1 year old WT mice,ctrl
MPM tumor 15,pert
skeletal muscle Crhr2-/- replicate2,pert
SKBR3 PR 1,pert
ARPE-19,ctrl
Asthmatic after Flovent,pert
brain_DLPFC_bipolar B_mr781,pert
Normal Rat Retinal Müller Cells (biological replicate 3),ctrl
BIO586222,pert
01LMX_Oligo,pert
11_3_MOE_430A_HE,pert
sampleID: SAM630148;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
NPC11,pert
ND_8,ctrl
tissue: Biceps muscle;	patient: P.b.8;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1y 5m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
Monocyte human familial combined hyperlipidemia (FCH) sample,ctrl
B6C3F1 male,ctrl
"52B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
intestine_wildtype_24hfasted_rep1,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 67;	Sex: male;	region: LC;	age: 40;	genotype: Y/X;TH/-,ctrl
"MCF-7 transfected with pcDNA3.2, rep.1",ctrl
N51722,ctrl
DBA/2JTCE liver sample batch 5,pert
HUH-YAP-#3,pert
MIST1-null pancreatic RNA with inducible MIST1 transgene 36 hours post-tamoxifen,pert
"Atria, Mutant, biological replicate 2",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 204,ctrl
"CFU-PreB colonies Hspa9+/-, biological replicate 5",pert
A673 cell line that has been treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50).,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 1,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
A549 alveolar epithelial cell line,ctrl
P14 - Lis1ko/+ 2,pert
pediatric AML GP1,pert
PancreaticSample25-Tumor,pert
"amnion mesenchymal cells, no treatment, biological rep3",ctrl
jos1986,ctrl
lox67 control mouse,ctrl
tissue: blood;	control: 6;	gender: female;	age: 40,ctrl
"HEK293E cells, TDP-43 siRNA, replicate 1",pert
GM19238_Kd_USF1_2,pert
Pediatric_GBM_42,ctrl
Unaffected MZ twin pair 5 (Unaffected patient of MZ twin pair CCN5),ctrl
MDS patient 14,pert
erStress_twins_AA_1757twin1_500nM_thapsigargin_4h,pert
tissue: white blood cells;	age: 10.88;	Sex: male,pert
Control Day14 (360L),ctrl
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks,ctrl
Vit A deficient 2a,pert
umbilical cord_bpd: 7F,pert
"Tfrc-/- (GFP-positive) kidney cells, biological rep2",pert
strain: Mixed;	genotype/variation: Nrf1 CKO;	gender: Female;	tissue: Liver;	age: 6weeks,pert
WT_PLACEBO_48hours_4,ctrl
Jejunum_POR-null_3,ctrl
"Control pancreas, sample 3",ctrl
S259A-3,pert
ILD Study Number 1035,pert
health control_1,ctrl
Waldenström’s macroglobulinemia (WM-PC 30639),pert
MDA-MB-231 cells transfected with precursor of miR-148b were analyzed 48h after transfection,pert
Skin_Tcfap2c Mutant E16.5_rep1,pert
EB_6_8d_299_HCHO_Nasal_Rat230_2_CIIT05024,pert
PND28 Rat Testis_Rat230-2_2hr Corn Oil_Animal#48_04005,ctrl
cerebellum_wild type_12 weeks_replicate 2,ctrl
29 year old male,ctrl
major non-tumor5,ctrl
"schizophrenia, BA10-41",pert
Myoblast-GATA4-KO-day3-2,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 70;	gender: male;	tumor grade: IV,pert
Diaphragm 7 Day mdx rep 3,pert
Huh7 cells_Mock Infected 48 hours_ rep3,ctrl
KO HPC Veh 26,pert
retina at age PN40,ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P7;	clone: C11,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 27.0;	age of psoriasis onset: 24,pert
Primary hepatocytes isolated from BL6 mouse strain treated with Wy14643 for 24h,pert
"Mouse embryonic fibroblasts, Bptf KO",pert
parental cell line: WB;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
chip number: 22;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.63;	rin: 9.1;	transfection date: 2011-10-17,pert
8 Weeks Heart Control rep 3,ctrl
cell type: epithelial cells,pert
RNA from whole tissue section of case 1343 labeled with Cy5,pert
T51315,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 60.6137,pert
HEK293 F5_doxycycline treated,ctrl
01LM6: new onset sJIA,pert
Genotype: HtrA2 wild type,ctrl
"NPCxhIPSC CON, replicate 2",ctrl
Prdm14 knockout 1,pert
siControl_1,ctrl
"amnion mesenchymal cells, 1h interleukin-1-beta, biological rep1",pert
cell line: CL1-0;	gender: male,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 167;	colon ratio (mg/mm): 2.783;	myeloperoxidase activity (u/mg): 0.199;	tissue: colon;	treatment: 5% DSS,pert
imanitib7,pert
Human skeletal muscle biopsy sample;	Patient #45 with NORM,ctrl
Cell line: NALM1,pert
Individual_777_PP_sample,pert
"D425-shOTX2_3, t=24",pert
C3H/HeJ Vehicle liver sample batch 6,ctrl
Age: 40;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
HeLa cells transfected with UPF1 siRNA 3 (experiment),pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 84,pert
"non-AD_FC, biological rep6",ctrl
"endometrioma, patient 19",pert
BP patient 111_biological replicate 1,pert
P1 mouse eyeball extracted total RNA_wildtype4,ctrl
CME-LaminA0d-3MA-S2,pert
Y HID_B003,ctrl
siControl,ctrl
"Liver, fasted",pert
01LNM_CTRL,ctrl
"fibroblast, MFS subject FB1286 rep 4",pert
"PDAC, sample 2",pert
HCC018N,ctrl
patient: 30277;	sample: normal,ctrl
"control embryonic stem cells, biological replicate 4",ctrl
"mortality: dead;	ethnicity: Hispanic;	gender: F;	age (yrs): 59;	ld: HCV;	creatnine: 1.4;	mdrd: 41;	gfr: 38;	protein: 0;	hematuria: 1;	c3: 1;	c4: 1;	rf: 96;	hcv: POS;	htn: 0;	dm: POS;	hba1c: 6.4;	meld: 14;	ana: POS;	gp: Nodular glomerulosclerosis, Diabetic Nephropathy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 0;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 1;	igm: 2;	c: 1;	empe: P;	bmwid: P;	bmd: P;	edd: P;	no of glomeruli: 6;	glomerulosclerosis: 0;	intact t: 0.9;	arteries: duplication;	if: IGG+IGM++IGA+C3+C1q+ capillary wall linear;	mesangium ig: O;	tissue: Kidney_Biopsy_Liver_disease",pert
Telencephalon cKO 2,pert
mouse cerebellar granule cells wild type 8,ctrl
FC 04,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 22 months old; Tissue: Brain; Treatment: 4 hours post LPS 0.33mg/kg BW ip.,pert
"Gender: female, Age: 41 years, Tissue: normal vulva,",ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug. At four hours prior to RNA isolation, 2.5uM sapphyrin PCI-2050 (final concentration) was added to the culture. After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
Strain: C57BL/6J;	Gender: female;	Age: 6 weeks;	Tissue: whole brain,ctrl
HCT 116  siChe-1 rep2,pert
"imr-32,ccnd1siRNA, t=48, 4",pert
ANL,pert
Ago2-IP RNA Wildtype-1,ctrl
striatum_wild type_24 weeks_replicate 3,ctrl
cell line: U-87 MG;	cell type: glioma,ctrl
11095 Normal Uninflamed descending colon,ctrl
"PBMC, healthy control, biological rep14",ctrl
Huh7 cells_JFH-1 Infected 24 hours_ rep2,pert
"HUVEC infected with Control Vector,  biological rep2",ctrl
Pre-frontal cortex from male C57Bl/6 mice 31 d after i.d. injection of Complete Freunds adjuvant,ctrl
MZ1774 mock rep 4,ctrl
"granulocyte, healthy control, biological rep6",ctrl
CLL 161-04 Control,ctrl
"granulocyte, healthy control, biological rep2",ctrl
cell line: CL-0;	transfection: vector control,ctrl
Tissue: whole retina,ctrl
HCC015N,ctrl
Halothane 5 exposures-1,pert
Leg 23 Day Control rep 1,ctrl
Cyclophosphamide-treated spleen 1 day - Biological Replicate 2 - Technical Replicate 2,pert
41A,pert
colon_epithelium_C57 mouse_12weeks_rep4,ctrl
"3T3-L1 siLSD1 48h, biological rep 1",pert
Pias1 null IFN-beta 4 h,pert
H1299_shLUC,ctrl
"fibroblast, control subject NM3 rep 1",ctrl
"t09, surgically resected from patient of gastric cancer.",pert
"Exp A, Animal #256, 200mg/kg D-Serine",pert
Primary epithelial cell culture from esophageal biopsies,ctrl
Oligodendrioglioma_1,pert
pediatric AML S06,pert
NT1,pert
RNA from whole tissue section of case 1047 labeled with Cy5,ctrl
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: valproic acid (VPA);	treatment time: 16 hours,pert
WI-38 cells exposed to 0.5 uM BPDE for 24 h,pert
strain: C57BL/6J;129S5/SvEvBrd;	genome/variation: Inha-/-;	cell type: granulosa cell;	treatment group: 44-46hr PMSG,pert
Gastrocnemius and Soleus muscles,pert
MCL_IGHV_MUT (R1942),pert
"twin pair: #9;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"A673 treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50), biological rep2",pert
"Notch3 knockout mouse cerebral microvascular fragments, biological rep3",pert
"ES cells: E14 (129P2/OlaHsd background), Genotype: Wild (Phgdh+/+), C57BL/6J background, Gestation: 13.5 days, Tissue: head",ctrl
"Atria, Control, biological replicate 1",ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: n/a;	maternal age: n/a,pert
A538 MI 1 day,pert
human preadipocytes+siCtrl_day6_rep1,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,pert
RNA from HCC_4N,ctrl
Individual_3777_PN_sample,pert
01N1J_PolyRF-,pert
Fetal liver CD-1 background,pert
Leg 112 Day control rep 1,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 35;	gender: female;	tumor grade: IV,pert
MDA-MB231 PIAS1 shRNA cells,pert
"Wt mouse, cerebellum, standard diet ad lib",ctrl
genotype: Wild type;	strain: C57BL6,ctrl
"gender: Male;	age: 79;	post-mortem delay: 4h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Peripheral blood mononuclear cells;	TTF=125min;	Race=Black/African American;	Sex=Male,pert
GATA-1deltaN mutant E12.5 fetal liver derived megakaryocytes,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 4,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 2,pert
"CFU-PreB colonies Hspa9+/-, biological replicate 2",pert
"KO mouse heart at 6-weeks old, biological rep2",pert
"Gender: female;	Age: 25;	Source: skin, left thigh",ctrl
NZM12 metastatic melanoma cells media-only control,ctrl
con-37_A,ctrl
CD8+_Tcells_severe_asthmatic_3,pert
"Mouse wt heart ventricular tissue at E17.5, pool of 2",ctrl
KO_PMΦ_rep1,pert
disease state: Mantle Cell Lymphoma;	cell type: B cell lymphocyte;	ighv status: MUT,pert
HF0131_U133P2,ctrl
"Vitamin C treated ES cells, Rep 3",pert
platelet_Ctrl_3,ctrl
EA_Case10_CD8,pert
11421 UC Uninflamed ascending colon,pert
"Eed KO BM LT-HSC, biological rep1",pert
Mouse Tibialis Anterior 4 weeks post birth,pert
BRCA1-KD-3 (mRNA),pert
JIA PBMC Pre treatment A235_L014,ctrl
KO 3 Quadriceps,pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: Control shRNA (Luc),ctrl
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression.",pert
"123, ADIPOOSE TISSUE, Before",ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 3,ctrl
Normal PBMC_sample 1,ctrl
protocol: AP-2 gamma targetting siRNA 3;	cell line: MCF7,pert
RNA from HCC_19T,pert
cumulus_nonPCOS_Lean_rep4,ctrl
heterozygot FH P278 (human CD3 positive T cells),pert
INSENS 2 0hr,ctrl
siIPMK + MMC experiment 1,pert
cell line: BV-173;	tissue: Human B cell precursor leukemia,ctrl
patient: 14;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
01-0060A_Day1_6,pert
"HeLa treated with Cas-II-gly, biological rep1",pert
Wild type 4,ctrl
IFN-KO,pert
5254 UC Uninflamed sigmoid colon,pert
"CBFb-SMMHCd179-221 animal 2, replicate 1",pert
"Heart, MAT1 CKO, 4wk, sample 2",pert
MCF-7 +ER siRNA + vehicle rep1 (MD37),pert
MPM tumor specimen 21,pert
"Crohn's Disease subject (44 year old hispanic female, SAK_1307613224)",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 180min;	race: Black/African American;	sex: Female,pert
"SLE patient, 1025V1",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 135min;	race: Black/African American;	Sex: Male;	fstl-1 (ng/ml): 176,pert
RNA from HCC_27N,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 24 hours,pert
OA2,ctrl
Dengue Hemorrhagic Fever Patient 49,pert
Cavin-1/PTRF KO #186,pert
SZ13,pert
Against CDK8-1 rep2,pert
status: Rapid;	age: 68;	gender: male;	tissue: cultured human fibroblasts,pert
"YPFH cells from M1, wild type control, biological replicate 2",ctrl
Human prostate cancer primary culture C24sx,pert
KM_001N,ctrl
brain_DLPFC_bipolar C_mr677,ctrl
B6.IL10 24 air 2,pert
Embryonic age 14.5 mutant rep2 (PKD1_59),pert
Skeletal muscle tibialis anterior (TA) from mdx line,ctrl
"Human LIMA artery from patient 2, control (unstented)",ctrl
Carboplatin;	Carboplatin 36 hours set 2,pert
murine medullary thymic epithelial cells,ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 26;	maternal age: 23,ctrl
Wildtype liver_saline-injected 12weeks repl2,ctrl
Wistar rat liver tissue following animal exposure to orotic acid for 14 days,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: trisomy8,pert
HEK cell lines expressing WT channel,ctrl
455MM,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype N/A;	matched/unmatched: unmatched,pert
ShKdm2b replicate 3,pert
Normal-ERα-positive breast cancer 34,ctrl
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
HCC010N,ctrl
Rosiglitazone treated cells Rep2,pert
GFP 0hr 282295433,ctrl
tissue: whole Gastrocnemius;	gender: adult male;	strain: CD1,ctrl
coc-51_C,pert
Old heart,ctrl
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed,pert
GC13_skin_5dpn_2,pert
cell type: DN4,ctrl
tissue: liver;	genotype: WT;	genetic background: C57BL/6,ctrl
E15.5 Tgfbr2 Wildtype Mouse Model,ctrl
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14536;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"PMA treated, no doxycycline; biological replicate 2",pert
affected status (disease state): control;	gender: female;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever drinker,ctrl
advanced HCC,pert
HL60 AML cells,ctrl
Squamous cell lung cancer X35nml,ctrl
pool of 3 normal E12.5 kidneys,ctrl
Colo-205 PLX Day 1,pert
H295R _2OHBDE85_rep1,pert
cell type: leukemic spleen cells;	genotype: CBFb-SMMHCd179-221 chimera,pert
"ALL_DS, K5 012109",pert
disease state: endometrioma;	patient: M1,pert
The caudate nucleus from a neurologically normal Jpanese male (aged 60 yr).,ctrl
MDS patient 6,pert
Ishikawa_LowDose_BPA_24h_rep1,pert
Cardiac Muscle_mdx_rep2,ctrl
BT474-J4_Lap_24-3,pert
Total RNA from MDA-MB-231 cells infected with a lentivirus shLOXL2,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 0h,pert
WILDTYPE cerebrum at 10 days,ctrl
chip number: 18;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.82;	rin: 9.5;	transfection date: 2012-03-26,pert
AFFS084-1-291004,ctrl
A VIS _B068,pert
strain: 129/Ola;	cell type: embryonic stem cells,pert
"N-56, NORM, M, GSF, 6 x ETOH, 14d",ctrl
Heart-Base_WT-3,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 37;	gender: male,pert
CML_6_GMP,pert
"AD_FC, biological rep14",pert
"NPTX1 shRNA Day 3, biological rep1",pert
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-D1a,ctrl
DOV13-(2),ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 24h,pert
HCT 116 control rep1,ctrl
.SAL_II_3,ctrl
multiple myeloma (MM 199),pert
strain: C57BL/6J;	genotype: Cmah KO;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,pert
NCCIT siNTC rep2,ctrl
"seminoma specimen, pT1, patient age: 40y",pert
normal skin,ctrl
Whole lung tissue_advanced IPF_explant,pert
WT-Fibr1 5,ctrl
Individual_5079_NN_sample,ctrl
"adult mouse jejunum, hnf1alpha control",ctrl
B4 363 b4-/- untreated,ctrl
RNA from HCC_6N,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: secretory endometrium,ctrl
boen marrow-derived macrophages,pert
"lymphoblastoid cell line from F16.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
10P-M4,pert
38A;pretreatment;female;breast tumor; nonresponder,ctrl
NuLi cell line biological rep2,ctrl
GFP,ctrl
S1C Sporadic-hippocampus,ctrl
Control Day7 (418L),ctrl
"gene expression of wild type oocyte, replicate 3",ctrl
PBMC from T cell LGL leukemia patient #101 (TLGL101),pert
Mouse No Cldn16 B9 457,pert
"Control Distal, Small Intestine 3 21 days old",ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/loxP,pert
A375 cells 24h Vemurafenib rep2,pert
H2009_shLUC,ctrl
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
chip number: 20;	transfection plate: 5;	target gene: RELA;	kd level: 0.79;	rin: 7.9;	transfection date: 2011-10-17,pert
"TGCT cell line NTera2/clone D1, untreated, undifferentiated and pluripotent",pert
Mening UNSTIM WB NP 12b,ctrl
plantaris muscle,pert
"C57BL/6J Saline treated, biological replicate 3",ctrl
"breast tumor epithelium,35",pert
aa_NY82,pert
liver_STZ treated diabetic_rep3,ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 5,pert
BT474-J4_Lap_24-1,pert
"human failing LV myocardium, Idiopathic44",pert
tissue: whole Gastrocnemius;	gender: adult male;	strain: CD1,pert
"acutely admitted, severely psychotic schizophrenia patient  A21",pert
very early HCC,pert
H441 transfected with scrambled siRNA 3,ctrl
Celecoxib_#4880,pert
PlagL2KO1,pert
Bronchial Epithelial Cells MMA biological 1753C,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 3,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 34;	Usage number: 4;	Exposures: 2,pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: no,pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 3;	age: Post natal day 3-9,pert
Control Braak α- synuclein Stage 0 C6SN,ctrl
INS-1 cell line #1 with non-induced HNF4a2,ctrl
"experiment 2, ethanol-treated 1",pert
CRC_celecoxib_M4858,pert
genotype/variation: GSK-3b-/-;	cell type: embryonic stem cells,pert
gfp control sample 2,ctrl
Control A549 cell Replicate2,ctrl
Sham 21 replicate 2,ctrl
Thyroid_papillary carcinoma 71,pert
"T3 fetal heart (treated on gd 14.5 via oral gavage, collected on gd17.5)",pert
10uM H2O2 rep 4,pert
skin_tissue,ctrl
HC IF 2 alcohol,pert
V5-P495,pert
Nrl-ko-Gfp 4 weeks replicate 2,pert
"Control #7, Untreated",ctrl
tissue: ankle joint;	genotype/variation: MMP-8 KO;	strain: C57BL/6,pert
"D425-control, t=16",ctrl
Melanoma allograft_AZD6244 100mg/kg 4 days,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 32;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: Hep G2;	genotype: wild-type THRA and;	treatment: with 100 nM T3 for 6h,pert
wild type MEF time 24 replicate 2,ctrl
Mnk_3149-R-B,ctrl
PGA-RMM-45m-1aA-s2,pert
Psoriatic arthritis PsA 17,pert
Liver_nash metformin_no.4,pert
WT3-3,ctrl
BL Day 1 siMut12 transfected biological rep3,pert
A549_EGFplus_rep2,ctrl
RNA from microdissected breast cancer cells from case 1405 labeled with Cy5,ctrl
"wt muscle 2, biological rep 2",ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 2;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
A_LS_Time0,ctrl
01N4L_Oligo,pert
"7B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"PC-3 cells, before treatment (0h)",ctrl
a_NY18,pert
Cardiacmyocyte,pert
fat_Wt_8wk_rep1,ctrl
MEF.FHL2mutE,pert
PB_DON040,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.683;	OD280: 0.839;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 294;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
lymphocytes_ctl_M_42y,ctrl
"AALE-Vector uninfected, biological rep1",ctrl
siLMO3_oligo2_FM_rep1,pert
wild type MEF time 6 replicate 2,ctrl
Cutaneous psoriasis without arthritis PsC 10,pert
tissue: Frontal cortex;	age: 83;	Sex: M,ctrl
pediatric AML S04,pert
strain: C57BL/6;	cell type: hepatocytes;	genotype/variation: GNMT-KO;	agent: aflatoxin B1 (AFB1),pert
Sham 5,ctrl
"Lymphoblastoid cell lines derived from family 1736, member 1",ctrl
Patient 8,ctrl
P0 - WTMixB 1,ctrl
"primary cortical neurons, NLGN1 shRNA",pert
"P16 mutant OC base, biological rep 1",pert
age: 42;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
db/m 6-2,pert
mouse B6xCF-1 RNAi transgenic,pert
Monocyte derived dendritic cells,pert
"gene expression of CTCF-depleted oocyte, replicate 4",pert
Retina wildtype 30 days 2,ctrl
human preadipocytes+siCtrl_day0_rep1,ctrl
Liver_hyperglycima_no.5,pert
stomach,ctrl
NBD inhibitory peptide-treated T-ALL1 100mM 16h,pert
Silberg2 (S11) 25091BE,pert
striatum SNCA knockout 21 month replicate 2,pert
db/m 6-4,pert
untreated AML blasts,ctrl
A HID I_B083,pert
Gallbladder - leptin treated,pert
4117-1 E2F1 Null,pert
Spleen & Lymph Node,ctrl
GIST Pre Treatment Biopsy 56,ctrl
liver_STZ 0.1% quercetin diet_rep4,pert
DMSO treated CEM-C1 cells_2,ctrl
SK-MEL-2 cells,pert
"treated with Roziglitazone, 1000 mg/kg in Methylcellulose soln per orally, extracted 48h after treatment, biol. rep1",pert
T6.01,ctrl
"lymphoblastoid cell line from F6.04, one out of seven of sensitive group, 50*10e6 cells",pert
"TGCT cell line NTera2/clone D1, treated 7 days with retinoic acid, differentiated",pert
NonIR-WT_Rep3,ctrl
1089PBMC,ctrl
P4_PMP22KO_2,pert
EB_2_24h_211_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Embryoid body formation (10 days) of Bmi1 transduced embryonic stem cells (CCE ES cells).,pert
"fibroblast, MFS subject FB1286 rep 3",pert
GM19238_Kd_NR3C1_3,pert
PCOS Endometrium Epithelial Cell_105.PC07_EpCAM,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: E2;	time: 24h,pert
V5-P122,pert
brain_DLPFC_bipolar C_mr521,ctrl
disease state: paediatric glioblastoma;	age: 15;	gender: M;	h3.3_status: G34R,pert
NINDS-RHS-Ctr_240h-1aUA-s2,ctrl
A_AN16115_F,pert
condition: Psoriasis;	patient: PS-C;	tissue: LS skin biopsy;	kit: Affy,pert
"brain, hippocampus: inhibitor-1 KO 3_e1_le1",pert
"SKO-transduced MEFs, Vc-, D3",ctrl
Aquaporin-11-/-_mouse P7 kidney #5-2,pert
scan batch: Batch 1;	group: control;	subject age: 4;	paternal age: 35;	maternal age: 33,ctrl
strain: C57BL/6;	genotype: PTEN+/- (epithelium);	age: 12 months;	tissue: lateral prostate,ctrl
No_abuse_4,ctrl
PGA-MAH-AJ_OVA24h-1aA-s2,pert
"Patient E, lesional skin",pert
subject id: 60;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Region of the left ventricle above the infarction (above the LAD artery),pert
CRC_nodrug_M4865,ctrl
genotype: Bcl6 knock-out;	cell type: FoxP3+ Treg,pert
"Patient 32, Macroscopically intact tissue",ctrl
LDLR_LF_2,pert
n10t24h,pert
"fibroblast, MFS subject FB992 rep 1",pert
Intestine_KO_biological rep1,pert
"human failing LV myocardium, Idiopathic83",pert
subject: 03A;	cohort: 3;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 40;	Sex: F;	batch: Batch_1,pert
Pediatric_GBM_24,ctrl
RA7,ctrl
treatment: naïve;	transgenic variant: AChE-S;	tissue: Caudate-Putamen;	genetic background: FVB/N,pert
CD8_T_cell_pool_melanoma_M11+M12,pert
cell type: monocyte;	disease state: homozygote FH,pert
CTRL_4_MEP,ctrl
"WT mouse skin treated once with TPA and collected 24 hr later, replicate 1",ctrl
8 Weeks Heart Control rep 2,ctrl
"Pancreas from adult Rkip-1 KO mice, biological replicate 1",ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.4;	colon weight (mg): 171;	colon ratio (mg/mm): 2.672;	myeloperoxidase activity (u/mg): 0.204;	tissue: colon;	treatment: 5% DSS,pert
BCells_WildType_day0_REP3,ctrl
H19_P_B2,pert
"ERbKO mouse aorta with placebo, biological rep3",pert
tissue: Hippocampus;	age: 95;	Sex: F,pert
Hippocampus pool from three SHA rats,ctrl
RTX5 T0,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 79;	Usage number: 1;	Exposures: 3,ctrl
cell type: MEFs;	genotype/variation: wild type,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Anoxia;	Tobacco Use: No;	1st technical replicate,pert
SCC-40_siZMPSTE24_rep.1,pert
RNA from microdissected breast cancer cells from case 68 labeled with Cy5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.918;	OD280: 0.454;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 301;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
disease state: endometrioma;	patient: 2,pert
ILKR211A3,pert
12467 UC Inflamed sigmoid colon,pert
E9.5 KLF1-/- erythroid-6,pert
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 68",pert
liver_knockout,pert
"HUVEC, atorvastatin 2",pert
106A,ctrl
Patient: C;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
SENS 1 0hr,ctrl
GM19238_Kd_NFYC_1,pert
Muscle PCOS 13,pert
"Metformin, biological rep2",pert
D2 patient,pert
3DKD_SerumStarved_rep3,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H421_2h_0.4mM_HG-U133A_2_YCHSUP501,pert
Targretin_mammary_3,pert
C57BL/6J Mouse Female Kidney,pert
"array 16, unimplanted",ctrl
Pax_S6,pert
WFS1 KO USHT_15_329_wt,pert
PZA treated-42d-1,pert
231_Empty_rep1,ctrl
"brain, hippocampus: C72-III_e1_le1",ctrl
strain: mixed C57BL6;	genotype/variation: Rptrflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
1 h,pert
KO HPC Veh 30,pert
Brain from 20 days Npc1+/- mouse1,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
"Sham NALT (PBS), biological replicate 2",ctrl
U87 untreated,ctrl
cell line: HEK293T,pert
"BOEC, normal 4",ctrl
healthy control H24,ctrl
Wt_cycling_rep1,ctrl
strain: C57BL/6;	tissue: cerebellum;	genotype/variation: Cxcr4 null,pert
OCI-Ly1_FOXP1 overexpression,ctrl
"Rat liver, treated with Caerulein, 50 µg/kg in saline i.p., extrated 48 hours after treatment, biological rep1",pert
118A,ctrl
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate A,pert
UV-SeV 3482,ctrl
MCAD 1,pert
BxPC3-KO111 rep 3,pert
"G42 cells from M1, wild type control, biological replicate 4",ctrl
"strain: C57BL/6J;	genotype: Tmod3-/-;	phenotype: small fetal liver, anemia",pert
"MCF-7 human cell line, siLRH-1_#2",pert
5245 UC Uninflamed sigmoid colon,pert
Rosi-treated diabetic,pert
Ishikawa_HighDose_BPA_48h_rep2,pert
G93A-SOD1 mouse,pert
Beta4 nAChR subunit null mice following nicotine-induced seizures,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: Vemurafenib 1000 nM for 48h,pert
3885-1 E2F WT,ctrl
Parkinson's disease sample x190,pert
QK-knockdown U87 transduced with a scrambled non-targeting microRNA (miR-NT),ctrl
"vector d2, rep 2",ctrl
colonic_mucosa_non_inflamed_877,pert
n5t6h,pert
T21_4,pert
GIST_PDGFRA_2,pert
"Cadmium 0.55 µM, biological rep3",pert
normal control,ctrl
Control LM2 Cell on HMVEC-L Replicate 2,ctrl
Healthy2-CD4,ctrl
strain: B6/C3H F1 hybrid;	gender: male;	age: 30-month-old,pert
AKO-rep3,pert
RV64.03_CONTROL_day25_Slide51,ctrl
Control replicate 5,ctrl
n11t24h,pert
Cyclophosphamide-treated spleen 1 day - Biological Replicate 3 - Technical Replicate 1,pert
Glioblastoma_6,pert
"wild-type DP cells, biological rep 3",ctrl
Mic29_muscle_control,ctrl
"Patient 999, baseline",ctrl
8 Month Wild Type Ovary_02,ctrl
"DMSO-treated, 6h after UV, Replicate E",ctrl
KU_45T,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.2;	colon weight (mg): 170;	colon ratio (mg/mm): 2.742;	myeloperoxidase activity (u/mg): 0.643;	tissue: colon;	treatment: 5% DSS,pert
human preadipocytes+oligo2_day6_rep1,pert
cell line: LNCaP,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G63,pert
KO_TER119+_rep3,pert
Cell line: BV-173,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
2 hr EE repl 1,pert
8 week old control mouse diaphragm,ctrl
19A;pretreatment;female;breast tumor,ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: control;	time: 24h;	gender: Male;	age: 73 years old,ctrl
"age at diagnosis: 35;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 0;	dfs-month: 65;	dfs-event: 0;	distant metastasis: 0",pert
"age at diagnosis: 37;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N3b;	er: 1;	pgr: 0;	dfs-month: 65;	dfs-event: 0;	distant metastasis: 0",pert
whole tissue section from case 1045,ctrl
umbilical cord_bpd: 9F,pert
WT_T. gondii-infected_5dpi_ileum,ctrl
"Metastatic, prostate cancer",pert
482MM,pert
"A pool of two pure subsets of peripheral blood CD8+ T cells (CD19- CD3+ CD4- CD8+ CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
PGA_MI_nilv_1h_392,pert
MBD1 WT #2,ctrl
Cerebellum_nontransgenic control S46_3.5 months_replicate 3,ctrl
cell line: bj-ipsc_1: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below,ctrl
Sex: male;	Age: 13;	SL: 6.36;	House: 1;	Severity: SS;	Ashworth: 4;	Zancolli: 3;	PEFF: -5;	PESF: -90;	AEFF: -70,pert
"Estradiol, rep 3",pert
3886-1 E2F1 Null,pert
Klf9 wild type (Klf9WT) mice jejunum; Age: PND 30,ctrl
"alveolar macrophages, smoker 058",pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
olfactory bulb,ctrl
0105-01-A,pert
231/ARF-2_2,pert
"Age: 56;	Sex: M;	Ancestry: African;	Smoking status: smoker, 80 pack-years",pert
"fibroblast, MFS subject FB969 rep 2",pert
"WT LSC, biological rep1",ctrl
Liver GPR120KO HFD #428,pert
LNCaP.FoxA1.5,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 6",pert
p300+/- Rep1,pert
KN-smoke-low-5 month+1d-R4,pert
Subject #8022-Preinfection,ctrl
A2058 Ctrl siRNA Rep3,ctrl
Diaphragm 56 Day control rep 2,ctrl
wt_P2_rep4,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 2 month;	treatment: fresh air, treatment over 2 month, 4x1h exposure per day",pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: Geminin knockdown, shRNAmir #9;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",pert
A5_scrb,ctrl
umbilical cord_bpd: 1C,pert
Mutant biological rep3,pert
D_Kin_2,pert
CuFi cell line biological rep1,ctrl
subject id: 42;	infection: DENV;	status: DF;	tissue: whole blood,pert
Ishikawa_HighDose_BPA_48h_rep4,pert
Convalescence samples,pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 26;	maternal age: 24,pert
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic. ",ctrl
newborn (P0) Krt1+/+ skin_replicate 2,ctrl
"NPTX1 shRNA Day 2, biological rep1",pert
strain: C57BL/6J;	genotype: HDC-EGFP;	age: 7 months;	tissue: colon tumor;	cell type: CD11b+Gr-1+ myeloid cells in the tumor stroma,ctrl
"Wild-type myeloid-derived suppressor cell from colon tumor, rep1",ctrl
11417 UC Uninflamed ascending colon,pert
Ring1b_KD_2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 24 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
Thyroid_papillary carcinoma 77,pert
Normal gastrocnemius,ctrl
"gender: Male;	age: 75;	post-mortem delay: 9h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 1,ctrl
"IKK2 -/- tumor, biological replicate 4",pert
AR-CO-24-2-548,ctrl
strain background: 129/B6 hybrid;	cell type: embryonic stem cells;	genotype/variation: wild-type control,ctrl
Individual_4162_PN_sample,pert
HeLa_06_21_04 TP-5,pert
No or early 2 rep10 (OHN),pert
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 12;	Brain pH: 6.70;	Post mortem interval (hours): 60;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Healthy control c1,ctrl
whole tissue section from case 1419,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 2 days adipocyte differentiation,pert
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: normal condition (Naïve);	treated with: DMSO for 4 hrs;	sample type: control,ctrl
Diaphragm 56 Day mdx rep 2,pert
"differentiated U937 cells, 1uM curcumin treated, 18h",pert
gender: male;	batch: 1;	age (years): 33;	patient id: Control_5;	fev1 (% predicted): 78;	fvc (% predicted): 77;	medication: None;	cell type: CD8+ T-cells,ctrl
MCF7 cell line _vehicle (control)_biological replicate 2,ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 105;	medication: Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd;	cell type: CD8+ T-cells",pert
DH 3,pert
HCT116 non-recombinant clone 27 (STAG2 wild-type),ctrl
Nerve_Diabetic_Vehicle_706,pert
Zmpste24-/- mouse embryonic fibroblasts (P3),pert
"liver, fed 1% quercetin diet for 14 days",pert
Psoriasis-Patient-M,pert
IFN/Vit-WT,ctrl
rd1_P6_rep3,pert
CF knockout LMCF CHN531,pert
blood_day6_patient6,pert
P85 dilated cardiomyopathy heart biopsy,pert
"DBA/2J ACU, Rep3",pert
WT2-iPS 2,ctrl
shRNA2-4-noDox-rep2,ctrl
mutant_POST_PDE_036,pert
multiple sclerosis_1,pert
"Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:19h",pert
tissue: Brain;	genotype: Npc1+/-;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
"fibroblast, control subject NF6 rep 1",ctrl
ApoD transgenic mouse rep_3 (CTG3),pert
Tendon;Teres minor_Non-lesional,ctrl
2120-03-A,pert
Control 14,ctrl
"heterozygous, control, biological rep2",pert
disease state: healthy;	tissue: tibialis anterior;	age at biopsy: 80;	Sex: male;	individual identifier: 2,ctrl
chip number: 16;	transfection plate: 3B;	target gene: EP300;	kd level: 0.72;	rin: 9.5;	transfection date: 2012-03-26,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu2,ctrl
"HCT116 cells with enforced miR-34a expression, technical replicate 1",pert
"MCF-10A cells, shRNA vector control",ctrl
"Pancreatic tumor cells, replicate 5",pert
Liver Tro2,pert
Sham 1,ctrl
Carbo Day14 (454L),pert
Subtype: RARS;	Karyotype: normal,pert
EE_IB_1_his_lcm,pert
Wild Type Time 0 replicate 3,ctrl
patient: 32054;	disease state: LGSC;	component: Invasive,pert
061J4_CTRL,ctrl
MiaPaCa2 rep-1,ctrl
Aldosterone-producing adenoma (APA5),pert
affected sister,pert
normal scar treated with hydrocortisone-3,pert
"wild type naïve CD4 positive cell, unstimulated, replicate 2",ctrl
CD4+ cells IL1RN wild type 1 month rep3,ctrl
wt-Gfp P2 replicate 1,ctrl
Strain: BALB/c;	Age: postnatal day 0;	Genotype: Ctip2 null mutant,pert
ctrl_518,ctrl
"FOXP3, WT, REP1, 72h",ctrl
"PCOS, biological rep 4",pert
01_NML,ctrl
NPC23,pert
brain_co_6M_rep1,ctrl
Differentiation of hES cells line VUB03_DM1 towards neural rosettes;	Neural precursor phenotype,pert
WT_TER119+_rep2,ctrl
24C-M4,ctrl
MDS patient 37,pert
genotype/variation: wildtype;	strain: C57BL/6;	age: newborn,ctrl
"SLE patient, 1011V1",pert
AA_Case9_CD8,pert
Bicalutamide_1,pert
Kidney_KO_baseline_rep3,pert
Pool stratagene human,pert
BIO586219,ctrl
4472-3 E2F3 Heterozygous,pert
"MAT1A knockout at 15 month age, peritumoral tissues, biological replicate 2",pert
IMR-32_pCMV_48hr_rep 2,ctrl
Adrenal CREMKO 0h batch 3 [AdKOh00.18],pert
MDS patient 27,pert
lung from Cmah KO mouse,pert
EA_Control4_CD20,ctrl
Bone marrow,pert
genotype: WT;	agent: DMSO,ctrl
9n,ctrl
"human failing LV myocardium, Ischemic9",pert
Obese Control-2,ctrl
testis,pert
Trastuzumab treated after 4 days (T3_2),pert
7d-IR-44,pert
F-IIP(NSIP)5_Cy3,pert
"Patient 112, baseline",ctrl
purified Gfp+ photoreceptor cells,ctrl
quadriceps_muscle_Wt_female_8wk_rep2,ctrl
Nerve_Diabetic_Vehicle_708,ctrl
WT3R2,pert
cell type: induced pluripotent stem cells,ctrl
Leg 23 Day control rep 2,ctrl
"FACS-sorted Lin-, c-kit+, Sca-1+ HSC from the bone marrow of PU.1 knockdown mice with targeted disruption of the distal enhancer (URE) –14kb upstream of the PU.1 gene.",pert
KO kidney pool 2,pert
SHR-vehicle pool sample1,pert
Hippocampus 2002 2 month Old,ctrl
"Normal ear skin from control mouse, biological replicate 1",ctrl
"NC1, biological replicate 1",ctrl
Infergen_24hr_rep3,pert
"siSCR ES, biological rep2",ctrl
"1833 shHMGA2, biological replicate 1",pert
11088 Normal Uninflamed descending colon,ctrl
Run7.aUa.010110d.SkMDbt1155D.CEL-DB stimulate,pert
NTG 2,ctrl
VIN_B109,pert
"BOEC, normal 8",ctrl
cell type: PBMC;	group: Patient;	patient treatment: Mtx,pert
S3,pert
patient: 267;	current medication: Mesalazine 800mg TDS;	birth date: 8/16/74;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: 5/10/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/15/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/20/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 9/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 5/1/03;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
mouse B6xCF-1  RNAi transgenic,pert
S015_Scz_M_56,pert
"patient 12, left arm treated with pimecrolimus until day 22",pert
HIF-1-/- control 3,pert
"genetic background: B6;	genotype/variation: wildtype;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",ctrl
m1-carcinoma5,pert
untreated Rb-/- MEFs-3,pert
"Human Umbilical Vein Endothelial Cell, Control, 0 hours",ctrl
"Control lung tissue, biological replicate 1",ctrl
27 year old female,ctrl
BCell_resting_sample3,pert
N4_Cy3,ctrl
TSC1KO QSC Technical Rep.2,pert
2i/LIF maintained Embryonic Stem Cell,ctrl
"rat hippocampus (CA1 region), sham, 18 months old, subject 10",ctrl
Control (shControl-1),ctrl
mouse model: 3xTG-AD;	gender: female;	age: 14 months old,ctrl
"Monuron-treated NRK-52E cells at 6h, biological rep 2",pert
Genotype: wild-type;	Age: 6-8 weeks,ctrl
Human skeletal muscle biopsy sample;	Patient #218 with NORM,ctrl
coc-16_A,pert
KU_43T,pert
"CFU-PreB colonies Wildtype littermate, biological replicate 1",ctrl
treatment: Vamp7 knockdown siRNA;	cell line: NTERA2/D1,pert
Human Non-progressor HIV Sample L015-CD8+ T cells,pert
3_DMSO-3,ctrl
A673 cell line that has been treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50).,pert
N51315,ctrl
Psoriatic arthritis PsA 14,pert
cell type: HVS-transformed T cells;	genotype/variation: ITK wild type,ctrl
cerebellum_wild type_6 weeks_replicate 3,ctrl
heart-30 months of age-resveratrol diet-biological replicate4,pert
"Control cells unstimulated, biological rep2",ctrl
FSH-NHM-2UA-S2,ctrl
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: EGFP,ctrl
PBMCs from Ulcerative Colitis subject,pert
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 37;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p29;	strain: E14,pert
"Du145-PCAT1 cMyc siRNA #3, replicate 2",pert
"Acute Myeloid Leukemia, sample 17",pert
Epithelials cells isolated from mouse mammary glands with PtenF341V expression,pert
n8t6h,pert
strain: ICR/B6D2;	tissue type: back skin,ctrl
"bipolar disorder, BA10-51",pert
ccRCC tumor of patient T84,pert
"schizophrenia, BA46-12",pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: gun shot wound,ctrl
48A,pert
Strain: C57BL/6;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal),ctrl
"MCF7, non specific control, biological rep1",ctrl
"Distal, Small Intestine 17 days old",ctrl
38A;pretreatment;female;breast tumor,ctrl
SKMEL28_t48h_rep1,pert
NSC_FBS_V3,ctrl
"CD1, E15 pregant mouse",pert
"Gender: Female, Age: 27, BMI: 21, Tissue: luteinized cumulus cells",ctrl
"age at diagnosis: 59;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N1a;	er: 1;	pgr: 0;	dfs-month: 25;	dfs-event: 0;	distant metastasis: 0",pert
Normal cortex of patient 325,ctrl
sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta;	agent: control (saline);	time: 14d,ctrl
"Prkaca+/- caudal vertebral bone, rep3",pert
"A pool of RNA from lung from three female mice with SM22-rtTA transgene on an FVB/N background, raised at Denver altitude (nearly normoxic), fed doxycycline for 8 weeks.",ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 70, stage IIB, HPV negative",pert
midbrain_wild type_24 weeks_replicate 1,ctrl
Sham 14 replicate 2,ctrl
1056-03-A,pert
A549 siRNA FAM60A CNTRL 2,ctrl
"liver, PPAR KO_ctr_115",pert
E14-99+/-vector-1,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),pert
Kidney_saline_6,ctrl
"Gastrocnemius muscle, WT mouse",ctrl
Individual_4697_PP_sample,pert
ILD Study Number 908,pert
LNCaP EtOH rep 2,ctrl
HDAC2 KO E17.5 Ventricle 2B,pert
skin total,ctrl
Invasive cancer originating in IPMN 3,pert
alveolar macrophage from bronchoalveolar lavage,pert
PBMC CCa T1,pert
11_PAH,pert
42A;pretreatment;female;breast tumor,ctrl
E14 - Lis1cko/ko 1,pert
"Mesodermal Precursor Cells derived from hES cells line VUB03_DM1, biological replicate 1",pert
tissue: Murine small intestine (jejunum);	genotype/variation: VillinCreERT2+_Brg1fl/fl,pert
S-IIP(UIP)16_Cy3,pert
3886-2 E2F1 Null,ctrl
FHCRCAML169016,pert
umbilical cord tissue; low gestational age,ctrl
mouse colon_hnf4control_rep2,ctrl
Ishikawa_HighDose_BPA_24h_rep2,pert
cell type: endometrial stromal cells;	growth phase: early passage,pert
Cell line: SUP-B15,pert
normal 1455,ctrl
12 hr KLF4 Time Course Control,ctrl
"Pancreatic tumor cells, replicate 2",pert
"brain, brainstem: PB4_e1_le1",pert
WFS1 KO USHT_06_333_wt,pert
coc-42_A,pert
HC-KO-28A,pert
"Spleen homogenate, uninfected",ctrl
Mnk_3133-S-B,ctrl
chip number: 7;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.7;	transfection date: 2011-03-29,pert
"SWR/J SAL, Rep3",ctrl
H19 HA 12h 3,pert
"strain background: 129/B6 mixed;	cell type: Ada3FL/FL MEF, immortalized;	infected with: control adenovirus",ctrl
gender: Male;	age: 56;	post-mortem delay: 16.5h;	ph: 6.4,pert
HIF-1-/- control 1,pert
Primary hepatocytes isolated from Donor 6 treated with Wy14643 for 24h,pert
"24hr non-specific siRNA, 16hr 10nM DHT treatment replicate 1",ctrl
V5-P075,pert
siCtrlVeh24h_3501,ctrl
Pancreatic Sample 7-Tumor,pert
eDeaf,pert
female;	29 yr old;	Hispanic,ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; PtenloxP/loxP,pert
IM16_case,pert
Sex: female;	Age at operation: 76 years;	Site: thigh;	Size in cm: 38.5x17.5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Preglaucoma control rep5 (OHN),ctrl
"NALT infected with wild type 90-226, biological rep4",pert
FoxM1 A,pert
Normal heart_G38,ctrl
"brain, cochlea: [13] Sample #13_le1",ctrl
"Distal, Small Intestine 17 days old",pert
TSC1KO QSC Technical Rep.1,pert
HA98-146A,pert
Brain CD8 T cells that are IL-10- rep2,pert
C57BL/10-SJL.Dysf QF replicate 2,pert
Strain: C57BL/6;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal);	C57BL/6 Winnie G9492A,pert
"D2_non-transgenic mice, lung tissue",ctrl
CUTLL1 GSI-rep2,ctrl
Gene expression profiling of Phgdh knockout embryo wild3,ctrl
whole tissue section from case 823,pert
IkL/L mouse thymic tumor,pert
WT KLS 1,ctrl
CTCF-depleted fully-grown GV oocyte from transgenic mice,pert
"SLE patient, 1020V1",pert
ethanol_ethanol_16,ctrl
A HID I_B048,pert
"Wild-type MEFs, biological rep2",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 110min;	race: Black/African American;	Sex: Male;	fstl-1 (ng/ml): 222,pert
"human nonfailing LV myocardium, NonFailing12",ctrl
"Nrl-ko-Gfp, Gfp+ photoreceptor cells",pert
NPCs derived from healthy control subject,ctrl
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject K,ctrl
CD34+ cells of CML patient after 7 days of Glivec therapy,pert
"human nonfailing LV myocardium, NonFailing4",ctrl
HCC015T,pert
Individual_4269_PP_sample,pert
Mock-treated A549,ctrl
061J0_CTRL,ctrl
FHCRCAML3653,pert
cell type: E9.0 embryonic cardiac progenitors,ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: mutant channel;	agent: untreated,pert
Control liver_4 pm_rep2,ctrl
colonoscopic biopsy from adult with affected colon with Crohn's disease,pert
Muscle KO Adult 0706,pert
GIST_KIT_3,pert
race: african american;	age (years): 65;	stage: IC;	grade: 2;	histology: endometrioid,pert
15d control_Pool 9,ctrl
EE_IC_2_cauc_lcm,pert
cell line: ARPE-19;	clone: 25;	genotype: Knockout,pert
3789-scrape,pert
cerebellum wild type 6 month replicate 2,pert
Liver from 1 year old- TAK1 KO mice,pert
"RORalpha1delDE, 1",pert
Subject #8035-8hr Postinfection,pert
fibroblast,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 142Q S25_3 months_replicate 1,pert
"Autoimmune pancreatic islets, day 3 cyclophosphamide treatment, rep 3",pert
patient: 205;	current medication: Pentaza 3g/d;	birth date: 6/8/79;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/03;	diagnosis date: 8/30/04;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 15;	crp: 19;	hb: 110;	wcc: 5;	neutrophils: 3;	albumin: 43;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: NEW;	smoking status: ex;	smoking start date: 1/1/85;	smoking stop date: 3/1/03;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
age_years: 56;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
SeroNeg-12,ctrl
SCC25+doxorubicin_rep1,pert
Uninjured Control - Epicenter Rep1,ctrl
"human failing LV myocardium, Ischemic92",pert
H1med,ctrl
Parp-2 KO_bone marrow cells,pert
Normal_2010,ctrl
Five-week-old C3H/HeN female mice liver,ctrl
EE_IA_1_aa_lcm,pert
482 cells scrambledshRNA rep2,ctrl
"Knockout Heart with no treatment, biological rep1",pert
umbilical cord_nobpd: 4D,ctrl
Brain CD8 T cells that are IL-10+ rep1,ctrl
Normospermic individual: Sample N9,ctrl
"NC1, biological replicate 6",ctrl
Liver_hyperglycima_no.1,pert
ES cell RNA,pert
liver endothelial cells,ctrl
L4/L5 dorsal root ganglia from adult rats (2 months old) 7 days after SNI surgery,pert
treatment: PLX4720;	time: Day3;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
ATCC CRL-1555,ctrl
"Liver, Normoxia 3",ctrl
01N1E: new onset sJIA,pert
rd1_P4_rep1,pert
Cerebellum_transgenic nuclear exclusion signal Htt exon1 142Q A39_10 months_replicate 2,pert
"Pancreas from adult Rkip-1 KO mice, biological replicate 2",ctrl
EA_Case19_CD20,pert
cadmium_16hr,pert
"whole right lung, 3 weeks after a bleomycin dose of 100mg/kg, given by osmotic minipump.",pert
LJMJDW16,pert
Aurka_R_+Dox_rep1,pert
brain_DLPFC_bipolar B_mr279,pert
Anaplastic Thyroid Carcinoma,pert
age at diagnosis: NA;	diagnosis: Within normal limits;	tumor grade: NA;	mininal stage grouping: NA;	t (extent of primary tumor): NA;	n (lymph node metastasis): NA;	er: NA;	pgr: NA;	dfs-month: NA;	dfs-event: NA;	distant metastasis: NA,ctrl
At Risk: +;	Age: 10;	Sex: F,pert
mouse embryonic stem cells,ctrl
Frontal_Cerebrocortex_Deltamethrin_1mg/kg_6hr_rep6,pert
expression array - BRAIN 2,ctrl
"Ishikawa cell line, BPA, 1uM, 8hr",pert
minor salivary gland,ctrl
C_Kin_1,pert
0191-01-C,ctrl
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: wild type,ctrl
Epithelials cells isolated from mouse mammary glands with Pten deletions,pert
V5-P266,pert
Saline treated mouse gallbladder 3,ctrl
"ME16C, 12h, 0.5uM DOX B",pert
primary leukemic cells purified from peripheral blood,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.626;	OD280: 0.845;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 75;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"All mice (C57BL/6) were free of Helicobacter species, housed in a specific pathogen free facility with 12-h light/dark cycles with free access to standard food and water.",pert
HUVEC_control_rep2,ctrl
BTBR-ob/ob;	Liver ;	Age: 14 weeks;	Gender: Male,pert
RV16;	Age = 18;	Sex = M,pert
VEC A,ctrl
human_hepatocyte_400uM_Ciprofloxacin_24hr,pert
Genotype: B6.Pdss2loxP/loxP;	Age: 213-day-old male;	40 mg liver used for RNA extraction,ctrl
Replicate 1 - CDB4124,pert
Diagnosis: AML M0;	Age: 61y ;	Gender: Female;	Blast %: 94;	Source: PB;	Cyto: tris4;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
genotype: Villin-Cre + / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 81,pert
Ngn3 EB3 ON replicate 1,pert
N40645,ctrl
"Overexpress TFPIbeta, biological rep. 3",pert
Rap1 knockout mouse embryonic fibroblasts,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.678;	OD280: 1.857;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 352;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
gender: Male;	cell type: hESC H1 cells;	genotype/variation: B2M KO,pert
4-HPR_LUNG_2,pert
FHCRCAML169011,pert
cell type: Endothelial cell;	agent: ethanol;	dose: 0.1%,ctrl
con-37_C,ctrl
"hMSC-Tert, control siRNA, undifferentiated",ctrl
"atRA RARaKO, set 3",pert
OE-SOX2_2,pert
"imr-32,ccnd1 siRNA,t=48,3",pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: control;	time: 12hr,ctrl
Thyroid_papillary carcinoma 86,pert
RENT1-1,pert
NOD2-L1007fsinsC_0h_MDP_biological replicate 1,pert
KPL4 + Medi5117,pert
MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 8hr,pert
GM19238_Kd_JUND_2,pert
5257 UC Uninflamed sigmoid colon,pert
"Epidydimal white adipose tissue from WT after 16 weeks of high fat diet feeding, replicate 3",ctrl
APPsa_R6_rep3,pert
PancreaticSample33-Normal,ctrl
Monocyte-RCC-untreated-2,pert
Zfx wt MA9 cells + 4-OHT [10977],pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 33;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
01MLE_Oligo,pert
"Fibroblasts from UIP histology lung tissue, IPF-22",pert
07_C57_KO,pert
E14 - WTMixA 3,ctrl
[Aiolos]-2,pert
AZ-521_uninduced_18h_rep2,ctrl
"schizophrenia, BA46-31",pert
"BOEC, at_risk 12",pert
"human failing LV myocardium, Idiopathic84",pert
shRNA control R2 T5,ctrl
"muscle, wild type",ctrl
"liver, QH2, 14 months",pert
GIST Pre Treatment Biopsy 50,pert
C2C12 myotubes 100uM H2O2 rep 3,pert
"AD_HI, biological rep3",pert
Megacaryocyte-Erythrocyte Progenitors,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu3,pert
HSC-Evi1-KO-2,pert
OSCE-6T,pert
DES D1,pert
20C-M4-D,ctrl
HCT116 with NFX1-91 knockdown,pert
mutant_embryonic brain_posterior,pert
whole right lung,ctrl
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P15;	genotype: Igf1 +/+,ctrl
Cancer 2,pert
3748-lcm,pert
RatLung_H72h_1,pert
Muscle 50 eccentric contractions 12 hours KO Adult 0706,pert
race: caucasian;	age (years): 60;	stage: IB;	grade: 1;	histology: endometrioid,pert
IFC 05,pert
abl siEZH2 at VEH rep 2,pert
Human prolactinoma 240,pert
Strain:C57BL/6J;	Gender: male;	Age:2-3 months;	Tissue:heart,ctrl
Knockout cre_ppar_beta_floxed_rep2,pert
Tiam1 silenced Y79 cells,pert
Human prostate cancer primary culture C28dx,pert
Muscle JDM (YJD-JDM-18UA-s2),pert
Heart_WT_4,ctrl
Rapamycin treated_1 3h,pert
Lung dnCREB-PBS replicate 2,pert
4013-3 E2F2 Null,pert
EB_07_19d_155_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"cerebellum,6weeks,WT",ctrl
C_AN12137_F,ctrl
"Pancreas from adult WT mice, biological replicate 3",pert
untreated_6hr,ctrl
Liver_TAK1KO_Rep4,pert
OE33 siRNA rep1,pert
tissue: primary skin cells;	genotype/variation: Adam10 wildtype,ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: M;	transfectant type: stably transfected with scramble control,ctrl
mouse_islets_ctrl_01,ctrl
"Neuroretina 8-week lean non-diabetic, Biological replica_4",ctrl
GEIM45-NORM,ctrl
4h 4OHT-treated-sample2,pert
Wildtype_TAC_Rep4,pert
Whole testis RNA from Crem-/- mouse #143 at 0h,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
colon_C57mouse_6weeks_rep1,ctrl
"Normal T-cells, CD3+, donor 2",ctrl
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 12/1/03,pert
RNA from HCC_12T,pert
Tobacco_abuse_2,pert
"A549, +TNFα, control siRNA, rep1",ctrl
Individual_4089_PN_sample,pert
"24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
autism with FMR1-FM AU066704,pert
primary CD4+ T cells from spleen and lymph nodes,pert
180C3,ctrl
VIN_B116,pert
"C57BL/6J female number 2, untreated control ear (#2_Wt-C-4)",ctrl
"GFPMYC negative GC B cells, Biological replicate 3",ctrl
"Patient 13, baseline",ctrl
cell line: SA-01;	treatment: with DMSO (0.1 % final),ctrl
healthy control H02,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.86575,pert
Ctrl PGC rep2,ctrl
Healthy individual of twinpair #10,ctrl
HCC PBMC_sample 6,pert
Healthy Donors 1,ctrl
C_AN01125_T,ctrl
renal_vesicle_wild_type_2,ctrl
"SKO-transduced MEFs, Vc treated, lysed on D6",pert
tissue: colon;	genotype/variation: HDAC2 KO,pert
CD4DecTp1-1,pert
Kidney from mice treated with 7 daily ip injections of vancomycin at 400 mg/kg,pert
P59 Non failing heart biopsy,ctrl
KO - 3 mo - repeat 1 - Cy3 - mAdbID:74592,pert
28A;pretreatment;female;breast tumor,ctrl
Spleen and lymph nodes,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 55;	gender: m;	treatment: NSAIDs/colchicine,ctrl
CD11b+Gr1+ cell sample_1 (derived from wild type mouse),ctrl
PGC-1a-/- rep2,ctrl
MB231 PIAS1 shRNA-SCM,pert
"cell line: MDA-MB-231;	disease state: Breast adenocarcinoma, estrogen receptor-negative;	genotype/variation: MTDH_WT_KD",pert
Heart_KO_3,pert
Patient no. 7: treated,pert
Primary hepatocytes isolated from BL6 mouse strain treated with Wy14643 for 6h,pert
NTG replicate 5,ctrl
Postmenopausal female. Estradiol treated. Patient 23.,pert
"ZR-75-1, 12h, sham B",ctrl
"Untreated TG2 knockout NB4, biological rep2",pert
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 9;	tissue: GIST Tumor,pert
Sample ID: TP26;	Twin Pair ID: CCN4.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 29;	Current Age (2007): 32;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
"MAT1A knockout at 3 month age, biological replicate 3",pert
Muscle PCOS 1,pert
cell line: HEK293;	sirna: control;	condition: confluent cell density,ctrl
P4_PMP22KO_3,pert
"209, ADIPOOSE TISSUE, Before",ctrl
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 3;	gender: male,pert
rtTA-Dmrt5 day 9 +Dox,pert
180D1,pert
agent: Nickel 140 µM,pert
AA_Control3_CD8,ctrl
caudate nucleus,pert
genotype: E-mu-BRD2;	cell-type: resting;	splenomegaly: none;	Ig clonality: polyclonal,pert
Spleen_wt_1m_rep3,ctrl
A3_tumor,pert
microdissected breast cancer cells from case 849,pert
"YPFH cells from M1, wild type control, biological replicate 3",ctrl
"Ulcerative Colitis (60 year old caucasian male, SAK_1305668541)",pert
Clinically localized primary prostate cancer P4,pert
THRA aI mutant + vehicle replicate 2,ctrl
wt Ang3,pert
ARF1 siRNA knockdown MDA-MB-231 sample 3,pert
T4B-LU,pert
Clinically localized primary prostate cancer tissue pool PX1,pert
Human Neural Stem Cell Line F3 Wild Type (replicate),ctrl
SZ19,pert
"Mice_non trans, biological rep4",ctrl
"NALT infected with wild type 90-226, biological rep1",pert
Superior Frontal Gyrus from a 2year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
sample: #3;	subject: Control case #2;	brain: T-346;	age: 84;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
pediatric AML GP5,pert
CLL 11-18 Control,ctrl
M238_R1_A_PLX,pert
Rosi-treated diabetic-2,pert
S259A-1,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: Rosiglitazone,pert
224 Day 3 siMut10 transfected biological rep3,pert
01LQE: normal control,ctrl
KGN,pert
patient14,pert
mouse liver D2,pert
"Skin biopsy, normal",ctrl
CCC103A,ctrl
U133A_B1,pert
5091212024_G,pert
"WM1205, no treatment",ctrl
Strain: C57BL/6JNIA;	Age: 15 months;	Gender: Male;	Tissue: Whole hippocampus,pert
3587-ls,pert
MDS17,pert
Wistar rat liver following animal exposure to orotic acid for 14 days,pert
mouse intestine pLagl2 wild type 2,ctrl
DS fibroblast,pert
HepG2_VehicleB_24hr,ctrl
female_alcoholic_337,pert
"Fibroblasts, formoterol, time 6h, patient 2, rep 1",pert
siPsmd14 replicate1,pert
"Mouse bone marrow-derived mast cells treated with IL3+SCF, rep 5",pert
KL3_muscle_control,ctrl
"Spi-60, biological rep 6",pert
Wildtype 1 (jos1523),ctrl
Ishikawa_HighDose_BPA_8h_rep1,pert
KU_42N,ctrl
"129P3/J ACU, Rep2",pert
RE550_DU145_Un3,ctrl
subject id: c4;	infection: control;	status: control;	tissue: whole blood,ctrl
IKK2 WT tumor,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: C;	experimental sample name: PC5-R,ctrl
strain: C57/Bl6;	gender: male;	genotype: Egr-1 knock-out;	age: 42 days;	tissue: retina,pert
"GATA6 knockout, biological rep 3",pert
"human failing LV myocardium, Ischemic43",pert
patient E1614,ctrl
siRNA-1-COLLAGEN,pert
Pax_C5,ctrl
EB_6_19d_312_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell type: Primary hepatocytes;	donor: 4;	agent: Wy14643;	time: 6h;	gender: Female;	age: 54 years old,pert
"siNC-BMSCs , biological rep2",ctrl
"Uninfected, replicate 1",ctrl
WT - Cre Control - 3 mo - repeat 3 - Cy5 - mAdbID:74590,ctrl
P5B Progranulin-cerebellum,pert
HCT116 PTEN +/+,ctrl
Mut3,pert
C57_HF_3,ctrl
Strain: C57BL/6J;	Gender: male	;	Age: day3;	Genotype: KO;	Tissue: brown fat ,pert
Skinbiopsy_96hoursnickel_controlsubject_k2,ctrl
Healthy control_sample14,ctrl
"P201 HCT-116, DNMT wildtype, DMSO-treated",ctrl
6L,pert
CSTB KO_cerebellum at P30,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA)",pert
control E14,ctrl
Atm+/+ untreated B,pert
"Control siRNA - 5 days osteoblast differentiation, rep3",ctrl
@52055800697862121408403718160373,pert
"-Rosi, -PPAR, 2hrs",ctrl
"Sodium arsenite added to food: None; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: 100 ppb, 5wk",pert
"24hr Hic5 siRNA, 16hr 10nM DHT treatment replicate 1",pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATM-1,pert
scc_11,pert
remitted schizophrenia patient  S14,pert
PTC BRAF mut 14,pert
Control 2 medium only,ctrl
diagnosis: UIP/IPF;	fvc-group: FVC3;	tissue: lung,pert
HEL cell line_JAK2 knockdown (Jak2-9 shRNA),pert
Parkinson's disease sample x106,pert
MCF7 cells treated with 2uM Doxorubicin for 24 hours Array 2,pert
"129P3/J SAL, Rep3",ctrl
Mouse old brain C30-Br-2,ctrl
saline ctr003,ctrl
Human hepatocellular carcinoma cell line infected with GFP protein (control) 3,ctrl
MRL/MpJ heart left ventrical (LAD ligation 60 day),pert
embryonic stem cell,pert
strain: F1 littermate of TCL1 (C3H/B6) and ID4+/+ (CD1) mice;	genotype/variation: ID4+/+TCL1-tg;	tissue type: spleen;	cell type: CD19+ B;	age of the mice: 1 month old,ctrl
"Aorta, Ang II 14d, #4",pert
E40C,ctrl
"Postnatal day 11 Cerebellum, wildtype; replicate 2",ctrl
Muscle JDM (YJD-JDM-16UA-s2),pert
"Rat liver, treated with NMF, 1000 mg/kg in saline i.p., extrated 48 hours after treatment, biological rep3",pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB without doxycycline,pert
"BT474-J4 breast cancer cell line, DMSO",ctrl
MDS patient 77,pert
cell line: KJD;	transformation: SV40 virus transformed;	cell type: epidermal keratinocyte,ctrl
N51783,ctrl
RNA from HCC_8N,ctrl
C57 24 air 1,ctrl
NTB_heart 3,ctrl
WT-smoke-high-5 month+1d-R3,ctrl
HepG2_control rep1,ctrl
cell line: REH E/R positive leukemia;	treatment: treated with specific E/R targeting shRNA,pert
Muscle_control_2,ctrl
Age: 46;	Cycle: Luteal;	BRCA1/2 mutation: BRCA2 C5910G;	Family History: Yes,ctrl
WT_P14_D3_Effector,ctrl
MIY_day_5-3,ctrl
mESC_undifferentiated_wild type_rep1,ctrl
subject: 37;	disease: CP;	muscle: ST;	gender: M;	age: 8.7;	gmfcs: 2;	popliteal angle: 95,pert
N6_Cy3,ctrl
CF (D508) subject4,pert
"schizophrenia, BA46-47",pert
EosWTCD25+#2,ctrl
Wildtype 1 (jos0532),ctrl
"Normal subject (28 year old caucasian female, SAK_1265909540)",ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 2",pert
gender: female;	age (years): 60;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
ILD Study Number 774,pert
"WT, PR04M009v0",ctrl
MOLM14-shGSK3A-Construct6-rep2,pert
Placenta_PE(LO)3 with Cy5,pert
PDAC_T_104,pert
V5-P446,pert
Mouse fetal liver_E14.5_WT_rep4,ctrl
Mtb infected-42d-6,pert
"male, 275-300g",ctrl
PGA-MAH-OuJAir-1aAv2-s1,ctrl
sMPNST cells with Brd4 shRNA induction,pert
"Normal subject (42 year old caucasian male, SAK_1254621275)",ctrl
OVCAR3_rep1//CD157_DS,ctrl
pSuper vector control 1,ctrl
Wild-type_macrophages_0h,ctrl
n22,ctrl
RA3,ctrl
tumor cell line HepG2 with knockdown of HIF-1α rep4,pert
FHCRCAML4653,pert
"Patient  H, lesion, 4 week",pert
DEX1_6HR,pert
"LCL GM19238, Kd HCST, 72hrs",pert
CME-Ctr_LaminA3d-1MA-S2,ctrl
Mening SWB WB NP 3b,pert
condition: Psoriasis;	patient: 292;	tissue: LS skin biopsy;	kit: Ovation,pert
Cmah KO_kidney_2,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 76 years,ctrl
NuLi cell line biological rep3,ctrl
Human prostate cancer primary culture C3dx,pert
Cell line MCF-7_control_expt1,ctrl
Hunk WT rep2,ctrl
lung Endothelial cells,ctrl
11083 Normal Uninflamed descending colon,ctrl
age_years: 44;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
cell type: CD43+/41+/235+ progenitors generated from Trisomy 21 iPSCs,pert
Zfx wt MA9 cells + Vehicle [10980],ctrl
CA96-116B,ctrl
HeLa_01-04-05 TP1_HG-U133A_2_Page_IMFGN0023_05-1_HSF1-2,pert
11_0037C_Day1_31,ctrl
PGA_MI_nilv_1w_670,pert
KO - knock-out Treated - 12 hrs - repeat 1 - Cy5 - mAdbID:61759,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 2h,pert
NLGN3_3,pert
siHIRA 2,pert
Striatum of 8-10 week old 129P3/J mice,pert
AGS control biological rep 2,ctrl
iFGFR1 mammary gland 24 hr AP20187,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 69;	gender: m;	treatment: NSAIDs,ctrl
lung_myd88_mock_repC,pert
ESC_Zfx-null_Replicate1,pert
MIG control biological replicate 3,ctrl
cell type: peripheral blood mononuclear;	disease state: multiple sclerosis,pert
HT-KO-8B,pert
AZ-521_doxycycline_24h_rep1,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 72;	tissue: Blood,pert
4 hour tunicamycin wild type D,ctrl
01J47_PolyRF-,pert
"Patient  J, lesion, 1 week",pert
siGL3E2 2,ctrl
MDS35,pert
UC Uninflamed terminal ileum,pert
age: 43;	sex: M;	disease status: control subject;	Filter number: 80;	Usage number: 4;	Exposures: 3,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Staph aureus,pert
01_NOR,ctrl
LC1026ni,pert
shRNA4-1-noDox-rep3,pert
Lung-sarcoidosis-rep5,pert
pLenti transduced cell lines overexpressing CDH1a,ctrl
20SAGEA2,pert
Wistar rat liver tissue following animal exposure to orotic acid for 3 days,pert
RV64.04_CONTROL_day25_Slide50,ctrl
cell line: HEK001,ctrl
sample: #1;	subject: Control case #1;	brain: T-199;	age: 82;	sex: Female;	region: Dorsal motor nucleus of the vagus,ctrl
liver_STZ treated diabetic_rep6,ctrl
"siDsRed-1, biological rep1",ctrl
KO MEF,pert
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: C57BL6-STAT1<tm1Dlv> (STAT1KO);	treatment: stimulated for 3 hours with medium alone,pert
Astrocytoma_4,pert
Testis,pert
A_AN00764_C,pert
"seminoma specimen, pT1, patient age: 29y",pert
human esophageal squamous cell carcinoma cell line_KYSE270,pert
CH1811,ctrl
TP06-612,ctrl
White adipose tissue in wild-type mice (rep2),ctrl
CLL 69-04 Control,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 7 hours,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: scrambled;	transfection time: 48h,ctrl
Biopsy 7 from cystectomy 15,pert
"shControl, normal growth, replicate 3",ctrl
"WI-38 cells, at 24 h after exposure to 0.1 uM BPDE, biological rep2",pert
Human Neural Stem cell line(Maternal transcript),ctrl
"10mg/kg/day PFOA, Rep 2, Block 1, liver (high dose)",pert
HL-60 cell line infected with GSK3A Construct 6 shRNA,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#2,pert
"AG825-treated, Sham UV, Replicate B",pert
human_hepatocyte_gatifloxacin_donorA_24hr_prep1,pert
LNCaP-control,ctrl
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: a SD supplemented with 100 mg/kgchow resveratrol ad libitum,pert
5214 UC Inflamed descending colon,pert
23C-M4-D,ctrl
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_5;	fev1 (% predicted): 44;	fvc (% predicted): 61;	medication: Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn;	cell type: CD8+ T-cells",pert
Sample Group: control; Gender: male; Age: 50; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
"RES-enriched Grape extract group, 12 months, patient number 62",pert
Psoriasis-6 baseline,pert
Peripheral blood mononuclear cells;	TTF=135min;	Race=White;	Sex=Male,pert
sirna: control;	plate: plastic;	cell line: MCF10A,ctrl
KO_IL-6_100_rep1,pert
Normal_Kidney_Biopsy_8,ctrl
cell line: SNU-398;	cell type: Hepatocellular carcinoma (HCC);	genotype/variation: scrambled control,ctrl
Prostate Cancer_MS 36C4,pert
tetO-Satb2 #3 +DOX,pert
"Control_TA, C3",ctrl
WT P10 replicate 3,ctrl
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with osteoarthritis",ctrl
strain: CD-1;	age: 20 week;	genotype: Wild type;	tissue: lung,ctrl
H21 Ctrl 24h 1,ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 49;	tissue: Blood,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 13.2375085557837;	age of psoriasis onset: 8,pert
Cpr-low_pool 1,pert
shCDK8_Time_30_1,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day1,ctrl
patient: 127;	current medication: Prednisolone 10mg Heparin Questran Gabapentin FA;	birth date: 9/9/36;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: Pseudomembranous Colitis;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
MLL_00107,ctrl
KO 0h TPA rep1,pert
Skeletal muscle tibialis anterior (TA) from Normal wild-type mice,ctrl
"twin pair: #2;	individual: diseased individual, inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",pert
Reference RNA e17.5 embryo,ctrl
V5-P053,pert
NSC_FOXO_NULL-3,pert
CD34+ cells isolated from the bone marrow of an MDS patient,pert
hOB695_shEV_2hr_IR,ctrl
Monocyte ATV rep 3,pert
PND28 Rat Testis_Rat230-2_6hr Corn Oil_Animal#34_04005,ctrl
"breast tumor epithelium,9",pert
A549_Cisplatin_rep3,pert
BL Day 1 siMut12 transfected biological rep2,pert
agent: Cadmium 0.55 µM,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119-;	genotype/variation: wildtype,ctrl
"Brain tissue from Fisher 344 male rat, Animal #270, 5mg/kg D-Serine",pert
siRNA-3-COLLAGEN,ctrl
Wild Type nr 658,ctrl
U937_ROS_curcumin_18h_rep1,pert
"Control cell, Replicate 1",ctrl
Untreated WT - repeat 1 - mAdbID:102765,ctrl
Intronic WT control rep2,ctrl
Globin_S1,pert
MDS patient 20,pert
"MEKi 4 days, biological rep3",pert
"SBC-5 cells, siEGR4 (target), 24 hr after siRNA, duplicate sample 1",pert
Brain (Inferior Olivary Nucleus)_Control_case1,ctrl
colon_IBD_923,pert
Testis,ctrl
Md02h028,pert
Ctr MCF10A.B2 1,ctrl
Reh_mock1,ctrl
WT KLS 2,ctrl
mouse cerebellum at P30 wild type 3,ctrl
"118, ADIPOOSE TISSUE, After",pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 26;	maternal age: 33,ctrl
Individual_3171_PN_sample,pert
"AD_FC, biological rep13",pert
WT biological replicate 1,ctrl
THP1-shControl-rep3,ctrl
whole blood_100265,pert
Patient: I;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
mouse colon_hnf4control_rep3,ctrl
KL1_muscle_control,ctrl
"human failing LV myocardium, Ischemic65",pert
30A;pretreatment;female;breast tumor,ctrl
cell line: RUES2;	cell type: human embryonic stem cells;	transduced with: control shRNA;	time point: Day 5 of cardiac differentiation; cardiovascular progenitor cell stage,ctrl
sample =XCGD1 treatment=Stimulated time=180 (min),pert
HTB58_antiEvi1siRNA_2,pert
Diagnosis: AML M4;	Age: 67y ;	Gender: Male;	Blast %: 75;	Source: PB;	Cyto: tris8;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
wild-type_CITCO_rep2,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),ctrl
Tumor-KO-rep2,pert
PA-1+(2),pert
"Patient 4, control tissue",ctrl
HeLa cells transiently transfected with control siRNA,ctrl
human prolactinoma,pert
Human fibroblast,ctrl
"Wildtype, 129 mouse pineal glands from postnatal day zero.",ctrl
"C57BL/6J Acute morphine treated, biological replicate 2",pert
CF knockout HMCF CHN539,pert
Cav1KO 1762,pert
brain_co_14M_rep3,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 6h ID283,pert
Muscle WT Aged 12171,ctrl
"endometrioma, patient M3",pert
H4-II-E-C3_high_rep3,pert
"liver, WT mouse, sample WT6",ctrl
Diagnosis: ET/AML;	Age: 51y ;	Gender: Male;	Blast %: 70;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: No data,pert
Dental pulp cells control sample triplicate 1,ctrl
X_p8_rep1,pert
shRNA2-4-noDox-rep3,ctrl
age_years: 43;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
"A673 treated with Puromycin for 5 days with concentration of 0.09 uM (EC50), biological rep3",pert
Md02h022,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
Pt34_Pre,ctrl
K562 cells CREB Knock-out,pert
tissue: lung;	genotype/variation: Tmem1002loxP/2loxp,ctrl
Psoriasis-1 baseline,pert
4mo wt3,ctrl
wild type E12.5 fetal liver derived megakaryocytes,ctrl
treatment: PLX4720;	time: Day1;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
Mouse WT mandibular molar [ABH_25A],ctrl
WT 2 Quadriceps,ctrl
Ngn3 EB3 OFF replicate 1,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 42 dpi,pert
murine lymph node,ctrl
tissue: ankle joint;	genotype/variation: MMP-8 wild type;	strain: C57BL/6,ctrl
disease state: psoriasis;	group: baseline,pert
VehVeh2,ctrl
EB_2_5d_219_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Cal51 cells,ctrl
A516 MI 7 day,pert
Normospermic individual: Sample N7,ctrl
RAW_0.7mM_HOCl_#1,pert
HCC003N,ctrl
Undifferentiated Dicer +/- (D4) ES cell line replicate_2,ctrl
IMR90 cells stably expressing H-RasV12 treated with vehicle,ctrl
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: vehicle,ctrl
cell line: BxPC3;	genotype: wild type;	beta-catenin gene (ctnnb1): wild type,ctrl
Control Day7 (420R),ctrl
Aurka_R_-Dox_rep2,ctrl
"Liposarcoma culture from tumor 394, untreated",ctrl
Human skeletal muscle biopsy sample;	Patient #110 with NORM,ctrl
age: 29;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Keratinocytes treated with EphB2 for 48h,pert
36SMOKEH,ctrl
Nrl-ko-Gfp P2 replicate 2,pert
"RNF40 siRNA - 5 days osteoblast differentiation, rep1",pert
MEFs carrying a tet-inducible Pten transgene,pert
TN 6,ctrl
Mouse fetal liver_E14.5_KO_rep1,pert
heart of mouse subjected 2 week to chronic intermittent hypoxia (2B),pert
Mnk_3176-R-B,ctrl
LT345 wild-type untreated,ctrl
Kidney_Aqp11+/+_P7_3-1,ctrl
SLE CD4 T cells 7,pert
Hippocampus 2003 2 month Old,ctrl
pooled reference mRNA from 4 harvests of MCF-7 cells,pert
gender: Female;	age: 33;	cell type: PBMC;	individual: Patient 108;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
3583-lcm,pert
PancreaticSample7-Tumor,pert
Healthy control 15,ctrl
"Hdh knock-in embryonic stem cells, Q20 line, biological replicate 2",pert
Vit A sufficient 4b,ctrl
01LN8: new onset sJIA,pert
KD control 13A,ctrl
"Nuclear RNA, HuR WT MEFs",ctrl
KM_028N,ctrl
cerebellum_wildtype_2,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N2, M0, G4",pert
2092N,ctrl
Mouse old brain w/ a-tocopherol aT-Br-3,pert
"shControl, normal growth, replicate 2",ctrl
liver_Wt_female_35wk_rep3,ctrl
Ribavirin Treated Cells 1,pert
HCC1937_2,ctrl
original diagnosis: ERA;	cell type: Peripheral blood mononuclear cells,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 40 yr;	population: white,ctrl
"Lesion Skin, LS-2",pert
cell line: M12;	treatment: control,ctrl
PTEN deletion Replicate2,pert
PBMC from T cell LGL leukemia patient #130 (TLGL130),pert
H2009_shPTK7-1,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 23;	gender: male,pert
GIST_KIT_13,pert
01JME: new onset sJIA,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch1",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 3,ctrl
Nasal Epithelium Inhalation Formaldehyde 6ppm 8d ID299,pert
Cell line expressing inducible GFP-progerin. Induction: day 5. Replicate A,pert
remitted schizophrenia patient  S04,pert
"Uninvolved Skin, NS-28",pert
"infected primary RPE, biological replicate 3",pert
osteoblast_control_rep1,ctrl
kidney_Q10_14M_rep2,pert
condition: Psoriasis;	patient: PS-N;	tissue: LS skin biopsy;	kit: Affy,pert
tissue: cervical cancer cell line HeLa,pert
"3T3-L1 siControl 48h, biological rep 3",ctrl
LIVER_diclofenac_repl1,pert
HLA risk: High;	Height: 170.4 cm;	Weight: 51.5 kg;	BMI: 17.6;	Age: 13.88 years;	Gender: Male;	Race: White;	Glucose: 196 mg/dl;	HbA1c: 6.2%,pert
C_AN19442_C,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A26",pert
NINDS-RHS-Kainate_240h-3aUA-s2,pert
HUVEC/NmenMC58_pilD_1h_rep1_1103,pert
BCells_Transgenic_day0_REP3,pert
Nod2-/-_laser captured Paneth cells,pert
4 hour tunicamycin CHOP-/- D,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:knockout,Treatment:cornoil,Batch:Batch1",pert
GFP Untreated 12hr 282295733,ctrl
01MLT_Oligo,pert
Native ko biological replicate 3,pert
MCF7_Control_Array_2,ctrl
JIA PBMC Post treatment A235_287(2),pert
24h 4OHT-treated-sample1,pert
NCI-H716_YAP1.3,pert
Bone-Marrow_SMM_S1335,pert
"Aorta, Ang II 14d, #1",pert
2008-Ets1 cells_rep1,pert
PGA-MAH-C3H_OVA6h-1aA-s2,pert
"disease group: Nonatopic Control;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 130;	ige (kiu/l): normal (0-48.5 kIU/L): 34.7;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
CD25+Xbp1WT,ctrl
PTC BRAF wt 10,pert
ACC Xenograft X12,pert
Nonlesional Epithelium Atopic Dermatitis rep3,pert
disease state: Healthy Control;	gender: Male,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 48 hours,pert
cbp+/- standard cage Rep3,pert
cell line,pert
RKO_NEGsiRNA_6hDMSO_REP1,ctrl
H9_d15_hepatic differentiated_2,ctrl
brain_DLPFC_bipolar C_mr284,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 62;	tissue: Blood,pert
"human failing LV myocardium, Idiopathic79",pert
strain: C57BL/6;	genotype/variation: Nrf2 Control;	gender: Female;	tissue: Liver;	age: 6weeks,ctrl
THP-1 cell line infected with GSK3A Construct 6 shRNA,pert
tissue: skin;	individual: Patient P12;	condition: ANL;	eczema severity: SCORAD: 0,pert
"nasopharyngeal carcinoma, specimen T17",pert
11383 Normal Uninflamed ascending colon,ctrl
"Patient I-c852T, MSI colorectal tumor",pert
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: B,pert
WT-MAC-SEV-1,pert
B10.H2g7 Idd3_T2,ctrl
Hippocampus of 2 months old WT males,ctrl
Integrin alpha7 transgenic mouse rep3,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Supraoptic nucleus,pert
subject id: 68;	infection: DENV;	status: DF;	tissue: whole blood,pert
G392E_on_rep2,pert
"H1299 treated with Lipofection GAPDH siRNA, 24hr",pert
cell line: SW1736;	time point: 6h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 6 h,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: scrambled;	transfection time: 48h,pert
strain: ICR/B6D2;	tissue type: back skin,pert
"Heart, Cmah KO, 2 months old",pert
autism with dup(15q) AU006504,pert
Myoblast-GATA4-OE-day3-2,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
liver_control_diet_rep5,ctrl
NonIR-KO_Rep2,pert
CD47 null Endothelial cells 1,pert
tissue: muscle;	sample group: calorie restrictive;	treatment: before;	gender: Female,ctrl
subject: 07U;	cohort: 7;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 34kb;	age (y): 49;	Sex: F;	batch: Batch_2,ctrl
wt Ang3,ctrl
3 wks TAC-1,pert
"LacZ, #1 repeat",ctrl
F-IIP(UIP)9_Cy3,pert
Pten cKO rep3,pert
Huh7 cells_JFH-1 Infected 24 hours_ rep3,pert
strain background: ICR;	genotype/variation: Pax6 flox alpha-cre;	developmental stage: E12;	tissue: Embryonic retina/optic cup,pert
muscle_Wt_35wk_rep4,ctrl
Control 10,ctrl
Bronchial Epithelial Cells SA biological 1964P,pert
"human post-mortem brain tissue, healthy control",pert
healthy control,ctrl
Cervical cancer_1509T,pert
BP patient 91_biological replicate 2,pert
EUR12_T3_PP_day1_045,pert
The RNA samples from DHT 0hr treated LNCaP cells,ctrl
RAW_2.1mM_HOCl_#1,pert
Normal Mouse Skeletal Muscle,ctrl
"Cerebral Palsy, Gracilis, Patient Replicate 1",pert
Cardian muscle Trained 5 week T5,ctrl
PTEN Delted Mouse Lungs,pert
wild type; 6 months,ctrl
Heart sample9,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with 100 nM T3 for 6h.,pert
Patient identifyier: Z;	Sex: female;	Age of patient: 42 years;	Duration of psoriasis: 36 years;	Body surface area: 5 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
WTT 160 bleomycin treated.,pert
A1_scrb,ctrl
WT-Fibr2 1,ctrl
WT - Cre Control - 5 mo - repeat 5 - Cy3 - mAdbID:74106,ctrl
Healthy12-CD8,ctrl
subject: 12B;	cohort: 12;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 49;	Sex: M;	batch: Batch_3,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 6hr",pert
Female - caucasian - N-01-M,ctrl
"Untreated Testes, biological rep 2",ctrl
tissue: liver;	genotype: p14 KO;	genetic background: C57BL/6,pert
Muscle Experiment 1,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 34 yr;	population: white,ctrl
HF0467_U133P2,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: FRAG.cRNA-IB,ctrl
tumor cell line HepG2 rep3,ctrl
"liver_LDLr-KO, biological replicate 2",ctrl
HC CJ 2 alcohol,pert
"E2-treated cells (3hr), biological rep_2",pert
Experiment TOX3 transient transfection replicate 2,pert
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 39;	Usage number: 1;	Exposures: 4,pert
wild-type mouse kidney - 3,ctrl
T5E-LU,pert
Gata-1 Knock Down C,pert
E_LS_Wk12,pert
"SS gland, early, patient 4, batch 1",pert
Control Day0 (395L),ctrl
small_intestine_complete,pert
CONTROL 1,ctrl
Liver TG replicate 3,pert
HF0813_U133P2,pert
TTF=100min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
LSK cells SRF wt 2,ctrl
Immortilised monocyte cell line,pert
S9B Sporadic-cerebellum,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 5 days adipocyte differentiation,ctrl
siRNA Smc3 [M3],pert
epithelium from colon of HDAC2 KO mouse no.2,pert
WT / Reference_13425476,ctrl
p53r2 siRNA 2,pert
231/NS (nonsilence)_2,ctrl
"CD14+ after 2 wk quercetin supplementation, biological replicate 2",pert
"64B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
"Nickel 400 µM, biologcial rep4, repeated microarray",pert
"PC from MM patient, isolated using CD38-APC",pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: dominant-negative Tcf4 transgene;	time: 24hr,pert
Hes6_Castrated OWJ39,pert
NICM pool 1 (n=2),pert
"Acute Myeloid Leukemia, sample 20",pert
23 Day Mouse Leg Muscle,ctrl
P1 mouse eyeball extracted total RNA_Brg1_cKO3_GSM618320,pert
NLGN3_2,pert
447MM,pert
293TsiScram-2,ctrl
K562 cells CREB Knock-out replicate 8,pert
8 week mouse gastrocnemius/soleus muscle,ctrl
2097-03-A,pert
"PBMC, healthy control, biological rep6",ctrl
Vit A sufficient 1b,ctrl
134B,ctrl
SA_12,pert
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: Heregulin,pert
220/0,pert
"spinal cord, ventral spinal cord: EP131/L - hSOD1(Chan)/e14-wildtype hSOD1",ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 4.0;	age of psoriasis onset: 69,pert
GC resistant clone C7H2-R19E7 treated for 6 hours with GC,pert
WT-smoke-med-5 month+1d-R1,ctrl
WildType_lung,ctrl
control peptide-treated KOPT-K 100mM 16h,ctrl
MIST1-null pancreatic RNA 36 hours post-tamoxifen,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 61;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
HT29 sensitive cells replicate 2,ctrl
heart_Q10_14M_rep3,pert
PBMCs_IS_1 [IS],pert
"Patient I-c800T, MSI colorectal tumor",pert
UV-SeV 3661,ctrl
"PC from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
Caries 1,pert
rtTA-Dmrt5 day 9 -Dox,ctrl
n9t6h,pert
sex: Male;	Age: 2.5 months;	additional patient information found in Series supplementary file,pert
"Right brain hemisphere ,C57BL male mouse,Haloperidol treated,Orally,12 weeks",pert
PancreaticSample32-Tumor,pert
mouse intestine pLagl2 knockout 2,pert
heterozygot FH P265,pert
"Cerebral Palsy, Gracilis, Patient Replicate 6",pert
"NASP siRNA treatment, sample #3",ctrl
OCI-Ly10_siFOXP1,pert
Individual_4689_NN_sample,ctrl
Teratozoospermic individual: Sample T3,pert
MDA-MB-231 cells siLuc (control) transfected rep1 HG-U133A,ctrl
vehicle treated experiment A (4mM HCL/1% BSA) 24 hours,ctrl
Wild type mouse liver,ctrl
HepG2-PARP2 depleted-3,pert
"PPARg d0, rep 2",pert
"Patient 998, 3 month of BETAFERON",pert
Individual_5346_NN_sample,ctrl
224 Day 2 siMut10 transfected biological rep3,pert
BALB/c control (198msn),ctrl
Expression data from BAT of the KRAP deficient mice (WT2),ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 31.51233,ctrl
"Strain: Wistar, Sex: male",ctrl
Sprague-Dawley Rat retina (male),ctrl
PS-NA cerebrum at 12 weeks,pert
mouselung_scid_control_rep03,pert
"Spi-21, biological rep 8",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.81;	choa: 112;	fata: 80;	eea: 1440;	wtkg: 99;	perfat: 57.6;	lbm: 38.9;	fat_mass: 5702.4,ctrl
S025_Scz_M_41,pert
59A;pretreatment;female;breast tumor,ctrl
F2,pert
"spleen follicular B in WT, biological rep1",ctrl
NoKD_SerumStarved_rep2,pert
MDA-LM2-shTARBP2,ctrl
Clozapine treated 12weeks AffyGC RMA rep6,pert
strain: C57BL/6;	genotype/variation: Nrf2 KO;	gender: Female;	tissue: Liver;	age: 6weeks,pert
HCC_7T,pert
PancreaticSample35-Tumor,pert
mammary_16wkWT_ker75,ctrl
brain_OFC_bipolar B_mr384,pert
male JAK2 WT liver sample 126,ctrl
142B,ctrl
"DMD skeletal muscle, biological rep13",pert
neuron_rep1,pert
"MCF-7 cells, siERK5 treatment 72h, 0.1%EtOH for 24h",pert
01UNZ_PolyRF+,pert
Patient no. 1: treated,pert
Healthy control_sample10,ctrl
RA_y,pert
rear leg muscle,pert
Strain: C57Bl/6; Tissue: liver,ctrl
tissue: Whole Brain;	developemental stage: E 18.5;	genotype/variation: Meg3 knock-out,pert
APBMNC.LPS-.3,ctrl
Normal PBMC Sample 8,ctrl
"129P3/J SAL, Rep1",ctrl
HNF4a2_2+,pert
remitted schizophrenia patient  S09,pert
"brain, cerebellum: RNA#35_le1",ctrl
S1_S010228,pert
4 h (2),pert
BCell_resting_sample4,pert
8 week old leg MDX rep 5,pert
Healthy control 14,ctrl
thyroid_normal_3,ctrl
Bronchial Epithelial Cells SA biological 1771E,pert
3735-lcm,pert
colon_IL10mouse_12weeks_rep4,pert
Kidney_50 mg/kg VCM ip_mouse #067,pert
3985-2 E2F1 Null,pert
AR-CO-24-3-570,ctrl
8 week old mouse leg muscle,pert
2d-IR-69,pert
condition: Psoriasis;	patient: PS-L;	tissue: LS skin biopsy;	kit: Affy,pert
"Histopathological diagnostic: oligodendroglioma, grade 3",pert
Jurkat cell line transfected with SIV Nef,pert
healthy control sample x192,ctrl
"MAT1A knockout at 8 month age, biological replicate 5",pert
Wild Type Mice fed Low fat diet 3,ctrl
Conditional Sample 1,ctrl
USF1 replicate 2,pert
"Control_TP, C1",ctrl
"NB4 cell line, TG2 knockout, ATRA, 72hr",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 68,ctrl
erStress_twins_AA_1733twin2_500nM_thapsigargin_4h,pert
disease state: paediatric glioblastoma;	age: 12;	gender: F;	h3.3_status: wt,ctrl
26 weeks female,ctrl
Cardiac Progenitor WT2,ctrl
"EtOH, RARaKO, set 4",ctrl
"testis with regular spermatogenesis with status after vasectomy, patient age: 34y",ctrl
Ero1-C104A/C131A non-induced biological repA,ctrl
DND41 Control 2,ctrl
CAB10_T6_PP_day14_036,pert
Patient no. 2: treated,pert
MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B,pert
breast normal 2,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: mid-UV,pert
MDS patient 23,pert
shRNA 691 R6 T5,pert
"HIV-1 positive male, 18-60 years old, weight loss of 5-15% in preceding 6 months, stable anti-retroviral therapy. CD4+ T-cells >50/ml, HIV copies =< 10,000/ml, free testosterone <50pg/ml.",pert
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA1-dox,ctrl
genotype: Wild-type;	replicate: 1;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
RNA from microdissected breast cancer cells from case 749 labeled with Cy5,ctrl
5274 UC Inflamed descending colon,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus monosomy7/del7q plus other,pert
"Entire small intestine, wild type, lubiprostone treated",pert
Normal cervix_03-5611,ctrl
Normal PBMC_sample 3,ctrl
Jurkat cell line,ctrl
Backskin_Get1_e18_KO1,pert
OC1-KO embryonic retina at E14,pert
model: Fischer 344;	gender: Male;	age: 7 to 8 months old,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 7.97878165639973;	age of psoriasis onset: 47,pert
gender: Male;	age: 44;	post-mortem delay: 4h;	ph: 6.3,pert
"Overexpress TFPIalpha, biological rep. 2",pert
"Chromium 10 µM, biological rep1",pert
Tendon_non-lesional_rep3,ctrl
PTC BRAF wt 4,pert
"ERaKO mouse aorta with placebo, biological rep3",pert
HC-KO-21B,pert
3 h-apra-2 nM,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis anterior;	age at biopsy: 48;	Sex: male,pert
"SPC(+)Cre(-), Dox E6.5-12.5, PN15; control",ctrl
"A549, -TNFα, Claudin 1 siRNA, rep3",pert
patient: 3;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
CTRL_1_CMP,ctrl
32054.INV,pert
"GNMT knockout at 8 month age, biological replicate 2",pert
8 wk old male C57BL10 EDL,ctrl
s3t2c,ctrl
G029-lcm,pert
human_hepatocyte_vehicle_donorB_24hr_prep1,ctrl
Tretinoin2,pert
Lck LIGHT Tg;	Age: 4-8 wks,pert
C1F-LU,ctrl
diseased_IL-13 2,pert
chip number: 16;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.87;	rin: 9.8;	transfection date: 2012-03-26,pert
Pancreatic Sample 6-Tumor,pert
Placenta_nl2,ctrl
Untreated Control 12weeks AffyGC RMA rep1,ctrl
ADHC1,pert
siRNA LMG4 treated HeLa cells 1,pert
Livers of TAK1 ko mice sacrificed at 4 weeks,pert
MA_14,pert
left lung lobe,pert
strain: C57BL/6;	genotype/variation: IkkβΔ,pert
Hec50co human endometrial cancer cells with a control scrambled ShRNA,ctrl
SKBR3-R_0.1uM_Lapatinib_2,pert
"108, ADIPOOSE TISSUE, Before",ctrl
Sex: male;	Age: 10;	SL: 3.37;	House: -;	Severity: C;	Ashworth: 1;	Zancolli: 0;	PEFF: 90;	PESF: 90;	AEFF: 90,ctrl
lrrk2 genotype: WT / WT,ctrl
WT-control-3,ctrl
platelet_Ctrl_8,ctrl
3985-2 E2F1 Null,ctrl
"IGF-treated cells (24hr), biological rep2",pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: Control shRNA (GFP),ctrl
PGA-FVB_3m_1f-m5,ctrl
Clozapine treated 12weeks AffyGC RMA rep5,pert
Lung tissue sample from the patient with ILD,pert
"mouse aorta cross strain comparison, C3H_T08_NC_01",ctrl
HUVEC_TNF-stimulated experiment 4,pert
chip number: 19;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.6;	rin: 9.2;	transfection date: 2012-03-26,pert
patient: 51677;	sample: normal,ctrl
WT replicate 3,ctrl
Myh11-CreERT2.Tgfbr2f/f Knockout 3,pert
cell line: HCT116;	clone: 10;	genotype: Knockout,pert
Series 3; old; 4 weeks after fracture,pert
"C57BL/6J Acute morphine treated, biological replicate 3",pert
Run8.aUa.010615d.SkMInS1076D.CEL-IS basal,ctrl
Intronic WT control rep1,ctrl
CH1814,ctrl
strain: C57BL/6J;	genotype/variation: Ifng-/-;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),pert
endothelial_rep10,pert
"125, MUSCLE, After",pert
Run1.a10a.000607jd.2.SkMNor916.CEL-IS stimulate,pert
PTEN-111 (-/-),ctrl
EA_Case3_CD4,pert
cells: spleen follicular B cells;	genotype: IRF8 KO;	genetic background: C57BL/6J-lrf8-/- x CD19-Cre,pert
CRC_celecoxib_M4866,pert
gender: male;	tissue: gastrocnemius muscle;	age: 7.5 months;	genotype: wild-type,ctrl
Normal Sample 3,ctrl
Array Type: HG-U133A_2;	Ratio: 1.98;	RNA Integrity Number: 9.9;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Frontal_Cerebrocortex_Permethrin_100mg/kg_6hr_rep5,pert
ab020 IM,pert
"EBF1 d2, rep 3",pert
Sample: alpha-TM180;	Replicate: 1;	Pool: NP,pert
Globin_S2,pert
tissue: testis;	genotype: wt;	age: 17dpp,ctrl
01LM1_PolyRF+,pert
AO C1,ctrl
PGA-MAH-C3H_PBS6h-3bA-s2,ctrl
genotype: Wild-type;	replicate: 2;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
cadmium_16hr_rep2,pert
23 Day Mouse leg muscle,pert
MS-proband,pert
tissue: amnion;	cell type: mesenchymal;	agent: interleukin-1-beta;	time: 1 hr,pert
SIRT4 KO mouse liver after 16 hrs fast,pert
F23.05,pert
IGROV-1-(2),ctrl
AGS cells - Celecoxib treated biological rep 2,pert
tissue type: Primary lung tumor;	histology: SQ,pert
Insm1 control #2_pituitary gland,ctrl
"Patient 24, Atheroma plaque",pert
Pertuzumab treated after 4 days (P3_1),pert
"Heart, MAT1 control, 4 wk, sample 1",ctrl
HOX424 Control Day7,ctrl
age: adult;	gender: male;	tissue: lung,pert
"brain, frontal cortex: Sample59_e1_le1",ctrl
WT - Cre Untreated - 0 hrs - repeat 3 - Cy3 - mAdbID:54711,ctrl
T91,pert
Non_Target_2,ctrl
DW301_WT_M,ctrl
"gene expression of wild type oocyte, replicate 1",ctrl
"PPARg d2, rep 2",pert
Zfx fl MA9 cells + 4-OHT [10950],pert
HA96-112A,pert
Mus musculus embryo E8.5 Tcof1+/-,pert
2IDC_tumor_ductal,pert
224 Day 1 siMut10 transfected biological rep1,pert
Skinbiopsy_48hoursnickel_controlsubject_k1,ctrl
11082 Normal Uninflamed descending colon,ctrl
"CL1-0, biological rep3",ctrl
"MTDH knockdown, biological replicate 1",pert
"siPRMT1 neuron, biological rep3",pert
Mus musculus liver - txnrd1 null,pert
"brain, hippocampus: LH1_e1_le1",pert
Hippocampus 1984 15 month Old,pert
"Epidydimal white adipose tissue from Casp1-/- after 16 weeks of high fat diet feeding, replicate 2",pert
PGA-MLS-Dex-1bAv2-s1,pert
pMX-Oct4 and pMX-jhdm1b vitamin C O+Jhdm1BVc+_2,pert
PGA-RMM-Ctr-3aA-s2,ctrl
OE-E6/E7 cells,ctrl
NoKD_rep3,ctrl
Subject 4 / lung subsegment instillated by LPS,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 141;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
wildtype_GV-stage_oocytes,ctrl
"TH cells from LC, wild type control, biological replicate 1",ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Control_case5,pert
PBMC of Rhesus Macaque,ctrl
"Mutant, biological rep2",pert
healthy control C5,ctrl
"S1P2-KO-hippocampus, biological rep10 (female)",pert
Human Uninfected Sample N110-CD8+ T cells,ctrl
Primary hepatocytes isolated from Donor 5 treated with DMSO for 6h,ctrl
"fibroblast, control subject NM6 rep 1",ctrl
N13,ctrl
RNA from HCC_10T,pert
HT29 DMSO Day8 rep1,ctrl
GIST_PDGFRA_6,pert
whole tissue section from case 849,pert
Regulatory T-cells CD4+CD25+ from HDAC6 knock out mice,ctrl
EB_6_19d_309_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Muscle PCOS case 121,pert
CONTROL;	Age = 20;	Sex = F,ctrl
Patient identifyier: G;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 19 years;	Body surface area: 12 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"Deltoid, control, cohort 12, subject 12U",ctrl
Proliferative Phase Normal,ctrl
T8C-LU,pert
Satb1-/- clone 1-1,pert
"brain, hippocampus: KA24-I_e1_le1",pert
patient: 30068;	sample: tumor,pert
Brain BA10 post-mortem control,ctrl
ALI patient #11,pert
B/OVX/P4/6h/UTX 129/SvImJ WT,pert
SCARKO d10 (4),pert
IRAK2 KO_macrophages_4h,pert
age: 66;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Muscle PCOS control 12,ctrl
Individual_5050_NN_sample,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 41 yr;	population: white;	dsm-iv: 296.72;	age of onset: 14 yr,pert
ACI DES-treated replicate 1,pert
CLL1-CD4,pert
Whole pancreas,ctrl
"AD_HI, biological rep2",pert
Heart sample8,ctrl
6 STAT6KO control macrophage,pert
MMP-8 wild type control mouse,ctrl
erStress_twins_AA_1757twin1_DMSO_4h,ctrl
wild type MEF(1),ctrl
"2 months, sham group, biological replicate 1",ctrl
3DKD,ctrl
TTF=140min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
SKBR3-R_Control_3,ctrl
Active ITP chip A,pert
"Patient I-c840T, MSI colorectal tumor",pert
Control d10 (1),ctrl
RNA from HCC_41N,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: F;	age: 56,pert
age (days old): 10;	genotype: wild type,ctrl
"breast tumor epithelium,57",pert
mESC_undifferentiated_Alkb1-/-_rep1,pert
"shZBP-89, biological rep2",pert
WFS1 KO USHT_10_322_ko,pert
human cellular RNA_primary airway epithelial cells_tracheobronchial _H510_2h_Con_HG-U133A_2_YCHSUP501,ctrl
"Patient F, uninvolved skin",ctrl
"Trim28 conditional KO mice Treg cell, replicate 1",pert
"TLR4 null sham kidney, biological rep1",pert
CCl4_CT20,ctrl
"Peripheral blood, patient without recurrent events [N26]",pert
prefrontal cortex (BA10);	bipolar disorder,pert
Gastrocnemius Muscle_Cmah KO_mdx_rep1,pert
"peripheral ganglion, unknown",ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: PTEN shRNA,pert
SV589_NoKD_Serum Starved,pert
"Brain tissue from Fisher 344 male rat, Animal #249, 500mg/kg D-Serine",pert
Amniocytes_trisomy 21_1551,pert
Untreated CLL3,ctrl
"siRNA, collagen plate, rep1",pert
"tissue: lung, lower lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 58",pert
"RISC-free control transfected, biological rep 1",ctrl
Subject #8007-Preinfection,pert
WT P10 replicate 2,ctrl
Liver_WT_Rep5,ctrl
PGA-MAH-C3H_PBS24h-4aA-s2,ctrl
Bronchial Epithelial Cells SA biological 1921X,pert
TL3 cell lines,ctrl
DBA d18 (119msn),pert
"Untreated, biological rep3",ctrl
genotype: Atxn1L-null;	strain: C57Bl/6;	cell type: HSC,pert
"KM-H2 cells, Non-silencing control, replicate 1",ctrl
ic10 -- Cell line 2 treated with mock APF#1,ctrl
3729-lcm,pert
"60B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; responder",pert
sample 1:;	age: 58;	gender: male;	sample 2;	age: 58;	gender: male;	sample 3:;	age: 57;	gender: male;	sample 4;	age: unknown;	gender: unknown,ctrl
MCF-7_E2_ethanol,pert
cell line: COV434;	transfection: Mutant,pert
MPZ-Tfam Knockout - rep1,pert
G93A 60 days sample 3,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 26.55342,ctrl
"endometrioma, patient M2",pert
HA00-13B,pert
"human nonfailing LV myocardium, NonFailing5",ctrl
"Pineal gland from NeuroD1 cKO mouse at ZT6, biological rep 1",pert
A549 siRNA FAM60A 3,pert
EB_6_5d_293_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
4n,ctrl
reduction mammoplasty patient 278,ctrl
GM19238_Kd_NS1_22,ctrl
Retina wt/wt rep1,ctrl
E14.5 Top2b+/+ brain,ctrl
Endometrium/Ovary-Disease 2,pert
CME-Emerin4d-3MA-S2,pert
phenotype: alcoholic;	gender: male;	case_id: 466;	age: 57;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 43;	brain ph at time of freezing: 6.46;	labeling_batch: 2,pert
BP22,pert
"cochlea at P3, ko, biological rep 1",pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: none,ctrl
chip number: 23;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.74;	rin: 9.6;	transfection date: 2012-03-26,pert
gender: Male;	strain: C57BL/6;	genotype/variation: B1+/+;	tissue: Epididymal fat;	age: 3 month-old,ctrl
4128-1 E2F2 Null,pert
strain: FVB/N;	age: 13.5 days;	tissue: whole body;	cell type: Fibroblasts;	genotype: Pten+/+,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 208,ctrl
Mnk_3206-R-B,ctrl
untreated-sample2,ctrl
U2OS shCHK1-4 replicate 1 [set 4],pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: other,pert
GIST Pre Treatment Biopsy 10,pert
Liver control pool3 Affy,ctrl
transfection: control shRNA;	cell line: J1 ES Cells;	background strain: 129S4/SvJae,ctrl
V5-P368,pert
CEM11_T4_PP_day3_040,pert
Primary hepatocytes isolated from NMRI mouse strain treated with Wy14643 for 24h,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 1,pert
gender: F;	age at blood draw: 48;	tissue: whole blood,pert
3979-2 E2F1 Null,pert
jzo029-rp1-v5_u74av2-met,ctrl
DNGM-7,pert
"D425-shOTX2_2, t=8",pert
strain background: (BALB/c x C57BL/6J) F1 obtained by breeding heterozygote mice(+/-) with a C57BL/6J and BALB/cA background;	genotype/variation: Shn2 deficient;	age: adult;	gender: male;	tissue: hippocampus,pert
tissue: blood;	control: 7;	gender: female;	age: 35,ctrl
shRNA-control-rep-1,ctrl
01-0062A_Day1_8,pert
cerebellum_wild type_24 weeks_replicate 3,ctrl
Series 3; old; 2 weeks after fracture,pert
"granulocyte, patient. Mtx rep6",pert
siIPMK no DNA Damage experiment 1,pert
liver_STZ 0.1% quercetin diet_rep5,pert
"PC-3 Luteolin, biological rep2 [mRNA]",pert
Control at 28 days of age,ctrl
c.2,ctrl
Eed KO E14 ESCs on day 7 #1,pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ scramble;	treatment: Ca 0.6mM, 72 h",ctrl
"BL6/C57 mouse heart, control, rep2",ctrl
WT_cells_rep2,ctrl
RNA from whole tissue section of case 469 labeled with Cy5,ctrl
SCLC cell line COR-L88,pert
ID: MLL_00110;	cell type: PBMC;	disease state: control,ctrl
8 week old leg control rep 5,ctrl
"human failing LV myocardium, Ischemic29",pert
Severe rep1 (retina),pert
liver_Q10_14M_rep3,pert
SLE8-TC,pert
Cdk4 +/- ES cell line,pert
prostate_Klf5 ko_rep1,pert
3586-1 E2F1 Null,pert
KO MEF cycling cells,pert
Luciferase shRNA_2 Days knockdown_rep2,ctrl
OE Sirt1 3,pert
Control 4_Huh7 [HDAC2 siRNA subset],ctrl
Plate vs. Nail:  1 Week Plate,pert
MCF-7 cells,pert
22A,pert
H1P_1,ctrl
HDAC1_G10-rep1,pert
"LCL GM19238, Kd STAT2, 72hrs",pert
BAL_46_A2B0,pert
mouse: 6;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
CCRPKO-PB_rep-1,pert
MS25_5A_LV_220307,ctrl
control female replicate 4,ctrl
"Normal subject (33 year old caucasian male, SAK_1274807443)",ctrl
T40843,pert
Parkinson's disease sample x122,pert
PlagL2WT1,ctrl
jejunum_0h_rep2,ctrl
Liver FC2,ctrl
"Heart, WT, 2 months old",ctrl
Individual_4379_NN_sample,ctrl
normal arterial tissue: sample #3,ctrl
Subject #8015-8hr Postinfection,ctrl
SENS 4 0hr,ctrl
Mock_cells_rep2,ctrl
non-CF subject 33,ctrl
Normal Adrenal Gland (AN15),ctrl
Bronchial Epithelial Cells SA biological 1989F,pert
Neocortex_Eomes_WT.6,ctrl
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 3,pert
Individual_4708_NN_sample,ctrl
"BMMCs from NTAL WT, noninfected, 2 h activated, biological rep2",ctrl
unstimulated(sparse)-2,ctrl
mixed reference (FR + CRG),pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 24 months;	genotype: Myc heterozygous,pert
metastatic melanoma culture,pert
"Ctrl OBCs, post doxycyclin withdrawal, rep5",ctrl
Parkinson's disease sample x016,pert
"human failing LV myocardium, Ischemic66",pert
Carbo Day14 (349R),pert
Tissue:  Primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,ctrl
Neuroblastoma SH-SY5Y cells_cloneG_stably transfected with RNAi against DJ-1_replicate2,pert
Mouse_ATF6bKO_colon_UT_rep2,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 35,ctrl
FW_18c_BV3965,ctrl
subject: 19U;	cohort: 19;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 79kb;	age (y): 41;	Sex: F;	batch: Batch_4,ctrl
Individual_5247_NN_sample,ctrl
subjectid: 5258;	imatinib: IM;	lbh589: NoLBH,pert
Cyclophosphamide-treated peripheral blood leukocytes 1 day - Biological Replicate 3 - Technical Replicate 1,pert
At Risk: +;	Age: 19;	Sex: F,pert
01LLC_PolyRF-,pert
testis wild type replicate2,ctrl
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
colon_epithelium_IL10mouse_12weeks_rep1,pert
Omental adipose tissue,pert
E14 - Lis1ko/+ 2,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 0, Units of Harvest Time Point: hr",ctrl
12494 UC Inflamed sigmoid colon,pert
Normal PBMC_sample 2,ctrl
WKY12-2,ctrl
C2C12 myotubes 0uM H2O2 rep 2,ctrl
Cal27_PBS2,ctrl
MCF-7cells treated with vehicle and ER siRNA,pert
Control 1 c,ctrl
Csbm/m Mouse_cerebellum_Standard diet Ad Lib_Replicate-4,ctrl
4A,pert
Primary hepatocytes isolated from BalbC mouse strain treated with Wy14643 for 6h,pert
Sciatic nerves from GNMT-WT mice,pert
Hippocampus_Soman_6h_rep2,pert
"Spleen, SRBC immunized mouse, 12 days post-immunization",pert
liver 0.1% quercetin diet rep2,pert
normal superficial temporal artery,ctrl
"acutely admitted, severely psychotic schizophrenia patient  A01",pert
No or early 1 rep7 (retina),pert
FHCRCAML1355,pert
LJMJDW22,pert
SP-KO-Nrf2-Female-2,pert
normal adjacent esophageal tissue from patient E1566,ctrl
age: 42;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: transfected with Ambion Silencer Select SOX2 siRNA;	cell type: embryonal carcinoma;	cell line: NTera-2;	passage: 40-50,pert
"liver RNA, ATP 7B KO mouse (first described Hum. Mol. Genet. (1999) 8:1665-1671)",pert
NINDS-RHS-Kainate_24h-3aUA-s2,pert
sciatic nerve of P4 Pmp22 transgenic mice,pert
"vestibualr organ at P15 of Igf1 -/-, biological rep 1",pert
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 37;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,ctrl
breast cancer patient 226,pert
umbilical cord_bpd: 6H,pert
Human umbilical vein endothelial cells (HUVEC),ctrl
WT - Cre Control - 5 mo - repeat 2 - Cy3 - mAdbID:74100,ctrl
Day: 24; Drug: Heroin; Phase: Withdrawal; Replicate: 2,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-11;	Primary Site:Tongue;	Age:32;	Sex:M;	TNM:T3N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
CDK9 Knock Down2,pert
Carboplatin;	Carboplatin 24 hours set 1,pert
cerebellar total RNA,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp1,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 50;	donor: 24;	disease state: Lesional,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: female;	age: 20 weeks;	genotype/variation: control",ctrl
"Peripheral blood, patient without recurrent events [N33]",pert
Setdb1 2lox/1lox/Cre plus tamoxifen 2,pert
disease state: paediatric glioblastoma;	age: 17;	gender: M;	h3.3_status: wt,ctrl
"ME16C, 12h, 0.5uM DOX",pert
"siYAP RNA #1 transfected, biological rep 4",pert
Postnatal 3 weeks mutant heart biological rep1,pert
Liver of pup exposed to 0.002 mg/kg BW BDE-47 rep2,pert
cerebellum wild type 6 month replicate 1,pert
Vehicle-Control 24 hours set 2,ctrl
12 h-apra-2 nM,pert
01LNL_CTRL,ctrl
"Fibroblasts, baseline, time 0, patient 1, rep 2",ctrl
Control for EGF 12h replicate 2,ctrl
"Wild type, snap frozen, gastrocnemus muscle, 10 month age animal",ctrl
MCF7_siRNA_GCMedControl_24h_AM0002_57.1,ctrl
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 1;	age: Post natal day 3-10,pert
"Brain tissue from Fisher 344 male rat, Animal #251, 500mg/kg D-Serine",pert
"Healthy volunteer, Control_11698",ctrl
10 days TAC-1,pert
7d-sham-80,ctrl
colon_normal_1431,ctrl
Atopic eczema,ctrl
liver_WT_replicate1,ctrl
LNCaP.FoxA1.1,pert
"Animal id 1026, left retina, 3 months, female, DBA/2J",ctrl
control participant P313,ctrl
"NRVM, Uncoated plates",ctrl
Pre-frontal cortex from male C57Bl/6 mice 31 d after i.d. injection of Type II collagen in Complete Freunds adjuvant,pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; no EGF,pert
Untreated after 4 days (C2_2),ctrl
RNA from whole tissue section of case 1363 labeled with Cy5,ctrl
diet_Lung_4,ctrl
pediatric AML PP1,pert
infection: MIR517A and GFP protein,pert
MDS patient 15,pert
U2-OS-ERb vehicle control 1,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: LPA,pert
SCHT control 1,ctrl
11381 Normal Uninflamed ascending colon,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp1,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	2nd technical replicate,pert
"Empty vector, collagen plate, rep2",ctrl
"Control maternal diet, wildtype",ctrl
murine adult bone marrow,pert
OSE_448,ctrl
status: Normal;	age: 75;	gender: male;	tissue: cultured human fibroblasts,ctrl
"Primary, localized, pooled, prostate cancer",pert
"DBA/2J CHR, Rep3",pert
lung_CLP_PPTA knockout_rep1,pert
ICM pool 2 (n=2),pert
normal control_CTL3,pert
"experiment I, passage 13, replicate 2",ctrl
Balb/c WT_1,ctrl
Calu3-Parental_1,ctrl
"WT MEFs, biological rep1",ctrl
RAW Untreated 2,ctrl
"Liver from control mice, biological replicate 1",ctrl
Mammary gland R1 8 hr rep2,pert
BIO586227,pert
"human failing LV myocardium, Ischemic49",pert
a_NY36,pert
EOM 56 Day mdx rep 3,pert
PBMCs from Normal subject,ctrl
gender: female;	strain: C3H/HeN;	genotype/variation: WT;	tissue: liver;	age: Five-weeks-old;	agent: control,ctrl
E8.5 embryo proper,ctrl
"metastasis: none;	Stage: 2a;	tissue: cancer, homogenized",pert
"IKK2 WT cell line, biological replicate 1",ctrl
sample =Healthy3 treatment=Control time=0 (min),ctrl
PGC-1a KO 1,pert
healthy control sample x120,ctrl
LECs from cirrhotic rats 3,pert
0992-01-c,ctrl
GBM_stem_4 days_1,ctrl
L428+MAT_rep1,pert
"Chromium 1 µM, biological rep4",pert
"Cervical cancer cell line, HeLa",pert
Duoden022KAF6T_066.txt,ctrl
hTERT-immortalized skin fibroblast cell line,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-12;	Primary Site:Maxilla;	Age:46;	Sex:Male;	TNM:T4N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	;	",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.84;	choa: 41.3;	fata: 38;	eea: 1290;	wtkg: 70.3;	perfat: 35.5;	lbm: 42.7;	fat_mass: 2495.65,ctrl
Skinbiopsy_7hoursnickel_controlsubject_k1,ctrl
microdissected breast cancer cells from case 1125,ctrl
gender: female;	age (years): 36;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: No treatment,ctrl
DLBCL cell line KARPAS-231 transfected with a LITAF-specific siRNA,pert
Liver_PXR KO_Vehicle_Rep2,pert
"CTLA-4 KO 5C.C7 T cells, biological rep2",pert
"215, ADIPOOSE TISSUE, Before",ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#5,pert
mammary stoma-4w-wt-rep3,ctrl
"PPARg2 expression construct, 72 hrs, No Rosiglitazone (PPAR_72_2)",pert
Mock infected macrophages harvested at 1h post-treatment from donor 2,ctrl
HMEC X MCF7-NCI,pert
C_AN19442_T,ctrl
C_AN15566_F,ctrl
Psoriasis-Patient-N,pert
"SLE patient, 1012V1",pert
MPM tumor 32,pert
Panc-1 Untreated Control 2,ctrl
wt_1,ctrl
"24hr non-specific siRNA, 16hr 10nM DHT treatment replicate 3",ctrl
"BOEC, at_risk 2",pert
"Wt, biological rep2",ctrl
29B,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 6h,pert
myoblast_untreated_rep2,ctrl
colon,pert
"Ulcerative Colitis (62 year old caucasian female, SAK_1305735600)",pert
Control Endometrium Epithelial Cell_030.UC208_EpCAM,ctrl
umbilical cord_bpd: 1D,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 45;	Usage number: 1;	Exposures: 3,pert
Individual_4397_PN_sample,pert
3578M patient’s mucosa,pert
"Ctrl OBCs, post doxycyclin withdrawal, rep1",ctrl
"Atm-/- untreated, C",ctrl
VMM-MUT_MyoD12h-3MP-s2,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: wild type;	treatment: control,ctrl
"TMD_EHL, T4",pert
Ileum_Wild Type_2,ctrl
T50,pert
Gender:M;	Age:41;	Tissue: Mucosa,ctrl
"Cell type: neuronal, age:47, gender:male, diagnostic group: control, PMI:11h",ctrl
cell line: MCF-10A,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: RNAi-4A,pert
wt_P6_rep1,ctrl
MF-12,ctrl
"BL from healthy donors, isolated using CD19-PE-Cy7.",ctrl
sample =Healthy3 treatment=Stimulated time=360 (min),ctrl
Mtb infected-42d-1,pert
"brain, adrenal medulla",ctrl
"Wild type, snap frozen, extensor digitorum longus muscle, 10 month age animal",ctrl
strain: CBA,ctrl
Jejunum,ctrl
status: Control;	gender: Male;	age: 45;	tissue: Blood,ctrl
E9.0 wt.2,ctrl
"Ulcerative Colitis (55 year old black female, SAK_1285134540)",pert
tissue: 2B1 cell line;	genotype/variation: N/A;	age: 4 days post-differentiation in-vitro,pert
MCF7 untreated,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 29.26301,pert
Control 1b,ctrl
G93A 60 days sample 2,pert
"KM-H2 PTPN1 Knockdown, technical rep2",pert
H_LS_Wk1,pert
Cmah KO_kidney_3,pert
Cerebellum_transgenic nuclear localization signal Htt exon1 18Q x50_16 months_replicate 3,pert
Liver_Wild Type_3,ctrl
"Lung tissue of Nrf2 knock-out mouse, control group",pert
"Patient  B, lesion, time: 0",ctrl
"TCF-1 KO CD8 memory T cells, biological rep3",pert
HT29 DMSO Day3 rep2,ctrl
T51681,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 32;	maternal age: 31,pert
X50 WT3	F2/33	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
HeLa,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATR-4,pert
Pre-Frontal cortex of naïve FVB/N mice,ctrl
background mouse strain: C57B16;	genotype: Jak2VF;	treatment: Vehicle,pert
status: Normal;	age: 64;	gender: female;	tissue: cultured human fibroblasts,ctrl
ovary_cultured_progesterone_rep2,pert
MDS patient 55,pert
Mist1KO caerulein rep2,pert
CD-49-Aff1,pert
liver_wild type_6 weeks_replicate_2,ctrl
immortalized cells derived from brown fat of PGC-1alpha KO mouse (mixed background). passage number: 4.,pert
HepG2_100uM_Trovafloxacin_24hr,pert
"Liver, fasting",ctrl
cell line: Panc1005;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T79,pert
Individual_4389_PN_sample,pert
breast cancer patient 237,pert
CD4IncTp2-8,pert
Adult 7d SNI; Biological replicate 3,pert
HT29 sensitive cells replicate 2,pert
siLMO3_oligo1_FM_rep1,pert
"brain, Entorhinal Cortex: 99-33 tangle_e1_le1",pert
HCC_8T,pert
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 2",pert
"patient 10, arm treated with pimecrolimus",pert
Gastrocnemius muscle wild-type mouse - control mouse for PPARalpha overexpressing -rep 2,ctrl
genotype: Fog2flox/delta;	treatment: no Cre;	age: 6-7 wks old;	gender: male;	tissue: heart,ctrl
Ngn3 ES3 ON replicate 1,pert
Hippocampus_Soman_168h_rep2,pert
WT rep2,ctrl
background: C57BL/6x129Sv/B6 hybrid;	genotype: WT;	age: 9 months;	tissue: caudal vertebral bone,ctrl
Clozapine treated 12weeks AffyGC RMA rep2,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 48 hours;	agent: air;	exposure dose: 0 ppm O3",pert
"Patient 21, Macroscopically intact tissue",ctrl
HLA risk: Medium;	Height: 175 cm;	Weight: 70 kg;	BMI: 22.9;	Age: 24.4 years;	Gender: Male;	Race: White;	Glucose: 288 mg/dl;	HbA1c: 8.8%,pert
striatum_wildtype_3,ctrl
WT MEF,ctrl
SRF silenced EtOH rep 1,ctrl
"MCF-7, 12h, 0.9uM DOX",pert
PGA-RMM-12h-3aA-s2,pert
23A;pretreatment;female;breast tumor,ctrl
P4_PMP22TG_1,pert
"wild-type, lung",ctrl
hOB1705_shEV_16hr_IR,pert
"Cell type: endothelial, age:54, gender:female, diagnostic group: schizophrenia, PMI:42h",pert
Bmpr2-Delx4 1,pert
Thioglycollate-elicited PPARg WT macrophages,ctrl
Mock_cells_rep3,ctrl
NL D,ctrl
BALB/c mouse untreated control,ctrl
"Immortalized MEFs WC, empty retroviral vector infected, rep3",ctrl
db/db 8 wk 1,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 120min;	race: White;	sex: Male,pert
age: 52;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Gender:M;	Age:41;	Tissue: Mucosa,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: DMEM,pert
V5-P405,pert
"Lens epithelium, SPARC knock-out mouse",pert
"A673 treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50), biological rep2",pert
U2OS osteosarcoma cell line transfected with shBAP1 #1 construct,pert
T30057,pert
"FA6 transiently transfected with AGR2 siRNA, transfection C",pert
ve_2m41,pert
PGA-MAH-HeJAir-1bAv2-s1,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.741;	Ratio: 2.11,pert
SENS 6 0hr,ctrl
B4 394 wild-type untreated,ctrl
"3T3-L1 siControl 24h, biological rep 1",pert
Normal control 1,ctrl
control participant P330 (human CD3 positive T cells),ctrl
neocortex,ctrl
strain: C57BL/6J;	tissue: WAT;	genotype/variation: Fsp27 knockout;	gender: male;	age: 3 month,pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 1 hour",pert
age: E14.5;	gender: male;	tissue: dorsal telencephalon;	genotype: wt;	genetic background: C57BL\6,ctrl
Nrl ko P2 replicate 3,pert
"HCT116 shControl, normal growth",ctrl
phenotype: control;	gender: female;	case_id: 410;	age: 78;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 11;	brain ph at time of freezing: 6.3;	labeling_batch: 1,ctrl
adenosquamous carcinoma 002,pert
CDF1-c (195msn),ctrl
A2AR_KO_saline_24h_rep1,pert
b36+,pert
nmd untreated 2,pert
"ERRa wt baseline heart, sample 1",pert
Ileum_Wild Type+Quercetin_2,pert
Leptin treated mouse gallbladder 7,ctrl
GM19238_Kd_RELA_2,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 55.22192,pert
GM19238_Kd_STAT2_2,pert
Strain:C57BL/6;	Gender:male;	Age:8 weeks,ctrl
Leg 28 Day mdx rep 2,pert
Individual_4426_PN_sample,pert
iFGFR1 mammary gland 0hr,ctrl
disease state: Schizophrenic;	gender: Female,pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Post mortem interval (hours): 47;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 12;	dfs-event: 0;	distant metastasis: 0",pert
NOMO-1_SCR,ctrl
GEIM193-U133A-Norm,ctrl
murine lungs,ctrl
SENS 2 0hr,ctrl
MCF10A_SFN_rep2,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: pineal gland;	time: ZT20,pert
T51677,pert
A39 NES 142Q TG7	F2/13	A39	NES Htt exon 1 142Q	Mouse	10 months	Cerebellum	Male,pert
genotype: Wildtype;	tissue: Liver;	genetic background: C57;	Sex: Female,ctrl
ACI control replicate 1,ctrl
Psoriasis-292,pert
"Liver from STZ-treated mice, biological replicate 5",pert
Resting CD4 T cells,pert
Nonlesional Epithelium Nonatopic Control rep2a,ctrl
High weight gainer Kozak1_ABI_ING_H3,pert
e_NY204,pert
cardiomyocyte control 1,ctrl
"ESCs overexpressed vector control, biological rep2",ctrl
RTX12 T12,pert
"imr-32,ccnd1 siRNA,T=48, 1",pert
Braak α-synuclein stages 5-6  BR56_3SN,pert
Subject 4_t=30days_placebo,ctrl
AtT20 cells overexpressing NSBP1WT protein rep1,pert
RNA-DHL4-R406-2H-1,pert
GIST Pre Treatment Biopsy 11,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: WT;	treatment: untreated,ctrl
Mist1KO saline rep2,pert
PGA-HMO-MObese-8aUA-s2,pert
KM_069N,ctrl
Sex: female;	Age at operation: 78 years;	Site: thigh;	Size in cm: 13x10x6;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: high;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
pediatric AML GP9,pert
tissue: Brain;	genotype: Npc1+/-;	age: 82 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
disease state: paediatric glioblastoma;	age: 5;	gender: M;	h3.3_status: K27M,pert
BCell_lymphoma_aggressive_sample5,pert
Strain: 129S2/SvPasCrlf;	Sex: male ;	Genotype: L1CAM knockout (-/Y),pert
01UN0,pert
OV90+(2),pert
"Rat_Tracheal_Control_2hr, rep4",ctrl
BN control replicate 1,ctrl
E10.5_otic_vesicle_wt_replicate2,ctrl
"WT-UN1,experimental replicate 1",ctrl
Young 9,ctrl
8 wk old male C57BL10 soleus,ctrl
"Control lung tissue, biological replicate 4",ctrl
"Control shRNA cells passage 11, rep 5",ctrl
high grade serous carcinoma_patient 11,pert
neuron_rep14,pert
"Patient 10, Atheroma plaque",pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.47945,pert
Liver-Cpr-null_pool 1,pert
Liver from 1 year old- WT mice,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Female,ctrl
8 hour after cadmium treatment,pert
"wdNHBE with KY/180 at 36hpi, biological rep1",pert
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 27;	Brain pH: 6.44;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Mening SWB WB SW 24a,pert
NPC Brain 40d MOuse1,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep6",pert
tissue: Frontal cortex;	age: 84;	Sex: M,pert
"brain, locus coeruleus neurons, wild type",ctrl
GAS-n7; normal gastrocnemus 7 month,ctrl
"Frontal cerebrocortex, permethrin (1mg/kg), 6 hours",pert
ACI DES-treated replicate 2,pert
CON-2-COLLAGEN,pert
Muscle control 17,ctrl
No or early 1 rep1 (OHN),pert
tissue: Frontal cortex;	age: 94;	Sex: M,pert
PFC FVB/N control 1,ctrl
SNB19 scramble siRNA replicate 1,ctrl
sorted CML CD34+CD38- cells treated with IM,pert
ARF1 siRNA knockdown MDA-MB-231 sample 4,pert
J_LS_Wk12,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: CTNNB1 mutation (S45P),pert
112A,ctrl
colon_CRC_1499,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 233,pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
S7A Sporadic-frontal,ctrl
strain: Sprague-Dawley;	gender: Female;	tissue: ovary;	developmental stage: day P4 cultured for 2 more days,ctrl
Bone-Marrow_MGUS_G1559,pert
"heart tissue, untreated controls",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 24.95342,pert
RPMI8226_shKLF2A#1,pert
normal control_CTL4,pert
SENS 5 4hr,pert
Human_macrophages_hypoxia_repA,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14535;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Crohn 08, CD08",pert
Mist1KO caerulein rep1,pert
s2t3c,ctrl
RKO_rep_3,pert
Control Day14 (440L),ctrl
cell line: CAL27;	treatment: 15 nm Cetuximab for 13 hours,pert
Squamous cell carcinoma 028,pert
MDS patient 38,pert
"Mouse organ of Corti from cochlea, apical half, Dicer1 conditional knockout",pert
HTB58_controlsiRNA_3,ctrl
Haloperidol treated 12weeks AffyGC RMA rep10,pert
"siYAP RNA #2 transfected, biological rep 3",pert
"diet: LRD-5001;	sodium arsenite added to drinking water: 100 ppb, 5wk",pert
5263 UC Inflamed sigmoid colon,pert
Dilated cardiomyopathy_G21,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 47;	gender: m;	treatment: NSAIDs,ctrl
cell line: T47D;	treatment: R5020 [10nM],pert
Wild type mice on a high fat diet (CH 4),ctrl
A_LS_Wk1,pert
Rap1 knockout white adipose tissue,pert
INS-1 cell line #4a with non-induced HNF1b mutant A263insGG,ctrl
Cbx2_KO_XX gonads at E11.5,pert
Subject #8012-Preinfection,pert
untreated_6hr_rep4,ctrl
"cochlea at P3, wt, biological rep 2",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 23,pert
cell type: T cell;	treatment: 37C;	genotype: HSF1+/+;	genetic background: mixed 129Sv.BALB/c background,ctrl
Healthy-2 baseline,ctrl
age: 37;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
AT2_shG1_rep1,pert
Esophagus CTR replicate 2,ctrl
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 24 hrs;	Drug: No Rosiglitazone present,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: SCM,ctrl
"Sample Type: cells, Cell Line: ATCC 16 Lu , Cell Type: human lung fibroblasts, Harvest Time Point: 12 hours",ctrl
b86-,pert
"brain, cochlea",pert
"BOEC, normal 5",ctrl
"Immortalized MEFs WA, v-src expression retroviral vector infected, rep3",pert
gender: Female;	age: 71;	post-mortem delay: 13h;	ph: 6.3,ctrl
WT vehicle (7991003028_A),ctrl
USF1 replicate 3,pert
"lymphoblastoid cell line from T4.02, one out of seven of insensitive group, 50*10e6 cells",pert
Untreated Myd88 knockout - repeat 4 - mAdbID:102774,pert
umbilical cord tissue; low gestational age,pert
HeLa cells infected with control retrovirus,pert
"Patient 15, Macroscopically intact tissue",ctrl
VCaP/NC siRNA #3,ctrl
HCC_40T,pert
"heart, Q10, 6 months",pert
"SWR/J Saline treated, biological replicate 1",ctrl
NPC_VUB01_1,ctrl
"DBA/2J Acute morphine treated, biological replicate 3",pert
Thymuse,ctrl
ILD Study Number S035,ctrl
Run7.aUa.001206d.SkMInS1091D.CEL-IS stimulate,pert
MCF10A_HER2_2,pert
subject id: 33;	infection: DENV;	status: DF;	tissue: whole blood,pert
No or early 2 rep3 (retina),pert
ILD Study Number 1113,pert
"LKR13, knockdown of GFP by shRNA",ctrl
patient E1796,ctrl
HCT116-Neo124 PTEN +/+,pert
41SAGEA,pert
"Sfrp5 KO HFD 8 weeks, biological rep3",pert
breast cancer patient 274,pert
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 3,ctrl
2B1_empty_vector_replicate1,ctrl
microdissected breast cancer cells from case 868,ctrl
colon_epithelium_C57 mouse_12weeks_rep5,ctrl
8A;pretreatment;female;breast tumor,ctrl
KO - knock-out Treated - 12 hrs - repeat 2 - Cy5 - mAdbID:61760,pert
"T6 fetal heart (treated on gd14.5 via oral gavage, collected on gd17.5)",pert
PKBa-/- MEF time 24 replicate 3,pert
PTEN_2,pert
unstimulated(confluent)-1,ctrl
"111, ADIPOOSE TISSUE, Before",ctrl
MKK7D transgenic female replicate 13 late timepoint,pert
sMPNST cells with control shRNA induction,ctrl
"prdm-Rosi, biological rep1",pert
baseline control 07,ctrl
tissue: liver tissue;	disease state: adjacent non-tumorous,ctrl
tissue: Frontal cortex;	age: 91;	Sex: F,pert
Control subject 34_biological replicate 1,ctrl
"53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Healthy-4 baseline,ctrl
KO_TER119-_rep4,pert
db/db 11-2,pert
untreated-sample1,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.89;	age of onset: 17 yr,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days. . The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
FVB; No Treatment #7,ctrl
PFR3K650E_replicate_1,pert
"Wild type sham, biological rep3",ctrl
MLL_00119,ctrl
PEC control - replicate 1,ctrl
healthy myeloid cells 7,ctrl
"C57BL/6J-Il10tm1Cgn, sample 1",pert
"MCF-7 cells-control, biological rep 1",ctrl
Bc_p60_3,pert
heart from control mouse,ctrl
"human failing LV myocardium, Idiopathic59",pert
affected status (disease state): control;	gender: female;	age-at-examination: 47;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
CLL cells,pert
Tendon_non-lesional_rep15,ctrl
"Gender: female;	Age: 62;	Source: skin, hip",ctrl
"LSK (Lin-, Sca-1+, c-Kit+) cells sorted from Lkb1 KO bone marrow cells",pert
PsOEt-10-LS,ctrl
"patient: 202;	current medication: Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118;	birth date: 10/3/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/68;	diagnosis date: 1/1/69;	joint problems: TRUE;	uc flare up: TRUE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Polymyalgia rheumatica;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 45, stage IB2, HPV negative",pert
"brain, cerebellum: RNA#18_le1",pert
"Nickel 140 µM, biological rep2",pert
pooled reference mRNA from 4 harvests of ZR-75-1 cells,pert
S8C Sporadic-hippocampus,ctrl
"Biceps, FSHD, cohort 12, subject 12B",pert
"nTreg Foxo1 WT, rep1",ctrl
Gfp purified cell,ctrl
MOLM-14 cell line infected with GSK3B Construct 2 shRNA,pert
Striatum of 8-10 week old DBA/2J mice,ctrl
gender: female;	mean age: 41.3;	mean bmi: 28.9;	depot: abdomen;	type: white adipose tissue;	ethnicity: Caucasian,ctrl
"schizophrenia, BA46-92",pert
Retina wildtype 42 days 1,ctrl
BP patient 79_biological replicate 1,pert
"HeLa control, biological rep3",ctrl
Bone-Marrow_MM_M833,pert
Nonlesional Epithelium Psoriasis rep2,pert
PBMC from T cell LGL leukemia patient #112 (TLGL112),pert
45A;pretreatment;female;breast tumor,ctrl
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Testis_KO_rep2,pert
"Liposarcoma culture from tumor 337, doxorubicin treated",pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor High CD34 positive expressing bone marrow progenitors GMP",ctrl
"GSL30, PR04M008v0",pert
Run8.aUa.010615d.SkMInS1084D.CEL-IS basal,ctrl
jzo014-rp1-v5-u74av2-met,pert
"Crohn's Disease subject (42 year old black female, SAK_1287526311)",pert
MCF-10A shCHK2-2 replicate 2 [set 5],pert
"Crohn's Disease subject (29 year old caucasian female, SAK_1280865117)",pert
Control_liver_2,ctrl
3DKD_SerumStarved->1hrEGF_rep1,pert
MDA-MB-231 cells transfected with negative control,ctrl
MDS patient 183,pert
CA2 NoCre Sox17D,ctrl
uterus - Early secretory endometrium from patient with endometriosis,pert
KU_36T,pert
batch: B;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 7",ctrl
"Peripheral blood, normal control [N61]",ctrl
S2C Sporadic-hippocampus,ctrl
"SW480, ezrin RNAi",pert
Subject #8028-Preinfection,pert
1104_CNTL,ctrl
"Du145-PCAT1 NT siRNA, replicate 1",ctrl
Nrl-ko-Gfp 4 weeks retina replicate 1,ctrl
very advanced HCC,pert
normal with no hydrocortisone treatment-4,ctrl
MRF control Oligodendrocyte Replicate 3,ctrl
60A;pretreatment;female;breast tumor; responder,ctrl
"Control #1, Untreated",ctrl
RTX4 T0,ctrl
t15,pert
Colon cancer tumor (control),ctrl
mock-2,ctrl
patient E1532,ctrl
HUVEC_6h_rep2_1107,ctrl
"42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days; nonresponder",pert
"Vehicle treated,  doxycycline treated; biological replicate 2",pert
cell line: SKM-1,ctrl
MS patient 8,pert
"Tumor sample from patient with p53 wild type, replicate 2",ctrl
Rybp#10 (OHT-)_12d,ctrl
7 wt,ctrl
"NTera-2 cells negative control, biological replicate 1",ctrl
adult peripheral blood mononuclear cells after LPS-treatment,pert
H15_S_B1,ctrl
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E14.5 embryo;;	Gender: male;;	Tissue: whole brain,pert
MCF-10A shCHK2-1 replicate 2 [set 5],pert
strain: C57/Bl6;	gender: N/A;	age: 4 month;	weight: 25-30g;	tissue: whole trachea,ctrl
gender: Female;	tissue: Tendon;Subscapularis;	age: 64;	donor: 23;	disease state: Non-lesional,ctrl
3: FCHL patient #98-1405,pert
Liver_PXR KO_Vehicle_Rep1,pert
tissue type: normal thyroid;	matched/unmatched: matched to T14,ctrl
Control 15,ctrl
Patient 1 c,pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-jhdm1b retrovirus,pert
P1C Progranulin-hippocampus,pert
phenotype: alcoholic;	gender: male;	case_id: 330;	age: 53;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 59.5;	brain ph at time of freezing: 6.75;	labeling_batch: 2,pert
"Tibialis Anterior Muscle, Desmin Knockout, Adult",pert
MDS49,pert
Cre_day_5-4,pert
PBMC from T cell Large granular lymphocyte leukemia patient#107,pert
duration of untreated disease in month:2.2;	age at onset:7.2,pert
"A673 treated with Puromycin for 3 days with concentration of 0.09 uM (EC50), biological rep3",pert
strain: Wistar;	agent (mother exposed to): vehicle;	gender (pup): male;	age (pup): PND70;	tissue (pup): hypothalamus,ctrl
1061-03-A-b,pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 25;	Brain pH: 6.3;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Tumor from MYF-5 CRE/SSM2 mouse CC17-A,pert
PancreaticSample-Tumor,pert
gastrocnemius-30 months of age-control diet-biological replicate1,ctrl
cerebrum_PSNA_ 0d_rep1,pert
Diaphragm 14 day mdx rep 3,pert
"Tracheal explants, Control, 2hr",ctrl
control-1,ctrl
"t07, surgically resected from patient of gastric cancer.",pert
6 Etoh 2,pert
HMEC -EGF then refed EGF for 1.5hrs,ctrl
Weight:Low;	CFstatus:knockout;	Sex:Male,pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 7.4;	colon weight (mg): 161;	colon ratio (mg/mm): 2.18;	myeloperoxidase activity (u/mg): 0.014;	tissue: colon;	treatment: 5% DSS,ctrl
SeV 3658,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
"Atm+/+ 30 min post IR, B",pert
